Drug.Name,Synonyms,ChEMBL ID,IDs,referenced_datasets,MOA,repurposing_target,Indication,Disease Area,Phase(RepHub),merge_issues,Type,Phase(ChEMBL),SMILES,InChIKey
R(-)-APOMORPHINE,(R)-(-)-APOMORPHINE;R(-)-APOMORPHINE,,BRD:BRD-BRD-K76022557-003-02-7;BRD:BRD-K76022557-003-02-7,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C;CALY;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C;HTR5A,PARKINSON'S DISEASE,,LAUNCHED,"Multiple values for repurposing_target: {'ADRA2A;ADRA2B;ADRA2C;CALY;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C;HTR5A', 'DRD2;HTR5A'}, taking the union",,NA,"CN1CCC2CCCC-3C2C1CC1CCC(O)C(O)C-31, CN1CCC2CCCC-3C2[C@H]1CC1CCC(O)C(O)C-31, CN1CCC2CCCC-3C2[C@H]1CC1CCC(O)C(O)C-31",
ROLIPRAM-R(-),(R)-(-)-ROLIPRAM;ROLIPRAM-R(-),,BRD:BRD-BRD-K75516118-001-03-3;BRD:BRD-K75516118-001-03-3,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A;PDE4B;PDE4C;PDE4D;PDE5A,,,PRECLINICAL,,,NA,"COC1CCC(CC1OC1CCCC1)[C@@H]1CNC(=O)C1, COC1CCC(CC1OC1CCCC1)[C@@H]1CNC(=O)C1",
STX209,(R)-;(R)-BACLOFEN;ARBACLOFEN;BACLOFEN;BACLOFEN (R)-FORM;BACLOFEN-(R);D-BACLOFEN;R-;R-(-)-BACLOFEN;R(-)-;STX-209;STX209,CHEMBL301742,BRD:BRD-BRD-K62353271-001-04-7;BRD:BRD-K62353271-001-04-7,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABBR1;GABBR2,,,PRECLINICAL,,Small molecule,3,"NC[C@H](CC(=O)O)c1ccc(Cl)cc1;NC[C@H](CC(O)=O)C1CCC(CL)CC1, NC[C@H](CC(O)=O)C1CCC(CL)CC1",KPYSYYIEGFHWSV-QMMMGPOBSA-N
(RAC)-TAVAPADON,(RAC)-TAVAPADON,,BRD:BRD-K00090657-001-01-9,rep_single_dose,,,,,,,,NA,,
BIS(ETHYL)SPERMINE,"1,12-BESM;BIS(ETHYL)SPERMINE",CHEMBL18794,BRD:BRD-BRD-K04603573-376-01-3;BRD:BRD-K04603573-376-01-3,rep_primary;rep_single_dose,POLYAMINE BIOSYNTHESIS INHIBITOR,,,,PHASE 2,,Small molecule,NA,CCNCCCNCCCCNCCCNCC,PGMIWVSHZMWSSI-UHFFFAOYSA-N
"1,3-DIPROPYL-8-PHENYLXANTHINE","1,3-DIPROPYL-8-PHENYLXANTHINE",,BRD:BRD-BRD-K41853443-001-02-9;BRD:BRD-K41853443-001-02-9,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,CCCN1C2[NH]C(NC2C(=O)N(CCC)C1=O)-C1CCCCC1,
"BUTANE-1,4-DIOL","1,4-BUTANEDIOL;BUTANE-1,4-DIOL",CHEMBL171623,BRD:BRD-K22346679-001-06-3,rep_single_dose,"BENZODIAZEPINE RECEPTOR AGONIST, GAMMA HYDROXYBUTYRIC ACID AGONIST",MAN1B1;PLA2G2A;PLA2G2E,,,,,Small molecule,NA,OCCCCO,WERYXYBDKMZEQL-UHFFFAOYSA-N
"1,5-DICAFFEOYLQUINIC-ACID","1,5-DICAFFEOYLQUINIC-ACID",,BRD:BRD-BRD-K53083666-001-01-0;BRD:BRD-K53083666-001-01-0,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,O[C@@H]1C[C@@](C[C@@H](OC(=O)\C=C\C2CCC(O)C(O)C2)[C@@H]1O)(OC(=O)\C=C\C1CCC(O)C(O)C1)C(O)=O,
"1-((Z)-3-CHLOROALLYL)-1,3,5,7-TETRAAZAADAMANTAN-1-IUM","1-((Z)-3-CHLOROALLYL)-1,3,5,7-TETRAAZAADAMANTAN-1-IUM",,BRD:BRD-BRD-K88956297-003-01-9;BRD:BRD-K88956297-003-01-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CL\C=C/C[N+]12CN3CN(CN(C3)C1)C2,
"1-(1,2-DIPHENYLETHYL)PIPERIDINE-(+/-)","1-(1,2-DIPHENYLETHYL)PIPERIDINE-(+/-)",,BRD:BRD-A86415025-050-01-0;BRD:BRD-BRD-A86415025-050-01-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,C(C(N1CCCCC1)C1CCCCC1)C1CCCCC1,
1-ACETYL-4-METHYLPIPERAZINE,1-ACETYL-4-METHYLPIPERAZINE,,BRD:BRD-BRD-K96055017-003-02-7;BRD:BRD-K96055017-003-02-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,CN1CCN(CC1)C(C)=O,
1-AZAKENPAULLONE,1-AZAKENPAULLONE,,BRD:BRD-BRD-K03273112-001-01-8;BRD:BRD-K03273112-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,CCNB1;CDK1;CDK5;GSK3B,,,PRECLINICAL,,,NA,BRC1CCC2[NH]C-3C(CC(=O)NC4CCCNC-34)C2C1,
DEOXYMANNOJIRIMYCIN,1-DEOXYMANNOJIRIMYCIN;DEOXYMANNOJIRIMYCIN,CHEMBL84844,BRD:BRD-BRD-K89665618-003-02-5;BRD:BRD-K89665618-003-02-5,rep_primary;rep_single_dose,ALPHA MANNOSIDASE INHIBITOR,MAN2A1,,,PRECLINICAL,,Small molecule,NA,OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O,LXBIFEVIBLOUGU-KVTDHHQDSA-N
1-EBIO,1-EBIO,,BRD:BRD-BRD-K70586315-001-02-4;BRD:BRD-K70586315-001-02-4,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNN1;KCNN2;KCNN3;KCNN4,,,PRECLINICAL,,,NA,"CCN1C2CCCCC2[NH]C1=O, CCN1C2CCCCC2[NH]C1=O",
1-ETHYL-2-PYRROLIDONE,1-ETHYL-2-PYRROLIDONE,,BRD:BRD-BRD-K08288352-001-03-6;BRD:BRD-K08288352-001-03-6,rep_primary;rep_single_dose,TRANSDERMAL ABSORPTION-ENHANCING COMPOUND,,,,PRECLINICAL,,,NA,CCN1CCCC1=O,
1-HEXADECANOL,1-HEXADECANOL,,BRD:BRD-BRD-K37203094-001-02-5;BRD:BRD-K37203094-001-02-5,rep_primary;rep_single_dose,,,COSMETIC,,LAUNCHED,,,NA,"CCCCCCCCCCCCCCCCO, CCCCCCCCCCCCCCCCO",
1-NAPHTHYL-PP1,1-NAPHTHYL-PP1,,BRD:BRD-BRD-K29542628-001-03-9;BRD:BRD-K29542628-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,SRC INHIBITOR,SRC,,,PRECLINICAL,,,NA,"CC(C)(C)N1NC(-C2CCCC3CCCCC23)C2C(N)NCNC12, CC(C)(C)N1NC(-C2CCCC3CCCCC23)C2C(N)NCNC12",
1-OCTANOL,1-OCTANOL,,BRD:BRD-BRD-K09338665-001-07-1;BRD:BRD-K09338665-001-07-1,rep_primary;rep_single_dose,,GJA1;GJA10;GJA3;GJA4;GJA5;GJA8;GJA9;GJB1;GJB2;GJB3;GJB4;GJB5;GJB6;GJB7;GJC1;GJC2;GJC3;GJD2;GJD3;GJD4;GJE1,,,PHASE 2,,,NA,"CCCCCCCCO, CCCCCCCCO",
1-PHENYLBIGUANIDE,1-PHENYLBIGUANIDE,,BRD:BRD-BRD-K31491153-003-05-9;BRD:BRD-K31491153-003-05-9,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR3A;HTR3B,,,PRECLINICAL,,,NA,NC(=N)NC(=N)NC1CCCCC1,
10-DEACETYLBACCATIN,10-DEACETYLBACCATIN,,BRD:BRD-BRD-K96631475-001-02-4;BRD:BRD-BRD-K96631475-001-04-0;BRD:BRD-K96631475-001-02-4;BRD:BRD-K96631475-001-04-0,rep_multi_dose;rep_primary;rep_single_dose,ANTITUMOR AGENT,,,,PRECLINICAL,,,NA,"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2CCCCC2)[C@]2(O)C[C@H](O)C(C)=C([C@@H](O)C1=O)C2(C)C, CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2CCCCC2)[C@]2(O)C[C@H](O)C(C)=C([C@@H](O)C1=O)C2(C)C, CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2CCCCC2)[C@]2(O)C[C@H](O)C(C)=C([C@@H](O)C1=O)C2(C)C",
10-DEBC,10-DEBC,,BRD:BRD-BRD-K70792160-003-04-6;BRD:BRD-K70792160-003-04-6,rep_primary;rep_single_dose,AKT INHIBITOR,PIM1,,,PRECLINICAL,,,NA,"CCN(CC)CCCCN1C2CCCCC2OC2CCC(CL)CC12, CCN(CC)CCCCN1C2CCCCC2OC2CCC(CL)CC12",
NSC-107124,(S)-10-HYDROXYCAMPTOTHECIN;10-HCPT;10-HYDROXY CAMPTOTHECIN;10-HYDROXY-CAMPTOTHECIN;10-HYDROXYCAMPTOTHECIN;10-HYDROXYCAMPTOTHECINE;HYDROXYCAMPTOTHECIN;IRINOTECAN RELATED COMPOUND A;NSC-107124,CHEMBL273862,BRD:BRD-BRD-K63784565-001-06-2;BRD:BRD-K63784565-001-06-2,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,PRECLINICAL,,Small molecule,3,"CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCC(O)CC4CC3CN1C2=O, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCC(O)CC4CC3CN1C2=O;CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(O)ccc3nc2-1",HAWSQZCWOQZXHI-FQEVSTJZSA-N
10058-F4,10058-F4,,BRD:BRD-BRD-K49460120-001-02-5;BRD:BRD-K49460120-001-02-5,rep_primary;rep_single_dose,C-MYC INHIBITOR,,,,PRECLINICAL,,,NA,"CCC1CCC(CC1)\C=C1\SC(=S)NC1=O, CCC1CCC(CC1)\C=C1\SC(=S)NC1=O, CCC1CCC(CC1)\C=C1\SC(=S)NC1=O",
1035270-39-3,1035270-39-3,,GDSC2:1786,gdsc,,,,,,,,NA,,
12-O-TETRADECANOYLPHORBOL-13-ACETATE,12-O-TETRADECANOYLPHORBOL-13-ACETATE,,BRD:BRD-BRD-K68552125-001-05-3;BRD:BRD-K68552125-001-05-3,rep_multi_dose;rep_primary;rep_single_dose,PKC ACTIVATOR,KCNT2;TRPV4,,,PHASE 2,,,NA,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@]2(O)[C@@H]3C=C(C)C(=O)[C@@]3(O)CC(CO)=C[C@H]2[C@@H]2C(C)(C)[C@]12OC(C)=O,
1400W,1400W,CHEMBL107251,BRD:BRD-BRD-K30237152-300-02-5;BRD:BRD-K30237152-300-02-5,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS1;NOS2;NOS3,,,PRECLINICAL,,Small molecule,NA,CC(=N)NCc1cccc(CN)c1;CC(=N)NCC1CCCC(CN)C1,RODUKNYOEVZQPR-UHFFFAOYSA-N
"16,16-DIMETHYLPROSTAGLANDIN-E2","16,16-DIMETHYLPROSTAGLANDIN-E2",,BRD:BRD-BRD-K92301463-001-05-5;BRD:BRD-K92301463-001-05-5,rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,HPGD,,,PHASE 2,,,NA,CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,
16-BETA-BROMOANDROSTERONE,16-BETA-BROMOANDROSTERONE,,CTRP:411726,ctrp,,,,,,,,NA,,
17-ALPHA-METHYLTESTOSTERONE,17-ALPHA-METHYLTESTOSTERONE,,BRD:BRD-BRD-K84036904-001-08-8;BRD:BRD-K84036904-001-08-8,rep_primary;rep_single_dose,AROMATASE INHIBITOR,AR,,,LAUNCHED,,,NA,"C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C, C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C",
17-HYDROXYPROGESTERONE-CAPROATE,17-HYDROXYPROGESTERONE-CAPROATE,,BRD:BRD-A29731977-001-04-5;BRD:BRD-BRD-A29731977-001-04-5,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,AR;ESR1;ESR2;NR1H4;NR1I2;NR3C1;PGR,,,LAUNCHED,,,NA,CCCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O,
17-PA,17-PA,,BRD:BRD-K07395323-001-02-9,rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,,,,,,,NA,,
1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE OXIME;1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME,,BRD:BRD-A37752546-001-01-9;BRD:BRD-A37752546-001-02-9;BRD:BRD-BRD-A37752546-001-01-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCCCCCCCCCCC([N+][O-])C1CC(C)CCC1O,
"1S,2R-PHENYLPROPANOLAMINE","1S,2R-PHENYLPROPANOLAMINE",,BRD:BRD-BRD-K27853494-003-04-7;BRD:BRD-K27853494-003-04-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA2A;ADRB1;ADRB2;DRD1,,,WITHDRAWN,,,NA,C[C@@H](N)[C@@H](O)C1CCCCC1,
"1S,3R-RSL-3","1S,3R-RSL-3",,CTRP:609060,ctrp,,,,,,,,NA,,
2'-C-METHYLGUANOSINE,2'-C-METHYLGUANOSINE,,BRD:BRD-BRD-K78092779-001-01-6;BRD:BRD-K78092779-001-01-6,rep_primary;rep_single_dose,HCV INHIBITOR,,,,PRECLINICAL,,,NA,C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1N1CNC2C(O)NC(N)NC12,
2'-MECCPA,2'-MECCPA,,BRD:BRD-BRD-K63932022-001-01-5;BRD:BRD-K63932022-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1,,,PRECLINICAL,,,NA,"C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1N1CNC2C(NC3CCCC3)NC(CL)NC12, C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1N1CNC2C(NC3CCCC3)NC(CL)NC12",
"2,3-DCPE","2,3-DCPE",,BRD:BRD-BRD-K61734568-003-02-1;BRD:BRD-K61734568-003-02-1,rep_multi_dose;rep_primary;rep_single_dose,BCL-XL DOWNREGULATOR,BCL2L1,,,PRECLINICAL,,,NA,OCCNCCCOC1CCCC(CL)C1CL,
"2,4-DIHYDROXYPYRIMIDINE-5-CARBOXYLIC ACID","2,4-DIHYDROXYPYRIMIDINE-5-CARBOXYLIC ACID",,BRD:BRD-K00078070-001-02-9,rep_single_dose,,,,,,,,NA,,
SR-1C5,".ALPHA.-DINITROPHENOL;2,4-DINITROPHENOL;ALDIFEN;CHEMOX;DINITROPHENOL;DINOFAN;FENOXYL CARBON N;MITCAL;MP-101;NITROPHEN;NITROPHENE;NSC-1532;SR-1C5",CHEMBL273386,BRD:BRD-BRD-K21910317-001-12-3;BRD:BRD-K21910317-001-12-3,rep_primary;rep_single_dose,ATP SYNTHASE INHIBITOR,APP,,,PRECLINICAL,,Small molecule,2,O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1;OC1CCC(CC1[N+]([O-])=O)[N+]([O-])=O,UFBJCMHMOXMLKC-UHFFFAOYSA-N
NSC-63890,"2,6-DIMETHYLPIPERIDINE;NANIOPINE;NANOFIN;NSC-63890",CHEMBL2104431,BRD:BRD-A21276153-001-01-1;BRD:BRD-BRD-A21276153-001-01-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CC1CCCC(C)N1,SDGKUVSVPIIUCF-UHFFFAOYSA-N
2-(3-MERCAPTOPROPYL)PENTANEDIOIC-ACID,2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID;2-(3-MERCAPTOPROPYL)PENTANEDIOIC-ACID,,BRD:BRD-A66788520-001-01-7;BRD:BRD-BRD-A66788520-001-01-7,rep_primary;rep_single_dose,GLUTAMATE CARBOXYPEPTIDASE INHIBITOR,FOLH1,,,PHASE 1,,,NA,OC(=O)CCC(CCCS)C(O)=O,
2-AMINOBENZENESULFONAMIDE,2-AMINOBENZENESULFONAMIDE,,BRD:BRD-BRD-K32681104-001-11-6;BRD:BRD-K32681104-001-11-6,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA12;CA14;CA2;CA6;CA9,,,PRECLINICAL,,,NA,NC1CCCCC1S(N)(=O)=O,
2-BENZYL-4-CHLOROPHENOL,2-BENZYL-4-CHLOROPHENOL,,BRD:BRD-K83982397-001-06-9,rep_single_dose,,,,,,,,NA,,
2-BFI,2-BFI,,BRD:BRD-BRD-K22745370-003-02-3;BRD:BRD-K22745370-003-02-3,rep_primary;rep_single_dose,IMIDAZOLINE RECEPTOR LIGAND,ADRA2A;ADRA2B;ADRA2C;MAOA;MAOB,,,PRECLINICAL,,,NA,C1CN=C(N1)C1CC2CCCCC2O1,
2-CHLORO-N6-CYCLOPENTYLADENOSINE,2-CHLORO-N6-CYCLOPENTYLADENOSINE,,BRD:BRD-BRD-K70088346-001-01-6;BRD:BRD-K70088346-001-01-6,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,,,NA,"OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(NC3CCCC3)NC(CL)NC12, OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(NC3CCCC3)NC(CL)NC12",
2-CHLOROADENOSINE,2-CHLOROADENOSINE,,BRD:BRD-BRD-K79511609-001-20-0;BRD:BRD-K79511609-001-20-0,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B,,,PRECLINICAL,,,NA,NC1NC(CL)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
2-CHLOROPYRAZINE,2-CHLOROPYRAZINE,,BRD:BRD-BRD-K84075000-001-05-5;BRD:BRD-K84075000-001-05-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CLC1CNCCN1,
2-CMDO,2-CMDO,,BRD:BRD-BRD-K92588747-051-02-7;BRD:BRD-K92588747-051-02-7,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD4,,,PRECLINICAL,,,NA,CN1CCN(CC1)C1=CC2CCCCC2OC2CCC(CL)CC12,
2-CYANOPYRIMIDINE,2-CYANOPYRIMIDINE,,BRD:BRD-BRD-K95015809-001-02-8;BRD:BRD-K95015809-001-02-8,rep_primary;rep_single_dose,CATHEPSIN INHIBITOR,,,,PRECLINICAL,,,NA,N#CC1NCCCN1,
2-DEOXYGLUCOSE,2-DEOXYGLUCOSE,,BRD:BRD-BRD-K97808269-001-02-7;BRD:BRD-K97808269-001-02-7,rep_primary;rep_single_dose,GLYCOLYSIS INHIBITOR,SLC2A1;SLC2A2;SLC2A3;SLC2A4,,,PHASE 2,,,NA,OC[C@H]1O[C@H](O)C[C@@H](O)[C@@H]1O,
2-ETHOXYBENZOIC-ACID,2-ETHOXYBENZOIC-ACID,,BRD:BRD-BRD-K04843302-001-02-5;BRD:BRD-K04843302-001-02-5,rep_primary;rep_single_dose,ANALGESIC AGENT,,,,PHASE 1,,,NA,CCOC1CCCCC1C(O)=O,
"2-ETHYL-1,3-HEXANEDIOL","2-ETHYL-1,3-HEXANEDIOL",,BRD:BRD-A55455283-001-01-3;BRD:BRD-BRD-A55455283-001-01-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"CCCC(O)C(CC)CO, CCCC(O)C(CC)CO",
2-ETHYLHEXYL 4-(DIMETHYLAMINO)BENZOATE,2-ETHYLHEXYL 4-(DIMETHYLAMINO)BENZOATE,,BRD:BRD-A49924714-001-08-9,rep_single_dose,,,,,,,,NA,,
2-FLUORO-2-DEOXY-D-GALACTOSE,2-FLUORO-2-DEOXY-D-GALACTOSE,,BRD:BRD-A53037300-001-01-0;BRD:BRD-BRD-A53037300-001-01-0,rep_primary;rep_single_dose,,LCT,,,PHASE 1,,,NA,OCC1OC(O)C(F)C(O)C1O,
SGN-2FF,2-FLUOROFUCOSE;SGN-2FF,CHEMBL4297429,BRD:BRD-K00004677-001-01-9,rep_single_dose,,,,,,,Small molecule,1,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](F)C=O,SQTFKIKSQNCWGJ-KCDKBNATSA-N
2-HYDROXYETHYL-SALICYLATE,2-HYDROXYETHYL-SALICYLATE,,BRD:BRD-BRD-K41866823-001-01-3;BRD:BRD-K41866823-001-01-3,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,OCCOC(=O)C1CCCCC1O,
HYDROXYFLUTAMIDE,.ALPHA.-HYDROXYFLUTAMIDE;2-HYDROXYFLUTAMIDE;HYDROXY-FLUTAMIDE;HYDROXYFLUTAMIDE,CHEMBL491,BRD:BRD-BRD-K82027074-001-07-5;BRD:BRD-K82027074-001-07-5,rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AR,,,PHASE 1/PHASE 2,,Small molecule,2,"CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1;CC(C)(O)C(=O)NC1CCC(C(C1)C(F)(F)F)[N+]([O-])=O, CC(C)(O)C(=O)NC1CCC(C(C1)C(F)(F)F)[N+]([O-])=O",YPQLFJODEKMJEF-UHFFFAOYSA-N
2-HYDROXYSACLOFEN,2-HYDROXYSACLOFEN,,BRD:BRD-A27924917-001-03-3;BRD:BRD-BRD-A27924917-001-03-3,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABBR1;GABBR2,,,PRECLINICAL,,,NA,NCC(O)(CS(O)(=O)=O)C1CCC(CL)CC1,
GUANIDINOBIOTIN,2-IMINOBIOTIN;GUANIDINOBIOTIN,CHEMBL1233598,BRD:BRD-BRD-K07954936-001-01-3;BRD:BRD-K07954936-001-01-3,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS1;NOS2,,,PHASE 2,,Small molecule,2,N=C1N[C@H]2[C@H](CS[C@H]2CCCCC(=O)O)N1;OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12,WWVANQJRLPIHNS-ZKWXMUAHSA-N
2-IODOHIPPURIC-ACID,2-IODOHIPPURIC-ACID,,BRD:BRD-BRD-K56634222-001-03-0;BRD:BRD-K56634222-001-03-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC(=O)CNC(=O)C1CCCCC1I,
2-IODOMELATONIN,2-IODOMELATONIN,,BRD:BRD-BRD-K25649279-001-02-0;BRD:BRD-K25649279-001-02-0,rep_primary;rep_single_dose,MELATONIN RECEPTOR AGONIST,MTNR1A;MTNR1B;NQO2,,,PRECLINICAL,,,NA,COC1CCC2[NH]C(I)C(CCNC(C)=O)C2C1,
NSC-659853,2-METHOXYESTRADIOL;2-METHOXYOESTRADIOL;NSC-659853,CHEMBL299613,BRD:BRD-BRD-K44408410-001-17-6;BRD:BRD-K44408410-001-17-6,rep_multi_dose;rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,COMT;CYP19A1;CYP1A1;CYP1B1;HIF1A;TUBB,,,PHASE 2,,Small molecule,2,"COC1CC2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2CC1O, COC1CC2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2CC1O, COC1CC2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2CC1O;COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12",CQOQDQWUFQDJMK-SSTWWWIQSA-N
2-METHYL-5-HYDROXYTRYPTAMINE,2-METHYL-5-HYDROXYTRYPTAMINE,,BRD:BRD-BRD-K64137799-003-02-5;BRD:BRD-K64137799-003-02-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1B;HTR1D;HTR1E;HTR1F;HTR3A;HTR3B;HTR6,,,PRECLINICAL,,,NA,"CC1[NH]C2CCC(O)CC2C1CCN, CC1[NH]C2CCC(O)CC2C1CCN",
2-METHYLIMIDAZOLE,2-METHYLIMIDAZOLE,,BRD:BRD-K68534611-001-07-8,rep_single_dose,CHOLESTEROL INHIBITOR,,,,,,,NA,,
2-OCTYLDODECAN-1-OL,2-OCTYLDODECAN-1-OL,,BRD:BRD-A51407134-001-01-9;BRD:BRD-BRD-A51407134-001-01-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"CCCCCCCCCCC(CO)CCCCCCCC, CCCCCCCCCCC(CO)CCCCCCCC",
2-OLEOYLGLYCEROL,2-OLEOYLGLYCEROL,,BRD:BRD-BRD-K77087341-001-02-4;BRD:BRD-K77087341-001-02-4,rep_primary;rep_single_dose,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR LIGAND,GPR119,,,PHASE 1,,,NA,CCCCCCCC\C=C/CCCCCCCC(=O)OC(CO)CO,
2-OXOGLUTARIC-ACID,2-OXOGLUTARIC-ACID,,BRD:BRD-BRD-K89712525-001-02-1;BRD:BRD-K89712525-001-02-1,rep_primary;rep_single_dose,,OXGR1,,,PRECLINICAL,,,NA,OC(=O)CCC(=O)C(O)=O,
2-PHENYLMELATONIN,2-PHENYLMELATONIN,,BRD:BRD-BRD-K41869275-001-02-8;BRD:BRD-K41869275-001-02-8,rep_primary;rep_single_dose,MELATONIN RECEPTOR AGONIST,MTNR1A;MTNR1B,,,PRECLINICAL,,,NA,"COC1CCC2[NH]C(C(CCNC(C)=O)C2C1)-C1CCCCC1, COC1CCC2[NH]C(C(CCNC(C)=O)C2C1)-C1CCCCC1",
2-PMDQ,2-PMDQ,,BRD:BRD-A04661934-001-02-9;BRD:BRD-BRD-A04661934-001-02-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A,,,PRECLINICAL,,,NA,O=C1NC2CCCCC2C2=NC(CN3CCN(CC3)C3CCCCC3)CN12,
2-PYRIDYLETHYLAMINE,2-PYRIDYLETHYLAMINE,,BRD:BRD-BRD-K17874705-300-03-2;BRD:BRD-K17874705-300-03-2,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH1,,,PRECLINICAL,,,NA,"NCCC1CCCCN1, NCCC1CCCCN1",
2-TEDC,2-TEDC,,BRD:BRD-BRD-K89072800-001-01-8;BRD:BRD-K89072800-001-01-8,rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX12,,,PRECLINICAL,,,NA,OC1CCC(\C=C(/C#N)C(=O)OCCC2CCCS2)CC1O,
2-THIOURACIL,2-THIOURACIL,,BRD:BRD-BRD-K58819470-001-05-9;BRD:BRD-K58819470-001-05-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"OC1CCNC(S)N1, OC1CCNC(S)N1",
2-[1-(4-PIPERONYL)PIPERAZINYL]BENZOTHIAZOLE,2-[1-(4-PIPERONYL)PIPERAZINYL]BENZOTHIAZOLE,,BRD:BRD-BRD-K91868854-001-03-6;BRD:BRD-K91868854-001-03-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR4,,,PRECLINICAL,,,NA,C(N1CCN(CC1)C1NC2CCCCC2S1)C1CCC2OCOC2C1,
20-HETE,20-HETE,,BRD:BRD-K00005345-001-01-9,rep_single_dose,ION CHANNEL ANTAGONIST,,,,,,,NA,,
VITICOSTERONE,20-HYDROXY-.ALPHA.-ECDYSONE;20-HYDROXYECDYSON;20-HYDROXYECDYSONE;BETA-ECDYSONE;BIO 101;BIO-101;BIO101;COMMISTERONE;CRUSTECDYSON;CRUSTECDYSONE;ECDYSTEN;ECDYSTERON;ECDYSTERONE;EKDISTEN;ISOINOKOSTERONE;NSC-629484;POLYPODIN A;POLYPODIN C;POLYPODINE A;POLYPODINE C;THE-7;VITICOSTERONE,CHEMBL224128,BRD:BRD-BRD-K28343777-001-01-6;BRD:BRD-K28343777-001-01-6,rep_primary;rep_single_dose,ECDYSONE RECEPTOR MODULATOR,,,,PRECLINICAL,,Small molecule,2,CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@@H]3CC[C@]12C;CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C,NKDFYOWSKOHCCO-YPVLXUMRSA-N
3'-FLUOROBENZYLSPIPERONE,3'-FLUOROBENZYLSPIPERONE,,BRD:BRD-BRD-K45662124-050-01-5;BRD:BRD-K45662124-050-01-5,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR LIGAND,DRD2,,,PRECLINICAL,,,NA,"FC1CCC(CC1)C(=O)CCCN1CCC2(CC1)N(CN(CC1CCCC(F)C1)C2=O)C1CCCCC1, FC1CCC(CC1)C(=O)CCCN1CCC2(CC1)N(CN(CC1CCCC(F)C1)C2=O)C1CCCCC1",
"3,3'-DICHLOROBENZALDAZINE","3,3'-DICHLOROBENZALDAZINE",,BRD:BRD-BRD-K82903013-001-01-4;BRD:BRD-K82903013-001-01-4,rep_primary;rep_single_dose,"GLUTAMATE RECEPTOR ALLOSTERIC LIGAND, GLUTAMATE RECEPTOR MODULATOR",GRM5,,,PRECLINICAL,"Multiple values for MOA: {'GLUTAMATE RECEPTOR ALLOSTERIC LIGAND', 'GLUTAMATE RECEPTOR ALLOSTERIC LIGAND, GLUTAMATE RECEPTOR MODULATOR'}, defaulting to 'GLUTAMATE RECEPTOR ALLOSTERIC LIGAND, GLUTAMATE RECEPTOR MODULATOR'",,NA,CLC1CCCC(C1)\C=N\N=C\C1CCCC(CL)C1,
"3,3'-DIINDOLYLMETHANE","3,3'-DIINDOLYLMETHANE",,BRD:BRD-BRD-K37846922-001-09-4;BRD:BRD-K37846922-001-09-4,rep_primary;rep_single_dose,"CHK INHIBITOR, CYTOCHROME P450 ACTIVATOR, INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",AR;HIF1A;IFNG;PI3,,,PHASE 3,,,NA,C(C1C[NH]C2CCCCC12)C1C[NH]C2CCCCC12,
"3,4-DCPG-(R)","3,4-DCPG-(R)",,BRD:BRD-K06204668-001-03-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,,,,NA,,
"3,5-DHPG-(S)","3,5-DHPG-(S)",,BRD:BRD-K57796080-001-04-9,rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM1,,,,,,NA,,
3-(4-METHYLBENZYLIDENE)CAMPHOR,3-(4-METHYLBENZYLIDENE)CAMPHOR,,BRD:BRD-A55464252-001-01-2;BRD:BRD-BRD-A55464252-001-01-2,rep_primary;rep_single_dose,ENDOCRINE DISRUPTOR,,SUNSCREEN LOTION,,LAUNCHED,,,NA,CC1CCC(CC1)\C=C1\C2CCC(C)(C1=O)C2(C)C,
3-ALPHA-BIS-(4-FLUOROPHENYL)-METHOXYTROPANE,3-ALPHA-BIS-(4-FLUOROPHENYL)-METHOXYTROPANE,,BRD:BRD-A85216385-003-02-4;BRD:BRD-BRD-A85216385-003-02-4,rep_primary;rep_single_dose,DOPAMINE UPTAKE INHIBITOR,CHRM1;SLC6A2;SLC6A3;SLC6A4,,,PRECLINICAL,,,NA,CN1C2CCC1CC(C2)OC(C1CCC(F)CC1)C1CCC(F)CC1,
3-ALPHA-HYDROXY-5-BETA-ANDROSTAN-17-ONE,3-ALPHA-HYDROXY-5-BETA-ANDROSTAN-17-ONE,,BRD:BRD-A43598550-001-09-4;BRD:BRD-BRD-A43598550-001-09-4,rep_primary;rep_single_dose,,HSD17B11;IGHG2;SULT2A1,,,PRECLINICAL,,,NA,C[C@]12CCC3[C@@H](CC[C@@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O,
3-AMINO-BENZAMIDE,3-AMINO-BENZAMIDE,,BRD:BRD-BRD-K08703257-001-12-1;BRD:BRD-K08703257-001-12-1;BRD:BRD-K08703257-001-13-9,rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,PARP1,,,PHASE 2,,,NA,"NC(=O)C1CCCC(N)C1, NC(=O)C1CCCC(N)C1",
3-AQC,3-AQC,,BRD:BRD-BRD-K38370968-050-01-3;BRD:BRD-K38370968-050-01-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR3A,,,PRECLINICAL,,,NA,C=CCN1CCN(CC1)C1NC2CCCCC2NC1C#N,
3-BROMO-7-NITROINDAZOLE,3-BROMO-7-NITROINDAZOLE,,BRD:BRD-BRD-K24689407-001-06-3;BRD:BRD-K24689407-001-06-3,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS1;NOS2;NOS3,,,PRECLINICAL,,,NA,"[O-][N+](=O)C1CCCC2C(BR)N[NH]C12, [O-][N+](=O)C1CCCC2C(BR)N[NH]C12",
3-BROMOPYRUVATE,3-BROMOPYRUVATE,,BRD:BRD-BRD-K92980438-001-03-3;BRD:BRD-K92980438-001-03-3,rep_primary;rep_single_dose,HEXOKINASE INHIBITOR,HK2,,,PRECLINICAL,,,NA,"OC(=O)C(=O)CBR, OC(=O)C(=O)CBR, OC(=O)C(=O)CBR",
3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(R),3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(R),,BRD:BRD-BRD-K76592088-001-02-1;BRD:BRD-K76592088-001-02-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C,,,PRECLINICAL,,,NA,N[C@@H](C(O)=O)C1CCC(O)C(C1)C(O)=O,
3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(S),3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(S),,BRD:BRD-BRD-K61585876-001-01-0;BRD:BRD-K61585876-001-01-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM1;GRM5,,,PRECLINICAL,,,NA,N[C@H](C(O)=O)C1CCC(O)C(C1)C(O)=O,
3-CL-AHPC,3-CL-AHPC,,CTRP:660796,ctrp,,,,,,,,NA,,
3-CPMT,3-CPMT,,BRD:BRD-A51713165-003-02-6;BRD:BRD-BRD-A51713165-003-02-6,rep_primary;rep_single_dose,DOPAMINE REUPTAKE INHIBITOR,,,,PRECLINICAL,,,NA,CN1C2CCC1CC(C2)OC(C1CCCCC1)C1CCC(CL)CC1,
3-DEAZAADENOSINE,3-DEAZAADENOSINE,,BRD:BRD-A79431551-001-01-1;BRD:BRD-BRD-A79431551-001-01-1,rep_primary;rep_single_dose,ADENOSYLHOMOCYSTEINASE INHIBITOR,AHCY,,,PHASE 2,,,NA,NC1NCCC2N(CNC12)[C@@H]1O[C@H](CO)C(O)C1O,
3-DEAZANEPLANOCIN-A,3-DEAZANEPLANOCIN-A,,BRD:BRD-BRD-K77791657-001-01-1;BRD:BRD-BRD-K77791657-003-01-7;BRD:BRD-K77791657-001-01-1;BRD:BRD-K77791657-003-01-7,rep_multi_dose;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,PRECLINICAL,,,NA,"NC1NCCC2N(CNC12)[C@@H]1C=C(CO)[C@@H](O)[C@H]1O, NC1NCCC2N(CNC12)[C@@H]1C=C(CO)[C@@H](O)[C@H]1O",
3-DEAZAURIDINE,3-DEAZAURIDINE,,BRD:BRD-A26105646-001-06-1;BRD:BRD-BRD-A26105646-001-06-1,rep_primary;rep_single_dose,CYTIDINE DEAMINASE INHIBITOR,,,,PRECLINICAL,,,NA,OCC1OC(C(O)C1O)N1C=CC(=O)CC1=O,
3-HYDROXY-3-PHENYLPENTANAMIDE,3-HYDROXY-3-PHENYLPENTANAMIDE,,BRD:BRD-A66143912-001-01-1;BRD:BRD-BRD-A66143912-001-01-1,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,,,,PHASE 1,,,NA,CCC(O)(CC(N)=O)C1CCCCC1,
3-INDOLEBUTYRIC-ACID,3-INDOLEBUTYRIC-ACID,,BRD:BRD-BRD-K43187796-001-02-3;BRD:BRD-K43187796-001-02-3,rep_primary;rep_single_dose,,B2M;HLA-A;TRAC;TRBC1,,,PRECLINICAL,,,NA,OC(=O)CCCC1C[NH]C2CCCCC12,
3-MATIDA,3-MATIDA,,BRD:BRD-A87125127-001-03-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM1,,,,,,NA,,
3-METHYL-GABA,3-METHYL-GABA,,BRD:BRD-K01825682-074-02-9,rep_single_dose,GABA AMINOTRANSFERASE ACTIVATOR,ABAT,,,,,,NA,,
3-METHYLADENINE,3-METHYLADENINE,CHEMBL292268,BRD:BRD-BRD-K81647657-001-04-3;BRD:BRD-K81647657-001-04-3,rep_primary;rep_single_dose,PI3K INHIBITOR,PI3,,,PRECLINICAL,,Small molecule,NA,"CN1CNC(=N)C2NC[NH]C12, CN1CNC(=N)C2NC[NH]C12;Cn1cnc(N)c2ncnc1-2",FSASIHFSFGAIJM-UHFFFAOYSA-N
3-MPPI,3-MPPI,,BRD:BRD-BRD-K62581435-001-03-8;BRD:BRD-K62581435-001-03-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR LIGAND,ADRA1A,,,PRECLINICAL,,,NA,COC1CCCCC1N1CCN(CCN2C(=O)[NH]C3C4CCCCC4[NH]C3C2=O)CC1,
3PO,3PO,,BRD:BRD-K58413118-001-01-8,rep_single_dose,PHOSPHOFRUCTOKINASE INHIBITOR,PFKFB3,,,,,,NA,,
"4,4-PENTAMETHYLENEPIPERIDINE","4,4-PENTAMETHYLENEPIPERIDINE",,BRD:BRD-BRD-K49545903-003-01-4;BRD:BRD-K49545903-003-01-4,rep_primary;rep_single_dose,M2 CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,C1CCC2(CC1)CCNCC2,
"4,5,6,7-TETRABROMOBENZOTRIAZOLE","4,5,6,7-TETRABROMOBENZOTRIAZOLE",,BRD:BRD-BRD-K97118047-001-03-8;BRD:BRD-K97118047-001-03-8,rep_primary;rep_single_dose,CASEIN KINASE INHIBITOR,AKT1;CHEK1;CSNK2A1;GSK3B;LCK;MAP2K1;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;PRKCA;ROCK1;RPS6KB1;SGK1,,,PRECLINICAL,,,NA,"BRC1C(BR)C(BR)C2[NH]NNC2C1BR, BRC1C(BR)C(BR)C2[NH]NNC2C1BR",
4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)-PIPERIDINE,4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)-PIPERIDINE,,BRD:BRD-BRD-K47337578-034-02-5;BRD:BRD-K47337578-034-02-5,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A,,,PRECLINICAL,,,NA,"FC1CCC(CC1)C(=O)C1CCN(CCCCC2CCCCC2)CC1, FC1CCC(CC1)C(=O)C1CCN(CCCCC2CCCCC2)CC1",
4-(AMINOMETHYL)BENZOIC-ACID,4-(AMINOMETHYL)BENZOIC-ACID,,BRD:BRD-K00003517-001-01-9,rep_single_dose,HEMOSTATIC AGENT,,,,,,,NA,,
"4-ACETYL-1,1-DIMETHYLPIPERAZINIUM","4-ACETYL-1,1-DIMETHYLPIPERAZINIUM",,BRD:BRD-BRD-K97019106-005-02-9;BRD:BRD-K97019106-005-02-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,CC(=O)N1CC[N+](C)(C)CC1,
4-AMINOHIPPURIC-ACID,4-AMINOHIPPURIC-ACID,,BRD:BRD-BRD-K65544384-001-15-8;BRD:BRD-K65544384-001-15-8,rep_primary;rep_single_dose,,SLC22A6,,,LAUNCHED,,,NA,"NC1CCC(CC1)C(=O)NCC(O)=O, NC1CCC(CC1)C(=O)NCC(O)=O, NC1CCC(CC1)C(=O)NCC(O)=O, NC1CCC(CC1)C(=O)NCC(O)=O, NC1CCC(CC1)C(=O)NCC(O)=O",
4-CHLOROPHENYLGUANIDINE,4-CHLOROPHENYLGUANIDINE,,BRD:BRD-BRD-K39160765-003-02-9;BRD:BRD-K39160765-003-02-9,rep_multi_dose;rep_primary;rep_single_dose,UROKINASE INHIBITOR,PLAUR,,,PRECLINICAL,,,NA,NC(=N)NC1CCC(CL)CC1,
4-CMTB,4-CMTB,,BRD:BRD-A54139254-001-09-2;BRD:BRD-BRD-A54139254-001-09-2,rep_primary;rep_single_dose,FREE FATTY ACID RECEPTOR AGONIST,FFAR2,,,PRECLINICAL,,,NA,CC(C)C(C(=O)NC1NCCS1)C1CCC(CL)CC1,
4-CPA,4-CPA,,BRD:BRD-K00078770-001-02-9,rep_single_dose,,,,,,,,NA,,
4-DAMP,4-DAMP,CHEMBL76897,BRD:BRD-K29313239-005-10-9,rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,,,,,Small molecule,NA,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-],WWJHRSCUAQPFQO-UHFFFAOYSA-M
4-GALACTOSYLLACTOSE,4-GALACTOSYLLACTOSE,,BRD:BRD-A32796301-001-01-6;BRD:BRD-BRD-A32796301-001-01-6,rep_primary;rep_single_dose,,AMY2B,,,PRECLINICAL,,,NA,OC[C@H]1O[C@@H](O[C@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,
4-HQN,4-HQN,,BRD:BRD-BRD-K91758890-001-10-0;BRD:BRD-K91758890-001-10-0,rep_primary;rep_single_dose,PARP INHIBITOR,PARP1,,,PRECLINICAL,,,NA,OC1NCNC2CCCCC12,
4-HYDROXY-PHENAZONE,4-HYDROXY-PHENAZONE,,BRD:BRD-BRD-K49759007-001-11-9;BRD:BRD-K49759007-001-11-9,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC1C(O)C(=O)N(-C2CCCCC2)N1C,
4-IBP,4-IBP,,BRD:BRD-BRD-K62537556-001-02-5;BRD:BRD-K62537556-001-02-5,rep_primary;rep_single_dose,SIGMA RECEPTOR AGONIST,SIGMAR1,,,PRECLINICAL,,,NA,IC1CCC(CC1)C(=O)NC1CCN(CC2CCCCC2)CC1,
4-IODO-6-PHENYLPYRIMIDINE,4-IODO-6-PHENYLPYRIMIDINE,,BRD:BRD-BRD-K25690923-001-02-4;BRD:BRD-K25690923-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,MIF,,,PRECLINICAL,,,NA,IC1CC(NCN1)-C1CCCCC1,
4-IODO-L-PHENYLALANINE,4-IODO-L-PHENYLALANINE,,BRD:BRD-BRD-K66664625-001-01-2;BRD:BRD-K66664625-001-01-2,rep_primary;rep_single_dose,,DPP4,,,PRECLINICAL,,,NA,N[C@H](CC1CCC(I)CC1)C(O)=O,
4-METHYLGENISTEIN,4-METHYLGENISTEIN,,BRD:BRD-BRD-K73303757-001-21-6;BRD:BRD-K73303757-001-21-6,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,CYP19A1;ESRRA;ESRRB;ESRRG;FASN,,,PRECLINICAL,,,NA,COC1CCC(CC1)-C1COC2CC(O)CC(O)C2C1=O,
4-METHYLHISTAMINE,4-METHYLHISTAMINE,CHEMBL275443,BRD:BRD-BRD-K70821460-300-02-4;BRD:BRD-K70821460-300-02-4,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH4,,,PRECLINICAL,,Small molecule,NA,Cc1nc[nH]c1CCN;CC1NC[NH]C1CCN,UGYXPZQILZRKJJ-UHFFFAOYSA-N
4-MU-8C,4-MU-8C,,BRD:BRD-BRD-K81316007-001-01-8;BRD:BRD-K81316007-001-01-8,rep_primary;rep_single_dose,IRE1 INHIBITOR,ERN1,,,PRECLINICAL,,,NA,CC1CC(=O)OC2C(C=O)C(O)CCC12,
4-P-PDOT,4-P-PDOT,,BRD:BRD-A67482312-001-02-6;BRD:BRD-BRD-A67482312-001-02-6,rep_primary;rep_single_dose,MELATONIN RECEPTOR ANTAGONIST,MTNR1A;MTNR1B,,,PRECLINICAL,,,NA,"CCC(=O)NC1CC(C2CCCCC2)C2CCCCC2C1, CCC(=O)NC1CC(C2CCCCC2)C2CCCCC2C1",
4-PHENOLSULFONIC-ACID,4-PHENOLSULFONIC-ACID,,BRD:BRD-BRD-K41024817-325-01-0;BRD:BRD-K41024817-325-01-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC1CCC(CC1)S(O)(=O)=O,
"4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE","4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE",,BRD:BRD-A40504327-003-02-9,rep_single_dose,DOPAMINE RELEASE INHIBITOR,,,,,,,NA,,
4-PPBP,4-PPBP,,BRD:BRD-BRD-K78061844-050-01-9;BRD:BRD-K78061844-050-01-9,rep_primary;rep_single_dose,SIGMA RECEPTOR LIGAND,SIGMAR1,,,PRECLINICAL,,,NA,"C(CCC1CCCCC1)CN1CCC(CC1)C1CCCCC1, C(CCC1CCCCC1)CN1CCC(CC1)C1CCCCC1",
4-PYRIMIDINECARBONITRILE,4-PYRIMIDINECARBONITRILE,,BRD:BRD-BRD-K04552268-001-02-4;BRD:BRD-K04552268-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,N#CC1CCNCN1,
4BP-TQS,4BP-TQS,,BRD:BRD-A18598741-001-02-9,rep_single_dose,NICOTINIC RECEPTOR AGONIST,CHRNA7,,,,,,NA,,
4E1RCAT,4E1RCAT,,BRD:BRD-BRD-K67173685-001-06-9;BRD:BRD-K67173685-001-06-9,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,EIF4E;EIF4G1,,,PRECLINICAL,,,NA,"OC(=O)C1CCC(CC1)N1C(=O)C(\C=C1C1CCCCC1)=C\C1CCC(O1)-C1CCC(CC1)[N+]([O-])=O, OC(=O)C1CCC(CC1)N1C(=O)C(\C=C1C1CCCCC1)=C\C1CCC(O1)-C1CCC(CC1)[N+]([O-])=O, OC(=O)C1CCC(CC1)N1C(=O)C(\C=C1C1CCCCC1)=C\C1CCC(O1)-C1CCC(CC1)[N+]([O-])=O",
HDAC INHIBITOR 4SC-202,4SC-202;DOMATINOSTAT;HDAC INHIBITOR 4SC-202,CHEMBL4283683,BRD:BRD-BRD-K11773281-075-02-4;BRD:BRD-K11773281-075-02-4,rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1,,,PHASE 1,,Small molecule,2,"Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1;CN1CC(CN1)-C1CCC(CC1)S(=O)(=O)N1CCC(\C=C\C(=O)NC2CCCCC2N)C1, CN1CC(CN1)-C1CCC(CC1)S(=O)(=O)N1CCC(\C=C\C(=O)NC2CCCCC2N)C1, CN1CC(CN1)-C1CCC(CC1)S(=O)(=O)N1CCC(\C=C\C(=O)NC2CCCCC2N)C1, CN1CC(CN1)-C1CCC(CC1)S(=O)(=O)N1CCC(\C=C\C(=O)NC2CCCCC2N)C1",PRXXYMVLYKJITB-IZZDOVSWSA-N
5'-CHLORO-5'-DEOXY-ENBA-(+/-),5'-CHLORO-5'-DEOXY-ENBA-(+/-),,BRD:BRD-A13598753-001-01-2;BRD:BRD-BRD-A13598753-001-01-2,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1,,,PRECLINICAL,,,NA,"O[C@@H]1[C@@H](CCL)O[C@H]([C@@H]1O)N1CNC2C(NC3CC4CCC3C4)NCNC12, O[C@@H]1[C@@H](CCL)O[C@H]([C@@H]1O)N1CNC2C(NC3CC4CCC3C4)NCNC12",
"5,7-DICHLOROKYNURENIC-ACID","5,7-DICHLOROKYNURENIC-ACID",,BRD:BRD-BRD-K60287130-001-05-7;BRD:BRD-K60287130-001-05-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GLRA2;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,PRECLINICAL,,,NA,"OC(=O)C1CC(O)C2C(CL)CC(CL)CC2N1, OC(=O)C1CC(O)C2C(CL)CC(CL)CC2N1",
"5-AMINO-3-D-RIBOFURANOSYLTHIAZOLO[4,5-D]PYRIMIDIN-2,7(3H,6H)-DIONE","5-AMINO-3-D-RIBOFURANOSYLTHIAZOLO[4,5-D]PYRIMIDIN-2,7(3H,6H)-DIONE",,BRD:BRD-BRD-K87535339-001-01-6;BRD:BRD-K87535339-001-01-6,rep_primary;rep_single_dose,,TLR7,,,PRECLINICAL,,,NA,NC1NC2N([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C(=O)SC2C(=O)[NH]1,
5-AMINOLEVULINIC-ACID,5-AMINOLEVULINIC-ACID,,BRD:BRD-BRD-K57631554-003-06-2;BRD:BRD-K57631554-003-06-2,rep_primary;rep_single_dose,OXIDIZING AGENT,ALAD,,,LAUNCHED,,,NA,"NCC(=O)CCC(O)=O, NCC(=O)CCC(O)=O",
NSC-127716,2'-DEOXY-5-AZACYTIDINE;5-AZA-2'-DEOXYCYTIDINE;DAC;DACOGEN;DECITABINE;NSC-127716,CHEMBL1201129,BRD:BRD-BRD-K79254416-001-22-6;BRD:BRD-K79254416-001-07-7;BRD:BRD-K79254416-001-21-8;BRD:BRD-K79254416-001-22-6;CTRP:347775,ctrp;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,HYPOMETHYLATING AGENT WITH DNA INCORPORATION,DNMT1;DNMT3A,"MYELODYSPLASTIC DISEASES (MDS), ANEMIA, CHRONIC MYELOID LEUKEMIA (CML)",,LAUNCHED,"Multiple values for MOA: {'DNA METHYLTRANSFERASE INHIBITOR', 'HYPOMETHYLATING AGENT WITH DNA INCORPORATION'}, defaulting to 'HYPOMETHYLATING AGENT WITH DNA INCORPORATION'
Multiple values for repurposing_target: {'DNMT1;DNMT3A', 'DNMT1'}, taking the union",Small molecule,4,"Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1;NC1NCN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)N1, NC1NCN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)N1, NC1NCN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)N1",XAUDJQYHKZQPEU-KVQBGUIXSA-N
VIDAZA,"5-AZACITIDINE;AZACITIDINE;AZACYTIDINE;LADAKAMYCIN;NSC-102816;ONUREG;U-18,496;U-18496;VIDAZA",CHEMBL1489,BRD:BRD-BRD-K03406345-001-27-8;BRD:BRD-K03406345-001-21-1;BRD:BRD-K03406345-001-26-0;BRD:BRD-K03406345-001-27-8;CTRP:26874,ctrp;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,HYPOMETHYLATING AGENT WITH DNA/RNA INCORPORATION,DNMT1;DNMT3A,"MYELODYSPLASTIC DISEASES (MDS), ANEMIA, CHRONIC MYELOMONOCYTIC LEUKEMIA (CMMOL)",,LAUNCHED,"Multiple values for MOA: {'HYPOMETHYLATING AGENT WITH DNA/RNA INCORPORATION', 'DNA METHYLTRANSFERASE INHIBITOR'}, defaulting to 'HYPOMETHYLATING AGENT WITH DNA/RNA INCORPORATION'
Multiple values for repurposing_target: {'DNMT1;DNMT3A', 'DNMT1'}, taking the union",Small molecule,4,"Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1;NC1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1, NC1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1, NC1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1",NMUSYJAQQFHJEW-KVTDHHQDSA-N
5-BDBD,5-BDBD,,BRD:BRD-BRD-K33690734-001-01-5;BRD:BRD-K33690734-001-01-5,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX4,,,PRECLINICAL,,,NA,"BRC1CCCC(C1)C1=NCC(=O)NC2C1OC1CCCCC21, BRC1CCCC(C1)C1=NCC(=O)NC2C1OC1CCCCC21",
5-CARBOXAMIDOTRYPTAMINE,5-CARBOXAMIDOTRYPTAMINE,,BRD:BRD-BRD-K92382976-050-01-1;BRD:BRD-K92382976-050-01-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR5A;HTR6;HTR7,,,PRECLINICAL,,,NA,NCCC1C[NH]C2CCC(CC12)C(N)=O,
5-FLUORO-3-PYRIDYL-METHANOL,5-FLUORO-3-PYRIDYL-METHANOL,,BRD:BRD-BRD-K73381198-001-01-1;BRD:BRD-K73381198-001-01-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OCC1CNCC(F)C1,
5-FLUOROPYRIMIDINE,5-FLUOROPYRIMIDINE,,BRD:BRD-K00004679-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,,NA,,
TOLAK,5 FU;5-FLUOROURACIL;5-FLUORURACIL;5-FU;5.F.U.;ACCUSITE;ACTIKERALL;ADRUCIL;CARAC;EFUDEX;EFUDIX;FLUORO-URACIL ROCHE;FLUOROPLEX;FLUOROURACIL;FLUOROURACILUM;FLUOROURICIL;FLURACIL;NSC-19893;PHTHORURACIL;QUEROPLEX;RO 2-9757;RO-2-9757;RO-29757;TOLAK,CHEMBL185,BRD:BRD-BRD-K24844714-001-24-5;BRD:BRD-K24844714-001-24-5;BRD:BRD-U00115293-001-01-9;CTRP:25344;GDSC1:179;GDSC2:1073,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose, INHIBITOR OF THYMIDYLATE SYNTHASE;PYRIMIDINE ANALOG,DPYD;TYMS,"COLORECTAL CANCER, BREAST CANCER, PANCREATIC CANCER, GASTRIC ADENOCARCINOMA",,LAUNCHED,"Multiple values for MOA: {'THYMIDYLATE SYNTHASE INHIBITOR', 'PYRIMIDINE ANALOG; INHIBITOR OF THYMIDYLATE SYNTHASE'}, defaulting to 'PYRIMIDINE ANALOG; INHIBITOR OF THYMIDYLATE SYNTHASE'
Multiple values for repurposing_target: {'TYMS', 'DPYD;TYMS'}, taking the union
Multiple values for structure_id: {'U00115293', 'K24844714'}, defaulting to None",Small molecule,4,"FC1C[NH]C(=O)[NH]C1=O, FC1C[NH]C(=O)[NH]C1=O;O=c1[nH]cc(F)c(=O)[nH]1",GHASVSINZRGABV-UHFFFAOYSA-N
5-HMF,5-HMF,,BRD:BRD-BRD-K86799112-001-02-0;BRD:BRD-K86799112-001-02-0,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,"OCC1CCC(C=O)O1, OCC1CCC(C=O)O1, OCC1CCC(C=O)O1",
5-HYDROXYECTOINE,5-HYDROXYECTOINE,,BRD:BRD-BRD-K03871161-001-01-9;BRD:BRD-K03871161-001-01-9;BRD:BRD-K03871161-001-02-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,O[C@H]1CNC(=C)N[C@@H]1C(O)=O,
5-HYDROXYMETHYL-TOLTERODINE,5-HYDROXYMETHYL-TOLTERODINE,,BRD:BRD-BRD-K24603946-001-02-1;BRD:BRD-K24603946-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM3,,,PHASE 1,,,NA,"CC(C)N(CC[C@H](C1CCCCC1)C1CC(CO)CCC1O)C(C)C, CC(C)N(CC[C@H](C1CCCCC1)C1CC(CO)CCC1O)C(C)C",
TRYPTOPHAN,5-HYDROXY-;5-HYDROXY-L-TRYPTOPHAN;5-HYDROXYTRYPTOPHAN;5-HYDROXYTRYPTOPHAN L-FORM;CINCOFARM;DL;DL-;DL-5-HTP;DL-5-HYDROXYTRYPTOPHAN;DL-HYDROXYTRYPTOPHAN;DL-OXITRIPTAN;HYDROXYTRYPTOPHAN;L-5-HTP;L-5-HYDROXYTRYPTOPHAN;LEVOTHYM;LEVOTININE;LEVOTONINE;NSC-92523;OXITRIPTAN;OXYFAN;PRETONINE;QUIETIM;SEROTONYL;TELESOL;TRIPTENE;TRYPTOPHAN,CHEMBL350221,BRD:BRD-A73930134-001-03-0;BRD:BRD-BRD-A73930134-001-03-0,rep_primary;rep_single_dose,NEUROTRANSMITTER,SLC36A1;SLC36A2,INSOMNIA,,LAUNCHED,,Small molecule,4,"N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O;NC(CC1C[NH]C2CCC(O)CC12)C(O)=O, NC(CC1C[NH]C2CCC(O)CC12)C(O)=O",LDCYZAJDBXYCGN-VIFPVBQESA-N
5-IODO-A-85380,5-IODO-A-85380,,BRD:BRD-BRD-K90065682-300-02-6;BRD:BRD-K90065682-300-02-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,PHASE 2,,,NA,"IC1CNCC(OC[C@@H]2CCN2)C1, IC1CNCC(OC[C@@H]2CCN2)C1",
5-METHYLFURMETHIODIDE,5-METHYLFURMETHIODIDE,CHEMBL1316369,BRD:BRD-BRD-K45437867-005-03-3;BRD:BRD-K45437867-005-03-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4,,,PRECLINICAL,,Small molecule,NA,"CC1CCC(C[N+](C)(C)C)O1, CC1CCC(C[N+](C)(C)C)O1;Cc1ccc(C[N+](C)(C)C)o1.[I-]",IHTCZSNKQINGDD-UHFFFAOYSA-M
5-METHYLHYDANTOIN-(L),5-METHYLHYDANTOIN-(L),,BRD:BRD-BRD-K56033645-001-07-5;BRD:BRD-K56033645-001-07-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,C[C@@H]1NC(=O)NC1=O,
5-OCTANOYLSALICYLIC-ACID,5-OCTANOYLSALICYLIC-ACID,,BRD:BRD-K00004681-001-01-9,rep_single_dose,PROTEIN KINASE ACTIVATOR,,,,,,,NA,,
5XE,5XE,,GDSC2:1852,gdsc,,,,,,,,NA,,
"6,7-DEHYDRO-17-ACETOXY-PROGESTERONE","6,_7-DEHYDRO-17-ACETOXY-PROGESTERONE;6,7-DEHYDRO-17-ACETOXY-PROGESTERONE",,BRD:BRD-BRD-K48329353-001-01-3;BRD:BRD-K48329353-001-01-3,rep_primary;rep_single_dose,STEROIDAL PROGESTIN,,,,PRECLINICAL,,,NA,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,
6-AMINOPENICILLANIC-ACID,6-AMINOPENICILLANIC-ACID,,BRD:BRD-K30284967-001-02-9,rep_single_dose,,,,,,,,NA,,
BENZYL AMINOPURINE,6-BENZYLAMINOPURINE;BENZYL AMINOPURINE,CHEMBL228862,BRD:BRD-BRD-K62929068-001-16-5;BRD:BRD-K62929068-001-16-5,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ACTIVATOR,,,,PRECLINICAL,,Small molecule,NA,c1ccc(CNc2ncnc3[nH]cnc23)cc1;N(CC1CCCCC1)C1NCNC2NC[NH]C12,NWBJYWHLCVSVIJ-UHFFFAOYSA-N
6-CHLOROMELATONIN,6-CHLOROMELATONIN,,BRD:BRD-BRD-K34663752-001-09-1;BRD:BRD-K34663752-001-09-1,rep_primary;rep_single_dose,MELATONIN RECEPTOR AGONIST,MTNR1A;MTNR1B,,,PRECLINICAL,,,NA,"COC1CC2C(CCNC(C)=O)C[NH]C2CC1CL, COC1CC2C(CCNC(C)=O)C[NH]C2CC1CL",
6-DIAZO-5-OXO-L-NORLEUCINE,6-DIAZO-5-OXO-L-NOR-LEUCINE;6-DIAZO-5-OXO-L-NORLEUCINE,CHEMBL97485,BRD:BRD-K84924563-001-04-9,rep_single_dose,"GLUTAMATE RECEPTOR ANTAGONIST, GLUTAMINASE INHIBITOR",,,,,,Small molecule,NA,[N-]=[N+]=CC(=O)CC[C@H](N)C(=O)O,YCWQAMGASJSUIP-YFKPBYRVSA-N
6-IODO-NORDIHYDROCAPSAICIN,6-IODO-NORDIHYDROCAPSAICIN,,BRD:BRD-BRD-K49236613-001-02-3;BRD:BRD-K49236613-001-02-3,rep_primary;rep_single_dose,TRPV ANTAGONIST,TRPV1,,,PRECLINICAL,,,NA,CCCCCCCCC(=O)NCC1CC(OC)C(O)CC1I,
THIOGUANINE DEOXYRIBOSIDE,2'-DEOXY-6-THIOGUANOSINE;2'-DEOXYTHIOGUANOSINE;2'-DESOXY-6-THIOGUANOSINE;6-THIO-2'-DEOXYGUANOSINE;BETA-2'-DEOXYTHIOGUANOSINE;NSC-71261;THIOGUANINE DEOXYRIBOSIDE,CHEMBL3250476,BRD:BRD-K00091271-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Nc1nc2c(ncn2[C@H]2C[C@H](O)[C@@H](CO)O2)c(=S)[nH]1,SCVJRXQHFJXZFZ-KVQBGUIXSA-N
"7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE","7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE",,BRD:BRD-BRD-K77756533-001-01-4;BRD:BRD-K77756533-001-01-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,O=C1N2CCCCC=C2NC2CCCCC12,
7-AMINOCEPHALOSPORANIC-ACID,7-AMINOCEPHALOSPORANIC-ACID,,BRD:BRD-BRD-K65377893-001-07-4;BRD:BRD-K65377893-001-07-4,rep_multi_dose;rep_primary;rep_single_dose,BETA LACTAMASE INHIBITOR,,,,PRECLINICAL,,,NA,"CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N)C2=O)C(O)=O, CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N)C2=O)C(O)=O",
7-CHLOROKYNURENIC-ACID,7-CHLOROKYNURENIC-ACID,,BRD:BRD-BRD-K84214706-001-05-7;BRD:BRD-K84214706-001-05-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C,,,PRECLINICAL,,,NA,"OC(=O)C1CC(O)C2CCC(CL)CC2N1, OC(=O)C1CC(O)C2CCC(CL)CC2N1",
7-HYDROXY-DPAT,7-HYDROXY-DPAT,,BRD:BRD-A18795974-004-07-3;BRD:BRD-BRD-A18795974-004-07-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD2;DRD3,,,PRECLINICAL,,,NA,"CCCN(CCC)C1CCC2CCC(O)CC2C1, CCCN(CCC)C1CCC2CCC(O)CC2C1, CCCN(CCC)C1CCC2CCC(O)CC2C1",
UCN-02,7-HYDROXYSTAUROSPORINE;KRX-0601;KW-2401;NSC-638850;UCN 01;UCN-01;UCN-02,CHEMBL574737,BRD:BRD-BRD-K45293975-001-02-0;BRD:BRD-K45293975-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,"CDK INHIBITOR, CHK INHIBITOR, PKC INHIBITOR",CDK1;CHEK1;CHEK2;GSK3B;LCK;MAPK14;MARK1;MARK3;PDPK1;PRKCA;PRKCB;PRKCD;PRKCE;PRKCG,,,PHASE 2,"Multiple values for repurposing_target: {'CDK1;CHEK1;CHEK2;GSK3B;LCK;MAPK14;MARK1;MARK3;PDPK1;PRKCA;PRKCB;PRKCD;PRKCE;PRKCG', 'CHEK1;MARK3;PDPK1'}, taking the union",Small molecule,2,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3CCCCC3C3C4[C@H](O)NC(=O)C4C4C5CCCCC5N2C4C13;CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,PBCZSGKMGDDXIJ-KRUBCLEUSA-N
7-KETO-DHEA,7-KETO-DHEA,,BRD:BRD-BRD-K07785030-001-01-6;BRD:BRD-K07785030-001-01-6,rep_primary;rep_single_dose,STEROID,,,,LAUNCHED,,,NA,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3C(=O)C=C2C1,
7-METHOXYTACRINE,7-METHOXYTACRINE,,BRD:BRD-BRD-K53156626-001-01-3;BRD:BRD-K53156626-001-01-3,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE,,,PHASE 2,,,NA,COC1CCC2NC3CCCCC3C(N)C2C1,
NSC-7861,7-METHYLXANTHINE;HETEROXANTHINE;METHYL XANTHINE;NSC-7861,CHEMBL321248,BRD:BRD-BRD-K41592905-001-01-6;BRD:BRD-K41592905-001-01-6,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,,,,PHASE 2,,Small molecule,2,Cn1cnc2[nH]c(=O)[nH]c(=O)c21;CN1CNC2NC(O)NC(O)C12,PFWLFWPASULGAN-UHFFFAOYSA-N
7-NITROINDAZOLE,7-NITROINDAZOLE,CHEMBL247378,BRD:BRD-BRD-K04430056-001-17-7;BRD:BRD-BRD-K04430056-236-02-1;BRD:BRD-K04430056-001-17-7;BRD:BRD-K04430056-236-02-1,rep_multi_dose;rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS1;NOS2;NOS3,,,PRECLINICAL,,Small molecule,NA,"[O-][N+](=O)C1CCCC2CN[NH]C12, [O-][N+](=O)C1CCCC2CN[NH]C12, [O-][N+](=O)C1CCCC2CN[NH]C12;O=[N+]([O-])c1cccc2cn[nH]c12",PQCAUHUKTBHUSA-UHFFFAOYSA-N
8-BROMO-CAMP,8-BROMO-CAMP,,BRD:BRD-A09554849-236-07-6;BRD:BRD-BRD-A09554849-236-07-6,rep_primary;rep_single_dose,PKA ACTIVATOR,,,,PRECLINICAL,,,NA,NC1NCNC2N([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C(BR)NC12,
8-BROMO-CGMP,8-BROMO-CGMP,,BRD:BRD-A00077618-236-07-6;BRD:BRD-BRD-A00077618-236-07-6,rep_multi_dose;rep_primary;rep_single_dose,PKA ACTIVATOR,PRKG1,,,PRECLINICAL,,,NA,NC1NC(O)C2NC(BR)N([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2N1,
8-HYDROXY-DPAT,8-HYDROXY-DPAT,,BRD:BRD-A48015106-004-08-9;BRD:BRD-BRD-A48015106-004-08-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,CDK1;CHEK1;CHEK2;GSK3B;HTR5A;HTR7;LCK;MAPK14;MARK1;PDPK1;PRKCA;PRKCB;PRKCD;PRKCE;PRKCG,,,PRECLINICAL,,,NA,CCCN(CCC)C1CCC2CCCC(O)C2C1,
8-HYDROXY-PIPAT,8-HYDROXY-PIPAT,,BRD:BRD-A60594020-034-01-1;BRD:BRD-BRD-A60594020-034-01-1,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR LIGAND,DRD2;DRD3,,,PRECLINICAL,,,NA,CCCN(C\C=C\I)C1CCC2CCCC(O)C2C1,
8-M-PDOT,8-M-PDOT,,BRD:BRD-A07232941-001-02-7;BRD:BRD-BRD-A07232941-001-02-7,rep_primary;rep_single_dose,MELATONIN RECEPTOR AGONIST,MTNR1A;MTNR1B,,,PRECLINICAL,,,NA,"CCC(=O)NC1CCC2CCCC(OC)C2C1, CCC(=O)NC1CCC2CCCC(OC)C2C1",
9-AMINOACRIDINE,9-AMINOACRIDINE,,BRD:BRD-BRD-K00535541-001-05-5;BRD:BRD-BRD-K00535541-001-06-3;BRD:BRD-K00535541-001-05-5;BRD:BRD-K00535541-001-06-3,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"NC1C2CCCCC2NC2CCCCC12, NC1C2CCCCC2NC2CCCCC12, NC1C2CCCCC2NC2CCCCC12",
NSC-603071,9-AMINO-20(S)-CAMPTOTHECIN;9-AMINOCAMPTOTHECIN;AMINOCAMPTOTHECIN;NSC-603071,CHEMBL274070,BRD:BRD-BRD-K09291936-001-13-3;BRD:BRD-K09291936-001-13-3,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,PHASE 2,,Small molecule,2,CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCCC(N)C4CC3CN1C2=O;CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(N)cccc3nc2-1,FUXVKZWTXQUGMW-FQEVSTJZSA-N
9-ANTHRACENECARBOXYLIC-ACID,9-ANTHRACENECARBOXYLIC-ACID,,BRD:BRD-K62607075-001-04-9,rep_single_dose,,ANO1;CLCN1,,,,,,NA,,
ELRAGLUSIB,9 ING 41;9-ING-41;ELRAGLUSIB,CHEMBL483465,BRD:BRD-K00091104-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3,FARXPFGGGGLENU-UHFFFAOYSA-N
968,968,,CTRP:660080,ctrp,,,,,,,,NA,,
A-1065-5,A-1065-5,,GDSC1:299;GDSC2:1594,gdsc,,,,,,,,NA,,
A-1070722,A-1070722,,BRD:BRD-BRD-K70329400-001-02-5;BRD:BRD-K70329400-001-02-5,rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3A;GSK3B,,,PRECLINICAL,,,NA,COC1CCC2C(NC(=O)NC3CCCC(N3)C(F)(F)F)CCNC2C1,
A-1120,A-1120,,BRD:BRD-K59060513-001-02-5,rep_single_dose,RETINOID RECEPTOR LIGAND,RBP4,,,,,,NA,,
A-1331852,A-1331852,,BRD:BRD-U00114866-001-01-9,oncref_1,INHIBITOR OF BCL-XL (BCL2L1),BCL2L1,,,,,,NA,,
A-317491,A-317491,CHEMBL596234,BRD:BRD-BRD-K38019854-323-01-4;BRD:BRD-K38019854-323-01-4,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX3,,,PRECLINICAL,,Small molecule,NA,"O=C(O)c1cc(C(=O)O)c(C(=O)N(Cc2cccc(Oc3ccccc3)c2)[C@H]2CCCc3ccccc32)cc1C(=O)O;OC(=O)C1CC(C(O)=O)C(CC1C(O)=O)C(=O)N(CC1CCCC(OC2CCCCC2)C1)[C@H]1CCCC2CCCCC12, OC(=O)C1CC(C(O)=O)C(CC1C(O)=O)C(=O)N(CC1CCCC(OC2CCCCC2)C1)[C@H]1CCCC2CCCCC12",VQGBOYBIENNKMI-LJAQVGFWSA-N
A-33903,A-33903,,BRD:BRD-A40302156-001-01-9;BRD:BRD-BRD-A40302156-001-01-9,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CC(=O)NC1C(=O)NC2CCCCC2C(=N1)C1CCCCC1,
A-366,A-366,,BRD:BRD-BRD-K06182768-001-02-3;BRD:BRD-K06182768-001-02-3,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT1;EHMT2,,,PRECLINICAL,,,NA,"COC1CC2C(CC1OCCCN1CCCC1)N=C(N)C21CCC1, COC1CC2C(CC1OCCCN1CCCC1)N=C(N)C21CCC1, COC1CC2C(CC1OCCCN1CCCC1)N=C(N)C21CCC1, COC1CC2C(CC1OCCCN1CCCC1)N=C(N)C21CCC1, COC1CC2C(CC1OCCCN1CCCC1)N=C(N)C21CCC1",
A-381393,A-381393,,BRD:BRD-K00005339-001-01-9,rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,,,,NA,,
A-412997,A-412997,,BRD:BRD-BRD-K62066682-300-01-0;BRD:BRD-K62066682-300-01-0,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD4,,,PRECLINICAL,,,NA,CC1CCCC(NC(=O)CN2CCC(CC2)C2CCCCN2)C1,
A-438079,A-438079,,BRD:BRD-K13223831-003-02-9,rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX7,,,,,,NA,,
A485,A-485;A485,CHEMBL4282264,BRD:BRD-K30233223-001-04-9;BRD:BRD-K30233223-001-08-9,oncref_2;rep_single_dose,HISTONE ACETYLTRANSFERASE INHIBITOR,CREBBP;EP300,,,,"Multiple values for MOA: {'HISTONE ACETYLTRANSFERASE INHIBITOR', 'INHIBITOR OF EP300/CREBBP HAT'}, defaulting to 'HISTONE ACETYLTRANSFERASE INHIBITOR'",Small molecule,NA,CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,VRVJKILQRBSEAG-LFPIHBKWSA-N
A-582941,A-582941,,BRD:BRD-K79743788-001-02-9,rep_single_dose,NICOTINIC RECEPTOR AGONIST,CHRNA7,,,,,,NA,,
A61603,A-61603;A61603,,BRD:BRD-A83650191-004-02-8;BRD:BRD-BRD-A83650191-004-02-8;BRD:BRD-BRD-K13142315-004-01-2;BRD:BRD-K13142315-004-01-2,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D,,,PRECLINICAL,"Multiple values for SMILES: {'CS(=O)(=O)NC1C(O)CCC2C(CCCC12)=C1NCCN1', 'CS(=O)(=O)NC1C(O)CCC2C(CCCC12)C1=NCCN1'}, defaulting to 'CS(=O)(=O)NC1C(O)CCC2C(CCCC12)C1=NCCN1'
Multiple values for repurposing_target: {'ADRA1A', 'ADRA1A;ADRA1B;ADRA1D'}, taking the union
Multiple values for structure_id: {'K13142315', 'A83650191'}, defaulting to None",,NA,CS(=O)(=O)NC1C(O)CCC2C(CCCC12)C1=NCCN1,
A-674563,A-674563,,BRD:BRD-BRD-K78177893-001-02-4;BRD:BRD-K78177893-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,AKT INHIBITOR,AKT1;PKIA;PRKACA,,,PRECLINICAL,,,NA,CC1N[NH]C2CCC(CC12)-C1CNCC(OC[C@@H](N)CC2CCCCC2)C1,
A-7,A-7,,BRD:BRD-BRD-K03301001-003-02-5;BRD:BRD-K03301001-003-02-5,rep_primary;rep_single_dose,CALMODULIN ANTAGONIST,,,,PRECLINICAL,,,NA,"NCCCCCCCCCCNS(=O)(=O)C1CCCC2C(CL)CCCC12, NCCCCCCCCCCNS(=O)(=O)C1CCCC2C(CL)CCCC12",
A-769662,A-769662,,BRD:BRD-BRD-K41918892-001-05-9;BRD:BRD-K41918892-001-05-9,rep_primary;rep_single_dose,AMPK ACTIVATOR,,,,PRECLINICAL,,,NA,"OC1CCCCC1-C1CCC(CC1)-C1CSC2[NH]C(=O)C(C#N)C(O)C12, OC1CCCCC1-C1CCC(CC1)-C1CSC2[NH]C(=O)C(C#N)C(O)C12",
A-784168,A-784168,,BRD:BRD-K87665527-001-02-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPV1,,,,,,NA,,
A-803467,A-803467,,BRD:BRD-BRD-K28570407-001-02-0;BRD:BRD-K28570407-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A,,,PRECLINICAL,,,NA,"COC1CC(NC(=O)C2CCC(O2)-C2CCC(CL)CC2)CC(OC)C1, COC1CC(NC(=O)C2CCC(O2)-C2CCC(CL)CC2)CC(OC)C1",
A-804598,A-804598,,BRD:BRD-K76894955-001-02-1;BRD:BRD-K94313941-001-03-9;CTRP:661033,ctrp;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX7,,,,"Multiple values for structure_id: {'K76894955', 'K94313941'}, defaulting to None",,NA,,
A-83-01,A-83-01,,GDSC1:477,gdsc,,,,,,,,NA,,
A-839977,A-839977,,BRD:BRD-K60427831-001-02-9,rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX7,,,,,,NA,,
A-867744,A-867744,,BRD:BRD-BRD-K33059059-001-01-0;BRD:BRD-K33059059-001-01-0,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,CHRNA3;CHRNA4;CHRNA7,,,PRECLINICAL,,,NA,CCC(=O)C1CC(-C2CCC(CL)CC2)N(C1C)-C1CCC(CC1)S(N)(=O)=O,
A-887826,A-887826,,BRD:BRD-K20239555-001-02-9,rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A,,,,,,NA,,
A922500,A-922500;A922500,,BRD:BRD-BRD-K28861668-001-01-9;BRD:BRD-BRD-K81614372-001-02-1;BRD:BRD-K28861668-001-01-9;BRD:BRD-K81614372-001-02-1,rep_primary;rep_single_dose,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,DGAT1,,,PRECLINICAL,"Multiple values for SMILES: {'OC(=O)[C@@H]1CCC[C@H]1C(=O)C1CCC(CC1)-C1CCC(NC(=O)NC2CCCCC2)CC1', 'OC(=O)[C@H]1CCC[C@H]1C(=O)C1CCC(CC1)-C1CCC(NC(=O)NC2CCCCC2)CC1'}, defaulting to 'OC(=O)[C@@H]1CCC[C@H]1C(=O)C1CCC(CC1)-C1CCC(NC(=O)NC2CCCCC2)CC1'
Multiple values for structure_id: {'K28861668', 'K81614372'}, defaulting to None",,NA,OC(=O)[C@@H]1CCC[C@H]1C(=O)C1CCC(CC1)-C1CCC(NC(=O)NC2CCCCC2)CC1,
A-939572,A-939572,,BRD:BRD-K99308908-001-02-9,oncref_1;rep_single_dose,INHIBITOR OF STEAROYL-COA DESATURASE 1,SCD,,,,"Multiple values for MOA: {'INHIBITOR OF STEAROYL-COA DESATURASE 1', 'STEAROYL-COA DESATURASE INHIBITOR'}, defaulting to 'INHIBITOR OF STEAROYL-COA DESATURASE 1'",,NA,,
A-967079,A-079;A-967079,CHEMBL3697701,BRD:BRD-BRD-K70744942-001-01-2;BRD:BRD-K70744942-001-01-2,rep_primary;rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPA1,,,PRECLINICAL,,Small molecule,NA,CCC(=N/O)\C(C)=C\C1CCC(F)CC1;CCC(=N\O)/C(C)=C/c1ccc(F)cc1,HKROEBDHHKMNBZ-CHBKHGQFSA-N
A-987306,A-987306,,BRD:BRD-K68982262-001-02-9,rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,ADORA1;AVPR1A;CCR1;CHRM1;CHRM2;CHRM3;CHRM4;DRD3;HTR1A;HTR1B;HTR2A;HTR2B;HTR3A;TACR2,,,,,,NA,,
A12B4C3,A12B4C3,,BRD:BRD-A30000356-001-02-9,rep_single_dose,POLYNUCLEOTIDE KINASE/PHOSPHATASE INHIBITOR,PNKP,,,,,,NA,,
A205804,A205804,,BRD:BRD-BRD-K77627880-001-04-0;BRD:BRD-K77627880-001-04-0,rep_primary;rep_single_dose,ICAM1 EXPRESSION INHIBITOR,ICAM1;SELE,,,PRECLINICAL,,,NA,"CC1CCC(SC2CNCC3SC(CC23)C(N)=O)CC1, CC1CCC(SC2CNCC3SC(CC23)C(N)=O)CC1, CC1CCC(SC2CNCC3SC(CC23)C(N)=O)CC1",
A66,A66,,BRD:BRD-BRD-K49055432-001-04-2;BRD:BRD-K49055432-001-04-2,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA,,,PRECLINICAL,,,NA,"CC1NC(NC(=O)N2CCC[C@H]2C(N)=O)SC1-C1CSC(N1)C(C)(C)C, CC1NC(NC(=O)N2CCC[C@H]2C(N)=O)SC1-C1CSC(N1)C(C)(C)C",
A740003,A740003,,BRD:BRD-A78952587-001-01-5;BRD:BRD-BRD-A78952587-001-01-5,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX7,,,PRECLINICAL,,,NA,"COC1CCC(CC(=O)NC(N\C(NC2CCCC3NCCCC23)=N\C#N)C(C)(C)C)CC1OC, COC1CCC(CC(=O)NC(N\C(NC2CCCC3NCCCC23)=N\C#N)C(C)(C)C)CC1OC",
A77636,A77636,,BRD:BRD-K72226571-003-02-9,rep_single_dose,DOPAMINE RECEPTOR AGONIST,CALY,,,,,,NA,,
AA-COCF3,AA-COCF3,,CTRP:411724,ctrp,,,,,,,,NA,,
AAI101,AAI101,,BRD:BRD-K00003450-001-01-9,rep_single_dose,LACTAMASE INHIBITOR,,,,,,,NA,,
AB-423,AB-423,,BRD:BRD-K00003109-001-01-9,rep_single_dose,HBV CAPSID ASSEMBLY INHIBITOR,,,,,,,NA,,
QUEMLICLUSTAT,AB-680;AB680;QUEMLICLUSTAT,CHEMBL4471306,BRD:BRD-K00090628-001-01-9,rep_single_dose,,,,,,,Small molecule,1,C[C@H](Nc1cc(Cl)nc2c1cnn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O)c1ccccc1F,MFYLCAMJNGIULC-KCVUFLITSA-N
ETRUMADENANT,AB-928;AB928;ETRUMADENANT,CHEMBL4740383,BRD:BRD-K00091111-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Cc1c(C#N)cccc1-c1cc(-c2cn(Cc3cccc(C(C)(C)O)n3)nn2)nc(N)n1,BUXIAWLTBSXYSW-UHFFFAOYSA-N
ZIAGEN,ABACAVIR;AVACAVIR;EPZICOM;NSC-742406;ZIAGEN,CHEMBL1380,BRD:BRD-BRD-K17443395-065-02-2;BRD:BRD-K17443395-065-02-2,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"NC1NC(NC2CC2)C2NCN([C@@H]3C[C@H](CO)C=C3)C2N1, NC1NC(NC2CC2)C2NCN([C@@H]3C[C@H](CO)C=C3)C2N1, NC1NC(NC2CC2)C2NCN([C@@H]3C[C@H](CO)C=C3)C2N1;Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1",MCGSCOLBFJQGHM-SCZZXKLOSA-N
BAY-W-6341-,ABAFUNGIN;BAY W 6341 ;BAY-W-6341;BAY-W-6341-,CHEMBL3989547,BRD:BRD-BRD-K77432251-001-01-2;BRD:BRD-K77432251-001-01-2,rep_primary;rep_single_dose,STEROL METHYLTRANSFERASE INHIBITOR,,,,PHASE 3,,Small molecule,-1,Cc1ccc(Oc2ccccc2-c2csc(N=C3NCCCN3)n2)c(C)c1;CC1CCC(OC2CCCCC2-C2CSC(N=C3NCCCN3)N2)C(C)C1,TYBHXIFFPVFXQW-UHFFFAOYSA-N
XEGLYZE,"5,5'-DIMETHYL-2,2'-DIPYRIDYL;6,6'-BI-3-PICOLINE;ABAMETAPIR;HA-44;HA44;XEGLYZE",CHEMBL2205807,BRD:BRD-BRD-K65498798-001-01-7;BRD:BRD-K65498798-001-01-7,rep_primary;rep_single_dose,METALLOPROTEINASE INHIBITOR,MMP9,,,PHASE 3,,Small molecule,4,Cc1ccc(-c2ccc(C)cn2)nc1;CC1CCC(NC1)-C1CCC(C)CN1,PTRATZCAGVBFIQ-UHFFFAOYSA-N
R3827,ABARELIX;PLENAXIS;PPI-149;R-382;R-3827;R382;R3827,CHEMBL1252,BRD:BRD-K00003158-001-01-9,rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,GNRHR,,,,,Protein,4,CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,AIWRTTMUVOZGPW-HSPKUQOVSA-N
ABBV-744,ABBV-744,CHEMBL4297454,BRD:BRD-K00003108-001-01-9,rep_single_dose,BROMODOMAIN INHIBITOR,,,,,,Small molecule,1,CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1,OEDSFMUSNZDJFD-UHFFFAOYSA-N
OPAGANIB,ABC 294640;ABC-294640;ABC294640;OPAGANIB,CHEMBL2158685,BRD:BRD-A70814879-001-01-2;BRD:BRD-BRD-A70814879-001-01-2,rep_primary;rep_single_dose,SPHINGOSINE KINASE INHIBITOR,SPHK2,,,PHASE 1/PHASE 2,,Small molecule,2,"CLC1CCC(CC1)C12CC3CC(CC(C3)(C1)C(=O)NCC1CCNCC1)C2, CLC1CCC(CC1)C12CC3CC(CC(C3)(C1)C(=O)NCC1CCNCC1)C2;O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2",CAOTVXGYTWCKQE-UHFFFAOYSA-N
VERZENIOS,ABEMACICLIB;LY-2835219;LY2835219;VERZENIO;VERZENIOS,CHEMBL3301610,BRD:BRD-BRD-K33622447-066-01-9;BRD:BRD-K33622447-001-03-9;BRD:BRD-K33622447-066-01-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF CDK4 AND CDK6,CDK4;CDK6,BREAST CANCER,,LAUNCHED,"Multiple values for MOA: {'CDK INHIBITOR', 'INHIBITOR OF CDK4 AND CDK6'}, defaulting to 'INHIBITOR OF CDK4 AND CDK6'",Small molecule,4,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1;CCN1CCN(CC2CCC(NC3NCC(F)C(N3)-C3CC(F)C4NC(C)N(C(C)C)C4C3)NC2)CC1,UZWDCWONPYILKI-UHFFFAOYSA-N
ZYTIGA,ABIRATERONE;CB 7598;CB-7598;NSC-741232;ZYTIGA,CHEMBL254328,BRD:BRD-BRD-K50071428-001-03-3;BRD:BRD-K50071428-001-03-3;CTRP:660363,ctrp;rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN BIOSYNTHESIS INHIBITOR,CYP11B1;CYP17A1,PROSTATE CANCER,,LAUNCHED,,Small molecule,4,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12;C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2C1CCCNC1,GZOSMCIZMLWJML-VJLLXTKPSA-N
ABIRATERONE-ACETATE,ABIRATERONE-ACETATE,,BRD:BRD-BRD-K24048528-001-01-7;BRD:BRD-BRD-K24048528-001-02-5;BRD:BRD-K24048528-001-01-7;BRD:BRD-K24048528-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN BIOSYNTHESIS INHIBITOR,CYP17A1,PROSTATE CANCER,,LAUNCHED,,,NA,"CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4C4CCCNC4)[C@@H]3CC=C2C1, CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4C4CCCNC4)[C@@H]3CC=C2C1",
NVP-ABL001,ABL-001;ABL001;ABL001-NX;ASCIMINIB;NVP-ABL001,CHEMBL4208229,BRD:BRD-K00003456-001-01-9,oncref_1;rep_single_dose,ALLOSTERIC INHIBITOR OF ABL1,ABL1,,,,"Multiple values for MOA: {'BCR-ABL KINASE INHIBITOR', 'ALLOSTERIC INHIBITOR OF ABL1'}, defaulting to 'ALLOSTERIC INHIBITOR OF ABL1'",Small molecule,4,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1,VOVZXURTCKPRDQ-CQSZACIVSA-N
ABT072,ABT 072;ABT-072;ABT072,CHEMBL4076467,BRD:BRD-K00004730-001-01-9,rep_single_dose,RNA POLYMERASE INHIBITOR,,,,,,Small molecule,2,COc1c(/C=C/c2ccc(NS(C)(=O)=O)cc2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C,XMZSTQYSBYEENY-RMKNXTFCSA-N
VENETOCLAX,ABT-199;GDC-0199;RG-7601;RG7601;VENCLEXTA;VENETOCLAX,CHEMBL3137309,BRD:BRD-BRD-K62391742-001-03-0;BRD:BRD-K62391742-001-03-0;BRD:BRD-K62391742-001-07-1;BRD:BRD-K62391742-001-09-7;CTRP:666541;GDSC1:412;GDSC2:1909,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF BCL2,BCL2,CHRONIC LYMPHOCYTIC LEUKEMIA (CLL),,LAUNCHED,"Multiple values for MOA: {'BCL INHIBITOR', 'INHIBITOR OF BCL2'}, defaulting to 'INHIBITOR OF BCL2'",Small molecule,4,"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1;CC1(C)CCC(CN2CCN(CC2)C2CCC(C(=O)NS(=O)(=O)C3CCC(NCC4CCOCC4)C(C3)[N+]([O-])=O)C(OC3CNC4[NH]CCC4C3)C2)=C(C1)C1CCC(CL)CC1, CC1(C)CCC(CN2CCN(CC2)C2CCC(C(=O)NS(=O)(=O)C3CCC(NCC4CCOCC4)C(C3)[N+]([O-])=O)C(OC3CNC4[NH]CCC4C3)C2)=C(C1)C1CCC(CL)CC1, CC1(C)CCC(CN2CCN(CC2)C2CCC(C(=O)NS(=O)(=O)C3CCC(NCC4CCOCC4)C(C3)[N+]([O-])=O)C(OC3CNC4[NH]CCC4C3)C2)=C(C1)C1CCC(CL)CC1",LQBVNQSMGBZMKD-UHFFFAOYSA-N
ABT-202,ABT-202,,BRD:BRD-A29844814-300-01-5;BRD:BRD-BRD-A29844814-300-01-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,PHASE 1,,,NA,NC1CCN(C1)C1CCCNC1,
ABT-239,ABT-239,,BRD:BRD-BRD-K22749967-046-02-3;BRD:BRD-K22749967-046-02-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1;HRH2;HRH3,,,PHASE 1,,,NA,C[C@@H]1CCCN1CCC1CC2CC(CCC2O1)-C1CCC(CC1)C#N,
NAVITOCLAX,A-855071.0;ABT-263;NAVITOCLAX,CHEMBL443684,BRD:BRD-BRD-K82746043-001-15-1;BRD:BRD-K82746043-001-15-1;BRD:BRD-K82746043-001-19-3;BRD:BRD-K82746043-001-24-9;CTRP:362342;GDSC1:1011;GDSC2:1011,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF BCL-XL/BCL2,BCL2;BCL2L1;BCL2L2,,,PHASE 2,"Multiple values for MOA: {'BCL INHIBITOR', 'INHIBITOR OF BCL-XL/BCL2'}, defaulting to 'INHIBITOR OF BCL-XL/BCL2'
Multiple values for repurposing_target: {'BCL2;BCL2L1;BCL2L2', 'BCL2;BCL2L1'}, taking the union",Small molecule,3,"CC1(C)CCC(=C(CN2CCN(CC2)C2CCC(CC2)C(=O)NS(=O)(=O)C2CCC(N[C@H](CCN3CCOCC3)CSC3CCCCC3)C(C2)S(=O)(=O)C(F)(F)F)C1)C1CCC(CL)CC1, CC1(C)CCC(=C(CN2CCN(CC2)C2CCC(CC2)C(=O)NS(=O)(=O)C2CCC(N[C@H](CCN3CCOCC3)CSC3CCCCC3)C(C2)S(=O)(=O)C(F)(F)F)C1)C1CCC(CL)CC1;CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1",JLYAXFNOILIKPP-KXQOOQHDSA-N
ABT-418 (HYDROCHLORIDE),ABT-418 (HYDROCHLORIDE),,BRD:BRD-K00075715-003-02-9,rep_single_dose,,,,,,,,NA,,
ABT-491,ABT-491,,BRD:BRD-BRD-K97233161-003-01-5;BRD:BRD-K97233161-003-01-5,rep_primary;rep_single_dose,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,PTAFR,,,PHASE 1,,,NA,CN(C)C(=O)N1CC(C(=O)C2CCC(CN3C(C)NC4CNCCC34)C(F)C2)C2C(CCCC12)C#C,
ABT-639 FREE BASE,ABT-639;ABT-639 FREE BASE,CHEMBL3590674,BRD:BRD-BRD-K11792081-001-01-4;BRD:BRD-K11792081-001-01-4,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1G;CACNA1H;CACNA1I,,,PHASE 2,,Small molecule,2,FC1CCCCC1NS(=O)(=O)C1CC(C(=O)N2CCN3CCC[C@@H]3C2)C(CL)CC1F;O=C(c1cc(S(=O)(=O)Nc2ccccc2F)c(F)cc1Cl)N1CCN2CCC[C@@H]2C1,AGPIHNZOZNKRGT-CYBMUJFWSA-N
ABT-702,ABT-702,,BRD:BRD-BRD-K36021395-300-02-4;BRD:BRD-K36021395-300-02-4,rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE KINASE INHIBITOR,ADK,,,PRECLINICAL,,,NA,"NC1NCNC2NC(CC(-C3CCCC(BR)C3)C12)-C1CCC(NC1)N1CCOCC1, NC1NCNC2NC(CC(-C3CCCC(BR)C3)C12)-C1CCC(NC1)N1CCOCC1",
ABT-724,A-369724;ABT-724,CHEMBL440687,BRD:BRD-BRD-K37714784-305-02-1;BRD:BRD-K37714784-305-02-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD4,,,PHASE 2,,Small molecule,NA,C(N1CCN(CC1)C1CCCCN1)C1NC2CCCCC2[NH]1;c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,FRPJGTNLZNXQEX-UHFFFAOYSA-N
ABT-737,ABT 737;ABT-737,CHEMBL376408,BRD:BRD-BRD-K56301217-001-07-4;BRD:BRD-K56301217-001-07-4;CTRP:411738,ctrp;rep_multi_dose;rep_primary;rep_single_dose,BCL INHIBITOR,BCL2;BCL2L1;BCL2L2,,,PHASE 1/PHASE 2,,Small molecule,1,"CN(C)CC[C@H](CSC1CCCCC1)NC1CCC(CC1[N+]([O-])=O)S(=O)(=O)NC(=O)C1CCC(CC1)N1CCN(CC2CCCCC2-C2CCC(CL)CC2)CC1, CN(C)CC[C@H](CSC1CCCCC1)NC1CCC(CC1[N+]([O-])=O)S(=O)(=O)NC(=O)C1CCC(CC1)N1CCN(CC2CCCCC2-C2CCC(CL)CC2)CC1;CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]",HPLNQCPCUACXLM-PGUFJCEWSA-N
NSC-742134,ABT-751;E 7010;E-7010;NSC-742134,CHEMBL20684,BRD:BRD-BRD-K91623615-001-05-0;BRD:BRD-K91623615-001-05-0,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB,,,PHASE 2,,Small molecule,2,"COC1CCC(CC1)S(=O)(=O)NC1CCCNC1NC1CCC(O)CC1, COC1CCC(CC1)S(=O)(=O)NC1CCCNC1NC1CCC(O)CC1, COC1CCC(CC1)S(=O)(=O)NC1CCCNC1NC1CCC(O)CC1;COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1",URCVCIZFVQDVPM-UHFFFAOYSA-N
RG-3635,A-741439;ABT 869;ABT-869;AL-39324;LINIFANIB;RG-3635,CHEMBL223360,GDSC1:277,gdsc,,,,,,,Small molecule,3,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,MPVGZUGXCQEXTM-UHFFFAOYSA-N
ABT263,ABT 263;ABT263,,GDSC1:1011;GDSC2:1011,gdsc,,,,,,,,NA,,
ABT737,ABT737,,GDSC2:1910,gdsc,,,,,,,,NA,,
VELIPARIB,ABT 888;ABT-888;ABT888;PARP-1 INHIBITOR ABT-888;VELIPARIB,CHEMBL506871,GDSC1:1018,gdsc,,,,,,,Small molecule,3,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,JNAHVYVRKWKWKQ-CYBMUJFWSA-N
ELCUBRAGISTAT,ABX-1431;ABX1431;ELCUBRAGISTAT,CHEMBL3945728,BRD:BRD-K00004603-001-01-9,rep_single_dose,MONOACYLGLYCEROL LIPASE INHIBITOR,,,,,,Small molecule,2,O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CCCC2)CC1,SQZJGTOZFRNWCX-UHFFFAOYSA-N
SPL-464,ABX 464;ABX-464;ABX464;OBEFAZIMOD;SPL-464,CHEMBL4297344,BRD:BRD-K00003394-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,2,FC(F)(F)Oc1ccc(Nc2ccc3cccc(Cl)c3n2)cc1,OZOGDCZJYVSUBR-UHFFFAOYSA-N
AC-186,AC-186,,BRD:BRD-BRD-K53788420-001-01-1;BRD:BRD-K53788420-001-01-1,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR2,,,PRECLINICAL,,,NA,OC1CCC(CC1)C1(CCC(F)(F)CC1)C1CCCCC1F,
AC-261066,AC-261066,,BRD:BRD-K31144453-001-03-9,rep_single_dose,RETINOID RECEPTOR AGONIST,RARB,,,,,,NA,,
AC-264613,AC-264613,,BRD:BRD-BRD-K81548480-001-01-2;BRD:BRD-K81548480-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,PAR AGONIST,F2RL1,,,PRECLINICAL,,,NA,"C\C(=N/NC(=O)[C@H]1[C@@H](CNC1=O)C1CCCCC1)C1CCCC(BR)C1, C\C(=N/NC(=O)[C@H]1[C@@H](CNC1=O)C1CCCCC1)C1CCCC(BR)C1",
AC-55541,AC-55541,,BRD:BRD-A27911617-001-01-7;BRD:BRD-BRD-A27911617-001-01-7,rep_primary;rep_single_dose,PARP INHIBITOR,PARP2,,,PRECLINICAL,,,NA,C\C(=N/NC(=O)C(NC(=O)C1CCCCC1)C1N[NH]C(=O)C2CCCCC12)C1CCCC(BR)C1,
AC-55649,AC-55649,,BRD:BRD-BRD-K93176058-001-03-6;BRD:BRD-K93176058-001-03-6,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA;RARB,,,PRECLINICAL,,,NA,"CCCCCCCCC1CCC(CC1)-C1CCC(CC1)C(O)=O, CCCCCCCCC1CCC(CC1)-C1CCC(CC1)C(O)=O",
AC-710,AC-710,,BRD:BRD-BRD-K15819326-001-01-6;BRD:BRD-K15819326-001-01-6,rep_primary;rep_single_dose,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,CSF1R;FLT3;KIT;PDGFRA;PDGFRB,,,PRECLINICAL,,,NA,CCN1C(C)(C)CC(CC1(C)C)OC1CCC(NC1)C(=O)NC1CCC(NC(=O)NC2CC(ON2)C(C)(C)C)CC1,
AC-7954-(+/-),AC-7954-(+/-),,BRD:BRD-A49544621-003-02-8;BRD:BRD-BRD-A49544621-003-02-8,rep_primary;rep_single_dose,UROTENSIN RECEPTOR AGONIST,UTS2R,,,PRECLINICAL,,,NA,"CN(C)CCC1(CC2CCCCC2C(=O)O1)C1CCC(CL)CC1, CN(C)CCC1(CC2CCCCC2C(=O)O1)C1CCC(CL)CC1",
AC1NDSS5,AC1NDSS5,,BRD:BRD-BRD-K10226125-245-01-5;BRD:BRD-K10226125-245-01-5,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,CCCCCCCCCCCCCCCCCC[S+](CCC)C1CCCCC1C(=O)OCC,
AC260584,AC260584,,BRD:BRD-K00004583-001-01-9,rep_single_dose,CHOLINERGIC RECEPTOR AGONIST,,,,,,,NA,,
AC55649,AC55649,,CTRP:375487,ctrp,,,,,,,,NA,,
NSC-105823,ACADESINE;GP-1-110;NSC-105823,CHEMBL1551724,BRD:BRD-BRD-K53448858-001-07-0;BRD:BRD-K53448858-001-07-0,rep_primary;rep_single_dose,AMPK ACTIVATOR,,,,PHASE 3,,Small molecule,3,"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N;NC(=O)C1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1N, NC(=O)C1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1N, NC(=O)C1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1N",RTRQQBHATOEIAF-UUOKFMHZSA-N
CALQUENCE,ACALABRUTINIB;ACP-196;CALQUENCE,CHEMBL3707348,BRD:BRD-BRD-K64034691-001-01-9;BRD:BRD-K64034691-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BTK,,,PHASE 3,,Small molecule,4,CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12;CC#CC(=O)N1CCC[C@H]1C1NC(-C2CCC(CC2)C(=O)NC2CCCCN2)C2C(N)NCCN12,WDENQIQQYWYTPO-IBGZPJMESA-N
GS9820,ACALISIB;CAL-120;CAL120;GS-9820;GS9820,CHEMBL4303323,BRD:BRD-BRD-K92517771-001-01-2;BRD:BRD-K92517771-001-01-2,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CB;PIK3CD,,,PHASE 1,,Small molecule,2,C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1;C[C@H](NC1NCNC2[NH]CNC12)C1NC2CCC(F)CC2C(=O)N1-C1CCCCC1,DOCINCLJNAXZQF-LBPRGKRZSA-N
ACAMPROSATE,ACAMPROSATE,CHEMBL1201293,BRD:BRD-BRD-K26262077-238-01-5;BRD:BRD-K26262077-238-01-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B;GRM5,ABSTINENCE FROM ALCOHOL,,LAUNCHED,,Small molecule,4,"CC(=O)NCCCS(=O)(=O)O;CC(=O)NCCCS(O)(=O)=O, CC(=O)NCCCS(O)(=O)=O",AFCGFAGUEYAMAO-UHFFFAOYSA-N
PRECOSE,ACARBOSE;BAY G 5421;BAY-G 5421;BAY-G-5421;GLUCOBAY;NSC-758915;PRECOSE,CHEMBL1566;CHEMBL404271,BRD:BRD-BRD-K44276885-001-07-4;BRD:BRD-K44276885-001-07-4,rep_primary;rep_single_dose,GLUCOSIDASE INHIBITOR,AMY2A;GAA;MGAM;SI,DIABETES MELLITUS,,LAUNCHED,,Oligosaccharide,4,"C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O, C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O, C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O, C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O;C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O",XUFXOAAUWZOOIT-SXARVLRPSA-N
ACDPP,ACDPP,,BRD:BRD-BRD-K68633617-003-02-9;BRD:BRD-K68633617-003-02-9,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM5,,,PRECLINICAL,,,NA,CN(C)C1NC(N)C(NC1CL)C(=O)NC1CCCNC1,
EP-501,ACEBILUSTAT;CTX-4430;EP-501,CHEMBL4297604,BRD:BRD-K00003255-001-01-9,rep_single_dose,LEUKOTRIENE INHIBITOR,,,,,,Small molecule,2,O=C(O)c1ccc(CN2C[C@@H]3C[C@H]2CN3Cc2ccc(Oc3ccc(-c4ncco4)cc3)cc2)cc1,GERJIEKMNDGSCS-DQEYMECFSA-N
SECTRAL,ACEBUTOLOL;C07AB04;SECTRAL,CHEMBL642,BRD:BRD-A29260609-003-26-0;BRD:BRD-BRD-A29260609-003-26-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,"HYPERTENSION, VENTRICULAR ARRHYTHMIAS",,LAUNCHED,,Small molecule,4,"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1;CCCC(=O)NC1CCC(OCC(O)CNC(C)C)C(C1)C(C)=O, CCCC(=O)NC1CCC(OCC(O)CNC(C)C)C(C1)C(C)=O",GOEMGAFJFRBGGG-UHFFFAOYSA-N
N-ACETYLPROCAINE AMIDE,ACECAINIDE;ACETYLPROCAINAMIDE;N-;N-ACETYL PROCAINAMIDE(<30%);N-ACETYL-PROCAINAMIDE;N-ACETYLNOVOCAINAMIDE;N-ACETYLPROCAINAMIDE;N-ACETYLPROCAINE AMIDE,CHEMBL1097,BRD:BRD-BRD-K07753030-003-17-6;BRD:BRD-K07753030-003-17-6,rep_primary;rep_single_dose,POLARIZATION INHIBITOR,SCN5A,,,PHASE 3,,Small molecule,-1,CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1;CCN(CC)CCNC(=O)C1CCC(NC(C)=O)CC1,KEECCEWTUVWFCV-UHFFFAOYSA-N
NSC-758239,3-QUINUCLIDINOL ACETATE (ESTER);3-QUINUCLIDINOL DL-FORM ACETATE (ESTER);ACECLIDINE;ACECLIDINE HCL;ACECLIDINE HYDROCHLORIDE;GLAUCOSTAT;NSC-657843;NSC-758239,CHEMBL20835,BRD:BRD-A32673558-003-03-9;BRD:BRD-BRD-A32673558-003-03-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,GLAUCOMA,,LAUNCHED,,Small molecule,2,"CC(=O)OC1CN2CCC1CC2;CC(=O)OC1CN2CCC1CC2, CC(=O)OC1CN2CCC1CC2, CC(=O)OC1CN2CCC1CC2",WRJPSSPFHGNBMG-UHFFFAOYSA-N
PRESERVEX,ACECLOFENAC;ACECLOFENAC BETADEX;GERBIN;PRESERVEX,CHEMBL93645,BRD:BRD-BRD-K68538666-001-12-3;BRD:BRD-K68538666-001-12-3,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGS2,"RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, OSTEOARTHRITIS, PERIARTHRITIS, LUMBAGO, ISCHIADYNIA",,LAUNCHED,,Small molecule,4,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl;OC(=O)COC(=O)CC1CCCCC1NC1C(CL)CCCC1CL,MNIPYSSQXLZQLJ-UHFFFAOYSA-N
SULFADIAMINE,"1399FCI-556;4',4'''-SULFONYLBIS(ACETANILIDEC);ACEDAPSONE;CI 556;CI-556;CN-1883;DADDS;DIACETYLDAPSONE;HANSOLAR;NSC-218125;NSC-655049;PAM MR 1165;PAM-MR-1165;SULFADIAMINE",CHEMBL154166,BRD:BRD-BRD-K97417064-001-02-4;BRD:BRD-K97417064-001-02-4,rep_primary;rep_single_dose,,,LEPROSY,,LAUNCHED,,Small molecule,-1,CC(=O)NC1CCC(CC1)S(=O)(=O)C1CCC(NC(C)=O)CC1;CC(=O)Nc1ccc(S(=O)(=O)c2ccc(NC(C)=O)cc2)cc1,AMTPYFGPPVFBBI-UHFFFAOYSA-N
P-ACETAMIDOBENZOIC ACID,ACEDOBEN;NSC-4002;P-ACETAMIDOBENZOIC ACID,CHEMBL112687,BRD:BRD-BRD-K47195926-001-06-6;BRD:BRD-K47195926-001-06-6,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,CC(=O)Nc1ccc(C(=O)O)cc1;CC(=O)NC1CCC(CC1)C(O)=O,QCXJEYYXVJIFCE-UHFFFAOYSA-N
NSC-52996,ACEFYLLINE;ACEPHYLLINE;CAFFEINE CARBOXYLIC ACID;DOXOPHYLLINE METABOLITE M2;NSC-52996,CHEMBL70246,BRD:BRD-BRD-K44004064-001-07-3;BRD:BRD-K44004064-001-07-3,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1,ASTHMA,,LAUNCHED,,Small molecule,4,Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O;CN1C2NCN(CC(O)=O)C2C(=O)N(C)C1=O,HCYFGRCYSCXKNQ-UHFFFAOYSA-N
ACEGLUTAMIDE,ACEGLUTAMIDE,,BRD:BRD-BRD-K13619941-213-01-8;BRD:BRD-K13619941-213-01-8,rep_primary;rep_single_dose,,,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,,NA,CC(=O)N[C@@H](CCC(N)=O)C(O)=O,
P(RS)-,ACELARIN;BIO-1031;CPF-31;CPF31;FOSGEMCITABINE PALABENAMIDE;GEMICTABINE PROTIDE;NUC-1031;P(RS)-,CHEMBL3126004,BRD:BRD-K00003531-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,Small molecule,3,C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccccc1)C(=O)OCc1ccccc1,NHTKGYOMICWFQZ-KKQYNPQSSA-N
RANTUDIL,ACEMETACIN;EMFLEX;NSC-757413;RANTUDIL,CHEMBL189171,BRD:BRD-BRD-K67563174-001-17-6;BRD:BRD-K67563174-001-17-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,OSTEOARTHRITIS,,LAUNCHED,,Small molecule,4,"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1;COC1CCC2N(C(=O)C3CCC(CL)CC3)C(C)C(CC(=O)OCC(O)=O)C2C1, COC1CCC2N(C(=O)C3CCC(CL)CC3)C(C)C(CC(=O)OCC(O)=O)C2C1",FSQKKOOTNAMONP-UHFFFAOYSA-N
ACENEURAMIC-ACID,ACENEURAMIC-ACID,,BRD:BRD-BRD-K36262466-001-06-3;BRD:BRD-K36262466-001-06-3,rep_primary;rep_single_dose,,AZGP1;CES1;MBL2;REG1A;SELE;SELP;SIGLEC1,,,PHASE 3,,,NA,CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O,
SINTHROME,ACENOCOUMARIN;ACENOCOUMAROL;MINI-SINTROM;NICOUMALONE;NSC-760052;SINTHROME,CHEMBL397420,BRD:BRD-A65051990-001-12-9;BRD:BRD-BRD-A65051990-001-12-9,rep_primary;rep_single_dose,VITAMIN K ANTAGONIST,VKORC1,DEEP VEIN THROMBOSIS (DVT),,LAUNCHED,,Small molecule,4,CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O;CC(=O)CC(C1CCC(CC1)[N+]([O-])=O)C1C(O)C2CCCCC2OC1=O,VABCILAOYCMVPS-UHFFFAOYSA-N
CONCENTRAT VO34,ACEPROMAZINE;ACETYLPROMAZINE;ACEZINE 2;ATRAVET;CONCENTRAT VO34,CHEMBL39560,BRD:BRD-BRD-K37814297-050-09-6;BRD:BRD-K37814297-050-09-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;DRD1;DRD2;HTR1A;HTR2A,SEDATIVE,,LAUNCHED,,Small molecule,-1,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2;CN(C)CCCN1C2CCCCC2SC2CCC(CC12)C(C)=O,NOSIYYJFMPDDSA-UHFFFAOYSA-N
ACESULFAME-POTASSIUM,ACESULFAME-POTASSIUM,,BRD:BRD-BRD-K50850824-237-04-8;BRD:BRD-K50850824-237-04-8,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 3,,,NA,"CC1=CC(=O)NS(=O)(=O)O1, CC1=CC(=O)NS(=O)(=O)O1, CC1=CC(=O)NS(=O)(=O)O1",
PHENALGENE,ACETAMINOPHEN RELATED COMPOUND D;ACETANILID;ACETANILIDE;ACETANILIDUM;ANTIFEBRIN;ANTIFEBRINUM;NSC-203231;NSC-7636;PHENALGENE,CHEMBL269644,BRD:BRD-BRD-K11094367-001-10-1;BRD:BRD-K11094367-001-10-1,rep_primary;rep_single_dose,HYDROGEN PEROXIDE DECOMPOSITION INHIBITOR,,,,PRECLINICAL,,Small molecule,-1,"CC(=O)Nc1ccccc1;CC(=O)NC1CCCCC1, CC(=O)NC1CCCCC1",FZERHIULMFGESH-UHFFFAOYSA-N
STOVARSOL,ACETARSOL;ACETARSONE;GYNOPLIX;NSC-13160;S.V.C.;STOVARSOL,CHEMBL1330792,BRD:BRD-BRD-K99048103-001-18-4;BRD:BRD-K99048103-001-18-4,rep_primary;rep_single_dose,,,DIARRHEA,,LAUNCHED,,Small molecule,4,"CC(=O)Nc1cc([As](=O)(O)O)ccc1O;CC(=O)NC1CC(CCC1O)[AS](O)(O)=O, CC(=O)NC1CC(CCC1O)[AS](O)(O)=O",ODFJOVXVLFUVNQ-UHFFFAOYSA-N
PHONURIT,ACETAMOX;ACETAZOLAMIDE;ACETAZOLAMIDUM;ATENEZO;DEFILTRAN;DIAMOX;DIAMOX SR;DIDOC;DIURIWAS;DONMOX;EDEMOX;EYTAZOX;GLAUPAX;L 579486;NEPHRAMIDE;NSC-145177;PHONURIT,CHEMBL20,BRD:BRD-BRD-K43457670-001-27-8;BRD:BRD-K43457670-001-27-8,rep_multi_dose;rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,AQP1;CA1;CA12;CA14;CA2;CA3;CA4;CA7,GLAUCOMA,,LAUNCHED,,Small molecule,4,CC(=O)Nc1nnc(S(N)(=O)=O)s1;CC(=O)NC1NNC(S1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N
NSC-759128,33006;ACETOHEXAMIDE;DIMELOR;DYMELOR;NSC-759128,CHEMBL1589,BRD:BRD-BRD-K52960356-001-15-5;BRD:BRD-K52960356-001-15-5,rep_primary;rep_single_dose,ATP CHANNEL BLOCKER,ABCC8;KCNJ1;KCNJ10;KCNJ11,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CC(=O)C1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1, CC(=O)C1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1;CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1",VGZSUPCWNCWDAN-UHFFFAOYSA-N
NSC-176136,ACETOHYDROXAMIC ACID;ACETOHYDROXAMIC-ACID;LITHOSTAT;NSC-176136,CHEMBL734,BRD:BRD-BRD-K21615095-001-08-4;BRD:BRD-K21615095-001-08-4,rep_primary;rep_single_dose,UREASE INHIBITOR,MMP12,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,CC(=O)NO,RRUDCFGSUDOHDG-UHFFFAOYSA-N
TINDAL,ACETOPHENAZINE;TINDAL,CHEMBL1085,BRD:BRD-BRD-K42938903-332-01-1;BRD:BRD-K42938903-332-01-1,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD2,PSYCHOSIS,,LAUNCHED,,Small molecule,4,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2;CC(=O)C1CCC2SC3CCCCC3N(CCCN3CCN(CCO)CC3)C2C1,WNTYBHLDCKXEOT-UHFFFAOYSA-N
ACETRIAZOIC-ACID,ACETRIAZOIC-ACID,,BRD:BRD-BRD-K46416130-001-07-7;BRD:BRD-K46416130-001-07-7,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"CC(=O)NC1C(I)CC(I)C(C(O)=O)C1I, CC(=O)NC1C(I)CC(I)C(C(O)=O)C1I",
ACETYL-11-KETO-BETA-BOSWELLIC-ACID,ACETYL-11-KETO-BETA-BOSWELLIC-ACID,,BRD:BRD-A44696962-001-01-4;BRD:BRD-BRD-A44696962-001-01-4,rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,HSD11B1;HSD11B2,,,PHASE 2,,,NA,C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)(C5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C,
ACETYL-FARNESYL-CYSTEINE,ACETYL-FARNESYL-CYSTEINE,,BRD:BRD-BRD-K79437791-001-05-7;BRD:BRD-K79437791-001-05-7,rep_primary;rep_single_dose,METHYLTRANSFERASE INHIBITOR,PPARG,ACNE VULGARIS (AV),,LAUNCHED,,,NA,"CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O, CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O",
ACETYL-L-LEUCINE,ACETYL-L-LEUCINE,CHEMBL56021,BRD:BRD-BRD-K27406233-001-07-7;BRD:BRD-K27406233-001-07-7,rep_primary;rep_single_dose,,,VERTIGO,,LAUNCHED,,Small molecule,3,CC(=O)N[C@@H](CC(C)C)C(=O)O;CC(C)C[C@H](NC(C)=O)C(O)=O,WXNXCEHXYPACJF-ZETCQYMHSA-N
ACETYLCHOLINE,ACETYLCHOLINE,CHEMBL667,BRD:BRD-BRD-K82381502-003-23-1;BRD:BRD-K82381502-003-23-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,ACHE;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;CHRNA2,"DROWSINESS, FATIGUE, HEADACHE, INDIGESTION, CHEST CONGESTION",,LAUNCHED,,Small molecule,4,"CC(=O)OCC[N+](C)(C)C;CC(=O)OCC[N+](C)(C)C, CC(=O)OCC[N+](C)(C)C",OIPILFWXSMYKGL-UHFFFAOYSA-N
YOURNAC,5052;A-CYS;ACC-600;ACETADOTE;ACETYL CYSTEINE;ACETYLCYSTEINE;AIRBRON;BRONCHOLYSIN;CETYLEV;EN-CYS;FABROL;FLUIMICIL;FLUIMUCETIN;FLUIMUCIL;FLUIMUCIL 600;FLUIMUCIL LONG;FLUIMUCIL N;ILUBE;MERCAPTURIC ACID;MUCOMYST;MUCOSIL;MUCOSIL-10;MUCOSIL-20;N-ACETYI-L-CYSTEINE;N-ACETYL-L-CYSTEINE;NSC-111180;ORISTAR NALC;ORONAC 600;PARVOLEX;RESPAIRE;RESPI-NAC;RK-0202;SIRAN;SOLMUCOL;SYNTEMUCOL;TIXAIR;YOURNAC,CHEMBL600,BRD:BRD-BRD-K59058747-001-18-3;BRD:BRD-BRD-K59058747-001-20-9;BRD:BRD-K59058747-001-18-3;BRD:BRD-K59058747-001-20-9,rep_multi_dose;rep_primary;rep_single_dose,MUCOLYTIC AGENT,ACY1;CHUK;GRIN1;GRIN2A;GRIN2B;GRIN2D;GRIN3A;GSS;IKBKB;RELA;SLC7A11,"ACETAMINOPHEN OVERDOSE, HEPATIC INJURY",,LAUNCHED,,Small molecule,4,"CC(=O)N[C@@H](CS)C(=O)O;CC(=O)N[C@@H](CS)C(O)=O, CC(=O)N[C@@H](CS)C(O)=O, CC(=O)N[C@@H](CS)C(O)=O",PWKSKIMOESPYIA-BYPYZUCNSA-N
ACETYLSALICYLSALICYLIC-ACID,ACETYLSALICYLSALICYLIC-ACID,,BRD:BRD-BRD-K46585355-001-14-3;BRD:BRD-K46585355-001-14-3,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,PRECLINICAL,,,NA,CC(=O)OC1CCCCC1C(=O)OC1CCCCC1C(O)=O,
SPIRAMYCIN I,ACETYLSPIRAMYCIN;IL 5902;IL-5902;NSC-55926;NSC-64393;NSC-758472;ROVAMICINA;ROVAMYCIN;ROVAMYCINE;ROVAMYCINE 250;RP 5337;RP-5337;SELECTOMYCIN;SPIRAMYCIN;SPIRAMYCIN I,CHEMBL453514,BRD:BRD-K00004968-001-01-9,rep_single_dose,OTHER ANTIBIOTIC,,,,,,Small molecule,4,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O,ACTOXUHEUCPTEW-CEUOBAOPSA-N
ACEXAMIC-ACID,ACEXAMIC-ACID,,BRD:BRD-BRD-K72215350-001-06-5;BRD:BRD-K72215350-001-06-5,rep_primary;rep_single_dose,5 ALPHA REDUCTASE INHIBITOR,GAST,WOUND HEALING,,LAUNCHED,,,NA,CC(=O)NCCCCCC(O)=O,
REDUCTOL,"ACIFRAN;ACIFRANUM;AY-25,712;AY-25712;REDUCTOL",CHEMBL278488,BRD:BRD-A29520968-001-02-7;BRD:BRD-BRD-A29520968-001-02-7,rep_primary;rep_single_dose,CHOLESTEROL INHIBITOR,HCAR2;HCAR3,,,PHASE 3,,Small molecule,-1,"CC1(c2ccccc2)OC(C(=O)O)=CC1=O;CC1(OC(=CC1=O)C(O)=O)C1CCCCC1, CC1(OC(=CC1=O)C(O)=O)C1CCCCC1",DFDGRKNOFOJBAJ-UHFFFAOYSA-N
OLBETAM,ACIPIMOX;NSC-759818;OLBETAM,CHEMBL345714,BRD:BRD-BRD-K63736853-001-04-8;BRD:BRD-K63736853-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,CHOLESTEROL INHIBITOR,HCAR2,HYPERLIPIDEMIA,,LAUNCHED,,Small molecule,4,"Cc1cnc(C(=O)O)c[n+]1[O-];CC1CNC(C[N+]1[O-])C(O)=O, CC1CNC(C[N+]1[O-])C(O)=O, CC1CNC(C[N+]1[O-])C(O)=O",DJQOOSBJCLSSEY-UHFFFAOYSA-N
ACITAZANOLAST HYDRATE,ACITAZANOLAST;ACITAZANOLAST HYDRATE,CHEMBL2104654,BRD:BRD-BRD-K74236708-001-01-9;BRD:BRD-K74236708-001-01-9,rep_primary;rep_single_dose,MEDIATOR RELEASE INHIBITOR,,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,-1,"O=C(O)C(=O)Nc1cccc(-c2nnn[nH]2)c1;OC(=O)C(=O)NC1CCCC(C1)-C1NNN[NH]1, OC(=O)C(=O)NC1CCCC(C1)-C1NNN[NH]1",VWQZJJZGISNFOE-UHFFFAOYSA-N
SORIATANE,ACITRETIN;ETRETIN;NEOTIGASON;RO 10-1670;RO 10-1670/000;RO-101670000;SORIATANE,CHEMBL1131,BRD:BRD-BRD-K62012036-001-14-4;BRD:BRD-K62012036-001-14-4,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA;RARB;RARG;RBP1;RXRA;RXRB;RXRG;STAT3,PSORIASIS,,LAUNCHED,,Small molecule,4,"COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C;COC1CC(C)C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)C1C, COC1CC(C)C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)C1C",IHUNBGSDBOWDMA-AQFIFDHZSA-N
U-42126,"ACIVICIN;AT 125;AT-125;NSC-163501;U 42,126;U 42126;U-42,126;U-42126",CHEMBL1231101,BRD:BRD-BRD-K13050541-001-01-9;BRD:BRD-K13050541-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,"GAMMA GLUTAMYLTRANSFERASE INHIBITOR, GAMMA GLUTAMYLTRANSFERASE INHIBITORS",CTPS1,,,PHASE 2,"Multiple values for MOA: {'GAMMA GLUTAMYLTRANSFERASE INHIBITOR, GAMMA GLUTAMYLTRANSFERASE INHIBITORS', 'GAMMA GLUTAMYLTRANSFERASE INHIBITORS'}, defaulting to 'GAMMA GLUTAMYLTRANSFERASE INHIBITOR, GAMMA GLUTAMYLTRANSFERASE INHIBITORS'",Small molecule,-1,N[C@H]([C@@H]1CC(CL)=NO1)C(O)=O;N[C@H](C(=O)O)[C@@H]1CC(Cl)=NO1,QAWIHIJWNYOLBE-OKKQSCSOSA-N
ACLIDINIUM ION,ACLIDINIUM;ACLIDINIUM CATION;ACLIDINIUM ION,CHEMBL1194325,BRD:BRD-BRD-K74363950-004-01-0;BRD:BRD-K74363950-004-01-0,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,"BRONCHITIS, EMPHYSEMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)",,LAUNCHED,,Small molecule,4,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1;OC(C(=O)O[C@H]1C[N+]2(CCCOC3CCCCC3)CCC1CC2)(C1CCCS1)C1CCCS1,ASMXXROZKSBQIH-VITNCHFBSA-N
SCH57068,ACOLBIFENE;EM-652;SCH-57068;SCH57068,CHEMBL68055,BRD:BRD-K00004720-001-01-9,rep_single_dose,ESTROGEN RECEPTOR ANTAGONIST,,,,,,Small molecule,3,CC1=C(c2ccc(O)cc2)[C@H](c2ccc(OCCN3CCCCC3)cc2)Oc2cc(O)ccc21,DUYNJNWVGIWJRI-LJAQVGFWSA-N
SCYX-7158,ACOZIBOROLE;SCTX-7158;SCYX-7158,CHEMBL2347704,BRD:BRD-K00003303-001-01-9,rep_single_dose,ANTITRYPANOSOMAL,,,,,,Small molecule,2,CC1(C)OB(O)c2cc(NC(=O)c3ccc(F)cc3C(F)(F)F)ccc21,PTYGDEXEGLDNAZ-UHFFFAOYSA-N
ACPC,ACPC,,BRD:BRD-BRD-K66465025-001-05-1;BRD:BRD-K66465025-001-05-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,PHASE 1,,,NA,NC1(CC1)C(O)=O,
SEMPREX,ACRIVASTINE;BENADRYL ALLGY RELIEF PLUS DECONGEST;BW 825C;BW-825C;SEMPREX,CHEMBL1224,BRD:BRD-BRD-K50163129-001-01-4;BRD:BRD-K50163129-001-01-4,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1;CC1CCC(CC1)C(=C/CN1CCCC1)\C1CCCC(\C=C\C(O)=O)N1,PWACSDKDOHSSQD-IUTFFREVSA-N
ACRIZANIB,ACRIZANIB,,BRD:BRD-K00093439-001-01-9,rep_single_dose,,,,,,,,NA,,
ACRYLATE,ACRYLATE,,BRD:BRD-M00184283-001-01-1,rep_single_dose,MUCUS PROTECTING AGENT,,,,,,,NA,,
MACITENTAN METABOLITE M6,ACT-132577;APROCITENTAN;MACITENTAN METABOLITE M6,CHEMBL2165326,BRD:BRD-K34843150-001-03-0,rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA;EDNRB,,,,,Small molecule,3,NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,DKULOVKANLVDEA-UHFFFAOYSA-N
ACT-462206,ACT-462206,CHEMBL3597952,BRD:BRD-BRD-K19781342-001-01-4;BRD:BRD-K19781342-001-01-4,rep_primary;rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR1;HCRTR2,,,PHASE 1,,Small molecule,1,"COC1CCC(CC1)S(=O)(=O)N1CCC[C@H]1C(=O)NC1CC(C)CC(C)C1, COC1CCC(CC1)S(=O)(=O)N1CCC[C@H]1C(=O)NC1CC(C)CC(C)C1;COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C)cc(C)c2)cc1",NHPQGZOBHSVTAQ-IBGZPJMESA-N
APINOCALTAMIDE,ACT-709478;APINOCALTAMIDE,CHEMBL4217292,BRD:BRD-K00003538-001-02-9,rep_single_dose,,,,,,,Small molecule,2,N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1,LSYANGLAZUZYFX-UHFFFAOYSA-N
YM-340790,(P-ACETAMIDOPHENYL)ACETIC ACID;ACTARIT;MIRABEGRON (M9);NSC-170317;YM-340790,CHEMBL1885632,BRD:BRD-BRD-K33483813-001-10-0;BRD:BRD-K33483813-001-10-0,rep_primary;rep_single_dose,INTERLEUKIN RECEPTOR AGONIST,,RHEUMATOID ARTHRITIS,,LAUNCHED,,Small molecule,-1,CC(=O)Nc1ccc(CC(=O)O)cc1;CC(=O)NC1CCC(CC(O)=O)CC1,MROJXXOCABQVEF-UHFFFAOYSA-N
ACTB-1003,ACTB-1003,,BRD:BRD-BRD-K35936936-001-01-6;BRD:BRD-K35936936-001-01-6,rep_primary;rep_single_dose,"FGFR INHIBITOR, VEGFR INHIBITOR",KDR;TEK,,,PHASE 1,,,NA,COCC1C(CN2CCOCC2)N2NCNC(N)C2C1-C1CCC(NC(=O)NC2CC(CCC2F)C(F)(F)F)C(F)C1,
ONCOSTATIN K,ACTINOMYCIN C1;ACTINOMYCIN D;ACTINOMYCIN I1;ACTINOMYCIN IV;ACTINOMYCIN X1;ACTINOMYCIN-D;COSMEGEN;COSMEGEN LYOVAC;DACTINOMYCIN;DACTINOMYCINUM;DILACTONE ACTINOMYCIN D ACID;GNF-PF-1977;GNF-PF-2290;MERACTINOMYCIN;NCI-C04682;NSC-3053;ONCOSTATIN K,CHEMBL1554,GDSC2:1811;GDSC2:1911,gdsc,,,,,,,Protein,4,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,RJURFGZVJUQBHK-IIXSONLDSA-N
ONCOSTATIN K,ACTINOMYCIN C1;ACTINOMYCIN D;ACTINOMYCIN I1;ACTINOMYCIN IV;ACTINOMYCIN X1;ACTINOMYCIN-D;COSMEGEN;COSMEGEN LYOVAC;DACTINOMYCIN;DACTINOMYCINUM;DILACTONE ACTINOMYCIN D ACID;GNF-PF-1977;GNF-PF-2290;MERACTINOMYCIN;NCI-C04682;NSC-3053;ONCOSTATIN K,CHEMBL1554,BRD:BRD-A42383464-001-06-3;BRD:BRD-BRD-A42383464-001-06-3,rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,"WILM'S TUMOR, EWING'S SARCOMA, RHABDOMYOSARCOMA, TESTICULAR CARCINOMA",,LAUNCHED,,Protein,4,"CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)C2CCC(C)C3OC4C(C)C(=O)C(N)C(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)C4NC23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O, CC(C)C1NC(=O)C(NC(=O)C2CCC(C)C3OC4C(C)C(=O)C(N)C(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)C4NC23)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C1=O;Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O",RJURFGZVJUQBHK-IIXSONLDSA-N
ACTINONIN,ACTINONIN,CHEMBL308333,BRD:BRD-K24621118-001-04-9,rep_single_dose,,,,,,,Small molecule,NA,CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N1CCC[C@H]1CO)C(C)C,XJLATMLVMSFZBN-VYDXJSESSA-N
NSC-165584,ACTINOQUINOL;NSC-165584,CHEMBL1356732,BRD:BRD-BRD-K08837089-236-01-6;BRD:BRD-K08837089-236-01-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CCOC1CCC(C2CCCNC12)S(O)(=O)=O;CCOc1ccc(S(=O)(=O)O)c2cccnc12,YAMVZYRZAMBCED-UHFFFAOYSA-N
BCT-197,ACUMAPIMOD;BCT-197,CHEMBL3545226,BRD:BRD-K00003220-001-01-9,rep_single_dose,P38 MAPK INHIBITOR,,,,,,Small molecule,2,,
RICOLINOSTAT,ACY-1215;ACY-63;RICOLINOSTAT,CHEMBL2364628,BRD:BRD-BRD-K82928847-001-04-7;BRD:BRD-K82928847-001-04-7;GDSC1:264,gdsc;rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC6;HDAC8,,,PHASE 1/PHASE 2,,Small molecule,2,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO;ONC(=O)CCCCCCNC(=O)C1CNC(NC1)N(C1CCCCC1)C1CCCCC1,QGZYDVAGYRLSKP-UHFFFAOYSA-N
ZOVIRAX,ACICLOVIR;ACICLOVIR SODIUM;ACICLOVIRUM;ACYCLOGUANOSINE;ACYCLOVIR;ACYCLOVIR SODIUM;ACYCLOVIR SODIUM SALT;AVACLYR;AVERT;AVIRAL;BW 248U;BW 248U SODIUM;BW-248U SODIUM;BW-248U-SODIUM;CLEARSORE;CYCLOVIR;CYMEX ULTRA;DUVIMEX;GERPEVIR;HERPETAD;LIPSORE;LYPSYL;NOVIRUS;NSC-645011;NSC-758477;RANOVIR;SITAVIG;SODIUM ACYCLOVIR;SOOTHELIP;SORAWAY;VIRALIEF;VIRASORB;VIROVIR 200;VIROVIR 400;VIROVIR 800;ZOVIRAX,CHEMBL1200380;CHEMBL184,BRD:BRD-BRD-K32318651-001-23-7;BRD:BRD-BRD-K32318651-001-24-5;BRD:BRD-K32318651-001-23-7;BRD:BRD-K32318651-001-24-5,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,PNP,"GENITIAL HERPES, SHINGLES, CHICKEN POX",,LAUNCHED,,Small molecule,4,"Nc1nc([O-])c2ncn(COCCO)c2n1.[Na+];Nc1nc2c(ncn2COCCO)c(=O)[nH]1;NC1NC2N(COCCO)CNC2C(=O)[NH]1, NC1NC2N(COCCO)CNC2C(=O)[NH]1, NC1NC2N(COCCO)CNC2C(=O)[NH]1, NC1NC2N(COCCO)CNC2C(=O)[NH]1, NC1NC2N(COCCO)CNC2C(=O)[NH]1",MKUXAQIIEYXACX-UHFFFAOYSA-N;RMLUKZWYIKEASN-UHFFFAOYSA-M
AD-5467,AD-5467,,BRD:BRD-A80280426-001-03-8;BRD:BRD-BRD-A80280426-001-03-8,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,AKR1B1,,,PHASE 2,,,NA,"CC(C)C1OC2C(CCCC2N(CC(O)=O)C1=S)C(C)C, CC(C)C1OC2C(CCCC2N(CC(O)=O)C1=S)C(C)C",
MRTX849,ADAGRASIB;KRAS G12C INHIBITOR MRTX849;MRTX-849;MRTX849,CHEMBL4594350,BRD:BRD-K00029445-001-03-9,oncref_1,INHIBITOR OF KRAS-G12C,KRAS,,,,,Small molecule,3,C=C(F)C(=O)N1CCN(c2nc(OC[C@@H]3CCCN3C)nc3c2CCN(c2cccc4cccc(Cl)c24)C3)C[C@@H]1CC#N,PEMUGDMSUDYLHU-ZEQRLZLVSA-N
DIFFERIN,ADAPALENE;CD 271;CD-271;DIFFERIN,CHEMBL1265,BRD:BRD-BRD-K33127281-001-05-6;BRD:BRD-K33127281-001-05-6,rep_multi_dose;rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA;RARB;RARG;RXRA;RXRB;RXRG,ACNE VULGARIS (AV),,LAUNCHED,,Small molecule,4,"COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2;COC1CCC(CC1C12CC3CC(CC(C3)C1)C2)-C1CCC2CC(CCC2C1)C(O)=O, COC1CCC(CC1C12CC3CC(CC(C3)C1)C2)-C1CCC2CC(CCC2C1)C(O)=O, COC1CCC(CC1C12CC3CC(CC(C3)C1)C2)-C1CCC2CC(CCC2C1)C(O)=O",LZCDAPDGXCYOEH-UHFFFAOYSA-N
ADAPREV,ADAPREV,,BRD:BRD-A73427433-240-01-3;BRD:BRD-BRD-A73427433-240-01-3,rep_multi_dose;rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,AKR1B1;GPI;HK1;IGF2R;M6PR;PYGM,,,PHASE 3,"Multiple values for repurposing_target: {'IGF2R;M6PR', 'AKR1B1;GPI;HK1;IGF2R;M6PR;PYGM'}, taking the union",,NA,OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O,
ADAPTAVIR,ADAPTAVIR,,BRD:BRD-BRD-K37151368-001-01-7;BRD:BRD-K37151368-001-01-7,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR5,,,PHASE 2,,,NA,C[C@@H](O)[C@H](NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O,
ADAROTENE,ADAROTENE,CHEMBL442016,BRD:BRD-BRD-K00152668-001-01-5;BRD:BRD-K00152668-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARB;RARG,,,PHASE 1,,Small molecule,NA,O=C(O)/C=C/c1ccc(-c2ccc(O)c(C34CC5CC(CC(C5)C3)C4)c2)cc1;OC(=O)\C=C\C1CCC(CC1)-C1CCC(O)C(C1)C12CC3CC(CC(C3)C1)C2,QAWBIEIZDDIEMW-FPYGCLRLSA-N
WY-50324,ADATANSERIN;WY-50324,CHEMBL2111138,BRD:BRD-BRD-K67789209-001-01-0;BRD:BRD-K67789209-001-01-0,rep_primary;rep_single_dose,"SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",HTR1A;HTR2A,,,PHASE 2,,Small molecule,-1,O=C(NCCN1CCN(c2ncccn2)CC1)C12CC3CC(CC(C3)C1)C2;O=C(NCCN1CCN(CC1)C1NCCCN1)C12CC3CC(CC(C3)C1)C2,HPFLVTSWRFCPCV-UHFFFAOYSA-N
SM04690,ADAVIVINT;LORECIVIVINT;SM-04690;SM04690,CHEMBL4297639,BRD:BRD-K00003499-001-01-9,rep_single_dose,WNT PATHWAY INHIBITOR,,,,,,Small molecule,3,CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5cncc(-c6cccc(F)c6)c5[nH]4)c3c2)c1,AQDWDWAYVBQMAM-UHFFFAOYSA-N
MK1775,ADAVOSERTIB;AZD 1775;AZD-1775;AZD1775;MK-1775;MK1775,CHEMBL1976040,BRD:BRD-BRD-K54256913-001-08-7;BRD:BRD-K54256913-001-08-7;BRD:BRD-U00115430-001-01-9;CTRP:418167;GDSC2:1179,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,WEE1 KINASE INHIBITOR,WEE1,,,PHASE 2,"Multiple values for MOA: {'WEE1 KINASE INHIBITOR', 'INHIBITOR OF WEE1'}, defaulting to 'WEE1 KINASE INHIBITOR'
Multiple values for structure_id: {'K54256913', 'U00115430'}, defaulting to None",Small molecule,2,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1;CN1CCN(CC1)C1CCC(NC2NCC3C(N2)N(-C2CCCC(N2)C(C)(C)O)N(CC=C)C3=O)CC1,BKWJAKQVGHWELA-UHFFFAOYSA-N
IMEPITOIN,ADD-233089;IMEPITOIN,,BRD:BRD-BRD-K43055376-001-01-2;BRD:BRD-K43055376-001-01-2;BRD:BRD-K43055376-001-04-9,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,,,,PHASE 1,,,NA,CLC1CCC(CC1)N1CC(=NC1=O)N1CCOCC1,
GS-0393,ADEFOVIR;GS 0393;GS-0393,CHEMBL484,BRD:BRD-BRD-K77484724-001-02-0;BRD:BRD-K77484724-001-02-0,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,HEPATITIS B,,LAUNCHED,,Small molecule,3,"Nc1ncnc2c1ncn2CCOCP(=O)(O)O;NC1NCNC2N(CCOCP(O)(O)=O)CNC12, NC1NCNC2N(CCOCP(O)(O)=O)CNC12",SUPKOOSCJHTBAH-UHFFFAOYSA-N
ADEFOVIR-DIPIVOXIL,ADEFOVIR-DIPIVOXIL,,BRD:BRD-BRD-K96159438-001-06-3;BRD:BRD-K96159438-001-06-3,rep_multi_dose;rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,HEPATITIS B,,LAUNCHED,,,NA,"CC(C)(C)C(=O)OCOP(=O)(COCCN1CNC2C(N)NCNC12)OCOC(=O)C(C)(C)C, CC(C)(C)C(=O)OCOP(=O)(COCCN1CNC2C(N)NCNC12)OCOC(=O)C(C)(C)C",
NSC-27132,ADELMIDROL;NSC-27132,CHEMBL2105967,BRD:BRD-K78097265-001-02-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,2,O=C(CCCCCCCC(=O)NCCO)NCCO,PAHZPHDAJQIETD-UHFFFAOYSA-N
NSC-14666,ADENINE;NSC-14666,CHEMBL226345,BRD:BRD-BRD-K26060080-065-05-6;BRD:BRD-K26060080-065-05-6,rep_primary;rep_single_dose,PROTEIN SYNTHESIS STIMULANT,ACACB;ACP1;APRT;MTAP;PECR;SRPK2,,,PRECLINICAL,,Small molecule,3,"Nc1[nH]cnc2ncnc1-2;NC1NCNC2[NH]CNC12, NC1NCNC2[NH]CNC12, NC1NCNC2[NH]CNC12, NC1NCNC2[NH]CNC12",GFFGJBXGBJISGV-UHFFFAOYSA-N
SR-96225,9-.BETA.-D-RIBOFURANOSYLADENINE;ADENOCARD;ADENOCOR;ADENOSCAN;ADENOSINE;NSC-7652;SR 96225;SR-96225,CHEMBL477,BRD:BRD-BRD-K01577834-001-15-1;BRD:BRD-K01577834-001-15-1,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3;PI4K2A;PI4K2B;TRPM4,WOLFF-PARKINSON-WHITE SYNDROME (WPW),,LAUNCHED,,Small molecule,4,"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O;NC1NCNC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O, NC1NCNC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O",OIRDTQYFTABQOQ-KQYNXXCUSA-N
ADENOSINE-PHOSPHATE,ADENOSINE-PHOSPHATE,,BRD:BRD-A10111329-001-04-6;BRD:BRD-BRD-A10111329-001-04-6,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ACSL1;ACSS1;ACSS2;ADCY1;ADK;CREB1;FBP1;HINT1;PDE4B;PDE4D;PIM1;PRKAA1;PRKAB1;PRKAB2;PYGL;TRPM4,,,LAUNCHED,,,NA,NC1NCNC2N(CNC12)C1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,
ADENOSINE-TRIPHOSPHATE,ADENOSINE-TRIPHOSPHATE,,BRD:BRD-A31990649-304-02-3;BRD:BRD-BRD-A31990649-304-02-3,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ABCA1;ABCB1;ABCB11;ABCC2;ABCC8;ABCC9;ABCG1;ABL1;ABL2;ACSL1;ACSS1;ACSS2;ACVR1;ACVR1B;ACVRL1;ADCY1;ADRBK1;ADRBK2;AFG3L2;AKT1;ALK;AMHR2;APAF1;ARAF;ASNA1;ASNS;ASS1;CDK15;GPR17;ITPR1;NAE1;NT5C2;P2RY1;P2RY11;P2RY13;P2RY2;P2RY4;PRKAA1;RYR1;RYR2;RYR3;SLC25A4;TNK2;TRPM4;TRPM7,,,PHASE 2,,,NA,"NC1NCNC2N(CNC12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O, NC1NCNC2N(CNC12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O, NC1NCNC2N(CNC12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O",
ADIPHENINE,ADIPHENINE,CHEMBL353846,BRD:BRD-BRD-K60907894-003-23-5;BRD:BRD-K60907894-003-23-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRNA1,SPASMS,,LAUNCHED,,Small molecule,-1,"CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1;CCN(CC)CCOC(=O)C(C1CCCCC1)C1CCCCC1, CCN(CC)CCOC(=O)C(C1CCCCC1)C1CCCCC1",JGOAIQNSOGZNBX-UHFFFAOYSA-N
ADIPIC-ACID,ADIPIC-ACID,,BRD:BRD-BRD-K10656395-001-02-1;BRD:BRD-K10656395-001-02-1,rep_primary;rep_single_dose,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,SLC22A6,,,PRECLINICAL,,,NA,OC(=O)CCCCC(O)=O,
ADIPORON,ADIPORON,,BRD:BRD-BRD-K68810443-001-01-9;BRD:BRD-K68810443-001-01-9,rep_primary;rep_single_dose,ADIPONECTIN RECEPTOR AGONIST,ADIPOR1;ADIPOR2,,,PRECLINICAL,,,NA,"O=C(COC1CCC(CC1)C(=O)C1CCCCC1)NC1CCN(CC2CCCCC2)CC1, O=C(COC1CCC(CC1)C(=O)C1CCCCC1)NC1CCN(CC2CCCCC2)CC1, O=C(COC1CCC(CC1)C(=O)C1CCCCC1)NC1CCN(CC2CCCCC2)CC1",
ADL5859,ADL5859,,BRD:BRD-BRD-K39624409-003-02-6;BRD:BRD-K39624409-003-02-6,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRD1,,,PHASE 2,,,NA,"CCN(CC)C(=O)C1CCC(CC1)C1=CC2(CCNCC2)OC2CCCC(O)C12, CCN(CC)C(=O)C1CCC(CC1)C1=CC2(CCNCC2)OC2CCCC(O)C12",
LY2409021,(-)-;ADOMEGLIVANT;LY-2409021;LY2409021,CHEMBL3707351,BRD:BRD-K00003302-001-01-9,rep_single_dose,GLUCAGON RECEPTOR ANTAGONIST,,,,,,Small molecule,2,Cc1cc(O[C@@H](CCC(F)(F)F)c2ccc(C(=O)NCCC(=O)O)cc2)cc(C)c1-c1ccc(C(C)(C)C)cc1,FASLTMSUPQDLIB-MHZLTWQESA-N
SLV-313,ADOPRAZINE;SLV-313,CHEMBL221692,BRD:BRD-BRD-K34870043-001-01-8;BRD:BRD-K34870043-001-01-8,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR AGONIST",DRD2;HTR1A,,,PHASE 2,,Small molecule,1,Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1;FC1CCC(CC1)-C1CNCC(CN2CCN(CC2)C2CCCC3OCCOC23)C1,IUVSEUFHPNITEQ-UHFFFAOYSA-N
OLMIFON,ADRAFINIL;OLMIFON,CHEMBL93077,BRD:BRD-A90926615-001-01-9;BRD:BRD-BRD-A90926615-001-01-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,FATIGUE,,LAUNCHED,,Small molecule,-1,"O=C(C[S+]([O-])C(c1ccccc1)c1ccccc1)NO;ONC(=O)CS(=O)C(C1CCCCC1)C1CCCCC1, ONC(=O)CS(=O)C(C1CCCCC1)C1CCCCC1",CGNMLOKEMNBUAI-UHFFFAOYSA-N
NSC-243611,ADRENALONE;ADRENONE;NSC-243611,CHEMBL2103996,BRD:BRD-BRD-K82343404-003-02-4;BRD:BRD-K82343404-003-02-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A,HEMORRHAGE,,LAUNCHED,,Small molecule,-1,"CNCC(=O)c1ccc(O)c(O)c1;CNCC(=O)C1CCC(O)C(O)C1, CNCC(=O)C1CCC(O)C(O)C1",PZMVOUYYNKPMSI-UHFFFAOYSA-N
ADRENOSTERONE,ADRENOSTERONE,,BRD:BRD-BRD-K17368287-001-18-3;BRD:BRD-K17368287-001-18-3,rep_primary;rep_single_dose,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,HSD11B1;HSD11B2,,,PRECLINICAL,,,NA,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,
VALRUBICIN IMPURITY,ADRIABLASTIN;ADRIABLASTINA CS;ADRIAMYCIN;ADRIAMYCIN PFS;ADRIAMYCIN RDF;ADRIBLASTINA;CAELYX;DOXIL;DOXIL (LIPOSOMAL);DOXORUBICIN;DOXORUBICIN CITRATE;DOXORUBICIN CITRIC ACID SALT;DOXORUBICIN HCL;DOXORUBICIN HYDROCHLORIDE;DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL);DOXORUBICIN LIPOSOMAL COMPLEX OF THE HYDROCHLORIDE;DOXORUBICIN-;DOXORUBICINI HYDROCHLORIDUM;EPIRUBICIN HYDROCHLORIDE IMPURITY;HYDROCHLORIDE;HYDROXYDAUNOMYCIN HYDROCHLORIDE;HYDROXYDAUNORUBICIN;LIPOSOMAL DOXORUBICIN HYDROCHLORIDE;MYOCET;NSC-123127;NSC-759155;PIRARUBICIN;RUBEX;TETRAHYDROPYRANYL;THEPRUBICIN;THP-ADM;VALRUBICIN IMPURITY,CHEMBL2354444;CHEMBL359744;CHEMBL53463,BRD:BRD-BRD-K92093830-003-30-8;BRD:BRD-K00094013-003-39-9;BRD:BRD-K92093830-003-30-8;CTRP:36599;GDSC1:133,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,DNA INTERCALATOR/INHIBITOR OF TOPOISOMERASE,TOP2A;TOP2B,"ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ACUTE MYELOID LEUKEMIA (AML), WILM'S TUMOR, BREAST CANCER, OVARIAN CANCER, HODGKIN'S LYMPHOMA, BLADDER CANCER, MULTIPLE MYELOMA",,LAUNCHED,"Multiple values for MOA: {'DNA INTERCALATOR/INHIBITOR OF TOPOISOMERASE', 'TOPOISOMERASE INHIBITOR'}, defaulting to 'DNA INTERCALATOR/INHIBITOR OF TOPOISOMERASE'
Multiple values for repurposing_target: {'TOP2A', 'TOP2A;TOP2B'}, taking the union
Multiple values for structure_id: {'K92093830', 'K00094013'}, defaulting to None",Small molecule,4,"COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(=O)CO, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(=O)CO, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(=O)CO, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(=O)CO, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(=O)CO, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(=O)CO;COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1",AOJJSUZBOXZQNB-TZSSRYMLSA-N
ADRIFORANT (HYDROCHLORIDE),ADRIFORANT (HYDROCHLORIDE),,BRD:BRD-K00075632-305-02-9,rep_single_dose,,,,,,,,NA,,
RASEGLURANT,ADX-10059;ADX10059;RASEGLURANT,CHEMBL3545036,BRD:BRD-BRD-K77911775-003-01-8;BRD:BRD-K77911775-003-01-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,GRM5,,,PHASE 2,,Small molecule,2,Cc1cc(C)c(N)c(C#Cc2cccc(F)c2)n1;CC1CC(C)C(N)C(N1)C#CC1CCCC(F)C1,MEDCLNYIYBERKO-UHFFFAOYSA-N
ADX-47273,ADX-47273,,BRD:BRD-BRD-K56543881-001-02-7;BRD:BRD-K56543881-001-02-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,GRM5,,,PRECLINICAL,,,NA,FC1CCC(CC1)C(=O)N1CCC[C@@H](C1)C1NC(NO1)-C1CCC(F)CC1,
NVP-AEE788,AEE 788;AEE-788;AEE788;GNF-PF-5343;NVP-AEE-788;NVP-AEE788,CHEMBL587723,BRD:BRD-BRD-K40718343-001-02-6;BRD:BRD-K40718343-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,"EGFR INHIBITOR, VEGFR INHIBITOR",EGFR;ERBB2;ERBB4;FGFR2;FGFR3;KDR,,,PHASE 1/PHASE 2,,Small molecule,2,"CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1;CCN1CCN(CC2CCC(CC2)-C2CC3C(N[C@H](C)C4CCCCC4)NCNC3[NH]2)CC1, CCN1CCN(CC2CCC(CC2)-C2CC3C(N[C@H](C)C4CCCCC4)NCNC3[NH]2)CC1, CCN1CCN(CC2CCC(CC2)-C2CC3C(N[C@H](C)C4CCCCC4)NCNC3[NH]2)CC1",OONFNUWBHFSNBT-HXUWFJFHSA-N
AEG3482,AEG3482,,BRD:BRD-BRD-K77634909-001-03-5;BRD:BRD-K77634909-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,HSP INDUCER,,,,PRECLINICAL,,,NA,"NS(=O)(=O)C1NN2CC(NC2S1)-C1CCCCC1, NS(=O)(=O)C1NN2CC(NC2S1)-C1CCCCC1",
AF38469,AF38469,,BRD:BRD-BRD-K47816470-001-01-8;BRD:BRD-K47816470-001-01-8,rep_primary;rep_single_dose,SORTILIN INHIBITOR,SORT1,,,PRECLINICAL,,,NA,CC1CCCC(NC(=O)C2CCC(CC2C(O)=O)C(F)(F)F)N1,
NSC-43242,AFALANINE;DL-;N-ACETYLPHENYLALANINE;NSC-43242,CHEMBL134570,BRD:BRD-BRD-K53205568-001-02-6;BRD:BRD-K53205568-001-02-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD2,,,PHASE 3,,Small molecule,-1,CC(=O)N[C@@H](CC1CCCCC1)C(O)=O;CC(=O)NC(Cc1ccccc1)C(=O)O,CBQJSKKFNMDLON-UHFFFAOYSA-N
SCENESSE,AFAMELANOTIDE;CUV-1647;CUV1647;MELANOTAN;MELANOTAN I;MELANOTAN-1;SCENESSE,CHEMBL441738,BRD:BRD-K00003330-001-01-9,rep_single_dose,MELANOCYTE-STIMULATING HORMONE MIMETIC,,,,,,Protein,4,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C,UAHFGYDRQSXQEB-LEBBXHLNSA-N
TOVOK,AFATINIB;BIBW 2992;BIBW-2992;BIBW2992;GILOTRIF;GIOTRIF;NSC-750691;TOMTOVOK;TOVOK,CHEMBL1173655,BRD:BRD-BRD-K66175015-001-09-0;BRD:BRD-K66175015-001-01-7;BRD:BRD-K66175015-001-09-0;CTRP:606135;GDSC1:1032;GDSC1:1377;GDSC2:1032,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"INHIBITOR OF EGFR, ERBB2, AND ERBB4",EGFR;ERBB2;ERBB4,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,"Multiple values for MOA: {'EGFR INHIBITOR', 'INHIBITOR OF EGFR, ERBB2, AND ERBB4'}, defaulting to 'INHIBITOR OF EGFR, ERBB2, AND ERBB4'",Small molecule,4,"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1;CN(C)C\C=C\C(=O)NC1CC2C(NC3CCC(F)C(CL)C3)NCNC2CC1O[C@H]1CCOC1, CN(C)C\C=C\C(=O)NC1CC2C(NC3CCC(F)C(CL)C3)NCNC2CC1O[C@H]1CCOC1, CN(C)C\C=C\C(=O)NC1CC2C(NC3CCC(F)C(CL)C3)NCNC2CC1O[C@H]1CCOC1",ULXXDDBFHOBEHA-CWDCEQMOSA-N
AIROMATE,AFLOQUALONE;AIROMATE,CHEMBL2105918,BRD:BRD-BRD-K69247067-001-01-8;BRD:BRD-K69247067-001-01-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,SEDATIVE,,LAUNCHED,,Small molecule,-1,Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O;CC1CCCCC1-N1C(CF)NC2CCC(N)CC2C1=O,VDOSWXIDETXFET-UHFFFAOYSA-N
DEBIO1452,AFN-1252;API 1252;API-1252;DEBIO-1452;DEBIO1452,CHEMBL1652621,BRD:BRD-BRD-K23791635-001-01-3;BRD:BRD-K23791635-001-01-3,rep_primary;rep_single_dose,FABI INHIBITOR,,,,PHASE 2,,Small molecule,2,Cc1c(CN(C)C(=O)/C=C/c2cnc3c(c2)CCC(=O)N3)oc2ccccc12;CN(CC1OC2CCCCC2C1C)C(=O)\C=C\C1=CNC2=NC(=O)CCC2=C1,QXTWSUQCXCWEHF-JXMROGBWSA-N
OBENOXAZINE,AFOBAZOL;AFOBAZOLE;APHOBAZOLE;CM-346;FABOMOTIZOLE;OBENOXAZINE,CHEMBL3707307,BRD:BRD-BRD-K37793595-003-01-7;BRD:BRD-K37793595-003-01-7,rep_multi_dose;rep_primary;rep_single_dose,ANXIOLYTIC,,ANXIETY,,LAUNCHED,,Small molecule,3,CCOC1CCC2[NH]C(SCCN3CCOCC3)NC2C1;CCOc1ccc2nc(SCCN3CCOCC3)[nH]c2c1,WWNUCVSRRUDYPP-UHFFFAOYSA-N
ESAFOXOLANER,(S)-;A1443;AFOXOLANER;AH252723;ESAFOXOLANER,CHEMBL2219412;CHEMBL4298144,BRD:BRD-K00084836-001-01-9,rep_single_dose,,,,,,,Small molecule,-1,O=C(CNC(=O)c1ccc(C2=NO[C@@](c3cc(Cl)cc(C(F)(F)F)c3)(C(F)(F)F)C2)c2ccccc12)NCC(F)(F)F,OXDDDHGGRFRLEE-QHCPKHFHSA-N
AG-1024,AG-1024,,BRD:BRD-BRD-K08310154-001-03-8;BRD:BRD-K08310154-001-03-8,rep_primary;rep_single_dose,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,IGF1R,,,PRECLINICAL,,,NA,CC(C)(C)C1CC(C=C(C#N)C#N)CC(BR)C1O,
AG-14361,AG-14361,,BRD:BRD-BRD-K00615600-001-12-9;BRD:BRD-K00615600-001-12-9,rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,PARP1,,,PRECLINICAL,,,NA,"CN(C)CC1CCC(CC1)-C1NC2CCCC3C(=O)NCCN1C23, CN(C)CC1CCC(CC1)-C1NC2CCCC3C(=O)NCCN1C23",
AG270,AG-270;AG270,CHEMBL4802164,BRD:BRD-U00115411-001-01-9,oncref_1,INHIBITOR OF METHIONINE ADENOSYLTRANSFERASE 2A,MAT2A,,,,,Unknown,1,,
AG-490,AG-490,,BRD:BRD-BRD-K47105409-001-14-5;BRD:BRD-K47105409-001-14-5,rep_primary;rep_single_dose,"EGFR INHIBITOR, JAK INHIBITOR",EGFR;JAK2;JAK3,,,PRECLINICAL,,,NA,"OC1CCC(CC1O)\C=C(/C#N)C(=O)NCC1CCCCC1, OC1CCC(CC1O)\C=C(/C#N)C(=O)NCC1CCCCC1, OC1CCC(CC1O)\C=C(/C#N)C(=O)NCC1CCCCC1",
AG-556,AG-556,,BRD:BRD-K81048131-001-03-9,rep_single_dose,TYROSINE KINASE INHIBITOR,,,,,,,NA,,
AGI-24512,AGI-24512,,BRD:BRD-K27773864-001-02-9,oncref_2,INHIBITOR OF MAT2A,MAT2A,,,,,,NA,,
AGI-5198,AGI-5198,,BRD:BRD-A56371469-001-03-3;BRD:BRD-BRD-A56371469-001-03-3;GDSC2:1913,gdsc;rep_primary;rep_single_dose,ISOCITRATE DEHYDROGENASE INHIBITOR,IDH1,,,PRECLINICAL,,,NA,CC1NCCN1CC(=O)N(C(C(=O)NC1CCCCC1)C1CCCCC1C)C1CCCC(F)C1,
AGI-6780,AGI-6780,,BRD:BRD-BRD-K04691817-001-01-8;BRD:BRD-K04691817-001-01-8;GDSC1:562;GDSC2:1634,gdsc;rep_primary;rep_single_dose,ISOCITRATE DEHYDROGENASE INHIBITOR,IDH2,,,PRECLINICAL,,,NA,FC(F)(F)C1CCCC(NC(=O)NC2CC(CCC2-C2CCSC2)S(=O)(=O)NC2CC2)C1,
AGK-2,AGK-2,,CTRP:411716,ctrp,,,,,,,,NA,,
AGMATINE,AGMATINE,CHEMBL58343,BRD:BRD-BRD-K49738308-065-04-9;BRD:BRD-K49738308-065-04-9,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,ADRA2C;ASIC3;CACNA1B;CHRNA1;GRIN1;KCNJ1;NISCH,,,PHASE 3,,Small molecule,NA,NCCCCN=C(N)N;NCCCCNC(N)=N,QYPPJABKJHAVHS-UHFFFAOYSA-N
AGN-192403,AGN-192403,,BRD:BRD-A18074780-003-02-0;BRD:BRD-BRD-A18074780-003-02-0,rep_primary;rep_single_dose,IMIDAZOLINE RECEPTOR LIGAND,NISCH,,,PRECLINICAL,,,NA,"CC(C)[C@@H]1C2CCC(C2)[C@H]1N, CC(C)[C@@H]1C2CCC(C2)[C@H]1N",
AGN-194310,AGN-194310,,BRD:BRD-BRD-K70262971-001-01-9;BRD:BRD-K70262971-001-01-9,rep_primary;rep_single_dose,RETINOID RECEPTOR ANTAGONIST,RXRA;RXRB;RXRG,,,PHASE 3,,,NA,CCC1CCC(CC1)C1=CC(C)(C)SC2CCC(CC12)C#CC1CCC(CC1)C(O)=O,
VTP-5183,AGN 195183;AGN-195183;IRX-5183;IRX5183;NRX-195183;NRX195183;VTP-195183;VTP-5183,CHEMBL107430,BRD:BRD-BRD-K32533226-001-01-3;BRD:BRD-K32533226-001-01-3,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA,,,PHASE 1/PHASE 2,,Small molecule,2,CC1(C)CCC(C)(C)C2C(CL)C(O)C(CC12)C(=O)NC1CC(F)C(C(O)=O)C(F)C1;CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Cl,PNAWUIKCVQSLFG-UHFFFAOYSA-N
VALDOXAN,AGOMELATINE;S-20098;S20098;THYMANAX;VALDOXAN,CHEMBL10878,BRD:BRD-BRD-K84698278-001-03-4;BRD:BRD-K84698278-001-03-4,rep_primary;rep_single_dose,"MELATONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",HTR2A;HTR2B;HTR2C;MTNR1A;MTNR1B,DEPRESSION,,LAUNCHED,,Small molecule,4,COc1ccc2cccc(CCNC(C)=O)c2c1;COC1CCC2CCCC(CCNC(C)=O)C2C1,YJYPHIXNFHFHND-UHFFFAOYSA-N
AGP-103,AGP-103,,BRD:BRD-BRD-K91495480-001-02-2;BRD:BRD-K91495480-001-02-2,rep_primary;rep_single_dose,MEMBRANE PERMEABILITY INHIBITOR,,,,LAUNCHED,,,NA,CCCCCCCCCCCCCCCCCCCCCC(O)=O,
AH-7614,AH-7614,,BRD:BRD-BRD-K10852420-001-02-5;BRD:BRD-K10852420-001-02-5,rep_primary;rep_single_dose,FREE FATTY ACID RECEPTOR ANTAGONIST,FFAR4,,,PRECLINICAL,,,NA,CC1CCC(CC1)S(=O)(=O)NC1C2CCCCC2OC2CCCCC12,
AH11110,AH11110,,BRD:BRD-A64808605-003-02-7;BRD:BRD-BRD-A64808605-003-02-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR LIGAND,ADRA1B,,,PRECLINICAL,,,NA,OC(COC1CCCCC1-C1CCCCC1)CC(=N)N1CCCCC1,
AH6809,AH6809,,BRD:BRD-BRD-K59339270-001-02-6;BRD:BRD-K59339270-001-02-6,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGDR;PTGER1;PTGER2;PTGER3,,,PRECLINICAL,,,NA,"CC(C)OC1CCC2C(C1)OC1CCC(CC1C2=O)C(O)=O, CC(C)OC1CCC2C(C1)OC1CCC(CC1C2=O)C(O)=O",
AI-10-49,AI-10-49,,BRD:BRD-K89899948-001-01-7,rep_single_dose,CORE BINDING FACTOR INHIBITOR,CBFB,,,,,,NA,,
AIM-100,AIM-100,,BRD:BRD-BRD-K85139301-001-01-3;BRD:BRD-K85139301-001-01-3,rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,TNK2,,,PRECLINICAL,,,NA,C(NC1NCNC2OC(C(-C3CCCCC3)C12)-C1CCCCC1)[C@@H]1CCCO1,
AJ76-(+),AJ76-(+),,BRD:BRD-BRD-K76677554-003-02-1;BRD:BRD-K76677554-003-02-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3;DRD4,,,PRECLINICAL,,,NA,CCCN[C@@H]1CCC2C(OC)CCCC2[C@@H]1C,
RAUWOLFINE,"(17R,21R)-AJMALAN-17,21-DIOL;AJMALAN-17,21-DIOL;AJMALINE;NSC-15627;RAUWOLFINE",CHEMBL2105617,BRD:BRD-A48300215-001-04-8;BRD:BRD-BRD-A48300215-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN5A,WOLFF-PARKINSON-WHITE SYNDROME (WPW),,LAUNCHED,,Small molecule,3,CC[C@H]1C2CC3[C@@H]4N(C)C5CCCCC5[C@]44C[C@@H](C2C4O)N3[C@@H]1O;CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O,CJDRUOGAGYHKKD-FUIWMBJSSA-N
AK-7,AK-7,,BRD:BRD-BRD-K09143580-001-01-0;BRD:BRD-K09143580-001-01-0,rep_primary;rep_single_dose,SIRT INHIBITOR,SIRT2,,,PRECLINICAL,,,NA,BRC1CCCC(NC(=O)C2CCCC(C2)S(=O)(=O)N2CCCCCC2)C1,
AK162157,AK162157,,GDSC2:1634,gdsc,,,,,,,,NA,,
AK175551,AK175551,,GDSC2:1618,gdsc,,,,,,,,NA,,
AK298746,AK298746,,GDSC2:1621,gdsc,,,,,,,,NA,,
AKBA,3-ACETYL-11-KETO-BETA-BOSWELLIC ACID;AKBA,CHEMBL237111,BRD:BRD-BRD-K54907283-001-01-2;BRD:BRD-K54907283-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX5,,,PHASE 3,,Small molecule,-1,C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C;CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4[C@@H](C)[C@H](C)CC[C@]4(C)CC[C@]23C)[C@@]1(C)C(=O)O,HMMGKOVEOFBCAU-BCDBGHSCSA-N
NSC-191832,AKLOMIDE;CLOMIDE;NSC-191832,CHEMBL1450565,BRD:BRD-BRD-K26807903-001-04-3;BRD:BRD-K26807903-001-04-3,rep_primary;rep_single_dose,,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,NC(=O)c1ccc([N+](=O)[O-])cc1Cl;NC(=O)C1CCC(CC1CL)[N+]([O-])=O,GFGSZUNNBQXGMK-UHFFFAOYSA-N
AL-8697,AL-8697,,BRD:BRD-BRD-K44731351-001-01-6;BRD:BRD-K44731351-001-01-6,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK14,,,PRECLINICAL,,,NA,CC1C(F)CC(CC1-C1C(F)CN2C(NNC2C1F)C(C)(C)C)C(=O)NC1CC1,
NSC-338157,ALACEPRIL;CETAPRIL;DU-1219;NSC-338157,CHEMBL2103775,BRD:BRD-BRD-K51784806-001-01-6;BRD:BRD-K51784806-001-01-6,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,HYPERTENSION,,LAUNCHED,,Small molecule,-1,C[C@H](CSC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1CCCCC1)C(O)=O;CC(=O)SC[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O,FHHHOYXPRDYHEZ-COXVUDFISA-N
RO-3-7008,ALAFOSFALIN;ALAPHOSPHIN;RO-3-7008,CHEMBL3989665,BRD:BRD-BRD-K80403280-001-02-1;BRD:BRD-K80403280-001-02-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,PHASE 1,,Small molecule,-1,C[C@H](N)C(=O)N[C@@H](C)P(=O)(O)O;C[C@H](N)C(=O)N[C@@H](C)P(O)(O)=O,BHAYDBSYOBONRV-IUYQGCFVSA-N
ALAGEBRIUM ION,ALAGEBRIUM;ALAGEBRIUM CATION;ALAGEBRIUM ION,CHEMBL2111081,BRD:BRD-BRD-K96029467-003-01-9;BRD:BRD-K96029467-003-01-9,rep_primary;rep_single_dose,GLYCOSYLATION INHIBITOR,,,,PHASE 2/PHASE 3,,Small molecule,2,Cc1sc[n+](CC(=O)c2ccccc2)c1C;CC1SC[N+](CC(=O)C2CCCCC2)C1C,LYLFQLCLUXOFOL-UHFFFAOYSA-N
SDX-102,ALANOSINE;L-ALANOSINE;NSC-153353;NSC-529469;SDX-102,CHEMBL452715,BRD:BRD-K00004718-001-01-9,rep_single_dose,ANTIMETABOLITE,,,,,,Small molecule,2,N[C@@H](CN(O)N=O)C(=O)O,MLFKVJCWGUZWNV-REOHCLBHSA-N
ALANTOLACTONE,ALANTOLACTONE,,BRD:BRD-K53731810-001-05-9,rep_single_dose,"APOPTOSIS STIMULANT, STAT INHIBITOR",STAT3,,,,,,NA,,
NSC-758657,ALAPROCLATE;GEA 654;GEA-654;NSC-758657,CHEMBL36591,BRD:BRD-A14966924-003-07-7;BRD:BRD-BRD-A14966924-003-07-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,SLC6A4,,,PHASE 2,,Small molecule,-1,CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1;CC(N)C(=O)OC(C)(C)CC1CCC(CL)CC1,FZSPJBYOKQPKCD-UHFFFAOYSA-N
ALARELIN,ALARELIN,,BRD:BRD-BRD-K42140276-402-01-4;BRD:BRD-K42140276-402-01-4,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,GNRH1,,,LAUNCHED,,,NA,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC1CNC[NH]1)NC(=O)[C@@H]1CCC(=O)N1,
ZENTEL,ALBENDAZOLE;ALBENDAZOLUM;ALBENZA;ANDAZOL;ESKAZOLE;NSC-220008;SK&F 62979;SK&F-62979;VALBAZEN;ZENTAL;ZENTEL,CHEMBL1483,BRD:BRD-BRD-K79131256-001-17-9;BRD:BRD-K79131256-001-17-9,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBA1A;TUBB;TUBB4B,"CYSTIC HYDATID DISEASE, PARENCHYMAL NEUROCYSTICERCOSIS",,LAUNCHED,,Small molecule,4,"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1;CCCSC1CCC2[NH]C(NC(=O)OC)NC2C1, CCCSC1CCC2[NH]C(NC(=O)OC)NC2C1",HXHWSAZORRCQMX-UHFFFAOYSA-N
ALBENDAZOLE-OXIDE,ALBENDAZOLE-OXIDE,,BRD:BRD-A67060370-001-02-9;BRD:BRD-BRD-A67060370-001-02-9,rep_primary;rep_single_dose,ANTHELMINTIC AGENT,,"CYSTIC HYDATID DISEASE, PARENCHYMAL NEUROCYSTICERCOSIS",,LAUNCHED,,,NA,CCCS(=O)C1CCC2NC(NC(=O)OC)[NH]C2C1,
VOLMAX,ACCUNEB;AEROLIN;AEROLIN 400;AEROLIN AUTO;AIROMIR;AIRSALB;ALBUTEROL;ASMASAL CLICKHALER;ASMASAL SPACEHALER;ASMAVEN;ASMAVENT;COBUTOLIN;COMBIVENT;COMBIVENT UDVS;DUONEB;ETINOLINE;IPRAMOL STERI-NEB;KENTAMOL;LIBETIST;MAXIVENT;NSC-757417;PROAIR HFA;PROVENTIL;PROVENTIL HFA;PROVENTIL-HFA;RIMASAL;SALAMOL E-BREATHE;SALAPIN;SALBULIN NOVOLIZER;SALBUTAMOL;SALBUTAMOLUM;SALBUVENT;SALIPRANEB;SCH 13949W;SCH-13949W;STERI-NEB SALAMOL;VENTMAX SR;VENTODISKS;VENTOLIN;VENTOLIN CR;VENTOLIN E-BREATHE;VENTOLIN HFA;VENTOLINE;VOLMAX,CHEMBL714,BRD:BRD-A88254928-001-07-9;BRD:BRD-BRD-A88254928-001-07-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2,ASTHMA,,LAUNCHED,,Small molecule,4,"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1;CC(C)(C)NCC(O)C1CCC(O)C(CO)C1, CC(C)(C)NCC(O)C1CCC(O)C(CO)C1",NDAUXUAQIAJITI-UHFFFAOYSA-N
R-89674,ALCAFTADINE;LASTACAFT;R 89674;R-89674,CHEMBL1201747,BRD:BRD-BRD-K55991142-001-01-6;BRD:BRD-K55991142-001-01-6,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,ALLERGIC CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1;CN1CCC(CC1)=C1C2NCC(C=O)N2CCC2CCCCC12,MWTBKTRZPHJQLH-UHFFFAOYSA-N
W 7320,ALCLOFENAC;MERVAN;W 7320,CHEMBL94081,BRD:BRD-BRD-K47492008-001-02-7;BRD:BRD-K47492008-001-02-7,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1,RHEUMATOID ARTHRITIS,,LAUNCHED,,Small molecule,4,C=CCOc1ccc(CC(=O)O)cc1Cl;OC(=O)CC1CCC(OCC=C)C(CL)C1,ARHWPKZXBHOEEE-UHFFFAOYSA-N
ALCLOMETASONE-DIPROPIONATE,ALCLOMETASONE-DIPROPIONATE,,BRD:BRD-A17407635-001-04-0;BRD:BRD-BRD-A17407635-001-04-0,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,CYP3A4;NR3C1;SERPINA6,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,CCC(=O)OCC(=O)C1(OC(=O)CC)[C@H](C)C[C@H]2C3[C@H](CL)CC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,
"N,N'-DIALLYLNORTOXIFERINIUM","ALCURONIUM;ALCURONIUM CATION;ALCURONIUM ION;DIALLYLNORTOXIFERINE;N,N'-DIALLYLNORTOXIFERINIUM",CHEMBL1180293;CHEMBL3305985,BRD:BRD-A84907376-300-03-8;BRD:BRD-BRD-A84907376-300-03-8,rep_primary;rep_single_dose,MUSCLE RELAXANT,CHRM1;CHRM2;CHRM3;CHRM4;CHRNA7,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,4,C=CC[N@@+]12CC[C@@]34c5ccccc5N5/C=C6/[C@H]7C[C@H]8[C@@]9(CC[N@@+]8(CC=C)C/C7=C/CO)c7ccccc7N(/C=C(/[C@@H](C[C@@H]31)/C(=C\CO)C2)[C@H]54)[C@@H]69;OC\C=C1/C[N@+]2(CC=C)CC[C@@]34[C@@H]2C[C@@H]1\C1=C\N2C5[C@]6(CC[N@@+]7(CC=C)C\C(=C/CO)[C@H](C[C@@H]67)\C5=C\N(C31)C1CCCCC41)C1CCCCC21,MUQUYTSLDVKIOF-CHJKCJHBSA-N
ALDA-1,ALDA-1,,BRD:BRD-BRD-K06890060-001-09-1;BRD:BRD-K06890060-001-09-1,rep_primary;rep_single_dose,ALDEHYDE DEHYDROGENASE ACTIVATOR,ALDH2,,,PRECLINICAL,,,NA,CLC1CCCC(CL)C1C(=O)NCC1CCC2OCOC2C1,
RO5424802,AF-802;AF802;ALECENSA;ALECTINIB;CH-5424802;CH5424802;RO-5424802;RO5424802,CHEMBL1738797,BRD:BRD-BRD-K11267252-001-04-4;BRD:BRD-K11267252-001-04-4;GDSC1:281,gdsc;rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK;MET,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,,Small molecule,4,"CCC1CC2C(=O)C3C([NH]C4CC(CCC34)C#N)C(C)(C)C2CC1N1CCC(CC1)N1CCOCC1, CCC1CC2C(=O)C3C([NH]C4CC(CCC34)C#N)C(C)(C)C2CC1N1CCC(CC1)N1CCOCC1;CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O",KDGFLJKFZUIJMX-UHFFFAOYSA-N
RO0728804,ALEGLITAZAR;R-1439;R1439;RO-0728804;RO0728804,CHEMBL519504,BRD:BRD-K00076061-001-02-9,rep_single_dose,,,,,,,Small molecule,3,CO[C@@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)O,DAYKLWSKQJBGCS-NRFANRHFSA-N
FOSAMAX,ALENDRONATE;ALENDRONIC ACID;BINOSTO;FOSAMAX,CHEMBL870,BRD:BRD-BRD-K75527158-360-04-9;BRD:BRD-K75527158-360-04-9,rep_primary;rep_single_dose,BONE RESORPTION INHIBITOR,ATP6V1A;FDPS;PTPN4;PTPRE;PTPRS,OSTEOPOROSIS,,LAUNCHED,,Small molecule,4,"NCCCC(O)(P(=O)(O)O)P(=O)(O)O;NCCCC(O)(P(O)(O)=O)P(O)(O)=O, NCCCC(O)(P(O)(O)=O)P(O)(O)=O, NCCCC(O)(P(O)(O)=O)P(O)(O)=O",OGSPWJRAVKPPFI-UHFFFAOYSA-N
WIN-21904,"ALEXIDINE;BISGUADINE;COMPOUND 904;STERWIN 904;WIN 21,904;WIN-21904",CHEMBL1195210,BRD:BRD-A27883417-300-01-6;BRD:BRD-BRD-A27883417-300-01-6,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHATIDYLGLYCEROPHOSPHATASE INHIBITOR,PTPMT1,,,PRECLINICAL,,Small molecule,-1,CCCCC(CC)C\N=C(/N)N\C(N)=N\CCCCCC\N=C(/N)N\C(N)=N\CC(CC)CCCC;CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC,LFVVNPBBFUSSHL-UHFFFAOYSA-N
UN ALPHA,.ALPHA.-CALCIDOL;1-ALPHA-VITAMIN D;1-HYDROXYCHOLECALCIFEROL;1-HYDROXYVITAMIN D3;1.ALPHA-HYDROXYCHOLECALCIFEROL;1.ALPHA.-HYDROXYCHOLECALCIFEROL;1.ALPHA.-HYDROXYVITAMIN D3;1.ALPHA.(OH)D3;ALFA D;ALFACALCIDOL;ALFAROL;ALPHA D3;ALPHACALCIDOL;ALPHAROL;ALSIODOL;BONDIOL;EINSALPHA;ETALPHA;ONE-ALPHA;OXYDEVIT;TEVABONE;UN ALFA;UN ALPHA,CHEMBL1601669,BRD:BRD-BRD-K49522529-001-02-9;BRD:BRD-BRD-K49522529-001-03-7;BRD:BRD-K49522529-001-02-9;BRD:BRD-K49522529-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,CYP27B1;VDR,VITAMIN D DEFICIENCY,,LAUNCHED,,Small molecule,4,"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O;CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C",OFHCOWSQAMBJIW-AVJTYSNKSA-N
ALFADOLONE-ACETATE,ALFADOLONE-ACETATE,,BRD:BRD-BRD-K51751936-001-09-1;BRD:BRD-K51751936-001-09-1,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,,,,PHASE 2,,,NA,CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C,
PHAXAN,ALFAXALONE;ALPHAXALONE;GR 2/234;PHAXAN,CHEMBL190279,BRD:BRD-BRD-K41445866-001-18-8;BRD:BRD-K41445866-001-18-8,rep_primary;rep_single_dose,"CHLORIDE CHANNEL AGONIST, BENZODIAZEPINE RECEPTOR AGONIST",GABBR1,GENERAL ANAESTHETIC,,LAUNCHED,"Multiple values for MOA: {'BENZODIAZEPINE RECEPTOR AGONIST, CHLORIDE CHANNEL AGONIST', 'CHLORIDE CHANNEL AGONIST, BENZODIAZEPINE RECEPTOR AGONIST'}, defaulting to 'CHLORIDE CHANNEL AGONIST, BENZODIAZEPINE RECEPTOR AGONIST'",Small molecule,-1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C,DUHUCHOQIDJXAT-OLVMNOGESA-N
UROXATRAL,ALFUZOSIN;NSC-760065;UROXATRAL,CHEMBL709,BRD:BRD-A09056319-003-07-7;BRD:BRD-BRD-A09056319-003-07-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;KCNH2,BENIGN PROSTATIC HYPERPLASIA (BPH),,LAUNCHED,,Small molecule,4,"COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC;COC1CC2NC(NC(N)C2CC1OC)N(C)CCCNC(=O)C1CCCO1, COC1CC2NC(NC(N)C2CC1OC)N(C)CCCNC(=O)C1CCCO1",WNMJYKCGWZFFKR-UHFFFAOYSA-N
ALGESTONE-ACETOPHENIDE,ALGESTONE-ACETOPHENIDE,,BRD:BRD-A41774846-001-01-4;BRD:BRD-BRD-A41774846-001-01-4,rep_primary;rep_single_dose,,,CONTRACEPTIVE,,LAUNCHED,,,NA,CC(=O)[C@@]12OC(C)(O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]21C)C1CCCCC1,
H-3774,ALIBENDOL;H 3774;H-3774,CHEMBL2105999,BRD:BRD-BRD-K60102752-001-02-2;BRD:BRD-K60102752-001-02-2,rep_primary;rep_single_dose,ANTISPASMODIC,,BILE STIMULATION,,LAUNCHED,,Small molecule,-1,C=CCc1cc(OC)c(O)c(C(=O)NCCO)c1;COC1CC(CC=C)CC(C(=O)NCCO)C1O,UMJHTFHIQDEGKB-UHFFFAOYSA-N
ALICAPISTAT,ALICAPISTAT,,BRD:BRD-K00091073-001-01-9,rep_single_dose,,,,,,,,NA,,
TRIMEPRAZINE,ALIMEMAZINE;BAYER-1219;DL-TRIMEPRAZINE;METHYLPROMAZINE;RP-6549;TEMARIL;TRIMEPRAZINE,CHEMBL829,BRD:BRD-A49225603-045-10-0;BRD:BRD-BRD-A49225603-045-10-0,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH1,SEDATIVE,,LAUNCHED,,Small molecule,4,CC(CN(C)C)CN1C2CCCCC2SC2CCCCC12;CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,ZZHLYYDVIOPZBE-UHFFFAOYSA-N
ST-567-BR-(AS-HBR),ALINIDINE;ST 567 BR (AS HBR);ST 567-BR (AS HBR);ST 567-BR [AS HYDROBROMIDE];ST-567;ST-567-BR-(AS-HBR),CHEMBL278581,BRD:BRD-K00004709-001-01-9,rep_single_dose,BRADYCARDIC EFFECT,,,,,,Small molecule,-1,C=CCN(C1=NCCN1)c1c(Cl)cccc1Cl,OXTYVEUAQHPPMV-UHFFFAOYSA-N
MLN8237,ALISERTIB;MLN 8237;MLN-8237;MLN8237,CHEMBL483158,BRD:BRD-BRD-K75295174-001-05-0;BRD:BRD-K75295174-001-05-0;CTRP:636711;GDSC1:431;GDSC2:1051,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA,,,PHASE 3,,Small molecule,3,COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O;COC1CC(NC2NCC3CN=C(C4CC(CL)CCC4-C3N2)C2C(F)CCCC2OC)CCC1C(O)=O,ZLHFILGSQDJULK-UHFFFAOYSA-N
ALISERTIB:NAVITOCLAX (2:1 MOL/MOL),ALISERTIB:NAVITOCLAX (2:1 MOL/MOL),,CTRP:660282,ctrp,,,,,,,,NA,,
ALISKIREN-HEMIFUMARATE,ALISKIREN-HEMIFUMARATE,,BRD:BRD-BRD-K30020243-051-02-5;BRD:BRD-K30020243-051-02-5,rep_primary;rep_single_dose,RENIN INHIBITOR,REN,HYPERTENSION,,LAUNCHED,,,NA,"COCCCOC1CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)CCC1OC, COCCCOC1CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)CCC1OC, COCCCOC1CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)CCC1OC",
UNIL-025,(D-MEALA)3-(ETVAL)4-CSA;ALISPORIVIR;DEB 025;DEB-025;DEB025;DEBIO 025;DEBIO-025;UNIL 025;UNIL-025,CHEMBL1651956,BRD:BRD-K00003135-001-01-9,rep_single_dose,CYCLOPHILIN INHIBITOR,,,,,,Protein,3,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,OLROWHGDTNFZBH-XEMWPYQTSA-N
VERGENTAN,ALIZAPRIDE;LITICAN;PLITICAN;SUPERAN;VERGENTAN,CHEMBL290194,BRD:BRD-A03061970-003-07-3;BRD:BRD-BRD-A03061970-003-07-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2,NAUSEA,,LAUNCHED,,Small molecule,3,C=CCN1CCCC1CNC(=O)c1cc2nn[nH]c2cc1OC;COC1CC2[NH]NNC2CC1C(=O)NCC1CCCN1CC=C,KSEYRUGYKHXGFW-UHFFFAOYSA-N
ALIZARIN,ALIZARIN,,BRD:BRD-BRD-K73191876-001-11-2;BRD:BRD-K73191876-001-11-2,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"OC1CCC2C(=O)C3CCCCC3C(=O)C2C1O, OC1CCC2C(=O)C3CCCCC3C(=O)C2C1O",
ALK2-IN-1,ALK2-IN-1,,BRD:BRD-K00091120-001-01-9,rep_single_dose,,,,,,,,NA,,
SEPTALAN,ALLANTOIN;ALWEXTIN;CORDIANINE;DL-ALLANTOIN;IDELALISIB METABOLITE M1A;NSC-7606;PSORALON;SD 101;SEPTALAN,CHEMBL593429,BRD:BRD-A96407378-001-15-1;BRD:BRD-BRD-A96407378-001-15-1,rep_primary;rep_single_dose,COSMETIC,,SKIN PROTECTANT,,LAUNCHED,,Small molecule,2,NC(=O)NC1NC(=O)NC1=O,POJWUDADGALRAB-UHFFFAOYSA-N
DIALLYL THIOSULFINATE,ALLICIN;DIALLYL THIOSULFINATE,CHEMBL359965,BRD:BRD-A60402836-001-01-0,rep_single_dose,CYTOKINE PRODUCTION INHIBITOR,TRPA1;TRPV1,,,,,Small molecule,2,C=CCS[S+]([O-])CC=C,JDLKFOPOAOFWQN-UHFFFAOYSA-N
ZYLORIC-300,ALLOPURINOL;ALLOPURINOLUM;ALORAL;ALULINE 100;ALULINE 300;BW 56-158;BW-56-158;CAPLENAL;COSURIC;HAMARIN 100;HAMARIN 300;LEDOPUR;LOPURIN;NSC-101655;NSC-1390;SUSPENDOL;TAKANARUMIN;URICTO;XANTHOMAX-100;XANTHOMAX-300;ZYLOPRIM;ZYLORIC;ZYLORIC-300,CHEMBL1467,BRD:BRD-BRD-K86307448-001-17-5;BRD:BRD-BRD-K86307448-001-19-1;BRD:BRD-K86307448-001-17-5;BRD:BRD-K86307448-001-19-1,rep_primary;rep_single_dose,XANTHINE OXIDASE INHIBITOR,XDH,"GOUT, KIDNEY STONES",,LAUNCHED,,Small molecule,4,"O=C1[NH]CNC2[NH]NCC12, O=C1[NH]CNC2[NH]NCC12, O=C1[NH]CNC2[NH]NCC12;Oc1ncnc2[nH]ncc12",OFCNXPDARWKPPY-UHFFFAOYSA-N
ALLOPURINOL-RIBOSIDE,ALLOPURINOL-RIBOSIDE,,BRD:BRD-A93407926-001-01-1;BRD:BRD-BRD-A93407926-001-01-1;BRD:BRD-K00004728-001-01-9,rep_primary;rep_single_dose,"ANTI-LEISHMANIAL AGENT, PHOSPHORYLASE INHIBITOR",,,,PHASE 2,"Multiple values for MOA: {'ANTI-LEISHMANIAL AGENT', 'ANTI-LEISHMANIAL AGENT, PHOSPHORYLASE INHIBITOR'}, defaulting to 'ANTI-LEISHMANIAL AGENT, PHOSPHORYLASE INHIBITOR'
Multiple values for structure_id: {'K00004728', 'A93407926'}, defaulting to None",,NA,OC[C@H]1O[C@H](C(O)[C@H]1O)N1[NH]CC2C1NCNC2=O,
STABILIZED,"ALLYL ISOTHIOCYANATE;ALLYLISOTHIOCYANATE;FEMA NO. 2034;MUSTARD;MUSTARD OIL;NSC-5572;OIL;OIL,MUSTARD;STABILIZED",CHEMBL233248,BRD:BRD-BRD-K33219225-001-01-9;BRD:BRD-K33219225-001-01-9,rep_primary;rep_single_dose,TRPV AGONIST,TRPA1,,,PRECLINICAL,,Small molecule,1,C=CCN=C=S,ZOJBYZNEUISWFT-UHFFFAOYSA-N
TIOSINAMINE,ALLYLTHIOUREA;NSC-1915;THIOSINAMINUM;TIOSINAMINE,CHEMBL1451910,BRD:BRD-BRD-K89634775-001-09-9;BRD:BRD-K89634775-001-09-9,rep_primary;rep_single_dose,NITRIFICATION INHIBITOR,,,,PRECLINICAL,,Small molecule,-1,"C=CCNC(N)=S;NC(S)=NCC=C, NC(S)=NCC=C",HTKFORQRBXIQHD-UHFFFAOYSA-N
MINALFEN,ALMINOPROFEN;MINALFEN,CHEMBL1765293,BRD:BRD-K00073457-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,C=C(C)CNc1ccc(C(C)C(=O)O)cc1,FPHLBGOJWPEVME-UHFFFAOYSA-N
ALMITRINE,ALMITRINE,CHEMBL1183717,BRD:BRD-BRD-K82677201-001-01-6;BRD:BRD-K82677201-001-01-6,rep_primary;rep_single_dose,NEUROTRANSMITTER AGONIST,ATP1A1,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),,LAUNCHED,,Small molecule,4,C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1;FC1CCC(CC1)C(N1CCN(CC1)C1NC(NCC=C)NC(NCC=C)N1)C1CCC(F)CC1,OBDOVFRMEYHSQB-UHFFFAOYSA-N
ALMOREXANT,ACT-078573;ALMOREXANT,CHEMBL455136,BRD:BRD-BRD-K84810405-003-01-1;BRD:BRD-K84810405-003-01-1,rep_multi_dose;rep_primary;rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR1;HCRTR2,,,PHASE 3,,Small molecule,3,CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1;CNC(=O)[C@H](N1CCC2CC(OC)C(OC)CC2[C@@H]1CCC1CCC(CC1)C(F)(F)F)C1CCCCC1,DKMACHNQISHMDN-RPLLCQBOSA-N
NSC-760092,ALMOTRIPTAN;LAS 31416;LAS-31416;NSC-760092,CHEMBL1505,BRD:BRD-BRD-K67601717-037-02-4;BRD:BRD-K67601717-037-02-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1B;HTR1D,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,"CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12;CN(C)CCC1C[NH]C2CCC(CS(=O)(=O)N3CCCC3)CC12, CN(C)CCC1C[NH]C2CCC(CS(=O)(=O)N3CCCC3)CC12",WKEMJKQOLOHJLZ-UHFFFAOYSA-N
ALOE-EMODIN,ALOE EMODIN;ALOE-EMODIN,CHEMBL40275,BRD:BRD-BRD-K04851519-001-06-8;BRD:BRD-K04851519-001-06-8,rep_primary;rep_single_dose,ANTICANCER AGENT,CASP8,,,PRECLINICAL,,Small molecule,NA,O=C1c2cccc(O)c2C(=O)c2c(O)cc(CO)cc21;OCC1CC(O)C2C(=O)C3C(O)CCCC3C(=O)C2C1,YDQWDHRMZQUTBA-UHFFFAOYSA-N
ALOFANIB,ALOFANIB,CHEMBL4594436,BRD:BRD-K00073093-001-02-9,rep_single_dose,,,,,,,Small molecule,1,Cc1cc([N+](=O)[O-])c(NS(=O)(=O)c2cccc(C(=O)O)c2)cc1-c1cccnc1,QUQGQIASFYWKAB-UHFFFAOYSA-N
VIPIDIA,ALOGLIPTIN;VIPIDIA,CHEMBL376359,BRD:BRD-BRD-K83003151-057-02-4;BRD:BRD-K83003151-057-02-4,rep_multi_dose;rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O;CN1C(=O)CC(N2CCCC(N)C2)N(CC2CCCCC2C#N)C1=O, CN1C(=O)CC(N2CCC[C@@H](N)C2)N(CC2CCCCC2C#N)C1=O, CN1C(=O)CC(N2CCC[C@@H](N)C2)N(CC2CCCCC2C#N)C1=O",ZSBOMTDTBDDKMP-OAHLLOKOSA-N
ALOPERINE,ALOPERINE,,BRD:BRD-BRD-K96391852-001-02-8;BRD:BRD-K96391852-001-02-8,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,C1CCN2C[C@H]3C[C@H](C=C4CCCN[C@@H]34)[C@H]2C1,
LOTRONEX,A03AE01;ALOSETRON;LOTRONEX,CHEMBL1110,BRD:BRD-BRD-K46742498-003-11-0;BRD:BRD-K46742498-003-11-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A,,,WITHDRAWN,,Small molecule,4,CC1[NH]CNC1CN1CCC2C(C1=O)C1CCCCC1N2C;Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,JSWZEAMFRNKZNL-UHFFFAOYSA-N
NSC-140025,"ALOVUDINE;CL 184,824;CL 184824;CL-184,824;CL-184824;NSC-140025",CHEMBL105318,BRD:BRD-K00004697-001-01-9,rep_single_dose,DNA SYNTHESIS MARKER,,,,,,Small molecule,2,Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O,UXCAQJAQSWSNPQ-XLPZGREQSA-N
NSC-694281,ALOXISTATIN;LOXISTATIN;NSC-694281,CHEMBL63440,BRD:BRD-BRD-K91188791-001-18-3;BRD:BRD-K91188791-001-18-3,rep_primary;rep_single_dose,PROTEASE INHIBITOR,CTSG,,,PHASE 3,,Small molecule,-1,"CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C;CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C, CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C, CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C, CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C",SRVFFFJZQVENJC-IHRRRGAJSA-N
VIJOICE,ALPELISIB;BYL-719;BYL719;NVP-BYL719;PIQRAY;VIJOICE,CHEMBL2396661,BRD:BRD-BRD-K54997624-001-06-0;BRD:BRD-K54997624-001-06-0;BRD:BRD-K54997624-001-10-9;CTRP:668495;GDSC2:1560,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF PI3 KINASE ALPHA,PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PHASE 3,"Multiple values for MOA: {'PI3K INHIBITOR', 'INHIBITOR OF PI3 KINASE ALPHA'}, defaulting to 'INHIBITOR OF PI3 KINASE ALPHA'
Multiple values for repurposing_target: {'PIK3CA', 'PIK3CA;PIK3CB;PIK3CD;PIK3CG'}, taking the union",Small molecule,4,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1;CC1NC(NC(=O)N2CCC[C@H]2C(N)=O)SC1-C1CCNC(C1)C(C)(C)C(F)(F)F,STUWGJZDJHPWGZ-LBPRGKRZSA-N
ALPHA-ASARONE,ALPHA-ASARONE,,BRD:BRD-K72536715-001-01-5,rep_single_dose,"CYTOCHROME P450 INHIBITOR, HMGCR INHIBITOR",HMGCR,,,,,,NA,,
ALPHA-GLUCOSYL-HESPERIDIN,ALPHA-GLUCOSYL-HESPERIDIN,,BRD:BRD-K00005238-001-01-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
ALPHA-LINOLENIC-ACID,ALPHA-LINOLENIC-ACID,,BRD:BRD-BRD-K33396764-001-08-7;BRD:BRD-K33396764-001-08-7,rep_primary;rep_single_dose,OMEGA 3 FATTY ACID STIMULANT,ELOVL4;FADS1;FADS2;FFAR1;FFAR4;PTGS2;SLC8A1;TRPV1,,,PHASE 3,,,NA,"CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O, CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O",
ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(R)-(-),ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(R)-(-),,BRD:BRD-BRD-K80028314-303-02-6;BRD:BRD-K80028314-303-02-6,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH3,,,PRECLINICAL,,,NA,C[C@@H](N)CC1C[NH]CN1,
ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(S)-(+),ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(S)-(+),,BRD:BRD-BRD-K28308851-303-01-8;BRD:BRD-K28308851-303-01-8,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH3,,,PRECLINICAL,,,NA,C[C@H](N)CC1C[NH]CN1,
ALPHA-METHYLSEROTONIN,ALPHA-METHYLSEROTONIN,,BRD:BRD-K01826806-050-02-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR4,,,,,,NA,,
ALPHA-TOCHOPHERYL-ACETATE,ALPHA-TOCHOPHERYL-ACETATE,,BRD:BRD-A61850409-001-10-7;BRD:BRD-BRD-A61850409-001-10-7,rep_primary;rep_single_dose,ANTIOXIDANT,,VITAMIN E DEFICIENCY,,LAUNCHED,,,NA,CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2C(C)C(OC(C)=O)C(C)C(C)C2O1,
SL-80.0342-00,ALPIDEM;SL 80.0342-00;SL-80.0342-00,CHEMBL54349,BRD:BRD-BRD-K66896751-001-02-4;BRD:BRD-K66896751-001-02-4,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1,,,WITHDRAWN,,Small molecule,4,CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12;CCCN(CCC)C(=O)CC1C(NC2CCC(CL)CN12)-C1CCC(CL)CC1,JRTIDHTUMYMPRU-UHFFFAOYSA-N
NSC-759561,ALPRENOLOL;NSC-759561,CHEMBL266195,BRD:BRD-A00993607-003-24-6;BRD:BRD-BRD-A00993607-003-24-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;HTR1A,ANGINA PECTORIS,,LAUNCHED,,Small molecule,-1,C=CCc1ccccc1OCC(O)CNC(C)C;CC(C)NCC(O)COC1CCCCC1CC=C,PAZJSJFMUHDSTF-UHFFFAOYSA-N
VITAROS,"ALPROSTADIL;CAVERJECT;CAVERJECT IMPULSE;EDEX;NSC-165559;ONO-1608;PGE1;PROSTAGLANDIN E1;PROSTIN;PROSTIN VR;PROSTIN VR PEDIATRIC;U-10,136;U-10136;VIRIDAL 10;VIRIDAL 20;VIRIDAL 5;VIRIDAL DUO;VITAROS",CHEMBL495,BRD:BRD-BRD-K52459643-001-17-7;BRD:BRD-K52459643-001-17-7,rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,CATSPER1;CATSPER2;CATSPER3;CATSPER4;PTGDR;PTGER1;PTGER2;PTGER4;PTGIR,CONGENITAL HEART DEFECTS,,LAUNCHED,,Small molecule,4,"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O, CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O",GMVPRGQOIOIIMI-DWKJAMRDSA-N
NSC-299132,ALRESTATIN;AY-22284;NSC-299132,CHEMBL63055,BRD:BRD-BRD-K35498378-001-06-1;BRD:BRD-K35498378-001-06-1,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,AKR1B1,,,PRECLINICAL,,Small molecule,-1,"O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O;OC(=O)CN1C(=O)C2CCCC3CCCC(C1=O)C23, OC(=O)CN1C(=O)C2CCCC3CCCC(C1=O)C23",GCUCIFQCGJIRNT-UHFFFAOYSA-N
LUMICITABINE,ALS-008176;ALS-8176;LUMICITABINE,CHEMBL3417258,BRD:BRD-BRD-K21415491-001-01-4,rep_primary,RNA POLYMERASE INHIBITOR,,,,PHASE 1,,Small molecule,2,CC(C)C(=O)OC[C@@]1(CCl)O[C@@H](n2ccc(N)nc2=O)[C@H](F)[C@@H]1OC(=O)C(C)C;NC1CCN([C@@H]2O[C@@](CO)(CCL)[C@@H](O)[C@H]2F)C(=O)N1,MJVKYGMNSQJLIN-KYZVSKTDSA-N
ALTANSERIN,ALTANSERIN,CHEMBL62919,BRD:BRD-BRD-K00610438-003-02-5;BRD:BRD-K00610438-003-02-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A,,,PHASE 2,,Small molecule,-1,"FC1CCC(CC1)C(=O)C1CCN(CCN2C(=S)[NH]C3CCCCC3C2=O)CC1, FC1CCC(CC1)C(=O)C1CCN(CCN2C(=S)[NH]C3CCCCC3C2=O)CC1;O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1",SMYALUSCZJXWHG-UHFFFAOYSA-N
P-1779,ALTHIAZIDE;ALTIZIDE;NSC-757786;P-1779,CHEMBL599870,BRD:BRD-A56675431-001-12-3;BRD:BRD-BRD-A56675431-001-12-3,rep_primary;rep_single_dose,DIURETIC,,HYPERTENSION,,LAUNCHED,,Small molecule,-1,C=CCSCC1Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1;NS(=O)(=O)C1CC2C(NC(CSCC=C)NS2(=O)=O)CC1CL,VGLGVJVUHYTIIU-UHFFFAOYSA-N
SIB-1765F,(-)-5-ETHYNYLNICOTINE;ALTINICLINE;SIB-1508Y;SIB-1765F,CHEMBL111659,BRD:BRD-BRD-K52681925-050-01-6;BRD:BRD-K52681925-050-01-6,rep_primary;rep_single_dose,NICOTINIC RECEPTOR AGONIST,CHRNA4;CHRNB2,,,PHASE 2,,Small molecule,-1,C#Cc1cncc([C@@H]2CCCN2C)c1;CN1CCC[C@H]1C1CNCC(C1)C#C,NUPUDYKEEJNZRG-LBPRGKRZSA-N
DP-5164,ALTIRATINIB;DCC-2701;DP-5164,CHEMBL3545365,BRD:BRD-BRD-K78627070-001-01-5;BRD:BRD-K78627070-001-01-5,rep_primary;rep_single_dose,"MET INHIBITOR, VEGFR INHIBITOR",KDR;MET;TEK,,,PHASE 1,"Multiple values for MOA: {'VEGFR INHIBITOR, MET INHIBITOR', 'MET INHIBITOR, VEGFR INHIBITOR'}, defaulting to 'MET INHIBITOR, VEGFR INHIBITOR'",Small molecule,1,FC1CCC(NC(=O)C2(CC2)C(=O)NC2CC(F)C(OC3CCNC(NC(=O)C4CC4)C3)CC2F)CC1;O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1,GNNDEPIMDAZHRQ-UHFFFAOYSA-N
RU-2267,A-35957;ALLYLTRENBOLONE;ALTRENOGEST;NSC-759180;REGU-MATE;RU-2267,CHEMBL1315492,BRD:BRD-BRD-K14619660-001-01-5;BRD:BRD-K14619660-001-01-5,rep_primary;rep_single_dose,PROGESTOGEN HORMONE,PGR,ESTRUS,,LAUNCHED,,Small molecule,-1,"C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(O)CC=C, C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(O)CC=C;C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C",VWAUPFMBXBWEQY-ANULTFPQSA-N
NSC-13875,ALTRETAMINE;HEXALEN;HEXAMETHYLMELAMINE;HEXASTAT;NSC-13875,CHEMBL1455,BRD:BRD-BRD-K67043667-001-26-4;BRD:BRD-K67043667-001-26-4,rep_multi_dose;rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,OVARIAN CANCER,,LAUNCHED,,Small molecule,4,"CN(C)c1nc(N(C)C)nc(N(C)C)n1;CN(C)C1NC(NC(N1)N(C)C)N(C)C, CN(C)C1NC(NC(N1)N(C)C)N(C)C",UUVWYPNAQBNQJQ-UHFFFAOYSA-N
PHENPROPAMINE,ALVERINE;PHENPROPAMINE,CHEMBL253371,BRD:BRD-BRD-K89055274-048-22-7;BRD:BRD-K89055274-048-22-7,rep_primary;rep_single_dose,MUSCLE RELAXANT,HTR1A,"IRRITABLE BOWEL SYNDROME, DIVERTICULAR DISEASE",,LAUNCHED,,Small molecule,4,"CCN(CCCc1ccccc1)CCCc1ccccc1;CCN(CCCC1CCCCC1)CCCC1CCCCC1, CCN(CCCC1CCCCC1)CCCC1CCCCC1",ZPFXAOWNKLFJDN-UHFFFAOYSA-N
NSC-707545,ALVESPIMYCIN;NSC-707545,CHEMBL383824,BRD:BRD-BRD-K83988098-001-02-0;BRD:BRD-BRD-K83988098-003-03-4;BRD:BRD-K83988098-001-02-0;BRD:BRD-K83988098-003-03-4,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1,,,PHASE 2,,Small molecule,2,"CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O;CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O, CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O",KUFRQPKVAWMTJO-LMZWQJSESA-N
LY246736,ADL 8-2698;ADL-8-2698;ALVIMOPAN;ALVIMOPAN ANHYDROUS;ALVIMOPAN DIHYDRATE;ANHYDROUS ALVIMOPAN;ENTEREG;LY-246736;LY-246736 DIHYDRATE;LY246736,CHEMBL270190,BRD:BRD-BRD-K07857022-002-01-1;BRD:BRD-K07857022-002-01-1,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1,POSTOPERATIVE ILEUS,,LAUNCHED,,Small molecule,4,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1;C[C@H]1CN(C[C@H](CC2CCCCC2)C(=O)NCC(O)=O)CC[C@@]1(C)C1CCCC(O)C1,UPNUIXSCZBYVBB-JVFUWBCBSA-N
NSC-649890,"ALVOCIDIB;ALVOCIDIB FREEBASE;FLAVOPIRIDOL;HL 275;HL-275;HMR 1275;HMR-1275;L 86 8275;L-868275;L86-8275;MDL 107,826A;MDL-107826A;NSC-649890",CHEMBL428690,BRD:BRD-BRD-K87909389-003-03-4;BRD:BRD-K87909389-003-03-4;CTRP:687720,ctrp;rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK4;CDK5;CDK6;CDK7;CDK8;CDK9;EGFR;PYGM,,,PHASE 2,,Small molecule,3,"CN1CC[C@@H]([C@H](O)C1)C1C(O)CC(O)C2C1OC(CC2=O)-C1CCCCC1CL, CN1CC[C@@H]([C@H](O)C1)C1C(O)CC(O)C2C1OC(CC2=O)-C1CCCCC1CL;CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1",BIIVYFLTOXDAOV-YVEFUNNKSA-N
ALX-40-4C,ALX-40-4C,,BRD:BRD-K00003337-019-01-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,,,,NA,,
ALX-5407,ALX-5407,,BRD:BRD-BRD-K53979406-003-02-8;BRD:BRD-K53979406-003-02-8,rep_primary;rep_single_dose,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",SLC6A9,,,PHASE 1,"Multiple values for MOA: {'GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR', 'GLYCINE TRANSPORTER 1 INHIBITOR'}, defaulting to 'GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR'",,NA,"CN(CC[C@@H](OC1CCC(CC1)-C1CCCCC1)C1CCC(F)CC1)CC(O)=O, CN(CC[C@@H](OC1CCC(CC1)-C1CCCCC1)C1CCC(F)CC1)CC(O)=O",
AM-1241,AM-1241,,BRD:BRD-A66116161-001-02-3;BRD:BRD-BRD-A66116161-001-02-3,rep_primary;rep_single_dose,CANNABINOID RECEPTOR AGONIST,CNR1;CNR2,,,PRECLINICAL,,,NA,CN1CCCCC1CN1CC(C(=O)C2CC(CCC2I)[N+]([O-])=O)C2CCCCC12,
AM-24,AM-24,,BRD:BRD-BRD-K59013864-001-01-1;BRD:BRD-K59013864-001-01-1,rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX5,,,PHASE 2,,,NA,OC1C(I)CC(I)CC1I,
AM-251,AM-251,,BRD:BRD-BRD-K92000912-001-12-6;BRD:BRD-K92000912-001-12-6,rep_multi_dose;rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1;GPR18;GPR55,,,PRECLINICAL,,,NA,"CC1C(NN(C1-C1CCC(I)CC1)-C1CCC(CL)CC1CL)C(=O)NN1CCCCC1, CC1C(NN(C1-C1CCC(I)CC1)-C1CCC(CL)CC1CL)C(=O)NN1CCCCC1",
AM-281,AM-281,,BRD:BRD-BRD-K59419204-001-02-7;BRD:BRD-K59419204-001-02-7,rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1;CNR2;GPR55,,,PRECLINICAL,,,NA,CC1C(NN(C1-C1CCC(I)CC1)-C1CCC(CL)CC1CL)C(=O)NN1CCOCC1,
AM-404,AM-404,,BRD:BRD-BRD-K55462201-001-07-3;BRD:BRD-K55462201-001-07-3,rep_multi_dose;rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, FAAH INHIBITOR, TRPV ANTAGONIST",CNR1;CNR2;FAAH;TRPV1,,,PRECLINICAL,,,NA,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NC1CCC(O)CC1,
AM-580,AM-580,,BRD:BRD-BRD-K06854232-001-19-9;BRD:BRD-K06854232-001-19-9;CTRP:58455,ctrp;rep_multi_dose;rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA,,,PRECLINICAL,,,NA,"CC1(C)CCC(C)(C)C2CC(CCC12)C(=O)NC1CCC(CC1)C(O)=O, CC1(C)CCC(C)(C)C2CC(CCC12)C(=O)NC1CCC(CC1)C(O)=O",
AM-630,AM-630,,BRD:BRD-BRD-K63533170-001-02-9;BRD:BRD-K63533170-001-02-9,rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1;CNR2,,,PRECLINICAL,,,NA,"COC1CCC(CC1)C(=O)C1C(C)N(CCN2CCOCC2)C2CC(I)CCC12, COC1CCC(CC1)C(=O)C1C(C)N(CCN2CCOCC2)C2CC(I)CCC12",
AM-92016,AM-92016,,BRD:BRD-A11813248-003-02-4;BRD:BRD-BRD-A11813248-003-02-4,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,GRIN1,,,PRECLINICAL,,,NA,"CN(CCC1CCC(CL)C(CL)C1)CC(O)COC1CCC(NS(C)(=O)=O)CC1, CN(CCC1CCC(CL)C(CL)C1)CC(O)COC1CCC(NS(C)(=O)=O)CC1",
AM211,AM-211;AM211,CHEMBL2181753,BRD:BRD-K00003152-001-01-9,rep_single_dose,PROSTAGLANDIN INHIBITOR,,,,,,Small molecule,1,CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)NCc1ccccc1,OPXIRFWNLBDKQB-UHFFFAOYSA-N
AM679,AM679,,BRD:BRD-BRD-K88443722-001-01-7;BRD:BRD-K88443722-001-01-7,rep_primary;rep_single_dose,"CANNABINOID RECEPTOR AGONIST, LIPOXYGENASE INHIBITOR",ALOX5AP;CNR1;CNR2,,,PRECLINICAL,,,NA,COC1CNC(NC1)-C1CCC(CN2C(CC(C)(C)C(O)=O)C(SC(C)(C)C)C3CC(OC[C@@H]4CC5CCCCC5N4C(C)=O)CCC23)CC1,
TCMDC-125869,AMANTADINE;AMANTIDINE;NSC-341865;SYMADINE;SYMMETREL;TCMDC-125869,CHEMBL660,BRD:BRD-BRD-K70330367-003-07-9;BRD:BRD-K70330367-003-07-9,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,DRD2;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A,"INFLUENZA A VIRUS INFECTION, PARKINSON'S DISEASE",,LAUNCHED,,Small molecule,4,"NC12CC3CC(CC(C3)C1)C2;NC12CC3CC(CC(C3)C1)C2, NC12CC3CC(CC(C3)C1)C2",DKNWSYNQZKUICI-UHFFFAOYSA-N
FARINGOSEPT,AMBAZONE;FARINGOSEPT,CHEMBL2103762,BRD:BRD-BRD-K11244467-001-08-5;BRD:BRD-K11244467-001-08-5,rep_multi_dose;rep_primary;rep_single_dose,DNA DAMAGE INDUCER,,,,PHASE 1,,Small molecule,-1,"N=C(N)NN=C1C=CC(=NNC(N)=S)C=C1;NC(=N)N=NC1CCC(NNC(S)=N)CC1, NC(=N)N=NC1CCC(NNC(S)=N)CC1, NC(=N)N=NC1CCC(NNC(S)=N)CC1",MLMFUKWWZIZRHX-VFWKFLPVSA-N
AMBENONIUM ION,AMBENONIUM;AMBENONIUM CATION;AMBENONIUM ION,CHEMBL1652,BRD:BRD-BRD-K11292736-300-02-8;BRD:BRD-K11292736-300-02-8,rep_primary;rep_single_dose,CHOLINESTERASE INHIBITOR,ACHE,MYASTHENIA GRAVIS,,LAUNCHED,,Small molecule,4,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl;CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1CCCCC1CL)CC1CCCCC1CL,OMHBPUNFVFNHJK-UHFFFAOYSA-P
VOLIBRIS,AMBRISENTAN;GSK-1325760;GSK-1325760A;GSK1325760;GSK1325760A;LETAIRIS;LU-208075;VOLIBRIS,CHEMBL1111,BRD:BRD-BRD-K41185545-001-02-3;BRD:BRD-K41185545-001-02-3,rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA;EDNRB,PULMONARY ARTERIAL HYPERTENSION (PAH),,LAUNCHED,,Small molecule,4,COC([C@H](OC1NC(C)CC(C)N1)C(O)=O)(C1CCCCC1)C1CCCCC1;COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O,OUJTZYPIHDYQMC-LJQANCHMSA-N
TABCIN,AMBROXOL;AMBROXOL HYDROCHLORIDE;TABCIN,CHEMBL153479,BRD:BRD-BRD-K56558538-003-11-9;BRD:BRD-K56558538-003-11-9,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,CYP3A4,BRONCHITIS,,LAUNCHED,,Small molecule,3,"Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1;NC1C(BR)CC(BR)CC1CN[C@H]1CC[C@H](O)CC1, NC1C(BR)CC(BR)CC1CN[C@H]1CC[C@H](O)CC1, NC1C(BR)CC(BR)CC1CN[C@H]1CC[C@H](O)CC1, NC1C(BR)CC(BR)CC1CN[C@H]1CC[C@H](O)CC1",JBDGDEWWOUBZPM-XYPYZODXSA-N
BBI503,AMCASERTIB;BBI-503;BBI503,CHEMBL3707349,BRD:BRD-K00003244-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,Small molecule,2,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(-c4csc(-c5ccccc5)n4)cc32)c1C,QDWKGEFGLQMDAM-ULJHMMPZSA-N
NSC-758620,AMCINONIDE;CL 34699;CL-34699;CYCLOCORT;NSC-758620,CHEMBL1200732,BRD:BRD-A36010170-001-04-0;BRD:BRD-BRD-A36010170-001-04-0,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,ANXA1;NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,Small molecule,4,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C;CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,ILKJAFIWWBXGDU-MOGDOJJUSA-N
AMD-3465,AMD-3465,,BRD:BRD-K03019184-439-02-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR4,,,,,,NA,,
X4P001,AMD 070;AMD-070;AMD-11070;AMD070;AMD11070;CXCR4 INHIBITOR X4P-001;MAVORIXAFOR;X 4P-001;X4P-001;X4P001,CHEMBL518924,BRD:BRD-BRD-K42948882-305-01-1;BRD:BRD-K42948882-305-01-1,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR5;CXCR4,,,PHASE 1/PHASE 2,"Multiple values for repurposing_target: {'CCR5;CXCR4', 'CXCR4'}, taking the union",Small molecule,3,NCCCCN(CC1NC2CCCCC2[NH]1)[C@H]1CCCC2CCCNC12;NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,WVLHHLRVNDMIAR-IBGZPJMESA-N
LY-201116,AMELTOLIDE;LY 201116;LY-201116,CHEMBL22916,BRD:BRD-BRD-K48173020-001-01-8;BRD:BRD-K48173020-001-01-8,rep_primary;rep_single_dose,ANTICONVULSANT,,,,PRECLINICAL,,Small molecule,-1,Cc1cccc(C)c1NC(=O)c1ccc(N)cc1;CC1CCCC(C)C1NC(=O)C1CCC(N)CC1,HZIWGOAXOBPQGY-UHFFFAOYSA-N
ASP2151,AMENAMEVIR;ASP-2151;ASP2151,CHEMBL4297592,BRD:BRD-K00004966-001-01-9,rep_single_dose,HELICASE PRIMASE INHIBITOR,,,,,,Small molecule,3,Cc1cccc(C)c1N(CC(=O)Nc1ccc(-c2ncon2)cc1)C(=O)C1CCS(=O)(=O)CC1,MNHNIVNAFBSLLX-UHFFFAOYSA-N
NSC-196473,AMETANTRONE;NSC-196473,CHEMBL49442,BRD:BRD-K00004726-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,Small molecule,-1,O=C1c2ccccc2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,FFGSXKJJVBXWCY-UHFFFAOYSA-N
AMEZINIUM ION,AMEZINIUM;AMEZINIUM CATION;AMEZINIUM ION,CHEMBL2110922,BRD:BRD-BRD-K51387999-067-01-6;BRD:BRD-K51387999-067-01-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,,,LAUNCHED,,Small molecule,-1,COc1cc(N)cn[n+]1-c1ccccc1;COC1CC(N)CN[N+]1-C1CCCCC1,VXROHTDSRBRJLN-UHFFFAOYSA-O
NSC-309467,AMFENAC;NSC-309467,CHEMBL25146,BRD:BRD-BRD-K82122102-323-01-1;BRD:BRD-K82122102-323-01-1,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,Nc1c(CC(=O)O)cccc1C(=O)c1ccccc1;NC1C(CC(O)=O)CCCC1C(=O)C1CCCCC1,SOYCMDCMZDHQFP-UHFFFAOYSA-N
J4.327C,.ALPHA.-BENZOYLTRIETHYLAMINE;AMFEPRAMONE;ANFEPRAMONE;ANFERPRAMON;C06954;D07444;DIETHYLCATHINONE;DIETHYLPROPION;J4.327C,CHEMBL1194666,BRD:BRD-A37288617-003-02-2;BRD:BRD-BRD-A37288617-003-02-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,SLC6A2;SLC6A3,OBESITY,,LAUNCHED,,Small molecule,4,CCN(CC)C(C)C(=O)c1ccccc1;CCN(CC)C(C)C(=O)C1CCCCC1,XXEPPPIWZFICOJ-UHFFFAOYSA-N
LY-141894,AMFLUTIZOLE;LY 141894;LY-141894,CHEMBL2106558,BRD:BRD-BRD-K50813454-001-01-9;BRD:BRD-K50813454-001-01-9,rep_primary;rep_single_dose,XANTHINE OXIDASE INHIBITOR,XDH,,,PHASE 2,,Small molecule,-1,Nc1c(-c2cccc(C(F)(F)F)c2)nsc1C(=O)O;NC1C(SNC1-C1CCCC(C1)C(F)(F)F)C(O)=O,KVMCEGAWQYTFKC-UHFFFAOYSA-N
AMG 333,AMG 333,,BRD:BRD-K00079528-001-02-9,rep_single_dose,,,,,,,,NA,,
SOVILNESIB,AMG 650;SOVILNESIB,,BRD:BRD-K00126785-001-01-9;BRD:BRD-U00114870-001-01-9,oncref_1;oncref_2,INHIBITOR OF KIF18A,KIF18A,,,,"Multiple values for structure_id: {'U00114870', 'K00126785'}, defaulting to None",,NA,,
TAPOTOCLAX,AMG 176;AMG-176;AMG176;MCL-1 INHIBITOR AMG 176;MCL-1 INHIBITOR AMG-176;TAPOTOCLAX,CHEMBL4446378,BRD:BRD-K43900408-001-02-9,rep_single_dose,MCL1 INHIBITOR,,,,,,Small molecule,1,CO[C@H]1/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c2ccc3c(c2)N(C[C@@H]2CC[C@H]21)C[C@@]1(CCCc2cc(Cl)ccc21)CO3,JQNINBDKGLWYMU-GEAQBIRJSA-N
AMG208,AMG 208;AMG-208;AMG208,CHEMBL496102,BRD:BRD-BRD-K32285926-001-02-1;BRD:BRD-K32285926-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,MET,,,PHASE 1,,Small molecule,2,COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1;COC1CCC2C(OCC3NNC4CCC(NN34)-C3CCCCC3)CCNC2C1,HEAIZQNMNCHNFD-UHFFFAOYSA-N
NAVTEMADLIN,AMG 232;AMG-232;KRT-232;MDM2 INHIBITOR AMG-232;NAVTEMADLIN,CHEMBL3125702,BRD:BRD-BRD-K64925568-001-01-8;BRD:BRD-K64925568-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,MDM INHIBITOR,MDM2,,,PHASE 1/PHASE 2,,Small molecule,2,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)C1CCCC(CL)C1)C1CCC(CL)CC1;CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,DRLCSJFKKILATL-YWCVFVGNSA-N
J3.391.906I,AMG-319;AMG319;J3.391.906I,CHEMBL3545048,BRD:BRD-A58947127-001-01-6;BRD:BRD-BRD-A58947127-001-01-6;BRD:BRD-BRD-K21077415-001-01-5;BRD:BRD-K21077415-001-01-5;GDSC2:2045,gdsc;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CD,,,PHASE 2,"Multiple values for SMILES: {'C[C@H](NC1NCNC2[NH]CNC12)C1CC2CCC(F)CC2NC1-C1CCCCN1', 'CC(NC1NCNC2NC[NH]C12)C1CC2CCC(F)CC2NC1-C1CCCCN1'}, defaulting to 'C[C@H](NC1NCNC2[NH]CNC12)C1CC2CCC(F)CC2NC1-C1CCCCN1'
Multiple values for structure_id: {'A58947127', 'K21077415'}, defaulting to None",Small molecule,2,C[C@H](NC1NCNC2[NH]CNC12)C1CC2CCC(F)CC2NC1-C1CCCCN1,
AMG-337,AMG 337;AMG-337,CHEMBL3545212,BRD:BRD-BRD-K27061362-001-01-6;BRD:BRD-K27061362-001-01-6,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF MET,MET,,,PHASE 2,"Multiple values for MOA: {'INHIBITOR OF MET', 'MET INHIBITOR'}, defaulting to 'INHIBITOR OF MET'",Small molecule,2,COCCOC1CNC2CCN([C@H](C)C3NNC4C(F)CC(CN34)-C3CNN(C)C3)C(=O)C2C1,
MURIZATOCLAX,AMG 397;AMG-397;MURIZATOCLAX,CHEMBL4650225,BRD:BRD-K00108790-001-01-9,rep_single_dose,,,,,,,Small molecule,1,CO[C@]1(CN2CCN3CCCC[C@@H]3C2)/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c2ccc3c(c2)N(C[C@@H]2CC[C@H]21)C[C@@]1(CCCc2cc(Cl)ccc21)CO3,BJTFTQIBRVBSBH-VCQPVEJUSA-N
AMG-487,AMG-487,,BRD:BRD-BRD-K90239174-001-01-8;BRD:BRD-K90239174-001-01-8,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,PHASE 2,,,NA,CCOC1CCC(CC1)-N1C(NC2NCCCC2C1=O)[C@@H](C)N(CC1CCCNC1)C(=O)CC1CCC(OC(F)(F)F)CC1,
AMG-487-(+/-),AMG-487-(+/-),,BRD:BRD-A01307728-001-01-4;BRD:BRD-BRD-A01307728-001-01-4,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR3,,,PHASE 2,,,NA,CCOC1CCC(CC1)-N1C(NC2NCCCC2C1=O)C(C)N(CC1CCCNC1)C(=O)CC1CCC(OC(F)(F)F)CC1,
SOTORASIB,AMG-510;AMG510;KRAS G12C INHIBITOR 9;KRAS MUTANT-TARGETING AMG 510;LUMAKRAS;SOTORASIB,CHEMBL4535757,BRD:BRD-K00010385-001-01-9;BRD:BRD-K00010385-001-04-9,oncref_1;rep_single_dose,INHIBITOR OF KRAS-G12C,KRAS,,,,"Multiple values for MOA: {'INHIBITOR OF KRAS-G12C', 'K-RAS INHIBITOR'}, defaulting to 'INHIBITOR OF KRAS-G12C'",Small molecule,4,C=CC(=O)N1CCN(c2nc(=O)n(-c3c(C)ccnc3C(C)C)c3nc(-c4c(O)cccc4F)c(F)cc23)[C@@H](C)C1,NXQKSXLFSAEQCZ-SFHVURJKSA-N
AMG-517,AMG-517,CHEMBL229430,BRD:BRD-BRD-K34185671-001-02-8;BRD:BRD-K34185671-001-02-8,rep_primary;rep_single_dose,TRPV ANTAGONIST,TRPV1,,,PHASE 1,,Small molecule,1,CC(=O)Nc1nc2c(Oc3cc(-c4ccc(C(F)(F)F)cc4)ncn3)cccc2s1;CC(=O)NC1NC2C(OC3CC(NCN3)-C3CCC(CC3)C(F)(F)F)CCCC2S1,YUTIXVXZQIQWGY-UHFFFAOYSA-N
AMG-548,AMG-548,CHEMBL585902,BRD:BRD-BRD-K86673452-001-01-7;BRD:BRD-K86673452-001-01-7,rep_primary;rep_single_dose,MAP KINASE INHIBITOR,MAPK11;MAPK12;MAPK13;MAPK14,,,PHASE 1,,Small molecule,1,"Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O;CN1C(NC[C@@H](N)CC2CCCCC2)NC(-C2CCNCC2)C(-C2CCC3CCCCC3C2)C1=O, CN1C(NC[C@@H](N)CC2CCCCC2)NC(-C2CCNCC2)C(-C2CCC3CCCCC3C2)C1=O",RQVKVJIRFKVPBF-VWLOTQADSA-N
AMG-837,AMG-837,,BRD:BRD-BRD-K43802723-340-01-9;BRD:BRD-K43802723-340-01-9,rep_primary;rep_single_dose,FREE FATTY ACID RECEPTOR AGONIST,FFAR1,,,PHASE 1,,,NA,CC#C[C@@H](CC(O)=O)C1CCC(OCC2CCCC(C2)-C2CCC(CC2)C(F)(F)F)CC1,
AMG-925,AMG-925,,BRD:BRD-BRD-K97452254-001-01-3;BRD:BRD-K97452254-001-01-3,rep_primary;rep_single_dose,"CDK INHIBITOR, FLT3 INHIBITOR",CDK4;CDK6;FLT3,,,PHASE 1,,,NA,C[C@H]1CC[C@@H](CC1)N1C2CNCCC2C2CNC(NC3CCC4CN(CCC4N3)C(=O)CO)NC12,
AMG-9810,AMG-9810,,BRD:BRD-BRD-K01995783-001-01-6;BRD:BRD-K01995783-001-01-6,rep_primary;rep_single_dose,TRPV ANTAGONIST,TRPV1,,,PRECLINICAL,,,NA,"CC(C)(C)C1CCC(CC1)\C=C\C(=O)NC1CCC2OCCOC2C1, CC(C)(C)C1CCC(CC1)\C=C\C(=O)NC1CCC2OCCOC2C1",
AMG-PERK-44,AMG-PERK-44,,BRD:BRD-BRD-K04374714-003-01-1;BRD:BRD-K04374714-003-01-1,rep_primary;rep_single_dose,PERK INHIBITOR,EIF2AK4,,,PRECLINICAL,,,NA,CC1CCC2CC(CCC2N1)-C1C(C)CCC(C(=O)C2C(-C3CCCCC3)N(C)N(-C3CCCCC3)C2=O)C1N,
AMG458,AMG458,,BRD:BRD-BRD-K21782625-001-02-4;BRD:BRD-BRD-K21782625-001-03-2;BRD:BRD-K21782625-001-02-4;BRD:BRD-K21782625-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,MET INHIBITOR,MET,,,PRECLINICAL,,,NA,"COC1CCC2C(OC3CCC(NC(=O)C4C(C)N(CC(C)(C)O)N(-C5CCCCC5)C4=O)NC3)CCNC2C1, COC1CCC2C(OC3CCC(NC(=O)C4C(C)N(CC(C)(C)O)N(-C5CCCCC5)C4=O)NC3)CCNC2C1",
MOTESANIB PHOSPHATE,AMG 706;AMG-706;AMG706;MOTESANIB;MOTESANIB DIPHOSPHATE;MOTESANIB PHOSPHATE,CHEMBL2107357;CHEMBL572881,GDSC1:1029,gdsc,,,,,,,Small molecule,3,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21.O=P(O)(O)O.O=P(O)(O)O,ONDPWWDPQDCQNJ-UHFFFAOYSA-N
AMG900,AMG 900;AMG-900;AMG900,CHEMBL2140408,BRD:BRD-BRD-K21728777-001-02-3;BRD:BRD-K21728777-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB;AURKC,,,PHASE 1,,Small molecule,1,Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1;CC1CSC(C1)-C1NNC(NC2CCC(OC3NCCCC3-C3CCNC(N)N3)CC2)C2CCCCC12,IVUGFMLRJOCGAS-UHFFFAOYSA-N
AMI-1,AMI-1,,BRD:BRD-K75114721-304-02-6,rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,PRMT1,,,,,,NA,,
SR58611,AMIBEGRON;SR-58611;SR58611,CHEMBL1193948,BRD:BRD-BRD-K24610819-003-01-8;BRD:BRD-K24610819-003-01-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB3,,,PHASE 3,,Small molecule,3,"CCOC(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2;CCOC(=O)COC1CCC2CC[C@@H](CC2C1)NC[C@H](O)C1CCCC(CL)C1, CCOC(=O)COC1CCC2CC[C@@H](CC2C1)NC[C@H](O)C1CCCC(CL)C1",RDJQCOBTKKAQAH-FPOVZHCZSA-N
NSC-4993,4-DIMETHYLAMINOANTIPYRINE;AMIDAZOPHENE;AMIDOPYRAZOLINE;AMIDOPYRINE;AMINOPHENAZONE;AMINOPYRINE;BRUFANEUXOL;DEREUMA;FEBRON;ITAMIDONE;MAMALLET A;NETSUSARIN;NSC-4993,CHEMBL288470,BRD:BRD-BRD-K12568846-001-14-6;BRD:BRD-K12568846-001-14-6,rep_primary;rep_single_dose,ANALGESIC AGENT,,DERMATITIS HERPETIFORMIS (DH),,LAUNCHED,,Small molecule,4,"Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C;CN(C)C1C(C)N(C)N(-C2CCCCC2)C1=O, CN(C)C1C(C)N(C)N(-C2CCCCC2)C1=O, CN(C)C1C(C)N(C)N(-C2CCCCC2)C1=O",RMMXTBMQSGEXHJ-UHFFFAOYSA-N
RUZURGI,"3,4-DAP;3,4-DIAMMONIOPYRIDINIUM;4-DAP;AMIFAMPRIDINE;DAP;DYNAMINE;NSC-521760;PYRIDINE-3,4-DIAMINE;RUZURGI",CHEMBL354077,BRD:BRD-BRD-K80262108-001-07-0;BRD:BRD-K80262108-001-07-0,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,,LAMBERT-EATON MYASTHENIC SYNDROME (LEMS),,LAUNCHED,,Small molecule,4,Nc1ccncc1N;NC1CCNCC1N,OYTKINVCDFNREN-UHFFFAOYSA-N
YM-08310,AMIFOSTINE;AMIFOSTINE ANHYDROUS;AMIFOSTINE DISULFIDE;AMIFOSTINE TRIHYDRATE;ETHIOFOS;ETHIOFOS ANHYDROUS;ETHYOL;GAMMAPHOS;NSC-296961;NSC-758236;WR-2721;WR-2721 TRIHYDRATE;YM-08310,CHEMBL1006,BRD:BRD-K73947551-001-04-4,rep_single_dose,REDUCING AGENT,ALPPL2;ENPP1,,,,,Small molecule,4,NCCCNCCSP(=O)(O)O,JKOQGQFVAUAYPM-UHFFFAOYSA-N
POTENTOX,AMIKACIN;AMIKACINUM;AMIKIN;BAY 41-6551;LUKADIN;NSC-177001;POTENTOX,CHEMBL177,BRD:BRD-A30051119-002-01-8;BRD:BRD-BRD-A30051119-002-01-8,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O;NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O, NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)C1O, NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O, NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O, NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O",LKCWBDHBTVXHDL-RMDFUYIESA-N
MIDAMOR,AMICLARAN;AMILORIDE;HYDRO-RIDE;MIDAMOR,CHEMBL945,BRD:BRD-BRD-K97181089-003-24-7;BRD:BRD-K97181089-003-24-7,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,AOC1;ASIC1;ASIC2;ASIC3;PKD2;PKD2L1;PLAU;SCNN1A;SCNN1B;SCNN1D;SCNN1G;SLC9A1;TRPC7;TRPV2,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N;NC(=N)NC(=O)C1NC(CL)C(N)NC1N, NC(=N)NC(=O)C1NC(CL)C(N)NC1N, NC(=N)NC(=O)C1NC(CL)C(N)NC1N, NC(=N)NC(=O)C1NC(CL)C(N)NC1N",XSDQTOBWRPYKKA-UHFFFAOYSA-N
AMINEPTINE,AMINEPTIN;AMINEPTINE,CHEMBL418995,BRD:BRD-BRD-K24219278-001-01-6;BRD:BRD-K24219278-001-01-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,SLC6A2;SLC6A4,,,WITHDRAWN,,Small molecule,4,O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21;OC(=O)CCCCCCNC1C2CCCCC2CCC2CCCCC12,ONNOFKFOZAJDHT-UHFFFAOYSA-N
AMINOCAPROIC-ACID,AMINOCAPROIC-ACID,,BRD:BRD-BRD-K64931368-003-01-4;BRD:BRD-K64931368-003-01-4,rep_primary;rep_single_dose,PLASMINOGEN ACTIVATOR INHIBITOR,LPA;PLAT;PLG,FIBRINOLYTIC BLEEDING,,LAUNCHED,,,NA,"NCCCCCC(O)=O, NCCCCCC(O)=O, NCCCCCC(O)=O",
ORIMETEN,AMINOGLUTETHIMIDE;CYTADREN;NSC-330915;ORIMETEN,CHEMBL488,BRD:BRD-A25234499-001-18-3;BRD:BRD-A25234499-001-19-1;BRD:BRD-BRD-A25234499-001-18-3,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR ANTAGONIST,CYP11A1;CYP19A1,"CUSHING'S SYNDROME, BREAST CANCER",,LAUNCHED,,Small molecule,4,"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O;CCC1(CCC(=O)NC1=O)C1CCC(N)CC1, CCC1(CCC(=O)NC1=O)C1CCC(N)CC1, CCC1(CCC(=O)NC1=O)C1CCC(N)CC1",ROBVIMPUHSLWNV-UHFFFAOYSA-N
PIMAGEDINE,AMINOGUANIDINE;PIMAGEDINE,CHEMBL225304,BRD:BRD-BRD-K25114078-003-08-1;BRD:BRD-K25114078-003-08-1,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,AKR1B1;NOS2;TIMP3,,,PHASE 3,"Multiple values for repurposing_target: {'AKR1B1;NOS2;TIMP3', 'NOS2'}, taking the union",Small molecule,1,"N=C(N)NN;NNC(N)=N, NNC(N)=N",HAMNKKUPIHEESI-UHFFFAOYSA-N
AMINOHYDROXYBUTYRIC-ACID,AMINOHYDROXYBUTYRIC-ACID,,BRD:BRD-A40777960-001-04-2;BRD:BRD-BRD-A40777960-001-04-2,rep_primary;rep_single_dose,,,EPILEPSY,,LAUNCHED,,,NA,NCC(O)CC(O)=O,
AMINOLEVULINIC-ACID-BENZYL-ESTER,AMINOLEVULINIC-ACID-BENZYL-ESTER,,BRD:BRD-BRD-K59998349-003-01-4;BRD:BRD-K59998349-003-01-4,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,NCC(=O)CCC(=O)OCC1CCCCC1,
AMINOMETHYLTRANSFERASE,AMINOMETHYLTRANSFERASE,,BRD:BRD-A28318179-003-08-5;BRD:BRD-BRD-A28318179-003-08-5,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS2,,,PRECLINICAL,,,NA,CC1CCN=C(N)S1,
NSC-759162,AMINOPENTAMIDE;AMINOPENTAMIDE ACID SULFATE;AMINOPENTAMIDE HYDROGEN SULFATE;AMINOPENTAMIDE SULFATE;AMINOPENTAMIDE SULPHATE;BL-139;CENTRINE;DIMEVAMIDE;DIMEVAMIDE SULFATE;DL-;NSC-759162,CHEMBL92915,BRD:BRD-A69917777-065-02-2;BRD:BRD-BRD-A69917777-065-02-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,"ACUTE ABDOMINAL VISCERAL SPASM, HYPERTROPHIC GASTRITIS (GHG), NAUSEA",,LAUNCHED,,Small molecule,-1,CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C;CC(CC(C(N)=O)(C1CCCCC1)C1CCCCC1)N(C)C,NARHAGIVSFTMIG-UHFFFAOYSA-N
TRUPHYLLINE,AMINOPHYLLIN;AMINOPHYLLINE;AMINOPHYLLINE DYE FREE;AMINOPHYLLINE IN SODIUM CHLORIDE;AMINOPHYLLINUM;AMMOPHYLLIN;AMNIVENT-225 SR;AMNIVENT-350 SR;CARDOPHYLLIN;LINAMPHETA;NSC-7919;PETERPHYLLIN;PHYLLOCONTIN;SOMOPHYLLIN;SOMOPHYLLIN-DF;SYNTOPHYLLIN;THEOPHYLLAMINE;THEOPHYLLINE ETHYLENEDIAMINE;THEOPHYLLINE-ETHYLENEDIAMINE;TRUPHYLLINE,CHEMBL1370561,BRD:BRD-BRD-K97799481-230-01-7,rep_primary,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3;HDAC2;PDE3A;PDE3B;PDE4A;PDE4B;PDE4C;PDE4D,"ASTHMA, BRONCHITIS, EMPHYSEMA",,LAUNCHED,,Small molecule,4,"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN;CN1C2NC[NH]C2C(=O)N(C)C1=O, CN1C2NC[NH]C2C(=O)N(C)C1=O",FQPFAHBPWDRTLU-UHFFFAOYSA-N
AMINOPURVALANOL-A,AMINOPURVALANOL-A,,BRD:BRD-BRD-K07762753-001-04-4;BRD:BRD-K07762753-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,"CDK INHIBITOR, TYROSINE KINASE INHIBITOR",CDK1;CDK2;CDK5;CDK6,,,PRECLINICAL,,,NA,"CC(C)[C@H](CO)NC1NC(NC2CC(N)CC(CL)C2)C2NCN(C(C)C)C2N1, CC(C)[C@H](CO)NC1NC(NC2CC(N)CC(CL)C2)C2NCN(C(C)C)C2N1",
TEEBACIN,4-AMINO-2-HYDROXY-;4-AMINOSALICYLIC ACID;AMINOSALICYLATE;AMINOSALICYLIC ACID;AMINOSALICYLIC ACID RESIN COMPLEX;BENZOIC ACID;GRANUPAS;NSC-2083;P-AMINOSALICYLIC ACID;PARA-AMINOSALICYLIC ACID;PARASAL;PAS;PASER;PASKALIUM;REZIPAS;TEEBACIN,CHEMBL1169,BRD:BRD-BRD-K80267133-001-17-7;BRD:BRD-BRD-K80267133-001-19-3;BRD:BRD-K80267133-001-17-7;BRD:BRD-K80267133-001-19-3;BRD:BRD-K80267133-325-22-9,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,ALOX5;CHUK;PLA2G2E;PTGS1;PTGS2,"INFLAMMATORY BOWEL DISEASE, ULCERATIVE COLITIS",,LAUNCHED,,Small molecule,4,"Nc1ccc(C(=O)O)c(O)c1;NC1CCC(C(O)=O)C(O)C1, NC1CCC(C(O)=O)C(O)C1, NC1CCC(C(O)=O)C(O)C1",WUBBRNOQWQTFEX-UHFFFAOYSA-N
RP-2921,AMINOTHIAZOLE;NSC-1900;RP 2921;RP-2921,CHEMBL344760,BRD:BRD-BRD-K13421763-001-06-2;BRD:BRD-K13421763-001-06-2,rep_primary;rep_single_dose,CYCLIN D INHIBITOR,NOS2,,,PRECLINICAL,,Small molecule,-1,"Nc1nccs1;NC1NCCS1, NC1NCCS1, NC1NCCS1",RAIPHJJURHTUIC-UHFFFAOYSA-N
VF-236,AMIDOX;AMIODAR;AMIODARONE;AMIODARONE HCL;AMIODARONE HYDROCHLORIDE;AMYBEN;CORDARONE;CORDARONE X;CORDARONE X 100;CORDARONE X 200;DARMIL;L-3428;MIODARON;NEXTERONE;NSC-343341;NSC-85442;ORTACRONE;PACERONE;RITMOCARDYL;SK&F-33134-A;SKF 33134-A;SKF-33134-A;TRANGOREX;VF-236,CHEMBL1083993;CHEMBL633,BRD:BRD-BRD-K17561142-003-32-5;BRD:BRD-K17561142-003-32-5,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,ADRB1;CACNA1H;CACNA2D2;KCNA7;KCNH2,VENTRICULAR ARRHYTHMIAS,,LAUNCHED,,Small molecule,4,"CCCCC1OC2CCCCC2C1C(=O)C1CC(I)C(OCCN(CC)CC)C(I)C1, CCCCC1OC2CCCCC2C1C(=O)C1CC(I)C(OCCN(CC)CC)C(I)C1, CCCCC1OC2CCCCC2C1C(=O)C1CC(I)C(OCCN(CC)CC)C(I)C1;CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1.Cl",ITPDYQOUSLNIHG-UHFFFAOYSA-N
SM-1213,AMIPRILOSE;SM-1213,CHEMBL1316321,BRD:BRD-BRD-K97643133-003-09-3;BRD:BRD-K97643133-003-09-3,rep_primary;rep_single_dose,CD ANTAGONIST,,,,PHASE 3,,Small molecule,-1,CN(C)CCCO[C@@H]1[C@H]2OC(C)(C)O[C@H]2O[C@@H]1[C@H](O)CO;CN(C)CCCO[C@H]1[C@H](O[C@@H]2OC(C)(C)O[C@H]12)[C@H](O)CO,YXBQLONCIPUQKO-UJPOAAIJSA-N
AMISELIMOD,2240442;AMISELIMOD,CHEMBL3707375,BRD:BRD-K00003223-003-01-9,rep_single_dose,SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR,,,,,,Small molecule,2,CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F,JVCPIJKPAKAIIP-UHFFFAOYSA-N
SULAMID,AMINOSULTOPRIDE;AMISULPRIDE;APD-421;APD421;BARHEMSYS;DAN-2163;DENIBAN;NSC-760085;SOCIAN;SOLIAN;SOLIAN 100;SOLIAN 200;SOLIAN 400;SOLIAN 50;SULAMID,CHEMBL243712,BRD:BRD-A60197193-001-14-6;BRD:BRD-BRD-A60197193-001-14-6,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3;HTR2A;HTR7,"PSYCHOSIS, BIPOLAR DISORDER, SCHIZOPHRENIA",,LAUNCHED,,Small molecule,4,"CCN1CCCC1CNC(=O)C1CC(C(N)CC1OC)S(=O)(=O)CC, CCN1CCCC1CNC(=O)C1CC(C(N)CC1OC)S(=O)(=O)CC;CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC",NTJOBXMMWNYJFB-UHFFFAOYSA-N
EB1010,"AMITIFADINE;DOV 21947;DOV-21,947;DOV-21947;EB1010",CHEMBL592374,BRD:BRD-A68942014-003-01-7;BRD:BRD-BRD-A68942014-003-01-7,rep_primary;rep_single_dose,SEROTONIN TRANSPORTER (SERT) INHIBITOR,SLC6A2;SLC6A3;SLC6A4,,,PHASE 3,,Small molecule,2,Clc1ccc([C@]23CNC[C@H]2C3)cc1Cl;CLC1CCC(CC1CL)C12CC1CNC2,BSMNRYCSBFHEMQ-KCJUWKMLSA-N
TRIPTANOL,AMITID;AMITRIL;AMITRIPTYLINE;DAMITRIPTYLINE;ELAVIL;ENDEP;ETRAFON-A;ETRAFON-FORTE;FLAVYL;LAROXYL;LIMBITROL;PROHEPTADIENE;SEROTEN;TRIPTANOL,CHEMBL629,BRD:BRD-BRD-K53737926-003-27-8;BRD:BRD-K53737926-003-27-8,rep_primary;rep_single_dose,"NOREPINEPHRINE INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃÂÂNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRB1;ADRB2;ADRB3;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;HRH1;HRH2;HRH4;HTR1A;HTR1B;HTR1D;HTR2A;HTR2C;HTR6;HTR7;KCNA1;KCND2;KCND3;KCNQ2;KCNQ3;NTRK1;NTRK2;OPRD1;OPRK1;OPRM1;SIGMAR1;SLC6A2;SLC6A4,DEPRESSION,,LAUNCHED,"Multiple values for MOA: {'NOREPINEPHRINE INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃ\x80\x93NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)', 'NOREPINEPHRINE INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)'}, defaulting to 'NOREPINEPHRINE INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃ\x80\x93NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)'",Small molecule,4,"CN(C)CCC=C1C2CCCCC2CCC2CCCCC12, CN(C)CCC=C1C2CCCCC2CCC2CCCCC12;CN(C)CCC=C1c2ccccc2CCc2ccccc21",KRMDCWKBEZIMAB-UHFFFAOYSA-N
SOLFA,AA-673;AMLEXANOX;AMOXANOX;APHTHASOL;APHTHEAL;CHX 3673;CHX-3673;ELICS;SOLFA,CHEMBL1096,BRD:BRD-BRD-K29530284-001-06-2;BRD:BRD-K29530284-001-06-2,rep_primary;rep_single_dose,HISTAMINE RECEPTOR MODULATOR,FGF1;IL3;PDE4A;PDE4B;PDE4C;PDE4D;S100A12;S100A13,"APHTHOUS ULCERS, ASTHMA, CONJUNCTIVITIS, ALLERGIC RHINITIS",,LAUNCHED,,Small molecule,4,"CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1;CC(C)C1CCC2OC3NC(N)C(CC3C(=O)C2C1)C(O)=O, CC(C)C1CCC2OC3NC(N)C(CC3C(=O)C2C1)C(O)=O",SGRYPYWGNKJSDL-UHFFFAOYSA-N
S-AMLODIPINE,(S)-;AMLODIPINE;ASTUDAL 5;CKD-330 COMPONENT AMLODIPINE;HGP-0904;HGP0904;ISTIN;LEVAMLODIPINE;NORVAS;NORVASC;S-AMLODIPINE,CHEMBL1491;CHEMBL2111097,BRD:BRD-A22032524-074-06-5;BRD:BRD-BRD-A22032524-074-06-5,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CA1;CACNA1B;CACNA1C;CACNA1D;CACNA1F;CACNA1S;CACNA2D1;CACNA2D3;CACNB1;CACNB2;SMPD1,"HYPERTENSION, CHRONIC STABLE ANGINA, VASOSPASTIC ANGINA, CORONARY ARTERY DISEASE (CAD)",,LAUNCHED,,Small molecule,4,"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl;CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1CCCCC1CL)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1CCCCC1CL)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1CCCCC1CL)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1CCCCC1CL)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1CCCCC1CL)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1CCCCC1CL)C(=O)OC",HTIQEAQVCYTUBX-KRWDZBQOSA-N
AMMONIUM-GLYCYRRHIZINATE,AMMONIUM-GLYCYRRHIZINATE,,BRD:BRD-BRD-K15318383-201-01-5;BRD:BRD-K15318383-201-01-5,rep_primary;rep_single_dose,THROMBIN INHIBITOR,HSD11B1;HSD11B2;SLCO1B1;SLCO1B3,COSMETIC,,LAUNCHED,,,NA,"C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@]4(C)CC[C@H](O[C@H]5O[C@@H]([C@@H](O)[C@H](O)[C@@H]5O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C(O)=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O, C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@]4(C)CC[C@H](O[C@H]5O[C@@H]([C@@H](O)[C@H](O)[C@@H]5O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C(O)=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O",
AMMONIUM-LACTATE,AMMONIUM-LACTATE,,BRD:BRD-BRD-M29182745-001-01-4;BRD:BRD-M29182745-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,,HCAR1,"XEROSIS CUTIS, ICHTHYOSIS VULGARIS",,LAUNCHED,,,NA,N.CC(O)C(O)=O,
AMMONIUM-PERFLUOROCAPRYLATE,AMMONIUM-PERFLUOROCAPRYLATE,,BRD:BRD-K32531356-001-03-9,rep_single_dose,PIM KINASE INHIBITOR,PIM1,,,,,,NA,,
AMN-082,AMN-082,,BRD:BRD-BRD-K23335153-300-02-5;BRD:BRD-K23335153-300-02-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,GRM7,,,PRECLINICAL,,,NA,"C(CNC(C1CCCCC1)C1CCCCC1)NC(C1CCCCC1)C1CCCCC1, C(CNC(C1CCCCC1)C1CCCCC1)NC(C1CCCCC1)C1CCCCC1",
SUNOQUINE,AMODIAQUIN;AMODIAQUINE;AMODIAQUINUM;GNF-PF-5648;NSC-13453;SJ000110703;SUNOQUINE,CHEMBL682,BRD:BRD-BRD-K91290917-300-01-8;BRD:BRD-K91290917-300-01-8,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HNMT,MALARIA,,LAUNCHED,,Small molecule,4,"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O;CCN(CC)CC1CC(NC2CCNC3CC(CL)CCC23)CCC1O, CCN(CC)CC1CC(NC2CCNC3CC(CL)CCC23)CCC1O",OVCDSSHSILBFBN-UHFFFAOYSA-N
NSC-308847,AMONAFIDE;AS-1413;NAFIDIMIDE;NSC-308847,CHEMBL428676,BRD:BRD-BRD-K56334280-001-05-1;BRD:BRD-K56334280-001-05-1,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A;TOP2B,,,PHASE 3,,Small molecule,3,CN(C)CCN1C(=O)C2CCCC3CC(N)CC(C1=O)C23;CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O,UPALIKSFLSVKIS-UHFFFAOYSA-N
RO 14-4767/000,AMOROLFINE;AMOROLFINE (AS HYDROCHLORIDE);AMOROLFINE HCL;AMOROLFINE HYDROCHLORIDE;LOCERYL;LOCERYL CURANAIL;OMICUR;RO 14-4767/000,CHEMBL489411,BRD:BRD-A37390343-003-03-5;BRD:BRD-BRD-A37390343-003-03-5,rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,,ONYCHOMYCOSIS,,LAUNCHED,,Small molecule,4,"CCC(C)(C)c1ccc(CC(C)CN2C[C@@H](C)O[C@@H](C)C2)cc1;CCC(C)(C)C1CCC(CC(C)CN2C[C@H](C)O[C@H](C)C2)CC1, CCC(C)(C)C1CCC(CC(C)CN2C[C@H](C)O[C@H](C)C2)CC1",MQHLMHIZUIDKOO-AYHJJNSGSA-N
NSC-759559,"AMOXAPINE;ASENDIN;ASENDIS;CL 67,772;CL 67772;CL-67,772;CL-67772;DEFANYL;NSC-759559",CHEMBL1113,BRD:BRD-BRD-K02265150-001-26-5;BRD:BRD-K02265150-001-26-5,rep_primary;rep_single_dose,NOREPINEPHRINE REPUTAKE INHIBITOR,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;DRD5;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;HRH1;HRH4;HTR1A;HTR1B;HTR2A;HTR2B;HTR2C;HTR3A;HTR6;HTR7;SLC6A2;SLC6A3;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2;CLC1CCC2OC3CCCCC3N=C(N3CCNCC3)C2C1, CLC1CCC2OC3CCCCC3N=C(N3CCNCC3)C2C1, CLC1CCC2OC3CCCCC3N=C(N3CCNCC3)C2C1",QWGDMFLQWFTERH-UHFFFAOYSA-N
ZOXYCIL 500,AMIX 125;AMIX 250;AMIX 500;AMOPEN;AMORAM;AMOXI-INJECT;AMOXI-TABS;AMOXICILLIN;AMOXICILLIN (ANHYDROUS);AMOXICILLIN (AS TRIHYDRATE);AMOXICILLIN ANHYDROUS;AMOXICILLIN HYDRATE;AMOXICILLIN PEDIATRIC;AMOXICILLIN TRIHYDRATE;AMOXICILLINE;AMOXICILLINUM TRIHYDRICUM;AMOXIDENT 250;AMOXIDENT 500;AMOXIL;AMOXIL FIZTAB;AMOXIL SF;AMOXYCILLIN;AMOXYKE;AMOXYMED;AMRIT;AQUACIL;ATOKSILIN;BIOMOX;BRL 2333;BRL-2333;DAMOXY;DEDOXIL;DEMOKSIL;DISPERMOX;FLEMOXIN SOLUTAB;GALENAMOX;LARGOPEN;LAROTID;MOKSILIN;MOXATAG;NSC-277174;POLYMOX;PROMOXIL;REMOXIL;RESPILLIN;ROBAMOX;SUMOX;TOPRAMOXIN;TRIMOX;UTIMOX;VETREMOX;WYMOX;ZOXYCIL 250;ZOXYCIL 500,CHEMBL1082,BRD:BRD-BRD-K55044200-001-14-6;BRD:BRD-BRD-K55044200-001-15-3;BRD:BRD-K55044200-001-14-6;BRD:BRD-K55044200-001-15-3,rep_multi_dose;rep_primary;rep_single_dose,PENICILLIN BINDING PROTEIN INHIBITOR,CYP2C19;SLC15A1;SLC15A2;SLC22A6,"SKIN INFECTIONS, DUODENAL ULCER DISEASE, GONORRHEA, EAR INFECTIONS, THROAT INFECTIONS, GENITOURINARY TRACT INFECTIONS, RESPIRATORY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O;CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCC(O)CC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCC(O)CC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCC(O)CC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCC(O)CC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCC(O)CC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCC(O)CC3)C(=O)N2[C@H]1C(O)=O",LSQZJLSUYDQPKJ-NJBDSQKTSA-N
AMPA-(RS),AMPA-(RS),,BRD:BRD-A34716233-004-03-5;BRD:BRD-BRD-A34716233-004-03-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIN1,,,PRECLINICAL,,,NA,"CC1ONC(O)C1CC(N)C(O)=O, CC1ONC(O)C1CC(N)C(O)=O",
AMPA-(S),AMPA-(S),,BRD:BRD-BRD-K92493880-001-03-0;BRD:BRD-K92493880-001-03-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIA2;GRIN1,,,PRECLINICAL,"Multiple values for repurposing_target: {'GRIA2;GRIN1', 'GRIN1'}, taking the union",,NA,CC1ONC(O)C1C[C@H](N)C(O)=O,
CX516,AMPALEX;BDP 12;BDP-12;CX 516;CX-516;CX516,CHEMBL136800,BRD:BRD-BRD-K24771047-001-01-6;BRD:BRD-K24771047-001-01-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIA1;GRIA2;GRIA3;GRIA4,,,PHASE 2,,Small molecule,2,O=C(c1ccc2nccnc2c1)N1CCCCC1;O=C(N1CCCCC1)C1CCC2NCCNC2C1,ANDGGVOPIJEHOF-UHFFFAOYSA-N
AMPEROZIDE,AMPEROZIDE,CHEMBL1079935,BRD:BRD-BRD-K52397688-003-06-4;BRD:BRD-K52397688-003-06-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,FAAH;HTR2A,PSYCHOSIS,,LAUNCHED,,Small molecule,-1,CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1;CCNC(=O)N1CCN(CCCC(C2CCC(F)CC2)C2CCC(F)CC2)CC1,NNAIYOXJNVGUOM-UHFFFAOYSA-N
AMPHOTERICIN-B,AMPHOTERICIN-B,,BRD:BRD-BRD-K27352494-001-03-6;BRD:BRD-K27352494-001-03-6,rep_primary;rep_single_dose,MEMBRANE PERMEABILITY ENHANCER,,FUNGAL INFECTION,,LAUNCHED,,,NA,"C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O",
WY 5103,ALPHA-AMINOBENZYLPENICILLIN;AMCILL;AMFIPEN;AMINOBENZYLPENICILLIN;AMINOBENZYLPENICILLIN TRIHYDRATE;AMPICILLIN;AMPICILLIN (ANHYDROUS);AMPICILLIN ANHYDROUS;AMPICILLIN HYDRATE;AMPICILLIN TRIHYDRATE;AMPICILLIN/AMPICILLIN TRIHYDRATE;AMPICILLINUM;AMPILAR;ANHYDROUS;ANHYDROUS AMPICILLIN;AY-6108;BRITCIN;BRL-1341;NSC-528986;OMNIPEN;OMNIPEN (AMPICILLIN);OMNIPEN-N;P-50;PENBRITIN;PENBRITIN-S;PFIZERPEN-A;POLY-CILLIN;POLYCILLIN;POLYCILLIN-N;POLYCILLIN-PRB;PRINCIPEN;PRINCIPEN '125';PRINCIPEN '250';PRINCIPEN '500';PROBAMPACIN;REDICILIN;SEMICILLIN;TOKIOCILLIN;TOTACILLIN;TOTACILLIN-N;ULTRABION;VIDOPEN;WY 5103,CHEMBL174,BRD:BRD-BRD-K68432770-236-23-1;BRD:BRD-K68432770-236-23-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"RESPIRATORY TRACT INFECTIONS, MENINGITIS, BACTERIAL SEPTICEMIA, ENDOCARDITIS, URINARY TRACT INFECTIONS, GASTROINTESTINAL INFECTIONS",,LAUNCHED,,Small molecule,4,"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O;CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3CCCCC3)C(=O)N2[C@H]1C(O)=O",AVKUERGKIZMTKX-NJBDSQKTSA-N
VX-478,141 W94;141W94;AGENERASE;AMPRENAVIR;J05AE05;KVX-478;VX-478,CHEMBL116,BRD:BRD-BRD-K47827687-001-02-2;BRD:BRD-K47827687-001-02-2,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1;CC(C)CN(C[C@@H](O)[C@H](CC1CCCCC1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1CCC(N)CC1,YMARZQAQMVYCKC-OEMFJLHTSA-N
THIACOCCID,AMPROCIDUM;AMPROL;AMPROLIUM;AMPROLIUM HYDROCHLORIDE;AMPROVINE;CORID;MEPYRIUM;NSC-523454;THIACOCCID,CHEMBL1179735;CHEMBL97350,BRD:BRD-BRD-K90027121-003-01-7;BRD:BRD-K90027121-003-01-7,rep_multi_dose;rep_primary;rep_single_dose,THIAMINE UPTAKE BLOCKER,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,"CCCC1NCC(C[N+]2CCCCC2C)C(N)N1, CCCC1NCC(C[N+]2CCCCC2C)C(N)N1;CCCc1ncc(C[n+]2ccccc2C)c(N)n1.[Cl-]",LCTXBFGHZLGBNU-UHFFFAOYSA-M
AMPYRONE,4-AMINOANTIPYRINE;AMPYRONE,CHEMBL1165011,BRD:BRD-K20484910-001-16-9,rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,,,Small molecule,NA,Cc1c(N)c(=O)n(-c2ccccc2)n1C,RLFWWDJHLFCNIJ-UHFFFAOYSA-N
WINCORAM,AMCORAL;AMRINONE;C01CE01;CARTONIC;CORDEMCURA;INAMRINONE;INOCOR;NSC-759805;VESISTOL;WIN 40680;WIN-40680;WINCORAM,CHEMBL12856,BRD:BRD-BRD-K45924332-001-16-8;BRD:BRD-K45924332-001-16-8,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A;PDE3B;PDE4B;TNF,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,4,Nc1cc(-c2ccncc2)c[nH]c1=O;NC1CC(C[NH]C1=O)-C1CCNCC1,RNLQIBCLLYYYFJ-UHFFFAOYSA-N
AMRUBICIN,AMRUBICIN,CHEMBL1186894,BRD:BRD-BRD-K13843533-001-01-7;BRD:BRD-K13843533-001-01-7,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A;TOP2B,"SMALL CELL LUNG CANCER, SMALL CELL LUNG CANCER",,LAUNCHED,,Small molecule,3,"CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O;CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C2C(O)C3C(=O)C4CCCCC4C(=O)C3C(O)C2C1, CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C2C(O)C3C(=O)C4CCCCC4C(=O)C3C(O)C2C1",VJZITPJGSQKZMX-XDPRQOKASA-N
SN-21429,ACRIDINYLANISIDIDE;AMEKRIN;AMSACRINE;AMSIDIL;AMSIDINE;AMSIDYL;CI-880;LAMASINE;M-AMSA;NCI-249992;NSC-156303;NSC-249992;SN-11841;SN-21429,CHEMBL43,BRD:BRD-BRD-K68346641-001-01-4;BRD:BRD-BRD-K68346641-001-02-2;BRD:BRD-K68346641-001-01-4;BRD:BRD-K68346641-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,KCNH2;TOP2A,"ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)",,LAUNCHED,,Small molecule,4,"COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12;COC1CC(NS(C)(=O)=O)CCC1NC1C2CCCCC2NC2CCCCC12, COC1CC(NS(C)(=O)=O)CCC1NC1C2CCCCC2NC2CCCCC12",XCPGHVQEEXUHNC-UHFFFAOYSA-N
AMTHAMINE,AMTHAMINE,CHEMBL293762,BRD:BRD-BRD-K39670393-303-02-1;BRD:BRD-K39670393-303-02-1,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH2,,,PRECLINICAL,,Small molecule,NA,Cc1nc(N)sc1CCN;CC1NC(N)SC1CCN,LHVRFUVVRXGZPV-UHFFFAOYSA-N
AMTOLMETIN-GUACIL,AMTOLMETIN-GUACIL,,BRD:BRD-BRD-K70924353-001-01-2;BRD:BRD-K70924353-001-01-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS",,LAUNCHED,,,NA,COC1CCCCC1OC(=O)CNC(=O)CC1CCC(C(=O)C2CCC(C)CC2)N1C,
MP470,AMUVATINIB;HPK 56;HPK-56;HPK56;MP 470;MP-470;MP470,CHEMBL2103851,BRD:BRD-BRD-K66538826-001-07-2;BRD:BRD-K66538826-001-07-2;GDSC1:293,gdsc;rep_primary;rep_single_dose,"FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAD51 INHIBITOR, RET TYROSINE KINASE INHIBITOR",KIT;MET,,,PHASE 2,,Small molecule,2,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1;S=C(NCC1CCC2OCOC2C1)N1CCN(CC1)C1NCNC2C3CCCCC3OC12,FOFDIMHVKGYHRU-UHFFFAOYSA-N
AMXT-1501 TETRAHYDROCHLORIDE,AMXT-1501 TETRAHYDROCHLORIDE,,BRD:BRD-K00091067-376-01-9,rep_single_dose,,,,,,,,NA,,
AMYGDALIN,AMYGDALIN,CHEMBL461727,BRD:BRD-BRD-K03504028-001-07-6;BRD:BRD-K03504028-001-07-6,rep_multi_dose;rep_primary;rep_single_dose,CASPASE ACTIVATOR,CASP3,,,PHASE 2,,Small molecule,NA,"N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1;OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H](C#N)C3CCCCC3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O, OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H](C#N)C3CCCCC3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O",XUCIJNAGGSZNQT-JHSLDZJXSA-N
AMYLEINE,AMYLEINE,,BRD:BRD-A09062839-003-10-0;BRD:BRD-BRD-A09062839-003-10-0,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,,,PRECLINICAL,,,NA,CCC(C)(CN(C)C)OC(=O)C1CCCCC1,
AMYLENE-HYDRATE,AMYLENE-HYDRATE,,BRD:BRD-BRD-K93502141-001-01-6;BRD:BRD-K93502141-001-01-6,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,,,PRECLINICAL,,,NA,"CCC(C)(C)O, CCC(C)(C)O",
AMYLOID P-IN-1,AMYLOID P-IN-1,,BRD:BRD-K00090622-001-01-9,rep_single_dose,,,,,,,,NA,,
AMZ30,AMZ30,,BRD:BRD-K00256256-001-06-1,rep_single_dose,PROTEIN PHOSPHATASE INHIBITOR,,,,,,,NA,,
AN2718,AN-2718;AN2718,CHEMBL211538,BRD:BRD-BRD-K21920947-001-02-1;BRD:BRD-K21920947-001-02-1,rep_primary;rep_single_dose,LEUCYL-TRNA SYNTHETASE INHIBITOR,,,,PHASE 1,,Small molecule,1,"OB1OCC2CC(CL)CCC12, OB1OCC2CC(CL)CCC12;OB1OCc2cc(Cl)ccc21",HMAFTPZYFJFEHK-UHFFFAOYSA-N
ANA-12,ANA-12,,BRD:BRD-A19609491-001-01-8;BRD:BRD-BRD-A19609491-001-01-8,rep_primary;rep_single_dose,TROPOMYOSIN RECEPTOR KINASE INHIBITOR,NTRK2,,,PRECLINICAL,,,NA,O=C(NC1CCCCC1C(=O)NC1CCCCNC1=O)C1CC2CCCCC2S1,
ANABASINE,ANABASINE,CHEMBL1526229,BRD:BRD-A24284985-001-09-9;BRD:BRD-BRD-A24284985-001-09-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,PRECLINICAL,,Small molecule,NA,C1CCC(NC1)C1CCCNC1;c1cncc([C@@H]2CCCCN2)c1,MTXSIJUGVMTTMU-JTQLQIEISA-N
MK0859,ANACETRAPIB;MK-0859;MK0859,CHEMBL1800807,BRD:BRD-BRD-K44366189-001-01-9;BRD:BRD-K44366189-001-01-9,rep_primary;rep_single_dose,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,CETP,,,PHASE 3,,Small molecule,3,COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C;COC1CC(F)C(CC1-C1CCC(CC1CN1[C@H](C)[C@H](OC1=O)C1CC(CC(C1)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C,MZZLGJHLQGUVPN-HAWMADMCSA-N
SUINY,ANAGLIPTIN;CWP-403;SK-0403;SUINY,CHEMBL1929396,BRD:BRD-K05355328-001-02-9,rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,,,,,Small molecule,3,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1,LDXYBEHACFJIEL-HNNXBMFYSA-N
XAGRID,AGRYLIN;ANAGRELIDE;XAGRID,CHEMBL760,BRD:BRD-BRD-K62200014-003-10-5;BRD:BRD-K62200014-003-10-5,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A,"THROMBOCYTHEMIA, MYELOPROLIFERATIVE NEOPLASMS",,LAUNCHED,,Small molecule,4,"CLC1CCC2N=C3NC(=O)CN3CC2C1CL, CLC1CCC2N=C3NC(=O)CN3CC2C1CL, CLC1CCC2N=C3NC(=O)CN3CC2C1CL;O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1",OTBXOEAOVRKTNQ-UHFFFAOYSA-N
ST-1291,ANAMORELIN;RC-1291;ST-1291,CHEMBL2110579,BRD:BRD-BRD-K01174345-001-01-9;BRD:BRD-K01174345-001-01-9,rep_primary;rep_single_dose,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,GHSR,,,PHASE 3,,Small molecule,3,CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1;CN(C)N(C)C(=O)[C@@]1(CC2CCCCC2)CCCN(C1)C(=O)[C@@H](CC1C[NH]C2CCCCC12)NC(=O)C(C)(C)N,VQPFSIRUEPQQPP-MXBOTTGLSA-N
ANANDAMIDE,ANANDAMIDE,CHEMBL15848,BRD:BRD-BRD-K42352790-001-05-3;BRD:BRD-K42352790-001-05-3,rep_multi_dose;rep_primary;rep_single_dose,CANNABINOID RECEPTOR AGONIST,CACNA1G;CACNA1H;CACNA1I;CNR1;CNR2;GLRA1;GPR18;GPR55;KCNA2;KCNK3;KCNK9;TRPM8;TRPV1,,,PHASE 2,,Small molecule,NA,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO;CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO,LGEQQWMQCRIYKG-DOFZRALJSA-N
ZD1033,ANASTROZOLE;ARIMIDEX;ICI D1033;ICI-D1033;NASTROSA;NSC-719344;NSC-759855;RVG-106400;ZD-1033;ZD1033,CHEMBL1399,BRD:BRD-BRD-K52172416-001-11-4;BRD:BRD-K52172416-001-11-4,rep_multi_dose;rep_primary;rep_single_dose,AROMATASE INHIBITOR,CYP19A1,BREAST CANCER,,LAUNCHED,,Small molecule,4,"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1;CC(C)(C#N)C1CC(CN2CNCN2)CC(C1)C(C)(C)C#N, CC(C)(C#N)C1CC(CN2CNCN2)CC(C1)C(C)(C)C#N, CC(C)(C#N)C1CC(CN2CNCN2)CC(C1)C(C)(C)C#N",YBBLVLTVTVSKRW-UHFFFAOYSA-N
ANDARINE,ANDARINE,,BRD:BRD-BRD-K82164249-001-03-5;BRD:BRD-K82164249-001-03-5,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,,,PHASE 1,,,NA,CC(=O)NC1CCC(OC[C@](C)(O)C(=O)NC2CCC(C(C2)C(F)(F)F)[N+]([O-])=O)CC1,
NSC-383468,ANDROGRAPHOLIDE;HMPL-004;HMPL004;NSC-383468,CHEMBL186141,BRD:BRD-A86619021-001-04-8;BRD:BRD-BRD-A86619021-001-04-8,rep_primary;rep_single_dose,TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,NFKB1,,,PHASE 2,,Small molecule,3,C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C\C=C3/[C@H](O)COC3=O)C(=C)CCC12;C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O,BOJKULTULYSRAS-OTESTREVSA-N
ANDROSTENONE,ANDROSTENONE,,BRD:BRD-A64011898-001-01-0;BRD:BRD-BRD-A64011898-001-01-0,rep_primary;rep_single_dose,STEROID,,,,PRECLINICAL,,,NA,CC12CCC3C(CCC4CC(=O)CCC34C)C1CC=C2,
ANDROSTERONE,ANDROSTERONE,CHEMBL87285,BRD:BRD-BRD-K12329651-001-18-8;BRD:BRD-K12329651-001-18-8,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,,,,PRECLINICAL,,Small molecule,NA,C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12;C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O,QGXBDMJGAMFCBF-HLUDHZFRSA-N
ANECORTAVE-ACETATE,ANECORTAVE-ACETATE,,BRD:BRD-A53566267-001-01-9;BRD:BRD-BRD-A53566267-001-01-9,rep_primary;rep_single_dose,ANGIOGENESIS INHIBITOR,,MACULAR DEGENERATION,,LAUNCHED,,,NA,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@]12C,
ANETHOLE-TRITHIONE,ANETHOLE-TRITHIONE,,BRD:BRD-BRD-K92490248-001-06-6;BRD:BRD-K92490248-001-06-6,rep_primary;rep_single_dose,GLUTATHIONE TRANSFERASE STIMULANT,,,,LAUNCHED,,,NA,"COC1CCC(CC1)-C1CC(=S)SS1, COC1CCC(CC1)-C1CC(=S)SS1",
ANGUIDINE,ANGUIDINE,,BRD:BRD-BRD-K45724504-001-01-6;BRD:BRD-K45724504-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,SLC5A1,,,PHASE 2,,,NA,CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]11CO1,
VER002,ANIDULAFUNGIN;D-70013;D70013;ECALTA;ERAXIS;LY-303366;LY303366;V-ECHINOCANDIN;VER-002;VER002,CHEMBL264241,BRD:BRD-A75305484-001-01-3;BRD:BRD-BRD-A75305484-001-01-3,rep_primary;rep_single_dose,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",,"CANDIDEMIA, FUNGAL INFECTION, ESOPHAGEAL CANDIDIASIS",,LAUNCHED,,Small molecule,4,CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1;CCCCCOC1CCC(CC1)-C1CCC(CC1)-C1CCC(CC1)C(=O)NC1CC(O)C(O)NC(=O)C2C(O)C(C)CN2C(=O)C(NC(=O)C(NC(=O)C2CC(O)CN2C(=O)C(NC1=O)C(C)O)C(O)C(O)C1CCC(O)CC1)C(C)O,JHVAMHSQVVQIOT-MFAJLEFUSA-N
SARPUL,1-P-ANISOYL-2-PYRROLIDINONE;AMPAMET;ANIRACETAM;DRAGANON;MEMODRIN;NSC-758223;RO 13-5057;RO-13-5057;RO-135057;SARPUL,CHEMBL36994,BRD:BRD-BRD-K88611939-001-22-4;BRD:BRD-K88611939-001-22-4,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,DRD2;GRIA1;GRIA2;GRIA3;GRIA4;HTR2A,,,LAUNCHED,,Small molecule,-1,"COc1ccc(C(=O)N2CCCC2=O)cc1;COC1CCC(CC1)C(=O)N1CCCC1=O, COC1CCC(CC1)C(=O)N1CCCC1=O, COC1CCC(CC1)C(=O)N1CCCC1=O",ZXNRTKGTQJPIJK-UHFFFAOYSA-N
NSC-759629,ANISINDIONE;MIRADON;NSC-759629,CHEMBL712,BRD:BRD-BRD-K47458712-001-20-7;BRD:BRD-K47458712-001-20-7,rep_primary;rep_single_dose,VITAMIN K ANTAGONIST,GGCX,DEEP VEIN THROMBOSIS (DVT),,LAUNCHED,,Small molecule,4,"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1;COC1CCC(CC1)C1C(=O)C2CCCCC2C1=O, COC1CCC(CC1)C1C(=O)C2CCCCC2C1=O, COC1CCC(CC1)C1C(=O)C2CCCCC2C1=O, COC1CCC(CC1)C1C(=O)C2CCCCC2C1=O, COC1CCC(CC1)C1C(=O)C2CCCCC2C1=O, COC1CCC(CC1)C1C(=O)C2CCCCC2C1=O",XRCFXMGQEVUZFC-UHFFFAOYSA-N
HYOSCYAMINE,(-)-6.BETA.-HYDROXYHYOSCYAMINE;6-HYDROXY-;6.BETA.-HYDROXYHYOSCYAMINE;ANISODAMINE;HYOSCYAMINE,CHEMBL2165224,BRD:BRD-A29623586-001-01-3;BRD:BRD-BRD-A29623586-001-01-3,rep_primary;rep_single_dose,LIPID PEROXIDASE INHIBITOR,ADRA1A,,,PHASE 3,,Small molecule,3,CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@@H](O)C2;CN1C2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)C1CCCCC1,WTQYWNWRJNXDEG-RBZJEDDUSA-N
TCMDC-125504,ANISOMYCIN;GNF-PF-4549;TCMDC-125504,CHEMBL423192,BRD:BRD-BRD-K91370081-001-25-1;BRD:BRD-K91370081-001-25-1,rep_multi_dose;rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,NHP2L1;RPL10L;RPL11;RPL13A;RPL15;RPL19;RPL23;RPL23A;RPL26L1;RPL3;RPL37;RPL8;RSL24D1,,,PRECLINICAL,,Small molecule,NA,COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1;COC1CCC(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)CC1,YKJYKKNCCRKFSL-RDBSUJKOSA-N
OCTATROPINE,ANISOTROPINE;OCTATROPINE,CHEMBL1186610,BRD:BRD-A06771424-004-01-7;BRD:BRD-BRD-A06771424-004-01-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,4,CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C;CCCC(CCC)C(=O)OC1C[C@@H]2CC[C@H](C1)[N+]2(C)C,XGGHHHBGPSNXFE-ZSHCYNCHSA-N
CATEQUENTINIB,AL 3818;AL-3818;AL3818;ANLOTINIB;CATEQUENTINIB,CHEMBL4303201,BRD:BRD-BRD-K36949735-001-01-1;BRD:BRD-K36949735-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,"VEGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",KDR;PDGFRB,,,PHASE 2/PHASE 3,"Multiple values for MOA: {'PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR', 'VEGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR'}, defaulting to 'VEGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR'",Small molecule,3,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1;COC1CC2C(OC3CCC4[NH]C(C)CC4C3F)CCNC2CC1OCC1(N)CC1,KSMZEXLVHXZPEF-UHFFFAOYSA-N
ANPIRTOLINE,ANPIRTOLINE,CHEMBL1316374,BRD:BRD-BRD-K55424922-003-02-8;BRD:BRD-K55424922-003-02-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1B,,,PHASE 1,,Small molecule,-1,"Clc1cccc(SC2CCNCC2)n1;CLC1CCCC(SC2CCNCC2)N1, CLC1CCCC(SC2CCNCC2)N1",GGALEXMXDMUMDM-UHFFFAOYSA-N
ANR-94,ANR-94,,BRD:BRD-BRD-K31170746-001-01-6;BRD:BRD-K31170746-001-01-6,rep_primary;rep_single_dose,"A1 ADENOSINE RECEPTOR ANTAGONIST, ADENOSINE RECEPTOR ANTAGONIST",ADORA2A,,,PRECLINICAL,"Multiple values for MOA: {'A1 ADENOSINE RECEPTOR ANTAGONIST', 'A1 ADENOSINE RECEPTOR ANTAGONIST, ADENOSINE RECEPTOR ANTAGONIST'}, defaulting to 'A1 ADENOSINE RECEPTOR ANTAGONIST, ADENOSINE RECEPTOR ANTAGONIST'",,NA,CCOC1NC2C(N)NCNC2N1CC,
ANSOFAXINE HYDROCHLORIDE,ANSOFAXINE HYDROCHLORIDE,,BRD:BRD-K00075778-003-02-9,rep_single_dose,,,,,,,,NA,,
ANTAGONIST-G,ANTAGONIST-G,,BRD:BRD-BRD-K25863791-001-01-8;BRD:BRD-K25863791-001-01-8,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,MAPK8,,,PHASE 1,,,NA,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC1CCCCC1)N(C)C(=O)[C@@H](CC1C[NH]C2CCCCC12)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,
ANTALARMIN,ANTALARMIN,CHEMBL296641,BRD:BRD-BRD-K01363385-003-01-5;BRD:BRD-K01363385-003-01-5,rep_primary;rep_single_dose,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",CRHR1,,,PRECLINICAL,"Multiple values for MOA: {'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST', 'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST'}, defaulting to 'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST'",Small molecule,NA,CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C;CCCCN(CC)C1NC(C)NC2N(C(C)C(C)C12)-C1C(C)CC(C)CC1C,IXPROWGEHNVJOY-UHFFFAOYSA-N
VASOCON-A,ANTAZ SULF;ANTAZOLINE;ATAZOLINE;VASOCON-A,CHEMBL1305,BRD:BRD-BRD-K99300445-003-21-6;BRD:BRD-K99300445-003-21-6,rep_primary;rep_single_dose,ANTIHISTAMINE,HRH1,"CONJUNCTIVITIS, NASAL CONGESTION",,LAUNCHED,,Small molecule,4,"C(N(CC1CCCCC1)C1CCCCC1)C1=NCCN1, C(N(CC1CCCCC1)C1CCCCC1)C1=NCCN1, C(N(CC1CCCCC1)C1CCCCC1)C1=NCCN1;c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1",REYFJDPCWQRWAA-UHFFFAOYSA-N
ANTHRANILIC-ACID,ANTHRANILIC-ACID,,BRD:BRD-BRD-K75167327-001-01-6,rep_primary,,,,,PRECLINICAL,,,NA,OC(=O)C1CCCCC1NC(=O)C12CC3CC(CC(C3)C1)C2,
ANTHRAQUINONE,"9,10-ANTHRAQUINONE;ANTHRACENE-9,10-DIONE;ANTHRAQUINONE",CHEMBL55659,BRD:BRD-K15957397-001-05-9,rep_single_dose,CDC INHIBITOR,CDC25B,,,,,Small molecule,NA,O=C1c2ccccc2C(=O)c2ccccc21,RZVHIXYEVGDQDX-UHFFFAOYSA-N
ANTIMONYL,ANTIMONYL,,BRD:BRD-A74328360-409-02-8,rep_single_dose,,,,,,,,NA,,
ATENGENAL,ANTINEOPLASTON A 10;ANTINEOPLASTON A10;ATENGENAL,CHEMBL1980825,BRD:BRD-K00091100-001-01-9,rep_single_dose,,,,,,,Small molecule,3,O=C1CC[C@H](NC(=O)Cc2ccccc2)C(=O)N1,OQGRFQCUGLKSAV-JTQLQIEISA-N
AOB3540,AK161197;AOB3540,,GDSC2:1622,gdsc,,,,,,,,NA,,
AP-18,AP-18,,BRD:BRD-K32143970-001-02-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPA1,,,,,,NA,,
RIMIDUCID,AP-1903;AP1903;RIMIDUCID,CHEMBL269259,BRD:BRD-BRD-K28383148-001-01-4;BRD:BRD-K28383148-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,,MTOR,,,PHASE 1/PHASE 2,,Small molecule,2,CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCCNC(=O)COc2cccc([C@@H](CCc3ccc(OC)c(OC)c3)OC(=O)[C@@H]3CCCCN3C(=O)[C@@H](CC)c3cc(OC)c(OC)c(OC)c3)c2)c1)c1cc(OC)c(OC)c(OC)c1;CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCC1CCC(OC)C(OC)C1)C1CCCC(OCC(=O)NCCNC(=O)COC2CCCC(C2)[C@@H](CCC2CCC(OC)C(OC)C2)OC(=O)[C@@H]2CCCCN2C(=O)[C@@H](CC)C2CC(OC)C(OC)C(OC)C2)C1)C1CC(OC)C(OC)C(OC)C1,GQLCLPLEEOUJQC-ZTQDTCGGSA-N
BRIGATINIB,ALUNBRIG;AP-26113;AP26113;BRIGATINIB,CHEMBL3545311,BRD:BRD-BRD-K56032964-001-02-1;BRD:BRD-K56032964-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK;EGFR,,,PHASE 2,,Small molecule,4,COC1CC(CCC1NC1NCC(CL)C(NC2CCCCC2P(C)(C)=O)N1)N1CCC(CC1)N(C)C;COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,AILRADAXUVEEIR-UHFFFAOYSA-N
RVX000222,APABETALONE;RVX-000222;RVX-208;RVX000222,CHEMBL2393130,BRD:BRD-BRD-K20001883-001-02-7;BRD:BRD-K20001883-001-02-7;GDSC2:1625,gdsc;rep_primary;rep_single_dose,APOLIPOPROTEIN EXPRESSION ENHANCER,BRD3,,,PHASE 3,,Small molecule,3,COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1;COC1CC(OC)C2C(C1)[NH]C(NC2=O)-C1CC(C)C(OCCO)C(C)C1,NETXMUIMUZJUTB-UHFFFAOYSA-N
WEB-2086-BS,APAFANT;WEB 2086 BS;WEB-2086;WEB-2086-BS,CHEMBL280164,BRD:BRD-BRD-K28115081-001-02-7;BRD:BRD-K28115081-001-02-7,rep_primary;rep_single_dose,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,PTAFR,,,PHASE 3,,Small molecule,-1,"CC1NNC2CN=C(C3CC(CCC(=O)N4CCOCC4)SC3-N12)C1CCCCC1CL, CC1NNC2CN=C(C3CC(CCC(=O)N4CCOCC4)SC3-N12)C1CCCCC1CL;Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2",JGPJQFOROWSRRS-UHFFFAOYSA-N
JNJ-56021927,APALUTAMIDE;ARN-509;ERLEADA;JNJ-56021927,CHEMBL3183409,BRD:BRD-BRD-K91308639-001-02-7;BRD:BRD-K91308639-001-02-7,rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,,PROSTATE CANCER,,LAUNCHED,,Small molecule,4,CNC(=O)C1CCC(CC1F)N1C(=S)N(C(=O)C11CCC1)C1CNC(C#N)C(C1)C(F)(F)F;CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,HJBWBFZLDZWPHF-UHFFFAOYSA-N
MT-3995,APARARENONE;MT-3995,CHEMBL3545392,BRD:BRD-K00003492-001-01-9,rep_single_dose,MINERALOCORTICOID RECEPTOR ANTAGONIST,,,,,,Small molecule,2,,
YN968D1 FREE BASE,APATINIB;APATINIB FREE BASE;RIVOCERANIB;YN968D1;YN968D1 FREE BASE,CHEMBL3186534,BRD:BRD-BRD-K25244359-066-03-4;BRD:BRD-K25244359-066-03-4,rep_multi_dose;rep_primary;rep_single_dose,RET TYROSINE KINASE INHIBITOR,CSK;KDR;KIT;RET,,,PHASE 3,,Small molecule,3,"N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1;O=C(NC1CCC(CC1)C1(CCCC1)C#N)C1CCCNC1NCC1CCNCC1, O=C(NC1CCC(CC1)C1(CCCC1)C#N)C1CCCNC1NCC1CCNCC1",WPEWQEMJFLWMLV-UHFFFAOYSA-N
NSC-226236,"2,2,5,7,9-PENTAMETHYL-6-CHROMANOL;APC-100;CHROMANE C1;NSC-226236",CHEMBL37676,BRD:BRD-BRD-K07449869-001-01-5;BRD:BRD-K07449869-001-01-5,rep_primary;rep_single_dose,"ANTI-INFLAMMATORY AGENT, ANDROGEN RECEPTOR ANTAGONIST",AR,,,PHASE 1/PHASE 2,"Multiple values for MOA: {'ANDROGEN RECEPTOR ANTAGONIST, ANTI-INFLAMMATORY AGENT', 'ANTI-INFLAMMATORY AGENT, ANDROGEN RECEPTOR ANTAGONIST'}, defaulting to 'ANTI-INFLAMMATORY AGENT, ANDROGEN RECEPTOR ANTAGONIST'",Small molecule,1,Cc1c(C)c2c(c(C)c1O)CCC(C)(C)O2;CC1C(C)C2OC(C)(C)CCC2C(C)C1O,SEBPXHSZHLFWRL-UHFFFAOYSA-N
APCK-110,APCK-110,,BRD:BRD-BRD-K72748448-001-01-0;BRD:BRD-K72748448-001-01-0,rep_primary;rep_single_dose,KIT INHIBITOR,KIT;STAT3,,,PRECLINICAL,,,NA,COC1CC(OC)CC(C1)-C1CCC2C(N[NH]C2N1)-C1CCC(F)CC1,
APD597,APD597,,BRD:BRD-BRD-K86226872-001-01-6;BRD:BRD-K86226872-001-01-6,rep_primary;rep_single_dose,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,GPR119,,,PHASE 1,,,NA,COC1C(NC2CCC(NC2C)S(C)(=O)=O)NCNC1OC1CCN(CC1)C(=O)OC(C)C,
APD668,APD668,,BRD:BRD-BRD-K10859802-001-01-0;BRD:BRD-K10859802-001-01-0,rep_primary;rep_single_dose,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,GPR119,,,PHASE 1,,,NA,CC(C)OC(=O)N1CCC(CC1)OC1NCNC2N(NCC12)-C1CCC(CC1F)S(C)(=O)=O,
APHIDICOLIN,APHIDICOLIN,CHEMBL29711,BRD:BRD-BRD-K85140930-001-12-7;BRD:BRD-K85140930-001-12-7,rep_multi_dose;rep_primary;rep_single_dose,RNA SYNTHESIS INHIBITOR,,,,PHASE 1,,Small molecule,NA,C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]1C[C@@H]3C[C@]21CC[C@]3(O)CO;C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]1C[C@@H]3C[C@@]12CC[C@]3(O)CO,NOFOAYPPHIUXJR-APNQCZIXSA-N
API-001,API-001,,BRD:BRD-BRD-K26325692-003-01-3;BRD:BRD-K26325692-003-01-3,rep_primary;rep_single_dose,SIGMA RECEPTOR ANTAGONIST,SIGMAR1,,,PHASE 2,,,NA,CC1CC(OCCN2CCOCC2)NN1-C1CCC2CCCCC2C1,
API-1,API-1,,BRD:BRD-K97840621-001-02-9,rep_single_dose,AKT INHIBITOR,AKT1;AKT2;AKT3,,,,,,NA,,
APICIDIN,ACIPIDIN;APICIDIN,CHEMBL430060,CTRP:61097,ctrp,,,,,,,Protein,NA,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC1=O,JWOGUUIOCYMBPV-GMFLJSBRSA-N
NSC-83244,APIGENIN;NSC-83244,CHEMBL28,BRD:BRD-BRD-K01493881-001-29-4;BRD:BRD-K01493881-001-29-4,rep_primary;rep_single_dose,"CASEIN KINASE INHIBITOR, CELL PROLIFERATION INHIBITOR",AKR1B1;AR;CDK6;CFTR;CYP19A1;CYP1B1;HSD17B1,,,PRECLINICAL,,Small molecule,NA,"O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12;OC1CCC(CC1)-C1CC(=O)C2C(O)CC(O)CC2O1, OC1CCC(CC1)-C1CC(=O)C2C(O)CC(O)CC2O1",KZNIFHPLKGYRTM-UHFFFAOYSA-N
ELIQUIS,APIXABAN;BMS-562247;BMS-562247-01;ELIQUIS,CHEMBL231779,BRD:BRD-BRD-K67121414-001-03-3;BRD:BRD-K67121414-001-03-3,rep_primary;rep_single_dose,COAGULATION FACTOR INHIBITOR,F10,"STROKE, SYSTEMIC EMBOLISM, PULMONARY EMBOLISM (PE), ATRIAL FIBRILLATION (AF), DEEP VEIN THROMBOSIS (DVT)",,LAUNCHED,,Small molecule,4,"COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1;COC1CCC(CC1)-N1NC(C(N)=O)C2CCN(C(=O)C12)C1CCC(CC1)N1CCCCC1=O, COC1CCC(CC1)-N1NC(C(N)=O)C2CCN(C(=O)C12)C1CCC(CC1)N1CCCCC1=O",QNZCBYKSOIHPEH-UHFFFAOYSA-N
NSC-209524,4-HYDROXY-3-METHOXYACETOPHENONE;ACETOVANILLONE;APOCYNIN;NSC-209524,CHEMBL346919,BRD:BRD-BRD-K64990520-001-08-4;BRD:BRD-K64990520-001-08-4,rep_primary;rep_single_dose,NADPH OXIDASE INHIBITOR,NOX4,,,PHASE 1,,Small molecule,1,COc1cc(C(C)=O)ccc1O;COC1CC(CCC1O)C(C)=O,DFYRUELUNQRZTB-UHFFFAOYSA-N
APOPTOSIS-ACTIVATOR-II,APOPTOSIS-ACTIVATOR-II,,BRD:BRD-BRD-K15164005-001-05-6;BRD:BRD-K15164005-001-05-6,rep_primary;rep_single_dose,CARBOXYLESTERASE INHIBITOR,BCHE;CES1,,,PRECLINICAL,,,NA,"CLC1CCC(CN2C(=O)C(=O)C3CCCCC23)CC1CL, CLC1CCC(CN2C(=O)C(=O)C3CCCCC23)CC1CL, CLC1CCC(CN2C(=O)C(=O)C3CCCCC23)CC1CL",
PRIMA-1MET,APR 246;APR-246;EPRENETAPOPT;PRIMA-1MET,CHEMBL3186011,BRD:BRD-A09004963-001-01-3;BRD:BRD-BRD-A09004963-001-01-3;GDSC2:1131,gdsc;rep_primary;rep_single_dose,P53 ACTIVATOR,TP53,,,PHASE 1/PHASE 2,,Small molecule,3,COCC1(CO)C(=O)C2CCN1CC2;COCC1(CO)N2CCC(CC2)C1=O,BGBNULCRKBVAKL-UHFFFAOYSA-N
IOPIDINE,APRACLONIDINE;IOPIDINE,CHEMBL647,BRD:BRD-BRD-K38911213-003-01-6;BRD:BRD-K38911213-003-01-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA2A;ADRA2B;ADRA2C,"GLAUCOMA, INTRAOCULAR PRESSURE",,LAUNCHED,,Small molecule,4,Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1;NC1CC(CL)C(NC2=NCCN2)C(CL)C1,IEJXVRYNEISIKR-UHFFFAOYSA-N
TMI-05,APRATASTAT;TMI-005;TMI-05,CHEMBL206815,BRD:BRD-BRD-K06883221-001-01-9;BRD:BRD-K06883221-001-01-9,rep_primary;rep_single_dose,"MATRIX METALLOPROTEASE INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",ADAM17;MMP1;MMP13;MMP9,,,PHASE 2,,Small molecule,2,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1CCC(OCC#CCO)CC1;CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO,MAVDNGWEBZTACC-HNNXBMFYSA-N
OTEZLA,APREMILAST;CC-10004;CC10004;OTEZLA,CHEMBL514800,BRD:BRD-BRD-K93208532-001-02-5;BRD:BRD-K93208532-001-02-5,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A;PDE4B;PDE4C;PDE4D,"PSORIASIS, PSORIATIC ARTHRITIS",,LAUNCHED,,Small molecule,4,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC;CCOC1CC(CCC1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2CCCC(NC(C)=O)C2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N
NSC-748825,"APREPITANT;CINVANTI;EMEND;L-754,030;MK-0869;MK-869;NSC-748825",CHEMBL1471,BRD:BRD-BRD-K65170927-001-01-6;BRD:BRD-K65170927-001-01-6,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1,"NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;C[C@H](O[C@H]1OCCN(CC2N[NH]C(=O)[NH]2)[C@H]1C1CCC(F)CC1)C1CC(CC(C1)C(F)(F)F)C(F)(F)F,ATALOFNDEOCMKK-OITMNORJSA-N
SPD -754,(-)-;APRICITABINE;AVX-754;BCH-10618;BCH-10652;SPD -754,CHEMBL210651,BRD:BRD-BRD-K55172746-001-01-3;BRD:BRD-K55172746-001-01-3,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,,,PHASE 3,,Small molecule,3,Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1;NC1CCN([C@H]2CO[C@@H](CO)S2)C(=O)N1,RYMCFYKJDVMSIR-RNFRBKRXSA-N
COMPOUND 99170,APRINDINE;COMPOUND 99170,CHEMBL1213033,BRD:BRD-BRD-K53236343-003-03-7;BRD:BRD-K53236343-003-03-7,rep_primary;rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,CALM1;SCN5A,CARDIAC ARRYTHMIA,,LAUNCHED,,Small molecule,-1,CCN(CC)CCCN(C1CC2CCCCC2C1)C1CCCCC1;CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1,NZLBHDRPUJLHCE-UHFFFAOYSA-N
SEDORMID,APRONAL;APRONALIDE;SEDORMID,CHEMBL509282,BRD:BRD-K00003524-001-01-9,rep_single_dose,CYTOCHROME P450 MODULATOR,,,,,,Small molecule,-1,C=CCC(C(=O)NC(N)=O)C(C)C,KSUUMAWCGDNLFK-UHFFFAOYSA-N
APTIGANEL,APTIGANEL,CHEMBL92484,BRD:BRD-BRD-K63919159-003-07-0;BRD:BRD-K63919159-003-07-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1,,,PHASE 3,,Small molecule,-1,"CCC1CCCC(C1)N(C)C(=N)NC1CCCC2CCCCC12, CCC1CCCC(C1)N(C)C(=N)NC1CCCC2CCCCC12;CCc1cccc(N(C)C(=N)Nc2cccc3ccccc23)c1",BFNCJMURTMZBTE-UHFFFAOYSA-N
LT-253(FORMER CODE),APTO-253;LOR-253;LOR-253(FORMER CODE);LT-253;LT-253(FORMER CODE),CHEMBL4297261,BRD:BRD-BRD-K68003372-001-01-6;BRD:BRD-K68003372-001-01-6,rep_primary;rep_single_dose,"KR""""""""UPPEL-LIKE FACTOR EXPRESSION ENHANCER, KRÃÂPPEL-LIKE FACTOR EXPRESSION ENHANCER",KLF4,,,PHASE 1,"Multiple values for MOA: {'KR""""""""UPPEL-LIKE FACTOR EXPRESSION ENHANCER, KRÃ\x9cPPEL-LIKE FACTOR EXPRESSION ENHANCER', 'KR""UPPEL-LIKE FACTOR EXPRESSION ENHANCER'}, defaulting to 'KR""""""""UPPEL-LIKE FACTOR EXPRESSION ENHANCER, KRÃ\x9cPPEL-LIKE FACTOR EXPRESSION ENHANCER'",Small molecule,1,CC1[NH]C2CCC(F)CC2C1-C1NC2C([NH]1)C1CCCNC1C1NCCCC21;Cc1[nH]c2ccc(F)cc2c1-c1nc2c3cccnc3c3ncccc3c2[nH]1,NIRXBXIPHUTNNI-UHFFFAOYSA-N
APY-29,APY-29,,BRD:BRD-K17511755-001-02-9,rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,ERN1,,,,,,NA,,
APY0201,APY0201,,BRD:BRD-K38627885-001-01-9,rep_single_dose,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,IL12A;IL12B;PIKFYVE,,,,,,NA,,
APYRAMIDE,APYRAMIDE,,BRD:BRD-K00004738-001-01-9,rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,,,,NA,,
AQ-13,AQ 13;AQ-13,CHEMBL4297695,BRD:BRD-K00003365-300-01-9,rep_single_dose,ANTIMALARIAL AGENT,,,,,,Unknown,2,,
AQ-RA741,AQ-RA741,,BRD:BRD-BRD-K81729199-001-02-8;BRD:BRD-K81729199-001-02-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM2,,,PRECLINICAL,,,NA,"CCN(CC)CCCCC1CCN(CC(=O)N2C3CCCCC3C(=O)NC3CCCNC23)CC1, CCN(CC)CCCCC1CCN(CC(=O)N2C3CCCCC3C(=O)NC3CCCNC23)CC1",
AQW-051,AQW-051,,BRD:BRD-K00004705-001-01-9,rep_single_dose,NICOTINIC RECEPTOR AGONIST,,,,,,,NA,,
PDK1 INHIBITOR AR-12,AR-12;OSU-03012;PDK1 INHIBITOR AR-12,CHEMBL1650595,BRD:BRD-BRD-K90497590-001-04-2;BRD:BRD-K90497590-001-04-2;GDSC1:167,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,PDPK1,,,PHASE 1,,Small molecule,1,"NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1;NCC(=O)NC1CCC(CC1)-N1NC(CC1-C1CCC2C(CCC3CCCCC23)C1)C(F)(F)F, NCC(=O)NC1CCC(CC1)-N1NC(CC1-C1CCC2C(CCC3CCCCC23)C1)C(F)(F)F, NCC(=O)NC1CCC(CC1)-N1NC(CC1-C1CCC2C(CCC3CCCCC23)C1)C(F)(F)F, NCC(=O)NC1CCC(CC1)-N1NC(CC1-C1CCC2C(CCC3CCCCC23)C1)C(F)(F)F",YULUCECVQOCQFQ-UHFFFAOYSA-N
REC-2282,(S)-HDAC 42;(S)-HDAC-42;AR-42;AR42;OSU-HDAC 42;REC-2282,CHEMBL191482,BRD:BRD-BRD-K13167095-001-02-9;BRD:BRD-K13167095-001-02-9;GDSC1:272,gdsc;rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1,,,PHASE 1,,Small molecule,2,CC(C)[C@H](C(=O)Nc1ccc(C(=O)NO)cc1)c1ccccc1;CC(C)[C@H](C(=O)NC1CCC(CC1)C(=O)NO)C1CCCCC1,LAMIXXKAWNLXOC-INIZCTEOSA-N
AR-9281,AR-9281,,BRD:BRD-K00078154-001-02-9,rep_single_dose,,,,,,,,NA,,
AR-A014418,AR-A014418,,BRD:BRD-BRD-K67860401-001-05-6;BRD:BRD-K67860401-001-05-6,rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3B,,,PRECLINICAL,,,NA,"COC1CCC(CNC(=O)NC2NCC(S2)[N+]([O-])=O)CC1, COC1CCC(CNC(=O)NC2NCC(S2)[N+]([O-])=O)CC1",
AR-C155858,AR-C155858,,BRD:BRD-K42325600-001-01-8,rep_single_dose,MONOCARBOXYLATE TRANSPORTER INHIBITOR,SLC16A1;SLC16A7,,,,,,NA,,
U-19920,"ALEXAN;ALEXAN 100;ARA-C;ARA-CYTIDINE;ARABINOCYTOSINE;ARABINOSYL CYTOSINE;ARACYTIDINE;ARACYTIN;ARACYTINE;CYTARABINE;CYTARABINE LIPOSOME;CYTARABINOSIDE;CYTARABINUM;CYTOSAR;CYTOSAR-U;DEPOCYT;DEPOCYTE;NSC-287459;SPONGOCYTIDINE;TARABINE PFS;U 19920A;U-19,920;U-19920",CHEMBL803,BRD:BRD-BRD-K71847383-001-12-5;BRD:BRD-K71847383-001-12-5;GDSC1:1006;GDSC2:1006,gdsc;oncref_2;rep_primary,RIBONUCLEOTIDE REDUCTASE INHIBITOR,POLA1;POLB;POLD1;POLE,"ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), ACUTE MYELOID LEUKEMIA (AML), NON-HODGKIN LYMPHOMA (NHL)",,LAUNCHED,"Multiple values for MOA: {'RIBONUCLEOTIDE REDUCTASE INHIBITOR', 'PYRIMIDINE NUCLEOSIDE ANALOG'}, defaulting to 'RIBONUCLEOTIDE REDUCTASE INHIBITOR'",Small molecule,4,"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1;NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1, NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1, NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1",UHDGCWIWMRVCDJ-CCXZUQQUSA-N
ARA-G,9-??-D-ARABINOFURANOSYL GUANINE;ARA-G,,GDSC1:427,gdsc,,,,,,,,NA,,
ICOMIDOCHOLIC ACID,ARACHIDYL AMIDO CHOLANOIC ACID;ARAMCHOL;C20-FABAC;ICOMIDOCHOLIC ACID,CHEMBL4297262,BRD:BRD-K00004646-001-01-9,rep_single_dose,STEAROYL-COA DESATURASE INHIBITOR,,,,,,Small molecule,3,CCCCCCCCCCCCCCCCCCCC(=O)N[C@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](O)[C@@H]1[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]12,SHKXZIQNFMOPBS-OOMQYRRCSA-N
UMIFENOVIR,ARBIDOL;UMIFENOVIR,CHEMBL1214598,BRD:BRD-BRD-K73881242-003-04-6;BRD:BRD-K73881242-003-04-6,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP3A4,INFLUENZA A VIRUS INFECTION,,LAUNCHED,,Small molecule,3,"CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12;CCOC(=O)C1C(CSC2CCCCC2)N(C)C2CC(BR)C(O)C(CN(C)C)C12, CCOC(=O)C1C(CSC2CCCCC2)N(C)C2CC(BR)C(O)C(CN(C)C)C12, CCOC(=O)C1C(CSC2CCCCC2)N(C)C2CC(BR)C(O)C(CN(C)C)C12, CCOC(=O)C1C(CSC2CCCCC2)N(C)C2CC(BR)C(O)C(CN(C)C)C12",KCFYEAOKVJSACF-UHFFFAOYSA-N
URSIN,ARBUTIN;ARBUTINUM;ARBUTOSIDE;NSC-4036;URSIN,CHEMBL232202,BRD:BRD-BRD-K08037784-001-12-6;BRD:BRD-K08037784-001-12-6,rep_primary;rep_single_dose,MELANIN INHIBITOR,TYR,,,PHASE 2/PHASE 3,,Small molecule,2,OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O;OC[C@H]1O[C@@H](OC2CCC(O)CC2)[C@H](O)[C@@H](O)[C@@H]1O,BJRNKVDFDLYUGJ-RMPHRYRLSA-N
ARC-239,ARC-239,,BRD:BRD-BRD-K93188295-300-02-2;BRD:BRD-K93188295-300-02-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A;ADRA2B;ADRA2C,,,PRECLINICAL,,,NA,COC1CCCCC1N1CCN(CCN2C(=O)C3CCCCC3C(C)(C)C2=O)CC1,
ARCTIGENIN,(-)-ARCTIGENIN;ARCTIGENIN,CHEMBL435734,BRD:BRD-BRD-K53523901-001-04-4;BRD:BRD-K53523901-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,CHUK;MAP2K1,,,PRECLINICAL,,Small molecule,NA,"COC1CC(C[C@@H]2[C@@H](CC3CCC(OC)C(OC)C3)COC2=O)CCC1O, COC1CC(C[C@@H]2[C@@H](CC3CCC(OC)C(OC)C3)COC2=O)CCC1O;COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O",NQWVSMVXKMHKTF-JKSUJKDBSA-N
ARCYRIAFLAVIN-A,ARCYRIAFLAVIN-A,,BRD:BRD-BRD-K72726508-001-02-1;BRD:BRD-K72726508-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CCND1;CDK4,,,PRECLINICAL,,,NA,"O=C1NC(=O)C2C1C1C3CCCCC3[NH]C1C1[NH]C3CCCCC3C21, O=C1NC(=O)C2C1C1C3CCCCC3[NH]C1C1[NH]C3CCCCC3C21",
ARDEPARIN,ARDEPARIN,,BRD:BRD-A83644949-236-01-6;BRD:BRD-BRD-A83644949-236-01-6,rep_primary;rep_single_dose,THROMBIN INHIBITOR,SERPINC1;SERPIND1,,,WITHDRAWN,,,NA,CC(=O)NC1C(O)OC(COS(O)(=O)=O)C(OC2OC(C(OC3OC(CO)C(OC4OC(C(O)C(O)C4OS(O)(=O)=O)C(O)=O)C(OS(O)(=O)=O)C3NS(O)(=O)=O)C(O)C2OS(O)(=O)=O)C(O)=O)C1O,
ARECAIDINE-BUT-2-YNYL-ESTER,ARECAIDINE BUT-2-YNYL ESTER;ARECAIDINE-BUT-2-YNYL-ESTER,CHEMBL1395412,BRD:BRD-BRD-K63792901-075-02-1;BRD:BRD-K63792901-075-02-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM2,,,PRECLINICAL,,Small molecule,NA,CC#CCOC(=O)C1=CCCN(C)C1,LBFWTPRSXIRKMZ-UHFFFAOYSA-N
ARECAIDINE-PROPARGYL-ESTER,ARECAIDINE-PROPARGYL-ESTER,,BRD:BRD-BRD-K23922020-075-02-9;BRD:BRD-K23922020-075-02-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4,,,PRECLINICAL,,,NA,"CN1CCC=C(C1)C(=O)OCC#C, CN1CCC=C(C1)C(=O)OCC#C",
NSC-56321,ARECOLINE;NSC-56321,CHEMBL7303,BRD:BRD-BRD-K88646909-004-16-2;BRD:BRD-K88646909-004-16-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4,,,PHASE 1,,Small molecule,-1,"COC(=O)C1=CCCN(C)C1;COC(=O)C1=CCCN(C)C1, COC(=O)C1=CCCN(C)C1",HJJPJSXJAXAIPN-UHFFFAOYSA-N
MD-805,ACOVA;ARGATROBAN;ARGATROBAN ANHYDROUS;ARGATROBAN HYDRATE;ARGATROBAN IN DEXTROSE;ARGATROBAN IN SODIUM CHLORIDE;ARGATROBAN MONOHYDRATE;ARGIPIDINE;DK-7419;GN-1600;GN1600;MCI-9038;MD-805,CHEMBL1166,BRD:BRD-A48261811-001-08-1;BRD:BRD-BRD-A48261811-001-08-1,rep_primary;rep_single_dose,THROMBIN INHIBITOR,F2,HEPARIN-INDUCED THROMBOCYTOPENIA (HIT),,LAUNCHED,,Small molecule,4,"C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C1CCCC2CC(C)CNC12, C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C1CCCC2CC(C)CNC12;CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1",KXNPVXPOPUZYGB-IOVMHBDKSA-N
ARGIRELINE,ARGIRELINE,,BRD:BRD-K00003332-001-01-9,rep_single_dose,NEUROTRANSMITTER RELEASE INHIBITOR,,,,,,,NA,,
ARGLABIN,ARGLABIN,CHEMBL2206431,BRD:BRD-BRD-K62734952-001-01-0;BRD:BRD-K62734952-001-01-0,rep_primary;rep_single_dose,FARNESYLTRANSFERASE INHIBITOR,FNTA;NFKB1,,,LAUNCHED,,Small molecule,NA,C=C1C(=O)O[C@@H]2[C@H]3C(C)=CC[C@@]34O[C@@]4(C)CC[C@@H]12;CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13,UVJYAKBJSGRTHA-CUZKYEQNSA-N
ARIMOCLOMOL (MALEATE),ARIMOCLOMOL (MALEATE),,BRD:BRD-K00090627-050-01-9,rep_single_dose,,,,,,,,NA,,
OPC-31,ABILIFY;ABILIFY MAINTENA;ABILIFY MAINTENA KIT;ABILIFY MYCITE;ABILIFY MYCITE KIT;ARIPIPRAZOLE;ARIPIPREX;NSC-759266;OPC-14597;OPC-31,CHEMBL1112,BRD:BRD-BRD-K70358946-001-15-7;BRD:BRD-K70358946-001-15-7,rep_multi_dose;rep_primary;rep_single_dose,"SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA2A;ADRA2B;ADRA2C;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HTR1A;HTR1B;HTR1D;HTR1E;HTR2A;HTR2C;HTR3A;HTR6;HTR7,"DEPRESSION, SCHIZOPHRENIA, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,4,"CLC1CCCC(N2CCN(CCCCOC3CCC4CCC(=O)NC4C3)CC2)C1CL, CLC1CCCC(N2CCN(CCCCOC3CCC4CCC(=O)NC4C3)CC2)C1CL, CLC1CCCC(N2CCN(CCCCOC3CCC4CCC(=O)NC4C3)CC2)C1CL;O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1",CEUORZQYGODEFX-UHFFFAOYSA-N
ARIPIPRAZOLE-LAUROXIL,ARIPIPRAZOLE-LAUROXIL,,BRD:BRD-K00004574-001-01-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,,,,,,,NA,,
R-(-)-MODAFINIL,(R)-;ARMODAFINIL;CEP-10952;CEP-10953;CRL-40982;MODAFINIL;NSC-751850;NSC-758711;NUVIGIL;R-(-)-MODAFINIL,CHEMBL1201192,BRD:BRD-BRD-K87278688-001-01-0;BRD:BRD-K87278688-001-01-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,SLC6A3,"OBSTRUCTIVE SLEEP APNEA, NARCOLEPSY, SHIFT WORK DISORDER (SWD)",,LAUNCHED,,Small molecule,4,NC(=O)C[S@@](=O)C(C1CCCCC1)C1CCCCC1;NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1,YFGHCGITMMYXAQ-LJQANCHMSA-N
LAS-31025,AROFYLLINE;LAS 31025;LAS-31025,CHEMBL1598450,BRD:BRD-BRD-K33852358-001-09-9;BRD:BRD-K33852358-001-09-9,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A,,,PHASE 3,,Small molecule,-1,CCCn1c(=O)c2[nH]cnc2n(-c2ccc(Cl)cc2)c1=O;CCCN1C(=O)N(-C2CCC(CL)CC2)C2[NH]CNC2C1=O,GVTLDPJNRVMCAL-UHFFFAOYSA-N
NSC-317940,AROTINOLOL;AROTINOLOL HYDROCHLORIDE;NSC-317940,CHEMBL93298,BRD:BRD-A28044053-001-01-7;BRD:BRD-BRD-A28044053-001-01-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB3,"HYPERTENSION, TREMORS",,LAUNCHED,,Small molecule,3,CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1;CC(C)(C)NCC(O)CSC1NC(CS1)-C1CCC(S1)C(N)=O,BHIAIPWSVYSKJS-UHFFFAOYSA-N
MIRANSERTIB,ARQ 092;ARQ 092 FREE BASE;ARQ-092;MIRANSERTIB,CHEMBL4297188,BRD:BRD-BRD-K60171656-001-01-6;BRD:BRD-K60171656-001-01-6,rep_primary;rep_single_dose,AKT INHIBITOR,AKT2,,,PHASE 1,,Small molecule,2,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1;NC1NCCCC1-C1NC2CCC(NC2N1-C1CCC(CC1)C1(N)CCC1)-C1CCCCC1,HNFMVVHMKGFCMB-UHFFFAOYSA-N
ARQ-621,ARQ 621;ARQ-621,CHEMBL4303449,BRD:BRD-BRD-K43436647-001-01-7;BRD:BRD-K43436647-001-01-7,rep_primary;rep_single_dose,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,KIF11,,,PHASE 1,,Small molecule,1,C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F;NCCCN([C@H](CC#C)C1NC2CC(CL)CCC2C(=O)N1NC1CCCCC1)C(=O)C1CCCC(CL)C1F,UPJSUQWHUVLLNW-XMMPIXPASA-N
NVP-MEK162,ARRY 438162;ARRY-162;ARRY-438162;BINIMETINIB;MEK-162;MEK162;MEKTOVI;NVP-MEK162,CHEMBL3187723,BRD:BRD-BRD-K82244583-001-01-3;BRD:BRD-K82244583-001-01-3;BRD:BRD-K82244583-001-02-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF MEK1 AND MEK2,MAP2K1;MAP2K2,,,PHASE 3,"Multiple values for MOA: {'MEK INHIBITOR', 'INHIBITOR OF MEK1 AND MEK2'}, defaulting to 'INHIBITOR OF MEK1 AND MEK2'",Small molecule,4,Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21;CN1CNC2C(F)C(NC3CCC(BR)CC3F)C(CC12)C(=O)NOCCO,ACWZRVQXLIRSDF-UHFFFAOYSA-N
VARLITINIB TOSYLATE,AR-00334543;AR00334543;AR00334543 ARRY-334543 ARRY-543;AR00334543 DITOSILATE;ARRY-334543;ARRY-334543 DITOSILATE;ARRY-543;ARRY-543 DITOSILATE;ASLAN-001;ASLAN001;VARLITINIB;VARLITINIB TOSILATE;VARLITINIB TOSYLATE,CHEMBL2103842;CHEMBL2105679,BRD:BRD-BRD-K46386702-001-02-1;BRD:BRD-K46386702-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,ERBB2,,,PHASE 2,,Small molecule,-1,C[C@@H]1COC(NC2CCC3NCNC(NC4CCC(OCC5NCCS5)C(CL)C4)C3C2)=N1;C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1,QSUPQMGDXOHVLK-FFXKMJQXSA-N
TUKYSA,ARRY-380;IRBINITINIB;ONT-380;TUCATINIB;TUKYSA,CHEMBL3989868,BRD:BRD-BRD-K26026438-001-01-0;BRD:BRD-K26026438-001-01-0,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF ERBB2 (HER2),ERBB2,,,PHASE 2,"Multiple values for MOA: {'INHIBITOR OF ERBB2 (HER2)', 'EGFR INHIBITOR'}, defaulting to 'INHIBITOR OF ERBB2 (HER2)'",Small molecule,4,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1;CC1CC(NC2NCNC3CCC(NC4=NC(C)(C)CO4)CC23)CCC1OC1CCN2NCNC2C1,SDEAXTCZPQIFQM-UHFFFAOYSA-N
FILANESIB,ARRY-520;FILANESIB,CHEMBL2347655,GDSC1:474,gdsc,,,,,,,Small molecule,2,CON(C)C(=O)N1N=C(c2cc(F)ccc2F)S[C@@]1(CCCN)c1ccccc1,LLXISKGBWFTGEI-FQEVSTJZSA-N
ARS-1620,ARS-1620,,BRD:BRD-K96889205-001-08-9,oncref_1,INHIBITOR OF KRAS-G12C,KRAS,,,,,,NA,,
ARS-1630,ARS-1630,,BRD:BRD-U00115351-001-01-9,oncref_1,LESS ACTIVE ENANTIOMER OF KRAS-G12C INHIBITOR ARS-1620,KRAS,,,,,,NA,,
ARS-853,ARS-853,,BRD:BRD-K65313170-001-02-9,oncref_1,INHIBITOR OF KRAS-G12C,KRAS,,,,,,NA,,
ARSANILIC-ACID,ARSANILIC-ACID,,BRD:BRD-BRD-K24179883-001-16-7;BRD:BRD-K24179883-001-16-7,rep_primary;rep_single_dose,,LYZ,,,PHASE 1,,,NA,NC1CCC(CC1)[AS](O)(O)=O,
ART558,ART558,,BRD:BRD-K00126476-001-01-9,oncref_2,INHIBITOR OF DNA POLGAMMA,POLQ,,,,,,NA,,
ARTELINIC ACID,ARTELINIC ACID,CHEMBL1208264,BRD:BRD-K00073067-001-02-9,rep_single_dose,,,,,,,Small molecule,NA,C[C@@H]1[C@H](OCc2ccc(C(=O)O)cc2)O[C@@H]2O[C@@]3(C)CC[C@@H]4[C@@H](C)CC[C@@H]1[C@]24OO3,UVNHKOOJXSALHN-LBIQBRDBSA-N
QING HAU SAU,(+)-ARTEMISININ;ARTEMISIN;ARTEMISININ;ARTEMISININUM;GNF-PF-5341;HUANGHUAHAOSU;NSC-369397;QING HAU SAU,CHEMBL567597,BRD:BRD-BRD-K13112821-001-17-4;BRD:BRD-K13112821-001-17-4,rep_multi_dose;rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,CYP2B6,MALARIA,,LAUNCHED,,Small molecule,4,"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4;C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4",BLUAFEHZUWYNDE-DKGJTOOQSA-N
ZYSUNATE,.ALPHA.-ARTESUNIC ACID;ARSUMAX;ARTESUNATE;ARTESUNATUM;ARTESUNIC ACID;DIHYDROQINGHAOSU HEMISUCCINATE;LJPC-0118;NSC-712571;PLASMOTRIN;QINGHAOZHI;SAPHNATE;ZYSUNATE,CHEMBL361497,BRD:BRD-BRD-K54634444-001-05-9;BRD:BRD-K54634444-001-05-9,rep_multi_dose;rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,MALARIA,,LAUNCHED,,Small molecule,4,"C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4;C[C@H]1[C@H](OC(=O)CCC(=O)O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3",FIHJKUPKCHIPAT-AHIGJZGOSA-N
SEPTOCAINE,40 045;40-045;ARTICAINE;CARTICAINE;HOE 045;HOE-045;SEPTOCAINE,CHEMBL1093,BRD:BRD-A70514680-003-11-2;BRD:BRD-BRD-A70514680-003-11-2,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,4,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC;CCCNC(C)C(=O)NC1C(C)CSC1C(=O)OC,QTGIAADRBBLJGA-UHFFFAOYSA-N
VEPDEGESTRANT,ARV 471;ARV-471;ARV471;VEPDEGESTRANT,CHEMBL5095210,BRD:BRD-U00114869-001-01-9,oncref_1,PROTAC DEGRADER OF ESTROGEN RECEPTOR 1,ESR1,,,,,Unknown,1,O=C1CC[C@H](N2Cc3cc(N4CCN(CC5CCN(c6ccc([C@@H]7c8ccc(O)cc8CC[C@@H]7c7ccccc7)cc6)CC5)CC4)ccc3C2=O)C(=O)N1,TZZDVPMABRWKIZ-XMOGEVODSA-N
ARV-825,ARV-825,,BRD:BRD-A00047421-001-01-7,rep_single_dose,BROMODOMAIN INHIBITOR,BRD4,,,,,,NA,,
AS-1269574,AS-1269574,,BRD:BRD-BRD-K07656463-001-01-5;BRD:BRD-K07656463-001-01-5,rep_primary;rep_single_dose,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,GPR119,,,PRECLINICAL,,,NA,CC1CC(NCCO)NC(N1)-C1CCC(BR)CC1,
AS-1892802,AS-1892802,,BRD:BRD-BRD-K27051047-001-01-0;BRD:BRD-K27051047-001-01-0,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK1,,,PRECLINICAL,,,NA,OC[C@@H](NC(=O)NC1CCC(CC1)-C1CCNCC1)C1CCCCC1,
AS-1949490,AS-1949490,,BRD:BRD-BRD-K61936403-001-01-7;BRD:BRD-K61936403-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,SHIP2 PHOSPHATASE INHIBITOR,INPP5D,,,PRECLINICAL,,,NA,"C[C@H](NC(=O)C1SCCC1OCC1CCC(CL)CC1)C1CCCCC1, C[C@H](NC(=O)C1SCCC1OCC1CCC(CL)CC1)C1CCCCC1",
AS-2034178,AS-2034178,,BRD:BRD-BRD-K75254015-001-01-9;BRD:BRD-K75254015-001-01-9,rep_primary;rep_single_dose,FREE FATTY ACID RECEPTOR AGONIST,FFAR1,,,PRECLINICAL,,,NA,OC(=O)CCC1CCC(NCC2CCCC3N(CCOC4CCCCC4)CCCC23)CC1F,
AS-2444697,AS-2444697,,BRD:BRD-K73565918-003-02-9,rep_single_dose,INTERLEUKIN INHIBITOR,IRAK4,,,,,,NA,,
AS-252424,AS-252424,,BRD:BRD-K14988953-001-04-4,rep_single_dose,PI3K INHIBITOR,PIK3CG,,,,,,NA,,
AS-604850,AS-604850,,BRD:BRD-BRD-K63915849-001-03-7;BRD:BRD-K63915849-001-03-7,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CG,,,PRECLINICAL,,,NA,FC1(F)OC2CCC(CC2O1)\C=C1/SC(=O)NC1=O,
PIMASERTIB,AS 703026;AS-703026;AS703026;EMD 1036239;EMD-1036239;G-02443714;MSC-1936369;MSC-1936369A;MSC-1936369B;MSC1936369A;MSC1936369A; AS703026; EMD 1036239;PIMASERTIB,CHEMBL2107832,BRD:BRD-BRD-K89014967-001-04-3;BRD:BRD-K89014967-001-04-3,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1;MAP2K2,,,PHASE 2,,Small molecule,2,O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F;OC[C@@H](O)CNC(=O)C1CCNCC1NC1CCC(I)CC1F,VIUAUNHCRHHYNE-JTQLQIEISA-N
AS-77,AS-77,,BRD:BRD-BRD-K62427771-001-01-0;BRD:BRD-K62427771-001-01-0,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNA3;KCNA5;KCNN4,,,PRECLINICAL,,,NA,O=C1CCC2C(OCCCCOC3CCCCC3)C3CCOC3CC2O1,
AS601245,AS601245,,GDSC1:207,gdsc,,,,,,,,NA,,
VADIMEZAN,AS-1404;ASA-404;ASA404;DMXAA;NSC-640488;VADIMEZAN,CHEMBL71263,BRD:BRD-BRD-K27938825-001-02-4;BRD:BRD-K27938825-001-02-4,rep_primary;rep_single_dose,ANGIOGENESIS INHIBITOR,,,,PHASE 3,,Small molecule,3,Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C;CC1CCC2C(OC3C(CC(O)=O)CCCC3C2=O)C1C,XGOYIMQSIKSOBS-UHFFFAOYSA-N
S-555739,ASAPIPRANT;BGE 175;BGE-175;BGE175;S-555739,CHEMBL3545043,BRD:BRD-K00003230-001-01-9,rep_single_dose,PROSTAGLANDIN INHIBITOR,,,,,,Small molecule,3,CC(C)Oc1ccc(S(=O)(=O)N2CCN(c3ccc(-c4ncco4)c(OCC(=O)O)c3)CC2)cc1,ZMZNWNTZRWXTJU-UHFFFAOYSA-N
ASARALDEHYDE,ASARALDEHYDE,CHEMBL1164301,BRD:BRD-BRD-K88219015-001-10-8;BRD:BRD-K88219015-001-10-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,,,PRECLINICAL,,Small molecule,NA,COC1CC(OC)C(C=O)CC1OC;COc1cc(OC)c(OC)cc1C=O,IAJBQAYHSQIQRE-UHFFFAOYSA-N
ASC-J9,ASC-J9,,BRD:BRD-BRD-K30331124-001-01-7;BRD:BRD-K30331124-001-01-7;BRD:BRD-K30331124-001-04-9,rep_primary;rep_single_dose,ANDROGEN RECEPTOR ENHANCER,AR,,,PHASE 2,,,NA,"COC1CCC(CC1OC)\C=C\C(=O)CC(=O)\C=C\C1CCC(OC)C(OC)C1, COC1CCC(CC1OC)\C=C\C(=O)CC(=O)\C=C\C1CCC(OC)C(OC)C1, COC1CCC(CC1OC)\C=C\C(=O)CC(=O)\C=C\C1CCC(OC)C(OC)C1",
L-683590,ASCOMYCIN;FK520;FR-900520;IMMUNOMYCIN;L-683590,CHEMBL8597,BRD:BRD-K88882192-001-03-3,rep_single_dose,CALCINEURIN INHIBITOR,FKBP1A,,,,,Small molecule,NA,CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,ZDQSOHOQTUFQEM-NURRSENYSA-N
ASCORBIC-ACID,ASCORBIC-ACID,,BRD:BRD-A85242401-001-12-3;BRD:BRD-BRD-A85242401-001-12-3,rep_primary;rep_single_dose,ANTIOXIDANT,ALKBH2;ALKBH3;BBOX1;DBH;EGLN1;EGLN2;EGLN3;KDM5D;LCT;OGFOD1;OGFOD2;P3H1;P3H2;P3H3;P4HA1;P4HTM;PAM;PHYH;PLOD1;PLOD2;PLOD3;SLC23A1;SLC23A2;TMLHE,SCURVY,,LAUNCHED,,,NA,"OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O",
SYCREST,ASENAPINE;SECUADO;SYCREST,CHEMBL3187365,BRD:BRD-BRD-K95260951-050-03-1;BRD:BRD-K95260951-050-03-1,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;DRD1;DRD2;DRD3;DRD4;HRH1;HRH2;HTR1A;HTR1B;HTR1D;HTR1E;HTR2A;HTR2B;HTR2C;HTR5A;HTR6;HTR7,"SCHIZOPHRENIA, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,4,"CN1C[C@H]2[C@H](C1)C1CC(CL)CCC1OC1CCCCC21, CN1C[C@H]2[C@H](C1)C1CC(CL)CCC1OC1CCCCC21.CN1C[C@@H]2[C@@H](C1)C1CC(CL)CCC1OC1CCCCC21, CN1C[C@H]2[C@H](C1)C1CC(CL)CCC1OC1CCCCC21;CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1",VSWBSWWIRNCQIJ-UHFFFAOYSA-N
ASIATIC-ACID,ASIATIC-ACID,,BRD:BRD-BRD-K35079116-001-02-5;BRD:BRD-BRD-K35079116-001-03-3;BRD:BRD-K35079116-001-02-5;BRD:BRD-K35079116-001-03-3,rep_primary;rep_single_dose,APOPTOSIS STIMULANT,PYGM,,,PRECLINICAL,,,NA,"C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O, C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O",
EMD-61753,ASIMADOLINE;EMD-61753,CHEMBL1190199,BRD:BRD-K00003477-001-01-9,rep_single_dose,OPIOID RECEPTOR AGONIST,OPRK1,,,,,Small molecule,3,CN(C(=O)C(c1ccccc1)c1ccccc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1,JHLHNYVMZCADTC-LOSJGSFVSA-N
PAC-14028,ASIVATREP;PAC-14028,CHEMBL3707398,BRD:BRD-K00003138-001-01-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,,,,,,Small molecule,3,,
ASP-2535,ASP-2535,,BRD:BRD-BRD-K07150325-001-01-7;BRD:BRD-K07150325-001-01-7,rep_primary;rep_single_dose,GLYCINE TRANSPORTER INHIBITOR,SLC6A9,,,PHASE 1,,,NA,"CC(C)C1NNC(-C2CCC(NC2)-C2CCCCC2)N1-C1CCCC2NONC12, CC(C)C1NNC(-C2CCC(NC2)-C2CCCCC2)N1-C1CCCC2NONC12",
QUIZARTINIB MONOHYDROCHLORIDE,AC 220;AC-010220;AC-010220 DIHYDROCHLORIDE;AC-220;AC-220 DIHYDROCHLORIDE;AC010220;AC010220 2HCL;AC010220.2HCL;AC220;AC220 2HCL;ASP-2689;QUIZARTINIB;QUIZARTINIB DIHYDROCHLORIDE;QUIZARTINIB HYDROCHLORIDE;QUIZARTINIB MONOHYDROCHLORIDE,CHEMBL2105709;CHEMBL576982,GDSC1:254,gdsc,,,,,,,Small molecule,3,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1.Cl.Cl,DHYPGRVMIOATAE-UHFFFAOYSA-N
ASP-6537,ASP-6537,,BRD:BRD-K82239282-001-02-9,rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,,,,NA,,
ASP-9521,ASP-9521,,BRD:BRD-K00003301-001-01-9,rep_single_dose,ALDO-KETO REDUCTASE INHIBITOR,,,,,,,NA,,
ASP3026,ASP 3026;ASP-3026;ASP3026,CHEMBL3545360,BRD:BRD-BRD-K06542892-001-01-9;BRD:BRD-K06542892-001-01-9,rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK,,,PHASE 1,,Small molecule,1,"COC1CC(CCC1NC1NCNC(NC2CCCCC2S(=O)(=O)C(C)C)N1)N1CCC(CC1)N1CCN(C)CC1, COC1CC(CCC1NC1NCNC(NC2CCCCC2S(=O)(=O)C(C)C)N1)N1CCC(CC1)N1CCN(C)CC1;COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1",MGGBYMDAPCCKCT-UHFFFAOYSA-N
ASP5878,ASP 5878;ASP-5878;ASP5878,CHEMBL4594428,BRD:BRD-K00091280-001-01-9,rep_single_dose,,,,,,,Small molecule,1,COc1cc(OC)c(F)c(COc2cnc(Nc3cnn(CCO)c3)nc2)c1F,VDZZYOJYLLNBTD-UHFFFAOYSA-N
ZERO-CAL,APM;ASPARTAME;ASPARTAME (E951);E-951;E951;INS NO.951;INS-951;METHYL ASPARTYLPHENYLALANATE;NSC-758953;NUTRASWEET;PAL SWEET;SC-18862;SLADEX;ZERO-CAL,CHEMBL171679,BRD:BRD-BRD-K78841970-001-13-8;BRD:BRD-K78841970-001-13-8,rep_primary;rep_single_dose,,TAS1R2;TRPV1,,,LAUNCHED,,Small molecule,3,"COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O;COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](N)CC(O)=O, COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](N)CC(O)=O, COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](N)CC(O)=O, COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](N)CC(O)=O",IAOZJIPTCAWIRG-QWRGUYRKSA-N
VAZALORE,2-(ACETYLOXY)-;8-HOUR BAYER;ACETOSALIC ACID;ACETYL SALICYLATE;ACETYLSALIC ACID;ACETYLSALICYLIC ACID;ACETYLSALICYLIC ACID (WHO-IP);ACETYLSALICYLICUM ACIDUM;ACIDUM ACETYLSALICYLICUM;ACIDUM ACETYLSALICYLICUM (WHO-IP);ALKA RAPID;ANADIN ALL NIGHT;ANGETTES 75;ASPIRIN;ASPRO CLR;BAY1019036;BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN;BENZOIC ACID;DANAMEP;DISPRIN CV;DISPRIN DIRECT;DURLAZA;ECOTRIN;ENPRIN;EQUI-PRIN;GENCARDIA;LEVIUS;MAX STRGH ASPRO CLR;MEASURIN;MICROPIRIN EC;NSC-27223;NSC-406186;NU-SEALS 300;NU-SEALS 600;NU-SEALS 75;NU-SEALS CARDIO 75;PAYNOCIL;PLATET;PLATET 300;POSTMI 300;POSTMI 75;SALICYLIC ACID ACETATE;VAZALORE,CHEMBL25,BRD:BRD-BRD-K11433652-001-17-0;BRD:BRD-K11433652-001-17-0,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,AKR1C1;ASIC3;EDNRA;HSPA5;IKBKB;NFKB1;NFKB2;NFKBIA;PRKAA1;PRKAA2;PRKAB1;PRKAB2;PRKAG1;PRKAG2;PRKAG3;PTGS1;PTGS2;RPS6KA3;TP53,"HEADACHE, FEVER, TOOTHACHE, MUSCLE PAIN",,LAUNCHED,,Small molecule,4,"CC(=O)Oc1ccccc1C(=O)O;CC(=O)OC1CCCCC1C(O)=O, CC(=O)OC1CCCCC1C(O)=O, CC(=O)OC1CCCCC1C(O)=O, CC(=O)OC1CCCCC1C(O)=O",BSYNRYMUTXBXSQ-UHFFFAOYSA-N
AST1306,ALL-3;ALLITINIB;ALS 1306;AST 1306;AST-1306;AST1306,CHEMBL1947204,BRD:BRD-BRD-K26838195-075-04-9;BRD:BRD-K26838195-075-04-9;GDSC1:381,gdsc;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2,,,PHASE 1,,Small molecule,2,C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1;FC1CCCC(COC2CCC(NC3NCNC4CCC(NC(=O)C=C)CC34)CC2CL)C1,MVZGYPSXNDCANY-UHFFFAOYSA-N
"R 43,512","ASTEMIZOLE;GNF-PF-2461;HISMANAL;NSC-329963;NSC-759570;POLLON-EZE;R 43,512",CHEMBL296419,BRD:BRD-BRD-K37249724-001-25-7;BRD:BRD-K37249724-001-25-7,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1;KCNH1;KCNH2,,,WITHDRAWN,,Small molecule,4,"COC1CCC(CCN2CCC(CC2)NC2NC3CCCCC3N2CC2CCC(F)CC2)CC1, COC1CCC(CCN2CCC(CC2)NC2NC3CCCCC3N2CC2CCC(F)CC2)CC1, COC1CCC(CCN2CCC(CC2)NC2NC3CCCCC3N2CC2CCC(F)CC2)CC1;COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1",GXDALQBWZGODGZ-UHFFFAOYSA-N
ASTILBIN,ASTILBIN,CHEMBL486017,BRD:BRD-K44845912-001-02-9,rep_single_dose,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",,,,,,Small molecule,NA,C[C@@H]1O[C@@H](O[C@H]2C(=O)c3c(O)cc(O)cc3O[C@@H]2c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,ZROGCCBNZBKLEL-MPRHSVQHSA-N
ASTRAGALOSIDE-A,ASTRAGALOSIDE-A,,BRD:BRD-BRD-K08188887-001-02-4;BRD:BRD-K08188887-001-02-4,rep_primary;rep_single_dose,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT",,,,PRECLINICAL,"Multiple values for MOA: {'ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT', 'ANTIINFLAMMATORY AGENT'}, defaulting to 'ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT'",,NA,CC(C)(O)[C@H]1CC[C@](C)(O1)[C@H]1[C@@H](O)C[C@@]2(C)[C@@H]3C[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C4(C)C,
TOLINAPANT,ASTX 660;ASTX-660;ASTX660;TOLINAPANT,CHEMBL4173974,BRD:BRD-K00003508-001-01-9,rep_single_dose,APOPTOSIS INHIBITOR,,,,,,Small molecule,1,C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2CCOC[C@H]2C)CN1,YCXOHEXZVKOGEV-DNRQZRRGSA-N
SUNVEPRA,ASUNAPREVIR;BMS 650032;BMS-650032;SUNVEPRA,CHEMBL2105735,BRD:BRD-BRD-K87028197-001-01-3;BRD:BRD-K87028197-001-01-3,rep_primary;rep_single_dose,HCV INHIBITOR,,,,PHASE 3,,Small molecule,3,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1;COC1CNC(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C2CC2)C2CC(CL)CCC12,XRWSZZJLZRKHHD-WVWIJVSJSA-N
ASYMMETRICAL-DIMETHYLARGININE,ASYMMETRICAL-DIMETHYLARGININE,,BRD:BRD-BRD-K36269323-300-02-6;BRD:BRD-K36269323-300-02-6,rep_multi_dose;rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS2;NOS3,,,PHASE 1,,,NA,CN(C)C(=N)NCCC[C@H](N)C(O)=O,
AT-1015,AT-1015,,BRD:BRD-K06496777-003-02-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A,,,,,,NA,,
XEVINAPANT,AT-406;D-1143;DEBIO 1143;DEBIO-1143;IAP INHIBITOR AT-406;SM-406;XEVINAPANT,CHEMBL2158051,BRD:BRD-K83030136-001-02-9;CTRP:710154,ctrp;rep_single_dose,IAP ANTAGONIST,,,,,,Small molecule,3,CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O,LSXUTRRVVSPWDZ-MKKUMYSQSA-N
CDKI AT7519,AT 7519;AT-7519;AT7519;CDKI AT7519,CHEMBL445813,BRD:BRD-BRD-K13390322-001-06-3;BRD:BRD-K13390322-001-06-3;GDSC1:219,gdsc;rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK4;CDK5;CDK6;CDK9,,,PHASE 2,,Small molecule,2,CLC1CCCC(CL)C1C(=O)NC1C[NH]NC1C(=O)NC1CCNCC1;O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,OVPNQJVDAFNBDN-UHFFFAOYSA-N
AT9283,AT 9283;AT-9283;AT9283,CHEMBL495727,BRD:BRD-BRD-K24576554-001-04-8;BRD:BRD-K24576554-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,"AURORA KINASE INHIBITOR, JAK INHIBITOR",AURKA;AURKB;JAK2;JAK3;RPS6KA6;STK17A,,,PHASE 2,,Small molecule,2,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1;O=C(NC1CC1)NC1C[NH]NC1-C1NC2CC(CN3CCOCC3)CCC2[NH]1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N
AT13148,AT-13148;AT13148,CHEMBL3544960,BRD:BRD-BRD-K32127727-001-04-2;BRD:BRD-K32127727-001-04-2;GDSC2:2170,gdsc;rep_primary;rep_single_dose,PROTEIN KINASE INHIBITOR,AKT1;AKT2;AKT3;ROCK1;ROCK2;SGK3,,,PHASE 1,,Small molecule,1,"NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1;NC[C@@](O)(C1CCC(CL)CC1)C1CCC(CC1)-C1CN[NH]C1, NC[C@@](O)(C1CCC(CL)CC1)C1CCC(CC1)-C1CN[NH]C1, NC[C@@](O)(C1CCC(CL)CC1)C1CCC(CC1)-C1CN[NH]C1, NC[C@@](O)(C1CCC(CL)CC1)C1CCC(CC1)-C1CN[NH]C1",IIRWNGPLJQXWFJ-KRWDZBQOSA-N
ONALESPIB,AT-13387;AT13387;ATI-13387X;ATI13387X;ONALESPIB,CHEMBL1214827,BRD:BRD-BRD-K58435339-001-03-0;BRD:BRD-K58435339-001-03-0;CTRP:688229,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"HSP ANTAGONIST, HSP INHIBITOR",HSP90AA1,,,PHASE 2,"Multiple values for MOA: {'HSP ANTAGONIST', 'HSP ANTAGONIST, HSP INHIBITOR'}, defaulting to 'HSP ANTAGONIST, HSP INHIBITOR'",Small molecule,2,"CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O;CC(C)C1CC(C(=O)N2CC3CCC(CN4CCN(C)CC4)CC3C2)C(O)CC1O, CC(C)C1CC(C(=O)N2CC3CCC(CN4CCN(C)CC4)CC3C2)C(O)CC1O",IFRGXKKQHBVPCQ-UHFFFAOYSA-N
CDKI AT7519,AT 7519;AT-7519;AT7519;CDKI AT7519,CHEMBL445813,GDSC1:219,gdsc,,,,,,,Small molecule,2,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,OVPNQJVDAFNBDN-UHFFFAOYSA-N
AT7867,AT7867,,BRD:BRD-BRD-K12040459-001-06-0;BRD:BRD-K12040459-001-06-0;CTRP:660409;GDSC1:356,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,AKT INHIBITOR,AKT2;GSK3B;PKIA;PRKACA,,,PRECLINICAL,,,NA,"CLC1CCC(CC1)C1(CCNCC1)C1CCC(CC1)-C1CN[NH]C1, CLC1CCC(CC1)C1(CCNCC1)C1CCC(CC1)-C1CN[NH]C1",
TRANSLARNA,ATALUREN;PTC-124;PTC124;TRANSLARNA,CHEMBL256997,BRD:BRD-BRD-K94830329-001-03-0;BRD:BRD-K94830329-001-03-0,rep_primary;rep_single_dose,"CFTR CHANNEL AGONIST, DYSTROPHIN STIMULANT",DMD,"DUCHENNE MUSCULAR DYSTROPHY (DMD), CYSTIC FIBROSIS",,LAUNCHED,,Small molecule,4,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1;OC(=O)C1CCCC(C1)-C1NOC(N1)-C1CCCCC1F,OOUGLTULBSNHNF-UHFFFAOYSA-N
S8993,ATAMPARIB;RBN 2397;RBN-2397;RBN2397;S8993,CHEMBL5095043,BRD:BRD-K00090629-001-01-9;BRD:BRD-K00090629-001-02-9,oncref_2;rep_single_dose,INHIBITOR OF PARP7,PARP7,,,,,Small molecule,1,C[C@@H](COCCC(=O)N1CCN(c2ncc(C(F)(F)F)cn2)CC1)Nc1cn[nH]c(=O)c1C(F)(F)F,UQZCQKXJAXKZQH-LBPRGKRZSA-N
REYATAZ,ATAZANAVIR;BMS-232632;CGP-73547;REYATAZ,CHEMBL1163,BRD:BRD-BRD-K09757388-065-04-0;BRD:BRD-K09757388-065-04-0,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C;COC(=O)N[C@H](C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)CN(CC1CCC(CC1)-C1CCCCN1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,AXRYRYVKAWYZBR-GASGPIRDSA-N
ATB-346,ATB-346,CHEMBL4211107,BRD:BRD-A52551912-001-02-9,rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGER2,,,,,Small molecule,2,COc1ccc2cc(C(C)C(=O)Oc3ccc(C(N)=S)cc3)ccc2c1,YCNMAPLPQYQJFC-UHFFFAOYSA-N
ATENOLOL-(+),ATENOLOL-(+),,BRD:BRD-K68075732-001-11-8,rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,,,,NA,,
ATENOLOL-(+/-),ATENOLOL-(+/-),,BRD:BRD-A20239487-001-24-9;BRD:BRD-BRD-A20239487-001-24-9,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;LTF;PLA2G2E,"HYPERTENSION, ANGINA PECTORIS",,LAUNCHED,"Multiple values for repurposing_target: {'ADRB1;ADRB2', 'ADRB1;ADRB2;LTF;PLA2G2E'}, taking the union",,NA,"CC(C)NCC(O)COC1CCC(CC(N)=O)CC1, CC(C)NCC(O)COC1CCC(CC(N)=O)CC1",
ATENOLOL-(-),ATENOLOL-(-),,BRD:BRD-BRD-K44993696-001-12-3;BRD:BRD-K44993696-001-12-3,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,PHASE 2,,,NA,"CC(C)NC[C@H](O)COC1CCC(CC(N)=O)CC1, CC(C)NC[C@H](O)COC1CCC(CC(N)=O)CC1",
ATGLISTATIN,ATGLISTATIN,,BRD:BRD-BRD-K43363084-001-01-3;BRD:BRD-K43363084-001-01-3,rep_primary;rep_single_dose,ADIPOSE TRIGLYCERIDE LIPASE INHIBITOR,,,,PRECLINICAL,,,NA,"CN(C)C(=O)NC1CCCC(C1)-C1CCC(CC1)N(C)C, CN(C)C(=O)NC1CCCC(C1)-C1CCC(CC1)N(C)C",
LY2456302,ATICAPRANT;CERC-501;JNJ-67953964;JNJ-67953964-AAA;JSPA-0658;JSPA0658;LY-2456302;LY2456302,CHEMBL1921847,BRD:BRD-K00003342-001-01-9,rep_single_dose,OPIOID RECEPTOR ANTAGONIST,,,,,,Small molecule,3,Cc1cc(C)cc([C@@H]2CCCN2Cc2ccc(Oc3ccc(C(N)=O)cc3F)cc2)c1,ZHPMYDSXGRRERG-DEOSSOPVSA-N
MPV-1248,4-(2-ETHYL-2-INDANYL)IMIDAZOLE.;ANTISEDAN;ATIPAMEZOLE;MPV-1248,CHEMBL353972,BRD:BRD-BRD-K39252998-003-01-5;BRD:BRD-K39252998-003-01-5,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,REVERSE SEDATIVE,,LAUNCHED,,Small molecule,1,"CCC1(c2c[nH]cn2)Cc2ccccc2C1;CCC1(CC2CCCCC2C1)C1CNC[NH]1, CCC1(CC2CCCCC2C1)C1CNC[NH]1",HSWPZIDYAHLZDD-UHFFFAOYSA-N
SKF-106615,ATIPRIMOD;SKF-106615,CHEMBL103735,BRD:BRD-BRD-K38527262-300-01-0;BRD:BRD-K38527262-300-01-0,rep_multi_dose;rep_primary;rep_single_dose,"JAK INHIBITOR, STAT INHIBITOR",JAK2;STAT3,,,PHASE 2,,Small molecule,2,CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1,SERHTTSLBVGRBY-UHFFFAOYSA-N
ATIZORAM,ATIZORAM,CHEMBL1229569,BRD:BRD-BRD-K76614248-001-01-2;BRD:BRD-K76614248-001-01-2,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A;PDE4B;PDE4C;PDE4D,,,PHASE 2,,Small molecule,-1,COc1ccc(C2CNC(=O)NC2)cc1O[C@H]1C[C@@H]2CC[C@H]1C2;COC1CCC(CC1O[C@H]1C[C@@H]2CC[C@H]1C2)C1CNC(=O)NC1,LITNEAPWQHVPOK-FFSVYQOJSA-N
KU-55933,ATM KINASE INHIBITOR;KU-55933,CHEMBL222102,BRD:BRD-BRD-K25311561-001-10-7;BRD:BRD-K25311561-001-10-7;BRD:BRD-K25311561-001-15-9;CTRP:58339;GDSC1:1030;GDSC2:1030,ctrp;gdsc;oncref_2;rep_primary;rep_single_dose,ATM KINASE INHIBITOR,ATM;PRKDC,,,PRECLINICAL,"Multiple values for MOA: {'INHIBITOR OF ATM', 'ATM KINASE INHIBITOR'}, defaulting to 'ATM KINASE INHIBITOR'
Multiple values for repurposing_target: {'ATM', 'ATM;PRKDC'}, taking the union",Small molecule,NA,"O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1;O=C1CC(OC(C1)-C1CCCC2SC3CCCCC3SC12)N1CCOCC1, O=C1CC(OC(C1)-C1CCCC2SC3CCCCC3SC12)N1CCOCC1",XRKYMMUGXMWDAO-UHFFFAOYSA-N
ATN-161,AC-PHSCN-NH2;ATN 161;ATN-161,CHEMBL4297456,BRD:BRD-BRD-K00521308-019-01-9;BRD:BRD-K00521308-019-01-9,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGA5;ITGAV;ITGB1;ITGB3,,,PHASE 2,,Protein,2,"CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1C[NH]CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O, CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1C[NH]CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O;CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O",MMHDBUJXLOFTLC-WOYTXXSLSA-N
STRATTERA,ATOMOXETINE;STRATTERA,CHEMBL641,BRD:BRD-BRD-K20141153-003-13-7;BRD:BRD-K20141153-003-13-7,rep_primary;rep_single_dose,NOREPINEPHRINE TRANSPORTER INHIBITOR,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B;SLC6A2;SLC6A3;SLC6A4,ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD),,LAUNCHED,,Small molecule,4,"CNCC[C@@H](Oc1ccccc1C)c1ccccc1;CNCC[C@@H](OC1CCCCC1C)C1CCCCC1, CNCC[C@@H](OC1CCCCC1C)C1CCCCC1, CNCC[C@@H](OC1CCCCC1C)C1CCCCC1",VHGCDTVCOLNTBX-QGZVFWFLSA-N
ZARATOR,ATORVASTATIN;CARDYL;LIPITOR;PREVENCOR;SORTIS;TAHOR;ZARATOR,CHEMBL1487,BRD:BRD-BRD-K69726342-238-02-4;BRD:BRD-K69726342-238-02-4;BRD:BRD-K69726342-238-05-9,rep_multi_dose;rep_primary;rep_single_dose,HMGCR INHIBITOR,AHR;DPP4;HMGCR,"STROKE, HEART ATTACK",,LAUNCHED,,Small molecule,4,"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O;CC(C)C1C(C(=O)NC2CCCCC2)C(C(-C2CCC(F)CC2)N1CC[C@@H](O)C[C@@H](O)CC(O)=O)-C1CCCCC1, CC(C)C1C(C(=O)NC2CCCCC2)C(C(-C2CCC(F)CC2)N1CC[C@@H](O)C[C@@H](O)CC(O)=O)-C1CCCCC1, CC(C)C1C(C(=O)NC2CCCCC2)C(C(-C2CCC(F)CC2)N1CC[C@@H](O)C[C@@H](O)CC(O)=O)-C1CCCCC1",XUKUURHRXDUEBC-KAYWLYCHSA-N
WELLVONE,566C;566C80;ATOVAQUONE;MEPRON;NSC-759582;WELLVONE,CHEMBL1450,BRD:BRD-A19795905-001-08-0;BRD:BRD-BRD-A19795905-001-08-0,rep_primary;rep_single_dose,MITOCHONDRIAL ELECTRON TRANSPORT INHIBITOR,DHODH,PNEUMONIA,,LAUNCHED,,Small molecule,4,"CLC1CCC(CC1)[C@H]1CC[C@@H](CC1)C1C(=O)C(=O)C2CCCCC2C1=O, CLC1CCC(CC1)[C@H]1CC[C@@H](CC1)C1C(=O)C(=O)C2CCCCC2C1=O;O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21",KUCQYCKVKVOKAY-CTYIDZIISA-N
ATPA,ATPA,,BRD:BRD-A65145453-001-06-1;BRD:BRD-BRD-A65145453-001-06-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIA2;GRIK1,,,PRECLINICAL,,,NA,"CC(C)(C)C1ONC(O)C1CC(N)C(O)=O, CC(C)(C)C1ONC(O)C1CC(N)C(O)=O",
ATR INHIBITOR 2,ATR INHIBITOR 2,,BRD:BRD-K00091072-001-01-9,rep_single_dose,,,,,,,,NA,,
ATRACTYLENOLIDE-I,ATRACTYLENOLIDE-I,,BRD:BRD-K00003732-001-01-9,rep_single_dose,JAK INHIBITOR,,,,,,,NA,,
ATRASENTAN,A-127722;ATRASENTAN,CHEMBL9194,BRD:BRD-BRD-K16295392-003-01-3;BRD:BRD-K16295392-003-01-3,rep_multi_dose;rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA,,,PHASE 3,,Small molecule,3,CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C1CCC(OC)CC1)C(O)=O)C1CCC2OCOC2C1;CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1,MOTJMGVDPWRKOC-QPVYNBJUSA-N
NSC-759876,506U;506U78;ARRANON;ATRIANCE;ATTRIANCE;GW-506U78;MAY;NELARABINE;NELZARABINE;NSC-686673;NSC-755985;NSC-759876,CHEMBL1201112,GDSC2:1814,gdsc,,,,,,,Small molecule,4,COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N
NSC-757064,(-)-ATROPINE;(-)-HYOSCYAMINE;(S)-;(S)-(-)-HYOSCYAMINE;ATROJECT;ATROPEN;ATROPHATE;ATROPINE;ATROPINE (AUTOINJECTOR);ATROPINUM;BELLAFOLINE;CYSTOSPAZ;DATURINE;DL-HYOSCYAMINE;DUBOISINE;HYOSCYAMINE;HYOSCYAMINUM;ISOPTO ATROPINE;L-HYOSCYAMINE;NSC-757064,CHEMBL1331216;CHEMBL517712,BRD:BRD-A27290375-330-01-1;BRD:BRD-BRD-A27290375-330-01-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,"CYCLOPLEGIA, MYDRIASIS, AMBLYOPIA",,LAUNCHED,,Small molecule,4,"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2;CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1CCCCC1, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1CCCCC1",RKUNBYITZUJHSG-FXUDXRNXSA-N
ATROPINE-OXIDE,ATROPINE-OXIDE,,BRD:BRD-K00004526-001-01-9,rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,,,,,,NA,,
ATUVECICLIB,ATUVECICLIB,CHEMBL4439321,BRD:BRD-K00003144-001-01-9,rep_single_dose,CDK9 INHIBITOR,,,,,,Small molecule,1,COc1cc(F)ccc1-c1ncnc(Nc2cccc(C[S@](C)(=N)=O)c2)n1,ACWKGTGIJRCOOM-HHHXNRCGSA-N
SK&F-39162,AURANOFIN;NSC-321521;RIDAURA;SK-39162;SK&F 39162;SK&F-39162,CHEMBL1366,BRD:BRD-BRD-K45995181-001-04-6;BRD:BRD-K45995181-001-04-6,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,IKBKB;PRDX5;TRPA1,RHEUMATOID ARTHRITIS,,LAUNCHED,,Small molecule,4,"CCP(CC)(CC)[AU]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O, CCP(CC)(CC)=[AU]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O, CCP(CC)(CC)=[AU]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O",
AURORA-A-INHIBITOR-I,AURORA-A-INHIBITOR-I,,BRD:BRD-BRD-K53561341-001-07-5;BRD:BRD-K53561341-001-07-5,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA,,,PRECLINICAL,,,NA,"CCN1CCN(CC1)C(=O)CC1CCC(NC2NCC(F)C(NC3CCC(CC3)C(=O)NC3CCCCC3CL)N2)CC1, CCN1CCN(CC1)C(=O)CC1CCC(NC2NCC(F)C(NC3CCC(CC3)C(=O)NC3CCCCC3CL)N2)CC1",
AUSTOCYSTIN D,AUSTOCYSTIN D,CHEMBL1966436,CTRP:416775,ctrp,,,,,,,Small molecule,NA,CC(C)(O)CCc1ccc(O)c2c(=O)c3c(O)c4c(cc3oc12)O[C@H]1OC=C[C@@]41O,VXTQFTUOAJRUDO-IFMALSPDSA-N
AUT-1,AUT-1,,BRD:BRD-K00005330-001-01-9,rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,,,,,,,NA,,
AUTOTAXIN-MODULATOR-1,AUTOTAXIN-MODULATOR-1,,BRD:BRD-A94640958-001-01-7;BRD:BRD-BRD-A94640958-001-01-7,rep_primary;rep_single_dose,AUTOTAXIN INHIBITOR,ENPP2,,,PRECLINICAL,,,NA,C[C@@H](N1C2CCC1CC(C2)C(O)=O)C1CCC2CCC(O[C@H]3CC[C@H](CC3)C(F)(F)F)C(C2C1)C(F)(F)F,
MP-412,AV-412;MP 412;MP-412,CHEMBL5095024,BRD:BRD-BRD-K23190681-001-01-1;BRD:BRD-K23190681-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,EGFR;ERBB2,,,PHASE 1,,Small molecule,1,C=CC(=O)Nc1cc(C#CC(C)(C)N2CCN(C)CC2)cc2ncnc(Nc3ccc(F)c(Cl)c3)c12.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1;CN1CCN(CC1)C(C)(C)C#CC1CC2NCNC(NC3CCC(F)C(CL)C3)C2CC1NC(=O)C=C,BRZCZOWSDKKGGK-UHFFFAOYSA-N
AV-608,AV-608,,BRD:BRD-BRD-K96615647-001-01-2;BRD:BRD-K96615647-001-01-2,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1,,,PHASE 2,,,NA,FC(F)(F)C1CC(CC(C1)C(F)(F)F)C(=O)N1CC[C@@H](C[C@H]1CC1CCC(CL)CC1)NC(=O)C1CCNC2CCCCC12,
TAVNEOS,AVACOPAN;CCX-168;CCX168;TAVNEOS,CHEMBL3989871,BRD:BRD-K00003256-001-01-9,rep_single_dose,COMPLEMENT INHIBITOR,,,,,,Small molecule,4,Cc1ccc(NC(=O)[C@H]2CCCN(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F,PUKBOVABABRILL-YZNIXAGQSA-N
CC122,AVADOMIDE;CC-122;CC122,CHEMBL3989934,BRD:BRD-A88644406-001-02-9,rep_single_dose,ANTITUMOR AGENT,,,,,,Small molecule,2,Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O,RSNPAKAFCAAMBH-UHFFFAOYSA-N
BMS-70816301,AVAGACESTAT;BMS 708163;BMS-708163;BMS-708163-01;BMS-70816301,CHEMBL1090771,BRD:BRD-BRD-K83720053-001-03-8;BRD:BRD-K83720053-001-03-8;GDSC1:1072;GDSC1:205,gdsc;rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,PSEN1,,,PHASE 2,,Small molecule,2,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1;NC(=O)[C@@H](CCC(F)(F)F)N(CC1CCC(CC1F)-C1NCON1)S(=O)(=O)C1CCC(CL)CC1,XEAOPVUAMONVLA-QGZVFWFLSA-N
TA-1790,AVANAFIL;SPEDRA;STENDRA;TA-1790,CHEMBL1963681,BRD:BRD-BRD-K65781196-001-03-0;BRD:BRD-K65781196-001-03-0,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A,ERECTILE DYSFUNCTION,,LAUNCHED,,Small molecule,4,"COc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl;COC1CCC(CNC2NC(NCC2C(=O)NCC2NCCCN2)N2CCC[C@H]2CO)CC1CL, COC1CCC(CNC2NC(NCC2C(=O)NCC2NCCCN2)N2CCC[C@H]2CO)CC1CL",WEAJZXNPAWBCOA-INIZCTEOSA-N
X720776,70C366;AVAPRITINIB;AYVAKIT;BLU-285;C-366;X-720776;X720776,CHEMBL4204794,BRD:BRD-K00003419-001-01-9,rep_single_dose,KIT INHIBITOR,,,,,,Small molecule,4,Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1,DWYRIWUZIJHQKQ-SANMLTNESA-N
CI-1011,AVASIMIBE;CI-1011,CHEMBL101309,BRD:BRD-BRD-K67901620-001-02-0;BRD:BRD-K67901620-001-02-0,rep_primary;rep_single_dose,ACAT INHIBITOR,CES1,,,PHASE 3,,Small molecule,-1,"CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1;CC(C)C1CC(C(C)C)C(CC(=O)NS(=O)(=O)OC2C(CCCC2C(C)C)C(C)C)C(C1)C(C)C, CC(C)C1CC(C(C)C)C(CC(=O)NS(=O)(=O)OC2C(CCCC2C(C)C)C(C)C)C(C1)C(C)C",PTQXTEKSNBVPQJ-UHFFFAOYSA-N
YM-477,AKR-501;AVATROMBOPAG;E-5501;E5501;YM-301477;YM-477,CHEMBL2103883,BRD:BRD-BRD-K68544925-001-01-1;BRD:BRD-K68544925-001-01-1,rep_primary;rep_single_dose,THROMBOPOIETIN RECEPTOR AGONIST,MPL,THROMBOCYTOPENIA,,LAUNCHED,,Small molecule,4,O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1;OC(=O)C1CCN(CC1)C1NCC(CC1CL)C(=O)NC1NC(-C2CC(CL)CS2)C(S1)N1CCN(CC1)C1CCCCC1,OFZJKCQENFPZBH-UHFFFAOYSA-N
AVE-0991,AVE-0991,,BRD:BRD-K36154108-001-01-7,rep_single_dose,ANGIOTENSIN RECEPTOR AGONIST,MRGPRX1,,,,,,NA,,
AVE-3085,AVE-3085,,BRD:BRD-K00004734-001-01-9,rep_single_dose,NITRIC OXIDE SYNTHASE STIMULANT,,,,,,,NA,,
AVEX-73,AVEX-73,,BRD:BRD-K00003435-003-01-9,rep_single_dose,SIGMA RECEPTOR AGONIST,,,,,,,NA,,
NXL104,AVIBACTAM;NXL-104;NXL-104 FREE ACID;NXL104,CHEMBL1689063,BRD:BRD-BRD-K85882401-323-01-5;BRD:BRD-K85882401-323-01-5,rep_primary;rep_single_dose,BETA LACTAMASE INHIBITOR,,"INTRA-ABDOMINAL INFECTIONS, URINARY TRACT INFECTIONS, PYELONEPHRITIS, INTRA-ABDOMINAL INFECTIONS, URINARY TRACT INFECTIONS, PYELONEPHRITIS, INTRA-ABDOMINAL INFECTIONS, URINARY TRACT INFECTIONS, PYELONEPHRITIS",,LAUNCHED,,Small molecule,4,"NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O;NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O, NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O, NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O",NDCUAPJVLWFHHB-UHNVWZDZSA-N
AVICIN D,AVICIN D,CHEMBL508651,CTRP:688975,ctrp,,,,,,,Small molecule,NA,C=C[C@](C)(O)CC/C=C(\CO)C(=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@@](C)(C=C)CC/C=C(\CO)C(=O)O[C@H]2C[C@]3(C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H](C)[C@H](O[C@@H]5O[C@@H](CO)[C@H](O)[C@H]5O)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]4O)[C@H](O)C[C@]4(C)C(=CC[C@@H]5[C@@]6(C)CC[C@H](O[C@@H]7O[C@H](CO[C@@H]8O[C@H](C)[C@H](O)[C@H](O)[C@H]8O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@@H](O)[C@H](O)[C@H]7NC(C)=O)C(C)(C)[C@@H]6CC[C@]54C)[C@@H]3CC2(C)C)O[C@@H]1C,HKEDBKXRDHFCFB-LUAQNYIXSA-N
EX-ACEA0010,A610;ABIVERTINIB;AC-0010;AC0010;ACEA100610;AVITINIB;EX-ACEA0010,CHEMBL4297865,BRD:BRD-K00003294-050-01-9,rep_single_dose,EGFR INHIBITOR,,,,,,Small molecule,3,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,UOFYSRZSLXWIQB-UHFFFAOYSA-N
SPEBRUTINIB BESYLATE,AVL-292;AVL-292 BESYLATE;BTK INHIBITOR CC-292;CC-292;CC-292 BESYLATE;SPEBRUTINIB;SPEBRUTINIB BESILATE;SPEBRUTINIB BESYLATE,CHEMBL3301600;CHEMBL3301625,BRD:BRD-BRD-K87782578-001-01-4;BRD:BRD-K87782578-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BTK;YES1,,,PHASE 2,,Small molecule,2,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1.O=S(=O)(O)c1ccccc1;COCCOC1CCC(NC2NCC(F)C(NC3CCCC(NC(=O)C=C)C3)N2)CC1,ABSXPNGWJFAPRT-UHFFFAOYSA-N
AVN-492,AVN-492,,BRD:BRD-K00003436-001-01-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,,,,NA,,
AVN944,AVN 944;AVN-944;AVN944,CHEMBL3349001,BRD:BRD-BRD-K62196610-001-01-6;BRD:BRD-K62196610-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,IMPDH1;IMPDH2,,,PHASE 2,,Small molecule,2,CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(-c3cnco3)c(OC)c2)c1;CC[C@H](CC#N)OC(=O)N[C@@H](C)C1CCCC(NC(=O)NC2CCC(-C3CNCO3)C(OC)C2)C1,GYCPCOJTCINIFZ-OXJNMPFZSA-N
PARSOL 1789,AVOBENZONE;BUTYL METHOXYDIBENZOYLMETHANE;ESCALOL 517;EUSOLEX 9020;NEOHELIOPAN 357;NSC-758680;PARSOL 1789,CHEMBL1200522,BRD:BRD-BRD-K14401183-001-10-7;BRD:BRD-K14401183-001-10-7,rep_primary;rep_single_dose,"TOPICAL SUNSCREEN AGENT, UV BLOCKER",TYR,"COSMETIC, SUNSCREEN LOTION",,LAUNCHED,"Multiple values for MOA: {'TOPICAL SUNSCREEN AGENT, UV BLOCKER', 'UV BLOCKER'}, defaulting to 'TOPICAL SUNSCREEN AGENT, UV BLOCKER'",Small molecule,4,"COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1;COC1CCC(CC1)C(=O)CC(=O)C1CCC(CC1)C(C)(C)C, COC1CCC(CC1)C(=O)CC(=O)C1CCC(CC1)C(C)(C)C",XNEFYCZVKIDDMS-UHFFFAOYSA-N
BCX-4161,AVORALSTAT;BCX-4161,CHEMBL4297502,BRD:BRD-K00003224-001-01-9,rep_single_dose,KALLIKREIN INHIBITOR,,,,,,Small molecule,3,C=Cc1cc(C(=O)Nc2ccc(C(=N)N)cc2)c(-c2ccc(C(=O)NCC3CC3)nc2C(=O)O)cc1OC,TUWMKPVJGGWGNL-UHFFFAOYSA-N
AVRAINVILLAMIDE,AVRAINVILLAMIDE,CHEMBL2042025,CTRP:411856,ctrp,,,,,,,Small molecule,NA,CC1(C)C=Cc2c(ccc3c2[N+]([O-])=C2C3=C[C@@]34NC(=O)[C@]5(CCCN5C3=O)C[C@H]4C2(C)C)O1,ALXLLOQTGLPCFG-ATANMQQVSA-N
AX-024,AX-024,,BRD:BRD-K00003479-003-01-9,rep_single_dose,CYTOKINE PRODUCTION INHIBITOR,,,,,,,NA,,
NSC-757441,AG-013736;AG-13736;AXITINIB;INLYTA;NSC-757441,CHEMBL1289926,BRD:BRD-BRD-K29905972-001-06-3;BRD:BRD-K29905972-001-06-3;CTRP:348990;GDSC1:1021;GDSC2:1021,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",CSF1;FLT1;FLT4;KDR;PLK4,RENAL CELL CARCINOMA (RCC),,LAUNCHED,,Small molecule,4,"CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1;CNC(=O)C1CCCCC1SC1CCC2C(\C=C\C3CCCCN3)N[NH]C2C1, CNC(=O)C1CCCCC1SC1CCC2C(\C=C\C3CCCCN3)N[NH]C2C1, CNC(=O)C1CCCCC1SC1CCC2C(\C=C\C3CCCCN3)N[NH]C2C1, CNC(=O)C1CCCCC1SC1CCC2C(\C=C\C3CCCCN3)N[NH]C2C1, CNC(=O)C1CCCCC1SC1CCC2C(\C=C\C3CCCCN3)N[NH]C2C1",RITAVMQDGBJQJZ-FMIVXFBMSA-N
AY-9944,AY-9944,,BRD:BRD-BRD-K77012840-300-01-6;BRD:BRD-K77012840-300-01-6,rep_primary;rep_single_dose,HEDGEHOG PATHWAY MODULATOR,,,,PRECLINICAL,,,NA,CLC1CCCCC1CNC[C@H]1CC[C@H](CNCC2CCCCC2CL)CC1,
BRD-K05804044-001-18-5,AZ 628;AZ-628;BRD-K05804044-001-18-5,,BRD:BRD-BRD-K05804044-001-06-0;BRD:BRD-K05804044-001-06-0;BRD:BRD-K05804044-001-18-5;BRD:BRD-K05804044-001-19-3;GDSC1:29,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF BRAF AND CRAF (RAF1),BRAF;RAF1,,,PRECLINICAL,"Multiple values for MOA: {'INHIBITOR OF BRAF AND CRAF (RAF1)', 'RAF INHIBITOR'}, defaulting to 'INHIBITOR OF BRAF AND CRAF (RAF1)'",,NA,"CC1CCC(NC(=O)C2CCCC(C2)C(C)(C)C#N)CC1NC1CCC2NCN(C)C(=O)C2C1, CC1CCC(NC(=O)C2CCCC(C2)C(C)(C)C#N)CC1NC1CCC2NCN(C)C(=O)C2C1, CC1CCC(NC(=O)C2CCCC(C2)C(C)(C)C#N)CC1NC1CCC2NCN(C)C(=O)C2C1, CC1CCC(NC(=O)C2CCCC(C2)C(C)(C)C#N)CC1NC1CCC2NCN(C)C(=O)C2C1",
AZ-10417808,AZ-10417808,,BRD:BRD-BRD-K36258877-001-03-1;BRD:BRD-K36258877-001-03-1,rep_primary;rep_single_dose,CASPASE INHIBITOR,CASP3,,,PRECLINICAL,,,NA,"[O-][N+](=O)C1CC(C(=O)NCC=C)C2NC(NC3CCC(CL)C(CL)C3)[NH]C(=O)C2C1, [O-][N+](=O)C1CC(C(=O)NCC=C)C2NC(NC3CCC(CL)C(CL)C3)[NH]C(=O)C2C1",
AZ-10606120,AZ-10606120,,BRD:BRD-K09907507-300-02-9,rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX7,,,,,,NA,,
AZ-12080282,AZ-12080282,,BRD:BRD-BRD-K05973499-300-01-0;BRD:BRD-K05973499-300-01-0,rep_primary;rep_single_dose,HEDGEHOG PATHWAY INHIBITOR,DHH,,,PRECLINICAL,,,NA,CC1CCC(CC1NC(=O)C1CCC(OCC2CCCCN2)CC1)-C1NCC[NH]1,
AZ-3146,AZ-3146,,CTRP:660087,ctrp,,,,,,,,NA,,
TBA-7371,AZ-7371;TBA-7371,CHEMBL3109802,BRD:BRD-K14661019-001-02-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,2,COc1ncnc(Cn2cc(C(=O)NCCO)c3ncc(C)cc32)c1C,VDRYGTNDKXIPSK-UHFFFAOYSA-N
AZ-960,AZ 960;AZ-960,,GDSC2:1250,gdsc,,,,,,,,NA,,
AZ191,AZ191,,BRD:BRD-BRD-K80935598-001-01-1;BRD:BRD-K80935598-001-01-1,rep_primary;rep_single_dose,DYRK INHIBITOR,DYRK1B,,,PRECLINICAL,,,NA,"COC1CC(CCC1NC1NCCC(N1)-C1CN(C)C2CNCCC12)N1CCN(C)CC1, COC1CC(CCC1NC1NCCC(N1)-C1CN(C)C2CNCCC12)N1CCN(C)CC1",
AZ20,AZ20,,BRD:BRD-BRD-K42436189-001-01-2;BRD:BRD-K42436189-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,ATR KINASE INHIBITOR,ATR;MTOR,,,PRECLINICAL,,,NA,"C[C@@H]1COCCN1C1CC(NC(N1)-C1CCCC2[NH]CCC12)C1(CC1)S(C)(=O)=O, C[C@@H]1COCCN1C1CC(NC(N1)-C1CCCC2[NH]CCC12)C1(CC1)S(C)(=O)=O",
AZ3146,AZ3146,,BRD:BRD-BRD-K59146805-001-03-7;BRD:BRD-K59146805-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,,,,PRECLINICAL,,,NA,"COC1CC(OC2CCN(C)CC2)CCC1NC1NCC2N(C)C(=O)N(C3CCCC3)C2N1, COC1CC(OC2CCN(C)CC2)CCC1NC1NCC2N(C)C(=O)N(C3CCCC3)C2N1, COC1CC(OC2CCN(C)CC2)CCC1NC1NCC2N(C)C(=O)N(C3CCCC3)C2N1",
AZ505,AZ505,,BRD:BRD-BRD-K76244476-362-02-5;BRD:BRD-K76244476-362-02-5,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,SMYD2,,,PRECLINICAL,,,NA,"OC1CCC(CCNCCN(C2CCCCC2)C(=O)CCNCCC2CCC(CL)C(CL)C2)C2OCC(=O)NC12, OC1CCC(CCNCCN(C2CCCCC2)C(=O)CCNCCC2CCC(CL)C(CL)C2)C2OCC(=O)NC12",
AZ6102,AZ6102,,GDSC2:2109,gdsc,,,,,,,,NA,,
AZ628,AZ628,,GDSC1:29,gdsc,,,,,,,,NA,,
AZ7550,AZ7550,,BRD:BRD-K00003515-003-01-9,rep_single_dose,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,,,,,,,NA,,
AZ960,AZ960,,BRD:BRD-BRD-K64888243-001-03-7;BRD:BRD-K64888243-001-03-7;GDSC2:1250,gdsc;rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,JAK2,,,PRECLINICAL,,,NA,"C[C@H](NC1NC(NC2CC(C)[NH]N2)C(F)CC1C#N)C1CCC(F)CC1, C[C@H](NC1NC(NC2CC(C)[NH]N2)C(F)CC1C#N)C1CCC(F)CC1",
PSYCHOSAN,ATARACTAN;AZACYCLONOL;CALMERAN;FRENOTON;FRENQUEL;GAMMA-PIPRADOL;PSYCHOSAN,CHEMBL127508,BRD:BRD-BRD-K97061094-001-21-4;BRD:BRD-K97061094-001-21-4,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,,,PRECLINICAL,,Small molecule,-1,"OC(c1ccccc1)(c1ccccc1)C1CCNCC1;OC(C1CCNCC1)(C1CCCCC1)C1CCCCC1, OC(C1CCNCC1)(C1CCCCC1)C1CCCCC1",ZMISODWVFHHWNR-UHFFFAOYSA-N
AZAGUANINE-8,AZAGUANINE-8,,BRD:BRD-K53114651-001-12-7,rep_single_dose,PURINE ANTAGONIST,PNP,,,,,,NA,,
AZALOMYCIN-B,AZALOMYCIN-B,,BRD:BRD-BRD-K96104201-001-01-5;BRD:BRD-K96104201-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,,,PRECLINICAL,,,NA,CC[C@@H]1[C@@H](C)O[C@](O)(C[C@H]1O[C@H]1C[C@H](O)[C@H](O)[C@H](C)O1)[C@@H](C)[C@H](O)[C@H](C)[C@@H]1OC(=O)\C=C\C=C\[C@@H](C)[C@H](OC(=O)\C=C\C=C\[C@@H]1C)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O[C@H]2C[C@H](O)[C@H](O)[C@H](C)O2)[C@H](CC)[C@@H](C)O1,
SUICALM,AZAPERONE;AZAPERONE FOR VETERINARY USE;NSC-170976;R 1929;R-1929;STRESNIL;SUICALM,CHEMBL340211,BRD:BRD-BRD-K45861246-001-13-4;BRD:BRD-K45861246-001-13-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3,SEDATIVE,,LAUNCHED,,Small molecule,-1,"FC1CCC(CC1)C(=O)CCCN1CCN(CC1)C1CCCCN1, FC1CCC(CC1)C(=O)CCCN1CCN(CC1)C1CCCCN1, FC1CCC(CC1)C(=O)CCCN1CCN(CC1)C1CCCCN1;O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1",XTKDAFGWCDAMPY-UHFFFAOYSA-N
RHEUMOX 600,AHR-3018;APAZONE;APAZONE DIHYDRATE;AZAPROPAZONE;AZAPROPAZONE DIHYDRATE;CINNOPROPAZONE;MI-85;MI-85DI;NSC-102824;PROLIXAN;RHEUMOX;RHEUMOX 600,CHEMBL1565476,BRD:BRD-A70182876-001-11-9,rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,,,,,Small molecule,4,CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O,MPHPHYZQRGLTBO-UHFFFAOYSA-N
P-165,"AZASERINE;CL 337;CL-337;CN-15,757;CN-15757;DIAZOACETATE (ESTER);L-SERINE;NSC-742;P-165",CHEMBL1095699,BRD:BRD-K47464228-001-14-9,rep_single_dose,PURINE ANTAGONIST,,,,,,Small molecule,-1,[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O,MZZGOOYMKKIOOX-VKHMYHEASA-N
AZASETRON HYDROCHLORIDE,AZASETRON;AZASETRON HYDROCHLORIDE,CHEMBL1598608,BRD:BRD-A44133049-003-07-8;BRD:BRD-BRD-A44133049-003-07-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A;HTR3B,GENITIAL HERPES,,LAUNCHED,,Small molecule,2,CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21;CN1C(=O)COC2C1CC(CL)CC2C(=O)NC1CN2CCC1CC2,WUKZPHOXUVCQOR-UHFFFAOYSA-N
TRINALIN,AZATADINE;OPTIMINE;TRINALIN,CHEMBL946,BRD:BRD-BRD-K77821588-364-01-2;BRD:BRD-K77821588-364-01-2,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,"CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1;CN1CCC(CC1)=C1C2CCCCC2CCC2CCCNC12, CN1CCC(CC1)=C1C2CCCCC2CCC2CCCNC12",SEBMTIQKRHYNIT-UHFFFAOYSA-N
OPRISINE 50,AZAMUNE;AZAPRESS;AZASAN;AZATHIOPRINE;AZATHIOPRINUM;BERKAPRINE;BW-57-322;IMMUNOPRIN 50;IMURAN;KENTAPRINE;NSC-39084;OPRISINE 50,CHEMBL1542,BRD:BRD-BRD-K32821942-001-21-3;BRD:BRD-K32821942-001-21-3,rep_multi_dose;rep_primary;rep_single_dose,DEHYDROGENASE INHIBITOR,HPRT1;IMPDH1;PPAT,"RENAL HOMOTRANSPLANTATION, RHEUMATOID ARTHRITIS",,LAUNCHED,,Small molecule,4,"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12;CN1CNC(C1SC1[NH]CNC2NCNC12)[N+]([O-])=O, CN1CNC(C1SC1[NH]CNC2NCNC12)[N+]([O-])=O, CN1CNC(C1SC1[NH]CNC2NCNC12)[N+]([O-])=O",LMEKQMALGUDUQG-UHFFFAOYSA-N
AZD4017,AZD 4017;AZD-4017;AZD4017,CHEMBL2153191,BRD:BRD-K00074831-001-02-9,rep_single_dose,,,,,,,Small molecule,2,CCCSc1nc(N2CCC[C@@H](CC(=O)O)C2)ccc1C(=O)NC1CCCCC1,NCDZABJPWMBMIQ-INIZCTEOSA-N
AZD-0364,AZD-0364,,BRD:BRD-K00091078-001-01-9,rep_single_dose,,,,,,,,NA,,
OLAPARIB COMPONENT OF KEYLYNK-010,AZ-2281;AZ2281;AZD-2281;AZD2281;KEYLYNK-010 COMPONENT OLAPARIB;KU-0059436;KU-59436;KU0059436;LYNPARZA;MK-7339;NSC-747856;OLAPARIB;OLAPARIB COMPONENT OF KEYLYNK-010,CHEMBL521686,BRD:BRD-BRD-K02113016-001-15-4;BRD:BRD-K02113016-001-02-2;BRD:BRD-K02113016-001-15-4;BRD:BRD-K02113016-001-19-6;CTRP:411867;GDSC1:1017;GDSC1:1495;GDSC2:1017,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF PARP1 AND PARP2,PARP1;PARP2,OVARIAN CANCER,,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF PARP1 AND PARP2', 'PARP INHIBITOR'}, defaulting to 'INHIBITOR OF PARP1 AND PARP2'",Small molecule,4,"FC1CCC(CC2N[NH]C(=O)C3CCCCC23)CC1C(=O)N1CCN(CC1)C(=O)C1CC1, FC1CCC(CC2N[NH]C(=O)C3CCCCC23)CC1C(=O)N1CCN(CC1)C(=O)C1CC1;O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1",FDLYAMZZIXQODN-UHFFFAOYSA-N
AZD6482,AK-55409;AZD 6482;AZD-6482;AZD6482,CHEMBL2165191,GDSC1:1066;GDSC1:156;GDSC2:2169,gdsc,,,,,,,Small molecule,2,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IRTDIKMSKMREGO-OAHLLOKOSA-N
CERALASERTIB,ATR KINASE INHIBITOR AZD6738;AZD 6738;AZD-6738;AZD6738;CERALASERTIB,CHEMBL4285417,GDSC2:1917,gdsc,,,,,,,Small molecule,3,C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2cc[nH]c3nccc2-3)n1,OHUHVTCQTUDPIJ-JYCIKRDWSA-N
AZD7648,AZD-7648;AZD7648,CHEMBL4650446,BRD:BRD-K00091088-001-01-9,rep_single_dose,,,,,,,Unknown,1,,
AZD7762,AZD 7762;AZD-7762;AZD7762,CHEMBL2041933,GDSC1:1022;GDSC2:1022,gdsc,,,,,,,Small molecule,1,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IAYGCINLNONXHY-LBPRGKRZSA-N
AZD8055,AZ-12600000;AZD 8055;AZD-8055;AZD8055,CHEMBL1801204,GDSC1:1059;GDSC2:1059,gdsc,,,,,,,Small molecule,1,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,KVLFRAWTRWDEDF-IRXDYDNUSA-N
AZD8186,AZD 8186;AZD-8186;AZD8186,CHEMBL3408248,GDSC2:1918,gdsc,,,,,,,Small molecule,1,C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12,LMJFJIDLEAWOQJ-CQSZACIVSA-N
AZD0156,AZD 0156;AZD-0156;AZD0156,CHEMBL4297899,BRD:BRD-K69555850-001-02-9,rep_single_dose,ATM KINASE INHIBITOR,,,,,,Unknown,1,,
SARACATINIB,AZ-10353926;AZD-0530;AZD0530;SARACATINIB,CHEMBL217092,GDSC1:38,gdsc,,,,,,,Small molecule,3,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,OUKYUETWWIPKQR-UHFFFAOYSA-N
AZD1080,AZD1080,,BRD:BRD-BRD-K61041538-001-03-0;BRD:BRD-K61041538-001-03-0,rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3A;GSK3B,,,PHASE 1,,,NA,"OC1[NH]C2CCC(CC2C1-C1CCC(CN2CCOCC2)CN1)C#N, OC1[NH]C2CCC(CC2C1-C1CCC(CN2CCOCC2)CN1)C#N, OC1[NH]C2CCC(CC2C1-C1CCC(CN2CCOCC2)CN1)C#N, OC1[NH]C2CCC(CC2C1-C1CCC(CN2CCOCC2)CN1)C#N",
AZD1208,AZD1208,,BRD:BRD-BRD-K21908111-001-01-8;BRD:BRD-K21908111-001-01-8,rep_primary;rep_single_dose,PIM KINASE INHIBITOR,PIM1;PIM2;PIM3,,,PHASE 1,,,NA,N[C@@H]1CCCN(C1)C1C(CCCC1-C1CCCCC1)\C=C1/SC(=O)NC1=O,
AZD1283,AZD1283,,BRD:BRD-BRD-K77060810-001-01-5;BRD:BRD-K77060810-001-01-5,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RY12,,,PRECLINICAL,,,NA,CCOC(=O)C1CC(C#N)C(NC1C)N1CCC(CC1)C(=O)NS(=O)(=O)CC1CCCCC1,
AZD1390,AZD 1390;AZD-1390;AZD1390,CHEMBL4594429,BRD:BRD-K00003509-001-01-9,rep_single_dose,ATM KINASE INHIBITOR,,,,,,Small molecule,1,CC(C)n1c(=O)n(C)c2cnc3cc(F)c(-c4ccc(OCCCN5CCCCC5)nc4)cc3c21,VQSZIPCGAGVRRP-UHFFFAOYSA-N
TC6683 HCL,AZD 1446;AZD-1446;AZD1446;AZD1446 FREE BASE;AZD1446 HCL;TC-6683;TC6683;TC6683 HCL,CHEMBL2179529,BRD:BRD-A44188509-001-01-2;BRD:BRD-BRD-A44188509-001-01-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA4;CHRNB2,,,PHASE 2,,Small molecule,2,CLC1CCC(O1)C(=O)N1CC2CNCC2C1;O=C(c1ccc(Cl)o1)N1CC2CNCC2C1,GTUIQNHJSXQMKW-UHFFFAOYSA-N
AZD1480,AZD 1480;AZD-1480;AZD1480,CHEMBL1231124,BRD:BRD-BRD-K65928735-001-04-3;BRD:BRD-K65928735-001-04-3;CTRP:660306,ctrp;rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2;JAK3,,,PHASE 1,,Small molecule,2,"C[C@H](NC1NCC(CL)C(NC2CC(C)[NH]N2)N1)C1NCC(F)CN1, C[C@H](NC1NCC(CL)C(NC2CC(C)[NH]N2)N1)C1NCC(F)CN1;Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1",PDOQBOJDRPLBQU-QMMMGPOBSA-N
MK1775,ADAVOSERTIB;AZD 1775;AZD-1775;AZD1775;MK-1775;MK1775,CHEMBL1976040,GDSC2:1179,gdsc,,,,,,,Small molecule,2,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,BKWJAKQVGHWELA-UHFFFAOYSA-N
AZD1940,AZD1940,,BRD:BRD-K00075152-001-02-9,rep_single_dose,,,,,,,,NA,,
AZD1981,AZD 1981;AZD-1981;AZD1981,CHEMBL1914489,BRD:BRD-BRD-K83186168-001-01-8;BRD:BRD-K83186168-001-01-8,rep_primary;rep_single_dose,CRTH RECEPTOR ANTAGONIST,PTGDR2,,,PHASE 2,,Small molecule,2,CC(=O)Nc1cccc2c1c(Sc1ccc(Cl)cc1)c(C)n2CC(=O)O;CC(=O)NC1CCCC2N(CC(O)=O)C(C)C(SC3CCC(CL)CC3)C12,JWYIGNODXSRKGP-UHFFFAOYSA-N
VISTUSERTIB,AZD-2014;AZD2014;VISTUSERTIB,CHEMBL2336325,BRD:BRD-BRD-K99113996-001-02-0;BRD:BRD-K99113996-001-02-0;BRD:BRD-K99113996-001-03-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF MTOR,MTOR,,,PHASE 2,"Multiple values for MOA: {'MTOR INHIBITOR', 'INHIBITOR OF MTOR'}, defaulting to 'INHIBITOR OF MTOR'",Small molecule,2,CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1;CNC(=O)C1CCCC(C1)-C1CCC2C(NC(NC2N1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C,JUSFANSTBFGBAF-IRXDYDNUSA-N
AZD2098,AZD2098,,BRD:BRD-K00076909-001-02-9,rep_single_dose,,,,,,,,NA,,
AZD2461,AZD2461,CHEMBL4098253,BRD:BRD-BRD-K85014146-001-02-5;BRD:BRD-K85014146-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,,,,PHASE 1,,Small molecule,1,COC1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1;COC1CCN(CC1)C(=O)C1CC(CC2N[NH]C(=O)C3CCCCC23)CCC1F,HYNBNUYQTQIHJK-UHFFFAOYSA-N
AZD2858,AZD2858,,BRD:BRD-BRD-K85849709-001-01-5;BRD:BRD-K85849709-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3B,,,PRECLINICAL,,,NA,CN1CCN(CC1)S(=O)(=O)C1CCC(CC1)-C1CNC(N)C(N1)C(=O)NC1CCCNC1,
AZD3264,AZD3264,,BRD:BRD-K14287049-001-01-3,rep_single_dose,IKK INHIBITOR,IKBKB,,,,,,NA,,
AZD3463,AZD3463,,BRD:BRD-BRD-K24593301-001-02-3;BRD:BRD-K24593301-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,"ALK TYROSINE KINASE RECEPTOR INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR",ALK;IGF1R,,,PRECLINICAL,,,NA,"COC1CC(CCC1NC1NCC(CL)C(N1)-C1C[NH]C2CCCCC12)N1CCC(N)CC1, COC1CC(CCC1NC1NCC(CL)C(N1)-C1C[NH]C2CCCCC12)N1CCC(N)CC1",
CS-1443,AZD 3514;AZD-3514;AZD3514;CS-1443,CHEMBL2346976,BRD:BRD-BRD-K84996356-001-01-1;BRD:BRD-K84996356-001-01-1,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,,,PHASE 1,,Small molecule,1,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1;CC(=O)N1CCN(CCOC2CCC(CC2)C2CCN(CC2)C2=NN3C(CC2)NNC3C(F)(F)F)CC1,JMEYDSHPKCSIJC-UHFFFAOYSA-N
ZORIFERTINIB,AZD 3759;AZD-3759;AZD3759;ZORIFERTINIB,CHEMBL3623290,BRD:BRD-BRD-K41626799-001-01-1;BRD:BRD-K41626799-001-01-1;GDSC2:1915,gdsc;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PHASE 1,,Small molecule,2,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C;COC1CC2NCNC(NC3CCCC(CL)C3F)C2CC1OC(=O)N1CCN(C)C[C@H]1C,MXDSJQHFFDGFDK-CYBMUJFWSA-N
AZD3839,AZD 3839;AZD-3839;AZD3839,CHEMBL2177913,BRD:BRD-K00004606-001-01-9,rep_single_dose,BETA-SECRETASE INHIBITOR,BACE1,,,,,Small molecule,1,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21,MRXBCEQZNKUUIP-DEOSSOPVSA-N
AZD3965,AZD 3965;AZD-3965;AZD3965,CHEMBL3335793,BRD:BRD-BRD-K25210703-001-01-9;BRD:BRD-K25210703-001-01-9,rep_primary;rep_single_dose,MONOCARBOXYLATE TRANSPORTER INHIBITOR,SLC16A1,,,PHASE 1,,Small molecule,1,CC(C)N1C2SC(CC3C(C)[NH]NC3C(F)(F)F)C(C(=O)N3C[C@](C)(O)CO3)C2C(=O)N(C)C1=O;Cc1[nH]nc(C(F)(F)F)c1Cc1sc2c(c1C(=O)N1C[C@](C)(O)CO1)c(=O)n(C)c(=O)n2C(C)C,PRNXOFBDXNTIFG-FQEVSTJZSA-N
AZD3988,AZD3988,,BRD:BRD-BRD-K73984371-001-01-1;BRD:BRD-K73984371-001-01-1,rep_primary;rep_single_dose,DIACYLGLYCEROL KINASE INHIBITOR,DGAT1,,,PRECLINICAL,,,NA,OC(=O)C[C@H]1CC[C@@H](CC1)C1CCC(NC(=O)C2NNC(NC3CCC(F)C(F)C3)O2)CC1,
AZD4282,AZD4282,,BRD:BRD-BRD-K72369578-001-04-1;BRD:BRD-K72369578-001-04-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,AGXT;AGXT2;ALAS1;ALAS2;BAAT;GARS;GATM;GCAT;GCSH;GLDC;GLRA1;GLRA2;GLRA3;GLRB;GLYAT;GLYATL1;GLYATL2;GNMT;GPR18;GPRC6A;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3B;GSS;PIPOX;SHMT1;SHMT2;SLC32A1;SLC36A1;SLC6A5;SLC6A9,,,PHASE 1,,,NA,NCC(O)=O,
KB-74810,ABSK-091;ABSK091;AZD 4547;AZD-4547;AZD4547;KB-74810,CHEMBL3184679,BRD:BRD-BRD-K28392481-001-05-1;BRD:BRD-K28392481-001-05-1;CTRP:660325;GDSC2:1786,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,FGFR INHIBITOR,FGFR1;FGFR2;FGFR3;FGFR4;IGF1R;KDR,,,PHASE 2/PHASE 3,,Small molecule,2,COC1CC(CCC2CC(NC(=O)C3CCC(CC3)N3C[C@H](C)N[C@H](C)C3)N[NH]2)CC(OC)C1;COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1,VRQMAABPASPXMW-UHFFFAOYSA-N
AZD4573,AZD 4573;AZD-4573;AZD4573,CHEMBL4462530,BRD:BRD-K00003106-001-01-9,rep_single_dose,CDK9 INHIBITOR,,,,,,Small molecule,2,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1,AVIWDYSJSPOOAR-LSDHHAIUSA-N
IMARADENANT,AZD 4635;AZD-4635;AZD4635;HTL-1071;HTL1071;IMARADENANT,CHEMBL4594442,BRD:BRD-K00003443-001-01-9,rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,Cc1cc(-c2nnc(N)nc2-c2ccc(F)cc2)cc(Cl)n1,NCWQLHHDGDXIJN-UHFFFAOYSA-N
AZD5069,AZD5069,,BRD:BRD-BRD-K34801930-001-01-9;BRD:BRD-K00003297-001-01-9,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR2,,,PHASE 2,,,NA,C[C@H](NC1CC(NS(=O)(=O)N2CCC2)NC(SCC2CCCC(F)C2F)N1)[C@@H](O)CO,
AZD5153,AZD 5153;AZD-5153;AZD5153,CHEMBL4078100,BRD:BRD-K00003528-457-01-9,rep_single_dose,BROMODOMAIN INHIBITOR,,,,,,Small molecule,1,COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12,RSMYFSPOTCDHHJ-GOSISDBHSA-N
SARUPARIB,AZD 5305;AZD-5305;AZD5305;SARUPARIB,CHEMBL5095220,BRD:BRD-K00126470-001-01-9,oncref_2,INHIBITOR OF PARP1,PARP1;PARP2,,,,,Small molecule,2,CCc1cc2ncc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,WQAVGRAETZEADU-UHFFFAOYSA-N
CAPIVASERTIB,AZC5363;AZD 5363;AZD-5363;AZD5363;CAPIVASERTIB,CHEMBL2325741,BRD:BRD-BRD-K99023089-001-03-7;BRD:BRD-K99023089-001-03-7;BRD:BRD-K99023089-001-06-9;GDSC2:1916,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"INHIBITOR OF AKT1, AKT2, AND AKT3",AKT1;AKT2;AKT3,,,PHASE 2,"Multiple values for MOA: {'AKT INHIBITOR', 'INHIBITOR OF AKT1, AKT2, AND AKT3'}, defaulting to 'INHIBITOR OF AKT1, AKT2, AND AKT3'",Small molecule,3,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2nc[nH]c3nccc2-3)CC1;NC1(CCN(CC1)C1NCNC2[NH]CCC12)C(=O)N[C@@H](CCO)C1CCC(CL)CC1,JDUBGYFRJFOXQC-KRWDZBQOSA-N
AZD5423,AZD 5423;AZD-5423;AZD5423,CHEMBL4072756,BRD:BRD-K00076418-001-02-9,rep_single_dose,,,,,,,Small molecule,2,COc1cccc([C@@H](Oc2ccc3c(cnn3-c3ccc(F)cc3)c2)[C@H](C)NC(=O)C(F)(F)F)c1,FCNQMDSJHADDFT-WNSKOXEYSA-N
AZD5438,AZD5438,,BRD:BRD-BRD-K72414522-001-06-7;BRD:BRD-K72414522-001-06-7,rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,KCNH2,,,PHASE 1,,,NA,"CC(C)N1C(C)NCC1-C1CCNC(NC2CCC(CC2)S(C)(=O)=O)N1, CC(C)N1C(C)NCC1-C1CCNC(NC2CCC(CC2)S(C)(=O)=O)N1, CC(C)N1C(C)NCC1-C1CCNC(NC2CCC(CC2)S(C)(=O)=O)N1",
AZD5582,AZD5582,,BRD:BRD-K88767641-001-01-7;GDSC2:1617,gdsc;rep_single_dose,XIAP INHIBITOR,BIRC2;BIRC3;XIAP,,,,,,NA,,
AZD5991,AZD 5991;AZD-5991;AZD5991,CHEMBL4297482,BRD:BRD-K00005264-001-01-9;BRD:BRD-K00005264-001-02-9,oncref_1;rep_single_dose,INHIBITOR OF MCL1,MCL1,,,,"Multiple values for MOA: {'INHIBITOR OF MCL1', 'MCL1 INHIBITOR'}, defaulting to 'INHIBITOR OF MCL1'",Small molecule,1,Cc1c2c(nn1C)CSCc1cc(n(C)n1)CSc1cc(c3ccccc3c1)OCCCc1c(C(=O)O)n(C)c3c-2c(Cl)ccc13,KBQCEQAXHPIRTF-UHFFFAOYSA-N
VOLITINIB,AZD 6094;AZD-6094;AZD6094;HMPL-504;SAVOLITINIB;VOLITINIB,CHEMBL3334567,GDSC2:1936,gdsc,,,,,,,Small molecule,3,C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21,XYDNMOZJKOGZLS-NSHDSACASA-N
SELUMETINIB,ARRY-142886;ARRY-886;AZD-6244;AZD6244;SELUMETINIB,CHEMBL1614701,GDSC1:1062;GDSC1:1498,gdsc,,,,,,,Small molecule,4,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,CYOHGALHFOKKQC-UHFFFAOYSA-N
AZD6482,AZD 6482;AZD-6482;AZD6482,CHEMBL2165191,BRD:BRD-BRD-K58772419-001-07-0;BRD:BRD-K58772419-001-07-0;CTRP:639390;GDSC1:1066;GDSC1:156;GDSC2:2169,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PHASE 1,,Small molecule,2,"C[C@@H](NC1CCCCC1C(O)=O)C1CC(C)CN2C1NC(CC2=O)N1CCOCC1, C[C@@H](NC1CCCCC1C(O)=O)C1CC(C)CN2C1NC(CC2=O)N1CCOCC1;Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1",IRTDIKMSKMREGO-OAHLLOKOSA-N
CERALASERTIB,ATR KINASE INHIBITOR AZD6738;AZD 6738;AZD-6738;AZD6738;CERALASERTIB,CHEMBL4285417,BRD:BRD-A36013532-001-01-3;BRD:BRD-BRD-A36013532-001-01-3;GDSC2:1917,gdsc;oncref_1;rep_primary;rep_single_dose,INHIBITOR OF ATR KINASE,ATR,,,PHASE 1/PHASE 2,"Multiple values for MOA: {'ATR KINASE INHIBITOR', 'INHIBITOR OF ATR KINASE'}, defaulting to 'INHIBITOR OF ATR KINASE'",Small molecule,3,C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2cc[nH]c3nccc2-3)n1;C[C@@H]1COCCN1C1CC(NC(N1)-C1CCNC2[NH]CCC12)C1(CC1)S(C)(=N)=O,OHUHVTCQTUDPIJ-JYCIKRDWSA-N
LANICEMINE,AR-R15896AR;AZD-6765;AZD6765;LANICEMINE,CHEMBL467084,BRD:BRD-A94033181-001-01-4;BRD:BRD-BRD-A94033181-001-01-4,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1,,,PHASE 2,,Small molecule,2,N[C@@H](Cc1ccccn1)c1ccccc1;NC(CC1CCCCN1)C1CCCCC1,FWUQWDCOOWEXRY-ZDUSSCGKSA-N
AZD7545,AZD7545,,BRD:BRD-A87435144-001-01-6;BRD:BRD-BRD-A87435144-001-01-6;CTRP:411814,ctrp;rep_primary;rep_single_dose,PYRUVATE DEHYDROGENASE KINASE INHIBITOR,PDK1,,,PHASE 1,,,NA,CN(C)C(=O)C1CCC(CC1)S(=O)(=O)C1CCC(NC(=O)C(C)(O)C(F)(F)F)C(CL)C1,
VELSECORAT,AZD 7594;AZD-7594;AZD7594;VELSECORAT,CHEMBL3666807,BRD:BRD-K00003100-001-01-9,rep_single_dose,GLUCOCORTICOID RECEPTOR MODULATOR,,,,,,Small molecule,2,C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2,ZZWJKLGCDHYVMB-BWGXUDETSA-N
AZD7687,AZD 7687;AZD-7687;AZD7687,CHEMBL4297354,BRD:BRD-BRD-K31495718-001-01-1;BRD:BRD-K31495718-001-01-1,rep_primary;rep_single_dose,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,DGAT1,,,PHASE 1,,Small molecule,1,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O;CC1NC(C)C(NC1C(N)=O)-C1CCC(CC1)[C@H]1CC[C@H](CC(O)=O)CC1,YXFNPRHZMOGREC-UHFFFAOYSA-N
AZD7762,AZD 7762;AZD-7762;AZD7762,CHEMBL2041933,BRD:BRD-BRD-K86525559-001-04-5;BRD:BRD-BRD-K86525559-001-07-8;BRD:BRD-K86525559-001-04-5;BRD:BRD-K86525559-001-07-8;BRD:BRD-K86525559-003-11-9;CTRP:660777;GDSC1:1022;GDSC2:1022,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF CHEK1,CHEK1;CHEK2,,,PHASE 1,"Multiple values for MOA: {'INHIBITOR OF CHEK1', 'CHK INHIBITOR'}, defaulting to 'INHIBITOR OF CHEK1'
Multiple values for repurposing_target: {'CHEK1;CHEK2', 'CHEK1'}, taking the union",Small molecule,1,"NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1;NC(=O)NC1CC(SC1C(=O)N[C@H]1CCCNC1)-C1CCCC(F)C1, NC(=O)NC1CC(SC1C(=O)N[C@H]1CCCNC1)-C1CCCC(F)C1, NC(=O)NC1CC(SC1C(=O)N[C@H]1CCCNC1)-C1CCCC(F)C1",IAYGCINLNONXHY-LBPRGKRZSA-N
INS1007,AZD 7986;AZD-7986;AZD7986;BRENSOCATIB;INS-1007;INS1007,CHEMBL3900409,BRD:BRD-K00003398-001-01-9,rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,,,,,,Small molecule,3,Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21,AEXFXNFMSAAELR-RXVVDRJESA-N
AZD8055,AZ-12600000;AZD 8055;AZD-8055;AZD8055,CHEMBL1801204,BRD:BRD-BRD-K69932463-001-10-6;BRD:BRD-K69932463-001-10-6;CTRP:609639;GDSC1:1059;GDSC2:1059,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PHASE 1,,Small molecule,1,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO;COC1CCC(CC1CO)-C1CCC2C(NC(NC2N1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C,KVLFRAWTRWDEDF-IRXDYDNUSA-N
AZD8186,AZD 8186;AZD-8186;AZD8186,CHEMBL3408248,BRD:BRD-BRD-K47289408-001-01-5;BRD:BRD-K47289408-001-01-5;GDSC2:1918,gdsc;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CB;PIK3CD,,,PHASE 1,,Small molecule,1,"C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12;C[C@@H](NC1CC(F)CC(F)C1)C1CC(CC2C1OC(CC2=O)N1CCOCC1)C(=O)N(C)C, C[C@@H](NC1CC(F)CC(F)C1)C1CC(CC2C1OC(CC2=O)N1CCOCC1)C(=O)N(C)C",LMJFJIDLEAWOQJ-CQSZACIVSA-N
AZD8329,AZD8329,,BRD:BRD-K00091077-001-01-9,rep_single_dose,,,,,,,,NA,,
AZD8330,ARRY-424704;ARRY-704;AZD 8330;AZD-8330;AZD8330,CHEMBL3182621,BRD:BRD-BRD-K37687095-001-06-9;BRD:BRD-K37687095-001-06-9,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP3K1,,,PHASE 1,,Small molecule,1,"Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O;CC1CC(C(=O)NOCCO)C(NC2CCC(I)CC2F)N(C)C1=O, CC1CC(C(=O)NOCCO)C(NC2CCC(I)CC2F)N(C)C1=O",RWEVIPRMPFNTLO-UHFFFAOYSA-N
AZD8797,AZD8797,,BRD:BRD-K03336321-001-02-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,,,,NA,,
AZD8835,AZD 8835;AZD-8835;AZD8835,CHEMBL3894518,BRD:BRD-BRD-K82894950-001-01-0;BRD:BRD-K82894950-001-01-0,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CD,,,PHASE 1,,Small molecule,1,CCn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1;CCN1NC(NC1-C1CNC(N)C(N1)-C1NNC(O1)C(C)(C)C)C1CCN(CC1)C(=O)CCO,ZGRDYKFVDCFJCZ-UHFFFAOYSA-N
SAPITINIB,AZD-8931;AZD8931;SAPITINIB,CHEMBL2408045,BRD:BRD-BRD-K98572433-001-02-9;BRD:BRD-K98572433-001-02-9;GDSC2:1549,gdsc;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2;ERBB3,,,PHASE 2,,Small molecule,2,CNC(=O)CN1CCC(CC1)OC1CC2C(NC3CCCC(CL)C3F)NCNC2CC1OC;CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,DFJSJLGUIXFDJP-UHFFFAOYSA-N
AZD9056,AZD 9056;AZD-9056;AZD9056,CHEMBL3545108,BRD:BRD-K13699028-003-02-9,rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,,,,,,Small molecule,2,O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CCCNCCCO)ccc1Cl,HSQAARMBHJCUOK-UHFFFAOYSA-N
AZD9272,AZD9272,,BRD:BRD-BRD-K61043483-001-01-5;BRD:BRD-K61043483-001-01-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM5,,,PRECLINICAL,,,NA,FC1CCC(NC1)-C1NOC(N1)-C1CC(F)CC(C1)C#N,
AZD9496,AZD 9496;AZD-9496;AZD9496,CHEMBL3623004,BRD:BRD-BRD-K73235735-001-02-7;BRD:BRD-K73235735-001-02-7,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1,,,PHASE 1,,Small molecule,1,"C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F;C[C@@H]1CC2C([NH]C3CCCCC23)[C@H](N1CC(C)(C)F)C1C(F)CC(\C=C\C(O)=O)CC1F, C[C@@H]1CC2C([NH]C3CCCCC23)[C@H](N1CC(C)(C)F)C1C(F)CC(\C=C\C(O)=O)CC1F",DFBDRVGWBHBJNR-BBNFHIFMSA-N
MPH966,ALVELESTAT;AZD-9668;AZD9668;MPH-966;MPH966,CHEMBL3617964,BRD:BRD-BRD-K31476763-001-01-5;BRD:BRD-K31476763-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,ELASTASE INHIBITOR,ELANE,,,PHASE 2,,Small molecule,2,Cc1c(-c2ccnn2C)cc(C(=O)NCc2ccc(S(C)(=O)=O)cn2)c(=O)n1-c1cccc(C(F)(F)F)c1;CC1C(CC(C(=O)NCC2CCC(CN2)S(C)(=O)=O)C(=O)N1-C1CCCC(C1)C(F)(F)F)-C1CCNN1C,QNQZWEGMKJBHEM-UHFFFAOYSA-N
AZELAIC-ACID,AZELAIC-ACID,,BRD:BRD-BRD-K08976401-001-18-5;BRD:BRD-K08976401-001-18-5,rep_primary;rep_single_dose,TYROSINASE INHIBITOR,AKR1D1;SRD5A2;TYR,ROSACEA,,LAUNCHED,,,NA,OC(=O)CCCCCCCC(O)=O,
NSC-758971,AZELASTINE;NSC-758971,CHEMBL639,BRD:BRD-A68888262-003-15-1;BRD:BRD-BRD-A68888262-003-15-1,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,"CN1CCCC(CC1)N1NC(CC2CCC(CL)CC2)C2CCCCC2C1=O, CN1CCCC(CC1)N1NC(CC2CCC(CL)CC2)C2CCCCC2C1=O;CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1",MBUVEWMHONZEQD-UHFFFAOYSA-N
TTP488,AZELIRAGON;PF-04494700;TTP-488;TTP448;TTP488,CHEMBL3989929,BRD:BRD-BRD-K51899933-001-02-6;BRD:BRD-K51899933-001-02-6,rep_primary;rep_single_dose,RAGE RECEPTOR ANTAGONIST,AGER,,,PHASE 3,,Small molecule,3,CCCCc1nc(-c2ccc(OCCCN(CC)CC)cc2)cn1-c1ccc(Oc2ccc(Cl)cc2)cc1;CCCCC1NC(CN1-C1CCC(OC2CCC(CL)CC2)CC1)-C1CCC(OCCCN(CC)CC)CC1,KJNNWYBAOPXVJY-UHFFFAOYSA-N
CALBLOCK,AZELNIDIPINE;CALBLOCK,CHEMBL1275868,BRD:BRD-A01098288-001-02-9;BRD:BRD-BRD-A01098288-001-02-9,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C,HYPERTENSION,,LAUNCHED,,Small molecule,3,"CC(C)OC(=O)C1=C(C)NC(N)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC1CN(C1)C(C1CCCCC1)C1CCCCC1, CC(C)OC(=O)C1=C(C)NC(N)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC1CN(C1)C(C1CCCCC1)C1CCCCC1, CC(C)OC(=O)C1=C(C)NC(N)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC1CN(C1)C(C1CCCCC1)C1CCCCC1;CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1",ZKFQEACEUNWPMT-UHFFFAOYSA-N
TAK-536,AZILSARTAN;TAK-536,CHEMBL57242,BRD:BRD-BRD-K81074237-001-02-3;BRD:BRD-K81074237-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1;AGTR2,HYPERTENSION,,LAUNCHED,,Small molecule,3,"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1;CCOC1NC2CCCC(C(O)=O)C2N1CC1CCC(CC1)-C1CCCCC1-C1NC(=O)O[NH]1, CCOC1NC2CCCC(C(O)=O)C2N1CC1CCC(CC1)-C1CCCCC1-C1NC(=O)O[NH]1",KGSXMPPBFPAXLY-UHFFFAOYSA-N
AZILSARTAN-MEDOXOMIL,AZILSARTAN-MEDOXOMIL,,BRD:BRD-BRD-K25723200-001-02-7;BRD:BRD-K25723200-001-02-7,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1;AGTR2,HYPERTENSION,,LAUNCHED,,,NA,"CCOC1NC2CCCC(C(=O)OCC3OC(=O)OC3C)C2N1CC1CCC(CC1)-C1CCCCC1-C1NC(=O)O[NH]1, CCOC1NC2CCCC(C(=O)OCC3OC(=O)OC3C)C2N1CC1CCC(CC1)-C1CCCCC1-C1NC(=O)O[NH]1, CCOC1NC2CCCC(C(=O)OCC3OC(=O)OC3C)C2N1CC1CCC(CC1)-C1CCCCC1-C1NC(=O)O[NH]1",
AZIMILIDE,AZIMILIDE,CHEMBL123558,BRD:BRD-BRD-K38913877-300-01-9;BRD:BRD-K38913877-300-01-9,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNA5;KCNE1;KCNH2;KCNQ1,,,PHASE 3,,Small molecule,3,CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1;CN1CCN(CCCCN2C(=O)CN(\N=C\C3CCC(O3)-C3CCC(CL)CC3)C2=O)CC1,MREBEPTUUMTTIA-PCLIKHOPSA-N
ZYTHROMAX,"ANHYDROUS AZITHROMYCIN;ARUZILINA;AZASITE;AZIROMYCIN;AZITHROCIN;AZITHROMYCIN;AZITHROMYCIN (AS DIHYDRATE);AZITHROMYCIN ANHYDROUS;AZITHROMYCIN DIHYDRATE;AZITHROMYCIN HYDRATE;AZIWIN;AZYTER;CLAMELLE;CP 62993;CP-62,993;CP-62993;DURASITE;HEMOMYCIN;MACROZIT;NSC-758625;SUMAMED;SUNAMED;TROZOCINA;UNSPECIFIED;UNSPECIFIED FORM;XITHRONE;XZ 405;XZ 450;XZ-450;ZITHROMAC;ZITHROMAX;ZMAX;ZYTHROMAX",CHEMBL529,BRD:BRD-BRD-K74501079-001-18-1;BRD:BRD-K74501079-001-18-1,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,MLNR,"PELVIC INFLAMMATORY DISEASE, PNEUMONIA",,LAUNCHED,,Small molecule,4,"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O;CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O",MQTOSJVFKKJCRP-BICOPXKESA-N
NSC-758227,AZLIN;AZLOCILLIN;J01CA09;NSC-758227,CHEMBL1537,BRD:BRD-A46717658-236-02-5;BRD:BRD-BRD-A46717658-236-02-5,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"GRAM-POSITIVE BACTERIAL INFECTIONS, GRAM-NEGATIVE BACTERIAL INFECTIONS",,LAUNCHED,,Small molecule,4,"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O;CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)SC2C(NC(=O)[C@H](NC(=O)N3CCNC3=O)C3CCCCC3)C(=O)N2C1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)C3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)C3CCCCC3)C(=O)N2[C@H]1C(O)=O",JTWOMNBEOCYFNV-NFFDBFGFSA-N
M-475271,AZM 475271;AZM-475271;M-475271,CHEMBL3545150,BRD:BRD-K51329597-001-02-9,rep_single_dose,SRC INHIBITOR,SRC,,,,,Small molecule,2,,
AZODICARBONAMIDE,AZODICARBONAMIDE,,BRD:BRD-BRD-K87036601-001-01-6;BRD:BRD-K87036601-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,,,PHASE 2,,,NA,"NC(=O)\N=N\C(N)=O, NC(=O)\N=N\C(N)=O",
AZOMYCIN-(2-NITROIMIDAZOLE),AZOMYCIN-(2-NITROIMIDAZOLE),,BRD:BRD-BRD-K26824830-001-02-0;BRD:BRD-K26824830-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,,,PRECLINICAL,,,NA,"[O-][N+](=O)C1NCC[NH]1, [O-][N+](=O)C1NCC[NH]1",
LURET,AZOSEMID;AZOSEMIDE;DIART;LURET,CHEMBL1097235,BRD:BRD-BRD-K68770713-001-01-8;BRD:BRD-K68770713-001-01-8,rep_primary;rep_single_dose,ELECTROLYTE REABSORPTION INHIBITOR,SLC12A1;SLC12A2,EDEMA,,LAUNCHED,,Small molecule,3,NS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2cccs2)cc1Cl;NS(=O)(=O)C1CC(-C2NNN[NH]2)C(NCC2CCCS2)CC1CL,HMEDEBAJARCKCT-UHFFFAOYSA-N
SQ-26776,AZACTAM;AZONAM;AZTREON;AZTREONAM;CAYSTON;NEBACTAM;NSC-646279;NSC-758913;PRIMBACTAM;SO 26776;SQ 26776;SQ-26776,CHEMBL158,BRD:BRD-BRD-K62607865-001-09-7;BRD:BRD-K62607865-001-09-7,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"URINARY TRACT INFECTIONS, RESPIRATORY TRACT INFECTIONS, BACTERIAL SEPTICEMIA, SKIN INFECTIONS, INTRA-ABDOMINAL INFECTIONS, GYNECOLOGIC INFECTIONS",,LAUNCHED,,Small molecule,4,"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O;C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C2CSC(N)N2)C(=O)N1S(O)(=O)=O, C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C2CSC(N)N2)C(=O)N1S(O)(=O)=O, C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C2CSC(N)N2)C(=O)N1S(O)(=O)=O",WZPBZJONDBGPKJ-VEHQQRBSSA-N
B02,B02,,CTRP:122255,ctrp,,,,,,,,NA,,
PENGLOBE,BACAMPICILLIN;PENGLOBE,CHEMBL1583,BRD:BRD-A41698174-003-12-0;BRD:BRD-BRD-A41698174-003-12-0,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"GRAM-POSITIVE BACTERIAL INFECTIONS, GRAM-NEGATIVE BACTERIAL INFECTIONS",,LAUNCHED,,Small molecule,4,"CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)C1CCCCC1)C2=O, CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)C1CCCCC1)C2=O, CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)C1CCCCC1)C2=O;CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C",PFOLLRNADZZWEX-FFGRCDKISA-N
BADGE,BADGE,,BRD:BRD-A16694057-001-06-8;BRD:BRD-BRD-A16694057-001-06-8,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PPARG,,,PRECLINICAL,,,NA,CC(C)(C1CCC(OCC2CO2)CC1)C1CCC(OCC2CO2)CC1,
NS-187,BAFETINIB;CNS-9;INNO-406;NS-187,CHEMBL206834,BRD:BRD-A75975749-001-01-4;BRD:BRD-BRD-A75975749-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,"BCR-ABL KINASE INHIBITOR, LYN TYROSINE KINASE INHIBITOR",ABL1;BCR;LYN,,,PHASE 2,,Small molecule,2,Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1;CN(C)C1CCN(CC2CCC(CC2C(F)(F)F)C(=O)NC2CCC(C)C(NC3NCC(CN3)-C3CNCNC3)C2)C1,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N
BAFILOMYCIN A1,BAFILOMYCIN A1,CHEMBL290814,CTRP:467037,ctrp,,,,,,,Small molecule,NA,CO/C1=C\C(C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O,XDHNQDDQEHDUTM-JQWOJBOSSA-N
BAFILOMYCIN-A1,BAFILOMYCIN-A1,,BRD:BRD-K00010387-001-01-9,rep_single_dose,ATPASE INHIBITOR,,,,,,,NA,,
BAG-956,BAG-956,,BRD:BRD-BRD-K00652956-001-01-5;BRD:BRD-K00652956-001-01-5,rep_primary;rep_single_dose,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,PIK3CG,,,PRECLINICAL,,,NA,CC1NC2CNC3CCC(CC3C2N1-C1CCC(CC1)C(C)(C)C#N)C#CC1CCCNC1,
NSC-661431,BAICALEIN;NOROXYLIN;NSC-661431,CHEMBL8260,BRD:BRD-BRD-K72327355-001-14-7;BRD:BRD-K72327355-001-14-7,rep_multi_dose;rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX5;GLO1;PREP;SELL;SELP;TNF;XDH,,,PRECLINICAL,,Small molecule,2,"O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12;OC1CC2OC(CC(=O)C2C(O)C1O)-C1CCCCC1, OC1CC2OC(CC(=O)C2C(O)C1O)-C1CCCCC1, OC1CC2OC(CC(=O)C2C(O)C1O)-C1CCCCC1",FXNFHKRTJBSTCS-UHFFFAOYSA-N
BAICALIN,BAICALIN,CHEMBL485818,BRD:BRD-BRD-K49962337-001-01-1;BRD:BRD-BRD-K49962337-001-02-9;BRD:BRD-K49962337-001-01-1;BRD:BRD-K49962337-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,BETA GLUCURONIDASE INHIBITOR,PREP,,,LAUNCHED,,Small molecule,NA,"O[C@H]1[C@H](OC2CC3OC(CC(=O)C3C(O)C2O)-C2CCCCC2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O, O[C@H]1[C@H](OC2CC3OC(CC(=O)C3C(O)C2O)-C2CCCCC2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O;O=C(O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O",IKIIZLYTISPENI-ZFORQUDYSA-N
UP-256,(S)-BAKUCHIOL;BAKUCHIOL;SYTENOL A;UP 256;UP-256,CHEMBL262344,BRD:BRD-BRD-K09785578-001-01-2;BRD:BRD-K09785578-001-01-2,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,HIF1A,,,PHASE 2,,Small molecule,1,"C=C[C@@](C)(/C=C/c1ccc(O)cc1)CCC=C(C)C;CC(C)=CCC[C@@](C)(C=C)\C=C\C1CCC(O)CC1, CC(C)=CCC[C@@](C)(C=C)\C=C\C1CCC(O)CC1",LFYJSSARVMHQJB-QIXNEVBVSA-N
NN-2344,BALAGLITAZONE;DRF-2593;NN-2344,CHEMBL2103991,BRD:BRD-A00147595-001-01-5;BRD:BRD-BRD-A00147595-001-01-5,rep_primary;rep_single_dose,"INSULIN SENSITIZER, PPAR RECEPTOR PARTIAL AGONIST",PPARG,,,PHASE 3,,Small molecule,3,Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O;CN1C(COC2CCC(CC3SC(=O)NC3=O)CC2)NC2CCCCC2C1=O,IETKPTYAGKZLKY-UHFFFAOYSA-N
RO4588161,BALAPIRAVIR;RO-4588161;RO4588161,CHEMBL550936,BRD:BRD-BRD-K47976015-001-01-2;BRD:BRD-K47976015-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,,,PHASE 2,,Small molecule,2,CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)N1CCC(N)NC1=O)N=[N+]=[N-];CC(C)C(=O)OC[C@@]1(N=[N+]=[N-])O[C@@H](n2ccc(N)nc2=O)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C,VKXWOLCNTHXCLF-DXEZIKHYSA-N
BALICATIB,AAE-581;AAE581;BALICATIB,CHEMBL371064,BRD:BRD-BRD-K27204852-001-01-9;BRD:BRD-K27204852-001-01-9,rep_primary;rep_single_dose,CATHEPSIN INHIBITOR,CTSK,,,PHASE 2,,Small molecule,2,"CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1;CCCN1CCN(CC1)C1CCC(CC1)C(=O)NC1(CCCCC1)C(=O)NCC#N, CCCN1CCN(CC1)C1CCC(CC1)C(=O)NC1(CCCCC1)C(=O)NCC#N",LLCRBOWRJOUJAE-UHFFFAOYSA-N
BALOFLOXACIN,BALOFLOXACIN,CHEMBL1210954,BRD:BRD-A47790386-001-03-6;BRD:BRD-BRD-A47790386-001-03-6,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,-1,"CNC1CCCN(C1)C1C(F)CC2C(C1OC)N(CC(C(O)=O)C2=O)C1CC1, CNC1CCCN(C1)C1C(F)CC2C(C1OC)N(CC(C(O)=O)C2=O)C1CC1;CNC1CCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2OC)C1",MGQLHRYJBWGORO-UHFFFAOYSA-N
RO5285119,BALOVAPTAN;RG-7314;RG7314;RO-5285119;RO5285119,CHEMBL4297183,BRD:BRD-K00091279-001-01-9,rep_single_dose,,,,,,,Small molecule,3,CN1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1,GMPZPHGHNDMRKL-RZDIXWSQSA-N
S-033447,BALOXAVIR;S-033447,CHEMBL4297215,BRD:BRD-K00003496-001-01-9,rep_single_dose,ENDONUCLEASE INHIBITOR,,,,,,Small molecule,2,O=C1c2c(O)c(=O)ccn2N([C@@H]2c3ccccc3SCc3c2ccc(F)c3F)[C@@H]2COCCN12,FIDLLEYNNRGVFR-CTNGQTDRSA-N
BALOXAVIR-MARBOXIL,BALOXAVIR-MARBOXIL,,BRD:BRD-K00003495-001-01-9,rep_single_dose,ENDONUCLEASE INHIBITOR,,,,,,,NA,,
BALSALAZIDE,BALSALAZIDE,CHEMBL1201346,BRD:BRD-BRD-K41410256-304-02-2;BRD:BRD-K41410256-304-02-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,ALOX5;PPARG;PTGS1;PTGS2,ULCERATIVE COLITIS,,LAUNCHED,,Small molecule,4,O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1;OC(=O)CCNC(=O)C1CCC(CC1)N=NC1CCC(O)C(C1)C(O)=O,IPOKCKJONYRRHP-FMQUCBEESA-N
BAM7,BAM7,,BRD:BRD-BRD-K07442505-001-03-6;BRD:BRD-K07442505-001-03-6;GDSC1:552,gdsc;rep_multi_dose;rep_primary;rep_single_dose,BAX ACTIVATOR,BAX,,,PRECLINICAL,,,NA,CCOC1CCCCC1N\N=C1C(=O)N(N=C\1C)C1NC(CS1)-C1CCCCC1,
BAMAQUIMAST,BAMAQUIMAST,CHEMBL2105906,BRD:BRD-K00003411-001-01-9,rep_single_dose,PROTON PUMP INHIBITOR,,,,,,Small molecule,-1,CCCn1c(=O)c(CCCOC(=O)NC)nc2ccccc21,HNQSZPBGDAJIJO-UHFFFAOYSA-N
BAMBUTEROL,BAMBUTEROL,CHEMBL521589,BRD:BRD-A17462676-003-11-6;BRD:BRD-BRD-A17462676-003-11-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2;BCHE,ASTHMA,,LAUNCHED,,Small molecule,3,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1;CN(C)C(=O)OC1CC(OC(=O)N(C)C)CC(C1)C(O)CNC(C)(C)C,ANZXOIAKUNOVQU-UHFFFAOYSA-N
BAN-ORL-24,BAN-ORL-24,,BRD:BRD-BRD-K47049295-300-01-5;BRD:BRD-K47049295-300-01-5,rep_multi_dose;rep_primary;rep_single_dose,NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST,OPRL1,,,PRECLINICAL,,,NA,"O=C(NCCCN1CCC2(CC1)OCC1CCCCC21)[C@H]1CCCN1CC1CCCCC1, O=C(NCCCN1CCC2(CC1)OCC1CCCCC21)[C@H]1CCCN1CC1CCCCC1, O=C(NCCCN1CCC2(CC1)OCC1CCCCC21)[C@H]1CCCN1CC1CCCCC1",
BANOXANTRONE,AQ-4N;BANOXANTRONE,CHEMBL117391,BRD:BRD-K00003159-300-01-9,rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A,,,,,Small molecule,-1,C[N+](C)([O-])CCNc1ccc(NCC[N+](C)(C)[O-])c2c1C(=O)c1c(O)ccc(O)c1C2=O,YZBAXVICWUUHGG-UHFFFAOYSA-N
BARASERTIB (WHO-DD),AZD 1152;AZD-1152;AZD1152;BARASERTIB;BARASERTIB (WHO-DD),CHEMBL415049,BRD:BRD-BRD-K31928526-001-02-1;BRD:BRD-K31928526-001-02-1;CTRP:601923,ctrp;rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB,,,PHASE 2/PHASE 3,,Small molecule,3,CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O;CCN(CCCOC1CCC2C(NC3CC(CC(=O)NC4CCCC(F)C4)[NH]N3)NCNC2C1)CCOP(O)(O)=O,GBJVVSCPOBPEIT-UHFFFAOYSA-N
BARASERTIB-HQPA,BARASERTIB-HQPA,,BRD:BRD-BRD-K63923597-001-10-0;BRD:BRD-K63923597-001-10-0,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKB,,,PHASE 2/PHASE 3,,,NA,"CCN(CCO)CCCOC1CCC2C(NC3CC(CC(=O)NC4CCCC(F)C4)[NH]N3)NCNC2C1, CCN(CCO)CCCOC1CCC2C(NC3CC(CC(=O)NC4CCCC(F)C4)[NH]N3)NCNC2C1",
SOLUBLE,BARBITAL;BARBITAL SODIUM;BARBITAL SODIUM SALT;BARBITONE;BARBITONE SODIUM;DIEMAL;DIETHYLBARBITURIC ACID;NSC-31352;SODIUM BARBITAL;SOLUBLE,CHEMBL2105904;CHEMBL444,BRD:BRD-BRD-K83359602-001-02-3;BRD:BRD-K83359602-001-02-3,rep_primary;rep_single_dose,SEDATIVE,CHRNA4;CHRNA7;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GRIA2;GRIK2,"SEDATIVE, SEIZURES",,LAUNCHED,,Small molecule,4,CCC1(CC)C(=O)[N-]C(=O)NC1=O.[Na+];CCC1(CC)C(=O)NC(=O)NC1=O,RGHFKWPGWBFQLN-UHFFFAOYSA-M
RTA-401,"2-CYANO-3,12-DIOXOOLEANA-1,9(11)-DIEN-28-OIC ACID;BARDOXOLONE;CDDO;RTA 401;RTA-401",CHEMBL1093059,BRD:BRD-BRD-K20545304-001-01-6;BRD:BRD-K20545304-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",NOS2;PPARG,,,PHASE 1,"Multiple values for MOA: {'NUCLEAR FACTOR ERYTHROID DERIVED, LIKE (NRF2) ACTIVATOR', 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'}, defaulting to 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'",Small molecule,1,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1;CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C1[C@@]2(C)C=C(C#N)C(=O)C(C)(C)[C@@H]2CC[C@@]31C)C(O)=O,TXGZJQLMVSIZEI-UQMAOPSPSA-N
RTA-402,BARDOXOLONE METHYL;BARDOXOLONE METHYL ESTER;CDDO-ME;CDDO-METHYL ESTER;NSC 713200;NSC-713200;RTA 402;RTA-402,CHEMBL1762621,CTRP:660318,ctrp,,,,,,,Small molecule,3,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,WPTTVJLTNAWYAO-KPOXMGGZSA-N
RTA-402,BARDOXOLONE METHYL;BARDOXOLONE METHYL ESTER;BARDOXOLONE-METHYL;CDDO-ME;CDDO-METHYL ESTER;NSC 713200;NSC-713200;RTA 402;RTA-402,CHEMBL1762621,BRD:BRD-BRD-K69694239-001-02-2;BRD:BRD-K69694239-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",PPARG;STAT3,,,PHASE 3,"Multiple values for MOA: {'NUCLEAR FACTOR ERYTHROID DERIVED, LIKE (NRF2) ACTIVATOR', 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'}, defaulting to 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'",Small molecule,3,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,WPTTVJLTNAWYAO-KPOXMGGZSA-N
OLUMIANT,BARICITINIB;BARICITINIB PHOSPHATE;BARICITINIB PHOSPHATE SALT;INCB-028050;INCB-28050;INCB028050;LY-3009104;LY3009104;OLUMIANT,CHEMBL2105759,BRD:BRD-BRD-K53581288-001-02-9;BRD:BRD-K53581288-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2,,,PHASE 3,,Small molecule,4,CCS(=O)(=O)N1CC(CC#N)(C1)N1CC(CN1)-C1NCNC2[NH]CCC12;CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,XUZMWHLSFXCVMG-UHFFFAOYSA-N
VASEXTEN,BARNIDIPINE;BARNIDIPINE HYDROCHLORIDE;MEPIRODIPINE;VASEXTEN,CHEMBL2103761,BRD:BRD-BRD-K78781788-003-01-9;BRD:BRD-K78781788-003-01-9,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,HYPERTENSION,,LAUNCHED,,Small molecule,-1,COC(=O)C1=C(C)NC(C)=C([C@H]1C1CCCC(C1)[N+]([O-])=O)C(=O)O[C@H]1CCN(CC2CCCCC2)C1;COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1,VXMOONUMYLCFJD-DHLKQENFSA-N
RO4917523,BASIMGLURANT;NOE-101;RG-7090;RG7090;RO-4917523;RO4917523,CHEMBL3301626,BRD:BRD-BRD-K62387885-001-01-9;BRD:BRD-K62387885-001-01-9,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM5,,,PHASE 2,,Small molecule,2,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1;CC1NC(C#CC2CCNC(CL)C2)C(C)N1-C1CCC(F)CC1,UPZWINBEAHDTLA-UHFFFAOYSA-N
RO5186582,BASMISANIL;RG-1662;RG1662;RO-5186582;RO5186582,CHEMBL3681419,BRD:BRD-K00003221-001-01-9,rep_single_dose,GABA RECEPTOR INVERSE AGONIST,,,,,,Small molecule,2,Cc1onc(-c2ccc(F)cc2)c1COc1ccc(C(=O)N2CCS(=O)(=O)CC2)cn1,VCGRFBXVSFAGGA-UHFFFAOYSA-N
TL-057,BATABULIN;T-138067;T-67;T138067;T67;TL 057;TL-057,CHEMBL79280,BRD:BRD-K00091286-001-01-9,rep_single_dose,,,,,,,Small molecule,2,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F,ROZCIVXTLACYNY-UHFFFAOYSA-N
TD-5959,BATEFENTEROL;GSK-961081A;GSK961081;GSK961081A;TD-5959,CHEMBL3039518,BRD:BRD-K00003148-001-01-9,rep_single_dose,"ACETYLCHOLINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR AGONIST",,,,,,Small molecule,2,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,URWYQGVSPQJGGB-DHUJRADRSA-N
BB-94,BATIMASTAT;BB-94,CHEMBL279786,BRD:BRD-BRD-K82818427-001-02-2;BRD:BRD-BRD-K82818427-001-04-8;BRD:BRD-K82818427-001-02-2;BRD:BRD-K82818427-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,ADAM28;ADAMTS5;MMP12;MMP16;MMP2;MMP8,,,PHASE 3,,Small molecule,-1,"CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO;CNC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC(C)C)[C@H](CSC1CCCS1)C(=O)NO, CNC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC(C)C)[C@H](CSC1CCCS1)C(=O)NO",XFILPEOLDIKJHX-QYZOEREBSA-N
TNO155,BATOPROTAFIB;PTPN11 INHIBITOR TNO155;SHP2 INHIBITOR TNO155;TNO 155;TNO-155;TNO155,CHEMBL4650521,BRD:BRD-K00084310-001-02-9,oncref_1,INHIBITOR OF SHP2,PTPN11,,,,,Small molecule,1,C[C@@H]1OCC2(CCN(c3cnc(Sc4ccnc(N)c4Cl)c(N)n3)CC2)[C@@H]1N,UCJZOKGUEJUNIO-IINYFYTJSA-N
JNJ-31001074,BAVISANT;JNJ-31001074,CHEMBL2103862,BRD:BRD-BRD-K79595931-312-01-3;BRD:BRD-K79595931-312-01-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH3,,,PHASE 2,,Small molecule,2,O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1;O=C(N1CCN(CC1)C1CC1)C1CCC(CN2CCOCC2)CC1,BGBVSGSIXIIREO-UHFFFAOYSA-N
BAX CHANNEL BLOCKER,BAX CHANNEL BLOCKER,,CTRP:18311,ctrp,,,,,,,,NA,,
BAX-CHANNEL-BLOCKER,BAX-CHANNEL-BLOCKER,,BRD:BRD-A18763547-300-05-5;BRD:BRD-BRD-A18763547-300-05-5,rep_primary;rep_single_dose,CYTOCHROME C RELEASE INHIBITOR,BAX,,,PRECLINICAL,,,NA,"OC(CN1CCNCC1)CN1C2CCC(BR)CC2C2CC(BR)CCC12, OC(CN1CCNCC1)CN1C2CCC(BR)CC2C2CC(BR)CCC12",
BAY 2416964,BAY 2416964,,BRD:BRD-K00091085-001-01-9,rep_single_dose,,,,,,,,NA,,
BAY-11-7082,BAY-11-7082,,BRD:BRD-BRD-K15025317-001-15-1;BRD:BRD-K15025317-001-15-1,rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,RELA,,,PRECLINICAL,,,NA,"CC1CCC(CC1)S(=O)(=O)\C=C\C#N, CC1CCC(CC1)S(=O)(=O)\C=C\C#N, CC1CCC(CC1)S(=O)(=O)\C=C\C#N",
BAY-117085,BAY-11-7085;BAY-117085,CHEMBL270299,BRD:BRD-BRD-K48684885-001-04-2;BRD:BRD-K48684885-001-04-2,rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,NFKBIA,,,PRECLINICAL,,Small molecule,NA,CC(C)(C)C1CCC(CC1)S(=O)(=O)\C=C\C#N;CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1,VHKZGNPOHPFPER-ONNFQVAWSA-N
BAY-1251152,BAY-1251152,,BRD:BRD-K00003533-001-01-9,rep_single_dose,CDK9 INHIBITOR,,,,,,,NA,,
BAY-1436032,BAY-1436032,,BRD:BRD-K00003359-001-01-9,rep_single_dose,ISOCITRATE DEHYDROGENASE INHIBITOR,,,,,,,NA,,
ELIMUSERTIB,BAY-1895344;ELIMUSERTIB,CHEMBL4647810,BRD:BRD-K00003422-003-01-9;BRD:BRD-U00115418-001-01-9,oncref_1;rep_single_dose,INHIBITOR OF ATR KINASE,ATR,,,,"Multiple values for MOA: {'ATR KINASE INHIBITOR', 'INHIBITOR OF ATR KINASE'}, defaulting to 'INHIBITOR OF ATR KINASE'
Multiple values for structure_id: {'U00115418', 'K00003422'}, defaulting to None",Small molecule,1,C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1,YBXRSCXGRPSTMW-CYBMUJFWSA-N
BAY-2402234,BAY-2402234,,BRD:BRD-K22379844-001-04-9,rep_single_dose,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,,,,,,,NA,,
BAY-293,BAY-293,CHEMBL4535474,BRD:BRD-U00115412-001-01-9,oncref_1,INHIBITOR OF THE KRAS-SOS1 INTERACTION,KRAS;SOS1,,,,,Unknown,NA,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,WEGLOYDTDILXDA-OAHLLOKOSA-N
BAY-41-2272,BAY-41-2272,,BRD:BRD-BRD-K32033120-001-01-1;BRD:BRD-K32033120-001-01-1,rep_primary;rep_single_dose,GUANYLYL CYCLASE ACTIVATOR,GUCY1A3;GUCY1B3,,,PRECLINICAL,,,NA,NC1NC(NCC1C1CC1)-C1NN(CC2CCCCC2F)C2NCCCC12,
BAY-60-6583,BAY-60-6583,,BRD:BRD-K32952627-001-02-9,rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,,,,NA,,
BAY-60-7550,BAY-60-7550,,BRD:BRD-K86932920-001-02-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE2A,,,,,,NA,,
BAY-61-3606,BAY-61-3606,,BRD:BRD-K53281329-300-01-5;GDSC1:178,gdsc;rep_single_dose,SYK INHIBITOR,SYK,,,,,,NA,,
BAY-6888,BAY-6888,,BRD:BRD-K85565846-001-02-9,oncref_2,INHIBITOR OF CSNK1A1 AND CSNK1D,CSNK1A1;CSNK1D,,,,,,NA,,
BAY-8002,BAY-8002,,BRD:BRD-K00005331-001-01-9,oncref_1;rep_single_dose,INHIBITOR OF MONOCARBOXYLATE TRANSPORTER 1,SLC16A1,,,,"Multiple values for MOA: {'INHIBITOR OF MONOCARBOXYLATE TRANSPORTER 1', 'MONOCARBOXYLATE TRANSPORTER INHIBITOR'}, defaulting to 'INHIBITOR OF MONOCARBOXYLATE TRANSPORTER 1'",,NA,,
BAY-85-8050,BAY-85-8050,,BRD:BRD-A11731518-001-01-7;BRD:BRD-BRD-A11731518-001-01-7,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,NC(CC(F)C(O)=O)C(O)=O,
BAY-85-8501,BAY-85-8501,,BRD:BRD-K00077971-001-02-9,rep_single_dose,,,,,,,,NA,,
BAY-87-2243,BAY-87-2243,,BRD:BRD-BRD-K70463136-001-01-5;BRD:BRD-K70463136-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,HIF1A,,,PHASE 1,,,NA,CC1CC(NN1CC1CCNC(C1)N1CCN(CC1)C1CC1)-C1NC(NO1)-C1CCC(OC(F)(F)F)CC1,
BAY-876,BAY-876,CHEMBL4448899,BRD:BRD-K00103299-001-01-9,oncref_1,INHIBITOR OF GLUT1,SLC2A1,,,,,Unknown,NA,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1,BKLJDIJJOOQUFG-UHFFFAOYSA-N
BAY-K-8644-(+/-),BAY-K-8644-(+/-),,BRD:BRD-A05457250-001-08-4;BRD:BRD-BRD-A05457250-001-08-4,rep_primary;rep_single_dose,"L-TYPE CALCIUM CHANNEL ACTIVATOR, L-TYPE CALCIUM CHANNEL BLOCKER",,,,PRECLINICAL,"Multiple values for MOA: {'L-TYPE CALCIUM CHANNEL ACTIVATOR, L-TYPE CALCIUM CHANNEL BLOCKER', 'L-TYPE CALCIUM CHANNEL ACTIVATOR'}, defaulting to 'L-TYPE CALCIUM CHANNEL ACTIVATOR, L-TYPE CALCIUM CHANNEL BLOCKER'",,NA,COC(=O)C1=C(C)NC(C)=C(C1C1CCCCC1C(F)(F)F)[N+]([O-])=O,
BAY-K-8644-(S)-(-),BAY-K-8644-(S)-(-),,BRD:BRD-BRD-K14329163-001-03-9;BRD:BRD-K14329163-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,L-TYPE CALCIUM CHANNEL ACTIVATOR,CACNA1C,,,PRECLINICAL,,,NA,COC(=O)C1=C(C)NC(C)=C([C@H]1C1CCCCC1C(F)(F)F)[N+]([O-])=O,
BAY-W-9798,BAY-W-9798,,BRD:BRD-BRD-K44471774-001-01-8;BRD:BRD-K44471774-001-01-8,rep_primary;rep_single_dose,ANTIOXIDANT,,,,PHASE 2,,,NA,COC(=O)C1=C(C)N(C)C(C)=C(C1C1CCC(CC1)C(F)(F)F)C(=O)OC,
BAY1125976,BAY 1125976;BAY-1125976;BAY1125976,CHEMBL4751394,BRD:BRD-K00003357-001-01-9,rep_single_dose,AKT INHIBITOR,,,,,,Small molecule,1,NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1,JBGYKRAZYDNCNV-UHFFFAOYSA-N
ROGARATINIB,BAY-1163877;BAY1163877;ROGARATINIB,CHEMBL3963485,BRD:BRD-K00003358-001-01-9;BRD:BRD-K00003358-001-03-9,oncref_1;rep_single_dose,"INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4",FGFR1;FGFR2;FGFR3;FGFR4,,,,"Multiple values for MOA: {'FGFR INHIBITOR', 'INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4'}, defaulting to 'INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4'",Small molecule,2,COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1,HNLRRJSKGXOYNO-UHFFFAOYSA-N
BAY1217389,BAY1217389,,BRD:BRD-K00003143-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,,NA,,
BAZ2-ICR,BAZ2-ICR,,BRD:BRD-K66830666-001-02-7,rep_single_dose,BROMODOMAIN INHIBITOR,ZNF215,,,,,,NA,,
BAZEDOXIFENE,BAZEDOXIFENE,CHEMBL46740,BRD:BRD-BRD-K90195324-003-02-5;BRD:BRD-K90195324-003-02-5,rep_primary;rep_single_dose,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),ESR1;ESR2,"OSTEOPOROSIS, MENOPAUSE",,LAUNCHED,,Small molecule,4,"Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12;CC1C(-C2CCC(O)CC2)N(CC2CCC(OCCN3CCCCCC3)CC2)C2CCC(O)CC12, CC1C(-C2CCC(O)CC2)N(CC2CCC(OCCN3CCCCCC3)CC2)C2CCC(O)CC12, CC1C(-C2CCC(O)CC2)N(CC2CCC(OCCN3CCCCCC3)CC2)C2CCC(O)CC12",UCJGJABZCDBEDK-UHFFFAOYSA-N
IACS-13909,BBP-398;IACS-13909,,BRD:BRD-U00115413-001-01-9,oncref_1,INHIBITOR OF SHP2,PTPN11,,,,,,NA,,
BC-11,BC-11,,BRD:BRD-K14646328-004-02-9,rep_single_dose,UROKINASE INHIBITOR,PLAU,,,,,,NA,,
BCI-540,BCI-540,,BRD:BRD-BRD-K23672206-001-01-4;BRD:BRD-K23672206-001-01-4,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,,,,PHASE 2,,,NA,CC1OC2NC3CCCCC3C(NC(=O)CN3CCCC3=O)C2C1C,
BCL-LZH-4,BCL-LZH-4,,CTRP:688516,ctrp,,,,,,,,NA,,
BCTC,BCTC,,BRD:BRD-K66541497-001-02-9,rep_single_dose,TRPV ANTAGONIST,TRPV1,,,,,,NA,,
BCX-1470,BCX-1470,,BRD:BRD-BRD-K90472149-066-01-0;BRD:BRD-K90472149-066-01-0,rep_primary;rep_single_dose,"COMPLEMENT INHIBITOR, SERINE PROTEASE INHIBITOR",CFD,,,PHASE 1,"Multiple values for MOA: {'SERINE PROTEASE INHIBITOR, COMPLEMENT INHIBITOR', 'COMPLEMENT INHIBITOR, SERINE PROTEASE INHIBITOR'}, defaulting to 'COMPLEMENT INHIBITOR, SERINE PROTEASE INHIBITOR'",,NA,NC(=N)C1CC2CCC(OC(=O)C3CCCS3)CC2S1,
BD-1008,BD-1008,,BRD:BRD-BRD-K17008822-303-02-1;BRD:BRD-K17008822-303-02-1,rep_primary;rep_single_dose,SIGMA RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,CN(CCN1CCCC1)CCC1CCC(CL)C(CL)C1,
BD-1047,BD-1047,,BRD:BRD-BRD-K36864847-303-02-5;BRD:BRD-K36864847-303-02-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,SIGMAR1,,,PRECLINICAL,,,NA,"CN(C)CCN(C)CCC1CCC(CL)C(CL)C1, CN(C)CCN(C)CCC1CCC(CL)C(CL)C1",
BD-1063,BD-1063,,BRD:BRD-BRD-K29668683-300-02-2;BRD:BRD-K29668683-300-02-2,rep_primary;rep_single_dose,SIGMA RECEPTOR ANTAGONIST,SIGMAR1,,,PRECLINICAL,,,NA,CN1CCN(CCC2CCC(CL)C(CL)C2)CC1,
BDF00016096,BDF00016096,,GDSC1:1530,gdsc,,,,,,,,NA,,
BDP-00009066,BDP-00009066,,GDSC2:1866,gdsc,,,,,,,,NA,,
BEBT-908,BEBT-908,,BRD:BRD-K00003291-001-01-9,rep_single_dose,PI3K INHIBITOR,,,,,,,NA,,
BEC,BEC,,CTRP:60679,ctrp,,,,,,,,NA,,
BMS-791325,BECLABUVIR;BMS-791325,CHEMBL3126842,BRD:BRD-K00003128-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,3,COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21,ZTTKEBYSXUCBSE-VSBZUFFNSA-N
NYDRANE,BECLAMIDE;BENZCHLORPROPAMIDE;BENZYLAMIDE;NEURACEN;NSC-67062;NYDRANE,CHEMBL64195,BRD:BRD-BRD-K44824027-001-02-1;BRD:BRD-K44824027-001-02-1,rep_primary;rep_single_dose,ANTICONVULSANT,,"SEDATIVE, SEIZURES",,LAUNCHED,,Small molecule,4,CLCCC(=O)NCC1CCCCC1;O=C(CCCl)NCc1ccccc1,JPYQFYIEOUVJDU-UHFFFAOYSA-N
ZONIVENT AQUANASAL,AEROBEC 100;AEROBEC 50;AEROBEC FTE 250;ASMABEC CLICKHALER;ASMABEC SPACEHALER;BECLAZONE 100;BECLAZONE 100 E-BREATHE;BECLAZONE 200;BECLAZONE 250;BECLAZONE 250 E-BREATHE;BECLAZONE 50;BECLAZONE 50 E-BREATHE;BECLOAQUA 50;BECLOFORTE;BECLOFORTE E-BREATHE;BECLOFORTE INTEGRA;BECLOFORTE-VM;BECLOMET DIPROP;BECLOMET HAYFEVER;BECLOMETASONE;BECLOMETASONE DIPROPIONATE;BECLOMETHASONE;BECLOMETHASONE DIPROPIONATE;BECLOMETHASONE DIPROPIONATE MONOHYDRATE;BECLOMIST;BECLOTAIDE;BECLOVENT;BECODISKS;BECONASE;BECONASE AQ;BECOTIDE;BECOTIDE 100;BECOTIDE 100 E-BREATHE;BECOTIDE 200;BECOTIDE 50;BECOTIDE 50 E-BREATHE;CLENIL MODULITE;CLIPPER;FILAIR 100;FILAIR 50;FILAIR FTE;FOSTAIR;FOSTAIR NEXTHALER;NASOBEC AQ;NASOBEC HAYFEVER;NSC-755901;PROPADERM;PROPADERM FTE;PROPADERM-A;PROPADERM-C;PULVINAL BECLOMET;QNASL;QVAR 100;QVAR 100 E-BREATHE;QVAR 40;QVAR 50;QVAR 50 E-BREATHE;QVAR 80;QVAR REDIHALER;RINO CLENIL;SCH 18020W;SCH 8020W;SCH-18020W;SGX-201;SGX-202;SGX-203;VANCENASE;VANCENASE AQ;VANCENASE POCKETHALER;VANCERIL;VANCERIL DOUBLE STRENGTH;VENTIDE;VIVABEC;ZONIVENT AQUANASAL,CHEMBL1200500;CHEMBL1586,BRD:BRD-A73385064-001-01-5;BRD:BRD-BRD-A73385064-001-01-5,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;SERPINA6,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(CL)C(O)CC2(C)C1(O)C(=O)CO;CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C,KUVIULQEHSCUHY-XYWKZLDCSA-N
BECLOMETHASONE-DIPROPIONATE,BECLOMETHASONE-DIPROPIONATE,,BRD:BRD-BRD-K97810537-001-12-8;BRD:BRD-BRD-K97810537-001-13-6;BRD:BRD-K97810537-001-12-8;BRD:BRD-K97810537-001-13-6,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,GPR97;NR3C1,ALLERGIC RHINITIS,,LAUNCHED,,,NA,"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](O)C[C@]12C, CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](O)C[C@]12C, CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](O)C[C@]12C",
TMC207,BEDAQUILINE;R-207910;R207910;SIRTURO;TMC-207;TMC207,CHEMBL376488,BRD:BRD-BRD-K90817094-001-02-6;BRD:BRD-K90817094-001-02-6,rep_primary;rep_single_dose,ATPASE INHIBITOR,,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,"COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12;COC1NC2CCC(BR)CC2CC1[C@@H](C1CCCCC1)[C@@](O)(CCN(C)C)C1CCCC2CCCCC12, COC1NC2CCC(BR)CC2CC1[C@@H](C1CCCCC1)[C@@](O)(CCN(C)C)C1CCCC2CCCCC12, COC1NC2CCC(BR)CC2CC1[C@@H](C1CCCCC1)[C@@](O)(CCN(C)C)C1CCCC2CCCCC12",QUIJNHUBAXPXFS-XLJNKUFUSA-N
BEFURALINE,BEFURALINE,CHEMBL1076256,BRD:BRD-BRD-K99077012-001-01-9;BRD:BRD-K99077012-001-01-9,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,O=C(c1cc2ccccc2o1)N1CCN(Cc2ccccc2)CC1;O=C(N1CCN(CC2CCCCC2)CC1)C1CC2CCCCC2O1,SRIJFPBZWUFLFD-UHFFFAOYSA-N
GSI-953,BEGACESTAT;GSI-953,CHEMBL463981,BRD:BRD-BRD-K58319700-001-01-1;BRD:BRD-K58319700-001-01-1,rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,PSEN1,,,PHASE 1,,Small molecule,1,"O=S(=O)(N[C@H](CO)C(C(F)(F)F)C(F)(F)F)c1ccc(Cl)s1;OC[C@@H](NS(=O)(=O)C1CCC(CL)S1)C(C(F)(F)F)C(F)(F)F, OC[C@@H](NS(=O)(=O)C1CCC(CL)S1)C(C(F)(F)F)C(F)(F)F",PSXOKXJMVRSARX-SCSAIBSYSA-N
NK-1006,AMINODEOXYKANAMYCIN;BEKANAMYCIN;BEKANAMYCIN SULFATE;KANAMYCIN B;KANTREX;KLEBCIL;NEBRAMYCIN V;NK 1006;NK-1006,CHEMBL176,BRD:BRD-BRD-K73425385-065-04-8;BRD:BRD-K73425385-065-04-8,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,3,"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O;NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O",SKKLOUVUUNMCJE-FQSMHNGLSA-N
PXD101,BELEODAQ;BELINOSTAT;NSC-726630;NSC726630;PX-105684;PXD-101;PXD101,CHEMBL408513,BRD:BRD-BRD-K17743125-001-08-4;BRD:BRD-K17743125-001-08-4;CTRP:60225;GDSC1:274,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC10;HDAC11;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9,PERIPHERAL T-CELL LYMPHOMA (PTCL),,LAUNCHED,,Small molecule,4,O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO;ONC(=O)\C=C\C1CCCC(C1)S(=O)(=O)NC1CCCCC1,NCNRHFGMJRPRSK-MDZDMXLPSA-N
BELIZATINIB,BELIZATINIB,,BRD:BRD-K00003245-001-01-9,rep_single_dose,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,,,,,,,NA,,
BELOTECAN,BELOTECAN,CHEMBL2111084,BRD:BRD-K00003160-003-01-9,rep_single_dose,TOPOISOMERASE INHIBITOR,,,,,,Small molecule,3,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C,LNHWXBUNXOXMRL-VWLOTQADSA-N
RG6185,BELVARAFENIB;GDC5573;HM95573;RG6185,CHEMBL3977543,BRD:BRD-K00091122-001-01-9;BRD:BRD-U00115427-001-01-9,oncref_1;rep_single_dose,"INHIBITOR OF BRAF, BRAF-V600E, AND CRAF",BRAF;CRAF,,,,"Multiple values for structure_id: {'K00091122', 'U00115427'}, defaulting to None",Small molecule,2,Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1csc2c(N)ncnc12,KVCQTKNUUQOELD-UHFFFAOYSA-N
WELIREG,BELZUTIFAN;MK-6482;MK6482;PT 2977;PT-2977;PT2977;WELIREG,CHEMBL4585668,BRD:BRD-K00091288-001-01-9,rep_single_dose,,,,,,,Small molecule,4,CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F,LOMMPXLFBTZENJ-ZACQAIPSSA-N
NSC-58187,BEMEGRIDE;MEGIBAL;MEGIMIDE;METHETHARIMIDE;NSC-58187,CHEMBL1214192,BRD:BRD-BRD-K14993104-001-05-9;BRD:BRD-K14993104-001-05-9,rep_primary;rep_single_dose,CHEMORECEPTOR AGONIST,GABRA1,POISON ANTIDOTE,,LAUNCHED,,Small molecule,-1,CCC1(C)CC(=O)NC(=O)C1,ORRZGUBHBVWWOP-UHFFFAOYSA-N
MDL-72222,"BEMESETRON;MDL 72,222;MDL-72,222;MDL-72222",CHEMBL2107804,BRD:BRD-A85587465-001-03-3;BRD:BRD-BRD-A85587465-001-03-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A;HTR3B,,,PHASE 3,,Small molecule,-1,"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1cc(Cl)cc(Cl)c1)C2;CN1C2CCC1CC(C2)OC(=O)C1CC(CL)CC(CL)C1, CN1C2CCC1CC(C2)OC(=O)C1CC(CL)CC(CL)C1",MNJNPLVXBISNSX-WDNDVIMCSA-N
NEXLETOL,BEMPEDOIC ACID;BEMPEDOIC-ACID;ESP-55016;ETC-1002;ETC1002;NEXLETOL,CHEMBL3545313,BRD:BRD-BRD-K63177377-001-01-8;BRD:BRD-K63177377-001-01-8,rep_primary;rep_single_dose,AMPK INHIBITOR,ACLY,,,PHASE 3,,Small molecule,4,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(=O)O)C(=O)O;CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O,HYHMLYSLQUKXKP-UHFFFAOYSA-N
BENACTYZINE,BENACTYZINE,CHEMBL70352,BRD:BRD-K85030058-003-16-9,rep_single_dose,BUTYRYLCHOLINESTERASE INHIBITOR,,,,,,Small molecule,-1,CCN(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1,IVQOFBKHQCTVQV-UHFFFAOYSA-N
P-(D-XYLOSYLAMINO)BENZOIC ACID,BENAXIBINE;P-(D-XYLOSYLAMINO)BENZOIC ACID,CHEMBL490070,BRD:BRD-A90642009-001-03-2;BRD:BRD-BRD-A90642009-001-03-2,rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,-1,O=C(O)c1ccc(NC2OC[C@@H](O)[C@H](O)[C@H]2O)cc1;OC1COC(NC2CCC(CC2)C(O)=O)C(O)C1O,HLDUHCYBUVVDOT-GZBOUJLJSA-N
LOTREL,BENAZEPRIL;BENAZEPRIL SANDOZ;BRIEM;C09AA07;CGS-14824A;CIBACEN WS;CIBACENE;FORTEEKOR;LOTENSIN;LOTREL,CHEMBL838,BRD:BRD-BRD-K49807096-003-15-5;BRD:BRD-K49807096-003-15-5,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O;CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]1CCC2CCCCC2N(CC(O)=O)C1=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]1CCC2CCCCC2N(CC(O)=O)C1=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]1CCC2CCCCC2N(CC(O)=O)C1=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]1CCC2CCCCC2N(CC(O)=O)C1=O",XPCFTKFZXHTYIP-PMACEKPBSA-N
BENDAMUSTINE,BENDAMUSTINE,CHEMBL487253,BRD:BRD-BRD-K17068645-003-04-2;BRD:BRD-K17068645-003-04-2;CTRP:374755,ctrp;rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,"CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), NON-HODGKIN LYMPHOMA (NHL)",,LAUNCHED,,Small molecule,4,"Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21;CN1C(CCCC(O)=O)NC2CC(CCC12)N(CCCL)CCCL, CN1C(CCCC(O)=O)NC2CC(CCC12)N(CCCL)CCCL",YTKUWDBFDASYHO-UHFFFAOYSA-N
IWAZAC,AF 1934 [LYSINE];BENDAZAC;BINDAZAC;IWAZAC,CHEMBL1089221,BRD:BRD-BRD-K19515365-001-02-6;BRD:BRD-K19515365-001-02-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"MUSCLE PAIN, JOINT PAIN",,LAUNCHED,,Small molecule,4,O=C(O)COc1nn(Cc2ccccc2)c2ccccc12;OC(=O)COC1NN(CC2CCCCC2)C2CCCCC12,BYFMCKSPFYVMOU-UHFFFAOYSA-N
NSC-60020,BENDAZOL;DIBASOL;DIBAZOL;NSC-60020,CHEMBL355063,BRD:BRD-K60379054-001-09-9,rep_single_dose,NITRIC OXIDE SYNTHASE STIMULANT,,,,,,Small molecule,-1,c1ccc(Cc2nc3ccccc3[nH]2)cc1,YTLQFZVCLXFFRK-UHFFFAOYSA-N
URIZIDE,APRINOX;BENDROFLUAZIDE;BENDROFLUMETHIAZIDE;BENZYDROFLUMETHIAZIDE;BERKOZIDE;CENTYL;NATURETIN;NATURETIN-10;NATURETIN-2.5;NATURETIN-5;NEO-BENDROMAX 2.5;NEO-BENDROMAX 5;NEO-NACLEX;NSC-758229;URIZIDE,CHEMBL1684,BRD:BRD-A80017228-001-25-7;BRD:BRD-BRD-A80017228-001-25-7,rep_multi_dose;rep_primary;rep_single_dose,SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,CA1;CA2;CA4;KCNMA1;SLC12A1;SLC12A3,HYPERTENSION,,LAUNCHED,,Small molecule,4,"NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O;NS(=O)(=O)C1CC2C(NC(CC3CCCCC3)NS2(=O)=O)CC1C(F)(F)F, NS(=O)(=O)C1CC2C(NC(CC3CCCCC3)NS2(=O)=O)CC1C(F)(F)F",HDWIHXWEUNVBIY-UHFFFAOYSA-N
BENETHAMINE,BENETHAMINE,,BRD:BRD-BRD-K13473780-001-02-1;BRD:BRD-K13473780-001-02-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,C(CC1CCCCC1)NCC1CCCCC1,
NSC-757396,BENFLUOREX;MEDIAXAL;NSC-757396,CHEMBL400599,BRD:BRD-A22305049-003-13-6;BRD:BRD-BRD-A22305049-003-13-6,rep_primary;rep_single_dose,GLUCONEOGENESIS INHIBITOR,HMGCR,,,WITHDRAWN,,Small molecule,4,CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1;CC(CC1CCCC(C1)C(F)(F)F)NCCOC(=O)C1CCCCC1,CJAVTWRYCDNHSM-UHFFFAOYSA-N
BENFLURALIN,BENFLURALIN,CHEMBL1256668,BRD:BRD-BRD-K33903083-001-03-5;BRD:BRD-K33903083-001-03-5,rep_primary;rep_single_dose,,CYP1A1;CYP1A2;CYP2B6;CYP3A4;ESR1;MMP1;SULT2A1;UGT1A1,,,PHASE 3,,Small molecule,NA,CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-];CCCCN(CC)C1C(CC(CC1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O,SMDHCQAYESWHAE-UHFFFAOYSA-N
S-BENZOYLTHIAMINE O-MONOPHOSPHATE,8088 C.B;8088 C.B.;8088-CB;8088CB;BENFOTHIAMINE;BENFOTIAMINE;BENPHOTHIAMINE;BENZOYLTHIAMINE MONOPHOSPHATE;BENZOYLTHIAMINE O-MONOPHOSPHATE;BENZOYLTHIAMINMONOPHOSPHAT;BIOTAMIN;NSC-758241;S-BENZOYLTHIAMINE MONOPHOSPHATE;S-BENZOYLTHIAMINE O-MONOPHOSPHATE,CHEMBL1491875;CHEMBL3183549,BRD:BRD-BRD-K07359318-001-03-9;BRD:BRD-K07359318-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,ANTIOXIDANT,AGER,LUMBAGO,,LAUNCHED,,Small molecule,3,"C\C(N(CC1CNC(C)NC1N)C=O)=C(\CCOP(O)(O)=O)SC(=O)C1CCCCC1, C\C(N(CC1CNC(C)NC1N)C=O)=C(/CCOP(O)(O)=O)SC(=O)C1CCCCC1, C\C(N(CC1CNC(C)NC1N)C=O)=C(\CCOP(O)(O)=O)SC(=O)C1CCCCC1;CC(=C(CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N",BTNNPSLJPBRMLZ-UHFFFAOYSA-N
BENIDIPINE HYDROCHLORIDE,BENIDIPINE;BENIDIPINE HYDROCHLORIDE,CHEMBL2074972;CHEMBL2105555;CHEMBL2218858,BRD:BRD-BRD-K97181463-003-01-1;BRD:BRD-K97181463-003-01-1,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1G,HYPERTENSION,,LAUNCHED,,Small molecule,3,"COC(=O)C1=C(C)NC(C)=C([C@@H]1C1CCCC(C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2CCCCC2)C1, COC(=O)C1=C(C)NC(C)=C([C@@H]1C1CCCC(C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2CCCCC2)C1;COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1",QZVNQOLPLYWLHQ-UHFFFAOYSA-N
R-4584,ANQUIL;BENPERIDOL;BENQUIL;MCN-JR-4584;NSC-170982;R-4584,CHEMBL297302,BRD:BRD-BRD-K79425933-001-09-3;BRD:BRD-K79425933-001-09-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,FC1CCC(CC1)C(=O)CCCN1CCC(CC1)N1C2CCCCC2[NH]C1=O;O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,FEBOTPHFXYHVPL-UHFFFAOYSA-N
COFREL,ASA 158/5 [AS PHOSPHATE];BENPROPERINE;BENPROPERINE PHOSPHATE;COFREL,CHEMBL2105910,BRD:BRD-A42423104-001-01-4;BRD:BRD-BRD-A42423104-001-01-4,rep_primary;rep_single_dose,ANTITUSSIVE,SCN5A,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,-1,CC(COc1ccccc1Cc1ccccc1)N1CCCCC1;CC(COC1CCCCC1CC1CCCCC1)N1CCCCC1,JTUQXGZRVLWBCR-UHFFFAOYSA-N
SERAZIDE,BENSERAZIDE;BENSERAZIDE (AS HYDROCHLORIDE);BENSERAZIDE HCL;BENSERAZIDE HYDROCHLORIDE;NSC-755907;RO 4-4602;RO-4-4602;SERAZIDE,CHEMBL1096979,BRD:BRD-A61194565-003-27-0;BRD:BRD-BRD-A61194565-003-27-0,rep_primary;rep_single_dose,DOPA DECARBOXYLASE INHIBITOR,DDC,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,"NC(CO)C(=O)NNCc1ccc(O)c(O)c1O;NC(CO)C(=O)NNCC1CCC(O)C(O)C1O, NC(CO)C(=O)NNCC1CCC(O)C(O)C1O",BNQDCRGUHNALGH-UHFFFAOYSA-N
CI-718,BENTAZEPAM;CI-718,CHEMBL1521495,BRD:BRD-BRD-K89490285-001-08-1;BRD:BRD-K89490285-001-08-1,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,,"ANXIETY, SEDATIVE, MUSCLE RELAXANT",,LAUNCHED,,Small molecule,-1,O=C1CN=C(C2C3CCCCC3SC2N1)C1CCCCC1;O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1,AIZFEOPQVZBNGH-UHFFFAOYSA-N
PFT,BENTIROMIDE;BTPABA;BTPABA PFT;BTPABA-PFT;BTPABAPFT;CHYMEX;E-2663;PFT,CHEMBL1200368,BRD:BRD-BRD-K58794715-001-01-8;BRD:BRD-K58794715-001-01-8,rep_primary;rep_single_dose,,HPN,PANCREAS DIAGNOSTIC AGENT,,LAUNCHED,,Small molecule,4,"O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1;OC(=O)C1CCC(NC(=O)[C@H](CC2CCC(O)CC2)NC(=O)C2CCCCC2)CC1, OC(=O)C1CCC(NC(=O)[C@H](CC2CCC(O)CC2)NC(=O)C2CCCCC2)CC1",SPPTWHFVYKCNNK-FQEVSTJZSA-N
NSC-220913,BENURESTAT;EU-2826;NSC-220913,CHEMBL2105796,BRD:BRD-BRD-K88553858-001-02-7;BRD:BRD-K88553858-001-02-7,rep_primary;rep_single_dose,UREASE INHIBITOR,,,,PHASE 1,,Small molecule,-1,O=C(CNC(=O)c1ccc(Cl)cc1)NO;ONC(=O)CNC(=O)C1CCC(CL)CC1,JFZGBMJPJZDNNT-UHFFFAOYSA-N
BENZAMIL,BENZAMIL,CHEMBL212579,BRD:BRD-BRD-K87158025-001-01-6;BRD:BRD-K87158025-001-01-6,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,ASIC1;PKD2L1;SCNN1A;SCNN1B;SCNN1D;SCNN1G;SLC8A1,,,PHASE 2,,Small molecule,NA,"N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)NCc1ccccc1;NC(NCC1CCCCC1)=NC(=O)C1NC(CL)C(N)NC1N, NC(NCC1CCCCC1)=NC(=O)C1NC(CL)C(N)NC1N",KXDROGADUISDGY-UHFFFAOYSA-N
UROLEAP,BENZBROMARON;BENZBROMARONE;BENZPROMARONE;DESURIC;L-2214;MJ 10061;MJ-10061;NARCARICIN MITE;NSC-85433;UROLEAP,CHEMBL388590,BRD:BRD-BRD-K11717138-001-30-3;BRD:BRD-K11717138-001-30-3,rep_primary;rep_single_dose,CHLORIDE CHANNEL BLOCKER,ABCC1,GOUT,,LAUNCHED,,Small molecule,4,"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1;CCC1OC2CCCCC2C1C(=O)C1CC(BR)C(O)C(BR)C1, CCC1OC2CCCCC2C1C(=O)C1CC(BR)C(O)C(BR)C1",WHQCHUCQKNIQEC-UHFFFAOYSA-N
BENZOTHONIUM,BENZETHONIUM;BENZETHONIUM CATION;BENZETHONIUM ION;BENZOTHONIUM,CHEMBL1182210,BRD:BRD-BRD-K72723676-003-17-8;BRD:BRD-K72723676-003-17-8,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A,FIRST-AID ANTISEPTIC,,LAUNCHED,,Small molecule,-1,"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1;CC(C)(C)CC(C)(C)C1CCC(OCCOCC[N+](C)(C)CC2CCCCC2)CC1, CC(C)(C)CC(C)(C)C1CCC(OCCOCC[N+](C)(C)CC2CCCCC2)CC1",SIYLLGKDQZGJHK-UHFFFAOYSA-N
ROCHAGAN,BENZNIDAZOLE;BENZNIDAZOLUM;BENZONIDAZOL;NSC-299972;RADANIL;RO 07-1051;RO-07-1051;RO-7-1051;ROCHAGAN,CHEMBL110,BRD:BRD-BRD-K56156805-001-09-6;BRD:BRD-K56156805-001-09-6,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,CHAGAS DISEASE,,LAUNCHED,,Small molecule,4,[O-][N+](=O)C1NCCN1CC(=O)NCC1CCCCC1;O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1,CULUWZNBISUWAS-UHFFFAOYSA-N
TYROZETS,AEZODENT;AMERICAINE;ANAESTHESIN;ANTHISAN PLUS;AR-01;AR01;BABY ANBESOL;BENZOCAINE;BENZOCAINUM;BURNEZE;CHILDREN'S CHLORASEPTIC;DEQUACAINE;ETHYL AMINOBENZOATE;ETHYL P-AMINOBENZOATE;ETHYL PABA;FLAVAMED;LANACANE;MEDILAVE;NESTOSYL;NORCAINE;NSC-41531;NSC-4688;ORAJEL;PARATHESIN;PARATHESINE;SUBCUTIN;TYROSOLVEN;TYROZETS,CHEMBL278172,BRD:BRD-BRD-K75466013-001-14-4;BRD:BRD-K75466013-001-14-4,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A,FIRST-AID ANTISEPTIC,,LAUNCHED,,Small molecule,4,"CCOC(=O)c1ccc(N)cc1;CCOC(=O)C1CCC(N)CC1, CCOC(=O)C1CCC(N)CC1",BLFLLBZGZJTVJG-UHFFFAOYSA-N
BENZOFENAC,BENZOFENAC,,BRD:BRD-BRD-K26556907-001-01-8;BRD:BRD-K26556907-001-01-8,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,OC(=O)CC1CCC(OCC2CCCCC2)C(CL)C1,
BENZOIC-ACID,BENZOIC-ACID,,BRD:BRD-BRD-K53397409-001-12-3;BRD:BRD-K53397409-001-12-3,rep_primary;rep_single_dose,FOOD PRESERVATIVE,DAO;HRSP12;PRDX5;RAB9A,TINEA PEDIS,,LAUNCHED,,,NA,"OC(=O)C1CCCCC1, OC(=O)C1CCCCC1, OC(=O)C1CCCCC1",
UNSPECIFIED,BENZOIN;BENZOIN RESIN;BENZOIN TINCTURE;BENZOIN USP;BENZOYLPHENYLCARBINOL;DESYL ALCOHOL;DL-BENZOIN;FEMA NO. 2132;GUM BENZOIN;GUM BENZOIN TINCTURE;NSC-8082;UNSPECIFIED,CHEMBL190677,BRD:BRD-A55748233-001-08-7;BRD:BRD-BRD-A55748233-001-08-7,rep_primary;rep_single_dose,,CES1,,,PRECLINICAL,,Small molecule,4,O=C(c1ccccc1)C(O)c1ccccc1;OC(C(=O)C1CCCCC1)C1CCCCC1,ISAOCJYIOMOJEB-UHFFFAOYSA-N
TESSALON,BENZONATATE;NSC-760128;TESSALON,CHEMBL1374379,BRD:BRD-BRD-K91699951-001-10-2;BRD:BRD-K91699951-001-10-2,rep_primary;rep_single_dose,LOCAL ANESTHETIC,SCN5A,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,4,CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1;CCCCNC1CCC(CC1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,MAFMQEKGGFWBAB-UHFFFAOYSA-N
BENZOQUINONIUM-DIBROMIDE,BENZOQUINONIUM-DIBROMIDE,,BRD:BRD-BRD-K18772613-303-02-4;BRD:BRD-K18772613-303-02-4,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRNA1,,,PRECLINICAL,,,NA,CC[N+](CC)(CCCNC1=CC(=O)C(NCCC[N+](CC)(CC)CC2CCCCC2)=CC1=O)CC1CCCCC1,
N-(P-CHLOROBENZOYL)-L-TRYPTOPHAN,BENZOTRIPT;N-(P-CHLOROBENZOYL)-L-TRYPTOPHAN,CHEMBL63544,BRD:BRD-A87983072-001-01-1;BRD:BRD-BRD-A87983072-001-01-1,rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKAR;CCKBR,,,PHASE 1,,Small molecule,-1,O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1;OC(=O)C(CC1C[NH]C2CCCCC12)NC(=O)C1CCC(CL)CC1,QJERBBQXOMUURJ-INIZCTEOSA-N
OXYQUINOLINE BENZOATE (SALT),BENZOXIQUINE;DIOXYLINE;NSC-3906;NSC-3951;OXINE BENZOATE;OXYQUINOLINE BENZOATE;OXYQUINOLINE BENZOATE (SALT),CHEMBL1170610,BRD:BRD-BRD-K70327191-001-02-2;BRD:BRD-K70327191-001-02-2,rep_primary;rep_single_dose,ANTIINFECTIVE DRUG,,,,PRECLINICAL,,Small molecule,-1,O=C(Oc1cccc2cccnc12)c1ccccc1;O=C(OC1CCCC2CCCNC12)C1CCCCC1,BHKPHCKISVSDGV-UHFFFAOYSA-N
NSC-759125,BENZAMIDOSALICYLATE;BENZOYLPAS;NSC-159686;NSC-759125,CHEMBL1487804,BRD:BRD-BRD-K20431737-001-08-1;BRD:BRD-K20431737-001-08-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,"O=C(Nc1ccc(C(=O)O)c(O)c1)c1ccccc1;OC(=O)C1CCC(NC(=O)C2CCCCC2)CC1O, OC(=O)C1CCC(NC(=O)C2CCCCC2)CC1O",GNZCRYWFWKFIDM-UHFFFAOYSA-N
BENZO[D]THIAZOLE-2(3H)-THIONE,BENZO[D]THIAZOLE-2(3H)-THIONE,,BRD:BRD-BRD-K55160477-001-04-7;BRD:BRD-K55160477-001-04-7,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,SC1NC2CCCCC2S1,
URESE,AQUATAG;BENZOTHIAZIDE;BENZTHIAZIDE;EXNA;FOVANE;NSC-755902;URESE,CHEMBL1201039,BRD:BRD-BRD-K21450440-001-14-6;BRD:BRD-K21450440-001-14-6,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA1;CA12;CA2;CA4;CA9;SLC12A3,"HYPERTENSION, EDEMA",,LAUNCHED,,Small molecule,4,"NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O;NS(=O)(=O)C1CC2C(CC1CL)N=C(CSCC1CCCCC1)NS2(=O)=O, NS(=O)(=O)C1CC2C(CC1CL)N=C(CSCC1CCCCC1)NS2(=O)=O",NDTSRXAMMQDVSW-UHFFFAOYSA-N
BENZTROPINE-MESYLATE,BENZTROPINE-MESYLATE,,BRD:BRD-BRD-K48061146-066-01-7;BRD:BRD-K48061146-066-01-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;HRH1;SLC6A3,"EXTRAPYRAMIDAL SYMPTOMS (EPS), PARKINSON'S DISEASE",,LAUNCHED,,,NA,CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(C1CCCCC1)C1CCCCC1,
BENZYDAMINE,APO-BENZYDAMINE;BENZINDAMINE;BENZYDAMINE,CHEMBL12610,BRD:BRD-BRD-K28542495-003-13-5;BRD:BRD-K28542495-003-13-5,rep_multi_dose;rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,,"MOUTH INFLAMMATION, THROAT INFLAMMATION",,LAUNCHED,,Small molecule,4,"CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12;CN(C)CCCOC1NN(CC2CCCCC2)C2CCCCC12, CN(C)CCCOC1NN(CC2CCCCC2)C2CCCCC12",CNBGNNVCVSKAQZ-UHFFFAOYSA-N
BENZYLDIMETHYLHEXADECYLAMMONIUM,BENZYLDIMETHYLHEXADECYLAMMONIUM,,BRD:BRD-BRD-K23403298-003-01-9;BRD:BRD-K23403298-003-01-9,rep_multi_dose;rep_primary;rep_single_dose,CATIONIC SURFACTANT,,,,PRECLINICAL,,,NA,CCCCCCCCCCCCCCCC[N+](C)(C)CC1CCCCC1,
BENZYLDIMETHYLOCTYLAMMONIUM,BENZYLDIMETHYLOCTYLAMMONIUM,,BRD:BRD-BRD-K11576103-003-01-1;BRD:BRD-K11576103-003-01-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCCCCCCC[N+](C)(C)CC1CCCCC1,
PFIZERPEN-AS,BENZYL PENICILLIN;BENZYLPENICILLIN;BENZYLPENICILLIN ;BICILLIN;CRYSTAPEN G;J01CE01;NSC-193396;PENICILLIN G;PENICILLIN-2;PERMAPEN;PFIZERPEN-AS,CHEMBL29,BRD:BRD-BRD-K55191674-237-18-3;BRD:BRD-K55191674-237-18-3,rep_primary;rep_single_dose,PENICILLIN BINDING PROTEIN INHIBITOR,,"CELLUITIS, MENINGITIS, ENDOCARDITIS, SYPHILIS, PNEUMONIA, BACTERIAL SEPTICEMIA",,LAUNCHED,,Small molecule,4,"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O;CC1(C)S[C@@H]2[C@H](NC(=O)CC3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)CC3CCCCC3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)CC3CCCCC3)C(=O)N2[C@H]1C(O)=O",JGSARLDLIJGVTE-MBNYWOFBSA-N
BEPHENIUM-HYDROXYNAPHTHOATE,BEPHENIUM-HYDROXYNAPHTHOATE,,BRD:BRD-BRD-K47878171-086-06-0;BRD:BRD-K47878171-086-06-0,rep_multi_dose;rep_primary;rep_single_dose,ANTHELMINTIC AGENT,,ASCARIASIS,,LAUNCHED,,,NA,"C[N+](C)(CCOC1CCCCC1)CC1CCCCC1, C[N+](C)(CCOC1CCCCC1)CC1CCCCC1, C[N+](C)(CCOC1CCCCC1)CC1CCCCC1",
BETOTASTINE,BEPOTASTINE;BEPREVE;BETOTASTINE,CHEMBL1201758,BRD:BRD-BRD-K98624455-074-02-8;BRD:BRD-K98624455-074-02-8,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1;OC(=O)CCCN1CCC(CC1)O[C@@H](C1CCC(CL)CC1)C1CCCCN1,YWGDOWXRIALTES-NRFANRHFSA-N
VASCOR,BEPADIN;BEPRIDIL;VASCOR,CHEMBL1008,BRD:BRD-A91008255-003-24-8;BRD:BRD-BRD-A91008255-003-24-8,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,ATP1A1;CACNA1A;CACNA1H;CACNA2D2;CALM1;KCNQ1;KCNQ4;PDE1A;PDE1B;TNNC1,ANGINA PECTORIS,,LAUNCHED,,Small molecule,4,"CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1;CC(C)COCC(CN(CC1CCCCC1)C1CCCCC1)N1CCCC1, CC(C)COCC(CN(CC1CCCCC1)C1CCCCC1)N1CCCC1, CC(C)COCC(CN(CC1CCCCC1)C1CCCCC1)N1CCCC1",UIEATEWHFDRYRU-UHFFFAOYSA-N
UMBELLATINE,BERBERICINE;BERBERIN;BERBERINE;BERBERONE;MAJARINE;THALSINE;UMBELLATIN;UMBELLATINE,CHEMBL295124,BRD:BRD-BRD-K14796088-003-26-8;BRD:BRD-K14796088-003-26-8,rep_multi_dose;rep_primary;rep_single_dose,LDL RECEPTOR ACTIVATOR,LDLR,,,PHASE 2/PHASE 3,,Small molecule,3,"COC1CCC2CC3-C4CC5OCOC5CC4CC[N+]3CC2C1OC, COC1CCC2CC3-C4CC5OCOC5CC4CC[N+]3CC2C1OC;COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2",YBHILYKTIRIUTE-UHFFFAOYSA-N
NSC-95437,5-METHOXYPSORALEN;BERGAPTAN;BERGAPTEN;BERGAPTENE;GERALEN;HERACLIN;MAJUDIN;METHOXSALEN RELATED COMPOUND A;NSC-95437,CHEMBL24171,BRD:BRD-BRD-K12968785-001-13-3;BRD:BRD-K12968785-001-13-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,4,"COc1c2ccoc2cc2oc(=O)ccc12;COC1C2CCOC2CC2OC(=O)CCC12, COC1C2CCOC2CC2OC(=O)CCC12",BGEBZHIAGXMEMV-UHFFFAOYSA-N
YANBAICAISU,BERGENIN;BERGENINUM;NSC-661749;NSC-757796;YANBAICAISU,CHEMBL273019,BRD:BRD-BRD-K04176066-001-08-3;BRD:BRD-K04176066-001-08-3,rep_primary;rep_single_dose,INTERLEUKIN INHIBITOR,IL1B;TNF,,,PRECLINICAL,,Small molecule,-1,"COC1C(O)CC2C(=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3C2C1O, COC1C(O)CC2C(=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3C2C1O;COc1c(O)cc2c(c1O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC2=O",YWJXCIXBAKGUKZ-HJJNZUOJSA-N
ISV-403,BESIFLOXACIN;ISV-403,CHEMBL1201760,BRD:BRD-BRD-K10196357-003-02-0;BRD:BRD-K10196357-003-02-0,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,N[C@@H]1CCCCN(C1)C1C(F)CC2C(C1CL)N(CC(C(O)=O)C2=O)C1CC1;N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1,QFFGVLORLPOAEC-SNVBAGLBSA-N
BET-BAY-002,BET-BAY-002,,BRD:BRD-BRD-K72735080-001-01-0;BRD:BRD-K72735080-001-01-0,rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,,,,PRECLINICAL,,,NA,CC1NNC(C[C@@H]2C=C(C3CCC(CL)CC3)C3CCCCC3-N3C(C)NNC23)O1,
BETA-AMYLOID-SYNTHESIS-INHIBITOR,BETA-AMYLOID-SYNTHESIS-INHIBITOR,,BRD:BRD-BRD-K38687824-001-02-5;BRD:BRD-K38687824-001-02-5,rep_primary;rep_single_dose,BETA AMYLOID SYNTHESIS INHIBITOR,APP,,,PRECLINICAL,,,NA,OC1CCCC(NC2CCC(NC3CCCC(O)C3)NN2)C1,
BETA-CCB,BETA-CCB,,BRD:BRD-BRD-K87349602-001-03-8;BRD:BRD-K87349602-001-03-8,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR LIGAND,GABRA1;GABRG2,,,LAUNCHED,,,NA,CCCCOC(=O)C1CC2C(CN1)[NH]C1CCCCC21,
BETA-FUNALTREXAMINE,BETA-FUNALTREXAMINE,,BRD:BRD-BRD-K95110148-003-01-5;BRD:BRD-K95110148-003-01-5,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1,,,PRECLINICAL,,,NA,"COC(=O)\C=C\C(=O)N[C@@H]1CC[C@@]2(O)[C@H]3CC4CCC(O)C5O[C@@H]1[C@]2(CCN3CC1CC1)C45, COC(=O)\C=C\C(=O)N[C@@H]1CC[C@@]2(O)[C@H]3CC4CCC(O)C5O[C@@H]1[C@]2(CCN3CC1CC1)C45",
BETA-GLYCEROPHOSPHORIC-ACID,BETA-GLYCEROPHOSPHORIC-ACID,,BRD:BRD-BRD-K39061174-001-01-0;BRD:BRD-K39061174-001-01-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OCC(CO)OP(O)(O)=O,
BETA-HYDROXY-BETA-METHYLBUTYRATE,BETA-HYDROXY-BETA-METHYLBUTYRATE,,BRD:BRD-BRD-M02899238-238-01-6;BRD:BRD-M02899238-238-01-6,rep_primary;rep_single_dose,PROTEIN SYNTHESIS STIMULANT,MTOR,,,PHASE 2/PHASE 3,,,NA,CC(C)(O)CC(O)=O.CC(C)(O)CC(O)=O,
NSC-3806,"(+/-)-;3-HYDROXYBUTANOATE;3-HYDROXYBUTYRIC ACID;3-HYDROXYBUTYRIC ACID, (+/-)-;BETA-HYDROXY-BUTYRATE;BETA-HYDROXYBUTYRATE;D,L-3 HYDROXYBUTYRATE;DL-;HYDROXYBUTYRIC ACID;NSC-3806",CHEMBL1162496,BRD:BRD-A41387824-001-06-0,rep_single_dose,,HCAR2,,,,,Small molecule,1,CC(O)CC(=O)O,WHBMMWSBFZVSSR-UHFFFAOYSA-N
BETA-LAPACHONE,BETA-LAPACHONE,,BRD:BRD-BRD-K28061410-001-06-6;BRD:BRD-K28061410-001-06-6,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,PHASE 2,,,NA,"CC1(C)CCC2=C(O1)C1CCCCC1C(=O)C2=O, CC1(C)CCC2=C(O1)C1CCCCC1C(=O)C2=O, CC1(C)CCC2=C(O1)C1CCCCC1C(=O)C2=O, CC1(C)CCC2=C(O1)C1CCCCC1C(=O)C2=O",
BETA-NAPHTHOL,BETA-NAPHTHOL,,BRD:BRD-BRD-K21164796-001-02-8;BRD:BRD-K21164796-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC1CCC2CCCCC2C1,
NSC-42617,BETAHISTINE;BETAHISTINE DIMESYLATE;BETAHISTINE DIMETHANESULFONATE;BETAHISTINE MESILATE;MERISLON;NSC-42617,CHEMBL24441;CHEMBL4298035,BRD:BRD-BRD-K91315211-300-05-7;BRD:BRD-K91315211-300-05-7,rep_primary;rep_single_dose,"HISTAMINE RECEPTOR AGONIST, HISTAMINE RECEPTOR ANTAGONIST",HRH1;HRH3,MENIERE'S DISEASE,,LAUNCHED,,Unknown,-1,"CNCCC1CCCCN1, CNCCC1CCCCN1",
NSC-166511,ABROMINE;ANHYDROUS;BETAINE;BETAINE ANHYDROUS;CYSTADANE;FEMA NO. 4223;NSC-166511,CHEMBL95889,BRD:BRD-BRD-K12014493-001-02-2;BRD:BRD-K12014493-001-02-2,rep_primary;rep_single_dose,NITRIC OXIDE DONOR,,HOMOCYSTINURIA,,LAUNCHED,,Small molecule,4,C[N+](C)(C)CC(=O)O;C[N+](C)(C)CC(O)=O,KWIUHFFTVRNATP-UHFFFAOYSA-O
VISUBETA,ALPHATREX;BETA-VAL;BETAMETHASONE;BETASOLAN;BETATREX;BETNELAN;CELESTONE;DERMABET;FLUBENISOLONE;LOTRISONE;NSC-39470;SCH 4831;SCH-4831;TACLONEX;UTICORT;VISUBETA,CHEMBL632,BRD:BRD-A02180903-001-04-5;BRD:BRD-BRD-A02180903-001-04-5,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,Small molecule,4,"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO;C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]2(C)[C@]1(O)C(=O)CO",UREBDLICKHMUKA-DVTGEIKXSA-N
BETAMETHASONE-ACETATE,BETAMETHASONE-ACETATE,,BRD:BRD-A92177080-001-02-1;BRD:BRD-BRD-A92177080-001-02-1,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,
BETAMETHASONE-BUTYRATE-PROPIONATE,BETAMETHASONE-BUTYRATE-PROPIONATE,,BRD:BRD-K00004736-001-01-9,rep_single_dose,,,,,,,,NA,,
BETAMETHASONE-DIPROPIONATE,BETAMETHASONE-DIPROPIONATE,,BRD:BRD-BRD-K58148589-001-03-6;BRD:BRD-K58148589-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C, CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C",
BETAMETHASONE-PHOSPHATE,BETAMETHASONE-PHOSPHATE,,BRD:BRD-K00005349-304-01-9,rep_single_dose,,,,,,,,NA,,
BETAMETHASONE-VALERATE,BETAMETHASONE-VALERATE,,BRD:BRD-BRD-K34032314-001-04-1;BRD:BRD-K34032314-001-04-1,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,"CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO, CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO, CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO",
NSC-192714,BETAMIPRON;CS-443;NSC-192714,CHEMBL1231530,BRD:BRD-BRD-K82142815-001-19-1;BRD:BRD-K82142815-001-19-1,rep_primary;rep_single_dose,PANIPENEM UPTAKE INHIBITOR,,RENAL TOXICITY,,LAUNCHED,,Small molecule,-1,"O=C(O)CCNC(=O)c1ccccc1;OC(=O)CCNC(=O)C1CCCCC1, OC(=O)CCNC(=O)C1CCCCC1",CWXYHOHYCJXYFQ-UHFFFAOYSA-N
SL-7521210 FREE BASE,(S)-;ALO-140102 FREE BASE;BETAXOLOL;BETOPTIC;BETOPTIC SUSP;KERLEDEX;KERLONE;LEVOBETAXOLOL;SL-7521210 FREE BASE,CHEMBL1201274;CHEMBL423,BRD:BRD-A02759312-003-24-5;BRD:BRD-BRD-A02759312-003-24-5;BRD:BRD-BRD-K17498618-344-02-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,"INTRAOCULAR PRESSURE, GLAUCOMA, OCULAR HYPERTENSION",,LAUNCHED,,Small molecule,4,"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1;CC(C)NCC(O)COC1CCC(CCOCC2CC2)CC1, CC(C)NCC(O)COC1CCC(CCOCC2CC2)CC1, CC(C)NCC(O)COC1CCC(CCOCC2CC2)CC1, CC(C)NCC(O)COC1CCC(CCOCC2CC2)CC1, CC(C)NCC(O)COC1CCC(CCOCC2CC2)CC1, COC1CCC(C[C@@H]2C3CC(OC)C(OC)CC3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCC3CC(OC)C(OC)CC3[C@H]2CC2CCC(OC)C(OC)C2)CC1OC",NWIUTZDMDHAVTP-UHFFFAOYSA-N
BETAZOLE,BETAZOLE,CHEMBL1201323,BRD:BRD-BRD-K20075662-300-04-0;BRD:BRD-K20075662-300-04-0,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH2,GASTRIC HYPERSECRETION DIAGNOSTIC,,LAUNCHED,,Small molecule,4,NCCc1cc[nH]n1;NCCC1CC[NH]N1,JXDFEQONERDKSS-UHFFFAOYSA-N
BETHANECHOL,BETHANECHOL,CHEMBL1482,BRD:BRD-A99833829-003-27-1;BRD:BRD-BRD-A99833829-003-27-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4,URINARY RETENTION,,LAUNCHED,,Small molecule,4,"CC(C[N+](C)(C)C)OC(N)=O;CC(C[N+](C)(C)C)OC(N)=O, CC(C[N+](C)(C)C)OC(N)=O, CC(C[N+](C)(C)C)OC(N)=O",NZUPCNDJBJXXRF-UHFFFAOYSA-O
BETP,BETP,,BRD:BRD-A60153876-001-01-0;BRD:BRD-BRD-A60153876-001-01-0,rep_primary;rep_single_dose,GLUCAGON-LIKE PEPTIDE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GLP1R,,,PRECLINICAL,,,NA,CCS(=O)C1NC(CC(N1)C(F)(F)F)-C1CCCC(OCC2CCCCC2)C1,
PRT054021,BETRIXABAN;BETRIXABAN MALEATE;BEVYXXA;PRT-054021;PRT054021,CHEMBL512351,BRD:BRD-BRD-K45275534-001-01-3;BRD:BRD-K45275534-001-01-3,rep_primary;rep_single_dose,COAGULATION FACTOR INHIBITOR,KCNH2,DEEP VEIN THROMBOSIS (DVT),,LAUNCHED,,Small molecule,4,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1;COC1CCC(NC(=O)C2CCC(CC2)C(=N)N(C)C)C(C1)C(=O)NC1CCC(CL)CN1,XHOLNRLADUSQLD-UHFFFAOYSA-N
NSC-677578,.BETA.-BETULINIC ACID;ALS-357;BETULIC ACID;BETULINIC ACID;LUPATIC ACID;MAIRIN;NSC-113090;NSC-677578,CHEMBL269277,CTRP:23256,ctrp,,,,,,,Small molecule,1,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,QGJZLNKBHJESQX-FZFNOLFKSA-N
BETULINIC-ACID,BETULINIC-ACID,,BRD:BRD-BRD-K45401373-001-20-9;BRD:BRD-BRD-K45401373-001-22-5;BRD:BRD-K45401373-001-20-9;BRD:BRD-K45401373-001-22-5,rep_multi_dose;rep_primary;rep_single_dose,"APOPTOSIS STIMULANT, NFKB PATHWAY INHIBITOR",GPBAR1,,,PHASE 1/PHASE 2,,,NA,"CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O, CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O, CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O",
NSC-132348,BEVANTOLOL;NSC-132348,CHEMBL314010,BRD:BRD-A18233884-003-02-7;BRD:BRD-BRD-A18233884-003-02-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRB1;ADRB2,"ANGINA PECTORIS, HYPERTENSION",,LAUNCHED,,Small molecule,2,COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC;COC1CCC(CCNCC(O)COC2CCCC(C)C2)CC1OC,HXLAFSUPPDYFEO-UHFFFAOYSA-N
CB5945,ADL-5945;ADL5945;BEVENOPRAN;CB-5945;CB5-945;CB5945,CHEMBL3039511,BRD:BRD-K00004680-001-01-9,rep_single_dose,OPIOID RECEPTOR ANTAGONIST,,,,,,Small molecule,3,COc1cc(CNCCC2CCOCC2)ccc1Oc1cnc(C(N)=O)cn1,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N
BEVIRIMAT-DIMEGLUMINE,BEVIRIMAT-DIMEGLUMINE,,BRD:BRD-BRD-K16898998-001-01-6;BRD:BRD-K16898998-001-01-6,rep_primary;rep_single_dose,HIV CAPSID ASSEMBLY INHIBITOR,,,,PHASE 2,,,NA,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,
THR1442,BEXAGLIFLOZIN;EGT-0001442;EGT-1442;EGT0001442;EGT1442;THR-1442;THR1442,CHEMBL1808388,BRD:BRD-K00003246-001-01-9,rep_single_dose,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,,,,,,Small molecule,3,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,BTCRKOKVYTVOLU-SJSRKZJXSA-N
TARGRETINE,BEXAROTENE;LG-100069;LG100069;LGD-1069;LGD1069;NSC-747528;TARGRETIN;TARGRETINE,CHEMBL1023,BRD:BRD-BRD-K92441787-001-04-1;BRD:BRD-K92441787-001-04-1;CTRP:374747;GDSC1:186,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RXRA;RXRB;RXRG,CUTANEOUS T-CELL LYMPHOMA (CTCL),,LAUNCHED,,Small molecule,4,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C;CC1CC2C(CC1C(=C)C1CCC(CC1)C(O)=O)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N
ZIMBACOL XL,BEZAFIBRATE;BEZAGEN XL;BEZALIP;BEZALIP-MONO;BEZATOL SR;BM 15.075;BM-15.075;BM-15075;FIBRAZATE XL;LIPAROL XL;NSC-758174;ZIMBACOL XL,CHEMBL264374,BRD:BRD-BRD-K46018455-001-27-6;BRD:BRD-K46018455-001-27-6,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA;PPARD;PPARG,CHOLESTEROL,,LAUNCHED,,Small molecule,4,"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O;CC(C)(OC1CCC(CCNC(=O)C2CCC(CL)CC2)CC1)C(O)=O, CC(C)(OC1CCC(CCNC(=O)C2CCC(CL)CC2)CC1)C(O)=O",IIBYAHWJQTYFKB-UHFFFAOYSA-N
WAKIX,BF-2.649;BF-2649;BF2.649;EUROPE;HBS-101;PITOLISANT;TIPROLISANT;WAKIX,CHEMBL462605,BRD:BRD-BRD-K21673112-003-01-3;BRD:BRD-K21673112-003-01-3,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH3,,,PHASE 3,,Small molecule,4,"Clc1ccc(CCCOCCCN2CCCCC2)cc1;CLC1CCC(CCCOCCCN2CCCCC2)CC1, CLC1CCC(CCCOCCCN2CCCCC2)CC1",NNACHAUCXXVJSP-UHFFFAOYSA-N
BFH772,BFH-722;BFH-772;BFH722;BFH772,CHEMBL4080062,BRD:BRD-K00003368-001-01-9,rep_single_dose,VEGFR INHIBITOR,,,,,,Small molecule,2,O=C(Nc1cccc(C(F)(F)F)c1)c1cccc2cc(Oc3cc(CO)ncn3)ccc12,JNLSTLQFDDAULK-UHFFFAOYSA-N
NVP-BGJ398,BGJ-398;BGJ398;INFIGRATINIB;MVP-BGJ398;NVP-BGJ398,CHEMBL1852688,BRD:BRD-BRD-K42728290-001-09-1;BRD:BRD-K42728290-001-09-1;BRD:BRD-U00115288-001-01-9,oncref_1;rep_primary;rep_single_dose,"INHIBITOR OF FGFR1, FGFR2, AND FGFR3",FGFR1;FGFR2;FGFR3;FGFR4;KDR,,,PHASE 2,"Multiple values for MOA: {'INHIBITOR OF FGFR1, FGFR2, AND FGFR3', 'FGFR INHIBITOR'}, defaulting to 'INHIBITOR OF FGFR1, FGFR2, AND FGFR3'
Multiple values for repurposing_target: {'FGFR1;FGFR2;FGFR3', 'FGFR1;FGFR2;FGFR3;FGFR4;KDR'}, taking the union
Multiple values for structure_id: {'U00115288', 'K42728290'}, defaulting to None",Small molecule,4,"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1;CCN1CCN(CC1)C1CCC(NC2CC(NCN2)N(C)C(=O)NC2C(CL)C(OC)CC(OC)C2CL)CC1, CCN1CCN(CC1)C1CCC(NC2CC(NCN2)N(C)C(=O)NC2C(CL)C(OC)CC(OC)C2CL)CC1, CCN1CCN(CC1)C1CCC(NC2CC(NCN2)N(C)C(=O)NC2C(CL)C(OC)CC(OC)C2CL)CC1, CCN1CCN(CC1)C1CCC(NC2CC(NCN2)N(C)C(=O)NC2C(CL)C(OC)CC(OC)C2CL)CC1, CCN1CCN(CC1)C1CCC(NC2CC(NCN2)N(C)C(=O)NC2C(CL)C(OC)CC(OC)C2CL)CC1",QADPYRIHXKWUSV-UHFFFAOYSA-N
BGP-15,BGP-15,CHEMBL4747845,BRD:BRD-K00003393-300-01-9,rep_single_dose,PARP INHIBITOR,,,,,,Small molecule,2,N=C(NOCC(O)CN1CCCCC1)c1cccnc1,MVLOQULXIYSERZ-UHFFFAOYSA-N
NVP-BGT226,BGT-226;BGT226;NVP-BGT-226;NVP-BGT226,CHEMBL3545096,BRD:BRD-BRD-K29415052-050-04-8;BRD:BRD-K29415052-050-04-8,rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,MTOR;PIK3CA;PIK3CB;PIK3CG,,,PHASE 1/PHASE 2,,Small molecule,2,"COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1.O=C(O)/C=C\C(=O)O;COC1CCC(CN1)-C1CCC2NCC3N(C)C(=O)N(-C4CCC(N5CCNCC5)C(C4)C(F)(F)F)C3C2C1, COC1CCC(CN1)-C1CCC2NCC3N(C)C(=O)N(-C4CCC(N5CCNCC5)C(C4)C(F)(F)F)C3C2C1",YUXMAKUNSXIEKN-BTJKTKAUSA-N
BHG712,BHG712,,GDSC1:295,gdsc,,,,,,,,NA,,
BHQ,BHQ,,BRD:BRD-K95603879-001-08-9,rep_single_dose,ATPASE INHIBITOR,ATP2A1,,,,,,NA,,
BI-0319,BI-0319,,BRD:BRD-K00127345-001-01-9,oncref_2,PROTAC DEGRADER OF PTK2,PTK2;VHL,,,,,,NA,,
BI-224436,BI-224436,,BRD:BRD-BRD-K53422148-001-01-8;BRD:BRD-K53422148-001-01-8,rep_primary;rep_single_dose,HIV INTEGRASE INHIBITOR,,,,PHASE 1,,,NA,CC1NC2CCCCC2C(-C2CCC3OCCC4CCNC2C34)C1[C@H](OC(C)(C)C)C(O)=O,
BI-2536,BI 2536;BI-2536,CHEMBL513909,BRD:BRD-BRD-K64890080-001-13-8;BRD:BRD-K64890080-001-13-8;CTRP:347813;GDSC1:60;GDSC2:1086,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,PLK INHIBITOR,BRD4;PLK1;PLK2;PLK3,,,PHASE 2,,Small molecule,2,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1;CC[C@H]1N(C2CCCC2)C2NC(NC3CCC(CC3OC)C(=O)NC3CCN(C)CC3)NCC2N(C)C1=O,XQVVPGYIWAGRNI-JOCHJYFZSA-N
BI-2852,BI-2852,,BRD:BRD-K00006885-001-03-9,oncref_1,INHIBITOR OF KRAS,KRAS,,,,,,NA,,
COMPOUND I-6,BI-3406;COMPOUND I-6,,BRD:BRD-U00115414-001-01-9,oncref_1;oncref_2,INHIBITOR OF THE KRAS-SOS1 INTERACTION,KRAS;SOS1,,,,,,NA,,
BI-3663,BI-3663,,BRD:BRD-U00115415-001-01-9,oncref_1,PROTAC DEGRADER OF PTK2,PTK2,,,,,,NA,,
BI-3802,BI-3802,,BRD:BRD-K00126481-001-03-9,oncref_2,BCL6-POLYMERIZER,BCL6,,,,,,NA,,
SUB 166499,BI 409306;BI-409306;OSORESNONTRINE;SUB 166499,CHEMBL4206492,BRD:BRD-K00003120-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,2,O=c1[nH]c(Cc2ccccn2)nc2c1cnn2C1CCOCC1,BZTIJCSHNVZMES-UHFFFAOYSA-N
BI-4206,BI-4206,,BRD:BRD-U00115416-001-01-9,oncref_1,INACTIVE STEREOISOMER OF PTK2 DEGRADER BI-0319,PTK2,,,,,,NA,,
BI-5521,BI-5521,,BRD:BRD-K00126784-001-01-9,oncref_2,INHIBITOR OF GSK3,GSK3A;GSK3B,,,,,,NA,,
BI-78D3,BI-78D3,,BRD:BRD-BRD-K73982490-001-02-9;BRD:BRD-K73982490-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,JNK INHIBITOR,MAPK8,,,PRECLINICAL,,,NA,"OC1NNC(SC2NCC(S2)[N+]([O-])=O)N1-C1CCC2OCCOC2C1, OC1NNC(SC2NCC(S2)[N+]([O-])=O)N1-C1CCC2OCCOC2C1",
BI-847325,BI-847325,,BRD:BRD-BRD-K37492701-001-02-9;BRD:BRD-K37492701-001-02-9,rep_primary;rep_single_dose,"AURORA KINASE INHIBITOR, MEK INHIBITOR",AURKA;AURKB;AURKC;MAP2K1;MAP2K2,,,PHASE 1,"Multiple values for MOA: {'MEK INHIBITOR, AURORA KINASE INHIBITOR', 'AURORA KINASE INHIBITOR, MEK INHIBITOR'}, defaulting to 'AURORA KINASE INHIBITOR, MEK INHIBITOR'",,NA,"CCNC(=O)C#CC1CCC2C(NC(=O)\C2=C(\NC2CCC(CN(C)C)CC2)C2CCCCC2)C1, CCNC(=O)C#CC1CCC2C(NC(=O)\C2=C(\NC2CCC(CN(C)C)CC2)C2CCCCC2)C1",
BI-9930,BI-9930,,BRD:BRD-U00115432-001-01-9,oncref_1,INACTIVE REGIOISOMER OF SOS1 ACTIVATOR VUBI1,SOS1,,,,,,NA,,
BI-D1870,BI-D1870,,BRD:BRD-A81370665-001-03-6;BRD:BRD-BRD-A81370665-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,RIBOSOMAL PROTEIN INHIBITOR,RPS6KA1;RPS6KA2;RPS6KA3;RPS6KA6,,,PRECLINICAL,,,NA,"CC(C)CCN1C(C)C(=O)N(C)C2CNC(NC3CC(F)C(O)C(F)C3)NC12, CC(C)CCN1C(C)C(=O)N(C)C2CNC(NC3CC(F)C(O)C(F)C3)NC12, CC(C)CCN1C(C)C(=O)N(C)C2CNC(NC3CC(F)C(O)C(F)C3)NC12",
BIA-10-2474,BIA-10-2474,,BRD:BRD-K00004735-001-01-9,rep_single_dose,FATTY ACID HYDROLASE INHIBITOR,,,,,,,NA,,
OMEGACIN,"BIAPENEM;CL 186,815;CL-186815;L-627;LJ C10,627;LJ-C10627;LJC-10627;OMEGACIN",CHEMBL285347,BRD:BRD-A80321291-001-03-2;BRD:BRD-BRD-A80321291-001-03-2,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"BACTERIAL SEPTICEMIA, PNEUMONIA, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,1,"C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3CN4CNC[N+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3CN4CNC[N+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3CN4CNC[N+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3CN4CNC[N+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3CN4CNC[N+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3CN4CNC[N+]4C3)=C(N2C1=O)C(O)=O;C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(SC3Cn4cnc[n+]4C3)[C@H](C)[C@H]12",MRMBZHPJVKCOMA-YJFSRANCSA-N
VARGATEF,BIBF 1120;BIBF-1120;BIBF1120;INTEDANIB;NINTEDANIB;OFEV;VARGATEF,CHEMBL502835,GDSC1:380,gdsc,,,,,,,Small molecule,4,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,XZXHXSATPCNXJR-ZIADKAODSA-N
BIBN4096,BIBN4096,,BRD:BRD-BRD-K43927145-001-01-2;BRD:BRD-K43927145-001-01-2,rep_primary;rep_single_dose,CALCITONIN ANTAGONIST,CALCA;CALCRL;RAMP1,,,PHASE 2,,,NA,"NCCCC[C@H](NC(=O)[C@@H](CC1CC(BR)C(O)C(BR)C1)NC(=O)N1CCC(CC1)N1CC2CCCCC2NC1=O)C(=O)N1CCN(CC1)C1CCNCC1, NCCCC[C@H](NC(=O)[C@@H](CC1CC(BR)C(O)C(BR)C1)NC(=O)N1CCC(CC1)N1CC2CCCCC2NC1=O)C(=O)N1CCN(CC1)C1CCNCC1, NCCCC[C@H](NC(=O)[C@@H](CC1CC(BR)C(O)C(BR)C1)NC(=O)N1CCC(CC1)N1CC2CCCCC2NC1=O)C(=O)N1CCN(CC1)C1CCNCC1",
BIBR-1532,BIBR-1532,,BRD:BRD-BRD-K04623885-001-07-5;BRD:BRD-K04623885-001-07-5;CTRP:417982;GDSC2:2043,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,TELOMERASE INHIBITOR,TERT,,,PRECLINICAL,,,NA,"C\C(=C/C(=O)NC1CCCCC1C(O)=O)C1CCC2CCCCC2C1, C\C(=C/C(=O)NC1CCCCC1C(O)=O)C1CCC2CCCCC2C1",
BIBU-1361,BIBU-1361,,BRD:BRD-BRD-K49294207-300-03-8;BRD:BRD-K49294207-300-03-8,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PRECLINICAL,,,NA,"CCN(CC)CC1CCN(CC1)C1NCC2NCNC(NC3CCC(F)C(CL)C3)C2N1, CCN(CC)CC1CCN(CC1)C1NCC2NCNC(NC3CCC(F)C(CL)C3)C2N1",
FALNIDAMOL,BIBX 1382;BIBX-1382;BIBX1382;FALNIDAMOL,CHEMBL258940,BRD:BRD-BRD-K70914287-300-02-8;BRD:BRD-K70914287-300-02-8,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2,,,PHASE 1,,Small molecule,1,"CN1CCC(CC1)NC1NCC2NCNC(NC3CCC(F)C(CL)C3)C2N1, CN1CCC(CC1)NC1NCC2NCNC(NC3CCC(F)C(CL)C3)C2N1;CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1",FTFRZXFNZVCRSK-UHFFFAOYSA-N
NSC-759816,"BICALUTAMIDE;CALUTIDE;CASODEX;COSUDEX;ICI 176,334;ICI-176334;ICI176,334-1;KALUMID;NSC-759816",CHEMBL409,BRD:BRD-A29485665-001-12-8;BRD:BRD-BRD-A29485665-001-12-8;GDSC1:150;GDSC1:1502,gdsc;rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AR,PROSTATE CANCER,,LAUNCHED,,Small molecule,4,"CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1;CC(O)(CS(=O)(=O)C1CCC(F)CC1)C(=O)NC1CCC(C#N)C(C1)C(F)(F)F, CC(O)(CS(=O)(=O)C1CCC(F)CC1)C(=O)NC1CCC(C#N)C(C1)C(F)(F)F, CC(O)(CS(=O)(=O)C1CCC(F)CC1)C(=O)NC1CCC(C#N)C(C1)C(F)(F)F",LKJPYSCBVHEWIU-UHFFFAOYSA-N
BICIFADINE,BICIFADINE,CHEMBL511099,BRD:BRD-A24208517-003-01-8;BRD:BRD-BRD-A24208517-003-01-8,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST",DRD2;SLC6A2;SLC6A4,,,PHASE 3,"Multiple values for MOA: {'SEROTONIN RECEPTOR ANTAGONIST, DOPAMINE REUPTAKE INHIBITOR', 'DOPAMINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST'}, defaulting to 'DOPAMINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST'",Small molecule,3,Cc1ccc(C23CNCC2C3)cc1;CC1CCC(CC1)C12CC1CNC2,OFYVIGTWSQPCLF-UHFFFAOYSA-N
GS-9883-01,BICTEGRAVIR;GS-9883;GS-9883-01,CHEMBL3989866,BRD:BRD-K00003247-001-01-9,rep_single_dose,HIV INTEGRASE INHIBITOR,,,,,,Small molecule,4,O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2,SOLUWJRYJLAZCX-LYOVBCGYSA-N
BICUCULLINE-(+),BICUCULLINE-(+),,BRD:BRD-A07870296-001-07-4;BRD:BRD-BRD-A07870296-001-07-4,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;KCNN1,,,PRECLINICAL,,,NA,"CN1CCC2CC3OCOC3CC2C1[C@@H]1OC(=O)C2C1CCC1OCOC21, CN1CCC2CC3OCOC3CC2C1[C@@H]1OC(=O)C2C1CCC1OCOC21",
BICUCULLINE-METHOCHLORIDE-(-),BICUCULLINE-METHOCHLORIDE-(-),,BRD:BRD-A57798559-004-02-3;BRD:BRD-BRD-A57798559-004-02-3,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,"C[N+]1(C)CCC2CC3OCOC3CC2C1[C@@H]1OC(=O)C2C1CCC1OCOC21, C[N+]1(C)CCC2CC3OCOC3CC2C1[C@@H]1OC(=O)C2C1CCC1OCOC21, C[N+]1(C)CCC2CC3OCOC3CC2C1[C@@H]1OC(=O)C2C1CCC1OCOC21",
BICYCLOL,BICYCLOL,CHEMBL482035,BRD:BRD-BRD-K16546375-001-01-4;BRD:BRD-K16546375-001-01-4,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,HSPA1A;HSPB1,,,LAUNCHED,,Small molecule,3,COC(=O)c1cc(OC)c2c(c1-c1c(CO)cc(OC)c3c1OCO3)OCO2;COC(=O)C1CC(OC)C2OCOC2C1-C1C2OCOC2C(OC)CC1CO,KXMTXZACPVCDMH-UHFFFAOYSA-N
BIFEMELANE HYDROCHLORIDE,BIFEMELANE;BIFEMELANE HYDROCHLORIDE,CHEMBL1192517,BRD:BRD-BRD-K18779551-003-07-8;BRD:BRD-K18779551-003-07-8,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RELEASE ENHANCER,MAOA;MAOB,"GLAUCOMA, SENILE DEMENTIA",,LAUNCHED,,Small molecule,-1,"CNCCCCOc1ccccc1Cc1ccccc1;CNCCCCOC1CCCCC1CC1CCCCC1, CNCCCCOC1CCCCC1CC1CCCCC1",QSQQPMHPCBLLGX-UHFFFAOYSA-N
DIPHENYL DIMETHYL BICARBOXYLATE,.ALPHA.-DDB;BIFENDATE;DIMETHYL DICARBOXYLATE BIPHENYL;DIPHENYL DIMETHYL BICARBOXYLATE,CHEMBL105184,BRD:BRD-BRD-K26581543-001-01-6;BRD:BRD-K26581543-001-01-6,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,1,COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)OC)cc(OC)c3c1OCO3)OCO2;COC(=O)C1CC(OC)C2OCOC2C1-C1C2OCOC2C(OC)CC1C(=O)OC,JMZOMFYRADAWOG-UHFFFAOYSA-N
NSC-758954,BAY H 4502;BAY-H-4502;BIFONAZOLE;D01AC10;MYCOSPOR;NSC-758954,CHEMBL277535,BRD:BRD-A94543220-001-24-7;BRD:BRD-BRD-A94543220-001-24-7,rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,CYP2B6,"TINEA PEDIS, TINEA CRURIS",,LAUNCHED,,Small molecule,4,"c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1;C1CN(CN1)C(C1CCCCC1)C1CCC(CC1)-C1CCCCC1, C1CN(CN1)C(C1CCCCC1)C1CCC(CC1)-C1CCCCC1",OCAPBUJLXMYKEJ-UHFFFAOYSA-N
CNF2024,BIIB 021;BIIB-021;BIIB021;CNF-2024;CNF2024,CHEMBL467399,BRD:BRD-BRD-K51967704-001-03-6;BRD:BRD-K51967704-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1,,,PHASE 2,,Small molecule,2,"COC1C(C)CNC(CN2CNC3C(CL)NC(N)NC23)C1C, COC1C(C)CNC(CN2CNC3C(CL)NC(N)NC23)C1C;COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C",QULDDKSCVCJTPV-UHFFFAOYSA-N
BIIB068,BIIB-068;BIIB068,CHEMBL4650450,BRD:BRD-K00091113-001-01-9,rep_single_dose,,,,,,,Unknown,1,,
ILAXTEN,BILASTINE;ILAXTEN,CHEMBL1742423,BRD:BRD-BRD-K51937257-001-01-4;BRD:BRD-K51937257-001-01-4,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21;CCOCCN1C(NC2CCCCC12)C1CCN(CCC2CCC(CC2)C(C)(C)C(O)=O)CC1,ACCMWZWAEFYUGZ-UHFFFAOYSA-N
BILOBALIDE,BILOBALIDE,CHEMBL133266,BRD:BRD-A41714661-001-02-0;BRD:BRD-BRD-A41714661-001-02-0,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GLRA1;GLRA2;GLRB;HTR3A;HTR3B,,,PRECLINICAL,,Small molecule,NA,CC(C)(C)[C@]1(O)C[C@@H]2OC(=O)C[C@@]22C(=O)O[C@@H]3OC(=O)[C@H](O)C123;CC(C)(C)[C@]1(O)CC2OC(=O)CC23C(=O)OC2OC(=O)[C@H](O)C231,MOLPUWBMSBJXER-YKFMWRJQSA-N
PROSTAMIDE,AGN 192024;AGN-192024;BIMATOPROST;DURYSTA;LATISSE;LUMIGAN;PROSTAMIDE,CHEMBL1200963,BRD:BRD-A45153512-001-01-0;BRD:BRD-BRD-A45153512-001-01-0,rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,AKR1C3;PTGER1;PTGER3;PTGFR,"INTRAOCULAR PRESSURE, GLAUCOMA, OCULAR HYPERTENSION",,LAUNCHED,,Small molecule,4,CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O;CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(O)CCC1CCCCC1,AQOKCDNYWBIDND-FTOWTWDKSA-N
TBC-1269,BIMOSIAMOSE;TBC-1269,CHEMBL1215923,BRD:BRD-K00077698-001-02-9,rep_single_dose,,,,,,,Small molecule,2,O=C(O)Cc1cccc(-c2cc(CCCCCCc3ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(-c4cccc(CC(=O)O)c4)c3)ccc2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)c1,RYWCQJDEHXJHRI-XJMXIVSISA-N
BIMU-8,BIMU-8,,BRD:BRD-A62743154-003-01-5;BRD:BRD-BRD-A62743154-003-01-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR4,,,PRECLINICAL,,,NA,CC(C)N1C2CCCCC2N(C(=O)NC2C[C@@H]3CC[C@H](C2)N3C)C1=O,
BINA,BINA,,BRD:BRD-A13293292-001-02-6;BRD:BRD-BRD-A13293292-001-02-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM2,,,PRECLINICAL,,,NA,CC1C2C(=O)C(CC2CC(OCC2CCCC(C2)-C2CCC(CC2)C(O)=O)C1C)C1CCCC1,
BINDARIT,AF 2838;AF-2838;BINDARIT,CHEMBL2107549,BRD:BRD-BRD-K36467523-001-02-8;BRD:BRD-K36467523-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,CCL2;CCL7;CCL8,,,PHASE 2,,Small molecule,2,CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(=O)O;CC(C)(OCC1NN(CC2CCCCC2)C2CCCCC12)C(O)=O,MTHORRSSURHQPZ-UHFFFAOYSA-N
BIO-1211,BIO-1211,,BRD:BRD-BRD-K03399463-001-01-6;BRD:BRD-K03399463-001-01-6,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGA4;ITGB1,,,PHASE 2,,,NA,CC(C)C[C@H](NC(=O)CC1CCC(NC(=O)NC2CCCCC2C)CC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O,
BIO-5192,BIO-5192,,BRD:BRD-BRD-K21318844-001-01-4;BRD:BRD-K21318844-001-01-4,rep_primary;rep_single_dose,INTEGRIN INHIBITOR,ITGA4;ITGB1,,,PRECLINICAL,,,NA,CC(C)C[C@H](N(C)C(=O)CC1CCC(NC(=O)NC2CCCCC2C)CC1)C(=O)NCC[C@H](NC(=O)[C@@H]1CCCN1S(=O)(=O)C1CC(CL)CC(CL)C1)C(O)=O,
VITAMIN H,BIOEPIDERM;BIOTIN;BIOTIN 100;D-BIOTIN;MD-1003;NSC-63865;RITATIN;VITAMIN B7;VITAMIN H,CHEMBL857,BRD:BRD-BRD-K89210380-001-13-7;BRD:BRD-K89210380-001-13-7,rep_primary;rep_single_dose,VITAMIN B,ACACA;ACACB;HLCS;MCCC1;MCCC2;PC;PCCA;PCCB;SLC5A6,,,LAUNCHED,,Small molecule,4,"O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21;OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12, OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12",YBJHBAHKTGYVGT-ZKWXMUAHSA-N
BIPENAMOL,BIPENAMOL,CHEMBL310160,BRD:BRD-BRD-K47690382-001-03-0;BRD:BRD-K47690382-001-03-0,rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,CTSC,,,PHASE 2,,Small molecule,-1,NCc1ccccc1Sc1ccccc1CO;NCC1CCCCC1SC1CCCCC1CO,HLAFSNJRKZLMPT-UHFFFAOYSA-N
NSC-759145,AKINETON;AKINETON-;BIPERIDEN;BIPERIDENUM;KL 373;NSC-759145,CHEMBL1101,BRD:BRD-A00546892-001-02-6;BRD:BRD-BRD-A00546892-001-02-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;CHRNA2,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,"OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1CCCCC1, OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1CCCCC1;OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2",YSXKPIUOCJLQIE-UHFFFAOYSA-N
BIRB 796,BIRB 796,,GDSC1:1042;GDSC2:1042,gdsc,,,,,,,,NA,,
DORAMAPIMOD,BIRB 796 BS;BIRB-796;BIRB-796 BS;DORAMAPIMOD,CHEMBL103667,CTRP:660412;GDSC1:1042;GDSC2:1042,ctrp;gdsc,,,,,,,Small molecule,2,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,MVCOAUNKQVWQHZ-UHFFFAOYSA-N
TL32711,BIRINAPANT;TL-32711;TL32711,CHEMBL3039522,BRD:BRD-BRD-K71221037-001-01-6;BRD:BRD-K71221037-001-01-6;CTRP:660778,ctrp;rep_multi_dose;rep_primary;rep_single_dose,XIAP INHIBITOR,BIRC2;XIAP,,,PHASE 2,,Small molecule,2,"CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12;CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC1C([NH]C2CC(F)CCC12)-C1[NH]C2CC(F)CCC2C1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC, CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC1C([NH]C2CC(F)CCC12)-C1[NH]C2CC(F)CCC2C1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC",PKWRMUKBEYJEIX-DXXQBUJASA-N
BIRT-377,BIRT-377,,BRD:BRD-BRD-K64880136-001-02-6;BRD:BRD-K64880136-001-02-6,rep_primary;rep_single_dose,LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN NEGATIVE MODULATOR,ICAM1,,,PRECLINICAL,,,NA,CN1C(=O)N(C(=O)[C@@]1(C)CC1CCC(BR)CC1)C1CC(CL)CC(CL)C1,
BIS(MALTOLATO)OXOVANADIUM(IV),BIS(MALTOLATO)OXOVANADIUM(IV),CHEMBL286447,BRD:BRD-BRD-K16180792-001-01-7;BRD:BRD-K16180792-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,TYROSINE PHOSPHATASE INHIBITOR,PTPN1,,,PHASE 2,,Small molecule,NA,CC1OCCC(=O)C1O[V](=O)OC1C(C)OCCC1=O,
THERALAX,BIOLAX;BISACODYL;CAPLETS;CORRECTOL TABLETS;DULCODOS;DULCOLAX;ENTROLAX;EVAC-Q-TABS;FEEN-A-MINT TABLETS;MODANE;NSC-755914;SK-BISACODYL;THERALAX,CHEMBL942,BRD:BRD-BRD-K39987650-001-24-1;BRD:BRD-K39987650-001-24-1,rep_multi_dose;rep_primary;rep_single_dose,LAXATIVE,,CONSTIPATION,,LAUNCHED,,Small molecule,4,"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1;CC(=O)OC1CCC(CC1)C(C1CCC(OC(C)=O)CC1)C1CCCCN1, CC(=O)OC1CCC(CC1)C(C1CCC(OC(C)=O)CC1)C1CCCCN1",KHOITXIGCFIULA-UHFFFAOYSA-N
NSC-337766,BISANTRENE;NSC-337766,CHEMBL139554;CHEMBL25336,BRD:BRD-K00003395-001-01-9,rep_single_dose,TOPOISOMERASE INHIBITOR,,,,,,Small molecule,3,C(=N/NC1=NCCN1)\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12,NJSMWLQOCQIOPE-OCHFTUDZSA-N
BISINDOLYLMALEIMIDE-IX,BISINDOLYLMALEIMIDE-IX,,BRD:BRD-BRD-K06543683-066-02-1;BRD:BRD-K06543683-066-02-1,rep_multi_dose;rep_primary;rep_single_dose,PKC INHIBITOR,AKT1;GSK3B;LCK;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;PRKCA;ROCK1;RPS6KB1;SIRT1,,,PRECLINICAL,,,NA,"CN1CC(C2=C(C(=O)NC2=O)C2CN(CCCSC(N)=N)C3CCCCC23)C2CCCCC12, CN1CC(C2=C(C(=O)NC2=O)C2CN(CCCSC(N)=N)C3CCCCC23)C2CCCCC12, CN1CC(C2=C(C(=O)NC2=O)C2CN(CCCSC(N)=N)C3CCCCC23)C2CCCCC12, CN1CC(C2=C(C(=O)NC2=O)C2CN(CCCSC(N)=N)C3CCCCC23)C2CCCCC12",
BISMUTH(III)-TRIFLUOROMETHANESULFONATE,BISMUTH(III)-TRIFLUOROMETHANESULFONATE,,BRD:BRD-BRD-M56276249-001-01-1;BRD:BRD-M56276249-001-01-1,rep_primary;rep_single_dose,DIRECT SUBSTITUTION CATALYST,,,,PRECLINICAL,,,NA,[BI].OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F,
BISMUTH-OXALATE,BISMUTH-OXALATE,,BRD:BRD-BRD-M02179497-001-01-1;BRD:BRD-M02179497-001-01-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,[BI].[BI].OC(=O)C(O)=O.OC(=O)C(O)=O.OC(=O)C(O)=O,
BISMUTH-SUBCITRATE-POTASSIUM,BISMUTH-SUBCITRATE-POTASSIUM,,BRD:BRD-A03880619-001-01-0;BRD:BRD-BRD-A03880619-001-01-0,rep_primary;rep_single_dose,,,DUODENAL ULCER DISEASE,,LAUNCHED,,,NA,"OC(=O)CC(O)(CC(=O)O[BI]1OC(=O)CC(O)(CC(O)=O)C(=O)O1)C(O)=O, OC(=O)CC(O)(CC(=O)O[BI]1OC(=O)CC(O)(CC(O)=O)C(=O)O1)C(O)=O",
BISMUTH-SUBSALICYLATE,BISMUTH-SUBSALICYLATE,,BRD:BRD-K80528473-001-03-0,rep_single_dose,ANTACID,,,,,,,NA,,
ZIAC,"BISOPROLOL;CL 297,939;CL-297939;EMD 33 512;EMD-33-512;ZEBETA;ZIAC",CHEMBL645,BRD:BRD-A89175223-051-14-8;BRD:BRD-BRD-A89175223-051-14-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1;CC(C)NCC(O)COC1CCC(COCCOC(C)C)CC1, CC(C)NCC(O)COC1CCC(COCCOC(C)C)CC1, CC(C)NCC(O)COC1CCC(COCCOC(C)C)CC1, CC(C)NCC(O)COC1CCC(COCCOC(C)C)CC1",VHYCDWMUTMEGQY-UHFFFAOYSA-N
BISPHENOL-A,BISPHENOL-A,,BRD:BRD-BRD-K41494493-001-13-8;BRD:BRD-K41494493-001-13-8,rep_primary;rep_single_dose,SYNTHETIC ESTROGEN,AR;ESR1;ESR2;ESRRG;PPARG,,,PHASE 1,,,NA,CC(C)(C1CCC(O)CC1)C1CCC(O)CC1,
NSC-47129,BITHIN;BITHIONOL;LOROTHIDOL;NSC-47129,CHEMBL290106,BRD:BRD-BRD-K39120595-304-04-7;BRD:BRD-K39120595-304-04-7,rep_primary;rep_single_dose,AUTOTAXIN INHIBITOR,ESR1;ESR2;MCL1,,,WITHDRAWN,,Small molecule,4,Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O;OC1C(CL)CC(CL)CC1SC1CC(CL)CC(CL)C1O,JFIOVJDNOJYLKP-UHFFFAOYSA-N
RO4917838,BITOPERTIN;PALIFLUTINE;R-1678;RG-1678;RO-4917838;RO-4917939;RO4917838,CHEMBL1169880;CHEMBL1171829,BRD:BRD-BRD-K13756951-001-01-4;BRD:BRD-K13756951-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,"GLYCINE TRANSPORTER INHIBITOR, GLYT-1 INHIBITOR",SLC6A5;SLC6A9,,,PHASE 3,,Small molecule,3,C[C@H](OC1CCC(CC1C(=O)N1CCN(CC1)C1NCC(CC1F)C(F)(F)F)S(C)(=O)=O)C(F)(F)F;C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(F)(F)F,YUUGYIUSCYNSQR-LBPRGKRZSA-N
BIVALIRUDIN IN 0.9% SODIUM CHLORIDE,ANGIOMAX;ANGIOMAX RTU;BG-8967;BG8967;BIVALIRUDIN;BIVALIRUDIN IN 0.9% SODIUM CHLORIDE,CHEMBL2103749,BRD:BRD-BRD-K73504359-001-01-3;BRD:BRD-K73504359-001-01-3,rep_primary;rep_single_dose,THROMBIN INHIBITOR,F2,ANGINA PECTORIS,,LAUNCHED,,Protein,4,"[2H]N[C@@H](CC1CCCCC1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1CCC(O)CC1)C(=O)N[C@@H](CC(C)C)C(O)=O, CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1CCCCC1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1CCC(O)CC1)C(=O)N[C@@H](CC(C)C)C(O)=O, CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1CCCCC1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1CCC(O)CC1)C(=O)N[C@@H](CC(C)C)C(O)=O;CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O",OIRCOABEOLEUMC-GEJPAHFPSA-N
BIX-01294,BIX-01294,,BRD:BRD-BRD-K26818574-305-04-3;BRD:BRD-BRD-K26818574-305-07-6;BRD:BRD-K26818574-305-04-3;BRD:BRD-K26818574-305-07-6;CTRP:53705,ctrp;rep_multi_dose;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT1;EHMT2,,,PRECLINICAL,,,NA,"COC1CC2NC(NC(NC3CCN(CC4CCCCC4)CC3)C2CC1OC)N1CCCN(C)CC1, COC1CC2NC(NC(NC3CCN(CC4CCCCC4)CC3)C2CC1OC)N1CCCN(C)CC1, COC1CC2NC(NC(NC3CCN(CC4CCCCC4)CC3)C2CC1OC)N1CCCN(C)CC1, COC1CC2NC(NC(NC3CCN(CC4CCCCC4)CC3)C2CC1OC)N1CCCN(C)CC1",
BIX-02188,BIX-02188,,BRD:BRD-BRD-K20290250-001-01-3;BRD:BRD-BRD-K20290250-001-02-1;BRD:BRD-K20290250-001-01-3;BRD:BRD-K20290250-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K5,,,PRECLINICAL,,,NA,"CN(C)CC1CCCC(N\C(C2CCCCC2)=C2/C(=O)NC3CC(CCC23)C(N)=O)C1, CN(C)CC1CCCC(N\C(C2CCCCC2)=C2/C(=O)NC3CC(CCC23)C(N)=O)C1",
BIX-02189,BIX-02189,,BRD:BRD-BRD-K73368362-001-07-5;BRD:BRD-K73368362-001-07-5,rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K5;MAPK7,,,PRECLINICAL,,,NA,"CN(C)CC1CCCC(N\C(C2CCCCC2)=C2/C(=O)NC3CC(CCC23)C(=O)N(C)C)C1, CN(C)CC1CCCC(N\C(C2CCCCC2)=C2/C(=O)NC3CC(CCC23)C(=O)N(C)C)C1",
BIX02189,BIX 02189;BIX02189,,GDSC1:279,gdsc,,,,,,,,NA,,
BIX02565,BIX02565,,BRD:BRD-K00126783-001-01-9,oncref_2,INHIBITOR OF RSK2,ADRA1A;ADRA1B;ADRA2A;ADRB2;LRRK2;NISCH;PRKD1;RSK1;RSK2;RSK3,,,,,,NA,,
BL-5583,BL-5583,,BRD:BRD-BRD-K75282704-001-02-4;BRD:BRD-K75282704-001-02-4,rep_primary;rep_single_dose,HYPERCALCAEMIC AGENT,,,,PRECLINICAL,,,NA,OC(=O)C1CC2CCCCC2S1,
BLEBBISTATIN,BLEBBISTATIN,,CTRP:50140,ctrp,,,,,,,,NA,,
BLEBBISTATIN-(+/-),BLEBBISTATIN-(+/-),,BRD:BRD-A75817871-001-06-7;BRD:BRD-BRD-A75817871-001-06-7,rep_primary;rep_single_dose,ATPASE INHIBITOR,MYH14;MYH2,,,PRECLINICAL,"Multiple values for repurposing_target: {'MYH14;MYH2', 'MYH2'}, taking the union",,NA,CC1CCC2N=C3N(CCC3(O)C(=O)C2C1)C1CCCCC1,
BLEBBISTATIN-(-),BLEBBISTATIN-(-),,BRD:BRD-BRD-K61295575-001-03-6;BRD:BRD-K61295575-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,ATPASE INHIBITOR,,,,PRECLINICAL,,,NA,CC1CCC2N=C3N(CC[C@@]3(O)C(=O)C2C1)C1CCCCC1,
NSC-125066,BLENAMAX;BLEO-KYOWA;BLEOCIN;BLEOMYCIN;BLEOMYCIN HEXAL;BLEOMYCIN HYDROCHLORIDE;BLEOMYCINS;NSC-125066,CHEMBL403664,GDSC1:190,gdsc,,,,,,,Small molecule,4,Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1,OYVAGSVQBOHSSS-UAPAGMARSA-O
BLEOMYCIN (50 UM),BLEOMYCIN (50 UM),,GDSC1:1378,gdsc,,,,,,,,NA,,
BLEOMYCIN A2,BLEOMYCIN A2,,CTRP:639531,ctrp,,,,,,,,NA,,
DSP-5423,AD-5423;BLONANSERIN;DSP-5423,CHEMBL178803,BRD:BRD-BRD-K25943794-001-02-3;BRD:BRD-K25943794-001-02-3,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",DRD2;HTR2A,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,3,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1;CCN1CCN(CC1)C1CC(-C2CCC(F)CC2)C2CCCCCCC2N1,XVGOZDAJGBALKS-UHFFFAOYSA-N
BLU9931,BLU9931,,BRD:BRD-K72898849-001-01-8,rep_single_dose,FGFR INHIBITOR,FGFR4,,,,,,NA,,
BLZ945,BLZ945,CHEMBL4227505,BRD:BRD-K83157152-001-02-9,rep_single_dose,CSF1R INHIBITOR,,,,,,Small molecule,2,CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1,ADZBMFGQQWPHMJ-RHSMWYFYSA-N
BML-190,BML-190,,BRD:BRD-BRD-K94379058-001-06-8;BRD:BRD-K94379058-001-06-8,rep_primary;rep_single_dose,CANNABINOID RECEPTOR INVERSE AGONIST,CNR2,,,PRECLINICAL,,,NA,"COC1CCC2N(C(=O)C3CCC(CL)CC3)C(C)C(CC(=O)N3CCOCC3)C2C1, COC1CCC2N(C(=O)C3CCC(CL)CC3)C(C)C(CC(=O)N3CCOCC3)C2C1",
BML-284,BML-284,,BRD:BRD-BRD-K42624714-001-04-1;BRD:BRD-K42624714-001-04-1,rep_primary;rep_single_dose,WNT AGONIST,,,,PRECLINICAL,,,NA,COC1CCCC(C1)-C1CC(NCC2CCC3OCOC3C2)NC(N)N1,
TALAZOPARIB,BMN 673;BMN 973;BMN-673;LT-673;TALAZOPARIB,CHEMBL3137320,GDSC1:1259;GDSC2:1259,gdsc,,,,,,,Small molecule,4,Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,HWGQMRYQVZSGDQ-HZPDHXFCSA-N
BMS 536924,BMS 536924,,GDSC1:1091;GDSC1:62;GDSC2:1091,gdsc,,,,,,,,NA,,
BMS-182874,BMS-182874,CHEMBL267458,BRD:BRD-K56509348-003-04-9,rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA,,,,,Small molecule,NA,Cc1noc(NS(=O)(=O)c2cccc3c(N(C)C)cccc23)c1C,MJRGSRRZKSJHOE-UHFFFAOYSA-N
BMS-191011,BMS-191011,,BRD:BRD-BRD-K95609758-001-03-7;BRD:BRD-K95609758-001-03-7,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNMA1,,,PRECLINICAL,,,NA,"OC1CCC(CL)CC1CN1NC(OC1=O)-C1CCC(CC1)C(F)(F)F, OC1CCC(CL)CC1CN1NC(OC1=O)-C1CCC(CC1)C(F)(F)F",
BMS-191095,BMS-191095,CHEMBL11594,BRD:BRD-BRD-K01231377-001-01-8;BRD:BRD-K01231377-001-01-8,rep_primary;rep_single_dose,"KATP ACTIVATOR, POTASSIUM CHANNEL AGONIST",,,,PHASE 1,,Small molecule,NA,CC1(C)Oc2ccc(C#N)cc2[C@H](N(Cc2ncc[nH]2)c2ccc(Cl)cc2)[C@H]1O;CC1(C)OC2CCC(CC2[C@@H]([C@H]1O)N(CC1NCC[NH]1)C1CCC(CL)CC1)C#N,SMIKIPXIDLITMP-LEWJYISDSA-N
BMS-195614,BMS-195614,,CTRP:660228,ctrp,,,,,,,,NA,,
BMS-207940,BMS-207940,,BRD:BRD-K00004634-001-01-9,rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,,,,,,,NA,,
BMS-214662,BMS 214662;BMS-214662,CHEMBL351706,BRD:BRD-K00003203-001-01-9,rep_single_dose,FARNESYLTRANSFERASE INHIBITOR,,,,,,Small molecule,1,N#Cc1ccc2c(c1)CN(S(=O)(=O)c1cccs1)[C@H](Cc1ccccc1)CN2Cc1c[nH]cn1,OLCWFLWEHWLBTO-HSZRJFAPSA-N
BMS-265246,BMS-265246,,BRD:BRD-BRD-K62814476-001-03-3;BRD:BRD-K62814476-001-03-3,rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2,,,PRECLINICAL,,,NA,"CCCCOC1C(CNC2[NH]NCC12)C(=O)C1C(F)CC(C)CC1F, CCCCOC1C(CNC2[NH]NCC12)C(=O)C1C(F)CC(C)CC1F",
BMS-270394,BMS-270394,,CTRP:660321,ctrp,,,,,,,,NA,,
BMS-299897,BMS-299897,,BRD:BRD-BRD-K02950022-001-02-9;BRD:BRD-K02950022-001-02-9,rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,,,,PHASE 1,,,NA,C[C@@H](N(C1CC(F)CCC1F)S(=O)(=O)C1CCC(CL)CC1)C1CCC(F)CC1CCCC(O)=O,
BMS-309403,BMS-309403,,BRD:BRD-BRD-K87956243-001-01-9;BRD:BRD-K87956243-001-01-9,rep_primary;rep_single_dose,FATTY ACID BINDING PROTEIN INHIBITOR,FABP4,,,PRECLINICAL,,,NA,CCC1C(C(NN1-C1CCCCC1-C1CCCC(OCC(O)=O)C1)-C1CCCCC1)-C1CCCCC1,
BMS-345541,BMS-345541,CHEMBL249697,BRD:BRD-BRD-K13566078-001-02-3;BRD:BRD-K13566078-001-02-3;CTRP:622911;GDSC1:203;GDSC2:1249,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,IKK INHIBITOR,CHUK;IKBKB,,,PRECLINICAL,,Small molecule,NA,"Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1;CC1CNC2C(NCCN)NC3CCC(C)CC3N12, CC1CNC2C(NCCN)NC3CCC(C)CC3N12",PSPFQEBFYXJZEV-UHFFFAOYSA-N
SNS-032,BMS-387032;BMS387032;SNS 032;SNS-032,CHEMBL296468,BRD:BRD-BRD-K43389698-001-09-9;BRD:BRD-K43389698-001-09-9,rep_multi_dose;rep_primary;rep_single_dose,"CDK INHIBITOR, CELL CYCLE INHIBITOR, MCL1 INHIBITOR",CDK2;CDK7;CDK9,,,PHASE 1,,Small molecule,1,"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1;CC(C)(C)C1CNC(CSC2CNC(NC(=O)C3CCNCC3)S2)O1, CC(C)(C)C1CNC(CSC2CNC(NC(=O)C3CCNCC3)S2)O1",OUSFTKFNBAZUKL-UHFFFAOYSA-N
BMS-470539,BMS-470539,,BRD:BRD-K22000702-300-02-9,rep_single_dose,MELANOCORTIN RECEPTOR AGONIST,MC1R,,,,,,NA,,
BMS-536924,BMS-536924,,BRD:BRD-K34581968-001-04-6;CTRP:411859;GDSC1:1091;GDSC1:62;GDSC2:1091,ctrp;gdsc;rep_single_dose,IGF-1 INHIBITOR,AKT1;CCNE1;CDK2;CYP3A4;ERBB2;IGF1R;KDR;LCK;MAPK1;MET;PDGFRA;PDGFRB,,,,,,NA,,
BMS-566419,BMS-566419,,BRD:BRD-K56932272-001-02-9,rep_single_dose,INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,IMPDH1;IMPDH2,,,,,,NA,,
PS-540446,BMS 582949;BMS-582949;PS-540446,CHEMBL1230065,BRD:BRD-K00003168-003-01-9,rep_single_dose,P38 MAPK INHIBITOR,,,,,,Small molecule,2,CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C,GDTQLZHHDRRBEB-UHFFFAOYSA-N
BMS-587101,BMS-587101,,BRD:BRD-BRD-K20093108-001-02-3;BRD:BRD-K20093108-001-02-3,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGAL;ITGB2,,,PHASE 2,,,NA,CN1C(=O)N(C(=O)[C@]11CN(CC2CC(CS2)C(O)=O)C[C@H]1C1CCC(CC1)C#N)C1CC(CL)CC(CL)C1,
BMS-599626,AC-480;AC480;BMS 599626;BMS-599626,CHEMBL1645462,BRD:BRD-BRD-K07106112-003-03-8;BRD:BRD-K07106112-003-03-8,rep_multi_dose;rep_primary;rep_single_dose,"EGFR INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",EGFR;ERBB2;ERBB4,,,PHASE 1,,Small molecule,1,"Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12;CC1C(NC(=O)OC[C@@H]2COCCN2)CN2NCNC(NC3CCC4N(CC5CCCC(F)C5)NCC4C3)C12, CC1C(NC(=O)OC[C@@H]2COCCN2)CN2NCNC(NC3CCC4N(CC5CCCC(F)C5)NCC4C3)C12",LUJZZYWHBDHDQX-QFIPXVFZSA-N
TEMSAVIR,BMS-626529;TEMSAVIR,CHEMBL3301620,BRD:BRD-BRD-K97883416-001-01-4;BRD:BRD-K97883416-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,HIV ATTACHMENT INHIBITOR,,,,PHASE 3,,Small molecule,1,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12;COC1CNC(-N2CNC(C)N2)C2[NH]CC(C(=O)C(=O)N3CCN(CC3)C(=O)C3CCCCC3)C12,QRPZBKAMSFHVRW-UHFFFAOYSA-N
BMS-626531,BMS-626531,,BRD:BRD-K00004550-001-01-9,rep_single_dose,P38 MAPK INHIBITOR,,,,,,,NA,,
BMS-649,BMS-649,,BRD:BRD-BRD-K25991633-001-01-9;BRD:BRD-K25991633-001-01-9,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RXRA,,,PRECLINICAL,,,NA,"CC1(C)CCC(C)(C)C2CC(CCC12)C1(OCCO1)C1CCC(CC1)C(O)=O, CC1(C)CCC(C)(C)C2CC(CCC12)C1(OCCO1)C1CCC(CC1)C(O)=O",
BMS-688521,BMS-688521,,BRD:BRD-BRD-K85649978-001-02-1;BRD:BRD-K85649978-001-02-1,rep_primary;rep_single_dose,"LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN RECEPTOR ANTAGONIST, ICAM1 ANTAGONIST",ICAM1,,,PRECLINICAL,"Multiple values for MOA: {'ICAM1 ANTAGONIST, LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN RECEPTOR ANTAGONIST', 'LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN RECEPTOR ANTAGONIST, ICAM1 ANTAGONIST'}, defaulting to 'LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN RECEPTOR ANTAGONIST, ICAM1 ANTAGONIST'",,NA,CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1C1CCC(CC1)C#N)C1CCC(CN1)C(O)=O)C1CC(CL)CC(CL)C1,
BMS-690514,BMS 6690514;BMS 690514;BMS-690514,CHEMBL3545396,BRD:BRD-BRD-K76239644-001-01-8;BRD:BRD-K76239644-001-01-8;BRD:BRD-K76239644-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,"EGFR INHIBITOR, VEGFR INHIBITOR",EGFR;ERBB2;FLT3;KDR,,,PHASE 2,,Small molecule,2,"COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1;COC1CCCC(NC2NCNN3CCC(CN4CC[C@@H](N)[C@H](O)C4)C23)C1, COC1CCCC(NC2NCNN3CCC(CN4CC[C@@H](N)[C@H](O)C4)C23)C1",CSGQVNMSRKWUSH-IAGOWNOFSA-N
BMS-707035,BMS 707035;BMS-707035,CHEMBL486226,BRD:BRD-BRD-K49555808-001-03-9;BRD:BRD-K49555808-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,HIV INTEGRASE INHIBITOR,,,,PHASE 2,,Small molecule,2,Cn1c(N2CCCCS2(=O)=O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O;CN1C(NC(C(=O)NCC2CCC(F)CC2)C(O)C1=O)N1CCCCS1(=O)=O,VNIWZCGZPBJWBI-UHFFFAOYSA-N
BMS-70816301,AVAGACESTAT;BMS 708163;BMS-708163;BMS-708163-01;BMS-70816301,CHEMBL1090771,GDSC1:1072;GDSC1:205,gdsc,,,,,,,Small molecule,2,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,XEAOPVUAMONVLA-QGZVFWFLSA-N
TANESPIMYCIN,17-AAG;17AAG;BMS-722782;CNF-1010;CNF1010;KOS-953;NSC-330507;TANESPIMYCIN,CHEMBL109480,GDSC1:1026,gdsc,,,,,,,Small molecule,3,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,AYUNIORJHRXIBJ-TXHRRWQRSA-N
BMS754807,BMS 754807;BMS-754807;BMS754807,CHEMBL575448,BRD:BRD-BRD-K13049116-001-05-7;BRD:BRD-K13049116-001-04-0;BRD:BRD-K13049116-001-05-7;CTRP:417981;GDSC1:184;GDSC2:2171,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF IGF1R AND INSR,AKT1;IGF1R;INSR,,,PHASE 2,"Multiple values for MOA: {'IGF-1 INHIBITOR', 'INHIBITOR OF IGF1R AND INSR'}, defaulting to 'INHIBITOR OF IGF1R AND INSR'
Multiple values for repurposing_target: {'IGF1R;INSR', 'AKT1;IGF1R'}, taking the union",Small molecule,2,"C[C@]1(CCCN1C1NC(NC2CC(N[NH]2)C2CC2)C2CCCN2N1)C(=O)NC1CCC(F)NC1, C[C@]1(CCCN1C1NC(NC2CC(N[NH]2)C2CC2)C2CCCN2N1)C(=O)NC1CCC(F)NC1, C[C@]1(CCCN1C1NC(NC2CC(N[NH]2)C2CC2)C2CCCN2N1)C(=O)NC1CCC(F)NC1;C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1",LQVXSNNAFNGRAH-QHCPKHFHSA-N
BMS-770767,BMS-770767,CHEMBL4802167,BRD:BRD-K00004655-001-01-9,rep_single_dose,11-BETA-HSD1 INHIBITOR,,,,,,Unknown,2,,
BMS-777607,ASLAN-002;ASLAN002;BMS-777607,CHEMBL460702,BRD:BRD-BRD-K40738845-001-05-0;BRD:BRD-K40738845-001-05-0,rep_primary;rep_single_dose,"AXL KINASE INHIBITOR, C-MET INHIBITOR, FLT3 INHIBITOR, HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR, MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR, TYROSINE KINASE INHIBITOR",AXL;MERTK;MET;MST1R;TYRO3,,,PHASE 1/PHASE 2,,Small molecule,2,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1;CCOC1CCN(-C2CCC(F)CC2)C(=O)C1C(=O)NC1CCC(OC2CCNC(N)C2CL)C(F)C1,VNBRGSXVFBYQNN-UHFFFAOYSA-N
XL-652,BMS 788;BMS-779788;EXEL 04286652;EXEL-04286652;XL 652;XL-014;XL-652,CHEMBL3545418,BRD:BRD-K00003305-001-01-9,rep_single_dose,LXR AGONIST,,,,,,Small molecule,1,,
BMS-806,BMS-806,,BRD:BRD-BRD-K55773932-001-02-0;BRD:BRD-K55773932-001-02-0,rep_primary;rep_single_dose,HIV ATTACHMENT INHIBITOR,,,,PHASE 1,,,NA,"COC1CC[NH]C2NCC(C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)C3CCCCC3)C12, COC1CC[NH]C2NCC(C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)C3CCCCC3)C12",
BMS-813160,BMS 813160;BMS-813160,CHEMBL4594419,BRD:BRD-K00003512-001-01-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O,CMVHFGNTABZQJU-HCXYKTFWSA-N
BMS-817378,BMS-817378,CHEMBL3545050,BRD:BRD-BRD-K81026553-234-01-8;BRD:BRD-K81026553-234-01-8,rep_primary;rep_single_dose,"C-MET INHIBITOR, VEGFR INHIBITOR",KDR;MET,,,PHASE 1,,Small molecule,1,NC1NCCC(OC2CCC(NC(=O)C3CN(COP(O)(O)=O)CC(-C4CCC(F)CC4)C3=O)CC2F)C1CL,
XL139,BMS-833923;BMS-833923 DIMESYLATE MONOHYDRATE;XL-139;XL139,CHEMBL3545403,BRD:BRD-BRD-K33245965-001-03-4;BRD:BRD-K33245965-001-03-4,rep_primary;rep_single_dose,SMOOTHENED RECEPTOR ANTAGONIST,SMO,,,PHASE 2,,Small molecule,2,"CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1;CNCC1CCC(C)C(NC(=O)C2CCC(NC3NC(-C4CCCCC4)C4CCCCC4N3)CC2)C1, CNCC1CCC(C)C(NC(=O)C2CCC(NC3NC(-C4CCCCC4)C4CCCCC4N3)CC2)C1, CNCC1CCC(C)C(NC(=O)C2CCC(NC3NC(-C4CCCCC4)C4CCCCC4N3)CC2)C1",KLRRGBHZCJLIEL-UHFFFAOYSA-N
XL-413,BMS-863233;XL-413,CHEMBL3544943;CHEMBL3544944,BRD:BRD-BRD-K12511835-003-02-0;BRD:BRD-K12511835-003-02-0,rep_primary;rep_single_dose,CDC INHIBITOR,CDC7;PIM1,,,PHASE 1/PHASE 2,,Small molecule,2,"Cl.O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12;CLC1CCC2OC3C(NC([NH]C3=O)[C@@H]3CCCN3)C2C1, CLC1CCC2OC3C(NC([NH]C3=O)[C@@H]3CCCN3)C2C1",UNDKJUKLBNARIZ-UHFFFAOYSA-N
OSUGACESTAT,AL-101;AL101;BM-0018;BM0018;BMS 906024;BMS-906024;OSUGACESTAT,CHEMBL4297269,BRD:BRD-K29343434-001-02-9,rep_single_dose,GAMMA SECRETASE INHIBITOR,,,,,,Small molecule,2,CN1C(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)N=C(c2ccccc2)c2ccccc21,AYOUDDAETNMCBW-GSHUGGBRSA-N
JAK2 INHIBITOR BMS-911543,BMS-911543;JAK2 INHIBITOR BMS-911543,CHEMBL3545215,BRD:BRD-K00003189-001-01-9,rep_single_dose,JAK INHIBITOR,,,,,,Small molecule,2,CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21,JCINBYQJBYJGDM-UHFFFAOYSA-N
RIMEGEPANT,BHV-3000;BMS-927711;RIMEGEPANT,CHEMBL2178422,BRD:BRD-BRD-K55781385-001-01-7;BRD:BRD-K55781385-001-01-7,rep_primary;rep_single_dose,CALCITONIN ANTAGONIST,CALCA,,,PHASE 2,,Small molecule,4,N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F;N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C3CCCNC3[NH]C2=O)C2NCCCC12)C1CCCC(F)C1F,KRNAOFGYEFKHPB-ANJVHQHFSA-N
BMS-935177,BMS-935177,,BRD:BRD-K00004721-001-01-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,,NA,,
BMS-983970,BMS-983970,,BRD:BRD-BRD-K22316123-001-01-9;BRD:BRD-K22316123-001-01-9,rep_primary;rep_single_dose,NOTCH SIGNALING INHIBITOR,,,,PHASE 1,,,NA,NC(=O)[C@@H](CC1CC1)[C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(C2CCCCC2)C2CCCC(F)C2NC1=O,
BMS-986020,AP-3152 FREE ACID;BMS-986020,CHEMBL4297270,BRD:BRD-BRD-K23952234-236-01-8;BRD:BRD-K00004586-001-01-9,rep_primary;rep_single_dose,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,LPAR1,,,PHASE 2,,Small molecule,2,"C[C@@H](OC(=O)NC1C(C)NOC1-C1CCC(CC1)-C1CCC(CC(O)=O)CC1)C1CCCCC1, C[C@@H](OC(=O)NC1C(C)NOC1-C1CCC(CC1)-C1CCC(CC(O)=O)CC1)C1CCCCC1, C[C@@H](OC(=O)NC1C(C)NOC1-C1CCC(CC1)-C1CCC(CC(O)=O)CC1)C1CCCCC1;Cc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1NC(=O)O[C@H](C)c1ccccc1",GQBRZBHEPUQRPL-LJQANCHMSA-N
BMS-986142,BMS-986142,CHEMBL3900554,BRD:BRD-K00004591-001-01-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,Small molecule,2,Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O,ZRYMMWAJAFUANM-INIZCTEOSA-N
BMS-986158,BET INHIBITOR BMS-986158;BMS-986158,CHEMBL4297458,BRD:BRD-K00003423-001-01-9,rep_single_dose,BROMODOMAIN INHIBITOR,,,,,,Small molecule,1,Cc1nnn(C)c1-c1cnc2c3ccc(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1,KGERZPVQIRYWRK-GDLZYMKVSA-N
SOTYKTU,BMS-986165;DEUCRAVACITINIB;SOTYKTU,CHEMBL4435170,BRD:BRD-K00091094-001-01-9,rep_single_dose,,,,,,,Small molecule,4,[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC,BZZKEPGENYLQSC-FIBGUPNXSA-N
BRANEBRUTINIB,BMS-986195;BRANEBRUTINIB,CHEMBL4297674,BRD:BRD-K00003110-001-01-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,Small molecule,2,CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1,VJPPLCNBDLZIFG-ZDUSSCGKSA-N
ONO-7701,BMS 986205;BMS-986205;F 001287;F-001287;LINRODOSTAT;ONO 7701;ONO-7701,CHEMBL4297598,BRD:BRD-K00003418-001-01-9,rep_single_dose,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",,,,,,Small molecule,3,C[C@@H](C(=O)Nc1ccc(Cl)cc1)C1CCC(c2ccnc3ccc(F)cc23)CC1,KRTIYQIPSAGSBP-KLAILNCOSA-N
BMS-CCR2-22,BMS-CCR2-22,,BRD:BRD-BRD-K15119094-001-01-1;BRD:BRD-K15119094-001-01-1,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR2,,,PRECLINICAL,,,NA,CSC1CCC(CC1)C(=O)N[C@@H]1CCCC[C@@H]1NC(=O)CNC(=O)C1CC(CCC1NC(=O)NC(C)C)C(F)(F)F,
BMS754807,BMS 754807;BMS-754807;BMS754807,CHEMBL575448,GDSC1:184,gdsc,,,,,,,Small molecule,2,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,LQVXSNNAFNGRAH-QHCPKHFHSA-N
XL184,BMS-907351;BMS-907351 FREE BASE;BMS907351;CABOMETYX;CABOZANTINIB;CABOZANTINIB MALATE;CABOZANTINIB S-MALATE;COMETRIQ;XL-184;XL-184 FREE BASE;XL184,CHEMBL2103868;CHEMBL2105717,BRD:BRD-BRD-K51544265-001-04-2;BRD:BRD-K51544265-001-04-2;BRD:BRD-K51544265-001-10-9;CTRP:660840;GDSC1:249,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,"RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",AXL;KDR;MET;RET;VEGFRS,MEDULLARY THYROID CANCER (MTC),,LAUNCHED,"Multiple values for MOA: {'RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR', 'INHIBITOR OF RECEPTOR TYROSINE KINASES'}, defaulting to 'RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR'
Multiple values for repurposing_target: {'KDR;MET;RET', 'AXL;KDR;MET;RET;VEGFRS'}, taking the union
Multiple values for repurposing_target: {'KDR;MET;RET', 'KDR;MET'}, taking the union",Small molecule,4,"COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC;COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC.O=C(O)C[C@H](O)C(=O)O;COC1CC2NCCC(OC3CCC(NC(=O)C4(CC4)C(=O)NC4CCC(F)CC4)CC3)C2CC1OC, COC1CC2NCCC(OC3CCC(NC(=O)C4(CC4)C(=O)NC4CCC(F)CC4)CC3)C2CC1OC",HFCFMRYTXDINDK-WNQIDUERSA-N;ONIQOQHATWINJY-UHFFFAOYSA-N
BMY-14802,BMY-14802,CHEMBL60859,BRD:BRD-A15435692-003-02-3;BRD:BRD-BRD-A15435692-003-02-3,rep_primary;rep_single_dose,SIGMA RECEPTOR ANTAGONIST,HTR1A,,,PHASE 2,,Small molecule,NA,OC(CCCN1CCN(c2ncc(F)cn2)CC1)c1ccc(F)cc1;OC(CCCN1CCN(CC1)C1NCC(F)CN1)C1CCC(F)CC1,ZXUYYZPJUGQHLQ-UHFFFAOYSA-N
BMY-45778,BMY-45778,,BRD:BRD-BRD-K84895041-001-02-4;BRD:BRD-K84895041-001-02-4,rep_primary;rep_single_dose,IP1 PROSTACYCLIN RECEPTOR AGONIST,PTGIR,,,PRECLINICAL,,,NA,OC(=O)COC1CCCC(C1)-C1OCNC1-C1NC(C(O1)-C1CCCCC1)-C1CCCCC1,
BMY-7378,BMY-7378,CHEMBL13647,BRD:BRD-BRD-K31054881-300-04-7;BRD:BRD-K31054881-300-04-7,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA1D;HTR1A,,,PRECLINICAL,,Small molecule,NA,"COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1;COC1CCCCC1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1, COC1CCCCC1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1",AYYCFGDXLUPJAQ-UHFFFAOYSA-N
BNC105,BNC105,,BRD:BRD-BRD-K20468903-001-01-6;BRD:BRD-K20468903-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,PHASE 2,,,NA,"COC1CCC2C(C(=O)C3CC(OC)C(OC)C(OC)C3)C(C)OC2C1O, COC1CCC2C(C(=O)C3CC(OC)C(OC)C(OC)C3)C(C)OC2C1O",
BNTX,7-BENZYLIDENENALTREXONE;BNTX,CHEMBL252172,BRD:BRD-A55484088-050-02-5;BRD:BRD-BRD-A55484088-050-02-5,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1,,,PRECLINICAL,,Small molecule,NA,"O=C1/C(=C/c2ccccc2)C[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5;OC1CCC2CC3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C(=O)\C(C[C@@]35O)=C\C1CCCCC1, OC1CCC2CC3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C(=O)\C(C[C@@]35O)=C\C1CCCCC1, OC1CCC2CC3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C(=O)\C(C[C@@]35O)=C\C1CCCCC1",WXOUFNFMPVMGFZ-BDQAUFNLSA-N
VICTRELIS,BOCEPREVIR;EBP 520;EBP-520;SCH 503034;SCH-503034;VICTRELIS,CHEMBL218394,BRD:BRD-A09735281-001-02-5;BRD:BRD-BRD-A09735281-001-02-5,rep_primary;rep_single_dose,HCV INHIBITOR,CMA1;CTSA;CTSF;CTSK;CTSL;CTSS,HEPATITIS C,,LAUNCHED,,Small molecule,4,"CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C;CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C, CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C, CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C",LHHCSNFAOIFYRV-DOVBMPENSA-N
BOPINDOLOL MALONATE,BOPINDOLOL;BOPINDOLOL MALONATE,CHEMBL357995,BRD:BRD-A07563059-035-01-3;BRD:BRD-BRD-A07563059-035-01-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3;HTR1A;HTR1B,"HYPERTENSION, CORONARY ARTERY DISEASE (CAD)",,LAUNCHED,,Small molecule,-1,Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1;CC1CC2C(OCC(CNC(C)(C)C)OC(=O)C3CCCCC3)CCCC2[NH]1,UUOJIACWOAYWEZ-UHFFFAOYSA-N
BORNYL-ACETATE,BORNYL-ACETATE,,BRD:BRD-A41385909-001-01-3;BRD:BRD-BRD-A41385909-001-01-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"CC(=O)OC1CC2CCC1(C)C2(C)C, CC(=O)OC1CC2CCC1(C)C2(C)C",
BORONOPHENYLALANINE,BORONOPHENYLALANINE,,BRD:BRD-BRD-K50122911-001-01-2;BRD:BRD-K50122911-001-01-2,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,"N[C@@H](CC1CCC(CC1)B(O)O)C(O)=O, N[C@@H](CC1CCC(CC1)B(O)O)C(O)=O",
VELCADE,BORTEZOMIB;BORTEZOMIB ACCORD;BORTEZOMIB HYDRATE;LDP-341;NSC-681239;PS-341;VELCADE,CHEMBL325041,BRD:BRD-BRD-K50691590-001-04-8;BRD:BRD-BRD-K88510285-001-11-1;BRD:BRD-BRD-K88510285-001-22-8;BRD:BRD-K88510285-001-11-1;BRD:BRD-K88510285-001-17-8;BRD:BRD-K88510285-001-22-8;CTRP:411737;GDSC1:104;GDSC2:1191,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"NFKB PATHWAY INHIBITOR, PROTEASOME INHIBITOR",PSMA1;PSMA2;PSMA3;PSMA4;PSMA5;PSMA6;PSMA7;PSMA8;PSMB1;PSMB10;PSMB11;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMD1;PSMD2;RELA,"MULTIPLE MYELOMA, MANTLE CELL LYMPHOMA (MCL)",,LAUNCHED,,Small molecule,4,"CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O;CC(C)C[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C1CNCCN1)B(O)O, CC(C)C[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C1CNCCN1)B(O)O, CC(C)C[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C1CNCCN1)B(O)O, CC(C)C[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C1CNCCN1)B(O)O, CC(C)C[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C1CNCCN1)B(O)O",GXJABQQUPOEUTA-RDJZCZTQSA-N
BOS-172722,BOS-172722,,BRD:BRD-K00003111-001-01-9,rep_single_dose,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,,,,,,,NA,,
TRACLEER,ANHYDROUS BOSENTAN;BOSENTAN;BOSENTAN ANHYDROUS;BOSENTAN HYDRATE;BOSENTAN MONOHYDRATE;RO 47-0203/029;RO-47-0203-029;RO-470203029;TRACLEER,CHEMBL957,BRD:BRD-BRD-K74763371-002-04-0;BRD:BRD-K74763371-002-04-0,rep_multi_dose;rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA;EDNRB,PULMONARY ARTERIAL HYPERTENSION (PAH),,LAUNCHED,,Small molecule,4,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO;COC1CCCCC1OC1C(NS(=O)(=O)C2CCC(CC2)C(C)(C)C)NC(NC1OCCO)-C1NCCCN1,GJPICJJJRGTNOD-UHFFFAOYSA-N
SKI-606,BOSULIF;BOSUTINIB;BOSUTINIB (AS MONOHYDRATE);BOSUTINIB HYDRATE;BOSUTINIB MONOHYDRATE;SK-606;SKI-606,CHEMBL288441,BRD:BRD-BRD-K99964838-001-11-9;BRD:BRD-K99964838-001-11-9;CTRP:660346;GDSC1:1019,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"ABL KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR, SRC INHIBITOR",ABL1;BCR;CAMK1D;CAMK2G;CDK2;FRK;FYN;HCK;LYN;MAP2K1;MAP2K2;MAP3K2;MAP4K5;SRC;STK10;STK24;STK4;TNK2;TXK,CHRONIC MYELOID LEUKEMIA (CML),,LAUNCHED,,Small molecule,4,"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl;COC1CC(NC2C(CNC3CC(OCCCN4CCN(C)CC4)C(OC)CC23)C#N)C(CL)CC1CL, COC1CC(NC2C(CNC3CC(OCCCN4CCN(C)CC4)C(OC)CC23)C#N)C(CL)CC1CL",UBPYILGKFZZVDX-UHFFFAOYSA-N
BP-554,BP-554,,BRD:BRD-BRD-K45479396-050-01-5;BRD:BRD-K45479396-050-01-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,,,PRECLINICAL,,,NA,"C(COC1CCC2OCOC2C1)CN1CCN(CC1)C1CCCCC1, C(COC1CCC2OCOC2C1)CN1CCN(CC1)C1CCCCC1",
BP-897,BP-897,CHEMBL25236,BRD:BRD-BRD-K17378184-300-05-9;BRD:BRD-K17378184-300-05-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA1A;ADRA1D;ADRA2A;DRD1;DRD2;DRD3;DRD4;HTR1A;HTR2B,,,PHASE 2,,Small molecule,NA,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1;COC1CCCCC1N1CCN(CCCCNC(=O)C2CCC3CCCCC3C2)CC1,MNHDKMDLOJSCGN-UHFFFAOYSA-N
BPD-00008900,BPD-00008900,,GDSC2:1998,gdsc,,,,,,,,NA,,
CYCLO(D-TRP-D-ASP-PRO-D-VAL-LEU),BQ-123;BQ123;CYCLO(D-TRP-D-ASP-PRO-D-VAL-LEU),CHEMBL1269102,BRD:BRD-A59961917-001-01-0;BRD:BRD-BRD-A59961917-001-01-0,rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA,,,PHASE 2,,Protein,2,CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O;CC(C)CC1NC(=O)C(NC(=O)C2CCCN2C(=O)C(CC(O)=O)NC(=O)C(CC2C[NH]C3CCCCC23)NC1=O)C(C)C,VYCMAAOURFJIHD-AOYLRGCGSA-N
BQ-788,BQ-788,,BRD:BRD-K02490038-236-03-8,rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRB,,,,,,NA,,
BQU57,BQU57,,BRD:BRD-A40257118-001-02-0,rep_single_dose,RAS GTPASE INHIBITOR,RALA;RALB,,,,,,NA,,
BRD-A02303741,BRD-A02303741,,CTRP:659371,ctrp,,,,,,,,NA,,
BRD-A02303741:CARBOPLATIN (1:1 MOL/MOL),BRD-A02303741:CARBOPLATIN (1:1 MOL/MOL),,CTRP:660271,ctrp,,,,,,,,NA,,
BRD-A02303741:NAVITOCLAX (2:1 MOL/MOL),BRD-A02303741:NAVITOCLAX (2:1 MOL/MOL),,CTRP:660268,ctrp,,,,,,,,NA,,
BRD-A05715709,BRD-A05715709,,CTRP:660342,ctrp,,,,,,,,NA,,
BRD-A71883111,BRD-A71883111,,CTRP:660145,ctrp,,,,,,,,NA,,
BRD-A86708339,BRD-A86708339,,CTRP:687769,ctrp,,,,,,,,NA,,
BRD-A94377914,BRD-A94377914,,CTRP:61724,ctrp,,,,,,,,NA,,
BRD-K01737880,BRD-K01737880,,CTRP:438345,ctrp,,,,,,,,NA,,
BRD-K02251932,BRD-K02251932,,CTRP:442141,ctrp,,,,,,,,NA,,
BRD-K02492147,BRD-K02492147,,CTRP:415688,ctrp,,,,,,,,NA,,
BRD-K03536150,BRD-K03536150,,CTRP:686134,ctrp,,,,,,,,NA,,
BRD-K03911514,BRD-K03911514,,CTRP:660424,ctrp,,,,,,,,NA,,
BRD-K04800985,BRD-K04800985,,CTRP:435086,ctrp,,,,,,,,NA,,
BRD-K07442505,BRD-K07442505,,CTRP:660229,ctrp,,,,,,,,NA,,
BRD-K09344309,BRD-K09344309,,CTRP:439882,ctrp,,,,,,,,NA,,
BRD-K09587429,BRD-K09587429,,CTRP:416842,ctrp,,,,,,,,NA,,
BRD-K11533227,BRD-K11533227,,CTRP:389297,ctrp,,,,,,,,NA,,
BRD-K13185470,BRD-K13185470,,CTRP:660839,ctrp,,,,,,,,NA,,
BRD-K13999467,BRD-K13999467,,CTRP:410270,ctrp,,,,,,,,NA,,
BRD-K14844214,BRD-K14844214,,CTRP:402775,ctrp,,,,,,,,NA,,
BRD-K16130065,BRD-K16130065,,CTRP:660425,ctrp,,,,,,,,NA,,
BRD-K16147474,BRD-K16147474,,CTRP:447732,ctrp,,,,,,,,NA,,
BRD-K17060750,BRD-K17060750,,CTRP:600054,ctrp,,,,,,,,NA,,
BRD-K19103580,BRD-K19103580,,CTRP:436211,ctrp,,,,,,,,NA,,
BRD-K20514654,BRD-K20514654,,CTRP:651304,ctrp,,,,,,,,NA,,
BRD-K24690302,BRD-K24690302,,CTRP:641721,ctrp,,,,,,,,NA,,
BRD-K26531177,BRD-K26531177,,CTRP:42319,ctrp,,,,,,,,NA,,
BRD-K27188169,BRD-K27188169,,CTRP:660798,ctrp,,,,,,,,NA,,
BRD-K27188169:NAVITOCLAX (2:1 MOL/MOL),BRD-K27188169:NAVITOCLAX (2:1 MOL/MOL),,CTRP:665818,ctrp,,,,,,,,NA,,
BRD-K27224038,BRD-K27224038,,CTRP:397964,ctrp,,,,,,,,NA,,
BRD-K27986637,BRD-K27986637,,CTRP:452570,ctrp,,,,,,,,NA,,
BRD-K28456706,BRD-K28456706,,CTRP:651642,ctrp,,,,,,,,NA,,
BRD-K29086754,BRD-K29086754,,CTRP:448891,ctrp,,,,,,,,NA,,
BRD-K29313308,BRD-K29313308,,CTRP:634814,ctrp,,,,,,,,NA,,
BRD-K30019337,BRD-K30019337,,CTRP:437263,ctrp,,,,,,,,NA,,
BRD-K30748066,BRD-K30748066,,CTRP:689506,ctrp,,,,,,,,NA,,
BRD-K33199242,BRD-K33199242,,CTRP:449707,ctrp,,,,,,,,NA,,
BRD-K33514849,BRD-K33514849,,CTRP:401251,ctrp,,,,,,,,NA,,
BRD-K34099515,BRD-K34099515,,CTRP:660064,ctrp,,,,,,,,NA,,
BRD-K34222889,BRD-K34222889,,CTRP:688888,ctrp,,,,,,,,NA,,
BRD-K34485477,BRD-K34485477,,CTRP:446716,ctrp,,,,,,,,NA,,
BRD-K35604418,BRD-K35604418,,CTRP:660230,ctrp,,,,,,,,NA,,
BRD-K37390332,BRD-K37390332,,CTRP:463198,ctrp,,,,,,,,NA,,
BRD-K41334119,BRD-K41334119,,CTRP:446546,ctrp,,,,,,,,NA,,
BRD-K41597374,BRD-K41597374,,CTRP:404452,ctrp,,,,,,,,NA,,
BRD-K42260513,BRD-K42260513,,CTRP:687715,ctrp,,,,,,,,NA,,
BRD-K44224150,BRD-K44224150,,CTRP:438564,ctrp,,,,,,,,NA,,
BRD-K45681478,BRD-K45681478,,CTRP:142931,ctrp,,,,,,,,NA,,
BRD-K48334597,BRD-K48334597,,CTRP:431987,ctrp,,,,,,,,NA,,
BRD-K48477130,BRD-K48477130,,CTRP:649754,ctrp,,,,,,,,NA,,
BRD-K49290616,BRD-K49290616,,CTRP:414479,ctrp,,,,,,,,NA,,
BRD-K50799972,BRD-K50799972,,CTRP:596868,ctrp,,,,,,,,NA,,
BRD-K51490254,BRD-K51490254,,CTRP:616355,ctrp,,,,,,,,NA,,
BRD-K51831558,BRD-K51831558,,CTRP:687661,ctrp,,,,,,,,NA,,
BRD-K52037352,BRD-K52037352,,CTRP:450415,ctrp,,,,,,,,NA,,
BRD-K55116708,BRD-K55116708,,CTRP:444779,ctrp,,,,,,,,NA,,
BRD-K55473186,BRD-K55473186,,CTRP:651306,ctrp,,,,,,,,NA,,
BRD-K58730230,BRD-K58730230,,CTRP:660797,ctrp,,,,,,,,NA,,
BRD-K61166597,BRD-K61166597,,CTRP:348633,ctrp,,,,,,,,NA,,
BRD-K63431240,BRD-K63431240,,CTRP:404566,ctrp,,,,,,,,NA,,
BRD-K64610608,BRD-K64610608,,CTRP:438776,ctrp,,,,,,,,NA,,
BRD-K66453893,BRD-K66453893,,CTRP:387472,ctrp,,,,,,,,NA,,
BRD-K66532283,BRD-K66532283,,CTRP:376693,ctrp,,,,,,,,NA,,
BRD-K70511574,BRD-K70511574,,CTRP:648987,ctrp,,,,,,,,NA,,
BRD-K71781559,BRD-K71781559,,CTRP:425733,ctrp,,,,,,,,NA,,
BRD-K71935468,BRD-K71935468,,CTRP:58566,ctrp,,,,,,,,NA,,
BRD-K75293299,BRD-K75293299,,CTRP:438691,ctrp,,,,,,,,NA,,
BRD-K78574327,BRD-K78574327,,CTRP:435898,ctrp,,,,,,,,NA,,
BRD-K79669418,BRD-K79669418,,CTRP:660139,ctrp,,,,,,,,NA,,
BRD-K80183349,BRD-K80183349,,CTRP:376307,ctrp,,,,,,,,NA,,
BRD-K84807411,BRD-K84807411,,CTRP:437906,ctrp,,,,,,,,NA,,
BRD-K85133207,BRD-K85133207,,CTRP:616408,ctrp,,,,,,,,NA,,
BRD-K86535717,BRD-K86535717,,CTRP:429535,ctrp,,,,,,,,NA,,
BRD-K88742110,BRD-K88742110,,CTRP:606670,ctrp,,,,,,,,NA,,
BRD-K90370028,BRD-K90370028,,CTRP:362207,ctrp,,,,,,,,NA,,
BRD-K92856060,BRD-K92856060,,CTRP:119769,ctrp,,,,,,,,NA,,
BRD-K94991378,BRD-K94991378,,CTRP:53556,ctrp,,,,,,,,NA,,
BRD-K96431673,BRD-K96431673,,CTRP:417262,ctrp,,,,,,,,NA,,
BRD-K96970199,BRD-K96970199,,CTRP:410703,ctrp,,,,,,,,NA,,
BRD-K97651142,BRD-K97651142,,CTRP:660135,ctrp,,,,,,,,NA,,
BRD-K99006945,BRD-K99006945,,CTRP:687395,ctrp,,,,,,,,NA,,
BRD-K99584050,BRD-K99584050,,CTRP:660140,ctrp,,,,,,,,NA,,
BRD-M00053801,BRD-M00053801,,CTRP:660890,ctrp,,,,,,,,NA,,
BRD1812,BRD1812,,CTRP:418162,ctrp,,,,,,,,NA,,
BRD1835,BRD1835,,CTRP:404070,ctrp,,,,,,,,NA,,
BRD4132,BRD4132,,CTRP:3588,ctrp,,,,,,,,NA,,
BRD4770,BRD4770,,BRD:BRD-BRD-K72264770-001-03-2;BRD:BRD-K72264770-001-03-2,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT2,,,PRECLINICAL,,,NA,"COC(=O)C1CCC2N(CCCC3CCCCC3)C(NC(=O)C3CCCCC3)NC2C1, COC(=O)C1CCC2N(CCCC3CCCCC3)C(NC(=O)C3CCCCC3)NC2C1",
BRD6340,BRD6340,,CTRP:12877,ctrp,,,,,,,,NA,,
BRD8899,BRD8899,,CTRP:608062,ctrp,,,,,,,,NA,,
BRD8958,BRD8958,,CTRP:418163,ctrp,,,,,,,,NA,,
BRD9647,BRD9647,,CTRP:37479,ctrp,,,,,,,,NA,,
BRD9876,BRD9876,,BRD:BRD-K89329876-001-08-9;CTRP:19153,ctrp;rep_single_dose,KINESIN INHIBITOR,KIF11,,,,,,NA,,
BRD9876:MK-1775 (4:1 MOL/MOL),BRD9876:MK-1775 (4:1 MOL/MOL),,CTRP:689136,ctrp,,,,,,,,NA,,
BREFELDIN A,BREFELDIN A,CHEMBL19980,CTRP:411714,ctrp,,,,,,,Small molecule,NA,C[C@H]1CCC/C=C/[C@@H]2C[C@H](O)C[C@H]2[C@H](O)/C=C/C(=O)O1,KQNZDYYTLMIZCT-KQPMLPITSA-N
BREFELDIN-A,BREFELDIN-A,,BRD:BRD-BRD-K77841042-001-14-1;BRD:BRD-K77841042-001-14-1,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,ARF1;CYTH2,,,PRECLINICAL,,,NA,"C[C@H]1CCC\C=C\[C@@H]2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1, C[C@H]1CCC\C=C\[C@@H]2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1, C[C@H]1CCC\C=C\[C@@H]2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1",
PT-141 FREE BASE,BREMELANOTIDE;PT-141;PT-141 FREE BASE,CHEMBL2070241,BRD:BRD-BRD-K06328344-015-01-7;BRD:BRD-K06328344-015-01-7,rep_primary;rep_single_dose,MELANOCORTIN RECEPTOR AGONIST,MC1R;MC2R;MC3R;MC4R;MC5R,,,PHASE 3,,Protein,4,CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O;CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2C[NH]C3CCCCC23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@H](CC2CNC[NH]2)NC1=O)C(O)=O,FFHBJDQSGDNCIV-MFVUMRCOSA-N
BREQUINAR,BREQUINAR,CHEMBL38434,BRD:BRD-BRD-K96123349-236-02-8;BRD:BRD-K96123349-236-02-8,rep_multi_dose;rep_primary;rep_single_dose,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,DHODH,,,PHASE 2,,Small molecule,2,Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O;CC1C(NC2CCC(F)CC2C1C(O)=O)-C1CCC(CC1)-C1CCCCC1F,PHEZJEYUWHETKO-UHFFFAOYSA-N
RO-166028000,BRETAZENIL;RO 16-6028/000;RO-166028000,CHEMBL366947,BRD:BRD-BRD-K96936751-001-01-4;BRD:BRD-K96936751-001-01-4,rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR PARTIAL AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6,,,PHASE 2,,Small molecule,-1,"CC(C)(C)OC(=O)C1NCN-2C1[C@@H]1CCCN1C(=O)C1C(BR)CCCC-21, CC(C)(C)OC(=O)C1NCN-2C1[C@@H]1CCCN1C(=O)C1C(BR)CCCC-21;CC(C)(C)OC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc1-2",LWUDDYHYYNNIQI-ZDUSSCGKSA-N
REXULTI,BREXPIPRAZOLE;OPC-34712;REXULTI,CHEMBL2105760,BRD:BRD-BRD-K00911143-001-01-9;BRD:BRD-K00911143-001-01-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR PARTIAL AGONIST,DRD2,"DEPRESSION, SCHIZOPHRENIA",,LAUNCHED,,Small molecule,4,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1;O=C1CCC2CCC(OCCCCN3CCN(CC3)C3CCCC4SCCC34)CC2[NH]1,ZKIAIYBUSXZPLP-UHFFFAOYSA-N
ON-014185,BRICICLIB;ON 014185;ON-013105;ON-014185,CHEMBL1206245,BRD:BRD-BRD-K05531427-001-01-7;BRD:BRD-K05531427-001-01-7,rep_primary;rep_single_dose,CYCLIN D INHIBITOR,CCND1,,,PHASE 1,,Small molecule,1,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(OP(=O)(O)O)c2)c(OC)c1;COC1CC(OC)C(\C=C\S(=O)(=O)CC2CCC(OC)C(OP(O)(O)=O)C2)C(OC)C1,LXENKEWVEVKKGV-BQYQJAHWSA-N
BRIGATINIB,ALUNBRIG;AP-26113;AP26113;BRIGATINIB,CHEMBL3545311,BRD:BRD-BRD-K56981171-001-01-0;BRD:BRD-K56981171-001-01-0;BRD:BRD-K56981171-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,"ALK TYROSINE KINASE RECEPTOR INHIBITOR, EGFR INHIBITOR",ALK;EGFR,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,,Small molecule,4,"COC1CC(CCC1NC1NCC(CL)C(NC2CCCCC2P(C)(C)=O)N1)N1CCC(CC1)N1CCN(C)CC1, COC1CC(CCC1NC1NCC(CL)C(NC2CCCCC2P(C)(C)=O)N1)N1CCC(CC1)N1CCN(C)CC1;COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1",AILRADAXUVEEIR-UHFFFAOYSA-N
BRILLIANT-GREEN,BRILLIANT-GREEN,,BRD:BRD-BRD-K60348325-065-09-9;BRD:BRD-K60348325-065-09-9,rep_multi_dose;rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,CCN(CC)C1CCC(CC1)C(C1CCCCC1)=C1C=CC(C=C1)=[N+](CC)CC,
UK-1430418 FREE BASE,AGN-190342 FREE BASE;BRIMONIDINE;NSC-318825;UK-14304;UK-1430418 FREE BASE,CHEMBL844,BRD:BRD-BRD-K68264559-045-02-4;BRD:BRD-BRD-K68264559-045-04-0;BRD:BRD-K68264559-045-02-4;BRD:BRD-K68264559-045-04-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C,"INTRAOCULAR PRESSURE, GLAUCOMA, OCULAR HYPERTENSION",,LAUNCHED,,Small molecule,4,"Brc1c(NC2=NCCN2)ccc2nccnc12;BRC1C(NC2=NCCN2)CCC2NCCNC12, BRC1C(NC2=NCCN2)CCC2NCCNC12, BRC1C(NC2=NCCN2)CCC2NCCNC12, BRC1C(NC2=NCCN2)CCC2NCCNC12, BRC1C(NC2=NCCN2)CCC2NCCNC12",XYLJNLCSTIOKRM-UHFFFAOYSA-N
TEMBEXA,BRINCIDOFOVIR;CMX 001;CMX-001;CMX001;HDP-CIDOFOVIR;HEXADECYLOXYPROPYL CIDOFOVIR;HEXADECYLOXYPROPYL-CIDOFOVIR;TEMBEXA,CHEMBL203321,BRD:BRD-K00004672-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,4,CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](CO)Cn1ccc(N)nc1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N
NSC-760050,AL-4862;AZOPT;BRINZOLAMIDE;NSC-760050,CHEMBL220491,BRD:BRD-BRD-K74913225-001-12-4;BRD:BRD-K74913225-001-12-4,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA1;CA12;CA14;CA2;CA4;CA5A;CA7,"INTRAOCULAR PRESSURE, GLAUCOMA, OCULAR HYPERTENSION",,LAUNCHED,,Small molecule,4,"CCN[C@H]1CN(CCCOC)S(=O)(=O)C2SC(CC12)S(N)(=O)=O, CCN[C@H]1CN(CCCOC)S(=O)(=O)C2SC(CC12)S(N)(=O)=O, CCN[C@H]1CN(CCCOC)S(=O)(=O)C2SC(CC12)S(N)(=O)=O;CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21",HCRKCZRJWPKOAR-JTQLQIEISA-N
BRIVANIB,BMS-540215;BRIVANIB,CHEMBL377300,BRD:BRD-BRD-K28428262-001-04-1;BRD:BRD-K28428262-001-04-1;CTRP:606246,ctrp;rep_primary;rep_single_dose,"FGFR INHIBITOR, VEGFR INHIBITOR",CYP3A4;FGFR1;FLT1;KCNH2;KDR,,,PHASE 3,,Small molecule,3,C[C@@H](O)COC1CN2NCNC(OC3CCC4[NH]C(C)CC4C3F)C2C1C;Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,WCWUXEGQKLTGDX-LLVKDONJSA-N
"BRIVANIB, BMS-540215","BRIVANIB, BMS-540215",,GDSC1:376,gdsc,,,,,,,,NA,,
BRIVANIB-ALANINATE,BRIVANIB-ALANINATE,,BRD:BRD-BRD-K57187269-001-02-4;BRD:BRD-K57187269-001-02-4,rep_primary;rep_single_dose,"FGFR INHIBITOR, VEGFR INHIBITOR",FGFR3,,,PHASE 3,,,NA,"C[C@H](COC1CN2NCNC(OC3CCC4[NH]C(C)CC4C3F)C2C1C)OC(=O)[C@H](C)N, C[C@H](COC1CN2NCNC(OC3CCC4[NH]C(C)CC4C3F)C2C1C)OC(=O)[C@H](C)N, C[C@H](COC1CN2NCNC(OC3CCC4[NH]C(C)CC4C3F)C2C1C)OC(=O)[C@H](C)N",
UCB-34714,BRIVARACETAM;BRIVIACT;UCB 34714;UCB-34714,CHEMBL607400,BRD:BRD-BRD-K00634421-001-01-0;BRD:BRD-K00634421-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,SV2A,SEIZURES,,LAUNCHED,,Small molecule,4,"CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1;CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1, CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1",MSYKRHVOOPPJKU-BDAKNGLRSA-N
ZOSTEX,BRIVUDIN;BRIVUDINE;BROMOVINYLDEOXYURIDINE;BVDU;NSC-633770;RP-101;RP101;ZOSTEX,CHEMBL31634,BRD:BRD-A63675168-001-01-6;BRD:BRD-BRD-A63675168-001-01-6,rep_primary;rep_single_dose,DNA DIRECTED DNA POLYMERASE INHIBITOR,,SHINGLES,,LAUNCHED,,Small molecule,2,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br;OC[C@H]1O[C@H](CC1O)N1CC(\C=C\BR)C(=O)[NH]C1=O,ODZBBRURCPAEIQ-PIXDULNESA-N
BRL-15572,"BRL-15,572;BRL-15572",CHEMBL534232,BRD:BRD-A51829654-003-07-7;BRD:BRD-BRD-A51829654-003-07-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR6,,,PRECLINICAL,,Small molecule,NA,"OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1;OC(CN1CCN(CC1)C1CCCC(CL)C1)C(C1CCCCC1)C1CCCCC1, OC(CN1CCN(CC1)C1CCCC(CL)C1)C(C1CCCCC1)C1CCCCC1, OC(CN1CCN(CC1)C1CCCC(CL)C1)C(C1CCCCC1)C1CCCCC1",QJHCTHPYUOXOGM-UHFFFAOYSA-N
BRL-26314,BRL-26314,,BRD:BRD-A57806482-001-01-4;BRD:BRD-BRD-A57806482-001-01-4,rep_primary;rep_single_dose,CHOLESTEROL INHIBITOR,LPL,,,PHASE 1,,,NA,OC(=O)C(CC1CCCCC1)NCC1CCC(CL)CC1,
BRL-37344,BRL-37344,,BRD:BRD-BRD-K07507905-236-02-6;BRD:BRD-K07507905-236-02-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2;ADRB3,,,PHASE 2,,,NA,"C[C@H](CC1CCC(OCC(O)=O)CC1)NC[C@H](O)C1CCCC(CL)C1, C[C@H](CC1CCC(OCC(O)=O)CC1)NC[C@H](O)C1CCCC(CL)C1",
BRL-44408,BRL-44408,,BRD:BRD-K01825677-050-02-9,rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A;ADRA2B;ADRA2C,,,,,,NA,,
BRL-50481,BRL-50481,,BRD:BRD-BRD-K84266862-001-03-2;BRD:BRD-K84266862-001-03-2,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE7A;PDE7B,,,PRECLINICAL,,,NA,"CN(C)S(=O)(=O)C1CC(CCC1C)[N+]([O-])=O, CN(C)S(=O)(=O)C1CC(CCC1C)[N+]([O-])=O",
BRL-52537,BRL-52537,,BRD:BRD-A37347161-003-02-6;BRD:BRD-BRD-A37347161-003-02-6,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRK1,,,PRECLINICAL,,,NA,CLC1CCC(CC(=O)N2CCCCC2CN2CCCC2)CC1CL,
BRL-54443,BRL-54443,,BRD:BRD-BRD-K17868609-001-05-0;BRD:BRD-K17868609-001-05-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1E;HTR1F,,,PRECLINICAL,,,NA,"CN1CCC(CC1)C1C[NH]C2CCC(O)CC12, CN1CCC(CC1)C1C[NH]C2CCC(O)CC12",
COMPOUND 14,BRM/BRG1 ATP INHIBITOR-1;COMPOUND 14,,BRD:BRD-K00103294-001-02-9,oncref_2,SWI/SNF ATPASE INHIBITOR,SMARCA2;SMARCA4,,,,,,NA,,
CONSONAR,BROFAROMINE;CONSONAR,CHEMBL160347,BRD:BRD-K00076468-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,COc1cc(Br)c2oc(C3CCNCC3)cc2c1,WZXHSWVDAYOFPE-UHFFFAOYSA-N
BROMANTAN,BROMANTAN,,BRD:BRD-BRD-K86358349-001-02-0;BRD:BRD-K86358349-001-02-0,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",,NEURASTHENIA,,LAUNCHED,,,NA,"BRC1CCC(NC2C3CC4CC(C3)CC2C4)CC1, BRC1CCC(NC2C3CC4CC(C3)CC2C4)CC1",
BROMEBRIC-ACID,BROMEBRIC-ACID,,BRD:BRD-K17874929-236-02-0,rep_single_dose,"DNA SYNTHESIS INHIBITOR, PURINE ANTAGONIST",,,,,,,NA,,
YELLOX,BROMFENAC;ISV-303;YELLOX,CHEMBL1077,BRD:BRD-BRD-K47679368-236-01-7;BRD:BRD-K47679368-236-01-7,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,WITHDRAWN,,Small molecule,4,Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1;NC1C(CC(O)=O)CCCC1C(=O)C1CCC(BR)CC1,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
FLUIBRON,BROMHEXINE;FLUIBRON,CHEMBL253376,BRD:BRD-BRD-K47631482-003-06-2;BRD:BRD-K47631482-003-06-2,rep_primary;rep_single_dose,MUCOLYTIC AGENT,,CHEST CONGESTION,,LAUNCHED,,Small molecule,4,"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1;CN(CC1CC(BR)CC(BR)C1N)C1CCCCC1, CN(CC1CC(BR)CC(BR)C1N)C1CCCCC1",OJGDCBLYJGHCIH-UHFFFAOYSA-N
NSC-759118,"2-(P-BROMOPHENYL)-1,3-INDANDIONE;BROMINDIONE;NSC-759118",CHEMBL288496,BRD:BRD-K50490982-001-09-9,rep_single_dose,ANTICOAGULANT,,,,,,Small molecule,-1,O=C1c2ccccc2C(=O)C1c1ccc(Br)cc1,NPUZIGSOEWMFKK-UHFFFAOYSA-N
UVALERAL,.ALPHA.-BROMISOVALERYLUREA;2-BROMO-3-METHYLBUTYRYLUREA;BROMISOVAL;BROMISOVALUM;BROMOVALUREE;BROMURAL;BROMVALERYLUREA;BROMVALETONE;BROVARIN;CALMOTIN;DAGRABROMYL;DIBROLUUR;DORMIGENE;UPIOL;UVALERAL,CHEMBL1515611,BRD:BRD-K00003522-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,-1,CC(C)C(Br)C(=O)NC(N)=O,CMCCHHWTTBEZNM-UHFFFAOYSA-N
SANDOZ 15-754,2-BROMO-;2-BROMO-.ALPHA.-ERGOCRYPTINE;BROMERGOCRYPTINE;BROMOCRIPTINE;CB-154;ERGOCRYPTINE;PARLODEL;SANDOZ 15-754,CHEMBL493,BRD:BRD-BRD-K14496212-066-04-8;BRD:BRD-K14496212-066-04-8,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C;HTR6;HTR7,"HYPERPROLACTINEMIA, PARKINSON'S DISEASE, ACROMEGALY",,LAUNCHED,,Small molecule,4,"CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5C(BR)[NH]C6CCCC(C4=C3)C56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C, CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5C(BR)[NH]C6CCCC(C4=C3)C56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C, CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5C(BR)[NH]C6CCCC(C4=C3)C56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C;CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12",OZVBMTJYIDMWIL-AYFBDAFISA-N
NSC-758391,BROMOPRIDE;MOVIPRIDE;NSC-758391,CHEMBL399510,BRD:BRD-BRD-K73642618-001-13-3;BRD:BRD-K73642618-001-13-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2,"NAUSEA, VOMITING, GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,LAUNCHED,,Small molecule,3,CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC;CCN(CC)CCNC(=O)C1CC(BR)C(N)CC1OC,GIYAQDDTCWHPPL-UHFFFAOYSA-N
BROMOSPORINE,BROMOSPORINE,,BRD:BRD-BRD-K44665581-001-01-8;BRD:BRD-K44665581-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,,,,PRECLINICAL,,,NA,"CCOC(=O)NC1CC(NN2C(C)NNC12)-C1CCC(C)C(NS(C)(=O)=O)C1, CCOC(=O)NC1CC(NN2C(C)NNC12)-C1CCC(C)C(NS(C)(=O)=O)C1",
R-11333,"BROMPERIDOL;IMPROMEN;NSC-759275;R 11,333;R-11333",CHEMBL28218,BRD:BRD-BRD-K78643075-001-11-6;BRD:BRD-K78643075-001-11-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1;OC1(CCN(CCCC(=O)C2CCC(F)CC2)CC1)C1CCC(BR)CC1,RKLNONIVDFXQRX-UHFFFAOYSA-N
LODRANE,(S)-;BPN;BROMFED;BROMFENEX;BROMPHENIRAMINE;BROMPHENIRAMINE D-FORM;BROTANE;DEXBROMPHENIRAMINE;DIMETANE;DIMETAPP;LODRANE,CHEMBL1201287;CHEMBL811,BRD:BRD-A68723818-050-32-5;BRD:BRD-BRD-A68723818-050-32-5,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;HRH1,"ALLERGIC RHINITIS, COMMON COLD",,LAUNCHED,,Small molecule,4,"CN(C)CCC(c1ccc(Br)cc1)c1ccccn1;CN(C)CCC(C1CCC(BR)CC1)C1CCCCN1, CN(C)CCC(C1CCC(BR)CC1)C1CCCCN1",ZDIGNSYAACHWNL-UHFFFAOYSA-N
NSC-141021,"2-BROMO-2-NITROPROPANE-1,3-DIOL;BRONOPOL;NSC-141021",CHEMBL1408862,BRD:BRD-K33457401-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,O=[N+]([O-])C(Br)(CO)CO,LVDKZNITIUWNER-UHFFFAOYSA-N
U-54461,"BROPIRIMINE;NSC-149027;U-54,461;U-54461",CHEMBL37387,BRD:BRD-BRD-K17500877-001-02-1;BRD:BRD-K17500877-001-02-1,rep_primary;rep_single_dose,INTERFERON INDUCER,,,,PHASE 3,,Small molecule,-1,NC1NC(-C2CCCCC2)C(BR)C(=O)[NH]1;Nc1nc(=O)c(Br)c(-c2ccccc2)[nH]1,CIUUIPMOFZIWIZ-UHFFFAOYSA-N
BROXALDINE,BROBENZOXALDINE;BROXALDINE,CHEMBL2104247,BRD:BRD-BRD-K36222532-001-01-8;BRD:BRD-K36222532-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,Cc1ccc2c(Br)cc(Br)c(OC(=O)c3ccccc3)c2n1;CC1CCC2C(BR)CC(BR)C(OC(=O)C3CCCCC3)C2N1,IJTPLVAAROHGGB-UHFFFAOYSA-N
BROXATEROL,BROXATEROL,CHEMBL2105475,BRD:BRD-A08316590-001-01-3;BRD:BRD-BRD-A08316590-001-01-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,,,PHASE 3,,Small molecule,-1,CC(C)(C)NCC(O)c1cc(Br)no1;CC(C)(C)NCC(O)C1CC(BR)NO1,JBRBWHCVRGURBA-UHFFFAOYSA-N
NSC-38297,BROXURIDINE;NSC-38297,CHEMBL222280,BRD:BRD-BRD-K79095980-001-09-6;BRD:BRD-K79095980-001-09-6,rep_primary;rep_single_dose,ANTIMETABOLITE,,,,PHASE 2,,Small molecule,2,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br;OC[C@H]1O[C@H](C[C@@H]1O)N1CC(BR)C(=O)[NH]C1=O,WOVKYSAHUYNSMH-RRKCRQDMSA-N
STAROGYN,BROXYQUINOLINE;DIBROMOHYDROXYQUINOLINE;NSC-1810;STAROGYN,CHEMBL223448,BRD:BRD-BRD-K23301018-001-11-7;BRD:BRD-K23301018-001-11-7,rep_multi_dose;rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,,,PHASE 1,,Small molecule,-1,"Oc1c(Br)cc(Br)c2cccnc12;OC1C(BR)CC(BR)C2CCCNC12, OC1C(BR)CC(BR)C2CCCNC12, OC1C(BR)CC(BR)C2CCCNC12",ZDASUJMDVPTNTF-UHFFFAOYSA-N
BRUCEANTINE,BRUCEANTIN;BRUCEANTINE,CHEMBL509895,BRD:BRD-A36057565-001-01-0;BRD:BRD-BRD-A36057565-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,,,PHASE 2,,Small molecule,NA,COC(=O)[C@]12OC[C@@]34[C@H]1[C@@H](OC(=O)\C=C(/C)C(C)C)C(=O)O[C@@H]3C[C@H]1C(C)C(=O)C(=O)C[C@]1(C)[C@H]4[C@@H](O)[C@@H]2O;COC(=O)[C@@]12OC[C@]34[C@H]([C@@H](O)[C@@H]1O)[C@@]1(C)CC(=O)C(O)=C(C)[C@@H]1C[C@H]3OC(=O)[C@H](OC(=O)/C=C(\C)C(C)C)[C@@H]24,IRQXZTBHNKVIRL-GOTQHHPNSA-N
NSC-757797,"10,11-DIMETHOXYSTRYCHNINE;2,3-DIMETHOXYSTRYCHNINE;BRUCINE;BRUCINUM;NSC-757797",CHEMBL501756,BRD:BRD-A41995253-001-04-5;BRD:BRD-BRD-A41995253-001-04-5,rep_primary;rep_single_dose,GLYCINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,,,PRECLINICAL,,Small molecule,-1,"COc1cc2c(cc1OC)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43;COC1CC2N3C4[C@@H]5C(CC3=O)OCC=C3CN6CC[C@]4([C@@H]6C[C@H]53)C2CC1OC, COC1CC2N3C4[C@@H]5C(CC3=O)OCC=C3CN6CC[C@]4([C@@H]6C[C@H]53)C2CC1OC, COC1CC2N3C4[C@@H]5C(CC3=O)OCC=C3CN6CC[C@]4([C@@H]6C[C@H]53)C2CC1OC",RRKTZKIUPZVBMF-IBTVXLQLSA-N
BRYOSTATIN 1,BRYOSTATIN;BRYOSTATIN 1,CHEMBL449158,GDSC1:197,gdsc,,,,,,,Small molecule,2,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,MJQUEDHRCUIRLF-TVIXENOKSA-N
BS-181,BS-181,,BRD:BRD-BRD-K31313613-003-04-2;BRD:BRD-K31313613-003-04-2,rep_primary;rep_single_dose,CDK INHIBITOR,CDK7,,,PRECLINICAL,,,NA,"CC(C)C1CNN2C(NCC3CCCCC3)CC(NCCCCCCN)NC12, CC(C)C1CNN2C(NCC3CCCCC3)CC(NCCCCCCN)NC12, CC(C)C1CNN2C(NCC3CCCCC3)CC(NCCCCCCN)NC12",
BSJ-03-123,BSJ-03-123,,BRD:BRD-K00126486-001-01-9,oncref_2,PROTAC DEGRADER OF CDK6,CDK6;CRBN,,,,,,NA,,
BSJ-4-116,BSJ-4-116,,BRD:BRD-U00115417-001-01-9,oncref_1,IMID-BASED DEGRADER OF CDK12,CDK12,,,,,,NA,,
BT-11,BT-11,,BRD:BRD-K00003444-001-01-9,rep_single_dose,CAMP STIMULANT,,,,,,,NA,,
BTB06584,BTB06584,,BRD:BRD-K37933329-001-03-9,rep_single_dose,ATPASE INHIBITOR,ATP5F1,,,,,,NA,,
BTB1,BTB1,,BRD:BRD-BRD-K89000287-001-01-1;BRD:BRD-K89000287-001-01-1,rep_primary;rep_single_dose,MITOTIC KINESIN INHIBITOR,KIF18A,,,PRECLINICAL,,,NA,[O-][N+](=O)C1CC(CL)CCC1S(=O)(=O)C1CCCCC1,
BTK-IN-1,BTK-IN-1,,BRD:BRD-K00003437-001-01-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,,NA,,
BTS,BTS,,BRD:BRD-BRD-K64178227-001-09-0;BRD:BRD-K64178227-001-09-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"CC1CCC(CC1)S(=O)(=O)NCC1CCCCC1, CC1CCC(CC1)S(=O)(=O)NCC1CCCCC1",
BTS-54505,BTS-54505,,BRD:BRD-A68304895-003-02-2;BRD:BRD-BRD-A68304895-003-02-2,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE REUPTAKE INHIBITOR,SLC6A2;SLC6A3;SLC6A4,,,WITHDRAWN,,,NA,"CC(C)CC(N)C1(CCC1)C1CCC(CL)CC1, CC(C)CC(N)C1(CCC1)C1CCC(CL)CC1",
BTS-71321,BTS-71321,,BRD:BRD-K00010938-001-01-9,rep_single_dose,,,,,,,,NA,,
BTS-72664,BTS-72664,,BRD:BRD-A65793993-001-01-6;BRD:BRD-BRD-A65793993-001-01-6,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABBR1,,,PHASE 1,,,NA,CC(OC1CCC(CL)CC1)C1CCNC2NCNN12,
BTT-3033,BTT-3033,,BRD:BRD-BRD-K01492390-001-01-9;BRD:BRD-K01492390-001-01-9,rep_primary;rep_single_dose,INTEGRIN INHIBITOR,ITGA2;ITGB1,,,PRECLINICAL,,,NA,CN(C1CCC(NC(=O)NC2CCCCC2)CC1)S(=O)(=O)C1CNN(C1)-C1CCC(F)CC1,
BTZ043-RACEMATE,BTZ043-RACEMATE,,BRD:BRD-A53037217-001-02-0;BRD:BRD-BRD-A53037217-001-02-0,rep_primary;rep_single_dose,DPRE1 INHIBITOR,,,,PRECLINICAL,,,NA,CC1COC2(CCN(CC2)C2NC(=O)C3CC(CC([N+]([O-])=O)C3S2)C(F)(F)F)O1,
BU-224,BU-224,,BRD:BRD-BRD-K55344148-003-02-6;BRD:BRD-K55344148-003-02-6,rep_primary;rep_single_dose,IMIDAZOLINE RECEPTOR LIGAND,MAOA;MAOB,,,PRECLINICAL,,,NA,C1CN=C(N1)C1CCC2CCCCC2N1,
BU-239,BU-239,,BRD:BRD-BRD-K11696279-003-02-3;BRD:BRD-K11696279-003-02-3,rep_primary;rep_single_dose,"IMIDAZOLINE RECEPTOR LIGAND, IMIDAZOLINE RECEPTOR AGONIST",,,,PRECLINICAL,"Multiple values for MOA: {'IMIDAZOLINE RECEPTOR AGONIST, IMIDAZOLINE RECEPTOR LIGAND', 'IMIDAZOLINE RECEPTOR LIGAND, IMIDAZOLINE RECEPTOR AGONIST'}, defaulting to 'IMIDAZOLINE RECEPTOR LIGAND, IMIDAZOLINE RECEPTOR AGONIST'",,NA,C1CN=C(N1)C1CNC2CCCCC2N1,
BU226,BU226,,BRD:BRD-BRD-K56115039-003-02-1;BRD:BRD-K56115039-003-02-1,rep_primary;rep_single_dose,IMIDAZOLINE RECEPTOR LIGAND,,,,PRECLINICAL,,,NA,C1CN=C(N1)C1CC2CCCCC2CN1,
NSC-759243,3-HYDROXY-4-BUTYROPHENETIDIDE;3-HYDROXY-P-BUTYROPHENETIDIDE;BETADID;BUCETIN;NSC-320045;NSC-759243,CHEMBL1697856,BRD:BRD-A88684804-001-04-3;BRD:BRD-BRD-A88684804-001-04-3,rep_primary;rep_single_dose,ANALGESIC AGENT,,,,WITHDRAWN,,Small molecule,4,CCOc1ccc(NC(=O)CC(C)O)cc1;CCOC1CCC(NC(=O)CC(C)O)CC1,LIAWQASKBFCRNR-UHFFFAOYSA-N
BUCILLAMINE,BUCILANT;BUCILLAMINE,CHEMBL80830,BRD:BRD-BRD-K24697665-001-01-4;BRD:BRD-K24697665-001-01-4,rep_primary;rep_single_dose,IMMUNOSUPPRESSANT,,RHEUMATOID ARTHRITIS,,LAUNCHED,,Small molecule,3,"CC(C)(S)C(=O)N[C@@H](CS)C(=O)O;CC(C)(S)C(=O)N[C@@H](CS)C(O)=O, CC(C)(S)C(=O)N[C@@H](CS)C(O)=O",VUAFHZCUKUDDBC-BYPYZUCNSA-N
NSC-143108,BUCLADESINE;BUCLADESINE SODIUM;DIBUTYRYL CAMP;DT-5621;NSC-143108,CHEMBL485980,BRD:BRD-A15931911-001-03-8;BRD:BRD-A94624445-236-17-0;BRD:BRD-BRD-A15931911-001-03-8;BRD:BRD-BRD-A94624445-236-17-0,rep_multi_dose;rep_primary;rep_single_dose,"ADENOSINE RECEPTOR AGONIST, CAMP STIMULANT",PRKACA,SKIN ULCER,,LAUNCHED,"Multiple values for structure_id: {'A15931911', 'A94624445'}, defaulting to None",Small molecule,-1,"CCCC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1OC(=O)CCC;CCCC(=O)NC1NCNC2N(CNC12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC, CCCC(=O)NC1NCNC2N(CNC12)C1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC, CCCC(=O)NC1NCNC2N(CNC12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC",CJGYSWNGNKCJSB-YVLZZHOMSA-N
BUCLIZINE,BUCLIZINE,CHEMBL1201271,BRD:BRD-A91444184-300-01-9;BRD:BRD-BRD-A91444184-300-01-9,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,CHRM1;HRH1,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1;CC(C)(C)C1CCC(CN2CCN(CC2)C(C2CCCCC2)C2CCC(CL)CC2)CC1,MOYGZHXDRJNJEP-UHFFFAOYSA-N
BUDIPINE,BUDIPINE,CHEMBL334491,BRD:BRD-BRD-K18324993-001-01-6;BRD:BRD-K18324993-001-01-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,-1,CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1;CC(C)(C)N1CCC(CC1)(C1CCCCC1)C1CCCCC1,QIHLUZAFSSMXHQ-UHFFFAOYSA-N
PARFENAC,ANDERM;BUFEXAMAC;BUTOXYPHENYLACETHYDROXAMIC ACID;CP 1044 J3;CP-1044-J3;DURADERMAL;NSC-758153;PARADERM;PARFENAC,CHEMBL94394,BRD:BRD-BRD-K36660044-001-24-2;BRD:BRD-K36660044-001-24-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,HDAC10;HDAC6,,,WITHDRAWN,,Small molecule,4,"CCCCOc1ccc(CC(=O)NO)cc1;CCCCOC1CCC(CC(=O)NO)CC1, CCCCOC1CCC(CC(=O)NO)CC1",MXJWRABVEGLYDG-UHFFFAOYSA-N
BUFLOMEDIL,BUFLOMEDIL,CHEMBL188921,BRD:BRD-BRD-K19462402-003-24-6;BRD:BRD-K19462402-003-24-6,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, CALCIUM CHANNEL BLOCKER",ADRA1A,PERIPHERAL ARTERY DISEASE (PAD),,LAUNCHED,,Small molecule,4,"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1;COC1CC(OC)C(C(=O)CCCN2CCCC2)C(OC)C1, COC1CC(OC)C(C(=O)CCCN2CCCC2)C(OC)C1",OWYLAEYXIQKAOL-UHFFFAOYSA-N
S95008.,BETINEX;BUMETANIDE;BUMEX;BURINEX;LIXIL;RO 10-6338;RO-10-6338;RO-106338;S-95008.;S95008.,CHEMBL1072,BRD:BRD-BRD-K38197229-001-29-9;BRD:BRD-K38197229-001-29-9,rep_multi_dose;rep_primary;rep_single_dose,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,CFTR;GPR35;SLC12A1;SLC12A2;SLC12A4;SLC12A5,"EDEMA, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,"CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1;CCCCNC1CC(CC(C1OC1CCCCC1)S(N)(=O)=O)C(O)=O, CCCCNC1CC(CC(C1OC1CCCCC1)S(N)(=O)=O)C(O)=O, CCCCNC1CC(CC(C1OC1CCCCC1)S(N)(=O)=O)C(O)=O",MAEIEVLCKWDQJH-UHFFFAOYSA-N
BUNAZOSIN HYDROCHLORIDE,BUNAZOSIN;BUNAZOSIN HYDROCHLORIDE,CHEMBL188185,BRD:BRD-BRD-K35034482-001-01-8;BRD:BRD-K35034482-001-01-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A,"GLAUCOMA, INTRAOCULAR PRESSURE",,LAUNCHED,,Small molecule,3,CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1;CCCC(=O)N1CCCN(CC1)C1NC(N)C2CC(OC)C(OC)CC2N1,RHLJLALHBZGAFM-UHFFFAOYSA-N
NVP-BKM120,BKM-120;BKM-120NX;BKM120-NX;BUPARLISIB;NVP-BKM-120;NVP-BKM120,CHEMBL2017974,BRD:BRD-BRD-K42191735-001-05-3;BRD:BRD-K42191735-001-05-3;GDSC2:1873,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CG,,,PHASE 3,,Small molecule,3,"NC1CC(C(CN1)-C1CC(NC(N1)N1CCOCC1)N1CCOCC1)C(F)(F)F, NC1CC(C(CN1)-C1CC(NC(N1)N1CCOCC1)N1CCOCC1)C(F)(F)F;Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1",CWHUFRVAEUJCEF-UHFFFAOYSA-N
BW-720C,BUPARVAQUONE;BUTALEX;BW-720C,CHEMBL292009,BRD:BRD-A07947329-001-01-4;BRD:BRD-BRD-A07947329-001-01-4,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,,,LAUNCHED,,Small molecule,-1,CC(C)(C)[C@H]1CC[C@H](CC2=C(O)C(=O)c3ccccc3C2=O)CC1;CC(C)(C)C1CCC(CC2C(=O)C(=O)C3CCCCC3C2=O)CC1,KLLIVCPQDTYMLC-HDJSIYSDSA-N
NYLIDRIN,BUPHENIN;BUPHENINE;NYLIDRIN,CHEMBL114655,BRD:BRD-A36267905-003-18-4;BRD:BRD-BRD-A36267905-003-18-4,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,RAYNAUD'S DISEASE,,LAUNCHED,,Small molecule,-1,"CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1;CC(CCC1CCCCC1)NC(C)C(O)C1CCC(O)CC1, CC(CCC1CCCCC1)NC(C)C(O)C1CCC(O)CC1",PTGXAUBQBSGPKF-UHFFFAOYSA-N
SCH-10595,BUPICOMIDE;NSC-329138;SCH 10595;SCH-10595,CHEMBL2106646,BRD:BRD-BRD-K51700582-001-01-2;BRD:BRD-K51700582-001-01-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1,,,PHASE 1,,Small molecule,-1,CCCCc1ccc(C(N)=O)nc1;CCCCC1CCC(NC1)C(N)=O,VKSPIPWLHGKJQO-UHFFFAOYSA-N
SKY0402,(-)-;(-)-BUPIVACAINE;(S)-;(S)-BUPIVACAINE;ANEKAIN;BUCAINE;BUPIVACAINE;BUPIVACAINE (-)-FORM;BUPIVACAINE LIPOSOME;BUPIVACAINE-;EXPAREL;L-BUPIVACAINE;LEVOBUPIVACAINE;LIPOSOMAL BUPIVACAINE;LIQ-865;LIQ865;MARCAINE;NOVABUPI;POSIMIR;ROPIVACAINE HYDROCHLORIDE IMPURITY;SENSORCAINE;SKY-0402;SKY0402,CHEMBL1098;CHEMBL1201193,BRD:BRD-A01636364-003-15-1;BRD:BRD-BRD-A01636364-003-15-1,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,KCNA5;PTGER1;SCN10A;SCN4A,"PERIPHERAL NERVE BLOCK, CAUDAL EPIDURAL BLOCK, LUMBAR EPIDURAL BLOCK",,LAUNCHED,,Small molecule,4,"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C;CCCCN1CCCCC1C(=O)NC1C(C)CCCC1C, CCCCN1CCCCC1C(=O)NC1C(C)CCCC1C",LEBVLXFERQHONN-UHFFFAOYSA-N
OPHTORENIN,B 1312 [AS HYDROCHLORIDE];BUPRANOL;BUPRANOLOL;BUPRANOLOL HYDROCHLORIDE;KL-255 [AS HYDROCHLORIDE];OPHTORENIN,CHEMBL305380,BRD:BRD-A48420483-001-02-3;BRD:BRD-BRD-A48420483-001-02-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3,"HYPERTENSION, GLAUCOMA",,LAUNCHED,,Small molecule,-1,"Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1;CC1CCC(CL)C(OCC(O)CNC(C)(C)C)C1, CC1CCC(CL)C(OCC(O)CNC(C)(C)C)C1",HQIRNZOQPUAHHV-UHFFFAOYSA-N
NSC-758686,AMFEBUTAMONE;BUPROPION;BUPROPION EXTENDED RELEASE;BUPROPION SLOW RELEASE;NSC-758686,CHEMBL894,BRD:BRD-A05186015-003-19-8;BRD:BRD-BRD-A05186015-003-19-8,rep_primary;rep_single_dose,DOPAMINE UPTAKE INHIBITOR,CHRNA3;SLC6A2;SLC6A3,DEPRESSION,,LAUNCHED,,Small molecule,4,"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1;CC(NC(C)(C)C)C(=O)C1CCCC(CL)C1, CC(NC(C)(C)C)C(=O)C1CCCC(CL)C1, CC(NC(C)(C)C)C(=O)C1CCCC(CL)C1",SNPPWIUOZRMYNY-UHFFFAOYSA-N
NSC-30781,AC 601;AC-601;BURAMATE;NSC-30223;NSC-30781,CHEMBL2103933,BRD:BRD-K30360804-001-02-9,rep_single_dose,ANTIEPILEPTIC,,,,,,Small molecule,-1,O=C(NCc1ccccc1)OCCO,YFLRYAVDPKONNX-UHFFFAOYSA-N
BURIXAFOR (HYDROBROMIDE),BURIXAFOR (HYDROBROMIDE),,BRD:BRD-K00091136-303-01-9,rep_single_dose,,,,,,,,NA,,
SUPREFACT,BUSERELIN;SUPRECUR;SUPREFACT,CHEMBL2110824,BRD:BRD-K00003161-015-01-9,rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,,,,,,Protein,4,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,CUWODFFVMXJOKD-UVLQAERKSA-N
GEN-BUSPIRONE,BCI-024;BUSPAR;BUSPIRONE;GEN-BUSPIRONE,CHEMBL49,BRD:BRD-BRD-K93461745-003-25-0;BRD:BRD-K93461745-003-25-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,DRD2;HTR1A,GENERALIZED ANXIETY DISORDER (GAD),,LAUNCHED,,Small molecule,4,"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1;O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1NCCCN1, O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1NCCCN1, O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1NCCCN1",QWCRAEMEVRGPNT-UHFFFAOYSA-N
SULPHABUTIN,BUSILVEX;BUSULFAN;BUSULFANUM;BUSULFEX;LEUCOSULFAN;MYELOSAN;MYELOSANUM;MYLERAN;NCI-C01592;NSC-750;SULPHABUTIN,CHEMBL820,BRD:BRD-BRD-K23204545-001-16-4;BRD:BRD-K23204545-001-16-4,rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,CHRONIC MYELOID LEUKEMIA (CML),,LAUNCHED,,Small molecule,4,"CS(=O)(=O)OCCCCOS(C)(=O)=O;CS(=O)(=O)OCCCCOS(C)(=O)=O, CS(=O)(=O)OCCCCOS(C)(=O)=O, CS(=O)(=O)OCCCCOS(C)(=O)=O",COVZYZSDYWQREU-UHFFFAOYSA-N
BUTABINDIDE,BUTABINDIDE,,BRD:BRD-K40581315-034-02-9,rep_single_dose,TRIPEPTIDYL PEPTIDASE INHIBITOR,TPP2,,,,,,NA,,
NSC-758632,BUTACAINE;NSC-758632,CHEMBL129529,BRD:BRD-BRD-K99622919-001-23-0;BRD:BRD-K99622919-001-23-0,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,-1,"CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1;CCCCN(CCCC)CCCOC(=O)C1CCC(N)CC1, CCCCN(CCCC)CCCOC(=O)C1CCC(N)CC1",HQFWVSGBVLEQGA-UHFFFAOYSA-N
BUTACLAMOL,BUTACLAMOL,CHEMBL8514,BRD:BRD-BRD-K23082237-003-01-5;BRD:BRD-K23082237-003-01-5,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR2A,,,PHASE 2,,Small molecule,-1,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1;CC(C)(C)[C@@]1(O)CCN2C[C@@H]3C4CCCCC4CCC4CCCC([C@H]2C1)C34,ZZJYIKPMDIWRSN-HWBMXIPRSA-N
TETRALLOBARBITAL,ALISOBUMAL;ALLYLBARBITURIC ACID;BUTALBITAL;BUTALBITAL CIII;ITOBARBITAL;SANDOPTAL;TETRALLOBARBITAL,CHEMBL454,BRD:BRD-BRD-K71350836-001-02-4;BRD:BRD-K71350836-001-02-4,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,CHRNA4;CHRNA7;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GRIA2;GRIK2,"HEADACHE, MUSCLE RELAXANT",,LAUNCHED,,Small molecule,4,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O;CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N
P-AMINOBENZOIC ACID BUTYL ESTER,BUTAMBEN;BUTESIN;BUTYL AMINOBENZOATE;BUTYL P-AMINOBENZOATE;BUTYL PABA;NSC-128464;P-AMINOBENZOIC ACID BUTYL ESTER,CHEMBL127516,BRD:BRD-BRD-K27217864-001-22-3;BRD:BRD-K27217864-001-22-3,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,,,,WITHDRAWN,,Small molecule,4,CCCCOC(=O)c1ccc(N)cc1;CCCCOC(=O)C1CCC(N)CC1,IUWVALYLNVXWKX-UHFFFAOYSA-N
TR-4979,BAY Q 4218;BAY-Q-4218;BAYQ-4218;BUTAPROST;TR-4979,CHEMBL271896,BRD:BRD-K00004715-001-01-9,rep_single_dose,PROSTAGLANDIN RECEPTOR AGONIST,,,,,,Small molecule,-1,CCCC1([C@H](O)C/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)OC)CCC1,XRISENIKJUKIHD-LHQZMKCDSA-N
BUTEIN,"3,4,2',4'-TETRAHYDROXYCHALONE;BUTEIN",CHEMBL128000,BRD:BRD-BRD-K17497770-001-03-6;BRD:BRD-K17497770-001-03-6,rep_primary;rep_single_dose,"EGFR INHIBITOR, SRC INHIBITOR",ACE,,,PRECLINICAL,,Small molecule,NA,"O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O;OC1CCC(C(=O)\C=C\C2CCC(O)C(O)C2)C(O)C1, OC1CCC(C(=O)\C=C\C2CCC(O)C(O)C2)C(O)C1",AYMYWHCQALZEGT-ORCRQEGFSA-N
MENTAX-TC,BUTENAFINE;MENTAX;MENTAX-TC,CHEMBL990,BRD:BRD-BRD-K90630139-003-05-9;BRD:BRD-K90630139-003-05-9,rep_primary;rep_single_dose,FUNGAL SQUALENE EPOXIDASE INHIBITOR,SQLE,"TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS",,LAUNCHED,,Small molecule,4,CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12;CN(CC1CCC(CC1)C(C)(C)C)CC1CCCC2CCCCC12,ABJKWBDEJIDSJZ-UHFFFAOYSA-N
BUTHIONINE-SULFOXIMINE,BUTHIONINE-SULFOXIMINE,,BRD:BRD-A47706533-001-02-6;BRD:BRD-BRD-A47706533-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,GLUTATHIONE TRANSFERASE INHIBITOR,GCLM,,,PHASE 1,,,NA,CCCCS(=N)(=O)CC[C@H](N)C(O)=O,
BUTIBUFEN,2-(P-ISOBUTYLPHENYL)BUTYRIC ACID;BUTIBUFEN,CHEMBL454450,BRD:BRD-A46136514-001-01-2;BRD:BRD-BRD-A46136514-001-01-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,WITHDRAWN,,Small molecule,-1,CCC(C(=O)O)c1ccc(CC(C)C)cc1;CCC(C(O)=O)C1CCC(CC(C)C)CC1,UULSXYSSHHRCQK-UHFFFAOYSA-N
NSC-758658,BUTOCONAZOLE;GYNAZOLE-1;GYNOFORT;NSC-758658,CHEMBL1295,BRD:BRD-A16665823-001-02-0;BRD:BRD-BRD-A16665823-001-02-0,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,VULVOVAGINAL CANDIDIASIS,,LAUNCHED,,Small molecule,4,"Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1;CLC1CCC(CCC(CN2CCNC2)SC2C(CL)CCCC2CL)CC1, CLC1CCC(CCC(CN2CCNC2)SC2C(CL)CCCC2CL)CC1",SWLMUYACZKCSHZ-UHFFFAOYSA-N
CM-6805,BUTOFILOLOL;CM-6805,CHEMBL157443,BRD:BRD-A27274504-001-01-6;BRD:BRD-BRD-A27274504-001-01-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,PHASE 2,,Small molecule,-1,CCCC(=O)c1cc(F)ccc1OCC(O)CNC(C)(C)C;CCCC(=O)C1CC(F)CCC1OCC(O)CNC(C)(C)C,NMBNQRJDEPOXCP-UHFFFAOYSA-N
BUTORPHANOL-(+)-TARTRATE,BUTORPHANOL-(+)-TARTRATE,,BRD:BRD-BRD-K42417338-045-01-9;BRD:BRD-K42417338-045-01-9,rep_primary;rep_single_dose,"OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST",OPRD1;OPRK1;OPRM1,"MUSCLE PAIN, HEADACHE, ABDOMINAL PAIN",,LAUNCHED,,,NA,OC1CCC2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)C2C1,
BUTYL-PARABEN,BUTYL-PARABEN,,BRD:BRD-BRD-K08287586-001-14-3;BRD:BRD-K08287586-001-14-3,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,,,PRECLINICAL,,,NA,CCCCOC(=O)C1CCC(O)CC1,
BUTYLATED-HYDROXYANISOLE,BUTYLATED-HYDROXYANISOLE,,BRD:BRD-BRD-K93035859-001-07-6;BRD:BRD-K93035859-001-07-6,rep_primary;rep_single_dose,ANTIOXIDANT,,,,PRECLINICAL,,,NA,COC1CCC(O)C(C1)C(C)(C)C,
BUTYLATED-HYDROXYTOLUENE,BUTYLATED-HYDROXYTOLUENE,,BRD:BRD-BRD-K53153417-001-10-4;BRD:BRD-K53153417-001-10-4,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA2,,,PHASE 1,,,NA,CC1CC(C(O)C(C1)C(C)(C)C)C(C)(C)C,
BUTYLIDENEPHTHALIDE,BUTYLIDENEPHTHALIDE,,BRD:BRD-K02260986-001-03-9,rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,,,,NA,,
BUTYLPHTHALIDE,BUTYLPHTHALIDE,,BRD:BRD-A59378440-001-01-3;BRD:BRD-BRD-A59378440-001-01-3,rep_primary;rep_single_dose,POTASSIUM CHANNEL ANTAGONIST,KCNK2,STROKE,,LAUNCHED,,,NA,CCCCC1OC(=O)C2CCCCC12,
BUTYLSCOPOLAMINE-BROMIDE,BUTYLSCOPOLAMINE-BROMIDE,,BRD:BRD-A53951045-004-01-6;BRD:BRD-BRD-A53951045-004-01-6,rep_multi_dose;rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,,ABDOMINAL PAIN,,LAUNCHED,,,NA,CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@@H](CO)C1CCCCC1,
VRT-752271,BVD-523;BVD-ERK;ULIXERTINIB;VRT-752271,CHEMBL3590106,BRD:BRD-BRD-K28965160-001-01-1;BRD:BRD-K28965160-001-01-1;GDSC2:1908;GDSC2:2047,gdsc;rep_multi_dose;rep_primary;rep_single_dose,MAP KINASE INHIBITOR,,,,PHASE 1/PHASE 2,,Small molecule,2,CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1;CC(C)NC1CC(-C2C[NH]C(C2)C(=O)N[C@H](CO)C2CCCC(CL)C2)C(CL)CN1,KSERXGMCDHOLSS-LJQANCHMSA-N
BVT-2733,BVT-2733,,BRD:BRD-BRD-K01742705-001-01-7;BRD:BRD-K01742705-001-01-7,rep_primary;rep_single_dose,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,HSD17B1,,,PRECLINICAL,,,NA,CN1CCN(CC1)C(=O)CC1CSC(NS(=O)(=O)C2CCCC(CL)C2C)N1,
BVT-948,BVT-948,,BRD:BRD-BRD-K68567222-001-01-2;BRD:BRD-K68567222-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,TYROSINE PHOSPHATASE INHIBITOR,PTPN1;PTPN11;PTPN2,,,PRECLINICAL,,,NA,"CC1(C)C(=O)NC2=C1C(=O)C(=O)C1CCCCC21, CC1(C)C2C(=NC1=O)C1CCCCC1C(=O)C2=O",
BW-180C,BW-180C,,BRD:BRD-BRD-K57927309-001-01-7;BRD:BRD-K57927309-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRD1;OPRM1,,,PHASE 2,,,NA,CC(C)C[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC1CCC(O)CC1)C(O)=O,
BW-348U87,BW-348U87,,BRD:BRD-K00004593-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,,NA,,
BW-373U86,BW-373U86,,BRD:BRD-BRD-K74990253-001-02-8;BRD:BRD-K74990253-001-02-8,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRD1,,,PRECLINICAL,,,NA,CCN(CC)C(=O)C1CCC(CC1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)C1CCCC(O)C1,
BW-616U,BW-616U,,BRD:BRD-BRD-K07061232-001-01-8;BRD:BRD-K07061232-001-01-8,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA,,,PRECLINICAL,,,NA,CNC(=O)C1CCC2C(=O)C3CCCCC3S(=O)(=O)C2C1,
BW-723C86,BW-723C86,CHEMBL1255834,BRD:BRD-A17428743-003-09-0;BRD:BRD-BRD-A17428743-003-09-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2A;HTR2B;HTR2C,,,PRECLINICAL,,Small molecule,NA,"CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12;CC(N)CC1C[NH]C2CCC(OCC3CCCS3)CC12, CC(N)CC1C[NH]C2CCC(OCC3CCCS3)CC12",ALFGDCNSEBJYSP-UHFFFAOYSA-N
BW-A4C,BW-A4C,,BRD:BRD-BRD-K80194255-001-01-9;BRD:BRD-K80194255-001-01-9,rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX5,,,PHASE 1,,,NA,CC(=O)N(O)C\C=C\C1CCCC(OC2CCCCC2)C1,
BW-B70C,BW-B70C,,BRD:BRD-A55946879-001-04-9,rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX5,,,,,,NA,,
BX-795,BX-795,CHEMBL577784,BRD:BRD-K47983010-001-15-3;GDSC1:1037,gdsc;rep_single_dose,IKK INHIBITOR,CDK2;CHEK1;GSK3B;KDR;PDK1;PDPK1,,,,,Small molecule,NA,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,VAVXGGRQQJZYBL-UHFFFAOYSA-N
BX-912,BX-912,,BRD:BRD-BRD-K49669041-001-08-4;BRD:BRD-K49669041-001-08-4;GDSC1:222,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PYRUVATE DEHYDROGENASE KINASE INHIBITOR,CDK2;CHEK1;GSK3B;KDR;PDK1;PDPK1,,,PRECLINICAL,,,NA,BRC1CNC(NC2CCCC(NC(=O)N3CCCC3)C2)NC1NCCC1C[NH]CN1,
BX795,BX795,,GDSC1:1037,gdsc,,,,,,,,NA,,
BYK-204165,BYK-204165,,BRD:BRD-BRD-K61665160-001-01-5;BRD:BRD-K61665160-001-01-5,rep_primary;rep_single_dose,PARP INHIBITOR,PARP1,,,PRECLINICAL,,,NA,"CN1CCCC1\C=C1/C(=O)NC(=O)C2CCCCC12, CN1CCCC1\C=C1/C(=O)NC(=O)C2CCCCC12",
C-021,C-021,,BRD:BRD-BRD-K98179423-300-01-3;BRD:BRD-K98179423-300-01-3,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR4,,,PRECLINICAL,,,NA,COC1CC2NC(NC(NC3CCCCCC3)C2CC1OC)N1CCC(CC1)N1CCCCC1,
PANOREX,17-1A;C-1;EDRECOLOMAB;MAB-17-1A;MAB17-1A;PANOREX,CHEMBL2108955,BRD:BRD-BRD-K72462751-001-02-7;BRD:BRD-K72462751-001-02-7,rep_primary;rep_single_dose,PROTEIN KINASE INHIBITOR,PRKCA,,,PRECLINICAL,,Antibody,3,"O=S(=O)(N1CCNCC1)C1CCCC2CNCCC12, O=S(=O)(N1CCNCC1)C1CCCC2CNCCC12",
C-75,C-75,,GDSC1:435,gdsc,,,,,,,,NA,,
C-751,C-751,,BRD:BRD-BRD-K15337272-001-01-3;BRD:BRD-K15337272-001-01-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCOC(=O)C1C[NH]CN1,
C11-ACETATE,C11-ACETATE,,BRD:BRD-K83914624-415-01-3,rep_single_dose,,ABAT;ACE;AKR1C3;CA2;CELA1;ESR2;FFAR2;FFAR3;HPRT1;LTA4H;MMP12;NOS1;NOS3;PLA2G1B;PTPN1;SOD1;TXN,,,,,,NA,,
C188-9,C188-9,,BRD:BRD-K00003114-001-01-9,rep_single_dose,STAT INHIBITOR,,,,,,,NA,,
C34,C34,,BRD:BRD-BRD-K43167535-001-01-3;BRD:BRD-K43167535-001-01-3,rep_primary;rep_single_dose,TOLL-LIKE RECEPTOR INHIBITOR,TLR4,,,PRECLINICAL,,,NA,CC(C)O[C@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O,
WNT-C59,C59;WNT-C59,,BRD:BRD-BRD-K78455053-001-01-2;BRD:BRD-K78455053-001-01-2;BRD:BRD-K78455053-001-05-9;GDSC1:574;GDSC2:1622,gdsc;oncref_2;rep_primary;rep_single_dose,PORCUPINE INHIBITOR,PORCN,,,PRECLINICAL,"Multiple values for MOA: {'PORCUPINE INHIBITOR', 'INHBITOR OF PORCN'}, defaulting to 'PORCUPINE INHIBITOR'",,NA,"CC1CC(CCN1)-C1CCC(CC(=O)NC2CCC(CC2)-C2CCCNC2)CC1, CC1CC(CCN1)-C1CCC(CC(=O)NC2CCC(CC2)-C2CCCNC2)CC1",
C6-CERAMIDE,C6-CERAMIDE,,CTRP:44554,ctrp,,,,,,,,NA,,
C646,C646,,BRD:BRD-BRD-K73383190-001-02-3;BRD:BRD-BRD-K73383190-001-03-1;BRD:BRD-K73383190-001-02-3;BRD:BRD-K73383190-001-03-1,rep_primary;rep_single_dose,HISTONE ACETYLTRANSFERASE INHIBITOR,EP300,,,PRECLINICAL,,,NA,"CC1=NN(C(=O)C1=CC1CCC(O1)-C1CC(C)C(C)CC1[N+]([O-])=O)C1CCC(CC1)C(O)=O, CC1=NN(C(=O)C1=CC1CCC(O1)-C1CC(C)C(C)CC1[N+]([O-])=O)C1CCC(CC1)C(O)=O",
EMAVUSERTIB,AU-4948;CA-4948;EMAVUSERTIB,CHEMBL4783351,BRD:BRD-K00003511-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,Small molecule,1,Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1,SJHNWSAWWOAWJH-MRXNPFEDSA-N
CABAGIN,CABAGIN,,BRD:BRD-K41504985-003-02-9,rep_single_dose,,,,,,,,NA,,
TREHALOSE,".ALPHA.,.ALPHA.-TREHALOSE;CABALETTA;MUSHROOM SUGAR;MYCOSE;NSC-2093;TREHALOSE",CHEMBL1236395,BRD:BRD-BRD-K54028654-001-02-6;BRD:BRD-K54028654-001-02-6,rep_primary;rep_single_dose,PHARMACOLOGICAL CHAPERONE,,,,PHASE 2,,Small molecule,3,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,HDTRYLNUVZCQOY-LIZSDCNHSA-N
XRP-6258,CABAZITAXEL;CABAZITAXEL ACETONATE;JEVTANA;JEVTANA KIT;NSC-761432;TXD 258;TXD-258;XRP 6258;XRP-6258,CHEMBL1201748,BRD:BRD-BRD-K06858286-001-01-3;BRD:BRD-K06858286-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,MICROTUBULE INHIBITOR,TUBA4A;TUBB;TUBB1,PROSTATE CANCER,,LAUNCHED,,Small molecule,4,CO[C@@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@@H](OC(=O)C3CCCCC3)[C@@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4CCCCC4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C;CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C,BMQGVNUXMIRLCK-OAGWZNDDSA-N
VELACTIS,CABASER;CABERGOLINE;DOSTINEX;FCE 21336;FCE-21336;VELACTIS,CHEMBL1201087,BRD:BRD-BRD-K86882815-001-03-2;BRD:BRD-K86882815-001-03-2,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C;HTR7,HYPERPROLACTINEMIA,,LAUNCHED,,Small molecule,4,"C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21;CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3C[NH]C4CCCC2C34)N(CC=C)C1, CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3C[NH]C4CCCC2C34)N(CC=C)C1",KORNTPPJEAJQIU-KJXAQDMKSA-N
S-265744,APRETUDE;CABOTEGRAVIR;GSK-1265744;GSK-1265744A;GSK1265744;GSK1265744A;GSK744;S-265744,CHEMBL2403238,BRD:BRD-BRD-K76819217-001-02-2;BRD:BRD-K76819217-001-02-2,rep_primary;rep_single_dose,HIV INTEGRASE INHIBITOR,,,,PHASE 2/PHASE 3,,Small molecule,4,"C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12;C[C@H]1CO[C@@H]2CN3CC(C(=O)NCC4CCC(F)CC4F)C(=O)C(O)C3C(=O)N12, C[C@H]1CO[C@@H]2CN3CC(C(=O)NCC4CCC(F)CC4F)C(=O)C(O)C3C(=O)N12",WCWSTNLSLKSJPK-LKFCYVNXSA-N
CACCINH-A01,CACCINH-A01,,BRD:BRD-A90751343-001-02-9,rep_single_dose,CALCIUM-ACTIVATED CHLORIDE CHANNEL INHIBITOR,CLCA1,,,,,,NA,,
CADAZOLID,ACT-179811;CADAZOLID,CHEMBL3707376,BRD:BRD-K00003370-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,3,O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4ccc(N5C[C@H](CO)OC5=O)cc4F)CC3)c(F)cc2c1=O,XWFCFMXQTBGXQW-GOSISDBHSA-N
CAFESTOL,CAFESTOL,CHEMBL1407645,BRD:BRD-BRD-K46741531-001-02-4;BRD:BRD-K46741531-001-02-4,rep_primary;rep_single_dose,PREGNANE X RECEPTOR AGONIST,,,,LAUNCHED,,Small molecule,NA,C[C@@]12CCC3OCCC3[C@H]1CC[C@@]13C[C@@H](CC[C@@H]21)[C@@](O)(CO)C3;C[C@@]12CCc3occc3[C@H]1CC[C@@]13C[C@@H](CC[C@H]12)[C@@](O)(CO)C3,DNJVYWXIDISQRD-HWUKTEKMSA-N
CAFFEIC-ACID,CAFFEIC-ACID,,BRD:BRD-BRD-K09900591-001-26-7;BRD:BRD-K09900591-001-26-7,rep_multi_dose;rep_primary;rep_single_dose,"HIV INTEGRASE INHIBITOR, LIPOXYGENASE INHIBITOR, NITRIC OXIDE PRODUCTION INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",ALOX5;MIF,,,PRECLINICAL,,,NA,"OC(=O)\C=C\C1CCC(O)C(O)C1, OC(=O)\C=C\C1CCC(O)C(O)C1",
CAFFEIC-ACID-PHENETHYL-ESTER,CAFFEIC-ACID-PHENETHYL-ESTER,,BRD:BRD-BRD-K96188950-001-16-9;BRD:BRD-K96188950-001-16-9,rep_multi_dose;rep_primary;rep_single_dose,HIV INTEGRASE INHIBITOR,RELA,,,PRECLINICAL,,,NA,"OC1CCC(\C=C\C(=O)OCCC2CCCCC2)CC1O, OC1CCC(\C=C\C(=O)OCCC2CCCCC2)CC1O",
ZANTHINE,"ANHYDROUS CAFFEINE;CAFCIT;CAFFEINE;CAFFEINE ANHYDROUS;CAFFEINE CITRATE;CAFFEINE MELTING POINT STANDARD;CAFFEINE MIXTURE WITH CITRIC ACID;CAFFEINE, CITRATED;CAFFEINUM;CITRATED;CITRATED CAFFEINE;COFFEINE;COFFEINUM;DURVITAN;FEMA NO. 2224;GUARANINE;METHYLTHEOBROMINE;NODOZ;NODOZ CAPLETS AND CHEWABLE TABLETS;NSC-5036;PEYONA;PRO-PLUS;SYNALGOS;THEINE;VIVARIN;YEAST-VITE;ZANTHINE",CHEMBL113;CHEMBL1200569,BRD:BRD-BRD-K02404261-001-16-7;BRD:BRD-K02404261-001-16-7,rep_primary;rep_single_dose,"ADENOSINE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",ADORA1;ADORA2A;ADORA2B;ADORA3;ATM;ITPR1;ITPR2;ITPR3;PDE10A;PDE11A;PDE1A;PDE1B;PDE1C;PDE2A;PDE3A;PDE3B;PDE4A;PDE4B;PDE4C;PDE4D;PDE5A;PDE6A;PDE6B;PDE6C;PDE7A;PDE7B;PDE8A;PDE8B;PDE9A;PIK3CA;PIK3CB;PIK3CD;PRKDC;RYR1;RYR2;RYR3,"FATIGUE, DROWSINESS, FATIGUE, DROWSINESS",,LAUNCHED,,Small molecule,4,Cn1c(=O)c2c(ncn2C)n(C)c1=O;CN1CNC2N(C)C(=O)N(C)C(=O)C12,RYYVLZVUVIJVGH-UHFFFAOYSA-N
ZYDELIG,CAL-101;GS-1101;GS-11CAL-101;IDELALISIB;ZYDELIG,CHEMBL2216870,CTRP:660430;GDSC1:238,ctrp;gdsc,,,,,,,Small molecule,4,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,IFSDAJWBUCMOAH-HNNXBMFYSA-N
U-32070E,"25-HYDROXYCHOLECALCIFEROL (CALCIFEDIOL);CALCIDIOL;CALCIFEDIOL;CALCIFEDIOL HYDRATE;CALDEROL;CTAP-101;CTAP101;DIDROGYL;HIDROFEROL;RAYALDEE;RAYALDY;U-32,070E;U-32070E",CHEMBL1040;CHEMBL3544909,BRD:BRD-BRD-K77175907-001-08-0;BRD:BRD-K77175907-001-08-0,rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,,,LAUNCHED,,Small molecule,4,"C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C;C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]12.O",WRLFSJXJGJBFJQ-WPUCQFJDSA-N
XAMIOL,CALCIPOTRIENE;CALCIPOTRIENE HYDRATE;CALCIPOTRIENE MONOHYDRATE;CALCIPOTRIOL;CALCIPOTRIOL ANHYDROUS;CALCIPOTRIOL HYDRATE;CALCIPOTRIOL MONOHYDRATE;CALCIPTRIOL;DOVOBET;DOVONEX;ENSTILAR;MC 903;MC-903;PRI-2201;SORILUX;XAMIOL,CHEMBL1200666,BRD:BRD-BRD-K56429665-001-09-6;BRD:BRD-K56429665-001-09-6,rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,PSORIASIS,,LAUNCHED,,Small molecule,4,"C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C;C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O",LWQQLNNNIPYSNX-UROSTWAQSA-N
UNSPECIFIED,CALCIMAR;CALCITARE;CALCITONIN;CALSYNAR;CIBACALCIN;FORCALTONIN;FORTICAL;MIACALCIC;PRO;PROCALCITONIN;PROCALCITONIN HUMAN;THROCALCITONIN;UNSPECIFIED,CHEMBL2207138;CHEMBL4594242,BRD:BRD-K00005332-019-01-9,rep_single_dose,CALCITONIN AGONIST,,,,,,Protein,4,,
VECTICAL,"1,25-DIHYDROXYVITAMIN D3;1,25-HYDROXYLATED VITAMIN D;1ALPHA,25-DIHYDROXYCHOLECALCIFEROL;1ALPHA,25-DIHYDROXYVITAMIN D3;CALCIJEX;CALCITRIOL;DIHYDROXYCHOLECALCIFEROL;DIHYDROXYVITAMIN D 3;RO 21-5535;RO-21-5535;RO-215535;ROCALTROL;SILKIS;TOPITRIOL;VECTICAL",CHEMBL846,BRD:BRD-BRD-K27316855-001-13-3;BRD:BRD-BRD-K27316855-001-19-0;BRD:BRD-K27316855-001-13-3;BRD:BRD-K27316855-001-19-0,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,"HYPOCALCEMIA, HYPOPARATHYROIDISM, OSTEOPOROSIS",,LAUNCHED,,Small molecule,4,"C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C;C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O",GMRQFYUYWCNGIN-NKMMMXOESA-N
CALCIUM-GLUCEPTATE,CALCIUM-GLUCEPTATE,,BRD:BRD-BRD-K35952844-238-01-2,rep_primary,,,,,LAUNCHED,,,NA,"OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O, OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O",
CALCIUM-LEVOFOLINATE,CALCIUM-LEVOFOLINATE,,BRD:BRD-BRD-K97009491-238-03-8;BRD:BRD-K97009491-238-03-8;BRD:BRD-K97009491-238-05-9,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,"NC1NC(=O)C2N(C=O)[C@@H](CNC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2[NH]1, NC1NC(=O)C2N(C=O)[C@@H](CNC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2[NH]1",
CALHEX-231,CALHEX-231,,BRD:BRD-K19811997-003-02-9,rep_single_dose,CALCIUM SENSING RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,CASR,,,,,,NA,,
GSK962040B,CAMICINAL;GSK-962040;GSK-962040B;GSK962040;GSK962040B,CHEMBL489095,BRD:BRD-BRD-K23248433-001-01-8;BRD:BRD-K23248433-001-01-8,rep_primary;rep_single_dose,MOTILIN RECEPTOR AGONIST,MLNR,,,PHASE 2,,Small molecule,3,C[C@H]1CN(CC2CCC(CC(=O)N3CCC(CC3)NC3CCCC(F)C3)CC2)CCN1;C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(Nc4cccc(F)c4)CC3)cc2)CCN1,RZKDEGZIFSJVNA-IBGZPJMESA-N
CAMKII-IN-1,CAMKII-IN-1,,BRD:BRD-BRD-K35772771-001-02-1;BRD:BRD-K35772771-001-02-1,rep_primary;rep_single_dose,CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR,AKT1;CAMK2A;CAMK4;MYLK,,,PRECLINICAL,,,NA,"CC1C(CL)CCCC1S(=O)(=O)NC1NC(NCCC2CCCCC2)NC2CCN(CC3CCCCC3)CC12, CC1C(CL)CCCC1S(=O)(=O)NC1NC(NCCC2CCCCC2)NC2CCN(CC3CCCCC3)CC12",
CAMOBUCOL,AGIX-4207;CAMOBUCOL,CHEMBL2104958,BRD:BRD-K00004732-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,-1,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(OCC(=O)O)c(C(C)(C)C)c1,FGBGXESDYFKUFX-UHFFFAOYSA-N
CAMOSTAT-MESILATE,CAMOSTAT-MESILATE,,BRD:BRD-BRD-K43806473-066-02-1;BRD:BRD-K43806473-066-02-1,rep_primary;rep_single_dose,PROTEASE INHIBITOR,PRSS1,PANCREATITIS,,LAUNCHED,,,NA,"CN(C)C(=O)COC(=O)CC1CCC(OC(=O)C2CCC(NC(N)=N)CC2)CC1, CN(C)C(=O)COC(=O)CC1CCC(OC(=O)C2CCC(NC(N)=N)CC2)CC1",
TOPOTECAN RELATED COMPOUND C,7-ETHYL-10-HYDROXY-;7-ETHYL-10-HYDROXY-CAMPTOTHECIN;7-ETHYL-10-HYDROXYCAMPTOTHECIN;CAMPTOTHECIN;CAMPTOTHECINE;IRINOTECAN RELATED COMPOUND B;IT-141;NK 012;NK-012;NK012;NSC-94600;SN 38;SN-38;TOPOTECAN RELATED COMPOUND C,CHEMBL65;CHEMBL837,BRD:BRD-BRD-K37890730-001-15-1;BRD:BRD-K37890730-001-15-1;GDSC2:1003,gdsc;rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,PHASE 3,,Small molecule,-1,"CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCCCC4CC3CN1C2=O, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCCCC4CC3CN1C2=O, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCCCC4CC3CN1C2=O;CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1",VSJKWCGYPAHWDS-FQEVSTJZSA-N
TOPOTECAN RELATED COMPOUND C,(+)-CAMPTOTHECIN;CAMPTOTHECIN;CAMPTOTHECINE;NSC-94600;TOPOTECAN RELATED COMPOUND C,CHEMBL65,GDSC2:1003,gdsc,,,,,,,Small molecule,-1,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CAMYLOFINE-CHLORHYDRATE,CAMYLOFINE-CHLORHYDRATE,,BRD:BRD-A91733352-300-04-5;BRD:BRD-BRD-A91733352-300-04-5,rep_multi_dose;rep_primary;rep_single_dose,,,ABDOMINAL PAIN,,LAUNCHED,,,NA,"CCN(CC)CCNC(C(=O)OCCC(C)C)C1CCCCC1, CCN(CC)CCNC(C(=O)OCCC(C)C)C1CCCCC1, CCN(CC)CCNC(C(=O)OCCC(C)C)C1CCCCC1",
TA-7284,CANAGLIFLOZIN;CANAGLIFLOZIN HEMIHYDRATE;CANAGLIFLOZIN HYDRATE;INVOKANA;JNJ-24831754-ZAE;JNJ-28431754;JNJ-28431754-AAA;TA-7284,CHEMBL2048484;CHEMBL2103841;CHEMBL4594217,BRD:BRD-BRD-K90868879-001-03-8;BRD:BRD-K90868879-001-03-8,rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,SLC5A1;SLC5A2,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1;Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.O;CC1CCC(CC1CC1CCC(S1)-C1CCC(F)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O, CC1CCC(CC1CC1CCC(S1)-C1CCC(F)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O",RCCZPUWDQVUJAB-FVYJGOGTSA-N;XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
TCV-116,AMIAS;ATACAND;CANDESARTAN;CANDESARTAN 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER;CANDESARTAN CILEXETIL;CANDESARTAN CILEXETIL RELATED COMPOUND G;CV-11974;NSC-758697;NSC-759858;RATACAND;TCV-116,CHEMBL1014;CHEMBL1016,BRD:BRD-BRD-K84091759-001-07-1;BRD:BRD-K84091759-001-07-1,rep_multi_dose;rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,"CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1;CCOC1NC2CCCC(C(O)=O)C2N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCOC1NC2CCCC(C(O)=O)C2N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCOC1NC2CCCC(C(O)=O)C2N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1",GHOSNRCGJFBJIB-UHFFFAOYSA-N
CANDESARTAN-CILEXTIL,CANDESARTAN-CILEXETIL;CANDESARTAN-CILEXTIL,,BRD:BRD-A65671304-001-07-5;BRD:BRD-BRD-A65671304-001-07-5,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1;AGTR2,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,,NA,"CCOC1NC2CCCC(C(=O)OC(C)OC(=O)OC3CCCCC3)C2N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCOC1NC2CCCC(C(=O)OC(C)OC(=O)OC3CCCCC3)C2N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1",
CI-1033,CANERTINIB;CI-1033,CHEMBL31965,BRD:BRD-BRD-K50168500-001-07-9;BRD:BRD-K50168500-001-07-9;CTRP:606138,ctrp;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,AKT1;EGFR;ERBB2;ERBB4,,,PHASE 3,,Small molecule,3,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1;FC1CCC(NC2NCNC3CC(OCCCN4CCOCC4)C(NC(=O)C=C)CC23)CC1CL,OMZCMEYTWSXEPZ-UHFFFAOYSA-N
KENGREXAL,AR-C69931MX;AR-C69931XX;CANGRELOR;CANGRELOR TETRASODIUM;CANGRELOR TETRASODIUM SALT;KENGREAL;KENGREXAL,CHEMBL1097279;CHEMBL334966,BRD:BRD-K00004669-001-01-9,rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,,,,,,Small molecule,4,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+],COWWROCHWNGJHQ-OPKBHZIBSA-J
SPIRONOLACTONE RELATED COMPOUND A,CANRENONE;NSC-261713;SC-9376;SPIRONOLACTONE METABOLITE M1;SPIRONOLACTONE RELATED COMPOUND A,CHEMBL1463345,BRD:BRD-A20644369-001-08-6;BRD:BRD-BRD-A20644369-001-08-6,rep_multi_dose;rep_primary;rep_single_dose,MINERALOCORTICOID RECEPTOR ANTAGONIST,NR3C2,,,WITHDRAWN,,Small molecule,4,C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1;C[C@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C1CC[C@@]21CCC(=O)O1,UJVLDDZCTMKXJK-WNHSNXHDSA-N
"CAP-232, TT-232, TLN-232","CAP-232, TT-232, TLN-232",,GDSC1:436,gdsc,,,,,,,,NA,,
CAPADENOSON,BAY 68-4986;BAY-68-4986;BAY-684986;CAPADENOSON,CHEMBL3235279,BRD:BRD-BRD-K97025174-001-01-4;BRD:BRD-K97025174-001-01-4,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1,,,PHASE 2,,Small molecule,2,N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)c(C#N)c1-c1ccc(OCCO)cc1;NC1NC(SCC2CSC(N2)-C2CCC(CL)CC2)C(C#N)C(-C2CCC(OCCO)CC2)C1C#N,CITWCLNVRIKQAF-UHFFFAOYSA-N
XELODA,CAPECITABINE;CAPECITABINE ACCORD;CAPECITABINE MEDAC;CAPECITABINE SUN;CAPECITABINE TEVA;CAPECITIBINE;CAPECYTABINE;CAPIIBINE;CAPTABIN;ECANSYA;NSC-759853;RO 09-1978/000;RO-09-1978000;RO-091978000;XELODA,CHEMBL1773,BRD:BRD-BRD-K61192372-001-05-5;BRD:BRD-BRD-K61192372-001-08-9;BRD:BRD-K61192372-001-05-5;BRD:BRD-K61192372-001-08-9,rep_multi_dose;rep_primary;rep_single_dose,"DNA SYNTHESIS INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",TYMS,"BREAST CANCER, COLORECTAL CANCER",,LAUNCHED,,Small molecule,4,"CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F;CCCCCOC(=O)NC1NC(=O)N(CC1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O, CCCCCOC(=O)NC1NC(=O)N(CC1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O, CCCCCOC(=O)NC1NC(=O)N(CC1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O, CCCCCOC(=O)NC1NC(=O)N(CC1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O",GAGWJHPBXLXJQN-UORFTKCHSA-N
NYP-INC280-NX,CAPMATINIB;INC-280;INC280;INCB-28060;INCB-28060 FREE BASE;NVP-INC280;NVP-INC280-NX;NYP-INC280-NX,CHEMBL3188267,BRD:BRD-BRD-K81016934-001-02-0;BRD:BRD-K81016934-001-02-0;BRD:BRD-K81016934-001-03-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF MET,MET,,,PHASE 2,"Multiple values for MOA: {'INHIBITOR OF MET', 'C-MET INHIBITOR'}, defaulting to 'INHIBITOR OF MET'",Small molecule,4,CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F;CNC(=O)C1CCC(CC1F)-C1CNC2NCC(CC3CCC4NCCCC4C3)N2N1,LIOLIMKSCNQPLV-UHFFFAOYSA-N
SULFATE (SALT),34977;CAPASTAT;CAPASTAT SULFATE;CAPASTAT SULPHATE;CAPOSTATIN;CAPREOMICIN;CAPREOMYCIN;CAPREOMYCIN DISULFATE;CAPREOMYCIN SULFATE;CAPREOMYCIN SULPHATE;CAPREOMYCINI SULFAS;CAPROMYCIN;NSC-755904;OGOSTAL;SULFATE (1:2) (SALT);SULFATE (SALT),CHEMBL2218913;CHEMBL2221250,BRD:BRD-A31362467-065-01-3;BRD:BRD-BRD-A31362467-065-01-3,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,TUBERCULOSIS,,LAUNCHED,,Protein,4,"C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H](C2CCNC(=N)N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC1=O.N=C1NCCC([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC2=O)N1.O=S(=O)(O)O.O=S(=O)(O)O;NCCCC(N)CC(=O)NCC1NC(=O)C(CO)NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC1=O)=C/NC(N)=O)C1CCNC(=N)N1, CC1NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC(=O)C(CNC(=O)CC(N)CCCN)NC1=O)=C/NC(N)=O)C1CCNC(=N)N1",TUATYNXRYJTQTQ-BVRBKCERSA-N
CP-424391-18,"CAPIMORELIN;CAPROMORELIN;CP-424,391;CP-424391;CP-424391-18",CHEMBL113313,BRD:BRD-K00003188-046-01-9,rep_single_dose,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,,,,,,Small molecule,2,CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O,KVLLHLWBPNCVNR-SKCUWOTOSA-N
CAPRYLIC-ACID,CAPRYLIC-ACID,,BRD:BRD-BRD-K35170555-001-09-5;BRD:BRD-K35170555-001-09-5,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,"CCCCCCCC(O)=O, CCCCCCCC(O)=O",
ZOSTRIX HP,ALGRX 4975;ALGRX-4975;AUSANIL;AXSAIN;CAPSAICIN;CAPZASIN-HP;CNTX-4975;DOLENON;FEMA NO. 3404;MIOTON;NGX-1998;NGX-4010;NSC-56353;OVOCAP;QUTENZA;RATDEN PE 40;TOGARASHI ORENJI;TRANS-CAPSAICIN;ZACIN;ZOSTRIX;ZOSTRIX HP,CHEMBL294199,BRD:BRD-BRD-K50590187-001-19-9;BRD:BRD-K50590187-001-19-9,rep_multi_dose;rep_primary;rep_single_dose,TRPV AGONIST,CFTR;TRPV1,"MUSCLE PAIN, RHEUMATOID ARTHRITIS",,LAUNCHED,,Small molecule,4,"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O;COC1CC(CNC(=O)CCCC\C=C\C(C)C)CCC1O, COC1CC(CNC(=O)CCCC\C=C\C(C)C)CCC1O",YKPUWZUDDOIDPM-SOFGYWHQSA-N
CAPSAZEPINE,CAPSAZEPINE,CHEMBL391997,BRD:BRD-BRD-K44849676-001-10-5;BRD:BRD-K44849676-001-10-5,rep_primary;rep_single_dose,TRPV AGONIST,TRPV1;TRPV4,,,PRECLINICAL,,Small molecule,NA,"Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2;OC1CC2CCCN(CC2CC1O)C(=S)NCCC1CCC(CL)CC1, OC1CC2CCCN(CC2CC1O)C(=S)NCCC1CCC(CL)CC1",DRCMAZOSEIMCHM-UHFFFAOYSA-N
NSC-760122,CAPTAMINE;NSC-760122,CHEMBL1395579,BRD:BRD-BRD-K81645907-001-01-1;BRD:BRD-K81645907-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CN(C)CCS,DENMGZODXQRYAR-UHFFFAOYSA-N
ZAPTO,"ACEPRIL;APOPRIL;C09AA01;CAPOTEN;CAPTOMAX;CAPTOMEX;CAPTOPRIL;CAPTOPRILUM;ECOPACE;FARCOPRIL;GARRANIL;HYPOPRESS;HYTENEZE 12.5;HYTENEZE 25;HYTENEZE 50;KAPLON;LOPRIL;MEPHA;NOYADA;NSC-757419;SA-333;SQ -14225;SQ 14,225;SQ-14225;TENSIOMIN;TENSOBON;ZAPTO",CHEMBL1560,BRD:BRD-BRD-K54529596-001-26-3;BRD:BRD-K54529596-001-26-3,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE;LTA4H;MMP2;MMP9,"HYPERTENSION, CONGESTIVE HEART FAILURE, MYOCARDIAL INFARCTION, DIABETES MELLITUS, DIABETIC NEPHROPATHY",,LAUNCHED,,Small molecule,4,"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O;C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O",FAKRSMQSSFJEIM-RQJHMYQMSA-N
CARAMIPHEN,CARAMIPHEN,CHEMBL61946,BRD:BRD-BRD-K59895502-001-01-9;BRD:BRD-K59895502-001-01-9,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRM1;CHRM2,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,-1,CCN(CC)CCOC(=O)C1(c2ccccc2)CCCC1;CCN(CC)CCOC(=O)C1(CCCC1)C1CCCCC1,OFAIGZWCDGNZGT-UHFFFAOYSA-N
SUACRON,BM 51052;BM-51052;CARAZOLOL;CONDUCTON;SUACRON,CHEMBL324665,BRD:BRD-A50675490-001-01-0;BRD:BRD-BRD-A50675490-001-01-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3,"ANGINA PECTORIS, CARDIAC ARRYTHMIA, HYPERTENSION, MYOCARDIAL INFARCTION",,LAUNCHED,,Small molecule,-1,CC(C)NCC(O)COc1cccc2[nH]c3ccccc3c12;CC(C)NCC(O)COC1CCCC2[NH]C3CCCCC3C12,BQXQGZPYHWWCEB-UHFFFAOYSA-N
NSC-32865,CARBACHOL;CARBACHOL CHLORIDE;CARBACHOLINE CHLORIDE;CARBAMOYLCHOLINE CHLORIDE;CARBASTAT;DORYL;MIOSTAT;NSC-32865,CHEMBL14;CHEMBL965,BRD:BRD-BRD-K75037734-003-13-9;BRD:BRD-K75037734-003-13-9,rep_multi_dose;rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;CHRNA2,INTRAOCULAR PRESSURE,,LAUNCHED,,Small molecule,4,"C[N+](C)(C)CCOC(N)=O, C[N+](C)(C)CCOC(N)=O;C[N+](C)(C)CCOC(N)=O.[Cl-]",AIXAANGOTKPUOY-UHFFFAOYSA-N
NSC-758942,CARBADOX;GS-6244;MECADOX;NSC-758942,CHEMBL13779,BRD:BRD-BRD-K56735750-001-06-8;BRD:BRD-K56735750-001-06-8,rep_primary;rep_single_dose,OTHER ANTIBIOTIC,,"DYSENTRY, ENTERITIS",,LAUNCHED,,Small molecule,-1,"COC(=O)N/N=C/c1c[n+]([O-])c2ccccc2[n+]1[O-];COC(=O)N\N=C\C1C[N+]([O-])C2CCCCC2[N+]1[O-], COC(=O)N\N=C\C1C[N+]([O-])C2CCCCC2[N+]1[O-], COC(=O)N\N=C\C1C[N+]([O-])C2CCCCC2[N+]1[O-]",OVGGLBAWFMIPPY-WUXMJOGZSA-N
TIMONIL 400 RET,ARBIL MR;BISTON;CARBAGEN SR;CARBAMAZEPINE;CARBAMAZEPINE ANHYDROUS;CARBAMAZEPINE EXTENDED RELEASE;CARBAMAZEPINUM;CARBATROL;CARNEXIV;EPIMAZ;EPIMAZ RET;EPITOL;EQUETRO;FINLEPSIN;G-32883;GEIGY 32883;KARBAMAZEPIN;KARBELEX;NEUROTOL;NEUROTOP;NSC-169864;SIRTAL;SIRTAL RET;STAZEPINE;TEGRETAL;TEGRETOL;TEGRETOL CHEWTAB;TEGRETOL PROLONGED RELEASE;TEGRETOL XR;TEGRETOL-XR;TELESMIN;TERIL;TERIL RET;TIMONIL;TIMONIL 200 RET;TIMONIL 400 RET,CHEMBL108,BRD:BRD-BRD-K71799949-001-36-4;BRD:BRD-K71799949-001-36-4,rep_primary;rep_single_dose,CARBOXAMIDE ANTIEPILEPTIC,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,Small molecule,4,"NC(=O)N1C2CCCCC2C=CC2CCCCC12, NC(=O)N1C2CCCCC2C=CC2CCCCC12, NC(=O)N1C2CCCCC2C=CC2CCCCC12;NC(=O)N1c2ccccc2C=Cc2ccccc21",FFGPTBGBLSHEPO-UHFFFAOYSA-N
SULEO-C,CARBARIL;CARBARYL;CARYLDERM;CLINICIDE;DERBAC;DERBAC-C;ENT-23969;NSC-27311;SULEO-C,CHEMBL46917,BRD:BRD-K54208592-001-10-9,rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,,,,,,Small molecule,4,CNC(=O)Oc1cccc2ccccc12,CVXBEEMKQHEXEN-UHFFFAOYSA-N
CARBARSONE,CARBARSONE,CHEMBL1331366,BRD:BRD-K94848716-001-12-9,rep_single_dose,ANTIPROTOZOAL AGENT,,,,,,Small molecule,NA,NC(=O)Nc1ccc([As](=O)(O)O)cc1,WWXBHTZSYYGCSG-UHFFFAOYSA-N
NSC-73742,ADRENOCHROME MONOSEMICARBAZONE;ADRENOCHROME SEMICARBAZONE;CARBAZOCHROME;NSC-73742,CHEMBL2051960,BRD:BRD-A11070335-236-02-1;BRD:BRD-BRD-A11070335-236-02-1,rep_primary;rep_single_dose,,,HEMORRHAGE,,LAUNCHED,,Small molecule,-1,CN1C(CC2=C\C(=N\NC(N)=O)C(=O)C=C12)S(O)(=O)=O;CN1CC(O)C2=C/C(=N/NC(N)=O)C(=O)C=C21,XSXCZNVKFKNLPR-SDQBBNPISA-N
THICOPER,A 118;BAS-67054F;BAVISTIN;CARBENDAZIM;DERROPRENE;EK-578;FB-642;FENBENDAZOLE RELATED COMPOUND A;LIGNASAN;NSC-109874;THICOPER,CHEMBL70971,BRD:BRD-BRD-K12906202-001-06-2;BRD:BRD-K12906202-001-06-2,rep_primary;rep_single_dose,"MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",TP53;TUBB,FUNGICIDE,,LAUNCHED,,Small molecule,1,COC(=O)Nc1nc2ccccc2[nH]1;COC(=O)NC1NC2CCCCC2[NH]1,TWFZGCMQGLPBSX-UHFFFAOYSA-N
CARBENOXOLONE,CARBENOXOLONE,CHEMBL499915,BRD:BRD-A29700858-304-01-8;BRD:BRD-A29700858-304-02-6;BRD:BRD-BRD-A29700858-304-01-8;BRD:BRD-BRD-A29700858-304-02-6,rep_primary;rep_single_dose,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,GJA1;GJA10;GJA3;GJA4;GJA5;GJA8;GJA9;GJB1;GJB2;GJB3;GJB4;GJB5;GJB6;GJB7;GJC1;GJC2;GJC3;GJD2;GJD3;GJD4;GJE1;HSD11B1;PANX1;PANX2;PANX3,"PEPTIC ULCER DISEASE (PUD), MOUTH INFLAMMATION",,LAUNCHED,,Small molecule,4,"CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12;CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O, CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O, CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O",OBZHEBDUNPOCJG-WBXJDKIVSA-N
PENTOXYVERINE,CARBETAPENTANE;PENTOXYVERINE,CHEMBL73234,BRD:BRD-BRD-K06181161-048-15-1;BRD:BRD-K06181161-048-15-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM2,"COMMON COLD, NASAL CONGESTION, BRONCHITIS",,LAUNCHED,,Small molecule,4,"CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1;CCN(CC)CCOCCOC(=O)C1(CCCC1)C1CCCCC1, CCN(CC)CCOCCOC(=O)C1(CCCC1)C1CCCCC1",CFJMRBQWBDQYMK-UHFFFAOYSA-N
PABAL,CARBETOCIN;DURATOCIN;DURATOCIN LONG ACTING;FE 992097;FE-992097;LV-101;PABAL,CHEMBL3301668,BRD:BRD-BRD-K56107812-001-01-7;BRD:BRD-K56107812-001-01-7,rep_primary;rep_single_dose,OXYTOCIN RECEPTOR AGONIST,OXTR,HEMORRHAGE,,LAUNCHED,,Protein,4,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O;CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCC(OC)CC2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O,NSTRIRCPWQHTIA-DTRKZRJBSA-N
NSC-758966,ATHYROMAZOLE;CARBIMAZOL HENNING;CARBIMAZOLE;NEO-MERCAZOLE 20;NEO-MERCAZOLE 5;NSC-758966,CHEMBL508102,BRD:BRD-BRD-K87156652-001-12-7;BRD:BRD-K87156652-001-12-7,rep_primary;rep_single_dose,ANTITHYROID AGENT,TPO,HYPERTHYROIDISM,,LAUNCHED,,Small molecule,4,"CCOC(=O)n1ccn(C)c1=S;CCOC(=O)N1CCN(C)C1=S, CCOC(=O)N1CCN(C)C1=S, CCOC(=O)N1CCN(C)C1=S",CFOYWRHIYXMDOT-UHFFFAOYSA-N
ROTOXAMINE,(S)-;CARBINOXAMINE;CLISTIN;MCN-R-73-Z;PALGIC;ROTOXAMINE,CHEMBL1740361;CHEMBL864,BRD:BRD-A29426959-050-13-2;BRD:BRD-BRD-A29426959-050-13-2,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"ALLERGIC RHINITIS, CONJUNCTIVITIS, VASOMOTOR RHINITIS, DERMATOGRAPHISM",,LAUNCHED,,Small molecule,-1,CN(C)CCO[C@@H](c1ccc(Cl)cc1)c1ccccn1;CN(C)CCOC(C1CCC(CL)CC1)C1CCCCN1,OJFSXZCBGQGRNV-INIZCTEOSA-N
PARAPLATIN,CARBOPLATIN;CARBOPLATINE;CARBOPLATINUM;JM-8;NSC-201345;NSC-241240;PARAPLATIN,CHEMBL1351,BRD:BRD-BRD-K90947825-001-02-7;BRD:BRD-K90947825-001-02-7;CTRP:26979,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"DNA ALKYLATING AGENT, DNA INHIBITOR",,OVARIAN CANCER,,LAUNCHED,,Small molecule,4,"N[PT]1(N)OC(=O)C2(CCC2)C(=O)O1, N[PT]1(N)OC(=O)C2(CCC2)C(=O)O1, N[PT]1(N)OC(=O)C2(CCC2)C(=O)O1, N[PT]1(N)OC(=O)C2(CCC2)C(=O)O1",
CARBOPLATIN:ETOPOSIDE (40:17 MOL/MOL),CARBOPLATIN:ETOPOSIDE (40:17 MOL/MOL),,CTRP:660223,ctrp,,,,,,,,NA,,
CARBOPLATIN:UNC0638 (2:1 MOL/MOL),CARBOPLATIN:UNC0638 (2:1 MOL/MOL),,CTRP:660130,ctrp,,,,,,,,NA,,
NSC-609974,CARBOXYAMIDOTRIAZOLE;L 651582;NSC-609974,CHEMBL95431,BRD:BRD-BRD-K68408772-001-05-4;BRD:BRD-K68408772-001-05-4,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CXCL8,,,PHASE 3,,Small molecule,3,NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)c1N;NC(=O)C1NNN(CC2CC(CL)C(C(=O)C3CCC(CL)CC3)C(CL)C2)C1N,WNRZHQBJSXRYJK-UHFFFAOYSA-N
CARBOXYLOSARTAN,CARBOXYLOSARTAN,,BRD:BRD-BRD-K23533833-001-01-9;BRD:BRD-K23533833-001-01-9,rep_primary;rep_single_dose,ANGIOTENSIN ANTAGONIST,AGTR1,,,PHASE 1,,,NA,CCCCC1NC(CL)C(C(O)=O)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1,
CARBOXYPYRIDINE-DISULFIDE,CARBOXYPYRIDINE-DISULFIDE,,BRD:BRD-BRD-K26530649-001-01-6;BRD:BRD-K26530649-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,OC(=O)C1CCC(SSC2CCC(CN2)C(O)=O)NC1,
CARCAINIUM (CHLORIDE),CARCAINIUM (CHLORIDE),,BRD:BRD-K00079286-003-02-9,rep_single_dose,,,,,,,,NA,,
CARDIOGENOL-C,CARDIOGENOL-C,,BRD:BRD-BRD-K99174507-003-02-0;BRD:BRD-K99174507-003-02-0,rep_primary;rep_single_dose,CARDIOMYOGENESIS INDUCER,,,,PRECLINICAL,,,NA,"COC1CCC(NC2NCCC(NCCO)N2)CC1, COC1CCC(NC2NCCC(NCCO)N2)CC1",
CARDIONOGEN-1,CARDIONOGEN-1,,BRD:BRD-K50905564-001-08-9,rep_single_dose,WNT SIGNALING INHIBITOR,CTNNB1,,,,,,NA,,
CAREBASTINE,CAREBASTINE,CHEMBL67654,BRD:BRD-BRD-K49554218-001-01-0;BRD:BRD-K49554218-001-01-0,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,,,PHASE 1,,Small molecule,-1,CC(C)(C(=O)O)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1;CC(C)(C(O)=O)C1CCC(CC1)C(=O)CCCN1CCC(CC1)OC(C1CCCCC1)C1CCCCC1,XGHOVGYJHWQGCC-UHFFFAOYSA-N
PR-171,CARFILZOMIB;KYPROLIS;NSC-758252;PR-171,CHEMBL451887,BRD:BRD-BRD-K15179879-001-03-2;BRD:BRD-K15179879-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,PROTEASOME INHIBITOR,PSMA1;PSMA2;PSMA3;PSMA4;PSMA5;PSMA6;PSMA7;PSMA8;PSMB1;PSMB10;PSMB11;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9,MULTIPLE MYELOMA,,LAUNCHED,,Protein,4,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1;CC(C)C[C@H](NC(=O)[C@H](CCC1CCCCC1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N
CARGLUMIC-ACID,CARGLUMIC-ACID,,BRD:BRD-BRD-K60240222-001-01-4;BRD:BRD-K60240222-001-01-4,rep_primary;rep_single_dose,CARBAMOYL PHOSPHATE SYNTHASE ACTIVATOR,CPS1,HYPERAMMONEMIA,,LAUNCHED,,,NA,NC(=O)N[C@@H](CCC(O)=O)C(O)=O,
HOE-642,CARIPORIDE;HOE-642,CHEMBL436559,BRD:BRD-BRD-K21670884-001-01-9;BRD:BRD-K21670884-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,SODIUM/HYDROGEN EXCHANGER INHIBITOR,SLC9A1,,,PHASE 3,,Small molecule,-1,CC(C)c1ccc(C(=O)N=C(N)N)cc1S(C)(=O)=O;CC(C)C1CCC(CC1S(C)(=O)=O)C(=O)N=C(N)N,IWXNYAIICFKCTM-UHFFFAOYSA-N
RGH-188,CARIPRAZINE;FRI-7000188;GED-129;MP-214;REAGILA;RGH-188,CHEMBL2028019,BRD:BRD-BRD-K57764956-001-02-8;BRD:BRD-K57764956-001-02-8,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1;CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2CCCC(CL)C2CL)CC1,KPWSJANDNDDRMB-QAQDUYKDSA-N
SOMA,CARISOMA;CARISOPRODOL;CARISOPRODOL CIV;NSC-172124;RELA;SOMA,CHEMBL1233,BRD:BRD-A99939097-001-24-2;BRD:BRD-BRD-A99939097-001-24-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CYP2C19,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,4,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N
NSC-758963,CARMOFUR;MIFUROL;NSC-758963,CHEMBL460499,BRD:BRD-BRD-K11630072-001-13-2;BRD:BRD-K11630072-001-13-2,rep_multi_dose;rep_primary;rep_single_dose,THYMIDYLATE SYNTHASE INHIBITOR,TYMS,"BREAST CANCER, COLORECTAL CANCER",,LAUNCHED,,Small molecule,-1,"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O;CCCCCCNC(=O)N1CC(F)C(=O)[NH]C1=O, CCCCCCNC(=O)N1CC(F)C(=O)[NH]C1=O, CCCCCCNC(=O)N1CC(F)C(=O)[NH]C1=O",AOCCBINRVIKJHY-UHFFFAOYSA-N
CARMOXIROLE,CARMOXIROLE,CHEMBL70159,BRD:BRD-BRD-K82484965-003-03-5;BRD:BRD-K82484965-003-03-5,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD2,,,PHASE 2,,Small molecule,-1,"O=C(O)c1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1;OC(=O)C1CCC2[NH]CC(CCCCN3CCC(=CC3)C3CCCCC3)C2C1, OC(=O)C1CCC2[NH]CC(CCCCN3CCC(=CC3)C3CCCCC3)C2C1",AFSOIHMEOKEZJF-UHFFFAOYSA-N
SRI-1720,BCNU;BECENUN;BICNU;BISCHLOROETHYL NITROSOUREA;CAMUSTINE;CARMUBRIS;CARMUSTINE;DTI-015;FDA-0345;GLIADEL;NSC-409962;SK-27702;SRI-1720,CHEMBL513,BRD:BRD-BRD-K36234266-001-09-8;BRD:BRD-K36234266-001-09-8;GDSC2:1807,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"DNA ALKYLATING AGENT, DNA INHIBITOR",GSR,"NON-HODGKIN LYMPHOMA (NHL), HODGKIN'S LYMPHOMA, MULTIPLE MYELOMA, GLIOBLASTOMA, BRAINSTEM GLIOMA, MEDULLOBLASTOMA, ASTROCYTOMA, EPENDYMOMA",,LAUNCHED,,Small molecule,4,[O-][N+]N(CCCL)C(=O)NCCCL;O=NN(CCCl)C(=O)NCCCl,DLGOEMSEDOSKAD-UHFFFAOYSA-N
CARNITINE-(D/L),CARNITINE-(D/L),,BRD:BRD-A89594340-003-11-5;BRD:BRD-BRD-A89594340-003-11-5,rep_primary;rep_single_dose,,,,,PHASE 3,,,NA,"C[N+](C)(C)CC(O)CC(O)=O, C[N+](C)(C)CC(O)CC(O)=O",
CAROVERIN,CAROVERIN,,BRD:BRD-K70161083-001-06-9,rep_single_dose,CYTOCHROME P450 INHIBITOR,,,,,,,NA,,
SPASMIUM,CAROVERINE;SPASMIUM,CHEMBL1729803,BRD:BRD-BRD-K65900713-003-01-0;BRD:BRD-K65900713-003-01-0,rep_primary;rep_single_dose,"CALCIUM CHANNEL BLOCKER, GLUTAMATE RECEPTOR ANTAGONIST",,TINNITUS,,LAUNCHED,"Multiple values for MOA: {'GLUTAMATE RECEPTOR ANTAGONIST, CALCIUM CHANNEL BLOCKER', 'CALCIUM CHANNEL BLOCKER, GLUTAMATE RECEPTOR ANTAGONIST'}, defaulting to 'CALCIUM CHANNEL BLOCKER, GLUTAMATE RECEPTOR ANTAGONIST'",Small molecule,-1,CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21;CCN(CC)CCN1C(=O)C(NC2CCCCC12)=CC1CCC(OC)CC1,MSPRUJDUTKRMLM-UHFFFAOYSA-N
FI-6654,CAROXAZONE;F.I. 6654;FI-6654,CHEMBL2104164,BRD:BRD-BRD-K92129045-001-01-6;BRD:BRD-K92129045-001-01-6,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,,,WITHDRAWN,,Small molecule,-1,NC(=O)CN1Cc2ccccc2OC1=O;NC(=O)CN1CC2CCCCC2OC1=O,KYCBWEZLKCTALM-UHFFFAOYSA-N
RO-20-5720-000,CARPROFEN;CARPROFEN FOR VETERINARY USE;NSC-297935;RIMADYL;RO 20-5720/000;RO-20-5720-000,CHEMBL1316,BRD:BRD-A17411484-001-11-9;BRD:BRD-BRD-A17411484-001-11-9,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,OSTEOARTHRITIS,,LAUNCHED,,Small molecule,4,"CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12;CC(C(O)=O)C1CCC2C(C1)[NH]C1CCC(CL)CC21, CC(C(O)=O)C1CCC2C(C1)[NH]C1CCC(CL)CC21",PUXBGTOOZJQSKH-UHFFFAOYSA-N
OXYPHENHYDRAZINE,CARSALAM;NSC-36166;OXYPHENHYDRAZINE,CHEMBL1720051,BRD:BRD-BRD-K13238618-001-05-9;BRD:BRD-K13238618-001-05-9,rep_primary;rep_single_dose,ANALGESIC AGENT,,,,PRECLINICAL,,Small molecule,-1,O=c1[nH]c(=O)c2ccccc2o1;O=C1[NH]C(=O)C2CCCCC2O1,OAYRYNVEFFWSHK-UHFFFAOYSA-N
OCUPRESS,CARTEOLOL;CARTROL;OCUPRESS,CHEMBL839,BRD:BRD-A42167015-003-10-2;BRD:BRD-BRD-A42167015-003-10-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3,"INTRAOCULAR PRESSURE, GLAUCOMA, OCULAR HYPERTENSION",,LAUNCHED,"Multiple values for repurposing_target: {'ADRB1;ADRB2', 'ADRB1;ADRB2;ADRB3'}, taking the union",Small molecule,4,CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2;CC(C)(C)NCC(O)COC1CCCC2NC(=O)CCC12,LWAFSWPYPHEXKX-UHFFFAOYSA-N
CARUMONAM,CARUMONAM,CHEMBL1614658,BRD:BRD-BRD-K71026158-304-01-0;BRD:BRD-K71026158-304-01-0,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"URINARY TRACT INFECTIONS, GRAM-NEGATIVE BACTERIAL INFECTIONS",,LAUNCHED,,Small molecule,-1,NC(=O)OC[C@@H]1[C@H](NC(=O)/C(=N\OCC(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O;NC(=O)OC[C@@H]1[C@H](NC(=O)C(=N/OCC(O)=O)\C2CSC(N)N2)C(=O)N1S(O)(=O)=O,UIMOJFJSJSIGLV-JNHMLNOCSA-N
TALLITON,BM 14.190;BM-14-190;BM-14.190;BM-14190;C07AG02;CARVEDILOL;COREG;COREG CR;CORONIS;DILATREND;DIMITONE;DQ-2466;EUCARDIC;EUCARDIC 12.5;EUCARDIC 25;EUCARDIC 3.125;EUCARDIC 6.25;KORVASAN;KREDEX;NSC-758694;SKF-105517;TALLITON,CHEMBL723,BRD:BRD-A10977446-001-12-1;BRD:BRD-BRD-A10977446-001-12-1,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;ADRB3;GJA1;HIF1A;KCNH2;NDUFC2;NPPB;SELE;VCAM1;VEGFA,"MYOCARDIAL INFARCTION, HYPERTENSION",,LAUNCHED,,Small molecule,4,"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12;COC1CCCCC1OCCNCC(O)COC1CCCC2[NH]C3CCCCC3C12, COC1CCCCC1OCCNCC(O)COC1CCCC2[NH]C3CCCCC3C12, COC1CCCCC1OCCNCC(O)COC1CCCC2[NH]C3CCCCC3C12, COC1CCCCC1OCCNCC(O)COC1CCCC2[NH]C3CCCCC3C12, COC1CCCCC1OCCNCC(O)COC1CCCC2[NH]C3CCCCC3C12",OGHNVEJMJSYVRP-UHFFFAOYSA-N
PARA-CARBOXYBENZENESULFONAMIDE (WEAK CARBONIC ANHYDRASE INHIBITOR),4-SULFAMOLYBENZOIC ACID;CARZENIDE;NSC-22976;P-SULFAMOYLBENZOIC ACID;PARA-CARBOXYBENZENESULFONAMIDE (WEAK CARBONIC ANHYDRASE INHIBITOR),CHEMBL414,BRD:BRD-BRD-K09295674-001-09-8;BRD:BRD-K09295674-001-09-8,rep_primary;rep_single_dose,,CA1;CA12;CA14;CA2;CA6;CA9,,,PRECLINICAL,,Small molecule,-1,NS(=O)(=O)c1ccc(C(=O)O)cc1;NS(=O)(=O)C1CCC(CC1)C(O)=O,UCAGLBKTLXCODC-UHFFFAOYSA-N
CASIN,CASIN,,BRD:BRD-A25043798-001-02-9,rep_single_dose,GTPASE INHIBITOR,CDC42,,,,,,NA,,
MK-991,"CANCIDAS;CASPOFUNGIN;CASPOFUNGIN ACETATE;L-743,872;L-743872;MK-991",CHEMBL499808,BRD:BRD-K00002625-402-02-9,rep_single_dose,"BACTERIAL CELL WALL SYNTHESIS INHIBITOR, FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",,,,,,Small molecule,4,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,JYIKNQVWKBUSNH-OGZDCFRISA-N
CASPOFUNGIN-ACETATE,CASPOFUNGIN-ACETATE,,BRD:BRD-BRD-K49793107-402-02-6;BRD:BRD-K49793107-402-02-6,rep_primary;rep_single_dose,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",,"CANDIDEMIA, ESOPHAGEAL CANDIDIASIS, ASPERGILLOSIS, PERITONITIS",,LAUNCHED,,,NA,"CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1CCC(O)CC1)[C@H](O)CCN, CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1CCC(O)CC1)[C@H](O)CCN",
NSC-625381,CASTANOSPERMINE;NSC-625381,CHEMBL311226,BRD:BRD-BRD-K20897876-001-10-0;BRD:BRD-K20897876-001-10-0,rep_primary;rep_single_dose,GLUCOSIDASE INHIBITOR,GAA;GBA,,,PHASE 2,,Small molecule,-1,"O[C@H]1[C@H](O)[C@@H](O)CN2CC[C@H](O)[C@H]12;O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12, O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12",JDVVGAQPNNXQDW-TVNFTVLESA-N
CATHARANTHINE,CATHARANTHINE,,BRD:BRD-K92377961-001-03-7,rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,,,,NA,,
CATHEPSIN-INHIBITOR-1,CATHEPSIN-INHIBITOR-1,,BRD:BRD-BRD-K40269473-001-02-2;BRD:BRD-K40269473-001-02-2,rep_primary;rep_single_dose,CATHEPSIN INHIBITOR,CTSB;CTSL;CTSV,,,PRECLINICAL,,,NA,CN1NC(CC1C(=O)N[C@@H](CC1CCCC(CL)C1)C(=O)NCC#N)C(C)(C)C,
CAY10505,CAY10505,,BRD:BRD-BRD-K40366680-001-03-3;BRD:BRD-K40366680-001-03-3,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CG,,,PRECLINICAL,,,NA,"FC1CCC(CC1)-C1CCC(\C=C2\SC(=O)NC2=O)O1, FC1CCC(CC1)-C1CCC(\C=C2\SC(=O)NC2=O)O1",
CAY10566,CAY10566,,GDSC1:416,gdsc,,,,,,,,NA,,
CAY10576,CAY10576,,CTRP:622913,ctrp,,,,,,,,NA,,
CAY10594,CAY10594,,CTRP:411824,ctrp,,,,,,,,NA,,
CAY10603,CAY10603,,GDSC1:276,gdsc,,,,,,,,NA,,
CAY10618,CAY10618,,CTRP:632104,ctrp,,,,,,,,NA,,
WINLEVI,BREEZULA;CB-03-01;CLASCOTERONE;CORTEXOLONE 17.ALPHA.-PROPIONATE;CORTODOXONE 17.ALPHA.-PROPIONATE;WINLEVI,CHEMBL3590187,BRD:BRD-BRD-K41779183-001-01-2;BRD:BRD-K41779183-001-01-2,rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AR,,,PHASE 3,,Small molecule,4,"CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C;CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)CO, CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)CO",GPNHMOZDMYNCPO-PDUMRIMRSA-N
CB-10-277,CB-10-277,,BRD:BRD-BRD-K59929863-001-01-9;BRD:BRD-K59929863-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,,,PHASE 1,,,NA,CN(C)\N=N\C1CCC(CC1)C(O)=O,
CB-103,CB-103,CHEMBL1420319,BRD:BRD-K99108507-001-10-9,rep_single_dose,,,,,,,Small molecule,2,CC(C)(C)c1ccc(Oc2ccc(N)cn2)cc1,WHIWGRCYMQLLAO-UHFFFAOYSA-N
CB-5083,CB 5083;CB-5083,CHEMBL3747513,BRD:BRD-BRD-K49048664-001-01-2;BRD:BRD-K49048664-001-01-2,rep_primary;rep_single_dose,VALOSIN-CONTAINING PROTEIN INHIBITOR,VCP,,,PHASE 1,,Small molecule,1,"Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2;CC1CC2C(CCCC2N1-C1NC2CCOCC2C(NCC2CCCCC2)N1)C(N)=O, CC1CC2C(CCCC2N1-C1NC2CCOCC2C(NCC2CCCCC2)N1)C(N)=O",RDALZZCKQFLGJP-UHFFFAOYSA-N
TELAGLENASTAT,CB-839;TELAGLENASTAT,CHEMBL3639788,BRD:BRD-BRD-K58070273-001-03-3;BRD:BRD-K58070273-001-03-3,rep_primary;rep_single_dose,GLUTAMINASE INHIBITOR,GLS,,,PHASE 1/PHASE 2,,Small molecule,2,"FC(F)(F)OC1CCCC(CC(=O)NC2CCC(CCCCC3NNC(NC(=O)CC4CCCCN4)S3)NN2)C1, FC(F)(F)OC1CCCC(CC(=O)NC2CCC(CCCCC3NNC(NC(=O)CC4CCCCN4)S3)NN2)C1;O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1",PRAAPINBUWJLGA-UHFFFAOYSA-N
CBB-1007,CBB-1007,,CTRP:687721,ctrp,,,,,,,,NA,,
CBIPES,CBIPES,,BRD:BRD-BRD-K34675210-003-01-4;BRD:BRD-K34675210-003-01-4,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM2,,,PRECLINICAL,,,NA,CCS(=O)(=O)N(CC1CCCNC1)C1CCCC(C1)-C1CCC(CC1)C#N,
CBL0137,CBL0137,,BRD:BRD-K00003273-003-01-9,rep_single_dose,HISTONE CHAPERONE INHIBITOR,,,,,,,NA,,
INOBRODIB,CBP/P300-IN-4;CCS 1477;CCS-1477;CCS1477;INOBRODIB,CHEMBL4785363,BRD:BRD-K00068629-001-02-9;BRD:BRD-K00068629-001-03-9,oncref_2;rep_single_dose,INHIBITOR OF EP300/CREBBP BRD,BRD4;CREBBP;EP300,,,,"Multiple values for Drug.Name: {'CBP/P300-IN-4', 'CCS1477'}, defaulting to 'CBP/P300-IN-4'",Small molecule,1,CO[C@H]1CC[C@H](n2c([C@@H]3CCCC(=O)N3c3ccc(F)c(F)c3)nc3cc(-c4c(C)noc4C)ccc32)CC1,SKDNDJWEBPQKCS-CLHVYKLBSA-N
N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE,"CBS,-N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE;N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE",,BRD:BRD-BRD-K64191834-001-03-1;BRD:BRD-K64191834-001-03-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,C1CCC(CC1)NSC1NC2CCCCC2S1,
CC-115,CC-115,CHEMBL3586573,BRD:BRD-BRD-K16755045-003-01-7;BRD:BRD-K16755045-003-01-7,rep_primary;rep_single_dose,"MTOR INHIBITOR, DNA PROTEIN KINASE INHIBITOR",MTOR,,,PHASE 1,"Multiple values for MOA: {'DNA PROTEIN KINASE INHIBITOR, MTOR INHIBITOR', 'MTOR INHIBITOR, DNA PROTEIN KINASE INHIBITOR'}, defaulting to 'MTOR INHIBITOR, DNA PROTEIN KINASE INHIBITOR'",Small molecule,2,"CCN1C(=O)CN=C2NC=C(N=C12)C1CCC(NC1C)-C1NNC[NH]1, CCN1C(=O)CN=C2NC=C(N=C12)C1CCC(NC1C)-C1NNC[NH]1, CCN1C(=O)CN=C2NC=C(N=C12)C1CCC(NC1C)-C1NNC[NH]1;CCN1C(=O)CNc2ncc(-c3ccc(-c4nc[nH]n4)nc3C)nc21",GMYLVKUGJMYTFB-UHFFFAOYSA-N
ONATASERTIB,ATG-008;CC-223;ONATASERTIB,CHEMBL3586404,BRD:BRD-K88737571-001-02-2,rep_single_dose,MTOR INHIBITOR,MTOR,,,,,Small molecule,2,CO[C@H]1CC[C@H](N2C(=O)CNc3ncc(-c4ccc(C(C)(C)O)nc4)nc32)CC1,UFKLYTOEMRFKAD-SHTZXODSSA-N
CC-401,CC-401,CHEMBL1614713,BRD:BRD-BRD-K45746021-003-01-9;BRD:BRD-K45746021-003-01-9,rep_primary;rep_single_dose,JNK INHIBITOR,MAPK8,,,PHASE 1,,Small molecule,2,C(CN1CCCCC1)OC1CCCC(C1)-C1N[NH]C2CCC(CC12)-C1NCN[NH]1;c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1,XDJCLCLBSGGNKS-UHFFFAOYSA-N
CC-90003,CC-90003,,BRD:BRD-K00003116-001-01-9,rep_single_dose,MAP KINASE INHIBITOR,,,,,,,NA,,
CC-90011 (BENZENESULFONATE),CC-90011 (BENZENESULFONATE),,BRD:BRD-K00091110-074-01-9,rep_single_dose,,,,,,,,NA,,
MEZIGDOMIDE,CC-92480;CC92480;MEZIGDOMIDE,CHEMBL4648616,BRD:BRD-K00087010-001-02-9,rep_single_dose,,,,,,,Small molecule,1,N#Cc1ccc(N2CCN(Cc3ccc(COc4cccc5c4CN([C@H]4CCC(=O)NC4=O)C5=O)cc3)CC2)c(F)c1,YTINZZFBHWSAGL-NDEPHWFRSA-N
TANZISERTIB,CC-930;JNK 930;JNK-930;TANZISERTIB,CHEMBL1950289,BRD:BRD-BRD-K48213016-001-01-8;BRD:BRD-K48213016-001-01-8,rep_primary;rep_single_dose,JNK INHIBITOR,,,,PHASE 2,,Small molecule,2,O[C@H]1CC[C@@H](CC1)NC1NCC2NC(NC3C(F)CC(F)CC3F)N([C@H]3CCOC3)C2N1;O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,IBGLGMOPHJQDJB-IHRRRGAJSA-N
CC4,CC4,,BRD:BRD-K17751100-001-02-9,rep_single_dose,NICOTINIC RECEPTOR AGONIST,CHRNB2,,,,,,NA,,
CCG-1423,CCG-1423,,BRD:BRD-A79726147-001-02-9,rep_single_dose,APOPTOSIS STIMULANT,RHOC;SRF,,,,,,NA,,
CCG-50014,CCG-50014,,BRD:BRD-BRD-K08893438-001-04-9;BRD:BRD-K08893438-001-04-9,rep_multi_dose;rep_primary;rep_single_dose,G PROTEIN SIGNALING INHIBITOR,RGS4;RGS8,,,PRECLINICAL,,,NA,"CC1CCC(CC1)-N1SC(=O)N(CC2CCC(F)CC2)C1=O, CC1CCC(CC1)-N1SC(=O)N(CC2CCC(F)CC2)C1=O, CC1CCC(CC1)-N1SC(=O)N(CC2CCC(F)CC2)C1=O",
XY-4083,ANVYLIC-3288;AVL-3288;CCMI;UCI-4083;XY-4083,CHEMBL429317,BRD:BRD-BRD-K16338837-001-02-6;BRD:BRD-K16338837-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,CHRNA7,,,PRECLINICAL,,Small molecule,1,"Cc1cc(/C(=C/Nc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)on1;CC1CC(ON1)C(=CNC1CCC(CL)CC1)C(=O)NC1CCC(CL)CC1, CC1CC(ON1)C(=CNC1CCC(CL)CC1)C(=O)NC1CCC(CL)CC1",VMAKIACTLSBBIY-BOPFTXTBSA-N
CCMQ,CCMQ,,BRD:BRD-K06159959-001-03-9,rep_single_dose,HOMOQUINOLINIC ACID BINDING INHIBITOR,,,,,,,NA,,
CCR1 ANTAGONIST 9,CCR1 ANTAGONIST 9,,BRD:BRD-K00091272-001-01-9,rep_single_dose,,,,,,,,NA,,
CCR2 ANTAGONIST 3,CCR2 ANTAGONIST 3,,BRD:BRD-K00077266-001-02-9,rep_single_dose,,,,,,,,NA,,
CCT-018159,CCT 018159;CCT-018159,,GDSC1:1170,gdsc,,,,,,,,NA,,
CCT-031374,CCT-031374,,BRD:BRD-K90999434-004-02-9,rep_single_dose,WNT SIGNALING INHIBITOR,CTNNB1,,,,,,NA,,
CCT007093,CCT007093,,GDSC1:1067,gdsc,,,,,,,,NA,,
CCT018159,CCT018159,,BRD:BRD-BRD-K65503129-001-06-3;BRD:BRD-K65503129-001-06-3;GDSC1:1170,gdsc;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1;HSP90AB1,,,PRECLINICAL,,,NA,"CCC1CC(-C2N[NH]C(C)C2-C2CCC3OCCOC3C2)C(O)CC1O, CCC1CC(-C2N[NH]C(C)C2-C2CCC3OCCOC3C2)C(O)CC1O",
CCT036477,CCT036477,,CTRP:417663,ctrp,,,,,,,,NA,,
CCT128930,CCT128930,,BRD:BRD-BRD-K76406695-001-02-9;BRD:BRD-K76406695-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,AKT INHIBITOR,PKIA;PRKACA,,,PRECLINICAL,,,NA,NC1(CC2CCC(CL)CC2)CCN(CC1)C1NCNC2[NH]CCC12,
CCT129202,CCT129202,,BRD:BRD-BRD-K57136142-001-02-4;BRD:BRD-K57136142-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB;AURKC,,,PRECLINICAL,,,NA,"CN(C)C1CCC(CC1)-C1NC2C(N3CCN(CC(=O)NC4NCCS4)CC3)C(CL)CNC2[NH]1, CN(C)C1CCC(CC1)-C1NC2C(N3CCN(CC(=O)NC4NCCS4)CC3)C(CL)CNC2[NH]1",
CCT137690,CCT137690,,BRD:BRD-BRD-K03289018-001-02-7;BRD:BRD-K03289018-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB;AURKC,,,PRECLINICAL,,,NA,"CN1CCN(CC1)C1CCC(CC1)-C1NC2C(N3CCN(CC4CC(C)ON4)CC3)C(BR)CNC2[NH]1, CN1CCN(CC1)C1CCC(CC1)-C1NC2C(N3CCN(CC4CC(C)ON4)CC3)C(BR)CNC2[NH]1, CN1CCN(CC1)C1CCC(CC1)-C1NC2C(N3CCN(CC4CC(C)ON4)CC3)C(BR)CNC2[NH]1",
CCT196969,CCT196969,,BRD:BRD-K00005244-001-01-9,rep_single_dose,RAF INHIBITOR,,,,,,,NA,,
CCT245737,CCT245737,,BRD:BRD-K00003276-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,,NA,,
CD-1530,CD-1530,,BRD:BRD-BRD-K09619322-001-03-8;BRD:BRD-K09619322-001-03-8;CTRP:375562,ctrp;rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARG,,,PRECLINICAL,,,NA,OC(=O)C1CCC(CC1)-C1CCC2CC(O)C(CC2C1)C12CC3CC(CC(C3)C1)C2,
CD-437,CD-437,,BRD:BRD-BRD-K28907958-001-04-3;BRD:BRD-K28907958-001-04-3;CTRP:375256,ctrp;rep_multi_dose;rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARG,,,PRECLINICAL,,,NA,"OC(=O)C1CCC2CC(CCC2C1)-C1CCC(O)C(C1)C12CC3CC(CC(C3)C1)C2, OC(=O)C1CCC2CC(CCC2C1)-C1CCC(O)C(C1)C12CC3CC(CC(C3)C1)C2",
CD532,CD532,,GDSC1:449,gdsc,,,,,,,,NA,,
CDBA,CDBA,,BRD:BRD-A08079565-001-01-8;BRD:BRD-BRD-A08079565-001-01-8,rep_primary;rep_single_dose,,,,,PHASE 3,,,NA,OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O,
CDK1-5-INHIBITOR,CDK1-5-INHIBITOR,,BRD:BRD-BRD-K87932577-001-02-4;BRD:BRD-K87932577-001-02-4,rep_primary;rep_single_dose,"CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",CDK1;CDK5;GSK3B,,,PRECLINICAL,,,NA,NC1N[NH]C2NC3CCCCC3NC12,
CDK9-IN-6,CDK9-IN-6,,BRD:BRD-BRD-K43914553-001-01-5;BRD:BRD-K43914553-001-01-5,rep_primary;rep_single_dose,CDK INHIBITOR,CDK9,,,PRECLINICAL,,,NA,COC[C@H](C)N[C@H]1CC[C@@H](CC1)NC1CC(C(CL)CN1)-C1CCCC(NCC2(CCOCC2)C#N)N1,
CDPPB,CDPPB,,BRD:BRD-BRD-K02213468-001-02-3;BRD:BRD-K02213468-001-02-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM5,,,PRECLINICAL,,,NA,O=C(NC1CC(NN1-C1CCCCC1)-C1CCCCC1)C1CCCC(C1)C#N,
CE-245677,CE 245677;CE-245677,CHEMBL3545120,BRD:BRD-K00076620-001-02-9,rep_single_dose,,,,,,,Small molecule,1,,
CE3F4,CE3F4,,BRD:BRD-A47940219-001-01-4;BRD:BRD-BRD-A47940219-001-01-4,rep_primary;rep_single_dose,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR INHIBITOR,RAPGEF3,,,PRECLINICAL,,,NA,CC1CCC2C(CC(BR)C(F)C2BR)N1C=O,
GRT6005,CEBRANOPADOL;GRT-6005;GRT6005,CHEMBL2364605,BRD:BRD-BRD-K48141473-001-01-7;BRD:BRD-K48141473-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRL1;OPRM1,,,PHASE 3,,Small molecule,3,CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12;CN(C)[C@]1(CC[C@@]2(CC1)OCCC1C2[NH]C2CCC(F)CC12)C1CCCCC1,CSMVOZKEWSOFER-RQNOJGIXSA-N
ZD-2171,AZD-2171;AZD2171;CEDIRANIB;RECENTIN;ZD-2171,CHEMBL491473,BRD:BRD-BRD-K86930074-001-05-0;BRD:BRD-K86930074-001-05-0;CTRP:606136;GDSC2:1922,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"KIT INHIBITOR, VEGFR INHIBITOR",CSF1R;FLT1;FLT3;FLT4;KDR;KIT;PDGFRA;PDGFRB,,,PHASE 3,,Small molecule,3,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1;COC1CC2C(OC3CCC4[NH]C(C)CC4C3F)NCNC2CC1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N
RANICLOR,BACTICLOR MR;CECLOR;CECLOR CD;CEFACLOR;CEFACLOR HYDRATE;CEFACLOR MONOHYDRATE;COMPOUND 99638;COMPOUND-99638;DISTACLOR;DISTACLOR MR;J01DC04;KEFTID;NSC-757422;RANICLOR,CHEMBL1201018;CHEMBL680,BRD:BRD-BRD-K20338176-001-17-7;BRD:BRD-K20338176-001-17-7,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"PNEUMONIA, SKIN INFECTIONS, URINARY TRACT INFECTIONS, RESPIRATORY TRACT INFECTIONS, TONSILLITIS, PHARYNGITIS",,LAUNCHED,,Small molecule,4,"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1;N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1.O;N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CL)=C(N2C1=O)C(O)=O)C1CCCCC1, N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CL)=C(N2C1=O)C(O)=O)C1CCCCC1, N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CL)=C(N2C1=O)C(O)=O)C1CCCCC1",QYIYFLOTGYLRGG-GPCCPHFNSA-N;WKJGTOYAEQDNIA-IOOZKYRYSA-N
ULTRACEF,ANHYDROUS CEFADROXIL;BAXAN;BL-S578;CEFADROPS;CEFADROXIL;CEFADROXIL (AS MONOHYDRATE);CEFADROXIL ANHYDROUS;CEFADROXIL HYDRATE;CEFADROXIL MONOHYDRATE;CEFADROXIL/CEFADROXIL HEMIHYDRATE;CEFATABS;DURACEF;DURICEF;MJF 11567-3;MJF-11567-3;NSC-756664;ULTRACEF,CHEMBL1644,BRD:BRD-A56858165-001-04-4;BRD:BRD-BRD-A56858165-001-04-4,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,SLC15A1;SLC15A2;SLC22A6;SLC22A8,"URINARY TRACT INFECTIONS, SKIN INFECTIONS, TONSILLITIS, PHARYNGITIS",,LAUNCHED,,Small molecule,4,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1;CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)C1CCC(O)CC1)C2=O)C(O)=O,BOEGTKLJZSQCCD-UEKVPHQBSA-N
SK&F-41558,CEFAZOLIN;CEPHAZOLIN;J01DB04;SK&F-41558,CHEMBL1435,BRD:BRD-K99750640-236-20-3,rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,PON1,,,,,Small molecule,4,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,MLYYVTUWGNIJIB-BXKDBHETSA-N
CEFCAPENE-PIVOXIL,CEFCAPENE-PIVOXIL,,BRD:BRD-BRD-K27515606-003-01-3;BRD:BRD-K27515606-003-01-3,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"SKIN INFECTIONS, PNEUMONIA, URINARY TRACT INFECTIONS",,LAUNCHED,,,NA,"CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1, CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1, CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1",
OMNICEF,BMY-28488;CEFDINIR;CEFDINIR ANHYDROUS;CEFZON;CI-983;FK 482;FK-482;NSC-758926;OMNICEF,CHEMBL927,BRD:BRD-BRD-K15766189-001-09-8;BRD:BRD-K15766189-001-09-8,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,MPO,"PNEUMONIA, TONSILLITIS, PHARYNGITIS, BRONCHITIS, SKIN INFECTIONS, OTITIS, SINUSITIS",,LAUNCHED,,Small molecule,4,"C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1;NC1NC(CS1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O, NC1NC(CS1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O, NC1NC(CS1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O",RTXOFQZKPXMALH-GHXIOONMSA-N
CEFDITOREN-PIVOXIL,CEFDITOREN-PIVOXIL,,BRD:BRD-BRD-K72167406-001-02-1;BRD:BRD-BRD-K72167406-001-03-9;BRD:BRD-K72167406-001-02-1;BRD:BRD-K72167406-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"PNEUMONIA, BRONCHITIS, SKIN INFECTIONS, TONSILLITIS, PHARYNGITIS",,LAUNCHED,,,NA,"CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(\C=C/C3SCNC3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(\C=C/C3SCNC3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(\C=C/C3SCNC3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1",
VNRX-5022,BMY-28142;CEFEPIME;J01DE01;MAXIPIME;RENAPIME;VNRX-5022,CHEMBL186,BRD:BRD-A12077521-003-01-5;BRD:BRD-BRD-A12077521-003-01-5,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"PNEUMONIA, URINARY TRACT INFECTIONS, SKIN INFECTIONS, INTRA-ABDOMINAL INFECTIONS",,LAUNCHED,,Small molecule,4,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1;CO\N=C(\C(=O)NC1C2SCC(C[N+]3(C)CCCC3)=C(N2C1=O)C(O)=O)C1CSC(N)N1,HVFLCNVBZFFHBT-ZKDACBOMSA-N
RO-15-8074,CEFETAMET;CEFETAMET PIVOXIL HYDROCHLORIDE;DEACETOXYCEFOTAXIME;LY-097964;LY-97964;LY097964;RO 15-8074;RO-15-8074,CHEMBL2103764,BRD:BRD-BRD-K27798832-001-01-5;BRD:BRD-K27798832-001-01-5,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"EAR INFECTIONS, PNEUMONIA, OTITIS, SINUSITIS, BRONCHITIS, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,-1,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C)CS[C@H]12)c1csc(N)n1;CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(O)=O)C1CSC(N)N1,MQLRYUCJDNBWMV-GHXIOONMSA-N
CEFETAMET-PIVOXIL,CEFETAMET-PIVOXIL,,BRD:BRD-BRD-K21372554-003-01-7;BRD:BRD-K21372554-003-01-7,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-POSITIVE BACTERIAL INFECTIONS,,LAUNCHED,,,NA,"CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)C1CSC(N)N1",
S-649266,CEFIDEROCOL;GSK2696266;S-649266,CHEMBL3989974,BRD:BRD-K00003257-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,4,CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)CS[C@H]12)c1csc(N)n1)C(=O)O,DBPPRLRVDVJOCL-FQRUVTKNSA-N
SUPRAX,"ANHYDROUS CEFIXIME;CEFIXIME;CEFIXIME ANHYDROUS;CEFIXIME HYDRATE;CEFIXIME TRIHYDRATE;CEFSPAN;CEPHORAL;CITROPEN;CL 284,635;CL-284635;FK 027;FK-027;FR 17027;FR-17027;OROKEN;SUPRAX",CHEMBL1541,BRD:BRD-BRD-K71059170-001-11-6;BRD:BRD-K71059170-001-11-6,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"URINARY TRACT INFECTIONS, OTITIS, PHARYNGITIS, TONSILLITIS, GONORRHEA, BRONCHITIS",,LAUNCHED,,Small molecule,4,"C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCC(=O)O)c3csc(N)n3)[C@H]2SC1;NC1NC(CS1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O, NC1NC(CS1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O, NC1NC(CS1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O",OKBVVJOGVLARMR-QSWIMTSFSA-N
SCE-1365,CEFMENOXIME;SCE-1365,CHEMBL1201224,BRD:BRD-A20839672-003-01-5;BRD:BRD-BRD-A20839672-003-01-5,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1;CO\N=C(\C(=O)NC1C2SCC(CSC3NNNN3C)=C(N2C1=O)C(O)=O)C1CSC(N)N1,HJJDBAOLQAWBMH-YCRCPZNHSA-N
U-72791,CEFMETAZOLE;U-72791,CHEMBL1201195,BRD:BRD-K48470486-236-11-6,rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,,,Small molecule,4,CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,SNBUBQHDYVFSQF-HIFRSBDPSA-N
CEFMINOX SODIUM,CEFMINOX;CEFMINOX SODIUM,CHEMBL1276342,BRD:BRD-BRD-K77073709-435-01-2;BRD:BRD-K77073709-435-01-2,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,-1,CO[C@]1(NC(=O)CSC[C@@H](N)C(O)=O)[C@H]2SCC(CSC3NNNN3C)=C(N2C1=O)C(O)=O;CO[C@@]1(NC(=O)CSC[C@@H](N)C(=O)O)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,JSDXOWVAHXDYCU-VXSYNFHWSA-N
TIMECEF,CEFODIZIME;CEFODIZIME DISODIUM;CEFODIZIME DISODIUM SALT;CEFODIZIME SODIUM;HR 221;HR 221 [AS SODIUM];HR-221;S 77 1221 B;S 77 1221 B [AS SODIUM];S 77-1221B;S-77-1221-B;S-77-1221B;THR 221;THR 221 [AS SODIUM];THR-221;TIMECEF,CHEMBL2303613,BRD:BRD-BRD-K22641081-304-01-8;BRD:BRD-K22641081-304-01-8,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"RESPIRATORY TRACT INFECTIONS, SKIN INFECTIONS, GONORRHEA",,LAUNCHED,,Small molecule,4,"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(C)c(CC(=O)O)s3)CS[C@H]12)c1csc(N)n1;CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3NC(C)C(CC(O)=O)S3)=C(N2C1=O)C(O)=O)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3NC(C)C(CC(O)=O)S3)=C(N2C1=O)C(O)=O)C1CSC(N)N1",XDZKBRJLTGRPSS-BGZQYGJUSA-N
MONOCEF,CEFONICID;MONOCEF,CHEMBL1601,BRD:BRD-BRD-K34058848-304-03-1;BRD:BRD-K34058848-304-03-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-POSITIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSC3NNNN3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)C1CCCCC1, O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSC3NNNN3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)C1CCCCC1, O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSC3NNNN3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)C1CCCCC1;O=C(O)C1=C(CSc2nnnn2CS(=O)(=O)O)CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12",DYAIAHUQIPBDIP-AXAPSJFSSA-N
PERACEF,CEFOPERAZONE;PERACEF,CHEMBL507674,BRD:BRD-BRD-K02292852-001-02-1;BRD:BRD-K02292852-001-02-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O;CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSC4NNNN4C)=C(N3C2=O)C(O)=O)C2CCC(O)CC2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSC4NNNN4C)=C(N3C2=O)C(O)=O)C2CCC(O)CC2)C(=O)C1=O",GCFBRXLSHGKWDP-XCGNWRKASA-N
PRECEF,BL-S786;CEFORANIDE;NSC-760049;PRECEF,CHEMBL1201046,BRD:BRD-BRD-K37848908-001-05-6;BRD:BRD-K37848908-001-05-6,rep_primary;rep_single_dose,PENICILLIN BINDING PROTEIN INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"NCc1ccccc1CC(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3CC(=O)O)CS[C@H]12;NCC1CCCCC1CC(=O)N[C@H]1[C@H]2SCC(CSC3NNNN3CC(O)=O)=C(N2C1=O)C(O)=O, NCC1CCCCC1CC(=O)N[C@H]1[C@H]2SCC(CSC3NNNN3CC(O)=O)=C(N2C1=O)C(O)=O",SLAYUXIURFNXPG-CRAIPNDOSA-N
CEFOSELIS,CEFOSELIS,CHEMBL2105940,BRD:BRD-BRD-K72339976-065-02-1;BRD:BRD-BRD-K72339976-065-03-9;BRD:BRD-BRD-K72339976-065-04-7;BRD:BRD-K72339976-065-02-1;BRD:BRD-K72339976-065-03-9;BRD:BRD-K72339976-065-04-7,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,LAUNCHED,,Small molecule,-1,"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1;CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CN3CCC(=N)N3CCO)=C(N2C1=O)C(O)=O)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CN3CCC(=N)N3CCO)=C(N2C1=O)C(O)=O)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CN3CCC(=N)N3CCO)=C(N2C1=O)C(O)=O)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CN3CCC(=N)N3CCO)=C(N2C1=O)C(O)=O)C1CSC(N)N1",BHXLLRXDAYEMPP-SBGRAJFYSA-N
CEFOTAXIME,CEFOTAXIM HIKMA;CEFOTAXIME,CHEMBL1730,BRD:BRD-K78364995-236-18-3,rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,,,Small molecule,4,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,GPRBEKHLDVQUJE-QSWIMTSFSA-N
YM-09330,"CEFOTAN;CEFOTETAN;CEFOTETAN DISODIUM;CEFOTETAN DISODIUM SALT;CEFOTETAN SODIUM;ICI 156,834;ICI-156,834;ICI-156834;NSC-760045;YAMATETAN;YM-09330",CHEMBL1201098;CHEMBL474579,BRD:BRD-A78723049-001-01-2;BRD:BRD-BRD-A78723049-001-01-2,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"URINARY TRACT INFECTIONS, RESPIRATORY TRACT INFECTIONS, SKIN INFECTIONS, GYNECOLOGIC INFECTIONS, CHLAMYDIA, INTRA-ABDOMINAL INFECTIONS, BONE AND JOINT INFECTIONS, SURGICAL PROPHYLAXIS",,LAUNCHED,,Small molecule,4,CO[C@]1(NC(=O)C2SC(S2)=C(C(N)=O)C(O)=O)C2SCC(CSC3NNNN3C)=C(N2C1=O)C(O)=O;CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)[O-])S2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+].[Na+],ZQQALMSFFARWPK-GLHLDKNHSA-L
J01DC07,ASPIL;CEFOTIAM;CERADON;J01DC07,CHEMBL1296,BRD:BRD-BRD-K02275692-300-02-6;BRD:BRD-K02275692-300-02-6,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"BACTERIAL SEPTICEMIA, BONE AND JOINT INFECTIONS, RESPIRATORY TRACT INFECTIONS, SKIN INFECTIONS, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1;CN(C)CCN1NNNC1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)CC1CSC(N)N1)C2=O)C(O)=O, CN(C)CCN1NNNC1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)CC1CSC(N)N1)C2=O)C(O)=O",QYQDKDWGWDOFFU-IUODEOHRSA-N
MEFOXITIN,CEFOXITIN;CEFOXITIN SODIUM;CEFOXITIN SODIUM SALT;CENOMYCIN;J01DC01;MEFOXIN;MEFOXITIN,CHEMBL1200530;CHEMBL996,BRD:BRD-BRD-K70976396-236-26-0;BRD:BRD-K70976396-236-26-0,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"RESPIRATORY TRACT INFECTIONS, URINARY TRACT INFECTIONS, INTRA-ABDOMINAL INFECTIONS, GYNECOLOGIC INFECTIONS, BACTERIAL SEPTICEMIA, BONE AND JOINT INFECTIONS, SKIN INFECTIONS",,LAUNCHED,,Small molecule,4,"CO[C@]1(NC(=O)CC2CCCS2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)CC2CCCS2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)CC2CCCS2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O;CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21",WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
CEFOZOPRAN HYDROCHLORIDE,CEFOZOPRAN;CEFOZOPRAN HYDROCHLORIDE,CHEMBL1276663,BRD:BRD-BRD-K46970505-003-01-9;BRD:BRD-K46970505-003-01-9,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,LAUNCHED,,Small molecule,-1,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccn4ncccc43)CS[C@H]12)c1nsc(N)n1;CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[N+]3CCN4NCCCC34)=C(N2C1=O)C(O)=O)C1NSC(N)N1,QDUIJCOKQCCXQY-WHJQOFBOSA-N
WY-44635,"CEFPIRAMIDE;NSC-759869;WY-44,635;WY-44635",CHEMBL1201204,BRD:BRD-BRD-K92872987-001-02-9;BRD:BRD-K92872987-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"Cc1cc(O)c(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)cn1;CC1CC(O)C(CN1)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSC3NNNN3C)=C(N2C1=O)C(O)=O)C1CCC(O)CC1, CC1CC(O)C(CN1)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSC3NNNN3C)=C(N2C1=O)C(O)=O)C1CCC(O)CC1, CC1CC(O)C(CN1)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSC3NNNN3C)=C(N2C1=O)C(O)=O)C1CCC(O)CC1",PWAUCHMQEXVFJR-PMAPCBKXSA-N
HR-810 FREE BASE,CEFIR;CEFPIROME;HR-810 FREE BASE,CHEMBL65794,BRD:BRD-BRD-K56542719-065-01-4;BRD:BRD-K56542719-065-01-4,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1csc(N)n1;CO\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[N+]3CCCC4CCCC34)=C(N2C1=O)C(O)=O)C1CSC(N)N1,DKOQGJHPHLTOJR-WHRDSVKCSA-N
NSC-759099,BBS-1067;BMY-28100-03-800;BMY-28167;CEFPROZIL;CEFPROZIL E-FORM;CEFPROZIL MONOHYDRATE;CEFZIL;NSC-759099,CHEMBL276568;CHEMBL3184906;CHEMBL3301800,BRD:BRD-BRD-K24871708-002-04-6;BRD:BRD-K24871708-002-04-6,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"PHARYNGITIS, TONSILLITIS, OTITIS, SINUSITIS, RESPIRATORY TRACT INFECTIONS, SKIN INFECTIONS, BRONCHITIS",,LAUNCHED,,Small molecule,4,"C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1CCC(O)CC1)C2=O)C(O)=O, C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1CCC(O)CC1)C2=O)C(O)=O, C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1CCC(O)CC1)C2=O)C(O)=O, C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1CCC(O)CC1)C2=O)C(O)=O;CC=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1.O",ALYUMNAHLSSTOU-PFBPGKLMSA-N
SEFTEM,7432-S;ACHN-383;ACHN383;CEDAX;CEFTIBUTEN;CEFTIBUTEN DIHYDRATE;CEFTIBUTEN HYDRATE;CEFTIBUTIN;NSC-758925;SCH 39720;SCH-39720;SEFTEM,CHEMBL1605,BRD:BRD-BRD-K11124378-001-04-6;BRD:BRD-K11124378-001-04-6,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"BRONCHITIS, OTITIS, PHARYNGITIS, TONSILLITIS",,LAUNCHED,,Small molecule,4,"Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1;NC1NC(CS1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O, NC1NC(CS1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O, NC1NC(CS1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O, NC1NC(CS1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O, NC1NC(CS1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O",UNJFKXSSGBWRBZ-BJCIPQKHSA-N
NAXCEL,CEFTIOFUR;CEFTIOFUR CRYSTALLINE FREE ACID;NAXCEL,CHEMBL222913,BRD:BRD-BRD-K82960980-003-01-9;BRD:BRD-BRD-K82960980-003-02-7;BRD:BRD-K82960980-003-01-9;BRD:BRD-K82960980-003-02-7,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"PNEUMONIA, RESPIRATORY TRACT INFECTIONS",,LAUNCHED,,Small molecule,-1,"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CS[C@H]12)c1csc(N)n1;CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)C3CCCO3)=C(N2C1=O)C(O)=O)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)C3CCCO3)=C(N2C1=O)C(O)=O)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)C3CCCO3)=C(N2C1=O)C(O)=O)C1CSC(N)N1",ZBHXIWJRIFEVQY-IHMPYVIRSA-N
CEFTIZOXIM,CEFTIZOXIM,,BRD:BRD-K04301924-236-03-2,rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,,,,NA,,
ZEVTERA,BAL-9141-000;BAL-9141000;BAL9141-000;CEFTOBIPROLE;RO 63-9141;RO-63-9141;RO-639141;ZEFTERA;ZEVTERA,CHEMBL520642,BRD:BRD-K00003117-001-01-9,rep_single_dose,ANTIINFECTIVE DRUG,,,,,,Small molecule,3,Nc1nc(/C(=N/O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(/C=C4\CCN([C@@H]5CCNC5)C4=O)CS[C@H]23)ns1,VOAZJEPQLGBXGO-SDAWRPRTSA-N
SODIUM CEFTRIAXONE,ANHYDROUS;CEFRADEN;CEFTRIAXON;CEFTRIAXONE;CEFTRIAXONE (AS SODIUM);CEFTRIAXONE DISODIUM SALT;CEFTRIAXONE DISODIUM SALT HEMIHEPTAHYDRATE;CEFTRIAXONE SODIUM;CEFTRIAXONE SODIUM ANHYDROUS;CEFTRIAXONE SODIUM HYDRATE;CEFTRIAXONE SODIUM SESQUATERHYDRATE;MEGION;RO 13-9904;RO-13-9904;ROCEFIN;ROCEPHIN;SODIUM CEFTRIAXONE,CHEMBL1200995;CHEMBL161;CHEMBL3183968,BRD:BRD-BRD-K96734425-304-01-7;BRD:BRD-K96734425-304-01-7,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"GONORRHEA, PNEUMONIA, OTITIS, SKIN INFECTIONS, URINARY TRACT INFECTIONS, PELVIC INFLAMMATORY DISEASE, BACTERIAL SEPTICEMIA, BONE AND JOINT INFECTIONS, INTRA-ABDOMINAL INFECTIONS, MENINGITIS, SURGICAL PROPHYLAXIS",,LAUNCHED,,Small molecule,4,"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(CSc3nc(=O)c([O-])nn3C)CS[C@H]12)c1csc(N)n1.O.O.O.[Na+].[Na+];CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3NC(=O)C(O)NN3C)=C(N2C1=O)C(O)=O)C1CSC(N)N1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3NC(=O)C(O)NN3C)=C(N2C1=O)C(O)=O)C1CSC(N)N1",XMCDZRXQAGFWAK-PMCOHIMVSA-L
ZINACEF,640/359;BRITACEF;CEFUROXIME;CEFUROXIME ACID;CEFUROXIME SODIUM;CEFUROXIME SODIUM SALT;CEFUROXIMINE;KEFUROX;SODIUM CEFUROXIME;ZINACEF,CHEMBL1436;CHEMBL2146124,BRD:BRD-BRD-K02733959-236-07-7;BRD:BRD-K02733959-236-07-7,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@H]12)c1ccco1.[Na+];CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1;CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)C1CCCO1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)C1CCCO1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)C1CCCO1",JFPVXVDWJQMJEE-IZRZKJBUSA-N;URDOHUPGIOGTKV-JTBFTWTJSA-M
SC-58635,CELEBRA;CELEBREX;CELECOXIB;DFN-15;DFN15;ELYXYB;NSC-719627;NSC-758624;ONSENAL;SC-58635,CHEMBL118,BRD:BRD-BRD-K02637541-001-18-0;BRD:BRD-K02637541-001-18-0,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,CA12;PDPK1;PTGS2,"OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, PRIMARY DYSMENORRHEA (PD)",,LAUNCHED,,Small molecule,4,"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1;CC1CCC(CC1)-C1CC(NN1-C1CCC(CC1)S(N)(=O)=O)C(F)(F)F, CC1CCC(CC1)-C1CC(NN1-C1CCC(CC1)S(N)(=O)=O)C(F)(F)F, CC1CCC(CC1)-C1CC(NN1-C1CCC(CC1)S(N)(=O)=O)C(F)(F)F",RZEKVGVHFLEQIL-UHFFFAOYSA-N
CELGOSIVIR,CELGOSIVIR,CHEMBL2110737,BRD:BRD-K00003204-003-01-9,rep_single_dose,GLUCOSIDASE INHIBITOR,,,,,,Small molecule,2,CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O,HTJGLYIJVSDQAE-VWNXEWBOSA-N
CELIPROLOL PCH,CELIPROLOL;CELIPROLOL PCH,CHEMBL27810,BRD:BRD-A95602221-003-02-1;BRD:BRD-BRD-A95602221-003-02-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A;ADRB1;ADRB2,EHLERS-DANLOS SYNDROME (EDS),,LAUNCHED,,Small molecule,4,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1;CCN(CC)C(=O)NC1CCC(OCC(O)CNC(C)(C)C)C(C1)C(C)=O,JOATXPAWOHTVSZ-UHFFFAOYSA-N
CENERIMOD,ACT-334441;ACT334441;CENERIMOD,CHEMBL4297505,BRD:BRD-K00003248-001-01-9,rep_single_dose,SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR,,,,,,Small molecule,2,CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CO,KJKKMMMRWISKRF-FQEVSTJZSA-N
TBR-652,CENICRIVIROC;TAK-652;TBR-652,CHEMBL2110727,BRD:BRD-K00003181-001-01-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,,,Small molecule,3,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1,PNDKCRDVVKJPKG-WHERJAGFSA-N
R-763,AS 703569;AS-703569;AS703569;AURORA KINASE INHIBITOR AS703569;CENISERTIB;R 763;R-763,CHEMBL1614709;CHEMBL1967878,BRD:BRD-K00075754-001-02-9,rep_single_dose,,,,,,,Small molecule,1,Cc1cc(Nc2ncc(F)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc1N1CCN(C)CC1;Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1,KSOVGRCOLZZTPF-QMKUDKLTSA-N;KSOVGRCOLZZTPF-UHFFFAOYSA-N
YKP3089,CENOBAMATE;XCOPRI;YKP-3089;YKP3089,CHEMBL3989949,BRD:BRD-K00003249-001-01-9,rep_single_dose,"GABA RECEPTOR MODULATOR, VOLTAGE-GATED SODIUM CHANNEL BLOCKER",,,,,,Small molecule,4,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl,GFHAXPJGXSQLPT-VIFPVBQESA-N
EB-1020 FREE BASE,"CENTANAFADINE;DOV 216,419;DOV 216,419 FREE BASE;DOV-216419;EB-1020;EB-1020 FREE BASE",CHEMBL3301621,BRD:BRD-K00004588-001-01-9,rep_single_dose,DOPAMINE REUPTAKE INHIBITOR,,,,,,Small molecule,3,c1ccc2cc([C@]34CNC[C@H]3C4)ccc2c1,HKHCSWPSUSWGLI-CABCVRRESA-N
CENTAZOLONE,CENTAZOLONE,,BRD:BRD-BRD-K31329721-001-08-2;BRD:BRD-K31329721-001-08-2,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,,,,PHASE 1,,,NA,NN1CNC2CC3CCCCC3CC2C1=O,
CENTHAQUIN,CENTHAQUIN,,BRD:BRD-K00004619-001-01-9,rep_single_dose,ANALGESIC AGENT,,,,,,,NA,,
CENTPROPAZINE,CENTPROPAZINE,,BRD:BRD-A28958257-001-01-2;BRD:BRD-BRD-A28958257-001-01-2,rep_primary;rep_single_dose,INOSITOL MONOPHOSPHATASE INHIBITOR,,,,PHASE 3,,,NA,"CCC(=O)C1CCC(OCC(O)CN2CCN(CC2)C2CCCCC2)CC1, CCC(=O)C1CCC(OCC(O)CN2CCN(CC2)C2CCCCC2)CC1",
RXDX-105,AB-024;AC-013773;AGERAFENIB;CEP-32496;RXDX 105;RXDX-105,CHEMBL2029988,BRD:BRD-BRD-K20722021-001-02-1;BRD:BRD-K20722021-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,RAF INHIBITOR,BRAF;RAF1,,,PHASE 1/PHASE 2,,Small molecule,1,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC;COC1CC2NCNC(OC3CCCC(NC(=O)NC4CC(ON4)C(C)(C)C(F)(F)F)C3)C2CC1OC,DKNUPRMJNUQNHR-UHFFFAOYSA-N
CEP-33779,CEP-33779,,BRD:BRD-BRD-K37237504-001-02-7;BRD:BRD-K37237504-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,JAK2,,,PRECLINICAL,,,NA,"CN1CCN(CC1)C1CCCC(NC2NC3C(CCCN3N2)-C2CCC(CC2)S(C)(=O)=O)C1, CN1CCN(CC1)C1CCCC(NC2NC3C(CCCN3N2)-C2CCC(CC2)S(C)(=O)=O)C1",
CEP-37440,ALK-FAK INHIBITOR CEP-37440;CEP-37440,CHEMBL3545051,BRD:BRD-BRD-K72827473-001-01-0;BRD:BRD-K72827473-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK,,,PHASE 1,,Small molecule,1,CNC(=O)C1CCCCC1NC1NC(NC2CCC3C[C@H](CCCC3C2OC)N2CCN(CCO)CC2)NCC1CL,
RXDX-106,CEP-40783;RXDX-106,CHEMBL4650515,BRD:BRD-K00003396-001-01-9,rep_single_dose,AXL KINASE INHIBITOR,,,,,,Unknown,0.5,,
CEPHALOMANNINE,CEPHALOMANNINE,CHEMBL305522,BRD:BRD-BRD-K68904758-001-03-5;BRD:BRD-K68904758-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,"C/C=C(\C)C(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C;C\C=C(/C)C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)C3CCCCC3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O)C1CCCCC1, C\C=C(/C)C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)C3CCCCC3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O)C1CCCCC1, C\C=C(/C)C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)C3CCCCC3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O)C1CCCCC1",DBXFAPJCZABTDR-WBYYIXQISA-N
CEPHALOSPORIN-C-ZN,CEPHALOSPORIN-C-ZN,,BRD:BRD-A44936478-001-01-1;BRD:BRD-BRD-A44936478-001-01-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,PRECLINICAL,,,NA,CC(=O)OCC1=C2N3C(SC1)[C@H](NC(=O)CCCC(N)C(=O)O[ZN]OC2=O)C3=O,
SEFFIN,CEFALOTIN;CEPHALOTHIN;SEFFIN,CHEMBL617,BRD:BRD-BRD-K28210218-236-08-1;BRD:BRD-K28210218-236-08-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"SKIN INFECTIONS, SURGICAL PROPHYLAXIS",,LAUNCHED,,Small molecule,4,CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1;CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CC1CCCS1)C2=O)C(O)=O,XIURVHNZVLADCM-IUODEOHRSA-N
CEPHAPIRIN,CEFAPIRIN;CEPHAPIRIN,CHEMBL1599,BRD:BRD-BRD-K49880111-236-09-2;BRD:BRD-K49880111-236-09-2,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,MASTITIS,,LAUNCHED,,Small molecule,4,"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1;CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSC1CCNCC1)C2=O)C(O)=O, CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSC1CCNCC1)C2=O)C(O)=O",UQLLWWBDSUHNEB-CZUORRHYSA-N
NSC-623442,(+)-CEPHARANTHINE;CEPHARANTHINE;NSC-623442,CHEMBL449782,BRD:BRD-BRD-K96194081-001-10-2;BRD:BRD-K96194081-001-10-2,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,,,,PHASE 2,,Small molecule,2,"COC1CCC2C[C@H]3N(C)CCC4CC(OC)C(OC5C6OCOC6CC6CCN(C)[C@@H](CC7CCC(OC1C2)CC7)C56)CC34, COC1CCC2C[C@H]3N(C)CCC4CC(OC)C(OC5C6OCOC6CC6CCN(C)[C@@H](CC7CCC(OC1C2)CC7)C56)CC34, COC1CCC2C[C@H]3N(C)CCC4CC(OC)C(OC5C6OCOC6CC6CCN(C)[C@@H](CC7CCC(OC1C2)CC7)C56)CC34;COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3c(cc4c(c3Oc3cc5c(cc3OC)CCN(C)[C@@H]5C2)OCO4)CCN1C",YVPXVXANRNDGTA-WDYNHAJCSA-N
CERAMIDE,CERAMIDE,CHEMBL155886,BRD:BRD-BRD-K41707108-001-05-6;BRD:BRD-K41707108-001-05-6,rep_primary;rep_single_dose,"PHOSPHOENOLPYRUVATE CARBOXYLASE ACTIVATOR, SERINE/THREONINE PROTEIN PHOSPHATASE ACTIVATOR",,COSMETIC,,LAUNCHED,,Small molecule,2,CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(C)=O;CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O,CRJGESKKUOMBCT-VQTJNVASSA-N
CERANIB-2,CERANIB-2,,CTRP:660078,ctrp,,,,,,,,NA,,
ZYKADIA,CERITINIB;CERITINIB[MI];LDK-378;LDK378;NVP-LDK-378-NX;NVP-LDK378-NX;ZYKADIA,CHEMBL2403108,BRD:BRD-BRD-K22149900-001-03-9;BRD:BRD-K22149900-001-03-9;BRD:BRD-K22149900-001-05-4,oncref_1;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK;FLT3;IGF1R;INSR;TSSK1B,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF ALK', 'ALK TYROSINE KINASE RECEPTOR INHIBITOR'}, defaulting to 'ALK TYROSINE KINASE RECEPTOR INHIBITOR'
Multiple values for repurposing_target: {'ALK;FLT3;IGF1R;INSR;TSSK1B', 'ALK'}, taking the union",Small molecule,4,"CC(C)OC1CC(C2CCNCC2)C(C)CC1NC1NCC(CL)C(NC2CCCCC2S(=O)(=O)C(C)C)N1, CC(C)OC1CC(C2CCNCC2)C(C)CC1NC1NCC(CL)C(NC2CCCCC2S(=O)(=O)C(C)C)N1, CC(C)OC1CC(C2CCNCC2)C(C)CC1NC1NCC(CL)C(NC2CCCCC2S(=O)(=O)C(C)C)N1, CC(C)OC1CC(C2CCNCC2)C(C)CC1NC1NCC(CL)C(NC2CCCCC2S(=O)(=O)C(C)C)N1;Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1",VERWOWGGCGHDQE-UHFFFAOYSA-N
CERULENIN,CERULENIN,CHEMBL45627,BRD:BRD-BRD-K52075040-001-09-7;BRD:BRD-K52075040-001-09-7;CTRP:52430,ctrp;rep_primary;rep_single_dose,FATTY ACID SYNTHASE INHIBITOR,FASN,FUNGAL INFECTION,,LAUNCHED,,Small molecule,NA,C/C=C/C/C=C/CCC(=O)[C@H]1O[C@H]1C(N)=O;C\C=C\C\C=C\CCC(=O)[C@H]1O[C@H]1C(N)=O,GVEZIHKRYBHEFX-NQQPLRFYSA-N
CERULETIDE,CAERULEIN;CERULEIN;CERULETIDE,CHEMBL1201355,BRD:BRD-K00003320-001-01-9,rep_single_dose,CCK RECEPTOR AGONIST,CCKAR,,,,,Protein,4,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,YRALAIOMGQZKOW-HYAOXDFASA-N
XYZAL,(-)-;(-)-CETIRIZINE;(R)-;(R)-CETIRIZINE;AC-170;CETIDERM;CETIRIZINE;CETIRIZINE (R)-FORM;LEVOCETIRIZINE;XAZAL;XYZAL,CHEMBL1000;CHEMBL1201191,BRD:BRD-A42571354-300-12-0;BRD:BRD-BRD-A42571354-300-12-0,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,"O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1;OC(=O)COCCN1CCN(CC1)C(C1CCCCC1)C1CCC(CL)CC1, OC(=O)COCCN1CCN(CC1)C(C1CCCCC1)C1CCC(CL)CC1, OC(=O)COCCN1CCN(CC1)C(C1CCCCC1)C1CCC(CL)CC1",ZKLPARSLTMPFCP-OAQYLSRUSA-N
PB-300,CETRIMONIUM;CETRIMONIUM CATION;CETRIMONIUM ION;CETYLTRIMETHYLAMMONIUM CATION;CETYLTRIMETHYLAMMONIUM ION;HEXADECYLTRIMETHYLAMMONIUM CATION;HEXADECYLTRIMETHYLAMMONIUM ION;PB-300,CHEMBL1183605,BRD:BRD-BRD-K47079459-004-04-6;BRD:BRD-K47079459-004-04-6,rep_multi_dose;rep_primary;rep_single_dose,,,COSMETIC,,LAUNCHED,,Small molecule,-1,"CCCCCCCCCCCCCCCC[N+](C)(C)C;CCCCCCCCCCCCCCCC[N+](C)(C)C, CCCCCCCCCCCCCCCC[N+](C)(C)C",RLGQACBPNDBWTB-UHFFFAOYSA-N
SB-075 ACETATE,CETRORELIX;CETRORELIX ACETATE;CETROTIDE;CETROTIDE ACETATE;D-20761;NS-75A;SB-075 ACETATE,CHEMBL1200490;CHEMBL2103735,BRD:BRD-BRD-K76315403-015-02-5;BRD:BRD-K76315403-015-02-5,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,GNRHR;LHCGR,PREMATURE LUTEINIZING HORMONE SURGES,,LAUNCHED,,Protein,4,CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O;CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1CCCNC1)NC(=O)[C@@H](CC1CCC(CL)CC1)NC(=O)[C@@H](CC1CCC2CCCCC2C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,KFEFLCOCAHJBEA-ANRVCLKPSA-N
CETYLPYRIDINIUM,CETYLPYRIDINIUM,CHEMBL305906,BRD:BRD-BRD-K87700323-003-05-1;BRD:BRD-K87700323-003-05-1,rep_multi_dose;rep_primary;rep_single_dose,,,"GINGIVITIS, MOUTH INFLAMMATION",,LAUNCHED,,Small molecule,4,"CCCCCCCCCCCCCCCC[n+]1ccccc1;CCCCCCCCCCCCCCCC[N+]1CCCCC1, CCCCCCCCCCCCCCCC[N+]1CCCCC1, CCCCCCCCCCCCCCCC[N+]1CCCCC1",NEUSVAOJNUQRTM-UHFFFAOYSA-N
SNK-508,AF-102B;AF102B;CEVIMELINE;CEVIMELINE HCL;CEVIMELINE HYDROCHLORIDE;CEVIMELINE HYDROCHLORIDE HEMIHYDRATE;CEVIMELINE HYDROCHLORIDE HYDRATE;EVOXAC;FKS-508;SALIGREN;SND-5008;SNI-2011;SNK-508,CHEMBL168815;CHEMBL2218917,BRD:BRD-BRD-M98279124-300-01-1;BRD:BRD-M98279124-300-01-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM3,SJOGREN'S SYNDROME,,LAUNCHED,,Small molecule,4,C[C@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1;CC1OC2(CS1)CN1CCC2CC1.Cl.O,JKJRNPOQQPBPOV-UHFFFAOYSA-N
CEVIPABULIN,CEVIPABULIN,CHEMBL1182714,BRD:BRD-A02473266-001-01-1;BRD:BRD-BRD-A02473266-001-01-1,rep_primary;rep_single_dose,"MICROTUBULE STIMULANT, TUBULIN POLYMERIZATION INHIBITOR",TUBB,,,PHASE 1,,Small molecule,1,CNCCCOc1cc(F)c(-c2c(Cl)nc3ncnn3c2N[C@@H](C)C(F)(F)F)c(F)c1;CNCCCOC1CC(F)C(C(F)C1)-C1C(CL)NC2NCNN2C1NC(C)C(F)(F)F,ZUZPCOQWSYNWLU-VIFPVBQESA-N
NAMODENOSON,CF-102;CF102;CHLORO-IB-MECA;CI-IB-MECA;CL-IB-MECA;NAMODENOSON,CHEMBL431733,BRD:BRD-BRD-K52396582-001-06-7;BRD:BRD-K52396582-001-06-7,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PHASE 2,,Small molecule,3,CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O;CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(NCC3CCCC(I)C3)NC(CL)NC12,IPSYPUKKXMNCNQ-PFHKOEEOSA-N
CFI-400945 FUMARATE,CFI 400945;CFI-400945;CFI-400945 FUMARATE,CHEMBL3408947;CHEMBL4297462,BRD:BRD-K27040396-051-02-9,rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,,,,,,Small molecule,2,COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@@H](C)O[C@@H](C)C5)cc4)n[nH]c3c1)C(=O)N2.O=C(O)/C=C/C(=O)O,AQCDFVLWUWJREO-WQVJSASDSA-N
LUVIXASERTIB,CFI-402257;CFI402257;LUVIXASERTIB,CHEMBL4469414,BRD:BRD-K00003409-001-01-9,rep_single_dose,DUAL SPECIFICITY PROTEIN KINASE INHIBITOR,,,,,,Small molecule,1,Cc1cc(-c2cnn3c(NC[C@H]4C[C@@](C)(O)C4)cc(Oc4cccnc4)nc23)ccc1C(=O)NC1CC1,PMQUGSPFUBGJCZ-CHOKWEPUSA-N
CFM-1571,CFM-1571,,BRD:BRD-BRD-K64341947-003-02-4;BRD:BRD-K64341947-003-02-4,rep_primary;rep_single_dose,GUANYLATE CYCLASE ACTIVATOR,,,,PRECLINICAL,,,NA,"COC1CCC(NC(=O)C2CC(OCCCN(C)C)NN2CC2CCCCC2)CC1, COC1CCC(NC(=O)C2CC(OCCCN(C)C)NN2CC2CCCCC2)CC1",
CFM-2,CFM-2,,BRD:BRD-BRD-K42859542-001-03-3;BRD:BRD-K42859542-001-03-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,COC1CC2CC(=O)NN=C(C3CCC(N)CC3)C2CC1OC,
CFTRINH-172,CFTRINH-172,,BRD:BRD-BRD-K72004355-001-01-9;BRD:BRD-K72004355-001-01-9,rep_primary;rep_single_dose,CHLORIDE CHANNEL BLOCKER,CFTR,,,PRECLINICAL,,,NA,"OC(=O)C1CCC(CC1)\C=C1\SC(=S)N(C1=O)C1CCCC(C1)C(F)(F)F, OC(=O)C1CCC(CC1)\C=C1\SC(=S)N(C1=O)C1CCCC(C1)C(F)(F)F, OC(=O)C1CCC(CC1)\C=C1\SC(=S)N(C1=O)C1CCCC(C1)C(F)(F)F",
NILOFABICIN,CG-400459;CG-400549;CG400549;NILOFABICIN,CHEMBL488937,BRD:BRD-BRD-K48888725-001-01-9;BRD:BRD-K48888725-001-01-9,rep_primary;rep_single_dose,FABI INHIBITOR,,,,PHASE 2,,Small molecule,2,"Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O;CC1C(N)CCCC1CN1CCC(OCCC2CCCS2)CC1=O, CC1C(N)CCCC1CN1CCC(OCCC2CCCS2)CC1=O",YCLREGRRHGLOAK-UHFFFAOYSA-N
CGH2466,CGH2466,,BRD:BRD-BRD-K82028950-300-02-9;BRD:BRD-K82028950-300-02-9,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2B;ADORA3,,,PRECLINICAL,,,NA,"NC1NC(C(S1)-C1CCNCC1)-C1CCC(CL)C(CL)C1, NC1NC(C(S1)-C1CCNCC1)-C1CCC(CL)C(CL)C1",
CGK-733,CGK-733,,BRD:BRD-A50737080-001-03-0;BRD:BRD-BRD-A50737080-001-03-0,rep_primary;rep_single_dose,"ATM KINASE INHIBITOR, ATR KINASE INHIBITOR",ATM;ATR,,,PRECLINICAL,,,NA,"[O-][N+](=O)C1CC(NC(=S)NC(NC(=O)C(C2CCCCC2)C2CCCCC2)C(CL)(CL)CL)CCC1F, [O-][N+](=O)C1CC(NC(=S)NC(NC(=O)C(C2CCCCC2)C2CCCCC2)C(CL)(CL)CL)CCC1F, [O-][N+](=O)C1CC(NC(=S)NC(NC(=O)C(C2CCCCC2)C2CCCCC2)C(CL)(CL)CL)CCC1F, [O-][N+](=O)C1CC(NC(=S)NC(NC(=O)C(C2CCCCC2)C2CCCCC2)C(CL)(CL)CL)CCC1F",
NVP-CGM-097,CGM 097;CGM-097;CGM097;NVP-CGM-097,CHEMBL3601398,BRD:BRD-BRD-K79584249-001-01-3;BRD:BRD-K79584249-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,MDM INHIBITOR,MDM2,,,PHASE 1,,Small molecule,1,"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2;COC1CC2CC(=O)N([C@@H](C3CCC(CL)CC3)C2CC1OC(C)C)C1CCC(CC1)N(C)C[C@H]1CC[C@@H](CC1)N1CCN(C)C(=O)C1, COC1CC2CC(=O)N([C@@H](C3CCC(CL)CC3)C2CC1OC(C)C)C1CCC(CC1)N(C)C[C@H]1CC[C@@H](CC1)N1CCN(C)C(=O)C1",CLRSLRWKONPSRQ-IIPSPAQQSA-N
CGP-12177,CGP-12177,CHEMBL420746,BRD:BRD-A40084411-003-07-7;BRD:BRD-BRD-A40084411-003-07-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2;ADRB3,,,PHASE 1,,Small molecule,NA,CC(C)(C)NCC(O)COc1cccc2[nH]c(=O)[nH]c12;CC(C)(C)NCC(O)COC1CCCC2[NH]C(O)NC12,UMQUQWCJKFOUGV-UHFFFAOYSA-N
CGP-13501,CGP-13501,,BRD:BRD-BRD-K95851186-001-07-8;BRD:BRD-K95851186-001-07-8,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABBR1,,,PRECLINICAL,,,NA,CC(C)(CC1CC(C(O)C(C1)C(C)(C)C)C(C)(C)C)C=O,
CGP-20712A,CGP-20712A,CHEMBL280822,BRD:BRD-A31575449-066-07-8;BRD:BRD-BRD-A31575449-066-07-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB3,,,PRECLINICAL,,Small molecule,NA,Cn1cc(C(F)(F)F)nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(C(N)=O)c2)cc1;CN1CC(NC1-C1CCC(OCC(O)CNCCOC2CCC(O)C(C2)C(N)=O)CC1)C(F)(F)F,GKJZEKSHCJELPL-UHFFFAOYSA-N
CGP-25454A,CGP-25454A,,BRD:BRD-K00003372-003-01-9,rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,,,,NA,,
CGP-37157,CGP-37157,,BRD:BRD-A35623999-001-05-7;BRD:BRD-BRD-A35623999-001-05-7,rep_primary;rep_single_dose,"MITOCHONDRIAL NA+/CA2+ EXCHANGER ANTAGONIST, SODIUM/CALCIUM EXCHANGE INHIBITOR",SLC8A1,,,PRECLINICAL,,,NA,"CLC1CCC2NC(=O)CSC(C3CCCCC3CL)C2C1, CLC1CCC2NC(=O)CSC(C3CCCCC3CL)C2C1",
CGP-37849,CGP-37849,CHEMBL29811,BRD:BRD-A90272038-001-01-7;BRD:BRD-BRD-A90272038-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,PHASE 1,,Small molecule,NA,"C/C(=C\C(N)C(=O)O)CP(=O)(O)O;C\C(CP(O)(O)=O)=C/C(N)C(O)=O, C\C(CP(O)(O)=O)=C/C(N)C(O)=O",BDYHNCZIGYIOGJ-DUXPYHPUSA-N
CGP-39551,CGP-39551,,BRD:BRD-K00004626-001-01-9,rep_single_dose,NMDA RECEPTOR ANTAGONIST,,,,,,,NA,,
CGP-52411,CGP-52411,,BRD:BRD-BRD-K13087974-001-02-5;BRD:BRD-K13087974-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PRECLINICAL,,,NA,"O=C1NC(=O)C2CC(NC3CCCCC3)C(NC3CCCCC3)CC12, O=C1NC(=O)C2CC(NC3CCCCC3)C(NC3CCCCC3)CC12",
CGP-53353,CGP-53353,CHEMBL7939,BRD:BRD-BRD-K32292990-001-03-6;BRD:BRD-K32292990-001-03-6,rep_primary;rep_single_dose,"EGFR INHIBITOR, PKC INHIBITOR",EGFR;PRKCB,,,PRECLINICAL,,Small molecule,NA,"FC1CCC(NC2CC3C(=O)NC(=O)C3CC2NC2CCC(F)CC2)CC1, FC1CCC(NC2CC3C(=O)NC(=O)C3CC2NC2CCC(F)CC2)CC1;O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21",RONQPWQYDRPRGG-UHFFFAOYSA-N
CGP-54626,CGP-54626,,BRD:BRD-A74208568-003-01-5;BRD:BRD-BRD-A74208568-003-01-5,rep_multi_dose;rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABBR1;GABBR2;KCTD12;KCTD16;KCTD8,,,PRECLINICAL,,,NA,"C[C@H](NC[C@H](O)CP(O)(=O)CC1CCCCC1)C1CCC(CL)C(CL)C1, C[C@H](NC[C@H](O)CP(O)(=O)CC1CCCCC1)C1CCC(CL)C(CL)C1",
CGP-55845,CGP-55845,,BRD:BRD-A89672324-001-03-0;BRD:BRD-BRD-A89672324-001-03-0,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABBR1;GABBR2;KCTD12;KCTD16;KCTD8,,,PRECLINICAL,,,NA,"C[C@H](NC[C@H](O)CP(O)(=O)CC1CCCCC1)C1CCC(CL)C(CL)C1, C[C@H](NC[C@H](O)CP(O)(=O)CC1CCCCC1)C1CCC(CL)C(CL)C1",
CGP-57380,CGP-57380,,BRD:BRD-BRD-K42500029-001-03-5;BRD:BRD-K42500029-001-03-5,rep_primary;rep_single_dose,MAP KINASE INHIBITOR,AURKB;LCK;MKNK1;MKNK2;SGK1,,,PRECLINICAL,,,NA,"NC1NCNC2[NH]NC(NC3CCC(F)CC3)C12, NC1NCNC2[NH]NC(NC3CCC(F)CC3)C12, NC1NCNC2[NH]NC(NC3CCC(F)CC3)C12",
CGP-60474,CGP-60474,,BRD:BRD-BRD-K79090631-001-22-3;BRD:BRD-K79090631-001-22-3;GDSC1:53,gdsc;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2,,,PRECLINICAL,,,NA,OCCCNC1CC(CCN1)-C1CCNC(NC2CCCC(CL)C2)N1,
CGP-71683,CGP-71683,,BRD:BRD-BRD-K34321528-003-01-2;BRD:BRD-K34321528-003-01-2,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPY5R,,,PRECLINICAL,,,NA,"NC1NC(NC[C@H]2CC[C@H](CNS(=O)(=O)C3CCCC4CCCCC34)CC2)NC2CCCCC12, NC1NC(NC[C@H]2CC[C@H](CNS(=O)(=O)C3CCCC4CCCCC34)CC2)NC2CCCCC12",
CGP-74514,CGP-74514,,BRD:BRD-BRD-K56239177-300-01-3;BRD:BRD-K56239177-300-01-3,rep_primary;rep_single_dose,CDK INHIBITOR,CDK1,,,PRECLINICAL,,,NA,CCN1CNC2C(NC3CCCC(CL)C3)NC(N[C@@H]3CCCC[C@@H]3N)NC12,
CGP-78608,CGP-78608,,BRD:BRD-K60946979-003-02-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,,,,NA,,
CGP-7930,CGP-7930,,BRD:BRD-BRD-K65786282-001-07-5;BRD:BRD-K65786282-001-07-5,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABBR1,,,PRECLINICAL,,,NA,"CC(C)(CO)CC1CC(C(O)C(C1)C(C)(C)C)C(C)(C)C, CC(C)(CO)CC1CC(C(O)C(C1)C(C)(C)C)C(C)(C)C",
CGS-15943,CGS-15943,CHEMBL16687,BRD:BRD-BRD-K49049886-001-08-7;BRD:BRD-K49049886-001-08-7,rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,,Small molecule,NA,Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12;NC1NC2CCC(CL)CC2C2NC(NN12)-C1CCCO1,MSJODEOZODDVGW-UHFFFAOYSA-N
CGS-20625,CGS-20625,,BRD:BRD-BRD-K68103045-001-02-9;BRD:BRD-K68103045-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,"BENZODIAZEPINE RECEPTOR AGONIST, GABA BENZODIAZEPINE SITE RECEPTOR PARTIAL AGONIST",GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6,,,PHASE 1,,,NA,"COC1CCC(CC1)-N1NC2C3CCCCCC3[NH]CC2C1=O, COC1CCC(CC1)-N1NC2C3CCCCCC3[NH]CC2C1=O",
CGS-21680,CGS-21680,CHEMBL331372,BRD:BRD-BRD-K12614344-003-01-8;BRD:BRD-K12614344-003-01-8,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,,Small molecule,NA,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc32)[C@H](O)[C@@H]1O;CCNC(=O)[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N1CNC2C(N)NC(NCCC3CCC(CCC(O)=O)CC3)NC12,PAOANWZGLPPROA-RQXXJAGISA-N
CGS-9896,CGS-9896,CHEMBL20042,BRD:BRD-BRD-K54093161-001-01-8;BRD:BRD-K54093161-001-01-8,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABRA1;GABRB2;GABRG2,,,PRECLINICAL,,Small molecule,NA,CLC1CCC(CC1)-N1[NH]C2C(CNC3CCCCC23)C1=O;O=C1C2C=Nc3ccccc3C2=NN1c1ccc(Cl)cc1,XJMIBNLJFYSGAR-UHFFFAOYSA-N
CH-170,CH-170,,BRD:BRD-BRD-K24820488-001-01-7;BRD:BRD-K24820488-001-01-7,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,CC1NC(CN2CNC3N(C)C(=O)N(C)C(=O)C23)NO1,
CH-5183284,CH-5183284,,BRD:BRD-BRD-K11683436-001-01-7;BRD:BRD-K11683436-001-01-7,rep_primary;rep_single_dose,FIBROBLAST GROWTH FACTOR INHIBITOR,FGFR1;FGFR2;FGFR3,,,PHASE 1,,,NA,"CC1NC2CCC(CC2[NH]1)-N1NCC(C(=O)C2CC3CCCCC3[NH]2)C1N, CC1NC2CCC(CC2[NH]1)-N1NCC(C(=O)C2CC3CCCCC3[NH]2)C1N",
CH-55,CH-55,,CTRP:660137,ctrp,,,,,,,,NA,,
CH223191,CH223191,,BRD:BRD-BRD-K22314899-001-02-4;BRD:BRD-K22314899-001-02-4,rep_primary;rep_single_dose,ARYL HYDROCARBON RECEPTOR ANTAGONIST,AHR,,,PRECLINICAL,,,NA,CC1CC(CCC1NC(=O)C1CCNN1C)\N=N\C1CCCCC1C,
PA799,CH 5132799;CH-5132799;CH5132799;IZORLISIB;PA-799;PA799,CHEMBL1684984,BRD:BRD-BRD-K28352084-001-02-3;BRD:BRD-K28352084-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PHASE 1,,Small molecule,1,"CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21;CS(=O)(=O)N1CCC2C1NC(NC2-C1CNC(N)NC1)N1CCOCC1, CS(=O)(=O)N1CCC2C1NC(NC2-C1CNC(N)NC1)N1CCOCC1",JEGHXKRHKHPBJD-UHFFFAOYSA-N
RO5424802,AF-802;AF802;ALECENSA;ALECTINIB;ALECTINIB HYDROCHLORIDE;CH 542802;CH-5424802;CH5424802;RO-5424802;RO5424802,CHEMBL1738797;CHEMBL3707320,GDSC1:281,gdsc,,,,,,,Small molecule,4,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,KDGFLJKFZUIJMX-UHFFFAOYSA-N
CH55,CH55,,BRD:BRD-K71487808-001-02-8,rep_single_dose,RETINOID RECEPTOR BINDER,RARA;RARB,,,,,,NA,,
CHC,CHC,,BRD:BRD-K60302405-001-04-5,rep_single_dose,MONOCARBOXYLATE TRANSPORTER INHIBITOR,SLC16A1,,,,,,NA,,
CHENODEOXYCHOLIC-ACID,CHENODEOXYCHOLIC-ACID,,BRD:BRD-BRD-K18135438-001-14-2;BRD:BRD-BRD-K18135438-001-16-7;BRD:BRD-K18135438-001-14-2;BRD:BRD-K18135438-001-16-7,rep_primary;rep_single_dose,"11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR, FXR AGONIST",HSD11B1;NR1H4,"CEREBRAL CHOLESTEROSIS, GALLSTONES",,LAUNCHED,,,NA,"C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C, C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C",
CHF5074,CHF5074,,BRD:BRD-BRD-K34508702-001-02-4;BRD:BRD-K34508702-001-02-4,rep_primary;rep_single_dose,GAMMA SECRETASE MODULATOR,PSEN1,,,PHASE 2,,,NA,OC(=O)C1(CC1)C1CCC(C(F)C1)-C1CCC(CL)C(CL)C1,
CHICAGO-SKY-BLUE-6B,CHICAGO-SKY-BLUE-6B,,BRD:BRD-BRD-K56483981-342-06-4;BRD:BRD-K56483981-342-06-4,rep_multi_dose;rep_primary;rep_single_dose,"GLUTAMATE INHIBITOR, MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR",MIF,,,PRECLINICAL,,,NA,COC1CC(CCC1\N=N\C1CCC2C(CC(C(N)C2C1O)S(O)(=O)=O)S(O)(=O)=O)-C1CCC(\N=N\C2CCC3C(CC(C(N)C3C2O)S(O)(=O)=O)S(O)(=O)=O)C(OC)C1,
TUCIDINOSTAT,CHIDAMIDE;CS-055;CS055;EPIDAZA;EPIDAZA IN CHINA;HBI-8000;TUCIDINOSTAT,CHEMBL3621988,BRD:BRD-BRD-K28537285-001-01-8;BRD:BRD-K28537285-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC10;HDAC3,,,LAUNCHED,,Small molecule,3,Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1;NC1CCC(F)CC1NC(=O)C1CCC(CNC(=O)\C=C\C2CCCNC2)CC1,SZMJVTADHFNAIS-BJMVGYQFSA-N
NSC-758879,CHINIOFON;NSC-758879,CHEMBL1788402;CHEMBL2104146,BRD:BRD-BRD-K52284881-236-02-4;BRD:BRD-K52284881-236-02-4,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,AMEBIASIS,,LAUNCHED,,Small molecule,-1,O=C([O-])O.O=S(=O)(O)c1cc(I)c(O)c2ncccc12.[Na+];OC1C(I)CC(C2CCCNC12)S(O)(=O)=O,FNXKBSAUKFCXIK-UHFFFAOYSA-M
CHIR-124,CHIR-124,,BRD:BRD-BRD-K02241333-001-02-7;BRD:BRD-K02241333-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,CHK INHIBITOR,CHEK1,,,PRECLINICAL,,,NA,CLC1CCC2[NH]C(=O)C(-C3NC4CCCCC4[NH]3)C(N[C@@H]3CN4CCC3CC4)C2C1,
CHIR-98014,CHIR-98014,,BRD:BRD-BRD-K42973005-001-04-0;BRD:BRD-K42973005-001-04-0,rep_multi_dose;rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3A;GSK3B,,,PRECLINICAL,,,NA,NC1NC(NCCNC2NCC(C(N2)-C2CCC(CL)CC2CL)-N2CCNC2)CCC1[N+]([O-])=O,
LADUVIGLUSIB,CHIR-911;CHIR-99021;CHR-00921;CHR00921;CT-99021;CT99021;FX03;LADUVIGLUSIB,CHEMBL412142,BRD:BRD-BRD-K16189898-003-03-3;BRD:BRD-K16189898-003-03-3;CTRP:347812;GDSC1:1241;GDSC1:154,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,CDK1;GSK3A;GSK3B;MAPK1,,,PRECLINICAL,"Multiple values for MOA: {'GLYCOGEN SYNTHASE KINASE INHIBITOR', 'INHIBITOR OF GSK3'}, defaulting to 'GLYCOGEN SYNTHASE KINASE INHIBITOR'
Multiple values for repurposing_target: {'CDK1;GSK3A;GSK3B;MAPK1', 'GSK3A;GSK3B'}, taking the union",Small molecule,-1,"CC1C[NH]C(N1)-C1CNC(NCCNC2CCC(CN2)C#N)NC1-C1CCC(CL)CC1CL, CC1C[NH]C(N1)-C1CNC(NCCNC2CCC(CN2)C#N)NC1-C1CCC(CL)CC1CL;Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1",AQGNHMOJWBZFQQ-UHFFFAOYSA-N
NSC-758888,.ALPHA.-CHLORALOSE;ALFAMAT;ALPHACHLORALOSE;ALPHAKIL;CHLORALOSE;NSC-758888,CHEMBL2104181,BRD:BRD-A98174560-001-02-1;BRD:BRD-BRD-A98174560-001-02-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,OC[C@@H](O)[C@H]1O[C@@H]2O[C@H](C(Cl)(Cl)Cl)O[C@@H]2[C@H]1O;OCC(O)[C@H]1O[C@@H]2O[C@@H](O[C@@H]2[C@H]1O)C(CL)(CL)CL,OJYGBLRPYBAHRT-IPQSZEQASA-N
NSC-3088,AMBOCHLORIN;CB-1348;CHLORAMBUCIL;CHLORAMBUCILUM;CHLORBUTIN;ECLORIL;LEUKERAN;LYMPHOLYSIN;NCI-3088;NSC-3088,CHEMBL515,BRD:BRD-BRD-K29458283-001-29-9;BRD:BRD-K29458283-001-29-9;CTRP:25334,ctrp;rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,"CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), HODGKIN'S LYMPHOMA",,LAUNCHED,,Small molecule,4,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1;OC(=O)CCCC1CCC(CC1)N(CCCL)CCCL,JCKYGMPEJWAADB-UHFFFAOYSA-N
XANTHEN-9-OL,9-HYDROXY-9-PHENYLXANTHENE;9-PHENYL-;9-PHENYL-9H-XANTHEN-9-OL;AMPHICOL;BROCHLOR;BROLENE ANTIBIOTIC;CHLORAMEX;CHLORAMPHENICOL;CHLORBIOTIC;CHLOROFAIR;CHLOROMYCETIN;CHLOROPTIC;CHLOROPTIC S.O.P.;ECONOCHLOR;GOLDEN EYE ANTIBIOTIC;KEMICETINE;KERNISPRAY;KLORAFECT;MYCHEL;MYCHEL-S;NSC-16331;NSC-3069;OPHTHOCHLOR;OPTOMYCIN;SNO PHENICOL;TEVCOCIN;TUBILUX INFECTED EYES;XANTHEN-9-OL,CHEMBL130,BRD:BRD-BRD-K08111712-001-16-7;BRD:BRD-K08111712-001-16-7,rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,CD55,"MENINGITIS, FEVER, CHOLERA",,LAUNCHED,,Small molecule,4,"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl;OC[C@@H](NC(=O)C(CL)CL)[C@H](O)C1CCC(CC1)[N+]([O-])=O, OC[C@@H](NC(=O)C(CL)CL)[C@H](O)C1CCC(CC1)[N+]([O-])=O",WIIZWVCIJKGZOK-RKDXNWHRSA-N
CHLORAMPHENICOL-PALMITATE,CHLORAMPHENICOL-PALMITATE,,BRD:BRD-BRD-K96424892-001-02-9;BRD:BRD-K96424892-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,"MENINGITIS, FEVER, CHOLERA",,LAUNCHED,,,NA,CCCCCCCCCCCCCCCC(=O)OC[C@H](NC(=O)C(CL)CL)[C@H](O)C1CCC(CC1)[N+]([O-])=O,
CHLORAZANIL,CHLORAZANIL,CHEMBL1984344,BRD:BRD-BRD-K21452876-003-01-8;BRD:BRD-K21452876-003-01-8,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,Nc1ncnc(Nc2ccc(Cl)cc2)n1;NC1NCNC(NC2CCC(CL)CC2)N1,YRZQHIVOIFJEEE-UHFFFAOYSA-N
TRIHISTAN,ALERGICIDE;CHLORCYCLIZINE;COMPD 47-282;NSC-25246;PERAZYL;TRIHISTAN,CHEMBL22150,BRD:BRD-A57133233-003-11-0;BRD:BRD-BRD-A57133233-003-11-0,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,1,CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1;CN1CCN(CC1)C(C1CCCCC1)C1CCC(CL)CC1,WFNAKBGANONZEQ-UHFFFAOYSA-N
MERFEN-INCOLORE,AVAGARD;CHLORHEXADINE;CHLORHEXIDINE;DENTISEPT;EXIDINE;HIBISTAT;MERFEN-INCOLORE,CHEMBL790,BRD:BRD-BRD-K52256627-300-06-6;BRD:BRD-K52256627-300-06-6,rep_multi_dose;rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,,"COSMETIC, SKIN INFECTIONS, GINGIVITIS",,LAUNCHED,,Small molecule,4,CLC1CCC(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2CCC(CL)CC2)CC1;N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,GHXZTYHSJHQHIJ-UHFFFAOYSA-N
NSC-158565,CHLORINDANOL;CLORINDANOL;NSC-158565,CHEMBL1449249,BRD:BRD-BRD-K01653460-001-01-1;BRD:BRD-K01653460-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,Oc1ccc(Cl)c2c1CCC2;OC1CCC(CL)C2CCCC12,ATAJVFBUUIBIEO-UHFFFAOYSA-N
CHLORINDIONE,CHLORINDIONE,,BRD:BRD-BRD-K61802864-001-08-8;BRD:BRD-K61802864-001-08-8,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CLC1CCC(CC1)C1C(=O)C2CCCCC2C1=O,
CHLORMADINONE-ACETATE,CHLORMADINONE-ACETATE,,BRD:BRD-A01593789-001-03-1;BRD:BRD-BRD-A01593789-001-03-1,rep_primary;rep_single_dose,5 ALPHA REDUCTASE INHIBITOR,PGR,"HYPERMENORRHEA, AMENORRHEA, OLIGOMENORRHEA, POLYMENORRHEA",,LAUNCHED,,,NA,CC(=O)O[C@@]1(CCC2C3C=C(CL)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O,
TRANCOPAL,CHLORMETHAZANONE;CHLORMEZANONE;LYSEEN NEW;NSC-169108;TRANCOPAL,CHEMBL1200714,BRD:BRD-A20348246-001-15-8;BRD:BRD-BRD-A20348246-001-15-8,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABRA1;TSPO,,,WITHDRAWN,,Small molecule,4,"CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1;CN1C(C2CCC(CL)CC2)S(=O)(=O)CCC1=O, CN1C(C2CCC(CL)CC2)S(=O)(=O)CCC1=O, CN1C(C2CCC(CL)CC2)S(=O)(=O)CCC1=O",WEQAYVWKMWHEJO-UHFFFAOYSA-N
CHLORMIDAZOLE,CHLORMIDAZOLE,CHEMBL152649,BRD:BRD-BRD-K60443845-001-08-6;BRD:BRD-K60443845-001-08-6,rep_multi_dose;rep_primary;rep_single_dose,FUNGAL LANOSTEROL DEMETHYLASE INHIBITOR,,FUNGAL INFECTION,,LAUNCHED,,Small molecule,-1,Cc1nc2ccccc2n1Cc1ccc(Cl)cc1;CC1NC2CCCCC2N1CC1CCC(CL)CC1,WNAQOLSMVPFGTE-UHFFFAOYSA-N
TRICHLORISOBUTYLALCOHOL,ANHYDROUS;ANHYDROUS CHLOROBUTANOL;CHLORBUTOL;CHLORETONE;CHLOROBUTANOL;CHLOROBUTANOLUM;NSC-44794;TRICHLORISOBUTYLALCOHOL,CHEMBL1439973,BRD:BRD-BRD-K39495750-001-01-2;BRD:BRD-K39495750-001-01-2,rep_primary;rep_single_dose,,,"ANESTHETIC, SEDATIVE",,LAUNCHED,,Small molecule,4,"CC(C)(O)C(Cl)(Cl)Cl;CC(C)(O)C(CL)(CL)CL, CC(C)(O)C(CL)(CL)CL",OSASVXMJTNOKOY-UHFFFAOYSA-N
P-CHLORO-M-CRESOL,CHLOROCRESOL;CHLOROCRESOLUM;NSC-4166;P-CHLORO-M-CRESOL,CHEMBL1230222,BRD:BRD-BRD-K89056082-001-07-7;BRD:BRD-K89056082-001-07-7,rep_primary;rep_single_dose,RYANODINE RECEPTOR ACTIVATOR,,FIRST-AID ANTISEPTIC,,LAUNCHED,,Small molecule,-1,"Cc1cc(O)ccc1Cl;CC1CC(O)CCC1CL, CC1CC(O)CCC1CL, CC1CC(O)CCC1CL",CFKMVGJGLGKFKI-UHFFFAOYSA-N
CHLOROGENIC-ACID,CHLOROGENIC-ACID,,BRD:BRD-BRD-K47114202-001-14-6;BRD:BRD-K47114202-001-14-6,rep_multi_dose;rep_primary;rep_single_dose,ANTIOXIDANT,SLC37A4,"HEADACHE, CHEST CONGESTION, ALLERGIC RHINITIS",,LAUNCHED,,,NA,"O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\C2CCC(O)C(O)C2)[C@@H]1O)C(O)=O, O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\C2CCC(O)C(O)C2)[C@@H]1O)C(O)=O",
CHLOROPROCAINE,2-CHLOROPROCAINE;CHLOROPROCAINE,CHEMBL1179047,BRD:BRD-BRD-K86864073-001-01-1;BRD:BRD-K86864073-001-01-1,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,ATP1A1;CHRNA10;GRIN3A;HTR3A;SCN10A;SLC6A3,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,4,CCN(CC)CCOC(=O)c1ccc(N)cc1Cl;CCN(CC)CCOC(=O)C1CCC(N)CC1CL,VDANGULDQQJODZ-UHFFFAOYSA-N
NSC-241038,CHLOROPYRAMINE;HALOPYRAMINE;NSC-241038,CHEMBL1194287,BRD:BRD-BRD-K83257731-003-23-5;BRD:BRD-K83257731-003-23-5,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"EDEMA, CONJUNCTIVITIS, ALLERGIC RHINITIS, ASTHMA",,LAUNCHED,,Small molecule,-1,CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1;CN(C)CCN(CC1CCC(CL)CC1)C1CCCCN1,ICKFFNBDFNZJSX-UHFFFAOYSA-N
NSC-187208,ARALEN;CHLOROCHINE;CHLOROQUINE;NSC-187208,CHEMBL76,BRD:BRD-A91699651-316-10-9;BRD:BRD-BRD-A91699651-316-10-9,rep_primary;rep_single_dose,ANTIMALARIAL AGENT,GSTA2;MRGPRX1;TLR9;TNF,"MALARIA, AMEBIASIS",,LAUNCHED,,Small molecule,4,"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12;CCN(CC)CCCC(C)NC1CCNC2CC(CL)CCC12, CCN(CC)CCCC(C)NC1CCNC2CC(CL)CCC12, CCN(CC)CCCC(C)NC1CCNC2CC(CL)CCC12",WHTVZRBIWZFKQO-UHFFFAOYSA-N
SALURIC,CHLOROTHIAZIDE;CHLOROTHIAZIDE-;CHLORTHIAZIDE;DIURIL;HYDROCHLOROTHIAZIDE IMPURITY;NSC-25693;SALURIC,CHEMBL842,BRD:BRD-BRD-K88682005-001-15-8;BRD:BRD-K88682005-001-15-8,rep_primary;rep_single_dose,DIURETIC,CA1;CA2;CA4;SLC12A3,HYPERTENSION,,LAUNCHED,,Small molecule,4,"NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O;NS(=O)(=O)C1CC2C(CC1CL)N=CNS2(=O)=O, NS(=O)(=O)C1CC2C(CC1CL)N=CNS2(=O)=O",JBMKAUGHUNFTOL-UHFFFAOYSA-N
TRIANISESTROL,CHLOROTRIANISENE;CHLORTRIANISESTROL;NSC-10108;TACE;TRIANISESTROL,CHEMBL1200761,BRD:BRD-BRD-K27062708-001-23-1;BRD:BRD-K27062708-001-23-1,rep_primary;rep_single_dose,ESTROGENIC HORMONE,ESR1;ESR2,"MENOPAUSE, PROSTATE CANCER",,LAUNCHED,,Small molecule,4,COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1;COC1CCC(CC1)C(CL)=C(C1CCC(OC)CC1)C1CCC(OC)CC1,BFPSDSIWYFKGBC-UHFFFAOYSA-N
NSC-3904,CAPITROL;CHLOROXINE;NSC-3904,CHEMBL1200596,BRD:BRD-BRD-K17075857-001-17-6;BRD:BRD-BRD-K17075857-001-18-4;BRD:BRD-K17075857-001-17-6;BRD:BRD-K17075857-001-18-4,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRK1,"DIARRHEA, INFLAMMATORY BOWEL DISEASE, GIARDIASIS, DANDRUFF",,LAUNCHED,,Small molecule,4,"Oc1c(Cl)cc(Cl)c2cccnc12;OC1C(CL)CC(CL)C2CCCNC12, OC1C(CL)CC(CL)C2CCCNC12, OC1C(CL)CC(CL)C2CCCNC12",WDFKMLRRRCGAKS-UHFFFAOYSA-N
CHLOROXOQUINOLINE,CHLOROXOQUINOLINE,,BRD:BRD-BRD-K83335125-001-07-0;BRD:BRD-K83335125-001-07-0,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,OC1CCNC2CC(CL)CCC12,
PARACHLOROMETOXYLENOL,CHLOROXYLENOL;NSC-4971;P-CHLORO-M-XYLENOL;PARACHLOROMETOXYLENOL,CHEMBL398440,BRD:BRD-BRD-K17223896-001-10-0;BRD:BRD-K17223896-001-10-0,rep_primary;rep_single_dose,ATP SYNTHASE INHIBITOR,,SKIN INFECTIONS,,LAUNCHED,,Small molecule,4,Cc1cc(O)cc(C)c1Cl;CC1CC(O)CC(C)C1CL,OSDLLIBGSJNGJE-UHFFFAOYSA-N
TELDRIN,(S)-;ANTAGONATE;CHLOR-TRIMETON;CHLORPHENAMINE;CHLORPHENIRAMINE;CHLORPHENIRAMINE D-FORM;D-;DAPRITON;DEXCHLORPHENIRAMINE;ISOCLOR;KLOROMIN;PHENETRON;TELDRIN,CHEMBL1201353;CHEMBL505,BRD:BRD-A04553218-050-16-2;BRD:BRD-BRD-A04553218-050-16-2,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1;SLC6A2;SLC6A3;SLC6A4,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,4,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1;CN(C)CCC(C1CCC(CL)CC1)C1CCCCN1,SOYKEARSMXGVTM-UHFFFAOYSA-N
U-19646,"CHLORPHENESIN;CHLORPHENESIN CARBAMATE;MAOLATE;NSC-6401;NSC-82943;U-19,646;U-19646",CHEMBL607710,BRD:BRD-A92262698-001-02-5;BRD:BRD-BRD-A92262698-001-02-5,rep_primary;rep_single_dose,MUSCLE RELAXANT,,"MUSCLE RELAXANT, SEDATIVE",,LAUNCHED,,Small molecule,4,"NC(=O)OCC(O)COc1ccc(Cl)cc1;OCC(O)COC1CCC(CL)CC1, OCC(O)COC1CCC(CL)CC1",SKPLBLUECSEIFO-UHFFFAOYSA-N
CHLORPHENOXAMINE,CHLORPHENOXAMINE,CHEMBL2110774,BRD:BRD-K00003537-001-01-9,rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,4,CN(C)CCOC(C)(c1ccccc1)c1ccc(Cl)cc1,KKHPNPMTPORSQE-UHFFFAOYSA-N
CHLORPHENSIN-CARBAMATE,CHLORPHENSIN-CARBAMATE,,BRD:BRD-A39230911-001-10-2;BRD:BRD-BRD-A39230911-001-10-2,rep_primary;rep_single_dose,MUSCLE RELAXANT,,,,PRECLINICAL,,,NA,NC(=O)OCC(O)COC1CCC(CL)CC1,
PROGUANIL HYDROCHLORIDE RELATED COMPOUND F,CHLORPROGUANIL;PROGUANIL HYDROCHLORIDE RELATED COMPOUND F,CHEMBL1213553,BRD:BRD-BRD-K25494650-003-01-8;BRD:BRD-K25494650-003-01-8,rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR,MALARIA,,LAUNCHED,,Small molecule,3,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1;CC(C)NC(=N)NC(=N)NC1CCC(CL)C(CL)C1,ISZNZKHCRKXXAU-UHFFFAOYSA-N
WINTERMIN,AMINAZINE;CHLORPROMAZINE;CHLORPROMAZINE HIBENZATE;CHLORPROMAZINE PHENOLPHTHALINATE;CHLORPROMAZINE TANNATE;CHLORPROMAZINUM;ELMARIN;ESMIND;FENACTIL;J2.794D;LARGACTIL;LARGACTILOTHIAZINE;MEGAPHEN;NOVOMAZINA;NSC-167745;NSC-226514;PROPAPHENIN;SANOPRON;SKF-2601A;SONAZINE;THORAZINE;WINTERMIN,CHEMBL71,BRD:BRD-BRD-K89997465-003-43-0;BRD:BRD-K89997465-003-43-0,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;CALM1;CHRM1;CHRM3;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HRH4;HTR1A;HTR2A;HTR2B;HTR2C;HTR6;HTR7;KCNH2;ORM1;ORM2;SMPD1;TRPC5,"SCHIZOPHRENIA, NAUSEA, VOMITING, ACUTE INTERMITTENT PORPHYRIA (AIP), TETANUS",,LAUNCHED,,Small molecule,4,"CN(C)CCCN1C2CCCCC2SC2CCC(CL)CC12, CN(C)CCCN1C2CCCCC2SC2CCC(CL)CC12, CN(C)CCCN1C2CCCCC2SC2CCC(CL)CC12;CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21",ZPEIMTDSQAKGNT-UHFFFAOYSA-N
NSC-626720,CHLORPROPAMIDE;DIABEMIDE;DIABINESE;GLUCAMIDE;GLYMESE;MELITASE;NSC-44634;NSC-626720,CHEMBL498,BRD:BRD-BRD-K97746869-001-27-0;BRD:BRD-K97746869-001-27-0,rep_multi_dose;rep_primary;rep_single_dose,ATP CHANNEL BLOCKER,ABCC8;KCNJ10;KCNJ11,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1;CCCNC(=O)NS(=O)(=O)C1CCC(CL)CC1, CCCNC(=O)NS(=O)(=O)C1CCC(CL)CC1",RKWGIWYCVPQPMF-UHFFFAOYSA-N
CHLORPROPHAM,CHLOROPROPHAM;CHLORPROPHAM,CHEMBL104560,BRD:BRD-BRD-K59590127-001-04-5;BRD:BRD-K59590127-001-04-5,rep_primary;rep_single_dose,ANTIVIRAL,,,,PHASE 1,,Small molecule,NA,CC(C)OC(=O)Nc1cccc(Cl)c1;CC(C)OC(=O)NC1CCCC(CL)C1,CWJSHJJYOPWUGX-UHFFFAOYSA-N
TRUXAL,CHLORPROTHIXENE;N-714;N-714RO 4-0403;NSC-18720;RO 4-0403;RO-4-0403;RO-40403;TARACTAN;TRUXAL,CHEMBL908,BRD:BRD-BRD-K36207157-001-07-0;BRD:BRD-BRD-K36207157-001-09-6;BRD:BRD-K36207157-001-07-0;BRD:BRD-K36207157-001-09-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;HRH1;HTR2A;HTR2B;HTR2C,"SCHIZOPHRENIA, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,4,"CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21;CN(C)CC\C=C1\C2CCCCC2SC2CCC(CL)CC12, CN(C)CC\C=C1\C2CCCCC2SC2CCC(CL)CC12, CN(C)CC\C=C1\C2CCCCC2SC2CCC(CL)CC12",WSPOMRSOLSGNFJ-AUWJEWJLSA-N
NSC-755891,CHLOROPYRIFOS;CHLORPYRIFOS;DURSBAN;ENT-27311;NSC-755891,CHEMBL463210,BRD:BRD-BRD-K08303368-001-10-0;BRD:BRD-K08303368-001-10-0,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE,,,LAUNCHED,,Small molecule,-1,CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl;CCOP(=S)(OCC)OC1NC(CL)C(CL)CC1CL,SBPBAQFWLVIOKP-UHFFFAOYSA-N
STEROXIN,CHLORQUINALDOL;CLORQUINALDOL;NSC-755830;STEROXIN,CHEMBL224325,BRD:BRD-BRD-K90374350-001-09-2;BRD:BRD-K90374350-001-09-2,rep_multi_dose;rep_primary;rep_single_dose,OTHER ANTIBIOTIC,,FUNGAL INFECTION,,LAUNCHED,,Small molecule,4,"Cc1ccc2c(Cl)cc(Cl)c(O)c2n1;CC1CCC2C(CL)CC(CL)C(O)C2N1, CC1CCC2C(CL)CC(CL)C(O)C2N1",GPTXWRGISTZRIO-UHFFFAOYSA-N
E702,CHLOROTETRACYCLINE;CHLORTETRACYCLINE;E702,CHEMBL404520,BRD:BRD-A25492003-003-14-1;BRD:BRD-BRD-A25492003-003-14-1;BRD:BRD-K00003353-003-01-9,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,CONJUNCTIVITIS,,LAUNCHED,"Multiple values for structure_id: {'K00003353', 'A25492003'}, defaulting to None",Small molecule,4,"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12;CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCC(CL)C4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCC(CL)C4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCC(CL)C4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O",CYDMQBQPVICBEU-XRNKAMNCSA-N
THALITONE,CHLORTALIDONE;CHLORTALIDONUM;CHLORTHALIDONE;G-33182;HYGROTON;NATRIURAN;NSC-69200;PHTHALAMUDINE;THALITONE,CHEMBL1055,BRD:BRD-A26384407-001-25-1;BRD:BRD-BRD-A26384407-001-25-1,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA1;CA12;CA14;CA2;CA4;CA7;SLC12A1;SLC12A3,"HYPERTENSION, EDEMA, CONGESTIVE HEART FAILURE, HEPATIC CIRRHOSIS, NEPHROTIC SYNDROME, ACUTE GLOMERULONEPHRITIS (AGN), CHRONIC RENAL FAILURE",,LAUNCHED,"Multiple values for repurposing_target: {'CA1;CA12;CA14;CA2;CA4;CA7;SLC12A1;SLC12A3', 'CA1;CA12;CA14;CA4;CA7;SLC12A1;SLC12A3'}, taking the union",Small molecule,4,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl;NS(=O)(=O)C1CC(CCC1CL)C1(O)NC(=O)C2CCCCC12,JIVPVXMEBJLZRO-UHFFFAOYSA-N
STRIFON FORTE DSC,CHLORZOXAZONE;NSC-26189;PARAFLEX;PARAFON;PARAFON FORTE;PARAFON FORTE DSC;PARAFON-FORTE;STRIFON;STRIFON FORTE DSC,CHEMBL1371,BRD:BRD-BRD-K98174813-001-18-0;BRD:BRD-K98174813-001-18-0,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,KCNMA1;KCNN4,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,4,"CLC1CCC2OC(=O)[NH]C2C1, CLC1CCC2OC(=O)[NH]C2C1;O=c1[nH]c2cc(Cl)ccc2o1",TZFWDZFKRBELIQ-UHFFFAOYSA-N
CHM-1,CHM-1,,CTRP:609674,ctrp,,,,,,,,NA,,
ZYMAD,"7-DEHYDROCHOLESTEROL;ACCRETE D3;ACIFEROL D3;ACTIVATED;ADCAL-D3;AK R215 COMPONENT COLECALCIFEROL;AK-R215 COMPONENT COLECALCIFEROL;AVITICOL;BIO-VITAMIN D3;BIOLIFE VITAMIN D3;CACIT D3;CALCEOS;CALCI-D;CALCICHEW D3;CALCICHEW D3 FTE;CALCICHEW D3 ONCE DAILY;CALDRINK D3;CALFOVIT D3;CHOLECALCIFEROL;COLECAL D3;COLECALCIFEROL;COLECALCIFEROLUM;COLEKAL-D3;COLEVIT D3;CUBICOLE D3;D-MAX;D-TRACETTEN;D-VIT3;D3 LEMON MELTS;D3-50;DEKRISTOL;DELSTEROL;DELTA-D;DEPARAL;DESUNIN;DIHYDROCHOLESTEROL;DLUX 400;E-D3;EBIVIT;EVACAL D3;FULTIUM DAILY D3;FULTIUM-D3;HUX D3;INVITA D3;ISO D3;KORA LIQUID;NATECAL D3;NATURE'S REMEDY VITAMIN D3;NEO-D;NPHD3;NSC-375571;OSTEOCAPS D3;PLENACHOL;PRO D3;PRO D3 FOLIC;PRO D3 FORTE;PROVITINA;RICKETON;ROYALVIT D3;STEXEROL-D3;STIVIT-D3;SUNVIT-D3 1,000;SUNVIT-D3 10,000;SUNVIT-D3 2,000;SUNVIT-D3 20,000;SUNVIT-D3 3,000;SUNVIT-D3 400;SUNVIT-D3 5,000;SUNVIT-D3 50,000;SUNVIT-D3 800;SYNERVIT-D3;THEICAL D-3;THORENS;VIGANTOL;VIGANTOLETTEN;VIGANTOLETTEN 500;VIT D3 STREULI;VITA-D3;VITAMIN D;VITAMIN D (CHOLECALCIFEROL);VITAMIN D 3;VITAMIN D ASSAY SYSTEM SUITABILITY;VITAMIN D-3;VITAMIN D3;VITAMIN D3 (AS CHOLECALCIFEROL);ZYMAD",CHEMBL1042,BRD:BRD-BRD-K62779383-001-05-5;BRD:BRD-K62779383-001-05-5,rep_multi_dose;rep_primary;rep_single_dose,,VDR,VITAMIN D DEFICIENCY,,LAUNCHED,,Small molecule,4,"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12;CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C, CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C, CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C",QYSXJUFSXHHAJI-YRZJJWOYSA-N
CHOLIC-ACID,CHOLIC-ACID,,BRD:BRD-BRD-K43164539-001-11-5;BRD:BRD-K43164539-001-11-5,rep_primary;rep_single_dose,BILE ACID,ADH1C;CES1;COX4I1;COX5A;COX5B;COX6A2;COX6B1;COX6C;COX7A1;COX7B;COX7C;COX8A;ESRRG;FABP6;FECH;GPBAR1;MT-CO1;MT-CO2;MT-CO3;PLA2G1B,"BILE ACID SYNTHESIS DISORDERS, PEROXISOMAL DISORDERS, ZELLWEGER SYNDROME",,LAUNCHED,,,NA,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,
SALICYLIC ACID CHOLINE SALT,ARTHROPAN;CHOLINE;CHOLINE SALICYLATE;CHOLINE SALICYLIC ACID SALT;CHOLINE SUBSALICYLATE;DINNEFORDS;ION(1-);SALICYLATE (SALT);SALICYLIC ACID;SALICYLIC ACID CHOLINE SALT,CHEMBL2104095;CHEMBL920,BRD:BRD-BRD-K77300776-001-02-5;BRD:BRD-K77300776-001-02-5,rep_primary;rep_single_dose,ACETYLCHOLINE PRECURSOR,ACHE;BCHE;CHRNA2;PCYT1A;PCYT1B;PHOSPHO1;PLD1;PLD2,,,PHASE 3,,Small molecule,4,"C[N+](C)(C)CCO, C[N+](C)(C)CCO;C[N+](C)(C)CCO.O=C([O-])c1ccccc1O",UDKCHVLMFQVBAA-UHFFFAOYSA-M
CHOLINE-ALFOSCERATE,CHOLINE-ALFOSCERATE,,BRD:BRD-A72390365-001-15-2;BRD:BRD-BRD-A72390365-001-15-2,rep_primary;rep_single_dose,ACETYLCHOLINE PRECURSOR,GM2A,,,LAUNCHED,,,NA,C[N+](C)(C)CCOP(O)(=O)OC[C@H](O)CO,
CHR-6494,CHR-6494,,BRD:BRD-BRD-K76259716-019-01-1;BRD:BRD-K76259716-019-01-1,rep_primary;rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,GSG2,,,PRECLINICAL,,,NA,"CCCNC1CCC2NCC(-C3CCC4[NH]NCC4C3)N2N1, CCCNC1CCC2NCC(-C3CCC4[NH]NCC4C3)N2N1",
CHROMANOL-(+/-),CHROMANOL-(+/-),,BRD:BRD-BRD-M02075109-001-01-1;BRD:BRD-M02075109-001-01-1,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,CCS(=O)(=O)N(C)[C@@H]1[C@@H](O)C(C)(C)OC2CCC(CC12)C#N.CCS(=O)(=O)N(C)[C@H]1[C@H](O)C(C)(C)OC2CCC(CC12)C#N,
"CHROMANOL-293B-(-)-[3R,4S]","CHROMANOL-293B-(-)-[3R,4S]",,BRD:BRD-BRD-K27911943-001-02-8;BRD:BRD-K27911943-001-02-8,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,CCS(=O)(=O)N(C)[C@@H]1[C@@H](O)C(C)(C)OC2CCC(CC12)C#N,
PICOLINIC-ACID,CHROMIUM-PICOLINATE;PICOLINIC-ACID,,BRD:BRD-BRD-K01029106-001-01-4;BRD:BRD-K01029106-001-01-4;BRD:BRD-K01029106-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,"CHELATING AGENT, INSULIN SENSITIZER",,,,PHASE 2,"Multiple values for MOA: {'CHELATING AGENT, INSULIN SENSITIZER', 'CHELATING AGENT'}, defaulting to 'CHELATING AGENT, INSULIN SENSITIZER'",,NA,"O=C(O[CR](OC(=O)C1CCCCN1)OC(=O)C1CCCCN1)C1CCCCN1, OC(=O)C1CCCCN1, OC(=O)C1CCCCN1",
NSC-758218,CHROMOCARB;NSC-758218,CHEMBL83628,BRD:BRD-BRD-K94720315-001-10-4;BRD:BRD-K94720315-001-10-4,rep_multi_dose;rep_primary;rep_single_dose,ANTISPASMODIC,,,,LAUNCHED,,Small molecule,-1,"O=C(O)c1cc(=O)c2ccccc2o1;OC(=O)C1CC(=O)C2CCCCC2O1, OC(=O)C1CC(=O)C2CCCCC2O1",RVMGXWBCQGAWBR-UHFFFAOYSA-N
NSC-407436,CHRYSIN;NSC-407436,CHEMBL117,BRD:BRD-BRD-K22861715-001-17-4;BRD:BRD-K22861715-001-17-4,rep_primary;rep_single_dose,BREAST CANCER RESISTANCE PROTEIN INHIBITOR,AKR1B1;CDK6;CYP19A1;CYP1B1,,,PHASE 1,,Small molecule,NA,O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12;OC1CC(O)C2C(C1)OC(CC2=O)-C1CCCCC1,RTIXKCRFFJGDFG-UHFFFAOYSA-N
CHRYSOPHANIC-ACID,CHRYSOPHANIC-ACID,,BRD:BRD-BRD-K59284035-001-07-9;BRD:BRD-K59284035-001-07-9,rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;MTOR,,,PRECLINICAL,,,NA,CC1CC(O)C2C(=O)C3C(O)CCCC3C(=O)C2C1,
CHUANXIONGZINE,CHUANXIONGZINE,,BRD:BRD-BRD-K25691735-001-09-5;BRD:BRD-K25691735-001-09-5,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CC1NC(C)C(C)NC1C,
SN-26606,CANERTINIB;CANERTINIB DIHYDROCHLORIDE;CANERTINIB HYDROCHLORIDE;CI-1033;PD-0183805;PD-0183805-002B;PD-183805;SN-26606,CHEMBL31965;CHEMBL545315,GDSC1:362,gdsc,,,,,,,Small molecule,3,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,JZZFDCXSFTVOJY-UHFFFAOYSA-N
CI-844,CI-844,,BRD:BRD-BRD-K83022601-001-01-0;BRD:BRD-K83022601-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,O(C1CCCCC1)C1CCCNC1,
CI-923,CI-923,,BRD:BRD-A50016482-001-01-7;BRD:BRD-BRD-A50016482-001-01-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,,,PHASE 1,,,NA,CCNC(C)CN1CCC2C(C1)C(=O)OC1CCCCC21,
CI-953,CI-953,,BRD:BRD-K00004748-001-01-9,rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,,,,,,,NA,,
CI-966,CI-966,,BRD:BRD-BRD-K67680372-003-02-6;BRD:BRD-K67680372-003-02-6,rep_primary;rep_single_dose,GAT INHIBITOR,SLC6A1,,,PHASE 1,,,NA,"OC(=O)C1=CCCN(CCOC(C2CCC(CC2)C(F)(F)F)C2CCC(CC2)C(F)(F)F)C1, OC(=O)C1=CCCN(CCOC(C2CCC(CC2)C(F)(F)F)C2CCC(CC2)C(F)(F)F)C1",
CL-976,CI-976;CL-976,CHEMBL22373,BRD:BRD-BRD-K88544581-001-06-1;BRD:BRD-K88544581-001-06-1;CTRP:375390,ctrp;rep_primary;rep_single_dose,ACAT INHIBITOR,ACAT1;CES1,,,PHASE 1,,Small molecule,NA,"CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC;CCCCCCCCCCC(C)(C)C(=O)NC1C(OC)CC(OC)CC1OC, CCCCCCCCCCC(C)(C)C(=O)NC1C(OC)CC(OC)CC1OC",WAFNZAURAWBNDZ-UHFFFAOYSA-N
NSC-2819,CATECHIN;CATECHINIC ACID;CATECHUIC ACID;CATERGEN;CIANIDANOL;CIANIDOL;D-;D-CATECHOL;NSC-2819,CHEMBL311498,BRD:BRD-BRD-K58736316-001-09-5;BRD:BRD-K58736316-001-09-5,rep_primary;rep_single_dose,FATTY ACID SYNTHASE INHIBITOR,PTGS1,,,WITHDRAWN,,Small molecule,4,O[C@H]1CC2C(O)CC(O)CC2O[C@@H]1C1CCC(O)C(O)C1;Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2,PFTAWBLQPZVEMU-DZGCQCFKSA-N
RO-22-7796,CIBENZOLINE;CIFENLINE;RO 22-7796;RO-22-7796,CHEMBL87045,BRD:BRD-BRD-K34251960-036-01-6;BRD:BRD-K34251960-036-01-6,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,,,,LAUNCHED,,Small molecule,-1,C1C(=C2NCCN2)C1(C1CCCCC1)C1CCCCC1;c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1,IPOBOOXFSRWSHL-UHFFFAOYSA-N
ZETONNA,ALVESCO;ALVESCO 160;ALVESCO 80;BI54903;CICLESONIDE;OMNARIS;RPR-251526;RPR251526;ZETONNA,CHEMBL2040682,BRD:BRD-BRD-K35245662-001-01-2;BRD:BRD-K35245662-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;SERPINA6,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C)C1CCCCC1;CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,LUKZNWIVRBCLON-GXOBDPJESA-N
PENLAC,CICLOPIROX;CYCLOPIROX;HOE 296B;HOE-296B;LOPROX;PENLAC,CHEMBL1413,BRD:BRD-BRD-K13044802-213-20-7;BRD:BRD-K13044802-213-20-7;CTRP:28784,ctrp;rep_multi_dose;rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,ATP1A1,ONYCHOMYCOSIS,,LAUNCHED,,Small molecule,4,"Cc1cc(C2CCCCC2)n(O)c(=O)c1;CC1CC(C2CCCCC2)N(O)C(=O)C1, CC1CC(C2CCCCC2)N(O)C(=O)C1, CC1CC(C2CCCCC2)N(O)C(=O)C1, CC1CC(C2CCCCC2)N(O)C(=O)C1, CC1CC(C2CCCCC2)N(O)C(=O)C1, CC1CC(C2CCCCC2)N(O)C(=O)C1",SCKYRAXSEDYPSA-UHFFFAOYSA-N
SQ-20824,CICLOPROFEN;NSC-293916;SQ 20824;SQ-20824,CHEMBL2104122,BRD:BRD-A94965935-001-01-6,rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,,,Small molecule,-1,CC(C(=O)O)c1ccc2c(c1)Cc1ccccc1-2,LRXFKKPEBXIPMW-UHFFFAOYSA-N
ZINOGRAF ME,27-400;ANTIBIOTIC S-7481F1;ATOPICA;CAPIMUNE;CAPSORIN;CEQUA;CICLOSPORIN;CICLOSPORIN A;CICLOSPORINUM;CYCLOSPORIN;CYCLOSPORIN A;CYCLOSPORINE;CYCLOSPORINE A;CYCLOSPORINE MICROEMULSION;DEXIMUNE;EQUORAL;GENGRAF;IKERVIS;MITOGARD;MODIFIED;NEOPLANTA;NEORAL;NEUROSTAT;NSC-290193;OL-27-400;OPTIMMUNE;RAMIHYPHIN A;RESTASIS;RESTASIS MULTIDOSE;SANDIMMUN;SANDIMMUNE;SANG-35;SANGCYA;SDZ-OXL-400;VANQUORAL;VERKAZIA;ZINOGRAF ME,CHEMBL160,CTRP:55512,ctrp,,,,,,,Protein,4,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,PMATZTZNYRCHOR-CGLBZJNRSA-N
CID-16020046,CID-16020046,,BRD:BRD-A59391172-001-07-7;BRD:BRD-BRD-A59391172-001-07-7,rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,GPR55,,,PRECLINICAL,,,NA,CC1CCC(CC1)-C1[NH]NC2C(=O)N(C(C12)C1CCCC(O)C1)C1CCC(CC1)C(O)=O,
CID-2011756,CID-2011756,,BRD:BRD-BRD-K92781136-001-08-9;BRD:BRD-K92781136-001-08-9,rep_primary;rep_single_dose,PROTEIN KINASE INHIBITOR,PKD1,,,PRECLINICAL,,,NA,CLC1CCCC(C1)-C1CCC(O1)C(=O)NC1CCC(CN2CCOCC2)CC1,
CID-2745687,CID-2745687,,BRD:BRD-K06405316-001-04-9,rep_single_dose,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,GPR35,,,,,,NA,,
CID-5458317,CID-5458317,,BRD:BRD-A08840375-001-01-3;BRD:BRD-BRD-A08840375-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,MAP KINASE PHOSPHATASE INHIBITOR,MAPK3,,,PRECLINICAL,,,NA,O=C1C2CCCCC2C(NC2CCCCC2)\C1=C/C1CCCCC1,
CID-5951923,CID-5951923,,CTRP:267119,ctrp,,,,,,,,NA,,
VISTIDE,ANHYDROUS CIDOFOVIR;CIDOFOVIR;CIDOFOVIR ANHYDROUS;CIDOFOVIR DIHYDRATE;GS-0504;HPMPC;HPMPC DIHYDRATE;NSC-742135;VISTIDE,CHEMBL152,BRD:BRD-BRD-K96153583-001-05-1;BRD:BRD-K96153583-001-05-1,rep_multi_dose;rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,"ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), CYTOMEGALOVIRUS RETINITIS",,LAUNCHED,,Small molecule,4,"Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1;NC1CCN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N1, NC1CCN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N1",VWFCHDSQECPREK-LURJTMIESA-N
U-63287,"ADD-3878;CIGLITAZONE;U-63,287;U-63287",CHEMBL7002,BRD:BRD-A93000692-001-08-1;BRD:BRD-BRD-A93000692-001-08-1,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARG,,,PHASE 2,,Small molecule,-1,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1;CC1(COC2CCC(CC3SC(=O)NC3=O)CC2)CCCCC1,YZFWTZACSRHJQD-UHFFFAOYSA-N
CIL41,CIL41,,CTRP:176181,ctrp,,,,,,,,NA,,
CIL55,CIL55,,CTRP:1788,ctrp,,,,,,,,NA,,
CIL55A,CIL55A,,CTRP:609061,ctrp,,,,,,,,NA,,
CIL56,CIL56,,CTRP:100490,ctrp,,,,,,,,NA,,
CIL70,CIL70,,CTRP:183526,ctrp,,,,,,,,NA,,
VASCACE,ANHYDROUS CILAZAPRIL;CILAZAPRIL;CILAZAPRIL ANHYDROUS;CILAZAPRIL HYDRATE;CILAZAPRIL MONOHYDRATE;CILAZAPRILUM;INHIBACE;INITISS;JUSTOR;RO 31-2848/006;RO-312848006;VASCACE,CHEMBL515606,BRD:BRD-BRD-K65518078-002-01-1;BRD:BRD-K65518078-002-01-1,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O;CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]1CCCN2CCC[C@@H](N2C1=O)C(O)=O,HHHKFGXWKKUNCY-FHWLQOOXSA-N
EMD-121974,CILENGITIDE;EMD 121974;EMD-12192;EMD-121974,CHEMBL429876,BRD:BRD-BRD-K57252450-001-02-5;BRD:BRD-K57252450-001-02-5,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGAV;ITGB3,,,PHASE 3,,Protein,3,CC(C)[C@@H]1N(C)C(=O)[C@@H](CC2CCCCC2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O;CC(C)[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccccc2)C(=O)N1C,AMLYAMJWYAIXIA-VWNVYAMZSA-N
SISCARD,ATELEC;CILNIDIPINE;CINALONG;FRC-8653;SISCARD,CHEMBL452076,BRD:BRD-A02743701-001-03-6;BRD:BRD-BRD-A02743701-001-03-6,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1B,HYPERTENSION,,LAUNCHED,,Small molecule,3,"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1;COCCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC\C=C\C1CCCCC1, COCCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC\C=C\C1CCCCC1, COCCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC\C=C\C1CCCCC1, COCCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC\C=C\C1CCCCC1",KJEBULYHNRNJTE-DHZHZOJOSA-N
PX104,CILOFEXOR;GS 9674;GS-9674;PX-104;PX104,CHEMBL4297613,BRD:BRD-K00004595-001-01-9,rep_single_dose,FXR AGONIST,,,,,,Small molecule,3,O=C(O)c1ccnc(N2CC(O)(c3ccc(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)cc3Cl)C2)c1,KZSKGLFYQAYZCO-UHFFFAOYSA-N
SB-207499,ARIFLO;CILOMILAST;SB 207499;SB-207499,CHEMBL511115,BRD:BRD-BRD-K38473998-001-02-0;BRD:BRD-K38473998-001-02-0,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A;PDE4B;PDE4D,,,PHASE 3,,Small molecule,3,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1;COC1CCC(CC1OC1CCCC1)C1(CCC(CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-OYOVHJISSA-N
OPC-3689,CILOSTAMIDE;OPC-3689,CHEMBL34431,BRD:BRD-BRD-K28578425-001-07-0;BRD:BRD-K28578425-001-07-0,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A;PDE3B,,,PRECLINICAL,,Small molecule,-1,"CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1;CN(C1CCCCC1)C(=O)CCCOC1CCC2[NH]C(=O)CCC2C1, CN(C1CCCCC1)C(=O)CCCOC1CCC2[NH]C(=O)CCC2C1",UIAYVIIHMORPSJ-UHFFFAOYSA-N
PLETAL,CILOSTAZOL;NSC-758936;OPC-13013;OPC-21;PLETAL,CHEMBL799,BRD:BRD-BRD-K67017579-001-28-1;BRD:BRD-K67017579-001-28-1,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A;PDE3B,CLAUDICATION,,LAUNCHED,,Small molecule,4,"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1;O=C1CCC2CC(OCCCCC3NNNN3C3CCCCC3)CCC2N1, O=C1CCC2CC(OCCCCC3NNNN3C3CCCCC3)CCC2N1, O=C1CCC2CC(OCCCCC3NNNN3C3CCCCC3)CCC2N1, O=C1CCC2CC(OCCCCC3NNNN3C3CCCCC3)CCC2N1",RRGUKTPIGVIEKM-UHFFFAOYSA-N
CILUPREVIR,BILN 2061 ZW;BILN-2061;BILN-2061-ZW;CILUPREVIR,CHEMBL297884,BRD:BRD-K00004667-001-01-9,rep_single_dose,SERINE PROTEASE INHIBITOR,,,,,,Small molecule,2,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)C[C@H]5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(C)C)n3)nc2c1,PJZPDFUUXKKDNB-KNINVFKUSA-N
CIM-0216,CIM-0216,,BRD:BRD-A75514485-001-02-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,TRPM3,,,,,,NA,,
CIMATEROL,"AB-A 66;AB-A 663;AB-A-66;ABA-663;AC 263,780;AC-263780;CIMATEROL",CHEMBL1374751,BRD:BRD-A65440446-001-04-1;BRD:BRD-BRD-A65440446-001-04-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2;ADRB3,,,PRECLINICAL,,Small molecule,-1,CC(C)NCC(O)c1ccc(N)c(C#N)c1;CC(C)NCC(O)C1CCC(N)C(C1)C#N,BUXRLJCGHZZYNE-UHFFFAOYSA-N
ZITA,ACID-EZE;ACILOC;ACINIL;ACITAK 200;ACITAK 400;ACITAK 800;BRUMETADINA;BRUMETIDINA;CIMAL;CIMETIDINE;CIMETIDINUM;DYSPAMET;GALENAMET;GASTROMET;KENTAMET;NSC-335308;PEPTIMAX 200;PEPTIMAX 400;PEPTIMAX 800;SKF-92334;STOMEDINE;TAGADINE;TAGAMET;TAGAMET 100;TAGAMET HB;TAGAMET HB 200;ULCEDIN;ULCIMET;ULCOMEDINA;ULTEC;VALMAGEN;ZITA,CHEMBL30,BRD:BRD-BRD-K34157611-001-16-0;BRD:BRD-K34157611-001-16-0;CTRP:26870,ctrp;rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2;SLC29A4;SLC47A1;SLC47A2,"DUODENAL ULCER DISEASE, PEPTIC ULCER DISEASE (PUD), GASTROESOPHAGEAL REFLUX DISEASE (GERD), AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM), ZOLLINGER-ELLISON SYNDROME, ENDOCRINE ADENOMA",,LAUNCHED,,Small molecule,4,"CN/C(=N\CCSCc1nc[nH]c1C)NC#N;CN\C(NCCSCC1NC[NH]C1C)=N/C#N, CN\C(NCCSCC1NC[NH]C1C)=N/C#N, CN\C(NCCSCC1NC[NH]C1C)=N/C#N, CN\C(NCCSCC1NC[NH]C1C)=N/C#N",AQIXAKUUQRKLND-UHFFFAOYSA-N
CIMETROPIUM ION,CIMETROPIUM;CIMETROPIUM CATION;CIMETROPIUM ION,CHEMBL2110773,BRD:BRD-A99899486-004-01-9;BRD:BRD-BRD-A99899486-004-01-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,IRRITABLE BOWEL SYNDROME,,LAUNCHED,,Small molecule,3,C[N+]1(CC2CC2)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12;C[N+]1(CC2CC2)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1CCCCC1,QVVOZYKELHAIPX-WVHCHWADSA-N
SENSIPAR,AMG 073;AMG-073;AMG073;CINACALCET;KRN-1493;KRN1493;SENSIPAR,CHEMBL1201284,BRD:BRD-BRD-K73838513-003-05-5;BRD:BRD-K73838513-003-05-5,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL ACTIVATOR,CASR,"HYPERPARATHYROIDISM, CHRONIC KIDNEY DISEASE (CKD), PARATHYROID CARCINOMA, HYPERCALCEMIA",,LAUNCHED,,Small molecule,4,C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12;C[C@@H](NCCCC1CCCC(C1)C(F)(F)F)C1CCCC2CCCCC12,VDHAWDNDOKGFTD-MRXNPFEDSA-N
CINACIGUAT,BAY 58-2667;CINACIGUAT,CHEMBL1236936,BRD:BRD-BRD-K73440166-001-01-3;BRD:BRD-K73440166-001-01-3,rep_primary;rep_single_dose,GUANYLATE CYCLASE ACTIVATOR,GUCY1A3;GUCY1B3,,,PHASE 2,,Small molecule,2,O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1;OC(=O)CCCCN(CCC1CCCCC1OCC1CCC(CCC2CCCCC2)CC1)CC1CCC(CC1)C(O)=O,WPYWMXNXEZFMAK-UHFFFAOYSA-N
RO-245913,CINALUKAST;RO 24-5913;RO-24-5913;RO-245913,CHEMBL283754,BRD:BRD-BRD-K53720352-001-03-2;BRD:BRD-K53720352-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,CYSLTR1,,,PHASE 2,,Small molecule,-1,"CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O;CCC(CC)(CC(=O)NC1CCCC(\C=C\C2NC(CS2)C2CCC2)C1)C(O)=O, CCC(CC)(CC(=O)NC1CCCC(\C=C\C2NC(CS2)C2CCC2)C1)C(O)=O, CCC(CC)(CC(=O)NC1CCCC(\C=C\C2NC(CS2)C2CCC2)C1)C(O)=O",BZMKNPGKXJAIDV-VAWYXSNFSA-N
CINANSERIN,CINANSERIN,CHEMBL18786,BRD:BRD-BRD-K40901640-003-01-6;BRD:BRD-K40901640-003-01-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A,,,PRECLINICAL,,Small molecule,-1,CN(C)CCCSc1ccccc1NC(=O)/C=C/c1ccccc1;CN(C)CCCSC1CCCCC1NC(=O)\C=C\C1CCCCC1,RSUVYMGADVXGOU-BUHFOSPRSA-N
NUPERCAINAL,CINCHOCAINE;DIBUCAINE;NSC-159055;NUPERCAINAL,CHEMBL1086,BRD:BRD-BRD-K99121711-003-19-7;BRD:BRD-K99121711-003-19-7,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,CALM1;SCN10A;SCN5A,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,4,"CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1;CCCCOC1CC(C(=O)NCCN(CC)CC)C2CCCCC2N1, CCCCOC1CC(C(=O)NCCN(CC)CC)C2CCCCC2N1",PUFQVTATUTYEAL-UHFFFAOYSA-N
TCMDC-123934,.ALPHA.-QUINIDINE;CINCHONIDINE;CINCHOVATINE-;NSC-5364;TCMDC-123934,CHEMBL533841,BRD:BRD-BRD-K39079086-001-07-6;BRD:BRD-K39079086-001-07-6,rep_primary;rep_single_dose,P GLYCOPROTEIN INHIBITOR,,,,PHASE 1,,Small molecule,-1,"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccccc12;O[C@@H]([C@@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)C1CCNC2CCCCC12, O[C@@H]([C@@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)C1CCNC2CCCCC12",KMPWYEUPVWOPIM-KODHJQJWSA-N
TCMDC-123933,"(8R,9S)-CINCHONINE;(9S)-;(9S)-CINCHONAN-9-OL;ANHYDROUS;ANHYDROUS CINCHONINE SULFATE;CINCHONAN-9-OL;CINCHONINE;CINCHONINE SULFATE;CINCHONINE SULFATE ANHYDROUS;CINCHONINE SULPHATE;CINCHONINUM SULPHURICUM;D-CINCHONINE;GNF-PF-3189;NSC-6176;SULFATE (2:1) (SALT);SULPHATE (2:1) (SALT);TCMDC-123933",CHEMBL2105783;CHEMBL588619,BRD:BRD-K36551084-001-04-9,rep_single_dose,P GLYCOPROTEIN INHIBITOR,CYP2D6,,,,,Small molecule,-1,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccccc12;C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccccc12.C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccccc12.O=S(=O)(O)O,KMPWYEUPVWOPIM-QAMTZSDWSA-N;WBBHOISPYYYBTC-SJFRDBBCSA-N
PHENYLCINCHONINIC ACID,CINCHOPHEN;NSC-2617;PHENYLCINCHONINIC ACID,CHEMBL348000,BRD:BRD-BRD-K72915123-001-18-1;BRD:BRD-K72915123-001-18-1,rep_primary;rep_single_dose,ANALGESIC AGENT,,GOUT,,LAUNCHED,,Small molecule,-1,"O=C(O)c1cc(-c2ccccc2)nc2ccccc12;OC(=O)C1CC(NC2CCCCC12)-C1CCCCC1, OC(=O)C1CC(NC2CCCCC12)-C1CCCCC1",YTRMTPPVNRALON-UHFFFAOYSA-N
CINEPAZET,CINEPAZET,CHEMBL2110784,BRD:BRD-BRD-K00531707-001-01-3;BRD:BRD-K00531707-001-01-3,rep_primary;rep_single_dose,VASODILATOR,,,,LAUNCHED,,Small molecule,-1,CCOC(=O)CN1CCN(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)CC1;CCOC(=O)CN1CCN(CC1)C(=O)\C=C\C1CC(OC)C(OC)C(OC)C1,XDUOTWNXVDBCDY-VOTSOKGWSA-N
MD-67350 FREE BASE,CINEPAZIDE;CINEPAZIDE MALEATE;MD 67350 [AS MALEATE];MD 67350 FREE BASE;MD-67350 FREE BASE,CHEMBL1874750,BRD:BRD-BRD-K46839850-050-04-2;BRD:BRD-K46839850-050-04-2,rep_primary;rep_single_dose,CALCIUM CHANNEL ACTIVATOR,,,,WITHDRAWN,,Small molecule,4,"COc1cc(/C=C/C(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC;COC1CC(CC(OC)C1OC)\C=C\C(=O)N1CCN(CC(=O)N2CCCC2)CC1, COC1CC(CC(OC)C1OC)\C=C\C(=O)N1CCN(CC(=O)N2CCCC2)CC1",RCUDFXMNPQNBDU-VOTSOKGWSA-N
CINFLUMIDE,BW 532U;BW-532U;CINFLUMIDE,CHEMBL132663,BRD:BRD-BRD-K25154476-001-01-4;BRD:BRD-K25154476-001-01-4,rep_primary;rep_single_dose,MUSCLE RELAXANT,,,,PHASE 2,,Small molecule,-1,FC1CCCC(C1)\C=C\C(=O)NC1CC1;O=C(/C=C/c1cccc(F)c1)NC1CC1,NCOOUEIQXVWKTO-QPJJXVBHSA-N
ZIMTALDEHYDE,.BETA.-PHENYLACROLEIN;ABION CA;CINNAMAL;CINNAMALDEHYDE;CINNAMIC ALDEHYDE;FEMA NO. 2286;NSC-16935;NSC-40346;XC-800;ZIMTALDEHYDE,CHEMBL293492,BRD:BRD-K26875402-001-13-9,rep_single_dose,"ALDOSE REDUCTASE INHIBITOR, TRPV AGONIST",TRPA1,,,,,Small molecule,-1,O=C/C=C/c1ccccc1,KJPRLNWUNMBNBZ-QPJJXVBHSA-N
CINNARAZINE,CINNARAZINE,,BRD:BRD-BRD-K07220430-001-18-4;BRD:BRD-BRD-K07220430-001-19-2;BRD:BRD-K07220430-001-18-4;BRD:BRD-K07220430-001-19-2,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,"MENIERE'S DISEASE, NAUSEA, VOMITING, COGAN'S SYNDROME",,LAUNCHED,,,NA,"C(\C=C\C1CCCCC1)N1CCN(CC1)C(C1CCCCC1)C1CCCCC1, C(\C=C\C1CCCCC1)N1CCN(CC1)C(C1CCCCC1)C1CCCCC1",
NSC-90326,CINOBUFAGIN METABOLITE M-2;CINOBUFOTALIN;NSC-90326,CHEMBL517341,BRD:BRD-K00003354-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,Small molecule,1,CC(=O)O[C@H]1[C@H]2O[C@]23[C@@H]2CC[C@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]2CC[C@]3(C)[C@H]1c1ccc(=O)oc1,KBKUJJFDSHBPPA-ZNCGZLKOSA-N
NSC-304467,64716;CINOBAC;CINOXACIN;NSC-304467,CHEMBL1208,BRD:BRD-BRD-K14704277-001-22-6;BRD:BRD-K14704277-001-22-6,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,"CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3;CCN1NC(C(O)=O)C(=O)C2CC3OCOC3CC12, CCN1NC(C(O)=O)C(=O)C2CC3OCOC3CC12",VDUWPHTZYNWKRN-UHFFFAOYSA-N
CINOXATE,CINOXATE,CHEMBL2104045,BRD:BRD-BRD-K17828029-001-01-5;BRD:BRD-K17828029-001-01-5,rep_primary;rep_single_dose,,,SUNSCREEN LOTION,,LAUNCHED,,Small molecule,4,CCOCCOC(=O)/C=C/c1ccc(OC)cc1;CCOCCOC(=O)\C=C\C1CCC(OC)CC1,CMDKPGRTAQVGFQ-RMKNXTFCSA-N
CINPA-1,CINPA-1,,BRD:BRD-K24570280-001-07-9,rep_single_dose,CAR ANTAGONIST,NR1H4;NR1I3;PPARG,,,,,,NA,,
TRANS,3-BROMO-N-ETHYLCINNAMAMIDE;CINROMIDE;NSC-335304;TRANS,CHEMBL93233,BRD:BRD-BRD-K66241279-001-01-8;BRD:BRD-K66241279-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 3,,Small molecule,-1,CCNC(=O)/C=C/c1cccc(Br)c1;CCNC(=O)\C=C\C1CCCC(BR)C1,LDCXGZCEMNMWIL-VOTSOKGWSA-N
CINTIRORGON,CINTIRORGON,,BRD:BRD-K00003458-001-01-9,rep_single_dose,ROR AGONIST,,,,,,,NA,,
NSC-170963,CINTRAMIDE;CINTRIAMIDE;NSC-170963,CHEMBL2107098,BRD:BRD-BRD-K24507548-001-01-8;BRD:BRD-K24507548-001-01-8,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,COc1cc(/C=C/C(N)=O)cc(OC)c1OC;COC1CC(CC(OC)C1OC)\C=C\C(N)=O,LRLKZVMLJBNNPE-SNAWJCMRSA-N
CIPAMFYLLINE,BRL 61063;BRL-61063;CIPAMFYLLINE,CHEMBL356323,BRD:BRD-K00004625-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,-1,Nc1nc2c([nH]1)c(=O)n(CC1CC1)c(=O)n2CC1CC1,KSPYMJJKQMWWNB-UHFFFAOYSA-N
NITD609,CIPARGAMIN;KAE-609;KAE609;NITD-609;NITD609,CHEMBL1082723,BRD:BRD-K27811785-001-02-9,rep_single_dose,ANTIMALARIAL AGENT,,,,,,Small molecule,2,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,CKLPLPZSUQEDRT-WPCRTTGESA-N
TROCADE,CIPEMASTAT;RO 32-3555/000;RO-32-03555;RO-323555000;TROCADE,CHEMBL115653,BRD:BRD-BRD-K95362002-001-01-1;BRD:BRD-K95362002-001-01-1,rep_primary;rep_single_dose,METALLOPROTEINASE INHIBITOR,ADAM17;MMP1;MMP13;MMP2;MMP3;MMP8;MMP9,,,PHASE 3,,Small molecule,-1,CN1C(=O)N(C[C@@H]([C@@H](CC2CCCC2)C(=O)N2CCCCC2)C(=O)NO)C(=O)C1(C)C;CN1C(=O)N(C[C@H](C(=O)NO)[C@@H](CC2CCCC2)C(=O)N2CCCCC2)C(=O)C1(C)C,GFUITADOEPNRML-SJORKVTESA-N
WIN-35833,CIPROFIBRATE;MODALIM;NSC-759617;WIN 35833;WIN-35833,CHEMBL557555,BRD:BRD-A49358627-001-14-6;BRD:BRD-BRD-A49358627-001-14-6,rep_multi_dose;rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA,HYPERLIPIDEMIA,,LAUNCHED,,Small molecule,4,"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O;CC(C)(OC1CCC(CC1)C1CC1(CL)CL)C(O)=O, CC(C)(OC1CCC(CC1)C1CC1(CL)CL)C(O)=O",KPSRODZRAIWAKH-UHFFFAOYSA-N
VELMONIT,BAY O 9867 FREE BASE;BAY Q 3939;BAY-O-9867 FREE BASE;BAY-Q-3939;BAYQ3939;CETRAXAL;CILOXAN;CIPRO;CIPROBAY;CIPROFLOXACIN;CIPROFLOXACINUM;NSC-758467;OTIPRIO;VELMONIT,CHEMBL8,BRD:BRD-BRD-K04804440-001-09-5;BRD:BRD-K04804440-001-09-5,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,OTITIS,,LAUNCHED,,Small molecule,4,"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O;OC(=O)C1CN(C2CC2)C2CC(N3CCNCC3)C(F)CC2C1=O, OC(=O)C1CN(C2CC2)C2CC(N3CCNCC3)C(F)CC2C1=O, OC(=O)C1CN(C2CC2)C2CC(N3CCNCC3)C(F)CC2C1=O",MYSWGUAQZAJSOK-UHFFFAOYSA-N
CIPROXIFAN,CIPROXIFAN,CHEMBL14638,BRD:BRD-BRD-K01767299-050-02-1;BRD:BRD-K01767299-050-02-1,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,ADRA2A;ADRA2C;HRH3;HRH4;HTR3A,,,PRECLINICAL,,Small molecule,NA,O=C(C1CC1)C1CCC(OCCCC2C[NH]CN2)CC1;O=C(c1ccc(OCCCc2c[nH]cn2)cc1)C1CC1,ACQBHJXEAYTHCY-UHFFFAOYSA-N
CIQ,CIQ,,BRD:BRD-A35425966-001-02-3;BRD:BRD-BRD-A35425966-001-02-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POTENTIATOR,GRIN2C;GRIN2D,,,PRECLINICAL,,,NA,COC1CCC(OCC2N(CCC3CC(OC)C(OC)CC23)C(=O)C2CCCC(CL)C2)CC1,
CIRAZOLINE,CIRAZOLINE,CHEMBL13852,BRD:BRD-BRD-K54142781-003-11-8;BRD:BRD-K54142781-003-11-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A,,,PRECLINICAL,,Small molecule,-1,"C(OC1CCCCC1C1CC1)C1=NCCN1, C(OC1CCCCC1C1CC1)C1=NCCN1;c1ccc(C2CC2)c(OCC2=NCCN2)c1",YAORIDZYZDUZCM-UHFFFAOYSA-N
"CIS-9,TRANS-11-CONJUGATED-LINOLEIC-ACID","CIS-9,TRANS-11-CONJUGATED-LINOLEIC-ACID",,BRD:BRD-BRD-K80025777-001-01-4;BRD:BRD-K80025777-001-01-4,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,CCCCCC\C=C\C=C/CCCCCCCC(O)=O,
CIS-ACONITIC-ACID,CIS-ACONITIC-ACID,,BRD:BRD-K71756122-001-02-5,rep_single_dose,,ACO2,,,,,,NA,,
CIS-ACPD,CIS-ACPD,,BRD:BRD-BRD-M29936662-001-02-0;BRD:BRD-M29936662-001-02-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM2;GRM3;GRM6;GRM7;GRM8,,,PRECLINICAL,,,NA,N[C@]1(CC[C@@H](C1)C(O)=O)C(O)=O.N[C@@]1(CC[C@H](C1)C(O)=O)C(O)=O,
UROCANIC ACID,(Z)-;CIS-;CIS-UROCANIC ACID;CIS-UROCANIC-ACID;IMIDAZOLE-4-ACRYLIC ACID;NSC-407934;UROCANIC ACID,CHEMBL1316726,BRD:BRD-BRD-K25146005-001-01-0;BRD:BRD-BRD-K52670952-003-01-4;BRD:BRD-K25146005-001-01-0;BRD:BRD-K52670952-003-01-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2A,,,PHASE 2,"Multiple values for SMILES: {'OC(=O)\\C=C/C1C[NH]CN1', 'OC(=O)\\C=C\\C1C[NH]CN1, OC(=O)\\C=C\\C1C[NH]CN1'}, defaulting to 'OC(=O)\\C=C\\C1C[NH]CN1, OC(=O)\\C=C\\C1C[NH]CN1'
Multiple values for structure_id: {'K25146005', 'K52670952'}, defaulting to None",Small molecule,1,"O=C(O)/C=C\c1c[nH]cn1;OC(=O)\C=C\C1C[NH]CN1, OC(=O)\C=C\C1C[NH]CN1",LOIYMIARKYCTBW-UPHRSURJSA-N
R-51619,"ALIMIX;CISAPRIDE;CISAPRIDE MONOHYDRATE;PREPULSID;PREPULSID QUICKLET;PROPULSID;PROPULSID QUICKSOLV;R-51,619;R-51619",CHEMBL1200788;CHEMBL1729,BRD:BRD-A12896037-001-04-3;BRD:BRD-BRD-A12896037-001-04-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2A;HTR3A;HTR4;KCNH2,,,WITHDRAWN,,Small molecule,4,"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC;COC1CN(CCCOC2CCC(F)CC2)CCC1NC(=O)C1CC(CL)C(N)CC1OC, CO[C@H]1CN(CCCOC2CCC(F)CC2)CC[C@H]1NC(=O)C1CC(CL)C(N)CC1OC, CO[C@H]1CN(CCCOC2CCC(F)CC2)CC[C@H]1NC(=O)C1CC(CL)C(N)CC1OC",DCSUBABJRXZOMT-UHFFFAOYSA-N
PLATINOL-AQ,(SP-4-2)-DIAMMINEDICHLOROPLATINUM;CIS-DDP;CIS-DIAMMINEDICHLOROPLATINUM;CIS-DIAMMINEDICHLOROPLATINUM II;CIS-DIAMMINEDICHLOROPLATINUM(II);CIS-PLATIN;CIS-PLATINUM II;CISPLATIN;CISPLATINUM;FAULDISCIPLA;INT-230-6 COMPONENT CISPLATIN;INT230-6 COMPONENT CISPLATIN;LIPLACIS;NSC-119875;PEYRONE'S SALT;PLATINOL;PLATINOL-AQ,CHEMBL11359;CHEMBL2068237,BRD:BRD-BRD-K69172251-001-08-9;BRD:BRD-K69172251-001-08-9;GDSC1:1005;GDSC2:1005,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"DNA ALKYLATING AGENT, DNA SYNTHESIS INHIBITOR",XIAP,"TESTICULAR CARCINOMA, OVARIAN CANCER, BLADDER CANCER",,LAUNCHED,,Small molecule,4,"N[PT](N)(CL)CL, N[PT](N)(CL)CL, N[PT](N)(CL)CL, N[PT](N)(CL)CL",
CITALOPRAM,CELEXA;CITADUR;CITALOPRAM,CHEMBL549,BRD:BRD-A47598013-004-16-0;BRD:BRD-BRD-A47598013-004-16-0,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),ADRA1A;CHRM1;HRH1;SLC6A2;SLC6A3;SLC6A4,DEPRESSION,,LAUNCHED,"Multiple values for repurposing_target: {'ADRA1A;CHRM1;HRH1;SLC6A2;SLC6A3;SLC6A4', 'SLC6A2;SLC6A4'}, taking the union",Small molecule,4,"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21;CN(C)CCCC1(OCC2CC(CCC12)C#N)C1CCC(F)CC1, CN(C)CCCC1(OCC2CC(CCC12)C#N)C1CCC(F)CC1, CN(C)CCCC1(OCC2CC(CCC12)C#N)C1CCC(F)CC1, CN(C)CCCC1(OCC2CC(CCC12)C#N)C1CCC(F)CC1",WSEQXVZVJXJVFP-UHFFFAOYSA-N
HDAC-IN-2,ACY-241;CITARINOSTAT;HDAC-IN-2,CHEMBL3693786,BRD:BRD-K00003202-001-01-9,rep_single_dose,HDAC INHIBITOR,,,,,,Small molecule,1,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO,VLIUIBXPEDFJRF-UHFFFAOYSA-N
CITCO,CITCO,,BRD:BRD-BRD-K53263234-001-05-2;BRD:BRD-K53263234-001-05-2,rep_primary;rep_single_dose,CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) AGONIST,NR1I3,,,PRECLINICAL,,,NA,"CLC1CCC(CC1)-C1NC2SCCN2C1\C=N\OCC1CCC(CL)C(CL)C1, CLC1CCC(CC1)-C1NC2SCCN2C1\C=N\OCC1CCC(CL)C(CL)C1",
NSC-122002,CDP-CHOLIN;CDP-CHOLINE;CERAXON;CITICOLINE;CITICOLINE SODIUM;CITICOLINE SODIUM SALT;CYTIDINE 5'-DIPHOSPHATE CHOLINE;CYTIDINE-5'-DIPHOSPHOCHOLINE;IP 302;IP 302 SODIUM;IP-302;IP-302 SODIUM;NICHOLIN;NSC-122002,CHEMBL1231700;CHEMBL1256994,BRD:BRD-A91728607-236-11-9;BRD:BRD-BRD-A91728607-236-11-9,rep_primary;rep_single_dose,"MEMBRANE PERMEABILITY ENHANCER, GLUTATHIONE TRANSFERASE STIMULANT",ACHE;SLC1A2,"STROKE, ALZHEIMER'S DISEASE, SENILE DEMENTIA, PARKINSON'S DISEASE, ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD), GLAUCOMA",,LAUNCHED,"Multiple values for MOA: {'GLUTATHIONE TRANSFERASE STIMULANT, MEMBRANE PERMEABILITY ENHANCER', 'MEMBRANE PERMEABILITY ENHANCER, GLUTATHIONE TRANSFERASE STIMULANT'}, defaulting to 'MEMBRANE PERMEABILITY ENHANCER, GLUTATHIONE TRANSFERASE STIMULANT'",Small molecule,3,"C[N+](C)(C)CCOP(=O)(O)OP(=O)([O-])OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O;C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(N)NC1=O, C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(N)NC1=O, C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(N)NC1=O",RZZPDXZPRHQOCG-OJAKKHQRSA-N
NSC-22878,CITIOLONE;NSC-22878,CHEMBL2104457,BRD:BRD-A57957888-001-08-0;BRD:BRD-BRD-A57957888-001-08-0,rep_primary;rep_single_dose,"LIPOTROPIC, MUCOLYTIC AGENT",,,,PRECLINICAL,,Small molecule,-1,CC(=O)NC1CCSC1=O,NRFJZTXWLKPZAV-UHFFFAOYSA-N
CJ-033466,CJ-033466,,BRD:BRD-K21306330-001-02-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR4,,,,,,NA,,
CJ-13610,CJ-13610,,BRD:BRD-K00004624-001-01-9,rep_single_dose,LIPOXYGENASE INHIBITOR,,,,,,,NA,,
RX-518,CK-101;OLAFERTINIB;RX-518,CHEMBL4297486,BRD:BRD-K00005246-001-01-9,rep_single_dose,EGFR INHIBITOR,,,,,,Small molecule,1,C=CC(=O)Nc1cccc(-c2cccc3cnc(Nc4ccc(N5CCN(CCO)CC5)c(F)c4F)nc23)c1,IDRGFNPZDVBSSE-UHFFFAOYSA-N
CK-636,CK-636,,BRD:BRD-BRD-K81572616-001-01-9;BRD:BRD-K81572616-001-01-9,rep_primary;rep_single_dose,ACTIN RELATED PROTEIN INHIBITOR,ACTR2;ACTR3;ARPC1B;ARPC2;ARPC3;ARPC4;ARPC5,,,PRECLINICAL,,,NA,"CC1[NH]C2CCCCC2C1CCNC(=O)C1CCCS1, CC1[NH]C2CCCCC2C1CCNC(=O)C1CCCS1",
SB-715992-S,CK-0238273;CK0238273;ISPINESIB;ISPINESIB MESILATE;ISPINESIB MESYLATE;SB-715992;SB-715992-S,CHEMBL228814;CHEMBL2347651,BRD:BRD-BRD-K64881305-001-03-7;BRD:BRD-K64881305-001-01-1;BRD:BRD-K64881305-001-03-7;GDSC1:208,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF KIF11,KIF11,,,PHASE 2,"Multiple values for MOA: {'INHIBITOR OF KIF11', 'KINESIN INHIBITOR'}, defaulting to 'INHIBITOR OF KIF11'",Small molecule,-1,"CC(C)[C@@H](N(CCCN)C(=O)C1CCC(C)CC1)C1NC2CC(CL)CCC2C(=O)N1CC1CCCCC1, CC(C)[C@@H](N(CCCN)C(=O)C1CCC(C)CC1)C1NC2CC(CL)CCC2C(=O)N1CC1CCCCC1, CC(C)[C@@H](N(CCCN)C(=O)C1CCC(C)CC1)C1NC2CC(CL)CCC2C(=O)N1CC1CCCCC1;CS(=O)(=O)O.Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1",MRKSDPIHUJSKRA-HZPIKELBSA-N
CKD-712,CKD-712,,BRD:BRD-A26458246-004-02-1;BRD:BRD-BRD-A26458246-004-02-1,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,JAK2;STAT1,,,PHASE 1,,,NA,"OC1CC2CCNC(CC3CCCC4CCCCC34)C2CC1O, OC1CC2CCNC(CC3CCCC4CCCCC34)C2CC1O",
CKI-7,CKI-7,,BRD:BRD-K34303607-300-01-4,rep_single_dose,CASEIN KINASE INHIBITOR,CSNK1G2,,,,,,NA,,
CL-218872,CL-218872,,BRD:BRD-BRD-K00662280-001-09-4;BRD:BRD-K00662280-001-09-4,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2,,,PHASE 1,,,NA,"CC1NNC2CCC(NN12)-C1CCCC(C1)C(F)(F)F, CC1NNC2CCC(NN12)-C1CCCC(C1)C(F)(F)F",
CL-225385,CL-225385,,BRD:BRD-BRD-K87573013-001-01-0;BRD:BRD-K87573013-001-01-0,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,O=C(CC#N)C1CCCCC1,
CL316243,CL316243,,BRD:BRD-BRD-K06467130-304-02-7;BRD:BRD-K06467130-304-02-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB3;UCP1;UCP2;UCP3,,,PHASE 2,,,NA,C[C@H](CC1CCC2OC(OC2C1)(C(O)=O)C(O)=O)NC[C@H](O)C1CCCC(CL)C1,
RWJ-26251,2-CDA;CLADARIBINE;CLADRIBINE;LEUSTAT;LEUSTATIN;LITAK;MAVENCLAD;NSC-05014;NSC-105014;NSC-105014-F;RWJ 26251;RWJ-26251,CHEMBL1619,BRD:BRD-BRD-K93034159-001-25-8;BRD:BRD-K93034159-001-25-8,rep_multi_dose;rep_primary;rep_single_dose,"ADENOSINE DEAMINASE INHIBITOR, RIBONUCLEOTIDE REDUCTASE INHIBITOR",ADA;PNP;POLA1;POLE;POLE2;POLE3;POLE4;RRM1;RRM2;RRM2B,HAIRY CELL LEUKEMIA,,LAUNCHED,,Small molecule,4,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1;NC1NC(CL)NC2N(CNC12)[C@H]1C[C@H](O)[C@@H](CO)O1,PTOAARAWEBMLNO-KVQBGUIXSA-N
HMR-1883,CLAMIKALANT;HMR-1883,CHEMBL12531,BRD:BRD-K00004576-001-01-9,rep_single_dose,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,,,,,,Small molecule,-1,CNC(=S)NS(=O)(=O)c1cc(CCNC(=O)c2cc(Cl)ccc2OC)ccc1OC,VXTKXGKPBOLHRY-UHFFFAOYSA-N
CLANFENUR,CLANFENUR,CHEMBL1876799,BRD:BRD-K62378877-001-05-9,rep_single_dose,ANTICANCER AGENT,,,,,,Small molecule,-1,CN(C)c1cccc(F)c1C(=O)NC(=O)Nc1ccc(Cl)cc1,SRLPZQAEBMZCIJ-UHFFFAOYSA-N
ZECLAR,6-O-METHYL-;6-O-METHYLERYTHROMYCIN;A-56268;ABBOTT-56268;BIAXIN;BIAXIN XL;BIAXIN XL PAC;CLARIE XL;CLARITHROMYCIN;CLARITHROMYCIN EXTENDED RELEASE;CLARITHROMYCIN IDENTITY;CLAROSIP;CYLLIND;ERYTHROMYCIN;FEBZIN XL;KLACID;KLARICID;KLARICID 500;KLARICID ADULT;KLARICID I.V.;KLARICID PAED;KLARICID XL;MACLADIN;MAVID;MYCIFOR XL;NSC-758704;PREVPAC;TE-031;VECLAM;XETININ XL;ZECLAR,CHEMBL1741,BRD:BRD-BRD-K49668410-001-18-8;BRD:BRD-K49668410-001-18-8,rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,CYP3A4,"PHARYNGITIS, TONSILLITIS, SINUSITIS, BRONCHITIS, PNEUMONIA, SKIN INFECTIONS, OTITIS",,LAUNCHED,,Small molecule,4,"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC;CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O",AGOYDEPGAOXOCK-KCBOHYOISA-N
MOTILEX,AMICOS;CLANZOFLAT;CLANZOL;CLAST;CLEBOPRIDE;CLEBOPRIDE HYDROGEN MALATE;CLEBOPRIDE MALATE;CLEBORIL;CLEPRID;LAS 9273;LAS-9273;MOTILEX,CHEMBL325109,BRD:BRD-BRD-K17294426-050-12-3;BRD:BRD-K17294426-050-12-3,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ACHE;DRD2,NAUSEA,,LAUNCHED,,Small molecule,4,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1;COC1CC(N)C(CL)CC1C(=O)NC1CCN(CC2CCCCC2)CC1,BVPWJMCABCPUQY-UHFFFAOYSA-N
NSC-756685,CLEMASTIN;CLEMASTINE;HS-592;NSC-756685,CHEMBL1626,BRD:BRD-BRD-K30240666-051-15-9;BRD:BRD-K30240666-051-15-9,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,4,"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1;CN1CCC[C@@H]1CCO[C@](C)(C1CCCCC1)C1CCC(CL)CC1, CN1CCC[C@@H]1CCO[C@](C)(C1CCCCC1)C1CCC(CL)CC1, CN1CCC[C@@H]1CCO[C@](C)(C1CCCCC1)C1CCC(CL)CC1, CN1CCC[C@@H]1CCO[C@](C)(C1CCCCC1)C1CCC(CL)CC1",YNNUSGIPVFPVBX-NHCUHLMSSA-N
NSC-46261,AL 20 [AS HYDROCHLORIDE];AL-20 FREE BASE;CLEMIZOLE;CLEMIZOLE HYDROCHLORIDE;NSC-46261,CHEMBL1407943,BRD:BRD-BRD-K04704168-003-14-3;BRD:BRD-K04704168-003-14-3,rep_primary;rep_single_dose,HCV INHIBITOR,,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,2,"CLC1CCC(CN2C(CN3CCCC3)NC3CCCCC23)CC1, CLC1CCC(CN2C(CN3CCCC3)NC3CCCCC23)CC1;Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1",CJXAEXPPLWQRFR-UHFFFAOYSA-N
SPIROPENT MITE,CLENBUTEROL;CLENBUTEROL HYDROCHLORIDE;CONTRASPASMIN;NAB 365;NSC-758633;PLANIPART;SPIROPENT;SPIROPENT MITE,CHEMBL49080,BRD:BRD-A75726477-003-21-3;BRD:BRD-BRD-A75726477-003-21-3,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2;ADRB3;NGF;TNF,"CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), ASTHMA",,LAUNCHED,,Small molecule,4,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1;CC(C)(C)NCC(O)C1CC(CL)C(N)C(CL)C1,STJMRWALKKWQGH-UHFFFAOYSA-N
CLEVIPREX,CLEVIDEPINE;CLEVIDEPINE BUTYRATE;CLEVIDIPINE;CLEVIDIPINE BUTYRATE;CLEVIPREX,CHEMBL1237132,BRD:BRD-A01563671-001-02-7;BRD:BRD-BRD-A01563671-001-02-7,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1D;CACNA1F;CACNA1S,HYPERTENSION,,LAUNCHED,,Small molecule,4,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl;CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(CL)C1CL)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N
LEVOVIR,CLEVUDINE;L-FMAU;LEVOVIR,CHEMBL458875,BRD:BRD-BRD-K18948558-001-01-9;BRD:BRD-K18948558-001-01-9,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,HEPATITIS B,,LAUNCHED,,Small molecule,3,CC1CN([C@H]2O[C@@H](CO)[C@H](O)[C@@H]2F)C(=O)[NH]C1=O;Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)c(=O)[nH]c1=O,GBBJCSTXCAQSSJ-XQXXSGGOSA-N
CLIDINIUM ION,CLIDINIUM;CLIDINIUM CATION;CLIDINIUM ION,CHEMBL620,BRD:BRD-A46066006-004-22-6;BRD:BRD-BRD-A46066006-004-22-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM3,"PEPTIC ULCER DISEASE (PUD), IRRITABLE BOWEL SYNDROME, ENTEROCOLITIS",,LAUNCHED,,Small molecule,4,C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(C1CCCCC1)C1CCCCC1;C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,HOOSGZJRQIVJSZ-UHFFFAOYSA-N
NSC-759808,BAY-E 6975;BAYPIVAL;CLIMBAZOLE;CRINIPAN AD;NSC-759808,CHEMBL1437764,BRD:BRD-A61676498-001-06-6;BRD:BRD-BRD-A61676498-001-06-6,rep_primary;rep_single_dose,ENZYME INDUCER,,"DANDRUFF, ECZEMA",,LAUNCHED,,Small molecule,-1,"CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1;CC(C)(C)C(=O)C(OC1CCC(CL)CC1)N1CCNC1, CC(C)(C)C(=O)C(OC1CCC(CL)CC1)N1CCNC1",OWEGWHBOCFMBLP-UHFFFAOYSA-N
CLINAFLOXACIN,CLINAFLOXACIN,CHEMBL278255,BRD:BRD-A93964801-003-03-3;BRD:BRD-BRD-A93964801-003-03-3,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,,,PHASE 3,,Small molecule,-1,"NC1CCN(C1)C1C(F)CC2C(C1CL)N(CC(C(O)=O)C2=O)C1CC1, NC1CCN(C1)C1C(F)CC2C(C1CL)N(CC(C(O)=O)C2=O)C1CC1, NC1CCN(C1)C1C(F)CC2C(C1CL)N(CC(C(O)=O)C2=O)C1CC1, NC1CCN(C1)C1C(F)CC2C(C1CL)N(CC(C(O)=O)C2=O)C1CC1;NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1",QGPKADBNRMWEQR-UHFFFAOYSA-N
U-21251,"7(S)-CHLORO-7-DEOXYLINCOMYCIN;ANTIROBE;CHLORODEOXYLINCOMYCIN;CHLOROLINCOMYCIN;CLEOCIN;CLEOCIN T;CLINDAMYCIN;SOBELIN;U-21,251;U-21251",CHEMBL1753,BRD:BRD-BRD-K23586533-001-03-6;BRD:BRD-K23586533-001-03-6,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,"RESPIRATORY TRACT INFECTIONS, PNEUMONIA, SKIN INFECTIONS, GYNECOLOGIC INFECTIONS, INTRA-ABDOMINAL INFECTIONS, BACTERIAL SEPTICEMIA, BONE AND JOINT INFECTIONS",,LAUNCHED,,Small molecule,4,"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1;CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)CL)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O, CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)CL)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O, CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)CL)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O",KDLRVYVGXIQJDK-AWPVFWJPSA-N
CLINDAMYCIN-PALMITATE,CLINDAMYCIN-PALMITATE,,BRD:BRD-A76672327-003-02-0;BRD:BRD-BRD-A76672327-003-02-0,rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,"INTRA-ABDOMINAL INFECTIONS, SKIN INFECTIONS, PNEUMONIA, PERITONITIS, GYNECOLOGIC INFECTIONS",,LAUNCHED,,,NA,CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C1CC(CCC)CN1C)C(C)CL,
CLINDAMYCIN-PHOSPHATE,CLINDAMYCIN-PHOSPHATE,,BRD:BRD-BRD-K27771035-001-02-5;BRD:BRD-K27771035-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,BACTERIAL VAGINOSIS,,LAUNCHED,,,NA,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)CL)[C@H]1O[C@H](SC)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]1O,
LIPOCLIN,CLINOFIBRATE;LIPOCLIN,CHEMBL1897738,BRD:BRD-A90625545-001-02-0;BRD:BRD-BRD-A90625545-001-02-0,rep_primary;rep_single_dose,LIPASE CLEARING FACTOR INHIBITOR,LPL,HYPERTRIGLYCERIDEMIA,,LAUNCHED,,Small molecule,-1,CCC(C)(Oc1ccc(C2(c3ccc(OC(C)(CC)C(=O)O)cc3)CCCCC2)cc1)C(=O)O;CCC(C)(OC1CCC(CC1)C1(CCCCC1)C1CCC(OC(C)(CC)C(O)=O)CC1)C(O)=O,BMOVQUBVGICXQN-UHFFFAOYSA-N
VIOFORM,4-STEARYLAMINO-PHENYL-TRIMETHYLAM. METILSULF.;CLIOQUINOL;DOMEFORM-HC;IODOCHLORHYDROXYQUIN;IODOCHLORHYDROXYQUINOLONE;NSC-3531;NSC-74938;ORALCER;QUIN-O-CREME;VIOFORM,CHEMBL497,BRD:BRD-BRD-K09255212-001-16-6;BRD:BRD-K09255212-001-16-6,rep_primary;rep_single_dose,CHELATING AGENT,OPRK1,,,WITHDRAWN,,Small molecule,4,Oc1c(I)cc(Cl)c2cccnc12;OC1C(I)CC(CL)C2CCCNC12,QCDFBFJGMNKBDO-UHFFFAOYSA-N
URBANYL,CLOBAZAM;COLBAZAM;FRISIUM;H 4723;H-4723;HR 376;HR-376;LM 2717;LM-2717;MYSTAN;NSC-336279;ONFI;PERIZAM;SYMPAZAN;TAPCLOB;URBADAN;URBANYL,CHEMBL70418,BRD:BRD-BRD-K52408781-001-02-8;BRD:BRD-K52408781-001-02-8,rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ,SEIZURES,,LAUNCHED,,Small molecule,4,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21;CN1C2CCC(CL)CC2N(C2CCCCC2)C(=O)CC1=O,CXOXHMZGEKVPMT-UHFFFAOYSA-N
CLOBENPROPIT,CLOBENPROPIT,CHEMBL14690,BRD:BRD-BRD-K71430621-303-02-3;BRD:BRD-K71430621-303-02-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1;HRH2;HRH3;HRH4,,,PRECLINICAL,,Small molecule,NA,CLC1CCC(CNC(=N)SCCCC2C[NH]CN2)CC1;N=C(NCc1ccc(Cl)cc1)SCCCc1c[nH]cn1,UCAIEVHKDLMIFL-UHFFFAOYSA-N
CLOBETASOL-PROPIONATE,CLOBETASOL-PROPIONATE,,BRD:BRD-BRD-K10799896-001-26-2;BRD:BRD-K10799896-001-26-2,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;PLA2G1B,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,"CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCL, CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCL, CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCL",
CLOBETASONE-BUTYRATE,CLOBETASONE-BUTYRATE,,BRD:BRD-BRD-K58810291-001-16-2;BRD:BRD-K58810291-001-16-2,rep_primary;rep_single_dose,CORTICOSTEROID AGONIST,NR3C1,"ECZEMA, PSORIASIS, DERMATITIS",,LAUNCHED,,,NA,CCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]12C)C(=O)CCL,
R05DB03,CLOBUTINOL;CLOBUTINOL HYDROCHLORIDE;IVERSAL;KAT 256 [AS HYDROCHLORIDE];R05DB03,CHEMBL1474889,BRD:BRD-A43809092-003-02-1;BRD:BRD-BRD-A43809092-003-02-1,rep_multi_dose;rep_primary;rep_single_dose,ANTITUSSIVE,,,,WITHDRAWN,,Small molecule,4,CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1;CC(CN(C)C)C(C)(O)CC1CCC(CL)CC1,KVHHQGIIZCJATJ-UHFFFAOYSA-N
CLOCORTOLONE-PIVALATE,CLOCORTOLONE-PIVALATE,,BRD:BRD-BRD-K38003476-001-09-1;BRD:BRD-K38003476-001-09-1,rep_multi_dose;rep_primary;rep_single_dose,STEROID,NR3C1;PLA2G1B,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,
CLODRONIC-ACID,CLODRONIC-ACID,,BRD:BRD-BRD-K72542090-304-02-4;BRD:BRD-K72542090-304-02-4,rep_primary;rep_single_dose,BONE RESORPTION INHIBITOR,SLC25A4;SLC25A5;SLC25A6,"OSTEOPOROSIS, HYPERPARATHYROIDISM, HYPERCALCEMIA, MULTIPLE MYELOMA",,LAUNCHED,,,NA,"OP(O)(=O)C(CL)(CL)P(O)(O)=O, OP(O)(=O)C(CL)(CL)P(O)(O)=O",
NSC-759857,CLOFARABINE;CLOLAR;EVOLTRA;NSC-759857,CHEMBL1750,BRD:BRD-BRD-K34022604-001-06-6;BRD:BRD-K34022604-001-06-6;CTRP:660288,ctrp;rep_multi_dose;rep_primary;rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,POLA1;POLD1;POLE;RRM1;RRM2;RRM2B,ACUTE LYMPHOBLASTIC LEUKEMIA (ALL),,LAUNCHED,,Small molecule,4,"Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F;NC1NC(CL)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F, NC1NC(CL)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F, NC1NC(CL)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F",WDDPHFBMKLOVOX-AYQXTPAHSA-N
NSC-141046,CHLOFAZIMINE;CLOFAZIMINE;CLOFAZIMINUM;COLFAZIMINE;G 30320;G-30320;LAMPRENE;NSC-141046,CHEMBL1292,BRD:BRD-BRD-K56614220-001-19-0;BRD:BRD-K56614220-001-19-0,rep_multi_dose;rep_primary;rep_single_dose,GK0582 INHIBITOR,,LEPROSY,,LAUNCHED,,Small molecule,4,"CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1;CC(C)\N=C1/CC2N(-C3CCC(CL)CC3)C3CCCCC3NC2CC1NC1CCC(CL)CC1, CC(C)\N=C1/CC2N(-C3CCC(CL)CC3)C3CCCCC3NC2CC1NC1CCC(CL)CC1, CC(C)\N=C1/CC2N(-C3CCC(CL)CC3)C3CCCCC3NC2CC1NC1CCC(CL)CC1",WDQPAMHFFCXSNU-BGABXYSRSA-N
TUSSISTOP,ANTITUSSIN;CHLOPHEDIANOL;CLOFEDANOL;NSC-113595;TUSSISTOP,CHEMBL1201313,BRD:BRD-A15687940-001-05-6;BRD:BRD-BRD-A15687940-001-05-6,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,4,CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl;CN(C)CCC(O)(C1CCCCC1)C1CCCCC1CL,WRCHFMBCVFFYEQ-UHFFFAOYSA-N
NSC-79389,ATROMID;ATROMID-S;AY-61123;CHLORFENISATE;CLOFIBRATE;ETHYL P-CHLOROPHENOXYISOBUTYRATE;ICI 28257;ICI-28257;NSC-79389,CHEMBL565,BRD:BRD-BRD-K45252063-001-13-6;BRD:BRD-K45252063-001-13-6,rep_multi_dose;rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,LPL;PPARA,"HYPERLIPIDEMIA, CHOLESTEROL",,LAUNCHED,,Small molecule,4,"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1;CCOC(=O)C(C)(C)OC1CCC(CL)CC1, CCOC(=O)C(C)(C)OC1CCC(CL)CC1, CCOC(=O)C(C)(C)OC1CCC(CL)CC1",KNHUKKLJHYUCFP-UHFFFAOYSA-N
CLOFIBRIC-ACID,CLOFIBRIC-ACID,,BRD:BRD-BRD-K19111024-001-20-9;BRD:BRD-K19111024-001-20-9,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA,,,LAUNCHED,,,NA,"CC(C)(OC1CCC(CL)CC1)C(O)=O, CC(C)(OC1CCC(CL)CC1)C(O)=O, CC(C)(OC1CCC(CL)CC1)C(O)=O",
OCTOFENE,CLOFOCTOL;NSC-758389;OCTOFENE,CHEMBL1476605,BRD:BRD-BRD-K02900412-001-11-3;BRD:BRD-K02900412-001-11-3,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,GRAM-POSITIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,-1,"CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1;CC(C)(C)CC(C)(C)C1CCC(O)C(CC2CCC(CL)CC2CL)C1, CC(C)(C)CC(C)(C)C1CCC(O)C(CC2CCC(CL)CC2CL)C1",HQVZOORKDNCGCK-UHFFFAOYSA-N
SCTZ [AS EDISYLATE],CHLORMETHIAZOLE;CLOMETHIAZOLE;DISTRANEURINE;HEMINEVRIN;SCTZ [AS EDISYLATE],CHEMBL315795,BRD:BRD-BRD-K50422030-001-05-3;BRD:BRD-K50422030-001-05-3,rep_primary;rep_single_dose,"GABA RECEPTOR ANTAGONIST, GABA RECEPTOR MODULATOR",GABRA1,"PARKINSON'S DISEASE, SEDATIVE, MUSCLE RELAXANT",,LAUNCHED,,Small molecule,4,"Cc1ncsc1CCCl;CC1NCSC1CCCL, CC1NCSC1CCCL",PCLITLDOTJTVDJ-UHFFFAOYSA-N
CLOMIPHENE,CLOMIFENE;CLOMIPHENE,CHEMBL2355051,BRD:BRD-BRD-K29950728-048-17-4;BRD:BRD-K29950728-048-17-4,rep_multi_dose;rep_primary;rep_single_dose,ESTROGEN RECEPTOR ANTAGONIST,ESR1,INFERTILITY,,LAUNCHED,,Small molecule,4,"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1;CCN(CC)CCOC1CCC(CC1)C(=C(/CL)C1CCCCC1)\C1CCCCC1, CCN(CC)CCOC1CCC(CC1)C(=C(/CL)C1CCCCC1)\C1CCCCC1, CCN(CC)CCOC1CCC(CC1)C(=C(/CL)C1CCCCC1)\C1CCCCC1",GKIRPKYJQBWNGO-UHFFFAOYSA-N
NSC-169865,3-CHLORO-IMINODIBENZYL;ANAFRANIL;ANAPRAMINE;CHLORIMIPRAMINE;CLOMICALM;CLOMIPRAMINE;NSC-169865,CHEMBL415,BRD:BRD-BRD-K52989797-003-26-4;BRD:BRD-K52989797-003-26-4,rep_primary;rep_single_dose,SEROTONIN TRANSPORTER (SERT) INHIBITOR,GSTP1;HTR2A;HTR2B;HTR2C;SLC6A2;SLC6A3;SLC6A4,OBSESSIVE COMPULSIVE DISORDER (OCD),,LAUNCHED,,Small molecule,4,"CN(C)CCCN1C2CCCCC2CCC2CCC(CL)CC12, CN(C)CCCN1C2CCCCC2CCC2CCC(CL)CC12, CN(C)CCCN1C2CCCCC2CCC2CCC(CL)CC12;CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21",GDLIGKIOYRNHDA-UHFFFAOYSA-N
RO-54023,CLONAZEPAM;CLONAZEPAM CIV;KLONOPIN;KLONOPIN RAPIDLY DISINTEGRATING;NSC-179913;RAVOTRIL;RIVATRIL;RIVOTRIL;RO 5-4023;RO-5-4023;RO-54023,CHEMBL452,BRD:BRD-BRD-K38183498-001-02-0;BRD:BRD-K38183498-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;TSPO,"SEIZURES, PANIC DISORDERS",,LAUNCHED,,Small molecule,4,[O-][N+](=O)C1CCC2NC(=O)CN=C(C3CCCCC3CL)C2C1;O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,DGBIGWXXNGSACT-UHFFFAOYSA-N
ST-155BS,CATAPRES;CATAPRES-TTS-1;CATAPRES-TTS-2;CATAPRES-TTS-3;CATARPRES-TTS;CLONIDINE;CLONIDINE EXTENDED RELEASE;CLORPRES;COMBIPRES;DURACLON;NEXICLON XR;ST-155-BS;ST-155BS,CHEMBL134,BRD:BRD-BRD-K98530306-003-18-3;BRD:BRD-K98530306-003-18-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C,"HYPERTENSION, ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)",,LAUNCHED,,Small molecule,4,"CLC1CCCC(CL)C1N=C1NCCN1, CLC1CCCC(CL)C1N=C1NCCN1, CLC1CCCC(CL)C1N=C1NCCN1;Clc1cccc(Cl)c1NC1=NCCN1",GJSURZIOUXUGAL-UHFFFAOYSA-N
SCH-10304,CLONIXIN;NSC-335505;SCH 10304;SCH-10304,CHEMBL1332971,BRD:BRD-K18399440-001-11-9,rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,,,Small molecule,-1,Cc1c(Cl)cccc1Nc1ncccc1C(=O)O,CLOMYZFHNHFSIQ-UHFFFAOYSA-N
CLONIXIN-LYSINATE,CLONIXIN-LYSINATE,,BRD:BRD-BRD-M63173034-001-03-6;BRD:BRD-M63173034-001-03-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,PAIN RELIEF,,LAUNCHED,,,NA,"NCCCC[C@H](N)C(O)=O.CC1C(CL)CCCC1NC1NCCCC1C(O)=O, NCCCC[C@H](N)C(O)=O.CC1C(CL)CCCC1NC1NCCCC1C(O)=O",
DT-327,AQUEX;CHLOSUDIMEPRIMYLUM;CLOPAMIDE;DT-327,CHEMBL1361347,BRD:BRD-A85651701-001-19-7;BRD:BRD-BRD-A85651701-001-19-7,rep_multi_dose;rep_primary;rep_single_dose,SODIUM/CHLORIDE COTRANSPORTER INHIBITOR,,HYPERTENSION,,LAUNCHED,,Small molecule,-1,CC1CCCC(C)N1NC(=O)C1CCC(CL)C(C1)S(N)(=O)=O;CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,LBXHRAWDUMTPSE-UHFFFAOYSA-N
NSC-758635,CLOPERASTINE;CLOPERASTINE FENDIZOATE;CLOPERASTINE HYDROCHLORIDE;HT-11;NSC-758635,CHEMBL415087,BRD:BRD-A80908310-003-13-8;BRD:BRD-BRD-A80908310-003-13-8,rep_primary;rep_single_dose,ANTITUSSIVE,,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,-1,Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1;CLC1CCC(CC1)C(OCCN1CCCCC1)C1CCCCC1,FLNXBVJLPJNOSI-UHFFFAOYSA-N
CLOPERASTINE-FENDIZOATE,CLOPERASTINE-FENDIZOATE,,BRD:BRD-K00003529-458-01-9,rep_single_dose,POTASSIUM CHANNEL ANTAGONIST,,,,,,,NA,,
ZYLLT,CLOPIDOGREL;CLOPIDOGREL 1A-PHARMA;CLOPIDOGREL ACINO;CLOPIDOGREL APOTEX;CLOPIDOGREL BENZENESULFONATE;CLOPIDOGREL BESILATE;CLOPIDOGREL BESYLATE;CLOPIDOGREL HEXAL;CLOPIDOGREL SANDOZ;CLOPIDOGREL-RATIOPHARM;GREPID;ISCOVER;NSC-758613;PLAVIX;R 130964;R-130964;SR 25990;SR-25990;ZYLLT,CHEMBL1771,BRD:BRD-BRD-K27721098-065-08-6;BRD:BRD-K27721098-065-08-6,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RY12,"MYOCARDIAL INFARCTION, STROKE, PERIPHERAL ARTERY DISEASE (PAD), ACUTE CORONARY SYNDROME (ACS)",,LAUNCHED,,Small molecule,4,"COC(=O)[C@@H](N1CCC2SCCC2C1)C1CCCCC1CL, COC(=O)[C@@H](N1CCC2SCCC2C1)C1CCCCC1CL, COC(=O)[C@@H](N1CCC2SCCC2C1)C1CCCCC1CL;COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1",GKTWGGQPFAXNFI-HNNXBMFYSA-N
NSC-253479,CLOPIDOL;NSC-253479,CHEMBL446918,BRD:BRD-BRD-K80036624-001-04-0;BRD:BRD-K80036624-001-04-0,rep_primary;rep_single_dose,,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,Cc1nc(C)c(Cl)c(O)c1Cl;CC1NC(C)C(CL)C(O)C1CL,ZDPIZLCVJAAHHR-UHFFFAOYSA-N
CLOPROSTENOL-(+/-),CLOPROSTENOL-(+/-),,BRD:BRD-BRD-K17850764-236-11-9;BRD:BRD-K17850764-236-11-9,rep_primary;rep_single_dose,PROSTAGLANDIN RECEPTOR AGONIST,PTGDR;PTGER1;PTGER3;PTGFR;TBXA2R,,,LAUNCHED,,,NA,O[C@@H](COC1CCCC(CL)C1)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,
TOBANUM,CHLORANOLOL;CLORANOLOL;TOBANUM,CHEMBL156791,BRD:BRD-A04971881-003-01-3;BRD:BRD-BRD-A04971881-003-01-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3,,,LAUNCHED,,Small molecule,-1,CC(C)(C)NCC(O)COc1cc(Cl)ccc1Cl;CC(C)(C)NCC(O)COC1CC(CL)CCC1CL,XYCMOTOFHFTUIU-UHFFFAOYSA-N
M&B 9302,CLORGILINE;CLORGYLINE;M&B 9302,CHEMBL8706,BRD:BRD-BRD-K73251053-003-22-2;BRD:BRD-K73251053-003-22-2,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA,,,PHASE 2,,Small molecule,-1,"C#CCN(C)CCCOc1ccc(Cl)cc1Cl;CN(CCCOC1CCC(CL)CC1CL)CC#C, CN(CCCOC1CCC(CL)CC1CL)CC#C",BTFHLQRNAMSNLC-UHFFFAOYSA-N
OCTOCLOTHEPINE,CLOROTEPINE;CLOTHEPIN;OCTOCLOTHEPINE,CHEMBL64249,BRD:BRD-A19053834-050-09-5;BRD:BRD-BRD-A19053834-050-09-5,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA1D;DRD2;HRH1;HTR2C;HTR6,PSYCHOSIS,,LAUNCHED,"Multiple values for MOA: {'ADRENERGIC RECEPTOR ANTAGONIST, DOPAMINE RECEPTOR ANTAGONIST', 'DOPAMINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR ANTAGONIST'}, defaulting to 'DOPAMINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR ANTAGONIST'",Small molecule,-1,CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1;CN1CCN(CC1)C1CC2CCCCC2SC2CCC(CL)CC12,XRYLGRGAWQSVQW-UHFFFAOYSA-N
CLORPRENALINE,CLORPRENALINE,CHEMBL1902627,BRD:BRD-A29281099-003-03-2;BRD:BRD-BRD-A29281099-003-03-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2,ASTHMA,,LAUNCHED,,Small molecule,-1,CC(C)NCC(O)c1ccccc1Cl;CC(C)NCC(O)C1CCCCC1CL,SSMSBSWKLKKXGG-UHFFFAOYSA-N
NSC-758901,CLORSULON;CLORSURON;CURATREM;MK-401;NSC-758901,CHEMBL1474129,BRD:BRD-BRD-K97521363-001-16-1;BRD:BRD-K97521363-001-16-1,rep_primary;rep_single_dose,GLYCOLYSIS INHIBITOR,,"GASTROINTESTINAL ROUNDWORMS, LUNGWORMS, LIVER FLUKES, LICE, MITES",,LAUNCHED,,Small molecule,-1,"NC1CC(C(CL)=C(CL)CL)C(CC1S(N)(=O)=O)S(N)(=O)=O, NC1CC(C(CL)=C(CL)CL)C(CC1S(N)(=O)=O)S(N)(=O)=O;Nc1cc(C(Cl)=C(Cl)Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O",QOVTVIYTBRHADL-UHFFFAOYSA-N
R-31520,"CLOSANTEL;NSC-335306;R 31,520;R-31520",CHEMBL12131,BRD:BRD-A19952358-001-11-3;BRD:BRD-BRD-A19952358-001-11-3,rep_primary;rep_single_dose,"CHITINASE INHIBITOR, NFKB PATHWAY INHIBITOR",,LIVER FLUKES,,LAUNCHED,,Small molecule,-1,"Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O;CC1CC(C(C#N)C2CCC(CL)CC2)C(CL)CC1NC(=O)C1CC(I)CC(I)C1O, CC1CC(C(C#N)C2CCC(CL)CC2)C(CL)CC1NC(=O)C1CC(I)CC(I)C1O, CC1CC(C(C#N)C2CCC(CL)CC2)C(CL)CC1NC(=O)C1CC(I)CC(I)C1O, CC1CC(C(C#N)C2CCC(CL)CC2)C(CL)CC1NC(=O)C1CC(I)CC(I)C1O",JMPFSEBWVLAJKM-UHFFFAOYSA-N
HF-2159,CLOTHIAPINE;CLOTIAPINE;ENTUMIN;HF-2159,CHEMBL304902,BRD:BRD-BRD-K10990317-001-04-5;BRD:BRD-K10990317-001-04-5,rep_primary;rep_single_dose,,,PSYCHOSIS,,LAUNCHED,,Small molecule,4,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1;CN1CCN(CC1)C1=NC2CCCCC2SC2CCC(CL)CC12,KAAZGXDPUNNEFN-UHFFFAOYSA-N
TRIVAGIZOLE 3,ABTRIM;ACTAVALL;BAY 5097;BAY-5097;CANDIDEN;CANESTEN;CANESTEN AF;CANESTEN CRM COMBI;CANESTEN INTERNAL;CANESTEN VC;CLOTRIMAZOLE;FUNGEDERM;GNF-PF-3499;GYNE-LOTRIMIN;GYNE-LOTRIMIN 3;GYNE-LOTRIMIN 3 COMBINATION PACK;GYNE-LOTRIMIN COMBINATION PACK;GYNIX;LOTRIMIN;MASNODERM;MYCELEX;MYCELEX-7;MYCELEX-7 COMBINATION PACK;MYCELEX-G;MYCIL GOLD;NSC-257473;PRIVACOM;SVT-15652;TRIMYSTEN;TRIVAGIZOLE;TRIVAGIZOLE 3,CHEMBL104,BRD:BRD-BRD-K15916496-001-27-9;BRD:BRD-K15916496-001-27-9,rep_multi_dose;rep_primary;rep_single_dose,"CYTOCHROME P450 INHIBITOR, IMIDAZOLINE RECEPTOR LIGAND",CYP3A4;KCNN4;NR1I2;NR1I3;TRPM2;TRPM4;TRPM8,"VULVOVAGINAL CANDIDIASIS, OROPHARYNGEAL CANDIDIASIS",,LAUNCHED,,Small molecule,4,"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1;CLC1CCCCC1C(C1CCCCC1)(C1CCCCC1)N1CCNC1, CLC1CCCCC1C(C1CCCCC1)(C1CCCCC1)N1CCNC1, CLC1CCCCC1C(C1CCCCC1)(C1CCCCC1)N1CCNC1",VNFPBHJOKIVQEB-UHFFFAOYSA-N
TEGOPEN,CLOXACILLIN;CLOXAPEN;ORBENIN;TEGOPEN,CHEMBL891,BRD:BRD-BRD-K01244426-236-12-1;BRD:BRD-K01244426-236-12-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-POSITIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O;CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1CCCCC1CL, CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1CCCCC1CL, CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1CCCCC1CL",LQOLIRLGBULYKD-JKIFEVAISA-N
NSC-35083,CLOXIQUINE;CLOXYQUIN;NSC-35083,CHEMBL225164,BRD:BRD-BRD-K46982791-001-09-4;BRD:BRD-K46982791-001-09-4,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNK18,,,PRECLINICAL,,Small molecule,-1,Oc1ccc(Cl)c2cccnc12;OC1CCC(CL)C2CCCNC12,CTQMJYWDVABFRZ-UHFFFAOYSA-N
ZAPONEX,CLOZAPINE;CLOZAPINE (CARACO);CLOZAPINE (CLOZARIL);CLOZAPINE (FAZACLO);CLOZAPINE (IVAX);CLOZAPINE (MYLAN);CLOZAPINE (TEVA);CLOZAPINE (UDL);CLOZAPINE (VERSACLOZ);CLOZAPINE RESOLUTION MIXTURE;CLOZARIL;FAZACLO;FAZACLO ODT;HF 1854;HF-1854;LEPONEX;NSC-757429;VERSACLOZ;ZAPONEX,CHEMBL42,BRD:BRD-BRD-K37289225-001-36-4;BRD:BRD-K37289225-001-36-4,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;CALY;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HRH4;HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR3A;HTR5A;HTR6;HTR7,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1;CN1CCN(CC1)C1=NC2CC(CL)CCC2NC2CCCCC12, CN1CCN(CC1)C1=NC2CC(CL)CCC2NC2CCCCC12, CN1CCN(CC1)C1=NC2CC(CL)CCC2NC2CCCCC12, CN1CCN(CC1)C1=NC2CC(CL)CCC2NC2CCCCC12",QZUDBNBUXVUHMW-UHFFFAOYSA-N
ZEGOCRACTIN,CM 4620;CM-4620;CM4620;ZEGOCRACTIN,CHEMBL4753998,BRD:BRD-K00003438-001-01-9,rep_single_dose,CALCIUM RELEASE ACTIVATED CHANNEL MODULATOR,,,,,,Small molecule,1,Cc1cccc(F)c1C(=O)Nc1cnc(-c2cc3c(cc2Cl)OC(F)(F)O3)cn1,QQMKTHUGOQDEIL-UHFFFAOYSA-N
CMP 5,CMP 5,,BRD:BRD-K00126471-001-01-9,oncref_2,PUTATIVE INHIBITOR OF PRMT5,PRMT5,,,,,,NA,,
CMPD-1,CMPD-1,,BRD:BRD-BRD-K54095730-001-03-1;BRD:BRD-K54095730-001-03-1,rep_multi_dose;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,GNRHR;MAPK14,,,PRECLINICAL,,,NA,"OC1CCC(NC(=O)CCCC2CCC(CC2)-C2CCCCC2F)CC1, OC1CCC(NC(=O)CCCC2CCC(CC2)-C2CCCCC2F)CC1",
CNQX,CNQX,,BRD:BRD-BRD-K19438463-001-05-5;BRD:BRD-K19438463-001-05-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1;GRIA2;GRIA3;GRIA4,,,PHASE 1,,,NA,"[O-][N+](=O)C1CC2[NH]C(=O)C(=O)[NH]C2CC1C#N, [O-][N+](=O)C1CC2[NH]C(=O)C(=O)[NH]C2CC1C#N",
CNX-2006,CNX-2006,,BRD:BRD-BRD-K24869513-001-02-1;BRD:BRD-K24869513-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PRECLINICAL,,,NA,COC1CC(NC2CN(CCF)C2)CCC1NC1NCC(C(NC2CCCC(NC(=O)C=C)C2)N1)C(F)(F)F,
CNX-774,CNX-774,,BRD:BRD-BRD-K48443249-001-01-0;BRD:BRD-K48443249-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BTK,,,PRECLINICAL,,,NA,CNC(=O)C1CC(OC2CCC(NC3NCC(F)C(NC4CCCC(NC(=O)C=C)C4)N3)CC2)CCN1,
CO-101244,CO-101244,,BRD:BRD-BRD-K55677650-003-02-9;BRD:BRD-K55677650-003-02-9,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN2B,,,PRECLINICAL,,,NA,"CC1CCC(CC2(O)CCN(CCOC3CCC(O)CC3)CC2)CC1, CC1CCC(CC2(O)CCN(CCOC3CCC(O)CC3)CC2)CC1",
CO-102862,CO-102862,,BRD:BRD-BRD-K70912147-001-01-8;BRD:BRD-K70912147-001-01-8,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN4A;SCN9A,,,PHASE 1,,,NA,NC(=O)N\N=C\C1CCC(OC2CCC(F)CC2)CC1,
TYBOST,"(R,R,S)-;COBICISTAT;COBICISTAT ON SILICON DIOXIDE;GS-9350;TYBOST",CHEMBL2095208,BRD:BRD-BRD-K51040301-001-02-1;BRD:BRD-K51040301-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP3A4;CYP3A43;CYP3A5;CYP3A7,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1;CC(C)C1NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2CCCCC2)NC(=O)OCC2CNCS2)CC2CCCCC2)CS1,ZCIGNRJZKPOIKD-CQXVEOKZSA-N
XL518,COBIMETINIB;COTELLIC;GDC 0623;GDC 0973;GDC-0623;GDC-0973;RG 7420;RG-7420;RG-7421;RG7420;XL 518;XL-518;XL518,CHEMBL2146883,BRD:BRD-BRD-K03390685-001-01-7;BRD:BRD-K03390685-001-01-7;BRD:BRD-K03390685-001-07-9,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF MAP2K1,MAP2K1,MELANOMA,,LAUNCHED,"Multiple values for MOA: {'MEK INHIBITOR', 'INHIBITOR OF MAP2K1'}, defaulting to 'INHIBITOR OF MAP2K1'",Small molecule,4,O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1;OC1(CN(C1)C(=O)C1CCC(F)C(F)C1NC1CCC(I)CC1F)[C@@H]1CCCCN1,BSMCAPRUBJMWDF-KRWDZBQOSA-N
RNR INHIBITOR COH29,COH-29;COH29;RNR INHIBITOR COH29,CHEMBL4297421,BRD:BRD-K00003307-001-01-9,rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,,,,,,Small molecule,1,O=C(Nc1nc(-c2ccc(O)c(O)c2)c(-c2ccccc2)s1)c1ccc(O)c(O)c1,LGGDLPSXAGQFSG-UHFFFAOYSA-N
NSC-683551,COL-3;INCYCLINIDE;METASTAT;NSC-683551,CHEMBL2104970,CTRP:665914,ctrp,,,,,,,Small molecule,2,NC(=O)C1=C(O)C[C@@H]2C[C@@H]3Cc4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C1=O,ZXFCRFYULUUSDW-OWXODZSWSA-N
NSC-757,(-)-COLCHICINE;COLCHCINE;COLCHICINE;COLCHICINUM;COLCHINEOS;COLCHISOL;COLCRYS;GLOPERBA;MITIGARE;NSC-757,CHEMBL107,BRD:BRD-BRD-K00259736-001-16-4;BRD:BRD-K00259736-001-16-4,rep_multi_dose;rep_primary;rep_single_dose,MICROTUBULE INHIBITOR,GLRA1;GLRA2;TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8,"GOUT, FEVER",,LAUNCHED,,Small molecule,4,"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2;COC1CC2CC[C@H](NC(C)=O)C3CC(=O)C(OC)CCC3-C2C(OC)C1OC, COC1CC2CC[C@H](NC(C)=O)C3CC(=O)C(OC)CCC3-C2C(OC)C1OC",IAKHMKGGTNLKSZ-INIZCTEOSA-N
COLESEVALAM,COLESEVALAM,,BRD:BRD-BRD-U08520523-000-01-0;BRD:BRD-U08520523-000-01-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,,
NSC-375489,BOFORSIN;COLFORSIN;FORSKOLIN;HL 362;HL-362;L 75 1362B;L-75-1362B;L-751362B;NSC-357088;NSC-375489,CHEMBL52606,BRD:BRD-A55416093-001-06-4;BRD:BRD-BRD-A55416093-001-06-4,rep_primary;rep_single_dose,ADENYLYL CYCLASE ACTIVATOR,ADCY2;ADCY5,,,PHASE 2,,Small molecule,-1,C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](O)[C@H](OC(C)=O)[C@@]2(C)O1;CC(=O)O[C@H]1[C@@H](O)C2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C,OHCQJHSOBUTRHG-KGGHGJDLSA-N
COLFORSIN-DAPROATE,COLFORSIN-DAPROATE,,BRD:BRD-BRD-K19388745-003-01-7;BRD:BRD-K19388745-003-01-7,rep_multi_dose;rep_primary;rep_single_dose,ADENYLYL CYCLASE ACTIVATOR,,,,LAUNCHED,,,NA,CN(C)CCC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C,
COLFOSCERIL-PALMITATE,COLFOSCERIL-PALMITATE,,BRD:BRD-A95886749-001-03-5;BRD:BRD-BRD-A95886749-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,PULMONARY SURFACTANT,,RESPIRATORY DISTRESS SYNDROME (RDS),,LAUNCHED,,,NA,"CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC, CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC",
COLISTIN-B-SULFATE,COLISTIN-B-SULFATE,,BRD:BRD-A36456202-001-01-3;BRD:BRD-BRD-A36456202-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL PERMEABILITY INDUCER,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,,NA,CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)C(CCN)NC1=O)C(C)O,
COMBRETASTATIN-A-4,COMBRETASTATIN-A-4,,BRD:BRD-BRD-K61195623-001-01-4;BRD:BRD-K61195623-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,PHASE 2,,,NA,COC1CCC(CC1O)\C=C/C1CC(OC)C(OC)C(OC)C1,
COMPOUND 1541A,COMPOUND 1541A,,CTRP:411827,ctrp,,,,,,,,NA,,
COMPOUND 1B,COMPOUND 1B,,CTRP:62111,ctrp,,,,,,,,NA,,
COMPOUND 23 CITRATE,COMPOUND 23 CITRATE,,CTRP:417451,ctrp,,,,,,,,NA,,
COMPOUND 7D-CIS,COMPOUND 7D-CIS,,CTRP:411805,ctrp,,,,,,,,NA,,
RINETERKIB,COMPOUND B;RINETERKIB,,BRD:BRD-K00126779-001-01-9,oncref_2,INHIBITOR OF ERK1 AND ERK2,BRAF;MAPK1;MAPK3;RAF1,,,,,,NA,,
COMPOUND-401,COMPOUND-401,,BRD:BRD-BRD-K19655798-001-01-9;BRD:BRD-K19655798-001-01-9,rep_primary;rep_single_dose,DNA DEPENDENT PROTEIN KINASE INHIBITOR,MTOR;PRKDC,,,PRECLINICAL,,,NA,O=C1CC(NC2C3CCCCC3CCN12)N1CCOCC1,
COMPOUND-58112,COMPOUND-58112,,BRD:BRD-BRD-K76139886-003-01-3;BRD:BRD-K76139886-003-01-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC1CCCC(CN2C[SI](C)(C)O[SI](C)(C)C2)C1,
COMPOUND-W,COMPOUND-W,,BRD:BRD-BRD-K98143539-001-02-2;BRD:BRD-K98143539-001-02-2,rep_primary;rep_single_dose,BETA-SECRETASE INHIBITOR,BACE1,,,PRECLINICAL,,,NA,OC(=O)C1CC(OC2CCC(CC2)[N+]([O-])=O)CC(OC2CCC(CC2)[N+]([O-])=O)C1,
CONIVAPTAN,CONIVAPTAN,CHEMBL1755,BRD:BRD-BRD-K37385792-003-02-1;BRD:BRD-K37385792-003-02-1,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR ANTAGONIST,AVPR1A;AVPR2,HYPONATREMIA,,LAUNCHED,,Small molecule,4,Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2;CC1NC2CCN(C(=O)C3CCC(NC(=O)C4CCCCC4-C4CCCCC4)CC3)C3CCCCC3-C2[NH]1,IKENVDNFQMCRTR-UHFFFAOYSA-N
CONVALLATOXIN,CONVALLATOXIN,CHEMBL399336,BRD:BRD-K00004559-001-01-9,rep_single_dose,CARDIAC GLYCOSIDE,,,,,,Small molecule,NA,C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O,HULMNSIAKWANQO-JQKSAQOKSA-N
COPANLISIB,BAY 80-6946;BAY-80-6946;BAY80-6946;COPANLISIB,CHEMBL3218576,BRD:BRD-BRD-K24666289-001-04-9;BRD:BRD-K24666289-001-04-9,rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CB;PIK3CD;PIK3CG,FOLLICULAR LYMPHOMA,,LAUNCHED,,Small molecule,4,"COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21;COC1C(OCCCN2CCOCC2)CCC2C3=NCCN3C(NC(=O)C3CNC(N)NC3)=NC12, COC1C(OCCCN2CCOCC2)CCC2C3=NCCN3C(NC(=O)C3CNC(N)NC3)=NC12",PZBCKZWLPGJMAO-UHFFFAOYSA-N
COPPER-HISTIDINE,COPPER-HISTIDINE,,BRD:BRD-BRD-K36449075-001-01-0;BRD:BRD-K36449075-001-01-0,rep_primary;rep_single_dose,,HAL;HARS;HDC;SLC15A3;SLC15A4;SLC38A3;SLC38A5,,,PHASE 3,,,NA,N[C@H](CC1C[NH]CN1)C(O)=O,
COR-170,COR-170,,BRD:BRD-BRD-K74965187-001-01-3;BRD:BRD-K74965187-001-01-3,rep_primary;rep_single_dose,CANNABINOID RECEPTOR INVERSE AGONIST,CNR2,,,PRECLINICAL,,,NA,CCCCCN1CC(C(=O)NC23CC4CC(CC(C4)C2)C3)C(=O)C2CC(CCC12)-C1CCCCC1,
NSC-63984,3'-DEOXYADENOSINE;9-CORDYCEPOSIDOADENINE;CORDYCEPIN;CORDYCEPINE;NSC-401022;NSC-63984,CHEMBL305686,BRD:BRD-BRD-K65428967-001-08-4;BRD:BRD-K65428967-001-08-4,rep_primary;rep_single_dose,DNA INHIBITOR,,,,PHASE 1/PHASE 2,,Small molecule,1,"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O;NC1NCNC2N(CNC12)[C@@H]1O[C@H](CO)C[C@H]1O, NC1NCNC2N(CNC12)[C@@H]1O[C@H](CO)C[C@H]1O",OFEZSBMBBKLLBJ-BAJZRUMYSA-N
COROSOLIC-ACID,COROSOLIC-ACID,,BRD:BRD-BRD-K27885593-001-06-8;BRD:BRD-K27885593-001-06-8,rep_primary;rep_single_dose,"PKC INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",HSD11B1;PTPN1,,,PHASE 2,,,NA,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O,
CORT-108297,ADS-108297;CORT 108297;CORT-108297,CHEMBL271220,BRD:BRD-K00004700-001-01-9,rep_single_dose,GLUCOCORTICOID RECEPTOR ANTAGONIST,,,,,,Small molecule,1,CCOC[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2,SLKURXRZHJOZOD-RUZDIDTESA-N
REICHSTEIN'S SUBSTANCE H,"11-B,21-DIHYDROXYPREGN-3,20-DIONE;17-DEOXYCORTISOL;CORTICOSTERON;CORTICOSTERONE;KENDALL'S COMPOUND B;NSC-9705;PREG-4-ENE-3,20-DIONE,11-B,21-DIHYDROXY-;REICHSTEIN'S SUBSTANCE H",CHEMBL110739,BRD:BRD-BRD-K73589401-001-23-6;BRD:BRD-K73589401-001-23-6,rep_primary;rep_single_dose,MINERALOCORTICOID RECEPTOR AGONIST,HSD11B1;NCOA1;NR3C2,,,PRECLINICAL,,Small molecule,3,"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO, C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO;C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO",OMFXVFTZEKFJBZ-HJTSIMOOSA-N
NSC-9703,CORTATE;CORTELAN;CORTISONE;CORTISONE 21-ACETATE;CORTISONE ACETATE;CORTISONE ACETICUM;CORTISTAB;CORTISYL;CORTONE;NSC-49420;NSC-9703,CHEMBL1499;CHEMBL1650,BRD:BRD-A62731508-001-05-8;BRD:BRD-BRD-A62731508-001-05-8,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,"ULCERATIVE COLITIS, RHEUMATOID ARTHRITIS, PSORIASIS, JOINT INFLAMMATION, ECZEMA",,LAUNCHED,,Small molecule,3,C[C@]12CC(=O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)CO;C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CORTISONE-ACETATE,CORTISONE-ACETATE,,BRD:BRD-BRD-K86161929-001-11-7;BRD:BRD-BRD-K86161929-001-13-3;BRD:BRD-K86161929-001-11-7;BRD:BRD-K86161929-001-13-3,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,"ASTHMA, RHEUMATOID ARTHRITIS, URTICARIA, OSTEOARTHRITIS, PSORIASIS, ALLERGIC RHINITIS, CONJUNCTIVITIS, ULCERATIVE COLITIS, MENINGITIS",,LAUNCHED,,,NA,"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C",
SUBSTANCE S,"11-DEOXY-;11-DEOXYCORTISOL;11-DEOXYCORTISONE;11-DEOXYHYDROCORTISONE;17-HYDROXY-11-DEOXYCORTICOSTERONE;17,21-DIHYDROXYPROGESTERONE;17.ALPHA.-HYDROXYCORTEXONE;CORTEXOLONE;CORTIFEN;CORTISOL;CORTODOXONE;NSC-18317;REICHSTEIN'S SUBSTANCE S;SK&F 3050;SKF-3050;SUBSTANCE S",CHEMBL253144,BRD:BRD-BRD-K32891457-001-15-5;BRD:BRD-K32891457-001-15-5,rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AR,,,PHASE 3,,Small molecule,2,"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO;C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO",WHBHBVVOGNECLV-OBQKJFGGSA-N
MELAMPOLIDE,COSTUNOLIDE;MELAMPOLIDE,CHEMBL86416,BRD:BRD-BRD-K26833429-001-02-8;BRD:BRD-K26833429-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,TELOMERASE INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,"C\C1=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2CC1, C\C1=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2CC1, C\C1=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2CC1;C=C1C(=O)O[C@@H]2/C=C(\C)CC/C=C(\C)CC[C@@H]12",HRYLQFBHBWLLLL-AHNJNIBGSA-N
COT-INHIBITOR-1,COT-INHIBITOR-1,,BRD:BRD-K98710228-001-01-6,rep_single_dose,MAPK-INTERACTING KINASE INHIBITOR,MAP3K8,,,,,,NA,,
COT-INHIBITOR-2,COT-INHIBITOR-2,,BRD:BRD-K49468759-001-04-2,rep_single_dose,MAPK-INTERACTING KINASE INHIBITOR,MAP3K8,,,,,,NA,,
COTI-2,COTI-2,,BRD:BRD-K00003348-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,,NA,,
NICOTINE RELATED COMPOUND C,COTININE;NICOTINE RELATED COMPOUND C,CHEMBL578211,BRD:BRD-BRD-K94144010-001-13-9;BRD:BRD-K94144010-001-13-9,rep_primary;rep_single_dose,NICOTINE METABOLITE,,,,PHASE 2,,Small molecule,2,CN1[C@@H](CCC1=O)C1CCCNC1;CN1C(=O)CC[C@H]1c1cccnc1,UIKROCXWUNQSPJ-VIFPVBQESA-N
TONKA BEAN CAMPHOR,"1,2-BENZOPYRONE;CIS-O-COUMARINIC ACID LACTONE;COUMARIN;COUMARIN (PROHIBITED);COUMARINIC LACTONE;COUMARINUM;CUMARIN;LODEMA;NCI-C07103;NSC-8774;O-HYDROXYCINNAMIC ACID LACTONE;TONKA BEAN CAMPHOR",CHEMBL6466,BRD:BRD-BRD-K23913458-001-20-7;BRD:BRD-K23913458-001-20-7,rep_primary;rep_single_dose,VITAMIN K ANTAGONIST,CA1;CA12;CA14;CA2;CA4;CA6;CA9;CYP2A6,"ULCERATIVE COLITIS, ASTHMA, CELIAC DISEASE",,LAUNCHED,,Small molecule,4,"O=c1ccc2ccccc2o1;O=C1CCC2CCCCC2O1, O=C1CCC2CCCCC2O1",ZYGHJZDHTFUPRJ-UHFFFAOYSA-N
COUMOPHOS,COUMOPHOS,,BRD:BRD-BRD-K41567533-001-08-3;BRD:BRD-K41567533-001-08-3,rep_primary;rep_single_dose,CHOLINESTERASE INHIBITOR,,,,PRECLINICAL,,,NA,CCOP(=S)(OCC)OC1CCC2C(C)C(CL)C(=O)OC2C1,
"CP-105,696","CP-105,696",,BRD:BRD-K00004654-001-01-9,rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,,,,,,,NA,,
CP-316819,CP-316819,,BRD:BRD-BRD-K53913008-001-01-5;BRD:BRD-K53913008-001-01-5,rep_primary;rep_single_dose,GLYCOGEN PHOSPHORYLASE INHIBITOR,PYGL,,,PRECLINICAL,,,NA,CON(C)C(=O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)C1CC2CC(CL)CCC2[NH]1,
CP-339818,CP-339818,CHEMBL281622,BRD:BRD-BRD-K52113681-003-02-1;BRD:BRD-K52113681-003-02-1,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNA3,,,PRECLINICAL,,Small molecule,NA,CCCCC/N=c1\ccn(Cc2ccccc2)c2ccccc12;CCCCCN=C1CCN(CC2CCCCC2)C2CCCCC12,MMGAVKCAGQCFHS-LSDHQDQOSA-N
CP-376395,CP-376395,,BRD:BRD-BRD-K31394475-001-01-9;BRD:BRD-K31394475-001-01-9,rep_primary;rep_single_dose,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",CRHR1,,,PHASE 1,"Multiple values for MOA: {'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST', 'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST'}, defaulting to 'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST'",,NA,"CCC(CC)NC1CC(C)NC(OC2C(C)CC(C)CC2C)C1C, CCC(CC)NC1CC(C)NC(OC2C(C)CC(C)CC2C)C1C",
CP-471474,CP-471474,,BRD:BRD-K33234937-001-02-9,rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,MMP1;MMP13;MMP2;MMP3;MMP9,,,,,,NA,,
CP-532623,CP-532623,,BRD:BRD-BRD-K36611520-001-01-6;BRD:BRD-K36611520-001-01-6,rep_primary;rep_single_dose,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,CETP,,,PHASE 1,,,NA,CC[C@@H]1C[C@H](N(CC2CC(CC(C2)C(F)(F)F)C(F)(F)F)C(C)=O)C2CC(CCC2N1C(=O)OC(C)C)C(F)(F)F,
PAN90806,"CP-547,632;CP-547632;CP-632;OSI-632;PAN 90806;PAN-90806;PAN90806",CHEMBL253969,BRD:BRD-K00004719-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,Small molecule,2,NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,HXHAJRMTJXHJJZ-UHFFFAOYSA-N
CP-640186,CP-640186,,BRD:BRD-K26921335-003-01-2,rep_single_dose,ACETYL-COA CARBOXYLASE INHIBITOR,ACACA;ACACB,,,,,,NA,,
CP-673451,CP-673451,,BRD:BRD-BRD-K43621685-001-02-5;BRD:BRD-K43621685-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,KIT;PDGFRA;PDGFRB,,,PRECLINICAL,,,NA,"COCCOC1CCC2N(CNC2C1)-C1CCC2CCCC(N3CCC(N)CC3)C2N1, COCCOC1CCC2N(CNC2C1)-C1CCC2CCCC(N3CCC(N)CC3)C2N1",
CP-724714,"CP-724,714;CP-724714",CHEMBL483321,BRD:BRD-BRD-K76908866-001-07-6;BRD:BRD-K76908866-001-07-6;GDSC1:255,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"EGFR INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",ERBB2,,,PHASE 2,,Small molecule,2,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1;COCC(=O)NC\C=C\C1CCC2NCNC(NC3CCC(OC4CCC(C)NC4)C(C)C3)C2C1,LLVZBTWPGQVVLW-SNAWJCMRSA-N
CP-775146,CP-775146,,BRD:BRD-BRD-K96843359-001-02-6;BRD:BRD-K96843359-001-02-6,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA,,,PRECLINICAL,,,NA,CC(C)C1CCC(CC(=O)N2CCC[C@H](C2)C2CCCC(OC(C)(C)C(O)=O)C2)CC1,
CP-91149,CP-91149,,BRD:BRD-BRD-K19171642-001-02-3;BRD:BRD-K19171642-001-02-3,rep_primary;rep_single_dose,GLYCOGEN PHOSPHORYLASE INHIBITOR,PYGL,,,PRECLINICAL,,,NA,CN(C)C(=O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)C1CC2CC(CL)CCC2[NH]1,
CP-93129,CP-93129,,BRD:BRD-BRD-K81876028-300-02-0;BRD:BRD-K81876028-300-02-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,,,PRECLINICAL,,,NA,O=C1CCC2[NH]CC(C3=CCNCC3)C2[NH]1,
CP-94253,CP-94253,,BRD:BRD-K33860217-003-04-0,rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1B,,,,,,NA,,
OTENABANT HYDROCHLORIDE,"CP-945,598;CP-945598;CP-945598-01;OTENABANT;OTENABANT HCL;OTENABANT HYDROCHLORIDE",CHEMBL2103817;CHEMBL562668,BRD:BRD-BRD-K09090949-001-01-9;BRD:BRD-K09090949-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1,,,PHASE 3,,Small molecule,3,CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1;CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1.Cl;CCNC1(CCN(CC1)C1NCNC2N(C(NC12)-C1CCCCC1CL)-C1CCC(CL)CC1)C(N)=O,KPYUQCJBZGQHPL-UHFFFAOYSA-N;UNAZAADNBYXMIV-UHFFFAOYSA-N
CP-99994,CP-99994,CHEMBL441225,BRD:BRD-BRD-K09946180-300-01-6;BRD:BRD-K09946180-300-01-6,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1,,,PHASE 2,,Small molecule,NA,COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1;COC1CCCCC1CN[C@H]1CCCN[C@H]1C1CCCCC1,DTQNEFOKTXXQKV-HKUYNNGSSA-N
TARCEVA,"CP-358;CP-358,774;CP-358,774-01;CP-358774;CP-358774-01;CP-35877401;CP358774;ERLOTINIB;ERLOTINIB HCL;ERLOTINIB HYDROCHLORIDE;OSI-774;R-1415;RG-1415;RO-508231;TARCEVA",CHEMBL1079742;CHEMBL553,BRD:BRD-BRD-K70401845-003-09-6;BRD:BRD-K70401845-001-15-7;BRD:BRD-K70401845-001-25-9;BRD:BRD-K70401845-003-09-6;CTRP:52928;GDSC1:1;GDSC2:1168,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF EGFR AND ERBB2,EGFR;ERBB2;NR1I2,"NON-SMALL CELL LUNG CANCER (NSCLC), PANCREATIC CANCER",,LAUNCHED,"Multiple values for MOA: {'EGFR INHIBITOR', 'INHIBITOR OF EGFR AND ERBB2'}, defaulting to 'INHIBITOR OF EGFR AND ERBB2'
Multiple values for repurposing_target: {'EGFR;NR1I2', 'EGFR;ERBB2'}, taking the union",Small molecule,4,"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1;C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl;COCCOC1CC2NCNC(NC3CCCC(C3)C#C)C2CC1OCCOC, COCCOC1CC2NCNC(NC3CCCC(C3)C#C)C2CC1OCCOC",AAKJLRGGTJKAMG-UHFFFAOYSA-N;GTTBEUCJPZQMDZ-UHFFFAOYSA-N
CP466722,1080622-86-1;CP 466722;CP-466722;CP466722,,GDSC1:152,gdsc,,,,,,,,NA,,
CP724714,CP724714,,GDSC1:255,gdsc,,,,,,,,NA,,
CPA-INHIBITOR,CPA-INHIBITOR,,BRD:BRD-A69126730-001-01-3;BRD:BRD-BRD-A69126730-001-01-3,rep_primary;rep_single_dose,CARBOXYPEPTIDASE INHIBITOR,CPA1;CPA2,,,PRECLINICAL,,,NA,ON(CC(CC1CCCCC1)C(O)=O)C(=O)CC1CCCCC1,
CPCCOET,CPCCOET,CHEMBL337583,BRD:BRD-A05729358-001-02-0;BRD:BRD-BRD-A05729358-001-02-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM1,,,PRECLINICAL,,Small molecule,NA,"CCOC(=O)[C@]12CC1/C(=N\O)c1ccccc1O2;CCOC(=O)C12CC1\C(=N/O)C1CCCCC1O2, CCOC(=O)C12CC1\C(=N/O)C1CCCCC1O2",FXCTZFMSAHZQTR-ZBUQWEBQSA-N
PELABRESIB MONOHYDRATE,CPI 0610;CPI-0610;CPI-0610 ANHYDROUS;CPI-232;CPI-267232;PELABRESIB;PELABRESIB ANHYDROUS;PELABRESIB MONOHYDRATE,CHEMBL4303404,BRD:BRD-BRD-K19871656-001-01-3;BRD:BRD-K19871656-001-01-3,rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD4,,,PHASE 1,,Small molecule,3,CC1NOC2[C@H](CC(N)=O)N=C(C3CCC(CL)CC3)C3CCCCC3-C12;Cc1noc2c1-c1ccccc1C(c1ccc(Cl)cc1)=N[C@H]2CC(N)=O,GCWIQUVXWZWCLE-INIZCTEOSA-N
CPI-1189,CP1-1189;CPI-1189,CHEMBL4297369,BRD:BRD-BRD-K11073688-001-01-6;BRD:BRD-K11073688-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,TUMOR NECROSIS FACTOR RELEASE INHIBITOR,TNF,,,PHASE 2,,Small molecule,2,CC(=O)Nc1ccc(C(=O)NC(C)(C)C)cc1;CC(=O)NC1CCC(CC1)C(=O)NC(C)(C)C,DJKNRCWSXSZACF-UHFFFAOYSA-N
LIRAMETOSTAT,CPI-1205;EZH2 INHIBITOR CPI-1205;LIRAMETOSTAT,CHEMBL4297463,BRD:BRD-K00003360-001-01-9,rep_single_dose,EZH2 INHIBITOR,,,,,,Small molecule,1,COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCN(CC(F)(F)F)CC2)c2ccccc12,HPODOLXTMDHLLC-QGZVFWFLSA-N
CPI-169,CPI-169,,BRD:BRD-K97181972-001-01-9,rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,,,,NA,,
CPI-203,CPI-203,,BRD:BRD-BRD-K15811707-001-02-0;BRD:BRD-K15811707-001-02-0,rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD4,,,PRECLINICAL,,,NA,"CC1SC-2C(C1C)C(=N[C@@H](CC(N)=O)C1NNC(C)N-21)C1CCC(CL)CC1, CC1SC-2C(C1C)C(=N[C@@H](CC(N)=O)C1NNC(C)N-21)C1CCC(CL)CC1",
CPI-360,CPI-360,,BRD:BRD-BRD-K18319422-001-01-7;BRD:BRD-K18319422-001-01-7,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,PRECLINICAL,,,NA,COC1CC(C)[NH]C(=O)C1CNC(=O)C1C(C)N([C@H](C)C2CCOCC2)C2CCCCC12,
V81444,CIFORADENANT;CPI-444;V-81444;V81444,CHEMBL4297184,BRD:BRD-K00003442-001-01-9,rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,Cc1ccc(-c2nc(N)nc3c2nnn3Cc2cccc(CO[C@H]3CCOC3)n2)o1,KURQKNMKCGYWRJ-HNNXBMFYSA-N
DEVIMISTAT,CPI 613;CPI-613;DEVIMISTAT,CHEMBL3186849,BRD:BRD-A06916187-001-02-9;BRD:BRD-BRD-A06916187-001-02-9;GDSC1:415,gdsc;rep_primary;rep_single_dose,PYRUVATE DEHYDROGENASE INHIBITOR,PDHA1,,,PHASE 2,,Small molecule,3,O=C(O)CCCCC(CCSCc1ccccc1)SCc1ccccc1;OC(=O)CCCCC(CCSCC1CCCCC1)SCC1CCCCC1,ZYRLHJIMTROTBO-UHFFFAOYSA-N
CPP,CPP,,BRD:BRD-BRD-K66094457-001-01-5;BRD:BRD-K66094457-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,PHASE 2,,,NA,"OC(=O)[C@H]1CN(CCCP(O)(O)=O)CCN1, OC(=O)[C@H]1CN(CCCP(O)(O)=O)CCN1, OC(=O)C1CN(CCCP(O)(O)=O)CCN1",
CPSI-1306-(+/-),CPSI-1306-(+/-),,BRD:BRD-A81603255-001-01-0;BRD:BRD-BRD-A81603255-001-01-0,rep_primary;rep_single_dose,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,MIF,,,PRECLINICAL,,,NA,FC1CCC(C2=NOC(CC(=O)N3CCOCC3)C2)C(F)C1,
CQS,CQS,,BRD:BRD-K56839624-001-06-9,rep_single_dose,,,,,,,,NA,,
CR-1-31B,CR-1-31B,,CTRP:418209,ctrp,,,,,,,,NA,,
CR8-(R),CR8-(R),,BRD:BRD-BRD-K40331046-305-01-5;BRD:BRD-K40331046-305-01-5,rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CCNA2,,,PRECLINICAL,,,NA,"CC[C@H](CO)NC1NC(NCC2CCC(CC2)-C2CCCCN2)C2NCN(C(C)C)C2N1, CC[C@H](CO)NC1NC(NCC2CCC(CC2)-C2CCCCN2)C2NCN(C(C)C)C2N1",
NSC-8752,COSMOCAIR C 100;CREATINE;KREATINUM;NEOTINE;NSC-8752,CHEMBL283800,BRD:BRD-BRD-K19615002-001-02-3;BRD:BRD-K19615002-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,,CKB;CKM;CKMT1A;CKMT2;GAMT;SLC6A8,,,LAUNCHED,,Small molecule,3,CN(CC(=O)O)C(=N)N;CN(CC(O)=O)C(N)=N,CVSVTCORWBXHQV-UHFFFAOYSA-N
NSC-13123,1-METHYLGLYCOCYAMIDINE;1-METHYLHYDANTOIN-2-IMIDE;CREATININE;KREATININUM;NSC-13123,CHEMBL65567,BRD:BRD-BRD-K13495773-001-11-4;BRD:BRD-K13495773-001-11-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,3,"CN1CC(=O)NC1=N;CN1CC(=O)NC1=N, CN1CC(=O)NC1=N",DDRJAANPRJIHGJ-UHFFFAOYSA-N
CREATINOL-PHOSPHATE,CREATINOL-PHOSPHATE,,BRD:BRD-BRD-K42991124-001-03-0;BRD:BRD-K42991124-001-03-0,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,"CN(CCOP(O)(O)=O)C(N)=N, CN(CCOP(O)(O)=O)C(N)=N",
LY3039478,CRENIGACESTAT;JSMD-194;JSMD194;LY-3039478;LY3039478,CHEMBL2338397,BRD:BRD-K00003129-001-01-9,rep_single_dose,NOTCH SIGNALING INHIBITOR,,,,,,Small molecule,1,C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@@H]1C(=O)N(CCO)c2ncccc2-c2ccccc21,YCBAQKQAINQRFW-UGSOOPFHSA-N
CRENOLANIB,"ARO 002;ARO-002;CP 868596;CP-868,596;CP-868596;CRENOLANIB",CHEMBL2105728,BRD:BRD-BRD-K22127577-001-03-7;BRD:BRD-K22127577-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,CSF1R;FLT3;KIT;PDGFRA;PDGFRB,,,PHASE 2,,Small molecule,3,"CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1;CC1(COC2CCC3N(CNC3C2)-C2CCC3CCCC(N4CCC(N)CC4)C3N2)COC1, CC1(COC2CCC3N(CNC3C2)-C2CCC3CCCC(N4CCC(N)CC4)C3N2)COC1",DYNHJHQFHQTFTP-UHFFFAOYSA-N
TRICRESOL,CRESOL;CRESOL (MIXED ISOMERS);CRESOLUM;CRESYLIC ACID;METHYL-;METHYLPHENOL;MIXED CRESOLS;NSC-756709;PHENOL;SINFECT;TRICRESOL,CHEMBL1410808,BRD:BRD-BRD-K56940914-001-04-2;BRD:BRD-K56940914-001-04-2,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,4,CC1CCC(O)CC1;Cc1ccc(O)cc1.Cc1cccc(O)c1.Cc1ccccc1O,QTWJRLJHJPIABL-UHFFFAOYSA-N
CRESOPIRINE,CRESOPIRINE,,BRD:BRD-BRD-K58648841-001-04-7;BRD:BRD-K58648841-001-04-7,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC(=O)OC1C(C)CCCC1C(O)=O,
CRIDANIMOD,CRIDANIMOD,CHEMBL1569545,BRD:BRD-BRD-K97939847-001-12-0;BRD:BRD-K97939847-001-12-0,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,,,LAUNCHED,,Small molecule,2,"O=C(O)Cn1c2ccccc2c(=O)c2ccccc21;OC(=O)CN1C2CCCCC2C(=O)C2CCCCC12, OC(=O)CN1C2CCCCC2C(=O)C2CCCCC12",UOMKBIIXHQIERR-UHFFFAOYSA-N
EUCRISA,AN-2728;AN2728;CRISABOROLE;EUCRISA,CHEMBL484785,BRD:BRD-BRD-K43230258-001-01-4;BRD:BRD-K43230258-001-01-4,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A;PDE4B;PDE4C;PDE4D,,,PHASE 3,"Multiple values for repurposing_target: {'PDE4A;PDE4B;PDE4C;PDE4D', 'PDE4B'}, taking the union",Small molecule,4,N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1;OB1OCC2CC(OC3CCC(CC3)C#N)CCC12,USZAGAREISWJDP-UHFFFAOYSA-N
CRISDESALAZINE,CRISDESALAZINE,,BRD:BRD-K00004545-001-01-9,rep_single_dose,FREE RADICAL SCAVENGER,,,,,,,NA,,
XALKORI,CRIZOTINIB;NSC-756645;PF-02341066;PF-2341066;XALKORI,CHEMBL601719,BRD:BRD-BRD-K78431006-001-10-2;BRD:BRD-K78431006-001-01-1;BRD:BRD-K78431006-001-10-2;BRD:BRD-K78431006-001-15-1;CTRP:628603;GDSC1:37;GDSC2:1083,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK;MET,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF ALK AND MET', 'ALK TYROSINE KINASE RECEPTOR INHIBITOR'}, defaulting to 'ALK TYROSINE KINASE RECEPTOR INHIBITOR'",Small molecule,4,"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl;C[C@@H](OC1CC(CNC1N)-C1CNN(C1)C1CCNCC1)C1C(CL)CCC(F)C1CL, C[C@@H](OC1CC(CNC1N)-C1CNN(C1)C1CCNCC1)C1C(CL)CCC(F)C1CL, C[C@@H](OC1CC(CNC1N)-C1CNN(C1)C1CCNCC1)C1C(CL)CCC(F)C1CL",KTEIFNKAUNYNJU-GFCCVEGCSA-N
CRIZOTINIB-(S),CRIZOTINIB-(S),,BRD:BRD-BRD-K40308497-001-01-2;BRD:BRD-BRD-K40308497-001-02-0;BRD:BRD-K40308497-001-01-2;BRD:BRD-K40308497-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,MTH1 INHIBITOR,NUDT1,,,PRECLINICAL,,,NA,"C[C@H](OC1CC(CNC1N)-C1CNN(C1)C1CCNCC1)C1C(CL)CCC(F)C1CL, C[C@H](OC1CC(CNC1N)-C1CNN(C1)C1CCNCC1)C1C(CL)CCC(F)C1CL",
CRIZOTINIB:PLX-4032 (2:1 MOL/MOL),CRIZOTINIB:PLX-4032 (2:1 MOL/MOL),,CTRP:660857,ctrp,,,,,,,,NA,,
EPC2407,CROLIBULIN;EPC 2407;EPC-2407;EPC2407,CHEMBL2103852,BRD:BRD-K00003162-001-01-9,rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,,,Small molecule,1,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC,JXONINOYTKKXQQ-CQSZACIVSA-N
CROMAKALIM,BRL 34915;BRL-34915;BRL34915;CROMAKALIM,CHEMBL49035,BRD:BRD-BRD-M89827113-001-01-5;BRD:BRD-M89827113-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,,KCNJ8,,,PHASE 2,,Small molecule,-1,CC1(C)Oc2ccc(C#N)cc2C(N2CCCC2=O)C1O;CC1(C)OC2CCC(CC2[C@H]([C@@H]1O)N1CCCC1=O)C#N.CC1(C)OC2CCC(CC2[C@@H]([C@H]1O)N1CCCC1=O)C#N,TVZCRIROJQEVOT-UHFFFAOYSA-N
CROMOGLICIC-ACID,CROMOGLICIC-ACID,,BRD:BRD-BRD-K20920669-304-09-1;BRD:BRD-K20920669-304-09-1,rep_primary;rep_single_dose,IMMUNOSUPPRESSANT,KCNMA1;S100P,"ASTHMA, CONJUNCTIVITIS, URTICARIA, ULCERATIVE COLITIS",,LAUNCHED,,,NA,"OC(COC1CCCC2OC(CC(=O)C12)C(O)=O)COC1CCCC2OC(CC(=O)C12)C(O)=O, OC(COC1CCCC2OC(CC(=O)C12)C(O)=O)COC1CCCC2OC(CC(=O)C12)C(O)=O",
NSC-758951,CROTAMITON;CROTAN;EURAX;N-ETHYL-O-CROTONOTOLUIDIDE;N-ETHYLCROTONO-O-TOLUIDIDE;NSC-758951,CHEMBL1200709,BRD:BRD-BRD-K57179821-001-15-4;BRD:BRD-K57179821-001-15-4,rep_primary;rep_single_dose,ANTIPRURITIC,,SCABIES,,LAUNCHED,,Small molecule,4,C/C=C/C(=O)N(CC)c1ccccc1C;CCN(C(=O)\C=C\C)C1CCCCC1C,DNTGGZPQPQTDQF-XBXARRHUSA-N
CRT0044876,CRT0044876,,BRD:BRD-BRD-K02816415-001-01-9;BRD:BRD-K02816415-001-01-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC(=O)C1CC2CCCC([N+]([O-])=O)C2[NH]1,
CRYSTAL-VIOLET,CRYSTAL-VIOLET,,BRD:BRD-BRD-K60025295-003-06-6;BRD:BRD-K60025295-003-06-6,rep_multi_dose;rep_primary;rep_single_dose,OTHER ANTIBIOTIC,,,,LAUNCHED,,,NA,"CN(C)C1CCC(CC1)C(C1CCC(CC1)N(C)C)=C1C=CC(C=C1)=[N+](C)C, CN(C)C1CCC(CC1)C(C1CCC(CC1)N(C)C)=C1C=CC(C=C1)=[N+](C)C, CN(C)C1CCC(CC1)C(C1CCC(CC1)N(C)C)=C1C=CC(C=C1)=[N+](C)C",
CS-110266,CS-110266,,BRD:BRD-BRD-K15519488-050-01-3;BRD:BRD-K15519488-050-01-3,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,SLC6A3,,,PRECLINICAL,,,NA,"C1CCN(CC1)C1(CCCCC1)C1CC2CCCCC2S1, C1CCN(CC1)C1(CCCCC1)C1CC2CCCCC2S1",
CS-917,CS-917,,BRD:BRD-BRD-K35601925-001-01-9;BRD:BRD-K35601925-001-01-9,rep_primary;rep_single_dose,FRUCTOSE BIPHOSPHATE INHIBITOR,FBP1,,,PHASE 2,,,NA,"CC(C)CC1SC(N)NC1-C1CCC(O1)P(O)(O)=O, CC(C)CC1SC(N)NC1-C1CCC(O1)P(O)(O)=O",
CT 99021,CHIR 99021;CHIR99021;CT 99021,,GDSC1:1241;GDSC1:154,gdsc,,,,,,,,NA,,
ZAURATEGRAST,CT-7758;CT7758;ZAURATEGRAST,CHEMBL4303708,BRD:BRD-BRD-K40870905-001-01-7;BRD:BRD-K40870905-001-01-7,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGA4,,,PHASE 2,,Small molecule,-1,O=C(O)[C@H](Cc1ccc(Nc2nccc3ccncc23)cc1)NC1=C(Br)C(=O)C12CCCCC2;OC(=O)[C@H](CC1CCC(NC2NCCC3CCNCC23)CC1)NC1=C(BR)C(=O)C11CCCCC1,KYHVWHYLKOHLKA-FQEVSTJZSA-N
SAMURACICLIB,CT-7001;CT7001;ICEC-0942;ICEC0942;SAMURACICLIB,CHEMBL4297488,BRD:BRD-K00003453-003-01-9,rep_single_dose,CDK INHIBITOR,,,,,,Small molecule,1,CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12,YCVGLKWJKIKVBI-MJGOQNOKSA-N
CTEP,CTEP,,BRD:BRD-BRD-K30572193-001-02-0;BRD:BRD-K30572193-001-02-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM5,,,PRECLINICAL,,,NA,CC1NC(C#CC2CCNC(CL)C2)C(C)N1-C1CCC(OC(F)(F)F)CC1,
RS-130830,CTS-1027;RO-1130830;RS-130830,CHEMBL440498,BRD:BRD-BRD-K53508936-001-01-0;BRD:BRD-K53508936-001-01-0,rep_primary;rep_single_dose,METALLOPROTEINASE INHIBITOR,MMP1;MMP13;MMP2;MMP3;MMP9,,,PHASE 2,,Small molecule,2,"O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1;ONC(=O)C1(CS(=O)(=O)C2CCC(OC3CCC(CL)CC3)CC2)CCOCC1, ONC(=O)C1(CS(=O)(=O)C2CCC(OC3CCC(CL)CC3)CC2)CCOCC1",ROSNVSQTEGHUKU-UHFFFAOYSA-N
CTS21166,CTS21166,,BRD:BRD-BRD-K89071957-001-01-1;BRD:BRD-K89071957-001-01-1,rep_primary;rep_single_dose,BETA-SECRETASE INHIBITOR,BACE1,,,PHASE 1,,,NA,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)C(C)C)[C@@H](O)C[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1CCCCC1)C(O)=O,
PF-9363,CTX-648;PF-9363,,BRD:BRD-K00126781-001-01-9,oncref_2,INHIBITOR OF KAT6A AND KAT6B,KAT6A;KAT6B,,,,,,NA,,
CU-CPT-4A,CU-CPT-4A,,BRD:BRD-K58234744-001-02-9,rep_single_dose,TOLL-LIKE RECEPTOR INHIBITOR,TLR3,,,,,,NA,,
CU-T12-9,CU-T12-9,,BRD:BRD-K89462779-001-02-9,rep_single_dose,TOLL-LIKE RECEPTOR AGONIST,TLR1;TLR2,,,,,,NA,,
NSC-521777,CUCURBITACIN I;NSC-521777,CHEMBL387737,CTRP:595102,ctrp,,,,,,,Small molecule,NA,CC(C)(O)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C,NISPVUDLMHQFRQ-MKIKIEMVSA-N
CUDC-101,CUDC 101;CUDC-101,CHEMBL598797,GDSC1:273,gdsc,,,,,,,Small molecule,1,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,PLIVFNIUGLLCEK-UHFFFAOYSA-N
CUDC-101,CUDC 101;CUDC-101,CHEMBL598797,BRD:BRD-BRD-K41278234-001-03-0;BRD:BRD-K41278234-001-03-0;GDSC1:273,gdsc;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2,,,PHASE 1,,Small molecule,1,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1;COC1CC2NCNC(NC3CCCC(C3)C#C)C2CC1OCCCCCCC(=O)NO,PLIVFNIUGLLCEK-UHFFFAOYSA-N
GDC-0917,CUDC 427;CUDC-427;GDC-0917,CHEMBL4297282,BRD:BRD-BRD-K69351586-001-01-0;BRD:BRD-K69351586-001-01-0,rep_primary;rep_single_dose,APOPTOSIS INHIBITOR,XIAP,,,PHASE 1,,Small molecule,1,"CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NC1SC(NC1-C1CCCCC1)-C1NCCO1, CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NC1SC(NC1-C1CCCCC1)-C1NCCO1;CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1sc(-c2ncco2)nc1-c1ccccc1)C1CCCCC1",HSHPBORBOJIXSQ-HARLFGEKSA-N
FIMEPINOSTAT,CUDC 907;CUDC-907;CUDC907;FIMEPINOSTAT,CHEMBL3622533,BRD:BRD-BRD-K77638923-001-02-0;BRD:BRD-K77638923-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,HDAC2;PIK3R1,,,PHASE 2,,Small molecule,2,COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1;COC1CCC(CN1)-C1NC(N2CCOCC2)C2SC(CN(C)C3NCC(CN3)C(=O)NO)CC2N1,JOWXJLIFIIOYMS-UHFFFAOYSA-N
CUR-61414,CUR-61414,,BRD:BRD-BRD-K69624312-001-01-1;BRD:BRD-K69624312-001-01-1,rep_primary;rep_single_dose,SMOOTHENED RECEPTOR ANTAGONIST,DHH;IHH;SMO,,,PHASE 1,,,NA,COC1CCCC(CN([C@H]2C[C@H](N(CC3CCC4OCOC4C3)C2)C(=O)N2CCNCC2)C(=O)CC(C)(C)C)C1,
TURMERIC YELLOW,C.I. 75300;C.I. NATURAL YELLOW 3;CI 75300;CI-75300;CURCUMIN;CURCUMIN E100;DIFERULOYLMETHANE;E 100;E-100;E100;HALDAR;INS NO. 100(I);INS-100(I);JIANGHUANGSU;KACHA HALDI;KURKUM;LIPOCURC;MERITA EARTH;NANOCURC;NATURAL YELLOW 3;NSC-32982;NSC-687842;TURMERIC YELLOW,CHEMBL116438,BRD:BRD-BRD-K07572174-001-39-4;BRD:BRD-K07572174-001-39-4;CTRP:28452,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, HISTONE ACETYLTRANSFERASE INHIBITOR, LIPOXYGENASE INHIBITOR, NFKB PATHWAY INHIBITOR",APP;CA1;CA12;CA14;CA2;CA4;CA6;CA9;CHRM3;CYP3A4;DNMT3B;EP300;MMP13;MMP9;NOS2;PTGS1;PTGS2;XDH,,,LAUNCHED,"Multiple values for repurposing_target: {'APP;CA1;CA12;CA14;CA2;CA4;CA6;CA9;CYP3A4;DNMT3B;EP300;MMP13;MMP9;NOS2;PTGS1;PTGS2;XDH', 'APP;CA1;CA12;CA14;CA2;CA4;CA6;CA9;CHRM3;CYP3A4;DNMT3B;EP300;MMP13;MMP9;NOS2;PTGS1;PTGS2;XDH'}, taking the union",Small molecule,3,"COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O;COC1CC(CCC1O)\C=C\C(=O)CC(=O)\C=C\C1CCC(O)C(OC)C1, COC1CC(CCC1O)\C=C\C(=O)CC(=O)\C=C\C1CCC(O)C(OC)C1, COC1CC(CCC1O)\C=C\C(=O)CC(=O)\C=C\C1CCC(O)C(OC)C1",ZIUSSTSXXLLKKK-KOBPDPAPSA-N
CURCUMOL,CURCUMOL,,BRD:BRD-BRD-K41933240-001-02-4;BRD:BRD-K41933240-001-02-4,rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2;JAK3,,,PHASE 1,,,NA,"CC(C)[C@@H]1C[C@@]23O[C@]1(O)CC(=C)[C@@H]2CC[C@@H]3C, CC(C)[C@@H]1C[C@@]23O[C@]1(O)CC(=C)[C@@H]2CC[C@@H]3C",
CUTAMESINE,CUTAMESINE,,BRD:BRD-BRD-K90777969-300-01-2;BRD:BRD-K90777969-300-01-2,rep_primary;rep_single_dose,SIGMA RECEPTOR AGONIST,SIGMAR1,,,PHASE 2,,,NA,"COC1CCC(CCN2CCN(CCCC3CCCCC3)CC2)CC1OC, COC1CCC(CCN2CCN(CCCC3CCCCC3)CC2)CC1OC",
CV-1808,CV-1808,,BRD:BRD-BRD-K49197823-001-09-8;BRD:BRD-K49197823-001-09-8,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA2A,,,PRECLINICAL,,,NA,NC1NC(NC2CCCCC2)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
CVT-10216,CVT-10216,,BRD:BRD-BRD-K60659193-001-02-8;BRD:BRD-K60659193-001-02-8,rep_primary;rep_single_dose,ALDEHYDE DEHYDROGENASE INHIBITOR,ALDH2,,,PHASE 1,,,NA,"CS(=O)(=O)NC1CCC(CC1)-C1COC2CC(OCC3CCCC(C3)C(O)=O)CCC2C1=O, CS(=O)(=O)NC1CCC(CC1)-C1COC2CC(OCC3CCCC(C3)C(O)=O)CCC2C1=O",
CW-008,CW-008,,BRD:BRD-K84068331-001-02-9,rep_single_dose,PKA ACTIVATOR,PRKACA,,,,,,NA,,
SILMITASERTIB,CX 4945;CX-4945;CX-4945 FREE ACID;CX4945;SILMITASERTIB,CHEMBL1230165,BRD:BRD-BRD-K81458380-001-04-9;BRD:BRD-K81458380-001-04-9,rep_multi_dose;rep_primary;rep_single_dose,CASEIN KINASE INHIBITOR,CSNK2A1;CSNK2A2;DAPK3;HIPK3,,,PHASE 1/PHASE 2,,Small molecule,2,O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12;OC(=O)C1CCC2C(C1)NC(NC1CCCC(CL)C1)C1CCNCC21,MUOKSQABCJCOPU-UHFFFAOYSA-N
CX516,AMPALEX;BDP 12;BDP-12;CX 516;CX-516;CX516,CHEMBL136800,BRD:BRD-BRD-K25140590-001-03-0;BRD:BRD-K25140590-001-03-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,,,,PHASE 2/PHASE 3,,Small molecule,2,O=C(c1ccc2nccnc2c1)N1CCCCC1;O=C(N1CCCCC1)C1CCC2OCOC2C1,ANDGGVOPIJEHOF-UHFFFAOYSA-N
PIDNARULEX,CX-5461;PIDNARULEX,CHEMBL4303309,BRD:BRD-BRD-K12787259-001-04-3;BRD:BRD-K12787259-001-04-3;GDSC1:300,gdsc;rep_multi_dose;rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,,,PHASE 1,,Small molecule,1,Cc1cnc(CNC(=O)c2c(=O)c3ccc(N4CCCN(C)CC4)nc3n3c2sc2ccccc23)cn1;CN1CCCN(CC1)C1CCC2C(N1)N1C3CCCCC3SC1C(C(=O)NCC1CNC(C)CN1)C2=O,XGPBJCHFROADCK-UHFFFAOYSA-N
CX5461,CX 5461;CX5461,,GDSC1:300,gdsc,,,,,,,,NA,,
ZABADINOSTAT,AZD-9468;CXD-101;CXD101;HDAC INHIBITOR CXD101;HDAC-IN-4;ZABADINOSTAT,CHEMBL4297489,BRD:BRD-K00003388-001-01-9,rep_single_dose,HDAC INHIBITOR,,,,,,Small molecule,1,Cc1nn(C)cc1CN1CCC(c2ccc(C(=O)Nc3ccccc3N)cc2)CC1,JHDZMASHNBKTPS-UHFFFAOYSA-N
NSC-24261,CYACETACIDE;CYACETAZIDE;NSC-24261,CHEMBL2106008,BRD:BRD-BRD-K39371216-001-01-3;BRD:BRD-K39371216-001-01-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,N#CCC(=O)NN;NNC(=O)CC#N,HPHBOJANXDKUQD-UHFFFAOYSA-N
TH-2602,CYAMEMAZINE;CYAMEPROMAZINE;FL-6229;KYAMEPROMAZIN;RP 7204;RP-7204;TERCIAN;TH-2602,CHEMBL2104153,BRD:BRD-A42881122-001-01-1;BRD:BRD-BRD-A42881122-001-01-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A;HTR2A;HTR2C;HTR7,"SCHIZOPHRENIA, ANXIETY",,LAUNCHED,,Small molecule,-1,CC(CN(C)C)CN1c2ccccc2Sc2ccc(C#N)cc21;CC(CN(C)C)CN1C2CCCCC2SC2CCC(CC12)C#N,SLFGIOIONGJGRT-UHFFFAOYSA-N
VITAMIN B12 NOS,"(57CO)VITAMIN B12;57CO;58CO;60CO;ANTIPERNICIN;BEHEPAN;BERUBIGEN;BETALIN 12;CALOMIST;CO-57;CO-58;CO-60;COBALT (57CO) CYANOCOBALAMIN;COBALT (57CO) CYANOCOBALAMINE;COBALT (58CO) CYANOCOBALAMIN;COBALT (58CO) CYANOCOBALAMINE;COBALT (60CO) CYANOCOBALAMIN;COBALT-58;COBAVITE;CYANOCOBALAMIN;CYANOCOBALAMIN (57 CO);CYANOCOBALAMIN (57CO);CYANOCOBALAMIN (58 CO);CYANOCOBALAMIN (58CO);CYANOCOBALAMIN (60 CO);CYANOCOBALAMIN (60CO);CYANOCOBALAMIN CO 57;CYANOCOBALAMIN CO 58;CYANOCOBALAMIN CO 60;CYANOCOBALAMIN CO-57;CYANOCOBALAMIN CO-58;CYANOCOBALAMIN CO-60;CYANOCOBALAMIN CO57;CYANOCOBALAMIN,CO-57;CYANOCOBALAMINUM;CYANOCOBALMIN;CYANOVIT-B12;CYCOBEMIN;CYTACON;CYTAMEN;DODECAVITE;DODEX;NASCOBAL;NORMOCYTIN;NSC-80365;PLECYAMIN;RACOBALAMIN-57;RACOBALAMIN-60;RADIOACTIVE 57CO VITAMIN B12;RADIOACTIVE 58CO VITAMIN B12;RADIOACTIVE 60CO VITAMIN B12;REDISOL;RUBIVAMINE;RUBIVITE;RUBRAMIN;RUBRAMIN PC;RUBRATOPE-57;RUBRATOPE-60;RUVITE;VI-TWEL;VIBALT;VIBISONE;VITAMIN B 12;VITAMIN B-12;VITAMIN B(BDI1)(BDI2);VITAMIN B12;VITAMIN B12 (AS CYANOCOBALAMIN );VITAMIN B12 NOS",CHEMBL2096655;CHEMBL2104118;CHEMBL2104381;CHEMBL2110563,BRD:BRD-A18627414-001-04-9;BRD:BRD-BRD-A18627414-001-04-9,rep_primary;rep_single_dose,"METHYLMALONYL COA MUTASE STIMULANT, VITAMIN B",MMAA;MMACHC;MTHFR;MTR;MTRR;MUT,"ANEMIA, FISH TAPEWORM INFESTATION, CELIAC DISEASE",,LAUNCHED,,Small molecule,4,"C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[CO+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1CNC2CC(C)C(C)CC12, C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[CO+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1CNC2CC(C)C(C)CC12",
CYANOPINDOLOL,CYANOPINDOLOL,CHEMBL378501,BRD:BRD-A47884604-051-01-2;BRD:BRD-BRD-A47884604-051-01-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;HTR1A;HTR1D,,,PHASE 2,,Small molecule,NA,CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)cc12;CC(C)(C)NCC(O)COC1CCCC2[NH]C(CC12)C#N,QXIUMMLTJVHILT-UHFFFAOYSA-N
CYANOQUINOLINE 11,CYANOQUINOLINE 11,,CTRP:417415,ctrp,,,,,,,,NA,,
FADRACICLIB,CYC-065;CYC065;FADRACICLIB,CHEMBL4297930,BRD:BRD-K00003404-001-01-9,rep_single_dose,CDK INHIBITOR,,,,,,Unknown,1,,
CYC116,CYC116,,BRD:BRD-BRD-K64866502-001-03-9;BRD:BRD-K64866502-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB;KDR,,,PHASE 1,,,NA,"CC1NC(N)SC1-C1CCNC(NC2CCC(CC2)N2CCOCC2)N1, CC1NC(N)SC1-C1CCNC(NC2CCC(CC2)N2CCOCC2)N1",
CYCLAMIC-ACID,CYCLAMIC-ACID,,BRD:BRD-BRD-K50785021-001-02-1;BRD:BRD-K50785021-001-02-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"OS(=O)(=O)NC1CCCCC1, OS(=O)(=O)NC1CCCCC1, OS(=O)(=O)NC1CCCCC1",
SPASMOCYCLON (3M),CYCLANDELATE;CYCLERGINE;CYCLOBRAL;CYCLOLYT;CYCLOMANDOL;CYCLOSPASMOL;NATIL;NOVODIL;NSC-758910;PEREBRAL;SPASMOCYCLON (3M),CHEMBL1480987,BRD:BRD-A27370296-001-03-0;BRD:BRD-BRD-A27370296-001-03-0,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA2D1;CES1,"CLAUDICATION, ARTERIOSCLEROSIS, RAYNAUD'S DISEASE",,LAUNCHED,,Small molecule,4,"CC1CC(CC(C)(C)C1)OC(=O)C(O)C1CCCCC1, CC1CC(CC(C)(C)C1)OC(=O)C(O)C1CCCCC1, CC1CC(CC(C)(C)C1)OC(=O)C(O)C1CCCCC1;CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1",WZHCOOQXZCIUNC-UHFFFAOYSA-N
NSC-26608,CYCLIZINE;MAREZINE;NSC-26608,CHEMBL648,BRD:BRD-BRD-K79501723-001-04-6;BRD:BRD-K79501723-001-04-6,rep_primary;rep_single_dose,HISTAMINE RECEPTOR MODULATOR,HRH1;SULT1E1,"NAUSEA, VOMITING, VERTIGO, MOTION SICKNESS",,LAUNCHED,,Small molecule,4,"CN1CCN(C(c2ccccc2)c2ccccc2)CC1;CN1CCN(CC1)C(C1CCCCC1)C1CCCCC1, CN1CCN(CC1)C(C1CCCCC1)C1CCCCC1",UVKZSORBKUEBAZ-UHFFFAOYSA-N
TNX-102,CYCLOBENZAPRINE;FLEXERIL;MK-130 (AS THE BASE);TNX-102,CHEMBL669,BRD:BRD-BRD-K42348709-003-13-1;BRD:BRD-K42348709-003-13-1,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST",HTR2A,SPASMS,,LAUNCHED,,Small molecule,4,CN(C)CCC=C1C2CCCCC2C=CC2CCCCC12;CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,JURKNVYFZMSNLP-UHFFFAOYSA-N
CYCLOCREATINE,CYCLOCREATINE,CHEMBL179900,BRD:BRD-BRD-K14379200-001-04-7;BRD:BRD-K14379200-001-04-7,rep_primary;rep_single_dose,CREATINE KINASE SUBSTRATE,,,,PHASE 1,,Small molecule,NA,NC1=NCCN1CC(=O)O;OC(=O)CN1CCNC1=N,AMHZIUVRYRVYBA-UHFFFAOYSA-N
CYCLOCYTIDINE,CYCLOCYTIDINE,,BRD:BRD-BRD-K67536197-003-11-4;BRD:BRD-K67536197-003-11-4,rep_multi_dose;rep_primary;rep_single_dose,"DNA SYNTHESIS INHIBITOR, RNA SYNTHESIS INHIBITOR",,,,PRECLINICAL,,,NA,"OC[C@H]1O[C@@H]2[C@@H](OC3NC(=N)CCN23)[C@@H]1O, OC[C@H]1O[C@@H]2[C@@H](OC3NC(=N)CCN23)[C@@H]1O",
U-4527,CICLOHEXIMIDE;CYCLOHEXIMIDE;GNF-PF-5118;NSC-171;NSC-185;TCMDC-125838;U-4527,CHEMBL123292,BRD:BRD-BRD-K36055864-001-19-2;BRD:BRD-K36055864-001-19-2,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,RPL3,,,PRECLINICAL,,Small molecule,-1,"C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1;C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC1CC(=O)NC(=O)C1, C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC1CC(=O)NC(=O)C1",YPHMISFOHDHNIV-FSZOTQKASA-N
CYCLOPAMINE,[3H]-CYCLOPAMINE;CYCLOPAMINE,CHEMBL254129,BRD:BRD-K58938839-001-06-9;GDSC1:17,gdsc;rep_single_dose,HEDGEHOG PATHWAY INHIBITOR,,,,,,Small molecule,NA,CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C,QASFUMOKHFSJGL-LAFRSMQTSA-N
SU-8341,CYCLOPENTHIAZIDE;NAVIDREX;NSC-107679;SU-8341,CHEMBL1373254,BRD:BRD-A41250306-001-11-7;BRD:BRD-BRD-A41250306-001-11-7,rep_primary;rep_single_dose,THIAZIDE DIURETIC,,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O;NS(=O)(=O)C1CC2C(NC(CC3CCCC3)NS2(=O)=O)CC1CL,BKYKPTRYDKTTJY-UHFFFAOYSA-N
CYCLOPENTOLATE,BELL PENTOLATE;CYCLOPENTOLATE,CHEMBL1201338,BRD:BRD-A77291778-003-22-0;BRD:BRD-BRD-A77291778-003-22-0,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,"MYDRIASIS, CYCLOPLEGIA",,LAUNCHED,,Small molecule,4,CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1;CN(C)CCOC(=O)C(C1CCCCC1)C1(O)CCCC1,SKYSRIRYMSLOIN-UHFFFAOYSA-N
REVIMMUNE,B-518;CICLOFOSFAMIDE;CYCLOBLASTIN;CYCLOPHOSPHAMIDE;CYCLOPHOSPHAMIDE ANHYDROUS;CYCLOPHOSPHAMIDE HYDRATE;CYCLOPHOSPHAMIDE MONOHYDRATE;CYCLOPHOSPHAMIDUM;CYCLOPHOSPHANUM;CYCLOSTIN;CYTOPHOSPHAN;CYTOPHOSPHANE;CYTOXAN;CYTOXAN (LYOPHILIZED);ENDOXAN;ENDOXAN MONOHYDRATE;ENDOXANA;LYOPHILIZED CYTOXAN;NEOSAR;NSC-26271;NSC-756711;PROCYTOX;REVIMMUNE,CHEMBL1200796;CHEMBL88,BRD:BRD-A09722536-002-18-0;BRD:BRD-BRD-A09722536-002-18-0;CTRP:32620;GDSC2:1512,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,CYP2A6;CYP2B6;CYP2C18;CYP2C19;CYP2C8;CYP2C9;CYP2D6;CYP3A4;CYP3A5;CYP3A7,"HODGKIN'S LYMPHOMA, SMALL LYMPHOCYTIC LYMPHOMA (SLL), BREAST CANCER, NEUROBLASTOMA, BURKITT'S LYMPHOMA, MULTIPLE MYELOMA, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), ACUTE MYELOID LEUKEMIA (AML), ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), CHRONIC MYELOID LEUKEMIA (CML), TRUE HISTIOCYTIC LYMPHOMA (THL), RETINOBLASTOMA, OVARIAN CANCER",,LAUNCHED,,Small molecule,4,"CLCCN(CCCL)P1(=O)NCCCO1, CLCCN(CCCL)P1(=O)NCCCO1, CLCCN(CCCL)P1(=O)NCCCO1;O.O=P1(N(CCCl)CCCl)NCCCO1",PWOQRKCAHTVFLB-UHFFFAOYSA-N
CYCLOPIAZONIC-ACID,CYCLOPIAZONIC-ACID,,BRD:BRD-A10420615-001-04-4;BRD:BRD-BRD-A10420615-001-04-4,rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP2A1,,,PRECLINICAL,,,NA,"CC(=O)C1C(=O)[C@@H]2[C@@H]3[C@@H](CC4CCCC5[NH]CC3C45)C(C)(C)N2C1=O, CC(=O)C1C(=O)[C@@H]2[C@@H]3[C@@H](CC4CCCC5[NH]CC3C45)C(C)(C)N2C1=O",
ZINOGRAF ME,27-400;ANTIBIOTIC S-7481F1;ATOPICA;CAPIMUNE;CAPSORIN;CEQUA;CICLOSPORIN;CICLOSPORIN A;CICLOSPORINUM;CYCLOSPORIN;CYCLOSPORIN A;CYCLOSPORIN-A;CYCLOSPORINE;CYCLOSPORINE A;CYCLOSPORINE MICROEMULSION;DEXIMUNE;EQUORAL;GENGRAF;IKERVIS;MITOGARD;MODIFIED;NEOPLANTA;NEORAL;NEUROSTAT;NSC-290193;OL-27-400;OPTIMMUNE;RAMIHYPHIN A;RESTASIS;RESTASIS MULTIDOSE;SANDIMMUN;SANDIMMUNE;SANG-35;SANGCYA;SDZ-OXL-400;VANQUORAL;VERKAZIA;ZINOGRAF ME,CHEMBL160,BRD:BRD-A69815203-001-07-6;BRD:BRD-BRD-A69815203-001-07-6;BRD:BRD-BRD-K13533483-001-16-2;BRD:BRD-K13533483-001-16-2,rep_multi_dose;rep_primary;rep_single_dose,CALCINEURIN INHIBITOR,ABCB11;CAMLG;FPR1;PPIA;PPIF;PPP3CA;PPP3R2;SLC10A1;SLCO1B1;SLCO1B3,"ORGAN REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS",,LAUNCHED,"Multiple values for Indication: {'ORGAN REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS', 'RHEUMATOID ARTHRITIS, PSORIASIS'}, defaulting to 'ORGAN REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS'
Multiple values for SMILES: {'CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C, CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C', 'CCC1NC(=O)C(C(O)C(C)C\\C=C\\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C, CCC1NC(=O)C(C(O)C(C)C\\C=C\\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C'}, defaulting to 'CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C, CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C'
Multiple values for repurposing_target: {'ABCB11;CAMLG;FPR1;PPIA;PPIF;PPP3CA;PPP3R2;SLC10A1;SLCO1B1;SLCO1B3', 'ABCB11;CAMLG;FPR1;PPIA;PPIF;PPP3R2;SLC10A1;SLCO1B1;SLCO1B3'}, taking the union
Multiple values for repurposing_target: {'ABCB11;CAMLG;FPR1;PPIA;PPIF;PPP3CA;PPP3R2;SLC10A1;SLCO1B1;SLCO1B3', 'PPP3CA', 'ABCB11;CAMLG;FPR1;PPIA;PPIF;PPP3R2;SLC10A1;SLCO1B1;SLCO1B3'}, taking the union
Multiple values for structure_id: {'A69815203', 'K13533483'}, defaulting to None",Protein,4,"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C;CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C, CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C",PMATZTZNYRCHOR-CGLBZJNRSA-N
NSC-26727,CYCLOVALONE;DIVANILLIDEN CYCLOHEXANONE;NSC-26727,CHEMBL17205;CHEMBL2362372,BRD:BRD-BRD-K59866480-001-07-3;BRD:BRD-K59866480-001-07-3,rep_multi_dose;rep_primary;rep_single_dose,BREAST CANCER RESISTANCE PROTEIN INHIBITOR,ABCG2,BILE STIMULATION,,LAUNCHED,,Small molecule,-1,"COc1cc(C=C2CCCC(=Cc3ccc(O)c(OC)c3)C2=O)ccc1O;COC1CC(CCC1O)\C=C1/CCC\C(C1=O)=C/C1CCC(O)C(OC)C1, COC1CC(CCC1O)\C=C1/CCC\C(C1=O)=C/C1CCC(O)C(OC)C1",DHKKONBXGAAFTB-UHFFFAOYSA-N
CYCLOVIROBUXIN-D,CYCLOVIROBUXIN-D,,BRD:BRD-BRD-K27799744-001-02-8;BRD:BRD-K27799744-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL MODULATOR,,,,PRECLINICAL,,,NA,"CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](NC)C4(C)C, CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](NC)C4(C)C",
CYCLUC1,CYCLUC1,,BRD:BRD-K00005335-001-01-9,rep_single_dose,,,,,,,,NA,,
CYM-50260,CYM-50260,,BRD:BRD-BRD-K69877120-001-01-7;BRD:BRD-K69877120-001-01-7,rep_primary;rep_single_dose,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",S1PR4,,,PRECLINICAL,"Multiple values for MOA: {'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST', 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'}, defaulting to 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'",,NA,FCC1CCC(OCCOC2CCC(CL)CC2CL)C(CL)N1,
CYM-50358,CYM-50358,,BRD:BRD-BRD-K80666802-003-01-0;BRD:BRD-K80666802-003-01-0,rep_primary;rep_single_dose,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,S1PR4,,,PRECLINICAL,,,NA,CC1CC(CN)CC(C)C1NC(=O)C1CCC(O1)-C1CC(CL)CCC1CL,
CYM-50769,CYM-50769,,BRD:BRD-BRD-K27732927-001-03-6;BRD:BRD-K27732927-001-03-6,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPBWR1,,,PRECLINICAL,,,NA,COC1CCC(OC2C(CL)CNN(C3C4CCCCC4-C4CCCCC34)C2=O)CC1,
CYM-5442,CYM-5442,,BRD:BRD-A43005764-003-01-5;BRD:BRD-BRD-A43005764-003-01-5,rep_primary;rep_single_dose,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",S1PR1,,,PRECLINICAL,"Multiple values for MOA: {'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST', 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'}, defaulting to 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'",,NA,CCOC1CCC(CC1OCC)-C1NC(NO1)-C1CCCC2C(CCC12)NCCO,
CYM-5520,CYM-5520,,BRD:BRD-BRD-K29151923-001-01-5;BRD:BRD-K29151923-001-01-5,rep_primary;rep_single_dose,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",S1PR2,,,PRECLINICAL,"Multiple values for MOA: {'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST', 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'}, defaulting to 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'",,NA,CC1CC(C(=O)CN2CC(CCC2=O)C#N)C(C)N1CC1CCCCC1,
CYM-5541,CYM-5541,,BRD:BRD-K75940276-001-04-9,rep_single_dose,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,S1PR3,,,,,,NA,,
CYPROHEPTADINE,CIPROVIT;CYPROHEPTADINE,CHEMBL516,BRD:BRD-BRD-K28143534-001-02-2;BRD:BRD-BRD-K28143534-003-25-9;BRD:BRD-K28143534-001-02-2;BRD:BRD-K28143534-003-25-9,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;CHRM1;CHRM2;CHRM3;HRH1;HTR2A;HTR2C;HTR6;HTR7,"ALLERGIC RHINITIS, VASOMOTOR RHINITIS, CONJUNCTIVITIS, URTICARIA, DERMATOGRAPHISM",,LAUNCHED,,Small molecule,4,"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1;CN1CCC(CC1)=C1C2CCCCC2C=CC2CCCCC12, CN1CCC(CC1)=C1C2CCCCC2C=CC2CCCCC12, CN1CCC(CC1)=C1C2CCCCC2C=CC2CCCCC12, CN1CCC(CC1)=C1C2CCCCC2C=CC2CCCCC12",JJCFRYNCJDLXIK-UHFFFAOYSA-N
CYPROTERONE-ACETATE,CYPROTERONE-ACETATE,,BRD:BRD-BRD-K41141507-001-16-2;BRD:BRD-K41141507-001-16-2;BRD:BRD-K41141507-001-18-9,rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,ADORA1;AR,PROSTATE CANCER,,LAUNCHED,,,NA,"CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(CL)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O, CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(CL)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O, CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(CL)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O",
NSC-759268,CGA 72662;CGA-72662;CYROMAZINE;NEPOREX;NSC-759268,CHEMBL1231107,BRD:BRD-BRD-K36711084-001-02-0;BRD:BRD-K36711084-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,"Nc1nc(N)nc(NC2CC2)n1;NC1NC(N)NC(NC2CC2)N1, NC1NC(N)NC(NC2CC2)N1",LVQDKIWDGQRHTE-UHFFFAOYSA-N
PROCYSBI,CYSTAGON;CYSTEAMINE;L-1573;MEA;MERCAPTAMINE;NSC-647528;PROCYSBI,CHEMBL602,BRD:BRD-K92611362-003-03-9,rep_single_dose,TISSUE TRANSGLUTAMINASE INHIBITOR,NPY2R;SST,,,,,Small molecule,4,NCCS,UFULAYFCSOUIOV-UHFFFAOYSA-N
LEXIBULIN,CYT 997;CYT-997;CYT997;LEXIBULIN,CHEMBL552212,BRD:BRD-BRD-K23363278-001-02-1;BRD:BRD-K23363278-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB,,,PHASE 2,,Small molecule,2,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1;CCC[C@H](NC1NC(NCC1C)-C1CCC(NC(=O)NCC)C(OC)C1)C1CCCNC1,MTJHLONVHHPNSI-IBGZPJMESA-N
MOMELOTINIB DIHYDROCHLORIDE,CYT-0387;CYT-11387;CYT-387;CYT-387 DIHYDROCHLORIDE;CYT387;CYT387 DIHYDROCHLORIDE;GS-0387;LM-1149;MOMELOTINIB;MOMELOTINIB DIHYDROCHLORIDE,CHEMBL1078178;CHEMBL2219411,BRD:BRD-BRD-K87737963-001-06-0;BRD:BRD-K87737963-001-06-0;BRD:BRD-K87737963-001-12-9;CTRP:660429,ctrp;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,"INHIBITOR OF JAK1, JAK2 AND ALK2",ALK2;JAK1;JAK2;JAK3,,,PHASE 3,"Multiple values for MOA: {'INHIBITOR OF JAK1, JAK2 AND ALK2', 'JAK INHIBITOR'}, defaulting to 'INHIBITOR OF JAK1, JAK2 AND ALK2'
Multiple values for repurposing_target: {'ALK2;JAK1;JAK2', 'JAK1;JAK2;JAK3'}, taking the union",Small molecule,1,"Cl.Cl.N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1;O=C(NCC#N)C1CCC(CC1)-C1CCNC(NC2CCC(CC2)N2CCOCC2)N1, O=C(NCC#N)C1CCC(CC1)-C1CCNC(NC2CCC(CC2)N2CCOCC2)N1",IPNATXQRPWRHKD-UHFFFAOYSA-N
U-19920A,CYTARABINE HCL;CYTARABINE HYDROCHLORIDE;CYTOSINE ARABINOSIDE HYDROCHLORIDE;NSC-63878;U-19920A,CHEMBL1256472,CTRP:62690,ctrp,,,,,,,Small molecule,3,Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,KCURWTAZOZXKSJ-JBMRGDGGSA-N
ULEXINE,6039 SOPHARMA;BAPTITOXINE;CYTISINE;CYTISINICLINE;CYTITON;NSC-407282;SOPHORINE;TABEX;ULEXINE,CHEMBL497939,BRD:BRD-BRD-K74186897-001-12-4;BRD:BRD-BRD-K74186897-001-13-2;BRD:BRD-K74186897-001-12-4;BRD:BRD-K74186897-001-13-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA2;CHRNA3;CHRNA4;CHRNA6;CHRNA7;CHRNB2;CHRNB4,NICOTINISM,,LAUNCHED,,Small molecule,3,"O=C1CCCC2[C@H]3CNC[C@H](C3)CN12, O=C1CCCC2[C@H]3CNC[C@H](C3)CN12, O=C1CCCC2[C@H]3CNC[C@H](C3)CN12, O=C1CCCC2[C@H]3CNC[C@H](C3)CN12;O=c1cccc2n1C[C@@H]1CNC[C@H]2C1",ANJTVLIZGCUXLD-DTWKUNHWSA-N
CYTOCHALASIN B,CYTOCHALASIN B,CHEMBL411729,CTRP:50163,ctrp,,,,,,,Small molecule,NA,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/[C@H](O)CCC[C@@H](C)C/C=C/[C@H]3[C@@H]1O,GBOGMAARMMDZGR-TYHYBEHESA-N
CYTOCHALASIN-B,CYTOCHALASIN-B,,BRD:BRD-BRD-K47000838-001-01-6;BRD:BRD-K47000838-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,MICROTUBULE INHIBITOR,ACTB,,,PHASE 2,,,NA,C[C@H]1[C@H]2[C@H](CC3CCCCC3)NC(=O)[C@]22OC(=O)\C=C/[C@H](O)CCC[C@@H](C)C\C=C\[C@H]2[C@H](O)C1=C,
NSC-371331,5-CLDC;CYTOCHLOR;NSC-371331,CHEMBL4297275,BRD:BRD-BRD-K48988407-001-01-2;BRD:BRD-K48988407-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,1,Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Cl;NC1NC(=O)N(CC1CL)[C@H]1C[C@@H](O)[C@@H](CO)O1,NGGRGTWYSXYVDK-RRKCRQDMSA-N
CZC-54252,CZC-54252,,BRD:BRD-BRD-K87021635-003-02-2;BRD:BRD-K87021635-003-02-2,rep_primary;rep_single_dose,LEUCINE RICH REPEAT KINASE INHIBITOR,LRRK2,,,PRECLINICAL,,,NA,COC1CC(CCC1NC1NCC(CL)C(NC2CCCCC2NS(C)(=O)=O)N1)N1CCOCC1,
CZC24832,CZC24832,,BRD:BRD-BRD-K01377300-001-01-1;BRD:BRD-K01377300-001-01-1;GDSC2:1615,gdsc;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CG,,,PRECLINICAL,,,NA,"CC(C)(C)NS(=O)(=O)C1CNCC(C1)-C1CC(F)C2NC(N)NN2C1, CC(C)(C)NS(=O)(=O)C1CNCC(C1)-C1CC(F)C2NC(N)NN2C1",
"MEVALONIC-D,-L-ACID-LACTONE","D,L-MEVALONIC-ACID-LACTONE;MEVALONIC-D,-L-ACID-LACTONE",,BRD:BRD-A05674712-001-06-0;BRD:BRD-BRD-A05674712-001-06-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC1(O)CCOC(=O)C1,
D-(+)-MALTOSE,D-(+)-MALTOSE,,BRD:BRD-BRD-K74377520-001-01-7;BRD:BRD-K74377520-001-01-7,rep_primary;rep_single_dose,,AMY2B;MGAM,,,PRECLINICAL,,,NA,OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,
GARSORASIB,D 1553;D-1553;GARSORASIB,CHEMBL5095066,BRD:BRD-U00115419-001-01-9,oncref_1,INHIBITOR OF KRAS-G12C,KRAS,,,,,Small molecule,-1,C=CC(=O)N1C[C@H](C)N(c2nc(=O)n(-c3c(C4CC4)ncnc3C3CC3)c3nc(-c4c(N)cccc4F)c(F)cc23)C[C@H]1C,DKFRWZJCNPETGI-SJORKVTESA-N
D-157495,D-157495,,BRD:BRD-K29066607-001-02-9,rep_single_dose,DECAPPING SCAVENGER ENZYME INHIBITOR,,,,,,,NA,,
D-3263 (FREE BASE),D 3263;D-3263;D-3263 (FREE BASE),CHEMBL3707315,BRD:BRD-K00003205-003-01-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,,,,,,Small molecule,1,,
D-4476,D-4476,,BRD:BRD-BRD-K09132007-001-07-5;BRD:BRD-K09132007-001-07-5,rep_multi_dose;rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,CSNK1A1;CSNK1D;TGFB1,,,PRECLINICAL,,,NA,"NC(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCCCN1)-C1CCC2OCCOC2C1, NC(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCCCN1)-C1CCC2OCCOC2C1",
D-64131,D-64131,,BRD:BRD-BRD-K26997899-001-02-2;BRD:BRD-K26997899-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,MICROTUBULE INHIBITOR,TUBB,,,PRECLINICAL,,,NA,COC1CCC2[NH]C(CC2C1)C(=O)C1CCCCC1,
D-7193,D-7193,,BRD:BRD-BRD-K32372024-001-01-0;BRD:BRD-K32372024-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CC(=O)N[C@@H](CSSC[C@H](NC(C)=O)C(O)=O)C(O)=O,
D-ALPHA-TOCOPHERYL-SUCCINATE,D-ALPHA-TOCOPHERYL-SUCCINATE,,BRD:BRD-BRD-K64636206-001-02-7;BRD:BRD-K64636206-001-02-7,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2C(C)C(OC(=O)CCC(O)=O)C(C)C(C)C2O1,
D-DELTA-TOCOPHEROL,D-DELTA-TOCOPHEROL,,BRD:BRD-BRD-K04657451-001-01-0;BRD:BRD-K04657451-001-01-0,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2CC(O)CC(C)C2O1,
D-PHENYLALANINE,D-PHENYLALANINE,CHEMBL379630,BRD:BRD-BRD-K00911807-003-01-2;BRD:BRD-K00911807-003-01-2,rep_primary;rep_single_dose,ENKEPHALINASE INHIBITOR,CCBL1;CRH;HCAR3,,,PRECLINICAL,,Small molecule,NA,"N[C@H](Cc1ccccc1)C(=O)O;N[C@H](CC1CCCCC1)C(O)=O, N[C@H](CC1CCCCC1)C(O)=O, N[C@H](CC1CCCCC1)C(O)=O",COLNVLDHVKWLRT-MRVPVSSYSA-N
D-SERINE,D-SERINE,,BRD:BRD-BRD-K71822263-001-03-2;BRD:BRD-K71822263-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GLRA1;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;SERPINB3,,,LAUNCHED,,,NA,N[C@H](CO)C(O)=O,
D609,D609,,BRD:BRD-A77118605-237-09-5,rep_single_dose,PHOSPHOLIPASE INHIBITOR,,,,,,,NA,,
DAA-1106,DAA-1106,,BRD:BRD-BRD-K01080633-001-01-9;BRD:BRD-K01080633-001-01-9,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,TSPO,,,PRECLINICAL,,,NA,COC1CCC(OC)C(CN(C(C)=O)C2CC(F)CCC2OC2CCCCC2)C1,
PRADAXA (DABIGATRAN),BIBR 953 ZW;BIBR-953;BIBR-953-ZW;DABIGATRAN;PRADAXA;PRADAXA (DABIGATRAN),CHEMBL48361,BRD:BRD-BRD-K38168441-001-03-7;BRD:BRD-K38168441-001-03-7,rep_primary;rep_single_dose,THROMBIN INHIBITOR,F2,"STROKE, SYSTEMIC EMBOLISM, PULMONARY EMBOLISM (PE), DEEP VEIN THROMBOSIS (DVT)",,LAUNCHED,,Small molecule,3,"Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21;CN1C(CNC2CCC(CC2)C(N)=N)NC2CC(CCC12)C(=O)N(CCC(O)=O)C1CCCCN1, CN1C(CNC2CCC(CC2)C(N)=N)NC2CC(CCC12)C(=O)N(CCC(O)=O)C1CCCCN1, CN1C(CNC2CCC(CC2)C(N)=N)NC2CC(CCC12)C(=O)N(CCC(O)=O)C1CCCCN1, CN1C(CNC2CCC(CC2)C(N)=N)NC2CC(CCC12)C(=O)N(CCC(O)=O)C1CCCCN1",YBSJFWOBGCMAKL-UHFFFAOYSA-N
DABIGATRAN-ETEXILATE,DABIGATRAN-ETEXILATE,,BRD:BRD-BRD-K57041787-001-02-6;BRD:BRD-K57041787-001-02-6,rep_primary;rep_single_dose,THROMBIN INHIBITOR,F2,"STROKE, SYSTEMIC EMBOLISM, PULMONARY EMBOLISM (PE), DEEP VEIN THROMBOSIS (DVT)",,LAUNCHED,,,NA,"CCCCCCOC(=O)\N=C(\N)C1CCC(NCC2NC3CC(CCC3N2C)C(=O)N(CCC(=O)OCC)C2CCCCN2)CC1, CCCCCCOC(=O)\N=C(\N)C1CCC(NCC2NC3CC(CCC3N2C)C(=O)N(CCC(=O)OCC)C2CCCCN2)CC1",
TAFINLAR,DABRAFENIB;GSK-2118436;GSK-2118436A;GSK2118436;GSK2118436A;TAFINLAR,CHEMBL2028663,BRD:BRD-BRD-K09951645-001-06-8;BRD:BRD-K09951645-001-06-8;BRD:BRD-K09951645-001-11-8;BRD:BRD-K09951645-001-14-9;CTRP:687954;GDSC1:1373;GDSC2:1373,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF BRAF,BRAF;LIMK1;NEK11;RAF1;SIK1,MELANOMA,,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF BRAF', 'RAF INHIBITOR'}, defaulting to 'INHIBITOR OF BRAF'
Multiple values for repurposing_target: {'BRAF;LIMK1;NEK11;RAF1;SIK1', 'BRAF'}, taking the union",Small molecule,4,"CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1;CC(C)(C)C1NC(C(S1)-C1CCNC(N)N1)-C1CCCC(NS(=O)(=O)C2C(F)CCCC2F)C1F, CC(C)(C)C1NC(C(S1)-C1CCNC(N)N1)-C1CCCC(NS(=O)(=O)C2C(F)CCCC2F)C1F, CC(C)(C)C1NC(C(S1)-C1CCNC(N)N1)-C1CCCC(NS(=O)(=O)C2C(F)CCCC2F)C1F",BFSMGDJOXZAERB-UHFFFAOYSA-N
RO-115-1240,DABUZALGRON;RO 115-1240;RO-115-1240,CHEMBL257978,BRD:BRD-K00073934-001-02-9,rep_single_dose,,,,,,,Small molecule,2,Cc1c(OCC2=NCCN2)ccc(Cl)c1NS(C)(=O)=O,FOYWMEJSRSBQGB-UHFFFAOYSA-N
NSC-45388,BIOCARBAZINE R;DACARBASINE;DACARBAZINE;DACARBAZINUM;DECARBAZINE;DIC;DICARBAZINE;DTIC;DTIC-DOME;NCI C04717;NSC-45388,CHEMBL476,BRD:BRD-BRD-K35520305-001-17-7;BRD:BRD-K35520305-001-16-9;BRD:BRD-K35520305-001-17-7;CTRP:32622,ctrp;rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,PGD;POLA2,"MELANOMA, HODGKIN'S LYMPHOMA",,LAUNCHED,,Small molecule,4,"CN(C)/N=N/c1[nH]cnc1C(N)=O;CN(C)\N=N\C1[NH]CNC1C(N)=O, CN(C)\N=N\C1[NH]CNC1C(N)=O",FDKXTQMXEQVLRF-ZHACJKMWSA-N
NVP-LAQ824,DACINOSTAT;LAQ-824;LAQ824;NVP-LAQ824,CHEMBL356066,BRD:BRD-BRD-K56957086-001-06-3;BRD:BRD-K56957086-001-06-3;GDSC1:200,gdsc;rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9,,,PHASE 1,,Small molecule,-1,"O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO;OCCN(CCC1C[NH]C2CCCCC12)CC1CCC(\C=C\C(=O)NO)CC1, OCCN(CCC1C[NH]C2CCCCC12)CC1CCC(\C=C\C(=O)NO)CC1",BWDQBBCUWLSASG-MDZDMXLPSA-N
EBP-883,BMS 790052;BMS-790052;DACLATASVIR;DAKLINZA;EBP 883;EBP-883,CHEMBL2023898,BRD:BRD-BRD-K82861010-001-02-5;BRD:BRD-K82861010-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,HCV INHIBITOR,,HEPATITIS C,,LAUNCHED,,Small molecule,4,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1NCC([NH]1)-C1CCC(CC1)-C1CCC(CC1)-C1CNC([NH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C;COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,FKRSSPOQAMALKA-CUPIEXAXSA-N
VIZIMPRO,DACOMITINIB;DACOMITINIB HYDRATE;DACOMITINIB MONOHYDRATE;PF-00299804;PF-00299804-03;VIZIMPRO,CHEMBL2105719;CHEMBL2110732,BRD:BRD-BRD-K57169635-001-04-5;BRD:BRD-K57169635-001-04-5,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2;ERBB4,,,PHASE 3,,Small molecule,4,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O;COC1CC2NCNC(NC3CCC(F)C(CL)C3)C2CC1NC(=O)\C=C\CN1CCCCC1,BSPLGGCPNTZPIH-IPZCTEOASA-N
ONCOSTATIN K,ACTINOMYCIN C1;ACTINOMYCIN D;ACTINOMYCIN I1;ACTINOMYCIN IV;ACTINOMYCIN X1;ACTINOMYCIN-D;COSMEGEN;COSMEGEN LYOVAC;DACTINOMYCIN;DACTINOMYCINUM;DILACTONE ACTINOMYCIN D ACID;GNF-PF-1977;GNF-PF-2290;MERACTINOMYCIN;NCI-C04682;NSC-3053;ONCOSTATIN K,CHEMBL1554,BRD:BRD-BRD-K70578146-001-06-7;BRD:BRD-K70578146-001-06-7;GDSC2:1811;GDSC2:1911,gdsc;rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,POLR2A,"TESTICULAR CARCINOMA, WILM'S TUMOR, RHABDOMYOSARCOMA, EWING'S SARCOMA, GESTATIONAL TROPHOBLASTIC DISEASE (GTD)",,LAUNCHED,,Protein,4,CC(C)[C@H]1NC(=O)[C@@H](NC(=O)C2CCC(C)C3OC4C(C)C(=O)C(N)C(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@H](NC5=O)C(C)C)C4NC23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O;Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,RJURFGZVJUQBHK-IIXSONLDSA-N
RTB101,BEZ-235;BEZ235;DACTOLISIB;NSC-751249;NVP-BEZ-235;NVP-BEZ235;NVP-BEZ235-NX;RTB-101;RTB101,CHEMBL1879463,GDSC1:1057;GDSC2:1057,gdsc,,,,,,,Small molecule,3,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
DAIDZEIN,"4',7-DIHYDROXYISOFLAVONE;DAIDZEIN",CHEMBL8145,BRD:BRD-BRD-K42095107-001-17-1;BRD:BRD-K42095107-001-17-1,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESRRA;ESRRB;ESRRG;TRPC5,,,PHASE 2,,Small molecule,2,"O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12;OC1CCC(CC1)-C1COC2CC(O)CCC2C1=O, OC1CCC(CC1)-C1COC2CC(O)CCC2C1=O, OC1CCC(CC1)-C1COC2CC(O)CCC2C1=O, OC1CCC(CC1)-C1COC2CC(O)CCC2C1=O, OC1CCC(CC1)-C1COC2CC(O)CCC2C1=O",ZQSIJRDFPHDXIC-UHFFFAOYSA-N
DAIDZIN,DADZIN;DAIDZIN,CHEMBL486422,BRD:BRD-K12979078-001-02-9,rep_single_dose,ANTIOXIDANT,ALDH2,,,,,Small molecule,NA,O=c1c(-c2ccc(O)cc2)coc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12,KYQZWONCHDNPDP-QNDFHXLGSA-N
DALARGIN,DALARGIN,,BRD:BRD-A89196962-300-01-7;BRD:BRD-BRD-A89196962-300-01-7,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRM1,,,PHASE 2,,,NA,CC(C)CC(NC(=O)C(CC1CCCCC1)NC(=O)CNC(=O)[C@H](C)NC(=O)C(N)CC1CCC(O)CC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O,
ZEVEN,"A-A-1;BI-397;BI397;DALBAVANCIN;MDL 64,397;MDL-64397;VER-001;VER001;VERO001;ZEVEN",CHEMBL3301669,BRD:BRD-K30177383-001-02-9,rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,PNLIP,,,,,Unknown,4,CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O,KGPGQDLTDHGEGT-SZUNQUCBSA-N
RO4607381,DALCETRAPIB;JTT-705;RO-4607381;RO4607381,CHEMBL313006,BRD:BRD-BRD-K18849474-001-04-4;BRD:BRD-K18849474-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,CETP,,,PHASE 3,,Small molecule,3,"CCC(CC)CC1(C(=O)Nc2ccccc2SC(=O)C(C)C)CCCCC1;CCC(CC)CC1(CCCCC1)C(=O)NC1CCCCC1SC(=O)C(C)C, CCC(CC)CC1(CCCCC1)C(=O)NC1CCCCC1SC(=O)C(C)C",YZQLWPMZQVHJED-UHFFFAOYSA-N
NSC-15041,AMPYRA;AMPYRA EXTENDED RELEASE;DALFAMPRIDINE;EL-970;FAMPRIDINE;FAMPRIDINE (4-AMINOPYRIDINE);FAMPYRA;NEURELAN;NSC-15041,CHEMBL284348,BRD:BRD-BRD-K22482860-001-21-4;BRD:BRD-K22482860-001-21-4,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNA1;KCNA10;KCNA2;KCNA3;KCNA4;KCNA5;KCNA6;KCNA7;KCNB1;KCNB2;KCNC1;KCNC2;KCNC3;KCNC4;KCND1;KCND2;KCND3;KCNF1;KCNG1;KCNG2;KCNG3;KCNG4;KCNH1;KCNH2;KCNH3;KCNH4;KCNH5;KCNH6;KCNH7;KCNH8;KCNJ13;KCNJ5;KCNQ1;KCNQ2;KCNQ3;KCNQ4;KCNQ5;KCNS1;KCNS2;KCNS3;KCNV1;KCNV2,MULTIPLE SCLEROSIS,,LAUNCHED,,Small molecule,4,"Nc1ccncc1;NC1CCNCC1, NC1CCNCC1",NUKYPUAOHBNCPY-UHFFFAOYSA-N
RP-54476,DALFOPRISTIN;RP 54476;RP-54476,CHEMBL1200937,BRD:BRD-K00003321-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,4,CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12,SUYRLXYYZQTJHF-VMBLUXKRSA-N
SKF96148,BM 13.505;BM-13505;BM13505;DALTROBAN;SK&F 96148;SKF-96148;SKF96148,CHEMBL71685,BRD:BRD-BRD-K26813177-001-03-2;BRD:BRD-K26813177-001-03-2,rep_primary;rep_single_dose,THROMBOXANE RECEPTOR ANTAGONIST,TBXA2R,,,PHASE 3,,Small molecule,-1,O=C(O)Cc1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1;OC(=O)CC1CCC(CCNS(=O)(=O)C2CCC(CL)CC2)CC1,IULOBWFWYDMECP-UHFFFAOYSA-N
DAMINOZIDE,DAMINOZIDE,,BRD:BRD-K83452553-001-07-9,rep_single_dose,KDM2A INHIBITOR,KDM2A;KDM7A;PHF8,,,,,,NA,,
WIN-17757,"DANAZOL;DANOCRINE;NSC-270916;WIN 17,757;WIN-17757",CHEMBL1479,BRD:BRD-A92537424-001-04-7;BRD:BRD-BRD-A92537424-001-04-7,rep_multi_dose;rep_primary;rep_single_dose,"ESTROGEN RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR AGONIST",AR;CCL2;ESR1;GNRHR;GNRHR2;PGR,"ENDOMETRIOSIS, ANGIOEDEMA",,LAUNCHED,,Small molecule,4,C[C@]12CCC3C(CCC4=CC5ONCC5C[C@]34C)C1CC[C@@]2(O)C#C;C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,POZRVZJJTULAOH-LHZXLZLDSA-N
ZP1609,DANEGAPTIDE;GAP-134;ZP-1609;ZP1609,CHEMBL560592,BRD:BRD-BRD-K35589454-003-01-1;BRD:BRD-K35589454-003-01-1,rep_primary;rep_single_dose,GAP JUNCTION MODULATOR,,,,PHASE 2,,Small molecule,3,NCC(=O)N1C[C@@H](C[C@H]1C(O)=O)NC(=O)C1CCCCC1;NCC(=O)N1C[C@H](NC(=O)c2ccccc2)C[C@H]1C(=O)O,BIZKIHUJGMSVFD-MNOVXSKESA-N
GSK1325756B,DANIRIXIN;GSK-1325756B;GSK1325756;GSK1325756B,CHEMBL3039531,BRD:BRD-BRD-K13769342-001-01-5;BRD:BRD-K13769342-001-01-5,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR2,,,PHASE 2,,Small molecule,2,CC1C(F)CCCC1NC(=O)NC1CCC(CL)C(C1O)S(=O)(=O)[C@H]1CCCNC1;Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O,NGYNBSHYFOFVLS-LBPRGKRZSA-N
DANOFLOXACIN,ADVOCIN;DANOFLOXACIN,CHEMBL157548,BRD:BRD-BRD-K45916615-066-02-5;BRD:BRD-K45916615-066-02-5,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,BOVINE RESPIRATORY DISEASE (BRD),,LAUNCHED,,Small molecule,-1,CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1;CN1C[C@@H]2C[C@H]1CN2C1CC2N(CC(C(O)=O)C(=O)C2CC1F)C1CC1,QMLVECGLEOSESV-RYUDHWBXSA-N
RO5190591,DANOPREVIR;R-05190591;R05190591;RO-5190591;RO5190591,CHEMBL258734,BRD:BRD-BRD-K08111240-001-02-8;BRD:BRD-K08111240-001-02-8,rep_primary;rep_single_dose,HCV INHIBITOR,,,,PHASE 2,,Small molecule,3,CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\[C@@H]2C[C@@]2(C(=O)NS(=O)(=O)C2CC2)NC(=O)[C@@H]2C[C@@H](OC(=O)N3Cc4cccc(F)c4C3)CN2C1=O;CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1CC2CCCC(F)C2C1)C(=O)NS(=O)(=O)C1CC1,ZVTDLPBHTSMEJZ-JSZLBQEHSA-N
SHA-458100,2-METHYLBENZOIC ACID ANILIDE;BAS-305;BAS-3050;BAS-3050F;BEBENIL;DANTROLENE;F-368;MEBENIL;NSC-227402;NSC-26404;O-METHYLBENZANILIDE;O-TOLUANILIDE;SHA-458100,CHEMBL1201288,BRD:BRD-BRD-K81272440-236-13-5;BRD:BRD-K81272440-236-13-5,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,RYR1;RYR3,"SPASMS, MALIGNANT HYPERTHERMIA (MH)",,LAUNCHED,,Small molecule,4,"[O-][N+](=O)C1CCC(CC1)-C1CCC(\C=N\N2CC(=O)NC2=O)O1, [O-][N+](=O)C1CCC(CC1)-C1CCC(\C=N\N2CC(=O)NC2=O)O1;O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1",OZOMQRBLCMDCEG-VIZOYTHASA-N
PILULES VINCHY N.F.,CHRYSAZIN;DANTHRON;DANTRON;DORBANE;ISTIZIN;NSC-38626;NSC-646568;PILULES VINCHY N.F.,CHEMBL53418,BRD:BRD-BRD-K10065684-001-07-4;BRD:BRD-K10065684-001-07-4,rep_primary;rep_single_dose,LAXATIVE,,,,WITHDRAWN,,Small molecule,4,O=C1c2cccc(O)c2C(=O)c2c(O)cccc21;OC1CCCC2C(=O)C3CCCC(O)C3C(=O)C12,QBPFLULOKWLNNW-UHFFFAOYSA-N
PHA-739358,DANUSERTIB;PHA-739358,CHEMBL402548,BRD:BRD-BRD-K07881437-001-03-8;BRD:BRD-BRD-K07881437-001-04-6;BRD:BRD-K07881437-001-03-8;BRD:BRD-K07881437-001-04-6,rep_multi_dose;rep_primary;rep_single_dose,"AURORA KINASE INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR",AURKA;AURKB;AURKC;FGFR1;NTRK1;RET;SLK,,,PHASE 2,,Small molecule,2,"CO[C@@H](C(=O)N1CC2[NH]NC(NC(=O)C3CCC(CC3)N3CCN(C)CC3)C2C1)C1CCCCC1, CO[C@@H](C(=O)N1CC2[NH]NC(NC(=O)C3CCC(CC3)N3CCN(C)CC3)C2C1)C1CCCCC1;CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1",XKFTZKGMDDZMJI-HSZRJFAPSA-N
LYN-045,BMS-512148;BMS-512148-05;DAPAGLIFLOZIN;DAPAGLIFLOZIN PROPANEDIOL;DAPAGLIFLOZIN PROPYLENE GLYCOL;FARXIGA;FORXIGA;LYN-045,CHEMBL2103802;CHEMBL429910,BRD:BRD-BRD-K58160573-001-05-4;BRD:BRD-K58160573-001-05-4,rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,SLC5A1;SLC5A2,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1;CCOC1CCC(CC2CC(CCC2CL)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC1, CCOC1CCC(CC2CC(CCC2CL)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC1",JVHXJTBJCFBINQ-ADAARDCZSA-N
OLT1177,DAPANSUTRILE;OLT-1177;OLT1177,CHEMBL3989943,BRD:BRD-K00004659-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,2,CS(=O)(=O)CCC#N,LQFRYKBDZNPJSW-UHFFFAOYSA-N
TCMDC-125839,DAPHNETIN;TCMDC-125839,CHEMBL244948,BRD:BRD-BRD-K61269089-001-05-5;BRD:BRD-K61269089-001-05-5,rep_primary;rep_single_dose,PROTEIN KINASE INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,O=c1ccc2ccc(O)c(O)c2o1;OC1CCC2CCC(=O)OC2C1O,ATEFPOUAMCWAQS-UHFFFAOYSA-N
DAPIPRAZOLE,DAPIPRAZOLE,CHEMBL1201216,BRD:BRD-BRD-K33133047-001-01-8;BRD:BRD-K33133047-001-01-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D,MYDRIASIS,,LAUNCHED,,Small molecule,4,CC1CCCCC1N1CCN(CCC2NNC3CCCCN23)CC1;Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1,RFWZESUMWJKKRN-UHFFFAOYSA-N
TMC-120,AIDS-105293;DAPIVIRINE;GEL-02;R-147681;TMC-120,CHEMBL70663,BRD:BRD-BRD-K12885236-001-02-7;BRD:BRD-K12885236-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,CYP3A4;CYP3A5,,,PHASE 3,,Small molecule,3,Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1;CC1CC(C)C(NC2CCNC(NC3CCC(CC3)C#N)N2)C(C)C1,ILAYIAGXTHKHNT-UHFFFAOYSA-N
K 22.175,APO 866;APO-866;APO866;DAPORINAD;FK 866;FK-866;K 22.175,CHEMBL566757,CTRP:418166;GDSC1:1248;GDSC2:1248,ctrp;gdsc,,,,,,,Small molecule,2,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,KPBNHDGDUADAGP-VAWYXSNFSA-N
LY-210448,DAPOXETINE;KUTUB;LY-210448,CHEMBL2110900,BRD:BRD-BRD-K51579475-003-02-4;BRD:BRD-K51579475-003-02-4,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),HTR1A;HTR1B;HTR2C;SLC6A4,PREMATURE EJACULATION (PE),,LAUNCHED,,Small molecule,4,CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1;CN(C)[C@@H](CCOC1CCCC2CCCCC12)C1CCCCC1,USRHYDPUVLEVMC-FQEVSTJZSA-N
GSK1278863,DAPRODUSTAT;GSK-1278863;GSK1278863,CHEMBL3544988,BRD:BRD-BRD-K06455935-001-01-3;BRD:BRD-K06455935-001-01-3,rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,EGLN1,,,PHASE 3,,Small molecule,3,O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O;OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,RUEYEZADQJCKGV-UHFFFAOYSA-N
SERVIDAPSON,ACZONE;DAPSONE;DAPSONUM;DIAMINODIPHENYLSULFONE;DIAPHENYLSULFONE;J04BA02;NOVOPHONE;NSC-6091;NSC-6091D;SERVIDAPSON,CHEMBL1043,BRD:BRD-BRD-K62363391-001-24-9;BRD:BRD-K62363391-001-24-9,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,DHFR,"DERMATITIS HERPETIFORMIS (DH), LEPROSY",,LAUNCHED,,Small molecule,4,NC1CCC(CC1)S(=O)(=O)C1CCC(N)CC1;Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,MQJKPEGWNLWLTK-UHFFFAOYSA-N
DAPT,DAPT,,BRD:BRD-BRD-K47177710-001-03-1;BRD:BRD-K47177710-001-03-1,rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,,,,PRECLINICAL,,,NA,"C[C@H](NC(=O)CC1CC(F)CC(F)C1)C(=O)N[C@H](C(=O)OC(C)(C)C)C1CCCCC1, C[C@H](NC(=O)CC1CC(F)CC(F)C1)C(=O)N[C@H](C(=O)OC(C)(C)C)C1CCCCC1, C[C@H](NC(=O)CC1CC(F)CC(F)C1)C(=O)N[C@H](C(=O)OC(C)(C)C)C1CCCCC1",
LY-164032,CIDECIN;CUBICIN;CUBICIN RF;DAPCIN;DAPTOMYCIN;DAPZURA RT;LY 146032;LY-146032;LY-164032,CHEMBL387675,BRD:BRD-BRD-K94358652-001-02-1;BRD:BRD-K94358652-001-02-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"SKIN INFECTIONS, ENDOCARDITIS",,LAUNCHED,,Protein,4,"CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C;CCCCCCCCCC(=O)N[C@@H](CC1C[NH]C2CCCCC12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2CCCCC2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@@H](C)CC(O)=O, CCCCCCCCCC(=O)N[C@@H](CC1C[NH]C2CCCCC12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2CCCCC2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@@H](C)CC(O)=O",DOAKLVKFURWEDJ-RWDRXURGSA-N
SB-480848,DARAPLADIB;SB-480848,CHEMBL204021,BRD:BRD-BRD-K19085898-001-01-8;BRD:BRD-K19085898-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHOLIPASE INHIBITOR,PLA2G7,,,PHASE 3,,Small molecule,3,CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2;CCN(CC)CCN(CC1CCC(CC1)-C1CCC(CC1)C(F)(F)F)C(=O)CN1C2CCCC2C(=O)NC1SCC1CCC(F)CC1,WDPFJWLDPVQCAJ-UHFFFAOYSA-N
WR-2978,CHLORIDIN;CHLORIDINE;DARAPRIM;GNF-PF-5586;MALACIDE;NSC-3061;PYRIMETHAMINE;PYRIMETHAMINUM;RP-4753;TCMDC-123831;TCMDC-125860;WR-2978,CHEMBL36,GDSC1:71,gdsc,,,,,,,Small molecule,4,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,WKSAUQYGYAYLPV-UHFFFAOYSA-N
DARGLITAZONE,CP-86325;DARGLITAZONE,CHEMBL55624,BRD:BRD-BRD-K82908348-001-01-9;BRD:BRD-K82908348-001-01-9,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PPARG,,,PHASE 2,,Small molecule,-1,Cc1oc(-c2ccccc2)nc1CCC(=O)c1ccc(CC2SC(=O)NC2=O)cc1;CC1OC(NC1CCC(=O)C1CCC(CC2SC(O)NC2O)CC1)-C1CCCCC1,QQKNSPHAFATFNQ-UHFFFAOYSA-N
UK-88525,DARIFENACIN;DARIFENACIN EXTENDED RELEASE;ENABLEX;UK-88525,CHEMBL1346,BRD:BRD-BRD-K95773607-004-03-8;BRD:BRD-K95773607-004-03-8,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,URINARY INCONTINENCE,,LAUNCHED,,Small molecule,4,"NC(=O)C([C@@H]1CCN(CCC2CCC3OCCC3C2)C1)(C1CCCCC1)C1CCCCC1, NC(=O)C([C@@H]1CCN(CCC2CCC3OCCC3C2)C1)(C1CCCCC1)C1CCCCC1;NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1",HXGBXQDTNZMWGS-RUZDIDTESA-N
ZIO-101,DARINAPARSIN;ZIO-101,CHEMBL3247378,CTRP:609121,ctrp,,,,,,,Small molecule,2,C[As](C)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,JGDXFQORBMPJGR-YUMQZZPRSA-N
ODM-201,BAY 1841788;BAY-1841788;BAY1841788;DAROLUTAMIDE;NUBEQA;ODM-201,CHEMBL4297185,BRD:BRD-A44971162-001-02-7;BRD:BRD-BRD-A44971162-001-02-7,rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AR,,,PHASE 3,,Small molecule,4,"C[C@@H](CN1CCC(N1)-C1CCC(C#N)C(CL)C1)NC(=O)C1CC([NH]N1)C(C)O, C[C@@H](CN1CCC(N1)-C1CCC(C#N)C(CL)C1)NC(=O)C1CC([NH]N1)C(C)O;CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1",BLIJXOOIHRSQRB-PXYINDEMSA-N
UIC-940T,(-)-DARUNAVIR;DARUNAVIR;MC-114;PREZISTA;TMC 114;TMC-114;TMC-41629;TMC114;UIC-94017;UIC-940T,CHEMBL1323,BRD:BRD-BRD-K84986517-001-01-8;BRD:BRD-K84986517-001-01-8,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,CYP3A4,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,CC(C)CN(C[C@@H](O)[C@H](CC1CCCCC1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)C1CCC(N)CC1;CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
LU-135252,DARUSENTAN;HMR-4005;LU-135252,CHEMBL23261,BRD:BRD-BRD-K54863166-001-01-9;BRD:BRD-K54863166-001-01-9,rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA,,,PHASE 3,,Small molecule,3,COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1;COC1CC(OC)NC(O[C@H](C(O)=O)C(OC)(C2CCCCC2)C2CCCCC2)N1,FEJVSJIALLTFRP-LJQANCHMSA-N
EXVIERA,ABT-333;DASABUVIR;DASABUVIR SODIUM MONOHYDRATE;EXVIERA,CHEMBL3137312,BRD:BRD-BRD-K02943813-001-01-9;BRD:BRD-K02943813-001-01-9,rep_primary;rep_single_dose,HCV INHIBITOR,,HEPATITIS C,,LAUNCHED,,Small molecule,4,COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C;COC1C(CC(CC1C(C)(C)C)-N1CCC(=O)[NH]C1=O)-C1CCC2CC(NS(C)(=O)=O)CCC2C1,NBRBXGKOEOGLOI-UHFFFAOYSA-N
SPRYCEL,BMS-354825;BMS-354825 HYDRATE;BMS-354825-03;DASATINIB;DASATINIB ANHYDROUS;DASATINIB HYDRATE;DASATINIB MONOHYDRATE;NSC-759877;SPRYCEL,CHEMBL1421,BRD:BRD-BRD-K49328571-001-15-0;BRD:BRD-K49328571-001-15-0;BRD:BRD-K49328571-001-16-8;CTRP:52882;GDSC1:51;GDSC2:1079,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"BCR-ABL KINASE INHIBITOR, EPHRIN INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, SRC INHIBITOR, TYROSINE KINASE INHIBITOR",ABL1;ABL2;BLK;EPHA2;EPHA3;EPHA5;EPHA6;EPHA8;EPHB1;EPHB2;EPHB4;FGR;FRK;FYN;HCK;KIT;LCK;LYN;PDGFRA;PDGFRB;SRC;SRMS;STAT5B;YES1,"CHRONIC MYELOID LEUKEMIA (CML), ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)",,LAUNCHED,"Multiple values for MOA: {'MULTIKINASE INHIBITOR (INCLUDING ABL1 AND PDGFRA)', 'BCR-ABL KINASE INHIBITOR, EPHRIN INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, SRC INHIBITOR, TYROSINE KINASE INHIBITOR'}, defaulting to 'BCR-ABL KINASE INHIBITOR, EPHRIN INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, SRC INHIBITOR, TYROSINE KINASE INHIBITOR'
Multiple values for repurposing_target: {'ABL1;ABL2;BLK;EPHA3;EPHA5;EPHA6;EPHA8;EPHB1;EPHB2;EPHB4;FRK;HCK;LCK;PDGFRA;SRC;YES1', 'ABL1;ABL2;BLK;EPHA2;FGR;FRK;FYN;HCK;KIT;LCK;LYN;PDGFRB;SRC;SRMS;STAT5B;YES1'}, taking the union",Small molecule,4,"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1;CC1NC(NC2NCC(S2)C(=O)NC2C(C)CCCC2CL)CC(N1)N1CCN(CCO)CC1, CC1NC(NC2NCC(S2)C(=O)NC2C(C)CCCC2CL)CC(N1)N1CCN(CCO)CC1",ZBNZXTGUTAYRHI-UHFFFAOYSA-N
SEP-225289,"(1R,4S)-TRANS-;(1R,4S)-TRANS-NORSERTRALINE;DASOTRALINE;NORSERTRALINE;SEP-225289",CHEMBL3301595,BRD:BRD-K00003142-003-01-9,rep_single_dose,DOPAMINE-NOREPINEPHRINE-SEROTONIN REUPTAKE INHIBITOR,,,,,,Small molecule,3,N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,SRPXSILJHWNFMK-MEDUHNTESA-N
DAU-5884,DAU-5884,,BRD:BRD-BRD-K31633810-003-02-8;BRD:BRD-K31633810-003-02-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM3,,,PRECLINICAL,,,NA,"CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)N1CC2CCCCC2NC1=O, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)N1CC2CCCCC2NC1=O",
WA-184,.BETA.-SITOSTEROL-GLUCOSIDE;ALEXANDRIN;AW 10;AW-10;BSS-G;BSSG;CORIANDRINOL;DAUCOSTERIN;DAUCOSTERINE;DAUCOSTEROL;EU-4906;LYONISIDE;NSC-165962;SITOGLUSIDE;WA 184;WA-184,CHEMBL506678,BRD:BRD-BRD-K14276241-001-01-2;BRD:BRD-K14276241-001-01-2,rep_primary;rep_single_dose,APOPTOSIS STIMULANT,,,,PHASE 2,,Small molecule,-1,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C;CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)C,NPJICTMALKLTFW-OFUAXYCQSA-N
VALRUBICIN IMPURITY,CERUBIDINE;DAUNOMYCIN;DAUNORUBICIN;DAUNORUBICIN-;DAUNOXOME;EPIRUBICIN HYDROCHLORIDE IMPURITY;FI 6339;FI-6339;NSC-83142;RP 13057;RP-13057;RUBIDOMYCIN;VALRUBICIN IMPURITY,CHEMBL178,BRD:BRD-BRD-K43389675-003-16-7;BRD:BRD-BRD-K43389675-003-20-9;BRD:BRD-K43389675-001-02-1;BRD:BRD-K43389675-003-16-7;BRD:BRD-K43389675-003-20-9,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,"RNA SYNTHESIS INHIBITOR, TOPOISOMERASE INHIBITOR",TOP2A;TOP2B,"ACUTE MYELOID LEUKEMIA (AML), ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)",,LAUNCHED,"Multiple values for MOA: {'RNA SYNTHESIS INHIBITOR, TOPOISOMERASE INHIBITOR', 'DNA INTERCALATOR/INHIBITOR OF TOPOISOMERASE'}, defaulting to 'RNA SYNTHESIS INHIBITOR, TOPOISOMERASE INHIBITOR'",Small molecule,4,"COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(C)=O, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(C)=O, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(C)=O, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(C)=O;COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1",STQGQHZAVUOBTE-VGBVRHCVSA-N
UK-38485,"DAZMEGREL;UK-38,485;UK-38485",CHEMBL283656,BRD:BRD-BRD-K20738689-001-01-2;BRD:BRD-K20738689-001-01-2,rep_primary;rep_single_dose,THROMBOXANE SYNTHASE INHIBITOR,TBXAS1,,,PHASE 2,,Small molecule,-1,Cc1c(Cn2ccnc2)c2ccccc2n1CCC(=O)O;CC1C(CN2CCNC2)C2CCCCC2N1CCC(O)=O,DEQLGSOHGTZKFB-UHFFFAOYSA-N
UK-37248,DAZOXIBEN;UK-37248,CHEMBL267473,BRD:BRD-BRD-K82767007-001-01-1;BRD:BRD-K82767007-001-01-1,rep_primary;rep_single_dose,THROMBOXANE SYNTHASE INHIBITOR,TBXAS1,,,PHASE 2,,Small molecule,-1,O=C(O)c1ccc(OCCn2ccnc2)cc1;OC(=O)C1CCC(OCCN2CCNC2)CC1,XQGZSYKGWHUSDH-UHFFFAOYSA-N
DBEQ,DBEQ,,BRD:BRD-BRD-K59204667-001-03-1;BRD:BRD-K59204667-001-03-1;CTRP:199337,ctrp;rep_primary;rep_single_dose,ATPASE INHIBITOR,CASP3,,,PRECLINICAL,,,NA,"C(NC1NC(NCC2CCCCC2)C2CCCCC2N1)C1CCCCC1, C(NC1NC(NCC2CCCCC2)C2CCCCC2N1)C1CCCCC1",
DBI,DBI,,GDSC1:196,gdsc,,,,,,,,NA,,
DBPR-211,DBPR-211,,BRD:BRD-K00004704-001-01-9,rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,,,,,,,NA,,
PRUSOGLIPTIN,DBPR-108;DBPR108;PRUSOGLIPTIN,CHEMBL1082462,BRD:BRD-BRD-K83020231-001-01-2;BRD:BRD-K83020231-001-01-2,rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,,,PHASE 1,,Small molecule,3,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,VQKSCYBKUIDZEI-STQMWFEESA-N
DC-260126,DC-260126,,BRD:BRD-K10596918-001-02-9,rep_single_dose,FREE FATTY ACID RECEPTOR ANTAGONIST,FFAR1,,,,,,NA,,
RIPRETINIB,DCC-2618;QINLOCK;RIPRETINIB,CHEMBL4216467,BRD:BRD-BRD-K49246350-001-01-1;BRD:BRD-K49246350-001-01-1,rep_primary;rep_single_dose,"PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, KIT INHIBITOR",KIT;PDGFRA,,,PHASE 1,"Multiple values for MOA: {'KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR', 'PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, KIT INHIBITOR'}, defaulting to 'PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, KIT INHIBITOR'",Small molecule,4,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21;CN1CC(CN1)-C1CC(OC2CC(F)C(NC(=O)C3(CC3)C(=O)NC3CCCCC3)CC2F)CCN1,CEFJVGZHQAGLHS-UHFFFAOYSA-N
VIMSELTINIB,DCC-3014;DP-6865;VIMSELTINIB,CHEMBL5095202,BRD:BRD-K00091116-001-01-9,rep_single_dose,,,,,,,Small molecule,3,Cc1nc(-c2cnc(NC(C)C)n(C)c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1,TVGAHWWPABTBCX-UHFFFAOYSA-N
DCEBIO,DCEBIO,,BRD:BRD-BRD-K89299012-001-06-0;BRD:BRD-K89299012-001-06-0,rep_multi_dose;rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNN2;KCNN3;KCNN4,,,PRECLINICAL,,,NA,"CCN1C(O)NC2CC(CL)C(CL)CC12, CCN1C(O)NC2CC(CL)C(CL)CC12, CCN1C(O)NC2CC(CL)C(CL)CC12",
DCP-LA,DCP-LA,,BRD:BRD-K00005344-001-01-9,rep_single_dose,PROTEIN KINASE ACTIVATOR,,,,,,,NA,,
DCPIB,DCPIB,,BRD:BRD-A39255369-001-03-1;BRD:BRD-BRD-A39255369-001-03-1,rep_primary;rep_single_dose,"CHLORIDE CHANNEL BLOCKER, GAP JUNCTION MODULATOR, GLUTAMATE INHIBITOR",SLC1A2,,,PRECLINICAL,,,NA,CCCCC1(CC2CC(OCCCC(O)=O)C(CL)C(CL)C2C1=O)C1CCCC1,
DDD107498 (SUCCINATE),DDD107498 (SUCCINATE),,BRD:BRD-K17754715-036-03-9,rep_single_dose,,,,,,,,NA,,
DDE-28,DDE-28,,GDSC1:192,gdsc,,,,,,,,NA,,
DDR1-IN-1,DDR1-IN-1,,BRD:BRD-K61845293-300-03-9,rep_single_dose,DISCOIDIN DOMAIN RECEPTOR INHIBITOR,DDR1;DDR2,,,,,,NA,,
DEAZAGUANINE,DEAZAGUANINE,,BRD:BRD-K00004562-001-01-9,rep_single_dose,DNA SYNTHESIS INHIBITOR,,,,,,,NA,,
HSP90 INHIBITOR DEBIO 0932,CUDC-305;CUDC305 (HSP90 INHIBITOR);DEBIO 0932;DEBIO-0932;HSP90 INHIBITOR DEBIO 0932,CHEMBL2419346,BRD:BRD-K00003157-001-01-9,rep_single_dose,HSP INHIBITOR,,,,,,Small molecule,1,CN(C)c1cc2c(cc1Sc1nc3c(N)nccc3n1CCNCC(C)(C)C)OCO2,RVJIQAYFTOPTKK-UHFFFAOYSA-N
DEBRISOQUINE,DEBRISOQUIN;DEBRISOQUINE,CHEMBL169901,BRD:BRD-BRD-K80419150-001-02-4;BRD:BRD-K80419150-001-02-4,rep_primary;rep_single_dose,ADRENERGIC NEURON BLOCKER,SLC6A2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"N=C(N)N1CCc2ccccc2C1;NC(=N)N1CCC2CCCCC2C1, NC(=N)N1CCC2CCCCC2C1",JWPGJSVJDAJRLW-UHFFFAOYSA-N
SYNCURINE,DECAMETHONIUM;DECAMETHONIUM CATION;DECAMETHONIUM ION;SYNCURINE,CHEMBL1190,BRD:BRD-BRD-K49783248-303-08-4;BRD:BRD-K49783248-303-08-4,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,ACHE;CHRNA2,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,4,"C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C;C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C, C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C",MTCUAOILFDZKCO-UHFFFAOYSA-N
VX-509,ADELATINIB;DECERNOTINIB;VRT-831509;VX-509,CHEMBL3039513,BRD:BRD-A95300432-001-01-3;BRD:BRD-BRD-A95300432-001-01-3,rep_primary;rep_single_dose,JAK INHIBITOR,JAK3,,,PHASE 2/PHASE 3,,Small molecule,2,CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F;CCC(C)(NC1CCNC(N1)-C1C[NH]C2NCCCC12)C(=O)NCC(F)(F)F,ASUGUQWIHMTFJL-QGZVFWFLSA-N
DECITABINE:CARBOPLATIN (1:1 MOL/MOL),DECITABINE:CARBOPLATIN (1:1 MOL/MOL),,CTRP:660250,ctrp,,,,,,,,NA,,
DECITABINE:NAVITOCLAX (2:1 MOL/MOL),DECITABINE:NAVITOCLAX (2:1 MOL/MOL),,CTRP:660180,ctrp,,,,,,,,NA,,
DECLOPRAMIDE,DECLOPRAMIDE,CHEMBL1618378,BRD:BRD-K00004661-001-01-9,rep_single_dose,CELL CYCLE INHIBITOR,,,,,,Small molecule,-1,CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1,YEYAKZXEBSVURO-UHFFFAOYSA-N
UCB-1402,DECLOXIZINE;NSC-289116;UCB 1402;UCB-1402,CHEMBL2106665,BRD:BRD-K00003318-300-01-9,rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,OCCOCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,OXBBIHZWNDPBMQ-UHFFFAOYSA-N
RO4995819,DECOGLURANT;RG1578;RO-4995819;RO4995819,CHEMBL3301593,BRD:BRD-K00079087-001-02-9,rep_single_dose,,,,,,,Small molecule,2,Nc1ccc(C#Cc2cnn3c(C(F)(F)F)cc(-c4ccc(C(F)(F)F)cc4)nc23)cn1,DMJHZVARRXJSEG-UHFFFAOYSA-N
NSC-339057,DECCOX;DECOQUINATE;HC 1528;HC-1528;M&B 15497;NSC-339057,CHEMBL416230,BRD:BRD-BRD-K17641316-001-04-8;BRD:BRD-K17641316-001-04-8,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,"CCCCCCCCCCOc1cc2c(O)c(C(=O)OCC)cnc2cc1OCC;CCCCCCCCCCOC1CC2C(O)C(CNC2CC1OCC)C(=O)OCC, CCCCCCCCCCOC1CC2C(O)C(CNC2CC1OCC)C(=O)OCC, CCCCCCCCCCOC1CC2C(O)C(CNC2CC1OCC)C(=O)OCC, CCCCCCCCCCOC1CC2C(O)C(CNC2CC1OCC)C(=O)OCC",JHAYEQICABJSTP-UHFFFAOYSA-N
VS-6063 HYDROCHLORIDE,DEFACTINIB;DEFACTINIB HYDROCHLORIDE;PF-04554878;VS-6063;VS-6063 HYDROCHLORIDE,CHEMBL3137305;CHEMBL3137331,BRD:BRD-BRD-K43578482-001-01-4;BRD:BRD-K43578482-001-01-4;BRD:BRD-K43578482-001-06-9,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,FOCAL ADHESION KINASE INHIBITOR,FAK;PTK2,,,PHASE 2,"Multiple values for MOA: {'FOCAL ADHESION KINASE INHIBITOR', 'INHIBITOR OF FAK'}, defaulting to 'FOCAL ADHESION KINASE INHIBITOR'
Multiple values for repurposing_target: {'PTK2', 'FAK'}, taking the union",Small molecule,2,"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1.Cl;CNC(=O)C1CCC(NC2NCC(C(NCC3NCCNC3N(C)S(C)(=O)=O)N2)C(F)(F)F)CC1, CNC(=O)C1CCC(NC2NCC(C(NCC3NCCNC3N(C)S(C)(=O)=O)N2)C(F)(F)F)CC1",RCHQNUQAHJNRBY-UHFFFAOYSA-N
OSVERAL,DEFERASIROX;EXJADE;ICL-670;ICL-670A;ICL670;ICL670A;JADENU;JADENU SPRINKLE;OSVERAL,CHEMBL550348,BRD:BRD-BRD-K97010173-001-04-1;BRD:BRD-K97010173-001-04-1;BRD:BRD-K97010173-001-06-9,rep_multi_dose;rep_primary;rep_single_dose,CHELATING AGENT,CYP3A4,"TRANSFUSIONAL HEMOSIDEROSIS, THALASSEMIA, IRON OVERLOAD",,LAUNCHED,,Small molecule,4,O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1;OC(=O)C1CCC(CC1)-N1NC(NC1-C1CCCCC1O)-C1CCCCC1O,BOFQWVMAQOTZIW-UHFFFAOYSA-N
PL1,APO-066;APO-66;CP-20;CP20;DEFERIPRON;DEFERIPRONE;DN-180-01-AF;DN-18001AF;FERRIPROX;L-1;L1;NSC-758880;PL-1;PL1,CHEMBL70927,BRD:BRD-BRD-K06878038-001-18-6;BRD:BRD-K06878038-001-18-6,rep_primary;rep_single_dose,CHELATING AGENT,UGT1A6,"TRANSFUSIONAL HEMOSIDEROSIS, THALASSEMIA, IRON OVERLOAD",,LAUNCHED,,Small molecule,4,"Cc1c(O)c(=O)ccn1C;CC1C(O)C(=O)CCN1C, CC1C(O)C(=O)CCN1C",TZXKOCQBRNJULO-UHFFFAOYSA-N
DEFEROXAMINE-MESYLATE,DEFEROXAMINE-MESYLATE,,BRD:BRD-BRD-K09821361-066-25-8;BRD:BRD-K09821361-066-25-8,rep_primary;rep_single_dose,CHELATING AGENT,,"ACUTE IRON INTOXICATION, IRON OVERLOAD",,LAUNCHED,,,NA,"CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN, CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN, CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN",
ZAMENE,CALCORT;DEFLAZACORT;EMFLAZA;MDL 458;MDL-458;MDL458;ZAMENE,CHEMBL1201891,BRD:BRD-BRD-K96006502-001-02-6;BRD:BRD-K96006502-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,JOINT INFLAMMATION,,LAUNCHED,,Small molecule,4,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C;CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C,FBHSPRKOSMHSIF-GRMWVWQJSA-N
RIDAFOROLIMUS,AP 23573;AP-23573;AP23573;DEFOROLIMUS;MK-8669;RIDAFOROLIMUS,CHEMBL2103839,BRD:BRD-BRD-K62304154-001-04-2;BRD:BRD-K62304154-001-04-2,rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PHASE 3,,Small molecule,3,"CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O, CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O;CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C",BUROJSBIWGDYCN-GAUTUEMISA-N
FIRMAGON,DEGARELIX;FE200486 (AS ACETATE SALT);FIRMAGON,CHEMBL415606,BRD:BRD-A88562598-001-01-7;BRD:BRD-BRD-A88562598-001-01-7,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,GNRHR,PROSTATE CANCER,,LAUNCHED,,Protein,4,CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O;CC(C)CC(NC(=O)C(CC1CCC(NC(N)=O)CC1)NC(=O)C(CC1CCC(NC(=O)C2CC(=O)NC(=O)N2)CC1)NC(=O)C(CO)NC(=O)C(CC1CCCNC1)NC(=O)C(CC1CCC(CL)CC1)NC(=O)C(CC1CCC2CCCCC2C1)NC(C)=O)C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(N)=O,MEUCPCLKGZSHTA-XYAYPHGZSA-N
DEHYDROACETIC-ACID,DEHYDROACETIC-ACID,,BRD:BRD-A17300716-001-01-5;BRD:BRD-BRD-A17300716-001-01-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC(=O)C1C(=O)OC(C)=CC1=O,
DEHYDROCHOLATE,DEHYDROCHOLATE,,BRD:BRD-A64125466-236-04-6;BRD:BRD-BRD-A64125466-236-04-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,C[C@H](CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)CC1CC3=O,
DEHYDROCHOLATE-ACID,DEHYDROCHOLATE-ACID,,BRD:BRD-A11551002-001-04-6;BRD:BRD-BRD-A11551002-001-04-6,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC(CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)C[C@H]1CC3=O,
DEHYDROCORYDALINE,DEHYDROCORYDALINE,CHEMBL1917176,BRD:BRD-BRD-K67186445-001-02-1;BRD:BRD-K67186445-001-02-1,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE,,,PHASE 3,,Small molecule,NA,"COc1cc2c(cc1OC)-c1c(C)c3ccc(OC)c(OC)c3c[n+]1CC2;COC1CC2CC[N+]3CC4C(OC)C(OC)CCC4C(C)C3-C2CC1OC, COC1CC2CC[N+]3CC4C(OC)C(OC)CCC4C(C)C3-C2CC1OC",RFKQJTRWODZPHF-UHFFFAOYSA-N
VAGINORM,BIOLAIF;DEHYDROANDROSTERONE;DEHYDROEPIANDROSTERONE;DEHYDROISOANDROSTERONE;DHEA;EM-760;ENZYMATIC THERAPY;INTRAROSA;NATROL DHEA;NSC-9896;PRASTERONE;VAGINORM,CHEMBL90593,BRD:BRD-BRD-K41256143-001-12-7;BRD:BRD-K41256143-001-12-7,rep_primary;rep_single_dose,PROTEIN SYNTHESIS STIMULANT,ESR1;ESR2;G6PD;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B;HSD17B1;NR1I2;NR1I3;PPARA;SIGMAR1;SULT2A1;SULT2B1,,,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12;C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O",FMGSKLZLMKYGDP-USOAJAOKSA-N
DEHYDROEPIANDROSTERONE-SULFATE,DEHYDROEPIANDROSTERONE-SULFATE,,BRD:BRD-BRD-K15360631-325-01-4;BRD:BRD-K15360631-325-01-4,rep_primary;rep_single_dose,"ANDROGEN RECEPTOR AGONIST, ESTROGEN RECEPTOR AGONIST",AR;ESR1;ESR2,MENOPAUSE,,LAUNCHED,,,NA,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@H](CC[C@]34C)OS(O)(=O)=O)[C@@H]1CCC2=O,
WQ-3034,ABT-492;DELAFLOXACIN;RX-3341;WQ-3034,CHEMBL2105637,BRD:BRD-K90991629-100-02-9,rep_single_dose,ANTIINFECTIVE DRUG,,,,,,Small molecule,4,Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F,DYDCPNMLZGFQTM-UHFFFAOYSA-N
OPC-67683,DELAMANID;DELTYBA;OPC 67683;OPC-67683,CHEMBL218650,BRD:BRD-BRD-K17480742-001-01-1;BRD:BRD-K17480742-001-01-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,C[C@]1(COC2CCC(CC2)N2CCC(CC2)OC2CCC(OC(F)(F)F)CC2)CN2CC(NC2O1)[N+]([O-])=O;C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,XDAOLTSRNUSPPH-XMMPIXPASA-N
NPH007098,CEP 18770;CEP-18770;CIP 18770;CIP-18770;CT 47098;CT-47098;DELANZOMIB;NPH 007098;NPH-007098;NPH007098,CHEMBL270515,BRD:BRD-BRD-K59325863-001-02-8;BRD:BRD-BRD-K59325863-001-03-6;BRD:BRD-K59325863-001-02-8;BRD:BRD-K59325863-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,PROTEASOME INHIBITOR,CMA1;CTSG;CYP3A4;ELANE,,,PHASE 1/PHASE 2,,Small molecule,1,"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O;CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1CCCC(N1)-C1CCCCC1)[C@@H](C)O)B(O)O, CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1CCCC(N1)-C1CCCCC1)[C@@H](C)O)B(O)O, CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1CCCC(N1)-C1CCCCC1)[C@@H](C)O)B(O)O, CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1CCCC(N1)-C1CCCCC1)[C@@H](C)O)B(O)O",SJFBTAPEPRWNKH-CCKFTAQKSA-N
DELAPRIL,DELAPRIL,CHEMBL589583,BRD:BRD-BRD-K00573984-003-01-5;BRD:BRD-K00573984-003-01-5,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,HYPERTENSION,,LAUNCHED,,Small molecule,3,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1;CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N(CC(O)=O)C1CC2CCCCC2C1,WOUOLAUOZXOLJQ-MBSDFSHPSA-N
U-90152,DELAVIRDINE;U-90152,CHEMBL593,BRD:BRD-BRD-K34068325-066-03-7;BRD:BRD-K34068325-066-03-7,rep_primary;rep_single_dose,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,CYP3A4,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1;CC(C)NC1CCCNC1N1CCN(CC1)C(=O)C1CC2CC(NS(C)(=O)=O)CCC2[NH]1, CC(C)NC1CCCNC1N1CCN(CC1)C(=O)C1CC2CC(NS(C)(=O)=O)CCC2[NH]1, CC(C)NC1CCCNC1N1CCN(CC1)C(=O)C1CC2CC(NS(C)(=O)=O)CCC2[NH]1, CC(C)NC1CCCNC1N1CCN(CC1)C(=O)C1CC2CC(NS(C)(=O)=O)CCC2[NH]1",WHBIGIKBNXZKFE-UHFFFAOYSA-N
KAI-9803,BMS-875944;DELCASERTIB;KAI-9803,CHEMBL2107872,BRD:BRD-K00003468-001-01-9,rep_single_dose,PKC INHIBITOR,,,,,,Protein,2,,
LEO-124249A,DELGOCITINIB;JTE-052;JTE-052A;LEO 124249;LEO 124249A;LEO-124249;LEO-124249A,CHEMBL4297507,BRD:BRD-K00003500-001-01-9,rep_single_dose,JAK INHIBITOR,,,,,,Small molecule,3,C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2,LOWWYYZBZNSPDT-ZBEGNZNMSA-N
LJPC-501,5-L-ISOLEUCINEANGIOTENSIN II;ANGIOTENSIN II;ANGIOTENSIN II (HUMAN TYPE);ANGIOTENSIN II HUMAN;ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE;DELIVERT;LJPC-501,CHEMBL408403,BRD:BRD-BRD-K45503887-001-01-1;BRD:BRD-K45503887-001-01-1,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR AGONIST,AGTR1;AGTR2,,,LAUNCHED,,Protein,4,CC[C@H](C)[C@H](NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1CNC[NH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CC1CCCCC1)C(O)=O;CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O,CZGUSIXMZVURDU-JZXHSEFVSA-N
LCB01-0371,DELPAZOLID;LCB-01-0371;LCB-010371;LCB01-0371,CHEMBL1673408,BRD:BRD-K00003363-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,2,CN1CCN(c2ccc(N3C[C@H](CO)OC3=O)cc2F)C=N1,QLUWQAFDTNAYPN-LLVKDONJSA-N
DELTARASIN,DELTARASIN,,BRD:BRD-BRD-K90830492-305-01-4;BRD:BRD-K90830492-305-01-4,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,KRAS,,,PRECLINICAL,,,NA,C(OC1CCC(CC1)-C1NC2CCCCC2N1CC1CCCCC1)[C@H](C1CCNCC1)N1C(NC2CCCCC12)-C1CCCCC1,
DEMECARIUM ION,DEMECARIUM;DEMECARIUM CATION;DEMECARIUM ION,CHEMBL1201229,BRD:BRD-BRD-K51471001-303-04-7;BRD:BRD-K51471001-303-04-7,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE;BCHE,"INTRAOCULAR PRESSURE, GLAUCOMA",,LAUNCHED,,Small molecule,4,CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1;CN(CCCCCCCCCCN(C)C(=O)OC1CCCC(C1)[N+](C)(C)C)C(=O)OC1CCCC(C1)[N+](C)(C)C,RWZVPVOZTJJMNU-UHFFFAOYSA-N
DEMETHYLCHLORTETRACYCLINE,DEMECLOCYCLINE;DEMETHYLCHLORTETRACYCLINE,CHEMBL1591,BRD:BRD-K00003347-003-01-9,rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,,,,,Small molecule,4,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12,FMTDIUIBLCQGJB-SEYHBJAFSA-N
DENATONIUM-BENZOATE,DENATONIUM-BENZOATE,,BRD:BRD-BRD-K34122555-057-11-5;BRD:BRD-K34122555-057-11-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC[N+](CC)(CC(=O)NC1C(C)CCCC1C)CC1CCCCC1,
TA-064,DENOPAMINE;KALGUT;TA 064;TA-064,CHEMBL493682,BRD:BRD-K00004656-001-01-9,rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,,,,,Small molecule,-1,COc1ccc(CCNC[C@H](O)c2ccc(O)cc2)cc1OC,VHSBBVZJABQOSG-INIZCTEOSA-N
POLVIR,DENOTIVIR;POLVIR,CHEMBL2104203,BRD:BRD-BRD-K01773083-001-01-4;BRD:BRD-K01773083-001-01-4,rep_primary;rep_single_dose,ANTIVIRAL,,"VIRUS HERPES SIMPLEX (HSV), SKIN INFECTIONS",,LAUNCHED,,Small molecule,-1,Cc1nsc(NC(=O)c2ccccc2)c1C(=O)Nc1ccc(Cl)cc1;CC1NSC(NC(=O)C2CCCCC2)C1C(=O)NC1CCC(CL)CC1,ZPBLNADJHWHOEP-UHFFFAOYSA-N
DEOXYCHOLIC-ACID,DEOXYCHOLIC-ACID,,BRD:BRD-BRD-K41170226-001-13-8;BRD:BRD-K41170226-001-13-8,rep_primary;rep_single_dose,"BILIVERDIN REDUCTASE A ACTIVATOR, G PROTEIN-COUPLED RECEPTOR AGONIST",EFTUD1;FPR1;GPBAR1,SUBMENTAL FAT,,LAUNCHED,,,NA,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,
DEOXYCORTICOSTERONE-ACETATE,DEOXYCORTICOSTERONE-ACETATE,,BRD:BRD-BRD-K24556098-001-16-7;BRD:BRD-BRD-K24556098-001-19-1;BRD:BRD-K24556098-001-16-7;BRD:BRD-K24556098-001-19-1,rep_multi_dose;rep_primary;rep_single_dose,PROGESTOGEN HORMONE,NR3C2,,,PRECLINICAL,,,NA,"CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C, CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C, CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C, CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C",
DEOXYEPINEPHRINE,DEOXYEPINEPHRINE,,BRD:BRD-BRD-K33151569-003-09-7;BRD:BRD-K33151569-003-09-7,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST",ADRA1A;DRD1;DRD2,,,PRECLINICAL,,,NA,CNCCC1CCC(O)C(O)C1,
DEPRODONE PROPIONATE,DEPRODONE PROPIONATE,,BRD:BRD-K00090631-001-01-9,rep_single_dose,,,,,,,,NA,,
DIBENZHEPTROPINE,DEPTROPINE;DIBENZHEPTROPINE,CHEMBL1946186,BRD:BRD-A65797496-048-09-3;BRD:BRD-BRD-A65797496-048-09-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,,,PRECLINICAL,,Small molecule,-1,CN1[C@@H]2CC[C@H]1C[C@@H](OC1c3ccccc3CCc3ccccc31)C2;CN1[C@H]2CC[C@@H]1CC(C2)OC1C2CCCCC2CCC2CCCCC12,ZWPODSUQWXAZNC-PMOLBWCYSA-N
DEQUALINIUM CATION,DEQUALINIUM;DEQUALINIUM CATION,CHEMBL333826,BRD:BRD-BRD-K77685957-300-09-1;BRD:BRD-K77685957-300-09-1,rep_multi_dose;rep_primary;rep_single_dose,PKC INHIBITOR,KCNN1;KCNN3,,,LAUNCHED,,Small molecule,4,"CC1CC(N)C2CCCCC2[N+]1CCCCCCCCCC[N+]1C(C)CC(N)C2CCCCC12, CC1CC(N)C2CCCCC2[N+]1CCCCCCCCCC[N+]1C(C)CC(N)C2CCCCC12;Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21",PCSWXVJAIHCTMO-UHFFFAOYSA-P
SC-59046,DERACOXIB;NSC-758935;SC-59046,CHEMBL28636,BRD:BRD-BRD-K68558722-001-04-0;BRD:BRD-K68558722-001-04-0,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,OSTEOARTHRITIS,,LAUNCHED,,Small molecule,-1,COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F;COC1CCC(CC1F)-C1CC(NN1-C1CCC(CC1)S(N)(=O)=O)C(F)F,WAZQAZKAZLXFMK-UHFFFAOYSA-N
DERAZANTINIB,ARQ 087;ARQ-087;ARQ087;DERAZANTINIB,CHEMBL4297187,BRD:BRD-K00003310-001-01-9,rep_single_dose,TYROSINE KINASE INHIBITOR,,,,,,Small molecule,2,COCCNCCc1cccc(Nc2ncc3c(n2)-c2ccccc2[C@H](c2ccccc2F)C3)c1,KPJDVVCDVBFRMU-AREMUKBSSA-N
TENSERPINA,(-)-;(-)-10-METHOXYDESERPIDINE;10-MD;10-METHOXY-;10-METHOXYDESERPIDINE;DEASERPYL;DECASERPIL;DECASERPIN;DECASERPINE;DECASERPYL;DECOSERPYL;DESERPIDINE;DESERPIDINE 10-METHOXYDESERPIDINE;HALMONYL;HARMONYL;METHOSERPIDINE;MINORAN;NEOSERPIN;NSC-169423;NSC-72138;R 694;R-694;RECANESCIN;RESERTENE;TENSERPINA,CHEMBL1200515;CHEMBL3989541,BRD:BRD-BRD-K29462201-001-01-9;BRD:BRD-K29462201-001-01-9,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE;SLC18A2,HYPERTENSION,,LAUNCHED,,Small molecule,-1,"CO[C@H]1[C@@H](C[C@@H]2CN3CCC4C([NH]C5CCCCC45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1CC(OC)C(OC)C(OC)C1, CO[C@H]1[C@@H](C[C@@H]2CN3CCC4C([NH]C5CCCCC45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1CC(OC)C(OC)C(OC)C1;COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccc(OC)cc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC",ULBNWNUHGJLQHO-VKMIBBQISA-N
ZYAN1,DESIDUSTAT;ZYAN-1;ZYAN1,CHEMBL4650314,BRD:BRD-K00003452-001-01-9,rep_single_dose,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,,,,,,Small molecule,3,O=C(O)CNC(=O)c1c(O)c2ccccc2n(OCC2CC2)c1=O,IKRKQQLJYBAPQT-UHFFFAOYSA-N
NORIMIPRAMINE,DEMETHYL-;DESIPRAMINE;IMIPRAMINE;MONODEMETHYLIMIPRAMINE;N-DESMETHYLIMIPRAMINE;NORIMIPRAMINE,CHEMBL72,BRD:BRD-BRD-K60762818-003-26-0;BRD:BRD-K60762818-003-26-0,rep_primary;rep_single_dose,TRICYCLIC ANTIDEPRESSANT,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD2;HRH1;HTR1A;HTR2A;HTR2C;SLC6A2;SLC6A4;SMPD1,DEPRESSION,,LAUNCHED,,Small molecule,4,"CNCCCN1C2CCCCC2CCC2CCCCC12, CNCCCN1C2CCCCC2CCC2CCCCC12;CNCCCN1c2ccccc2CCc2ccccc21",HCYAFALTSJYZDH-UHFFFAOYSA-N
DESISOBUTYRYL-CICLESONIDE,DESISOBUTYRYL-CICLESONIDE,,BRD:BRD-K00003103-001-01-9,rep_single_dose,CYTOCHROME P450 INHIBITOR,,,,,,,NA,,
DESLANOSIDE,CEDILANID-D;DEACETYLANATOSIDE C;DESACETYL-LANATOSIDE C;DESLANOSIDE,CHEMBL1614,BRD:BRD-BRD-K99919177-001-01-3;BRD:BRD-K99919177-001-01-3,rep_primary;rep_single_dose,NA/K-ATPASE INHIBITOR,ATP1A1;ATP1A2;ATP1A3;ATP1A4;ATP1B1;ATP1B2;ATP1B3;FXYD2,"CONGESTIVE HEART FAILURE, CARDIAC ARRYTHMIA",,LAUNCHED,,Small molecule,4,C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@@H](O)[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1;C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,OBATZBGFDSVCJD-LALPQLPRSA-N
SCH-34117,AERIUS;ALLEX;AZOMYR;CLARINEX;DASSELTA;DENOSIN;DESCARBOETHOXYLORATADINE;DESLORATADINE;DESLORATADINE ACTAVIS;DESLORATADINE TEVA;LORATADINE RELATED COMPOUND A;LORATADINE RELATED COMPOUND A RS;MIDETORIN;NEOCLARITYN;NSC-759824;OPULIS;SCH 34117;SCH-34117,CHEMBL1172,BRD:BRD-BRD-K82357231-001-17-5;BRD:BRD-K82357231-001-17-5,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,4,"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1;CLC1CCC2C(CCC3CCCNC3C2=C2CCNCC2)C1, CLC1CCC2C(CCC3CCCNC3C2=C2CCNCC2)C1, CLC1CCC2C(CCC3CCCNC3C2=C2CCNCC2)C1",JAUOIFJMECXRGI-UHFFFAOYSA-N
SOMAGARD [AS ACETATE],D-TRP LHRH-PEA;D-TRP-LHRH-PEA;DESLORELIN;SOMAGARD [AS ACETATE],CHEMBL2365665,BRD:BRD-K00003134-001-01-9,rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,,,,,,Protein,2,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,GJKXGJCSJWBJEZ-XRSSZCMZSA-N
DESMOPRESSIN-ACETATE,DESMOPRESSIN-ACETATE,,BRD:BRD-A49399758-015-01-8;BRD:BRD-BRD-A49399758-015-01-8,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR AGONIST,AVPR1A;AVPR1B;AVPR2;OXTR,"CENTRAL DIABETES INSIPIDUS, NOCTURNAL ENURESIS",,LAUNCHED,,,NA,NC(=O)CCC1NC(=O)C(CC2CCCCC2)NC(=O)C(CC2CCC(O)CC2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O,
ZELLETA,AIZEA;CERAZETTE;CERELLE;DESOGESTREL;DESOMONO;FEANOLLA;MIRCETTE;NACREZ;ORG 2969;ORG-2969;ZELLETA,CHEMBL1533,BRD:BRD-BRD-K46061689-001-01-9;BRD:BRD-K46061689-001-01-9,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,ESR1;PGR,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC;CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,RPLCPCMSCLEKRS-BPIQYHPVSA-N
VERDESO,D-2083;D2083;DESONATE;DESONIDE;DESOWEN;NSC-759226;TRIDESILON;VERDESO,CHEMBL1201109,BRD:BRD-BRD-K21528677-001-02-8;BRD:BRD-BRD-K21528677-001-03-6;BRD:BRD-K21528677-001-02-8;BRD:BRD-K21528677-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;PLA2G1B,CROHN'S DISEASE,,LAUNCHED,,Small molecule,4,"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1;CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO",WBGKWQHBNHJJPZ-LECWWXJVSA-N
TOPICORT LP,A-41-304;A-41304;DESOXIMETASONE;DESOXYMETHASONE;HOE 304;HOE-304;J83.644C;NSC-759189;R 2113;R-2113;STIEDEX;STIEDEX LP;STIEDEX LPN;TOPICORT;TOPICORT LP,CHEMBL1766,BRD:BRD-A49447682-001-02-4;BRD:BRD-BRD-A49447682-001-02-4,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;PLA2G1B,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,Small molecule,4,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO;C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,VWVSBHGCDBMOOT-IIEHVVJPSA-N
PERCORTEN,DESOXYCORTICOSTERONE PIVALATE;DESOXYCORTICOSTERONE TRIMETHYLACETATE;DESOXYCORTICOSTERONE-PIVALATE;PERCORTEN,CHEMBL1200592,BRD:BRD-BRD-K26024145-001-01-9;BRD:BRD-K26024145-001-01-9,rep_primary;rep_single_dose,CORTICOSTEROID AGONIST,NR3C2,ADDISON'S DISEASE,,LAUNCHED,,Small molecule,4,CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,VVOIQBFMTVCINR-WWMZEODYSA-N
PERCORTEN,11-DEOXYCORTICOSTERONE;11-DEOXYCORTICOSTERONE ACETATE;21-HYDROXYPROGESTERONE;DEOXYCORTICOSTERONE;DEOXYCORTICOSTERONE ACETATE;DEOXYCORTONE;DESOXYCORTICOSTERONE;DESOXYCORTICOSTERONE ACETATE;DESOXYCORTONE;DESOXYCORTONE ACETATE;DOCA;NSC-11319;NSC-9567;PERCORTEN,CHEMBL1200542,BRD:BRD-BRD-K98521173-001-19-4;BRD:BRD-K98521173-001-19-4,rep_multi_dose;rep_primary;rep_single_dose,MINERALOCORTICOID RECEPTOR AGONIST,NR3C1;NR3C2,,,PRECLINICAL,,Small molecule,4,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO;CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,VPGRYOFKCNULNK-ACXQXYJUSA-N
DESOXYPEGANINE,DESOXYPEGANINE,,BRD:BRD-BRD-K13819402-003-10-2;BRD:BRD-K13819402-003-10-2,rep_primary;rep_single_dose,"ACETYLCHOLINESTERASE INHIBITOR, MONOAMINE OXIDASE INHIBITOR",ACHE,,,PHASE 1,,,NA,C1CN2CC3CCCCC3N=C2C1,
PRISTIQ,D-VENIZ;DESVENLAFAXINE;KHEDEZLA;MDD-XR;NEWVEN;O-DESMETHYLVENLAFAXINE;ODV;PRISTIQ,CHEMBL1118,BRD:BRD-A98845662-036-03-7;BRD:BRD-BRD-A98845662-036-03-7,rep_primary;rep_single_dose,SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),SLC6A2;SLC6A3;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1;CN(C)CC(C1CCC(O)CC1)C1(O)CCCCC1, CN(C)CC(C1CCC(O)CC1)C1(O)CCCCC1, CN(C)CC(C1CCC(O)CC1)C1(O)CCCCC1, CN(C)CC(C1CCC(O)CC1)C1(O)CCCCC1, CN(C)CC(C1CCC(O)CC1)C1(O)CCCCC1, CN(C)CC(C1CCC(O)CC1)C1(O)CCCCC1",KYYIDSXMWOZKMP-UHFFFAOYSA-N
DETOMIDINE,DETOMIDINE,CHEMBL2110829,BRD:BRD-BRD-K77597856-003-02-5;BRD:BRD-K77597856-003-02-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A,SEDATIVE,,LAUNCHED,,Small molecule,-1,Cc1cccc(Cc2c[nH]cn2)c1C;CC1CCCC(CC2C[NH]CN2)C1C,RHDJRPPFURBGLQ-UHFFFAOYSA-N
MK-329,"DEVAZEPIDE;L-364,718;L-364718;MK-329",CHEMBL9506,BRD:BRD-K31238592-001-02-9,rep_single_dose,CCK RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c2ccccc2)c2ccccc21,NFHRQQKPEBFUJK-HSZRJFAPSA-N
TOBRADEX,AEROSEB-DEX;DALALONE;DECADERM;DECADRON;DECADRON-75;DECADRON-LA;DECASPRAY;DEXACEN-4;DEXACORT;DEXACORTISYL;DEXAFREE;DEXAIR;DEXAMETHASONE;DEXAMETHASONE 21-PHOSPHATE DISODIUM SALT;DEXAMETHASONE INTENSOL;DEXAMETHASONE METASULFOBENZOATE SODIUM;DEXAMETHASONE PALMITATE;DEXAMETHASONE SODIUM PHOSPHATE;DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE;DEXAMETHASONE VALERATE;DEXONE;DEXONE 0.5;DEXONE 0.75;DEXONE 1.5;DEXONE 4;DEXSOL;DEXTENZA;DEXYCU;DEXYCU KIT;DROPODEX;FLUORMETHYLPREDNISOLONE;GPPE EAR SPY;HEMADY;HEXADROL;ISV-305;KORTICO INJECTION;MARTAPAN;MAXIDEX;MAXITROL;MYMETHASONE;NEODECADRON;NSC-34521;NSC-756722;ORADEXON;OTO-104;OTOMIZE;OZURDEX;SOFRADEX;SPERSADEX COMP;TLC-399;TLC399;TOBRADEX,CHEMBL1200637;CHEMBL2021430;CHEMBL384467,BRD:BRD-A10188456-001-04-9;BRD:BRD-BRD-A10188456-001-04-9;BRD:BRD-BRD-K38775274-001-22-1;BRD:BRD-K38775274-001-22-1;CTRP:277354,ctrp;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,ANXA1;NOS2;NR0B1;NR3C1;NR3C2,"HYPERCALCEMIA, RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OSTEOARTHRITIS, ALLERGIC RHINITIS, ULCERATIVE COLITIS, ANEMIA, MULTIPLE SCLEROSIS, ENTERITIS, LUPUS, DERMATITIS HERPETIFORMIS (DH), NEPHROTIC SYNDROME, PSORIASIS",,LAUNCHED,"Multiple values for structure_id: {'A10188456', 'K38775274'}, defaulting to None",Small molecule,4,"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO;C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO",UREBDLICKHMUKA-CXSFZGCWSA-N
TOBRADEX,AEROSEB-DEX;DALALONE;DECADERM;DECADRON;DECADRON-75;DECADRON-LA;DECASPRAY;DEXACEN-4;DEXACORT;DEXACORTISYL;DEXAFREE;DEXAIR;DEXAMETHASONE;DEXAMETHASONE INTENSOL;DEXAMETHASONE METASULFOBENZOATE SODIUM;DEXAMETHASONE PALMITATE;DEXAMETHASONE VALERATE;DEXONE;DEXONE 0.5;DEXONE 0.75;DEXONE 1.5;DEXONE 4;DEXSOL;DEXTENZA;DEXYCU;DEXYCU KIT;DROPODEX;FLUORMETHYLPREDNISOLONE;GPPE EAR SPY;HEMADY;HEXADROL;ISV-305;KORTICO INJECTION;MARTAPAN;MAXIDEX;MAXITROL;MYMETHASONE;NEODECADRON;NSC-34521;ORADEXON;OTO-104;OTOMIZE;OZURDEX;SOFRADEX;SPERSADEX COMP;TOBRADEX,CHEMBL384467,BRD:BRD-K00090644-001-01-9,rep_single_dose,,,,,,,Small molecule,4,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,UREBDLICKHMUKA-CXSFZGCWSA-N
DEXAMETHASONE-ACETATE,DEXAMETHASONE-ACETATE,,BRD:BRD-BRD-K47635719-001-21-1;BRD:BRD-K47635719-001-21-1,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,,"HYPERCALCEMIA, RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OSTEOARTHRITIS, ALLERGIC RHINITIS, ULCERATIVE COLITIS, ANEMIA, MULTIPLE SCLEROSIS, ENTERITIS, LUPUS, DERMATITIS HERPETIFORMIS (DH), NEPHROTIC SYNDROME, PSORIASIS",,LAUNCHED,,,NA,"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O",
DEXAMETHASONE-SODIUM-PHOSPHATE,DEXAMETHASONE-SODIUM-PHOSPHATE,,BRD:BRD-A83802939-304-04-2;BRD:BRD-BRD-A83802939-304-04-2,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,"HYPERCALCEMIA, RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OSTEOARTHRITIS, ALLERGIC RHINITIS, ULCERATIVE COLITIS, ANEMIA, MULTIPLE SCLEROSIS, ENTERITIS, LUPUS, DERMATITIS HERPETIFORMIS (DH), NEPHROTIC SYNDROME, PSORIASIS",,LAUNCHED,,,NA,"C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O, C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O",
DEXCHLORPHENIRAMINE,(S)-;CHLORPHENAMINE;CHLORPHENIRAMINE;CHLORPHENIRAMINE D-FORM;D-;DAPRITON;DEXCHLORPHENIRAMINE,CHEMBL1201353,BRD:BRD-BRD-K39462424-050-09-8;BRD:BRD-K39462424-050-09-8,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,"ALLERGIC CONJUNCTIVITIS, ALLERGIC RHINITIS, URTICARIA, ANGIOEDEMA",,LAUNCHED,,Small molecule,4,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1;CN(C)CC[C@@H](C1CCC(CL)CC1)C1CCCCN1,SOYKEARSMXGVTM-HNNXBMFYSA-N
S 5614,D-FENFLURAMINE;DEXFENFLURAMINE;FENFLURAMINE D-FORM;ISOLIPAN;J13.711A;S 5614,CHEMBL248702,BRD:BRD-BRD-K58626373-003-07-8;BRD:BRD-K58626373-003-07-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2C;SLC6A4,,,WITHDRAWN,,Small molecule,4,CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1;CCN[C@@H](C)CC1CCCC(C1)C(F)(F)F,DBGIVFWFUFKIQN-VIFPVBQESA-N
SEROPHEN,DEXFOSFOSERINE;DL-;DL-O-PHOSPHORYLSERINE;DL-PHOSPHOSERINE;ENERGOSERINA;FOSFORINA;GNF-PF-1028;L-;L-O-PHOSPHOSERINE;L-O-SERINE PHOSPHATE;L-PHOSPHOSERINE;NSC-760136;NSC-90791;O-PHOSPHORYL-L-SERINE;O-PHOSPHOSERINE;PHOSPHOSERINE;SERINE PHOSPHATE;SERIPHOS;SEROPHEN,CHEMBL284377,BRD:BRD-BRD-K30019776-003-01-5;BRD:BRD-K30019776-003-01-5,rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,CFTR;GRM4;GRM6;GRM7;GRM8;KCNC4;PDPK1;PIM1;PRKACA;PRKCQ;PYGL;PYGM;REG1A;RHO;SERPINB3;SMAD2;TAOK2,,,PRECLINICAL,,Small molecule,-1,"N[C@@H](COP(=O)(O)O)C(=O)O;N[C@@H](COP(O)(O)=O)C(O)=O, N[C@@H](COP(O)(O)=O)C(O)=O",BZQFBWGGLXLEPQ-REOHCLBHSA-N
TAK-390,(R)-;(R)-LANSOPRAZOLE;DEXILANT;DEXILANT SOLUTAB;DEXLANSOPRAZOLE;KAPIDEX;LANSOPRAZOLE;LANSOPRAZOLE R-FORM;NSC-758710;T-168390;TAK-390,CHEMBL1201863,BRD:BRD-BRD-K05900209-001-03-4;BRD:BRD-K05900209-001-03-4,rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP4A;ATP4B,"GASTROESOPHAGEAL REFLUX DISEASE (GERD), EROSIVE ESOPHAGITIS (EE)",,LAUNCHED,,Small molecule,4,"CC1C(OCC(F)(F)F)CCNC1C[S@@](=O)C1NC2CCCCC2[NH]1, CC1C(OCC(F)(F)F)CCNC1C[S@@](=O)C1NC2CCCCC2[NH]1, CC1C(OCC(F)(F)F)CCNC1C[S@@](=O)C1NC2CCCCC2[NH]1;Cc1c(OCC(F)(F)F)ccnc1C[S@@+]([O-])c1nc2ccccc2[nH]1",MJIHNNLFOKEZEW-RUZDIDTESA-N
LOXIGLUMIDE (R)-FORM,(R)-;CR-2017;DEXLOXIGLUMIDE;LOXIGLUMIDE;LOXIGLUMIDE (R)-FORM,CHEMBL550781,BRD:BRD-BRD-K07609981-001-01-7;BRD:BRD-K07609981-001-01-7,rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKAR,,,PHASE 3,,Small molecule,3,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1;CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)C1CCC(CL)C(CL)C1,QNQZBKQEIFTHFZ-GOSISDBHSA-N
PRECEDEX,(S)-;DEXMEDETOMIDINE;MEDETOMIDINE;MPV-1440;PRECEDEX,CHEMBL778,BRD:BRD-K18423410-003-02-5,rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C,,,,,Small molecule,4,Cc1cccc([C@H](C)c2c[nH]cn2)c1C,CUHVIMMYOGQXCV-NSHDSACASA-N
NIGULDIPINE,(R)-NIGULDIPINE;DEXNIGULDIPINE;NIGULDIPINE,CHEMBL2051956,BRD:BRD-BRD-K44309363-003-02-1;BRD:BRD-K44309363-003-02-1,rep_primary;rep_single_dose,CALMODULIN ANTAGONIST,ADORA3,,,PHASE 2,,Small molecule,-1,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1CCCCC1)C1CCCCC1;COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@@H]1c1cccc([N+](=O)[O-])c1,SVJMLYUFVDMUHP-MGBGTMOVSA-N
PANTOTHENOL,(+)-PANTHENOL;D-PANTHENOL;D-PANTHENOL 50;D-PANTOTHENYL ALCOHOL;DEXPANTHENOL;ILOPAN;MOTILYN;PANTOTHENOL,CHEMBL1200979,BRD:BRD-A59413292-001-08-2;BRD:BRD-BRD-A59413292-001-08-2,rep_primary;rep_single_dose,,,PARALYTIC ILEUS,,LAUNCHED,,Small molecule,4,"CC(C)(CO)[C@@H](O)C(=O)NCCCO;CC(C)(CO)[C@@H](O)C(=O)NCCCO, CC(C)(CO)C(O)C(=O)NCCCO",SNPLKNRPJHDVJA-ZETCQYMHSA-N
ZINECARD,(S)-;ADR-529;CARDIOXANE;D-;DEXRAZOXANE;ICRF-187;NSC-169780;RAZOXANE;ZINECARD,CHEMBL1738,BRD:BRD-BRD-K07265709-003-05-6;BRD:BRD-K07265709-003-05-6,rep_multi_dose;rep_primary;rep_single_dose,"CHELATING AGENT, TOPOISOMERASE INHIBITOR",TOP2A;TOP2B,CARDIOMYOPATHY,,LAUNCHED,,Small molecule,4,"C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1;C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1, C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1, C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1",BMKDZUISNHGIBY-ZETCQYMHSA-N
MACRODEX,AQUASITE;DEXTRAN;DEXTRAN 1;DEXTRAN 40;DEXTRAN 70;DEXTRAN HM;DEXTRAN-70;DEXTRAN-HM;HIGH MOLECULAR WEIGHT;LMWD;MACRODEX,CHEMBL1697742;CHEMBL2108026;CHEMBL2108451,BRD:BRD-BRD-K67117832-001-01-9;BRD:BRD-K67117832-001-01-9,rep_primary;rep_single_dose,,,"THROMBOSIS, HYPOVOLEMIA",,LAUNCHED,,Oligosaccharide,3,OC[C@H]1O[C@H](OC[C@H]2O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,
XELSTRYM,(S)-;AMFETAMINE;AMPHETAMINE;D-;D-AMPHETAMINE;DEXAMFETAMINE;DEXAMPEX;DEXAMPHETAMINE;DEXEDRINE;DEXIDRINE;DEXTROAMPHETAMINE;DEXTROAMPHETAMINE RESIN COMPLEX;DEXTROSTAT;FERNDEX;NSC-73713;XELSTRYM,CHEMBL612,BRD:BRD-BRD-K21160401-065-01-0;BRD:BRD-K21160401-065-01-0,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,ADRA1A;ADRA1B;SLC18A2;SLC6A2;SLC6A3;TAAR1,"ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD), NARCOLEPSY",,LAUNCHED,,Small molecule,4,C[C@H](N)Cc1ccccc1;C[C@H](N)CC1CCCCC1,KWTSXDURSIMDCE-QMMMGPOBSA-N
NSC-751452,DEXTROMETHORPHAN;DIMETANE-DX;NSC-751452,CHEMBL52440,BRD:BRD-BRD-K33211335-004-01-7;BRD:BRD-K33211335-004-01-7,rep_primary;rep_single_dose,"GLUTAMATE RECEPTOR ANTAGONIST, SIGMA RECEPTOR AGONIST",CHRNA2;CHRNA3;CHRNA4;CHRNA7;CHRNB2;CHRNB4;CYBA;CYBB;GRIN3A;NCF1;NCF2;NCF4;OPRD1;OPRK1;OPRM1;PGRMC1;RAC1;RAC2;SIGMAR1;SLC6A2;SLC6A4,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,4,COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3;COC1CCC2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)C2C1,MKXZASYAUGDDCJ-NJAFHUGGSA-N
DEXTROROTATION-NIMORAZOLE-PHOSPHATE-ESTER,DEXTROROTATION-NIMORAZOLE-PHOSPHATE-ESTER,,BRD:BRD-K00003272-001-01-9,rep_single_dose,ANTIINFECTIVE DRUG,,,,,,,NA,,
YOURGLUCO,ALPHA-D-;ANHYDROUS;ANHYDROUS DEXTROSE;ANHYDROUS GLUCOSE;CAPD;CLINTEC;D-GLUCOSE;DEXTRO ENERGY;DEXTROGEL;DEXTROSE;DEXTROSE ANHYDROUS;DEXTROSE SOLUTION;GAMBROSOL;GLUCOSE;GLUCOSE ANHYDROUS;GLUCOSE INJECTION;GLUCOSE-40;GLUCOSUM;GRAPE SUGAR;GSF-SYRUP;INSTA-GLUCOSE;LIQUID;LIQUID GLUCOSE;NSC-406891;RAPILOSE;UNSPECIFIED;UNSPECIFIED FORM;YOURGLUCO,CHEMBL1222250,BRD:BRD-BRD-K51431759-001-02-9;BRD:BRD-K51431759-001-02-9,rep_primary;rep_single_dose,,,HYPOGLYCEMIA,,LAUNCHED,,Small molecule,4,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O;OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-GASJEMHNSA-N
DFB,DFB,,BRD:BRD-BRD-K82002057-001-01-2;BRD:BRD-K82002057-001-01-2,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM5,,,PRECLINICAL,,,NA,FC1CCCC(C1)\C=N\N=C\C1CCCC(F)C1,
DG-172,DG-172,,BRD:BRD-K75748943-300-02-9,rep_single_dose,PPAR RECEPTOR INVERSE AGONIST,PPARD,,,,,,NA,,
DG051,DG051,,BRD:BRD-K00003486-003-01-9,rep_single_dose,LEUKOTRIENE SYNTHESIS INHIBITOR,,,,,,,NA,,
DH-97,DH-97,,BRD:BRD-K06014311-001-04-9,rep_single_dose,MELATONIN RECEPTOR ANTAGONIST,MTNR1B,,,,,,NA,,
DHBP,DHBP,,BRD:BRD-K41262162-303-11-9,rep_single_dose,RYANODINE RECEPTOR BLOCKER,,,,,,,NA,,
ZONDAR,AC-201;AC-203;ARTRODAR;DIACEREIN;DIACERHEIN;DIACETYLRHEIN;DIORA;FISIODAR;M-01AX21;M01AX21;NSC-758147;RHEIN DIACETATE;SF-277;VERBORIL;ZONDAR,CHEMBL41286,BRD:BRD-BRD-K69122748-001-10-1;BRD:BRD-K69122748-001-10-1,rep_primary;rep_single_dose,INTERLEUKIN INHIBITOR,IL1B,OSTEOARTHRITIS,,LAUNCHED,,Small molecule,4,"CC(=O)OC1CCCC2C(=O)C3CC(CC(OC(C)=O)C3C(=O)C12)C(O)=O, CC(=O)OC1CCCC2C(=O)C3CC(CC(OC(C)=O)C3C(=O)C12)C(O)=O, CC(=O)OC1CCCC2C(=O)C3CC(CC(OC(C)=O)C3C(=O)C12)C(O)=O;CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O",TYNLGDBUJLVSMA-UHFFFAOYSA-N
NSC-6083,"ACETAMINOPHEN RELATED COMPOUND A;DIACETAMATE;N,O-DIACETYL-4-AMINOPHENO;NSC-33893;NSC-6083",CHEMBL2106185,BRD:BRD-BRD-K93611241-001-02-2;BRD:BRD-K93611241-001-02-2,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CC(=O)Nc1ccc(OC(C)=O)cc1;CC(=O)NC1CCC(OC(C)=O)CC1,UJAOSPFULOFZRR-UHFFFAOYSA-N
DIADENOSINE-TETRAPHOSPHATE,DIADENOSINE-TETRAPHOSPHATE,,BRD:BRD-A15035311-001-01-8;BRD:BRD-BRD-A15035311-001-01-8,rep_primary;rep_single_dose,ADENOSINE KINASE INHIBITOR,P2RY13;P2RY2,,,PHASE 1,,,NA,NC1NCNC2N(CNC12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H](C(O)C2O)N2CNC3C(N)NCNC23)C(O)C1O,
VAL-083,"1,2:5,6-DIANHDROGALACTITOL;1,2:5,6-DIANHYDROGALACTITOL;DIANHYDROGALACTITOL;DULCITOL DIEPOXIDE;NSC-132313;NSC-1323313;VAL-083",CHEMBL3137322,BRD:BRD-BRD-K68502831-001-01-2;BRD:BRD-K68502831-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,,,,PHASE 1,,Small molecule,3,O[C@@H]([C@@H](O)[C@H]1CO1)[C@@H]1CO1;O[C@H]([C@H](O)[C@@H]1CO1)[C@H]1CO1,AAFJXZWCNVJTMK-GUCUJZIJSA-N
DIARYLPROPIONITRILE,"2,3-BIS(4-HYDROXYPHENYL)PROPANENITRILE;DIARYLPROPIONITRILE",CHEMBL334773,BRD:BRD-A27143604-001-02-0;BRD:BRD-BRD-A27143604-001-02-0,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR2,,,PRECLINICAL,,Small molecule,NA,N#CC(Cc1ccc(O)cc1)c1ccc(O)cc1;OC1CCC(CC(C#N)C2CCC(O)CC2)CC1,GHZHWDWADLAOIQ-UHFFFAOYSA-N
DIATRIZOIC-ACID,DIATRIZOIC-ACID,,BRD:BRD-BRD-K48247567-001-01-9;BRD:BRD-K48247567-001-01-9,rep_primary;rep_single_dose,,,CONTRAST AGENT,,LAUNCHED,,,NA,CC(=O)NC1C(I)C(NC(C)=O)C(I)C(C(O)=O)C1I,
NSC-408735,BW 49-210;BW-49-210;BW-49210;DIAVERIDINE;NSC-408735,CHEMBL19633,BRD:BRD-BRD-K97464279-001-03-5;BRD:BRD-K97464279-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,,,,LAUNCHED,,Small molecule,-1,COc1ccc(Cc2cnc(N)nc2N)cc1OC;COC1CCC(CC2CNC(N)NC2N)CC1OC,LDBTVAXGKYIFHO-UHFFFAOYSA-N
WY-3467,ALUPRAM 10;ALUPRAM 2;ALUPRAM 5;ANSIOLISINA;APOZEPAM;ATENSINE;CENTRAZEPAM;DIACEPIN;DIALAR;DIALAR FTE;DIASTAT;DIASTAT ACUDIAL;DIAZEPAM;DIAZEPAM CIV;DIAZEPAM INTENSOL;DIZAC;E-PAM;LA III;LA-III;NRL-1;NSC-169897;NSC-77518;PAXEL;Q-PAM;RELANIUM;RO 5-2807;RO-5-2807;RO-52807;SCRIPTOPAM;SERENACK;SERVIZEPAM;SOLIS;STESOLID;TENSIUM;TRANIMUL;TRANQUASE;VALCLAIR;VALIUM;VALRELEASE;VALTOCO;VIVOL;WY-3467,CHEMBL12,BRD:BRD-BRD-K16508793-001-05-9;BRD:BRD-K16508793-001-05-9,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,ADRA1A;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GABRR1;GABRR2;GABRR3;TSPO,"GENERALIZED ANXIETY DISORDER (GAD), ABSTINENCE FROM ALCOHOL, HALLUCINOSIS, TREMORS",,LAUNCHED,,Small molecule,4,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21;CN1C2CCC(CL)CC2C(=NCC1=O)C1CCCCC1,AAOVKJBEBIDNHE-UHFFFAOYSA-N
DIAZOOXONORLEUCINE,DIAZOOXONORLEUCINE,,BRD:BRD-BRD-K38458514-001-01-8;BRD:BRD-K38458514-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,PHASE 2,,,NA,N[C@@H](CCC(=O)C=[N+]=N)C(O)=O,
SRG-95213,DIAZOXIDE;DIAZOXIDUM;EUDEMINE;EUDEMINE INJECTION;EUDIMINE;HYPERSTAT;HYPERTONALUM;MUTABASE;NSC-64198;NSC-76130;PROGLYCEM;SCH 6783;SCH-6783;SRG 95213;SRG-95213,CHEMBL181,BRD:BRD-BRD-K73109821-001-20-1;BRD:BRD-K73109821-001-20-1,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,ATP1A1;CA1;CA2;KCNJ11;KCNJ8;KCNMA1;SLC12A3,HYPOGLYCEMIA,,LAUNCHED,,Small molecule,4,"CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1;CC1=NC2CCC(CL)CC2S(=O)(=O)N1, CC1=NC2CCC(CL)CC2S(=O)(=O)N1, CC1=NC2CCC(CL)CC2S(=O)(=O)N1",GDLBFKVLRPITMI-UHFFFAOYSA-N
YO-01027,DIBENZAZEPINE;YO-01027,,BRD:BRD-BRD-K04622161-001-02-3;BRD:BRD-K04622161-001-02-3;BRD:BRD-K04622161-001-05-9,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHBITOR OF GAMMA-SECRETASE COMPLEX,PSEN1,,,PRECLINICAL,"Multiple values for MOA: {'GAMMA SECRETASE INHIBITOR', 'INHBITOR OF GAMMA-SECRETASE COMPLEX'}, defaulting to 'INHBITOR OF GAMMA-SECRETASE COMPLEX'",,NA,"C[C@H](NC(=O)CC1CC(F)CC(F)C1)C(=O)N[C@H]1C2CCCCC2-C2CCCCC2N(C)C1=O, C[C@H](NC(=O)CC1CC(F)CC(F)C1)C(=O)N[C@H]1C2CCCCC2-C2CCCCC2N(C)C1=O",
DIBENZEPINE,DIBENZEPINE,CHEMBL99486,BRD:BRD-BRD-K79145749-003-02-2;BRD:BRD-K79145749-003-02-2,rep_primary;rep_single_dose,NOREPINEPHRINE REPUTAKE INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,CN(C)CCN1C(=O)c2ccccc2Nc2ccccc21;CN(C)CCN1C2CCCCC2N(C)C2CCCCC2C1=O,STBMTRPPGSYEFD-UHFFFAOYSA-N
NSC-2843,DIBENZOTHIOPHENE;NSC-2843,CHEMBL219828,BRD:BRD-BRD-K46863940-001-06-2;BRD:BRD-K46863940-001-06-2,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,"c1ccc2c(c1)sc1ccccc12;C1CCC2C(C1)SC1CCCCC21, C1CCC2C(C1)SC1CCCCC21, C1CCC2C(C1)SC1CCCCC21",IYYZUPMFVPLQIF-UHFFFAOYSA-N
DIBUTYL-PHTHALATE,DIBUTYL-PHTHALATE,,BRD:BRD-BRD-K73477617-001-08-5;BRD:BRD-K73477617-001-08-5,rep_primary;rep_single_dose,,TRPA1,,,PRECLINICAL,,,NA,CCCCOC(=O)C1CCCCC1C(=O)OCCCC,
DICHLORISONE-ACETATE,DICHLORISONE-ACETATE,,BRD:BRD-BRD-K54187111-001-08-4;BRD:BRD-BRD-K54187111-001-09-2;BRD:BRD-K54187111-001-08-4;BRD:BRD-K54187111-001-09-2,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](CL)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](CL)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](CL)C[C@]12C",
NSC-2654,BICHLORACETIC ACID;BICHLOROACETIC ACID;DICHLORACETIC ACID;DICHLORETHANOIC ACID;DICHLOROACETATE;DICHLOROACETIC ACID;DICHLOROETHANOIC ACID;NSC-2654,CHEMBL13960,BRD:BRD-BRD-M97302542-001-03-6;BRD:BRD-M97302542-001-03-6;BRD:BRD-M97302542-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,PYRUVATE DEHYDROGENASE KINASE INHIBITOR,PDK1,,,PHASE 3,,Small molecule,3,"[NA].OC(=O)C(CL)CL, [NA].OC(=O)C(CL)CL;O=C(O)C(Cl)Cl",JXTHNDFMNIQAHM-UHFFFAOYSA-N
PARABIS,ANTHIPHEN;DICHLOROPHEN;DIDROXANE;G-4;NSC-38642;PARABIS,CHEMBL33845,BRD:BRD-BRD-K62326629-001-19-0;BRD:BRD-K62326629-001-19-0,rep_primary;rep_single_dose,ANTICESTODAL AGENT,,,,LAUNCHED,,Small molecule,-1,"Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O;OC1CCC(CL)CC1CC1CC(CL)CCC1O, OC1CCC(CL)CC1CC1CC(CL)CCC1O",MDNWOSOZYLHTCG-UHFFFAOYSA-N
TASK TABS,ATGARD;DDVP;DICHLORVOS;EQUIGARD;EQUIGEL;NSC-6738;SD 1750;SD-1750;TASK TABS,CHEMBL167911,BRD:BRD-BRD-K23779958-001-05-8;BRD:BRD-K23779958-001-05-8,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,,,,LAUNCHED,,Small molecule,-1,COP(=O)(OC)OC=C(Cl)Cl;COP(=O)(OC)OC=C(CL)CL,OEBRKCOSUFCWJD-UHFFFAOYSA-N
VECOXAN,"CLINACOX;DICLAZURIL;DICLAZURIL FOR VETERINARY USE;NSC-759642;NUOQIU;P-64433;R-64-433;R-64433;R64,433;VECOXAN",CHEMBL284733,BRD:BRD-A06426627-001-03-5;BRD:BRD-BRD-A06426627-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,EQUINE PROTOZOAL MYELOENCEPHALITIS (EPM),,LAUNCHED,,Small molecule,-1,"CLC1CCC(CC1)C(C#N)C1C(CL)CC(CC1CL)-N1NCC(=O)[NH]C1=O, CLC1CCC(CC1)C(C#N)C1C(CL)CC(CC1CL)-N1NCC(=O)[NH]C1=O;N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl",ZSZFUDFOPOMEET-UHFFFAOYSA-N
ZORVOLEX CAPSULES,ARTHROTEC;CAMBIA;CATAFLAM;DICLOFENAC;DICLOFENAC ACID;DICLOFENAC FREE ACID;LAS-41007;LAS41007;SOLARAZE;VOLTAREN;VOLTAREN OPHTHALMIC;VOLTAREN XR;VOLTAREN-XR;ZORVOLEX;ZORVOLEX CAPSULES,CHEMBL139,BRD:BRD-BRD-K08252256-236-33-8;BRD:BRD-K08252256-236-33-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,AKR1C3;ALOX5;ASIC1;ASIC3;KCNQ2;KCNQ3;PLA2G2A;PPARG;PTGS1;PTGS2;SCN4A,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, MIGRAINE HEADACHE",,LAUNCHED,,Small molecule,4,"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl;OC(=O)CC1CCCCC1NC1C(CL)CCCC1CL, OC(=O)CC1CCCCC1NC1C(CL)CCCC1CL, OC(=O)CC1CCCCC1NC1C(CL)CCCC1CL, OC(=O)CC1CCCCC1NC1C(CL)CCCC1CL",DCOPUUMXTXDBNB-UHFFFAOYSA-N
ORATROL,DARANIDE;DICHLORPHENAMIDE;DICLOFENAMIDE;KEVEYIS;ORATROL,CHEMBL17,BRD:BRD-BRD-K71499074-001-12-9;BRD:BRD-K71499074-001-12-9,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA1;CA12;CA2;CA4;CA7,"GLAUCOMA, EPILEPSY",,LAUNCHED,,Small molecule,4,NS(=O)(=O)C1CC(CL)C(CL)C(C1)S(N)(=O)=O;NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,GJQPMPFPNINLKP-UHFFFAOYSA-N
J1.874.218G,DICLOFENSINE;J1.874.218G,CHEMBL287257,BRD:BRD-A51078674-003-01-0;BRD:BRD-BRD-A51078674-003-01-0,rep_primary;rep_single_dose,DOPAMINE REUPTAKE INHIBITOR,DRD1;MAOA;MAOB,,,PHASE 3,,Small molecule,-1,COc1ccc2c(c1)CN(C)CC2c1ccc(Cl)c(Cl)c1;COC1CCC2C(CN(C)CC2C1)C1CCC(CL)C(CL)C1,ZJDCGVDEEHWEIG-UHFFFAOYSA-N
R-13423,BRL-1702;DICLOXACILLIN;DYCILL;DYNAPEN;PATHOCIL;R-13423,CHEMBL893,BRD:BRD-BRD-K05673000-236-12-1;BRD:BRD-K05673000-236-12-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,GRAM-POSITIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O;CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1C(CL)CCCC1CL, CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1C(CL)CCCC1CL, CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1C(CL)CCCC1CL",YFAGHNZHGGCZAX-JKIFEVAISA-N
NSC-41834,BISHYDROXYCOUMARIN;DICOUMAROL;DICOUMAROLUM;DICUMAROL;NSC-17860;NSC-221570;NSC-41834,CHEMBL1466,BRD:BRD-BRD-K82236179-213-01-0;BRD:BRD-K82236179-213-01-0,rep_primary;rep_single_dose,NADPH INHIBITOR,CRYZ;NQO1;VKORC1,DEEP VEIN THROMBOSIS (DVT),,LAUNCHED,,Small molecule,4,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O;OC1C(CC2C(O)C3CCCCC3OC2=O)C(=O)OC2CCCCC12,DOBMPNYZJYQDGZ-UHFFFAOYSA-N
DICYCLOHEXYLAMINE,DICYCLOHEXYLAMINE,,BRD:BRD-BRD-K57091285-001-07-7;BRD:BRD-K57091285-001-07-7,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,C1CCC(CC1)NC1CCCCC1,
KOLANTYL,BENTYL;DICYCLOMINE;DICYCLOVERINE;DICYMINE;KOLANTYL,CHEMBL1123,BRD:BRD-BRD-K68507560-003-24-6;BRD:BRD-K68507560-003-24-6,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3,IRRITABLE BOWEL SYNDROME,,LAUNCHED,,Small molecule,4,"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1;CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1, CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1",CURUTKGFNZGFSE-UHFFFAOYSA-N
VIDEX EC,(-)-DIDANOSINE;BMY-40900;DDI;DIDANOSINE;DIDANOSINE SYSTEM SUITABILITY MIXTURE;DIDANOSINUM;DIDEOXYINOSINE (DDI);NSC-612049;VIDEX;VIDEX EC,CHEMBL1460,BRD:BRD-BRD-K99063460-001-13-1;BRD:BRD-K99063460-001-13-1,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,PNP,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1;OC[C@@H]1CC[C@@H](O1)N1CNC2C(O)NCNC12, OC[C@@H]1CC[C@@H](O1)N1CNC2C(O)NCNC12",BXZVVICBKDXVGW-NKWVEPMBSA-N
DIDEOXYADENOSINE,DIDEOXYADENOSINE,,BRD:BRD-BRD-K84794093-001-07-5;BRD:BRD-K84794093-001-07-5,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,,,PHASE 1,,,NA,NC1NCNC2N(CNC12)[C@H]1CC[C@@H](CO)O1,
DIDOX,DIDOX,,BRD:BRD-BRD-K94146583-001-01-6;BRD:BRD-K94146583-001-01-6,rep_primary;rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,RRM1,BREAST CANCER,,LAUNCHED,,,NA,ONC(=O)C1CCC(O)C(O)C1,
RETALON,.ALPHA.-;.ALPHA.-DIENESTROL DIACETATE;CYCLADIENE;DEHYDROSTILBESTROL;DIENESTROL;DIENESTROL DIACETATE;DIENESTROL TRANS-FORM;DIENOESTROL;DIENOL;DINOVEX;ESTRAGARD;ESTRAGUARD;ESTRORAL;FOLLIDIENE;GYNEFOLLIN;HORMOFEMIN;NSC-59809;OESTRASID;OESTRODIENE;OESTRORAL;RESTROL;RETALON,CHEMBL1018,BRD:BRD-BRD-K95309561-001-24-7;BRD:BRD-K95309561-001-24-7,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1,MENOPAUSE,,LAUNCHED,,Small molecule,4,C/C=C(C(=C/C)/c1ccc(O)cc1)\c1ccc(O)cc1;C\C=C(C1CCC(O)CC1)\C(C1CCC(O)CC1)=C\C,NFDFQCUYFHCNBW-SCGPFSFSSA-N
ZK-37659,DIENOGEST;ENDOMETRION;M 18575;M-18575;MJR-35;STS 557;STS-557;ZK 37659;ZK-37659,CHEMBL1201864,BRD:BRD-BRD-K50853363-001-02-3;BRD:BRD-K50853363-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,"CONTRACEPTIVE, ENDOMETRIOSIS",,LAUNCHED,,Small molecule,4,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,AZFLJNIPTRTECV-FUMNGEBKSA-N
HETRAZAN,CAMIN;DIETHYLCARBAMAZINE;HETRAZAN,CHEMBL684,BRD:BRD-BRD-K45542189-048-22-1;BRD:BRD-K45542189-048-22-1,rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX5;PTGS1,FILARIASIS,,LAUNCHED,,Small molecule,4,CCN(CC)C(=O)N1CCN(C)CC1,RCKMWOKWVGPNJF-UHFFFAOYSA-N
TAMPOVAGAN,APSTIL;CYREN A;DIETHYLSTILBESTROL;DISTILBENE;ESTROBENE;ESTROGENINE;ESTROMENIN;FONATOL;NEW-ESTRANOL 1;NSC-3070;PALESTROL;STILBESTRO;STILBESTROFORM;STILBESTROL;STILBETIN;STILBOESTEROL;STILBOESTROL;SYNESTRIN;SYNTHESTRIN;TAMPOVAGAN,CHEMBL411,BRD:BRD-BRD-K45330754-001-21-7;BRD:BRD-K45330754-001-21-7,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1;ESR2;ESRRB;ESRRG,,,WITHDRAWN,,Small molecule,4,"CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1;CC\C(C1CCC(O)CC1)=C(\CC)C1CCC(O)CC1, CC\C(C1CCC(O)CC1)=C(\CC)C1CCC(O)CC1",RGLYKWWBQGJZGM-ISLYRVAYSA-N
ORISTAR DEET,"DEET;DEET N,N-DIETHYL-META-TOLUAMIDE;DIETHYL TOLUAMIDE;DIETHYLTOLUAMIDE;DIETHYLTOLUAMIDUM;ENT-20218;ENT-22542;N,N-DIETHYL 3-METHYL BENZAMIDE;NSC-33840;ORISTAR DEET",CHEMBL1453317,BRD:BRD-BRD-K94080537-001-09-7;BRD:BRD-K94080537-001-09-7,rep_primary;rep_single_dose,IONOTROPIC RECEPTOR IR40A ACTIVATOR,,SUNSCREEN LOTION,,LAUNCHED,,Small molecule,4,CCN(CC)C(=O)c1cccc(C)c1;CCN(CC)C(=O)C1CCCC(C)C1,MMOXZBCLCQITDF-UHFFFAOYSA-N
OPA-15406,DIFAMILAST;OPA-15406,CHEMBL3989968,BRD:BRD-K00091099-001-01-9,rep_single_dose,,,,,,,Small molecule,3,CCOc1ccccc1C(=O)NCc1coc(-c2ccc(OC(F)F)c(OC(C)C)c2)n1,VFBILHPIHUPBPZ-UHFFFAOYSA-N
N1-(D-PHENYLALANYL-D-PHENYLALANYL-D-LEUCYL-D-LYSYL)-4-AMINO-,4-PIPERIDINECARBOXYLIC ACID;CR-845;CR-845 ACETATE;CR845;DIFELIKEFALIN;DIFELIKEFALIN ACETATE;FE-202845;FE202845;KORSUVA;MR-13A9;MR13A9;N1-(D-PHENYLALANYL-D-PHENYLALANYL-D-LEUCYL-D-LYSYL)-4-AMINO-,CHEMBL3989915,BRD:BRD-K00077991-001-02-9,rep_single_dose,,,,,,,Protein,4,CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(C(=O)O)CC1,FWMNVWWHGCHHJJ-SKKKGAJSSA-N
Z-876,DIFENAX;DIFENPIRAMIDE;DIPHENPYRAMIDE;NSC-305337;Z-876,CHEMBL1489662,BRD:BRD-BRD-K96206066-001-07-9;BRD:BRD-K96206066-001-07-9,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PROSTAGLANDIN INHIBITOR",,,,LAUNCHED,,Small molecule,-1,O=C(Cc1ccc(-c2ccccc2)cc1)Nc1ccccn1;O=C(CC1CCC(CC1)-C1CCCCC1)NC1CCCCN1,PWHROYKAGRUWDQ-UHFFFAOYSA-N
DIFLORASONE-DIACETATE,DIFLORASONE-DIACETATE,,BRD:BRD-A66869276-001-02-9;BRD:BRD-BRD-A66869276-001-02-9,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,C[C@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(C)=O)C(=O)COC(C)=O,
PULSAFLOX,DICURAL;DIFLOXACIN;PULSAFLOX,CHEMBL6259,BRD:BRD-BRD-K73923631-003-02-9;BRD:BRD-K73923631-003-02-9,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,"SKIN INFECTIONS, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,-1,"CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1;CN1CCN(CC1)C1CC2N(CC(C(O)=O)C(=O)C2CC1F)-C1CCC(F)CC1, CN1CCN(CC1)C1CC2N(CC(C(O)=O)C(=O)C2CC1F)-C1CCC(F)CC1",NOCJXYPHIIZEHN-UHFFFAOYSA-N
NSC-756728,DIFLUNISAL;DOLOBID;DOLOBID 500;NSC-756728,CHEMBL898,BRD:BRD-BRD-K22031190-001-23-6;BRD:BRD-K22031190-001-23-6,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGS1;PTGS2,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS",,LAUNCHED,,Small molecule,4,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O;OC(=O)C1CC(CCC1O)-C1CCC(F)CC1F,HUPFGZXOMWLGNK-UHFFFAOYSA-N
W-6309,DIFLUPREDNATE;DUREZOL;W 6309;W-6309,CHEMBL1201749,BRD:BRD-BRD-K33720171-001-01-0;BRD:BRD-K33720171-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,ENDOGENOUS UVEITIS,,LAUNCHED,,Small molecule,4,CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C;CCCC(=O)O[C@]1(CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)COC(C)=O,WYQPLTPSGFELIB-JTQPXKBDSA-N
L-5418,DIFTALONE;L-5418,CHEMBL1536675,BRD:BRD-BRD-K80076813-001-08-8;BRD:BRD-K80076813-001-08-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,THYROIDITIS,,LAUNCHED,,Small molecule,-1,O=C1c2ccccc2CN2C(=O)c3ccccc3CN12;O=C1N2CC3CCCCC3C(=O)N2CC2CCCCC12,CXSJGNHRBWJXEA-UHFFFAOYSA-N
UZARIGENIN,DIGITOXIGENIN;DIGOXIGENIN;UZARIGENIN,CHEMBL1453,BRD:BRD-BRD-K18518344-001-15-9;BRD:BRD-K18518344-001-15-9,rep_multi_dose;rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP1A1,,,PRECLINICAL,,Small molecule,NA,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O;C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@@H]2C1=CC(=O)OC1,XZTUSOXSLKTKJQ-CESUGQOBSA-N
TRADIGAL,CRISTAPURAT;CRYSTALLINE;CRYSTODIGIN;DIGIMERCK;DIGITALIN;DIGITOPHYLLIN;DIGITOXIN;DIGITOXINUM;DIGITOXOSIDE;GLUCODIGIN;LANATOXIN;NATIVELLE DIGITALINE;NSC-7529;PURPURID;TRADIGAL,CHEMBL254219,BRD:BRD-A93236127-001-04-5;BRD:BRD-BRD-A93236127-001-04-5,rep_multi_dose;rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP1A1,,,LAUNCHED,,Small molecule,4,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O;C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,WDJUZGPOPHTGOT-XUDUSOBPSA-N
DIGOXIGENIN,DIGOXIGENIN,CHEMBL1153,BRD:BRD-BRD-K18619710-001-14-4;BRD:BRD-K18619710-001-14-4,rep_multi_dose;rep_primary;rep_single_dose,STEROID,,,,PRECLINICAL,,Small molecule,NA,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O;C[C@@]12[C@H](CC[C@]1(O)[C@@H]1CC[C@@H]3C[C@@H](O)CC[C@]3(C)[C@H]1C[C@H]2O)C1=CC(=O)OC1,SHIBSTMRCDJXLN-KCZCNTNESA-N
VANOXIN,.ALPHA.-ACETYLDIGOXIN;.BETA.-METHYLDIGOXIN;3'''-ACETATE;4'''-.BETA.-METHYLDIGOXIN;4'''-O-METHYL-;4'''-O-METHYLDIGOXIN;ACETYLDIGOXIN;BETA;BETA-ACETYLDIGOXIN;DIGAMEX;DIGOXIN;DIGOXIN PEDIATRIC;DIGOXINUM;DYNAMOS;FARGOXIN;LANATILIN;LANIRAPID;LANITOP;LANOCARDIN;LANOXICAPS;LANOXIN;LANOXIN PEDIATRIC;LANOXIN-125;LANOXIN-PG;MAPLUXIN;MEDIGOXIN;METHYLDIGOXIN;METILDIGOXIN;NATIGOXIN;NSC-95100;ROUGOXIN;SANDOLANID;STILLACOR-;TOLOXIN;VANOXIN,CHEMBL1697843;CHEMBL1751;CHEMBL2074725,BRD:BRD-A94756469-001-04-7;BRD:BRD-BRD-A94756469-001-04-7;BRD:BRD-K23478508-001-27-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"INHIBITOR OF THE SODIUM-POTASSIUM ATPASE (ATP1A1/ATP1B1, ATP1A2/ATP1B1, ATP1A2/ATP1B3)",ATP1A1;ATP1A2;ATP1B1;ATP1B3,"CONGESTIVE HEART FAILURE, ATRIAL FIBRILLATION (AF)",,LAUNCHED,"Multiple values for MOA: {'ATPASE INHIBITOR', 'INHIBITOR OF THE SODIUM-POTASSIUM ATPASE (ATP1A1/ATP1B1, ATP1A2/ATP1B1, ATP1A2/ATP1B3)'}, defaulting to 'INHIBITOR OF THE SODIUM-POTASSIUM ATPASE (ATP1A1/ATP1B1, ATP1A2/ATP1B1, ATP1A2/ATP1B3)'
Multiple values for repurposing_target: {'ATP1A1', 'ATP1A1;ATP1A2;ATP1B1;ATP1B3'}, taking the union
Multiple values for structure_id: {'A94756469', 'K23478508'}, defaulting to None",Small molecule,4,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O;C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,LTMHDMANZUZIPE-PUGKRICDSA-N
DIHOMO-GAMMA-LINOLENIC-ACID,DIHOMO-GAMMA-LINOLENIC-ACID,,BRD:BRD-BRD-K20152659-001-04-6;BRD:BRD-K20152659-001-04-6,rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,PTGS1;PTGS2,,,PHASE 2,,,NA,"CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O, CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O, CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O",
REL-DIHYDREXIDINE,(-)-;(-)-DIHYDREXIDINE;DAR-0100;DAR-0100A;DAR0100A;DIHYDREXIDINE;REL-DIHYDREXIDINE,CHEMBL25856,BRD:BRD-K31471398-003-06-9,rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD1;DRD2;DRD3;DRD4;DRD5,,,,,Small molecule,2,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2,BGOQGUHWXBGXJW-RHSMWYFYSA-N
SANTECXIN,.BETA.-;.BETA.-DIHYDROARTEMISININ;ALAXIN;ARTEMETHER RELATED COMPOUND A;ARTENIMOL;ARTENIMOLUM;COTECXIN;COTEXIN;DI-HYDROQINGHAOSU;DIHYDROARTEMISININ;DIHYDROARTEMISININE;DIHYDROQINGHAOSU;DYNAMAX;GNF-PF-5634;SALAXIN;SANTECXIN,CHEMBL252518,BRD:BRD-BRD-K62213621-001-01-6;BRD:BRD-K62213621-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,ANTIMALARIAL AGENT,,MALARIA,,LAUNCHED,,Small molecule,4,"C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4;C[C@H]1[C@@H](O)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3",BJDCWCLMFKKGEE-CMDXXVQNSA-N
GNF-PF-3462,"9,10-DIHYDROERGOCRISTINE;DIHYDROERGOCRISTINE;GNF-PF-3462",CHEMBL601773,BRD:BRD-BRD-K97440753-066-18-1;BRD:BRD-K97440753-066-18-1,rep_multi_dose;rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, PROLACTIN INHIBITOR",ADRA1A;ADRB1;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR2A;HTR3A;HTR4;HTR5A;HTR6;HTR7,,,LAUNCHED,,Small molecule,-1,"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O;CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](CC4C[NH]C5CCCC3C45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3CCCCC3)N2C1=O, CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](CC4C[NH]C5CCCC3C45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3CCCCC3)N2C1=O",DEQITUUQPICUMR-HJPBWRTMSA-N
NEOMIGRAN,"9,10-DIHYDROERGOTAMINE;DIHYDROERGOTAMINE;MAP-0004;MAP0004;NEOMIGRAN",CHEMBL1732,BRD:BRD-BRD-K72166146-066-05-4;BRD:BRD-K72166146-066-05-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,ADRA2A;DRD2;HTR1B;HTR1D;HTR1E;HTR1F;HTR2B;HTR7,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,"CN1C[C@@H](C[C@H]2[C@H]1CC1C[NH]C3CCCC2C13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3CCCCC3)N2C1=O, CN1C[C@@H](C[C@H]2[C@H]1CC1C[NH]C3CCCC2C13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3CCCCC3)N2C1=O, CN1C[C@@H](C[C@H]2[C@H]1CC1C[NH]C3CCCC2C13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3CCCCC3)N2C1=O;CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21",LUZRJRNZXALNLM-JGRZULCMSA-N
TELOCAPIL,AMPELOPSIN;AMPELOPTIN;DIHYDROMYRICETIN;MYRICELINE SPE;TELOCAPIL,CHEMBL3348861,BRD:BRD-BRD-K01614093-001-02-6;BRD:BRD-K01614093-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,2,"O[C@@H]1[C@H](OC2CC(O)CC(O)C2C1=O)C1CC(O)C(O)C(O)C1, O[C@@H]1[C@H](OC2CC(O)CC(O)C2C1=O)C1CC(O)C(O)C(O)C1, O[C@@H]1[C@H](OC2CC(O)CC(O)C2C1=O)C1CC(O)C(O)C(O)C1, O[C@@H]1[C@H](OC2CC(O)CC(O)C2C1=O)C1CC(O)C(O)C(O)C1;O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O",KJXSIXMJHKAJOD-LSDHHAIUSA-N
DIHYDROROTENONE,DIHYDROROTENONE,CHEMBL3039021,GDSC2:1827,gdsc,,,,,,,Small molecule,NA,COc1cc2c(cc1OC)[C@@H]1C(=O)c3ccc4c(c3O[C@@H]1CO2)CC(C(C)C)O4,DTFARBHXORYQBF-XHEPWMPHSA-N
VIBRIOMYCIN,ABIOCINE;DIHYDRO-;DIHYDROSTREPTOMYCIN;STREPTOMYCIN;VIBRIOMYCIN,CHEMBL1950576,BRD:BRD-A67363467-001-01-3;BRD:BRD-BRD-A67363467-001-01-3,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,,,WITHDRAWN,,Small molecule,4,CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O;CN[C@H]1C(O)C(O)C(CO)OC1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)OC(C)[C@]1(O)CO,ASXBYYWOLISCLQ-HZYVHMACSA-N
STANOLONE,4-DIHYDROTESTOSTERONE;5ALPHA-DIHYDROTESTOSTERONE;ANABOLEX;ANDRACTIM;ANDROSTANOLONE;DIHYDROTESTOSTERONE;DIHYDROTESTOSTERONE (DHT);NEODROL;NSC-10972;STANOLONE,CHEMBL27769,BRD:BRD-BRD-K22525962-001-05-0;BRD:BRD-K22525962-001-05-0,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,AR;HSD17B1,"TETANY, HYPOPARATHYROIDISM",,LAUNCHED,,Small molecule,2,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O;C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,NVKAWKQGWWIWPM-ABEVXSGRSA-N
VITADYE,DIHYDROXYACETONE;FEMA NO. 4033;NSC-24343;VITADYE,CHEMBL1229937,BRD:BRD-K18637542-001-01-7,rep_single_dose,,,,,,,Small molecule,4,O=C(CO)CO,RXKJFZQQPQGTFL-UHFFFAOYSA-N
DIHYDROXYPHENYLGLYCINE,DIHYDROXYPHENYLGLYCINE,,BRD:BRD-A20589515-001-03-9,rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM1;GRM5,,,,,,NA,,
DILAZEP DIHYDROCHLORIDE,DILAZEP;DILAZEP DIHYDROCHLORIDE,CHEMBL126075,BRD:BRD-BRD-K48722258-300-10-2;BRD:BRD-K48722258-300-10-2,rep_primary;rep_single_dose,ADENOSINE REUPTAKE INHIBITOR,SLC29A1,,,LAUNCHED,,Small molecule,-1,"COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC;COC1CC(CC(OC)C1OC)C(=O)OCCCN1CCCN(CCCOC(=O)C2CC(OC)C(OC)C(OC)C2)CC1, COC1CC(CC(OC)C1OC)C(=O)OCCCN1CCCN(CCCOC(=O)C2CC(OC)C(OC)C(OC)C2)CC1",QVZCXCJXTMIDME-UHFFFAOYSA-N
SB681323,DILMAPIMOD;GW-681323;SB-681323;SB681323,CHEMBL2103838,BRD:BRD-K00003459-001-01-9,rep_single_dose,P38 MAPK INHIBITOR,,,,,,Small molecule,2,Cc1cc(F)ccc1-c1nc(NC(CO)CO)nc2c1ccc(=O)n2-c1c(F)cccc1F,ORVNHOYNEHYKJG-UHFFFAOYSA-N
DILOXANIDE,DILOXANIDE,CHEMBL2103768,BRD:BRD-BRD-K10974103-001-21-1;BRD:BRD-K10974103-001-21-1,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,AMEBIASIS,,LAUNCHED,,Small molecule,-1,CN(C(=O)C(Cl)Cl)c1ccc(O)cc1;CN(C(=O)C(CL)CL)C1CCC(OC(=O)C2CCCO2)CC1,GZZZSOOGQLOEOB-UHFFFAOYSA-N
TIAZAC,CARDIZEM;DILT-CD;DILTIAZEM;DILTIAZEM EXTENDED RELEASE;DILTZAC;DITIAZ;SURAZEM;TIAMATE;TIAZAC,CHEMBL23,BRD:BRD-A69636825-003-04-7;BRD:BRD-BRD-A69636825-003-04-7,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1S;CACNA2D1;CACNG1;HTR3A;KCNA5,"HYPERTENSION, ANGINA PECTORIS",,LAUNCHED,,Small molecule,4,"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1;COC1CCC(CC1)[C@@H]1SC2CCCCC2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O, COC1CCC(CC1)C1SC2CCCCC2N(CCN(C)C)C(=O)C1OC(C)=O, COC1CCC(CC1)[C@@H]1SC2CCCCC2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O, COC1CCC(CC1)[C@@H]1SC2CCCCC2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O",HSUGRBWQSSZJOP-RTWAWAEBSA-N
DIM-C-PPHCO2ME,DIM-C-PPHCO2ME,,BRD:BRD-K00005337-001-01-9,rep_single_dose,NUCLEAR RECEPTOR ANTAGONIST,,,,,,,NA,,
DIMAPRIT,DIMAPRIT,CHEMBL12344,BRD:BRD-BRD-K23541596-300-07-2;BRD:BRD-K23541596-300-07-2,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH2;HRH3;HRH4,,,PRECLINICAL,,Small molecule,NA,"CN(C)CCCSC(=N)N;CN(C)CCCSC(N)=N, CN(C)CCCSC(N)=N",OLHQOJYVQUNWPL-UHFFFAOYSA-N
DIMEMORFAN PHOSPHATE,DIMEMORFAN;DIMEMORFAN PHOSPHATE,CHEMBL2106325,BRD:BRD-BRD-K29812331-011-01-7;BRD:BRD-K29812331-011-01-7,rep_primary;rep_single_dose,SIGMA RECEPTOR AGONIST,SIGMAR1,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,-1,Cc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC1CCC(C)CC31,KBEZZLAAKIIPFK-NJAFHUGGSA-N
SULFACTIN,"1-PROPANOL;2,3-DIMERCAPTO;2,3-DITHIOPROPAN-1-OL;2,3-DITHIOPROPANOL;2,3,-DIMERCAPTO-1-PROPANOL;ANTI-LEWISITE;ANTOXOL;B.A.L.;BAL;DICAPTOL;DIMERCAPROL;DIMERCAPROLUM;DIMERSOL;NSC-39515;NSC-4646;PANOBAL;SULFACTIN",CHEMBL1597,BRD:BRD-A56152450-001-02-0;BRD:BRD-BRD-A56152450-001-02-0,rep_primary;rep_single_dose,CHELATING AGENT,,METAL TOXICITY,,LAUNCHED,,Small molecule,4,"OCC(S)CS;OCC(S)CS, OCC(S)CS",WQABCVAJNWAXTE-UHFFFAOYSA-N
DIMERCAPTOSUCCINIC-ACID,DIMERCAPTOSUCCINIC-ACID,,BRD:BRD-BRD-K88701661-001-02-9;BRD:BRD-K88701661-001-02-9,rep_primary;rep_single_dose,CHELATING AGENT,DNMT1,METAL TOXICITY,,LAUNCHED,,,NA,"OC(=O)[C@@H](S)[C@@H](S)C(O)=O, OC(=O)[C@@H](S)[C@@H](S)C(O)=O",
TAVOCEPT,BNP-7787;BNP7787;DIMESNA;NSC-716976;NSC-760345;TAVOCEPT,CHEMBL2009034;CHEMBL2104318,BRD:BRD-BRD-K30126819-304-02-7;BRD:BRD-K30126819-304-02-7,rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,PHASE 3,,Small molecule,3,"O=S(=O)([O-])CCSSCCS(=O)(=O)[O-].[Na+].[Na+];OS(=O)(=O)CCSSCCS(O)(=O)=O, OS(=O)(=O)CCSSCCS(O)(=O)=O",KQYGMURBTJPBPQ-UHFFFAOYSA-L
DIMETHINDENE-(S)-(+),DIMETHINDENE-(S)-(+),,BRD:BRD-BRD-K83192048-050-02-7;BRD:BRD-K83192048-050-02-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,HRH1,,,PRECLINICAL,,,NA,"C[C@@H](C1=C(CCN(C)C)CC2CCCCC12)C1CCCCN1, C[C@@H](C1=C(CCN(C)C)CC2CCCCC12)C1CCCCN1",
QUINISOCAINE,DIMETHISOQUIN;NSC-39695;QUINISOCAINE,CHEMBL127643,BRD:BRD-BRD-K73391359-003-10-2;BRD:BRD-K73391359-003-10-2,rep_multi_dose;rep_primary;rep_single_dose,LOCAL ANESTHETIC,,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,-1,CCCCc1cc2ccccc2c(OCCN(C)C)n1;CCCCC1CC2CCCCC2C(OCCN(C)C)N1,XNMYNYSCEJBRPZ-UHFFFAOYSA-N
DIMETHYL-FUMARATE,DIMETHYL-FUMARATE,,BRD:BRD-BRD-K31111078-001-04-2;BRD:BRD-K31111078-001-04-2,rep_primary;rep_single_dose,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",KEAP1,MULTIPLE SCLEROSIS,,LAUNCHED,"Multiple values for MOA: {'NUCLEAR FACTOR ERYTHROID DERIVED, LIKE (NRF2) ACTIVATOR', 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'}, defaulting to 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'",,NA,"COC(=O)\C=C\C(=O)OC, COC(=O)\C=C\C(=O)OC, COC(=O)\C=C\C(=O)OC",
RP-8595,ALAZOL;DIMETRIDAZOLE;EMTRYL;NSC-226253;RP 8595;RP-8595,CHEMBL38938,BRD:BRD-BRD-K72728560-001-01-4;BRD:BRD-K72728560-001-01-4,rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,,,LAUNCHED,,Small molecule,-1,Cc1ncc([N+](=O)[O-])n1C;CC1NCC(N1C)[N+]([O-])=O,IBXPYPUJPLLOIN-UHFFFAOYSA-N
DIMINAZENE-ACETURATE,DIMINAZENE-ACETURATE,,BRD:BRD-BRD-K92848252-001-01-9;BRD:BRD-K92848252-001-01-9,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME ACTIVATOR,AOC1;PRDX5;PRSS1,,,PHASE 3,,,NA,"NC(=N)C1CCC(N\N=N\C2CCC(CC2)C(N)=N)CC1, NC(=N)C1CCC(N\N=N\C2CCC(CC2)C(N)=N)CC1, NC(=N)C1CCC(N\N=N\C2CCC(CC2)C(N)=N)CC1",
OPTIMIZER INSECTICIDE,DIAZINON;DIMPYLATE;G-24480;NEW Z DIAZINON;NSC-8938;OPTIMIZER INSECTICIDE,CHEMBL388560,BRD:BRD-BRD-K60567437-001-10-2;BRD:BRD-K60567437-001-10-2,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE,,,LAUNCHED,,Small molecule,-1,CCOP(=S)(OCC)Oc1cc(C)nc(C(C)C)n1;CCOP(=S)(OCC)OC1CC(C)NC(N1)C(C)C,FHIVAFMUCKRCQO-UHFFFAOYSA-N
SCH-727965,DINACICLIB;MK-7965;SCH 727965;SCH-727965,CHEMBL2103840,BRD:BRD-BRD-K13662825-001-07-5;BRD:BRD-K13662825-001-07-5;CTRP:687578;GDSC2:1180,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK5;CDK9,,,PHASE 3,,Small molecule,3,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12;CCC1CNN2C(NCC3CCC[N+]([O-])C3)CC(NC12)N1CCCC[C@H]1CCO,PIMQWRZWLQKKBJ-SFHVURJKSA-N
ZOAMIX,"3,5-DINITRO-O-TOLUAMIDE;D.O.T.;DINITOLMIDE;DINITROTOLUAMIDE;METHYLDINITROBENZAMIDE;NSC-758213;ZOALELE;ZOALENE;ZOAMIX",CHEMBL472565,BRD:BRD-BRD-K93240442-001-08-4;BRD:BRD-K93240442-001-08-4,rep_primary;rep_single_dose,,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,Cc1c(C(N)=O)cc([N+](=O)[O-])cc1[N+](=O)[O-];CC1C(CC(CC1[N+]([O-])=O)[N+]([O-])=O)C(N)=O,ZEFNOZRLAWVAQF-UHFFFAOYSA-N
U-14583,"DINOPROST;PGF2A;PGF2ALPHA;PROSMON;PROSTAGLANDIN F2-ALPHA;PROSTAGLANDIN F2.ALPHA.;PROSTAGLANDIN F2ALPHA;U-14,583;U-14583",CHEMBL815,BRD:BRD-BRD-K81672972-001-03-1;BRD:BRD-K81672972-001-03-1,rep_primary;rep_single_dose,PROSTACYCLIN ANALOG,PTGDR;PTGDR2;PTGER1;PTGER2;PTGER3;PTGER4;PTGFR;PTGIR;TBXA2R,LABOR INDUCTION,,LAUNCHED,,Small molecule,4,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,PXGPLTODNUVGFL-YNNPMVKQSA-N
U-12062,"CERVIDIL;DINOPROSTONE;DINOPROSTONE BETA-CYCLODEXTRIN CLATHRATE;ENZAPROST E;MINPROSTIN E2;NSC-165560;NSC-196514;PREPIDIL;PROPESS;PROSTAGLANDIN E2;PROSTIN E2;U-12,062;U-12062",CHEMBL548,BRD:BRD-BRD-K26521938-001-09-8;BRD:BRD-K26521938-001-09-8,rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,CATSPER1;CATSPER2;CATSPER3;CATSPER4;PTGDR;PTGDR2;PTGER1;PTGER2;PTGER3;PTGER4;PTGFR;TBXA2R,,,WITHDRAWN,,Small molecule,4,"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O, CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O",XEYBRNLFEZDVAW-ARSRFYASSA-N
DINOTEFURAN,DINOTEFURAN,CHEMBL2228155,BRD:BRD-K00084839-001-01-9,rep_single_dose,,,,,,,Small molecule,NA,CN/C(=N/CC1CCOC1)N[N+](=O)[O-],YKBZOVFACRVRJN-UHFFFAOYSA-N
DIOSCIN,DIOSCIN,CHEMBL507001,BRD:BRD-BRD-K37723606-001-01-5;BRD:BRD-K37723606-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,APOPTOSIS STIMULANT,CXCR3,,,PRECLINICAL,,Small molecule,NA,C[C@@H]1[C@@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](CC[C@]5(C)[C@@H]4CC[C@]23C)O[C@@H]2O[C@@H](CO)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)O[C@]11CC[C@@H](C)CO1;C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,VNONINPVFQTJOC-ZGXDEBHDSA-N
DIOSGENIN,DIOSGENIN,,BRD:BRD-BRD-K28690501-001-02-1;BRD:BRD-K28690501-001-02-1,rep_primary;rep_single_dose,STEROID,,,,PRECLINICAL,,,NA,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@]11CC[C@@H](C)CO1,
DIOSMETINE,DIOSMETIN;DIOSMETINE,CHEMBL90568,BRD:BRD-BRD-K26862302-001-05-2;BRD:BRD-K26862302-001-05-2,rep_primary;rep_single_dose,ARYL HYDROCARBON RECEPTOR AGONIST,CYP1B1,COSMETIC,,LAUNCHED,,Small molecule,NA,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1O;COC1CCC(CC1O)-C1CC(=O)C2C(O)CC(O)CC2O1,MBNGWHIJMBWFHU-UHFFFAOYSA-N
VENOSMINE,BAROSMIN;BUCHU RESIN;DAFLON;DIOSMETIN 7-RUTINOSIDE;DIOSMIN;DIOSVEN;DIOVEN;DIOVENOR;FLEBAVEN;FLEBAVENA;FLEBOSMIL;FLEBOSTEN;HEMERVEN;HESPERIDIN;INSUVEN;LITOSMIL;NSC-758417;TOVENE;VARINON;VEN-DETREX;VENOSMINE,CHEMBL231884,BRD:BRD-BRD-K94436377-001-10-2;BRD:BRD-K94436377-001-10-2,rep_primary;rep_single_dose,"ARYL HYDROCARBON RECEPTOR AGONIST, CAPILLARY STABILIZING AGENT",AHR,"CHRONIC VENOUS INSUFFICIENCY (CVI), EDEMA, DEEP VEIN THROMBOSIS (DVT), STATIS DERMATITIS, HEAVY LEG SYNDROME",,LAUNCHED,,Small molecule,4,"COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O;COC1CCC(CC1O)-C1CC(=O)C2C(O)CC(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC2O1, COC1CCC(CC1O)-C1CC(=O)C2C(O)CC(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC2O1, COC1CCC(CC1O)-C1CC(=O)C2C(O)CC(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC2O1",GZSOSUNBTXMUFQ-YFAPSIMESA-N
SPECTRA-SORB UV 24,BENZOPHENONE-8;DIOXYBENZONE;NSC-56769;SPECTRA-SORB UV 24,CHEMBL1326877,BRD:BRD-BRD-K22193694-001-13-6;BRD:BRD-K22193694-001-13-6,rep_primary;rep_single_dose,TOPICAL SUNSCREEN AGENT,,,,PRECLINICAL,,Small molecule,-1,COc1ccc(C(=O)c2ccccc2O)c(O)c1;COC1CCC(C(=O)C2CCCCC2O)C(O)C1,MEZZCSHVIGVWFI-UHFFFAOYSA-N
SUSTAMINE,ALA-GLN;ALANYL GLUTAMINE;ALANYL-GLUTAMINE DIPEPTIDE;DIPEPTAMIN;FEMA NO. 4712;GLUTAMAX;L-ALANYL-L-GLUTAMINE;L-ALANYL-L-GLUTAMINE AMINO ACID;SUSTAMINE,CHEMBL3707366,BRD:BRD-BRD-K11595419-001-01-4;BRD:BRD-K11595419-001-01-4,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,3,"C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)O;C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O, C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O",HJCMDXDYPOUFDY-WHFBIAKZSA-N
DIPERODON ANHYDROUS,DIPERODON;DIPERODON ANHYDROUS,CHEMBL338667,BRD:BRD-A30693873-003-12-8;BRD:BRD-BRD-A30693873-003-12-8,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,,,PRECLINICAL,,Small molecule,-1,"O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1;O=C(NC1CCCCC1)OCC(CN1CCCCC1)OC(=O)NC1CCCCC1, O=C(NC1CCCCC1)OCC(CN1CCCCC1)OC(=O)NC1CCCCC1",YUGZHQHSNYIFLG-UHFFFAOYSA-N
DIPHEMANIL ION,DIPHEMANIL;DIPHEMANIL CATION;DIPHEMANIL ION,CHEMBL1201340,BRD:BRD-BRD-K93441486-067-12-8;BRD:BRD-K93441486-067-12-8,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM3,SPASMS,,LAUNCHED,,Small molecule,4,C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1;C[N+]1(C)CCC(CC1)=C(C1CCCCC1)C1CCCCC1,LCTZPQRFOZKZNK-UHFFFAOYSA-N
DIPHENCYPRONE,DIPHENCYPRONE,,BRD:BRD-BRD-K51730347-001-06-4;BRD:BRD-K51730347-001-06-4,rep_primary;rep_single_dose,IMMUNOSTIMULANT,,,,PHASE 2,,,NA,"O=C1C(C1-C1CCCCC1)-C1CCCCC1, O=C1C(C1-C1CCCCC1)-C1CCCCC1",
SILPHEN,ANTITUSSIVE;BELDIN;BELIX;BENADRYL;BENYLIN;DIBENIL;DIPHEN;DIPHENHDYRA;DIPHENHYDRAMINE;DIPHENHYDRAMINE CITRATE;DIPHENHYDRAMINE LAURYLSULFATE;DIPHENHYDRAMINE TANNATE;HYDRAMINE;RESTAMIN;SILPHEN,CHEMBL1201089;CHEMBL657,BRD:BRD-BRD-K47278471-003-26-3;BRD:BRD-K47278471-003-26-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,HEADACHE,,LAUNCHED,,Small molecule,4,"CN(C)CCOC(c1ccccc1)c1ccccc1;CN(C)CCOC(C1CCCCC1)C1CCCCC1, CN(C)CCOC(C1CCCCC1)C1CCCCC1",ZZVUWRFHKOJYTH-UHFFFAOYSA-N
VONTROL,DIFENIDOL;DIFENIDOL HYDROCHLORIDE;DIPHENIDOL;SK-478;SK&F 478;SK&F-478;VONTROL,CHEMBL936,BRD:BRD-BRD-K01663662-003-20-2;BRD:BRD-K01663662-003-20-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4,VERTIGO,,LAUNCHED,,Small molecule,4,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1;OC(CCCN1CCCCC1)(C1CCCCC1)C1CCCCC1,OGAKLTJNUQRZJU-UHFFFAOYSA-N
DIPHENYLENEIODONIUM,DIPHENYLENEIODONIUM,CHEMBL365739,BRD:BRD-BRD-K65814004-003-02-9;BRD:BRD-K65814004-003-02-9,rep_multi_dose;rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS2;NOS3,,,PRECLINICAL,,Small molecule,NA,[I+]1C2CCCCC2-C2CCCCC12;c1ccc2c(c1)[I+]c1ccccc1-2,QFXKXRXFBRLLPQ-UHFFFAOYSA-N
DIPHENYLPYRALINE,DIPHENYLPYRALINE,CHEMBL1492,BRD:BRD-BRD-K22936972-003-23-6;BRD:BRD-K22936972-003-23-6,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",HRH1;SLC6A3,ALLERGIC RHINITIS,,LAUNCHED,"Multiple values for MOA: {'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR', 'DOPAMINE UPTAKE INHIBITOR'}, defaulting to 'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR'",Small molecule,4,"CN1CCC(CC1)OC(C1CCCCC1)C1CCCCC1, CN1CCC(CC1)OC(C1CCCCC1)C1CCCCC1;CN1CCC(OC(c2ccccc2)c2ccccc2)CC1",OWQUZNMMYNAXSL-UHFFFAOYSA-N
DPE,DIPIVALYL EPINEPHRINE;DIPIVEFRIN;DIPIVEFRINE;DPE,CHEMBL1201262,BRD:BRD-A47494775-003-11-3;BRD:BRD-BRD-A47494775-003-11-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ACHE;ADRA1A;ADRA2A;ADRB2;BCHE,"GLAUCOMA, INTRAOCULAR PRESSURE",,LAUNCHED,,Small molecule,4,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1;CNCC(O)C1CCC(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)C1,OCUJLLGVOUDECM-UHFFFAOYSA-N
DIPRAGLURANT,ADX-48621;ADX48621;DIPRAGLURANT,CHEMBL2346738,BRD:BRD-BRD-K64838454-001-01-0;BRD:BRD-K64838454-001-01-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,GRM5,,,PHASE 2,,Small molecule,2,Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1;FC1CCC2NC(CCC#CC3CCCCN3)CN2C1,LZXMUJCJAWVHPZ-UHFFFAOYSA-N
DIPT,DIPT,,BRD:BRD-BRD-K75385383-001-01-5;BRD:BRD-K75385383-001-01-5,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",HTR1A;HTR2A;HTR2C,,,LAUNCHED,,,NA,CC(C)N(CCC1C[NH]C2CCCCC12)C(C)C,
VASYROL,ATTIA;B01AC07;CEREBROVASE 100;CEREBROVASE 25;DIPYRIDAMOLE;IV PERSANTINE;MODAPLATE;NSC-515776;OFCRAM PR;PERSANTIN;PERSANTIN RET;PERSANTINE;PYRIDANTIN;RA-8;VASYROL,CHEMBL932,BRD:BRD-BRD-K86301799-001-34-8;BRD:BRD-K86301799-001-34-8,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,ADA;PDE10A;PDE1A;PDE1B;PDE1C;PDE2A;PDE3A;PDE3B;PDE4A;PDE4B;PDE4C;PDE4D;PDE5A;PDE6A;PDE6B;PDE6C;PDE6D;PDE6G;PDE6H;PDE7A;PDE7B;PDE8A;PDE8B;PDE9A;SLC29A1,"CORONARY ARTERY DISEASE (CAD), PERIPHERAL ARTERY DISEASE (PAD), HYPERTENSION",,LAUNCHED,,Small molecule,4,"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1;OCCN(CCO)C1NC(N2CCCCC2)C2NC(NC(N3CCCCC3)C2N1)N(CCO)CCO, OCCN(CCO)C1NC(N2CCCCC2)C2NC(NC(N3CCCCC3)C2N1)N(CCO)CCO, OCCN(CCO)C1NC(N2CCCCC2)C2NC(NC(N3CCCCC3)C2N1)N(CCO)CCO, OCCN(CCO)C1NC(N2CCCCC2)C2NC(NC(N3CCCCC3)C2N1)N(CCO)CCO, OCCN(CCO)C1NC(N2CCCCC2)C2NC(NC(N3CCCCC3)C2N1)N(CCO)CCO",IZEKFCXSFNUWAM-UHFFFAOYSA-N
NSC-758212,DIACETYLSALICYLIC ACID;DIPYROCETYL;NSC-758212,CHEMBL1451173,BRD:BRD-K47608922-001-05-9,rep_single_dose,CHELATING AGENT,,,,,,Small molecule,-1,CC(=O)Oc1cccc(C(=O)O)c1OC(C)=O,NYIZXMGNIUSNKL-UHFFFAOYSA-N
INS-365,DIQUAFOSOL;INS-365,CHEMBL221326,BRD:BRD-K00003514-342-01-9,rep_single_dose,PURINERGIC RECEPTOR ACTIVATOR,,,,,,Small molecule,3,O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1,NMLMACJWHPHKGR-NCOIDOBVSA-N
NSC-758672,DIRITHROMYCIN;DYNABAC;LY 237216;LY-237216;NORTRON;NSC-758672,CHEMBL1237072;CHEMBL3039471,BRD:BRD-BRD-K52756523-001-24-7;BRD:BRD-K52756523-001-24-7,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,BRONCHITIS,,LAUNCHED,,Small molecule,4,"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H](C2C)C1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O;CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O",WLOHNSSYAXHWNR-DWIOZXRMSA-N
DIROXIMEL-FUMARATE,DIROXIMEL-FUMARATE,,BRD:BRD-BRD-K87386013-001-01-7;BRD:BRD-K87386013-001-01-7,rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,PHASE 3,,,NA,COC(=O)\C=C\C(=O)OCCN1C(=O)CCC1=O,
SEARLE-703,(RS)-DISOPYRAMIDE;DICORANTIL;DISOPYRAMIDE;DL-DISOPYRAMIDE;H-3292;ISORYTHM;LISPINE;NORPACE;RITMILEN;RYTHMODAN P;SC-7031;SEARLE-703,CHEMBL517,BRD:BRD-A29734509-011-13-6;BRD:BRD-BRD-A29734509-011-13-6,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,CHRM1;CHRM2;CHRM3;KCND2;KCND3;KCNH2;SCN5A,"VENTRICULAR TACHYCARDIA (VT), VENTRICULAR ARRHYTHMIAS",,LAUNCHED,,Small molecule,4,"CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C;CC(C)N(CCC(C(N)=O)(C1CCCCC1)C1CCCCN1)C(C)C, CC(C)N(CCC(C(N)=O)(C1CCCCC1)C1CCCCN1)C(C)C",UVTNFZQICZKOEM-UHFFFAOYSA-N
TETRAETHYLDISULFANEDICARBOTHIOAMIDE,ANTABUSE;DISULFIRAM;ESPERAL;NSC-25953;ORA-102;ORA102;TETRAETHYLDISULFANEDICARBOTHIOAMIDE,CHEMBL964,BRD:BRD-BRD-K32744045-001-31-2;BRD:BRD-K32744045-001-31-2;BRD:BRD-K32744045-001-38-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"ALDEHYDE DEHYDROGENASE INHIBITOR, DNA METHYLTRANSFERASE INHIBITOR, TRPV AGONIST",ALDH1A1;ALDH2;DBH,ABSTINENCE FROM ALCOHOL,,LAUNCHED,"Multiple values for MOA: {'COPPER IONOPHORE; INHIBITOR OF ALDEHYDE DEHYDROGENASE', 'ALDEHYDE DEHYDROGENASE INHIBITOR, DNA METHYLTRANSFERASE INHIBITOR, TRPV AGONIST'}, defaulting to 'ALDEHYDE DEHYDROGENASE INHIBITOR, DNA METHYLTRANSFERASE INHIBITOR, TRPV AGONIST'
Multiple values for repurposing_target: {'ALDH1A1', 'ALDH2;DBH'}, taking the union",Small molecule,4,"CCN(CC)C(=S)SSC(=S)N(CC)CC;CCN(CC)C(=S)SSC(=S)N(CC)CC, CCN(CC)C(=S)SSC(=S)N(CC)CC, CCN(CC)C(=S)SSC(=S)N(CC)CC",AUZONCFQVSMFAP-UHFFFAOYSA-N
DITIOCARB-SODIUM-TRIHYDRATE,DITIOCARB-SODIUM-TRIHYDRATE,,BRD:BRD-BRD-K40654626-236-01-5;BRD:BRD-K40654626-236-01-5,rep_primary;rep_single_dose,IMMUNOSTIMULANT,CA1;CA2;CA4,,,PHASE 3,,,NA,"CCN(CC)C(S)=S, CCN(CC)C(S)=S",
DITOLYLGUANIDINE,DI-O-TOLYLGUANIDINE;DITOLYLGUANIDINE,CHEMBL282433,BRD:BRD-BRD-K33459542-001-07-4;BRD:BRD-K33459542-001-07-4,rep_primary;rep_single_dose,SIGMA RECEPTOR AGONIST,GRIN1;GRIN2A;GRIN2B;SIGMAR1,,,PRECLINICAL,,Small molecule,NA,Cc1ccccc1NC(=N)Nc1ccccc1C;CC1CCCCC1NC(=N)NC1CCCCC1C,OPNUROKCUBTKLF-UHFFFAOYSA-N
GDC-6036,DIVARASIB;GDC 6036;GDC-6036,CHEMBL5095236,BRD:BRD-K00126478-001-01-9,oncref_2,INHIBITOR OF KRAS-G12C,KRAS,,,,,Small molecule,2,C=CC(=O)N1CCN(c2nc(OC[C@@H]3CCCN3C)nc3c(F)c(-c4nc(N)cc(C)c4C(F)(F)F)c(Cl)cc23)[C@@H](C)C1,ZRBPIAWWRPFDPY-IRXDYDNUSA-N
NSC-402561,BIS(ETHYLXANTHOGEN);DIETHYLDIXANTHOGEN;DIEXANTHOGEN;DIXANTHOGEN;NSC-402561,CHEMBL331743,BRD:BRD-BRD-K05919151-001-01-6;BRD:BRD-K05919151-001-01-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CCOC(=S)SSC(=S)OCC,FVIGODVHAVLZOO-UHFFFAOYSA-N
UCB-3412,DIXYRAZINE;DYXIRAZINE;ESUCOS;J21.394B;UCB-3412,CHEMBL3275586,BRD:BRD-K00003339-001-01-9,rep_single_dose,ANTIPSYCHOTIC,,,,,,Small molecule,-1,CC(CN1CCN(CCOCCO)CC1)CN1c2ccccc2Sc2ccccc21,MSYUMPGNGDNTIQ-UHFFFAOYSA-N
DIZOCILPINE-(+),DIZOCILPINE-(+),,BRD:BRD-BRD-K58930050-050-15-8;BRD:BRD-K58930050-050-15-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,PRECLINICAL,,,NA,"C[C@]12N[C@H](CC3CCCCC13)C1CCCCC21, C[C@]12N[C@H](CC3CCCCC13)C1CCCCC21, C[C@]12N[C@H](CC3CCCCC13)C1CCCCC21",
DIZOCILPINE-(-),DIZOCILPINE-(-),,BRD:BRD-BRD-K23163214-050-15-1;BRD:BRD-K23163214-050-15-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,PHASE 1,,,NA,"C[C@@]12N[C@@H](CC3CCCCC13)C1CCCCC21, C[C@@]12N[C@@H](CC3CCCCC13)C1CCCCC21",
DM4,DM4,,BRD:BRD-K00090635-001-01-9,rep_single_dose,,,,,,,,NA,,
DMAB-ANABASEINE,DMAB-ANABASEINE,,BRD:BRD-BRD-K26573499-300-02-1;BRD:BRD-K26573499-300-02-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,CHRNA7,,,PRECLINICAL,,,NA,"CN(C)C1CCC(CC1)\C=C1CCCN=C/1C1CCCNC1, CN(C)C1CCC(CC1)\C=C1CCCN=C/1C1CCCNC1",
DMEOB,DMEOB,,BRD:BRD-BRD-K36775483-001-01-4;BRD:BRD-K36775483-001-01-4,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,GRM5,,,PRECLINICAL,,,NA,COC1CCCC(C1)\C=N\N=C\C1CCCC(OC)C1,
DMH1,DMH1,,BRD:BRD-BRD-K39381259-001-01-0;BRD:BRD-K39381259-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ACVR1,,,PRECLINICAL,,,NA,"CC(C)OC1CCC(CC1)-C1CNC2C(CNN2C1)-C1CCNC2CCCCC12, CC(C)OC1CCC(CC1)-C1CNC2C(CNN2C1)-C1CCNC2CCCCC12",
DMH4,DMH4,,BRD:BRD-BRD-K40575944-001-01-5;BRD:BRD-K40575944-001-01-5,rep_primary;rep_single_dose,VEGFR INHIBITOR,KDR,,,PRECLINICAL,,,NA,C(CN1CCOCC1)OC1CCC(CC1)-C1CNC2C(CNN2C1)-C1CCCCC1,
DMNB,DMNB,,BRD:BRD-BRD-K03564313-001-03-3;BRD:BRD-K03564313-001-03-3,rep_primary;rep_single_dose,DNA DEPENDENT PROTEIN KINASE INHIBITOR,,,,PRECLINICAL,,,NA,COC1CC(C=O)C(CC1OC)[N+]([O-])=O,
DMOG,DIMETHYLOXALYLGLCINE;DMOG,,GDSC1:165,gdsc,,,,,,,,NA,,
DMP-543,DMP-543,,BRD:BRD-BRD-K89274813-001-02-3;BRD:BRD-K89274813-001-02-3,rep_primary;rep_single_dose,ACETYLCHOLINE RELEASE ENHANCER,,,,PHASE 2,,,NA,"FC1CC(CC2(CC3CCNC(F)C3)C3CCCCC3C(=O)C3CCCCC23)CCN1, FC1CC(CC2(CC3CCNC(F)C3)C3CCCCC3C(=O)C3CCCCC23)CCN1",
DMP-777,DMP-777,,BRD:BRD-BRD-K54936858-001-01-6;BRD:BRD-K54936858-001-01-6,rep_primary;rep_single_dose,ELASTASE INHIBITOR,MPO,,,PHASE 2,,,NA,CCC[C@@H](NC(=O)N1[C@@H](OC2CCC(CC2)C(=O)N2CCN(C)CC2)C(CC)(CC)C1=O)C1CCC2OCOC2C1,
DMPS,DMPS,,BRD:BRD-A22971209-001-01-0,rep_single_dose,CHELATING AGENT,,,,,,,NA,,
DNQX,DNQX,CHEMBL155265,BRD:BRD-BRD-K64400208-001-08-3;BRD:BRD-K64400208-001-08-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1;GRIA2;GRIK1;GRIN1;GRIN2A;GRIN2B,,,PRECLINICAL,,Small molecule,NA,"[O-][N+](=O)C1CC2[NH]C(=O)C(=O)[NH]C2CC1[N+]([O-])=O, [O-][N+](=O)C1CC2[NH]C(=O)C(=O)[NH]C2CC1[N+]([O-])=O, [O-][N+](=O)C1CC2[NH]C(=O)C(=O)[NH]C2CC1[N+]([O-])=O;O=[N+]([O-])c1cc2nc(O)c(O)nc2cc1[N+](=O)[O-]",RWVIMCIPOAXUDG-UHFFFAOYSA-N
RACEMIC DOBUTAMINE,COMPOUND 81929;COMPOUND-81929;DL-DOBUTAMINE;DOBUTAMINE;DOBUTREX;RACEMIC DOBUTAMINE,CHEMBL926,BRD:BRD-A78322124-003-14-0;BRD:BRD-BRD-A78322124-003-14-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,4,"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1;CC(CCC1CCC(O)CC1)NCCC1CCC(O)C(O)C1, CC(CCC1CCC(O)CC1)NCCC1CCC(O)C(O)C1, CC(CCC1CCC(O)CC1)NCCC1CCC(O)C(O)C1, CC(CCC1CCC(O)CC1)NCCC1CCC(O)C(O)C1, CC(CCC1CCC(O)CC1)NCCC1CCC(O)C(O)C1",JRWZLRBJNMZMFE-UHFFFAOYSA-N
XRP6976,BIND 014;CKD-810;DOCEFREZ;DOCETAXEL;DOCETAXEL (AS TRIHYDRATE);DOCETAXEL ANHYDROUS;DOCETAXEL HYDRATE;DOCETAXEL TRIHYDRATE;NSC-628503;RP 56976;RP-56976;TAXCEUS;TAXOTERE;XRP6976,CHEMBL3545252;CHEMBL92,BRD:BRD-BRD-K30577245-001-04-3;BRD:BRD-BRD-K30577245-341-01-9;BRD:BRD-K30577245-001-04-3;BRD:BRD-K30577245-001-05-0;BRD:BRD-K30577245-341-01-9;CTRP:660364;GDSC1:1007;GDSC2:1007;GDSC2:1819,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,BCL2;MAP2;MAP4;MAPT;NR1I2;TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8,"BREAST CANCER, NON-SMALL CELL LUNG CANCER (NSCLC), PROSTATE CANCER, GASTRIC ADENOCARCINOMA, HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)",,LAUNCHED,"Multiple values for repurposing_target: {'BCL2;MAP2;MAP4;MAPT;NR1I2;TUBB;TUBB1', 'BCL2;MAP2;MAP4;MAPT;NR1I2;TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8'}, taking the union",Small molecule,4,"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2CCCCC2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C3CCCCC3)C(C)=C([C@@H](O)C1=O)C2(C)C, CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2CCCCC2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C3CCCCC3)C(C)=C([C@@H](O)C1=O)C2(C)C, CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2CCCCC2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C3CCCCC3)C(C)=C([C@@H](O)C1=O)C2(C)C;CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O",XCDIRYDKECHIPE-QHEQPUDQSA-N
DOCETAXEL:TANESPIMYCIN (2:1 MOL/MOL),DOCETAXEL:TANESPIMYCIN (2:1 MOL/MOL),,CTRP:660217,ctrp,,,,,,,,NA,,
DOCONEXENT-ETHYL-ESTER,DOCONEXENT-ETHYL-ESTER,,BRD:BRD-BRD-K61937613-001-01-1;BRD:BRD-K61937613-001-01-1,rep_primary;rep_single_dose,OMEGA 3 FATTY ACID STIMULANT,,,,LAUNCHED,,,NA,CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,
STENOL 1822,ABREVA;BEHENIC ALCOHOL;BEHENYL ALCOHOL;DOCOSANOL;LIDAKOL;N-DOCOSANOL;NSC-8407;STENOL 1822,CHEMBL1200453,BRD:BRD-BRD-K50050533-001-02-1;BRD:BRD-K50050533-001-02-1,rep_primary;rep_single_dose,LIPASE CLEARING FACTOR INHIBITOR,TLR7,COLD SORE,,LAUNCHED,,Small molecule,4,"CCCCCCCCCCCCCCCCCCCCCCO;CCCCCCCCCCCCCCCCCCCCCCO, CCCCCCCCCCCCCCCCCCCCCCO, CCCCCCCCCCCCCCCCCCCCCCO",NOPFSRXAKWQILS-UHFFFAOYSA-N
SPOLION 8,DIOCTO;DOCUSATE;DOCUSATES;SPOLION 8,CHEMBL1477036,BRD:BRD-A00092689-236-04-9,rep_single_dose,LAXATIVE,,,,,,Small molecule,4,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,HNSDLXPSAYFUHK-UHFFFAOYSA-N
DOFEQUIDAR,DOFEQUIDAR,CHEMBL65067,BRD:BRD-A14941520-051-01-0;BRD:BRD-BRD-A14941520-051-01-0,rep_primary;rep_single_dose,"MRP INHIBITOR, P GLYCOPROTEIN INHIBITOR",ABCB1,,,PHASE 3,,Small molecule,1,O=C(C(c1ccccc1)c1ccccc1)N1CCN(CC(O)COc2cccc3ncccc23)CC1;OC(COC1CCCC2NCCCC12)CN1CCN(CC1)C(=O)C(C1CCCCC1)C1CCCCC1,KLWUUPVJTLHYIM-UHFFFAOYSA-N
UK-68798,"DOFETILIDE;TIKOSYN;UK-68,798;UK-68798",CHEMBL473,BRD:BRD-BRD-K86887724-001-10-6;BRD:BRD-K86887724-001-10-6,rep_multi_dose;rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNH1;KCNH2;KCNJ12;KCNK2,,,WITHDRAWN,,Small molecule,4,"CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1;CN(CCOC1CCC(NS(C)(=O)=O)CC1)CCC1CCC(NS(C)(=O)=O)CC1, CN(CCOC1CCC(NS(C)(=O)=O)CC1)CCC1CCC(NS(C)(=O)=O)CC1, CN(CCOC1CCC(NS(C)(=O)=O)CC1)CCC1CCC(NS(C)(=O)=O)CC1",IXTMWRCNAAVVAI-UHFFFAOYSA-N
DOLASETRON,DOLASETRON,CHEMBL2368925,BRD:BRD-BRD-K28029915-001-02-2;BRD:BRD-K28029915-001-02-2,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A,"NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,"O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12;O=C(O[C@H]1C[C@H]2C[C@H]3C[C@@H](C1)N2CC3=O)C1C[NH]C2CCCCC12, O=C(O[C@H]1C[C@H]2C[C@H]3C[C@@H](C1)N2CC3=O)C1C[NH]C2CCCCC12",UKTAZPQNNNJVKR-KJGYPYNMSA-N
DOLOSTATIN 10,DOLASTATIN 10;DOLASTATIN-10;DOLOSTATIN 10,CHEMBL39541,BRD:BRD-BRD-K78567475-001-01-4;BRD:BRD-K78567475-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB,,,PHASE 2,,Small molecule,2,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C;CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC1CCCCC1)C1NCCS1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C,OFDNQWIFNXBECV-VFSYNPLYSA-N
TIVICAY,DOLUTEGRAVIR;GSK 1349572;GSK-1349572;GSK1349572;S-349572;TIVICAY,CHEMBL1229211,BRD:BRD-BRD-K36386086-001-01-1;BRD:BRD-K36386086-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,HIV INTEGRASE INHIBITOR,CYP3A4;CYP3A5;CYP3A7;POU2F2;UGT1A1,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12;C[C@H]1CCO[C@H]2CN3CC(C(=O)NCC4CCC(F)CC4F)C(=O)C(O)C3C(=O)N12,RHWKPHLQXYSBKR-BMIGLBTASA-N
PHENODODECINIUM,DOMIPHEN;DOMIPHEN CATION;DOMIPHEN ION;PHENODODECINIUM,CHEMBL1187011,BRD:BRD-BRD-K30431096-004-01-3;BRD:BRD-K30431096-004-01-3,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,4,CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1;CCCCCCCCCCCC[N+](C)(C)CCOC1CCCCC1,YXUPZGKORWTXID-UHFFFAOYSA-N
VIVADONE,"DOMILIUM;DOMPERIDONE;EVOXIN;MOTILIUM;MOTILIUM 10;MOTILIUM INSTANTS;NSC-299589;NSC-759575;R 33,812;R-33812;VIVADONE",CHEMBL219916,BRD:BRD-BRD-K38305202-001-17-4;BRD:BRD-K38305202-001-17-4,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3,FESCUE TOXICOSIS,,LAUNCHED,,Small molecule,4,"CLC1CCC2N(C3CCN(CCCN4C5CCCCC5[NH]C4=O)CC3)C(=O)[NH]C2C1, CLC1CCC2N(C3CCN(CCCN4C5CCCCC5[NH]C4=O)CC3)C(=O)[NH]C2C1, CLC1CCC2N(C3CCN(CCCN4C5CCCCC5[NH]C4=O)CC3)C(=O)[NH]C2C1;O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1",FGXWKSZFVQUSTL-UHFFFAOYSA-N
E-2020,ARICEPT;D-797;DONAZ;DONEPEZIL;E-2020,CHEMBL502,BRD:BRD-A49160188-003-12-7;BRD:BRD-BRD-A49160188-003-12-7,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE;HTR2A,ALZHEIMER'S DISEASE,,LAUNCHED,,Small molecule,4,"COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2;COC1CC2CC(CC3CCN(CC4CCCCC4)CC3)C(=O)C2CC1OC, COC1CC2CC(CC3CCN(CC4CCCCC4)CC3)C(=O)C2CC1OC",ADEBPBSSDYVVLD-UHFFFAOYSA-N
F-11356,DONITRIPTAN;DONITRIPTAN HYDROCHLORIDE;F-11356,CHEMBL1742428,BRD:BRD-BRD-K31092604-003-03-5;BRD:BRD-K31092604-003-03-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR5A;HTR6,,,PHASE 2,,Small molecule,2,N#Cc1ccc(N2CCN(C(=O)COc3ccc4[nH]cc(CCN)c4c3)CC2)cc1;NCCC1C[NH]C2CCC(OCC(=O)N3CCN(CC3)C3CCC(CC3)C#N)CC12,SOHCKWZVTCTQBG-UHFFFAOYSA-N
SINEMET,A-DOPAMINE;CARBILEV;DOBUTAMINE A;DOPAMINE;INTROPIN;MEDOPA;NSC-173182;OXYTYRAMINE;PARCOPA;SINEMET,CHEMBL59,BRD:BRD-BRD-K43887077-003-26-3;BRD:BRD-K43887077-003-26-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DBH;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR7;SLC6A2;SLC6A3;SLC6A4,"VENTRICULAR ARRHYTHMIAS, DEPRESSION, HEADACHE, TREMORS",,LAUNCHED,,Small molecule,4,"NCCc1ccc(O)c(O)c1;NCCC1CCC(O)C(O)C1, NCCC1CCC(O)C(O)C1, NCCC1CCC(O)C(O)C1",VYFYYTLLBUKUHU-UHFFFAOYSA-N
DORAMAPIMOD,BIRB 796 BS;BIRB-796;BIRB-796 BS;DORAMAPIMOD,CHEMBL103667,BRD:BRD-BRD-K74065929-001-07-2;BRD:BRD-K74065929-001-07-2;GDSC1:1042;GDSC2:1042,gdsc;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK11;MAPK12;MAPK13;MAPK14,,,PHASE 2,,Small molecule,2,"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1;CC1CCC(CC1)-N1NC(CC1NC(=O)NC1CCC(OCCN2CCOCC2)C2CCCCC12)C(C)(C)C, CC1CCC(CC1)-N1NC(CC1NC(=O)NC1CCC(OCCN2CCOCC2)C2CCCCC12)C(C)(C)C",MVCOAUNKQVWQHZ-UHFFFAOYSA-N
UK-67994,"DECTOMAX;DORAMECTIN;L 701023;L-701023;NSC-760342;UK 67994;UK-67,994;UK-67994",CHEMBL2361641,BRD:BRD-A16350940-001-01-9;BRD:BRD-BRD-A16350940-001-01-9,rep_primary;rep_single_dose,,,GASTROINTESTINAL ROUNDWORMS,,LAUNCHED,,Small molecule,-1,CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O;CO[C@H]1C[C@H](OC2[C@H](C)OC(C[C@@H]2OC)O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(C5)O[C@H](C5CCCCC5)[C@@H](C)C=C2)[C@]34O)O[C@@H](C)[C@@H]1O,QLFZZSKTJWDQOS-YDBLARSUSA-N
PIFELTRO,DORAVIRINE;MK-1439;MK-1439A;PIFELTRO,CHEMBL2364608,BRD:BRD-K00003231-001-01-9,rep_single_dose,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,,,,,Small molecule,4,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O,ZIAOVIPSKUPPQW-UHFFFAOYSA-N
DORSOMORPHIN,DORSOMORPHIN,CHEMBL478629,BRD:BRD-K54233340-001-02-2,rep_single_dose,AMPK INHIBITOR,ACVR1;BMPR1A;BMPR1B;EPHA2;FKBP1A;FLT1;FLT3;KDR;LCK;MKNK1;PRKAA1;RPS6KA1;SRC,,,,,Small molecule,NA,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,XHBVYDAKJHETMP-UHFFFAOYSA-N
SINOGLIATIN,DORZAGLIATIN;HMS-5552;HMS5552;RO-5305552;RO5305552;SINOGLIATIN,CHEMBL4297508,BRD:BRD-K00090645-001-01-9,rep_single_dose,,,,,,,Small molecule,3,CC(C)C[C@@H](C(=O)Nc1ccn(C[C@@H](O)CO)n1)N1CC(Oc2ccccc2Cl)=CC1=O,HMUMWSORCUWQJO-QAPCUYQASA-N
TRUSOPT,DORZANT;DORZOLAMIDE;MK-507;TRANS-(-)-;TRUSOPT,CHEMBL218490,BRD:BRD-BRD-K71075609-003-01-0;BRD:BRD-K71075609-003-01-0,rep_multi_dose;rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA1;CA12;CA14;CA2;CA4;CA7,"INTRAOCULAR PRESSURE, GLAUCOMA",,LAUNCHED,,Small molecule,4,CCN[C@@H]1C[C@H](C)S(=O)(=O)C2SC(CC12)S(N)(=O)=O;CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,IAVUPMFITXYVAF-XPUUQOCRSA-N
DOTHIRPIN,DOSULEPIN;DOTHIEPIN;DOTHIRPIN,CHEMBL1492500,BRD:BRD-BRD-K54759182-003-08-0;BRD:BRD-K54759182-003-08-0,rep_primary;rep_single_dose,"NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃÂÂNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), TRICYCLIC ANTIDEPRESSANT",CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;HRH1;SLC6A2;SLC6A4,DEPRESSION,,LAUNCHED,"Multiple values for MOA: {'NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃ\x80\x93NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), TRICYCLIC ANTIDEPRESSANT', 'NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), TRICYCLIC ANTIDEPRESSANT'}, defaulting to 'NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃ\x80\x93NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), TRICYCLIC ANTIDEPRESSANT'",Small molecule,4,CN(C)CC/C=C1\c2ccccc2CSc2ccccc21;CN(C)CC\C=C1/C2CCCCC2CSC2CCCCC12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N
DOTMP,DOTMP,,BRD:BRD-K00004678-001-01-9,rep_single_dose,,,,,,,,NA,,
TKI-258,CHIR-258;DOVITINIB;GFKI-258;NVP-TKI258;TKI-258,CHEMBL522892,BRD:BRD-BRD-K85402309-001-06-6;BRD:BRD-BRD-K85402309-389-03-2;BRD:BRD-K85402309-001-06-6;BRD:BRD-K85402309-043-01-9;BRD:BRD-K85402309-389-03-2,rep_multi_dose;rep_primary;rep_single_dose,"EGFR INHIBITOR, FGFR INHIBITOR, FLT3 INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",CSF1R;EGFR;FGFR1;FGFR2;FGFR3;FLT1;FLT3;FLT4;INSR;KDR;KIT;PDGFRA;PDGFRB,,,PHASE 3,,Small molecule,3,"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1;CN1CCN(CC1)C1CCC2NC([NH]C2C1)-C1C(N)C2C(F)CCCC2[NH]C1=O, CN1CCN(CC1)C1CCC2NC([NH]C2C1)-C1C(N)C2C(F)CCCC2[NH]C1=O, CN1CCN(CC1)C1CCC2NC([NH]C2C1)-C1C(N)C2C(F)CCCC2[NH]C1=O, CN1CCN(CC1)C1CCC2NC([NH]C2C1)-C1C(N)C2C(F)CCCC2[NH]C1=O, CN1CCN(CC1)C1CCC2NC([NH]C2C1)-C1C(N)C2C(F)CCCC2[NH]C1=O, CN1CCN(CC1)C1CCC2NC([NH]C2C1)-C1C(N)C2C(F)CCCC2[NH]C1=O",PIQCTGMSNWUMAF-UHFFFAOYSA-N
DOXAPRAM,DOCATONE;DOXAPRAM,CHEMBL1754,BRD:BRD-A46179541-311-02-0;BRD:BRD-BRD-A46179541-311-02-0,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNK3;KCNK9,"RESPIRATORY DEPRESSION, CENTRAL NERVOUS SYSTEM DEPRESSION, ACUTE HYPERCAPNIA (AHC)",,LAUNCHED,,Small molecule,4,"CCN1CC(CCN2CCOCC2)C(C1=O)(C1CCCCC1)C1CCCCC1, CCN1CC(CCN2CCOCC2)C(C1=O)(C1CCCCC1)C1CCCCC1;CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O",XFDJYSQDBULQSI-UHFFFAOYSA-N
UK-33274,C02CA04;CARDURA;DOXAZOSIN;UK-33274,CHEMBL707,BRD:BRD-A13188892-066-21-5;BRD:BRD-BRD-A13188892-066-21-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;KCNH2;KCNH6;KCNH7,"BENIGN PROSTATIC HYPERPLASIA (BPH), HYPERTENSION",,LAUNCHED,,Small molecule,4,"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC;COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1COC2CCCCC2O1, COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1COC2CCCCC2O1, COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1COC2CCCCC2O1",RUZYUOTYCVRMRZ-UHFFFAOYSA-N
ZONALON,(Z)-;CIDOXEPIN;DOXEPIN;DOXEPIN TRANS-FORM HYDROCHLORIDE;P-3693A;SINEPIN;SINEQUAN;ZONALON,CHEMBL101740;CHEMBL1628227,BRD:BRD-BRD-K37694030-003-12-7;BRD:BRD-K37694030-003-12-7,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD2;HRH1;HRH2;HRH4;HTR1A;HTR2A;HTR2B;HTR2C;HTR6;KCNH2;SLC6A2;SLC6A4,"DEPRESSION, ANXIETY",,LAUNCHED,,Small molecule,4,"CN(C)CC\C=C1\C2CCCCC2COC2CCCCC12, CN(C)CC\C=C1\C2CCCCC2COC2CCCCC12;CN(C)CCC=C1c2ccccc2COc2ccccc21",ODQWQRRAPPTVAG-UHFFFAOYSA-N
TSA-840,1-.ALPHA.-HYDROXYERGOCALCIFEROL;1-ALPHA-HYDROXYERGOCALCIFEROL;1-HYDROXYERGOCALCIFEROL;1.ALPHA.-HYDROXYERGOCALCIFEROL;1.ALPHA.-HYDROXYVITAMIN D2;DOXERCALCIFEROL;GZ427397;HECTOROL;TSA-840,CHEMBL1200810,BRD:BRD-BRD-K82928892-001-02-5;BRD:BRD-K82928892-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,"CHRONIC KIDNEY DISEASE (CKD), HYPERPARATHYROIDISM",,LAUNCHED,,Small molecule,4,"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O;CC(C)[C@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1\C[C@@H](O)C[C@H](O)C1=C, CC(C)[C@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1\C[C@@H](O)C[C@H](O)C1=C",HKXBNHCUPKIYDM-CGMHZMFXSA-N
RO-219738,5'-DEOXY-5-FLUOROURIDINE (5'-DFUR);CAPECITABINE RELATED COMPOUND B;DOXIFLURIDINE;FLUTRON;FULTURON;FURTULON;NSC-758890;RO 219738;RO-219738,CHEMBL1130,BRD:BRD-BRD-K58262659-001-09-7;BRD:BRD-K58262659-001-09-7,rep_multi_dose;rep_primary;rep_single_dose,THYMIDYLATE SYNTHASE INHIBITOR,TYMS,COLORECTAL CANCER,,LAUNCHED,,Small molecule,3,"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O;C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CC(F)C(=O)[NH]C1=O, C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CC(F)C(=O)[NH]C1=O",ZWAOHEXOSAUJHY-ZIYNGMLESA-N
VENTAX,ABC 12/3;ANSIMAR;DIOXYFILLINE;DOXOFYLLINE;DOXOPHYLLINE;MAXIVENT;NSC-759645;SYNASMA;VENTAX,CHEMBL1527608,BRD:BRD-BRD-K70507123-001-09-7;BRD:BRD-K70507123-001-09-7,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;PDE4A;PDE4B;PDE4C;PDE4D,ASTHMA,,LAUNCHED,,Small molecule,3,"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O;CN1C2NCN(CC3OCCO3)C2C(=O)N(C)C1=O, CN1C2NCN(CC3OCCO3)C2C(=O)N(C)C1=O",HWXIGFIVGWUZAO-UHFFFAOYSA-N
DOXORUBICIN:NAVITOCLAX (2:1 MOL/MOL),DOXORUBICIN:NAVITOCLAX (2:1 MOL/MOL),,CTRP:660280,ctrp,,,,,,,,NA,,
XYROSA,DOXIROBE;DOXYCHEL;DOXYCYCLINE;DOXYCYCLINE MONOHYDRATE;DOXYLIN;GS-3065;MONODOX;ORACEA;SUPRACYCLIN;VIBRAMYCIN;XYROSA,CHEMBL1200699,BRD:BRD-A08545410-003-07-8;BRD:BRD-A08545410-003-08-6;BRD:BRD-A08545410-311-01-8;BRD:BRD-A08545410-311-03-4;BRD:BRD-BRD-A08545410-003-07-8;BRD:BRD-BRD-A08545410-003-08-6;BRD:BRD-BRD-A08545410-311-01-8;BRD:BRD-BRD-A08545410-311-03-4,rep_multi_dose;rep_primary;rep_single_dose,METALLOPROTEINASE INHIBITOR,MMP8,PERIODONTITIS,,LAUNCHED,,Small molecule,4,"C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)C2C(O)CCCC12, C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)C2C(O)CCCC12, C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)C2C(O)CCCC12, C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)C2C(O)CCCC12, C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)C2C(O)CCCC12;C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O",XQTWDDCIUJNLTR-CVHRZJFOSA-N
UNISOM,DECAPRYN;DOXY-SLEEP-AID;DOXYLAMINE;UNISOM,CHEMBL1004,BRD:BRD-A44008656-036-25-8;BRD:BRD-BRD-A44008656-036-25-8,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,CHRM1;HRH1,SEDATIVE,,LAUNCHED,,Small molecule,4,"CN(C)CCOC(C)(c1ccccc1)c1ccccn1;CN(C)CCOC(C)(C1CCCCC1)C1CCCCN1, CN(C)CCOC(C)(C1CCCCC1)C1CCCCN1",HCFDWZZGGLSKEP-UHFFFAOYSA-N
DPC,DPC,,BRD:BRD-K00004636-001-01-9,rep_single_dose,,,,,,,,NA,,
DPC-681,DPC-681,,BRD:BRD-BRD-K37087535-001-01-1;BRD:BRD-K37087535-001-01-1,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,,,,PHASE 1,,,NA,CC(C)CN(C[C@@H](O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)CNCC1CCCC(F)C1)C(C)(C)C)S(=O)(=O)C1CCCC(N)C1,
DPCPX,DPCPX,,BRD:BRD-BRD-K01824921-001-18-5;BRD:BRD-K01824921-001-18-5,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PHASE 1,,,NA,CCCN1C2[NH]C(NC2C(=O)N(CCC)C1=O)C1CCCC1,
DPI-201106,DPI-201106,,BRD:BRD-A64553394-001-04-4;BRD:BRD-BRD-A64553394-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL ACTIVATOR,ADRB2,,,PHASE 2,,,NA,OC(COC1CCCC2[NH]C(CC12)C#N)CN1CCN(CC1)C(C1CCCCC1)C1CCCCC1,
DPO-1,DPO-1,,BRD:BRD-BRD-K99922388-001-02-0;BRD:BRD-K99922388-001-02-0,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNA5,,,PRECLINICAL,,,NA,CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1P(=O)(C1CCCCC1)C1CCCCC1,
TESMILIFENE HYDROCHLORIDE,BMS-217380-01;BMY-33419;DPP-E;DPPE;NSC-741196;NSC-76285;TESMILIFENE HCL;TESMILIFENE HYDROCHLORIDE,CHEMBL2107467,BRD:BRD-BRD-K80315159-051-02-0;BRD:BRD-K80315159-051-02-0,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,ABCB1;HRH1,,,PHASE 3,,Small molecule,-1,CCN(CC)CCOC1CCC(CC2CCCCC2)CC1;CCN(CC)CCOc1ccc(Cc2ccccc2)cc1.Cl,TXLHNFOLHRXMAU-UHFFFAOYSA-N
DQP-1105,DQP-1105,,BRD:BRD-A67976398-001-02-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN2C;GRIN2D,,,,,,NA,,
DR-2313,DR-2313,,BRD:BRD-K94920105-001-05-9,rep_single_dose,PARP INHIBITOR,PARP1;PARP3,,,,,,NA,,
DR-4485,DR-4485,,BRD:BRD-A39794701-003-01-6;BRD:BRD-BRD-A39794701-003-01-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR7,,,PRECLINICAL,,,NA,CLC1CCC(CC1)C1=CCN(CCCCC23CCCC4C2C(NC3=O)CCC4CL)CC1,
DRF053-(R),DRF053-(R),,BRD:BRD-BRD-K25486274-300-01-0;BRD:BRD-K25486274-300-01-0,rep_primary;rep_single_dose,CDK INHIBITOR,CSNK1A1,,,PRECLINICAL,,,NA,"CC[C@H](CO)NC1NC(NC2CCCC(C2)-C2CCCCN2)C2NCN(C(C)C)C2N1, CC[C@H](CO)NC1NC(NC2CCCC(C2)-C2CCCCN2)C2NCN(C(C)C)C2N1",
NSC-757809,CYCLOADIPHENINE;DROFENINE;NSC-757809,CHEMBL442444,BRD:BRD-A22267103-003-13-1;BRD:BRD-BRD-A22267103-003-13-1,rep_primary;rep_single_dose,,,SPASMS,,LAUNCHED,,Small molecule,-1,CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1;CCN(CC)CCOC(=O)C(C1CCCCC1)C1CCCCC1,AGJBLWCLQCKRJP-UHFFFAOYSA-N
K060E,3-HYDROXYTAMOXIFEN;DROLOXIFENE;E-DROLOXIFENE;FK-435;K-060;K-21060E;K060;K060E,CHEMBL487,BRD:BRD-BRD-K38477637-001-01-0;BRD:BRD-K38477637-001-01-0,rep_primary;rep_single_dose,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),ESR1,,,PHASE 3,,Small molecule,3,CC/C(=C(/c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1;CC\C(=C(\C1CCC(OCCN(C)C)CC1)C1CCCC(O)C1)C1CCCCC1,ZQZFYGIXNQKOAV-OCEACIFDSA-N
DROMOSTANOLONE-PROPIONATE,DROMOSTANOLONE-PROPIONATE,,BRD:BRD-A38706605-001-01-2;BRD:BRD-BRD-A38706605-001-01-2,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,BREAST CANCER,,LAUNCHED,,,NA,CCC(=O)OC1CCC2C3CCC4CC(=O)C(C)CC4(C)C3CCC12C,
SR33589,DRONEDARONE;SR-33589;SR33589,CHEMBL184412,BRD:BRD-BRD-K05524748-003-04-4;BRD:BRD-K05524748-003-04-4,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;CACNA1C;CACNA1D;CACNA1F;CACNA1S;CACNB1;CACNB2;CACNB3;CACNB4;KCNA5;KCNH2;KCNK2;SCN1A,ATRIAL FIBRILLATION (AF),,LAUNCHED,,Small molecule,4,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1;CCCCN(CCCC)CCCOC1CCC(CC1)C(=O)C1C(CCCC)OC2CCC(NS(C)(=O)=O)CC12,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
R-4749,DRIDOL;DROLEPTAN;DROPERIDOL;INAPSINE;MCN-JR-4749;NSC-169874;R-4749,CHEMBL1108,BRD:BRD-BRD-K97158071-001-18-1;BRD:BRD-K97158071-001-18-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;DRD2;DRD3;DRD4;HTR2A,"NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,"FC1CCC(CC1)C(=O)CCCN1CCC(=CC1)N1C2CCCCC2[NH]C1=O, FC1CCC(CC1)C(=O)CCCN1CCC(=CC1)N1C2CCCCC2[NH]C1=O;O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1",RMEDXOLNCUSCGS-UHFFFAOYSA-N
UCB-1967,(-)-DROPROPIZINE;(S)-;(S)-(-)-DROPROPIZINE;(S)-ISOMER;CATABEX;DANKA;DIPROPIZINE;DITUSTAT;DOPROPIZIN;DROPROPIZINE;DROPROPIZINE S-FORM;KATRIL;L-DROPROPIZINE;LARYLIN;LEVODROPROPIZINE;LEVOPRONT;LEVOTUSS;NSC-757820;RAPITUX;RIBEX;TUSSILEX;U.C.B.-1967;UCB 1967;UCB-1967,CHEMBL1288810;CHEMBL151445,BRD:BRD-A29349577-001-23-0;BRD:BRD-BRD-A29349577-001-23-0,rep_primary;rep_single_dose,ANTITUSSIVE,,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,3,"OCC(O)CN1CCN(c2ccccc2)CC1;OCC(O)CN1CCN(CC1)C1CCCCC1, OCC(O)CN1CCN(CC1)C1CCCCC1, OCC(O)CN1CCN(CC1)C1CCCCC1",PTVWPYVOOKLBCG-UHFFFAOYSA-N
ZK-30595,ANGELIQ;DROSPIRENONE;NSC-760103;SLYND;ZK 30595;ZK-30595,CHEMBL1509,BRD:BRD-BRD-K04394237-001-03-7;BRD:BRD-BRD-K04394237-001-06-0;BRD:BRD-K04394237-001-03-7;BRD:BRD-K04394237-001-06-0,rep_multi_dose;rep_primary;rep_single_dose,MINERALOCORTICOID RECEPTOR ANTAGONIST,AR;NR3C2;PGR,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1, C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1, C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1, C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1;C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12",METQSPRSQINEEU-HXCATZOESA-N
DROTIN,DIHYDROETHAVERINE;DIHYDROISOPERPARINE;DROTAVERIN;DROTAVERINE;DROTIN,CHEMBL551978,BRD:BRD-BRD-K14658796-003-01-6;BRD:BRD-K14658796-003-01-6,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,CACNA1C;PDE4A,LABOR INDUCTION,,LAUNCHED,,Small molecule,3,"CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC;CCOC1CCC(\C=C2\NCCC3CC(OCC)C(OCC)CC23)CC1OCC, CCOC1CCC(\C=C2\NCCC3CC(OCC)C(OCC)CC23)CC1OCC",OMFNSKIUKYOYRG-MOSHPQCFSA-N
NORTHERA,DOPS;DROXIDOPA;L-DOPS;L-THREO-DOPS;NORTHERA,CHEMBL2103827,BRD:BRD-BRD-K20372197-001-03-1;BRD:BRD-K20372197-001-03-1,rep_primary;rep_single_dose,NOREPINEPHRINE PRECURSOR,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;ADRB3;PAH,"HYPERTENSION, PARKINSON'S DISEASE",,LAUNCHED,,Small molecule,4,"N[C@@H]([C@H](O)C1CCC(O)C(O)C1)C(O)=O, N[C@@H]([C@H](O)C1CCC(O)C(O)C1)C(O)=O;N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1",QXWYKJLNLSIPIN-JGVFFNPUSA-N
DROXINOSTAT,DROXINOSTAT,,BRD:BRD-BRD-K11558771-001-13-9;BRD:BRD-K11558771-001-13-9,rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC6;HDAC8,,,PRECLINICAL,,,NA,CC1CC(CL)CCC1OCCCC(=O)NO,
DS-1971A,DS-1971;DS-1971A,CHEMBL4633566,BRD:BRD-K00091281-001-01-9,rep_single_dose,,,,,,,Small molecule,1,Cn1nccc1[C@H]1CCCC[C@@H]1Oc1cc(F)c(S(=O)(=O)Nc2ccncn2)cc1Cl,OJKONCJPCULNOW-DYVFJYSZSA-N
DS2-(806622),DS2-(806622),,BRD:BRD-BRD-K09619578-001-01-3;BRD:BRD-K09619578-001-01-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"CLC1CCC(CC1)C(=O)NC1C(NC2CCCCN12)-C1CCCS1, CLC1CCC(CC1)C(=O)NC1C(NC2CCCCN12)-C1CCCS1",
DSM265,DSM-265;DSM265,CHEMBL1956285,BRD:BRD-K35498911-001-02-9,rep_single_dose,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,,,,,,Small molecule,2,Cc1cc(Nc2ccc(S(F)(F)(F)(F)F)cc2)n2nc(C(C)(F)F)nc2n1,OIZSVTOIBNSVOS-UHFFFAOYSA-N
DSPC,DSPC,,BRD:BRD-K00004570-001-01-9,rep_single_dose,,,,,,,,NA,,
DSR-6434,DSR-6434,,BRD:BRD-K46384285-001-02-9,rep_single_dose,TOLL-LIKE RECEPTOR AGONIST,TLR7,,,,,,NA,,
DU-728,DU-728,,BRD:BRD-BRD-K08859203-001-01-9;BRD:BRD-K08859203-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,STRUCTURAL GLYCOPROTEIN ANTAGONIST,ITGA2B;ITGB3,,,PHASE 1,,,NA,N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O,
LY248686,(-)-;(-)-DULOXETINE;(R)-;(R)-DULOXETINE;CYMBALTA;DULOXETINE;LY-248686;LY248686,CHEMBL1175;CHEMBL336920,BRD:BRD-BRD-K71103788-003-12-0;BRD:BRD-K71103788-003-12-0,rep_primary;rep_single_dose,"NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃÂÂNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",HTR2A;HTR2C;HTR6;SLC6A2;SLC6A3;SLC6A4,"DEPRESSION, GENERALIZED ANXIETY DISORDER (GAD), MUSCLE PAIN, PERIPHERAL NEUROPATHY",,LAUNCHED,"Multiple values for MOA: {'NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)', 'NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃ\x80\x93NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)'}, defaulting to 'NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINÃ\x80\x93NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)'",Small molecule,4,"CNCC[C@H](Oc1cccc2ccccc12)c1cccs1;CNCC[C@H](OC1CCCC2CCCCC12)C1CCCS1, CNCC[C@H](OC1CCCC2CCCCC12)C1CCCS1, CNCC[C@H](OC1CCCC2CCCCC12)C1CCCS1",ZEUITGRIYCTCEM-KRWDZBQOSA-N
DUP-697,DUP-697,CHEMBL42485,BRD:BRD-BRD-K06221026-001-06-8;BRD:BRD-K06221026-001-06-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,,,PHASE 1,,Small molecule,NA,"CS(=O)(=O)c1ccc(-c2cc(Br)sc2-c2ccc(F)cc2)cc1;CS(=O)(=O)C1CCC(CC1)-C1CC(BR)SC1-C1CCC(F)CC1, CS(=O)(=O)C1CCC(CC1)-C1CC(BR)SC1-C1CCC(F)CC1",AJFTZWGGHJXZOB-UHFFFAOYSA-N
SGX942,ARG-ILE-VAL-PRO-ALA-NH2;DUSQUETIDE;IMX-942;SGX-94;SGX-942;SGX94;SGX942,CHEMBL3545314,BRD:BRD-K00073831-019-02-9,rep_single_dose,,,,,,,Protein,3,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O)C(C)C,ZUJBBVJXXYRPFS-DYKIIFRCSA-N
NSC-759880,AVODART;AVOLVE;DUASTRIDE;DUTASTERIDE;GG-745;GI 198745;GI-198745;NSC-740477;NSC-759880,CHEMBL1200969,BRD:BRD-BRD-K30373883-001-02-8;BRD:BRD-K30373883-001-02-8,rep_primary;rep_single_dose,5 ALPHA REDUCTASE INHIBITOR,SRD5A1;SRD5A2;SRD5A3,BENIGN PROSTATIC HYPERPLASIA (BPH),,LAUNCHED,"Multiple values for repurposing_target: {'SRD5A1;SRD5A2', 'SRD5A1;SRD5A2;SRD5A3'}, taking the union",Small molecule,4,C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3cc(C(F)(F)F)ccc3C(F)(F)F)CC[C@@H]12;C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC1CC(CCC1C(F)(F)F)C(F)(F)F,JWJOTENAMICLJG-QWBYCMEYSA-N
IPI-145,COPIKTRA;DUVELISIB;DUVELISIB HYDRATE;DUVELISIB MONOHYDRATE;INK-1147;INK-1197;IPI-145,CHEMBL3039502,BRD:BRD-BRD-K93468883-001-02-0;BRD:BRD-K93468883-001-02-0,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PHASE 3,,Small molecule,4,C[C@H](NC1NCNC2[NH]CNC12)C1CC2CCCC(CL)C2C(=O)N1-C1CCCCC1;C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1,SJVQHLPISAIATJ-ZDUSSCGKSA-N
DVD-111,DVD-111,,BRD:BRD-BRD-K22520627-001-01-7;BRD:BRD-K22520627-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CC1CCCCC1,
DWK-1339,DWK-1339,,BRD:BRD-K00003171-001-01-9,rep_single_dose,BETA AMYLOID AGGREGATION INHIBITOR,,,,,,,NA,,
DY131,DY131,,BRD:BRD-BRD-K58343622-001-01-6;BRD:BRD-K58343622-001-01-6,rep_primary;rep_single_dose,ESTROGEN-RELATED RECEPTOR AGONIST,ESRRB;ESRRG,,,PRECLINICAL,,,NA,"CCN(CC)C1CCC(CC1)\C=N\NC(=O)C1CCC(O)CC1, CCN(CC)C1CCC(CC1)\C=N\NC(=O)C1CCC(O)CC1",
DYCLONINE,DYCLONINE,CHEMBL1201217,BRD:BRD-BRD-K72259270-003-25-6;BRD:BRD-K72259270-003-25-6,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A;SCN5A,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,4,"CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1;CCCCOC1CCC(CC1)C(=O)CCN1CCCCC1, CCCCOC1CCC(CC1)C(=O)CCN1CCCCC1, CCCCOC1CCC(CC1)C(=O)CCN1CCCCC1, CCCCOC1CCC(CC1)C(=O)CCN1CCCCC1, CCCCOC1CCC(CC1)C(=O)CCN1CCCCC1",BZEWSEKUUPWQDQ-UHFFFAOYSA-N
NSC-92336,DUPHASTON;DUPHASTON-HRT;DYDROGESTERONE;GYNOREST;ISOPREGNENONE;NSC-92336,CHEMBL1200853,BRD:BRD-BRD-K68620903-001-11-4;BRD:BRD-K68620903-001-11-4,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,INFERTILITY,,LAUNCHED,,Small molecule,4,"CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C;CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C, CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C, CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C",JGMOKGBVKVMRFX-HQZYFCCVSA-N
DYNASORE,DYNASORE,CHEMBL1209885,BRD:BRD-K87718015-001-04-9,rep_single_dose,DYNAMIN INHIBITOR,DNM1;DNM1L;DNM2,,,,,Small molecule,NA,O=C(N/N=C/c1ccc(O)c(O)c1)c1cc2ccccc2cc1O,SYNDQCRDGGCQRZ-VXLYETTFSA-N
DYNOLE-34-2,DYNOLE-34-2,,BRD:BRD-K23479488-001-02-9,rep_single_dose,DYNAMIN INHIBITOR,DNM1,,,,,,NA,,
NSC-14305,DILOR;DILOR-400;DIPROPHYLLINE;DYPHILLINE;DYPHYLLINE;GLYPHYLLINE;LUFYLLIN;NEOTHYLLINE;NSC-14305,CHEMBL1752,BRD:BRD-A00827783-001-24-6;BRD:BRD-BRD-A00827783-001-24-6,rep_primary;rep_single_dose,"ADENOSINE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",ADORA1;ADORA2A;PDE3A;PDE4A;PDE4B;PDE4C;PDE4D;PDE7A;PDE7B,"ASTHMA, BRONCHITIS, EMPHYSEMA",,LAUNCHED,,Small molecule,4,"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O;CN1C2NCN(CC(O)CO)C2C(=O)N(C)C1=O, CN1C2NCN(CC(O)CO)C2C(=O)N(C)C1=O",KSCFJBIXMNOVSH-UHFFFAOYSA-N
E-2001,E-2001,,BRD:BRD-K00004561-001-01-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
E-2012,E-2012,,BRD:BRD-BRD-K50564936-001-01-6;BRD:BRD-K50564936-001-01-6,rep_primary;rep_single_dose,GAMMA SECRETASE MODULATOR,APH1A;APH1B;PSENEN,,,PHASE 1,,,NA,"COC1CC(CCC1-N1CNC(C)C1)\C=C1/CCCN([C@@H](C)C2CCC(F)CC2)C1=O, CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC",
E-4031,E-4031,,BRD:BRD-BRD-K41713976-300-02-6;BRD:BRD-K41713976-300-02-6,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNH1;KCNH2,,,PHASE 1,,,NA,"CC1CCCC(CCN2CCC(CC2)C(=O)C2CCC(NS(C)(=O)=O)CC2)N1, CC1CCCC(CCN2CCC(CC2)C(=O)C2CCC(NS(C)(=O)=O)CC2)N1",
E-64,E-64,CHEMBL374508,BRD:BRD-BRD-K06273313-001-07-9;BRD:BRD-K06273313-001-07-9,rep_primary;rep_single_dose,"CALPAIN INHIBITOR, CYSTEINE PROTEASE INHIBITOR",CTSS,,,PRECLINICAL,"Multiple values for MOA: {'CYSTEINE PROTEASE INHIBITOR, CALPAIN INHIBITOR', 'CALPAIN INHIBITOR, CYSTEINE PROTEASE INHIBITOR'}, defaulting to 'CALPAIN INHIBITOR, CYSTEINE PROTEASE INHIBITOR'",Small molecule,NA,"CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(O)=O)C(=O)NCCCCN=C(N)N, CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(O)=O)C(=O)NCCCCN=C(N)N;CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCN=C(N)N",LTLYEAJONXGNFG-DCAQKATOSA-N
E7386,E 7386;E-7386;E7386,CHEMBL4297491,BRD:BRD-K00091075-001-01-9,rep_single_dose,,,,,,,Small molecule,1,C=CCN1CC(=O)N2[C@@H](Cc3ccc(O)cc3F)C(=O)N(Cc3cccc(N4CC(N5CCN(CC)CC5)C4)n3)C[C@@H]2N1C(=O)NCc1ccccc1,ZGNKNLOBYFTGRG-GIWKVKTRSA-N
E1210,E1210,,BRD:BRD-K00079239-001-02-9,rep_single_dose,,,,,,,,NA,,
E3330,E3330,,BRD:BRD-K00004649-001-01-9,rep_single_dose,NFKB PATHWAY INHIBITOR,,,,,,,NA,,
E7046,E7046,,BRD:BRD-K00003449-001-01-9,rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,,,,,,,NA,,
STENOPARIB,2X-121;E-7449;E7449;PARP INHIBITOR 2X-121;STENOPARIB,CHEMBL3644587,BRD:BRD-BRD-K05444225-001-01-7;BRD:BRD-K05444225-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,PARP1;PARP2;TNKS;TNKS2,,,PHASE 1/PHASE 2,,Small molecule,2,"O=C1[NH][NH]C2NC(CN3CC4CCCCC4C3)NC3CCCC1C23, O=C1[NH][NH]C2NC(CN3CC4CCCCC4C3)NC3CCCC1C23, O=C1[NH][NH]C2NC(CN3CC4CCCCC4C3)NC3CCCC1C23;O=c1[nH]nc2c3c(cccc13)N=C(CN1Cc3ccccc3C1)N2",JLFSBHQQXIAQEC-UHFFFAOYSA-N
ER-68203-00,E-7820;E7820;ER-68203-00,CHEMBL4297376,BRD:BRD-K00003172-001-01-9,rep_single_dose,ANGIOGENESIS INHIBITOR,,,,,,Small molecule,2,Cc1ccc(NS(=O)(=O)c2cccc(C#N)c2)c2[nH]cc(C#N)c12,LWGUASZLXHYWIV-UHFFFAOYSA-N
EACT,EACT,,BRD:BRD-BRD-K53030960-001-01-4;BRD:BRD-K53030960-001-01-4,rep_primary;rep_single_dose,CALCIUM-ACTIVATED CHLORIDE CHANNEL INHIBITOR,ANO1,,,PRECLINICAL,,,NA,COCCN(C(=O)C1CC(OC)C(OC)C(OC)C1)C1NC(CS1)-C1CCCCC1,
EB-47,EB-47,,BRD:BRD-BRD-K66998413-300-01-6;BRD:BRD-K66998413-300-01-6,rep_primary;rep_single_dose,PARP INHIBITOR,PARP1,,,PRECLINICAL,,,NA,NC1NCNC2N(CNC12)[C@H]1O[C@H]([C@H](O)[C@@H]1O)C(=O)N1CCN(CC(=O)NC2CCCC3C(=O)NCC23)CC1,
RP-64305,EBASTINE;KESTINE;LAS W-090;LAS-W-090;RP 64305;RP-64305,CHEMBL305660,BRD:BRD-BRD-K13314656-001-01-0;BRD:BRD-K13314656-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,CYP3A4;HRH1,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,3,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1;CC(C)(C)C1CCC(CC1)C(=O)CCCN1CCC(CC1)OC(C1CCCCC1)C1CCCCC1,MJJALKDDGIKVBE-UHFFFAOYSA-N
EBPC,EBPC,,BRD:BRD-A96485169-001-14-3;BRD:BRD-BRD-A96485169-001-14-3,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,AKR1B1,,,PRECLINICAL,,,NA,CCOC(=O)C1CN(CC2CCCCC2)C(=O)C1=O,
EBROTIDINE,EBROTIDINE,CHEMBL1742471,BRD:BRD-BRD-K22421059-001-02-3;BRD:BRD-K22421059-001-02-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,,,WITHDRAWN,,Small molecule,4,"NC(=N)NC1NC(CSCCN\C=N\S(=O)(=O)C2CCC(BR)CC2)CS1, NC(=N)NC1NC(CSCCN\C=N\S(=O)(=O)C2CCC(BR)CC2)CS1, NC(=N)NC1NC(CSCCN\C=N\S(=O)(=O)C2CCC(BR)CC2)CS1;NC(N)=Nc1nc(CSCCN/C=N/S(=O)(=O)c2ccc(Br)cc2)cs1",ZQHFZHPUZXNPMF-UHFFFAOYSA-N
SPI-1005,DR-3305;DR3305;EBSELEN;NSC-639762;NSC-757883;SPI-1005,CHEMBL51085,BRD:BRD-BRD-K29359156-001-30-1;BRD:BRD-K29359156-001-30-1,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, GLUTATHIONE PEROXIDASE AGONIST, H+/K+-ATPASE INHIBITOR, NITRIC OXIDE SYNTHASE INHIBITOR",ALB,,,PHASE 2/PHASE 3,,Small molecule,3,O=c1c2ccccc2[se]n1-c1ccccc1;O=C1N([SE]C2CCCCC12)-C1CCCCC1,DYEFUKCXAQOFHX-UHFFFAOYSA-N
EC-144,EC-144,,BRD:BRD-BRD-K41705163-001-01-1;BRD:BRD-K41705163-001-01-1,rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1;HSP90AB1,,,PRECLINICAL,,,NA,COC1C(C)CNC(CN2CC(C#CCC(C)(C)O)C3C(CL)NC(N)NC23)C1C,
EC-23,EC-23,,BRD:BRD-BRD-K81004638-001-01-7;BRD:BRD-K81004638-001-01-7,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA;RARB;RARG,,,PRECLINICAL,,,NA,"CC1(C)CCC(C)(C)C2CC(CCC12)C#CC1CCC(CC1)C(O)=O, CC1(C)CCC(C)(C)C2CC(CCC12)C#CC1CCC(CC1)C(O)=O",
EC5026,EC5026,,BRD:BRD-K00091074-001-01-9,rep_single_dose,,,,,,,,NA,,
ECABAPIDE,ECABAPIDE,CHEMBL2104348,BRD:BRD-BRD-K47371940-001-01-6;BRD:BRD-K47371940-001-01-6,rep_primary;rep_single_dose,,,,,PHASE 3,,Small molecule,-1,CNC(=O)c1cccc(NCC(=O)NCCc2ccc(OC)c(OC)c2)c1;CNC(=O)C1CCCC(NCC(=O)NCCC2CCC(OC)C(OC)C2)C1,JTAGHJPZEDNHHA-UHFFFAOYSA-N
ECABET SODIUM,ECABET;ECABET SODIUM,CHEMBL2104585,BRD:BRD-BRD-K03353589-236-01-4;BRD:BRD-K03353589-236-01-4,rep_primary;rep_single_dose,"GASTRIN INHIBITOR, UREASE INHIBITOR",NOXO1,DRY EYE SYNDROME,,LAUNCHED,,Small molecule,3,CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2;CC(C)C1CC2CC[C@H]3[C@@](C)(CCC[C@]3(C)C2CC1S(O)(=O)=O)C(O)=O,IWCWQNVIUXZOMJ-MISYRCLQSA-N
ECAMSULE-TRIETHANOLAMINE,ECAMSULE-TRIETHANOLAMINE,,BRD:BRD-A47953250-001-01-7;BRD:BRD-BRD-A47953250-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,,,"SKIN PROTECTANT, SUNSCREEN LOTION",,LAUNCHED,,,NA,CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/C1CCC(CC1)\C=C1\C2CCC(CS(O)(=O)=O)(C1=O)C2(C)C,
GNF-PF-1958,ECHINOMYCIN;GNF-PF-1958,CHEMBL510650,BRD:BRD-A68969091-001-12-7;BRD:BRD-BRD-A68969091-001-12-7,rep_multi_dose;rep_primary;rep_single_dose,DNA INTERCALATING AGENT,,,,PHASE 2,,Small molecule,NA,CS[C@H]1SC[C@H]2C(=O)N(C)[C@@H](C(C)C)C(=O)OC[C@@H](NC(=O)c3cnc4ccccc4n3)C(=O)N[C@@H](C)C(=O)N(C)[C@@H]1C(=O)N(C)[C@@H](C(C)C)C(=O)OC[C@@H](NC(=O)c1cnc3ccccc3n1)C(=O)N[C@@H](C)C(=O)N2C;CSC1SCC2N(C)C(=O)C(C)NC(=O)C(COC(=O)C(C(C)C)N(C)C(=O)C1N(C)C(=O)C(C)NC(=O)C(COC(=O)C(C(C)C)N(C)C2=O)NC(=O)C1CNC2CCCCC2N1)NC(=O)C1CNC2CCCCC2N1,AUJXLBOHYWTPFV-VLNMHYLBSA-N
PHOSPHOLINE IODIDE,217-MI;ECHODIDE;ECHOTHIOPHATE IODIDE;ECOSTIGMINE IODIDE;ECOTHIOPATE IODIDE;PHOSPHOLINE IODIDE,CHEMBL1200367,BRD:BRD-K00075140-005-02-9,rep_single_dose,,,,,,,Small molecule,4,CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-],OVXQHPWHMXOFRD-UHFFFAOYSA-M
SPECTAZOLE,ECONAZOLE;NSC-187789;SPECTAZOLE,CHEMBL808,BRD:BRD-A51820102-008-28-9;BRD:BRD-BRD-A51820102-008-28-9,rep_primary;rep_single_dose,"LANOSTEROL DEMETHYLASE INHIBITOR, STEROL DEMETHYLASE INHIBITOR",CYP51A1;NPY1R;NPY2R;TRPM2;TRPV5,"TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS, TINEA VERSICOLOR, CUTANEOUS CANDIDIASIS",,LAUNCHED,,Small molecule,4,"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1;CLC1CCC(COC(CN2CCNC2)C2CCC(CL)CC2CL)CC1, CLC1CCC(COC(CN2CCNC2)C2CCC(CL)CC2CL)CC1",LEZWWPYKPKIXLL-UHFFFAOYSA-N
ECTOINE,ECTOINE,,BRD:BRD-K34566599-001-03-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,,NA,,
ECTOINE-ZWITTERION,ECTOINE-ZWITTERION,,BRD:BRD-BRD-K60902958-001-01-9;BRD:BRD-K60902958-001-01-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC(=O)[C@@H]1CCNC(=C)N1,
R-483,BM-131258;EDAGLITAZONE;R-483,CHEMBL3990804,BRD:BRD-A25182582-001-01-8;BRD:BRD-BRD-A25182582-001-01-8,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARG,,,PHASE 2,,Small molecule,-1,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2SC(=O)NC2=O)c2sccc12;CC1OC(NC1CCOC1CCC(CC2SC(=O)NC2=O)C2SCCC12)-C1CCCCC1,HAAXAFNSRADSMK-UHFFFAOYSA-N
EDASALONEXENT,CAT 1004;CAT-1004;EDASALONEXENT,CHEMBL3786673,BRD:BRD-K00003258-001-01-9,rep_single_dose,NFKB PATHWAY INHIBITOR,,,,,,Small molecule,3,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCNC(=O)c1ccccc1O,JQLBBYLGWHUHRW-KUBAVDMBSA-N
NSC-343649,EDELFOSINE;ET-18-OME;NSC-324368;NSC-343649,CHEMBL28509,BRD:BRD-A30403214-001-03-3;BRD:BRD-BRD-A30403214-001-03-3,rep_primary;rep_single_dose,PHOSPHOLIPASE INHIBITOR,,,,PHASE 2,,Small molecule,-1,"CCCCCCCCCCCCCCCCCCOC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC, CCCCCCCCCCCCCCCCCCOC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC;CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC",MHFRGQHAERHWKZ-UHFFFAOYSA-N
TETRAHYDROXYPROPYL ETHYLENEDIAMINE,EDETOL;EDITOL;ENTPROL;NEUTROL TE;NSC-369219;QUADROL;TETRAHYDROXYPROPYL ETHYLENEDIAMINE,CHEMBL1573178,BRD:BRD-A78588743-001-03-4;BRD:BRD-BRD-A78588743-001-03-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CC(O)CN(CCN(CC(C)O)CC(C)O)CC(C)O,NSOXQYCFHDMMGV-UHFFFAOYSA-N
TINOSTAMUSTINE,EDO-S 101;EDO-S-101;EDO-S101;TINOSTAMUSTINE,CHEMBL3989941,BRD:BRD-K00003432-001-01-9,rep_single_dose,HDAC INHIBITOR,,,,,,Small molecule,1,Cn1c(CCCCCCC(=O)NO)nc2cc(N(CCCl)CCCl)ccc21,GISXTRIGVCKQBX-UHFFFAOYSA-N
EDONERPIC-MALEATE,EDONERPIC-MALEATE,,BRD:BRD-K00003259-050-01-9,rep_single_dose,BETA AMYLOID INHIBITOR,,,,,,,NA,,
LIXIANA,DU-176;EDOXABAN;LIXIANA,CHEMBL1269025,BRD:BRD-BRD-K29322660-001-01-9;BRD:BRD-K29322660-001-01-9,rep_primary;rep_single_dose,COAGULATION FACTOR INHIBITOR,F10,"STROKE, PULMONARY EMBOLISM (PE), SYSTEMIC EMBOLISM, DEEP VEIN THROMBOSIS (DVT), ATRIAL FIBRILLATION (AF)",,LAUNCHED,,Small molecule,4,CN(C)C(=O)[C@@H]1CC[C@H](NC(=O)C(=O)NC2CCC(CL)CN2)[C@H](C1)NC(=O)C1NC2CCN(C)CC2S1;CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1,HGVDHZBSSITLCT-JLJPHGGASA-N
RWJ-15817,5-ETHYL-3-(2'-DEOXYRIBOSYL)URACIL;EDOXUDINE;EDU;EUDR;NSC-758405;ORF 15817;ORF-15817;RWJ 15817;RWJ-15817,CHEMBL318153,BRD:BRD-BRD-K86892782-001-17-0;BRD:BRD-K86892782-001-17-0,rep_primary;rep_single_dose,DNA DIRECTED DNA POLYMERASE INHIBITOR,,VIRUS HERPES SIMPLEX (HSV),,LAUNCHED,,Small molecule,-1,CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O;CCC1CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)[NH]C1=O,XACKNLSZYYIACO-DJLDLDEBSA-N
TENSILON,EDROPHONIUM;EDROPHONIUM CATION;EDROPHONIUM ION;ENLON;ENLON-PLUS;REVERSOL;TENSILON,CHEMBL1104,BRD:BRD-BRD-K81128206-003-24-4;BRD:BRD-K81128206-003-24-4,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE;BCHE,MYASTHENIA GRAVIS,,LAUNCHED,,Small molecule,4,CC[N+](C)(C)c1cccc(O)c1;CC[N+](C)(C)C1CCCC(O)C1,VWLHWLSRQJQWRG-UHFFFAOYSA-O
EED226,EED226,,BRD:BRD-BRD-K19002914-001-01-3;BRD:BRD-K19002914-001-01-3,oncref_1;rep_primary;rep_single_dose,ALLOSTERIC INHIBITOR OF EED,EED,,,PRECLINICAL,"Multiple values for MOA: {'ALLOSTERIC INHIBITOR OF EED', 'POLYCOMB PROTEIN INHIBITOR'}, defaulting to 'ALLOSTERIC INHIBITOR OF EED'",,NA,CS(=O)(=O)C1CCC(CC1)-C1CNC(NCC2CCCO2)N2CNNC12,
"EEF2K INHIBITOR, A-484954","EEF2K INHIBITOR, A-484954",,GDSC1:409,gdsc,,,,,,,,NA,,
EF5,EF5,,BRD:BRD-K00004643-001-01-9,rep_single_dose,CYTOCHROME P450 ACTIVATOR,,,,,,,NA,,
RSR13,EFAPROXIRAL;RSR-13;RSR13,CHEMBL18901,BRD:BRD-BRD-K37355418-236-01-6;BRD:BRD-K37355418-236-01-6,rep_primary;rep_single_dose,"HAEMOGLOBIN OXYGEN RELEASE STIMULANT, HEMOGLOBIN OXYGEN RELEASE STIMULANT",HBA1;HBB,,,PHASE 3,"Multiple values for MOA: {'HAEMOGLOBIN OXYGEN RELEASE STIMULANT, HEMOGLOBIN OXYGEN RELEASE STIMULANT', 'HAEMOGLOBIN OXYGEN RELEASE STIMULANT'}, defaulting to 'HAEMOGLOBIN OXYGEN RELEASE STIMULANT, HEMOGLOBIN OXYGEN RELEASE STIMULANT'",Small molecule,3,Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1;CC1CC(C)CC(NC(=O)CC2CCC(OC(C)(C)C(O)=O)CC2)C1,BNFRJXLZYUTIII-UHFFFAOYSA-N
NSC-759562,EFAROXAN;NSC-759562,CHEMBL57895,BRD:BRD-A10739734-003-10-6;BRD:BRD-BRD-A10739734-003-10-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADORA2A,,,PHASE 2,,Small molecule,-1,"CCC1(C2=NCCN2)Cc2ccccc2O1;CCC1(CC2CCCCC2O1)C1=NCCN1, CCC1(CC2CCCCC2O1)C1=NCCN1",RATZLMXRALDSJW-UHFFFAOYSA-N
INOLITAZONE,EFATUTAZONE;INOLITAZONE,CHEMBL3545280,BRD:BRD-A24560335-300-01-2;BRD:BRD-BRD-A24560335-300-01-2,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARG,,,PHASE 2,,Small molecule,2,Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N;CC1CC(OC2CCC3NC(COC4CCC(CC5SC(=O)NC5=O)CC4)N(C)C3C2)CC(C)C1N,JCYNMRJCUYVDBC-UHFFFAOYSA-N
VIRADAY,(-)-EFAVIRENZ;DMP-266;EFAVIRENZ;EFAVIRENZ TEVA;EFAVIRENZUM;L-743726;NSC-742403;STOCRIN;SUSTIVA;SUSTIVA 600;VIRADAY,CHEMBL223228,BRD:BRD-BRD-K40758068-001-08-2;BRD:BRD-K40758068-001-08-2,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,CYP1A2;CYP2B6;CYP2C19;CYP2C9;CYP2D6;CYP3A4,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,FC(F)(F)[C@]1(OC(=O)NC2CCC(CL)CC12)C#CC1CC1;O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,XPOQHMRABVBWPR-ZDUSSCGKSA-N
KP-103,CLENAFIN;EFINACONAZOLE;IDP-108;JUBLIA;KP-103,CHEMBL2103877,BRD:BRD-A30774155-001-01-2;BRD:BRD-BRD-A30774155-001-01-2,rep_primary;rep_single_dose,LANOSTEROL DEMETHYLASE INHIBITOR,CYP51A1,ONYCHOMYCOSIS,,LAUNCHED,,Small molecule,4,C[C@@H](N1CCC(=C)CC1)C(O)(CN1CNCN1)C1CCC(F)CC1F;C=C1CCN([C@H](C)[C@](O)(Cn2cncn2)c2ccc(F)cc2F)CC1,NFEZZTICAUWDHU-RDTXWAMCSA-N
EFLETIRIZINE,EFLETIRIZINE,CHEMBL2104290,BRD:BRD-K00004551-001-01-9,rep_single_dose,ANTIHISTAMINE,,,,,,Small molecule,-1,O=C(O)COCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,BAWMMJAUVBLLEE-UHFFFAOYSA-N
VANIQA,EFLORNITHINE;ORNIDYL;VANIQA,CHEMBL830,BRD:BRD-A96292436-003-16-1;BRD:BRD-BRD-A96292436-003-16-1,rep_primary;rep_single_dose,ORNITHINE DECARBOXYLASE INHIBITOR,ARG2;ODC1,FACIAL HAIR REDUCTION,,LAUNCHED,,Small molecule,4,NCCCC(N)(C(=O)O)C(F)F;NCCCC(N)(C(F)F)C(O)=O,VLCYCQAOQCDTCN-UHFFFAOYSA-N
NSC-758891,EFLOXATE;NSC-758891,CHEMBL1349073,BRD:BRD-BRD-K55166090-001-09-0;BRD:BRD-K55166090-001-09-0,rep_primary;rep_single_dose,VASODILATOR,,,,PRECLINICAL,,Small molecule,-1,CCOC(=O)COc1ccc2c(=O)cc(-c3ccccc3)oc2c1;CCOC(=O)COC1CCC2C(C1)OC(CC2=O)-C1CCCCC1,ZVXBAHLOGZCFTP-UHFFFAOYSA-N
EFONIDIPINE HYDROCHLORIDE,EFONIDIPINE;EFONIDIPINE HYDROCHLORIDE,CHEMBL2074922,BRD:BRD-K00004292-003-02-9,rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,,,Small molecule,-1,CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1,NSVFSAJIGAJDMR-UHFFFAOYSA-N
EFONIDIPINE-MONOETHANOLATE,EFONIDIPINE-MONOETHANOLATE,,BRD:BRD-BRD-M92675308-003-07-1;BRD:BRD-M92675308-003-07-1,rep_multi_dose;rep_primary;rep_single_dose,"L-TYPE CALCIUM CHANNEL BLOCKER, T-TYPE CALCIUM CHANNEL BLOCKER",CACNA1C;CACNA1G,,,LAUNCHED,,,NA,"CCO.CC1=C(C(C2CCCC(C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1CCCCC1)C1CCCCC1, CCO.CC1=C(C(C2CCCC(C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1CCCCC1)C1CCCCC1, CCO.CC1=C(C(C2CCCC(C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1CCCCC1)C1CCCCC1",
EG00229,EG00229,,BRD:BRD-BRD-K50653584-001-01-2;BRD:BRD-K50653584-001-01-2,rep_primary;rep_single_dose,NEUROPILIN RECEPTOR ANTAGONIST,NRP1,,,PRECLINICAL,,,NA,"NC(=N)NCCC[C@H](NC(=O)C1SCCC1NS(=O)(=O)C1CCCC2NSNC12)C(O)=O, NC(=N)NCCC[C@H](NC(=O)C1SCCC1NS(=O)(=O)C1CCCC2NSNC12)C(O)=O",
NVP-EGF816-NX,EGF-816;EGF816;NAZARTINIB;NVP-EGF816-NX,CHEMBL3787344,BRD:BRD-BRD-K22514639-001-05-7;BRD:BRD-K22514639-001-04-0;BRD:BRD-K22514639-001-05-7,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PHASE 2,,Small molecule,2,"Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1;CN(C)C\C=C\C(=O)N1CCCC[C@H](C1)N1C(NC(=O)C2CCNC(C)C2)NC2CCCC(CL)C12, CN(C)C\C=C\C(=O)N1CCCC[C@H](C1)N1C(NC(=O)C2CCNC(C)C2)NC2CCCC(CL)C12",IOMMMLWIABWRKL-WUTDNEBXSA-N
LY354740,EGLUMEGAD;EGLUMETAD;EGLUMETAD ANHYDROUS;LY-354740;LY354740,CHEMBL8759,BRD:BRD-BRD-K65359424-001-01-3;BRD:BRD-K65359424-001-01-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM2;GRM3;GRM6;GRM8,,,PHASE 2,,Small molecule,-1,"N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O, N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O;N[C@@]1(C(=O)O)CC[C@H]2[C@H](C(=O)O)[C@H]21",VTAARTQTOOYTES-RGDLXGNYSA-N
EHOP-016,EHOP-016,,BRD:BRD-BRD-K32289541-001-01-0;BRD:BRD-K32289541-001-01-0,rep_primary;rep_single_dose,RAS GTPASE INHIBITOR,RAC1;RAC3,,,PRECLINICAL,,,NA,CCN1C2CCCCC2C2CC(NC3CCNC(NCCCN4CCOCC4)N3)CCC12,
EHT-1864,EHT 1864;EHT-1864,,GDSC1:1069,gdsc,,,,,,,,NA,,
EI1,EI1,,BRD:BRD-K91535048-001-01-2,rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,,,,NA,,
EIF-2ALPHA INHIBITOR,EIF-2ALPHA INHIBITOR,,GDSC1:111,gdsc,,,,,,,,NA,,
EIPA,EIPA,,BRD:BRD-K88120876-001-10-9,rep_single_dose,"SODIUM/HYDROGEN EXCHANGER INHIBITOR, TRANSIENT RECEPTOR POTENTIAL POLYCYSTIC INHIBITOR",ADRA2A;ASIC1;PKD2L1,,,,,,NA,,
EIT-HYDROBROMIDE,EIT-HYDROBROMIDE,,BRD:BRD-BRD-K81623406-004-08-3;BRD:BRD-K81623406-004-08-3,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS2;NOS3,,,PRECLINICAL,,,NA,CCSC(N)=N,
WAY-EKB-569,EKB 569;EKB-569;PELITINIB;WAY-EKB-569,CHEMBL607707,GDSC1:282,gdsc,,,,,,,Small molecule,2,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,WVUNYSQLFKLYNI-AATRIKPKSA-N
RAD1901,ELACESTRANT;ER-306323;RAD-1901;RAD1901,CHEMBL4297509,BRD:BRD-K00003295-300-01-9,rep_single_dose,ESTROGEN RECEPTOR DEGRADER,,,,,,Small molecule,3,CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1,SIFNOOUKXBRGGB-AREMUKBSSA-N
LY335979,ELACRIDAR;LY-335979;LY335979,CHEMBL396298,BRD:BRD-BRD-K88807631-001-01-3;BRD:BRD-K88807631-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,P GLYCOPROTEIN INHIBITOR,ABCB1,,,PHASE 1,,Small molecule,-1,"COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2;COC1CC2CCN(CCC3CCC(NC(=O)C4CCCC5C4[NH]C4C(OC)CCCC4C5=O)CC3)CC2CC1OC, COC1CC2CCN(CCC3CCC(NC(=O)C4CCCC5C4[NH]C4C(OC)CCCC4C5=O)CC3)CC2CC1OC, COC1CC2CCN(CCC3CCC(NC(=O)C4CCCC5C4[NH]C4C(OC)CCCC4C5=O)CC3)CC2CC1OC",OSFCMRGOZNQUSW-UHFFFAOYSA-N
P-4055,CP 4055;CP-4055;ELACYTARABINE;P-4055,CHEMBL2105665,BRD:BRD-K00004609-001-01-9,rep_single_dose,ANTINEOPLASTIC AGENT,DCK,,,,,Small molecule,3,CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@@H](O)[C@@H]1O,FLFGNMFWNBOBGE-FNNZEKJRSA-N
GFT505,ELAFIBRANOR;GFT-505;GFT505,CHEMBL3707395,BRD:BRD-BRD-K03165895-001-01-9;BRD:BRD-K03165895-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA;PPARD;PPARG,,,PHASE 3,"Multiple values for repurposing_target: {'PPARA;PPARD', 'PPARA;PPARD;PPARG'}, taking the union",Small molecule,3,CSc1ccc(C(=O)/C=C/c2cc(C)c(OC(C)(C)C(=O)O)c(C)c2)cc1;CSC1CCC(CC1)C(=O)\C=C\C1CC(C)C(OC(C)(C)C(O)=O)C(C)C1,AFLFKFHDSCQHOL-IZZDOVSWSA-N
NBI-56418,ELAGOLIX;NBI-56418,CHEMBL1208155,BRD:BRD-BRD-K55808645-001-01-4;BRD:BRD-K55808645-001-01-4,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,GNRHR,,,PHASE 3,,Small molecule,4,COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)O)c3ccccc3)c2=O)c1F;COC1CCCC(C1F)-C1C(C)N(CC2C(F)CCCC2C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C2CCCCC2)C1=O,HEAUOKZIVMZVQL-VWLOTQADSA-N
ELAMIPRETIDE (TFA),ELAMIPRETIDE (TFA),,BRD:BRD-K00079505-019-02-9,rep_single_dose,,,,,,,,NA,,
MK-8742,ELBASVIR;MK-8742,CHEMBL3039514,BRD:BRD-BRD-K09735259-001-01-3;BRD:BRD-K09735259-001-01-3,rep_primary;rep_single_dose,HCV INHIBITOR,,HEPATITIS C,,LAUNCHED,,Small molecule,4,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1NCC([NH]1)-C1CCC2-C3CC4CC(CCC4N3[C@@H](OC2C1)C1CCCCC1)-C1CNC([NH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C;COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc3c(c2)O[C@@H](c2ccccc2)n2c-3cc3cc(-c4c[nH]c([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)n4)ccc32)c[nH]1)C(C)C,BVAZQCUMNICBAQ-PZHYSIFUSA-N
ELCPK,ELCPK,,CTRP:609056,ctrp,,,,,,,,NA,,
ELDECALCITOL,ED-71;ELDECALCITOL,CHEMBL4297608,BRD:BRD-K00003316-001-01-9,rep_single_dose,BONE FORMATION STIMULANT,VDR,,,,,Small molecule,3,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)[C@@H](OCCCO)[C@@H]1O,FZEXGDDBXLBRTD-AYIMTCTASA-N
GS-6615,ELECLAZINE;GS-6615,CHEMBL3707392,BRD:BRD-K00003225-003-01-9,rep_single_dose,LATE SODIUM CURRENT INHIBITOR,,,,,,Small molecule,3,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,YNUAEEJQYHYLMS-UHFFFAOYSA-N
ELENBECESTAT,E-2609;E2609;ELENBECESTAT,CHEMBL4204869,BRD:BRD-K00091278-001-01-9,rep_single_dose,,,,,,,Small molecule,3,C[C@H]1OC[C@]2(c3cc(NC(=O)c4cnc(C(F)F)cn4)ccc3F)N=C(N)SC[C@H]12,AACUJFVOHGRMTR-DPXNYUHVSA-N
ELEPHANTIN,ELEPHANTIN,CHEMBL399907,GDSC2:1835,gdsc,,,,,,,Small molecule,NA,C=C1C(=O)O[C@H]2[C@H]1[C@@H](OC(=O)C=C(C)C)CC1=C[C@@H](C[C@@]3(C)O[C@H]23)OC1=O,HSTUUCOYVIWGLJ-DXUAHVLSSA-N
STA-4783,ELESCLOMOL;GSK-842879;GSK-842879A;STA-4783,CHEMBL1972860,BRD:BRD-BRD-K82135108-001-04-3;BRD:BRD-K82135108-001-02-7;BRD:BRD-K82135108-001-04-3;GDSC1:1031,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose, ANTI-MITOCHONDRIAL VIA INHIBITION OF FDX1;COPPER IONOPHORE,FDX1;HSPA1A,,,PHASE 3,"Multiple values for MOA: {'OXIDATIVE STRESS INDUCER', 'COPPER IONOPHORE; ANTI-MITOCHONDRIAL VIA INHIBITION OF FDX1'}, defaulting to 'COPPER IONOPHORE; ANTI-MITOCHONDRIAL VIA INHIBITION OF FDX1'
Multiple values for repurposing_target: {'HSPA1A', 'FDX1'}, taking the union",Small molecule,3,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1;CN(NC(=O)CC(=O)NN(C)C(=S)C1CCCCC1)C(=S)C1CCCCC1,BKJIXTWSNXCKJH-UHFFFAOYSA-N
UK-116044-04 FREE BASE,"ELETRIPTAN;RELPAX;UK-116,044;UK-116,044-04 [AS HYDROBROMIDE);UK-116,044-04 FREE BASE;UK-116044;UK-116044-04;UK-116044-04 FREE BASE",CHEMBL1510,BRD:BRD-BRD-K30652337-004-02-1;BRD:BRD-K30652337-004-02-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2B;HTR7,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,"CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12;CN1CCC[C@@H]1CC1C[NH]C2CCC(CCS(=O)(=O)C3CCCCC3)CC12, CN1CCC[C@@H]1CC1C[NH]C2CCC(CCS(=O)(=O)C3CCCCC3)CC12, CN1CCC[C@@H]1CC1C[NH]C2CCC(CCS(=O)(=O)C3CCCCC3)CC12, CN1CCC[C@@H]1CC1C[NH]C2CCC(CCS(=O)(=O)C3CCCCC3)CC12",PWVXXGRKLHYWKM-LJQANCHMSA-N
VX-445,"3-PYRIDINECARBOXAMIDE;ELEXACAFTOR;N-((1,3-DIMETHYL-1H-PYRAZOL-4-YL)SULFONYL)-6-(3-(3,3,3-TRIFLUORO-2,2-DIMETHYLPROPOXY)-1H-PYRAZOL-1-YL)-2-((4S)-2,2,4-TRIMETHYL-1-PYRROLIDINYL)-;VX-445",CHEMBL4298128,BRD:BRD-K00093437-001-01-9,rep_single_dose,,,,,,,Small molecule,4,Cc1nn(C)cc1S(=O)(=O)NC(=O)c1ccc(-n2ccc(OCC(C)(C)C(F)(F)F)n2)nc1N1C[C@@H](C)CC1(C)C,MVRHVFSOIWFBTE-INIZCTEOSA-N
GENZ-99067,CERDELGA;ELIGLUSTAT;GENZ 99067;GENZ-99067,CHEMBL2110588,BRD:BRD-BRD-K86410485-046-01-0;BRD:BRD-K86410485-046-01-0,rep_primary;rep_single_dose,GLYCOSYL TRANSFERASE INHIBITOR,UGCG,"GAUCHER DISEASE, GAUCHER DISEASE",,LAUNCHED,,Small molecule,4,"CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2;CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1CCC2OCCOC2C1, CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1CCC2OCCOC2C1",FJZZPCZKBUKGGU-AUSIDOKSSA-N
ELIPRODIL,ELIPRODIL,CHEMBL28564,BRD:BRD-A61392169-001-02-7;BRD:BRD-BRD-A61392169-001-02-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2B,,,PHASE 3,,Small molecule,2,OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1;OC(CN1CCC(CC2CCC(F)CC2)CC1)C1CCC(CL)CC1,GGUSQTSTQSHJAH-UHFFFAOYSA-N
ELLAGIC-ACID,ELLAGIC-ACID,,BRD:BRD-BRD-K30466858-001-09-6;BRD:BRD-K30466858-001-09-6,rep_primary;rep_single_dose,"GLUTATHIONE TRANSFERASE INHIBITOR, NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",CA1;CA12;CA14;CA2;CA3;CA4;CA5A;CA5B;CA6;CA7;CA9;CSNK2A1;GSK3B;PRKACA;PRKCA;PRKCB;SQLE;SYK,,,PHASE 2,,,NA,"OC1CC2C3C(OC(=O)C4CC(O)C(O)C(OC2=O)C34)C1O, OC1CC2C3C(OC(=O)C4CC(O)C(O)C(OC2=O)C34)C1O, OC1CC2C3C(OC(=O)C4CC(O)C(O)C(OC2=O)C34)C1O",
ELN-441958,ELN-441958,,BRD:BRD-BRD-K50699835-001-01-2;BRD:BRD-K50699835-001-01-2,rep_primary;rep_single_dose,BRADYKININ RECEPTOR ANTAGONIST,BDKRB1,,,PRECLINICAL,,,NA,CLC1CCCC2CN(C(=O)C12)C1CCCC(C1)C(=O)N1CCC2(CC1)CCN(CC2)C1CCNCC1,
RO-26-9228,BXL-628;ELOCALCITOL;RO-26-9228,CHEMBL3545094,CTRP:660319,ctrp,,,,,,,Small molecule,2,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)C/C=C/C(O)(CC)CC)=CCC23)C[C@@H](O)C[C@@H]1O,XDBOQJCMEXOPMU-BAHYQGKPSA-N
ELOXATIN,ELOXATIN,,GDSC2:1089,gdsc,,,,,,,,NA,,
KPT-8602,ELTANEXOR;KPT-8602,CHEMBL4297623,BRD:BRD-K00003369-001-01-9,rep_single_dose,EXPORTIN INHIBITOR,,,,,,Small molecule,1,NC(=O)/C(=C/n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)c1cncnc1,JFBAVWVBLRIWHM-AWNIVKPZSA-N
ZULRESSO,ALLOPREGNAN-3.ALPHA.-OL-20-ONE;ALLOPREGNANOLONE;ALLOTETRAHYDROPROGESTERONE;BREXANOLONE;ELTANOLONE;KABI 2213;KABI-2213;NSC-82867;PREGNAN-3.ALPHA.-OL-20-ONE;PREGNANOLONE;SAGE-547;SGE-102;SKF-6455;ZULRESSO,CHEMBL207538;CHEMBL210952,BRD:BRD-BRD-K18172896-001-02-5;BRD:BRD-K18172896-001-02-5,rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,GABRA1;GABRB2;GABRG2,,,PHASE 3,,Small molecule,4,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,AURFZBICLPNKBZ-SYBPFIFISA-N
ELTOPRAZINE,DU-28853;ELTOPRAZINE,CHEMBL282614,BRD:BRD-BRD-K86171477-001-01-3;BRD:BRD-K86171477-001-01-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B,,,PHASE 2,,Small molecule,2,"c1cc2c(c(N3CCNCC3)c1)OCCO2;C1CN(CCN1)C1CCCC2OCCOC12, C1CN(CCN1)C1CCCC2OCCOC12, C1CN(CCN1)C1CCCC2OCCOC12",WVLHGCRWEHCIOT-UHFFFAOYSA-N
SB497115,ELTROMBOPAG;REVOLADE;SB497115,CHEMBL461101,BRD:BRD-BRD-K40496271-396-01-1;BRD:BRD-K40496271-396-01-1,rep_multi_dose;rep_primary;rep_single_dose,THROMBOPOIETIN RECEPTOR AGONIST,MPL,"ANEMIA, HEPATITIS C, THROMBOCYTOPENIA",,LAUNCHED,,Small molecule,4,"CC1=NN(C(=O)C\1=N\NC1CCCC(-C2CCCC(C2)C(O)=O)C1O)C1CCC(C)C(C)C1, CC1=NN(C(=O)C\1=N\NC1CCCC(-C2CCCC(C2)C(O)=O)C1O)C1CCC(C)C(C)C1, CC1=NN(C(=O)C\1=N\NC1CCCC(-C2CCCC(C2)C(O)=O)C1O)C1CCC(C)C(C)C1;CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O",XDXWLKQMMKQXPV-QYQHSDTDSA-N
VIBERZI,ELUXADOLINE;JNJ-27018966;TRUBERZI;VIBERZI,CHEMBL2159122,BRD:BRD-BRD-K39560679-001-01-1;BRD:BRD-K39560679-001-01-1,rep_primary;rep_single_dose,"OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST, OPIOID RECEPTOR MODULATOR",OPRD1;OPRK1;OPRM1,IRRITABLE BOWEL SYNDROME,,LAUNCHED,"Multiple values for MOA: {'OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST, OPIOID RECEPTOR MODULATOR', 'OPIOID RECEPTOR MODULATOR'}, defaulting to 'OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST, OPIOID RECEPTOR MODULATOR'",Small molecule,4,COC1CCC(CN([C@@H](C)C2NCC([NH]2)-C2CCCCC2)C(=O)[C@@H](N)CC2C(C)CC(CC2C)C(N)=O)CC1C(O)=O;COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2ncc(-c3ccccc3)[nH]2)cc1C(=O)O,QFNHIDANIVGXPE-FNZWTVRRSA-N
VITEKTA,ELVITEGRAVIR;GS-9137;JTK-303;VITEKTA,CHEMBL204656,BRD:BRD-BRD-K54472332-001-03-4;BRD:BRD-K54472332-001-03-4,rep_primary;rep_single_dose,HIV INTEGRASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C;COC1CC2N(CC(C(O)=O)C(=O)C2CC1CC1CCCC(CL)C1F)[C@H](CO)C(C)C,JUZYLCPPVHEVSV-LJQANCHMSA-N
EMAMECTIN,EMAMECTIN,CHEMBL3138875,BRD:BRD-K00003516-057-01-9,rep_single_dose,GABA RECEPTOR AGONIST,,,,,,Small molecule,NA,CC[C@H](C)C1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,CXEGAUYXQAKHKJ-MYANALBDSA-N
EMBELIN,EMBELIN,CHEMBL221137,BRD:BRD-BRD-K86727142-001-12-4;BRD:BRD-K86727142-001-12-4;GDSC1:172,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"HCV INHIBITOR, XIAP INHIBITOR",XIAP,,,PRECLINICAL,,Small molecule,NA,"CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O;CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O, CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O, CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O",IRSFLDGTOHBADP-UHFFFAOYSA-N
EMBERINE,EMBELIC ACID;EMBERINE,,GDSC1:172,gdsc,,,,,,,,NA,,
TEPOTINIB,EMD 1214063;EMD-1214063;EMD1214063;MSC-2156119;MSC-2156119J;MSC2156119;TEPOTINIB,CHEMBL3402762,BRD:BRD-BRD-K97963946-001-01-3;BRD:BRD-K97963946-001-01-3,rep_primary;rep_single_dose,HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR,MET,,,PHASE 1,,Small molecule,4,CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1;CN1CCC(COC2CNC(NC2)-C2CCCC(CN3NC(CCC3=O)-C3CCCC(C3)C#N)C2)CC1,AHYMHWXQRWRBKT-UHFFFAOYSA-N
EMD-386088,EMD-386088,,BRD:BRD-BRD-K47659338-003-02-8;BRD:BRD-K47659338-003-02-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR6,,,PRECLINICAL,,,NA,"CC1[NH]C2CCC(CL)CC2C1C1=CCNCC1, CC1[NH]C2CCC(CL)CC2C1C1=CCNCC1",
EMD-53998,EMD-53998,,BRD:BRD-A65248799-001-01-7;BRD:BRD-BRD-A65248799-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,TNNC1,,,PHASE 1,,,NA,COC1CCC(CC1OC)C(=O)N1CCCC2CC(CCC12)C1=NNC(=O)SC1C,
EMD-66684,EMD-66684,,BRD:BRD-BRD-K88759641-003-02-8;BRD:BRD-K88759641-003-02-8,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,,,PRECLINICAL,,,NA,"CCCCC1NC2CCN(CC(=O)N(C)C)C(=O)C2N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCCCC1NC2CCN(CC(=O)N(C)C)C(=O)C2N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1",
EMD534085,EMD534085,,BRD:BRD-K00003185-001-01-9,rep_single_dose,KINESIN INHIBITOR,,,,,,,NA,,
EMEDASTINE,EMADINE;EMEDASTINE,CHEMBL594,BRD:BRD-BRD-K15010214-364-02-7;BRD:BRD-K15010214-364-02-7,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,"CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21;CCOCCN1C(NC2CCCCC12)N1CCCN(C)CC1, CCOCCN1C(NC2CCCCC12)N1CCCN(C)CC1",KBUZBQVCBVDWKX-UHFFFAOYSA-N
EMERAMIDE,EMERAMIDE,CHEMBL4297510,BRD:BRD-K00003226-001-01-9,rep_single_dose,ANTIOXIDANT,,,,,,Small molecule,2,O=C(NCCS)c1cccc(C(=O)NCCS)c1,JUTBAVRYDAKVGQ-UHFFFAOYSA-N
TCMDC-125531,"(-)-EMETINE;6',7',10,11-TETRAMETHOXY-;6',7',10,11-TETRAMETHOXYEMETAN;CEPHAELINE METHYL ETHER;EMETAN;EMETIN;EMETINE;EMETINUM;GNF-PF-196;NSC-33669;TCMDC-125531",CHEMBL50588,BRD:BRD-A25687296-300-04-3;BRD:BRD-BRD-A25687296-300-04-3,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,RPS2,,,PHASE 2,,Small molecule,-1,"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21;CC[C@H]1CN2CCC3CC(OC)C(OC)CC3C2C[C@@H]1CC1NCCC2CC(OC)C(OC)CC12, CC[C@H]1CN2CCC3CC(OC)C(OC)CC3[C@@H]2C[C@@H]1C[C@H]1NCCC2CC(OC)C(OC)CC12",AUVVAXYIELKVAI-CKBKHPSWSA-N
EMIGLITATE,BAY O 1248;BAY-O-1248;EMIGLITATE,CHEMBL2106304,BRD:BRD-K00003206-001-01-9,rep_single_dose,ALPHA GLUCOSIDE INHIBITOR,,,,,,Small molecule,-1,CCOC(=O)c1ccc(OCCN2C[C@H](O)[C@@H](O)[C@H](O)[C@H]2CO)cc1,NWWORXYTJRPSMC-QKPAOTATSA-N
EMIXUSTAT,ACU-4429;EMIXUSTAT,CHEMBL2107821,BRD:BRD-K00003290-003-01-9,rep_single_dose,RETINOID ISOMEROHYDROLASE INHIBITOR,,,,,,Small molecule,3,NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1,WJIGGYYSZBWCGC-MRXNPFEDSA-N
PF-1022-221,BAY 44-4400;BAY-44-4400;EMODEPSIDE;PF 1022-221;PF-1022-221,CHEMBL2104404,BRD:BRD-K00003414-001-01-9,rep_single_dose,NEMATOCIDE,,,,,,Small molecule,2,CC(C)C[C@H]1C(=O)O[C@H](Cc2ccc(N3CCOCC3)cc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](Cc2ccc(N3CCOCC3)cc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N1C,ZMQMTKVVAMWKNY-YSXLEBCMSA-N
EMODIN,EMODIN,CHEMBL289277,BRD:BRD-BRD-K58685305-001-20-4;BRD:BRD-K58685305-001-20-4,rep_primary;rep_single_dose,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,CSNK2A1,,,PRECLINICAL,,Small molecule,NA,CC1CC(O)C2C(=O)C3C(O)CC(O)CC3C(=O)C2C1;Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O,RHMXXJGYXNZAPX-UHFFFAOYSA-N
PENTOIL,EMORFAZONE;PENTOIL,CHEMBL2103954,BRD:BRD-BRD-K90629600-001-01-4;BRD:BRD-K90629600-001-01-4,rep_primary;rep_single_dose,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, CYCLOOXYGENASE INHIBITOR",,MOUTH INFLAMMATION,,LAUNCHED,"Multiple values for MOA: {'ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, CYCLOOXYGENASE INHIBITOR', 'ANTIINFLAMMATORY AGENT, CYCLOOXYGENASE INHIBITOR'}, defaulting to 'ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, CYCLOOXYGENASE INHIBITOR'",Small molecule,-1,CCOC1C(CNN(C)C1=O)N1CCOCC1;CCOc1c(N2CCOCC2)cnn(C)c1=O,URJQOOISAKEBKW-UHFFFAOYSA-N
EMOXIPIN,EMOXIPIN,,BRD:BRD-BRD-K28982731-001-01-6;BRD:BRD-K28982731-001-01-6,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CCC1NC(C)CCC1O,
JARDIANCE,BI 10773;BI-10773;BI10773;EMPAGLIFLOZIN;JARDIANCE,CHEMBL2107830,BRD:BRD-BRD-K53765467-001-02-1;BRD:BRD-K53765467-001-02-1,rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,SLC5A1;SLC5A2,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O;OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1CCC(CL)C(CC2CCC(O[C@H]3CCOC3)CC2)C1,OBWASQILIWPZMG-QZMOQZSNSA-N
VAY785,EMRICASAN;IDN 6556;IDN-6556;PF 03491390;PF-03491390;VAY-785;VAY785,CHEMBL197672,BRD:BRD-K00023644-001-01-9,rep_single_dose,CASPASE INHIBITOR,CASP1;CASP3;CASP7,,,,,Small molecule,2,C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F,SCVHJVCATBPIHN-SJCJKPOMSA-N
RACIVIR,"(-)-;(-)-EMTRICITABINE;(-)-FTC;(+/-)-;524-W-91;524W91;BIKTARVY;BW-524W91;COVIRACIL;DL-;EMTRICITABINE;EMTRICITABINE, (+/-)-;EMTRICITABINUM;EMTRIVA;FTC;FTC-(-);PSI-5004;RACIVIR",CHEMBL161381;CHEMBL885,BRD:BRD-BRD-K61452026-001-04-6;BRD:BRD-K61452026-001-04-6,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,2,Nc1nc(=O)n(C2CSC(CO)O2)cc1F;NC1NC(=O)N(CC1F)[C@@H]1CS[C@H](CO)O1,XQSPYNMVSIKCOC-UHFFFAOYSA-N
VASOTEC,C09AA02;ENALAPRIL;LEXXEL;OLINAPRIL;VASERETIC;VASOTEC,CHEMBL578,BRD:BRD-BRD-K57545991-050-23-1;BRD:BRD-K57545991-050-23-1,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,"HYPERTENSION, CONGESTIVE HEART FAILURE, LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)",,LAUNCHED,,Small molecule,4,"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O;CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O",GBXSMTUPTTWBMN-XIRDDKMYSA-N
VASOTEC I.V.,ENALAPRIL DIACID DIHYDRATE;ENALAPRIL DIACID DIHYDRATE ANHYDROUS;ENALAPRILAT;ENALAPRILAT DIHYDRATE;MK-421;MK-422;NSC-760053;VASOTEC;VASOTEC I.V.,CHEMBL3989406;CHEMBL577,BRD:BRD-BRD-K99447003-335-04-1;BRD:BRD-K99447003-335-04-1,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,HYPERTENSION,,LAUNCHED,,Small molecule,4,"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O;C[C@H](N[C@@H](CCC1CCCCC1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](N[C@@H](CCC1CCCCC1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](N[C@@H](CCC1CCCCC1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](N[C@@H](CCC1CCCCC1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](N[C@@H](CCC1CCCCC1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O",MZYVOFLIPYDBGD-MLZQUWKJSA-N
JTZ-951,ENARODUSTAT;JTZ-951,CHEMBL4297619,BRD:BRD-K00090634-001-01-9,rep_single_dose,,,,,,,Small molecule,3,O=C(O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12,NALAUGMPMIVAOW-UHFFFAOYSA-N
ENASIDENIB,AG 221;AG-221;CC-90007 FREE BASE;ENASIDENIB,CHEMBL3989908,BRD:BRD-BRD-K70601687-001-01-3;BRD:BRD-K70601687-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,ISOCITRATE DEHYDROGENASE INHIBITOR,IDH1,ACUTE MYELOID LEUKEMIA (AML),,LAUNCHED,,Small molecule,4,CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1;CC(C)(O)CNC1NC(NC2CCNC(C2)C(F)(F)F)NC(N1)-C1CCCC(N1)C(F)(F)F,DYLUUSLLRIQKOE-UHFFFAOYSA-N
ENCIPRAZINE,ENCIPRAZINE,CHEMBL101284,BRD:BRD-A62197763-001-01-1;BRD:BRD-BRD-A62197763-001-01-1,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABRA1,,,PHASE 3,,Small molecule,-1,COc1ccccc1N1CCN(CC(O)COc2cc(OC)c(OC)c(OC)c2)CC1;COC1CCCCC1N1CCN(CC(O)COC2CC(OC)C(OC)C(OC)C2)CC1,KSQCNASWXSCJTD-UHFFFAOYSA-N
NVP-LGX818-NXA,BRAFTOVI;ENCORAFENIB;LGX-818;LGX818;NVP-LGX-818-NXA;NVP-LGX818;NVP-LGX818-NXA,CHEMBL3301612,BRD:BRD-A56085258-001-01-8;BRD:BRD-BRD-A56085258-001-01-8;BRD:BRD-K00003576-001-01-9;BRD:BRD-K00003576-001-03-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF BRAF,BRAF,,,PHASE 3,"Multiple values for MOA: {'INHIBITOR OF BRAF', 'RAF INHIBITOR'}, defaulting to 'INHIBITOR OF BRAF'
Multiple values for structure_id: {'K00003576', 'A56085258'}, defaulting to None",Small molecule,4,COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1;COC(=O)NC(C)CNC1NCCC(N1)-C1CN(NC1-C1CC(CL)CC(NS(C)(=O)=O)C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N
ENDO-IWR-1,ENDO-IWR-1,,BRD:BRD-BRD-K61314889-001-04-4;BRD:BRD-BRD-K61314889-001-05-1;BRD:BRD-K61314889-001-04-4;BRD:BRD-K61314889-001-05-1,rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,TNKS;TNKS2,,,PRECLINICAL,,,NA,"O=C(NC1CCCC2CCCNC12)C1CCC(CC1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O, O=C(NC1CCCC2CCCNC12)C1CCC(CC1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O, O=C(NC1CCCC2CCCNC12)C1CCC(CC1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O",
R-E-235CA2,ALYRANE;ANESTHETIC COMPOUND NO. 347;COMPOUND 347;EFRANE;ENFLURANE;ETHRANE;METHYLFLURETHER;NSC-115944;OHIO 347;R-E-235CA2,CHEMBL1257,BRD:BRD-A51831848-001-01-7;BRD:BRD-BRD-A51831848-001-01-7,rep_primary;rep_single_dose,MEMBRANE PERMEABILITY INHIBITOR,ATP2C1;ATP5D;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GLRA1;GLRB;GRIA1;KCNA1;KCNK10;KCNK18;KCNK2;KCNK3;KCNK9;KCNN4,,,LAUNCHED,,Small molecule,4,FC(F)OC(F)(F)C(F)Cl;FC(F)OC(F)(F)C(F)CL,JPGQOUSTVILISH-UHFFFAOYSA-N
R-23979,"AMOLDEN MP 100;BROMAZIL;CGA-41333;CLINAFARM;DECCOSIL;DECCOZIL;ENILCONAZOLE;ENILCONAZOLE FOR VETERINARY USE;FLOPRO IMZ;FLORASAN;FRESHGARD;FUNGAFLOR;FUNGAZIL;IMAVEROL;IMAZALIL;MAGNATE;NSC-759313;NUZONE;R 23,979;R-23979",CHEMBL356918,BRD:BRD-A11776908-065-01-5;BRD:BRD-BRD-A11776908-065-01-5,rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,CYP19A1;CYP1A2;CYP2B6;CYP2C9;CYP2J2;CYP3A4;CYP3A5;NR1I2;PPARA;PTGER2,SKIN INFECTIONS,,LAUNCHED,,Small molecule,-1,C=CCOC(Cn1ccnc1)c1ccc(Cl)cc1Cl;CLC1CCC(C(CN2CCNC2)OCC=C)C(CL)C1,PZBPKYOVPCNPJY-UHFFFAOYSA-N
ENIPORIDE,EMD-96785;ENIPORIDE,CHEMBL64360,BRD:BRD-K00004568-001-01-9,rep_single_dose,SODIUM/HYDROGEN ANTIPORT INHIBITOR,,,,,,Small molecule,-1,Cc1cc(-n2cccc2)c(S(C)(=O)=O)cc1C(=O)N=C(N)N,UADMBZFZZOBWBB-UHFFFAOYSA-N
ENISAMIUM-IODIDE,ENISAMIUM-IODIDE,,BRD:BRD-BRD-K10029415-005-06-9;BRD:BRD-K10029415-005-06-9,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,C[N+]1CCC(CC1)C(=O)NCC1CCCCC1,
RO-317453,ENMD 2076;ENMD 981693;ENMD-2076;ENMD-2076 FREE BASE;ENMD-981693;MKC 1;MKC-1;R-440;RO 31-7453;RO-31-7453;RO-317453,CHEMBL482968;CHEMBL52885,BRD:BRD-BRD-K68488863-001-04-9;BRD:BRD-K68488863-001-04-9,rep_multi_dose;rep_primary;rep_single_dose,"AURORA KINASE INHIBITOR, FLT3 INHIBITOR, VEGFR INHIBITOR",AURKA;FLT3;KDR;PDGFRA;PTK2;SRC,,,PHASE 2,,Small molecule,2,Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21;CN1CCN(CC1)C1CC(NC2CC(C)[NH]N2)NC(\C=C\C2CCCCC2)N1,OVSKGTONMLKNPZ-UHFFFAOYSA-N
SUNRABIN,ENOCITABINE;NSC-239336;SUNRABIN,CHEMBL2106589,BRD:BRD-BRD-K32007074-001-02-9;BRD:BRD-K32007074-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,CMPK1;RRM1;TYMS,,,LAUNCHED,,Small molecule,-1,"CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1;CCCCCCCCCCCCCCCCCCCCCC(=O)NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)N1, CCCCCCCCCCCCCCCCCCCCCC(=O)NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)N1",SAMRUMKYXPVKPA-VFKOLLTISA-N
PENETREX,AT-2266;CI-919;COMPRECIN;ENOXACIN;FLUMARK;NSC-629661;NSC-758416;PD 107779;PD-107779;PENETREX,CHEMBL826,BRD:BRD-BRD-K78113049-001-16-2;BRD:BRD-K78113049-001-16-2,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A,"URINARY TRACT INFECTIONS, GONORRHEA",,LAUNCHED,,Small molecule,4,"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21;CCN1CC(C(O)=O)C(=O)C2CC(F)C(NC12)N1CCNCC1, CCN1CC(C(O)=O)C(=O)C2CC(F)C(NC12)N1CCNCC1, CCN1CC(C(O)=O)C(=O)C2CC(F)C(NC12)N1CCNCC1",IDYZIJYBMGIQMJ-UHFFFAOYSA-N
PERFAN,"ENOXIMONE;MDL 17,043;MDL-17043;PERFAN",CHEMBL249856,BRD:BRD-BRD-K21152241-001-07-3;BRD:BRD-K21152241-001-07-3,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,4,CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1;CSC1CCC(CC1)C(=O)C1[NH]C(O)NC1C,ZJKNESGOIKRXQY-UHFFFAOYSA-N
URALENIC ACID,ENOXOLONE;GLYCYRRHETIC ACID;NSC-35347;NSC-35350;RHETINIC ACID;URALENIC ACID,CHEMBL230006,BRD:BRD-BRD-K96137854-001-17-1;BRD:BRD-K96137854-001-17-1,rep_primary;rep_single_dose,GAP JUNCTION MODULATOR,HSD11B1,"PEPTIC ULCER DISEASE (PUD), COMMON COLD",,LAUNCHED,,Small molecule,2,"C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O, C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O;CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12",MPDGHEJMBKOTSU-YKLVYJNSSA-N
ENPROFYLLINE,D 4028;D-4028;ENPROFYLLINE,CHEMBL279898,BRD:BRD-BRD-K35007173-001-07-5;BRD:BRD-K35007173-001-07-5,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,ADORA1;ADORA2A;ADORA2B;ADORA3;PDE4A;PDE4B,,,PHASE 3,,Small molecule,-1,CCCn1c(=O)[nH]c(=O)c2nc[nH]c21;CCCN1C2NC[NH]C2C(=O)[NH]C1=O,SIQPXVQCUCHWDI-UHFFFAOYSA-N
NSC-758616,BAY VP 2674;BAYTRIL;ENROFLOXACIN;ENROFLOXACIN FOR VETERINARY USE;NSC-758616,CHEMBL15511,BRD:BRD-BRD-K76534306-001-22-7;BRD:BRD-K76534306-001-22-7,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,"GRAM-NEGATIVE BACTERIAL INFECTIONS, GRAM-NEGATIVE BACTERIAL INFECTIONS",,LAUNCHED,,Small molecule,-1,"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1;CCN1CCN(CC1)C1CC2N(CC(C(O)=O)C(=O)C2CC1F)C1CC1, CCN1CCN(CC1)C1CC2N(CC(C(O)=O)C(=O)C2CC1F)C1CC1",SPFYMRJSYKOXGV-UHFFFAOYSA-N
X-396 HCL,ENSARTINIB DIHYDROCHLORIDE;ENSARTINIB HYDROCHLORIDE;X-396 HCL,CHEMBL4297219,BRD:BRD-K00073038-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,C[C@@H]1CN(C(=O)c2ccc(NC(=O)c3cc(O[C@H](C)c4c(Cl)ccc(F)c4Cl)c(N)nn3)cc2)C[C@H](C)N1.Cl.Cl,IERUINQRGJAECT-ISUJJMBGSA-N
OR-611,COMTAN;COMTESS;ENTACAPONE;ENTACAPONE ORION;ENTACAPONE TEVA;OR-611,CHEMBL953,BRD:BRD-BRD-K83636919-001-04-8;BRD:BRD-K83636919-001-04-8,rep_primary;rep_single_dose,CATECHOL O METHYLTRANSFERASE INHIBITOR,COMT,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,"CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1;CCN(CC)C(=O)C(\C#N)=C\C1CC(O)C(O)C(C1)[N+]([O-])=O, CCN(CC)C(=O)C(\C#N)=C\C1CC(O)C(O)C(C1)[N+]([O-])=O, CCN(CC)C(=O)C(\C#N)=C\C1CC(O)C(O)C(C1)[N+]([O-])=O",JRURYQJSLYLRLN-BJMVGYQFSA-N
ENTASOBULIN,ENTASOBULIN,,BRD:BRD-K00004610-001-01-9,rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,,,,NA,,
SQ34676,ANHYDROUS ENTECAVIR;BARACLUDE;BMS-200475-01;ENTECAVIR;ENTECAVIR ANHYDROUS;ENTECAVIR HYDRATE;ENTECAVIR MONOHYDRATE;SQ-34676;SQ34676,CHEMBL713,BRD:BRD-BRD-K08206212-002-01-0;BRD:BRD-K08206212-002-01-0,rep_primary;rep_single_dose,"DNA REPLICATION INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",,HEPATITIS B,,LAUNCHED,,Small molecule,4,C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)[nH]c(N)nc21;NC1NC(=O)C2NCN([C@H]3C[C@H](O)[C@@H](CO)C3=C)C2[NH]1,QDGZDCVAUDNJFG-FXQIFTODSA-N
SNDX-275,ENTINOSTAT;MS-27-275;MS-275;MS-275-27;SNDX-275,CHEMBL27759,BRD:BRD-BRD-K77908580-001-09-6;BRD:BRD-K77908580-001-09-6;CTRP:60218;GDSC1:88;GDSC2:1593,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC9,,,PHASE 3,,Small molecule,3,"Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1;NC1CCCCC1NC(=O)C1CCC(CNC(=O)OCC2CCCNC2)CC1, NC1CCCCC1NC(=O)C1CCC(CNC(=O)OCC2CCCNC2)CC1",INVTYAOGFAGBOE-UHFFFAOYSA-N
SYK INHIBITOR GS-9973,ENTOSPLETINIB;GS-9973;SYK INHIBITOR GS-9973,CHEMBL3265032,GDSC2:1630,gdsc,,,,,,,Small molecule,3,c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1,XSMSNFMDVXXHGJ-UHFFFAOYSA-N
RXDX-101,ENTRECTINIB;NMS-E628;ROZLYTREK;RXDX-101,CHEMBL1983268,BRD:BRD-BRD-K39009484-001-01-4;BRD:BRD-K39009484-001-01-4,rep_primary;rep_single_dose,"ALK TYROSINE KINASE RECEPTOR INHIBITOR, PROTO-ONCOGENE TYROSINE PROTEIN KINASE INHIBITOR",ALK;NTRK1;NTRK2;NTRK3;ROS1,,,PHASE 2,,Small molecule,4,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1;CN1CCN(CC1)C1CCC(C(=O)NC2N[NH]C3CCC(CC4CC(F)CC(F)C4)CC23)C(NC2CCOCC2)C1,HAYYBYPASCDWEQ-UHFFFAOYSA-N
XTANDI,ENZALUTAMIDE;MDV 3100;MDV-3100;MDV3100;XTANDI,CHEMBL1082407,BRD:BRD-BRD-K56851771-001-06-8;BRD:BRD-K56851771-001-06-8;BRD:BRD-K56851771-001-09-9,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF ANDROGEN RECEPTOR,AR,PROSTATE CANCER,,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF ANDROGEN RECEPTOR', 'ANDROGEN RECEPTOR ANTAGONIST'}, defaulting to 'INHIBITOR OF ANDROGEN RECEPTOR'",Small molecule,4,CNC(=O)C1CCC(CC1F)N1C(=S)N(C(=O)C1(C)C)C1CCC(C#N)C(C1)C(F)(F)F;CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,WXCXUHSOUPDCQV-UHFFFAOYSA-N
LY317615,DB-102;DB102;ENZASTAURIN;KINENZA;LY-317615;LY317615,CHEMBL300138,BRD:BRD-BRD-K79404599-001-09-3;BRD:BRD-K79404599-001-09-3;GDSC1:229,gdsc;rep_primary;rep_single_dose,PKC INHIBITOR,AKT1;GSK3B;PRKCA;PRKCB;PRKCD;PRKCG,,,PHASE 3,,Small molecule,3,CN1CC(C2=C(C(=O)NC2=O)C2CN(C3CCN(CC4CCCCN4)CC3)C3CCCCC23)C2CCCCC12;Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,AXRCEOKUDYDWLF-UHFFFAOYSA-N
EO-1428,EO-1428,,BRD:BRD-BRD-K42452249-001-02-5;BRD:BRD-K42452249-001-02-5,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK11;MAPK14,,,PRECLINICAL,,,NA,"CC1CCCCC1C(=O)C1CCC(NC2CCC(BR)CC2N)CC1CL, CC1CCCCC1C(=O)C1CCC(NC2CCC(BR)CC2N)CC1CL",
INCB024360,EPACADOSTAT;INCB-024360;INCB024360,CHEMBL3545369,BRD:BRD-BRD-K79450420-001-01-8;BRD:BRD-BRD-K79450420-001-02-6;BRD:BRD-K79450420-001-01-8;BRD:BRD-K79450420-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",IDO1,,,PHASE 3,"Multiple values for Phase: {'PHASE 2', 'PHASE 3'}, defaulting to 'PHASE 3'
Multiple values for SMILES: {'NS(=O)(=O)NCCNC1NONC1\\C(NC1CCC(F)C(BR)C1)=N\\O', 'NS(=O)(=O)NCCNC1NONC1\\C(NC1CCC(F)C(BR)C1)=N\\O, NS(=O)(=O)NCCNC1NONC1\\C(NC1CCC(F)C(BR)C1)=N\\O'}, defaulting to 'NS(=O)(=O)NCCNC1NONC1\\C(NC1CCC(F)C(BR)C1)=N\\O, NS(=O)(=O)NCCNC1NONC1\\C(NC1CCC(F)C(BR)C1)=N\\O'",Small molecule,3,"NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1;NS(=O)(=O)NCCNC1NONC1\C(NC1CCC(F)C(BR)C1)=N\O, NS(=O)(=O)NCCNC1NONC1\C(NC1CCC(F)C(BR)C1)=N\O",FBKMWOJEPMPVTQ-UHFFFAOYSA-N
TANGLIN,ALDONIL;ALDORIN;EPALRESTAT;KINEDAK;TANGLIN,CHEMBL56337,BRD:BRD-BRD-K98054437-001-09-9;BRD:BRD-K98054437-001-09-9,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,AKR1B1,DIABETIC NEPHROPATHY,,LAUNCHED,,Small molecule,3,"CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1;CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1CCCCC1, CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1CCCCC1, CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1CCCCC1, CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1CCCCC1",CHNUOJQWGUIOLD-NFZZJPOKSA-N
U-100592,"EPEREZOLID;U-100,592;U-100592",CHEMBL47955,BRD:BRD-BRD-K47554101-001-01-2;BRD:BRD-K47554101-001-01-2,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,,,PHASE 1,,Small molecule,-1,CC(=O)NC[C@H]1CN(C(=O)O1)C1CCC(N2CCN(CC2)C(=O)CO)C(F)C1;CC(=O)NC[C@H]1CN(c2ccc(N3CCN(C(=O)CO)CC3)c(F)c2)C(=O)O1,SIMWTRCFFSTNMG-AWEZNQCLSA-N
EPERISONE HYDROCHLORIDE,EPERISONE;EPERISONE HYDROCHLORIDE,CHEMBL1902981,BRD:BRD-A04252265-003-01-4;BRD:BRD-BRD-A04252265-003-01-4,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CYP2J2,"AMYOTROPHIC LATERAL SCLEROSIS (ALS), SPASMS, HEAD INJURY, SPINAL INJURY",,LAUNCHED,,Small molecule,3,CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1;CCC1CCC(CC1)C(=O)C(C)CN1CCCCC1,SQUNAWUMZGQQJD-UHFFFAOYSA-N
GSK2251052,AN-3365;AN3365;EPETRABOROLE;GSK-2251052;GSK2251052,CHEMBL3549142,BRD:BRD-K00003130-003-01-9,rep_single_dose,LEUCYL-TRNA SYNTHETASE INHIBITOR,,,,,,Small molecule,2,NC[C@H]1OB(O)c2c(OCCCO)cccc21,FXQIIDINBDJDKL-SNVBAGLBSA-N
XENADRINE,(-)-EPHEDRINE;ANHYDROUS;EPHEDRINE;EPHEDRINUM;L-EPHEDRINE;NSC-170951;NSC-8971;XENADRINE,CHEMBL211456,BRD:BRD-BRD-K45014108-003-01-8;BRD:BRD-K45014108-003-01-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ACHE;ADRA1A;ADRB2;SLC18A2;SLC6A2,"HYPOTENSION, ASTHMA, NARCOLEPSY, OBESITY",,LAUNCHED,,Small molecule,4,CN[C@@H](C)[C@H](O)c1ccccc1;CN[C@@H](C)[C@H](O)C1CCCCC1,KWGRBVOPPLSCSI-WPRPVWTQSA-N
EPHEDRINE-(RACEMIC),EPHEDRINE-(RACEMIC),,BRD:BRD-A54236247-003-04-3;BRD:BRD-BRD-A54236247-003-04-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA2A;ADRB1;ADRB2;ATF1;ATF2;ATF3;ATF4;ATF5;ATF6;ATF7;FOS;IL2;JDP2;JUN;NFATC1;SLC6A2;SLC6A3;SLC6A4;TNF,"HYPOTENSION, ASTHMA, NARCOLEPSY, OBESITY",,LAUNCHED,"Multiple values for repurposing_target: {'ADRA1A;ADRA2A;ADRB1;ADRB2;ATF1;ATF2;ATF3;ATF4;ATF5;ATF6;ATF7;FOS;IL2;JDP2;JUN;NFATC1;SLC6A2;SLC6A3;SLC6A4;TNF', 'ADRA1A;ADRA2A'}, taking the union",,NA,CNC(C)C(O)C1CCCCC1,
EPI-001,EPI-001,,BRD:BRD-K00077340-001-02-9,rep_single_dose,,,,,,,,NA,,
EPIANDROSTERONE,EPI-ANDOSTERONE;EPIANDROSTERONE,CHEMBL272195,BRD:BRD-BRD-K42756753-001-01-9;BRD:BRD-K42756753-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,STEROID,G6PD,,,PRECLINICAL,,Small molecule,NA,C[C@]12CC[C@@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O;C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,QGXBDMJGAMFCBF-LUJOEAJASA-N
EPICATECHIN-GALLATE-(-),EPICATECHIN-GALLATE-(-),,BRD:BRD-BRD-K50660797-001-05-1;BRD:BRD-K50660797-001-05-1,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,BACE1;FASN,,,PHASE 2,,,NA,"OC1CC(O)C2C[C@@H](OC(=O)C3CC(O)C(O)C(O)C3)[C@H](OC2C1)C1CCC(O)C(O)C1, OC1CC(O)C2C[C@@H](OC(=O)C3CC(O)C(O)C(O)C3)[C@H](OC2C1)C1CCC(O)C(O)C1",
EPIGALLOCATECHIN-(-),EPIGALLOCATECHIN-(-),,BRD:BRD-K27529556-001-04-9,rep_single_dose,,,,,,,,NA,,
EPIGALLOCATECHIN-3-MONOGALLATE,EPIGALLOCATECHIN-3-MONOGALLATE,,CTRP:28801,ctrp,,,,,,,,NA,,
EPIGALLOCATECHIN-GALLATE-(-),EPIGALLOCATECHIN-GALLATE-(-),,BRD:BRD-BRD-K55591206-001-20-7;BRD:BRD-K55591206-001-20-7,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,ELANE;EP300;FASN;KAT2B;MMP14;MMP2,,,PHASE 2/PHASE 3,,,NA,"OC1CC(O)C2C[C@@H](OC(=O)C3CC(O)C(O)C(O)C3)[C@H](OC2C1)C1CC(O)C(O)C(O)C1, OC1CC(O)C2C[C@@H](OC(=O)C3CC(O)C(O)C(O)C3)[C@H](OC2C1)C1CC(O)C(O)C(O)C1, OC1CC(O)C2C[C@@H](OC(=O)C3CC(O)C(O)C(O)C3)[C@H](OC2C1)C1CC(O)C(O)C(O)C1, OC1CC(O)C2C[C@@H](OC(=O)C3CC(O)C(O)C(O)C3)[C@H](OC2C1)C1CC(O)C(O)C(O)C1",
WAL-801,ELESTAT;EPINASTINE;PURIVIST;WAL-801,CHEMBL1106,BRD:BRD-A98990573-003-01-3;BRD:BRD-BRD-A98990573-003-01-3,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA2A;HRH1;HRH2;HTR2A;HTR7,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,NC1=NCC2c3ccccc3Cc3ccccc3N12;NC1=NCC2N1C1CCCCC1CC1CCCCC21,WHWZLSFABNNENI-UHFFFAOYSA-N
VAPONEFRIN,(-)-(R)-EPINEPHRINE;(-)-EPINEPHRINE;(R)-;ADREN CO;ADRENACLICK;ADRENALIN;ADRENALINE;ADRENALINUM;ANA-GUARD;ANA-KIT;ANAPEN;ANAPHYLACTIC SHOCK DRUG KIT;ASMA-VYDRIN;ASTHMAHALER;AUVI-Q;BRONKAID MIST;BROVON;DL-;DL-ADRENALINE;EMERADE;EPI E Z PEN JR;EPINEPHRINE;EPINEPHRINE (COPACKAGED);EPINEPHRINE DL-FORM;EPINEPHRINE HCL;EPINEPHRINE HYDROCHLORIDE;EPINEPHRINE RACEMIC;EPINEPHRINUM;EPIPEN;EPIPEN E Z PEN;EPIPEN JR;EPIPEN JR.;EPIRENAMINE;EPPY;GLAUPOSINE;GPPE INH SOLN;JEXT;L-EPINEPHRINE HYDROCHLORIDE;LEVO-METHYLAMINOETHANOLCATECHOL;MEDIHALER-EPI;NEPHRIDINE;NSC-62786;PRIMATENE;PRIMATENE MIST;RACEPINEFRINE;RACEPINEFRINE HYDROCHLORIDE;RACEPINEPHRINE;RIDDOBRON;RIDDOFAN;RYBARVIN;SIMPLENE;SOLN MADE TO RYBARVIN FOR;SUS-PHRINE;SUS-PHRINE SULFITE FREE;SUS-PHRINE SULFITE-FREE;SUS-PHRINE SULPHITE-FREE;SUSPHRINE;SYMJEPI;TONOGEN;TWINJECT;TWINJECT 0.15;TWINJECT 0.3;VAPONEFRIN,CHEMBL1740;CHEMBL679,BRD:BRD-BRD-K63126190-003-01-6;BRD:BRD-K63126190-003-01-6,rep_multi_dose;rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR AGONIST, CARBONIC ANHYDRASE ACTIVATOR, NEUROTRANSMITTER",ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;ADRB3;PAH;TNF,"CARDIAC ARREST, ANAPHYLACTIC SHOCK, ASTHMA",,LAUNCHED,"Multiple values for MOA: {'ADRENERGIC RECEPTOR AGONIST, CARBONIC ANHYDRASE ACTIVATOR, NEUROTRANSMITTER', 'ADRENERGIC RECEPTOR AGONIST, NEUROTRANSMITTER'}, defaulting to 'ADRENERGIC RECEPTOR AGONIST, CARBONIC ANHYDRASE ACTIVATOR, NEUROTRANSMITTER'",Small molecule,0.5,"CNC[C@H](O)C1CCC(O)C(O)C1, CNC[C@H](O)C1CCC(O)C(O)C1, CNC[C@H](O)C1CCC(O)C(O)C1, CNC[C@H](O)C1CCC(O)C(O)C1, CNC[C@H](O)C1CCC(O)C(O)C1, CNC[C@H](O)C1CCC(O)C(O)C1;CNCC(O)c1ccc(O)c(O)c1",UCTWMZQNUQWSLP-UHFFFAOYSA-N
METHOPYRIMAZOLE,DA-398;EPIRIZOLE;MEBRON;MEPIRIZOLE;METHOPYRIMAZOLE,CHEMBL1411693,BRD:BRD-BRD-K39339537-001-21-0;BRD:BRD-K39339537-001-21-0,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,COc1cc(C)nc(-n2nc(C)cc2OC)n1;COC1CC(C)NN1-C1NC(C)CC(OC)N1,RHAXSHUQNIEUEY-UHFFFAOYSA-N
NSC-256942,4'-EPI-ADRIAMYCIN;ELLENCE;EPIADRIAMYCIN;EPIDOXORUBICIN;EPIRUBICIN;FARMORUBICIN;NSC-256942,CHEMBL417,BRD:BRD-BRD-K04548931-003-16-5;BRD:BRD-K04548931-003-16-5;GDSC2:1511,gdsc;rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,CHD1;TOP2A,BREAST CANCER,,LAUNCHED,,Small molecule,4,"COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(=O)CO, COC1CCCC2C(=O)C3C(O)C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C4C(O)C3C(=O)C12)C(=O)CO;COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1",AOJJSUZBOXZQNB-VTZDEGQISA-N
EPITALON (TFA),EPITALON (TFA),,BRD:BRD-K00078221-019-02-9,rep_single_dose,,,,,,,,NA,,
NSC-194684,10275-S;EPITHIOANDROSTANOL;EPITIOSTANOL;NSC-194684,CHEMBL2106161,BRD:BRD-BRD-K02314383-001-01-3;BRD:BRD-K02314383-001-01-3,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,AR,,,LAUNCHED,,Small molecule,-1,C[C@]12C[C@H]3S[C@H]3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12;C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O,OBMLHUPNRURLOK-XGRAFVIBSA-N
SC-6611O,EPLERENONE;INSPRA;SC-66110;SC-6611O,CHEMBL1095097,BRD:BRD-BRD-K19761926-001-02-8;BRD:BRD-BRD-K19761926-001-03-6;BRD:BRD-K19761926-001-02-8;BRD:BRD-K19761926-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,NR3C2,"CONGESTIVE HEART FAILURE, HYPERTENSION",,LAUNCHED,,Small molecule,4,"COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13, COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13, COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13;COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13",JUKPWJGBANNWMW-VWBFHTRKSA-N
U-53217,"ACT-385781A;EPOPROSTENOL;FLOLAN;PG-I2;PGI2;PGX;PROSTACYCLIN;PROSTAGLANDIN I2;PROSTAGLANDIN X;U-53,217;U-53217",CHEMBL1139,BRD:BRD-BRD-K64054020-001-03-5;BRD:BRD-K64054020-001-03-5,rep_primary;rep_single_dose,PROSTACYCLIN ANALOG,P2RY12;PTGER1;PTGER4;PTGIR;PTGIS,HYPERTENSION,,LAUNCHED,,Small molecule,4,CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)O[C@H]2C[C@H]1O;CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O,KAQKFAOMNZTLHT-OZUDYXHBSA-N
EPOTHILONE-A,EPOTHILONE-A,,BRD:BRD-BRD-K71823332-001-03-7;BRD:BRD-K71823332-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,MICROTUBULE STABILIZING AGENT,,,,PRECLINICAL,,,NA,C[C@H]1CCC[C@H]2O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C1CSC(C)N1,
EPOTHILONE-B,EPOTHILONE-B,,BRD:BRD-BRD-K68164687-001-01-6;BRD:BRD-K68164687-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,"MICROTUBULE STABILIZING AGENT, TUBULIN POLYMERIZATION INHIBITOR",TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA4A;TUBA8;TUBB;TUBB1;TUBB3;TUBB4A;TUBB4B,,,PHASE 3,,,NA,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@@H](OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C1CSC(C)N1,
EPOTHILONE-D,EPOTHILONE-D,,BRD:BRD-BRD-K52762805-001-01-2;BRD:BRD-K52762805-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,"MICROTUBULE STABILIZING AGENT, TUBULIN POLYMERIZATION INHIBITOR",TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA4A;TUBA8;TUBB;TUBB1;TUBB3;TUBB4A;TUBB4B,,,PHASE 2,,,NA,C[C@H]1CCC\C(C)=C/C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C1CSC(C)N1,
EPPTB,EPPTB,,BRD:BRD-BRD-K42536037-001-01-3;BRD:BRD-K42536037-001-01-3,rep_primary;rep_single_dose,TRACE AMINE ASSOCIATED RECEPTOR ANTAGONIST,TAAR1,,,PRECLINICAL,,,NA,CCOC1CCCC(NC(=O)C2CCC(N3CCCC3)C(C2)C(F)(F)F)C1,
EPRAZINONE HYDROCHLORIDE,EPRAZINONE;EPRAZINONE HYDROCHLORIDE,CHEMBL1885437,BRD:BRD-A72212290-300-01-4;BRD:BRD-BRD-A72212290-300-01-4,rep_primary;rep_single_dose,MUCOLYTIC AGENT,,BRONCHOSPASM,,LAUNCHED,,Small molecule,-1,"CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1;CCOC(CN1CCN(CC(C)C(=O)C2CCCCC2)CC1)C1CCCCC1, CCOC(CN1CCN(CC(C)C(=O)C2CCCCC2)CC1)C1CCCCC1",BSHWLCACYCVCJE-UHFFFAOYSA-N
MK-397,EPRINEX;EPRINOMECTIN;EPRINOMECTIN B1A;EPRINOMECTIN COMPONENT B1A;MK 397;MK-397,CHEMBL3989594,BRD:BRD-A91366704-001-01-9;BRD:BRD-BRD-A91366704-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,,"GASTROINTESTINAL ROUNDWORMS, LUNGWORMS",,LAUNCHED,,Unknown,-1,CC[C@H](C)C1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC(C)=O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)C(C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@H]1NC(C)=O;CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](NC(C)=O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C,VBPOFUHCXIRECN-ZWZBFTKFSA-N
SK&F 105657,EPRISTERIDE;SK&F 105657,CHEMBL138225,BRD:BRD-K00003478-001-01-9,rep_single_dose,5 ALPHA REDUCTASE INHIBITOR,,,,,,Small molecule,-1,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C=C(C(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C,VAPSMQAHNAZRKC-PQWRYPMOSA-N
EPROBEMIDE,EPROBEMIDE,CHEMBL2104298,BRD:BRD-BRD-K17979676-001-01-2;BRD:BRD-K17979676-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA,DEPRESSION,,LAUNCHED,,Small molecule,-1,CLC1CCC(CC1)C(=O)NCCCN1CCOCC1;O=C(NCCCN1CCOCC1)c1ccc(Cl)cc1,YYFGRAGNYHYWEZ-UHFFFAOYSA-N
EPRODISATE,EPRODISATE,CHEMBL2111092,BRD:BRD-BRD-K11463116-304-03-5;BRD:BRD-K11463116-304-03-5,rep_primary;rep_single_dose,"AMYLOID PROTEIN INHIBITOR, ANTIAMYLOIDOGENIC AGENT",SAA1,,,PHASE 3,"Multiple values for MOA: {'ANTIAMYLOIDOGENIC AGENT, AMYLOID PROTEIN INHIBITOR', 'AMYLOID PROTEIN INHIBITOR, ANTIAMYLOIDOGENIC AGENT'}, defaulting to 'AMYLOID PROTEIN INHIBITOR, ANTIAMYLOIDOGENIC AGENT'",Small molecule,3,"O=S(=O)(O)CCCS(=O)(=O)O;OS(=O)(=O)CCCS(O)(=O)=O, OS(=O)(=O)CCCS(O)(=O)=O, OS(=O)(=O)CCCS(O)(=O)=O",MGNVWUDMMXZUDI-UHFFFAOYSA-N
TEVETEN,EPROSARTAN;SK-108566;SK&F 108566;SK&F-108566;TEVETEN,CHEMBL813,BRD:BRD-BRD-K67977190-066-02-3;BRD:BRD-K67977190-066-02-3,rep_multi_dose;rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1;CCCCC1NCC(\C=C(/CC2CCCS2)C(O)=O)N1CC1CCC(CC1)C(O)=O, CCCCC1NCC(\C=C(/CC2CCCS2)C(O)=O)N1CC1CCC(CC1)C(O)=O",OROAFUQRIXKEMV-LDADJPATSA-N
INTEGRILIN,EPTIFIBATIDE;INTEGRELIN;INTEGRILIN,CHEMBL1174,BRD:BRD-A90547603-001-02-5;BRD:BRD-BRD-A90547603-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,PLATELET AGGREGATION INHIBITOR,ITGA2B;ITGB3,"ACUTE CORONARY SYNDROME (ACS), PERCUTANEOUS CORONARY INTERVENTION (PCI)",,LAUNCHED,,Protein,4,N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O;NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(CC2C[NH]C3CCCCC23)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O,CZKPOZZJODAYPZ-LROMGURASA-N
EPZ-004777,EPZ-004777,,GDSC2:1237,gdsc,,,,,,,,NA,,
PINOMETOSTAT ANHYDROUS,EPZ-005676;EPZ-5676;PINOMETOSTAT;PINOMETOSTAT ANHYDROUS,CHEMBL3414626,BRD:BRD-BRD-K26531771-001-01-4;BRD:BRD-BRD-K26531771-001-02-2;BRD:BRD-K26531771-001-01-4;BRD:BRD-K26531771-001-02-2;GDSC2:1563,gdsc;rep_multi_dose;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,DOT1L,,,PHASE 1,,Small molecule,1,"CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)[C@H]1C[C@@H](CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1;CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(N)NCNC12)[C@@H]1C[C@H](CCC2NC3CC(CCC3[NH]2)C(C)(C)C)C1, CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(N)NCNC12)[C@@H]1C[C@H](CCC2NC3CC(CCC3[NH]2)C(C)(C)C)C1",LXFOLMYKSYSZQS-LURJZOHASA-N
TAZEMETOSTAT,E-7438;E7438;EPZ-6438;EPZ6438;TAZEMETOSTAT,CHEMBL3414621,BRD:BRD-BRD-K11215326-001-03-7;BRD:BRD-K11215326-001-03-7;BRD:BRD-K11215326-001-06-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,PHASE 2,"Multiple values for MOA: {'INHIBITOR OF EZH2', 'HISTONE LYSINE METHYLTRANSFERASE INHIBITOR'}, defaulting to 'HISTONE LYSINE METHYLTRANSFERASE INHIBITOR'",Small molecule,4,"CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1;CCN(C1CCOCC1)C1CC(CC(C(=O)NCC2C(C)CC(C)[NH]C2=O)C1C)-C1CCC(CN2CCOCC2)CC1, CCN(C1CCOCC1)C1CC(CC(C(=O)NCC2C(C)CC(C)[NH]C2=O)C1C)-C1CCC(CN2CCOCC2)CC1",NSQSAUGJQHDYNO-UHFFFAOYSA-N
EPZ004777,EPZ004777,,BRD:BRD-BRD-K69070623-003-01-7;BRD:BRD-K69070623-003-01-7;GDSC2:1237,gdsc;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,DOT1L,,,PRECLINICAL,,,NA,"CC(C)N(CCCNC(=O)NC1CCC(CC1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC2C(N)NCNC12, CC(C)N(CCCNC(=O)NC1CCC(CC1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC2C(N)NCNC12, CC(C)N(CCCNC(=O)NC1CCC(CC1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC2C(N)NCNC12",
EPZ005687,EPZ005687,,BRD:BRD-BRD-K57754230-001-02-7;BRD:BRD-K57754230-001-02-7,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,PRECLINICAL,,,NA,CC1CC(C)C(CNC(=O)C2CC(CC3N(NCC23)C2CCCC2)-C2CCC(CN3CCOCC3)CC2)C(=O)[NH]1,
EPZ011989,EPZ011989,,BRD:BRD-BRD-K87468701-001-01-0;BRD:BRD-K87468701-001-01-0,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,PRECLINICAL,,,NA,CCN([C@H]1CC[C@@H](CC1)N(C)CCOC)C1CC(CC(C(=O)NCC2C(C)CC(C)[NH]C2=O)C1C)C#CCN1CCOCC1,
EPZ015666,EPZ015666,,BRD:BRD-BRD-K70446295-001-01-7;BRD:BRD-K70446295-001-01-7,rep_primary;rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,PRMT5,,,PRECLINICAL,,,NA,O[C@@H](CNC(=O)C1CC(NC2COC2)NCN1)CN1CCC2CCCCC2C1,
EPZ020411,EPZ020411,,BRD:BRD-K33586289-003-02-8,rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,PRMT6,,,,,,NA,,
NSC-10971,EQUILIN;NSC-10971,CHEMBL323533,BRD:BRD-A88080608-001-04-2;BRD:BRD-BRD-A88080608-001-04-2,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,HSD17B1,,,PRECLINICAL,,Small molecule,-1,C[C@]12CC[C@H]3C(=CCc4cc(O)ccc43)[C@@H]1CCC2=O;CC12CCC3C(=CCC4CC(O)CCC34)C1CCC2=O,WKRLQDKEXYKHJB-HFTRVMKXSA-N
EQUOL,EQUOL,,BRD:BRD-BRD-K54847683-001-03-2;BRD:BRD-BRD-K54847683-001-04-0;BRD:BRD-K54847683-001-03-2;BRD:BRD-K54847683-001-04-0,rep_multi_dose;rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1;ESR2,,,LAUNCHED,,,NA,"OC1CCC(CC1)[C@H]1COC2CC(O)CCC2C1, OC1CCC(CC1)[C@H]1COC2CC(O)CCC2C1",
ER-27319,ER-27319,,BRD:BRD-BRD-K11927976-050-02-9;BRD:BRD-K11927976-050-02-9,rep_multi_dose;rep_primary;rep_single_dose,"MEDIATOR RELEASE INHIBITOR, SYK INHIBITOR",SYK,,,PRECLINICAL,,,NA,"CC1CCC2C(C1C)N(CCCN)C1CCCCC1C2=O, CC1CCC2C(C1C)N(CCCN)C1CCCCC1C2=O, CC1CCC2C(C1C)N(CCCN)C1CCCCC1C2=O",
ER-50891,ER-50891,,BRD:BRD-K18347943-001-02-9,rep_single_dose,RETINOID RECEPTOR ANTAGONIST,RARA,,,,,,NA,,
ERASTIN,ERASTIN,CHEMBL401989,BRD:BRD-A25004090-001-08-4;BRD:BRD-BRD-A25004090-001-08-4;CTRP:63578,ctrp;rep_multi_dose;rep_primary;rep_single_dose,ION CHANNEL ANTAGONIST,VDAC2,,,PRECLINICAL,,Small molecule,NA,"CCOC1CCCCC1-N1C(=O)C2CCCCC2NC1C(C)N1CCN(CC1)C(=O)COC1CCC(CL)CC1, CCOC1CCCCC1-N1C(=O)C2CCCCC2NC1C(C)N1CCN(CC1)C(=O)COC1CCC(CL)CC1;CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O",BKQFRNYHFIQEKN-UHFFFAOYSA-N
TP-434,ERAVACYCLINE;TP-434,CHEMBL1951095,BRD:BRD-K00003240-300-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,4,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12,HLFSMUUOKPBTSM-ISIOAQNYSA-N
RO-17-6218,"1,25-DIHYDROXYCALCIFEROL;1,25-DIHYDROXYERGOCALCIFEROL;1,25-DIHYDROXYVITAMIN D2;1.ALPHA.,25-DIHYDROXYVITAMIN D2;ERCALCITRIOL;RO-17-6218",CHEMBL4303615,BRD:BRD-BRD-K84163249-001-01-9;BRD:BRD-K84163249-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,,,PHASE 1,,Small molecule,-1,"C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C;C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O",ZGLHBRQAEXKACO-XJRQOBMKSA-N
JNJ-42756493,BALVERSA;ERDAFITINIB;JNJ-42756493,CHEMBL3545376,BRD:BRD-BRD-K84868168-001-01-0;BRD:BRD-K84868168-001-01-0,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4",FGFR1;FGFR2;FGFR3;FGFR4,,,PHASE 2,"Multiple values for MOA: {'FGFR INHIBITOR', 'INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4'}, defaulting to 'INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4'",Small molecule,4,COC1CC(OC)CC(C1)N(CCNC(C)C)C1CCC2NCC(NC2C1)-C1CNN(C)C1;COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,OLAHOMJCDNXHFI-UHFFFAOYSA-N
MUCOTEC,ERDOSTEINE;MUCOTEC,CHEMBL1697744,BRD:BRD-A05515753-001-03-2;BRD:BRD-BRD-A05515753-001-03-2,rep_primary;rep_single_dose,MUCOLYTIC AGENT,,"BRONCHITIS, COUGH SUPPRESSANT, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), RESPIRATORY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"O=C(O)CSCC(=O)NC1CCSC1=O;OC(=O)CSCC(=O)NC1CCSC1=O, OC(=O)CSCC(=O)NC1CCSC1=O, OC(=O)CSCC(=O)NC1CCSC1=O",QGFORSXNKQLDNO-UHFFFAOYSA-N
VITAMIN D2,CALCIFEROL;CALCIFEROL IN ARACH OIL;CALTRATE;D-FORTE;DELTALIN;DRISDOL;ECIFEROL D2;ERGO-D2;ERGOCALCIFEROL;ERGOCALCIFEROLUM;ERGORAL D2;ERGORONE;LANES;NSC-62792;OLEOVITAMIN D;OSTELIN;OSTO-D2;STEROGYL;STEROGYL 15H;STEROGYL-15;SYNTHETIC;UVESTEROL D;VIOSTEROL;VIOSTEROL IN OIL;VITAMIN D;VITAMIN D (ERGOCALCIFEROL);VITAMIN D 2;VITAMIN D2,CHEMBL1536,BRD:BRD-BRD-K56155962-001-12-1;BRD:BRD-K56155962-001-12-1,rep_primary;rep_single_dose,VITAMIN ANALOG,VDR,"HYPOPARATHYROIDISM, RICKETS, HYPOPHOSPHATEMIA",,LAUNCHED,,Small molecule,4,"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12;CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C",MECHNRXZTMCUDQ-RKHKHRCZSA-N
ERGOTOCINE,ERGOBASINE;ERGOMETRINE;ERGONOVINE;ERGOSTETRINE;ERGOTOCINE,CHEMBL119443,BRD:BRD-A26387268-050-04-4;BRD:BRD-BRD-A26387268-050-04-4,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST",ADRA1A;HTR1E,POSTPARTUM HEMORRHAGE (PPH),,LAUNCHED,,Small molecule,4,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1;CC(CO)NC(=O)C1CN(C)[C@@H]2CC3C[NH]C4CCCC(C2=C1)C34,WVVSZNPYNCNODU-XTQGRXLLSA-N
HALAVEN,ER-086526;ERIBULIN;HALAVEN,CHEMBL1683590,BRD:BRD-K00003156-066-01-9,rep_single_dose,MICROTUBULE INHIBITOR,,,,,,Small molecule,4,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C,UFNVPOGXISZXJD-JBQZKEIOSA-N
SONIDEGIB,ERISMODEGIB;LDE 225;LDE-225;LDE225;NVP-LDE 225;NVP-LDE-225;NVP-LDE225;SONIDEGIB,CHEMBL2105737,CTRP:636425,ctrp,,,,,,,Small molecule,4,Cc1c(C(=O)Nc2ccc(N3C[C@@H](C)O[C@@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1,VZZJRYRQSPEMTK-CALCHBBNSA-N
ERK5-IN-1,ERK5-IN-1,,BRD:BRD-K64857848-001-06-4;GDSC1:106,gdsc;rep_single_dose,MAP KINASE INHIBITOR,MAPK7,,,,,,NA,,
ERLOTINIB:PLX-4032 (2:1 MOL/MOL),ERLOTINIB:PLX-4032 (2:1 MOL/MOL),,CTRP:660768,ctrp,,,,,,,,NA,,
SERBA-1,ERTEBEREL;LY-500307;LY500307;SERBA-1,CHEMBL278703,BRD:BRD-BRD-K80608265-001-01-6;BRD:BRD-K80608265-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1;ESR2,,,PHASE 2,,Small molecule,2,Oc1ccc([C@@H]2Oc3ccc(O)cc3[C@@H]3CCC[C@@H]32)cc1;OC1CCC(CC1)[C@@H]1OC2CCC(O)CC2[C@@H]2CCC[C@H]12,XIESSJVMWNJCGZ-VKJFTORMSA-N
STEGLATRO,ERTUGLIFLOZIN;ERTUGLIFLOZIN L-PYROGLUTAMIC ACID;ERTUGLIFLOZIN PIDOLATE;MK-8835;PF-04971729;PF-04971729-00;PF04971729;STEGLATRO,CHEMBL1770248,BRD:BRD-BRD-K10071630-001-01-0;BRD:BRD-K10071630-001-01-0,rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,SLC5A2,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1;CCOC1CCC(CC2CC(CCC2CL)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)CC1,MCIACXAZCBVDEE-CUUWFGFTSA-N
ERYTHRITOL,ERYTHRITOL,,BRD:BRD-BRD-K79315489-001-07-8;BRD:BRD-K79315489-001-07-8,rep_multi_dose;rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,"OC[C@H](O)[C@H](O)CO, OC[C@H](O)[C@H](O)CO",
ZINERYT,2'-PROPIONATE;6-O-METHYL-;6-O-METHYLERYTHROMYCIN;9-(O-METHYLOXIME);A-56268;A/T/S;ABBOTT-56268;AKNE-MYCIN;AKNEMYCIN PLUS;BENZAMYCIN;BIAXIN;BIAXIN XL;BIAXIN XL PAC;BRISTAMYCIN;C-SOLVE-2;CLARIE XL;CLARITHROMYCIN;CLARITHROMYCIN EXTENDED RELEASE;CLARITHROMYCIN IDENTITY;CLAROSIP;CYLLIND;E-BASE;E-GLADES;E-MYCIN;E-SOLVE 2;EMGEL;ERASIS;ERTHROMYCIN A 9-(O-METHYLOXIME);ERY-TAB;ERYACNE 2;ERYACNE 4;ERYC;ERYC 125;ERYC SPRINKLES;ERYCETTE;ERYDERM;ERYGEL;ERYMAX;ERYMAX SPRINKLE;ERYPAR;ERYTHRA-DERM;ERYTHRO 200;ERYTHRO-STATIN;ERYTHROCIN;ERYTHROMYCIN;ERYTHROMYCIN 9-(O-METHYLOXIME);ERYTHROMYCIN ACISTRATE;ERYTHROMYCIN ESTOLATE IMPURITY;ERYTHROMYCIN LACTOBIONATE;ERYTHROMYCIN METHYLOXIME;ERYTHROMYCIN PROPIONATE;ERYTHROMYCINI LACTOBIONAS;FEBZIN XL;FREE ERYTHROMYCIN-;GALLIMYCIN;ILOTYCIN;ISOTREXIN;J01FA01;KERYMAX;KLACID;KLARICID;KLARICID 500;KLARICID ADULT;KLARICID I.V.;KLARICID PAED;KLARICID XL;LEXITHROMYCIN;MACLADIN;MAVID;MONOPROPIONYLERYTHROMYCIN;MYCIFOR XL;NSC-55929;NSC-758704;OFTALMOLOSA CUSI ERITROMICINA;PAEDIATHROCIN;PCE;PFIZER-E;PREVPAC;PROPIOCINE;R-P MYCIN;RETCIN;ROBIMYCIN;ROMMIX 250 EC;ROMMIX 500 EC;SANSAC;STATICIN;STERILE ERYTHROMYCIN LACTOBIONATE;STIEMYCIN;T-STAT;TE-031;TILORYTH;VECLAM;WY-483 14;WY-48314;WYAMYCIN;XETININ XL;ZECLAR;ZINERYT,CHEMBL1200506;CHEMBL1741;CHEMBL2106397;CHEMBL2110577;CHEMBL2220427;CHEMBL532,BRD:BRD-BRD-K63550407-001-12-7;BRD:BRD-BRD-K63550407-001-13-5;BRD:BRD-K63550407-001-12-7;BRD:BRD-K63550407-001-13-5,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,MLNR,"LISTERIA, RESPIRATORY TRACT INFECTIONS, SKIN INFECTIONS, SYPHILIS, AMEBIASIS, PELVIC INFLAMMATORY DISEASE, CHLAMYDIA, DIPHTHERIA, ERYTHRASMA",,LAUNCHED,,Small molecule,4,"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O;CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O",ULGZDMOVFRHVEP-RWJQBGPGSA-N
ERYTHROMYCIN-ETHYLSUCCINATE,ERYTHROMYCIN-ETHYLSUCCINATE,,BRD:BRD-BRD-K51677086-001-12-0;BRD:BRD-K51677086-001-12-0,rep_primary;rep_single_dose,"CYTOCHROME P450 INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",ABCB1;ALB;CYP3A4;CYP51A1;KCNH2;MLNR;SLC47A1,"LISTERIA, RESPIRATORY TRACT INFECTIONS, SKIN INFECTIONS, SYPHILIS, AMEBIASIS, PELVIC INFLAMMATORY DISEASE, CHLAMYDIA, DIPHTHERIA, ERYTHRASMA",,LAUNCHED,,,NA,"CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C, CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C, CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C",
SODIUM ANHYDROUS,E127;ERYTHROSINE;ERYTHROSINE SODIUM ANHYDROUS;NSC-36685;SODIUM ANHYDROUS,CHEMBL1332616,BRD:BRD-BRD-K14920963-304-02-7;BRD:BRD-K14920963-304-02-7,rep_primary;rep_single_dose,COLORING AGENT,,,,PRECLINICAL,,Small molecule,-1,O=C1OC2(c3ccccc31)c1cc(I)c(O)c(I)c1Oc1c2cc(I)c(O)c1I;OC(=O)C1CCCCC1-C1C2CC(I)C(O)C(I)C2OC2C(I)C(=O)C(I)CC12,OALHHIHQOFIMEF-UHFFFAOYSA-N
HEXAPRAZOLE,ESAPRAZOLE;EXAPRAZOLE;HEXAPRAZOLE,CHEMBL1983100,BRD:BRD-BRD-K92426617-001-06-3;BRD:BRD-K92426617-001-06-3,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,"O=C(CN1CCNCC1)NC1CCCCC1;O=C(CN1CCNCC1)NC1CCCCC1, O=C(CN1CCNCC1)NC1CCCCC1",RTFADALJKSFJDZ-UHFFFAOYSA-N
XL550,CS-3150;ESAXERENONE;XL-550;XL550,CHEMBL3545393,BRD:BRD-K00003374-001-01-9,rep_single_dose,MINERALOCORTICOID RECEPTOR ANTAGONIST,,,,,,Small molecule,3,,
LU-26-054,CIPRALEX;ESCITALOPRAM;ESERTIA;ESITOL;LU-26-054,CHEMBL1508,BRD:BRD-BRD-K70301876-034-13-7;BRD:BRD-K70301876-034-13-7,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),ADRA1A;CHRM1;HRH1;SLC6A2;SLC6A3;SLC6A4,"DEPRESSION, GENERALIZED ANXIETY DISORDER (GAD)",,LAUNCHED,,Small molecule,4,"CN(C)CCC[C@]1(OCC2CC(CCC12)C#N)C1CCC(F)CC1, CN(C)CCC[C@]1(OCC2CC(CCC12)C#N)C1CCC(F)CC1;CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21",WSEQXVZVJXJVFP-FQEVSTJZSA-N
NSC-26665,ESCULIN;NSC-26665,CHEMBL482581,BRD:BRD-BRD-K36270037-001-01-7;BRD:BRD-K36270037-001-01-7,rep_primary;rep_single_dose,ANTIOXIDANT,,,,PHASE 1,,Small molecule,NA,O=c1ccc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2o1;OC[C@H]1O[C@@H](OC2CC3CCC(=O)OC3CC2O)[C@@H](O)[C@@H](O)[C@@H]1O,XHCADAYNFIFUHF-TVKJYDDYSA-N
ESI-09,ESI-09,,BRD:BRD-BRD-K77139516-001-02-2;BRD:BRD-K77139516-001-02-2,rep_primary;rep_single_dose,EPAC INHIBITOR,RAPGEF3;RAPGEF4,,,PRECLINICAL,,,NA,"CC(C)(C)C1CC(NO1)C(=O)C(\C#N)=N\NC1CCCC(CL)C1, CC(C)(C)C1CC(NO1)C(=O)C(\C#N)=N\NC1CCCC(CL)C1",
ESLICARBAZEPINE-ACETATE,ESLICARBAZEPINE-ACETATE,,BRD:BRD-BRD-K61237927-001-01-7;BRD:BRD-K61237927-001-01-7,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,,NA,CC(=O)O[C@H]1CC2CCCCC2N(C(N)=O)C2CCCCC12,
ESMOLOL,ASL-8052-001;ESMOLOL,CHEMBL768,BRD:BRD-A07395371-003-10-0;BRD:BRD-BRD-A07395371-003-10-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1,"VENTRICULAR TACHYCARDIA (VT), HYPERTENSION",,LAUNCHED,,Small molecule,4,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1;COC(=O)CCC1CCC(OCC(O)CNC(C)C)CC1,AQNDDEOPVVGCPG-UHFFFAOYSA-N
VENTRA,(S)-;A02BC05;EMOZUL;ESOMEPRAZOLE;INEXIUM PARANOVA;NEXIUM;NEXIUM CONTROL;NEXIUM I.V.;OMEPRAZOLE;OMEPRAZOLE S-FORM;VENTRA,CHEMBL1201320,BRD:BRD-BRD-K61443506-239-01-6;BRD:BRD-K61443506-239-01-6;BRD:BRD-K61443506-239-03-9,rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP4A,"GASTROESOPHAGEAL REFLUX DISEASE (GERD), ZOLLINGER-ELLISON SYNDROME, PEPTIC ULCER DISEASE (PUD)",,LAUNCHED,,Small molecule,4,"COc1ccc2[nH]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1;COC1CCC2[NH]C(NC2C1)[S@@](=O)CC1NCC(C)C(OC)C1C, COC1CCC2[NH]C(NC2C1)[S@@](=O)CC1NCC(C)C(OC)C1C, COC1CCC2[NH]C(NC2C1)[S@@](=O)CC1NCC(C)C(OC)C1C",SUBDBMMJDZJVOS-DEOSSOPVSA-N
ESONARIMOD,ESONARIMOD,CHEMBL2003782,BRD:BRD-K00003282-001-01-9,rep_single_dose,ANTIRHEUMATIC DRUG,,,,,,Small molecule,-1,CC(=O)SCC(CC(=O)c1ccc(C)cc1)C(=O)O,YRSSFEUQNAXQMX-UHFFFAOYSA-N
ESTETROL MONOHYDRATE,15.ALPHA.-HYDROXYESTRIOL;E-4;E4;ESTETROL;ESTETROL (ANHYDROUS);ESTETROL (HYDROUS);ESTETROL ANHYDROUS;ESTETROL HYDRATE;ESTETROL MONOHYDRATE,CHEMBL1230314,BRD:BRD-BRD-K75445017-001-01-1;BRD:BRD-K75445017-001-01-1,rep_primary;rep_single_dose,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),ESR1,,,PHASE 3,,Small molecule,4,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O;C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O,AJIPIJNNOJSSQC-NYLIRDPKSA-N
ZUMENON,.ALPHA.-;.ALPHA.-ESTRADIOL;17-.BETA.-OESTRADIOL;17-BETA-OESTRADIOL;17.ALPHA.-ESTRADIOL;17.BETA.-ESTRADIOL;17A-ESTRADIOL;17ALPHA-ESTRADIOL;17BETA-ESTRADIOL;ADGYN ESTRO;AGOFOLLIN;ALFATRADIOL;ALORA;AQUAGEN;BEDOL;CLIMARA;CLIMARA PRO;DEPO-ESTRADIOL;DERMESTRIL 100;DERMESTRIL 25;DERMESTRIL 50;DERMESTRIL SEPTEM 25;DERMESTRIL SEPTEM 50;DERMESTRIL SEPTEM 75;DESTRADIOL;DIHYDROTHEELIN;DIHYDROXYESTRIN;DIVIGEL;E-CYPIONATE;ELESTRIM;ELESTRIN;ELLESTE SOLO;ELLESTE SOLO MX 40;ELLESTE SOLO MX 80;ESCLIM;ESTRACE;ESTRADERM;ESTRADERM MX 100;ESTRADERM MX 25;ESTRADERM MX 50;ESTRADERM MX 75;ESTRADERM TTS 100;ESTRADERM TTS 25;ESTRADERM TTS 50;ESTRADIOL;ESTRADIOL 17-.ALPHA.;ESTRADIOL 17-BETA;ESTRADIOL ANHYDROUS;ESTRADIOL HEMIHYDRATE;ESTRADIOL VALERATE METABOLITE E2;ESTRASORB;ESTRING;ESTROGEL;EVAMIST;EVOREL 100;EVOREL 25;EVOREL 50;EVOREL 75;FEMATRIX 40;FEMATRIX 80;FEMPATCH;FEMSEVEN 100;FEMSEVEN 50;FEMSEVEN 75;GVNODIOL;GYNERGON;GYNODIOL;GYNOESTRYL;GYNOGEN;IMVEXXY;INNOFEM;MENOREST 37.5;MENOREST 50;MENOREST 75;MENORING 50;MENOSTAR;MINIVELLE;NSC-20293;NSC-9895;OESTRADIOL;PROGYNOVA TS;SANDRENA;VAGIFEM;VAGIFEM 18;VAGIFEM 8;VIVELLE;VIVELLE-DOT;WC-3011;WC3011;ZUMENON,CHEMBL135;CHEMBL286452,BRD:BRD-BRD-K18910433-001-36-6;BRD:BRD-BRD-K18910433-001-43-2;BRD:BRD-K18910433-001-36-6;BRD:BRD-K18910433-001-43-2,rep_multi_dose;rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1;ESR2;GPER1;KCNMA1;NR1I2,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O;C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CC[C@@H]2O",VOXZDWNPVJITMN-ZBRFXRBCSA-N
ESTRADIOL-3-O-SULFAMATE,ESTRADIOL-3-O-SULFAMATE,,BRD:BRD-K00004741-001-01-9,rep_single_dose,STERYL SULFATASE INHIBITOR,,,,,,,NA,,
ESTRADIOL-ACETATE,ESTRADIOL-ACETATE,,BRD:BRD-BRD-K53319039-001-01-8;BRD:BRD-K53319039-001-01-8,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1,"MENOPAUSE, VAGINAL ATROPHY",,LAUNCHED,,,NA,CC(=O)OC1CCC2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2C1,
ESTRADIOL-BENZOATE,ESTRADIOL-BENZOATE,,BRD:BRD-A74765037-001-01-1;BRD:BRD-BRD-A74765037-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,CONTRACEPTIVE AGENT,ESR1,,,PRECLINICAL,,,NA,C[C@]12CCC3C(CCC4CC(OC(=O)C5CCCCC5)CCC34)C1CC[C@@H]2O,
ESTRADIOL-CYPIONATE,ESTRADIOL-CYPIONATE,,BRD:BRD-A91452556-001-04-0;BRD:BRD-BRD-A91452556-001-04-0,rep_multi_dose;rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1,"HYPOESTROGENISM, MENOPAUSE",,LAUNCHED,,,NA,C[C@]12CCC3C(CCC4CC(O)CCC34)C1CC[C@@H]2OC(=O)CCC1CCCC1,
ESTRADIOL-VALERATE,ESTRADIOL-VALERATE,,BRD:BRD-BRD-K66766661-001-19-2;BRD:BRD-K66766661-001-19-2,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1,"PROSTATE CANCER, HYPOESTROGENISM, MENOPAUSE, VAGINAL ATROPHY",,LAUNCHED,,,NA,"CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4CC(O)CCC4[C@H]3CC[C@]12C, CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4CC(O)CCC4[C@H]3CC[C@]12C",
RO-222296000,ESTRAMUSTINE;NSC-89201;RO 22-2296/000;RO-22-2296000;RO-222296000,CHEMBL1575,BRD:BRD-A70858459-001-01-7;BRD:BRD-BRD-A70858459-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,ESR1;ESR2;MAP1A;MAP2,PROSTATE CANCER,,LAUNCHED,,Small molecule,3,C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O;C[C@]12CCC3C(CCC4CC(OC(=O)N(CCCL)CCCL)CCC34)C1CC[C@@H]2O,FRPJXPJMRWBBIH-RBRWEJTLSA-N
ESTRAMUSTINE-PHOSPHATE,ESTRAMUSTINE-PHOSPHATE,,BRD:BRD-BRD-K00077635-304-01-2;BRD:BRD-K00077635-304-01-2,rep_multi_dose;rep_primary;rep_single_dose,"DNA SYNTHESIS INHIBITOR, MICROTUBULE INHIBITOR",ESR1;ESR2;MAP1A;MAP2,PROSTATE CANCER,,LAUNCHED,,,NA,C[C@]12CC[C@H]3[C@@H](CCC4CC(OC(=O)N(CCCL)CCCL)CCC34)[C@@H]1CC[C@@H]2OP(O)(O)=O,
TRIHYDROXYESTRIN,"16.ALPHA.-HYDROXYESTRADIOL;16.ALPHA.,17.BETA.-ESTRIOL;AACIFEMINE;COLPOGYN;ESTRIOL;ESTRIOL ACETATE BENZOATE;ESTRIOL PROPIONATE;ESTRIOL SUCCINATE;GYNEST;INCURIN;NSC-12169;OESTRIOL;ORTHO-GYNEST;OVESTIN;THEELOL;TRIHYDROXYESTRIN",CHEMBL193482,BRD:BRD-BRD-K17016787-001-16-7;BRD:BRD-K17016787-001-16-7,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1;ESR2,"MENOPAUSE, VAGINAL ATROPHY, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O;C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1C[C@@H](O)[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1C[C@@H](O)[C@@H]2O, CC12CCC3C(CCC4CC(O)CCC34)C1C[C@H](O)[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1C[C@@H](O)[C@@H]2O",PROQIPRRNZUXQM-ZXXIGWHRSA-N
WAY 164397,"1,3,5-ESTRATRIEN-3-OL-17-ONE;ESTRADIOL METABOLITE E1;ESTROGENIC SUBSTANCE;ESTRONE;FOLLICULAR HORMONE;FOLLICULAR-HORMONE;FOLLICULIN;FOLLICULINUM;KETOHYDROXYESTRIN;NATURAL ESTROGENIC SUBSTANCE-ESTRONE;NSC-9699;OESTRONE;THEELIN;THELYKININ;TOKOKIN;WAY 164397",CHEMBL1405,BRD:BRD-BRD-K81839095-001-25-1;BRD:BRD-BRD-K81839095-001-30-1;BRD:BRD-K81839095-001-25-1;BRD:BRD-K81839095-001-30-1,rep_multi_dose;rep_primary;rep_single_dose,"ESTROGEN RECEPTOR AGONIST, ESTROGENIC HORMONE",ESR1;ESR2,,,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O;C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CCC2=O",DNXHEGUUPJUMQT-CBZIJGRNSA-N
SULESTREX PIPERAZINE,ESTRONE SULFATE PIPERAZINE SALT;ESTROPIPATE;HARMOGEN;NSC-758912;OGEN;OGEN .625;OGEN 1.25;OGEN 2.5;OGEN 5;ORTHO-EST;PIPERAZINE ESTRONE SULFATE;PIPERAZINE ESTRONE SULPHATE;SULESTREX PIPERAZINE,CHEMBL1200980,BRD:BRD-A22143024-231-03-8;BRD:BRD-BRD-A22143024-231-03-8,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1;ESR2,"OSTEOPOROSIS, MENOPAUSE, VAGINAL ATROPHY, HYPOESTROGENISM",,LAUNCHED,,Small molecule,4,C[C@]12CCC3C(CCC4CC(OS(O)(=O)=O)CCC34)C1CCC2=O;C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O,HZEQBCVBILBTEP-ZFINNJDLSA-N
ZOPICLONE S-FORM,(S)-ZOPICLONE;ESTORRA;ESZOPICLON;ESZOPICLONE;ESZOPICLONE CIV;GSK-1755165;LUNESTA;ZOPICLONE S-FORM,CHEMBL1522,BRD:BRD-BRD-K29220403-001-10-8;BRD:BRD-K29220403-001-10-8,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;TSPO,INSOMNIA,,LAUNCHED,,Small molecule,4,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1;CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2NCCNC12)C1CCC(CL)CN1,GBBSUAFBMRNDJC-INIZCTEOSA-N
ETACRYNIC-ACID,ETACRYNIC-ACID,,BRD:BRD-BRD-K63630713-001-25-8;BRD:BRD-K63630713-001-25-8,rep_primary;rep_single_dose,SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,ATP1A1;SLC12A1,"HYPERTENSION, CONGESTIVE HEART FAILURE, EDEMA, HEPATIC CIRRHOSIS, CHRONIC RENAL FAILURE, NEPHROTIC SYNDROME",,LAUNCHED,,,NA,CCC(=C)C(=O)C1CCC(OCC(O)=O)C(CL)C1CL,
ETAFENONE HYDROCHLORIDE,ETAFENONE;ETAFENONE HYDROCHLORIDE,CHEMBL1736151,BRD:BRD-BRD-K84971356-001-01-4;BRD:BRD-K84971356-001-01-4,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,LAUNCHED,,Small molecule,-1,CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1;CCN(CC)CCOC1CCCCC1C(=O)CCC1CCCCC1,OEGDFSLNGABBKJ-UHFFFAOYSA-N
MD-141,DICYNENE;DICYNENE 1000;DICYNONE;DIETHYLAMINE DOBESILATE;E 141;E-141;ETAMSILATE;ETAMSYLATE;ETHAMSYLATE;MD 141;MD-141,CHEMBL1514715,BRD:BRD-BRD-K71055333-224-05-8;BRD:BRD-K71055333-224-05-8,rep_primary;rep_single_dose,"HAEMOSTATIC AGENT, HEMOSTATIC AGENT",,HEMORRHAGE,,LAUNCHED,"Multiple values for MOA: {'HAEMOSTATIC AGENT, HEMOSTATIC AGENT', 'HAEMOSTATIC AGENT'}, defaulting to 'HAEMOSTATIC AGENT, HEMOSTATIC AGENT'",Small molecule,4,"CCNCC.O=S(=O)(O)c1cc(O)ccc1O;OC1CCC(O)C(C1)S(O)(=O)=O, OC1CCC(O)C(C1)S(O)(=O)=O",HBGOLJKPSFNJSD-UHFFFAOYSA-N
SR-2508,ETANIDAZOLE;NSC-301467;RADINYL;SR 2508;SR-2508,CHEMBL47405,BRD:BRD-BRD-K96042922-001-09-8;BRD:BRD-K96042922-001-09-8,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,PHASE 3,,Small molecule,-1,O=C(Cn1ccnc1[N+](=O)[O-])NCCO;OCCNC(=O)CN1CCNC1[N+]([O-])=O,WCDWBPCFGJXFJZ-UHFFFAOYSA-N
SQ-20009,EHT-0202;ETAZOLATE;SQ-20009,CHEMBL356388,BRD:BRD-BRD-K64755930-003-03-2;BRD:BRD-K64755930-003-03-2,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,GABRB3;PDE4A,,,PHASE 2,,Small molecule,2,CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C;CCOC(=O)C1CNC2N(CC)NCC2C1NN=C(C)C,OPQRBXUBWHDHPQ-UHFFFAOYSA-N
ETC-1922159,ETC-159;ETC-1922159,CHEMBL3633802,BRD:BRD-BRD-K54264768-001-01-2;BRD:BRD-K54264768-001-01-2,rep_primary;rep_single_dose,"PORCUPINE INHIBITOR, BETA CATENIN INHIBITOR",PORCN,,,PHASE 1,"Multiple values for MOA: {'BETA CATENIN INHIBITOR, PORCUPINE INHIBITOR', 'PORCUPINE INHIBITOR, BETA CATENIN INHIBITOR'}, defaulting to 'PORCUPINE INHIBITOR, BETA CATENIN INHIBITOR'",Small molecule,1,Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc(-c3ccccc3)nn2)n(C)c1=O;CN1C2NCN(CC(=O)NC3CCC(NN3)-C3CCCCC3)C2C(=O)N(C)C1=O,QTRXIFVSTWXRJJ-UHFFFAOYSA-N
ETC1907206,AUM-001;AUM001;ETC-206;ETC1907206,CHEMBL4211649,BRD:BRD-K00003115-001-01-9,rep_single_dose,MAPK-INTERACTING KINASE INHIBITOR,,,,,,Small molecule,2,N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1,FWRFPHJSGLYXTD-UHFFFAOYSA-N
P-DIETHYLSULFAMOYLBENZOIC ACID,ETEBENECID;ETHEBENECID;NSC-49467;P-DIETHYLSULFAMOYLBENZOIC ACID,CHEMBL1705586,BRD:BRD-BRD-K24443618-001-10-2;BRD:BRD-K24443618-001-10-2,rep_primary;rep_single_dose,URICOSURIC BLOCKER,,,,PRECLINICAL,,Small molecule,-1,CCN(CC)S(=O)(=O)c1ccc(C(=O)O)cc1;CCN(CC)S(=O)(=O)C1CCC(CC1)C(O)=O,UACOQEQOBAQRDQ-UHFFFAOYSA-N
ETELCALCETIDE (HYDROCHLORIDE),ETELCALCETIDE (HYDROCHLORIDE),,BRD:BRD-K00078514-003-02-9,rep_single_dose,,,,,,,,NA,,
RMI-16238,"ANTILON;ETEROBARB;EX 12-095;EX-12-095;RMI 16,238;RMI-16238",CHEMBL327407,BRD:BRD-BRD-K64834129-001-19-6;BRD:BRD-K64834129-001-19-6,rep_primary;rep_single_dose,ANTICONVULSANT,,,,PHASE 2,,Small molecule,-1,CCC1(C(=O)N(COC)C(=O)N(COC)C1=O)C1CCCCC1;CCC1(c2ccccc2)C(=O)N(COC)C(=O)N(COC)C1=O,DACOQFZGGLCXMA-UHFFFAOYSA-N
NSC-621878,ETACIZIN;ETHACIZIN;ETHACIZINE;ETHACYZIN;ETMOZINE DAA;EZ-55;NIK-244;NSC-621878,CHEMBL1997663,BRD:BRD-BRD-K10667240-001-01-7;BRD:BRD-K10667240-001-01-7,rep_primary;rep_single_dose,ANTICONVULSANT,,"VENTRICULAR TACHYCARDIA (VT), WOLFF-PARKINSON-WHITE SYNDROME (WPW)",,LAUNCHED,,Small molecule,-1,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN(CC)CC)c1ccccc1S2;CCOC(=O)NC1CCC2SC3CCCCC3N(C(=O)CCN(CC)CC)C2C1,PQXGNJKJMFUPPM-UHFFFAOYSA-N
ETHACRIDINE-LACTATE-MONOHYDRATE,ETHACRIDINE-LACTATE-MONOHYDRATE,,BRD:BRD-BRD-K24715592-406-02-1;BRD:BRD-K24715592-406-02-1,rep_multi_dose;rep_primary;rep_single_dose,DNA INTERCALATING AGENT,,,,PRECLINICAL,,,NA,"CCOC1CCC2NC3CC(N)CCC3C(N)C2C1, CCOC1CCC2NC3CC(N)CCC3C(N)C2C1, CCOC1CCC2NC3CC(N)CCC3C(N)C2C1",
ETHAMBUTOL,ETHAMBUTOL,CHEMBL44884,BRD:BRD-BRD-K93231391-300-05-6;BRD:BRD-K93231391-300-05-6,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,"CC[C@@H](CO)NCCN[C@@H](CC)CO;CC[C@@H](CO)NCCN[C@@H](CC)CO, CC[C@@H](CO)NCCN[C@@H](CC)CO",AEUTYOVWOVBAKS-UWVGGRQHSA-N
VANDID,CLAIRVAN;EMIVAN;ETAMIVAN;ETHAMIVAN;NSC-406087;VANDID,CHEMBL1229908,BRD:BRD-BRD-K38055836-001-21-1;BRD:BRD-K38055836-001-21-1,rep_primary;rep_single_dose,RESPIRATORY STIMULANT,,,,PRECLINICAL,,Small molecule,4,"CCN(CC)C(=O)c1ccc(O)c(OC)c1;CCN(CC)C(=O)C1CCC(O)C(OC)C1, CCN(CC)C(=O)C1CCC(O)C(OC)C1",BQJODPIMMWWMFC-UHFFFAOYSA-N
ETHANOLAMINE-OLEATE,ETHANOLAMINE-OLEATE,,BRD:BRD-M75061779-001-01-2,rep_single_dose,IMMUNOSTIMULANT,F12;FABP4;FFAR1;FFAR4;PLD2,,,,,,NA,,
ETHQUINOL,ETHAVERINE;ETHQUINOL,CHEMBL1555736,BRD:BRD-BRD-K36756879-003-08-7;BRD:BRD-K36756879-003-08-7,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,"MUSCLE RELAXANT, SPASMS",,LAUNCHED,,Small molecule,-1,CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC;CCOC1CCC(CC2NCCC3CC(OCC)C(OCC)CC23)CC1OCC,ZOWYFYXTIWQBEP-UHFFFAOYSA-N
O-ETHOXYBENZAMIDE,ETENZAMIDE;ETHENZAMIDE;J3.352I;NSC-28787;O-ETHOXYBENZAMIDE,CHEMBL1483877,BRD:BRD-BRD-K88308881-001-06-8;BRD:BRD-K88308881-001-06-8,rep_primary;rep_single_dose,ANALGESIC AGENT,,"HEADACHE, FEVER, COMMON COLD",,LAUNCHED,,Small molecule,-1,CCOc1ccccc1C(N)=O;CCOC1CCCCC1C(N)=O,SBNKFTQSBPKMBZ-UHFFFAOYSA-N
ETHIMIZOL,ETHIMIZOL,,BRD:BRD-BRD-K19672466-001-02-3;BRD:BRD-K19672466-001-02-3,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,CCN1CNC(C(=O)NC)C1C(=O)NC,
ETHINYL-ESTRADIOL,ETHINYL-ESTRADIOL,,BRD:BRD-BRD-K48195008-001-19-9;BRD:BRD-K48195008-001-19-9,rep_multi_dose;rep_primary;rep_single_dose,"ESTROGEN RECEPTOR AGONIST, ESTROGENIC HORMONE",ESR1;ESR2;NR1I2,CONTRACEPTIVE,,LAUNCHED,,,NA,"C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CCC34)[C@@H]1CC[C@@]2(O)C#C",
TRECATOR-SC,1314 TH;1314-TH;BAYER 5312;ETHIONAMIDE;ETHIONAMIDUM;NIZOTIN;NSC-255115;TRECATOR;TRECATOR-SC,CHEMBL1441,BRD:BRD-BRD-K51207550-001-23-0;BRD:BRD-K51207550-001-23-0,rep_primary;rep_single_dose,MYCOLIC SYNTHESIS INHIBITOR,,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,"CCc1cc(C(N)=S)ccn1;CCC1CC(CCN1)C(S)=N, CCC1CC(CCN1)C(S)=N",AEOCXXJPGCBFJA-UHFFFAOYSA-N
TROSINONE,ANHYDROHYDROXYPROGESTERONE;ETHISTERONE;NSC-9565;ORA-LUTIN;PRANONE;PREGNENINOLONE;SYNGESTROTABS;TROSINONE,CHEMBL241694,BRD:BRD-A29111201-001-04-8;BRD:BRD-BRD-A29111201-001-04-8,rep_primary;rep_single_dose,PROGESTOGEN HORMONE,TYR,,,LAUNCHED,,Small molecule,3,"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C;CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C",CHNXZKVNWQUJIB-CEGNMAFCSA-N
ETHOPABATE,ETHOPABATE,CHEMBL458769,BRD:BRD-BRD-K02475039-001-01-0;BRD:BRD-K02475039-001-01-0,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,CCOc1cc(NC(C)=O)ccc1C(=O)OC;CCOC1CC(NC(C)=O)CCC1C(=O)OC,GOVWOKSKFSBNGD-UHFFFAOYSA-N
ZARONTIN,"CI-366;CN-10,395;CN-10395;EMESIDE;ETHOSUXIMIDE;ETHOSUXIMIDUM;NSC-64013;PM-671;PYKNOLEPSINUM;SUXINUTIN;ZARONTIN",CHEMBL696,BRD:BRD-A99633051-001-07-0;BRD:BRD-BRD-A99633051-001-07-0,rep_primary;rep_single_dose,SUCCINIMIDE ANTIEPILEPTIC,CACNA1G;CACNA1H;CACNA1I,EPILEPSY,,LAUNCHED,,Small molecule,4,"CCC1(C)CC(=O)NC1=O;CCC1(C)CC(=O)NC1=O, CCC1(C)CC(=O)NC1=O",HAPOVYFOVVWLRS-UHFFFAOYSA-N
PEGANONE,ACCENON;ETHOTOIN;NSC-760074;PEGANONE,CHEMBL1095,BRD:BRD-A30205217-001-11-2;BRD:BRD-BRD-A30205217-001-11-2,rep_primary;rep_single_dose,HYDANTOIN ANTIEPILEPTIC,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,Small molecule,4,"CCN1C(=O)NC(C1=O)C1CCCCC1, CCN1C(=O)NC(C1=O)C1CCCCC1;CCN1C(=O)NC(c2ccccc2)C1=O",SZQIFWWUIBRPBZ-UHFFFAOYSA-N
ETHOXYQUIN,ETHOXYQUIN,,BRD:BRD-K56792340-001-14-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
NSC-10679,CARDRASE;ETHAMIDE;ETHOXZOLAMIDE;NSC-10679,CHEMBL18,BRD:BRD-BRD-K18131774-001-17-6;BRD:BRD-K18131774-001-17-6,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA1;CA12;CA13;CA14;CA2;CA3;CA4;CA5A;CA5B;CA6;CA7;CA9,"GLAUCOMA, DUODENAL ULCER DISEASE",,LAUNCHED,,Small molecule,4,"CCOc1ccc2nc(S(N)(=O)=O)sc2c1;CCOC1CCC2NC(SC2C1)S(N)(=O)=O, CCOC1CCC2NC(SC2C1)S(N)(=O)=O",OUZWUKMCLIBBOG-UHFFFAOYSA-N
ETHYL-PARABEN,ETHYL-PARABEN,,BRD:BRD-BRD-K02464583-001-02-2;BRD:BRD-K02464583-001-02-2,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCOC(=O)C1CCC(O)CC1,
ETHYL-VANILLIN,ETHYL-VANILLIN,,BRD:BRD-BRD-K82104468-001-05-0;BRD:BRD-K82104468-001-05-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCOC1CC(C=O)CCC1O,
ETHYLENEDIAMINETETRAACETIC-ACID,ETHYLENEDIAMINETETRAACETIC-ACID,,BRD:BRD-BRD-K82603084-408-01-1;BRD:BRD-K82603084-408-01-1,rep_primary;rep_single_dose,PKC INHIBITOR,,METAL TOXICITY,,LAUNCHED,,,NA,OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O,
ETHYLNOREPINEPHRINE,ETHYLNOREPINEPHRINE,CHEMBL31159,BRD:BRD-A68509429-003-03-9;BRD:BRD-BRD-A68509429-003-03-9,rep_primary;rep_single_dose,BRONCHODILATOR,,,,PRECLINICAL,,Small molecule,-1,CCC(N)C(O)c1ccc(O)c(O)c1;CCC(N)C(O)C1CCC(O)C(O)C1,LENNRXOJHWNHSD-UHFFFAOYSA-N
ETHYNODIOL-DIACETATE,ETHYNODIOL-DIACETATE,,BRD:BRD-BRD-K46331928-001-05-8;BRD:BRD-BRD-K46331928-001-06-6;BRD:BRD-K46331928-001-05-8;BRD:BRD-K46331928-001-06-6,rep_primary;rep_single_dose,,ESR1;PGR,CONTRACEPTIVE,,LAUNCHED,,,NA,"CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1, CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1, CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1",
ETHYNYLCYTIDINE,ETHYNYLCYTIDINE,,BRD:BRD-K00003207-001-01-9,rep_single_dose,ANTIMETABOLITE,,,,,,,NA,,
ETICLOPRIDE,ETICLOPRIDE,CHEMBL8946,BRD:BRD-BRD-K50417881-003-17-4;BRD:BRD-K50417881-003-17-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3;DRD4,,,PRECLINICAL,,Small molecule,-1,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O;CCN1CCC[C@H]1CNC(=O)C1C(O)C(CC)CC(CL)C1OC,AADCDMQTJNYOSS-LBPRGKRZSA-N
ETIDOCAINE (HYDROCHLORIDE),ETIDOCAINE (HYDROCHLORIDE),,BRD:BRD-K00074616-003-02-9,rep_single_dose,,,,,,,,NA,,
ETIDRONIC-ACID,ETIDRONIC-ACID,,BRD:BRD-BRD-K37949327-001-06-3;BRD:BRD-K37949327-001-06-3,rep_primary;rep_single_dose,BONE RESORPTION INHIBITOR,ATP6V1A;PTPRS,"PAGET'S DISEASE, HETEROTOPIC OSSIFICATION",,LAUNCHED,,,NA,"CC(O)(P(O)(O)=O)P(O)(O)=O, CC(O)(P(O)(O)=O)P(O)(O)=O, CC(O)(P(O)(O)=O)P(O)(O)=O",
ETIFENIN,ETIFENIN,CHEMBL1323453,BRD:BRD-K63979671-001-11-9,rep_single_dose,RENAL FUNCTION DIAGNOSTIC AGENT,,,,,,Small molecule,-1,CCc1cccc(CC)c1NC(=O)CN(CC(=O)O)CC(=O)O,WNIDXAKKFOKNEF-UHFFFAOYSA-N
HOE-36801,36-801;ETIFOXINE;HOE 36801;HOE-36801,CHEMBL2106227,BRD:BRD-K01826330-001-01-9,rep_single_dose,GABA RECEPTOR MODULATOR,GABRA1;GABRA2;GABRA3;GABRA5,,,,,Small molecule,3,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1,IBYCYJFUEJQSMK-UHFFFAOYSA-N
UPDORMIN,APOCRETIN;CARDANAT;CIRCUPON;CORCANFOL;DL-ETILEFRIN;EFFONTIL;EFFORTIL;EFFORTIL DEPOT PERLONGETTEN;EFORTIL;ETHYLEFRINE;ETILEFRIN;ETILEFRIN HYDROCHLORIDE;ETILEFRINE;ETILEFRINE HCL;ETILEFRINE HYDROCHLORIDE;KERTASIN;N-ETHYLNORPHENYLEPHRINE;PHETANOL;PULSAMIN;S-40032;S-40032-7;THOMASIN;UPDORMIN,CHEMBL86882,BRD:BRD-A09925278-003-05-6;BRD:BRD-BRD-A09925278-003-05-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRB1,"HEADACHE, NASAL CONGESTION, FEVER, COUGH SUPPRESSANT, COMMON COLD",,LAUNCHED,,Small molecule,4,CCNCC(O)c1cccc(O)c1;CCNCC(O)C1CCCC(O)C1,SQVIAVUSQAWMKL-UHFFFAOYSA-N
TV-1203,ETILEVODOPA;L-DOPA ETHYL ESTER;TV-1203,CHEMBL1823681,BRD:BRD-BRD-K90982969-001-01-2;BRD:BRD-K90982969-001-01-2,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD3,,,PHASE 3,,Small molecule,2,"CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1;CCOC(=O)[C@@H](N)CC1CCC(O)C(O)C1, CCOC(=O)[C@@H](N)CC1CCC(O)C(O)C1",NULMGOSOSZBEQL-QMMMGPOBSA-N
SEDEKOPAN,ETIZOLAM;SEDEKOPAN,CHEMBL1289779,BRD:BRD-BRD-K68232413-001-01-2;BRD:BRD-K68232413-001-01-2,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1,"INSOMNIA, ANXIETY",,LAUNCHED,,Small molecule,-1,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl;CCC1CC2C(S1)-N1C(C)NNC1CN=C2C1CCCCC1CL,VMZUTJCNQWMAGF-UHFFFAOYSA-N
ZEDOLAC,"(-)-;(-)-(R)-ETODOLAC;(-)-ETODOLAC;(R)-;(RS)-ETODOLIC ACID;AY-24-236;AY-24,236;AY-24236;EBRETIN;ECCOXOLAC;EDOLAN;ETODOLAC;ETODOLIC ACID;ETOLYN;ETOPAN XL;FLANCOX;KS-1056;LODIN XL;LODINE;LODINE SR;LODINE XL;NAPILAC;NIH-9918;NSC-282126;R-ETODOLAC;RAK-593;RAMODAR;SDX-101;TEDOLAN;ULTRADOL;ZEDOLAC",CHEMBL1716091;CHEMBL622,BRD:BRD-A74667430-001-23-6;BRD:BRD-BRD-A74667430-001-23-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2;RXRA,"OSTEOARTHRITIS, RHEUMATOID ARTHRITIS",,LAUNCHED,,Small molecule,4,"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3;CCC1CCCC2C3CCOC(CC)(CC(O)=O)C3[NH]C12, CCC1CCCC2C3CCOC(CC)(CC(O)=O)C3[NH]C12",NNYBQONXHNTVIJ-UHFFFAOYSA-N
WHR-5020,BAY D 1107;BAY-D-1107;BAYD-1107;ETOFENAMATE;TVX-485;TVX485;WHR-5020,CHEMBL1451633,BRD:BRD-BRD-K73541271-001-03-6;BRD:BRD-K73541271-001-03-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"MUSCLE PAIN, JOINT PAIN",,LAUNCHED,,Small molecule,-1,O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1;OCCOCCOC(=O)C1CCCCC1NC1CCCC(C1)C(F)(F)F,XILVEPYQJIOVNB-UHFFFAOYSA-N
ETOFIBRATE,ETOFIBRATE,CHEMBL358150,BRD:BRD-BRD-K49338325-001-03-4;BRD:BRD-K49338325-001-03-4,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA,HYPERTRIGLYCERIDEMIA,,LAUNCHED,,Small molecule,-1,CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1;CC(C)(OC1CCC(CL)CC1)C(=O)OCCOC(=O)C1CCCNC1,XXRVYAFBUDSLJX-UHFFFAOYSA-N
THEOPROPANOL,BETA-HYDROXYETHYL THEOPHYLLINE;DOXOPHYLLINE METABOLITE M4;ETOFYLLINE;FREKAPHYLLIN;KT-200G;NSC-113373;OXYETHYLTHEOPHYLLINE;OXYPHYLLIN;OXYPHYLLINE;PHYLLOCORMIN N;SOLUPHYLLINE;THEOPHYLLINE ISOPROPANOLAMINE;THEOPHYLLINE RELATED COMPOUND F;THEOPROPANOL,CHEMBL699,BRD:BRD-BRD-K83064458-001-23-0;BRD:BRD-K83064458-001-23-0,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1,"ASTHMA, BRONCHITIS",,LAUNCHED,,Small molecule,-1,Cn1c(=O)c2c(ncn2CCO)n(C)c1=O;CN1C2NCN(CCO)C2C(=O)N(C)C1=O,NWPRCRWQMGIBOT-UHFFFAOYSA-N
ETOFYLLINE-CLOFIBRATE,ETOFYLLINE-CLOFIBRATE,,BRD:BRD-BRD-K49840922-001-05-1;BRD:BRD-K49840922-001-05-1,rep_multi_dose;rep_primary;rep_single_dose,PLATELET AGGREGATION INHIBITOR,PPARA,,,LAUNCHED,,,NA,CN1C2NCN(CCOC(=O)C(C)(C)OC3CCC(CL)CC3)C2C(=O)N(C)C1=O,
NSC-759160,AMIDATE;ETOMIDATE;HYPNOMIDATE;NSC-759160,CHEMBL681,BRD:BRD-BRD-K55055802-001-10-2;BRD:BRD-K55055802-001-10-2,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,ADRA2B;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ,GENERAL ANAESTHETIC,,LAUNCHED,,Small molecule,4,"CCOC(=O)c1cncn1[C@H](C)c1ccccc1;CCOC(=O)C1CNCN1[C@H](C)C1CCCCC1, CCOC(=O)C1CNCN1[C@H](C)C1CCCCC1, CCOC(=O)C1CNCN1[C@H](C)C1CCCCC1",NPUKDXXFDDZOKR-LLVKDONJSA-N
ETOMOXIR,ETOMOXIR,CHEMBL2051959,BRD:BRD-BRD-K32405725-001-02-8;BRD:BRD-K32405725-001-02-8;CTRP:660082,ctrp;rep_multi_dose;rep_primary;rep_single_dose,CARNITINE PALMITOYLTRANSFERASE INHIBITOR,CPT1A,,,PHASE 2,,Small molecule,-1,CCOC(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1;CCOC(=O)[C@@]1(CCCCCCOC2CCC(CL)CC2)CO1,DZLOHEOHWICNIL-QGZVFWFLSA-N
ORG-3236,ETONOGESTREL;IMPLANON;NEXPLANON;ORG 3236;ORG-3236,CHEMBL1531,BRD:BRD-A08302182-001-01-7;BRD:BRD-BRD-A08302182-001-01-7,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,ESR1;PGR,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC;CCC12CC(=C)C3C(CCC4=CC(=O)CCC34)C1CC[C@@]2(O)C#C,GCKFUYQCUCGESZ-BPIQYHPVSA-N
VP-16213,ETOPOSIDE;ETOPOSIDE RESOLUTION MIXTURE;ETOPOSIDUM;NSC-141540;SINTOPOZID;TOPOSAR;VEPESID;VP-16-213;VP-16213,CHEMBL44657,BRD:BRD-BRD-K37798499-001-27-2;BRD:BRD-K37798499-001-18-1;BRD:BRD-K37798499-001-27-2;CTRP:48589;GDSC1:134,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF TOPOISOMERASE,TOP2A;TOP2B,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF TOPOISOMERASE', 'TOPOISOMERASE INHIBITOR'}, defaulting to 'INHIBITOR OF TOPOISOMERASE'",Small molecule,4,"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O;COC1CC(CC(OC)C1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)C2CC3OCOC3CC12, COC1CC(CC(OC)C1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)C2CC3OCOC3CC12, COC1CC(CC(OC)C1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)C2CC3OCOC3CC12, COC1CC(CC(OC)C1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)C2CC3OCOC3CC12, COC1CC(CC(OC)C1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)C2CC3OCOC3CC12, COC1CC(CC(OC)C1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)C2CC3OCOC3CC12",VJJPUSNTGOMMGY-MRVIYFEKSA-N
ETOPOSIDE-PHOSPHATE,ETOPOSIDE-PHOSPHATE,,BRD:BRD-BRD-K72533376-001-01-2;BRD:BRD-K72533376-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A,"TESTICULAR CARCINOMA, SMALL CELL LUNG CANCER",,LAUNCHED,,,NA,COC1CC(CC(OC)C1OP(O)(O)=O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)C2CC3OCOC3CC12,
MK-0663,ARCOXIA;ETORICOXIB;L-791456;MK-0663,CHEMBL416146,BRD:BRD-BRD-K54770957-001-04-3;BRD:BRD-K54770957-001-04-3,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,"RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OSTEOARTHRITIS, GOUT, ANKYLOSING SPONDYLITIS",,LAUNCHED,,Small molecule,4,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1;CC1CCC(CN1)-C1NCC(CL)CC1-C1CCC(CC1)S(C)(=O)=O,MNJVRJDLRVPLFE-UHFFFAOYSA-N
O-(2-ETHOXYETHOXY)BENZAMIDE,ETHOSALAMIDE;ETOSALAMIDE;O-(2-ETHOXYETHOXY)BENZAMIDE,CHEMBL2104260,BRD:BRD-BRD-K60914966-001-01-4;BRD:BRD-K60914966-001-01-4,rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,PRECLINICAL,,Small molecule,-1,CCOCCOc1ccccc1C(N)=O;CCOCCOC1CCCCC1C(N)=O,XBNRCMFFZFCWMH-UHFFFAOYSA-N
ETP-45658,ETP-45658,,BRD:BRD-BRD-K15858023-001-01-0;BRD:BRD-K15858023-001-01-0,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PRECLINICAL,,,NA,CN1NCC2C(NC(NC12)-C1CCCC(O)C1)N1CCOCC1,
ETP-45835,ETP-45835,,GDSC1:447,gdsc,,,,,,,,NA,,
ETP-46464,ETP-46464,,BRD:BRD-BRD-K24556407-001-02-3;BRD:BRD-K24556407-001-02-3;BRD:BRD-K24556407-001-03-9;CTRP:666716,ctrp;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF ATR KINASE AND MTOR,ATR;MTOR,,,PRECLINICAL,"Multiple values for MOA: {'ATR KINASE INHIBITOR', 'INHIBITOR OF ATR KINASE AND MTOR'}, defaulting to 'INHIBITOR OF ATR KINASE AND MTOR'",,NA,CC(C)(C#N)C1CCC(CC1)N1C(=O)OCC2CNC3CCC(CC3C12)-C1CNC2CCCCC2C1,
ETRABAMINE,ETRABAMINE,CHEMBL2106160,BRD:BRD-K00004658-001-01-9,rep_single_dose,DOPAMINE RECEPTOR AGONIST,,,,,,Small molecule,-1,CNC1CCc2ncsc2C1,YDSVAKPJAOSZJA-UHFFFAOYSA-N
ETRASIMOD,APD-334;APD-334(FREE ACID);APD334;ETRASIMOD,CHEMBL3358920,BRD:BRD-K00003139-001-01-9,rep_single_dose,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,,,,,,Small molecule,3,O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21,MVGWUTBTXDYMND-QGZVFWFLSA-N
TMC125,ETRAVIRINE;INTELENCE;R-165335;R165335;TMC 125;TMC-125;TMC125,CHEMBL308954,BRD:BRD-BRD-K74717603-001-02-2;BRD:BRD-K74717603-001-02-2,rep_primary;rep_single_dose,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,CYP2C19;CYP2C9;CYP3A4,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br;CC1CC(CC(C)C1OC1NC(NC2CCC(CC2)C#N)NC(N)C1BR)C#N,PYGWGZALEOIKDF-UHFFFAOYSA-N
TIGASON,ACITRETIN RELATED COMPOUND B;ETHYL ETRINOATE;ETRETINATE;NSC-297936;RO 10-9359;RO-10-9359;RO-109359;TEGISON;TIGASON,CHEMBL464,BRD:BRD-K49076555-001-05-6,rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,RARA;RXRG,,,,,Small molecule,4,CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C,HQMNCQVAMBCHCO-DJRRULDNSA-N
MSP-2017,(-)-MSP-2017;ETRIPAMIL;MS)-MSP-2017;MSP-2017,CHEMBL3707312,BRD:BRD-K00090659-001-01-9,rep_single_dose,,,,,,,Small molecule,3,COC(=O)c1cccc(CCN(C)CCC[C@@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)c1,VAZNEHLGJGSQEL-MHZLTWQESA-N
NSC-8895,4-ALLYLCATECHOL 2-METHYL ETHER;BIOXEDA;CARYOPHILLIC ACID;DENTOGUM;EUGENOL;FEMA NO. 2467;NSC-209525;NSC-8895,CHEMBL42710,BRD:BRD-BRD-K32977963-001-05-0;BRD:BRD-K32977963-001-05-0,rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AR,TOOTHACHE,,LAUNCHED,,Small molecule,0.5,C=CCc1ccc(O)c(OC)c1;COC1CC(CC=C)CCC1O,RRAFCDWBNXTKKO-UHFFFAOYSA-N
EUK-134,EUK-134,,BRD:BRD-K19741031-001-01-4,rep_single_dose,CATALASE STIMULANT,APP;SOD2,,,,,,NA,,
NSC-122413,EUPATILIN;NSC-122413,CHEMBL312750,BRD:BRD-BRD-K47031502-001-01-6;BRD:BRD-K47031502-001-01-6,rep_primary;rep_single_dose,MUCUS PROTECTING AGENT,,,,LAUNCHED,,Small molecule,-1,"COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)cc1OC;COC1CCC(CC1OC)-C1CC(=O)C2C(O)C(OC)C(O)CC2O1, COC1CCC(CC1OC)-C1CC(=O)C2C(O)C(OC)C(O)CC2O1",DRRWBCNQOKKKOL-UHFFFAOYSA-N
LY2484595,EVACETRAPIB;LY-2484595;LY2484595,CHEMBL2017179,BRD:BRD-BRD-K16551357-001-03-2;BRD:BRD-K16551357-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,CETP,,,PHASE 3,,Small molecule,3,"Cc1cc(C)c2c(c1)[C@@H](N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(C)n1)CCCN2C[C@H]1CC[C@H](C(=O)O)CC1;CC1CC(C)C2N(C[C@H]3CC[C@@H](CC3)C(O)=O)CCC[C@H](N(CC3CC(CC(C3)C(F)(F)F)C(F)(F)F)C3NNN(C)N3)C2C1, CC1CC(C)C2N(C[C@H]3CC[C@@H](CC3)C(O)=O)CCC[C@H](N(CC3CC(CC(C3)C(F)(F)F)C(F)(F)F)C3NNN(C)N3)C2C1",IHIUGIVXARLYHP-YBXDKENTSA-N
EVANS-BLUE,EVANS-BLUE,,BRD:BRD-BRD-K24548560-342-02-1;BRD:BRD-K24548560-342-02-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,GRIA1;PTPN1,,,LAUNCHED,,,NA,CC1CC(CCC1\N=N\C1CCC2C(CC(C(N)C2C1O)S(O)(=O)=O)S(O)(=O)=O)-C1CCC(C(C)C1)\N=N\C1CCC2C(CC(C(N)C2C1O)S(O)(=O)=O)S(O)(=O)=O,
EVATANEPAG,"CP-533,536;CP-533536;EVATANEPAG",CHEMBL563646,BRD:BRD-BRD-K11452913-001-01-9;BRD:BRD-K11452913-001-01-9,rep_primary;rep_single_dose,PROSTAGLANDIN INHIBITOR,PTGER2;PTGER4,,,PHASE 2,,Small molecule,2,CC(C)(C)c1ccc(CN(Cc2cccc(OCC(=O)O)c2)S(=O)(=O)c2cccnc2)cc1;CC(C)(C)C1CCC(CN(CC2CCCC(OCC(O)=O)C2)S(=O)(=O)C2CCCNC2)CC1,WOHRHWDYFNWPNG-UHFFFAOYSA-N
NW-3509,EVENAMIDE;NW-3509,CHEMBL3678076,BRD:BRD-K00004688-001-01-9,rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,,,,,,Small molecule,2,CCCCOc1cccc(CCNCC(=O)N(C)C)c1,GRHBODILPPXVKN-UHFFFAOYSA-N
ZORTRESS,40-O-(2-HYDROXYETHYL)-RAPAMYCIN;AFINITOR;AFINITOR DISPERZ;CERTICAN;EVEROLIMUS;RAD 666;RAD-001;RAD-666;RAD001;SDZ RAD;SDZ-RAD;VOTUBIA;ZORTRESS,CHEMBL1908360,BRD:BRD-BRD-K13514097-001-05-3;BRD:BRD-K13514097-001-04-6;BRD:BRD-K13514097-001-05-3;BRD:BRD-U00115429-001-01-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF MTOR VIA FKBP12 (FKBP1A),FKBP1A;MTOR,"BREAST CANCER, NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET), RENAL CELL CARCINOMA (RCC), SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA), TUBEROUS SCLEROSIS COMPLEX (TSC), RENAL ANGIOMYOLIPOMA",,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF MTOR VIA FKBP12 (FKBP1A)', 'MTOR INHIBITOR'}, defaulting to 'INHIBITOR OF MTOR VIA FKBP12 (FKBP1A)'
Multiple values for repurposing_target: {'FKBP1A;MTOR', 'MTOR'}, taking the union
Multiple values for structure_id: {'K13514097', 'U00115429'}, defaulting to None",Small molecule,4,"CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO, CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO;CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C",HKVAMNSJSFKALM-GKUWKFKPSA-N
MSC2364447C,EVOBRUTINIB;M-2951;MSC-2364447C;MSC2364447C,CHEMBL4072833,BRD:BRD-K00003405-001-01-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,Small molecule,3,C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1,QUIWHXQETADMGN-UHFFFAOYSA-N
MT-4580,EVOCALCET;KHK-7580;KHK7580;MT-4580,CHEMBL4297621,BRD:BRD-K00003250-001-01-9,rep_single_dose,CALCIUM SENSITIZER,,,,,,Small molecule,3,C[C@@H](N[C@H]1CCN(c2ccc(CC(=O)O)cc2)C1)c1cccc2ccccc12,RZNUIYPHQFXBAN-XLIONFOSSA-N
EVODIAMINE,EVODIAMINE,CHEMBL486598,BRD:BRD-A68631409-001-05-4;BRD:BRD-BRD-A68631409-001-05-4,rep_multi_dose;rep_primary;rep_single_dose,"ATPASE INHIBITOR, TRPV AGONIST",TRPV1,,,PRECLINICAL,,Small molecule,NA,"CN1c2ccccc2C(=O)N2CCc3c([nH]c4ccccc34)[C@@H]21;CN1C2N(CCC3C2[NH]C2CCCCC32)C(=O)C2CCCCC12, CN1C2N(CCC3C2[NH]C2CCCCC32)C(=O)C2CCCCC12",TXDUTHBFYKGSAH-GOSISDBHSA-N
EVOGLIPTIN (TARTRATE),EVOGLIPTIN (TARTRATE),,BRD:BRD-K00076940-046-02-9,rep_single_dose,,,,,,,,NA,,
MT4666,ENCENICLINE;ENCENICLINE HYDROCHLORIDE;EVP-6124;EVP-6124 HYDROCHLORIDE;MT-4666;MT4666,CHEMBL2151572;CHEMBL3137323,BRD:BRD-BRD-K71603915-003-01-8;BRD:BRD-K71603915-003-01-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA7,,,PHASE 3,,Small molecule,3,CLC1CCCC2CC(SC12)C(=O)N[C@H]1CN2CCC1CC2;O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1,SSRDSYXGYPJKRR-ZDUSSCGKSA-N
EVP4593,EVP4593,,BRD:BRD-BRD-K68395654-001-03-1;BRD:BRD-K68395654-001-03-1,rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,,,,PRECLINICAL,,,NA,"NC1CCC2NCNC(NCCC3CCC(OC4CCCCC4)CC3)C2C1, NC1CCC2NCNC(NCCC3CCC(OC4CCCCC4)CC3)C2C1, NC1CCC2NCNC(NCCC3CCC(OC4CCCCC4)CC3)C2C1",
VACTOSERTIB,EW-7197;TEW 7197;TEW-7197;VACTOSERTIB,CHEMBL3260567,BRD:BRD-BRD-K74396648-001-01-4;BRD:BRD-K74396648-001-01-4,rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,ACVR1B;TGFBR1,,,PHASE 1,,Small molecule,2,Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1;CC1CCCC(N1)-C1[NH]C(CNC2CCCCC2F)NC1-C1CCC2NCNN2C1,FJCDSQATIJKQKA-UHFFFAOYSA-N
EX-527,EX-527,CHEMBL382277,BRD:BRD-A73908300-001-06-7;BRD:BRD-BRD-A73908300-001-06-7;CTRP:608999;GDSC1:341,ctrp;gdsc;rep_primary;rep_single_dose,SIRT INHIBITOR,SIRT1,,,PHASE 2,,Small molecule,2,"NC(=O)C1CCCC2C1[NH]C1CCC(CL)CC21, NC(=O)C1CCCC2C1[NH]C1CCC(CL)CC21;NC(=O)C1CCCC2c3cc(Cl)ccc3NC12",NYORQUCSPQVLTE-UHFFFAOYSA-N
O-(HEXYLOXY)BENZAMIDE,EXALAMIDE;NSC-758449;O-(HEXYLOXY)BENZAMIDE,CHEMBL1405973,BRD:BRD-BRD-K12609457-001-03-1;BRD:BRD-K12609457-001-03-1,rep_primary;rep_single_dose,MEMBRANE PERMEABILITY INHIBITOR,,,,LAUNCHED,,Small molecule,-1,CCCCCCOc1ccccc1C(N)=O;CCCCCCOC1CCCCC1C(N)=O,CKSJXOVLXUMMFF-UHFFFAOYSA-N
MF-6003,EP-23905;EXAMORELIN;HEXARELIN;MF-6003,CHEMBL108335,BRD:BRD-BRD-K35304636-001-01-0;BRD:BRD-K35304636-001-01-0,rep_primary;rep_single_dose,GROWTH HORMONE RELEASING FACTOR AGONIST,GHRHR;GHSR,,,PHASE 2,,Protein,-1,C[C@H](NC(=O)[C@@H](CC1C(C)[NH]C2CCCCC12)NC(=O)[C@@H](N)CC1CNC[NH]1)C(=O)N[C@@H](CC1C[NH]C2CCCCC12)C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](CCCCN)C(N)=O;Cc1[nH]c2ccccc2c1C[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O,RVWNMGKSNGWLOL-GIIHNPQRSA-N
EXATECAN-MESYLATE,EXATECAN-MESYLATE,,BRD:BRD-BRD-K92150287-066-01-2;BRD:BRD-K92150287-066-01-2,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,PHASE 3,,,NA,"CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CC(F)C(C)C5CC[C@H](N)C(C3CN1C2=O)C45, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CC(F)C(C)C5CC[C@H](N)C(C3CN1C2=O)C45",
PNU-155971,AROMASIN;EXEMESTANE;FCE-24304;FCE24304;NSC-758907;PNU-155971,CHEMBL1200374,BRD:BRD-BRD-K33425534-001-12-5;BRD:BRD-K33425534-001-12-5,rep_multi_dose;rep_primary;rep_single_dose,AROMATASE INHIBITOR,CYP19A1,BREAST CANCER,,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O;C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12",BFYIZQONLCFLEV-DAELLWKTSA-N
NSC-729477,ADH 1;ADH-1;CYS-HIS-ALA-VAL-CYS;EXHERIN;NSC-729477,CHEMBL3818130,BRD:BRD-BRD-K81795818-019-01-4;BRD:BRD-K81795818-019-01-4,rep_primary;rep_single_dose,CADHERIN ANTAGONIST,CDH2,,,PHASE 2,,Protein,1,CC(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O;CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC2CNC[NH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(N)=O)NC(C)=O,FQVLRGLGWNWPSS-BXBUPLCLSA-N
NSC-680919,EXIFONE;NSC-680919,CHEMBL329522,BRD:BRD-BRD-K65716359-001-02-1;BRD:BRD-K65716359-001-02-1,rep_primary;rep_single_dose,NOOTROPIC AGENT,TYR,,,WITHDRAWN,,Small molecule,4,"O=C(c1cc(O)c(O)c(O)c1)c1ccc(O)c(O)c1O;OC1CCC(C(=O)C2CC(O)C(O)C(O)C2)C(O)C1O, OC1CCC(C(=O)C2CC(O)C(O)C(O)C2)C(O)C1O",XEDWWPGWIXPVRQ-UHFFFAOYSA-N
SULINDAC SULFONE,APTOSYN;EXISULIND;FGN-1;PREVATEC;SULINDAC RELATED COMPOUND B;SULINDAC SULFONE,CHEMBL488025,BRD:BRD-BRD-K37708699-001-01-4;BRD:BRD-K37708699-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A,,,PHASE 3,,Small molecule,3,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1;CC1=C(CC(O)=O)C2CC(F)CCC2C\1=C/C1CCC(CC1)S(C)(=O)=O,MVGSNCBCUWPVDA-MFOYZWKCSA-N
EXO-1,EXO-1,,BRD:BRD-BRD-K78633253-001-10-3;BRD:BRD-K78633253-001-10-3,rep_primary;rep_single_dose,ARF INHIBITOR,,,,PRECLINICAL,,,NA,"COC(=O)C1CCCCC1NC(=O)C1CCC(F)CC1, COC(=O)C1CCCCC1NC(=O)C1CCC(F)CC1",
EXO-IWR-1,EXO-IWR-1,,BRD:BRD-K96155658-001-02-9,rep_single_dose,WNT SIGNALING INHIBITOR NEGATIVE CONTROL,TNKS,,,,,,NA,,
TLK-199,EZATIOSTAT;TLK-199,CHEMBL2110585,BRD:BRD-BRD-K98963219-001-01-2;BRD:BRD-K98963219-001-01-2,rep_primary;rep_single_dose,GLUTATHIONE TRANSFERASE INHIBITOR,GSTP1,,,PHASE 2,,Small molecule,2,"CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1;CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCC1CCCCC1)C(=O)N[C@@H](C(=O)OCC)C1CCCCC1, CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCC1CCCCC1)C(=O)N[C@@H](C(=O)OCC)C1CCCCC1, CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCC1CCCCC1)C(=O)N[C@@H](C(=O)OCC)C1CCCCC1",GWEJFLVSOGNLSS-WPFOTENUSA-N
ZETIA,EZETIMIBE;EZETROL;MK0653;NSC-758923;SCH-58235;SCH58235;ZETIA,CHEMBL1138,BRD:BRD-BRD-K42260897-001-07-6;BRD:BRD-BRD-K42260897-001-09-2;BRD:BRD-K42260897-001-07-6;BRD:BRD-K42260897-001-09-2,rep_primary;rep_single_dose,"CHOLESTEROL INHIBITOR, NIEMANN-PICK C1-LIKE 1 PROTEIN ANTAGONIST",ANPEP;NPC1L1;SOAT1,"HYPERLIPIDEMIA, HYPERCHOLESTEROLEMIA, SITOSTEROLEMIA",,LAUNCHED,,Small molecule,4,"O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1;OC(CC[C@@H]1[C@H](N(C1=O)C1CCC(F)CC1)C1CCC(O)CC1)C1CCC(F)CC1, O[C@@H](CC[C@@H]1[C@H](N(C1=O)C1CCC(F)CC1)C1CCC(O)CC1)C1CCC(F)CC1, O[C@@H](CC[C@@H]1[C@H](N(C1=O)C1CCC(F)CC1)C1CCC(O)CC1)C1CCC(F)CC1, O[C@@H](CC[C@@H]1[C@H](N(C1=O)C1CCC(F)CC1)C1CCC(O)CC1)C1CCC(F)CC1",OLNTVTPDXPETLC-XPWALMASSA-N
SMTC-1100,BMN 195;BMN-195;EZUTROMID;SMT C1100;SMT-C1100;SMTC-1100,CHEMBL1773683,BRD:BRD-BRD-K25570267-001-01-4;BRD:BRD-K25570267-001-01-4,rep_primary;rep_single_dose,UTROPHIN ENHANCER,UTRN,,,PHASE 2,,Small molecule,2,CCN(CC)C1CCC(CC1)-N1NC2CC(C)C(N)CC2N1;CCS(=O)(=O)c1ccc2oc(-c3ccc4ccccc4c3)nc2c1,KSGCNXAZROJSNW-UHFFFAOYSA-N
F-11440,F-11440,,BRD:BRD-BRD-K87948281-001-01-9;BRD:BRD-K87948281-001-01-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,,,PHASE 2,,,NA,CN1C(=O)CNN(CCCCN2CCN(CC2)C2NCCCN2)C1=O,
F-16915,F-16915,,BRD:BRD-K00003299-001-01-9,rep_single_dose,,,,,,,,NA,,
F351,F351,,BRD:BRD-BRD-K41267922-001-01-4;BRD:BRD-K41267922-001-01-4,rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,TGFB1,,,PHASE 2,,,NA,CC1CCC(=O)N(C1)-C1CCC(O)CC1,
R-FADROZOLE,(R)-;CGS-16949A;DEXFADROSTAT;FADROZOLE;R-FADROZOLE,CHEMBL287677;CHEMBL9298,BRD:BRD-A25619068-003-03-4;BRD:BRD-BRD-A25619068-003-03-4,rep_primary;rep_single_dose,AROMATASE INHIBITOR,CYP11B1;CYP19A1,BREAST CANCER,,LAUNCHED,,Small molecule,-1,N#Cc1ccc([C@H]2CCCc3cncn32)cc1;N#CC1CCC(CC1)C1CCCC2CNCN12,CLPFFLWZZBQMAO-CQSZACIVSA-N
FAGOMINE,D-FAGOMINE;FAGOMINE,CHEMBL108084,BRD:BRD-BRD-K61536264-001-01-3;BRD:BRD-K61536264-001-01-3,rep_primary;rep_single_dose,GLUCOSIDASE INHIBITOR,GLB1,,,PHASE 2,,Small molecule,NA,OC[C@H]1NCC[C@@H](O)[C@@H]1O,YZNNBIPIQWYLDM-HSUXUTPPSA-N
HORNEL,FALECALCITORIOL;FALECALCITRIOL;FLOCALCITRIOL;HORNEL,CHEMBL2106158,BRD:BRD-BRD-K08251020-001-01-0;BRD:BRD-K08251020-001-01-0,rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,HYPERPARATHYROIDISM,,LAUNCHED,,Small molecule,-1,"C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C;C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(O)(C(F)(F)F)C(F)(F)F)CC[C@@H]23)C[C@@H](O)C[C@@H]1O",XPYGGHVSFMUHLH-UUSULHAXSA-N
NSC-758921,BRL-42810;FAMCICLOVIR;FAMVIR;NSC-758921,CHEMBL880,BRD:BRD-BRD-K45033733-001-12-2;BRD:BRD-K45033733-001-12-2,rep_multi_dose;rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,"COLD SORE, GENITIAL HERPES, SHINGLES",,LAUNCHED,,Small molecule,4,"CC(=O)OCC(CCN1CNC2CNC(N)NC12)COC(C)=O, CC(=O)OCC(CCN1CNC2CNC(N)NC12)COC(C)=O;CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O",GGXKWVWZWMLJEH-UHFFFAOYSA-N
YM-11170,AMFAMOX;FADUL;FAMODIL;FAMOSAN;FAMOTIDINE;FAMOTIDINE PRESERVATIVE FREE;FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK);FAMOXAL;FLUXID;GANOR;GASTRIDIN;GASTROPEN;L 643341;LECEDIL;MK-208;MOTIAX;MUCLOX;NSC-757810;PEPCID;PEPCID AC;PEPCID PRESERVATIVE FREE;PEPCID RPD;PEPCIDAC;PEPDINE;PEPDUL;YM-11170,CHEMBL902,BRD:BRD-BRD-K00673382-001-18-9;BRD:BRD-K00673382-001-18-9,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,HEARTBURN,,LAUNCHED,,Small molecule,4,"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1;NC(N)=NC1NC(CSCC\C(N)=N/S(N)(=O)=O)CS1, NC(N)=NC1NC(CSCC\C(N)=N/S(N)(=O)=O)CS1",XUFQPHANEAPEMJ-UHFFFAOYSA-N
NSC-759244,FAMPROFAZONE;NSC-759244,CHEMBL1475693,BRD:BRD-A08255417-001-14-7;BRD:BRD-BRD-A08255417-001-14-7,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,PRECLINICAL,,Small molecule,-1,"CC(C)c1c(CN(C)C(C)Cc2ccccc2)n(C)n(-c2ccccc2)c1=O;CC(CC1CCCCC1)N(C)CC1C(C(C)C)C(=O)N(-C2CCCCC2)N1C, CC(CC1CCCCC1)N(C)CC1C(C(C)C)C(=O)N(-C2CCCCC2)N1C",GNUXVOXXWGNPIV-UHFFFAOYSA-N
RP-62203,FANANSERIN;RP 62203;RP-62203,CHEMBL83894,BRD:BRD-BRD-K08998509-001-02-4;BRD:BRD-K08998509-001-02-4,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",HTR2A,,,PHASE 2,,Small molecule,-1,"FC1CCC(CC1)N1CCN(CCCN2C3CCCC4CCCC(C34)S2(=O)=O)CC1, FC1CCC(CC1)N1CCN(CCCN2C3CCCC4CCCC(C34)S2(=O)=O)CC1;O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1",VGIGHGMPMUCLIQ-UHFFFAOYSA-N
FANETIZOLE,FANETIZOLE,CHEMBL1993793,BRD:BRD-BRD-K60798049-001-03-8;BRD:BRD-K60798049-001-03-8,rep_primary;rep_single_dose,NEUTROPHIL SUPEROXIDE PRODUCTION,,,,PHASE 3,,Small molecule,-1,C(CC1CCCCC1)NC1NC(CS1)-C1CCCCC1;c1ccc(CCNc2nc(-c3ccccc3)cs2)cc1,WEEYMMXMBFJUAI-UHFFFAOYSA-N
SR-33557,FANTOFARONE;SR 33557;SR-33557,CHEMBL285855,BRD:BRD-K00003465-001-01-9,rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,,,Small molecule,-1,COc1ccc(CCN(C)CCCOc2ccc(S(=O)(=O)c3c(C(C)C)cn4ccccc34)cc2)cc1OC,ITAMRBIZWGDOHW-UHFFFAOYSA-N
FAPI-4,FAPI-4,,BRD:BRD-K00091294-001-01-9,rep_single_dose,,,,,,,,NA,,
SCH-900460,CX 691;CX-691;CX691;FARAMPATOR;ORG 24448;ORG-24448;SCH-900460,CHEMBL1276138,BRD:BRD-K00003507-001-01-9,rep_single_dose,IONOTROPIC GLUTAMATE RECEPTOR AGONIST,,,,,,Small molecule,2,O=C(c1ccc2nonc2c1)N1CCCCC1,XFVRBYKKGGDPAJ-UHFFFAOYSA-N
FARNESYL-THIOSALICYLIC-ACID-AMIDE,FARNESYL-THIOSALICYLIC-ACID-AMIDE,,BRD:BRD-BRD-K14590126-001-01-6;BRD:BRD-K14590126-001-01-6,rep_primary;rep_single_dose,RAS GTPASE INHIBITOR,HRAS,,,PHASE 1,,,NA,CC(C)=CCC\C(C)=C\CC\C(C)=C\CSC1CCCCC1C(N)=O,
FROPENEM,FAROPENEM;FROPENEM,CHEMBL556262,BRD:BRD-A49622760-001-01-9;BRD:BRD-BRD-A49622760-001-01-9,rep_primary;rep_single_dose,LACTAMASE INHIBITOR,,"PNEUMONIA, BRONCHITIS, SKIN INFECTIONS, URINARY TRACT INFECTIONS, SINUSITIS",,LAUNCHED,,Small molecule,3,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C([C@H]3CCCO3)S[C@H]12;CC(O)C1C2SC(C3CCCO3)=C(N2C1=O)C(O)=O,HGGAKXAHAYOLDJ-FHZUQPTBSA-N
FAROPENEM-MEDOXOMIL,FAROPENEM-MEDOXOMIL,,BRD:BRD-BRD-K59045783-001-01-1;BRD:BRD-K59045783-001-01-1,rep_primary;rep_single_dose,LACTAMASE INHIBITOR,,"SINUSITIS, PNEUMONIA, BRONCHITIS, SKIN INFECTIONS, URINARY TRACT INFECTIONS",,LAUNCHED,,,NA,"C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCC1OC(=O)OC1C, C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCC1OC(=O)OC1C, C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCC1OC(=O)OC1C",
FASLODEX,FASLODEX,,GDSC2:1200,gdsc,,,,,,,,NA,,
NS105,AEVI-001;AEVI001;FASORACETAM;LAM-105;LAM-105 ANHYDROUS;LAM105 ANHYDROUS;NFC-1 ANHYDROUS;NFC1 ANHYDROUS;NS-105;NS105,CHEMBL2106179,BRD:BRD-K00004571-001-01-9,rep_single_dose,GABA RECEPTOR ANTAGONIST,,,,,,Small molecule,2,O=C1CC[C@H](C(=O)N2CCCCC2)N1,GOWRRBABHQUJMX-MRVPVSSYSA-N
ZK-258594,AT 877;AT-877;FASUDIL;HA 1077;HA-1077;NSC-759827;ZK-258594,CHEMBL38380,BRD:BRD-BRD-K76617868-003-11-9;BRD:BRD-K76617868-003-11-9,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,PKIA;PRKACA;ROCK1;ROCK2,CEREBRAL VASOSPASM,,LAUNCHED,,Small molecule,3,"O=S(=O)(c1cccc2cnccc12)N1CCCNCC1;O=S(=O)(N1CCCNCC1)C1CCCC2CNCCC12, O=S(=O)(N1CCCNCC1)C1CCCC2CNCCC12, O=S(=O)(N1CCCNCC1)C1CCCC2CNCCC12, O=S(=O)(N1CCCNCC1)C1CCCC2CNCCC12",NGOGFTYYXHNFQH-UHFFFAOYSA-N
T-705,AVIGAN;FAVIPIRAVIR;T-705,CHEMBL221722,BRD:BRD-BRD-K04264130-001-01-4;BRD:BRD-K04264130-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,,,PHASE 3,,Small molecule,3,NC(=O)c1nc(F)cnc1O;NC(=O)C1NC(F)CNC1O,ZCGNOVWYSGBHAU-UHFFFAOYSA-N
FDCYD,FDCYD,,BRD:BRD-BRD-K18157228-001-01-7;BRD:BRD-K18157228-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,DNA METHYLTRANSFERASE INHIBITOR,,,,PHASE 2,,,NA,NC1NC(=O)N(CC1F)[C@H]1C[C@H](O)[C@@H](CO)O1,
NCGC00099374,FDI-6;NCGC00099374,,BRD:BRD-K00126477-001-01-9,oncref_2,INHIBITOR OF FOXM1,FOXM1,,,,,,NA,,
RINTAL,BAY H 5757;BAY VH 5757;BAY-H-5757;BAY-VH-5757;BAYH-5757;BAYVH-5757;COMBOTEL;FEBANTEL;FEBANTEL FOR VETERINARY USE;NEGABOT PLUS PASTE;ORATEL;RINTAL,CHEMBL1080983,BRD:BRD-K00076917-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,COCC(=O)Nc1cc(Sc2ccccc2)ccc1N=C(NC(=O)OC)NC(=O)OC,HMCCXLBXIJMERM-UHFFFAOYSA-N
VALBIL,FEBUPROL;NSC-30151;VALBIL,CHEMBL2104223,BRD:BRD-K00004566-001-01-9,rep_single_dose,CHOLERETIC AGENT,,,,,,Small molecule,-1,CCCCOCC(O)COc1ccccc1,WBLXZPHICYCDGN-UHFFFAOYSA-N
ULORIC,ADENURIC;FEBUXOSTAT;NSC-758874;TMX-67;ULORIC,CHEMBL1164729,BRD:BRD-BRD-K48367671-001-05-9;BRD:BRD-K48367671-001-05-9,rep_primary;rep_single_dose,XANTHINE OXIDASE INHIBITOR,XDH,HYPERURICEMIA,,LAUNCHED,,Small molecule,4,"CC(C)COC1CCC(CC1C#N)-C1NC(C)C(S1)C(O)=O, CC(C)COC1CCC(CC1C#N)-C1NC(C)C(S1)C(O)=O, CC(C)COC1CCC(CC1C#N)-C1NC(C)C(S1)C(O)=O;Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O",BQSJTQLCZDPROO-UHFFFAOYSA-N
VA-106483,FEDOVAPAGON;VA-106483,CHEMBL518043,BRD:BRD-K00075618-001-03-9,rep_single_dose,,,,,,,Small molecule,2,Cc1cc(C(=O)N2CCCCc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C,RUOLFWZIFNQQGH-DEOSSOPVSA-N
TG101348,FEDRATINIB;SAR-302503;SAR302503;TG-101348;TG101348,CHEMBL1287853,BRD:BRD-BRD-K12502280-001-08-0;BRD:BRD-K12502280-001-08-0;BRD:BRD-K12502280-001-19-9;CTRP:411808;GDSC1:306,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,"FLT3 INHIBITOR, JAK INHIBITOR",BRD4;FLT3;JAK1;JAK2;JAK3;RET;TYK2,,,PHASE 3,"Multiple values for MOA: {'FLT3 INHIBITOR, JAK INHIBITOR', 'INHIBITOR OF JAK2'}, defaulting to 'FLT3 INHIBITOR, JAK INHIBITOR'
Multiple values for repurposing_target: {'BRD4;JAK1;JAK2;JAK3;TYK2', 'FLT3;JAK1;JAK2;RET'}, taking the union",Small molecule,4,"CC1CNC(NC2CCC(OCCN3CCCC3)CC2)NC1NC1CCCC(C1)S(=O)(=O)NC(C)(C)C, CC1CNC(NC2CCC(OCCN3CCCC3)CC2)NC1NC1CCCC(C1)S(=O)(=O)NC(C)(C)C;Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1",JOOXLOJCABQBSG-UHFFFAOYSA-N
W-554,ADD-03055;FELBAMATE;FELBATOL;NSC-759866;TALOXA;W-554,CHEMBL1094,BRD:BRD-BRD-K99107520-001-24-1;BRD:BRD-K99107520-001-24-1,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B,EPILEPSY,,LAUNCHED,,Small molecule,4,"NC(=O)OCC(COC(N)=O)c1ccccc1;NC(=O)OCC(COC(N)=O)C1CCCCC1, NC(=O)OCC(COC(N)=O)C1CCCCC1, NC(=O)OCC(COC(N)=O)C1CCCCC1, NC(=O)OCC(COC(N)=O)C1CCCCC1",WKGXYQFOCVYPAC-UHFFFAOYSA-N
TRAXAM,"CL 83,544;CL-83544;DOLINAC;FELBINAC;FELBINAC ETHYL;FLEXFREE;L-141;LJC 10,141;LJC-10141;LY-61017;NAPAGELN;NSC-16284;TARGET;TRAXAM",CHEMBL413965,BRD:BRD-BRD-K91740057-001-19-8;BRD:BRD-K91740057-001-19-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,CTSL,"RHEUMATOID ARTHRITIS, MUSCLE PAIN",,LAUNCHED,,Small molecule,4,O=C(O)Cc1ccc(-c2ccccc2)cc1;OC(=O)CC1CCC(CC1)-C1CCCCC1,QRZAKQDHEVVFRX-UHFFFAOYSA-N
VASCALPHA,C08CA02;CABREN;CARDIOPLEN XL;FELODIPINE;FELOGEN XL;FELOTENS XL;FOLPIK XL;H 154/82;H-154/82;KELOC SR;NEOFEL XL;NSC-760343;PARMID XL;PINEFELD XL;PLENDIL;PRESLOW;VASCALPHA,CHEMBL1480,BRD:BRD-A30815329-001-10-5;BRD:BRD-BRD-A30815329-001-10-5,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1D;CACNA1F;CACNA1H;CACNA1S;CACNA2D1;CACNA2D2;CACNB2;CALM1;CFTR;NR3C2;PDE1A;PDE1B;TNNC1;TNNC2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl;CCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(CL)C1CL)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(CL)C1CL)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(CL)C1CL)C(=O)OC",RZTAMFZIAATZDJ-UHFFFAOYSA-N
PLV-2,FELYPRESSIN;PLV-2,CHEMBL1908309;CHEMBL3989781,BRD:BRD-K00003319-001-01-9,rep_single_dose,VASOPRESSIN RECEPTOR AGONIST,,,,,,Protein,-1,NCCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,SFKQVVDKFKYTNA-OGNLOKFRSA-N
PHENACON,FENACLON;PHENACON,CHEMBL2106620,BRD:BRD-BRD-K08791496-001-01-0;BRD:BRD-K08791496-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CLCCC(=O)NCCC1CCCCC1;O=C(CCCl)NCCc1ccccc1,BITWVVLBVUMFHU-UHFFFAOYSA-N
PANACUR AQUASOL,FENBENDAZOLE;FENBENDAZOLE FOR VETERINARY USE;HOE 881V;HOE 881Y;HOE-881V;HOE-881Y;NSC-757824;PANACUR;PANACUR AQUASOL,CHEMBL37161,BRD:BRD-BRD-K51318897-001-15-3;BRD:BRD-K51318897-001-15-3,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB,"GASTROINTESTINAL PARASITES, GASTROINTESTINAL ROUNDWORMS",,LAUNCHED,,Small molecule,-1,"COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1;COC(=O)NC1NC2CCC(SC3CCCCC3)CC2[NH]1, COC(=O)NC1NC2CCC(SC3CCCCC3)CC2[NH]1",HDDSHPAODJUKPD-UHFFFAOYSA-N
NSC-757812,"CINOPAL;CL 82,204;CL-82204;FENBUFEN;FENBUZIP 300;FENBUZIP 450;LEDERFEN 450;LEDERFEN CP;LEDERFEN F;NSC-757812",CHEMBL277522,BRD:BRD-BRD-K12513978-001-24-1;BRD:BRD-K12513978-001-24-1,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,LAUNCHED,,Small molecule,4,O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1;OC(=O)CCC(=O)C1CCC(CC1)-C1CCCCC1,ZPAKPRAICRBAOD-UHFFFAOYSA-N
FENCLONINE-(+/-),FENCLONINE-(+/-),,BRD:BRD-A81615860-003-01-7;BRD:BRD-BRD-A81615860-003-01-7,rep_primary;rep_single_dose,TRYPTOPHAN HYDROXYLASE INHIBITOR,PAH;TPH1;TPH2,,,PRECLINICAL,,,NA,NC(CC1CCC(CL)CC1)C(O)=O,
FENDILINE,FENDILINE,CHEMBL254832,BRD:BRD-A71033472-003-23-9;BRD:BRD-BRD-A71033472-003-23-9,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,HTR2B,,,PRECLINICAL,,Small molecule,-1,CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1;CC(NCCC(C1CCCCC1)C1CCCCC1)C1CCCCC1,NMKSAYKQLCHXDK-UHFFFAOYSA-N
RO7010939,FENEBRUTINIB;G-02599853;G02599853;GDC-0853;RG-7845;RG7845;RO-7010939;RO7010939,CHEMBL4065122,BRD:BRD-K25290930-001-03-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,Small molecule,3,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1,WNEODWDFDXWOLU-QHCPKHFHSA-N
FENIGAM,FENIGAM,,BRD:BRD-A66920069-001-01-3;BRD:BRD-BRD-A66920069-001-01-3,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABBR1;GABBR2,"POSTTRAUMATIC STRESS DISORDER, ANXIETY, DEPRESSION",,LAUNCHED,,,NA,NCC(CC(O)=O)C1CCCCC1,
MCN-3377-98,FENOBAM;MCN-3377-98,CHEMBL2103779;CHEMBL239800,BRD:BRD-BRD-K41160163-001-06-8;BRD:BRD-K41160163-001-06-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM5,,,PHASE 2,,Small molecule,1,"CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1;CN1CC(=O)N=C1NC(=O)NC1CCCC(CL)C1, CN1CC(=O)N=C1NC(=O)NC1CCCC(CL)C1;CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1.O",DWPQODZAOSWNHB-UHFFFAOYSA-N;UNFQKKSADLVQJE-UHFFFAOYSA-N
TRIGLIDE,ANTARA;ANTARA (MICRONIZED);FENOFIBRATE;FENOFIBRATE (MICRONIZED);FENOFIBRATE DELAYED RELEASE;FENOFIBRATE MICRONIZED;FENOGAL;FENOGLIDE;LIPANTIL;LIPANTIL MICRO 200;LIPANTIL MICRO 267;LIPANTIL MICRO 67;LIPIDIL;LIPOFEN;NSC-281319;SUPRALIP 160;TRICOR;TRICOR (MICRONIZED);TRIGLIDE,CHEMBL672,BRD:BRD-BRD-K50388907-001-30-4;BRD:BRD-K50388907-001-30-4,rep_multi_dose;rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,MMP25;PPARA,"HYPERCHOLESTEROLEMIA, HYPERTRIGLYCERIDEMIA",,LAUNCHED,,Small molecule,4,"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1;CC(C)OC(=O)C(C)(C)OC1CCC(CC1)C(=O)C1CCC(CL)CC1, CC(C)OC(=O)C(C)(C)OC1CCC(CC1)C(=O)C1CCC(CL)CC1, CC(C)OC(=O)C(C)(C)OC1CCC(CC1)C(=O)C1CCC(CL)CC1",YMTINGFKWWXKFG-UHFFFAOYSA-N
FENOFIBRIC-ACID,FENOFIBRIC-ACID,,BRD:BRD-BRD-K30213273-001-01-6;BRD:BRD-K30213273-001-01-6,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CLCN1;PPARA,DYSLIPIDEMIA,,LAUNCHED,,,NA,CC(C)(OC1CCC(CC1)C(=O)C1CCC(CL)CC1)C(O)=O,
SK&F-82526,CARLACOR;FENOLDOPAM;SK-82526;SK&F-82526,CHEMBL588,BRD:BRD-A50684349-003-02-9;BRD:BRD-BRD-A50684349-003-02-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;DRD1;DRD4;DRD5,HYPERTENSION,,LAUNCHED,,Small molecule,4,"Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1;OC1CCC(CC1)C1CNCCC2C(CL)C(O)C(O)CC12, OC1CCC(CC1)C1CNCCC2C(CL)C(O)C(O)CC12",TVURRHSHRRELCG-UHFFFAOYSA-N
PROGESIC,53858;FENOPROFEN;LILLY-53858;NALFON;NSC-757813;PROGESIC,CHEMBL1297,BRD:BRD-A81129465-001-03-8;BRD:BRD-BRD-A81129465-001-03-8,rep_multi_dose;rep_primary;rep_single_dose,PROSTAGLANDIN INHIBITOR,PTGS1;PTGS2;SLC5A8,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS",,LAUNCHED,,Small molecule,4,"CC(C(=O)O)c1cccc(Oc2ccccc2)c1;CC(C(O)=O)C1CCCC(OC2CCCCC2)C1, CC(C(O)=O)C1CCCC(OC2CCCCC2)C1, CC(C(O)=O)C1CCCC(OC2CCCCC2)C1",RDJGLLICXDHJDY-UHFFFAOYSA-N
TH-1165A FREE BASE,AIRUM;BERODUAL;BERODUAL N;BEROTEC;BEROTEC [AS HYDROBROMIDE];BEROTEC 100;BEROTEC 200;DOSBEROTEC;DUOVENT;FENOTEROL;FENOTEROL HBR;FENOTEROL HYDROBROMIDE;NSC-757811;PARTUSISTEN;TH 1165A;TH 1165A [AS HYDROBROMIDE SALT];TH 1165A FREE BASE;TH-1165;TH-1165A;TH-1165A FREE BASE,CHEMBL32800,BRD:BRD-A97104540-004-15-0;BRD:BRD-BRD-A97104540-004-15-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2;ADRB3,,,WITHDRAWN,,Small molecule,4,CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1;CC(CC1CCC(O)CC1)NCC(O)C1CC(O)CC(O)C1,LSLYOANBFKQKPT-UHFFFAOYSA-N
SPASMOPRIV,FENOVERINE;SPASMOPRIV,CHEMBL1512949,BRD:BRD-BRD-K77564118-001-03-1;BRD:BRD-K77564118-001-03-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,SPASMS,,LAUNCHED,,Small molecule,3,O=C(CN1CCN(Cc2ccc3c(c2)OCO3)CC1)N1c2ccccc2Sc2ccccc21;O=C(CN1CCN(CC2CCC3OCOC3C2)CC1)N1C2CCCCC2SC2CCCCC12,UBAJTZKNDCEGKL-UHFFFAOYSA-N
RII RETINAMIDE,4-HPR;ALL-TRANS-4'-HYDROXYRETINANILIDE;FENRETINIDE;MCN-R-1967;N-(4-HYDROXYPHENYL)-;N-(4-HYDROXYPHENYL)RETINAMIDE;NSC-760419;RETINAMIDE;RII RETINAMIDE,CHEMBL7301,BRD:BRD-BRD-K89085489-001-23-2;BRD:BRD-K89085489-001-23-2,rep_multi_dose;rep_primary;rep_single_dose,"APOPTOSIS STIMULANT, RETINOID RECEPTOR AGONIST",RARA,,,PHASE 3,,Small molecule,3,"CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(=O)NC1CCC(O)CC1, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(=O)NC1CCC(O)CC1, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(=O)NC1CCC(O)CC1, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(=O)NC1CCC(O)CC1;CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1",AKJHMTWEGVYYSE-FXILSDISSA-N
FENSPIRIDE,EURESPAL;FENSPIRIDE,CHEMBL576127,BRD:BRD-BRD-K26739552-003-15-4;BRD:BRD-K26739552-003-15-4,rep_primary;rep_single_dose,BRONCHODILATOR,,"ASTHMA, OTITIS, SINUSITIS, RHINOPHARYNGITIS, LARYNGITIS",,LAUNCHED,,Small molecule,4,"O=C1NCC2(CCN(CCc3ccccc3)CC2)O1;O=C1NCC2(CCN(CCC3CCCCC3)CC2)O1, O=C1NCC2(CCN(CCC3CCCCC3)CC2)O1",FVNFBBAOMBJTST-UHFFFAOYSA-N
TIGUVON,FENTHION;NSC-755881;PRO-SPOT;SPOTTON;TIGUVON,CHEMBL1604375,BRD:BRD-BRD-K67217586-001-08-0;BRD:BRD-K67217586-001-08-0,rep_primary;rep_single_dose,CHOLINESTERASE INHIBITOR,,,,LAUNCHED,,Small molecule,-1,COP(=S)(OC)Oc1ccc(SC)c(C)c1;COP(=S)(OC)OC1CCC(SC)C(C)C1,PNVJTZOFSHSLTO-UHFFFAOYSA-N
WY-21894,"FENTIAZAC;NSC-282191;WY-21,894;WY-21894",CHEMBL589092,BRD:BRD-BRD-K16077845-001-06-1;BRD:BRD-K16077845-001-06-1,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"MUSCLE PAIN, JOINT PAIN",,LAUNCHED,,Small molecule,-1,O=C(O)Cc1sc(-c2ccccc2)nc1-c1ccc(Cl)cc1;OC(=O)CC1SC(NC1-C1CCC(CL)CC1)-C1CCCCC1,JIEKMACRVQTPRC-UHFFFAOYSA-N
FENTICONAZOLE,FENTICONAZOLE,CHEMBL1651990,BRD:BRD-A33697453-008-02-4;BRD:BRD-BRD-A33697453-008-02-4,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,VULVOVAGINAL CANDIDIASIS,,LAUNCHED,,Small molecule,4,Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1;CLC1CCC(C(CN2CCNC2)OCC2CCC(SC3CCCCC3)CC2)C(CL)C1,ZCJYUTQZBAIHBS-UHFFFAOYSA-N
FERB-033,FERB-033,,BRD:BRD-BRD-K61642990-001-01-0;BRD:BRD-K61642990-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,ERBB2,,,PRECLINICAL,,,NA,"O\N=C\C1CCC(-C2CCC(O)C(F)C2)C(CL)C1O, O\N=C\C1CCC(-C2CCC(O)C(F)C2)C(CL)C1O",
FERROQUINE,FERROQUINE,,BRD:BRD-K00003281-001-01-9,rep_single_dose,ANTIMALARIAL AGENT,,,,,,,NA,,
FERROSTATIN-1,FERROSTATIN-1,,BRD:BRD-K97375133-001-04-9,rep_single_dose,FERROPTOSIS INHIBITOR,,,,,,,NA,,
FERULIC-ACID,FERULIC-ACID,,BRD:BRD-BRD-K66295376-001-13-1;BRD:BRD-K66295376-001-13-1,rep_primary;rep_single_dose,ANTIOXIDANT,CA1;CA12;CA14;CA2;CA4;CA6;CA9,,,PHASE 2,,,NA,"COC1CC(\C=C\C(O)=O)CCC1O, COC1CC(\C=C\C(O)=O)CCC1O, COC1CC(\C=C\C(O)=O)CCC1O, COC1CC(\C=C\C(O)=O)CCC1O",
FESOTERODINE,FESOTERODINE,CHEMBL1201764,BRD:BRD-BRD-K46731503-050-01-8;BRD:BRD-K46731503-050-01-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,URINARY INCONTINENCE,,LAUNCHED,,Small molecule,4,"CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1;CC(C)N(CC[C@H](C1CCCCC1)C1CC(CO)CCC1OC(=O)C(C)C)C(C)C, CC(C)N(CC[C@H](C1CCCCC1)C1CC(CO)CCC1OC(=O)C(C)C)C(C)C",DCCSDBARQIPTGU-HSZRJFAPSA-N
QAW039,FEVIPIPRANT;NVP-QAW039;QAW-039;QAW039,CHEMBL3137332,BRD:BRD-K00003232-001-01-9,rep_single_dose,PROSTAGLANDIN INHIBITOR,,,,,,Small molecule,3,Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1C(F)(F)F,GFPPXZDRVCSVNR-UHFFFAOYSA-N
FEXARAMINE,FEXARAMINE,CHEMBL192966,BRD:BRD-BRD-K08864679-001-02-2;BRD:BRD-K08864679-001-02-2,rep_primary;rep_single_dose,FXR AGONIST,NR1H4,,,PRECLINICAL,,Small molecule,NA,"COC(=O)/C=C/c1cccc(N(Cc2ccc(-c3ccc(N(C)C)cc3)cc2)C(=O)C2CCCCC2)c1;COC(=O)\C=C\C1CCCC(C1)N(CC1CCC(CC1)-C1CCC(CC1)N(C)C)C(=O)C1CCCCC1, COC(=O)\C=C\C1CCCC(C1)N(CC1CCC(CC1)-C1CCC(CC1)N(C)C)C(=O)C1CCCCC1",VLQTUNDJHLEFEQ-KGENOOAVSA-N
HOE-239,FEXINIDAZOLE;HOE 239;HOE-239,CHEMBL1631694,BRD:BRD-BRD-K37069697-001-01-3;BRD:BRD-K37069697-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2/PHASE 3,,Small molecule,4,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1;CSC1CCC(OCC2NCC(N2C)[N+]([O-])=O)CC1,MIWWSGDADVMLTG-UHFFFAOYSA-N
FEXOFENADINE,ALLEGRA;FEXOFENADINE,CHEMBL914,BRD:BRD-A73368467-003-17-6;BRD:BRD-BRD-A73368467-003-17-6,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,4,"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1;CC(C)(C(O)=O)C1CCC(CC1)C(O)CCCN1CCC(CC1)C(O)(C1CCCCC1)C1CCCCC1, CC(C)(C(O)=O)C1CCC(CC1)C(O)CCCN1CCC(CC1)C(O)(C1CCCCC1)C1CCCCC1, CC(C)(C(O)=O)C1CCC(CC1)C(O)CCCN1CCC(CC1)C(O)(C1CCCCC1)C1CCCCC1, CC(C)(C(O)=O)C1CCC(CC1)C(O)CCCN1CCC(CC1)C(O)(C1CCCCC1)C1CCCCC1",RWTNPBWLLIMQHL-UHFFFAOYSA-N
FEZOLINETANT,A-2693;A2693;AS-3472693-00;AS3472693-00;ES-256364;ESN-364;ESN364;FEZOLINETANT,CHEMBL3608680,BRD:BRD-K00003287-001-01-9,rep_single_dose,NEUROKININ RECEPTOR ANTAGONIST,,,,,,Small molecule,3,Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1,PPSNFPASKFYPMN-SECBINFHSA-N
FG-2216,FG-2216,,BRD:BRD-BRD-K56807945-001-01-2;BRD:BRD-K56807945-001-01-2,rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,EGLN1;EGLN2;HIF1A,,,PHASE 2,,,NA,OC(=O)CNC(=O)C1NC(CL)C2CCCCC2C1O,
ROXADUSTAT,ASP-1517;ASP1517;FG-4592;FG4592;ROXADUSTAT,CHEMBL2338329,BRD:BRD-BRD-K14385366-001-04-4;BRD:BRD-K14385366-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,EGLN1;EGLN2;EGLN3,,,PHASE 3,"Multiple values for repurposing_target: {'EGLN1;EGLN2;EGLN3', 'EGLN2'}, taking the union",Small molecule,4,"Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12;CC1NC(C(=O)NCC(O)=O)C(O)C2CCC(OC3CCCCC3)CC12, CC1NC(C(=O)NCC(O)=O)C(O)C2CCC(OC3CCCCC3)CC12",YOZBGTLTNGAVFU-UHFFFAOYSA-N
FG-7142,FG-7142,,BRD:BRD-BRD-K61951118-001-07-9;BRD:BRD-K61951118-001-07-9,rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,,,,PRECLINICAL,,,NA,"CNC(=O)C1CC2C(CN1)[NH]C1CCCCC21, CNC(=O)C1CC2C(CN1)[NH]C1CCCCC21",
ROBLITINIB,FGF401;ROBLITINIB,CHEMBL3545293,BRD:BRD-K00003424-001-01-9;BRD:BRD-K00003424-001-03-9,oncref_2;rep_single_dose,INHIBITOR OF FGFR4,FGFR4,,,,"Multiple values for MOA: {'INHIBITOR OF FGFR4', 'FGFR INHIBITOR'}, defaulting to 'INHIBITOR OF FGFR4'",Small molecule,2,,
FGIN-1-27,FGIN-1-27,,BRD:BRD-BRD-K09778810-001-10-6;BRD:BRD-K09778810-001-10-6;CTRP:61775,ctrp;rep_primary;rep_single_dose,INOSITOL MONOPHOSPHATASE INHIBITOR,TSPO,,,PRECLINICAL,,,NA,"CCCCCCN(CCCCCC)C(=O)CC1C([NH]C2CCCCC12)-C1CCC(F)CC1, CCCCCCN(CCCCCC)C(=O)CC1C([NH]C2CCCCC12)-C1CCC(F)CC1",
FGIN-1-43,FGIN-1-43,,BRD:BRD-BRD-K66093087-001-03-1;BRD:BRD-K66093087-001-03-1,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,TSPO,,,PRECLINICAL,,,NA,"CCCCCCN(CCCCCC)C(=O)CC1C([NH]C2CCC(CL)CC12)-C1CCC(CL)CC1, CCCCCCN(CCCCCC)C(=O)CC1C([NH]C2CCC(CL)CC12)-C1CCC(CL)CC1",
FH-535,FH-535,,BRD:BRD-K48112880-001-04-9,rep_single_dose,"PPAR RECEPTOR ANTAGONIST, WNT SIGNALING INHIBITOR",PPARD;PPARG,,,,,,NA,,
FH1,FH1,,BRD:BRD-BRD-K44777625-001-03-5;BRD:BRD-K44777625-001-03-5,rep_primary;rep_single_dose,HEPATOCYTE FUNCTION ENHANCER,,,,PRECLINICAL,,,NA,"CC(=O)NC1CCC(CC2CCC(NC(C)=O)CC2)CC1, CC(=O)NC1CCC(CC2CCC(NC(C)=O)CC2)CC1",
FH535,FH535,,GDSC1:173,gdsc,,,,,,,,NA,,
NSC-382097,FIAC;FIACITABINE;NSC-382097,CHEMBL272557,BRD:BRD-BRD-K07160047-001-01-3;BRD:BRD-K07160047-001-01-3,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,,,PHASE 2,,Small molecule,2,Nc1nc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I;NC1NC(=O)N(CC1I)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,GIMSJJHKKXRFGV-BYPJNBLXSA-N
FIDARESTAT,ALDOS;FIDARESTAT,CHEMBL84446,BRD:BRD-A63752151-001-01-2;BRD:BRD-BRD-A63752151-001-01-2,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,AKR1B1,,,PHASE 3,,Small molecule,-1,NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)c2cc(F)ccc2O1;NC(=O)C1CC2(NC(=O)NC2=O)C2CC(F)CCC2O1,WAAPEIZFCHNLKK-UFBFGSQYSA-N
PAR-101,DIFICID;DIFICLIR;FIDAXOMICIN;OPT-80;PAR-101,CHEMBL1255800,BRD:BRD-BRD-K57371763-001-01-7;BRD:BRD-K57371763-001-01-7,rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,DIARRHEA,,LAUNCHED,,Small molecule,4,CC[C@H]1\C=C(C)/[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)C3C(O)C(CL)C(O)C(CL)C3CC)[C@H](O)[C@@H]2OC)\C(=O)O[C@H](C\C=C(C)\C=C(C)[C@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@H]1O)[C@@H](C)O;CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C,ZVGNESXIJDCBKN-UUEYKCAUSA-N
FILANESIB,ARRY-520;FILANESIB,CHEMBL2347655,BRD:BRD-BRD-K37379014-001-01-2;BRD:BRD-K37379014-001-01-2;BRD:BRD-K37379014-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,"KINESIN INHIBITOR, KINESIN-LIKE SPINDLE PROTEIN INHIBITOR",KIF11,,,PHASE 3,,Small molecule,2,"CON(C)C(=O)N1N=C(c2cc(F)ccc2F)S[C@@]1(CCCN)c1ccccc1;CON(C)C(=O)N1N=C(S[C@@]1(CCCN)C1CCCCC1)C1CC(F)CCC1F, CON(C)C(=O)N1N=C(S[C@@]1(CCCN)C1CCCCC1)C1CC(F)CCC1F",LLXISKGBWFTGEI-FQEVSTJZSA-N
GS-6034 FREE BASE,FILGOTINIB;G-146034;G146034;GLPG-0634;GLPG0634;GS-6034 FREE BASE,CHEMBL3301607,BRD:BRD-BRD-K16803204-001-01-6;BRD:BRD-K16803204-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2;JAK3;TYK2,,,PHASE 2,,Small molecule,4,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1;O=C(NC1NC2CCCC(-C3CCC(CN4CCS(=O)(=O)CC4)CC3)N2N1)C1CC1,RIJLVEAXPNLDTC-UHFFFAOYSA-N
PF-868554,FILIBUVIR;PF-00868554;PF-868554,CHEMBL490672,BRD:BRD-K00091264-001-01-9,rep_single_dose,,,,,,,Small molecule,3,CCc1cc(CC[C@]2(C3CCCC3)CC(O)=C(Cc3nc4nc(C)cc(C)n4n3)C(=O)O2)cc(CC)n1,SLVAPEZTBDBAPI-GDLZYMKVSA-N
FIMASARTAN,FIMASARTAN,CHEMBL1951143,BRD:BRD-BRD-K21586122-001-01-9;BRD:BRD-K21586122-001-01-9,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,"HYPERTENSION, CONGESTIVE HEART FAILURE, HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,3,"CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1;CCCCC1NC(C)C(CC(=S)N(C)C)C(=O)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCCCC1NC(C)C(CC(=S)N(C)C)C(=O)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1",AMEROGPZOLAFBN-UHFFFAOYSA-N
XTORO,AL-60371;FINAFLOXACIN;XTORO,CHEMBL1908370,BRD:BRD-BRD-K98384930-003-01-5;BRD:BRD-K98384930-003-01-5,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,"INTRA-ABDOMINAL INFECTIONS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), CYSTIC FIBROSIS",,LAUNCHED,,Small molecule,4,N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12;OC(=O)C1CN(C2CC2)C2C(C#N)C(N3C[C@@H]4NCCO[C@H]4C3)C(F)CC2C1=O,FYMHQCNFKNMJAV-HOTGVXAUSA-N
PROSTIDE,AINDEEM;FINASTERIDE;MK-906;NSC-741485;NSC-759318;PROPECIA;PROSCAR;PROSTIDE,CHEMBL710,BRD:BRD-BRD-K01095011-001-15-9;BRD:BRD-K01095011-001-15-9,rep_primary;rep_single_dose,5 ALPHA REDUCTASE INHIBITOR,AKR1D1;SRD5A1;SRD5A2,ANDROGENETIC ALOPECIA,,LAUNCHED,,Small molecule,4,"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C;CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C, CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C",DBEPLOCGEIEOCV-WSBQPABSSA-N
KERENDIA,BAY 94-8862;BAY-94-8862;BAY94-8862;FINERENONE;KERENDIA,CHEMBL2181927,BRD:BRD-K00075103-001-02-9,rep_single_dose,,,,,,,Small molecule,4,CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,BTBHLEZXCOBLCY-QGZVFWFLSA-N
GILENYA,FINGOLIMOD;FINGOLIMOD (AS HYDROCHLORIDE);FINGOLIMOD HCL;FINGOLIMOD HYDROCHLORID;FINGOLIMOD HYDROCHLORIDE;FTY-720;FTY-720 HYDROCHLORIDE;FTY720;FTY720 HYDROCHLORIDE;GILENIA;GILENYA,CHEMBL314854;CHEMBL544665,BRD:BRD-BRD-K88025533-003-03-3;BRD:BRD-K88025533-003-03-3;CTRP:640157,ctrp;rep_primary;rep_single_dose,"IMMUNOSUPPRESSANT, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE PHOSPHATE RECEPTOR AGONIST",S1PR1;S1PR5,MULTIPLE SCLEROSIS,,LAUNCHED,"Multiple values for MOA: {'IMMUNOSUPPRESSANT, SPHINGOSINE PHOSPHATE RECEPTOR AGONIST', 'IMMUNOSUPPRESSANT, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE PHOSPHATE RECEPTOR AGONIST'}, defaulting to 'IMMUNOSUPPRESSANT, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE PHOSPHATE RECEPTOR AGONIST'",Small molecule,4,"CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1;CCCCCCCCC1CCC(CCC(N)(CO)CO)CC1, CCCCCCCCC1CCC(CCC(N)(CO)CO)CC1;CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1.Cl",KKGQTZUTZRNORY-UHFFFAOYSA-N;SWZTYAVBMYWFGS-UHFFFAOYSA-N
NSC-758407,FIPEXIDE;NSC-758407,CHEMBL254857,BRD:BRD-BRD-K37688416-003-13-1;BRD:BRD-K37688416-003-13-1,rep_primary;rep_single_dose,PSYCHOACTIVE DRUG,,,,WITHDRAWN,,Small molecule,4,CLC1CCC(OCC(=O)N2CCN(CC3CCC4OCOC4C3)CC2)CC1;O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1,BFUJHVVEMMWLHC-UHFFFAOYSA-N
FIPI,FIPI,,BRD:BRD-BRD-K61560897-003-01-4;BRD:BRD-K61560897-003-01-4,rep_primary;rep_single_dose,PHOSPHOLIPASE INHIBITOR,PLD1;PLD2,,,PRECLINICAL,,,NA,FC1CCC2[NH]C(CC2C1)C(=O)NCCN1CCC(CC1)N1C2CCCCC2[NH]C1=O,
TERMIDOR,FIPRONIL;FIPRONIL (EMA EPAR: VETERINARY);MB 46030;MB-46030;NSC-758960;RM 1601;RM-1601;TERMIDOR,CHEMBL101326,BRD:BRD-A50675702-001-07-1;BRD:BRD-BRD-A50675702-001-07-1,rep_primary;rep_single_dose,"CHLORIDE CHANNEL BLOCKER, GABA GATED CHLORIDE CHANNEL BLOCKER",,,,LAUNCHED,,Small molecule,-1,N#Cc1nn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)c(N)c1[S+]([O-])C(F)(F)F;NC1C(C(NN1-C1C(CL)CC(CC1CL)C(F)(F)F)C#N)S(=O)C(F)(F)F,ZOCSXAVNDGMNBV-UHFFFAOYSA-N
SB-683699,FIRATEGRAST;SB-683699,CHEMBL2104967,BRD:BRD-BRD-K17513304-001-01-9;BRD:BRD-K17513304-001-01-9,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGA4,,,PHASE 2,,Small molecule,2,CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1;CCOCC1CC(OC)C(-C2CCC(C[C@H](NC(=O)C3C(F)CCCC3F)C(O)=O)CC2)C(OC)C1,YLFZHHDVRSYTKT-NRFANRHFSA-N
PREVICOX,"EQUIOXX;FIROCOXIB;FIROCOXIB (EMA EPAR: VETERINARY);LIBRENS;ML-1,785,713;ML-1785713;NSC-758895;PREVICOX",CHEMBL69998,BRD:BRD-BRD-K09090523-001-02-1;BRD:BRD-K09090523-001-02-1,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,OSTEOARTHRITIS,,LAUNCHED,,Small molecule,-1,CC1(C)OC(=O)C(OCC2CC2)=C1C1CCC(CC1)S(C)(=O)=O;CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1,FULAPETWGIGNMT-UHFFFAOYSA-N
NDI-010976,FIRSOCOSTAT;GS-0976;GS-ACC;ND-630;NDI-010976,CHEMBL3407547,BRD:BRD-K00003236-001-01-9,rep_single_dose,ACETYL-COA CARBOXYLASE INHIBITOR,,,,,,Small molecule,2,COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(=O)O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1,ZZWWXIBKLBMSCS-FQEVSTJZSA-N
NSC-656275,5-DESOXYQUERCETIN;C.I. 75620;C.I. NATURAL BROWN 1;FISETIN;FISIDENOLON 1521;NSC-407010;NSC-656275,CHEMBL31574,BRD:BRD-K31836715-001-06-8,rep_single_dose,AURORA KINASE INHIBITOR,CDK6;FASN,,,,,Small molecule,2,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,XHEFDIBZLJXQHF-UHFFFAOYSA-N
X439161,BLU-111362;BLU-554;BLU111362;FISOGATINIB;X-439161;X439161,CHEMBL4514636,BRD:BRD-K00003377-001-01-9,rep_single_dose,FIBROBLAST GROWTH FACTOR INHIBITOR,,,,,,Small molecule,1,C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1,MGZKYOAQVGSSGC-DLBZAZTESA-N
FK-33-824,FK-33-824,,BRD:BRD-A01907367-001-01-7;BRD:BRD-BRD-A01907367-001-01-7,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRM1,,,PHASE 2,,,NA,C[C@H](NC(=O)[C@@H](N)CC1CCC(O)CC1)C(=O)NCC(=O)N(C)[C@@H](CC1CCCCC1)C(=O)N[C@H](CO)CCS(C)=O,
FK-3311,FK-3311,,BRD:BRD-BRD-K38350380-001-01-8;BRD:BRD-K38350380-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,,,PHASE 2,,,NA,CC(=O)C1CCC(NS(C)(=O)=O)C(OC2CCC(F)CC2F)C1,
FK-409,FK-409,,BRD:BRD-K00005243-001-01-9,rep_single_dose,GUANYLYL CYCLASE ACTIVATOR,,,,,,,NA,,
K 22.175,APO 866;APO-866;APO866;DAPORINAD;FK 866;FK-866;K 22.175,CHEMBL566757,BRD:BRD-BRD-K58550667-001-08-7;BRD:BRD-K58550667-001-08-7,rep_multi_dose;rep_primary;rep_single_dose,NIACINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITOR,NAMPT,,,PHASE 2,,Small molecule,2,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1;O=C(NCCCCC1CCN(CC1)C(=O)C1CCCCC1)\C=C\C1CCCNC1,KPBNHDGDUADAGP-VAWYXSNFSA-N
FK-888,FK-888,,BRD:BRD-BRD-K83508485-001-02-7;BRD:BRD-K83508485-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1;TACR2,,,PHASE 2,,,NA,"CN(CC1CCCCC1)C(=O)[C@H](CC1CCC2CCCCC2C1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)C1CN(C)C2CCCCC12, CN(CC1CCCCC1)C(=O)[C@H](CC1CCC2CCCCC2C1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)C1CN(C)C2CCCCC12",
FK962,FK-962;FK962,CHEMBL4802206,BRD:BRD-BRD-K80607346-001-01-1;BRD:BRD-K80607346-001-01-1,rep_primary;rep_single_dose,SOMATOSTATIN RECEPTOR AGONIST,,,,PHASE 2,,Unknown,2,CC(=O)N1CCC(CC1)NC(=O)C1CCC(F)CC1,
K 22.175,APO 866;APO-866;APO866;DAPORINAD;FK 866;FK-866;FK866;K 22.175,CHEMBL566757,GDSC1:1248;GDSC2:1248,gdsc,,,,,,,Small molecule,2,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,KPBNHDGDUADAGP-VAWYXSNFSA-N
NSC-649890,"ALVOCIDIB;ALVOCIDIB FREEBASE;FLAVOPIRIDOL;HL 275;HL-275;HMR 1275;HMR-1275;L 86 8275;L-868275;L86-8275;MDL 107,826A;MDL-107826A;NSC-649890",CHEMBL428690,GDSC1:432,gdsc,,,,,,,Small molecule,3,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,BIIVYFLTOXDAOV-YVEFUNNKSA-N
FLAVOXATE,BLADURIL;FLAVOXATE,CHEMBL1493,BRD:BRD-BRD-K47639036-003-06-6;BRD:BRD-K47639036-003-06-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2,"URINARY INCONTINENCE, INTERSTITIAL CYSTITIS (IC), URETHRITIS, PROSTATITIS",,LAUNCHED,,Small molecule,4,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O;CC1C(OC2C(CCCC2C1=O)C(=O)OCCN1CCCCC1)-C1CCCCC1,SPIUTQOUKAMGCX-UHFFFAOYSA-N
THN-102 COMPONENT FLECAINIDE,FLECAINIDE;NSC-719273;THN-102 COMPONENT FLECAINIDE,CHEMBL652,BRD:BRD-A09472452-015-23-4;BRD:BRD-BRD-A09472452-015-23-4,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,KCNA5;KCNA7;SCN4A;SCN5A,"VENTRICULAR TACHYCARDIA (VT), ATRIAL FIBRILLATION (AF), VENTRICULAR ARRHYTHMIAS",,LAUNCHED,,Small molecule,4,"FC(F)(F)COC1CCC(OCC(F)(F)F)C(C1)C(=O)NCC1CCCCN1, FC(F)(F)COC1CCC(OCC(F)(F)F)C(C1)C(=O)NCC1CCCCN1, FC(F)(F)COC1CCC(OCC(F)(F)F)C(C1)C(=O)NCC1CCCCN1;O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F",DJBNUMBKLMJRSA-UHFFFAOYSA-N
RO-236240000,AM-833;FLEROXACIN;MEGALOCIN;MEGALONE;RO 23-6240/000;RO-236240;RO-236240000,CHEMBL6273,BRD:BRD-BRD-K61717546-001-04-3;BRD:BRD-BRD-K61717546-001-05-0;BRD:BRD-K61717546-001-04-3;BRD:BRD-K61717546-001-05-0,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A,"GONORRHEA, ENTERITIS, DIARRHEA, RESPIRATORY TRACT INFECTIONS",,LAUNCHED,,Small molecule,-1,"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1;CN1CCN(CC1)C1C(F)CC2C(C1F)N(CCF)CC(C(O)=O)C2=O, CN1CCN(CC1)C1C(F)CC2C(C1F)N(CCF)CC(C(O)=O)C2=O",XBJBPGROQZJDOJ-UHFFFAOYSA-N
FLESINOXAN,FLESINOXAN,CHEMBL1742477,BRD:BRD-K00091287-001-01-9,rep_single_dose,,,,,,,Small molecule,-1,O=C(NCCN1CCN(c2cccc3c2OC[C@H](CO)O3)CC1)c1ccc(F)cc1,NYSDRDDQELAVKP-SFHVURJKSA-N
FLI-06,FLI-06,,BRD:BRD-A44500574-001-01-8;BRD:BRD-BRD-A44500574-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,NOTCH SIGNALING INHIBITOR,,,,PRECLINICAL,,,NA,"CC1=C(C(C2CCC(CC2)[N+]([O-])=O)C2=C(CC(C)(C)CC2=O)N1)C(=O)OC1CCCCC1, CC1=C(C(C2CCC(CC2)[N+]([O-])=O)C2=C(CC(C)(C)CC2=O)N1)C(=O)OC1CCCCC1, CC1=C(C(C2CCC(CC2)[N+]([O-])=O)C2=C(CC(C)(C)CC2=O)N1)C(=O)OC1CCCCC1",
FLIBANSERIN,ADDYI;BIMT 17;BIMT 17 BS;BIMT-17;BIMT-17-BS;ECTRIS;FLIBANSERIN,CHEMBL231068,BRD:BRD-BRD-K33637378-001-01-7;BRD:BRD-K33637378-001-01-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,DRD4;HTR1A;HTR2A,HYPOACTIVE SEXUAL DESIRE DISORDER,,LAUNCHED,,Small molecule,4,FC(F)(F)C1CCCC(C1)N1CCN(CCN2C3CCCCC3[NH]C2=O)CC1;O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,PPRRDFIXUUSXRA-UHFFFAOYSA-N
MAXIPOST,BMS-204352;BMS-204352-01;FLINDOKALNER;MAXIPOST,CHEMBL266510,BRD:BRD-BRD-K56740996-001-01-3;BRD:BRD-K56740996-001-01-3,rep_primary;rep_single_dose,POTASSIUM CHANNEL AGONIST,KCNMA1;KCNN4;KCNQ2;KCNQ4;KCNQ5,,,PHASE 3,,Small molecule,3,"COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21;COC1CCC(CL)CC1[C@]1(F)C(=O)NC2CC(CCC12)C(F)(F)F, COC1CCC(CL)CC1[C@]1(F)C(=O)NC2CC(CCC12)C(F)(F)F",ULYONBAOIMCNEH-HNNXBMFYSA-N
RU-15750,DIRALGAN;FLOCTAFENIN;FLOCTAFENINE;IDALON;IDARAC;NOVODOLAN;R 4318;R-4138;R-4318;RU 15750;RU-15750,CHEMBL2105075,BRD:BRD-A23418262-001-01-5;BRD:BRD-BRD-A23418262-001-01-5,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2c(C(F)(F)F)cccc12;OCC(O)COC(=O)C1CCCCC1NC1CCNC2C(CCCC12)C(F)(F)F,APQPGQGAWABJLN-UHFFFAOYSA-N
PHLOROPROPIOPHENONE,EPHTANON;FLOPROPIONE;NSC-97909;PHLOROPROPIOPHENONE,CHEMBL1605835,BRD:BRD-BRD-K43383936-001-05-2;BRD:BRD-K43383936-001-05-2,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A,SPASMS,,LAUNCHED,,Small molecule,-1,"CCC(=O)c1c(O)cc(O)cc1O;CCC(=O)C1C(O)CC(O)CC1O, CCC(=O)C1C(O)CC(O)CC1O",PTHLEKANMPKYDB-UHFFFAOYSA-N
SCH-25298,FLORFENICOL;NSC-759287;NUFLOR;SCH 25298;SCH-25298,CHEMBL1241590,BRD:BRD-A30886737-001-02-9;BRD:BRD-BRD-A30886737-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,BOVINE RESPIRATORY DISEASE (BRD),,LAUNCHED,,Small molecule,-1,"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1;CS(=O)(=O)C1CCC(CC1)C(O)[C@H](CF)NC(=O)C(CL)CL, CS(=O)(=O)C1CCC(CC1)[C@@H](O)[C@@H](CF)NC(=O)C(CL)CL",AYIRNRDRBQJXIF-NXEZZACHSA-N
FLORIFENINE,FLORIFENINE,CHEMBL2104893,BRD:BRD-K00004567-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,-1,O=C(OCCN1CCCC1)c1ccccc1Nc1ccnc2cc(C(F)(F)F)ccc12,DQOYUDHAZMAVLD-UHFFFAOYSA-N
MANOPLAX,BTS 49 465;BTS-49-465;BTS-49465;FLOSEQUINAN;MANOPLAX,CHEMBL1908307,BRD:BRD-A79643124-001-01-9;BRD:BRD-BRD-A79643124-001-01-9,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,WITHDRAWN,,Small molecule,4,Cn1cc([S+](C)[O-])c(=O)c2ccc(F)cc21;CN1CC(S(C)=O)C(=O)C2CCC(F)CC12,UYGONJYYUKVHDD-UHFFFAOYSA-N
NSC-27640,5-FLUORO-2-DEOXYURIDINE;5-FUDR;F.U.D.R.;FLOXURIDINE;FLUORURIDINE DEOXYRIBOSE;FUDR;NSC-27640,CHEMBL917,BRD:BRD-A03757454-001-03-4;BRD:BRD-BRD-K47832606-001-30-1;BRD:BRD-K47832606-001-30-1,rep_multi_dose;rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,TYMS,COLORECTAL CANCER,,LAUNCHED,"Multiple values for structure_id: {'K47832606', 'A03757454'}, defaulting to None",Small molecule,4,"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F;OC[C@H]1OC(C[C@H]1O)N1CC(F)C(=O)[NH]C1=O, OC[C@H]1O[C@H](C[C@@H]1O)N1CC(F)C(=O)[NH]C1=O",ODKNJVUHOIMIIZ-RRKCRQDMSA-N
FLT3-IN-1,FF-10101;FF-10101-01;FLT3-IN-1,CHEMBL4650283,BRD:BRD-K00003510-001-01-9,rep_single_dose,FLT3 INHIBITOR,,,,,,Small molecule,1,CCCNc1nc(Nc2ccc(C#N)cc2)ncc1C#CCCCNC(=O)[C@H](C)N(C)C(=O)/C=C/CN(C)C,HJFSVYUFOXAVAA-YUAYGMJFSA-N
R-17889,"FLUBENDAZOLE;NSC-313680;R 17,889;R-17,889;R-17889",CHEMBL1454946,BRD:BRD-BRD-K86003836-001-10-5;BRD:BRD-K86003836-001-10-5,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB,GASTROINTESTINAL PARASITES,,LAUNCHED,,Small molecule,-1,"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1;COC(=O)NC1NC2CC(CCC2[NH]1)C(=O)C1CCC(F)CC1, COC(=O)NC1NC2CC(CCC2[NH]1)C(=O)C1CCC(F)CC1",CPEUVMUXAHMANV-UHFFFAOYSA-N
FLUCICLOVINE,FLUCICLOVINE,CHEMBL1908917,BRD:BRD-K00085357-001-01-9,rep_single_dose,,,,,,,Small molecule,4,N[C@]1(C(=O)O)C[C@@H](F)C1,NTEDWGYJNHZKQW-IWLYVCSRSA-N
ZOXIN 500,ABBOFLOX;BRL 2039;BRL-2039;CULPEN;FLOXACILLIN;FLOXACILLIN SODIUM;FLOXACILLIN SODIUM ANHYDROUS;FLOXAPEN;FLUCLOMIX-250;FLUCLOMIX-500;FLUCLOXACILLIN;FLUCLOXACILLIN SODIUM;FLUCLOXACILLIN SODIUM ANHYDROUS;FLUCLOXACILLIN SODIUM MONOHYDRATE;FLUCLOXIN;GALFLOXIN;LADROPEN;NSC-277175;RIMAFLOX;STAFOXIL;STAPHLIPEN;STAPHYLEX;ZOXIN 250;ZOXIN 500,CHEMBL222645,BRD:BRD-BRD-K27871792-001-01-8;BRD:BRD-K27871792-001-01-8,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"GRAM-POSITIVE BACTERIAL INFECTIONS, TONSILLITIS, SINUSITIS, PNEUMONIA, ECZEMA, ENDOCARDITIS, MENINGITIS, ENTERITIS, BACTERIAL SEPTICEMIA",,LAUNCHED,,Small molecule,4,"Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O;CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1C(F)CCCC1CL, CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1C(F)CCCC1CL",UIOFUWFRIANQPC-JKIFEVAISA-N
ZOLTEC,"ALKANAZOLE;BAYT-006267;BAYT006267;CANESTEN ORAL;DIFLUCAN;DIFLUCAN IN SODIUM CHLORIDE;DIFLUCAN ONE;DIFLUCONAZOLE;FLUCONAZOLE;FLUCONAZOLE IN SODIUM CHLORIDE;FLUCONAZOLI;NSC-758661;TRIFLUCAN;UK-49,858;UK-49858;ZOLTEC",CHEMBL106,BRD:BRD-BRD-K05977355-001-19-0;BRD:BRD-K05977355-001-19-0,rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,CYP51A1,"ESOPHAGEAL CANDIDIASIS, MENINGITIS",,LAUNCHED,,Small molecule,4,"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;OC(CN1CNCN1)(CN1CNCN1)C1CCC(F)CC1F, OC(CN1CNCN1)(CN1CNCN1)C1CCC(F)CC1F, OC(CN1CNCN1)(CN1CNCN1)C1CCC(F)CC1F",RFHAOTPXVQNOHP-UHFFFAOYSA-N
RO-29915,ALCOBON;ANCOBAN;ANCOBON;ANCOTIL;FLOUROCYTOSINE;FLUCYTOSINE;FLUCYTOSINUM;FLUOROCYTOSINE;NSC-103805;RO 2-9915;RO-2-9915;RO-29915,CHEMBL1463,BRD:BRD-BRD-K82143716-001-19-9;BRD:BRD-K82143716-001-19-9,rep_primary;rep_single_dose,OTHER ANTIFUNGAL,DNMT1,"BACTERIAL SEPTICEMIA, ENDOCARDITIS, URINARY TRACT INFECTIONS, MENINGITIS",,LAUNCHED,,Small molecule,4,"Nc1nc(=O)[nH]cc1F;NC1NC(=O)[NH]CC1F, NC1NC(=O)[NH]CC1F",XRECTZIEBJDKEO-UHFFFAOYSA-N
FLUDARA,FLUDARA,,GDSC2:1813,gdsc,,,,,,,,NA,,
OFORTA,2-F-ARA-AMP;2-F-ARAA;2-FLUORO ARA-A;2-FLUORO-ARA-A;2-FLUOROVIDARABINE;FLUDARA;FLUDARABINE;FLUDARABINE 5'-MONOPHOSPHATE;FLUDARABINE MONOPHOSPHATE;FLUDARABINE PHOSPHATE;FLURADOSA;NSC-118218;NSC-118218H;NSC-312887;NSC-328002;OFORTA,CHEMBL1096882;CHEMBL1568,BRD:BRD-BRD-K66788707-001-14-3;BRD:BRD-K66788707-001-14-3;GDSC2:1813,gdsc;rep_multi_dose;rep_primary;rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,ADA;DCK;POLA1;RRM1;RRM2,CHRONIC LYMPHOCYTIC LEUKEMIA (CLL),,LAUNCHED,"Multiple values for repurposing_target: {'ADA;RRM1;RRM2', 'ADA;DCK;POLA1;RRM1;RRM2'}, taking the union",Small molecule,4,"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O;NC1NC(F)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O, NC1NC(F)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O, NC1NC(F)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O",GIUYCYHIANZCFB-FJFJXFQQSA-N
FLUDARABINE-PHOSPHATE,FLUDARABINE-PHOSPHATE,,BRD:BRD-BRD-K71106091-001-06-1;BRD:BRD-K71106091-001-06-1,rep_multi_dose;rep_primary;rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,DCK;POLA1;POLD1;POLE;RRM1;RRM2;RRM2B,CHRONIC LYMPHOCYTIC LEUKEMIA (CLL),,LAUNCHED,,,NA,"NC1NC(F)NC2N(CNC12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O, NC1NC(F)NC2N(CNC12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O, NC1NC(F)NC2N(CNC12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O",
FLUDROCORTISONE-ACETATE,FLUDROCORTISONE-ACETATE,,BRD:BRD-BRD-K06408664-001-03-5;BRD:BRD-K06408664-001-03-5;BRD:BRD-K06408664-001-04-9,rep_primary;rep_single_dose,,AR;NR3C1;NR3C2,"ADDISON'S DISEASE, ADRENOGENITAL SYNDROME",,LAUNCHED,,,NA,"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C",
NSC-757869,33379;CORDRAN;CORDRAN SP;FLUDROXICORTIDE;FLUDROXYCORTIDE;FLURANDRENOLIDE;FLURANDRENOLONE;HAELAN;HAELAN-C;HAELAN-X;NSC-757869,CHEMBL1201012,BRD:BRD-A49765801-001-04-1;BRD:BRD-BRD-A49765801-001-04-1,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;SERPINA6,"SKIN INFECTIONS, PSORIASIS",,LAUNCHED,,Small molecule,4,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1;CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)CC[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,POPFMWWJOGLOIF-XWCQMRHXSA-N
FLUFENAMIC-ACID,FLUFENAMIC-ACID,,BRD:BRD-BRD-K44067360-001-30-3;BRD:BRD-K44067360-001-30-3,rep_multi_dose;rep_primary;rep_single_dose,CHLORIDE CHANNEL BLOCKER,AKR1C3;ANO1;AR;GJA1;GJA10;GJA3;GJA4;GJA5;GJA8;GJA9;GJB1;GJB2;GJB3;GJB4;GJB5;GJB6;GJB7;GJC1;GJC2;GJC3;GJD2;GJD3;GJD4;GJE1;PANX1;PANX2;PANX3;PKD2L1;PTGS1;PTGS2;TRPC5;TRPM2;TRPM5,,,PRECLINICAL,,,NA,"OC(=O)C1CCCCC1NC1CCCC(C1)C(F)(F)F, OC(=O)C1CCCCC1NC1CCCC(C1)C(F)(F)F",
HHGV-678,FLUMATINIB;FLUMBATINIB;HH-GV678;HHGV-678,CHEMBL3545413,BRD:BRD-BRD-K68870568-066-01-5;BRD:BRD-K68870568-066-01-5,rep_multi_dose;rep_primary;rep_single_dose,BCR-ABL KINASE INHIBITOR,ABL1;PDGFRB,,,PHASE 3,,Small molecule,3,Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1;CN1CCN(CC2CCC(CC2C(F)(F)F)C(=O)NC2CNC(C)C(NC3NCCC(N3)-C3CCCNC3)C2)CC1,BJCJYEYYYGBROF-UHFFFAOYSA-N
ROMAZICON,ANEXATE;FLUMAZENIL;FLUMAZEPIL;LANEXAT;MAZICON;NSC-759193;RO 15-1788/000;RO-15-1788;RO-151788;RO-151788000;RO-1722;RO-41-8157;ROMAZICON,CHEMBL407,BRD:BRD-BRD-K98769987-001-23-7;BRD:BRD-K98769987-001-23-7,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR ANTAGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ,SEDATIVE,,LAUNCHED,,Small molecule,4,"CCOC(=O)C1NCN-2C1CN(C)C(=O)C1CC(F)CCC-21, CCOC(=O)C1NCN-2C1CN(C)C(=O)C1CC(F)CCC-21, CCOC(=O)C1NCN-2C1CN(C)C(=O)C1CC(F)CCC-21, CCOC(=O)C1NCN-2C1CN(C)C(=O)C1CC(F)CCC-21;CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2",OFBIFZUFASYYRE-UHFFFAOYSA-N
ZYXORIN,FLUMECINOL;ZYXORIN,CHEMBL2107440,BRD:BRD-A44181516-001-01-8;BRD:BRD-BRD-A44181516-001-01-8,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,CCC(O)(c1ccccc1)c1cccc(C(F)(F)F)c1;CCC(O)(C1CCCCC1)C1CCCC(C1)C(F)(F)F,DVASNQYQOZHAJN-UHFFFAOYSA-N
NSC-757806,APURONE;FLUMEQUINE;NSC-757806,CHEMBL370252,BRD:BRD-A69777949-001-24-2;BRD:BRD-BRD-A69777949-001-24-2,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,-1,"CC1CCc2cc(F)cc3c(=O)c(C(=O)O)cn1c23;CC1CCC2CC(F)CC3C2N1CC(C(O)=O)C3=O, CC1CCC2CC(F)CC3C2N1CC(C(O)=O)C3=O",DPSPPJIUMHPXMA-UHFFFAOYSA-N
U-10974,"FLUCORT;FLUMETASONE;FLUMETHASONE;NSC-54702;U-10,974;U-10974",CHEMBL1201392,BRD:BRD-BRD-K61496577-001-19-4;BRD:BRD-BRD-K61496577-001-20-2;BRD:BRD-K61496577-001-19-4;BRD:BRD-K61496577-001-20-2,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;PLA2G1B,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,Small molecule,-1,"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO;C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO",WXURHACBFYSXBI-GQKYHHCASA-N
FLUMETHASONE-PIVALATE,FLUMETHASONE-PIVALATE,,BRD:BRD-A50064262-001-04-7;BRD:BRD-BRD-A50064262-001-04-7,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;SERPINA6,,,LAUNCHED,,,NA,C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C,
FLUNARIZINE,FLUNARIZINE,CHEMBL30008,BRD:BRD-BRD-K29582677-300-10-6;BRD:BRD-K29582677-300-10-6,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1G;CACNA1H;CACNA1I;CALM1;HRH1,"MIGRAINE HEADACHE, VERTIGO, PERIPHERAL ARTERY DISEASE (PAD)",,LAUNCHED,,Small molecule,4,"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1;FC1CCC(CC1)C(N1CCN(C\C=C\C2CCCCC2)CC1)C1CCC(F)CC1, FC1CCC(CC1)C(N1CCN(C\C=C\C2CCCCC2)CC1)C1CCC(F)CC1, FC1CCC(CC1)C(N1CCN(C\C=C\C2CCCCC2)CC1)C1CCC(F)CC1, FC1CCC(CC1)C(N1CCN(C\C=C\C2CCCCC2)CC1)C1CCC(F)CC1",SMANXXCATUTDDT-QPJJXVBHSA-N
SYNTARIS HAYFEVER,AEROBID;AEROSPAN;AEROSPAN HFA;FLUNISOLIDE;FLUNISOLIDE ANHYDROUS;FLUNISOLIDE HEMIHYDRATE;NASALIDE;NASAREL;NSC-757871;RS-3999;SYNTARIS;SYNTARIS HAYFEVER,CHEMBL1512,BRD:BRD-A65449987-001-10-4;BRD:BRD-BRD-A65449987-001-10-4,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,NR3C1,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1;CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@@]2(O1)C(=O)CO,XSFJVAJPIHIPKU-XWCQMRHXSA-N
FLUNIXIN-MEGLUMIN,FLUNIXIN-MEGLUMIN,,BRD:BRD-BRD-K99984802-100-13-5;BRD:BRD-K99984802-100-13-5,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,,,,LAUNCHED,,,NA,"CC1C(NC2NCCCC2C(O)=O)CCCC1C(F)(F)F, CC1C(NC2NCCCC2C(O)=O)CCCC1C(F)(F)F",
FLUOCINOLONE-ACETONIDE,FLUOCINOLONE-ACETONIDE,,BRD:BRD-A15297126-001-04-3;BRD:BRD-BRD-A15297126-001-04-3;BRD:BRD-BRD-K94353609-001-21-6;BRD:BRD-K94353609-001-21-6,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;SERPINA6,SEBORRHEIC DERMATITIS,,LAUNCHED,"Multiple values for structure_id: {'K94353609', 'A15297126'}, defaulting to None",,NA,"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C, CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO",
VANOS,FLUOCINOLIDE;FLUOCINONIDE;FLUOCINONIDE EMULSIFIED BASE;LIDEX;LIDEX-E;METOSYN;METOSYN FAPG;NSC-101791;VANOS,CHEMBL1501,BRD:BRD-BRD-K57886322-001-16-6;BRD:BRD-K57886322-001-16-6,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;SERPINA6;SMO,"SEBORRHEIC DERMATITIS, ECZEMA",,LAUNCHED,,Small molecule,4,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C;CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,WJOHZNCJWYWUJD-IUGZLZTKSA-N
YELLOW 8,ACID YELLOW 73;ACID YELLOW 73 SODIUM SALT;AK-FLUOR;C.I. 45350;C.I. ACID YELLOW 73;CI 45350;CI 45350:1;DISODIUM SALT;FLUOR-AMPS;FLUORESCEIN;FLUORESCEIN DISODIUM SALT;FLUORESCEIN SODIUM;FLUORESCEINUM NATRICUM;FLUORESCITE;FLUORETS;FUNDUSCEIN;FUNDUSCEIN-25;KI201;KI202;KI202(1);KI202(2);NSC-667256;NSC-759114;RESORCINOL PHTHALEIN SODIUM;RETINOFLUOR;SOLUBLE;SOLUBLE FLUORESCEIN;URANIN;URANINE;URANINE WSS;YELLOW 7;YELLOW 8,CHEMBL1628233;CHEMBL177756;CHEMBL4297067,BRD:BRD-BRD-K21913543-001-02-4;BRD:BRD-K21913543-001-02-4,rep_primary;rep_single_dose,,SLC22A6,OPHTHALMOLOGY DIAGNOSTIC,,LAUNCHED,,Small molecule,4,O=C([O-])c1ccccc1-c1c2ccc(=O)cc-2oc2cc([O-])ccc12.[Na+].[Na+];OC1CCC2C(OC3CC(O)CCC3C22OC(=O)C3CCCCC23)C1,NJDNXYGOVLYJHP-UHFFFAOYSA-L
OXYLONE,FLUATON;FLUOR-OP;FLUOROMETHOLONE;FML FORTE;FML FTE;FML-NEO;NSC-33001;OXYLONE,CHEMBL1200600,BRD:BRD-A13133631-001-04-0;BRD:BRD-BRD-A13133631-001-04-0,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,EYE INFLAMMATION,,LAUNCHED,,Small molecule,4,C[C@H]1CC2C3CC[C@](O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)C2(C)C=CC(=O)C=C12;CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,FAOZLTXFLGPHNG-KNAQIMQKSA-N
FLUOROMETHOLONE-ACETATE,FLUOROMETHOLONE-ACETATE,,BRD:BRD-BRD-K02528732-001-02-4;BRD:BRD-K02528732-001-02-4,rep_primary;rep_single_dose,,NR3C1,EYE INFLAMMATION,,LAUNCHED,,,NA,"C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12, C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12",
FLUOROMETHYLCHOLINE,FLUOROMETHYLCHOLINE,CHEMBL3707346,BRD:BRD-BRD-K51199656-003-01-4;BRD:BRD-K51199656-003-01-4,rep_multi_dose;rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,3,C[N+](C)(C)CCOCF;C[N+](C)(CF)CCO,TYUACEBEGBGGMO-UHFFFAOYSA-N
SYMBYAX,ADOFEN;FELICIUM;FLUCTIN;FLUNEURIN;FLUOX-PUREN;FLUOXEREN;FLUOXETIN RATIOPHARM;FLUOXETINE;FLUOXETINE (AS HYDROCHLORIDE);FLUOXETINE HYDROCHLORIDE;FLUSOL;FLUVAL;FLUXET;FONTEX;FOXETIN;LOVAN;LY-110140;LY110140;NSC-283480;NSC-758685;OLENA;OXACTIN;PROZAC;PROZAC 60;PROZAC WEEKLY;PROZEP;PROZIT;RANFLUTIN;RECONCILE;SARAFEM;SELFEMRA;SYMBYAX,CHEMBL1201082;CHEMBL41,BRD:BRD-A31159102-003-30-4;BRD:BRD-BRD-A31159102-003-30-4,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),ANO1;HTR2B;SLC6A4,"DEPRESSION, OBSESSIVE COMPULSIVE DISORDER (OCD), BULIMIA NERVOSA, PANIC DISORDERS, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,4,"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1;CNCCC(OC1CCC(CC1)C(F)(F)F)C1CCCCC1, CNCCC(OC1CCC(CC1)C(F)(F)F)C1CCCCC1, CNCCC(OC1CCC(CC1)C(F)(F)F)C1CCCCC1, CNCCC(OC1CCC(CC1)C(F)(F)F)C1CCCCC1",RTHCYVBBDHJXIQ-UHFFFAOYSA-N
ORA-TESTRYL,ANDROID-F;ANDROXY;FLUOXIMESTERONE;FLUOXYMESTERONE;FLUOXYMESTERONE CIII;HALOTESTIN;NSC-10704;NSC-12165;ORA-TESTRYL,CHEMBL1445,BRD:BRD-BRD-K24255045-001-05-3;BRD:BRD-K24255045-001-05-3,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR;ESR1;NR3C1;PRLR,HYPOGONADISM,,LAUNCHED,,Small molecule,4,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C;C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,YLRFCQOZQXIBAB-RBZZARIASA-N
TRANS-FLUPENTIXOL,.BETA.-FLUPENTHIXOL;(E)-;E-FLUPENTHIXOL;E-FLUPENTIXOL;FLUPENTHIXOL;FLUPENTIXOL;FLUPENTIXOLE;LC 44;LC-44;N-7009;TRANS-FLUPENTHIXOL;TRANS-FLUPENTIXOL,CHEMBL42055;CHEMBL54661,BRD:BRD-BRD-K70487031-001-02-8;BRD:BRD-K70487031-001-02-8,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;CHRM1;DRD1;DRD2;DRD3;DRD5;HTR2A,"SCHIZOPHRENIA, DEPRESSION",,LAUNCHED,,Small molecule,2,OCCN1CCN(CC/C=C2\c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1;OCCN1CCN(CC\C=C2\C3CCCCC3SC3CCC(CC23)C(F)(F)F)CC1,NJMYODHXAKYRHW-BLLMUTORSA-N
SQ 16144,"FLUFENAN;FLUPHENAZINE;FLUPHENAZINE ENANTATE;FLUPHENAZINE ENANTHATE;FLUPHENAZINE MALEATE;FLUPHENAZINI ENANTAS;MODITEN ENANT;NSC-62323;PERMITIL;PROLIXIN;PROLIXIN ENANTHATE;SQ 16,114;SQ 16144",CHEMBL1200951;CHEMBL726,BRD:BRD-BRD-K55127134-300-11-2;BRD:BRD-K55127134-300-11-2,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CALM1;DRD1;DRD2;DRD5;HRH1;HTR2A;HTR6;HTR7,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1;OCCN1CCN(CCCN2C3CCCCC3SC3CCC(CC23)C(F)(F)F)CC1,LRWSFOSWNAQHHW-UHFFFAOYSA-N
W-2964,FLUPIRTINE;FLUPIRTINTE;W-2964,CHEMBL255044,BRD:BRD-BRD-K50720187-051-03-1;BRD:BRD-K50720187-051-03-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,ADRA2A;KCNQ1;KCNQ2,PAIN RELIEF,,LAUNCHED,,Small molecule,4,"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N;CCOC(=O)NC1CCC(NCC2CCC(F)CC2)NC1N, CCOC(=O)NC1CCC(NCC2CCC(F)CC2)NC1N, CCOC(=O)NC1CCC(NCC2CCC(F)CC2)NC1N, CCOC(=O)NC1CCC(NCC2CCC(F)CC2)NC1N, CCOC(=O)NC1CCC(NCC2CCC(F)CC2)NC1N",JUUFBMODXQKSTD-UHFFFAOYSA-N
FLUPRAZINE,FLUPRAZINE,CHEMBL2106753,BRD:BRD-BRD-K44091134-001-01-9;BRD:BRD-K44091134-001-01-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B,,,PHASE 1,,Small molecule,-1,NC(=O)NCCN1CCN(c2cccc(C(F)(F)F)c2)CC1;NC(=O)NCCN1CCN(CC1)C1CCCC(C1)C(F)(F)F,CHQKHXJPWDSTPY-UHFFFAOYSA-N
FLURALANER (EMA EPAR: VETERINARY),A-1443;A1443;AH-252723;AH252723;BRAVECTO;FLURALANER;FLURALANER (EMA EPAR: VETERINARY),CHEMBL2364610,BRD:BRD-K00003239-001-01-9,rep_single_dose,GABA RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,Cc1cc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)ccc1C(=O)NCC(=O)NCC(F)(F)F,MLBZKOGAMRTSKP-UHFFFAOYSA-N
FLURBIPROFEN-(+/-),FLURBIPROFEN-(+/-),,BRD:BRD-A86044036-001-26-5;BRD:BRD-BRD-A86044036-001-26-5,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS",,LAUNCHED,,,NA,"CC(C(O)=O)C1CCC(C(F)C1)-C1CCCCC1, CC(C(O)=O)C1CCC(C(F)C1)-C1CCCCC1",
FLURBIPROFEN-(S)-(+),FLURBIPROFEN-(S)-(+),,BRD:BRD-BRD-K69907333-001-10-6;BRD:BRD-K69907333-001-10-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS",,LAUNCHED,,,NA,"C[C@H](C(O)=O)C1CCC(C(F)C1)-C1CCCCC1, C[C@H](C(O)=O)C1CCC(C(F)C1)-C1CCCCC1",
FLURBIPROFEN-AXETIL,FLURBIPROFEN-AXETIL,,BRD:BRD-K00004724-001-01-9,rep_single_dose,ANALGESIC AGENT,,,,,,,NA,,
FLURIZAN,FLURIZAN,,BRD:BRD-BRD-K75410565-001-02-9;BRD:BRD-K75410565-001-02-9,rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,APH1B;BACE1;IKBKG;PSEN1;PSEN2;PTGS1;PTGS2,,,PHASE 3,,,NA,C[C@@H](C(O)=O)C1CCC(C(F)C1)-C1CCCCC1,
SK&F 6539,FLUROTHYL;FLUROTYL;HEXAFLUORODIETHYL ETHER;INDOKLON;NSC-760127;SK&F 6539,CHEMBL477874,BRD:BRD-BRD-K14763542-001-02-3;BRD:BRD-K14763542-001-02-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,"FC(F)(F)COCC(F)(F)F;FC(F)(F)COCC(F)(F)F, FC(F)(F)COCC(F)(F)F",KGPPDNUWZNWPSI-UHFFFAOYSA-N
NSC-760364,FLUOROMAR;FLUROXENE;NSC-760364,CHEMBL141446,BRD:BRD-BRD-K56908511-001-01-2;BRD:BRD-K56908511-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,LOCAL ANESTHETIC,,,,PRECLINICAL,,Small molecule,-1,"C=COCC(F)(F)F;FC(F)(F)COC=C, FC(F)(F)COC=C",DLEGDLSLRSOURQ-UHFFFAOYSA-N
REDEPTIN,FLUSPIRILENE;IMAP;MCN-JR-6218;R 6218;R-6218;REDEPTIN,CHEMBL46516,BRD:BRD-BRD-K77947974-001-16-3;BRD:BRD-K77947974-001-16-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CACNG1;DRD2;HRH1;HTR1A;HTR1D;HTR1E;HTR2A,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,FC1CCC(CC1)C(CCCN1CCC2(CC1)N(CNC2=O)C1CCCCC1)C1CCC(F)CC1;O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,QOYHHIBFXOOADH-UHFFFAOYSA-N
SCH-13521,CHIMAX;DROGENIL;EULEXIN;FLUTAMIDE;NSC-215876;SCH 13521;SCH-13521,CHEMBL806,BRD:BRD-BRD-K28307902-001-21-7;BRD:BRD-K28307902-001-21-7,rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AHR;AR,PROSTATE CANCER,,LAUNCHED,,Small molecule,4,"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1;CC(C)C(=O)NC1CCC(C(C1)C(F)(F)F)[N+]([O-])=O, CC(C)C(=O)NC1CCC(C(C1)C(F)(F)F)[N+]([O-])=O, CC(C)C(=O)NC1CCC(C(C1)C(F)(F)F)[N+]([O-])=O",MKXKFYHWDHIYRV-UHFFFAOYSA-N
FLUTEMETAMOL,[3H]-FLUTEMETAMOL;FLUTEMETAMOL,CHEMBL579205,BRD:BRD-K00071586-001-01-9,rep_single_dose,,,,,,,Small molecule,4,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F,VVECGOCJFKTUAX-UHFFFAOYSA-N
VERAMYST,ALLERMIST;ARNUITY ELLIPTA;AVAMYS;ENNHALE;FLONASE SENSIMIST ALLERGY RELIEF;FLUTICASONE FUROATE;FURAMIST;GSK 685 698;GSK-685968;GSK685968;GW-685698X;GW685698X;RELVAR ELLIPTA;TRELEGY ELLIPTA;VERAMYST,CHEMBL1676,BRD:BRD-K00084841-001-01-9,rep_single_dose,,,,,,,Small molecule,4,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,XTULMSXFIHGYFS-VLSRWLAYSA-N
FLUTICASONE-PROPIONATE,FLUTICASONE-PROPIONATE,,BRD:BRD-BRD-K62310379-001-10-5;BRD:BRD-K62310379-001-10-5,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;NR3C2;PGR;PLA2G4A,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,"CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF, CCC(=O)O[C@@]1([C@H](C)CC2C3CC(F)C4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@]12C)C(=O)SCF, CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF, CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF",
UR-4056,FLUTRIMAZOLE;MICETAL;UR-4056,CHEMBL2107430,BRD:BRD-A00218260-001-03-4;BRD:BRD-BRD-A00218260-001-03-4,rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,,MYCOSIS,,LAUNCHED,,Small molecule,4,Fc1ccc(C(c2ccccc2)(c2ccccc2F)n2ccnc2)cc1;FC1CCC(CC1)C(C1CCCCC1)(C1CCCCC1F)N1CCNC1,QHMWCHQXCUNUAK-UHFFFAOYSA-N
NSC-758896,FLUVAS;FLUVASTATIN;NSC-758896,CHEMBL1078;CHEMBL2220442,BRD:BRD-BRD-K66296774-236-11-3;BRD:BRD-K66296774-236-10-5;BRD:BRD-K66296774-236-11-3;CTRP:660322,ctrp;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF HMGCR,HMGCR,"HYPERCHOLESTEROLEMIA, CONGENITAL HEART DEFECTS",,LAUNCHED,"Multiple values for MOA: {'HMGCR INHIBITOR', 'INHIBITOR OF HMGCR'}, defaulting to 'INHIBITOR OF HMGCR'",Small molecule,4,"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21;CC(C)N1C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(-C2CCC(F)CC2)C2CCCCC12, CC(C)N1C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(-C2CCC(F)CC2)C2CCCCC12, CC(C)N1C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(-C2CCC(F)CC2)C2CCCCC12, CC(C)N1C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(-C2CCC(F)CC2)C2CCCCC12",FJLGEFLZQAZZCD-VAWYXSNFSA-N
N06AB08,FLUVOXAMINE;N06AB08,CHEMBL814,BRD:BRD-BRD-K53517854-051-01-4;BRD:BRD-K53517854-051-01-4,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),SLC6A4,OBSESSIVE COMPULSIVE DISORDER (OCD),,LAUNCHED,,Small molecule,4,"COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1;COCCCC\C(C1CCC(CC1)C(F)(F)F)=N/OCCN, COCCCC\C(C1CCC(CC1)C(F)(F)F)=N/OCCN, COCCCC\C(C1CCC(CC1)C(F)(F)F)=N/OCCN",CJOFXWAVKWHTFT-XSFVSMFZSA-N
FMOC-L-LEUCINE,FMOC-L-LEUCINE,,BRD:BRD-BRD-K15327298-001-05-5;BRD:BRD-K15327298-001-05-5,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,,,,PHASE 2,,,NA,CC(C)C[C@H](NC(=O)OCC1C2CCCCC2-C2CCCCC12)C(O)=O,
FN-1501,FN-1501,CHEMBL4594474,BRD:BRD-K00003096-001-01-9,rep_single_dose,TYROSINE KINASE INHIBITOR,,,,,,Unknown,1,,
FOLIC-ACID,FOLIC-ACID,,BRD:BRD-BRD-K18673820-001-15-5;BRD:BRD-K18673820-001-15-5,rep_primary;rep_single_dose,FOLATE RECEPTOR LIGAND,FOLR2;FOLR3;SLC19A1;SLC46A1,MEGALOBLASTIC ANEMIA,,LAUNCHED,,,NA,NC1NC(=O)C2NC(CNC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2[NH]1,
NSC-760365,4-METHYLPYRAZOLE;4-MP;ANTIZOL;FOMEPIZOLE;NSC-760365,CHEMBL1308,BRD:BRD-BRD-K56810756-001-03-0;BRD:BRD-K56810756-001-03-0,rep_primary;rep_single_dose,ALCOHOL DEHYDROGENASE INHIBITOR,ADH1A;ADH1B;ADH1C;AKR1A1;CAT,POISON ANTIDOTE,,LAUNCHED,,Small molecule,4,"Cc1cn[nH]c1;CC1CN[NH]C1, CC1CN[NH]C1",RIKMMFOAQPJVMX-UHFFFAOYSA-N
FOMOCAINE,FOMOCAIN;FOMOCAINE,CHEMBL1407844,BRD:BRD-BRD-K44942188-001-09-1;BRD:BRD-K44942188-001-09-1,rep_primary;rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL MODULATOR,,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,-1,C(CN1CCOCC1)CC1CCC(COC2CCCCC2)CC1;c1ccc(OCc2ccc(CCCN3CCOCC3)cc2)cc1,CVHGCWVMTZWGAY-UHFFFAOYSA-N
FONDAPARINUX,FONDAPARINUX,CHEMBL1201202;CHEMBL1276258,BRD:BRD-K00003513-363-01-9,rep_single_dose,COAGULATION FACTOR INHIBITOR,F10;SERPINC1,,,,,Oligosaccharide;Small molecule,4,CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](COC[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](COC[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)[O-])[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)[O-])[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+];CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O,KANJSNBRCNMZMV-ABRZTLGGSA-N;TXIFUDXAZRPJLS-CMHJJOLKSA-D
XL880,EXEL-2880;FORETINIB;GSK-089;GSK-1363089;GSK-1363089G;GSK089;GSK1363089;GSK1363089G;XL-880;XL880,CHEMBL1230609,BRD:BRD-BRD-K03449891-001-08-6;BRD:BRD-K03449891-001-08-6;CTRP:628607;GDSC1:308;GDSC2:2040,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,VEGFR INHIBITOR,FLT1;FLT4;KDR;MET,,,PHASE 2,,Small molecule,2,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1;COC1CC2C(OC3CCC(NC(=O)C4(CC4)C(=O)NC4CCC(F)CC4)CC3F)CCNC2CC1OCCCN1CCOCC1,CXQHYVUVSFXTMY-UHFFFAOYSA-N
NSC-282175,"4-OH-ANDROSTENE-3,17-DIONE;CGP 32349;CGP-32349;FORMESTANE;LENTARON;NSC-282175",CHEMBL132530,BRD:BRD-A26503646-001-16-6;BRD:BRD-BRD-A26503646-001-16-6,rep_multi_dose;rep_primary;rep_single_dose,AROMATASE INHIBITOR,CYP19A1,BREAST CANCER,,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@@H]1CCC2=O;C[C@]12CCC(=O)C(O)=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12",OSVMTWJCGUFAOD-KZQROQTASA-N
NSC-93360,7-HYDROXY-4'-METHOXYISOFLAVONE;BIOCHANIN B;FLAVOSIL;FORMONONETIN;FORMONONETOL;MYCONATE;MYCOTECH;NEOCHANIN;NSC-93360,CHEMBL242341,BRD:BRD-BRD-K55567017-001-12-3;BRD:BRD-K55567017-001-12-3,rep_primary;rep_single_dose,ALCOHOL DEHYDROGENASE INHIBITOR,ADH1C;SLC5A2,,,PRECLINICAL,,Small molecule,2,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1;COC1CCC(CC1)-C1COC2CC(O)CCC2C1=O,HKQYGTCOTHHOMP-UHFFFAOYSA-N
FORMOTEROL,FORADIL;FORMOTEROL,CHEMBL1256786,BRD:BRD-BRD-K54006094-051-01-7;BRD:BRD-K54006094-051-01-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,"ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BRONCHOSPASM",,LAUNCHED,,Small molecule,4,"COC1CCC(C[C@H](C)NC[C@@H](O)C2CCC(O)C(NC=O)C2)CC1, COC1CCC(C[C@H](C)NC[C@@H](O)C2CCC(O)C(NC=O)C2)CC1, COC1CCC(C[C@H](C)NC[C@@H](O)C2CCC(O)C(NC=O)C2)CC1, COC1CCC(C[C@H](C)NC[C@@H](O)C2CCC(O)C(NC=O)C2)CC1;COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1",BPZSYCZIITTYBL-UHFFFAOYSA-N
NSC-717904,BCX-1777;FODOSINE;FORODESINE;NSC-717904,CHEMBL218291,BRD:BRD-BRD-K16505263-003-02-9;BRD:BRD-K16505263-003-02-9,rep_multi_dose;rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,PNP,,,PHASE 2,,Small molecule,2,"O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12;OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1C[NH]C2C1[NH]CNC2=O, OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1C[NH]C2C1[NH]CNC2=O",IWKXDMQDITUYRK-KUBHLMPHSA-N
SR-27417,FOROPAFANT;SR-27417,CHEMBL1628662,BRD:BRD-BRD-K57774929-001-01-3;BRD:BRD-K57774929-001-01-3,rep_primary;rep_single_dose,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,PTAFR,,,PHASE 3,,Small molecule,-1,CC(C)c1cc(C(C)C)c(-c2csc(N(CCN(C)C)Cc3cccnc3)n2)c(C(C)C)c1;CC(C)C1CC(C(C)C)C(-C2CSC(N2)N(CCN(C)C)CC2CCCNC2)C(C1)C(C)C,VVBFISAUNSXQGZ-UHFFFAOYSA-N
NSC-375489,BOFORSIN;COLFORSIN;FORSKOLIN;HL 362;HL-362;L 75 1362B;L-75-1362B;L-751362B;NSC-357088;NSC-375489,CHEMBL52606,BRD:BRD-BRD-K09602097-001-13-6;BRD:BRD-K09602097-001-13-6,rep_multi_dose;rep_primary;rep_single_dose,ADENYLYL CYCLASE ACTIVATOR,ADCY2;ADCY5;GNAS,,,LAUNCHED,,Small molecule,-1,"C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](O)[C@H](OC(C)=O)[C@@]2(C)O1;CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C, CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C, CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C",OHCQJHSOBUTRHG-KGGHGJDLSA-N
GW433908A,FOSAMPRENAVIR;GW-433908;GW433908;GW433908A,CHEMBL1664,BRD:BRD-BRD-K59110290-238-01-7;BRD:BRD-K59110290-238-01-7,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1;CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1CCCCC1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1CCC(N)CC1,MLBVMOWEQCZNCC-OEMFJLHTSA-N
FOSAPREPITANT-DIMEGLUMINE,FOSAPREPITANT-DIMEGLUMINE,,BRD:BRD-BRD-K23848629-401-03-7;BRD:BRD-K23848629-401-03-7,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1,"NAUSEA, VOMITING",,LAUNCHED,,,NA,"C[C@@H](O[C@H]1OCCN(CC2NN(C(=O)[NH]2)P(O)(O)=O)[C@H]1C1CCC(F)CC1)C1CC(CC(C1)C(F)(F)F)C(F)(F)F, C[C@@H](O[C@H]1OCCN(CC2NN(C(=O)[NH]2)P(O)(O)=O)[C@H]1C1CCC(F)CC1)C1CC(CC(C1)C(F)(F)F)C(F)(F)F, C[C@@H](O[C@H]1OCCN(CC2NN(C(=O)[NH]2)P(O)(O)=O)[C@H]1C1CCC(F)CC1)C1CC(CC(C1)C(F)(F)F)C(F)(F)F, C[C@@H](O[C@H]1OCCN(CC2NN(C(=O)[NH]2)P(O)(O)=O)[C@H]1C1CCC(F)CC1)C1CC(CC(C1)C(F)(F)F)C(F)(F)F",
PHOSBRETABULIN,COMBRETASTATIN A-4 PHOSPHATE;COMBRETASTATIN A4 PHOSPHATE;FOSBRETABULIN;PHOSBRETABULIN,CHEMBL1206232,BRD:BRD-BRD-K06814349-304-01-9;BRD:BRD-K06814349-304-01-9;BRD:BRD-K06814349-304-02-7,rep_multi_dose;rep_primary;rep_single_dose,"TUBULIN POLYMERIZATION INHIBITOR, VE-CADHERIN ANTAGONIST",CDH5,,,PHASE 3,,Small molecule,3,"COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O;COC1CCC(C=CC2CC(OC)C(OC)C(OC)C2)CC1OP(O)(O)=O, COC1CCC(CC1OP(O)(O)=O)\C=C/C1CC(OC)C(OC)C(OC)C1, COC1CCC(CC1OP(O)(O)=O)\C=C/C1CC(OC)C(OC)C(OC)C1, COC1CCC(C=CC2CC(OC)C(OC)C(OC)C2)CC1OP(O)(O)=O",WDOGQTQEKVLZIJ-WAYWQWQTSA-N
J05AD01,DIHYDROXYPHOSPHINECARBOXYLIC ACID OXIDE;FOSCARNET;J05AD01,CHEMBL666,BRD:BRD-BRD-K85146014-314-05-4;BRD:BRD-K85146014-314-05-4,rep_multi_dose;rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,"CYTOMEGALOVIRUS RETINITIS, ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), VIRUS HERPES SIMPLEX (HSV)",,LAUNCHED,,Small molecule,4,"O=C(O)P(=O)(O)O;OC(=O)P(O)(O)=O, OC(=O)P(O)(O)=O, OC(=O)P(O)(O)=O",ZJAOAACCNHFJAH-UHFFFAOYSA-N
PF-04171327,FOSDAGROCORAT;PF-04171327,CHEMBL3137316,BRD:BRD-K00091282-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](OP(=O)(O)O)(C(F)(F)F)CC[C@@]21Cc1ccccc1,BVXLAHSJXXSWFF-KEKPKEOLSA-N
UK-292663,"FLUCONAZOLE DIHYDROGEN PHOSPHATE;FOSFLUCONAZOLE;PRODIF;UK-292,663;UK-292663",CHEMBL1908301,BRD:BRD-K00003384-001-01-9,rep_single_dose,OTHER ANTIFUNGAL,,,,,,Small molecule,-1,O=P(O)(O)OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,GHJWNRRCRIGGIO-UHFFFAOYSA-N
ZTI-01,CALCIUM FOSFOMYCIN;FOSFOCINA;FOSFOMYCIN;FOSFOMYCIN CALCIUM;FOSFOMYCIN CALCIUM HYDRATE;FOSFOMYCIN SODIUM;J01XX01;MONUROL;NSC-758170;ZTI-01,CHEMBL1757,BRD:BRD-A10652366-238-04-1;BRD:BRD-BRD-A10652366-238-04-1;BRD:BRD-BRD-K81101512-234-01-9;BRD:BRD-K81101512-234-01-9,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,URINARY TRACT INFECTIONS,,LAUNCHED,"Multiple values for structure_id: {'K81101512', 'A10652366'}, defaulting to None",Small molecule,4,"C[C@@H]1O[C@@H]1P(=O)(O)O;C[C@@H]1O[C@@H]1P(O)(O)=O, CC1OC1P(O)(O)=O",YMDXZJFXQJVXBF-STHAYSLISA-N
NSC-46475,AYDOLID;DISODIUM SALICYLPHOSPHATE;FOSFOSAL;NSC-46475,CHEMBL287275,BRD:BRD-BRD-K28687144-001-08-7;BRD:BRD-K28687144-001-08-7,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PTGS1;PTGS2,,,LAUNCHED,,Small molecule,-1,"O=C(O)c1ccccc1OP(=O)(O)O;OC(=O)C1CCCCC1OP(O)(O)=O, OC(=O)C1CCCCC1OP(O)(O)=O",FFKUDWZICMJVPA-UHFFFAOYSA-N
SQ-28555,C09AA09;FOSENOPRIL;FOSINOPRIL;MONOPRIL;SQ-28555,CHEMBL3039598,BRD:BRD-A51382177-236-03-0;BRD:BRD-BRD-A51382177-236-03-0,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,"CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C;CCC(=O)O[C@@H](OP(=O)(CCCCC1CCCCC1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C, CCC(=O)O[C@@H](OP(=O)(CCCCC1CCCCC1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C",BIDNLKIUORFRQP-XYGFDPSESA-N
NP-06,FOSPHENYTOIN;NP-06,CHEMBL1201336,BRD:BRD-BRD-K53809807-304-02-4;BRD:BRD-K53809807-304-02-4,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN5A,"EPILEPSY, SEIZURES",,LAUNCHED,,Small molecule,4,"O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O;OP(O)(=O)OCN1C(=O)NC(C1=O)(C1CCCCC1)C1CCCCC1, OP(O)(=O)OCN1C(=O)NC(C1=O)(C1CCCCC1)C1CCCCC1",XWLUWCNOOVRFPX-UHFFFAOYSA-N
R935788 FREE ACID,FOSTAMATINIB;R-788;R-788 FREE ACID;R-935788;R-935788 FREE ACID;R788 FREE ACID;R935788 FREE ACID,CHEMBL2103830,BRD:BRD-BRD-K85178109-001-02-3;BRD:BRD-K85178109-001-02-3,rep_primary;rep_single_dose,SYK INHIBITOR,SYK,CHRONIC IMMUNE THROMBOCYTOPENIA (ITP),,LAUNCHED,,Small molecule,4,"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC;COC1CC(NC2NCC(F)C(NC3CCC4OC(C)(C)C(=O)N(COP(O)(O)=O)C4N3)N2)CC(OC)C1OC, COC1CC(NC2NCC(F)C(NC3CCC4OC(C)(C)C(=O)N(COP(O)(O)=O)C4N3)N2)CC(OC)C1OC",GKDRMWXFWHEQQT-UHFFFAOYSA-N
FOSTEMSAVIR,BMS-663068;BMS-663068 FREE ACID;FOSTEMSAVIR,CHEMBL3301594,BRD:BRD-K00003191-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,4,COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O,SWMDAPWAQQTBOG-UHFFFAOYSA-N
WNT-5A DERIVED HEXAPEPTIDE FOXY-5,FOXY 5;FOXY-5;FOXY5;N-FORMYL-MET-ASP-GLY-CYS-GLU-LEU;WNT-5A DERIVED HEXAPEPTIDE FOXY-5,CHEMBL4297281,BRD:BRD-BRD-K13005598-001-02-3;BRD:BRD-K13005598-001-02-3,rep_primary;rep_single_dose,WNT5A PEPTIDE MIMETIC,WNT5A,,,PHASE 1,,Protein,2,CSCC[C@H](NC=O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O;CSCC[C@H](NC=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O,WFZPJYYCTSHDJI-ATIWLJMLSA-N
FPA-124,FPA-124,,BRD:BRD-BRD-M17926088-001-01-3;BRD:BRD-M17926088-001-01-3,rep_primary;rep_single_dose,AKT INHIBITOR,,,,PRECLINICAL,,,NA,"CL[CU]CL.NC(=S)N\N=C\C1COC2CCCCC2C1=O, CL[CU]CL.NC(=S)N\N=C\C1COC2CCCCC2C1=O",
FPH1-(BRD-6125),FPH1-(BRD-6125),,BRD:BRD-BRD-K61250484-001-02-3;BRD:BRD-K61250484-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,HEPATOCYTE FUNCTION ENHANCER,,,,PRECLINICAL,,,NA,CC1CCC(CL)CC1N(CC(=O)NC1C(F)CCCC1F)S(C)(=O)=O,
FPL-12495,FPL-12495,,BRD:BRD-A09368919-001-01-7;BRD:BRD-BRD-A09368919-001-01-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,PHASE 1,,,NA,CC(N)(CC1CCCCC1)C1CCCCC1,
FPL-55712 SODIUM SALT,FPL-55712;FPL-55712 SODIUM SALT,CHEMBL267475;CHEMBL267976,BRD:BRD-A96456596-001-02-2;BRD:BRD-BRD-A96456596-001-02-2,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,,,,PHASE 1,,Small molecule,NA,CCCc1c(OCC(O)COc2ccc3c(=O)cc(C(=O)[O-])oc3c2CCC)ccc(C(C)=O)c1O.[Na+];CCCC1C(OCC(O)COC2CCC3C(OC(CC3=O)C(O)=O)C2CCC)CCC(C(C)=O)C1O,ZDEVPOBNLIVGFA-UHFFFAOYSA-M
FPL-62064,FPL-62064,,BRD:BRD-BRD-K59875992-001-01-8;BRD:BRD-K59875992-001-01-8,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR",,,,PHASE 2,,,NA,COC1CCC(NC2CCN(N2)-C2CCCCC2)CC1,
FPL-64176,FPL-64176,,BRD:BRD-BRD-K78959463-001-13-2;BRD:BRD-K78959463-001-13-2,rep_primary;rep_single_dose,CALCIUM CHANNEL ACTIVATOR,CACNA1C;CACNA1S,,,PRECLINICAL,,,NA,"COC(=O)C1C(C)[NH]C(C)C1C(=O)C1CCCCC1CC1CCCCC1, COC(=O)C1C(C)[NH]C(C)C1C(=O)C1CCCCC1CC1CCCCC1",
FPS-ZM1,FPS-ZM1,,BRD:BRD-BRD-K87691185-001-01-2;BRD:BRD-K87691185-001-01-2,rep_primary;rep_single_dose,RAGE RECEPTOR ANTAGONIST,AGER,,,PRECLINICAL,,,NA,CLC1CCC(CC1)C(=O)N(CC1CCCCC1)C1CCCCC1,
FQI-1,FQI-1,,CTRP:102193,ctrp,,,,,,,,NA,,
FQI-2,FQI-2,,CTRP:609091,ctrp,,,,,,,,NA,,
FR-122047,FR-122047,CHEMBL275809,BRD:BRD-BRD-K30990140-003-02-4;BRD:BRD-K30990140-003-02-4,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,COc1ccc(-c2nc(C(=O)N3CCN(C)CC3)sc2-c2ccc(OC)cc2)cc1;COC1CCC(CC1)-C1NC(SC1-C1CCC(OC)CC1)C(=O)N1CCN(C)CC1,UBHKJRYGKOSQDJ-UHFFFAOYSA-N
FR-139317,FR-139317,,BRD:BRD-BRD-K19318328-001-01-3;BRD:BRD-K19318328-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA,,,PHASE 1,,,NA,"CC(C)C[C@H](NC(=O)N1CCCCCC1)C(=O)N[C@H](CC1CN(C)C2CCCCC12)C(=O)N[C@H](CC1CCCCN1)C(O)=O, CC(C)C[C@H](NC(=O)N1CCCCCC1)C(=O)N[C@H](CC1CN(C)C2CCCCC12)C(=O)N[C@H](CC1CCCCN1)C(O)=O",
FR-180204,FR-180204,,BRD:BRD-BRD-K68756823-001-07-1;BRD:BRD-K68756823-001-07-1;GDSC1:263,gdsc;rep_primary;rep_single_dose,MAP KINASE INHIBITOR,MAPK1;MAPK3,,,PRECLINICAL,,,NA,"NC1[NH]NC2NNC(CC12)-C1C(NN2CCCCC12)-C1CCCCC1, NC1[NH]NC2NNC(CC12)-C1C(NN2CCCCC12)-C1CCCCC1",
FR180204,ERK INHIBITOR II;FR 180204;FR180204,,GDSC1:263,gdsc,,,,,,,,NA,,
FRAKEFAMIDE (TFA),FRAKEFAMIDE (TFA),,BRD:BRD-K00077076-019-02-9,rep_single_dose,,,,,,,,NA,,
FRAX486,FRAX486,,BRD:BRD-K57243773-001-01-6,rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,PAK1;PAK2;PAK3;PAK4,,,,,,NA,,
FRENTIZOLE,COMPOUND 53616;FRENTIZOLE,CHEMBL128988,BRD:BRD-BRD-K07202345-001-19-4;BRD:BRD-K07202345-001-19-4,rep_multi_dose;rep_primary;rep_single_dose,IMMUNOSUPPRESSANT,,,,PHASE 1,,Small molecule,-1,COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1;COC1CCC2NC(NC(=O)NC3CCCCC3)SC2C1,JHBWYQRKOUBPCA-UHFFFAOYSA-N
ONO-6818,FRESELESTAT;ONO-6818,CHEMBL25892,BRD:BRD-K00004668-001-01-9,rep_single_dose,ELASTASE INHIBITOR,CELA1;ELANE,,,,,Small molecule,-1,CC(C)C(NC(=O)Cn1c(-c2ccccc2)ncc(N)c1=O)C(=O)c1nnc(C(C)(C)C)o1,YSIHYROEMJSOAS-UHFFFAOYSA-N
MYLATRIP,ALLERGO FILMTABLETTEN;FROVA;FROVATRIPTAN;MIGARD;MYLATRIP,CHEMBL1279,BRD:BRD-BRD-K08255599-365-01-1;BRD:BRD-K08255599-365-01-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1;CN[C@@H]1CCC2[NH]C3CCC(CC3C2C1)C(N)=O,XPSQPHWEGNHMSK-SECBINFHSA-N
HMPL013,FRUQUINTINIB;HMPL-013;HMPL013,CHEMBL4303214,BRD:BRD-BRD-K70504253-001-01-3;BRD:BRD-K70504253-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,VEGFR INHIBITOR,KDR,,,PHASE 3,,Small molecule,3,CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12;CNC(=O)C1C(C)OC2CC(OC3NCNC4CC(OC)C(OC)CC34)CCC12,BALLNEJQLSTPIO-UHFFFAOYSA-N
FSC231,FSC231,,CTRP:660079,ctrp,,,,,,,,NA,,
SHP-627,FT-011;FT-11;FT011;SHP-627,CHEMBL1075834,BRD:BRD-K00003378-001-01-9,rep_single_dose,TGF BETA RECEPTOR INHIBITOR,,,,,,Small molecule,2,C#CCOc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC,UIWZIDIJCUEOMT-PKNBQFBNSA-N
FTI-277,FTI-277,,GDSC1:166,gdsc,,,,,,,,NA,,
YOUFUDING,ATILLON;BMS-200604;CITOFUR;COPAROGIN;EXONAL;FENTAL;FRANROSE;FT-207;FTORAFUR;FULAID;FULFEEL;FURAFLUOR;FUROFUTRAN;FUTRAFUL;J356.722B;LAMAR;LIFRIL;MJF-12264;NEBERK;NITOBANIL;NSC-148958;SINOFLUROL;SUNFURAL;TEFSIEL C;TEGAFUR;TEGAFUR-URACIL;UFTORAL;YOUFUDING,CHEMBL20883,BRD:BRD-BRD-K99383816-001-02-7;BRD:BRD-BRD-K99383816-001-03-5;BRD:BRD-K99383816-001-02-7;BRD:BRD-K99383816-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,THYMIDYLATE SYNTHASE INHIBITOR,TYMS,COLORECTAL CANCER,,LAUNCHED,,Small molecule,4,"FC1CN([C@H]2CCCO2)C(=O)[NH]C1=O, FC1CN([C@H]2CCCO2)C(=O)[NH]C1=O;O=c1[nH]c(=O)n(C2CCCO2)cc1F",WFWLQNSHRPWKFK-UHFFFAOYSA-N
GILENYA, GILENIA; GILENYA; IMUSERA; TDI-132;FINGOLIMOD;FINGOLIMOD (AS HYDROCHLORIDE);FINGOLIMOD HCL;FINGOLIMOD HYDROCHLORID;FINGOLIMOD HYDROCHLORIDE;FTY-720;FTY-720 HYDROCHLORIDE;FTY720;FTY720 HYDROCHLORIDE;GILENIA;GILENYA,CHEMBL314854;CHEMBL544665,GDSC1:546,gdsc,,,,,,,Small molecule,4,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1;CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1.Cl,KKGQTZUTZRNORY-UHFFFAOYSA-N;SWZTYAVBMYWFGS-UHFFFAOYSA-N
SEBATROL,ALL-TRANS-;ALL-TRANS-FUCOXANTHIN;CHEBI:5186;FUCOXANTHIN;SEBATROL,CHEMBL1773903,BRD:BRD-K00003355-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,Small molecule,2,CC(=O)O[C@H]1CC(C)(C)C(=C=C/C(C)=C/C=C/C(C)=C/C=C(C)/C=C/C=C(\C)C(=O)C[C@@]23O[C@]2(C)C[C@@H](O)CC3(C)C)[C@](C)(O)C1,MNUMHDZZMWCBBX-JWAQYZNWSA-N
FUDOSTEINE,CLEANAL;FUDOSTEINE,CHEMBL1555183,BRD:BRD-BRD-K54838207-001-02-0;BRD:BRD-BRD-K54838207-001-03-8;BRD:BRD-K54838207-001-02-0;BRD:BRD-K54838207-001-03-8,rep_multi_dose;rep_primary;rep_single_dose,MUCOLYTIC AGENT,,CHEST CONGESTION,,LAUNCHED,,Small molecule,-1,"N[C@@H](CSCCCO)C(=O)O;N[C@@H](CSCCCO)C(O)=O, N[C@@H](CSCCCO)C(O)=O",KINWYTAUPKOPCQ-YFKPBYRVSA-N
FULACIMSTAT,BAY-1142524;BAY1142524;FULACIMSTAT,CHEMBL4297596,BRD:BRD-K00078209-001-02-9,rep_single_dose,,,,,,,Small molecule,2,Cn1c(=O)oc2cc(-n3cc(C(=O)O)c(=O)n([C@@H]4CCc5c4cccc5C(F)(F)F)c3=O)ccc21,JDARDSVOVYVQST-MRXNPFEDSA-N
ZD9238,"FASLODEX;FULVESTRANT;ICI 182,780;ICI-182780;NSC-759879;ZD-182780;ZD-9238;ZD9238",CHEMBL1358,BRD:BRD-A85667082-001-12-7;BRD:BRD-A85667082-001-13-5;BRD:BRD-BRD-A85667082-001-12-7;CTRP:464880;GDSC2:1200;GDSC2:1816,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF ESTROGEN RECEPTOR 1,ESR1;ESR2;GPER1,BREAST CANCER,,LAUNCHED,"Multiple values for MOA: {'ESTROGEN RECEPTOR ANTAGONIST', 'INHIBITOR OF ESTROGEN RECEPTOR 1'}, defaulting to 'INHIBITOR OF ESTROGEN RECEPTOR 1'
Multiple values for repurposing_target: {'ESR1;ESR2;GPER1', 'ESR1'}, taking the union",Small molecule,4,"C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC1CC(O)CCC31, C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC1CC(O)CCC31, C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC1CC(O)CCC31, C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC1CC(O)CCC31",VWUXBMIQPBEWFH-WCCTWKNTSA-N
ZGN-201,(-)-FUMAGILLIN;AMEBACILIN;FUMAGILLIN;FUMIDIL;NSC-9168;ZGN-201,CHEMBL32838,BRD:BRD-A99367815-001-04-9,rep_single_dose,METHIONINE AMINOPEPTIDASE INHIBITOR,METAP2,,,,,Small molecule,-1,CO[C@@H]1[C@H](OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,NGGMYCMLYOUNGM-CSDLUJIJSA-N
FUMONISIN B1,FUMONISIN B1,CHEMBL1241092,CTRP:616353,ctrp,,,,,,,Small molecule,NA,CCCC[C@@H](C)[C@@H](OC(=O)C[C@H](CC(=O)O)C(=O)O)[C@@H](OC(=O)C[C@H](CC(=O)O)C(=O)O)[C@@H](C)C[C@H](O)CCCC[C@@H](O)C[C@H](O)[C@H](C)N,YXBNQTGKGCNTPV-VCEHAEOKSA-N
FUMONISIN-B1,FUMONISIN-B1,,BRD:BRD-K61915943-001-02-9,rep_single_dose,,CERS1,,,,,,NA,,
XPF-002,FUNAPIDE;TV-45070;XEN-401-S;XEN-402;XEN402;XPF-002,CHEMBL3707218,BRD:BRD-K00004702-001-01-9,rep_single_dose,SODIUM CHANNEL BLOCKER,,,,,,Small molecule,2,O=C1N(Cc2ccc(C(F)(F)F)o2)c2ccccc2[C@]12COc1cc3c(cc12)OCO3,NEBUOXBYNAHKFV-NRFANRHFSA-N
FURAZIDINE,AKRITOIN;FURAGIN;FURAGINUM;FURAZIDIN;FURAZIDINE,CHEMBL3707254,BRD:BRD-K00003314-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,-1,O=C1CN(/N=C/C=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,DECBQELQORZLLP-UAIOPKHMSA-N
NSC-527986,(S)-;ALTAFUR;FURALTADONE;LEVOFURALTADON;LEVOFURALTADONE;NF-602;NF-902 [AS HYDROCHLORIDE];NITROFURMETHONE;NSC-42388;NSC-527986,CHEMBL1189513;CHEMBL3989463,BRD:BRD-A67514145-003-05-8;BRD:BRD-BRD-A67514145-003-05-8,rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,,,LAUNCHED,,Small molecule,-1,"[O-][N+](=O)C1CCC(\C=N\N2CC(CN3CCOCC3)OC2=O)O1, [O-][N+](=O)C1CCC(\C=N\N2CC(CN3CCOCC3)OC2=O)O1, [O-][N+](=O)C1CCC(\C=N\N2CC(CN3CCOCC3)OC2=O)O1;O=C1O[C@@H](CN2CCOCC2)CN1/N=C/c1ccc([N+](=O)[O-])o1",YVQVOQKFMFRVGR-NGPAHMQLSA-N
FURAMIDINE,FURAMIDINE,CHEMBL24057,BRD:BRD-K77758223-300-02-9,rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,PRMT1,,,,,Small molecule,-1,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)o2)cc1,ZJHZBDRZEZEDGB-UHFFFAOYSA-N
NSC-6469,FURALL;FURAZOLIDONE;FUROXONE;NIFURAZOLIDONE;NSC-6469,CHEMBL1103,BRD:BRD-BRD-K11756522-001-09-9;BRD:BRD-K11756522-001-09-9,rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,"DIARRHEA, ENTERITIS, CHOLERA",,LAUNCHED,,Small molecule,4,[O-][N+](=O)C1CCC(\C=N\N2CCOC2=O)O1;O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,PLHJDBGFXBMTGZ-WEVVVXLNSA-N
FUREGRELATE,FUREGRELATE,CHEMBL1204948,BRD:BRD-BRD-K55529781-236-03-8;BRD:BRD-K55529781-236-03-8,rep_primary;rep_single_dose,THROMBOXANE SYNTHASE INHIBITOR,TBXAS1,,,PHASE 1,,Small molecule,-1,O=C(O)c1cc2cc(Cc3cccnc3)ccc2o1;OC(=O)C1CC2CC(CC3CCCNC3)CCC2O1,VHWFITPGPFLBGT-UHFFFAOYSA-N
TENKOFRUSE,ALUZINE 20;ALUZINE 40;ALUZINE 500;AQUAMED;DISAL;DIURESAL;DRYPTAL;FROOP;FRUMAX;FRUMIL;FRUSEMIDE;FRUSETIC;FRUSID;FRUSOL;FUROSEMIDE;FUROSEMIDUM;HYDROLED;LASIX;LASIX RET;LB-502;LOGIRENE;MARSEMIDE;MIRFAT;NSC-269420;OEDEMEX;RUSYDE;TENKOFRUSE,CHEMBL35,BRD:BRD-BRD-K78010432-001-21-5;BRD:BRD-K78010432-001-21-5,rep_primary;rep_single_dose,DIURETIC,CA2;GPR35;SLC12A1;SLC12A2,"EDEMA, HYPERTENSION, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME",,LAUNCHED,,Small molecule,4,"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl;NS(=O)(=O)C1CC(C(O)=O)C(NCC2CCCO2)CC1CL, NS(=O)(=O)C1CC(C(O)=O)C(NCC2CCCO2)CC1CL, NS(=O)(=O)C1CC(C(O)=O)C(NCC2CCCO2)CC1CL",ZZUFCTLCJUWOSV-UHFFFAOYSA-N
TTFD,ALIARON F;ALINAMIN-F;FURSULTIAMIN;FURSULTIAMINE;FURSULTIAMINE HYDROCHLORIDE;JUDOLOR;TTFD,CHEMBL1740659,BRD:BRD-A71157293-003-10-0;BRD:BRD-BRD-A71157293-003-10-0,rep_primary;rep_single_dose,VITAMIN B,,,,LAUNCHED,,Small molecule,4,C/C(=C(/CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N;C\C(N(CC1CNC(C)NC1N)C=O)=C(\CCO)SSCC1CCCO1,JTLXCMOFVBXEKD-FOWTUZBSSA-N
FURVINA,FURVINA,,BRD:BRD-K00004693-001-01-9,rep_single_dose,QUORUM SENSING SIGNALING INHIBITOR,,,,,,,NA,,
FUSIDIC-ACID,FUSIDIC-ACID,,BRD:BRD-A06935312-001-04-3;BRD:BRD-BRD-A06935312-001-04-3,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,ACNE VULGARIS (AV),,LAUNCHED,,,NA,C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]1(C)C2[C@H](O)C[C@@H]2[C@]1(C)C[C@H](OC(C)=O)\C2=C(/CCC=C(C)C)C(O)=O,
TAS-120,FGFR-IN-1;FUTIBATINIB;LYTGOBI;TAS 120;TAS-120,CHEMBL3701238,BRD:BRD-K00003392-001-01-9;BRD:BRD-U00115431-001-01-9,oncref_1;rep_single_dose,"INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4",FGFR1;FGFR2;FGFR3;FGFR4,,,,"Multiple values for MOA: {'FGFR INHIBITOR', 'INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4'}, defaulting to 'INHIBITOR OF FGFR1, FGFR2, FGFR3, AND FGFR4'
Multiple values for structure_id: {'K00003392', 'U00115431'}, defaulting to None",Small molecule,4,C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1,KEIPNCCJPRMIAX-HNNXBMFYSA-N
G-1,G-1,,BRD:BRD-BRD-K62696033-001-01-4;BRD:BRD-K62696033-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,GPER1,,,PRECLINICAL,,,NA,CC(=O)C1CCC2N[C@H]([C@H]3CC=C[C@H]3C2C1)C1CC2OCOC2CC1BR,
G-15,G-15,,BRD:BRD-BRD-M30288325-001-01-4;BRD:BRD-M30288325-001-01-4,rep_primary;rep_single_dose,ESTROGEN RECEPTOR ANTAGONIST,GPER1,,,PRECLINICAL,,,NA,BRC1CC2OCOC2CC1[C@H]1NC2CCCCC2[C@H]2C=CC[C@@H]12.BRC1CC2OCOC2CC1[C@@H]1NC2CCCCC2[C@@H]2C=CC[C@H]12,
G-749,DENFIVONTINIB;G-749,CHEMBL4544478,BRD:BRD-K00003126-001-01-9,rep_single_dose,TYROSINE KINASE INHIBITOR,,,,,,Small molecule,-1,CN1CCC(Nc2nc(Nc3ccc(Oc4ccccc4)cc3)c3c(=O)[nH]cc(Br)c3n2)CC1,SXWMIXPJPNCXQQ-UHFFFAOYSA-N
G007-LK,G007-LK,,BRD:BRD-BRD-K12198961-001-01-8;BRD:BRD-K12198961-001-01-8,rep_primary;rep_single_dose,TANKYRASE INHIBITOR,TNKS;TNKS2,,,PRECLINICAL,,,NA,CS(=O)(=O)C1CCC(NC1)-C1NNC(\C=C\C2NNC(O2)-C2CCC(CC2)C#N)N1-C1CCCCC1CL,
GABA-LINOLEAMIDE,GABA-LINOLEAMIDE,,BRD:BRD-BRD-K46254452-001-01-5;BRD:BRD-K46254452-001-01-5,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,,,,PHASE 2,,,NA,CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCCC(O)=O,
NSC-759254,CI-945;DM-1796;GABAPENTIN;GOE 3450;GOE-3450;GRALISE;NEURONTIN;NSC-742194;NSC-759254,CHEMBL940,BRD:BRD-BRD-K62737565-003-02-6;BRD:BRD-K62737565-003-02-6,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,ADORA1;CACNA1A;CACNA1B;CACNA1C;CACNA1D;CACNA1E;CACNA1F;CACNA1G;CACNA1H;CACNA1I;CACNA1S;CACNA2D1;CACNA2D2;CACNA2D3;CACNA2D4;CACNB1;CACNB2;CACNB3;CACNB4;CACNG1;CACNG2;CACNG3;CACNG4;CACNG5;CACNG6;CACNG7;CACNG8;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B,"VIRUS HERPES SIMPLEX (HSV), SHINGLES, SEIZURES, RESTLESS LEG SYNDROME",,LAUNCHED,,Small molecule,4,"NCC1(CC(=O)O)CCCCC1;NCC1(CC(O)=O)CCCCC1, NCC1(CC(O)=O)CCCCC1, NCC1(CC(O)=O)CCCCC1",UGJMXCAKCUNAIE-UHFFFAOYSA-N
GABAPENTIN-ENACARBIL,GABAPENTIN-ENACARBIL,,BRD:BRD-A86665761-001-01-1;BRD:BRD-BRD-A86665761-001-01-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,CACNA1A;CACNA1B;CACNA1C;CACNA1D;CACNA1E;CACNA1F;CACNA1G;CACNA1H;CACNA1I;CACNA1S;CACNA2D1;CACNA2D2;CACNA2D3;CACNA2D4;CACNB1;CACNB2;CACNB3;CACNB4;CACNG1;CACNG2;CACNG3;CACNG4;CACNG5;CACNG6;CACNG7;CACNG8,"RESTLESS LEG SYNDROME, POSTHERPETIC NEURALGIA",,LAUNCHED,,,NA,CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1,
GABAZINE,GABAZINE,CHEMBL32503,BRD:BRD-BRD-K79905821-004-03-6;BRD:BRD-K79905821-004-03-6,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRG2,,,PRECLINICAL,,Small molecule,NA,"COc1ccc(-c2ccc(=N)n(CCCC(=O)O)n2)cc1;COC1CCC(CC1)-C1CCC(=N)N(CCCC(O)=O)N1, COC1CCC(CC1)-C1CCC(=N)N(CCCC(O)=O)N1",ACVGNKYJVGNLIL-UHFFFAOYSA-N
GABEXATE MESILATE,GABEXATE;GABEXATE MESILATE,CHEMBL87563,BRD:BRD-BRD-K59256312-066-15-7;BRD:BRD-K59256312-066-15-7,rep_primary;rep_single_dose,SERINE PROTEASE INHIBITOR,PRSS1;TPSAB1,PANCREATITIS,,LAUNCHED,,Small molecule,3,"CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1;CCOC(=O)C1CCC(OC(=O)CCCCCNC(N)=N)CC1, CCOC(=O)C1CCC(OC(=O)CCCCCNC(N)=N)CC1, CCOC(=O)C1CCC(OC(=O)CCCCCNC(N)=N)CC1, CCOC(=O)C1CCC(OC(=O)CCCCCNC(N)=N)CC1, CCOC(=O)C1CCC(OC(=O)CCCCCNC(N)=N)CC1",YKGYIDJEEQRWQH-UHFFFAOYSA-N
NSC-759585,GABOXADOL;LU 02-030;LU-02-030;LU-02030;MK-0928;NSC-759585,CHEMBL312443,BRD:BRD-BRD-K89104321-003-14-8;BRD:BRD-K89104321-003-14-8,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRD;GABRR1;GABRR2;GABRR3,,,PHASE 3,,Small molecule,3,"Oc1noc2c1CCNC2;OC1NOC2CNCCC12, OC1NOC2CNCCC12, OC1NOC2CNCCC12",ZXRVKCBLGJOCEE-UHFFFAOYSA-N
ZK-135079,BAY86-4875;GADAVIST;GADOBUTROL;GADOGRAF;GADOVIST;PROTOVIST;ZK 135079;ZK-135079,CHEMBL2218860,BRD:BRD-A67181951-001-01-2;BRD:BRD-BRD-A67181951-001-01-2,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,MRI CONTRAST AGENT,,LAUNCHED,,Small molecule,4,OCC(O)[C@@H](CO)N1CCN2CCN3CCN(CC1)CC(=O)O[GD](OC(=O)C3)OC(=O)C2,
S-041,GADODIAMIDE;GADODIAMIDE ANHYDROUS;GDDTPA-BMA;OMNISCAN;S-041,CHEMBL1200346,BRD:BRD-BRD-K38140108-002-01-2;BRD:BRD-K38140108-002-01-2,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,MRI CONTRAST AGENT,,LAUNCHED,,Small molecule,4,CNC(=O)CN1CCN2CCN(CC(=O)NC)CC(=O)O[GD](OC(=O)C1)OC(=O)C2,
GADOTERATE-MEGLUMINE,GADOTERATE-MEGLUMINE,,BRD:BRD-BRD-K11099631-001-07-6;BRD:BRD-K11099631-001-07-6,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,MRI CONTRAST AGENT,,LAUNCHED,,,NA,"OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1, OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1",
SQ-32692,"GADOTERIDOL;NSC-760055;PROHANCE;PROHANCE MULTIPACK;SQ 32,692;SQ-32692",CHEMBL1200593,BRD:BRD-A72401848-001-02-2;BRD:BRD-BRD-A72401848-001-02-2,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,MRI CONTRAST AGENT,,LAUNCHED,,Small molecule,4,"CC(O)CN1CCN2CCN3CCN(CC1)CC(=O)O[GD](OC(=O)C2)OC(=O)C3, CC(O)CN1CCN2CCN3CCN(CC1)CC(=O)O[GD](OC(=O)C2)OC(=O)C3",
GAL-021,GAL-021,,BRD:BRD-K00003410-001-01-9,rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,,,,NA,,
ZEEBRAL XL,(-)-GALANTAMINE;(-)-GALANTHAMINE;ACUMOR XL;CONSION XL;ELMINO XL;GALANTAMINE;GALANTHAMINE;GALSYA XL;GALZEMIC XL;GATALIN XL;GAZYLAN XL;LOTPROSIN XL;LUVENTA XL;NSC-100058;RAZADYNE;REMINYL;REMINYL XL;ZEEBRAL XL,CHEMBL659,BRD:BRD-BRD-K49481516-004-18-3;BRD:BRD-K49481516-004-18-3,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE;BCHE;CHRNA1;CHRNA10;CHRNA2;CHRNA3;CHRNA4;CHRNA5;CHRNA6;CHRNA7;CHRNA9;CHRNB1;CHRNB2;CHRNB3;CHRNB4;CHRND;CHRNE;CHRNG,SENILE DEMENTIA,,LAUNCHED,,Small molecule,4,"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2;COC1CCC2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1C24, COC1CCC2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1C24",ASUTZQLVASHGKV-JDFRZJQESA-N
VN/124-1,GALETERONE;TOK 001;TOK-001;VN 124;VN-124;VN/124;VN/124-1,CHEMBL2105738,BRD:BRD-A07986123-001-02-8;BRD:BRD-BRD-A07986123-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR;CYP17A1,,,PHASE 3,,Small molecule,3,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12;C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C1CC=C2N1CNC2CCCCC12,PAFKTGFSEFKSQG-PAASFTFBSA-N
IMMUCILLIN A,BCX-4430;BCX4430;GALIDESIVIR;IMMUCILLIN A,CHEMBL1236524,BRD:BRD-K00003270-003-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,1,Nc1ncnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12,AMFDITJFBUXZQN-KUBHLMPHSA-N
GALLAMINE-TRIETHIODIDE,GALLAMINE-TRIETHIODIDE,,BRD:BRD-BRD-K43106192-320-11-8;BRD:BRD-K43106192-320-11-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,ACHE;CHRM2;CHRNA1;CHRNA2,MUSCLE RELAXANT,,LAUNCHED,,,NA,"CC[N+](CC)(CC)CCOC1CCCC(OCC[N+](CC)(CC)CC)C1OCC[N+](CC)(CC)CC, CC[N+](CC)(CC)CCOC1CCCC(OCC[N+](CC)(CC)CC)C1OCC[N+](CC)(CC)CC, CC[N+](CC)(CC)CCOC1CCCC(OCC[N+](CC)(CC)CC)C1OCC[N+](CC)(CC)CC",
GALLIBISCOQUINAZOLE,GALLIBISCOQUINAZOLE,,GDSC2:1830,gdsc,,,,,,,,NA,,
GALLIC-ACID,GALLIC-ACID,,BRD:BRD-BRD-K77345217-001-05-0;BRD:BRD-K77345217-001-05-0,rep_primary;rep_single_dose,"BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR, PPAR RECEPTOR AGONIST",CA1;CA12;CA14;CA2;CA4;CA6;CA9;SELP,,,PRECLINICAL,,,NA,OC(=O)C1CC(O)C(O)C(O)C1,
GALLIUM-TRIQUINOLIN-8-OLATE,GALLIUM-TRIQUINOLIN-8-OLATE,,BRD:BRD-K46648676-001-01-8,rep_single_dose,,,,,,,,NA,,
METHOXYVERAPAMIL,(+/-)-METHOXYVERAPAMIL;D-600;DL-D-600;GALLOPAMIL;LU-30-029;METHOXYVERAPAMIL,CHEMBL51149;CHEMBL523367,BRD:BRD-A52922642-001-03-7;BRD:BRD-BRD-A52922642-001-03-7,rep_primary;rep_single_dose,L-TYPE CALCIUM CHANNEL BLOCKER,ATP2A2,"HYPERTENSION, CARDIAC ARRYTHMIA",,LAUNCHED,,Small molecule,2,COc1cc(C(C#N)(CCCN(C)CCc2ccccc2)C(C)C)cc(OC)c1OC;COC1CCC(CCN(C)CCCC(C#N)(C(C)C)C2CC(OC)C(OC)C(OC)C2)CC1OC,IERWCEALNGTKIK-UHFFFAOYSA-N
GAMBOGIC-ACID,GAMBOGIC-ACID,,BRD:BRD-BRD-K08542803-001-03-1;BRD:BRD-K08542803-001-02-3;BRD:BRD-K08542803-001-03-1,rep_multi_dose;rep_primary;rep_single_dose,CASPASE ACTIVATOR,BCL2,,,PHASE 2,,,NA,"CC(C)=CCC[C@@]1(C)OC2C(CC=C(C)C)C3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)C3C(O)C2C=C1)C(=O)[C@]5(C\C=C(\C)C(O)=O)OC6(C)C, CC(C)=CCC[C@@]1(C)OC2C(CC=C(C)C)C3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)C3C(O)C2C=C1)C(=O)[C@]5(C\C=C(\C)C(O)=O)OC6(C)C, CC(C)=CCC[C@@]1(C)OC2C(CC=C(C)C)C3O[C@@]45[C@H]6C[C@@H](C=C4C(=O)C3C(O)C2C=C1)C(=O)[C@]5(C\C=C(\C)C(O)=O)OC6(C)C",
ZACTRAN,"GAMITHROMYCIN;ML-1,709,460;ML-1709460;ML-460;ZACTRAN",CHEMBL2107342,BRD:BRD-K00003489-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,-1,CCCN1C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@H]1C,VWAMTBXLZPEDQO-UZSBJOJWSA-N
GAMMA-AMINOBUTYRIC-ACID,GAMMA-AMINOBUTYRIC-ACID,,BRD:BRD-BRD-K77245796-003-01-6;BRD:BRD-K77245796-003-01-6,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABBR1;GABBR2;GABRA1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GATM;KCTD12;KCTD16;KCTD8;SLC6A1,,,PRECLINICAL,,,NA,NCCCC(O)=O,
GAMMA-LINOLENIC-ACID,GAMMA-LINOLENIC-ACID,,BRD:BRD-BRD-K18059238-001-10-4;BRD:BRD-K18059238-001-10-4,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR AGONIST",PTGS1;PTGS2,,,PHASE 2,,,NA,"CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O, CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O, CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O",
ZTALMY,CCD 1042;CCD-1042;DEA NO. 2401;GANAXOLONE;ZTALMY,CHEMBL1568698,BRD:BRD-BRD-K28217197-001-01-4;BRD:BRD-K28217197-001-01-4,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6,,,PHASE 3,,Small molecule,4,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C,PGTVWKLGGCQMBR-FLBATMFCSA-N
ZIRGAN,BW 759U;BW-759U;CYMEVENE;CYTOVENE;CYTOVENE IV;GANCICLOVIR;GANCICLOVIR (AS SODIUM);GANCICLOVIR SODIUM;GANCICLOVIR SODIUM SALT;GANCYCLOVIR;GANZYK-RTU;NSC-759656;RS-21592;RS-21592 SODIUM;VALGANCICLOVIR HYDROCHLORIDE IMPURITY A;VIRGAN;VITRASERT;ZIRGAN,CHEMBL1200850;CHEMBL182,BRD:BRD-BRD-K22662435-001-18-3;BRD:BRD-BRD-K22662435-001-19-1;BRD:BRD-K22662435-001-18-3;BRD:BRD-K22662435-001-19-1,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,CYTOMEGALOVIRUS (CMV),,LAUNCHED,,Small molecule,4,"Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1;NC1NC2N(COC(CO)CO)CNC2C(=O)[NH]1, NC1NC2N(COC(CO)CO)CNC2C(=O)[NH]1, NC1NC2N(COC(CO)CO)CNC2C(=O)[NH]1",IRSCQMHQWWYFCW-UHFFFAOYSA-N
STA-9090,GANETESPIB;STA 9090;STA-9090,CHEMBL2103879,BRD:BRD-BRD-K38852836-001-02-1;BRD:BRD-K38852836-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1,,,PHASE 3,,Small molecule,3,CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O;CC(C)C1CC(-C2N[NH]C(=O)N2-C2CCC3N(C)CCC3C2)C(O)CC1O,RVAQIUULWULRNW-UHFFFAOYSA-N
GANGLIOSIDE-GM1,GANGLIOSIDE-GM1,,BRD:BRD-A30703952-201-01-2;BRD:BRD-BRD-A30703952-201-01-2,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(OC4OC(CO)C(O)C(O)C4O)C3NC(C)=O)C(OC3(CC(O)C(NC(C)=O)C(O3)C(O)C(O)CO)C(O)=O)C2O)C(O)C1O)[C@H](O)\C=C\CCCCCCCCCCCCC,
GANODERIC-ACID-A,GANODERIC-ACID-A,,BRD:BRD-K00003733-001-01-9,rep_single_dose,JAK INHIBITOR,,,,,,,NA,,
GANT-58,GANT-58,,BRD:BRD-BRD-K64451768-001-05-4;BRD:BRD-K64451768-001-05-4,rep_primary;rep_single_dose,GLI ANTAGONIST,GLI1,,,PRECLINICAL,,,NA,C1CC(CCN1)-C1SC(C(C1-C1CCNCC1)-C1CCNCC1)-C1CCNCC1,
GANT-61,GANT-61,,BRD:BRD-K09485525-001-03-9;CTRP:609332,ctrp;rep_single_dose,GLI ANTAGONIST,GLI1;GLI2,,,,,,NA,,
T-3811,GARENOXACIN;T-3811,CHEMBL215303,BRD:BRD-BRD-K77038618-356-01-3;BRD:BRD-K77038618-356-01-3,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A,RESPIRATORY TRACT INFECTIONS,,LAUNCHED,,Small molecule,-1,C[C@H]1NCc2cc(-c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)ccc21;C[C@H]1NCC2CC(CCC12)-C1CCC2C(C1OC(F)F)N(CC(C(O)=O)C2=O)C1CC1,NJDRXTDGYFKORP-LLVKDONJSA-N
GASTRODIN,GASTRODIN,CHEMBL274739,BRD:BRD-BRD-K81613478-001-01-8;BRD:BRD-K81613478-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,NA,OC[C@@H]1O[C@@H](OC2CCC(CO)CC2)[C@H](O)[C@@H](O)[C@@H]1O;OCc1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,PUQSUZTXKPLAPR-UJPOAAIJSA-N
ZYMER,AM-1155;BMS-206584-01;BMS-20658401;GATIFLO;GATIFLOXACIN;GATIFLOXACIN (SESQUIHYDRATE);GATIFLOXACIN ANHYDROUS;GATIFLOXACIN HYDRATE;GATIFLOXACIN SESQUIHYDRATE;NSC-758701;PD-135432;TEQUIN;ZYMAR;ZYMAXID;ZYMER,CHEMBL31,BRD:BRD-A74980173-001-11-9;BRD:BRD-BRD-A74980173-001-11-9,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,,,WITHDRAWN,,Small molecule,4,"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12;COC1C(N2CCNC(C)C2)C(F)CC2C1N(CC(C(O)=O)C2=O)C1CC1, COC1C(N2CCNC(C)C2)C(F)CC2C1N(CC(C(O)=O)C2=O)C1CC1",XUBOMFCQGDBHNK-UHFFFAOYSA-N
GV-150526X,GAVESTINEL;GV 150526X;GV-150526X,CHEMBL44793,BRD:BRD-BRD-K81981783-236-02-9;BRD:BRD-K81981783-236-02-9,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GLRB;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B,,,PHASE 3,"Multiple values for repurposing_target: {'GLRB;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B', 'GLRB'}, taking the union",Small molecule,-1,"O=C(/C=C/c1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)Nc1ccccc1;OC(=O)C1[NH]C2CC(CL)CC(CL)C2C1\C=C\C(=O)NC1CCCCC1, OC(=O)C1[NH]C2CC(CL)CC(CL)C2C1\C=C\C(=O)NC1CCCCC1, OC(=O)C1[NH]C2CC(CL)CC(CL)C2C1\C=C\C(=O)NC1CCCCC1",WZBNEZWCNKUOSM-VOTSOKGWSA-N
GBR-12783,GBR-12783,,BRD:BRD-BRD-K92015269-300-01-2;BRD:BRD-K92015269-300-01-2,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",,,,PRECLINICAL,"Multiple values for MOA: {'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR', 'DOPAMINE UPTAKE INHIBITOR'}, defaulting to 'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR'",,NA,C(CN1CCN(C\C=C\C2CCCCC2)CC1)OC(C1CCCCC1)C1CCCCC1,
GBR-12935,GBR-12935,,BRD:BRD-BRD-K50135270-300-02-3;BRD:BRD-K50135270-300-02-3,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",AGTR1;SLC6A3,,,PRECLINICAL,"Multiple values for MOA: {'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR', 'DOPAMINE UPTAKE INHIBITOR'}, defaulting to 'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR'",,NA,C(CN1CCN(CCOC(C2CCCCC2)C2CCCCC2)CC1)CC1CCCCC1,
GBR-13069,GBR-13069,,BRD:BRD-BRD-K92577649-300-01-2;BRD:BRD-K92577649-300-01-2,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",SLC6A3,,,PRECLINICAL,"Multiple values for MOA: {'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR', 'DOPAMINE UPTAKE INHIBITOR'}, defaulting to 'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR'",,NA,FC1CCC(CC1)C(OCCN1CCN(C\C=C\C2CCCCC2)CC1)C1CCC(F)CC1,
TASELISIB,GDC-0032;RG-7604;TASELISIB,CHEMBL2387080,BRD:BRD-BRD-K44844162-001-01-6;BRD:BRD-K44844162-001-01-6;BRD:BRD-K44844162-001-04-0;GDSC2:1561,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"INHIBITOR OF PI3 KINASE ALPHA, DELTA, AND GAMMA",PIK3CA;PIK3CD;PIK3CG,,,PHASE 3,"Multiple values for MOA: {'PI3K INHIBITOR', 'INHIBITOR OF PI3 KINASE ALPHA, DELTA, AND GAMMA'}, defaulting to 'INHIBITOR OF PI3 KINASE ALPHA, DELTA, AND GAMMA'
Multiple values for repurposing_target: {'PIK3CA;PIK3CD;PIK3CG', 'PIK3CA'}, taking the union",Small molecule,3,CC(C)N1NC(C)NC1-C1CN2CCOC3CC(CCC3-C2N1)-C1CNN(C1)C(C)(C)C(N)=O;Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1,BEUQXVWXFDOSAQ-UHFFFAOYSA-N
RG7440,GDC-0068;IPATASERTIB;RG-7440;RG7440,CHEMBL2177390,BRD:BRD-BRD-K71480163-001-01-4;BRD:BRD-K43002773-001-05-9;BRD:BRD-K71480163-001-01-4;GDSC2:1924,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"INHIBITOR OF AKT1, AKT2, AND AKT3",AKT1;AKT2;AKT3;PRKG1,,,PHASE 2,"Multiple values for MOA: {'INHIBITOR OF AKT1, AKT2, AND AKT3', 'AKT INHIBITOR'}, defaulting to 'INHIBITOR OF AKT1, AKT2, AND AKT3'
Multiple values for repurposing_target: {'AKT1;AKT2;AKT3;PRKG1', 'AKT1;AKT2;AKT3'}, taking the union
Multiple values for structure_id: {'K43002773', 'K71480163'}, defaulting to None",Small molecule,3,CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1;CC(C)NC[C@@H](C(=O)N1CCN(CC1)C1NCNC2[C@@H](O)C[C@@H](C)C12)C1CCC(CL)CC1,GRZXWCHAXNAUHY-NSISKUIASA-N
RO7113755,GDC-0077;GDC0077;INAVOLISIB;RG-6114;RG6114;RO-7113755;RO7113755,CHEMBL4650215,BRD:BRD-K00003420-001-01-9;BRD:BRD-K00126777-001-01-9;BRD:BRD-K63191384-001-04-9,oncref_2;rep_single_dose,INHIBITOR OF PIK3CA,PIK3CA,,,,"Multiple values for MOA: {'PI3K INHIBITOR', 'INHIBITOR OF PIK3CA'}, defaulting to 'INHIBITOR OF PIK3CA'",Small molecule,2,C[C@H](Nc1ccc2c(c1)OCCn1cc(N3C(=O)OC[C@H]3C(F)F)nc1-2)C(N)=O,SGEUNORSOZVTOL-CABZTGNLSA-N
RG-7666,G-02441729;G02441729;GDC-0084;GDC0084;PAXALISIB;RG-7666,CHEMBL3813842,BRD:BRD-K00003309-001-01-9,rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",,,,,,Small molecule,2,CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,LGWACEZVCMBSKW-UHFFFAOYSA-N
GDC-0152,GDC-0152,CHEMBL2063869,BRD:BRD-BRD-K68938568-001-01-7;BRD:BRD-K68938568-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,XIAP INHIBITOR,BIRC2;BIRC3;BIRC7;XIAP,,,PHASE 1,,Protein,1,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NC1SNNC1-C1CCCCC1;CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1,WZRFLSDVFPIXOV-LRQRDZAKSA-N
GDC-0339,GDC-0339,,BRD:BRD-K00126479-001-01-9,oncref_2,INHIBITOR OF PIM,PIM1;PIM2;PIM3,,,,,,NA,,
RG-7603,GDC-0349;RG-7603,CHEMBL2331680,BRD:BRD-BRD-K43187018-001-03-3;BRD:BRD-K43187018-001-03-3,rep_multi_dose;rep_primary;rep_single_dose,PIM KINASE INHIBITOR,PIK3CA,,,PHASE 1,,Small molecule,1,"CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1;CCNC(=O)NC1CCC(CC1)-C1NC2CN(CCC2C(N1)N1CCOC[C@@H]1C)C1COC1, CCNC(=O)NC1CCC(CC1)-C1NC2CN(CCC2C(N1)N1CCOC[C@@H]1C)C1COC1",RGJOJUGRHPQXGF-INIZCTEOSA-N
VISMODEGIB,ERIVEDGE;GDC-0449;NSC-747691;NSC-755986;VISMODEGIB,CHEMBL473417,BRD:BRD-BRD-K44827188-001-06-0;BRD:BRD-K44827188-001-06-0;BRD:BRD-K44827188-001-12-9;GDSC1:1033,gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,"HEDGEHOG PATHWAY INHIBITOR, SMOOTHENED RECEPTOR ANTAGONIST",SMO,BASAL CELL CARCINOMA (BCC),,LAUNCHED,"Multiple values for MOA: {'HEDGEHOG PATHWAY INHIBITOR, SMOOTHENED RECEPTOR ANTAGONIST', 'INHIBITOR OF SMO'}, defaulting to 'HEDGEHOG PATHWAY INHIBITOR, SMOOTHENED RECEPTOR ANTAGONIST'",Small molecule,4,CLC1CC(CCC1C(=O)NC1CCC(CL)C(C1)-C1CCCCN1)S(C)(=O)=O;CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,BPQMGSKTAYIVFO-UHFFFAOYSA-N
RG-7741,GDC-0575;RG-7741,CHEMBL3545199,BRD:BRD-K00003112-001-01-9,rep_single_dose,CHK INHIBITOR,,,,,,Small molecule,1,,
XL518,COBIMETINIB;COTELLIC;GDC 0623;GDC 0973;GDC-0623;GDC-0973;RG 7420;RG-7420;RG-7421;RG7420;XL 518;XL-518;XL518,CHEMBL2146883,BRD:BRD-BRD-K46908090-001-02-2;BRD:BRD-K46908090-001-02-2,rep_primary;rep_single_dose,MEK INHIBITOR,,,,PHASE 1,,Small molecule,4,"O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1;OCCONC(=O)C1CCC2CNCN2C1NC1CCC(I)CC1F, OCCONC(=O)C1CCC2CNCN2C1NC1CCC(I)CC1F, OCCONC(=O)C1CCC2CNCN2C1NC1CCC(I)CC1F, OCCONC(=O)C1CCC2CNCN2C1NC1CCC(I)CC1F",BSMCAPRUBJMWDF-KRWDZBQOSA-N
RG6046,ARN-810;BRILANESTRANT;GDC-0810;RG-6046;RG6046,CHEMBL3581693,BRD:BRD-BRD-K61923022-001-02-4;BRD:BRD-K61923022-001-02-4;GDSC2:1925,gdsc;rep_primary;rep_single_dose,SELECTIVE ESTROGEN RECEPTOR DESTABILIZER,ESR1,,,PHASE 2,,Small molecule,2,CC/C(=C(/c1ccc(/C=C/C(=O)O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl;CC\C(=C(\C1CCC(\C=C\C(O)=O)CC1)C1CCC2[NH]NCC2C1)C1CCC(F)CC1CL,BURHGPHDEVGCEZ-KJGLQBJMSA-N
GDC-0834,GDC-0834,,BRD:BRD-A30984645-001-01-5;BRD:BRD-BRD-A30984645-001-01-5,rep_primary;rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BTK,,,PHASE 1,,,NA,"CN1CCN(C)C(=O)C1C1CCC(NC2NC(CN(C)C2=O)-C2CCCC(NC(=O)C3CC4CCCCC4S3)C2C)CC1, CN1CCN(C)C(=O)C1C1CCC(NC2NC(CN(C)C2=O)-C2CCCC(NC(=O)C3CC4CCCCC4S3)C2C)CC1",
GDC-0879,GDC-0879,,BRD:BRD-BRD-K67578145-001-09-7;BRD:BRD-BRD-K67578145-001-12-1;BRD:BRD-K67578145-001-09-7;BRD:BRD-K67578145-001-12-1;CTRP:606248,ctrp;rep_multi_dose;rep_primary;rep_single_dose,RAF INHIBITOR,BRAF,,,PRECLINICAL,,,NA,"OCCN1CC(C(N1)-C1CCNCC1)-C1CCC2C(CC\C2=N/O)C1, OCCN1CC(C(N1)-C1CCNCC1)-C1CCC2C(CC\C2=N/O)C1, OCCN1CC(C(N1)-C1CCNCC1)-C1CCC2C(CC\C2=N/O)C1",
RG-6047,GDC-0927;RG-6047,CHEMBL4297758,BRD:BRD-K00003101-001-02-9,rep_single_dose,ESTROGEN RECEPTOR ANTAGONIST,,,,,,Unknown,1,,
RG-7321,CDC-0941;GDC 0941;GDC-0941;PICTILISIB;PICTRELISIB;RG-7321,CHEMBL521851,BRD:BRD-BRD-K52911425-001-09-8;BRD:BRD-K52911425-001-01-5;BRD:BRD-K52911425-001-09-8;CTRP:639759;GDSC1:1058;GDSC1:1527;GDSC2:1058,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF PI3 KINASE ALPHA AND DELTA,PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PHASE 2,"Multiple values for MOA: {'PI3K INHIBITOR', 'INHIBITOR OF PI3 KINASE ALPHA AND DELTA'}, defaulting to 'INHIBITOR OF PI3 KINASE ALPHA AND DELTA'
Multiple values for repurposing_target: {'PIK3CA;PIK3CB;PIK3CD;PIK3CG', 'PIK3CA;PIK3CD'}, taking the union",Small molecule,2,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1;CS(=O)(=O)N1CCN(CC2CC3NC(NC(N4CCOCC4)C3S2)-C2CCCC3[NH]NCC23)CC1,LHNIIDJUOCFXAP-UHFFFAOYSA-N
RG7422,APITOLISIB;G-038390;G-038390.1;GDC-0980;GDC-0980.1;GNE-390;RG-7422;RG7422,CHEMBL1922094,BRD:BRD-BRD-K23228615-001-02-8;BRD:BRD-K23228615-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",FGR;MAP3K9;MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG;SYK,,,PHASE 2,,Small molecule,2,"C[C@H](O)C(=O)N1CCN(CC2SC3C(NC(NC3C2C)-C2CNC(N)NC2)N2CCOCC2)CC1, C[C@H](O)C(=O)N1CCN(CC2SC3C(NC(NC3C2C)-C2CNC(N)NC2)N2CCOCC2)CC1;Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12",YOVVNQKCSKSHKT-HNNXBMFYSA-N
RG-7842,GDC-0994;GDC0994;RAVOXERTINIB;RG-7842,CHEMBL3544964,BRD:BRD-A20830788-001-01-9;BRD:BRD-BRD-A20830788-001-01-9,rep_primary;rep_single_dose,MAP KINASE INHIBITOR,MAPK1;MAPK3,,,PHASE 1,,Small molecule,1,Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1;CN1NCCC1NC1NCCC(N1)-C1CCN(C(CO)C2CCC(CL)C(F)C2)C(=O)C1,RZUOCXOYPYGSKL-GOSISDBHSA-N
MIGOPROTAFIB,GDC-1971;MIGOPROTAFIB,,BRD:BRD-K00126782-001-01-9,oncref_2,INHIBITOR OF SHP2,PTPN11,,,,,,NA,,
GDC0068,GDC 0068;GDC0068,,GDSC2:1924,gdsc,,,,,,,,NA,,
VISMODEGIB,ERIVEDGE;GDC-0449;GDC0449;NSC-747691;NSC-755986;VISMODEGIB,CHEMBL473417,GDSC1:1033,gdsc,,,,,,,Small molecule,4,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,BPQMGSKTAYIVFO-UHFFFAOYSA-N
GDC0810,GDC 0810;GDC0810,,GDSC2:1925,gdsc,,,,,,,,NA,,
RG7422,APITOLISIB;G-038390;G-038390.1;GDC-0980;GDC-0980.1;GDC0980;GNE-390;RG-7422;RG7422,CHEMBL1922094,GDSC1:382,gdsc,,,,,,,Small molecule,2,Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,YOVVNQKCSKSHKT-HNNXBMFYSA-N
GEDUNIN,GEDUNIN,CHEMBL465226,BRD:BRD-BRD-K02703275-001-07-5;BRD:BRD-K02703275-001-07-5,rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1,,,PRECLINICAL,,Small molecule,NA,CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](OC(=O)[C@H]4O[C@@]34[C@]12C)C1CCOC1;CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@H](c4ccoc4)OC(=O)[C@H]4O[C@]43[C@@]21C,YJXDGWUNRYLINJ-BHAPSIHVSA-N
RO4926219,AF-219;GEFAPIXANT;R-1646;R1646;RG-1646;RG1646;RO-4926219;RO4926219,CHEMBL3716057,BRD:BRD-K00004589-001-01-9,rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,,,,,,Small molecule,3,COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O,HLWURFKMDLAKOD-UHFFFAOYSA-N
ZD1839,GEFITINIB;IRESSA;NSC-759856;ZD-1839;ZD1839,CHEMBL939,BRD:BRD-BRD-K64052750-001-17-5;BRD:BRD-K64052750-001-17-5;BRD:BRD-K64052750-001-22-5;CTRP:52926;GDSC1:1010;GDSC2:1010,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,,Small molecule,4,"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1;COC1CC2NCNC(NC3CCC(F)C(CL)C3)C2CC1OCCCN1CCOCC1, COC1CC2NCNC(NC3CCC(F)C(CL)C3)C2CC1OCCCN1CCOCC1, COC1CC2NCNC(NC3CCC(F)C(CL)C3)C2CC1OCCCN1CCOCC1, COC1CC2NCNC(NC3CCC(F)C(CL)C3)C2CC1OCCCN1CCOCC1",XGALLCVXEZPNRQ-UHFFFAOYSA-N
NSC-122750,GELDANAMYCIN;NSC-122750,CHEMBL278315,BRD:BRD-K43570081-001-02-4,rep_single_dose,HSP INHIBITOR,HSP90AA1,,,,,Small molecule,2,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,QTQAWLPCGQOSGP-KSRBKZBZSA-N
GEMCABENE,GEMCABENE,CHEMBL2110686,BRD:BRD-K00077939-001-02-9,rep_single_dose,,,,,,,Small molecule,2,CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O,SDMBRCRVFFHJKR-UHFFFAOYSA-N
NSC-233811,CI-720;GEMCADIOL;NSC-233811,CHEMBL2105082,BRD:BRD-BRD-K43890836-001-01-6;BRD:BRD-K43890836-001-01-6,rep_primary;rep_single_dose,ANTILIPEMIC,,,,PHASE 2,,Small molecule,-1,CC(C)(CO)CCCCCCC(C)(C)CO,DJKWDKJYFYUEBQ-UHFFFAOYSA-N
NSC-613327,GEMCITABINE;GEMZAR;LY-188011;LY188011;NSC-613327,CHEMBL888,BRD:BRD-BRD-K15108141-001-06-6;BRD:BRD-K15108141-001-06-6;BRD:BRD-U00115291-001-01-9;CTRP:411863;GDSC1:135;GDSC2:1190,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,CMPK1;RRM1;RRM2;TYMS,"OVARIAN CANCER, BREAST CANCER, NON-SMALL CELL LUNG CANCER (NSCLC), PANCREATIC CANCER",,LAUNCHED,"Multiple values for MOA: {'RIBONUCLEOTIDE REDUCTASE INHIBITOR', 'INHIBITOR OF DNA REPLICATION'}, defaulting to 'RIBONUCLEOTIDE REDUCTASE INHIBITOR'
Multiple values for structure_id: {'K15108141', 'U00115291'}, defaulting to None",Small molecule,4,"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1;NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)C(=O)N1, NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)C(=O)N1, NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)C(=O)N1, NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)C(=O)N1",SDUQYLNIPVEERB-QPPQHZFASA-N
GEMCITABINE-ELAIDATE,GEMCITABINE-ELAIDATE,,BRD:BRD-BRD-K09456915-001-01-2;BRD:BRD-K09456915-001-01-2,rep_primary;rep_single_dose,"APOPTOSIS INHIBITOR, DNA SYNTHESIS INHIBITOR",CMPK1;RRM1;TYMS,,,PHASE 1,"Multiple values for MOA: {'DNA SYNTHESIS INHIBITOR, APOPTOSIS INHIBITOR', 'APOPTOSIS INHIBITOR, DNA SYNTHESIS INHIBITOR'}, defaulting to 'APOPTOSIS INHIBITOR, DNA SYNTHESIS INHIBITOR'",,NA,CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@@H](N2CCC(N)NC2=O)C(F)(F)[C@@H]1O,
NSC-757024,CI-719;EMFIB;GEMFIBROZIL;LOPID;NSC-757024,CHEMBL457,BRD:BRD-BRD-K11129031-001-27-5;BRD:BRD-K11129031-001-27-5,rep_primary;rep_single_dose,LIPOPROTEIN LIPASE ACTIVATOR,LPL;PPARA;SLCO1B1;SLCO1B3;SLCO2B1,"HYPERLIPIDEMIA, CORONARY HEART DISEASE",,LAUNCHED,,Small molecule,4,"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1;CC1CCC(C)C(OCCCC(C)(C)C(O)=O)C1, CC1CCC(C)C(OCCCC(C)(C)C(O)=O)C1",HEMJJKBWTPKOJG-UHFFFAOYSA-N
GEMIFLOXACIN,FACTIV;GEMIFLOXACIN,CHEMBL430,BRD:BRD-A40787240-066-04-6;BRD:BRD-BRD-A40787240-066-04-6,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,"BRONCHITIS, PNEUMONIA",,LAUNCHED,,Small molecule,4,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN;CO\N=C1/CN(CC1CN)C1NC2N(CC(C(O)=O)C(=O)C2CC1F)C1CC1,ZRCVYEYHRGVLOC-HYARGMPZSA-N
LC15-0444,GEMIGLIPTIN;LC-15-0444;LC-150444;LC15-0444,CHEMBL3707235,BRD:BRD-K00003182-001-01-9,rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,,,,,,Small molecule,3,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1CC(F)(F)CCC1=O,ZWPRRQZNBDYKLH-VIFPVBQESA-N
GEMILUKAST,GEMILUKAST,,BRD:BRD-K00078614-001-02-9,rep_single_dose,,,,,,,,NA,,
GENENTECH CPD 10,GENENTECH CPD 10,,GDSC1:225,gdsc,,,,,,,,NA,,
GENIPIN,GENIPIN,CHEMBL459016,BRD:BRD-BRD-K28824103-001-02-8;BRD:BRD-BRD-K28824103-001-04-4;BRD:BRD-K28824103-001-02-8;BRD:BRD-K28824103-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,CHOLERETIC AGENT,,,,PRECLINICAL,,Small molecule,NA,"COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12;COC(=O)C1=CO[C@@H](O)[C@H]2[C@@H]1CC=C2CO, COC(=O)C1=CO[C@@H](O)[C@H]2[C@@H]1CC=C2CO, COC(=O)C1=CO[C@@H](O)[C@H]2[C@@H]1CC=C2CO",AZKVWQKMDGGDSV-BCMRRPTOSA-N
GENIPOSIDE,GENIPOSIDE,CHEMBL462894,BRD:BRD-BRD-K57275767-001-02-4;BRD:BRD-BRD-K57275767-001-03-2;BRD:BRD-K57275767-001-02-4;BRD:BRD-K57275767-001-03-2,rep_primary;rep_single_dose,GLP RECEPTOR AGONIST,GLP1R,,,PRECLINICAL,,Small molecule,NA,"COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2C(CO)=CC[C@H]12;COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1CC=C2CO, COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]2[C@@H]1CC=C2CO",IBFYXTRXDNAPMM-BVTMAQQCSA-N
GENIPOSIDIC-ACID,GENIPOSIDIC-ACID,,BRD:BRD-BRD-K73771095-001-02-5;BRD:BRD-BRD-K73771095-001-03-3;BRD:BRD-K73771095-001-02-5;BRD:BRD-K73771095-001-03-3,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,PRECLINICAL,,,NA,"OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@H]3CC=C(CO)[C@@H]23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O, OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@H]3CC=C(CO)[C@@H]23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O",
SPARTEINE L-.ALPHA.-ISOSPARTEINE,".ALPHA.-ISOSPARTEIN;.ALPHA.-ISOSPARTEINE;.ALPHA.-SPARTEINE;(-)-;(-)-.ALPHA.-ISOSPARTEINE;11-ISOSPARTEINE;4',5,7-TRIHYDROXYISOFLAVONE;ALPHA-;BIO 300;BIO-300;BONISTEIN;FW-635I-2;GENISTEIN;GENISTEINE-ALKALOID;ISOSPARTEINE;NPI-031L;NSC-36586;NSC-366737;SIPI-807-1;SOPHORICOL;SPARTEINE L-.ALPHA.-ISOSPARTEINE",CHEMBL44,BRD:BRD-BRD-K43797669-001-30-4;BRD:BRD-K43797669-001-28-8;BRD:BRD-K43797669-001-30-4,rep_multi_dose;rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,CFTR;ESR1;ESR2;ESRRA;ESRRB;ESRRG;NCOA1;NCOA2;PPARG;PTK2B;TOP2A;TRPC5,,,PHASE 2/PHASE 3,,Small molecule,2,"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12;OC1CCC(CC1)-C1COC2CC(O)CC(O)C2C1=O, OC1CCC(CC1)-C1COC2CC(O)CC(O)C2C1=O, OC1CCC(CC1)-C1COC2CC(O)CC(O)C2C1=O, OC1CCC(CC1)-C1COC2CC(O)CC(O)C2C1=O",TZBJGXHYKVUXJN-UHFFFAOYSA-N
GENTIOPICRIN,GENTIOPICRIN,,BRD:BRD-BRD-K33131085-001-07-2;BRD:BRD-K33131085-001-07-2,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR DOWNREGULATOR,GRIN2B,,,PHASE 3,,,NA,OC[C@H]1O[C@@H](O[C@@H]2OC=C3C(=O)OCC=C3[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O,
GENZ-123346,GENZ-123346,,BRD:BRD-K70693421-001-01-1,rep_single_dose,GLUCOSYLCERAMIDASE INHIBITOR,UGCG,,,,,,NA,,
GENZ-644282,GENZ-644282,CHEMBL191958,BRD:BRD-BRD-K99475619-001-01-2;BRD:BRD-K99475619-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,PHASE 1,,Small molecule,1,CNCCn1c(=O)c2cc(OC)c(OC)cc2c2cnc3cc4c(cc3c21)OCO4;CNCCN1C2C(CNC3CC4OCOC4CC23)C2CC(OC)C(OC)CC2C1=O,BAORCAMWLWRZQG-UHFFFAOYSA-N
GEPEFRINE,D-.ALPHA.-METHYL-M-TYRAMINE;GEPEFRINE,CHEMBL2105064;CHEMBL3989731,BRD:BRD-A04447196-001-01-8;BRD:BRD-BRD-A04447196-001-01-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,HYPOTENSION,,LAUNCHED,,Small molecule,-1,C[C@H](N)Cc1cccc(O)c1;CC(N)Cc1cccc(O)c1;CC(N)CC1CCCC(O)C1,WTDGMHYYGNJEKQ-UHFFFAOYSA-N;WTDGMHYYGNJEKQ-ZETCQYMHSA-N
GEPON,GEPON,,BRD:BRD-A56754222-001-01-2;BRD:BRD-BRD-A56754222-001-01-2,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,CC(C)[C@@H](NC(=O)C(NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)C(CCCNC(N)=N)NC(=O)C(CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)C(CCC(O)=O)NC(=O)[C@H](N)C(C)O)C(C)O)C(=O)N[C@H](CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NC(CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
GSK2140944,GEPOTIDACIN;GSK-2140944;GSK2140944,CHEMBL3317856,BRD:BRD-K33499285-001-02-9,rep_single_dose,TOPOISOMERASE INHIBITOR,,,,,,Small molecule,3,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,PZFAZQUREQIODZ-LJQANCHMSA-N
SH-B-331,GESTODENE;SH B 331;SH-B-331,CHEMBL1213583,BRD:BRD-BRD-K97197005-001-03-2;BRD:BRD-K97197005-001-03-2,rep_primary;rep_single_dose,CONTRACEPTIVE AGENT,,CONTRACEPTIVE,,LAUNCHED,,Small molecule,3,C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC;CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C,SIGSPDASOTUPFS-XUDSTZEESA-N
RU-2323,A 46 745;A-46-745;A-46745;DIMETRIOSE;GESTRINONE;R 2323;R-2323;RU 2323;RU-2323,CHEMBL1868702,BRD:BRD-BRD-K97472745-001-01-8;BRD:BRD-K97472745-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR ANTAGONIST,AR;ESR1;PGR,ENDOMETRIOSIS,,LAUNCHED,,Small molecule,4,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC;CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C,BJJXHLWLUDYTGC-ANULTFPQSA-N
GF109203X,GF109203X,,BRD:BRD-K31342827-001-13-8,rep_single_dose,PKC INHIBITOR,PDPK1;PIM1;PRKCI;PRKCZ,,,,,,NA,,
GGSTOP,GGSTOP,,BRD:BRD-A25625670-001-02-7,rep_single_dose,GAMMA GLUTAMYLTRANSFERASE INHIBITOR,GGT1,,,,,,NA,,
GGTI-298,GGTI-298,,BRD:BRD-BRD-K19669037-001-01-1;BRD:BRD-K19669037-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,GGTASE INHIBITOR,CDKN1A,,,PRECLINICAL,,,NA,COC(=O)[C@H](CC(C)C)NC(=O)C1CCC(NC[C@@H](N)CS)CC1-C1CCCC2CCCCC12,
GIDAZEPAM,GIDAZEPAM,,BRD:BRD-BRD-K22588750-001-07-0;BRD:BRD-K22588750-001-07-0,rep_multi_dose;rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,,,,LAUNCHED,,,NA,NNC(=O)CN1C2CCC(BR)CC2C(=NCC1=O)C1CCCCC1,
GILTERITINIB,ASP-2215;ASP2215;GILTERITINIB,CHEMBL3301622,BRD:BRD-BRD-K72280606-001-01-2;BRD:BRD-K72280606-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,FLT3 INHIBITOR,FLT3,,,PHASE 3,,Small molecule,4,CCC1NC(C(N)=O)C(NC2CCC(N3CCC(CC3)N3CCN(C)CC3)C(OC)C2)NC1NC1CCOCC1;CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1,GYQYAJJFPNQOOW-UHFFFAOYSA-N
GIMESTAT,GIMERACIL;GIMESTAT,CHEMBL1730601,BRD:BRD-BRD-K35687421-001-02-5;BRD:BRD-K35687421-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,DIHYDROPYRIMIDINE DEHYDROGENASE INHIBITOR,DPYD,GASTRIC ADENOCARCINOMA,,LAUNCHED,,Small molecule,3,"OC1CC(=O)[NH]CC1CL, OC1CC(=O)[NH]CC1CL;Oc1cc(O)c(Cl)cn1",ZPLQIPFOCGIIHV-UHFFFAOYSA-N
GINKGOLIDE-A,GINKGOLIDE-A,,BRD:BRD-A95121829-001-08-9;BRD:BRD-BRD-A95121829-001-08-9,rep_multi_dose;rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GLRA1;GLRB,,,PRECLINICAL,,,NA,C[C@@H]1C(=O)O[C@H]2CC34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O,
GINKGOLIDE-B,GINKGOLIDE-B,,BRD:BRD-A59001851-001-02-1;BRD:BRD-BRD-A59001851-001-02-1,rep_primary;rep_single_dose,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,GLRA1;GLRA2;GLRA3;GLRB;HTR3A;HTR3B,,,PHASE 3,,,NA,"C[C@@H]1C(=O)OC2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O, C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O, C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O",
GINSENOSIDE-C-K,GINSENOSIDE-C-K,,BRD:BRD-BRD-K01942833-001-01-8;BRD:BRD-K01942833-001-01-8,rep_primary;rep_single_dose,"NFKB PATHWAY INHIBITOR, NITRIC OXIDE SYNTHASE INHIBITOR",PTGS2,,,PRECLINICAL,,,NA,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C,
GINSENOSIDE-RD,GINSENOSIDE-RD,,BRD:BRD-A84810646-001-01-6;BRD:BRD-BRD-A84810646-001-01-6,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,PHASE 3,,,NA,CC(C)=CCCC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C,
GINSENOSIDE-RE,GINSENOSIDE-RE,,BRD:BRD-K00003326-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,,NA,,
GINSENOSIDE-RG3,GINSENOSIDE-RE3;GINSENOSIDE-RG3,,BRD:BRD-A44511856-001-01-4;BRD:BRD-BRD-A44511856-001-01-4,rep_primary;rep_single_dose,"ANGIOGENESIS INHIBITOR, APOPTOSIS STIMULANT",KCNH2,,,LAUNCHED,,,NA,CC(C)=CCCC(C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C,
GIVINOSTAT,GIVINOSTAT,CHEMBL1213492,BRD:BRD-BRD-K13810148-311-03-2;BRD:BRD-K13810148-311-03-2,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9,,,PHASE 2,,Small molecule,3,CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1;CCN(CC)CC1CCC2CC(COC(=O)NC3CCC(CC3)C(=O)NO)CCC2C1,YALNUENQHAQXEA-UHFFFAOYSA-N
GK921,GK921,,BRD:BRD-K38272302-001-02-7,rep_single_dose,TRANSGLUTAMINASE INHIBITOR,TGM2,,,,,,NA,,
GKA-50,GKA-50,,BRD:BRD-K03827870-001-02-9,rep_single_dose,GLUCOKINASE ACTIVATOR,GCK,,,,,,NA,,
GKT137831,GKT137831,,BRD:BRD-BRD-K79710622-001-02-9;BRD:BRD-K79710622-001-02-9,rep_primary;rep_single_dose,NADPH OXIDASE INHIBITOR,NOX1;NOX4,,,PHASE 2,,,NA,"CN(C)C1CCCC(C1)-C1N(C)C(=O)CC2[NH]N(-C3CCCCC3CL)C(=O)C12, CN(C)C1CCCC(C1)-C1N(C)C(=O)CC2[NH]N(-C3CCCCC3CL)C(=O)C12, CN(C)C1CCCC(C1)-C1N(C)C(=O)CC2[NH]N(-C3CCCCC3CL)C(=O)C12",
R-1707,GLAFENIN;GLAFENINE;GLAPHENINE;GLYCERYLAMINOPHENAQUINE;NSC-757808;R 1707;R-1707,CHEMBL146095,BRD:BRD-A38076815-003-10-3;BRD:BRD-BRD-A38076815-003-10-3,rep_primary;rep_single_dose,DELTAF508-CFTR CORRECTORS,CFTR,,,WITHDRAWN,,Small molecule,4,"O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12;OCC(O)COC(=O)C1CCCCC1NC1CCNC2CC(CL)CCC12, OCC(O)COC(=O)C1CCCCC1NC1CCNC2CC(CL)CCC12",GWOFUCIGLDBNKM-UHFFFAOYSA-N
PF-4449913,GLASDEGIB;PF-04449913;PF-4449913,CHEMBL2043437,BRD:BRD-BRD-K34341643-001-01-4;BRD:BRD-K34341643-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,HEDGEHOG PATHWAY INHIBITOR,SMO,,,PHASE 2,,Small molecule,4,CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1;CN1CC[C@H](C[C@@H]1C1NC2CCCCC2[NH]1)NC(=O)NC1CCC(CC1)C#N,SFNSLLSYNZWZQG-VQIMIIECSA-N
GLECAPREVIR,A-1282576;A-1282576.0;A-12825760;ABT-493;GLECAPREVIR,CHEMBL3545363,BRD:BRD-K00003260-001-01-9,rep_single_dose,SERINE PROTEASE INHIBITOR,,,,,,Small molecule,4,CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC/C=C/C(F)(F)c2nc3ccccc3nc2O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4(C)CC4)C[C@H]3C(F)F)N(C2)C1=O,MLSQGNCUYAMAHD-ITNVBOSISA-N
STI571,GLEEVEC;GLIVEC;IMATINIB (AS MESILATE);IMATINIB ACCORD;IMATINIB MEDAC;IMATINIB MESILATE;IMATINIB MESYLATE;IMATINIB METHANE SULFONATE;IMATINIB METHANESULFONATE;NSC-716051;QTI-571;QTI571;STI 571;STI-571;STI571,CHEMBL1642,GDSC1:34,gdsc,,,,,,,Small molecule,4,CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,YLMAHDNUQAMNNX-UHFFFAOYSA-N
MGCD265,GLESATINIB;MG-90265;MG-90265X;MG90265;MG90265GLY;MG90265H9;MG90265X;MGCD-265;MGCD265,CHEMBL3989914,BRD:BRD-K00003288-003-01-9,rep_single_dose,TYROSINE KINASE INHIBITOR,,,,,,Small molecule,2,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1,YRCHYHRCBXNYNU-UHFFFAOYSA-N
ZICRON PR,BILXONA;DACADIS MR;DIAGLYK;DIAMICRON;DIAMICRON MR;EDICIL;GLICLAZIDE;GLIMICRON;GLIMIL;J3.151H;NAZDOL MR;NSC-758673;S-1702;S-852;SE 1702;SE-1702;VAMJU;VITILE XL;ZICLASEG;ZICRON;ZICRON PR,CHEMBL427216,BRD:BRD-A61154809-001-15-9;BRD:BRD-BRD-A61154809-001-15-9,rep_primary;rep_single_dose,"ATP CHANNEL BLOCKER, INSULIN SECRETAGOGUE",ABCC8;VEGFA,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CC1CCC(CC1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1, CC1CCC(CC1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1, CC1CCC(CC1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1;Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1",BOVGTQGAOIONJV-UHFFFAOYSA-N
NSC-759809,AMARYL;GLIMEPIRIDE;HOE 490;HOE-490;NIDDARYL;NSC-759809,CHEMBL1481,BRD:BRD-BRD-K34776109-001-16-6;BRD:BRD-K34776109-001-16-6,rep_primary;rep_single_dose,INSULIN SECRETAGOGUE,ABCC8;KCNJ1;KCNJ11,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CCC1=C(C)CN(C(=O)NCCC2CCC(CC2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O, CCC1=C(C)CN(C(=O)NCCC2CCC(CC2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O, CCC1=C(C)CN(C(=O)NCCC2CCC(CC2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O;CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O",WIGIZIANZCJQQY-RUCARUNLSA-N
NSC-759120,"CP-28,720;CP-28720;GLIBENESE;GLIPIZIDE;GLIPIZIDE SLOW RELEASE;GLUCOTROL;GLUCOTROL XL;K 4024;K-4024;MINODIAB 2.5;MINODIAB 5;NSC-759120",CHEMBL1073,BRD:BRD-BRD-K12219985-001-26-1;BRD:BRD-K12219985-001-26-1,rep_primary;rep_single_dose,SULFONYLUREA,ABCC8;KCNJ10;KCNJ11;PPARG,"DIABETES MELLITUS, HYPERGLYCEMIA",,LAUNCHED,,Small molecule,4,"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1;CC1CNC(CN1)C(=O)NCCC1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1, CC1CNC(CN1)C(=O)NCCC1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1",ZJJXGWJIGJFDTL-UHFFFAOYSA-N
GLURENORM,ARDF 26;ARDF-26;GLIQUIDONE;GLURENORM,CHEMBL383634,BRD:BRD-BRD-K80396088-001-12-0;BRD:BRD-K80396088-001-12-0,rep_primary;rep_single_dose,SULFONYLUREA,ABCC8;KCNJ10;KCNJ8,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,COC1CCC2C(C1)C(=O)N(CCC1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C;COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C,LLJFMFZYVVLQKT-UHFFFAOYSA-N
MEMOGAIN,BENZGALANTAMINE;GALANTAMINE BENZOATE;GLN-1062;MEMOGAIN,CHEMBL5095056,BRD:BRD-K00004731-001-01-9,rep_single_dose,CHOLINESTERASE INHIBITOR,,,,,,Small molecule,-1,COc1ccc2c3c1O[C@H]1C[C@@H](OC(=O)c4ccccc4)C=C[C@@]31CCN(C)C2,JKVNJTYHRABHIY-WXVUKLJWSA-N
GLPG0187,GLPG-0187;GLPG0187,CHEMBL3319236,BRD:BRD-K00003380-001-01-9,rep_single_dose,INTEGRIN ANTAGONIST,,,,,,Small molecule,1,COc1ccc(S(=O)(=O)N[C@@H](CNc2nc(C)nc(N3CCC(c4ccc5c(n4)NCCC5)CC3)c2C)C(=O)O)cc1,CXHCNOMGODVIKB-VWLOTQADSA-N
GLPG0492,(-)-GLPG-0492;DT-200;G 100192;GLPG-0492;GLPG0492,CHEMBL3545417,BRD:BRD-BRD-K15893360-001-01-8;BRD:BRD-K15893360-001-01-8,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,,,PHASE 1,,Small molecule,1,CN1C(=O)N(C(=O)[C@@]1(CO)C1CCCCC1)C1CCC(C#N)C(C1)C(F)(F)F,
GLPG0492-R-ENANTIOMER,GLPG0492-R-ENANTIOMER,,BRD:BRD-BRD-K04643927-001-01-6;BRD:BRD-K04643927-001-01-6,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,,,PHASE 1,,,NA,CN1C(=O)N(C(=O)[C@]1(CO)C1CCCCC1)C1CCC(C#N)C(C1)C(F)(F)F,
GLPG0974,GLPG-0974;GLPG0974,CHEMBL3353541,BRD:BRD-K00078613-001-02-9,rep_single_dose,,,,,,,Small molecule,2,C[C@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12,MPMKMQHJHDHPBE-RUZDIDTESA-N
GLPG1837,GLPG1837,,BRD:BRD-K00003095-001-01-9,rep_single_dose,CFTR CHANNEL POTENTIATOR,,,,,,,NA,,
MEDIFLEX,CHITOSAMINE;GLUCOSAMINE;MEDIFLEX,CHEMBL493287;CHEMBL606759,BRD:BRD-BRD-K29918010-003-04-1;BRD:BRD-K29918010-003-04-1,rep_primary;rep_single_dose,GLYCOSYLATED PROTEIN PRECURSOR,IFNG;IL1B;MMP9;NFKB2;TNF,"MUSCLE PAIN, RHEUMATOID ARTHRITIS, JOINT PAIN, BACKACHE",,LAUNCHED,,Small molecule,4,N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O;N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,MSWZFWKMSRAUBD-IVMDWMLBSA-N
NUTRESTORE,ENDARI;FEMA NO. 3684;GLUTAMINE;GLUTAMINE-(L);L-GLUTAMINE;LEVOGLUTAMIDE;NSC-27421;NUTRESTORE,CHEMBL930,BRD:BRD-BRD-K83896451-001-06-7;BRD:BRD-K83896451-001-06-7,rep_primary;rep_single_dose,,CTPS1;GLUL;GPRC6A;PPAT,"DIARRHEA, MUCOSITIS, MUSCLE PAIN, JOINT PAIN, PEPTIC ULCER DISEASE (PUD), ULCERATIVE COLITIS, CROHN'S DISEASE, ANXIETY, INSOMNIA",,LAUNCHED,,Small molecule,4,"N[C@@H](CCC(N)=O)C(O)=O, N[C@@H](CCC(N)=O)C(O)=O;NC(=O)CC[C@H](N)C(=O)O",ZDXPYRJPNDTMRX-VKHMYHEASA-N
TATHIONE,AEC GLUTATHIONE;GLUTATHIONE;GLUTHAM;ISETHION;L-GLUTATHIONE REDUCED;REDUCED L-GLUTATHIONE;TATHIONE,CHEMBL1543,BRD:BRD-BRD-K69346723-001-04-8;BRD:BRD-K69346723-001-04-8,rep_primary;rep_single_dose,ANTIOXIDANT,ESD;GGT1;GLO1;GLRX;GLRX2;GPX1;GPX2;GPX3;GPX4;GPX5;GPX6;GPX7;GPX8;GSR;GSS;GSTA1;GSTA2;GSTA3;GSTA4;GSTA5;GSTK1;GSTM1;GSTM2;GSTM3;GSTM4;GSTM5;GSTO1;GSTO2;GSTP1;GSTT1;GSTZ1;HAGH;HPGDS;LTC4S;MGST1;MGST2;MGST3;TXNDC12,,,PHASE 3,,Small molecule,3,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O;N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O,RWSXRVCMGQZWBV-WDSKDSINSA-N
GLUTATHIONE-MONOISOPROPYL-ESTER,GLUTATHIONE-MONOISOPROPYL-ESTER,,BRD:BRD-BRD-K58937086-001-01-4;BRD:BRD-K58937086-001-01-4,rep_primary;rep_single_dose,LIPID PEROXIDASE INHIBITOR,,,,PHASE 2,,,NA,"CC(C)OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(O)=O, CC(C)OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(O)=O",
GLY-GLN,GLY-GLN,,BRD:BRD-BRD-K85066592-001-01-6;BRD:BRD-K85066592-001-01-6,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,NCC(=O)N[C@@H](CCC(N)=O)C(O)=O,
U-26452,"CALABREN;CIRARA;DAONIL;DIABETA;DIABETAMIDE 2.5;DIABETAMIDE 5;EUGLUCON;GLIBENCLAMIDE;GLIBENCLAMIDUM;GLIKEN;GLYBENCLAMIDE;GLYBURIDE;GLYBURIDE (MICRONIZED);GLYNASE;GLYNASE PRESTAB;HB 419;HB-419;LEDERGLIB;LIBANIL;MALIX;MICRONASE;NSC-759618;SEMI-DAONIL;U-26,45;U-26,452;U-26452",CHEMBL472,BRD:BRD-BRD-K36927236-001-32-6;BRD:BRD-K36927236-001-32-6,rep_primary;rep_single_dose,"ATP CHANNEL BLOCKER, INSULIN SECRETAGOGUE, SULFONYLUREA",ABCA1;ABCB11;ABCC8;ABCC9;CFTR;CPT1A;KCNJ1;KCNJ11;KCNJ5;KCNJ8;SLCO2B1,"DIABETES MELLITUS, HYPERGLYCEMIA",,LAUNCHED,,Small molecule,4,"COC1CCC(CL)CC1C(=O)NCCC1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1, COC1CCC(CL)CC1C(=O)NCCC1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1, COC1CCC(CL)CC1C(=O)NCCC1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1, COC1CCC(CL)CC1C(=O)NCCC1CCC(CC1)S(=O)(=O)NC(=O)NC1CCCCC1;COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1",ZNNLBTZKUZBEKO-UHFFFAOYSA-N
GLYCEROL-MONOLAURATE,GLYCEROL MONOLAURATE;GLYCEROL-MONOLAURATE,CHEMBL510533,BRD:BRD-A10773072-001-03-4;BRD:BRD-BRD-A10773072-001-03-4,rep_primary;rep_single_dose,BETA LACTAMASE INHIBITOR,,,,LAUNCHED,,Small molecule,NA,CCCCCCCCCCCC(=O)OCC(O)CO,ARIWANIATODDMH-UHFFFAOYSA-N
GLYCEROL-PHENYLBUTYRATE,GLYCEROL-PHENYLBUTYRATE,,BRD:BRD-K00003520-001-01-9,rep_single_dose,SIGMA RECEPTOR LIGAND,,,,,,,NA,,
GLYCITEIN,GLYCITEIN,CHEMBL513024,BRD:BRD-BRD-K78303961-001-02-3;BRD:BRD-K78303961-001-02-3,rep_primary;rep_single_dose,TUMOR NECROSIS FACTOR RELEASE INHIBITOR,TNF,,,PHASE 3,,Small molecule,NA,COc1cc2c(=O)c(-c3ccc(O)cc3)coc2cc1O;COC1CC2C(CC1O)OCC(-C1CCC(O)CC1)C2=O,DXYUAIFZCFRPTH-UHFFFAOYSA-N
TARODYN,AD-237;AHR-504;CHF-5259;CHF5259;CUVPOSA;DARTISLA ODT;ERYTHRO-;GLYCOPYRROLATE;GLYCOPYRRONE BROMIDE;GLYCOPYRRONIUM (AS BROMIDE);GLYCOPYRRONIUM BROMIDE;GLYRX-PF;LONHALA MAGNAIR KIT;NODAPTON;NSC-250836;NSC-251251;NSC-251252;NVA-237;NVA237;ORG-NC-45;PT-001;PT001;ROBANUL;ROBINUL;ROBINUL FORTE;ROBINUL FTE;SEEBRI;SIALANAR;TARODYL;TARODYN,CHEMBL1201027,BRD:BRD-A81233518-004-16-1;BRD:BRD-BRD-A81233518-004-16-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,4,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1CCCCC1;C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-],VPNYRYCIDCJBOM-UHFFFAOYSA-M
GM-1485,GM-1485,,BRD:BRD-K00004613-001-01-9,rep_single_dose,IMMUNOPHILIN LIGAND,FKBP1A,,,,,,NA,,
GMX-1778,CHS 828;CHS-828;GMX 1778;GMX-1778,CHEMBL17289,CTRP:411843,ctrp,,,,,,,Small molecule,1,N#CN=C(NCCCCCCOc1ccc(Cl)cc1)Nc1ccncc1,BOIPLTNGIAPDBY-UHFFFAOYSA-N
GMX1778,GMX1778,,BRD:BRD-BRD-K69832040-001-01-9;BRD:BRD-K69832040-001-01-9,rep_primary;rep_single_dose,NAMPT INHIBITOR,NAMPT,,,PHASE 1/PHASE 2,,,NA,CLC1CCC(OCCCCCCN\C(NC#N)=N\C2CCNCC2)CC1,
GNE-049,GNE-049,,BRD:BRD-K00126493-001-01-9,oncref_2,INHIBITOR OF EP300/CREBBP BRD,BRD4;BRET;CREBBP;EP300,,,,,,NA,,
GNE-477,GNE-477,,BRD:BRD-K12609995-001-02-9,rep_single_dose,,,,,,,,NA,,
GNE-7915,GNE-7915,,BRD:BRD-K33963447-001-03-9,rep_single_dose,LEUCINE RICH REPEAT KINASE INHIBITOR,,,,,,,NA,,
GNE317,GNE 317;GNE-317;GNE317,,GDSC2:1926,gdsc,,,,,,,,NA,,
GNF-2,GNF-2,,BRD:BRD-BRD-K97056771-001-13-1;BRD:BRD-K97056771-001-13-1;GDSC1:52,gdsc;rep_primary;rep_single_dose,BCR-ABL KINASE INHIBITOR,ABL1;BCR,,,PRECLINICAL,,,NA,"NC(=O)C1CCCC(C1)-C1CC(NC2CCC(OC(F)(F)F)CC2)NCN1, NC(=O)C1CCCC(C1)-C1CC(NC2CCC(OC(F)(F)F)CC2)NCN1",
GNF-5,GNF-5,,BRD:BRD-BRD-K87632963-001-03-0;BRD:BRD-K87632963-001-03-0,rep_primary;rep_single_dose,BCR-ABL KINASE INHIBITOR,ABL1;BCR,,,PRECLINICAL,,,NA,OCCNC(=O)C1CCCC(C1)-C1NCNC(NC2CCC(CC2)OC(F)(F)F)C1,
GNF-7,GNF-7,,BRD:BRD-K69075588-001-02-9,rep_single_dose,"GLUCOKINASE INHIBITOR, PROTEIN KINASE INHIBITOR",GCK;TNK2,,,,,,NA,,
GNTI,GNTI,,BRD:BRD-K64748124-300-06-9,rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRK1;OPRM1,,,,,,NA,,
GO-6983,GO-6983,,BRD:BRD-BRD-K36984403-001-02-7;BRD:BRD-K36984403-001-02-7,rep_primary;rep_single_dose,PROTEIN KINASE INHIBITOR,PRKCA;PRKCB;PRKCD;PRKCG;PRKCZ,,,PRECLINICAL,,,NA,"COC1CCC2N(CCCN(C)C)CC(C3=C(C(=O)NC3=O)C3C[NH]C4CCCCC34)C2C1, COC1CCC2N(CCCN(C)C)CC(C3=C(C(=O)NC3=O)C3C[NH]C4CCCCC34)C2C1",
GOLGICIDE-A,GOLGICIDE-A,,BRD:BRD-A57886255-001-01-1;BRD:BRD-BRD-A57886255-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,ARF INHIBITOR,GBF1,,,PRECLINICAL,,,NA,FC1CC(F)C2NC([C@@H]3CC=C[C@@H]3C2C1)C1CCCNC1,
GOLVATINIB,E-7050;E7050;GOLVATINIB,CHEMBL3039525,BRD:BRD-BRD-K69001009-001-02-8;BRD:BRD-K69001009-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,VEGFR INHIBITOR,KDR;MET,,,PHASE 2,,Small molecule,2,CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1;CN1CCN(CC1)C1CCN(CC1)C(=O)NC1CC(OC2CCC(NC(=O)C3(CC3)C(=O)NC3CCC(F)CC3)C(F)C2)CCN1,UQRCJCNVNUFYDX-UHFFFAOYSA-N
RELEFACT LH-RH,FERTIRAL LH-RH;GONADORELIN;GONADORELIN DECAPEPTIDE;GONADOTROPIN-RELEASING HORMONE;HUMAN GONADOLIBERIN-I;RELEFACT LH-RH,CHEMBL1007,BRD:BRD-BRD-K96874295-015-01-0;BRD:BRD-K96874295-015-01-0,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,GNRHR;GNRHR2,"CYSTIC OVARIES, REPRODUCTIVE SYNCHRONY",,LAUNCHED,,Protein,4,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC1C[NH]CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O;CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,XLXSAKCOAKORKW-AQJXLSMYSA-N
GOSERELIN-ACETATE,GOSERELIN-ACETATE,,BRD:BRD-BRD-K99504665-001-01-2;BRD:BRD-K99504665-001-01-2,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,GNRHR;LHCGR,"PROSTATE CANCER, BREAST CANCER, ENDOMETRIOSIS",,LAUNCHED,,,NA,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC1C[NH]CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,
TASH 1,(-)-GOSSYPOL;BL-193;GOSSYPOL;NO FERTIL;NSC-56817;NSC-624336;POGOSIN;TASH 1,CHEMBL51483,BRD:BRD-BRD-K19295594-015-14-3;BRD:BRD-K19295594-015-14-3;CTRP:25036,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"BCL INHIBITOR, MCL1 INHIBITOR",BCL2,,,PHASE 2,,Small molecule,3,"CC(C)C1C(O)C(O)C(C=O)C2C(O)C(C(C)CC12)-C1C(C)CC2C(C(C)C)C(O)C(O)C(C=O)C2C1O, CC(C)C1C(O)C(O)C(C=O)C2C(O)C(C(C)CC12)-C1C(C)CC2C(C(C)C)C(O)C(O)C(C=O)C2C1O, CC(C)C1C(O)C(O)C(C=O)C2C(O)C(C(C)CC12)-C1C(C)CC2C(C(C)C)C(O)C(O)C(C=O)C2C1O, CC(C)C1C(O)C(O)C(C=O)C2C(O)C(C(C)CC12)-C1C(C)CC2C(C(C)C)C(O)C(O)C(C=O)C2C1O, CC(C)C1C(O)C(O)C(C=O)C2C(O)C(C(C)CC12)-C1C(C)CC2C(C(C)C)C(O)C(O)C(C=O)C2C1O, CC(C)C1C(O)C(O)C(C=O)C2C(O)C(C(C)CC12)-C1C(C)CC2C(C(C)C)C(O)C(O)C(C=O)C2C1O;Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O",QBKSWRVVCFFDOT-UHFFFAOYSA-N
GP1A,GP1A,,BRD:BRD-BRD-K65285700-001-02-3;BRD:BRD-K65285700-001-02-3,rep_primary;rep_single_dose,CANNABINOID RECEPTOR AGONIST,CNR2,,,PRECLINICAL,,,NA,CC1CCC-2C(CC3C(NN(C-23)-C2CCC(CL)CC2CL)C(=O)NN2CCCCC2)C1,
GP2A,GP2A,,BRD:BRD-BRD-K34608650-001-02-4;BRD:BRD-K34608650-001-02-4,rep_primary;rep_single_dose,CANNABINOID RECEPTOR AGONIST,CNR2,,,PRECLINICAL,,,NA,CC1CCC-2C(CC3C(NN(C-23)-C2CCC(CL)CC2CL)C(=O)NC2CCCCC2)C1,
GPBAR-A,GPBAR-A,,BRD:BRD-BRD-K67397687-001-01-3;BRD:BRD-K67397687-001-01-3,rep_primary;rep_single_dose,"G PROTEIN COUPLED RECEPTOR AGONIST, G PROTEIN-COUPLED RECEPTOR AGONIST",GPBAR1,,,PRECLINICAL,"Multiple values for MOA: {'G PROTEIN COUPLED RECEPTOR AGONIST, G PROTEIN-COUPLED RECEPTOR AGONIST', 'G PROTEIN COUPLED RECEPTOR AGONIST'}, defaulting to 'G PROTEIN COUPLED RECEPTOR AGONIST, G PROTEIN-COUPLED RECEPTOR AGONIST'",,NA,FC1CCCCC1-C1CCNC2OCC(=O)N(CC3CC(CC(C3)C(F)(F)F)C(F)(F)F)CC12,
GPI-1046,GPI-1046,CHEMBL6367,BRD:BRD-BRD-K44869961-001-01-6;BRD:BRD-K44869961-001-01-6,rep_primary;rep_single_dose,FKBP INHIBITOR,FKBP1A,,,PRECLINICAL,,Small molecule,NA,CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc1cccnc1;CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCC1CCCNC1,OQAHHWOPVDDWHD-INIZCTEOSA-N
GPI-688,GPI-688,,BRD:BRD-A90201073-001-02-9,rep_single_dose,GLYCOGEN PHOSPHORYLASE INHIBITOR,,,,,,,NA,,
GPP-78,GPP-78,,BRD:BRD-BRD-K83289131-003-01-0;BRD:BRD-K83289131-003-01-0,rep_primary;rep_single_dose,NAMPT INHIBITOR,NAMPT,,,PRECLINICAL,,,NA,O=C(CCCCCCCN1CC(NN1)-C1CCCNC1)NC1CCCCC1-C1CCCCC1,
GPR120-MODULATOR-1,GPR120-MODULATOR-1,,BRD:BRD-BRD-K19409553-001-01-6;BRD:BRD-K19409553-001-01-6,rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR MODULATOR,FFAR4,,,PRECLINICAL,,,NA,CC1CC(OCC2NC(CS2)-C2CCCCC2CL)CCC1OCC(O)=O,
GR-103691,GR-103691,,BRD:BRD-BRD-K50891186-001-04-4;BRD:BRD-K50891186-001-04-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD3,,,PRECLINICAL,,,NA,COC1CCCCC1N1CCN(CCCCNC(=O)C2CCC(CC2)-C2CCC(CC2)C(C)=O)CC1,
GR-113808,GR-113808,,BRD:BRD-BRD-K49945136-001-10-0;BRD:BRD-K49945136-001-10-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR4,,,PRECLINICAL,,,NA,CN1CC(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)C2CCCCC12,
GR-127935,GR-127935,CHEMBL15928,BRD:BRD-BRD-K11911061-003-11-9;BRD:BRD-K11911061-003-11-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR6,,,PRECLINICAL,,Small molecule,NA,COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1;COC1CCC(NC(=O)C2CCC(CC2)-C2CCC(CC2C)-C2NOC(C)N2)CC1N1CCN(C)CC1,YDBCEBYHYKAFRX-UHFFFAOYSA-N
GR-135531,GR-135531,,BRD:BRD-BRD-K83023055-001-02-7;BRD:BRD-K83023055-001-02-7,rep_primary;rep_single_dose,MELATONIN RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,COC(=O)NC1CCC2[NH]CC(CCNC(C)=O)C2C1,
GR-144053,GR-144053,,BRD:BRD-BRD-K12120659-305-02-2;BRD:BRD-K12120659-305-02-2,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGA2B;ITGB3,,,PRECLINICAL,,,NA,NC(=N)C1CCC(CC1)N1CCN(CC1)C1CCN(CC(O)=O)CC1,
GR-159897,GR-159897,,BRD:BRD-BRD-K52394958-001-02-7;BRD:BRD-K52394958-001-02-7,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TAC1;TACR2,,,PRECLINICAL,,,NA,"COC1(C[S@@](=O)C2CCCCC2)CCN(CCC2C[NH]C3CCC(F)CC23)CC1, COC1(C[S@@](=O)C2CCCCC2)CCN(CCC2C[NH]C3CCC(F)CC23)CC1",
GR-79236,GR-79236,CHEMBL2163568,BRD:BRD-BRD-K40578143-001-02-6;BRD:BRD-K40578143-001-02-6,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A,,,PHASE 1,,Small molecule,NA,OC[C@H]1O[C@@H](n2cnc3c(N[C@H]4CCC[C@@H]4O)ncnc32)[C@H](O)[C@@H]1O;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(N[C@H]3CCC[C@@H]3O)NCNC12,GYWXTRVEUURNEW-TVDBPQCTSA-N
GR125487,GR125487,,BRD:BRD-BRD-K62594868-082-08-6;BRD:BRD-K62594868-082-08-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR4,,,PRECLINICAL,,,NA,COC1[NH]C2CCC(F)CC2C1C(=O)OCC1CCN(CCNS(C)(=O)=O)CC1,
GR46611,GR46611,,BRD:BRD-BRD-K98155362-001-07-7;BRD:BRD-K98155362-001-07-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1D,,,PRECLINICAL,,,NA,"COC1CCC(CNC(=O)\C=C\C2CCC3[NH]CC(CCN(C)C)C3C2)CC1, COC1CCC(CNC(=O)\C=C\C2CCC3[NH]CC(CCN(C)C)C3C2)CC1",
GRAMINE,GRAMINE,CHEMBL254348,BRD:BRD-BRD-K26005076-001-12-8;BRD:BRD-K26005076-001-12-8,rep_primary;rep_single_dose,NOREPINEPHRINE REPUTAKE INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,CN(C)Cc1c[nH]c2ccccc12;CN(C)CC1C[NH]C2CCCCC12,OCDGBSUVYYVKQZ-UHFFFAOYSA-N
SUSTOL,APF-530;APF530;BRL 43694;BRL-43694;GRANISETRON;KYTRIL;LY-278584;SANCUSO;SUSTOL,CHEMBL289469,BRD:BRD-A10967948-003-06-3;BRD:BRD-BRD-A10967948-003-06-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A,"NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,"CN1C2CCCC1CC(C2)NC(=O)C1NN(C)C2CCCCC12, CN1C2CCCC1CC(C2)NC(=O)C1NN(C)C2CCCCC12;CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2",MFWNKCLOYSRHCJ-UHFFFAOYSA-N
RQ-7,"423;AAT-007;CJ 023423;CJ-023;CJ-023,423;CJ-023423;GRAPIPRANT;MR-10A7;MR10A7;RQ-00000007;RQ-7",CHEMBL3039498,BRD:BRD-BRD-K62050508-001-01-0;BRD:BRD-K62050508-001-01-0,rep_primary;rep_single_dose,PROSTAGLANDIN INHIBITOR,PTGER4,OSTEOARTHRITIS,,LAUNCHED,,Small molecule,2,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1;CCC1NC2C(C)NC(C)CC2N1-C1CCC(CCNC(=O)NS(=O)(=O)C2CCC(C)CC2)CC1,HZVLFTCYCLXTGV-UHFFFAOYSA-N
MK-5172 MONOHYDRATE,GRAZOPREVIR;GRAZOPREVIR HYDRATE;GRAZOPREVIR MONOHYDRATE;MK-5172;MK-5172 ANHYDROUS;MK-5172 MONOHYDRATE,CHEMBL2063090;CHEMBL3039533,BRD:BRD-BRD-K24943235-001-01-3;BRD:BRD-K24943235-001-01-3,rep_primary;rep_single_dose,HCV INHIBITOR,,,,LAUNCHED,,Small molecule,4,"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1C[C@H]1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1CC1;COC1CCC2NC3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)OC3NC2C1)C(C)(C)C, COC1CCC2NC3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)OC3NC2C1)C(C)(C)C",OBMNJSNZOWALQB-NCQNOWPTSA-N
ULTRAMICROSIZE,"FULCIN;FULCIN 125;FULCIN 500;FULSOVIN;FULVICIN;FULVICIN P/G;FULVICIN P/G 165;FULVICIN P/G 330;FULVICIN-P/G;FULVICIN-U/F;GRIFULVIN;GRIFULVIN V;GRIS-PEG;GRISACTIN;GRISACTIN ULTRA;GRISACTIN V;GRISEOFULVIN;GRISEOFULVIN MICROSIZE;GRISEOFULVIN PERMEABILITY DIAMETER;GRISEOFULVIN,MICROSIZE;GRISEOFULVIN,ULTRAMICROSIZE;GRISEOFULVINUM;GRISOL AF;GRIVATE;MICROCRYSTALLINE;MICROSIZE;NSC-34533;NSC-755822;ULTRAGRIS-165;ULTRAGRIS-330;ULTRAMICROCRYSTALLINE;ULTRAMICROSIZE",CHEMBL562,BRD:BRD-BRD-K08273968-001-19-0;BRD:BRD-K08273968-001-19-0,rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,KRT12,"RINGWORM, TINEA PEDIS",,LAUNCHED,,Small molecule,4,"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O;COC1CC(OC)C(CL)C2O[C@]3([C@H](C)CC(=O)C=C3OC)C(=O)C12, COC1CC(OC)C(CL)C2O[C@]3([C@H](C)CC(=O)C=C3OC)C(=O)C12",DDUHZTYCFQRHIY-RBHXEPJQSA-N
GS-39783,GS-39783,CHEMBL392394,BRD:BRD-BRD-K75478907-001-02-3;BRD:BRD-K75478907-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABBR1,,,PRECLINICAL,,Small molecule,NA,CSc1nc(NC2CCCC2)c([N+](=O)[O-])c(NC2CCCC2)n1;CSC1NC(NC2CCCC2)C(C(NC2CCCC2)N1)[N+]([O-])=O,GSGVDKOCBKBMGG-UHFFFAOYSA-N
GS-6201,CVT-6883;GS 6201;GS-6201,CHEMBL260933,BRD:BRD-BRD-K68453341-001-01-1;BRD:BRD-K68453341-001-01-1,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PHASE 1,,Small molecule,1,CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O;CCCN1C(=O)N(CC)C2NC([NH]C2C1=O)-C1CNN(CC2CCCC(C2)C(F)(F)F)C1,KOYXXLLNCXWUNF-UHFFFAOYSA-N
VESATOLIMOD,GS-9620;VESATOLIMOD,CHEMBL2424780,BRD:BRD-BRD-K73585091-001-02-3;BRD:BRD-K73585091-001-02-3,rep_primary;rep_single_dose,TOLL-LIKE RECEPTOR AGONIST,TLR7,,,PHASE 2,,Small molecule,2,"CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC(=O)N2;CCCCOC1NC(N)C2NC(=O)CN(CC3CCCC(CN4CCCC4)C3)C2N1, CCCCOC1NC(N)C2NC(=O)CN(CC3CCCC(CN4CCCC4)C3)C2N1",VFOKSTCIRGDTBR-UHFFFAOYSA-N
GS-967,GS-967,,BRD:BRD-K26526496-001-03-9,rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,,,,,,,NA,,
SYK INHIBITOR GS-9973,ENTOSPLETINIB;GS-9973;SYK INHIBITOR GS-9973,CHEMBL3265032,BRD:BRD-BRD-K76719364-001-02-5;BRD:BRD-K76719364-001-02-5;GDSC2:1630,gdsc;rep_multi_dose;rep_primary;rep_single_dose,SYK INHIBITOR,SYK,,,PHASE 2,,Small molecule,3,"C1CN(CCO1)C1CCC(NC2NC(CN3CCNC23)-C2CCC3CN[NH]C3C2)CC1, C1CN(CCO1)C1CCC(NC2NC(CN3CCNC23)-C2CCC3CN[NH]C3C2)CC1, C1CN(CCO1)C1CCC(NC2NC(CN3CCNC23)-C2CCC3CN[NH]C3C2)CC1, C1CN(CCO1)C1CCC(NC2NC(CN3CCNC23)-C2CCC3CN[NH]C3C2)CC1;c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1",XSMSNFMDVXXHGJ-UHFFFAOYSA-N
GSK0660,GSK-0660;GSK0660,,BRD:BRD-BRD-K98684188-001-02-9;BRD:BRD-K98684188-001-02-9,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PPARD,,,PRECLINICAL,,,NA,"COC(=O)C1SCCC1S(=O)(=O)NC1CCC(NC2CCCCC2)CC1OC, COC(=O)C1SCCC1S(=O)(=O)NC1CCC(NC2CCCCC2)CC1OC",
GSK1070916,GSK 1070916A;GSK-1070916;GSK-1070916A;GSK1070916,CHEMBL1090479,GDSC1:226,gdsc,,,,,,,Small molecule,1,CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1,QTBWCSQGBMPECM-UHFFFAOYSA-N
GSK-1904529A,GSK 1904529A;GSK-1904529A,,GDSC1:202;GDSC2:1093,gdsc,,,,,,,,NA,,
GSK-2578215A,GSK 2578215A;GSK-2578215A,,GDSC2:1927,gdsc,,,,,,,,NA,,
GSK-3 INHIBITOR IX,GSK-3 INHIBITOR IX,,CTRP:52582,ctrp,,,,,,,,NA,,
GSK-3-INHIBITOR-IX,GSK-3-INHIBITOR-IX,,BRD:BRD-BRD-K04923131-001-15-4;BRD:BRD-K04923131-001-15-4,rep_multi_dose;rep_primary;rep_single_dose,"GLYCOGEN SYNTHASE KINASE INHIBITOR, LIPOXYGENASE INHIBITOR",GSK3A;GSK3B,,,PRECLINICAL,,,NA,"O\N=C1/C(NC2CCCCC12)=C1/C(=O)NC2CC(BR)CCC12, O\N=C1/C(NC2CCCCC12)=C1/C(=O)NC2CC(BR)CCC12",
GSK37647,GSK-37647;GSK37647,,BRD:BRD-BRD-K26514105-001-01-7;BRD:BRD-K26514105-001-01-7,rep_primary;rep_single_dose,FREE FATTY ACID RECEPTOR AGONIST,FFAR4,,,PRECLINICAL,,,NA,COC1CCC(CC1)S(=O)(=O)NC1C(C)CC(C)CC1C,
GSK-626616,GSK-626616,,BRD:BRD-K00090633-001-01-9,rep_single_dose,,,,,,,,NA,,
GSK-650394,GSK 650394;GSK-650394,CHEMBL558642,GDSC1:177,gdsc,,,,,,,Small molecule,NA,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,WVSBGSNVCDAMCF-UHFFFAOYSA-N
GSK690693,GSK 690693;GSK-690693;GSK690693,CHEMBL494089,GDSC1:326,gdsc,,,,,,,Small molecule,1,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,KGPGFQWBCSZGEL-ZDUSSCGKSA-N
GSK-J1,GSK-J1,,BRD:BRD-BRD-K32847255-001-01-1;BRD:BRD-K32847255-001-01-1,rep_primary;rep_single_dose,HISTONE DEMETHYLASE INHIBITOR,KDM6B,,,PRECLINICAL,,,NA,"OC(=O)CCNC1CC(NC(N1)-C1CCCCN1)N1CCC2CCCCC2CC1, OC(=O)CCNC1CC(NC(N1)-C1CCCCN1)N1CCC2CCCCC2CC1",
GSK-J2,GSK-J2,,BRD:BRD-BRD-K82484347-001-01-2;BRD:BRD-K82484347-001-01-2,rep_primary;rep_single_dose,HISTONE DEMETHYLASE INHIBITOR,,,,PRECLINICAL,,,NA,"OC(=O)CCNC1CC(NC(N1)-C1CCCNC1)N1CCC2CCCCC2CC1, OC(=O)CCNC1CC(NC(N1)-C1CCCNC1)N1CCC2CCCCC2CC1",
GSK-J4,GSK-J4,,BRD:BRD-BRD-K98203492-003-04-1;BRD:BRD-K98203492-003-04-1;CTRP:687735,ctrp;rep_multi_dose;rep_primary;rep_single_dose,HISTONE LYSINE DEMETHYLASE INHIBITOR,KDM6A;KDM6B,,,PRECLINICAL,,,NA,"CCOC(=O)CCNC1CC(NC(N1)-C1CCCCN1)N1CCC2CCCCC2CC1, CCOC(=O)CCNC1CC(NC(N1)-C1CCCCN1)N1CCC2CCCCC2CC1",
GSK-J5,GSK-J5,,BRD:BRD-BRD-K55438324-001-01-8;BRD:BRD-K55438324-001-01-8,rep_primary;rep_single_dose,HISTONE DEMETHYLASE CONTROL,,,,PRECLINICAL,,,NA,CCOC(=O)CCNC1CC(NC(N1)-C1CCCNC1)N1CCC2CCCCC2CC1,
GSK-LSD-1,GSK-LSD-1,,BRD:BRD-K33521504-300-01-6,rep_single_dose,HISTONE LYSINE DEMETHYLASE INHIBITOR,KDM1A,,,,,,NA,,
GSK615,GSK-1059615;GSK-615;GSK1059615;GSK615,CHEMBL3544966,BRD:BRD-BRD-K06750613-001-07-3;BRD:BRD-K06750613-001-07-3;CTRP:606471;GDSC1:374,ctrp;gdsc;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CG,,,PHASE 1,,Small molecule,1,"O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1;O=C1NC(=O)\C(S1)=C\C1CCC2NCCC(-C3CCNCC3)C2C1, O=C1NC(=O)\C(S1)=C\C1CCC2NCCC(-C3CCNCC3)C2C1",QDITZBLZQQZVEE-YBEGLDIGSA-N
GSK1070916,GSK 1070916A;GSK-1070916;GSK-1070916A;GSK1070916,CHEMBL1090479,BRD:BRD-BRD-K36740062-001-06-6;BRD:BRD-K36740062-001-06-6;GDSC1:226,gdsc;rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB;AURKC;CYP2D6;CYP3A4,,,PHASE 1,,Small molecule,1,CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1;CCN1CC(C(N1)-C1CCC(NC(=O)N(C)C)CC1)-C1CCNC2[NH]C(CC12)-C1CCCC(CN(C)C)C1,QTBWCSQGBMPECM-UHFFFAOYSA-N
TRAMETINIB,GSK-1120212;GSK1120212;JTP 74057;JTP-74057;MEKINIST;TMT-212;TMT212;TRAMETINIB,CHEMBL2103875,BRD:BRD-BRD-K12343256-001-08-9;BRD:BRD-K12343256-001-08-9;BRD:BRD-K12343256-001-11-3;BRD:BRD-K12343256-001-14-7;CTRP:687418;GDSC1:1372;GDSC2:1372,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF MEK1 AND MEK2,MAP2K1;MAP2K2,MELANOMA,,LAUNCHED,"Multiple values for MOA: {'MEK INHIBITOR', 'INHIBITOR OF MEK1 AND MEK2'}, defaulting to 'INHIBITOR OF MEK1 AND MEK2'",Small molecule,4,"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1;CC(=O)NC1CCCC(C1)-N1C2C(C)C(=O)N(C)C(NC3CCC(I)CC3F)C2C(=O)N(C2CC2)C1=O, CC(=O)NC1CCCC(C1)-N1C2C(C)C(=O)N(C)C(NC3CCC(I)CC3F)C2C(=O)N(C2CC2)C1=O, CC(=O)NC1CCCC(C1)-N1C2C(C)C(=O)N(C)C(NC3CCC(I)CC3F)C2C(=O)N(C2CC2)C1=O, CC(=O)NC1CCCC(C1)-N1C2C(C)C(=O)N(C)C(NC3CCC(I)CC3F)C2C(=O)N(C2CC2)C1=O",LIRYPHYGHXZJBZ-UHFFFAOYSA-N
GSK2816126A,GSK126;GSK2816126;GSK2816126A,CHEMBL3287735,BRD:BRD-BRD-K21867462-001-02-9;BRD:BRD-K21867462-001-02-9;BRD:BRD-K21867462-001-03-7,oncref_1;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,PHASE 1,"Multiple values for MOA: {'INHIBITOR OF EZH2', 'HISTONE LYSINE METHYLTRANSFERASE INHIBITOR'}, defaulting to 'HISTONE LYSINE METHYLTRANSFERASE INHIBITOR'",Small molecule,1,"CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3ccc(N4CCNCC4)nc3)cc21;CC[C@H](C)N1CC(C)C2C(CC(CC12)-C1CCC(NC1)N1CCNCC1)C(=O)NCC1C(C)CC(C)[NH]C1=O, CC[C@H](C)N1CC(C)C2C(CC(CC12)-C1CCC(NC1)N1CCNCC1)C(=O)NCC1C(C)CC(C)[NH]C1=O",FKSFKBQGSFSOSM-QFIPXVFZSA-N
GSK1292263,GSK 1292263;GSK-1292263;GSK-1292263A;GSK-263A;GSK1292263,CHEMBL3187503,BRD:BRD-BRD-K60341624-001-02-2;BRD:BRD-K60341624-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,GRPR,,,PHASE 2,,Small molecule,2,CC(C)C1NOC(N1)N1CCC(COC2CCC(NC2)-C2CCC(CC2)S(C)(=O)=O)CC1;CC(C)c1noc(N2CCC(COc3ccc(-c4ccc(S(C)(=O)=O)cc4)nc3)CC2)n1,AYJRTVVIBJSSKN-UHFFFAOYSA-N
GSK1562590,GSK1562590,,BRD:BRD-K36697397-003-02-9,rep_single_dose,UROTENSIN RECEPTOR ANTAGONIST,UTS2R,,,,,,NA,,
GSK163090,GSK-163090;GSK163090,CHEMBL1631540,BRD:BRD-BRD-K69669039-001-01-8;BRD:BRD-K69669039-001-01-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A;HTR1B;HTR1D,,,PHASE 2,,Small molecule,2,CC1CCC2C(CCCC2N1)N1CCN(CCC2CCCC(C2)N2CCNC2=O)CC1;Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1,ANGUXJDGJCHGOG-UHFFFAOYSA-N
GSK1838705A,GSK1838705A,,BRD:BRD-BRD-K06749501-001-02-1;BRD:BRD-K06749501-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,ALK;IGF1R;INSR;RPS6KA1,,,PRECLINICAL,,,NA,"CNC(=O)C1C(F)CCCC1NC1NC(NC2CC3N(CCC3CC2OC)C(=O)CN(C)C)NC2[NH]CCC12, CNC(=O)C1C(F)CCCC1NC1NC(NC2CC3N(CCC3CC2OC)C(=O)CN(C)C)NC2[NH]CCC12, CNC(=O)C1C(F)CCCC1NC1NC(NC2CC3N(CCC3CC2OC)C(=O)CN(C)C)NC2[NH]CCC12",
GSK189254,GSK-189254;GSK189254,CHEMBL517140,BRD:BRD-K00003166-001-01-9,rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,CNC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1,WROHEWWOCPRMIA-UHFFFAOYSA-N
GSK1904529A,GSK1904529A,,BRD:BRD-BRD-K04833372-001-06-2;BRD:BRD-K04833372-001-06-2;GDSC1:202;GDSC2:1093,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"IGF-1 INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR, INSULIN RECEPTOR LIGAND",IGF1R;INSR,,,PRECLINICAL,,,NA,CCC1CC(NC2NCCC(N2)-C2C(NC3CCCCN23)-C2CCC(OC)C(C2)C(=O)NC2C(F)CCCC2F)C(OC)CC1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O,
GSK2110183C,AFURESERTIB;ASB-183;ASB183;GSK-2110183;GSK-2110183C;GSK2110183;GSK2110183C,CHEMBL2219422,BRD:BRD-BRD-K25412176-001-01-9;BRD:BRD-K25412176-001-01-9;BRD:BRD-K25412176-001-04-9;GDSC2:1912,gdsc;rep_multi_dose;rep_primary;rep_single_dose,AKT INHIBITOR,AKT1;AKT2;AKT3,,,PHASE 2,,Small molecule,2,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl;CN1NCC(CL)C1-C1CC(SC1CL)C(=O)N[C@H](CN)CC1CCCC(F)C1,AFJRDFWMXUECEW-LBPRGKRZSA-N
GSK2110183C,AFURESERTIB;ASB-183;ASB183;GSK-2110183;GSK-2110183C;GSK2110183;GSK2110183C,CHEMBL2219422,GDSC2:1912,gdsc,,,,,,,Small molecule,2,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,AFJRDFWMXUECEW-LBPRGKRZSA-N
OMIPALISIB,GSK-2126458;GSK2126458;OMIPALISIB,CHEMBL1236962,BRD:BRD-BRD-K07972848-001-02-0;BRD:BRD-K07972848-001-02-0;GDSC1:283,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PHASE 1,,Small molecule,1,COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F;COC1NCC(CC1NS(=O)(=O)C1CCC(F)CC1F)-C1CCC2NCCC(-C3CCNNC3)C2C1,CGBJSGAELGCMKE-UHFFFAOYSA-N
UPROSERTIB,AKT INHIBITOR GSK-2141795;AKT INHIBITOR GSK2141795;GSK-2141795;GSK-2141795C;GSK2141795;GSK2141795C;UPROSERTIB,CHEMBL3137336,GDSC2:1553;GDSC2:2106,gdsc,,,,,,,Small molecule,2,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,AXTAPYRUEKNRBA-JTQLQIEISA-N
GSK2190915B,AM-803;AM803;FIBOFLAPON;GSK-2190915;GSK2190915;GSK2190915B,CHEMBL1922660,BRD:BRD-BRD-K15691453-236-01-6;BRD:BRD-K15691453-236-01-6,rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX5AP,,,PHASE 2,,Small molecule,3,CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1;CCOC1CCC(CN1)-C1CCC(CN2C(CC(C)(C)C(O)=O)C(SC(C)(C)C)C3CC(OCC4CCC(C)CN4)CCC23)CC1,DFQGDHBGRSTTHX-UHFFFAOYSA-N
GSK2193874,GSK2193874,,BRD:BRD-K90737788-001-02-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPV4,,,,,,NA,,
GSK2194069,GSK2194069,,BRD:BRD-BRD-K95123482-001-01-6;BRD:BRD-K95123482-001-01-6,rep_primary;rep_single_dose,FATTY ACID SYNTHASE INHIBITOR,FASN,,,PRECLINICAL,,,NA,O=C(C1CC1)N1CC[C@@H](CC2N[NH]C(=O)N2-C2CCC(CC2)-C2CCC3OCCC3C2)C1,
GSK2239633A,GSK2239633A,,BRD:BRD-K00003364-001-01-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,,,,NA,,
GSK2245035,GSK-2245035;GSK2245035,CHEMBL4297492,BRD:BRD-K00074079-001-02-9,rep_single_dose,,,,,,,Small molecule,2,CCC[C@H](C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1,LFMPVTVPXHNXOT-HNNXBMFYSA-N
GSK2256098,GSK-2256098;GSK2256098,CHEMBL4742157,BRD:BRD-K00003379-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,Small molecule,2,CONC(=O)c1ccccc1Nc1cc(Nc2cc(C)nn2C(C)C)ncc1Cl,BVAHPPKGOOJSPU-UHFFFAOYSA-N
GSK2256294A,GSK2256294A,,BRD:BRD-BRD-K62738477-001-01-7;BRD:BRD-K62738477-001-01-7,rep_primary;rep_single_dose,EPOXIDE HYDOLASE INHIBITOR,EPHX2,,,PHASE 1,,,NA,CNC1NC(C)NC(N[C@H]2CCC[C@H](C2)C(=O)NCC2CCC(CC2C(F)(F)F)C#N)N1,
LINERIXIBAT,GSK-2330672;GSK2330672;LINERIXIBAT,CHEMBL2387408,BRD:BRD-BRD-K05858796-001-01-7;BRD:BRD-K05858796-001-01-7,rep_primary;rep_single_dose,BILE ACID TRANSPORTER INHIBITOR,SLC10A2,,,PHASE 2,,Small molecule,3,CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(=O)O)CC(=O)O)c(OC)cc2[C@@H](c2ccccc2)N1;CCCC[C@]1(CC)CS(=O)(=O)C2CC(CNC(CC(O)=O)CC(O)=O)C(OC)CC2[C@H](N1)C1CCCCC1,CZGVOBIGEBDYTP-VSGBNLITSA-N
GSK2334470,GSK2334470,,BRD:BRD-K70642949-001-03-7,rep_single_dose,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,AURKA;AURKB;PDPK1,,,,,,NA,,
GSK239512,GSK-239512;GSK-239512A;GSK239512,CHEMBL3092650,BRD:BRD-K00004689-001-01-9,rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,O=C1CCCN1c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1,YFRBKEVUUCQYOW-UHFFFAOYSA-N
GSK256066,GSK-256066;GSK256066,CHEMBL570015,BRD:BRD-BRD-K37590257-001-02-8;BRD:BRD-K37590257-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A,,,PHASE 2,,Small molecule,2,COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1;COC1CCCC(NC2C(CNC3C(C)CC(CC23)S(=O)(=O)C2CCCC(C2)C(=O)N(C)C)C(N)=O)C1,JFHROPTYMMSOLG-UHFFFAOYSA-N
GSK2578215A,GSK2578215A,,BRD:BRD-BRD-K30185465-001-03-0;BRD:BRD-K30185465-001-03-0;GDSC2:1927,gdsc;rep_primary;rep_single_dose,LEUCINE RICH REPEAT KINASE INHIBITOR,LRRK2,,,PRECLINICAL,,,NA,FC1CC(CCN1)-C1CCC(OCC2CCCCC2)C(C1)C(=O)NC1CCCNC1,
GSK2606414,GSK2606414,,BRD:BRD-K81689258-001-04-8;GDSC2:1618,gdsc;rep_single_dose,PROTEIN KINASE INHIBITOR,EIF2AK3;MYLK2,,,,,,NA,,
GSK2636771,GSK 2636771;GSK-2636771;GSK2636771,CHEMBL3188551,BRD:BRD-BRD-K49215523-001-04-2;BRD:BRD-K49215523-001-04-2;CTRP:668723,ctrp;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CB,,,PHASE 2,,Small molecule,2,"Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F;CC1NC2C(CC(CC2N1CC1CCCC(C1C)C(F)(F)F)N1CCOCC1)C(O)=O, CC1NC2C(CC(CC2N1CC1CCCC(C1C)C(F)(F)F)N1CCOCC1)C(O)=O",XTKLTGBKIDQGQL-UHFFFAOYSA-N
GSK2656157,GSK2656157,,BRD:BRD-BRD-K41104902-001-01-3;BRD:BRD-K41104902-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,PERK INHIBITOR,,,,PRECLINICAL,,,NA,CC1CCCC(CC(=O)N2CCC3C2CCC(-C2CN(C)C4NCNC(N)C24)C3F)N1,
GSK269962,GSK269962,,BRD:BRD-BRD-K89464729-001-03-1;BRD:BRD-K89464729-001-03-1,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK1;ROCK2,,,PRECLINICAL,,,NA,CCN1C(NC2CNC(OC3CCCC(NC(=O)C4CCC(OCCN5CCOCC5)CC4)C3)CC12)-C1NONC1N,
GSK269962A,GSK 269962A;GSK269962A,,GDSC1:1192;GDSC1:127;GDSC2:1192,gdsc,,,,,,,,NA,,
GSK2801,GSK2801,,BRD:BRD-BRD-K48062199-001-01-8;BRD:BRD-K48062199-001-01-8,rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BAZ2A;BAZ2B,,,PRECLINICAL,,,NA,CCCOC1CCN2C(CC(-C3CCCCC3S(C)(=O)=O)C2C1)C(C)=O,
GSK2830371,GSK2830371,,BRD:BRD-K17472821-001-01-2,rep_multi_dose;rep_single_dose,PROTEIN PHOSPHATASE INHIBITOR,PPM1D,,,PRECLINICAL,,,NA,"CC1NCC(CL)CC1NCC1CCC(S1)C(=O)N[C@@H](CC1CCCC1)C(=O)NC1CC1, CC1NCC(CL)CC1NCC1CCC(S1)C(=O)N[C@@H](CC1CCCC1)C(=O)NC1CC1",
GSK2837808A,GSK2837808A,,BRD:BRD-K50679358-001-02-9,rep_single_dose,LACTATE DEHYDROGENASE INHIBITOR,LDHA,,,,,,NA,,
GSK2838232,GSK2838232,CHEMBL4303141,BRD:BRD-BRD-K08398903-001-01-1;BRD:BRD-K08398903-001-01-1,rep_primary;rep_single_dose,HIV GAG INHIBITOR,,,,PHASE 1,,Small molecule,2,"CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2([C@@H](O)CN(CCN(C)C)Cc2ccc(Cl)cc2)CC1=O;CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)CC1CCC(CL)CC1, CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)CC1CCC(CL)CC1",MEOWKUXNVNJAMY-PZFKGGKESA-N
GSK2879552,GSK2879552,CHEMBL3786182,BRD:BRD-BRD-K09223495-001-01-4;BRD:BRD-K09223495-001-01-4,rep_primary;rep_single_dose,HISTONE LYSINE DEMETHYLASE INHIBITOR,KDM1A,,,PHASE 1,,Small molecule,1,O=C(O)c1ccc(CN2CCC(CN[C@@H]3C[C@H]3c3ccccc3)CC2)cc1;OC(=O)C1CCC(CN2CCC(CN[C@@H]3C[C@H]3C3CCCCC3)CC2)CC1,LRULVYSBRWUVGR-FCHUYYIVSA-N
GSK2881078,GSK2881078,CHEMBL3545174,BRD:BRD-K97656802-001-02-9,rep_single_dose,ANDROGEN RECEPTOR MODULATOR,,,,,,Small molecule,2,,
ROR GAMA MODULATOR 1,GSK-2981278;GSK2981278;ROR GAMA MODULATOR 1,CHEMBL4225088,BRD:BRD-K00003292-001-01-9,rep_single_dose,ROR MODULATOR,,,,,,Small molecule,1,CCc1ccc(N(CC(C)C)S(=O)(=O)c2ccc(OCC3CCOCC3)c(CO)c2)cc1,LZLBRISQTJVZNP-UHFFFAOYSA-N
GSK2982772,GSK2982772,CHEMBL4071864,BRD:BRD-K00003429-001-01-9,rep_single_dose,RIPK INHIBITOR,,,,,,Small molecule,2,CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21,LYPAFUINURXJSG-AWEZNQCLSA-N
GSK2983559 (FREE ACID),GSK2983559 (FREE ACID),,BRD:BRD-K00091265-001-01-9,rep_single_dose,,,,,,,,NA,,
HDAC-IN-3,.ALPHA.-(((6-(3-(HYDROXYAMINO)-3-OXOPROPYL)-3-PYRIDINYL)METHYL)AMINO)-;(.ALPHA.S)-;CHR 5154;CHR-5154;CHR5154;CYCLOHEXANEACETIC ACID;CYCLOPENTYL ESTER;GSK-3117391;GSK3117391;HDAC-IN-3,CHEMBL4297494,BRD:BRD-K00004614-001-01-9,rep_single_dose,HDAC INHIBITOR,,,,,,Small molecule,2,O=C(CCc1ccc(CN[C@H](C(=O)OC2CCCC2)C2CCCCC2)cn1)NO,AFDPFLDWOXXHQM-NRFANRHFSA-N
GSK3179106,GSK-3179106;GSK3179106,CHEMBL3355009,BRD:BRD-K00003373-001-01-9,rep_single_dose,RET TYROSINE KINASE INHIBITOR,,,,,,Small molecule,1,CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1,IDXKJSSOUXWLDB-UHFFFAOYSA-N
PEMRAMETOSTAT,EPZ-015938;EPZ015938;GSK 3326595;GSK-3326595;GSK-3326595A;GSK3326595;PEMRAMETOSTAT,CHEMBL4466233,BRD:BRD-K00003421-001-01-9,oncref_1;rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,PRMT5,,,,"Multiple values for MOA: {'SAM-COOPERATIVE INHIBITOR OF PRMT5', 'PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR'}, defaulting to 'PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR'",Small molecule,2,CC(=O)N1CCC(Nc2cc(C(=O)NC[C@H](O)CN3CCc4ccccc4C3)ncn2)CC1,JLCCNYVTIWRPIZ-NRFANRHFSA-N
GSK3484862,GSK3484862,,BRD:BRD-K00095917-001-04-9,oncref_2,NON-COVALENT INHIBITOR OF DNMT1,DNMT1,,,,,,NA,,
GSK356278,GSK-356278;GSK356278,CHEMBL4297384,BRD:BRD-K00004711-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,1,CCn1ncc2c(NC3CCOCC3)c(-c3nnc(Cc4sc(C)nc4C)o3)cnc21,AWDJJMXJUOHGLC-UHFFFAOYSA-N
ZINC1912685,BDBM50134936;CHEMBL147806;GSK 369796;GSK-369796;GSK369796;N-TERT-BUTYL ISOQUINE;N-TERT-BUTYLISOQUINE;NTBISQ;ZINC1912685,CHEMBL147806,BRD:BRD-K00003121-300-01-9,rep_single_dose,POTASSIUM CHANNEL ANTAGONIST,,,,,,Small molecule,1,CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O,ZVMMVSSEAMUNGI-UHFFFAOYSA-N
GSK3787,GSK3787,,BRD:BRD-BRD-K03155172-001-02-2;BRD:BRD-K03155172-001-02-2,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PPARD,,,PRECLINICAL,,,NA,"FC(F)(F)C1CCC(NC1)S(=O)(=O)CCNC(=O)C1CCC(CL)CC1, FC(F)(F)C1CCC(NC1)S(=O)(=O)CCNC(=O)C1CCC(CL)CC1",
GSK4112,GSK4112,,CTRP:660081,ctrp,,,,,,,,NA,,
GSK429286A,GSK429286A,,BRD:BRD-A10523515-001-07-9;BRD:BRD-BRD-A10523515-001-07-9;GDSC1:230,gdsc;rep_multi_dose;rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK1,,,PRECLINICAL,,,NA,"CC1=C(C(CC(=O)N1)C1CCC(CC1)C(F)(F)F)C(=O)NC1CC2CN[NH]C2CC1F, CC1=C(C(CC(=O)N1)C1CCC(CC1)C(F)(F)F)C(=O)NC1CC2CN[NH]C2CC1F, CC1=C(C(CC(=O)N1)C1CCC(CC1)C(F)(F)F)C(=O)NC1CC2CN[NH]C2CC1F",
GSK461364,GSK461364,,BRD:BRD-BRD-K92428232-001-10-6;BRD:BRD-K92428232-001-10-6;CTRP:649862,ctrp;rep_multi_dose;rep_primary;rep_single_dose,PLK INHIBITOR,PLK1,,,PHASE 1,,,NA,C[C@@H](OC1CC(SC1C(N)=O)-N1CNC2CCC(CN3CCN(C)CC3)CC12)C1CCCCC1C(F)(F)F,
GSK503,GSK503,,BRD:BRD-BRD-K72293620-001-01-7;BRD:BRD-K72293620-001-01-7,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,PRECLINICAL,,,NA,CC(C)N1CC(C)C2C(CC(CC12)-C1CCC(NC1)N1CCN(C)CC1)C(=O)NCC1C(C)CC(C)[NH]C1=O,
MOLIBRESIB,BET INHIBITOR GSK525762;GSK-525762;GSK-525762A;GSK525762;GSK525762A;I-BET 762;MOLIBRESIB,CHEMBL1232461,CTRP:660245;GDSC1:275;GDSC2:1624,ctrp;gdsc,,,,,,,Small molecule,2,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21,AAAQFGUYHFJNHI-SFHVURJKSA-N
GSK591,EPZ015866;GSK3203591;GSK591,,GDSC2:2110,gdsc,,,,,,,,NA,,
GSK602,GSK 602;GSK-602;GSK602,,GDSC2:1928,gdsc,,,,,,,,NA,,
GSK650394,GSK650394,,BRD:BRD-BRD-K14991967-001-02-6;BRD:BRD-K14991967-001-02-6;GDSC1:177,gdsc;rep_multi_dose;rep_primary;rep_single_dose,SERUM/GLUCOCORTICOID REGULATED KINASE INHIBITOR,SGK1;SGK2,,,PRECLINICAL,,,NA,"OC(=O)C1CCC(CC1C1CCCC1)-C1C[NH]C2NCC(CC12)-C1CCCCC1, OC(=O)C1CCC(CC1C1CCCC1)-C1C[NH]C2NCC(CC12)-C1CCCCC1, OC(=O)C1CCC(CC1C1CCCC1)-C1C[NH]C2NCC(CC12)-C1CCCCC1",
GSK656,GSK656,,BRD:BRD-K00003483-003-01-9,rep_single_dose,LEUCYL-TRNA SYNTHETASE INHIBITOR,,,,,,,NA,,
GSK690693,GSK 690693;GSK-690693;GSK690693,CHEMBL494089,BRD:BRD-BRD-K25325018-001-05-6;BRD:BRD-K25325018-001-05-6;GDSC1:326,gdsc;rep_primary;rep_single_dose,AKT INHIBITOR,AKT1;AKT2;AKT3;PAK4;PAK6;PAK7;PRKCQ;PRKG1;PRKX,,,PHASE 1,,Small molecule,1,"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21;CCN1C(NC2C(NCC(OC[C@H]3CCCNC3)C12)C#CC(C)(C)O)-C1NONC1N, CCN1C(NC2C(NCC(OC[C@H]3CCCNC3)C12)C#CC(C)(C)O)-C1NONC1N, CCN1C(NC2C(NCC(OC[C@H]3CCCNC3)C12)C#CC(C)(C)O)-C1NONC1N",KGPGFQWBCSZGEL-ZDUSSCGKSA-N
GSK9027,GSK9027,,BRD:BRD-BRD-K29328421-001-01-6;BRD:BRD-K29328421-001-01-6,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,,,PRECLINICAL,,,NA,FC1CCC(CC1)-N1NCC2CC(CCC12)-C1CCC(NS(=O)(=O)CC2CCCCC2)CC1C(F)(F)F,
GSK923295,GSK-295;GSK-923295;GSK-923295A;GSK923295,CHEMBL4303470,BRD:BRD-BRD-K89015388-001-01-7;BRD:BRD-K89015388-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,CENTROMERE ASSOCIATED PROTEIN INHIBITOR,CENPE,,,PHASE 1,,Small molecule,1,CC(C)Oc1ccc(C(=O)N[C@H](CNC(=O)CN(C)C)Cc2ccc(-c3cn4cccc([C@H](C)O)c4n3)cc2)cc1Cl;CC(C)OC1CCC(CC1CL)C(=O)N[C@H](CNC(=O)CN(C)C)CC1CCC(CC1)-C1CN2CCCC([C@H](C)O)C2N1,WHMXDBPHBVLYRC-OFVILXPXSA-N
GTP-14564,GTP-14564,,BRD:BRD-BRD-K16664969-001-03-3;BRD:BRD-K16664969-001-03-3,rep_multi_dose;rep_primary;rep_single_dose,"FLT3 INHIBITOR, TYROSINE KINASE INHIBITOR",CSF1R;FLT3;KIT;PDGFRB,,,PRECLINICAL,,,NA,"C1CCC(CC1)-C1N[NH]C2C1OC1CCCCC21, C1CCC(CC1)-C1N[NH]C2C1OC1CCCCC21",
GTPL5238,GTPL5238,,GDSC1:175,gdsc,,,,,,,,NA,,
GTPL6653,GTPL6653,,GDSC2:1615,gdsc,,,,,,,,NA,,
GTPL7710,AOB5560;GTPL7710,,GDSC2:1617,gdsc,,,,,,,,NA,,
GTPL7898,AOB2313;GTPL7898,,GDSC2:1629,gdsc,,,,,,,,NA,,
GTPL8240,AK175558;AOB3680;GSK343;GTPL8240,,GDSC2:1627,gdsc,,,,,,,,NA,,
GTS21,GTS21,,BRD:BRD-BRD-K14235254-001-01-2;BRD:BRD-K14235254-001-01-2,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR AGONIST,CHRNA7,,,PHASE 1/PHASE 2,,,NA,COC1CCC(\C=C2CCCN=C/2C2CCCNC2)C(OC)C1,
PRONTOMUCIL,ASPIRIN GUAIACOL ESTER;GUACETISAL;PRONTOMUCIL,CHEMBL2105097,BRD:BRD-BRD-K00739965-001-01-9;BRD:BRD-K00739965-001-01-9,rep_primary;rep_single_dose,IMMUNOSUPPRESSANT,,,,LAUNCHED,,Small molecule,-1,COc1ccccc1OC(=O)c1ccccc1OC(C)=O;COC1CCCCC1OC(=O)C1CCCCC1OC(C)=O,HSJFYRYGGKLQBT-UHFFFAOYSA-N
SGI-110 FREE ACID,GUADECITABINE;SGI-110;SGI-110 FREE ACID,CHEMBL3544916,BRD:BRD-K00003187-236-01-9,rep_single_dose,DNA METHYLTRANSFERASE INHIBITOR,,,,,,Small molecule,3,Nc1ncn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3O)[C@@H](CO)O2)c(=O)n1,GUWXKKAWLCENJA-WGWHJZDNSA-N
TIXYLIX CHESTY COUGH,AMONIDRON;CVT-2534;FAMEL;FRANOLYN CHESTY;GECOLATE;GLYCEROL GUAIACOLATE;GLYCERYL GUAIACOLATE;GUAIACOL GLYCERYL ETHER;GUAIFENESIN;GUAIFENSIN;GUAIPHENESIN;HUMABID;HUSTOSIL;LIQUFRUTA;METHPHENOXYDIOL;MUCINEX;NIROLEX FOR CHESTY COUGH DECONGESTANT;NSC-62112;ROBITUSSIN;TIXYLIX CHESTY COUGH,CHEMBL980,BRD:BRD-A90515964-001-16-5;BRD:BRD-BRD-A90515964-001-16-5,rep_primary;rep_single_dose,EXPECTORANT,,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,4,"COc1ccccc1OCC(O)CO;COC1CCCCC1OCC(O)CO, COC1CCCCC1OCC(O)CO",HSRJKNPTNIJEKV-UHFFFAOYSA-N
GUANABEN-ACETATE,GUANABEN-ACETATE,,BRD:BRD-BRD-K62736196-015-11-0;BRD:BRD-BRD-K62736196-015-13-6;BRD:BRD-K62736196-015-11-0;BRD:BRD-K62736196-015-13-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C,HYPERTENSION,,LAUNCHED,,,NA,"NC(=N)N\N=C\C1C(CL)CCCC1CL, NC(=N)N\N=C\C1C(CL)CCCC1CL, NC(=N)N\N=C\C1C(CL)CCCC1CL, NC(=N)N\N=C\C1C(CL)CCCC1CL",
HYLOREL,GUANADREL;HYLOREL,CHEMBL1037,BRD:BRD-A14262390-065-01-8;BRD:BRD-BRD-A14262390-065-01-8,rep_primary;rep_single_dose,ADRENERGIC INHIBITOR,SLC6A2,HYPERTENSION,,LAUNCHED,,Small molecule,4,N=C(N)NCC1COC2(CCCCC2)O1;NC(=N)NCC1COC2(CCCCC2)O1,HPBNRIOWIXYZFK-UHFFFAOYSA-N
GUANCYDINE,CL 2422;CL-2422;GUANCIDINE;GUANCYDINE,CHEMBL1697839,BRD:BRD-K00005334-001-01-9,rep_single_dose,ANTIHYPERTENSIVE AGENT,,,,,,Small molecule,-1,CCC(C)(C)N/C(N)=N/C#N,VZVGEDRCVUKSEL-UHFFFAOYSA-N
ISMELIN,ESIMIL;GUANETHIDINE;ISMELIN,CHEMBL765,BRD:BRD-BRD-K62676709-065-05-5;BRD:BRD-K62676709-065-05-5,rep_primary;rep_single_dose,ADRENERGIC INHIBITOR,SLC6A2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"N=C(N)NCCN1CCCCCCC1;NC(=N)NCCN1CCCCCCC1, NC(=N)NCCN1CCCCCCC1",ACGDKVXYNVEAGU-UHFFFAOYSA-N
TENEX,GUANFACINE;INTUNIV;NSC-759121;TENEX,CHEMBL862,BRD:BRD-BRD-K32830106-001-02-6;BRD:BRD-BRD-K32830106-003-20-4;BRD:BRD-K32830106-001-02-6;BRD:BRD-K32830106-003-20-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C,HYPERTENSION,,LAUNCHED,,Small molecule,4,"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl;NC(=N)NC(=O)CC1C(CL)CCCC1CL, NC(=N)NC(=O)CC1C(CL)CCCC1CL, NC(=N)NC(=O)CC1C(CL)CCCC1CL",INJOMKTZOLKMBF-UHFFFAOYSA-N
HP-1598,(3-PHENOXYPROPYL);(3-PHENOXYPROPYL)QUANIDINE;GUANIDINE;GUANOXYFEN;HP-1598,CHEMBL2110935;CHEMBL821,BRD:BRD-BRD-K76037122-001-02-5;BRD:BRD-K76037122-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,ALDH2;DLG4;GAMT;RNASE1,LAMBERT-EATON MYASTHENIC SYNDROME (LEMS),,LAUNCHED,,Small molecule,-1,"N=C(N)NCCCOc1ccccc1;NC(N)=N, NC(N)=N",UEIBTMGAIXZRBV-UHFFFAOYSA-N
GUANIDINOETHYLDISULFIDE-BICARBONATE,GUANIDINOETHYLDISULFIDE-BICARBONATE,,BRD:BRD-K69191882-065-01-6,rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS2,,,,,,NA,,
GUANOSINE,GUANOSINE,CHEMBL375655,BRD:BRD-BRD-K92976206-001-01-5;BRD:BRD-K92976206-001-01-5,rep_primary;rep_single_dose,,PNP,,,PRECLINICAL,,Small molecule,NA,Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1;NC1NC2N(CNC2C(=O)[NH]1)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O,NYHBQMYGNKIUIF-UUOKFMHZSA-N
GUE-1654,GUE-1654,,BRD:BRD-BRD-K18745919-001-01-3;BRD:BRD-K18745919-001-01-3,rep_primary;rep_single_dose,OXOEICOSANOID RECEPTOR MODULATOR,OXER1,,,PRECLINICAL,,,NA,CSC1NC2CCC3NC(NC(=O)C(C4CCCCC4)C4CCCCC4)SC3C2S1,
GUSACITINIB,ASN-002;ASN002;EN-3351;EN3351;GUSACITINIB,CHEMBL4594275,BRD:BRD-K00091102-001-01-9,rep_single_dose,,,,,,,Small molecule,2,N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1,NLFLXLJXEIUQDL-UHFFFAOYSA-N
GUVACINE,GUVACINE,CHEMBL76768,BRD:BRD-BRD-K01980392-003-11-6;BRD:BRD-K01980392-003-11-6,rep_primary;rep_single_dose,GABA UPTAKE INHIBITOR,SLC6A1;SLC6A11;SLC6A12;SLC6A13,,,PRECLINICAL,,Small molecule,NA,O=C(O)C1=CCCNC1;OC(=O)C1=CCCNC1,QTDZOWFRBNTPQR-UHFFFAOYSA-N
GW-0742,GW-0742,,BRD:BRD-BRD-K82983861-001-04-3;BRD:BRD-K82983861-001-04-3,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARD,,,PRECLINICAL,,,NA,"CC1NC(SC1CSC1CCC(OCC(O)=O)C(C)C1)-C1CCC(C(F)C1)C(F)(F)F, CC1NC(SC1CSC1CCC(OCC(O)=O)C(C)C1)-C1CCC(C(F)C1)C(F)(F)F, CC1NC(SC1CSC1CCC(OCC(O)=O)C(C)C1)-C1CCC(C(F)C1)C(F)(F)F",
GW-1100,GW-1100,,BRD:BRD-K23614267-001-01-2,rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,FFAR1,,,,,,NA,,
GW-1929,GW-1929,,BRD:BRD-A15415227-003-02-9;BRD:BRD-BRD-A15415227-003-02-9,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARG,,,PRECLINICAL,,,NA,CN(CCOC1CCC(CC(NC2CCCCC2C(=O)C2CCCCC2)C(O)=O)CC1)C1CCCCN1,
GW632580X,GW-2580;GW632580X,CHEMBL261849,BRD:BRD-BRD-K24242599-001-02-8;BRD:BRD-K24242599-001-02-8;GDSC1:193,gdsc;rep_primary;rep_single_dose,CFMS KINASE INHIBITOR,CSF1R,,,PRECLINICAL,,Small molecule,NA,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1;COC1CCC(COC2CCC(CC3CNC(N)NC3N)CC2OC)CC1,MYQAUKPBNJWPIE-UHFFFAOYSA-N
GW-311616,GW-311616,,BRD:BRD-BRD-K37864785-001-01-0;BRD:BRD-K37864785-001-01-0,rep_primary;rep_single_dose,"LEUKOCYTE ELASTASE INHIBITOR, ELASTASE INHIBITOR",ELANE,,,PHASE 1,"Multiple values for MOA: {'ELASTASE INHIBITOR, LEUKOCYTE ELASTASE INHIBITOR', 'LEUKOCYTE ELASTASE INHIBITOR, ELASTASE INHIBITOR'}, defaulting to 'LEUKOCYTE ELASTASE INHIBITOR, ELASTASE INHIBITOR'",,NA,CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)\C=C\CN2CCCCC2)N(C1=O)S(C)(=O)=O,
GW-3965,GW-3965,,BRD:BRD-BRD-K33818169-003-04-6;BRD:BRD-K33818169-003-04-6,rep_multi_dose;rep_primary;rep_single_dose,LXR AGONIST,NR1H2;NR1H3,,,PRECLINICAL,,,NA,"OC(=O)CC1CCCC(OCCCN(CC(C2CCCCC2)C2CCCCC2)CC2CCCC(C2CL)C(F)(F)F)C1, OC(=O)CC1CCCC(OCCCN(CC(C2CCCCC2)C2CCCCC2)CC2CCCC(C2CL)C(F)(F)F)C1, OC(=O)CC1CCCC(OCCCN(CC(C2CCCCC2)C2CCCCC2)CC2CCCC(C2CL)C(F)(F)F)C1",
GW-405833,GW-405833,,BRD:BRD-BRD-K10705233-001-02-2;BRD:BRD-K10705233-001-02-2;CTRP:375447,ctrp;rep_multi_dose;rep_primary;rep_single_dose,CANNABINOID RECEPTOR AGONIST,CNR2,,,PRECLINICAL,,,NA,COC1CCC2N(C(=O)C3CCCC(CL)C3CL)C(C)C(CCN3CCOCC3)C2C1,
GW-4064,GW-4064,,BRD:BRD-BRD-K88186167-001-04-8;BRD:BRD-K88186167-001-04-8,rep_primary;rep_single_dose,FXR AGONIST,NR1H4,,,PRECLINICAL,,,NA,"CC(C)C1ONC(C1COC1CCC(\C=C\C2CCCC(C2)C(O)=O)C(CL)C1)-C1C(CL)CCCC1CL, CC(C)C1ONC(C1COC1CCC(\C=C\C2CCCC(C2)C(O)=O)C(CL)C1)-C1C(CL)CCCC1CL",
GW-438014A,GW-438014A,,BRD:BRD-BRD-K13039700-066-01-2;BRD:BRD-K13039700-066-01-2,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPY5R,,,PRECLINICAL,,,NA,O=C(NC1NC2CCCCC2N1CCC1CCCCC1)C1CCCCC1,
GW-441756,GW-441756,,BRD:BRD-BRD-K41312087-001-02-7;BRD:BRD-K41312087-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,GROWTH FACTOR RECEPTOR INHIBITOR,NTRK1,,,PRECLINICAL,,,NA,"CN1CC(\C=C2/C(=O)NC3CCCNC23)C2CCCCC12, CN1CC(\C=C2/C(=O)NC3CCCNC23)C2CCCCC12",
GW501516,CARDARINE;GSK-516;GW-1516;GW-501516;GW501516,CHEMBL38943,BRD:BRD-BRD-K14880289-001-02-2;BRD:BRD-K14880289-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA;PPARD,,,PHASE 2,,Small molecule,2,"Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C)ccc1OCC(=O)O;CC1NC(SC1CSC1CCC(OCC(O)=O)C(C)C1)-C1CCC(CC1)C(F)(F)F, CC1NC(SC1CSC1CCC(OCC(O)=O)C(C)C1)-C1CCC(CC1)C(F)(F)F",YDBLKRPLXZNVNB-UHFFFAOYSA-N
GW-542573X,GW-542573X,,BRD:BRD-K36485341-001-02-9,rep_single_dose,CALCIUM CHANNEL ACTIVATOR,KCNN1,,,,,,NA,,
GW-583340,GW-583340,,BRD:BRD-BRD-K79930101-300-03-7;BRD:BRD-K79930101-300-03-7,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2,,,PRECLINICAL,,,NA,"CS(=O)(=O)CCNCC1NC(CS1)-C1CCC2NCNC(NC3CCC(OCC4CCCC(F)C4)C(CL)C3)C2C1, CS(=O)(=O)CCNCC1NC(CS1)-C1CCC2NCNC(NC3CCC(OCC4CCCC(F)C4)C(CL)C3)C2C1",
GW-627368,GW-627368,,BRD:BRD-BRD-K50005760-001-01-1;BRD:BRD-K50005760-001-01-1,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGER4,,,PRECLINICAL,,,NA,CCOC1C2CN(C(=O)C2C(OCC)C2CCCCC12)C1CCC(CC(=O)NS(=O)(=O)C2CCCCC2)CC1,
GW-6471,GW-6471,,BRD:BRD-BRD-K20828910-001-02-0;BRD:BRD-K20828910-001-02-0,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PPARA,,,PRECLINICAL,,,NA,"CCC(=O)NC[C@H](CC1CCC(OCCC2NC(OC2C)-C2CCCCC2)CC1)N\C(C)=C/C(=O)C1CCC(CC1)C(F)(F)F, CCC(=O)NC[C@H](CC1CCC(OCCC2NC(OC2C)-C2CCCCC2)CC1)N\C(C)=C/C(=O)C1CCC(CC1)C(F)(F)F",
GW7647,GW-7647;GW7647,CHEMBL21241,BRD:BRD-BRD-K96263742-001-14-8;BRD:BRD-K96263742-001-14-8,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA,,,PRECLINICAL,,Small molecule,NA,"CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(=O)O;CC(C)(SC1CCC(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)CC1)C(O)=O, CC(C)(SC1CCC(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)CC1)C(O)=O",PKNYXWMTHFMHKD-UHFFFAOYSA-N
GW-788388,GW-788388,,BRD:BRD-BRD-K78086729-001-02-7;BRD:BRD-K78086729-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,LCK;MAPK14;TGFBR1,,,PRECLINICAL,,,NA,"O=C(NC1CCOCC1)C1CCC(CC1)-C1CC(CCN1)-C1C[NH]NC1-C1CCCCN1, O=C(NC1CCOCC1)C1CCC(CC1)-C1CC(CCN1)-C1C[NH]NC1-C1CCCCN1",
GW-803430,GW-803430,,BRD:BRD-BRD-K65576800-001-01-6;BRD:BRD-K65576800-001-01-6,rep_primary;rep_single_dose,MELANIN INHIBITOR,KCNH2;MCHR1,,,PHASE 1,,,NA,COC1CC(CCC1OCCN1CCCC1)-N1CNC2CC(SC2C1=O)-C1CCC(CL)CC1,
GW842166X,"GW 842166;GW 842166X;GW-842,166X;GW-842166;GW842166;GW842166X",CHEMBL225411,BRD:BRD-BRD-K26823213-001-02-9;BRD:BRD-K26823213-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,CANNABINOID RECEPTOR AGONIST,CNR2,,,PHASE 2,,Small molecule,2,FC(F)(F)C1NC(NC2CCC(CL)CC2CL)NCC1C(=O)NCC1CCOCC1;O=C(NCC1CCOCC1)c1cnc(Nc2ccc(Cl)cc2Cl)nc1C(F)(F)F,TWQYWUXBZHPIIV-UHFFFAOYSA-N
GW-843682X,GW-843682X,,BRD:BRD-BRD-K90382497-001-10-7;BRD:BRD-K90382497-001-10-7;CTRP:348997,ctrp;rep_multi_dose;rep_primary;rep_single_dose,PLK INHIBITOR,PLK1;PLK3,,,PRECLINICAL,,,NA,"COC1CC2NCN(-C3CC(OCC4CCCCC4C(F)(F)F)C(S3)C(N)=O)C2CC1OC, COC1CC2NCN(-C3CC(OCC4CCCCC4C(F)(F)F)C(S3)C(N)=O)C2CC1OC",
GW9508,GW-9508;GW9508,CHEMBL207881,BRD:BRD-BRD-K71534238-001-10-0;BRD:BRD-K71534238-001-10-0,rep_primary;rep_single_dose,"FREE FATTY ACID RECEPTOR AGONIST, G PROTEIN-COUPLED RECEPTOR AGONIST",FFAR1;FFAR4,,,PRECLINICAL,,Small molecule,NA,"O=C(O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1;OC(=O)CCC1CCC(NCC2CCCC(OC3CCCCC3)C2)CC1, OC(=O)CCC1CCC(NCC2CCCC(OC3CCCCC3)C2)CC1, OC(=O)CCC1CCC(NCC2CCCC(OC3CCCCC3)C2)CC1",DGENZVKCTGIDRZ-UHFFFAOYSA-N
GW-9662,GW-9662,,BRD:BRD-BRD-K93258693-001-17-3;BRD:BRD-K93258693-001-17-3,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,NCOA2;PPARG;RXRA,,,PRECLINICAL,,,NA,"[O-][N+](=O)C1CCC(CL)C(C1)C(=O)NC1CCCCC1, [O-][N+](=O)C1CCC(CL)C(C1)C(=O)NC1CCCCC1",
GW274150,GW-274150;GW274150,CHEMBL114551,BRD:BRD-K65840970-001-02-9,rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,,,,,,Small molecule,2,CC(=N)NCCSCC[C@H](N)C(=O)O,MOLOJNHYNHBPCW-ZETCQYMHSA-N
GW441756,GW 441756;GW441756,,GDSC1:1023,gdsc,,,,,,,,NA,,
GW7604,GW7604,,BRD:BRD-K00073895-001-02-9,rep_single_dose,,,,,,,,NA,,
GW843682X (AN-13),GW843682X;GW843682X (AN-13),CHEMBL514499,GDSC1:87,gdsc,,,,,,,Small molecule,NA,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,JSKUWFIZUALZLX-UHFFFAOYSA-N
GX2580,CFMS RECEPTOR TYROSINE KINASE INHIBITOR;GX2580,,GDSC1:193,gdsc,,,,,,,,NA,,
GZD824,GZD824,,BRD:BRD-BRD-K35329391-334-01-7;BRD:BRD-K35329391-334-01-7,rep_multi_dose;rep_primary;rep_single_dose,BCR-ABL KINASE INHIBITOR,ABL1;BCR,,,PRECLINICAL,,,NA,CN1CCN(CC2CCC(NC(=O)C3CCC(C)C(C3)C#CC3CNC4[NH]NCC4C3)CC2C(F)(F)F)CC1,
H-151,H-151,,BRD:BRD-K00005333-001-01-9,rep_single_dose,STING ANTAGONIST,,,,,,,NA,,
H-89,H-89,,BRD:BRD-BRD-K27737647-300-03-0;BRD:BRD-K27737647-300-03-0,rep_primary;rep_single_dose,PKA INHIBITOR,GSG2;PKIA;PRKACA,,,PRECLINICAL,,,NA,"BRC1CCC(\C=C\CNCCNS(=O)(=O)C2CCCC3CNCCC23)CC1, BRC1CCC(\C=C\CNCCNS(=O)(=O)C2CCCC3CNCCC23)CC1, BRC1CCC(\C=C\CNCCNS(=O)(=O)C2CCCC3CNCCC23)CC1",
H-VAL-PRO-PRO-OH (TFA),H-VAL-PRO-PRO-OH (TFA),,BRD:BRD-K00073449-019-02-9,rep_single_dose,,,,,,,,NA,,
H2L-5765834,H2L-5765834,,BRD:BRD-BRD-K26439554-001-01-3;BRD:BRD-K26439554-001-01-3,rep_primary;rep_single_dose,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,LPAR1;LPAR3,,,PRECLINICAL,,,NA,OC(=O)C1CCC2C(=O)N(C(=O)C2C1)C1CCCC(OC2CCC(CC2)[N+]([O-])=O)C1,
HA-1004,HA-1004,,BRD:BRD-BRD-K05434375-001-06-5;BRD:BRD-K05434375-001-06-5,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,PHASE 2,,,NA,NC(=N)NCCNS(=O)(=O)C1CCCC2CNCCC12,
HA-130,HA-130,,BRD:BRD-K64452997-001-02-9,rep_single_dose,AUTOTAXIN INHIBITOR,ENPP2,,,,,,NA,,
HA-966-(R)-(+),HA-966-(R)-(+),,BRD:BRD-BRD-K58046914-001-03-8;BRD:BRD-K58046914-001-03-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIA1,,,PRECLINICAL,,,NA,N[C@@H]1CCN(O)C1=O,
HA-966-(S)-(-),HA-966-(S)-(-),,BRD:BRD-BRD-K41304947-001-03-2;BRD:BRD-K41304947-001-03-2,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1,,,PRECLINICAL,,,NA,N[C@H]1CCN(O)C1=O,
HA14-1,HA14-1,,BRD:BRD-BRD-K18163608-001-05-6;BRD:BRD-K18163608-001-05-6,rep_multi_dose;rep_primary;rep_single_dose,BCL INHIBITOR,BCL2,,,PRECLINICAL,,,NA,"CCOC(=O)[C@@H](C#N)[C@@H]1C2CC(BR)CCC2OC(N)=C1C(=O)OCC, CCOC(=O)[C@@H](C#N)[C@@H]1C2CC(BR)CCC2OC(N)=C1C(=O)OCC",
SQ-18566,HALCINONIDE;HALOG;HALOG-E;NSC-758413;SO 18566;SO-18566;SQ 18566;SQ-18566,CHEMBL1200845,BRD:BRD-A88138582-001-04-8;BRD:BRD-BRD-A88138582-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,Small molecule,4,"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1;CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCL, CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCL",MUQNGPZZQDCDFT-JNQJZLCISA-N
HALOBETASOL-PROPIONATE,HALOBETASOL-PROPIONATE,,BRD:BRD-BRD-K65877271-001-01-8;BRD:BRD-K65877271-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;PLA2G1B,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,CCC(=O)O[C@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)CCL,
HALOFANTRINE,DL-WR-171669;HALOFANTRINE,CHEMBL1107,BRD:BRD-A51964809-003-12-6;BRD:BRD-BRD-A51964809-003-12-6,rep_multi_dose;rep_primary;rep_single_dose,ANTIMALARIAL AGENT,KCNH2;KCNN4,MALARIA,,LAUNCHED,,Small molecule,4,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12;CCCCN(CCCC)CCC(O)C1CC2C(CL)CC(CL)CC2C2CC(CCC12)C(F)(F)F,FOHHNHSLJDZUGQ-UHFFFAOYSA-N
HT-100,HALOCUR;HALOFUGINON;HALOFUGINONE;HT-100,CHEMBL1197091,BRD:BRD-BRD-K54247840-004-01-3;BRD:BRD-K54247840-004-01-3,rep_multi_dose;rep_primary;rep_single_dose,COLLAGENASE INHIBITOR,COL1A1;MMP2,SCLERODERMA,,LAUNCHED,,Small molecule,2,O[C@H]1CCCN[C@@H]1CC(=O)CN1CNC2CC(BR)C(CL)CC2C1=O;O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O,LVASCWIMLIKXLA-UHFFFAOYSA-N
R-34301,"HALOPEMIDE;NSC-354856;R 34,301;R-34301",CHEMBL245621,BRD:BRD-BRD-K50055394-001-03-6;BRD:BRD-K50055394-001-03-6,rep_primary;rep_single_dose,PHOSPHOLIPASE INHIBITOR,PLD1;PLD2,,,PHASE 2,,Small molecule,-1,O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1;OC1NC2CC(CL)CCC2N1C1CCN(CCNC(=O)C2CCC(F)CC2)CC1,NBHPRWLFLUBAIE-UHFFFAOYSA-N
SERENACE,DOLPIN;DOZIC;FORTUNAN;HALDOL;HALDOL SOLUTAB;HALOPERIDOL;HALOPERIDOL DECANOATE IMPURITY;HALOPERIDOL-;KENTACE;KESELEN;MCN-JR-1625;NSC-170973;NSC-615296;R-1625;SERENACE,CHEMBL54,BRD:BRD-BRD-K67783091-001-26-1;BRD:BRD-K67783091-001-26-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD2;DRD3;DRD4;DRD5;GRIN2B;HRH1;HTR1A;HTR1D;HTR2A;HTR2B;HTR7;KCNH1,"SCHIZOPHRENIA, TOURETTE'S DISORDER",,LAUNCHED,,Small molecule,4,"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1;OC1(CCN(CCCC(=O)C2CCC(F)CC2)CC1)C1CCC(CL)CC1, OC1(CCN(CCCC(=O)C2CCC(F)CC2)CC1)C1CCC(CL)CC1, OC1(CCN(CCCC(=O)C2CCC(F)CC2)CC1)C1CCC(CL)CC1",LNEPOXFFQSENCJ-UHFFFAOYSA-N
HALOPERIDOL-DECANOATE,HALOPERIDOL-DECANOATE,,BRD:BRD-BRD-K80859331-001-01-5;BRD:BRD-K80859331-001-01-5,rep_primary;rep_single_dose,PSYCHOACTIVE DRUG,DRD2;DRD3;DRD4;HTR2A,SCHIZOPHRENIA,,LAUNCHED,,,NA,CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2CCC(F)CC2)CC1)C1CCC(CL)CC1,
NSC-100071,HALOPROGIN;HALOTEX;M-1028;MYCANDEN;NSC-100071,CHEMBL1289,BRD:BRD-BRD-K13238168-001-02-0;BRD:BRD-K13238168-001-02-0,rep_primary;rep_single_dose,OTHER ANTIFUNGAL,,TINEA PEDIS,,LAUNCHED,,Small molecule,4,Clc1cc(Cl)c(OCC#CI)cc1Cl;CLC1CC(CL)C(OCC#CI)CC1CL,CTETYYAZBPJBHE-UHFFFAOYSA-N
RHIDIALOTHAN,FLUOTHANE;FREON 123B1;HALOTHANE;HALOTHANUM;NSC-143490;RHIDIALOTHAN,CHEMBL931,BRD:BRD-A20550616-001-02-9;BRD:BRD-BRD-A20550616-001-02-9,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,ATP2C1;ATP5D;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GLRA1;GLRB;GNG2;GRIN2A;GRIN3A;GRIN3B;KCNJ3;KCNJ6;KCNK10;KCNK12;KCNK13;KCNK15;KCNK18;KCNK2;KCNK3;KCNK9;KCNMA1;KCNN4;MT-ND1;NPSR1;RHO,GENERAL ANAESTHETIC,,LAUNCHED,,Small molecule,4,"FC(F)(F)C(Cl)Br;FC(F)(F)C(CL)BR, FC(F)(F)C(CL)BR",BCQZXOMGPXTTIC-UHFFFAOYSA-N
HARMANE,HARMANE,,BRD:BRD-BRD-K12630395-001-14-9;BRD:BRD-K12630395-001-14-9,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,,,PRECLINICAL,,,NA,CC1NCCC2C3CCCCC3[NH]C12,
NSC-124147,HARRINGTONINE;NSC-124147,CHEMBL433257,BRD:BRD-BRD-K96358241-001-01-9;BRD:BRD-K96358241-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,,,PHASE 3,,Small molecule,NA,COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4;COC(=O)C[C@@](O)(CCC(C)(C)O)C(=O)O[C@H]1[C@@H]2C3CC4OCOC4CC3CCN3CCC[C@]23C=C1OC,HAVJATCHLFRDHY-KSZYUSJVSA-N
HBED,HBED,,BRD:BRD-K00004555-001-01-9,rep_single_dose,CHELATING AGENT,,,,,,,NA,,
HBX-41108,HBX-41108,,CTRP:679843,ctrp,,,,,,,,NA,,
HC-030031,HC-030031,,BRD:BRD-BRD-K73815512-001-02-5;BRD:BRD-K73815512-001-02-5,rep_primary;rep_single_dose,TRPA1 CHANNEL BLOCKER,TRPA1,,,PHASE 1,,,NA,CC(C)C1CCC(NC(=O)CN2CNC3N(C)C(=O)N(C)C(=O)C23)CC1,
HC-067047,HC-067047,,BRD:BRD-K03391209-001-02-0;CTRP:660083,ctrp;rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPV4,,,,,,NA,,
HC-070,HC-070,,BRD:BRD-K00004601-001-01-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,,,,,,,NA,,
REC-2282,(S)-HDAC 42;(S)-HDAC-42;AR 42;AR-42;AR42;HDAC-42;OSU-HDAC 42;REC-2282,CHEMBL191482,GDSC1:272,gdsc,,,,,,,Small molecule,2,CC(C)[C@H](C(=O)Nc1ccc(C(=O)NO)cc1)c1ccccc1,LAMIXXKAWNLXOC-INIZCTEOSA-N
HECLIN,HECLIN,,BRD:BRD-K49788188-001-02-9,rep_single_dose,UBIQUITIN LIGASE INHIBITOR,NEDD4;SMURF2;WWP1,,,,,,NA,,
HEMADO,HEMADO,,BRD:BRD-BRD-K34672903-001-01-7;BRD:BRD-K34672903-001-01-7,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,,,NA,"CCCCC#CC1NC(NC)C2NCN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2N1, CCCCC#CC1NC(NC)C2NCN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2N1",
HEMATOXYLIN,HEMATOXYLIN,CHEMBL477197,BRD:BRD-BRD-K78342372-001-02-4;BRD:BRD-K78342372-001-02-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,NA,"Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2;OC1CC2C[C@@]3(O)COC4C(CCC(O)C4O)[C@H]3C2CC1O, OC1CC2C[C@@]3(O)COC4C(CCC(O)C4O)[C@H]3C2CC1O",WZUVPPKBWHMQCE-XJKSGUPXSA-N
PHENODIN,FERRIHEME HYDROXIDE;FERRIPORPHYRIN HYDROXIDE;FERRIPROTOPORPHYRIN BASIC;HEMATIN;HEMIN;HYDROXYHEMIN;NSC-122707;PHENODIN,CHEMBL1200662;CHEMBL3707238,BRD:BRD-K74057164-001-01-6,rep_single_dose,ENZYME INDUCER,,,,,,Small molecule,-1,,
HEMOGLOBIN-MODULATORS-1,HEMOGLOBIN-MODULATORS-1,,BRD:BRD-BRD-K43639297-001-01-9,rep_primary,HEMOGLOBIN MODULATOR,,,,PHASE 3,,,NA,CC(C)N1NCCC1-C1NCCCC1COC1CCCC(O)C1C=O,
HEMOMEX-S,HEMOMEX-S,,BRD:BRD-BRD-K15231341-001-01-5;BRD:BRD-K15231341-001-01-5,rep_primary;rep_single_dose,,PPARG,,,LAUNCHED,,,NA,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@@]21C,
HEPSULFAM,HEPSULFAM,,BRD:BRD-K00004739-001-01-9,rep_single_dose,DNA CROSS-LINKING,,,,,,,NA,,
HEPTAMINOL,6-HYDROXY-6-METHYL-2-HEPTAMINE;CORASORE;GINKOR;HEPTAMINOL,CHEMBL2111076,BRD:BRD-A32988684-003-08-7;BRD:BRD-BRD-A32988684-003-08-7,rep_primary;rep_single_dose,VASOCONSTRICTOR,,HYPOTENSION,,LAUNCHED,,Small molecule,-1,CC(N)CCCC(C)(C)O,LREQLEBVOXIEOM-UHFFFAOYSA-N
HER2-INHIBITOR-1,HER2-INHIBITOR-1,,BRD:BRD-K89709433-001-03-9,rep_single_dose,EGFR INHIBITOR,,,,,,,NA,,
TCMDC-135395,HESPERADIN;TCMDC-135395,CHEMBL514409,BRD:BRD-BRD-K58122457-001-02-2;BRD:BRD-K58122457-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKB,,,PRECLINICAL,,Small molecule,NA,"CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2;CCS(=O)(=O)NC1CCC2NC(=O)\C(C2C1)=C(/NC1CCC(CN2CCCCC2)CC1)C1CCCCC1, CCS(=O)(=O)NC1CCC2NC(=O)\C(C2C1)=C(/NC1CCC(CN2CCCCC2)CC1)C1CCCCC1",GLDSKRNGVVYJAB-DQSJHHFOSA-N
NSC-57654,HESPERETIN;NSC-57654,CHEMBL399121,BRD:BRD-BRD-K30553453-001-13-2;BRD:BRD-K30553453-001-13-2,rep_primary;rep_single_dose,ACAT INHIBITOR,DGAT1;MTTP;SOAT1;SOAT2,,,LAUNCHED,,Small molecule,NA,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O;COC1CCC(CC1O)[C@@H]1CC(=O)C2C(O)CC(O)CC2O1,AIONOLUJZLIMTK-AWEZNQCLSA-N
VENOSMINE,BAROSMIN;BUCHU RESIN;DAFLON;DIOSMETIN 7-RUTINOSIDE;DIOSMIN;DIOSVEN;DIOVEN;DIOVENOR;FLEBAVEN;FLEBAVENA;FLEBOSMIL;FLEBOSTEN;HEMERVEN;HESPERIDIN;INSUVEN;LITOSMIL;NSC-31048;NSC-758417;TOVENE;VARINON;VEN-DETREX;VENOSMINE,CHEMBL231884;CHEMBL449317,BRD:BRD-BRD-K38903228-001-13-5;BRD:BRD-K38903228-001-13-5,rep_primary;rep_single_dose,FLAVANONE GLYCOSIDE,AURKB;CACNA1B,,,LAUNCHED,"Multiple values for repurposing_target: {'CACNA1B', 'AURKB;CACNA1B'}, taking the union",Small molecule,4,"COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O;COC1CCC(CC1O)[C@@H]1CC(=O)C2C(O)CC(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC2O1, COC1CCC(CC1O)[C@@H]1CC(=O)C2C(O)CC(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC2O1, COC1CCC(CC1O)[C@@H]1CC(=O)C2C(O)CC(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC2O1",GZSOSUNBTXMUFQ-YFAPSIMESA-N
TURGEX,'GERMA-MEDICA ''MG''';E-Z SCRUB;GAMOPHEN;GERMA-MEDICA;GERMA-MEDICA 'MG';HEXA-GERM;HEXACHLOROPHENE;HEXASCRUB;PHISO-SCRUB;PHISOHEX;PRE-OP;PRE-OP II;SCRUBTEAM SURGICAL SPONGEBRUSH;SEPTI-SOFT;SEPTISOL;SOY-DOME;TURGEX,CHEMBL496,BRD:BRD-BRD-K99792991-001-34-9;BRD:BRD-K99792991-001-34-9,rep_multi_dose;rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,GLUD1;SDHD,GRAM-POSITIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl;OC1C(CL)CC(CL)C(CL)C1CC1C(O)C(CL)CC(CL)C1CL,ACGUYXCXAPNIKK-UHFFFAOYSA-N
HEXATHONIDE,HEXAMETHONE;HEXAMETHONIUM;HEXAMETHONIUM CATION;HEXAMETHONIUM ION;HEXATHONIDE,CHEMBL100622,BRD:BRD-BRD-K10598093-303-06-1;BRD:BRD-K10598093-303-06-1,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRNA2;CHRNA3;CHRNA4;CHRNA6,,,PRECLINICAL,,Small molecule,-1,"C[N+](C)(C)CCCCCC[N+](C)(C)C;C[N+](C)(C)CCCCCC[N+](C)(C)C, C[N+](C)(C)CCCCCC[N+](C)(C)C, C[N+](C)(C)CCCCCC[N+](C)(C)C",VZJFGSRCJCXDSG-UHFFFAOYSA-N
HEXAMETHYLENEBISACETAMIDE,HEXAMETHYLENEBISACETAMIDE,CHEMBL291481,BRD:BRD-BRD-K04710043-001-17-8;BRD:BRD-K04710043-001-17-8,rep_multi_dose;rep_primary;rep_single_dose,"AKT INHIBITOR, DIFFERENTIATION INDUCER, NFKB PATHWAY INHIBITOR",AKT1,,,PHASE 2,,Small molecule,NA,CC(=O)NCCCCCCNC(C)=O,BNQSTAOJRULKNX-UHFFFAOYSA-N
HEXAMINOLEVULINATE,HEXAMINOLEVULINATE,CHEMBL1201784,BRD:BRD-BRD-K73753850-003-01-6;BRD:BRD-K73753850-003-01-6,rep_multi_dose;rep_primary;rep_single_dose,,,DIAGNOSTIC AGENT,,LAUNCHED,,Small molecule,4,CCCCCCOC(=O)CCC(=O)CN,RYQOILLJDKPETL-UHFFFAOYSA-N
NSC-9894,ERYTHROHEXESTROL;HEXESTROL;HEXESTROL DIPHOSPHATE SODIUM;MESO-HEXESTROL;MESOHEXESTROL;NSC-9894,CHEMBL6615,BRD:BRD-BRD-K69253806-001-02-0;BRD:BRD-K69253806-001-02-0,rep_primary;rep_single_dose,SYNTHETIC ESTROGEN,AKR1C1;ESR1;ESR2,,,LAUNCHED,,Small molecule,-1,"CCC(C(CC)C1CCC(O)CC1)C1CCC(O)CC1, CC[C@@H]([C@@H](CC)C1CCC(O)CC1)C1CCC(O)CC1, CC[C@@H]([C@@H](CC)C1CCC(O)CC1)C1CCC(O)CC1;CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1",PBBGSZCBWVPOOL-UHFFFAOYSA-N
ST1512,HEXOPRENALINE;IPRADOL;ST-1512;ST1512,CHEMBL1589896,BRD:BRD-A33894669-065-01-9;BRD:BRD-BRD-A33894669-065-01-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,ASTHMA,,LAUNCHED,,Small molecule,-1,OC(CNCCCCCCNCC(O)C1CCC(O)C(O)C1)C1CCC(O)C(O)C1;Oc1ccc(C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2)cc1O,OXLZNBCNGJWPRV-UHFFFAOYSA-N
OSMOCAINE,CYCLAINE;HEXYLCAINE;OSMOCAINE,CHEMBL1197,BRD:BRD-A97730597-003-11-5;BRD:BRD-BRD-A97730597-003-11-5,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A;SCN5A,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,4,CC(CNC1CCCCC1)OC(=O)c1ccccc1;CC(CNC1CCCCC1)OC(=O)C1CCCCC1,DKLKMKYDWHYZTD-UHFFFAOYSA-N
SUCRETS,E-586;HEXYLRESORCINOL;INS NO.586;INS-586;SUCRETS,CHEMBL443605,BRD:BRD-BRD-K99946902-001-07-5;BRD:BRD-K99946902-001-07-5,rep_multi_dose;rep_primary;rep_single_dose,LOCAL ANESTHETIC,TYR,"SKIN INFECTIONS, FIRST-AID ANTISEPTIC",,LAUNCHED,,Small molecule,4,CCCCCCc1ccc(O)cc1O;CCCCCCC1CCC(O)CC1O,WFJIVOKAWHGMBH-UHFFFAOYSA-N
HG-5-113-01,HG-5-113-01,,GDSC1:1142,gdsc,,,,,,,,NA,,
HG-5-88-01,HG-5-88-01,,GDSC1:1143,gdsc,,,,,,,,NA,,
HIGENAMINE,DL-DEMETHYLCOCLAURINE;HIGENAMINE,CHEMBL19344,BRD:BRD-A55204514-003-01-2;BRD:BRD-BRD-A55204514-003-01-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,,,PHASE 1,,Small molecule,1,OC1CCC(CC2NCCC3CC(O)C(O)CC23)CC1;Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1,WZRCQWQRFZITDX-UHFFFAOYSA-N
HIPPURIC-ACID,HIPPURIC-ACID,,BRD:BRD-BRD-K62914667-001-13-9;BRD:BRD-K62914667-001-13-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC(=O)CNC(=O)C1CCCCC1,
NSC-33792,.BETA.-AMINOETHYLGLYOXALINE;ERGAMINE;ERGOTIDINE;HISTAMINE;NSC-33792,CHEMBL90,BRD:BRD-BRD-K01674964-300-06-3;BRD:BRD-K01674964-300-06-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH1;HRH2;HRH3;HRH4,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,"NCCc1c[nH]cn1;NCCC1C[NH]CN1, NCCC1C[NH]CN1, NCCC1C[NH]CN1, NCCC1C[NH]CN1, NCCC1C[NH]CN1, NCCC1C[NH]CN1",NTYJJOPFIAHURM-UHFFFAOYSA-N
HJC-0350,HJC-0350,,BRD:BRD-BRD-K34411045-001-01-9;BRD:BRD-K34411045-001-01-9,rep_primary;rep_single_dose,GTPASE INHIBITOR,RAPGEF4,,,PRECLINICAL,,,NA,CC1CC(C)N(C1)S(=O)(=O)C1C(C)CC(C)CC1C,
HKI-357,HKI-357,CHEMBL178654,BRD:BRD-BRD-K58811567-001-01-9;BRD:BRD-K58811567-001-01-9,rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PHASE 1,,Small molecule,1,"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C;CCOC1CC2NCC(C#N)C(NC3CCC(OCC4CCCC(F)C4)C(CL)C3)C2CC1NC(=O)\C=C\CN(C)C, CCOC1CC2NCC(C#N)C(NC3CCC(OCC4CCCC(F)C4)C(CL)C3)C2CC1NC(=O)\C=C\CN(C)C",NERXPXBELDBEPZ-RMKNXTFCSA-N
HLCL-61,HLCL-61,,BRD:BRD-BRD-K73746696-003-01-8;BRD:BRD-K73746696-003-01-8,rep_primary;rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,PRMT5,,,PRECLINICAL,,,NA,CCN1C2CCCCC2C2CC(CNCC3CCCCC3OC)CCC12,
HLI 373,HLI 373,,CTRP:481311,ctrp,,,,,,,,NA,,
PGP INHIBITOR HM30181AK,ENCEQUIDAR;HM-30181;HM30181;HM30181AK;PGP INHIBITOR HM30181AK,CHEMBL4594298,BRD:BRD-K74319597-001-02-9,rep_single_dose,P GLYCOPROTEIN INHIBITOR,,,,,,Small molecule,3,COc1cc2c(cc1OC)CN(CCc1ccc(-n3nnc(-c4cc(OC)c(OC)cc4NC(=O)c4cc(=O)c5ccccc5o4)n3)cc1)CC2,AHJUHHDDCJQACA-UHFFFAOYSA-N
POZIOTINIB,HM 781-36;HM 781-36B;HM-781-36;HM-781-36B;HM781-36B;NOV-1201;NOV-120101;NOV120101;POZIOTINIB,CHEMBL3545154,BRD:BRD-BRD-K50010139-001-02-3;BRD:BRD-K50010139-001-01-5;BRD:BRD-K50010139-001-02-3;BRD:BRD-K50010139-001-11-9,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,PAN-HER RECEPTOR TYROSINE KINASE INHIBITOR,EGFR;ERBB2;ERBB4,,,PHASE 2,"Multiple values for MOA: {'PAN-HER RECEPTOR TYROSINE KINASE INHIBITOR', 'EGFR INHIBITOR'}, defaulting to 'PAN-HER RECEPTOR TYROSINE KINASE INHIBITOR'",Small molecule,3,"C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1;COC1CC2NCNC(NC3CCC(CL)C(CL)C3F)C2CC1OC1CCN(CC1)C(=O)C=C, COC1CC2NCNC(NC3CCC(CL)C(CL)C3F)C2CC1OC1CCN(CC1)C(=O)C=C",LPFWVDIFUFFKJU-UHFFFAOYSA-N
IVX-214,HMN-214;IVX-214,CHEMBL3545431,BRD:BRD-BRD-K70511574-001-06-9;BRD:BRD-K70511574-001-06-9,rep_multi_dose;rep_primary;rep_single_dose,PLK INHIBITOR,PLK1,,,PHASE 1,,Small molecule,1,COC1CCC(CC1)S(=O)(=O)N(C(C)=O)C1CCCCC1\C=C\C1CC[N+]([O-])CC1,
HOKU-81,HOKU-81,,BRD:BRD-K00003598-001-01-9,rep_single_dose,BRONCHODILATOR,,,,,,,NA,,
HOMATROPINE,HOMATROPINE,CHEMBL1618018,BRD:BRD-A74975734-004-09-9;BRD:BRD-A74975734-004-10-7;BRD:BRD-BRD-A74975734-004-09-9;BRD:BRD-BRD-A74975734-004-10-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CES1;CHRM1,PUPIL DILATION,,LAUNCHED,,Small molecule,4,"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2;CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)C1CCCCC1, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)C1CCCCC1",ZTVIKZXZYLEVOL-MCOXGKPRSA-N
HOMATROPINE-METHYLBROMIDE,HOMATROPINE-METHYLBROMIDE,,BRD:BRD-A43999749-004-04-1;BRD:BRD-BRD-A43999749-004-04-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,UVEAL TRACT INFLAMMATION,,LAUNCHED,,,NA,C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(O)C1CCCCC1,
WICRON,CUROSAJIN;HOMOCHLORCYCLIZINE;HOMOCHLORCYCLIZINE HYDROCHLORIDE;LYSILAN;NSC-25132;SA-97;SANKUMIN;WICRON,CHEMBL1515447,BRD:BRD-A22769835-300-05-7;BRD:BRD-BRD-A22769835-300-05-7,rep_primary;rep_single_dose,ANTIHISTAMINE,HRH1,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,-1,CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1;CN1CCCN(CC1)C(C1CCCCC1)C1CCC(CL)CC1,WEUCDJCFJHYFRL-UHFFFAOYSA-N
SYNRIBO,CEFLATONIN;CGX-635;HOMOHARRINGTONIN;HOMOHARRINGTONINE;MYELOSTAT;NSC-141633;OMACETAXINE MEPESUCCINATE;OMAPRO;SYNRIBO,CHEMBL46286,BRD:BRD-BRD-K76674262-001-03-3;BRD:BRD-K76674262-001-03-3,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,RPL3,CHRONIC MYELOID LEUKEMIA (CML),,LAUNCHED,,Small molecule,4,COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4;COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2C3CC4OCOC4CC3CCN3CCC[C@]23C=C1OC,HYFHYPWGAURHIV-JFIAXGOJSA-N
HOMOQUINOLINIC-ACID,HOMOQUINOLINIC-ACID,,BRD:BRD-BRD-K30519779-001-03-1;BRD:BRD-K30519779-001-03-1,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,PRECLINICAL,,,NA,OC(=O)CC1CCCNC1C(O)=O,
NSC-164918,EUSOLEX;HELIOPHAN;HOMOMENTHYL SALICYLATE;HOMOSALATE;NSC-164918,CHEMBL1377575,BRD:BRD-A34751532-001-06-9;BRD:BRD-BRD-A34751532-001-06-9,rep_multi_dose;rep_primary;rep_single_dose,HSP INDUCER,,,,PRECLINICAL,,Small molecule,-1,CC1CC(CC(C)(C)C1)OC(=O)C1CCCCC1O;CC1CC(OC(=O)c2ccccc2O)CC(C)(C)C1,WSSJONWNBBTCMG-UHFFFAOYSA-N
HONOKIOL,HONOKIOL,CHEMBL16901,BRD:BRD-BRD-K98493452-001-14-9;BRD:BRD-K98493452-001-14-9,rep_primary;rep_single_dose,AKT INHIBITOR,ALOX5;PTGS1;PTGS2,,,PHASE 3,,Small molecule,NA,C=CCc1ccc(O)c(-c2ccc(O)c(CC=C)c2)c1;OC1CCC(CC1CC=C)-C1CC(CC=C)CCC1O,FVYXIJYOAGAUQK-UHFFFAOYSA-N
HORDENINE,HORDENINE,CHEMBL505789,BRD:BRD-BRD-K93631643-001-02-4;BRD:BRD-K93631643-001-02-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,NA,"CN(C)CCc1ccc(O)cc1;CN(C)CCC1CCC(O)CC1, CN(C)CCC1CCC(O)CC1",KUBCEEMXQZUPDQ-UHFFFAOYSA-N
HP-228,HP-228,,BRD:BRD-K00004723-001-01-9,rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,,,,,,,NA,,
HPGDS-IN-1,HPGDS-IN-1,,BRD:BRD-K00003140-001-01-9,rep_single_dose,PROSTAGLANDIN INHIBITOR,,,,,,,NA,,
PHOTOCHLOR,HPPH;PHOTOCHLOR,CHEMBL500853,BRD:BRD-K00003730-001-01-9,rep_single_dose,PHOTOSENSITIZING AGENT,,,,,,Small molecule,2,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)O)[C@@H]3C,PVXGCBZIVFCMJK-NMWXTPPCSA-N
"SODIUM 2,2-DIMETHYLBUTYRATE","DIMEBUTATE SODIUM;HQK-1001;SODIUM 2,2 DIMETHYLBUTYRATE;SODIUM 2,2-DIMETHYLBUTYRATE",CHEMBL1650317,BRD:BRD-BRD-K44963273-001-06-9;BRD:BRD-K44963273-001-06-9,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,2,"CCC(C)(C)C(=O)[O-].[Na+];CCC(C)(C)C(O)=O, CCC(C)(C)C(O)=O",OOPXYEYPPHJHSE-UHFFFAOYSA-M
HS-276,HS-276,,BRD:BRD-K00126475-001-01-9,oncref_2,INHIBITOR OF TAK1,CAMKKÎ-1;CLK2;CSNK1G2;GCK;IRAK1;MAP4K5;NUAK;TAK1;ULK2,,,,,,NA,,
HSR6071,HSR6071,,BRD:BRD-K00004745-001-01-9,rep_single_dose,ANTIALLERGIC AGENT,,,,,,,NA,,
SNAP-37889,HT-2157;SNAP-37889,CHEMBL4297765,BRD:BRD-K00003386-001-01-9,rep_single_dose,GALANIN RECEPTOR 3 ANTAGONIST,,,,,,Unknown,1,,
HTH-01-015,HTH-01-015,,BRD:BRD-K58726989-001-02-7,rep_single_dose,PROTEIN KINASE INHIBITOR,NUAK1,,,,,,NA,,
HTHQ,HTHQ,,BRD:BRD-K00003389-001-01-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
HTMT,HTMT,,BRD:BRD-A66435872-332-01-8;BRD:BRD-BRD-A66435872-332-01-8,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH4,,,PRECLINICAL,,,NA,"CC(CCCCC(=O)NC1CCC(CC1)C(F)(F)F)NCCC1C[NH]CN1, CC(CCCCC(=O)NC1CCC(CC1)C(F)(F)F)NCCC1C[NH]CN1",
HUPERZINE-A,HUPERZINE-A,,BRD:BRD-BRD-K62240499-001-05-9;BRD:BRD-K62240499-001-05-9,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE,,,PHASE 2,,,NA,"C\C=C1/[C@@H]2CC3[NH]C(=O)CCC3[C@@]1(N)CC(C)=C2, C\C=C1/[C@@H]2CC3[NH]C(=O)CCC3[C@@]1(N)CC(C)=C2, C\C=C1/[C@@H]2CC3[NH]C(=O)CCC3[C@@]1(N)CC(C)=C2",
WIN-24933,"HYCANTHONE;NSC-134434;NSC-142982;WIN 24,933;WIN-24933",CHEMBL22077,BRD:BRD-BRD-K50406511-001-26-0;BRD:BRD-K50406511-001-26-0,rep_primary;rep_single_dose,RNA SYNTHESIS INHIBITOR,,SCHISTOSOMIASIS,,LAUNCHED,,Small molecule,-1,CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12;CCN(CC)CCNC1CCC(CO)C2SC3CCCCC3C(=O)C12,MFZWMTSUNYWVBU-UHFFFAOYSA-N
NSC-126699,HYDRALAZINE;HYDRALAZINE POLISTIREX;NSC-126699,CHEMBL276832,BRD:BRD-BRD-K82103381-003-09-4;BRD:BRD-K82103381-003-09-4,rep_primary;rep_single_dose,VASODILATOR,AOC3;P4HA1,HYPERTENSION,,LAUNCHED,,Small molecule,4,"NNc1nncc2ccccc12;NNC1NNCC2CCCCC12, NNC1NNCC2CCCCC12, NNC1NNCC2CCCCC12, NNC1NNCC2CCCCC12",RPTUSVTUFVMDQK-UHFFFAOYSA-N
"HYDRASTINE-(1R,9S)","HYDRASTINE-(1R,-9S);HYDRASTINE-(1R,9S)",,BRD:BRD-BRD-K02715688-001-02-1;BRD:BRD-K02715688-001-02-1,rep_primary;rep_single_dose,TYROSINE HYDROXYLASE INHIBITOR,,,,PRECLINICAL,,,NA,COC1CCC2[C@H](OC(=O)C2C1OC)[C@@H]1N(C)CCC2CC3OCOC3CC12,
NSC-755892,HYDRASTININE;NSC-755892,CHEMBL1314044;CHEMBL1623232,BRD:BRD-A57900429-003-05-8;BRD:BRD-BRD-A57900429-003-05-8,rep_primary;rep_single_dose,HAEMOSTATIC AGENT,,,,PRECLINICAL,,Small molecule,-1,"CN1CCc2cc3c(cc2C1O)OCO3;CN1CCC2CC3OCOC3CC2C1O, CN1CCC2CC3OCOC3CC2C1O",YOJQZPVUNUQTDF-UHFFFAOYSA-N
ZIDE,APO-HYDRO;APRESAZIDE;CAROZIDE;CHLOROSULTHIADIL;COPALIA-HCT;DAFIRO-HCT;DIHYDROCHLORURITE;ESIDREX;ESIDRIX;EXFORGE-HCT;HCTZ;HIDROTIAZIDA;HYDRO-D;HYDROCHLOROTHIAIZIDE;HYDROCHLOROTHIAZIDE;HYDROCHLOROTHIAZIDE INTENSOL;HYDROCHLOROTHIAZIDUM;HYDRODIURIL;HYDROSALURIC;IDROTIAZIDE;IMPRIDA-HCT;LOTENSIN HCT;MEGADIURIL;MICROZIDE;NEWTOLIDE;NSC-53477;ORETIC;PANTEMON;RASILEZ-HCT;SERVITHIAZID;SU-5879;UNIPRES;VETIDREX;ZIDE,CHEMBL435,BRD:BRD-BRD-K13078532-001-28-4;BRD:BRD-K13078532-001-28-4,rep_primary;rep_single_dose,THIAZIDE DIURETIC,CA1;CA12;CA2;CA4;CA9;KCNMA1;SLC12A3,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O;NS(=O)(=O)C1CC2C(NCNS2(=O)=O)CC1CL, NS(=O)(=O)C1CC2C(NCNS2(=O)=O)CC1CL",JZUFKLXOESDKRF-UHFFFAOYSA-N
ZENOXONE,ACETASOL HC;ACTICORT;AEROSEB-HC;ALA-CORT;ALA-SCALP;ALKINDI SPRINKLE;ALPHADERM;ANFLAM;ANUCORT-HC;ANUGESIC HC;ANUSOL HC;ANUSOL PLUS HC;ANUSOL SOOTHING RELIEF;ANUSOL-HC;BALNEOL-HC;BETA-HC;CALMURID HC;CANESTEN HC;CETACORT;CIPRO HC;COBADEX;COLOCORT;COR-OTICIN;CORLAN;CORT-DOME;CORTEF;CORTENEM;CORTENEMA;CORTIFOAM;CORTISOL;CORTRIL;DAKTACORT;DAKTACORT HYDROCORT;DERMA CARE HYDROCORT;DERMACORT;DERMASPRAY DEMANG;DIODERM;DOME-CORT;ECONACORT;EFCORTELAN P;ELDECORT;EPICORT;EURAX-HC;EURAX-HYDROCORT;EVACORT;EXE-CORT;FLEXICORT;GERMOLOIDS HC;GLYCORT;GREGODERM;H-CORT;HC (HYDROCORTISONE);HC #1;HC #4;HI-COR;HYDRO-RX;HYDROCORT IN CALAMINE OILY;HYDROCORT IN CETOMACROGOL FOR A;HYDROCORT IN WTE SOFT PARAF;HYDROCORTISONE;HYDROCORTISONE IN ABSORBASE;HYDROCORTONE;HYDRODERM;HYDRODERM HC;HYTONE;JUNGLE FOR;LOCOID;MEDICORT;MICORT-HC;MILDISON LIPOCREAM;NEO-CORTEF;NOGENIC HC;NSC-10483;NUTRACORT;NYBADEX;NYSTAFORM-HC;OPHTHOCORT;OTOSEPTIL;OTOSPORIN;PENECORT;PERINAL;PLENADREN;PROCTOCORT;PROCTOCREAM HC;PROCTOFOAM HC;PROCTOSEDYL;QUINOCORT;SENTIAL HC;STIE-CORT;SYNACORT;TERRA-CORTRIL;TERRA-CORTRIL NYSTATIN;TEXACORT;TIMOCORT;TIMODINE;TOPISONE;TRI-CICATRIN;U-CORT;UNIROID;UNIROID HC;XYLOPROCT;ZENOXONE,CHEMBL389621,BRD:BRD-BRD-K93568044-001-32-0;BRD:BRD-K93568044-001-32-0,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,ANXA1;NOS2;NR3C1;NR3C2,"ECZEMA, PSORIASIS, SEBORRHEIC DERMATITIS, ITCHING",,LAUNCHED,,Small molecule,4,"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO;C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO",JYGXADMDTFJGBT-VWUMJDOOSA-N
HYDROCORTISONE-ACETATE,HYDROCORTISONE-ACETATE,,BRD:BRD-A65767837-001-04-4;BRD:BRD-BRD-A65767837-001-04-4,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;NR3C2,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C,
HYDROCORTISONE-BUTYRATE,HYDROCORTISONE-BUTYRATE,,BRD:BRD-BRD-K99199077-001-16-1;BRD:BRD-K99199077-001-16-1,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,"CORTICOSTEROID-RESPONSIVE DERMATOSES, ECZEMA",,LAUNCHED,,,NA,"CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO, CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO",
HYDROCORTISONE-HEMISUCCINATE,HYDROCORTISONE-HEMISUCCINATE,,BRD:BRD-A07000685-001-04-4;BRD:BRD-BRD-A07000685-001-04-4,rep_primary;rep_single_dose,,,,,PHASE 2/PHASE 3,,,NA,C[C@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O,
HYDROCORTISONE-PHOSPHATE,HYDROCORTISONE-PHOSPHATE,,BRD:BRD-A46186775-369-02-0;BRD:BRD-BRD-A46186775-369-02-0,rep_primary;rep_single_dose,,ANXA1;NOS2;NR3C1,"ASTHMA, NAUSEA, VOMITING, MULTIPLE MYELOMA, CONTACT DERMATITIS, ENTERITIS, COLITIS",,LAUNCHED,,,NA,CC12C[C@H](O)C3C(CCC4=CC(=O)CCC34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O,
HYDROCORTISONE-VALERATE,HYDROCORTISONE-VALERATE,,BRD:BRD-A25143711-001-02-2;BRD:BRD-BRD-A25143711-001-02-2,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,CCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)CO,
SALURON,DIUCARDIN;HYDRENOX;HYDROFLUMETHIAZIDE;NSC-44627;SALURON,CHEMBL1763,BRD:BRD-BRD-K36862742-001-25-6;BRD:BRD-K36862742-001-25-6,rep_primary;rep_single_dose,SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,ATP1A1;CA1;CA12;CA2;CA4;CA9;KCNMA1;SLC12A1;SLC12A3,"EDEMA, CONGESTIVE HEART FAILURE, HEPATIC CIRRHOSIS, NEPHROTIC SYNDROME, CHRONIC RENAL FAILURE, ACUTE GLOMERULONEPHRITIS (AGN), HYPERTENSION",,LAUNCHED,,Small molecule,4,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O;NS(=O)(=O)C1CC2C(NCNS2(=O)=O)CC1C(F)(F)F,DMDGGSIALPNSEE-UHFFFAOYSA-N
NSC-757410,DIHYDROQUINIDINE;HYDROCONCHININE;HYDROQUINIDINE;NSC-757410,CHEMBL1906890,BRD:BRD-A06390036-001-04-6;BRD:BRD-BRD-A06390036-001-04-6,rep_primary;rep_single_dose,ANTIARRHYTHMIC,,CARDIAC ARRYTHMIA,,LAUNCHED,,Small molecule,3,CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12;CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)C1CCNC2CCC(OC)CC12,LJOQGZACKSYWCH-NBGVHYBESA-N
NEO-CYTAMEN,ALPHAREDISOL;COBALIN-H;CYANOKIT;HEPAVIT;HYDROXOCOBALAMIN;HYDROXOCOBALAMIN ACETATE;HYDROXOCOBALAMIN ANHYDROUS;HYDROXOCOBALAMINUM ANHYDROUS;HYDROXOCOBEMINE;HYDROXOMIN;HYDROXYCOBALAMIN;MEGAMILBEDOCE;NEO-CYTAMEN,CHEMBL2103737,BRD:BRD-K00003525-003-01-9,rep_single_dose,VITAMIN B,,,,,,Small molecule,4,,
RACEMIC P-HYDROXYAMPHETAMINE,DL-4-HYDROXYAMPHETAMINE;DL-P-HYDROXYAMPHETAMINE;HYDROXYAMFETAMINE;HYDROXYAMPHETAMINE;NORVERITOL;NSC-170995;P-(2-AMINOPROPYL)-;P-HYDROXYAMPHETAMINE;PHENOL;PULSOTON;RACEMIC P-HYDROXYAMPHETAMINE,CHEMBL1546,BRD:BRD-A80871782-004-06-9;BRD:BRD-BRD-A80871782-004-06-9,rep_primary;rep_single_dose,TRACE AMINE ASSOCIATED RECEPTOR AGONIST,TAAR1,MYDRIASIS,,LAUNCHED,,Small molecule,4,CC(N)Cc1ccc(O)cc1;CC(N)CC1CCC(O)CC1,GIKNHHRFLCDOEU-UHFFFAOYSA-N
POLIRREUMIN,HYDROXYCHLOROQUINE;POLIRREUMIN,CHEMBL1535,BRD:BRD-A99117172-065-04-0;BRD:BRD-BRD-A99117172-065-04-0,rep_primary;rep_single_dose,ANTIMALARIAL AGENT,TLR7;TLR9,MALARIA,,LAUNCHED,,Small molecule,4,"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12;CCN(CCO)CCCC(C)NC1CCNC2CC(CL)CCC12, CCN(CCO)CCCC(C)NC1CCNC2CC(CL)CCC12",XXSMGPRMXLTPCZ-UHFFFAOYSA-N
HYDROXYFASUDIL,HYDROXY-FASUDIL;HYDROXYFASUDIL,CHEMBL1233300,BRD:BRD-BRD-K77793136-003-03-0;BRD:BRD-K77793136-003-03-0,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,PKIA;PRKACA;ROCK1,,,PRECLINICAL,,Small molecule,NA,O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1;OC1NCCC2C(CCCC12)S(=O)(=O)N1CCCNCC1,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
U-3096,17-OHPC;17.ALPHA.-CAPROYLOXY-P4;17.ALPHA.-HYDROXYPROGESTERONE;DELALUTIN;DEPO-PROLUTON;HORMOFORT;HYDROXYPROGESTERONE;HYDROXYPROGESTERONE CAPROATE;HYDROXYPROGESTERONE HEXANOATE;HYLUTIN;MAKENA;MAKENA (AUTOINJECTOR);MAKENA PRESERVATIVE FREE;NSC-15468;NSC-17592;OXIPROGESTERONE CAPROATE;PHARLON;PRIMOLUT DEPOT;PROCYTE DEPO;PROGE;PROLUTON DEPOT;SYNGYNON;TERALUTIL;U-3096,CHEMBL1062;CHEMBL1200848,BRD:BRD-A39791822-001-05-1;BRD:BRD-BRD-A39791822-001-05-1,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,SPONTANEOUS PRETERM BIRTH,,LAUNCHED,,Small molecule,2,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C;CC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,DBPWSSGDRRHUNT-CEGNMAFCSA-N
HYDROXYPROGESTERONE-ACETATE,HYDROXYPROGESTERONE-ACETATE,,BRD:BRD-BRD-K92902018-001-01-9;BRD:BRD-K92902018-001-01-9,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,,,LAUNCHED,,,NA,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,
HYDROXYPROPYL-BETA-CYCLODEXTRIN,HYDROXYPROPYL-BETA-CYCLODEXTRIN,,BRD:BRD-A01412266-001-01-0;BRD:BRD-BRD-A01412266-001-01-0,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,
HYDROXYSAFFLOR-YELLOW-A,HYDROXYSAFFLOR-YELLOW-A,,BRD:BRD-K00003327-001-01-9,rep_single_dose,ANTITUMOR AGENT,,,,,,,NA,,
HYDROXYSTILBAMIDINE,HYDROXYSTILBAMIDINE,CHEMBL1301,BRD:BRD-BRD-K62186992-334-02-8;BRD:BRD-K62186992-334-02-8,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,4,N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1;NC(=N)C1CCC(CC1)\C=C\C1CCC(CC1O)C(N)=N,TUESWZZJYCLFNL-DAFODLJHSA-N
"HYDROXYTACRINE-MALEATE-(R,S)","HYDROXYTACRINE-MALEATE-(R,S)",,BRD:BRD-A98299281-050-09-6;BRD:BRD-BRD-A98299281-050-09-6,rep_multi_dose;rep_primary;rep_single_dose,CHOLINESTERASE INHIBITOR,ACHE,,,PRECLINICAL,,,NA,NC1C2C(O)CCCC2NC2CCCCC12,
HYDROXYTOLUIC-ACID,HYDROXYTOLUIC-ACID,,BRD:BRD-BRD-K75608666-001-08-3;BRD:BRD-K75608666-001-08-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC1CCCC(C(O)=O)C1O,
SQ-1089,DROXIA;HYDREA;HYDROXYCARBAMIDE;HYDROXYUREA;NSC-32065;SIKLOS;SQ 1089;SQ-1089,CHEMBL467,BRD:BRD-BRD-K51747290-001-12-3;BRD:BRD-BRD-K51747290-001-13-1;BRD:BRD-K51747290-001-12-3;BRD:BRD-K51747290-001-13-1,rep_multi_dose;rep_primary;rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,RRM1;RRM2;RRM2B,"CHRONIC MYELOID LEUKEMIA (CML), HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)",,LAUNCHED,,Small molecule,4,"NC(=O)NO;NC(=O)NO, NC(=O)NO, NC(=O)NO",VSNHCAURESNICA-UHFFFAOYSA-N
VISTARIL,ATARAX;ATARAXOID;HYDROXIZINE CHLORIDE;HYDROXYZINE;HYDROXYZINE DIHYDROCHLORIDE;HYDROXYZINE HYDROCHLORIDE;MAREX;NSC-169188;ORGATRAX;TRAN-Q;TRANQUIZINE;U.C.B-4492;UCERAX;VISTARIL,CHEMBL1201007;CHEMBL3186993;CHEMBL896,BRD:BRD-A62428732-300-06-3;BRD:BRD-BRD-A62428732-300-06-3,rep_primary;rep_single_dose,ANTIHISTAMINE,HRH1,"ANXIETY, URTICARIA, ITCHING, DERMATOSIS, ANXIETY, URTICARIA, ITCHING, DERMATOSIS",,LAUNCHED,,Small molecule,4,"Cl.Cl.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1;OCCOCCN1CCN(CC1)C(C1CCCCC1)C1CCC(CL)CC1, OCCOCCN1CCN(CC1)C(C1CCCCC1)C1CCC(CL)CC1",ANOMHKZSQFYSBR-UHFFFAOYSA-N
HYGROMYCIN-B,HYGROMYCIN-B,,BRD:BRD-A67101513-001-03-7;BRD:BRD-BRD-A67101513-001-03-7,rep_primary;rep_single_dose,POLYPEPTIDE SYNTHESIS INHIBITOR,,,,PRECLINICAL,,,NA,CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H]3OC4(O[C@@H]3[C@@H]2O)O[C@H](C(N)CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H]1O,
NSC-9408,4-METHYLUMBELLIFERONE;CANTABILINE;HYMECROMONE;LM-94;NSC-19026;NSC-9408,CHEMBL12208,BRD:BRD-BRD-K46424862-001-14-1;BRD:BRD-K46424862-001-14-1,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,,,PHASE 2,,Small molecule,2,"Cc1cc(=O)oc2cc(O)ccc12;CC1CC(=O)OC2CC(O)CCC12, CC1CC(=O)OC2CC(O)CCC12",HSHNITRMYYLLCV-UHFFFAOYSA-N
HYODEOXYCHOLIC-ACID,HYODEOXYCHOLIC-ACID,,BRD:BRD-BRD-K44009692-001-02-3;BRD:BRD-K44009692-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,ATHEROSCLEROSIS FORMATION INHIBITOR,,,,PHASE 1,,,NA,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,
NSC-757064,(-)-6.BETA.-HYDROXYHYOSCYAMINE;(-)-ATROPINE;(-)-HYOSCYAMINE;(S)-;(S)-(-)-HYOSCYAMINE;6-HYDROXY-;6.BETA.-HYDROXYHYOSCYAMINE;ANISODAMINE;ATROPINE;BELLAFOLINE;CYSTOSPAZ;DATURINE;DUBOISINE;HYOSCYAMINE;HYOSCYAMINUM;L-HYOSCYAMINE;NSC-757064,CHEMBL1331216;CHEMBL2165224,BRD:BRD-BRD-K40530731-001-11-6;BRD:BRD-K40530731-001-11-6,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4,"PEPTIC ULCER DISEASE (PUD), ACUTE ABDOMINAL VISCERAL SPASM, ULCERATIVE COLITIS, INTERSTITIAL CYSTITIS (IC), ENTEROCOLITIS, IRRITABLE BOWEL SYNDROME, TREMORS, ALLERGIC RHINITIS",,LAUNCHED,,Small molecule,4,"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2;CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1CCCCC1, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1CCCCC1",RKUNBYITZUJHSG-FXUDXRNXSA-N
HYPERFORIN,HYPERFORIN,CHEMBL501711,CTRP:660327,ctrp,,,,,,,Small molecule,NA,CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@@]2(CC=C(C)C)C(=O)[C@]1(C(=O)C(C)C)C(=O)C(CC=C(C)C)=C2O,KGSZHKRKHXOAMG-HQKKAZOISA-N
SGX301,HIPERICIN;HYPERICIN;HYPERICUM RED;NSC-407313;SGX-301;SGX301,CHEMBL286494,BRD:BRD-BRD-K29673530-001-05-4;BRD:BRD-K29673530-001-05-4,rep_multi_dose;rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,,,,PHASE 2,,Antibody,3,Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65;CC1CC(O)C2C3C1C1C(C)CC(O)C4C1C1C3C3C(C(O)CC(O)C3C2=O)C2C(O)CC(O)C(C12)C4=O,BTXNYTINYBABQR-UHFFFAOYSA-N
HYPERIN,HYPERIN,,BRD:BRD-A63780829-001-11-4;BRD:BRD-BRD-A63780829-001-11-4,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,ACE;AKR1B1,,,PRECLINICAL,,,NA,OCC1OC(OC2C(OC3CC(O)CC(O)C3C2=O)-C2CCC(O)C(O)C2)C(O)C(O)C1O,
HYPOESTOXIDE,HYPOESTOXIDE,,BRD:BRD-A51571244-001-01-9;BRD:BRD-BRD-A51571244-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,IKK INHIBITOR,IKBKB;IL1B;TNF,,,PHASE 1,,,NA,CC(=O)O[C@H]1CC2(C)OC2CCC2(C)OC2CC2CC(=O)C(=C)C1C2(C)C,
HYPOXANTHINE,HYPOXANTHINE,CHEMBL1427,BRD:BRD-BRD-K03739921-001-06-8;BRD:BRD-K03739921-001-06-8,rep_primary;rep_single_dose,PARP INHIBITOR,PNP,,,PRECLINICAL,,Small molecule,NA,O=c1[nH]cnc2nc[nH]c12;O=C1[NH]CNC2NC[NH]C12,FDGQSTZJBFJUBT-UHFFFAOYSA-N
I-BET-762,I-BET-762,,BRD:BRD-BRD-K08109215-001-06-4;BRD:BRD-K08109215-001-06-4;GDSC1:275;GDSC2:1624,gdsc;rep_multi_dose;rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD2;BRD3;BRD4,,,PHASE 2,,,NA,CCNC(=O)C[C@@H]1N=C(C2CCC(CL)CC2)C2CC(OC)CCC2-N2C(C)NNC12,
I-BET151,I-BET151,,BRD:BRD-BRD-K36363294-001-04-2;BRD:BRD-K36363294-001-04-2;CTRP:660206,ctrp;rep_multi_dose;rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD2;BRD3;BRD4,,,PRECLINICAL,,,NA,"COC1CC2C3N([C@H](C)C4CCCCN4)C(=O)[NH]C3CNC2CC1-C1C(C)NOC1C, COC1CC2C3N([C@H](C)C4CCCCN4)C(=O)[NH]C3CNC2CC1-C1C(C)NOC1C",
I-BRD9,I-BRD9,,BRD:BRD-BRD-K04972057-001-01-1;BRD:BRD-K04972057-001-01-1;GDSC2:1928,gdsc;rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD9,,,PRECLINICAL,,,NA,"CCN1CC(-C2CCCC(C2)C(F)(F)F)C2SC(CC2C1=O)C(=N)NC1CCS(=O)(=O)CC1, CCN1CC(-C2CCCC(C2)C(F)(F)F)C2SC(CC2C1=O)C(=N)NC1CCS(=O)(=O)CC1",
I-BZA,I-BZA,,BRD:BRD-BRD-K14762862-001-01-9;BRD:BRD-K14762862-001-01-9,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CCN(CC)CCNC(=O)C1CCC(I)CC1,
I-BZA2,I-BZA2,,BRD:BRD-BRD-K71698503-003-01-6;BRD:BRD-K71698503-003-01-6,rep_primary;rep_single_dose,,,,,PHASE 3,,,NA,CCN(CC)CCNC(=O)C1CCCCC1I,
I-CBP-112,I-CBP-112,,BRD:BRD-K57090026-001-04-9,rep_single_dose,BROMODOMAIN INHIBITOR,CREBBP;EP300,,,,,,NA,,
OXIDATIVE PHOSPHORYLATION INHIBITOR IACS-010759,IACS 010759;IACS-010759;IACS-10759;OXIDATIVE PHOSPHORYLATION INHIBITOR IACS-010759,CHEMBL4650499,BRD:BRD-K00003105-003-01-9,rep_single_dose,MITOCHONDRIAL COMPLEX I INHIBITOR,,,,,,Unknown,1,,
PICLIDENOSON,ALB-7208;CF-101;CF101;IB-MECA;PICLIDENOSON,CHEMBL119709;CHEMBL3989873,BRD:BRD-BRD-K31135544-001-07-0;BRD:BRD-K31135544-001-07-0,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PHASE 3,,Small molecule,3,CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccc(I)cc4)ncnc32)[C@H](O)[C@@H]1O;CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(NCC3CCCC(I)C3)NCNC12,JTZRECOPNKCRTE-MOROJQBDSA-N
QUODIXOR,BONDENZA;BONDRONAT;BONIVA;BONVIVA;IASIBON;IBANDRONATE;IBANDRONIC ACID;IBANDRONIC ACID ACCORD;IBANDRONIC ACID SANDOZ;IBANDRONIC ACID TEVA;NSC-722623;QUODIXOR,CHEMBL997,BRD:BRD-BRD-K08681769-323-03-7;BRD:BRD-K08681769-323-03-7,rep_primary;rep_single_dose,BONE RESORPTION INHIBITOR,FDPS,OSTEOPOROSIS,,LAUNCHED,,Small molecule,4,"CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O;CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O, CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O, CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O",MPBVHIBUJCELCL-UHFFFAOYSA-N
IBC-293,IBC-293,,BRD:BRD-BRD-K15196155-001-02-3;BRD:BRD-K15196155-001-02-3,rep_primary;rep_single_dose,HYDROXYCARBOXYLIC ACID RECEPTOR AGONIST,HCAR3,,,PRECLINICAL,,,NA,CC(C)N1NNC2CC(CCC12)C(O)=O,
IBERDOMIDE,CC-220;IBERDOMIDE,CHEMBL3989927,BRD:BRD-K00003408-001-01-9,rep_single_dose,CEREBLON MODULATOR,,,,,,Small molecule,3,O=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1,IXZOHGPZAQLIBH-NRFANRHFSA-N
VENGLUSTAT,GENZ-682452;GENZ-682452-AA;GZ-402671;GZ/SAR402671;GZ402671;IBIGLUSTAT;SAR-402671;SAR402671;VENGLUSTAT,CHEMBL4297611,BRD:BRD-K14063023-001-02-9,rep_single_dose,GLUCOSYLCERAMIDASE INHIBITOR,,,,,,Small molecule,3,CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1,YFHRCLAKZBDRHN-MRXNPFEDSA-N
IBMX,IBMX,,BRD:BRD-BRD-K94979336-001-20-0;BRD:BRD-K94979336-001-20-0,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,ADORA1;PDE2A;PDE3B;PDE4D;PDE5A;PDE6G;PDE7A;PDE8A;PDE9A,,,PRECLINICAL,,,NA,CC(C)CN1C2[NH]CNC2C(=O)N(C)C1=O,
IBOTENIC-ACID,IBOTENIC-ACID,,BRD:BRD-A02971356-001-09-9,rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIN1,,,,,,NA,,
OPF-009,IBROLIPIM;NO-1886;OPF 009;OPF-009,CHEMBL34234,BRD:BRD-BRD-K62490786-001-01-1;BRD:BRD-K62490786-001-01-1,rep_primary;rep_single_dose,LIPOPROTEIN LIPASE ACTIVATOR,LPL,,,PHASE 2,,Small molecule,-1,CCOP(=O)(Cc1ccc(C(=O)Nc2ccc(Br)cc2C#N)cc1)OCC;CCOP(=O)(CC1CCC(CC1)C(=O)NC1CCC(BR)CC1C#N)OCC,KPRTURMJVWXURQ-UHFFFAOYSA-N
PCI-32765-00,CRA-032765;IBRUTINIB;IMBRUVICA;PC-32765;PCI 32765;PCI-32765;PCI-32765-00,CHEMBL1873475,BRD:BRD-BRD-K70301465-001-02-6;BRD:BRD-K70301465-001-02-6;BRD:BRD-K70301465-001-05-9;CTRP:660994;GDSC2:1799,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BLK;BMX;BTK,"CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MANTLE CELL LYMPHOMA (MCL), WALDENSTROM'S MACROGLOBULINEMIA (WM)",,LAUNCHED,,Small molecule,4,"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1;NC1NCNC2N(NC(-C3CCC(OC4CCCCC4)CC3)C12)[C@@H]1CCCN(C1)C(=O)C=C, NC1NCNC2N(NC(-C3CCC(OC4CCCCC4)CC3)C12)[C@@H]1CCCN(C1)C(=O)C=C",XYFPWWZEPKGCCK-GOSISDBHSA-N
MN-166,AV-411;AV411;IBUDILAST;KETAS;MN-166,CHEMBL19449,BRD:BRD-BRD-K16444452-001-09-1;BRD:BRD-K16444452-001-09-1,rep_primary;rep_single_dose,"LEUKOTRIENE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",IL1B;IL6;PDE3A;PDE4A;PDE4B;PDE4C;PDE4D;PDE5A,"ASTHMA, STROKE",,LAUNCHED,,Small molecule,3,"CC(C)C(=O)c1c(C(C)C)nn2ccccc12;CC(C)C(=O)C1C(NN2CCCCC12)C(C)C, CC(C)C(=O)C1C(NN2CCCCC12)C(C)C",ZJVFLBOZORBYFE-UHFFFAOYSA-N
U-18573,"ACHES-N-PAIN;ADVIL;ADVIL LIQUI-GELS;ADVIL MIGRAINE LIQUI-GELS;ANADIN JOINT PAIN;ANADIN LIQUIFAST;ANADIN PERIOD PAIN RELIEF;ANADIN ULTRA;APSIFEN;APSIFEN-F;ARTHROFEN 200;ARTHROFEN 400;ARTHROFEN 600;BRUFEN RET;BURANA;CALDOLOR;CAP-PROFEN;CHILDREN'S ADVIL;CHILDREN'S ADVIL-FLAVORED;CHILDREN'S ELIXSURE;CHILDREN'S IBUPROFEN;CHILDREN'S MOTRIN;CO-OP;CODAFEN CONTINUS;CUPROFEN FOR CHILD;CUPROFEN PLUS;DEEP RELIEF;EBUFAC;FEMAFEN;FENBID;FENBID FTE;FENPAED;FEVERFEN;FLEXIMEX;IB-100;IBU-SLO;IBU-TAB;IBU-TAB 200;IBUCALM;IBUDERM;IBUFAC;IBUGEL;IBUGEL FTE;IBULAR;IBULEVE;IBUMED;IBUMETIN;IBUMOUSSE;IBUPRIN;IBUPROFEN;IBUPROFENUM;IBUPROHM;IBUSPRAY;IBUTIME;INABRIN;INFANT'S ADVIL;INOVEN;IP-82;ISISFEN;JUNIFEN;JUNIOR STRENGTH ADVIL;JUNIOR STRENGTH IBUPROFEN;JUNIOR STRENGTH MOTRIN;LIDIFEN;LIDIFEN-F;LOBUFEN;M01AE01;MANDAFEN;MANORFEN;MAXA-GESIC;MEDIPREN;MIDOL;MIDOL LIQUID GELS;MIGRAFEN;MOTRIN;MOTRIN IB;MOTRIN MIGRAINE PAIN;NOVAPRIN;NSC-256857;NUPRIN;NUROFEN 400;NUROFEN BACK PAIN SR;NUROFEN CHILD;NUROFEN FOR CHILD;NUROFEN PLUS;NUROFEN RECOVERY;NUROFEN SINUS;NUROFEN SOLB;ORBIFEN;PACIFENE;PAXOFEN;PEDEA;PEDIATRIC ADVIL;PHENSIC;PHOR PAIN;PHORPAIN;PHORPAIN MAX STRGH;PROFEN;PROFLEX;PROFLEX SR;RD 13621;RELCOFEN;RIMAFEN;RUFEN;SECLODIN;SUSPREN;TAB-PROFEN;U-18,573;U-18573",CHEMBL521,BRD:BRD-A17655518-001-24-4;BRD:BRD-BRD-A17655518-001-24-4,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"HEADACHE, MUSCLE PAIN, RHEUMATOID ARTHRITIS, BACKACHE, COMMON COLD, MENSTRUAL PAIN, FEVER, TOOTHACHE",,LAUNCHED,,Small molecule,4,"CC(C)Cc1ccc(C(C)C(=O)O)cc1;CC(C)CC1CCC(CC1)C(C)C(O)=O, CC(C)CC1CCC(CC1)C(C)C(O)=O",HEFNNWSXXWATRW-UHFFFAOYSA-N
IBUPROFEN-(S),IBUPROFEN-(S),,BRD:BRD-BRD-K14965640-001-12-4;BRD:BRD-K14965640-001-12-4,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,ASIC1;BCL2;CFTR;FABP2;PLAT;PPARG;PTGS1;PTGS2;SLC5A8;THBD,,,PRECLINICAL,,,NA,"CC(C)CC1CCC(CC1)[C@H](C)C(O)=O, CC(C)CC1CCC(CC1)[C@H](C)C(O)=O",
IBUPROFEN-PICONOL,IBUPROFEN-PICONOL,,BRD:BRD-A75224450-001-02-4;BRD:BRD-BRD-A75224450-001-02-4,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,LAUNCHED,,,NA,"CC(C)CC1CCC(CC1)C(C)C(=O)OCC1CCCCN1, CC(C)CC1CCC(CC1)C(C)C(=O)OCC1CCCCN1",
NSC-305528,IBUDROS;IBUPROXAM;NSC-305528,CHEMBL292707,BRD:BRD-A40940854-001-01-1;BRD:BRD-BRD-A40940854-001-01-1,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PROSTAGLANDIN INHIBITOR",ALOX5,"FEVER, JOINT INFLAMMATION, PAIN RELIEF",,LAUNCHED,,Small molecule,-1,CC(C)Cc1ccc(C(C)C(=O)NO)cc1;CC(C)CC1CCC(CC1)C(C)C(=O)NO,BYPIURIATSUHDW-UHFFFAOYSA-N
MK-677,"IBUTAMOREN;L-163,191;MK-677",CHEMBL13817,BRD:BRD-BRD-K44771174-066-01-0;BRD:BRD-K44771174-066-01-0,rep_primary;rep_single_dose,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,GHR;GHSR,,,PHASE 2,,Small molecule,2,"CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12;CC(C)(N)C(=O)N[C@H](COCC1CCCCC1)C(=O)N1CCC2(CN(C3CCCCC23)S(C)(=O)=O)CC1, CC(C)(N)C(=O)N[C@H](COCC1CCCCC1)C(=O)N1CCC2(CN(C3CCCCC23)S(C)(=O)=O)CC1",UMUPQWIGCOZEOY-JOCHJYFZSA-N
IBUTILIDE,IBUTILIDE,CHEMBL533,BRD:BRD-A74391928-051-01-3;BRD:BRD-A74391928-051-02-1;BRD:BRD-BRD-A74391928-051-01-3;BRD:BRD-BRD-A74391928-051-02-1,rep_multi_dose;rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,CACNA1C;CACNA2D1;CACNB1;CACNG1;KCNH2;KCNH6;KCNH7;KCNJ11;KCNK1;KCNK6,ATRIAL FIBRILLATION (AF),,LAUNCHED,,Small molecule,4,"CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1;CCCCCCCN(CC)CCCC(O)C1CCC(NS(C)(=O)=O)CC1, CCCCCCCN(CC)CCCC(O)C1CCC(NS(C)(=O)=O)CC1, CCCCCCCN(CC)CCCC(O)C1CCC(NS(C)(=O)=O)CC1",ALOBUEHUHMBRLE-UHFFFAOYSA-N
IC-87114,IC-87114,,CTRP:55307;GDSC1:236,ctrp;gdsc,,,,,,,,NA,,
ICA-069673,ICA-069673,,BRD:BRD-K59839632-001-02-9,rep_single_dose,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,KCNQ2;KCNQ3,,,,,,NA,,
ICA-110381,ICA-110381,,BRD:BRD-K71686520-001-02-9,rep_single_dose,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,KCNQ2,,,,,,NA,,
ICA-121431,ICA-121431,,BRD:BRD-BRD-K03149601-001-02-6;BRD:BRD-K03149601-001-02-6,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN1A;SCN3A,,,PRECLINICAL,,,NA,O=C(NC1CCC(CC1)S(=O)(=O)NC1NCCS1)C(C1CCCCC1)C1CCCCC1,
ICARIIN,EPIMEDII HERBA ICARIIN;ICARIIN,CHEMBL553204,BRD:BRD-BRD-K65639003-001-09-0;BRD:BRD-K65639003-001-09-0,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A,,,PHASE 3,,Small molecule,3,"COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1;COC1CCC(CC1)-C1OC2C(CC=C(C)C)C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC(O)C2C(=O)C1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O, COC1CCC(CC1)-C1OC2C(CC=C(C)C)C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)CC(O)C2C(=O)C1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O",TZJALUIVHRYQQB-XLRXWWTNSA-N
SGN162,ICARITIN;SGN-162;SGN162,CHEMBL498485,BRD:BRD-BRD-K24476327-001-01-3;BRD:BRD-K24476327-001-01-3,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PDE5A,,,PHASE 2,,Small molecule,3,"COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2O)cc1;COC1CCC(CC1)-C1OC2C(CC=C(C)C)C(O)CC(O)C2C(=O)C1O, COC1CCC(CC1)-C1OC2C(CC=C(C)C)C(O)CC(O)C2C(=O)C1O",TUUXBSASAQJECY-UHFFFAOYSA-N
ICATIBANT-ACETATE,ICATIBANT-ACETATE,,BRD:BRD-BRD-K63772874-001-02-2;BRD:BRD-K63772874-001-02-2,rep_primary;rep_single_dose,BRADYKININ RECEPTOR ANTAGONIST,ANPEP;BDKRB2,ANGIOEDEMA,,LAUNCHED,,,NA,"N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1CCCS1)C(=O)N[C@@H](CO)C(=O)N1CC2CCCCC2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O, N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1CCCS1)C(=O)N[C@@H](CO)C(=O)N1CC2CCCCC2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O, N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1CCCS1)C(=O)N[C@@H](CO)C(=O)N1CC2CCCCC2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O",
ICG-001,ICG-001,,BRD:BRD-BRD-K94455792-001-01-8;BRD:BRD-K94455792-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,BETA-CATENIN INHIBITOR,CTNNB1,,,PRECLINICAL,,,NA,OC1CCC(C[C@H]2N3[C@H](CN(CC4CCCC5CCCCC45)C2=O)N(CCC3=O)C(=O)NCC2CCCCC2)CC1,
"ICI-118,551","ICI-118,551",,BRD:BRD-BRD-K74603273-003-01-1;BRD:BRD-K74603273-003-01-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB2;ADRB3,,,PHASE 2,,,NA,CC(C)N[C@@H](C)[C@H](O)COC1CCC(C)C2CCCC12,
ICI-162846,ICI-162846,,BRD:BRD-BRD-K11071038-001-01-7;BRD:BRD-K11071038-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,,,PHASE 1,,,NA,NC(=O)CCCCN1CCC(N1)\N=C(/N)NCC(F)(F)F,
ICI-169369,ICI-169369,,BRD:BRD-K00004569-001-01-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,,,,NA,,
NSC-759816,"(R)-BICALUTAMIDE;BICALUTAMIDE;CALUTIDE;CASODEX;COSUDEX;ICI 176,334;ICI 176334;ICI-176334;ICI176,334-1;KALUMID;NSC-759816",CHEMBL409;CHEMBL63560,GDSC1:150;GDSC1:1502,gdsc,,,,,,,Small molecule,4,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,LKJPYSCBVHEWIU-UHFFFAOYSA-N
"ICI-185,282","ICI-185,282",,BRD:BRD-BRD-K29133151-001-03-2;BRD:BRD-K29133151-001-03-2,rep_primary;rep_single_dose,THROMBOXANE RECEPTOR ANTAGONIST,,,,PHASE 1,,,NA,OC(=O)CCC\C=C/C[C@@H]1CO[C@@H](O[C@@H]1C1CCCCC1O)C(F)(F)F,
ICI-192605,ICI-192605,,BRD:BRD-BRD-K59433843-001-01-7;BRD:BRD-K59433843-001-01-7,rep_primary;rep_single_dose,THROMBOXANE RECEPTOR ANTAGONIST,TBXA2R,,,PHASE 2,,,NA,"OC(=O)CC\C=C/C[C@@H]1CO[C@@H](O[C@@H]1C1CCCCC1O)C1CCCCC1CL, OC(=O)CC\C=C/C[C@@H]1CO[C@@H](O[C@@H]1C1CCCCC1O)C1CCCCC1CL",
ICI-199441,"ICI-199,441;ICI-199441",CHEMBL38576,BRD:BRD-BRD-K73290745-003-02-6;BRD:BRD-K73290745-003-02-6,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,CYP2D6;OPRD1;OPRK1;OPRM1;UTS2R,,,PRECLINICAL,,Small molecule,NA,"CN([C@H](CN1CCCC1)C1CCCCC1)C(=O)CC1CCC(CL)C(CL)C1, CN([C@H](CN1CCCC1)C1CCCCC1)C(=O)CC1CCC(CL)C(CL)C1;CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H](CN1CCCC1)c1ccccc1",AEJOEPSMZCEYJN-HXUWFJFHSA-N
"ICI-215,001","ICI-215,001",,BRD:BRD-BRD-K52487250-003-01-2;BRD:BRD-K52487250-003-01-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB3,,,PRECLINICAL,,,NA,O[C@@H](CNCCOC1CCC(OCC(O)=O)CC1)COC1CCCCC1,
ICI-63197,ICI-63197,,BRD:BRD-BRD-K52219182-001-02-4;BRD:BRD-K52219182-001-02-4,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,PRECLINICAL,,,NA,"CCCN1C2NC(N)NN2CC(C)C1=O, CCCN1C2NC(N)NN2CC(C)C1=O",
ICI-89406,ICI-89406,CHEMBL11268,BRD:BRD-A03359064-001-02-3;BRD:BRD-BRD-A03359064-001-02-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,,,PHASE 1,,Small molecule,NA,N#Cc1ccccc1OCC(O)CNCCNC(=O)Nc1ccccc1;OC(CNCCNC(=O)NC1CCCCC1)COC1CCCCC1C#N,HTLWRKRZKFAAAH-UHFFFAOYSA-N
ICL1100013,ICL1100013,,GDSC1:1266,gdsc,,,,,,,,NA,,
RO-482622,AR-100;ICLAPRIM;RO 48-2622;RO-48-2622;RO-482622,CHEMBL134561,BRD:BRD-K00003415-001-01-9,rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,,,,,,Small molecule,3,COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)OC(C1CC1)C=C2,HWJPWWYTGBZDEG-UHFFFAOYSA-N
ICOMUCRET,15(S)-HETE;AL-12959;ICOMUCRET,CHEMBL594621,BRD:BRD-BRD-K41234004-001-03-1;BRD:BRD-K41234004-001-03-1,rep_primary;rep_single_dose,MUCIN PRODUCTION ENHANCER,LTB4R2,,,PHASE 3,,Small molecule,-1,CCCCC[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O;CCCCC[C@H](O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O,JSFATNQSLKRBCI-VAEKSGALSA-N
TIMNODONIC ACID,ALL-CIS-FATTY ACID 20:5 OMEGA-3;C20:5 (N-3);EICOSAPENTAENOATE;EICOSAPENTAENOIC ACID;EICOSAPENTAENOIC ACID (C20:5 N3);EPA 45G;ICOSAPENT;INCROMEGA E 7010SR;OMEGA-3 MARINE TRIGLYCERIDES;ROPUFA 70;TIMNODONIC ACID,CHEMBL460026,BRD:BRD-BRD-K47192521-001-05-4;BRD:BRD-K47192521-001-05-4,rep_primary;rep_single_dose,PLATELET AGGREGATION INHIBITOR,ACSL3;ACSL4;FADS1;FFAR1;PPARD;PPARG;PTGS1;PTGS2;SLC8A1;TRPV1,HYPERTRIGLYCERIDEMIA,,LAUNCHED,,Small molecule,3,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O;CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N
ICOTINIB,BPI-2009;BPI-2009H;ICOTINIB,CHEMBL2087361,BRD:BRD-BRD-K31698212-001-02-9;BRD:BRD-K31698212-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,,Small molecule,3,C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1;C#CC1CCCC(NC2NCNC3CC4OCCOCCOCCOC4CC23)C1,QQLKULDARVNMAL-UHFFFAOYSA-N
ICRT-14,ICRT-14,,BRD:BRD-K18634484-001-02-9,rep_single_dose,"BETA CATENIN INHIBITOR, WNT SIGNALING INHIBITOR",CTNNB1;TCF4,,,,,,NA,,
ID-1101,ID-1101,,BRD:BRD-BRD-K90305467-001-01-3;BRD:BRD-K90305467-001-01-3,rep_primary;rep_single_dose,INSULIN SENSITIZER,INS,,,PHASE 1,,,NA,C[C@H](O)[C@H](C)[C@H](N)C(O)=O,
ID-8,ID-8,,BRD:BRD-BRD-K39166528-001-01-0;BRD:BRD-K39166528-001-01-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"COC1CCC(CC1)-N1C(C)C([N+]([O-])=O)C2CCC(O)CC12, COC1CCC(CC1)-N1C(C)C([N+]([O-])=O)C2CCC(O)CC12",
SGS518,IDALOPIRDINE;LU AE-58054;LU AE58054;LU-AE-58054;LU-AE58054;LY-483518;LY483518;SGS-518;SGS518,CHEMBL3286580,BRD:BRD-BRD-K79102359-003-01-6;BRD:BRD-K79102359-003-01-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR6,,,PHASE 3,,Small molecule,3,FC(F)C(F)(F)COC1CCCC(CNCCC2C[NH]C3CC(F)CCC23)C1;Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1,YBAWYTYNMZWMMJ-UHFFFAOYSA-N
IDARUBICIN,IDAMYCIN;IDARUBICIN,CHEMBL1117,BRD:BRD-BRD-K69650333-003-13-2;BRD:BRD-BRD-K69650333-003-14-0;BRD:BRD-K69650333-003-13-2;BRD:BRD-K69650333-003-14-0,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A,ACUTE MYELOID LEUKEMIA (AML),,LAUNCHED,,Small molecule,4,"C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2C(O)C3C(=O)C4CCCCC4C(=O)C3C(O)C12)C(C)=O, C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2C(O)C3C(=O)C4CCCCC4C(=O)C3C(O)C12)C(C)=O;CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O",XDXDZDZNSLXDNA-TZNDIEGXSA-N
RO5503781,IDASANUTLIN;RG-7388;RG7388;RO-5503781;RO5503781,CHEMBL2402737,BRD:BRD-BRD-K62627508-001-01-5;BRD:BRD-K62627508-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,MDM INHIBITOR,MDM2;TP53,,,PHASE 3,,Small molecule,3,COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F;COC1CC(CCC1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]1C1CCCC(CL)C1F)C1CCC(CL)CC1F)C(O)=O,TVTXCJFHQKSQQM-LJQIRTBHSA-N
RX-781094,DL-IDAZOXAN;IDAZOXAN;NSC-759867;RACEMIC IDAZOXAN;RX-781094,CHEMBL10316,BRD:BRD-A18696154-003-22-6;BRD:BRD-BRD-A18696154-003-22-6,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A;PTGS2,,,PHASE 3,"Multiple values for repurposing_target: {'ADRA2A;PTGS2', 'ADRA2A'}, taking the union",Small molecule,3,"c1ccc2c(c1)OCC(C1=NCCN1)O2;C1CN=C(N1)C1COC2CCCCC2O1, C1CN=C(N1)C1COC2CCCCC2O1",HPMRFMKYPGXPEP-UHFFFAOYSA-N
IDAZOXANE,IDAZOXANE,,BRD:BRD-BRD-K70759443-001-01-4;BRD:BRD-K70759443-001-01-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A;ADRA2B;ADRA2C,,,PRECLINICAL,,,NA,C1CNC(N1)=C1COC2CCCCC2O1,
SOVRIMA,HYDROXYDECYL UBIQUINONE;IDEBENONE;NSC-759228;ORISTAR HDU;RAXONE;SOVRIMA,CHEMBL252556,BRD:BRD-BRD-K37516142-001-10-5;BRD:BRD-K37516142-001-10-5,rep_primary;rep_single_dose,CALCIUM CHANNEL MODULATOR,,"ALZHEIMER'S DISEASE, FRIEDREICH'S ATAXIA, LEBER HEREDITARY OPTIC NEUROPATHY (LHON)",,LAUNCHED,,Small molecule,4,"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O;COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O, COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O, COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O",JGPMMRGNQUBGND-UHFFFAOYSA-N
ZYDELIG,CAL-101;GS-1101;GS-11CAL-101;IDELALISIB;ZYDELIG,CHEMBL2216870,BRD:BRD-BRD-K60866521-001-07-1;BRD:BRD-K60866521-001-07-1;GDSC1:238,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CB;PIK3CD;PIK3CG,CHRONIC LYMPHOCYTIC LEUKEMIA (CLL),,LAUNCHED,,Small molecule,4,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1;CC[C@H](NC1NCNC2[NH]CNC12)C1NC2CCCC(F)C2C(=O)N1-C1CCCCC1,IFSDAJWBUCMOAH-HNNXBMFYSA-N
IDF-11774,IDF-11774,,BRD:BRD-K00003098-001-01-9,rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,,,,,,,NA,,
IDH-305,IDH-305,,BRD:BRD-K00003457-001-01-9,rep_single_dose,ISOCITRATE DEHYDROGENASE INHIBITOR,,,,,,,NA,,
IDH-C35,IDH-C35,,GDSC2:1913,gdsc,,,,,,,,NA,,
IDO1-IN-5,IDO1-IN-5,,BRD:BRD-K00091266-001-01-9,rep_single_dose,,,,,,,,NA,,
IDO5L,IDO5L,,BRD:BRD-BRD-K22356203-001-01-8;BRD:BRD-K22356203-001-01-8,rep_primary;rep_single_dose,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",IDO1,,,PRECLINICAL,,,NA,NC1NONC1\C(NO)=N/C1CCC(F)C(CL)C1,
STOXIL,5-IUDR;5IUDR;ALLERGAN 211;ALLERGAN-211;DENDRID;HERPLEX;IDOX;IDOXURIDINE;IDOXURIDINUM;IDU;JODDEOXIURIDIN;KERECID;NSC-39661;OPHTHALMADINE;SK&F 14287;SK&F-14287;STOXIL,CHEMBL788,BRD:BRD-BRD-K76634210-001-12-1;BRD:BRD-BRD-K76634210-001-14-7;BRD:BRD-K76634210-001-12-1;BRD:BRD-K76634210-001-14-7,rep_multi_dose;rep_primary;rep_single_dose,"DNA DIRECTED DNA POLYMERASE INHIBITOR, DNA SYNTHESIS INHIBITOR",,VIRUS HERPES SIMPLEX (HSV),,LAUNCHED,"Multiple values for MOA: {'DNA DIRECTED DNA POLYMERASE INHIBITOR, DNA SYNTHESIS INHIBITOR', 'DNA DIRECTED DNA POLYMERASE INHIBITOR'}, defaulting to 'DNA DIRECTED DNA POLYMERASE INHIBITOR, DNA SYNTHESIS INHIBITOR'",Small molecule,4,"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I;OC[C@H]1O[C@H](C[C@@H]1O)N1CC(I)C(=O)[NH]C1=O, OC[C@H]1O[C@H](C[C@@H]1O)N1CC(I)C(=O)[NH]C1=O",XQFRJNBWHJMXHO-RRKCRQDMSA-N
IDRA-21,IDRA-21,,BRD:BRD-A14344385-001-03-2;BRD:BRD-BRD-A14344385-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRIA1;GRIA2;GRIA3;GRIA4,,,PRECLINICAL,,,NA,"CC1NC2CCC(CL)CC2S(=O)(=O)N1, CC1NC2CCC(CL)CC2S(=O)(=O)N1",
PHENOXODIOL,DEHYDROEQUOL;IDRONOXIL;NV-06;PHENOXODIOL,CHEMBL1957038,BRD:BRD-BRD-K74671368-001-01-8;BRD:BRD-K74671368-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,XIAP INHIBITOR,ENOX2;SPHK1,,,PHASE 3,,Small molecule,1,Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1;OC1CCC(CC1)C1=CC2CCC(O)CC2OC1,ZZUBHVMHNVYXRR-UHFFFAOYSA-N
IEM1460,IEM1460,,BRD:BRD-BRD-K13829090-303-02-9;BRD:BRD-K13829090-303-02-9,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA2,,,PRECLINICAL,,,NA,"C[N+](C)(C)CCCCCNCC12CC3CC(CC(C3)C1)C2, C[N+](C)(C)CCCCCNCC12CC3CC(CC(C3)C1)C2",
IEM1754,IEM1754,,BRD:BRD-BRD-K80060353-303-03-9;BRD:BRD-K80060353-303-03-9,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1,,,PRECLINICAL,,,NA,"NCCCCCNCC12CC3CC(CC(C3)C1)C2, NCCCCCNCC12CC3CC(CC(C3)C1)C2",
VADILEX,IFENPRODIL;IFENPRODIL HEMITARTRATE;IFENPRODIL TARTRATE;NP-120;RC 61-91;RC-61-91;VADILEX,CHEMBL305187,BRD:BRD-A24191444-046-02-1;BRD:BRD-A24191444-046-03-9;BRD:BRD-BRD-A24191444-046-02-1;BRD:BRD-BRD-A24191444-046-03-9,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, GLUTAMATE RECEPTOR ANTAGONIST",GRIN1;GRIN2B,,,LAUNCHED,,Small molecule,4,"CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1;CC(C(O)C1CCC(O)CC1)N1CCC(CC2CCCCC2)CC1, CC(C(O)C1CCC(O)CC1)N1CCC(CC2CCCCC2)CC1, CC(C(O)C1CCC(O)CC1)N1CCC(CC2CCCCC2)CC1, CC(C(O)C1CCC(O)CC1)N1CCC(CC2CCCCC2)CC1",UYNVMODNBIQBMV-UHFFFAOYSA-N
Z4942,IFEX;IFOSFAMIDE;IFSOFAMIDE;ISOCYCLOPHOSPHAMIDE;ISOPHOSPHAMIDE;MITOXANA;MJF 9325;MJF-9325;NSC-109724;Z-4942;Z4942,CHEMBL1024,BRD:BRD-A67097164-001-18-7;BRD:BRD-BRD-A67097164-001-18-7;CTRP:35319,ctrp;rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,CYP2A6;CYP2B6;CYP2C18;CYP2C19;CYP2C8;CYP2C9;CYP3A4;CYP3A5;CYP3A7;PTGS1,"TESTICULAR CARCINOMA, HEMORRHAGIC CYSTITIS",,LAUNCHED,,Small molecule,4,"CLCCNP1(=O)OCCCN1CCCL, CLCCNP1(=O)OCCCN1CCCL;O=P1(NCCCl)OCCCN1CCCl",HOMGKSMUEGBAAB-UHFFFAOYSA-N
IGMESINE,IGMESINE,CHEMBL2110660,BRD:BRD-A48376327-003-01-5;BRD:BRD-BRD-A48376327-003-01-5,rep_primary;rep_single_dose,SIGMA RECEPTOR AGONIST,SIGMAR1,,,PHASE 2,,Small molecule,-1,CCC(C/C=C/c1ccccc1)(c1ccccc1)N(C)CC1CC1;CCC(C\C=C\C1CCCCC1)(N(C)CC1CC1)C1CCCCC1,VCZSWYIFCKGTJI-JLHYYAGUSA-N
T-614,CARERAM;IGURATIMOD;KOLBET;T-614,CHEMBL2107455,BRD:BRD-BRD-K15426076-001-01-2;BRD:BRD-K15426076-001-01-2,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, NFKB PATHWAY INHIBITOR",PTGS2,RHEUMATOID ARTHRITIS,,LAUNCHED,,Small molecule,3,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1;CS(=O)(=O)NC1CC2OCC(NC=O)C(=O)C2CC1OC1CCCCC1,ANMATWQYLIFGOK-UHFFFAOYSA-N
IKK INHIBITOR 3,BMS345541;IKK INHIBITOR 3,,GDSC1:203,gdsc,,,,,,,,NA,,
IKK-16,IKK-16,,BRD:BRD-BRD-K14618467-001-04-6;BRD:BRD-K14618467-001-04-6,rep_multi_dose;rep_primary;rep_single_dose,IKK INHIBITOR,IKBKB,,,PRECLINICAL,,,NA,"O=C(N1CCC(CC1)N1CCCC1)C1CCC(NC2NCCC(N2)-C2CC3CCCCC3S2)CC1, O=C(N1CCC(CC1)N1CCCC1)C1CCC(NC2NCCC(N2)-C2CC3CCCCC3S2)CC1, O=C(N1CCC(CC1)N1CCCC1)C1CCC(NC2NCCC(N2)-C2CC3CCCCC3S2)CC1",
IKK-2-INHIBITOR,IKK-2-INHIBITOR,,BRD:BRD-BRD-K26373640-001-05-1;BRD:BRD-K26373640-001-05-1,rep_primary;rep_single_dose,"IKK INHIBITOR, SYK INHIBITOR",IKBKB,,,PRECLINICAL,,,NA,"NC(=O)C1SC(CC1N)-C1CCSC1, NC(=O)C1SC(CC1N)-C1CCSC1, NC(=O)C1SC(CC1N)-C1CCSC1",
IKK-2-INHIBITOR-V,IKK-2-INHIBITOR-V,,BRD:BRD-BRD-K74305673-001-06-2;BRD:BRD-K74305673-001-06-2,rep_multi_dose;rep_primary;rep_single_dose,"IKK INHIBITOR, NFKB PATHWAY INHIBITOR",IKBKB,,,PHASE 1,,,NA,"OC1CCC(CL)CC1C(=O)NC1CC(CC(C1)C(F)(F)F)C(F)(F)F, OC1CCC(CL)CC1C(=O)NC1CC(CC(C1)C(F)(F)F)C(F)(F)F",
NOLTEC,ILAPRAZOLE;NOLTEC,CHEMBL2106370,BRD:BRD-K00003427-001-01-9,rep_single_dose,PROTON PUMP INHIBITOR,,,,,,Small molecule,3,COc1ccnc(C[S+]([O-])c2nc3cc(-n4cccc4)ccc3[nH]2)c1C,HRRXCXABAPSOCP-UHFFFAOYSA-N
ILEPCIMIDE,ANTIEPILEPSIRINE;ILEPCIMIDE,CHEMBL118478,BRD:BRD-BRD-K43873574-001-01-8;BRD:BRD-K43873574-001-01-8,rep_primary;rep_single_dose,ANTICONVULSANT,,,,PHASE 3,,Small molecule,-1,O=C(/C=C/c1ccc2c(c1)OCO2)N1CCCCC1;O=C(C=CC1CCC2OCOC2C1)N1CCCCC1,BLPUOQGPBJPXRL-FNORWQNLSA-N
ILOMASTAT,GALARDIN;GM6001;ILOMASTAT,CHEMBL19611,BRD:BRD-BRD-K51662849-001-05-4;BRD:BRD-BRD-K51662849-001-08-8;BRD:BRD-K51662849-001-05-4;BRD:BRD-K51662849-001-08-8,rep_multi_dose;rep_primary;rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,ACAN;ADAM28;MMP1;MMP12;MMP13;MMP14;MMP2;MMP3;MMP8;MMP9,,,PHASE 3,,Small molecule,-1,"CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(=O)NO)CC(C)C;CNC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC(C)C)CC(=O)NO, CNC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC(C)C)CC(=O)NO",NITYDPDXAAFEIT-DYVFJYSZSA-N
ILOPERIDONE,FANAPT;HP 873;HP-873;ILOPERIDONE,CHEMBL14376,BRD:BRD-BRD-K48722833-001-07-6;BRD:BRD-K48722833-001-07-6,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA2C;DRD1;DRD2;DRD3;DRD4;HRH1;HTR1A;HTR2A;HTR6;HTR7,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1;COC1CC(CCC1OCCCN1CCC(CC1)C1NOC2CC(F)CCC12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N
ILORASERTIB,A-968660;A-968660.0;ABBOTT-968660;ABT-348;ILORASERTIB,CHEMBL1980297,BRD:BRD-K00077460-001-02-9,rep_single_dose,,,,,,,Small molecule,2,Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,WPHKIQPVPYJNAX-UHFFFAOYSA-N
IM156,HL-156A;HL156A;HL271 ACETATE;IM-156;IM156,CHEMBL4650309,BRD:BRD-K00091083-015-01-9,rep_single_dose,,,,,,,Small molecule,1,CC(=O)O.N=C(NC(=N)N1CCCC1)Nc1ccc(OC(F)(F)F)cc1,AGFDCTOLSXWRDZ-UHFFFAOYSA-N
STI571,GLAMOX;GLEEVEC;GLIVEC;IMATINIB;IMATINIB (AS MESILATE);IMATINIB ACCORD;IMATINIB MEDAC;IMATINIB MESILATE;IMATINIB MESYLATE;IMATINIB METHANE SULFONATE;IMATINIB METHANESULFONATE;NSC-716051;NSC-743414;NSC-759854;QTI-571;QTI571;STI 571;STI-571;STI571,CHEMBL1642;CHEMBL941,BRD:BRD-BRD-K92723993-001-06-7;BRD:BRD-K92723993-001-06-7;BRD:BRD-K92723993-001-17-4;CTRP:345041;GDSC1:34,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",ABL1;CSF1R;DDR1;KIT;NTRK1;PDGFRA;PDGFRB;RET,"CHRONIC MYELOID LEUKEMIA (CML), ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), MYELODYSPLASTIC DISEASES (MDS), AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM), HYPEREOSINOPHILIC SYNDROME (HES), CHRONIC EOSINOPHILIC LEUKEMIA (CEL), DERMATOFIBROSARCOMA PROTUBERANS (DFSP), GASTROINTESTINAL STROMAL TUMORS (GIST)",,LAUNCHED,"Multiple values for MOA: {'BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR', 'INHIBITOR OF BCR-ABL1, PDGFRA, AND KIT'}, defaulting to 'BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR'
Multiple values for repurposing_target: {'ABL1;KIT;PDGFRA', 'ABL1;CSF1R;DDR1;KIT;NTRK1;PDGFRA;PDGFRB;RET'}, taking the union",Small molecule,4,"CN1CCN(CC2CCC(CC2)C(=O)NC2CCC(C)C(NC3NCCC(N3)-C3CCCNC3)C2)CC1, CN1CCN(CC2CCC(CC2)C(=O)NC2CCC(C)C(NC3NCCC(N3)-C3CCCNC3)C2)CC1, CN1CCN(CC2CCC(CC2)C(=O)NC2CCC(C)C(NC3NCCC(N3)-C3CCCNC3)C2)CC1;CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1",YLMAHDNUQAMNNX-UHFFFAOYSA-N
IMAZODAN,CI-914;IMAZODAN,CHEMBL12831,BRD:BRD-K96298462-001-08-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,-1,O=C1CCC(c2ccc(-n3ccnc3)cc2)=NN1,VXMYWVMXSWJFCV-UHFFFAOYSA-N
IMD-0354,IMD-0354,CHEMBL3545089,GDSC1:442,gdsc,,,,,,,Small molecule,1,,
IMEGLIMIN,EMD-387008;IMEGLIMIN,CHEMBL4297514,BRD:BRD-BRD-K55822903-003-01-8;BRD:BRD-K55822903-003-01-8,rep_primary;rep_single_dose,GLUCONEOGENESIS INHIBITOR,,,,PHASE 2,,Small molecule,2,"C[C@@H]1N=C(N)NC(=N1)N(C)C, C[C@@H]1N=C(N)NC(=N1)N(C)C;C[C@H]1N=C(N(C)C)N=C(N)N1",GFICWFZTBXUVIG-SCSAIBSYSA-N
IMETIT,IMETIT,CHEMBL19439,BRD:BRD-BRD-K33183200-303-02-4;BRD:BRD-K33183200-303-02-4,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH3;HRH4,,,PRECLINICAL,,Small molecule,NA,N=C(N)SCCc1c[nH]cn1;NC(=N)SCCC1C[NH]CN1,PEHSVUKQDJULKE-UHFFFAOYSA-N
NSC-313425,AMPLIMEXON;IMEXON;NSC-313425,CHEMBL146428,BRD:BRD-A78195072-001-06-2;BRD:BRD-BRD-A78195072-001-06-2,rep_primary;rep_single_dose,"APOPTOSIS STIMULANT, RIBONUCLEOTIDE REDUCTASE INHIBITOR",RRM1;RRM2,,,PHASE 2,,Small molecule,2,N=C1NC(=O)N2CC12,BIXBBIPTYBJTRY-UHFFFAOYSA-N
WP-697,4'-EPI-ADRIAMYCIN;ELLENCE;EPIADRIAMYCIN;EPIDOXORUBICIN;EPIRUBICIN;EPIRUBICIN HCL;EPIRUBICIN HYDROCHLORIDE;FARMORUBICIN;FARMORUBICINA;IMI-28;NSC-256942;NSC-759195;PHARMORUBICIN;WP-697,CHEMBL1200981;CHEMBL417,GDSC2:1511,gdsc,,,,,,,Small molecule,4,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.Cl,MWWSFMDVAYGXBV-FGBSZODSSA-N
IMIDACLOPRID,IMIDACLOPRID,CHEMBL406819,BRD:BRD-BRD-K76609936-001-08-4;BRD:BRD-K76609936-001-08-4,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRFAM7A,,,LAUNCHED,,Small molecule,NA,[O-][N+](=O)NC1=NCCN1CC1CCC(CL)NC1;O=[N+]([O-])/N=C1\NCCN1Cc1ccc(Cl)nc1,YWTYJOPNNQFBPC-UHFFFAOYSA-N
URITOS,IMIDAFENACIN;KRP-197;ONO-8025;STAYBLA;URITOS,CHEMBL53366,BRD:BRD-BRD-K29626940-001-01-5;BRD:BRD-K29626940-001-01-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM3,"SPASMS, SPASMS",,LAUNCHED,,Small molecule,3,"Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1;CC1NCCN1CCC(C(N)=O)(C1CCCCC1)C1CCCCC1, CC1NCCN1CCC(C(N)=O)(C1CCCCC1)C1CCCCC1",SQKXYSGRELMAAU-UHFFFAOYSA-N
TANATRIL,HIPERTENE;IMIDAPRIL;IMIDAPRIL HCL;IMIDAPRIL HYDROCHLORIDE;IMIDAPRIL MONOHYDROCHLORIDE;TA 6366;TA-6366;TANATRIL,CHEMBL317094,BRD:BRD-BRD-K34332569-001-01-3;BRD:BRD-K34332569-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1[C@H](CN(C)C1=O)C(O)=O;CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O,KLZWOWYOHUKJIG-BPUTZDHNSA-N
IMIDAZOACRIDINONE,IMIDAZOACRIDINONE,,BRD:BRD-K00004617-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,,NA,,
IMIDUREA,IMIDAZOLIDINYL UREA;IMIDUREA,CHEMBL65433,BRD:BRD-K00003682-001-01-9,rep_single_dose,OTHER ANTIBIOTIC,,,,,,Small molecule,-1,O=C(NCNC(=O)NC1C(=O)NC(=O)N1CO)NC1C(=O)NC(=O)N1CO,ZCTXEAQXZGPWFG-UHFFFAOYSA-N
IMILOXAN,IMILOXAN,CHEMBL347695,BRD:BRD-A10903566-003-07-7;BRD:BRD-BRD-A10903566-003-07-7,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A;ADRA2B,,,PHASE 1,,Small molecule,-1,CCn1ccnc1CC1COc2ccccc2O1;CCN1CCNC1CC1COC2CCCCC2O1,UXABARREKCJULM-UHFFFAOYSA-N
TRIMIPRAMINE MALEATE IMPURITY,ANTIDEPRIN;BERKOMINE;CRISTALIA;DEMETHYL-;DESIPRAMINE;IMIPRAMINE;IMIPRAMINE-;JANIMINE;MELIPRAMINE;MONODEMETHYLIMIPRAMINE;N-DESMETHYLIMIPRAMINE;NORIMIPRAMINE;NSC-169866;ORG-2463;PRAMINE;PRESAMINE;SERMONIL;TOFRANIL;TOFRANIL-PM;TRIMIPRAMINE MALEATE IMPURITY,CHEMBL11;CHEMBL72,BRD:BRD-BRD-K38436528-003-26-1;BRD:BRD-K38436528-003-26-1,rep_primary;rep_single_dose,"NOREPINEPHRINE REPUTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",ADRA1A;ADRA1B;ADRA1D;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD5;HRH1;HTR1A;HTR2A;HTR2C;HTR6;HTR7;KCND2;KCND3;KCNH1;KCNH2;SLC6A2;SLC6A3;SLC6A4,"DEPRESSION, NOCTURNAL ENURESIS",,LAUNCHED,,Small molecule,4,"CN(C)CCCN1C2CCCCC2CCC2CCCCC12, CN(C)CCCN1C2CCCCC2CCC2CCCCC12, CN(C)CCCN1C2CCCCC2CCC2CCCCC12;CN(C)CCCN1c2ccccc2CCc2ccccc21",BCGWQEUPMDMJNV-UHFFFAOYSA-N
ZYCLARA,ALDARA;IMIQUIMOD;NSC-369100;NSC-759651;R-837;S-26308;S26308;TMX-101;ZYCLARA,CHEMBL1282,BRD:BRD-BRD-K26657438-001-15-2;BRD:BRD-K26657438-001-15-2,rep_multi_dose;rep_primary;rep_single_dose,"INTERFERON INDUCER, TOLL-LIKE RECEPTOR AGONIST",TLR7;TLR8,"ACTINIC KERATOSIS (AK), GENITAL WARTS, BASAL CELL CARCINOMA (BCC)",,LAUNCHED,,Small molecule,4,"CC(C)CN1CNC2C(N)NC3CCCCC3C12, CC(C)CN1CNC2C(N)NC3CCCCC3C12, CC(C)CN1CNC2C(N)NC3CCCCC3C12;CC(C)Cn1cnc2c(N)nc3ccccc3c21",DOUYETYNHWVLEO-UHFFFAOYSA-N
IMIRESTAT,AL-1576;HOE 843;HOE-843;IMIRESTAT,CHEMBL269455,BRD:BRD-K00003208-001-01-9,rep_single_dose,ALDOSE REDUCTASE INHIBITOR,,,,,,Small molecule,-1,O=C1NC(=O)C2(N1)c1cc(F)ccc1-c1ccc(F)cc12,QCCHBHSAIQIQGO-UHFFFAOYSA-N
IMISOPASEM-MANGANESE,IMISOPASEM-MANGANESE,,BRD:BRD-K00003154-001-01-9,rep_single_dose,SUPEROXIDE DISMUTASE MIMETIC,,,,,,,NA,,
IMMEPIP,IMMEPIP,CHEMBL18661,BRD:BRD-BRD-K25906698-303-02-7;BRD:BRD-K25906698-303-02-7,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH3;HRH4,,,PRECLINICAL,,Small molecule,NA,C(C1CCNCC1)C1C[NH]CN1;c1nc(CC2CCNCC2)c[nH]1,MCNGUYXRBCIGOV-UHFFFAOYSA-N
IMMETHRIDINE,IMMETHRIDINE,CHEMBL82298,BRD:BRD-BRD-K49519092-303-03-0;BRD:BRD-K49519092-303-03-0,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH3,,,PHASE 1,,Small molecule,NA,"C(C1CNC[NH]1)C1CCNCC1, C(C1CNC[NH]1)C1CCNCC1;c1cc(Cc2cnc[nH]2)ccn1",DFVSGZHJSIEEQQ-UHFFFAOYSA-N
IMPENTAMINE,IMPENTAMINE,CHEMBL417096,BRD:BRD-K20049318-303-03-9,rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH3,,,,,Small molecule,NA,NCCCCCc1c[nH]cn1,MZCJWLAXZRFUPI-UHFFFAOYSA-N
IMPORTAZOLE,IMPORTAZOLE,,CTRP:46792,ctrp,,,,,,,,NA,,
IMRECOXIB,BAP-909;IMRECOXIB,CHEMBL504535,BRD:BRD-K00074641-001-02-9,rep_single_dose,,,,,,,Small molecule,1,CCCN1CC(c2ccc(S(C)(=O)=O)cc2)=C(c2ccc(C)cc2)C1=O,AXMZZGKKZDJGAZ-UHFFFAOYSA-N
IMREG-1,IMREG-1,,BRD:BRD-BRD-K00926464-001-01-8;BRD:BRD-K00926464-001-01-8,rep_primary;rep_single_dose,,,,,PHASE 3,,,NA,N[C@@H](CC1CCC(O)CC1)C(=O)NCC(=O)NCC(O)=O,
SB-40,INARIGIVIR;ORI-9020;SB-40,CHEMBL1084430,BRD:BRD-K00003532-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,2,CO[C@@H]1[C@H](OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)C[C@@H]2O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O,LYMICVBGNUEHGE-FUQPUAIBSA-N
INARIGIVIR-SOPROXIL,INARIGIVIR-SOPROXIL,,BRD:BRD-K00004751-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,,NA,,
RUXOLITINIB,INC-424;INC424;INCB-018424;INCB-18424;INCB018424;JAKAVI;RUXOLITINIB,CHEMBL1789941,BRD:BRD-BRD-K53972329-001-07-0;BRD:BRD-K53972329-001-07-0;BRD:BRD-K53972329-001-09-6;CTRP:639450;GDSC1:206;GDSC2:1507,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF JAK1 AND JAK2,JAK1;JAK2;JAK3;TYK2,"MYELOFIBROSIS, POLYCYTHEMIA VERA",,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF JAK1 AND JAK2', 'JAK INHIBITOR'}, defaulting to 'INHIBITOR OF JAK1 AND JAK2'
Multiple values for repurposing_target: {'JAK1;JAK2;JAK3;TYK2', 'JAK1;JAK2'}, taking the union",Small molecule,4,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1;N#CC[C@H](C1CCCC1)N1CC(CN1)-C1NCNC2[NH]CCC12,HFNKQEVNSGCOJV-OAHLLOKOSA-N
INCB-003284,INCB-003284,,BRD:BRD-BRD-K28059174-334-01-2;BRD:BRD-K28059174-334-01-2,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,PHASE 2,,,NA,COC1CCC(CN1)C1(O)CCC(CC1)N1CC[C@H](C1)NC(=O)CNC(=O)C1CCCC(C1)C(F)(F)F,
INCB057643,INCB-057643;INCB057643,CHEMBL4594412,BRD:BRD-K00003102-001-01-9,rep_single_dose,BROMODOMAIN INHIBITOR,,,,,,Small molecule,1,CN1C(=O)C(C)(C)Oc2c(-c3cn(C)c(=O)c4[nH]ccc34)cc(S(C)(=O)=O)cc21,VZSAMEOETVNDQH-UHFFFAOYSA-N
INCB-3284,INCB-3284,,BRD:BRD-BRD-K67628093-001-01-9;BRD:BRD-K67628093-001-01-9,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR2,,,PHASE 2,,,NA,COC1CCC(CN1)[C@]1(O)CC[C@@H](CC1)N1CC[C@H](C1)NC(=O)CNC(=O)C1CCCC(C1)C(F)(F)F,
PEMIGATINIB,FGFR INHIBITOR INCB054828;INCB-054828;INCB054828;PEMAZYRE;PEMIGATINIB,CHEMBL4297522,BRD:BRD-K00104124-001-01-9;BRD:BRD-U00115287-001-01-9,oncref_1;rep_single_dose,"INHIBITOR OF FGFR1, FGFR2, AND FGFR3",FGFR1;FGFR2;FGFR3,,,,"Multiple values for structure_id: {'K00104124', 'U00115287'}, defaulting to None",Small molecule,4,CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3[nH]c(CN4CCOCC4)cc3c21,HCDMJFOHIXMBOV-UHFFFAOYSA-N
NSC-683551,COL-3;INCYCLINIDE;METASTAT;NSC-683551,CHEMBL2104970,BRD:BRD-K00003344-001-01-9,rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,,,,,,Small molecule,2,NC(=O)C1=C(O)C[C@@H]2C[C@@H]3Cc4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C1=O,ZXFCRFYULUUSDW-OWXODZSWSA-N
QABI49,INDACATEROL;INDACTEROL;ONBREZ;QAB-149;QAB149;QABI49,CHEMBL1095777,BRD:BRD-BRD-K89208535-051-01-5;BRD:BRD-K89208535-051-01-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),,LAUNCHED,,Small molecule,4,CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2;CCC1CC2CC(CC2CC1CC)NC[C@H](O)C1CCC(O)C2[NH]C(=O)CCC12,QZZUEBNBZAPZLX-QFIPXVFZSA-N
LM-5008,INDALPINE;LM-5008,CHEMBL276520,BRD:BRD-BRD-K64973364-001-01-4;BRD:BRD-K64973364-001-01-4,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),SLC6A4,,,WITHDRAWN,,Small molecule,4,C(CC1C[NH]C2CCCCC12)C1CCNCC1;c1ccc2c(CCC3CCNCC3)c[nH]c2c1,SADQVAVFGNTEOD-UHFFFAOYSA-N
VEROXIL,ARIFON;BAJATEN;CARDIDE SR;DAMIDE;ETHIBIDE XL;FLUBEST;FLUDEX;FLUDIN;FLUPAMID;INDAFLEX;INDAMIDE;INDAMOL;INDAPAMIDE;INDAXA 2.5;INDIPAM XL;IPAMIX;KYD-041;LORVAS;LOZOL;MAPEMID XL;NATRILIX;NATRILIX SR;NATRIX;NINDAXA 2.5;NORANAT;NSC-757075;OPUMIDE 2.5;RAWEL XL;S-1520;SE-1520;TANDIX;TENSAID XL;TERTENSIF;VARBIM XL;VEROXIL,CHEMBL406,BRD:BRD-A95869247-001-26-9;BRD:BRD-BRD-A95869247-001-26-9,rep_primary;rep_single_dose,THIAZIDE DIURETIC,CA2;HTR3A;KCNE1;KCNQ1;SLC12A3,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,"Multiple values for repurposing_target: {'KCNE1;KCNQ1;SLC12A3', 'CA2;HTR3A;KCNE1;KCNQ1;SLC12A3'}, taking the union",Small molecule,4,"CC1CC2CCCCC2N1NC(=O)C1CCC(CL)C(C1)S(N)(=O)=O, CC1CC2CCCCC2N1NC(=O)C1CCC(CL)C(C1)S(N)(=O)=O;CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1",NDDAHWYSQHTHNT-UHFFFAOYSA-N
INDATRALINE,INDATRALINE,CHEMBL296602,BRD:BRD-BRD-K01649396-003-07-1;BRD:BRD-K01649396-003-07-1,rep_primary;rep_single_dose,NOREPINEPHRINE TRANSPORTER INHIBITOR,MAOA;MAOB,,,PRECLINICAL,,Small molecule,-1,"CN[C@@H]1C[C@H](C2CCCCC12)C1CCC(CL)C(CL)C1, CN[C@@H]1C[C@H](C2CCCCC12)C1CCC(CL)C(CL)C1;CNC1CC(c2ccc(Cl)c(Cl)c2)c2ccccc21",SVFXPTLYMIXFRX-UHFFFAOYSA-N
PPM-204,INDEGLITAZAR;PPM-204,CHEMBL1232583,BRD:BRD-K00003177-001-01-9,rep_single_dose,PPAR RECEPTOR AGONIST,NCOA1;PPARA;PPARD;PPARG,,,,,Small molecule,2,COc1ccc(S(=O)(=O)n2cc(CCC(=O)O)c3cc(OC)ccc32)cc1,YMPALHOKRBVHOJ-UHFFFAOYSA-N
INDELOXAZINE,INDELOXAZINE,CHEMBL2105022,BRD:BRD-A59747053-003-01-3;BRD:BRD-BRD-A59747053-003-01-3,rep_primary;rep_single_dose,"NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",,,,WITHDRAWN,,Small molecule,-1,C(OC1CCCC2C=CCC12)C1CNCCO1;C1=Cc2cccc(OCC3CNCCO3)c2C1,MADRVGBADLFHMO-UHFFFAOYSA-N
ZIO-301,D-24851;INDIBULIN;ZIO-301,CHEMBL49642,BRD:BRD-BRD-K74057757-001-01-9;BRD:BRD-K74057757-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,PHASE 1/PHASE 2,,Small molecule,1,CLC1CCC(CN2CC(C(=O)C(=O)NC3CCNCC3)C3CCCCC23)CC1;O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12,SOLIIYNRSAWTSQ-UHFFFAOYSA-N
MK-639,CRIXIVAN;INDINAVIR;INDINAVIR ANHYDROUS;INDINAVIR MONOHYDRATE;INDINAVIR SYSTEM SUITABILITY;L-735524;MK-639,CHEMBL115,BRD:BRD-BRD-K33226500-001-01-0;BRD:BRD-K33226500-001-01-0,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,CYP3A4;CYP3A5;CYP3A7,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,CC(C)(C)NC(=O)[C@@H]1CN(CC2CCCNC2)CCN1C[C@@H](O)C[C@@H](CC1CCCCC1)C(=O)N[C@@H]1[C@H](O)CC2CCCCC12;CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,CBVCZFGXHXORBI-PXQQMZJSSA-N
NBI-34060,CALENTHYS;CL-285489;INDIPLON;NBI-34060,CHEMBL262075,BRD:BRD-BRD-K90948141-001-01-4;BRD:BRD-K90948141-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1,,,PHASE 3,,Small molecule,3,"CC(=O)N(C)c1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1;CN(C(C)=O)C1CCCC(C1)-C1CCNC2C(CNN12)C(=O)C1CCCS1, CN(C(C)=O)C1CCCC(C1)-C1CCNC2C(CNN12)C(=O)C1CCCS1",CBIAWPMZSFFRGN-UHFFFAOYSA-N
NSC-105327,C.I. 75790;COUROUPITINE B;INDIRUBIN;NSC-105327,CHEMBL1276127,BRD:BRD-BRD-K17894950-001-14-3;BRD:BRD-K17894950-001-14-3,rep_multi_dose;rep_primary;rep_single_dose,"CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",CDK1;CDK5;GSK3A,,,PHASE 2/PHASE 3,,Small molecule,2,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O;O=C1NC2CCCCC2\C1=C1\NC2CCCCC2C1=O,CRDNMYFJWFXOCH-YPKPFQOOSA-N
INDIRUBIN-3MONOXIME,INDIRUBIN-3-MONOXIME;INDIRUBIN-3-OXIME;INDIRUBIN-3'-MONOOXIME;INDIRUBIN-3'-OXIME;INDIRUBIN-3MONOXIME,CHEMBL126077,BRD:BRD-BRD-K19136521-001-08-9;BRD:BRD-K19136521-001-08-9,rep_primary;rep_single_dose,"CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",CDK1;CDK2;CDK5;CDK5R1;GSK3B,,,PRECLINICAL,,Small molecule,NA,O\N=C1C2CCCCC2NC/1=C1\C(=O)NC2CCCCC12;O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,FQCPPVRJPILDIK-UHFFFAOYSA-N
INDISULAM,E-7070;E7070;INDISULAM,CHEMBL77517,BRD:BRD-BRD-K17610631-001-03-3;BRD:BRD-K17610631-001-03-3;CTRP:411874,ctrp;rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CA1;CA12;CA14;CA2;CA6;CA7;CA9,,,PHASE 2,,Small molecule,2,NS(=O)(=O)C1CCC(CC1)S(=O)(=O)NC1CCCC2C(CL)C[NH]C12;NS(=O)(=O)c1ccc(S(=O)(=O)Nc2cccc3c(Cl)c[nH]c23)cc1,SETFNECMODOHTO-UHFFFAOYSA-N
INDIUM(III)-ISOPROPOXIDE,INDIUM(III)-ISOPROPOXIDE,,BRD:BRD-BRD-M08274809-001-01-7;BRD:BRD-M08274809-001-01-7,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,[IN].CC(C)O.CC(C)O.CC(C)O,
K-3920,IBUSTRIN;INDOBUFEN;K-2930;K-3920,CHEMBL1765292,BRD:BRD-A16296925-001-01-3;BRD:BRD-BRD-A16296925-001-01-3,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PLATELET AGGREGATION INHIBITOR",PTGS1;PTGS2,THROMBOSIS,,LAUNCHED,,Small molecule,3,CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1;CCC(C(O)=O)C1CCC(CC1)N1CC2CCCCC2C1=O,AYDXAULLCROVIT-UHFFFAOYSA-N
INDOCYANINE-GREEN,INDOCYANINE-GREEN,,BRD:BRD-BRD-K80762071-236-02-5;BRD:BRD-K80762071-236-02-5,rep_primary;rep_single_dose,CONTRAST AGENT,SLCO1B1,,,LAUNCHED,,,NA,"CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)C3CCC4CCCCC4C3C2(C)C)N(CCCCS(O)(=O)=O)C2CCC3CCCCC3C12, CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)C3CCC4CCCCC4C3C2(C)C)N(CCCCS(O)(=O)=O)C2CCC3CCCCC3C12, CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)C3CCC4CCCCC4C3C2(C)C)N(CCCCS(O)(=O)=O)C2CCC3CCCCC3C12",
NSC-525801,INDOLE 3-CARBINOL;INDOLE-3-CARBINOL;NSC-525801,CHEMBL155625,BRD:BRD-BRD-K01815685-001-15-5;BRD:BRD-K01815685-001-15-5,rep_primary;rep_single_dose,"ARYL HYDROCARBON RECEPTOR AGONIST, INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",AHR,,,PHASE 2/PHASE 3,,Small molecule,2,OCc1c[nH]c2ccccc12;OCC1C[NH]C2CCCCC12,IVYPNXXAYMYVSP-UHFFFAOYSA-N
TIVORBEX,ACONIP;ARTRACIN;ARTRACIN SR;BERLIND 75 RET;DURAMETACIN;FLEXIN-25 CONTINUS;FLEXIN-50 CONTINUS;FLEXIN-75 CONTINUS;IMBRILON;INDO-LEMMON;INDO-PAED;INDOCID RET;INDOCID-R;INDOCIN;INDOCIN SR;INDODERM;INDOFLEX;INDOLAR;INDOLAR SR;INDOMAX-25;INDOMAX-75 SR;INDOMETACIN;INDOMETACIN FARNESIL;INDOMETACINUM;INDOMETHACIN;INDOMOD;INDOPTOL;INDOTARD MR 75;LEDMECIN;MAXIMET SR;MOBILAN;NSC-757061;NSC-77541;PARDELPRIN MR;REUMACIDE;RHEUMACIN LA;RIMACID;SLO-INDO;TIVORBEX,CHEMBL6,BRD:BRD-BRD-K57222227-001-30-1;BRD:BRD-K57222227-001-30-1,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,GLO1;PLA2G2A;PPARA;PPARG;PTGDR2;PTGR2;PTGS1;PTGS2;SLC46A1,"RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, OSTEOARTHRITIS, BURSITIS, TENDINITIS",,LAUNCHED,,Small molecule,4,"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1;COC1CCC2N(C(=O)C3CCC(CL)CC3)C(C)C(CC(O)=O)C2C1, COC1CCC2N(C(=O)C3CCC(CL)CC3)C(C)C(CC(O)=O)C2C1, COC1CCC2N(C(=O)C3CCC(CL)CC3)C(C)C(CC(O)=O)C2C1",CGIGDMFJXJATDK-UHFFFAOYSA-N
REUMOFENE,BOR-IND;FLOSIN;FLOSINT;INDOPROFEN;ISINDONE;K 4277;K-4277;NSC-757065;PRAXIS;REUMOFENE,CHEMBL15870,BRD:BRD-A44090213-001-25-6;BRD:BRD-BRD-A44090213-001-25-6,rep_multi_dose;rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",CXCR1;CXCR2;PTGS1;PTGS2,,,WITHDRAWN,,Small molecule,4,CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1;CC(C(O)=O)C1CCC(CC1)N1CC2CCCCC2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N
WY-21901,BARATOL;DORALESE TILTAB;INDORAMIN;WY 21901;WY-21901,CHEMBL279516,BRD:BRD-BRD-K76953762-001-08-5;BRD:BRD-K76953762-001-08-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2B;ADRA2C,"BENIGN PROSTATIC HYPERPLASIA (BPH), HYPERTENSION",,LAUNCHED,,Small molecule,4,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1;O=C(NC1CCN(CCC2C[NH]C3CCCCC23)CC1)C1CCCCC1,JXZZEXZZKAWDSP-UHFFFAOYSA-N
INDOXACARB,INDOXACARB,CHEMBL197676,BRD:BRD-K00089583-001-01-9,rep_single_dose,,,,,,,Small molecule,NA,COC(=O)N(C(=O)N1CO[C@@]2(C(=O)OC)Cc3cc(Cl)ccc3C2=N1)c1ccc(OC(F)(F)F)cc1,VBCVPMMZEGZULK-NRFANRHFSA-N
NLG-8189,1-METHYLTRYPTOPHAN;D-;D-1-METHYLTRYPTOPHAN;D-1MT;INDOXIMOD;NLG-8189,CHEMBL571209,BRD:BRD-BRD-K93255255-001-02-1;BRD:BRD-K93255255-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",IDO1,,,PHASE 2,,Small molecule,2,Cn1cc(C[C@@H](N)C(=O)O)c2ccccc21;CN1CC(C[C@@H](N)C(O)=O)C2CCCCC12,ZADWXFSZEAPBJS-SNVBAGLBSA-N
INGENOL,INGENOL,CHEMBL2165402,BRD:BRD-K00003329-001-01-9,rep_single_dose,PKC ACTIVATOR,PRKCD;PRKCE,,,,,Small molecule,3,CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1O)[C@H]1[C@@H](C[C@H]3C)C1(C)C,VEBVPUXQAPLADL-POYOOMFHSA-N
INGENOL-MEBUTATE,INGENOL-MEBUTATE,,BRD:BRD-BRD-K93779381-001-01-9;BRD:BRD-K93779381-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,PKC ACTIVATOR,PRKCA;PRKCB;PRKCD;PRKCE;PRKCG,ACTINIC KERATOSIS (AK),,LAUNCHED,,,NA,C\C=C(\C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C,
INH1,INH1,,BRD:BRD-BRD-K70177501-003-01-4;BRD:BRD-K70177501-003-01-4,rep_multi_dose;rep_primary;rep_single_dose,HEC1 INHIBITOR,NDC80,,,PRECLINICAL,,,NA,CC1CCC(C(C)C1)-C1CSC(NC(=O)C2CCCCC2)N1,
TYDANTIL,INIMUR;MACMIROR;MAGMILOR;METHYLMERCADONE;NF-113;NIFURATEL;OMNES;POLMIROR;SAP-113;TYDANTIL,CHEMBL514315,BRD:BRD-A71407503-001-01-8;BRD:BRD-BRD-A71407503-001-01-8,rep_primary;rep_single_dose,OTHER ANTIFUNGAL,,,,LAUNCHED,,Small molecule,-1,"CSCC1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)O1;CSCC1CN(\N=C\C2CCC(O2)[N+]([O-])=O)C(=O)O1, CSCC1CN(\N=C\C2CCC(O2)[N+]([O-])=O)C(=O)O1",SRQKTCXJCCHINN-NYYWCZLTSA-N
INIPARIB,BSI-201;INIPARIB,CHEMBL1170047,BRD:BRD-BRD-K11153516-001-05-5;BRD:BRD-K11153516-001-05-5,rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,PARP1,,,PHASE 3,,Small molecule,3,NC(=O)c1ccc(I)c([N+](=O)[O-])c1;NC(=O)C1CCC(I)C(C1)[N+]([O-])=O,MDOJTZQKHMAPBK-UHFFFAOYSA-N
NSC-757441,AG-013736;AG-13736;AXITINIB;INLYTA;NSC-757441,CHEMBL1289926,GDSC1:1021;GDSC2:1021,gdsc,,,,,,,Small molecule,4,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,RITAVMQDGBJQJZ-FMIVXFBMSA-N
NSC-20262,HYPOXANTHINE RIBOSIDE;HYPOXANTHOSINE;INO-1001;INOSINE;INOTIN;NSC-20262,CHEMBL1556,BRD:BRD-BRD-K79612754-001-19-1;BRD:BRD-BRD-K79612754-001-21-7;BRD:BRD-K79612754-001-19-1;BRD:BRD-K79612754-001-21-7,rep_multi_dose;rep_primary;rep_single_dose,NEUROTROPHIC AGENT,PARP1;PNP,,,LAUNCHED,,Small molecule,3,"O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(O)NCNC12, OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(O)NCNC12, OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(O)NCNC12",UGQMRVRMYYASKQ-KQYNXXCUSA-N
SCYLLO-INOSITOL,"3-O-METHYL-;3-O-METHYL-D-CHIRO-INOSITOL;AZD-103;CATHRTOMANNITOL;COCOSITOL;CYCLOHEXANE-1,2,3,4,5,6-HEXAOL;CYCLOHEXANEHEXOL;D-3-O-METHYL-CHIRO-INOSITOL;D-CHIRO-;D-CHIRO-INOSITOL;D-PINITOL;ELND-005;ELND005;I-INOSITOL;INOSITOL;INZITOL;MATEZIT;MESO-INOSITOL;METHYLINOSITOL;MYO;MYO-;MYO-INOSITOL;NDI 18;NIC5-15;NSC-128700;NSC-25142;NSC-404118;NSC-55551;NSC-8101;PINIOL;PINITOL;PINITOL B;QUERCINITOL;SCYLLITOL;SCYLLO-;SCYLLO-CYCLOHEXANEHEXOL;SCYLLO-INOSITOL",CHEMBL1222251;CHEMBL468154;CHEMBL493737,BRD:BRD-BRD-K52618540-001-09-9;BRD:BRD-K52618540-001-09-9,rep_primary;rep_single_dose,INSULIN SENSITIZER,CDIPT;GBA,,,LAUNCHED,,Small molecule,2,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O;O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O,CDAISMWEOUEBRE-CDRYSYESSA-N
INOSITOL-HEXANICOTINATE,INOSITOL-HEXANICOTINATE,,BRD:BRD-BRD-K82800842-001-01-9;BRD:BRD-K82800842-001-01-9,rep_primary;rep_single_dose,,,"STATIS DERMATITIS, CLAUDICATION, RAYNAUD'S DISEASE, HYPERTENSION, INSOMNIA, ATHEROSCLEROSIS, RESTLESS LEG SYNDROME, SCHIZOPHRENIA, PSORIASIS, ACNE VULGARIS (AV)",,LAUNCHED,,,NA,O=C(O[C@H]1[C@H](OC(=O)C2CCCNC2)[C@@H](OC(=O)C2CCCNC2)[C@H](OC(=O)C2CCCNC2)[C@H](OC(=O)C2CCCNC2)[C@@H]1OC(=O)C1CCCNC1)C1CCCNC1,
OCALIVA,6-ECDCA;6-ETHYLCHENODEOXYCHOLIC ACID;DSP-1747;INT-747;OBETICHOLIC ACID;OCALIVA,CHEMBL566315,BRD:BRD-BRD-K30968378-001-01-9;BRD:BRD-K30968378-001-01-9,rep_primary;rep_single_dose,FXR AGONIST,,,,PHASE 3,,Small molecule,4,CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12;CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(O)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12,ZXERDUOLZKYMJM-ZWECCWDJSA-N
INT-767,INT-767,,BRD:BRD-BRD-K33067152-236-01-1;BRD:BRD-K33067152-236-01-1,rep_primary;rep_single_dose,FXR AGONIST,GPBAR1,,,PHASE 1,,,NA,CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCOS(O)(=O)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12,
INTEGRIN-ANTAGONIST-1,INTEGRIN-ANTAGONIST-1,,BRD:BRD-BRD-K88165431-003-01-4;BRD:BRD-K88165431-003-01-4,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGAV;ITGB6,,,PHASE 1,,,NA,CC1CC(C)N(N1)-C1CCCC(C1)[C@@H](CN1CC[C@@H](CCC2=CC=C3CCCN=C3N2)C1)CC(O)=O,
INX-189,BMS-986094;INX 08189;INX-08189;INX-089;INX-189,CHEMBL1209734,BRD:BRD-K00004752-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,2,COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(N[C@@H](C)C(=O)OCC(C)(C)C)Oc2cccc3ccccc23)[C@@H](O)[C@@]1(C)O,YFXGICNMLCGLHJ-RSKRLRQZSA-N
MIBG-I-123,(131I)-MIBG;131 I-MIBG;131I-MIBG;3-IODOBENZYLGUANIDINE;3-IODOBENZYLGUANIDINE (131I);ADREVIEW;AZEDRA;I-123 HEMISULFATE;I-123 HEMISULPHATE;I-131;I-131 METAIODOBENZYLGUANIDINE;IOBENGUANE;IOBENGUANE (127-I);IOBENGUANE (131 I);IOBENGUANE (131I);IOBENGUANE I 123 HEMISULFATE;IOBENGUANE I 123 HEMISULPHATE;IOBENGUANE I 131;IOBENGUANE I-123 HEMISULFATE;IOBENGUANE I-123 HEMISULPHATE;IOBENGUANE I-131;IOBENGUANE SULFATE I 123;IOBENGUANE SULFATE I-123;IOBENGUANE SULPHATE I 123;IOBENGUANE SULPHATE I-123;IODINE (131I) IOBENGUANE;IODOBENZYLGUANIDINE SULFATE I 123;M131IBG;METAIODOBENZYLGUANIDINE I-131;MIBG I-131;MIBG-I-123,CHEMBL1615779;CHEMBL3989523;CHEMBL818,BRD:BRD-BRD-K43860855-065-11-9;BRD:BRD-K43860855-065-11-9,rep_multi_dose;rep_primary;rep_single_dose,ANTINEOPLASTIC AGENT,,"NEUROBLASTOMA, CONGESTIVE HEART FAILURE, PHEOCHROMOCYTOMA",,LAUNCHED,,Small molecule,4,"N=C(N)NCc1cccc([123I])c1.N=C(N)NCc1cccc([123I])c1.O=S(=O)(O)O;NC(=N)NCC1CCCC(I)C1, NC(=N)NCC1CCCC(I)C1",XNACDNPGABUBFR-FKNPGSCZSA-N
IOCETAMIC-ACID,IOCETAMIC-ACID,,BRD:BRD-A37492983-001-10-3;BRD:BRD-BRD-A37492983-001-10-3,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,CONTRAST AGENT,,LAUNCHED,,,NA,CC(CN(C(C)=O)C1C(I)CC(I)C(N)C1I)C(O)=O,
NSC-757423,ADIPIODONE;CHOLOGRAFIN;IODIPAMIDE;NSC-757423,CHEMBL1165268,BRD:BRD-BRD-K67261995-001-11-7;BRD:BRD-K67261995-001-11-7,rep_multi_dose;rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,ALB,CONTRAST AGENT,,LAUNCHED,,Small molecule,4,O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I;OC(=O)C1C(I)CC(I)C(NC(=O)CCCCC(=O)NC2C(I)CC(I)C(C(O)=O)C2I)C1I,FFINMCNLQNTKLU-UHFFFAOYSA-N
VISIPAQUE 320,2-5410-3A;2-541O-3A;IODIXANOL;NSC-760069;VISIPAQUE;VISIPAQUE 270;VISIPAQUE 320,CHEMBL1200507,BRD:BRD-A08660406-001-05-9;BRD:BRD-BRD-A08660406-001-05-9,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,CONTRAST AGENT,,LAUNCHED,,Unknown,4,"CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I;CC(=O)N(CC(O)CN(C(C)=O)C1C(I)C(C(=O)NCC(O)CO)C(I)C(C(=O)NCC(O)CO)C1I)C1C(I)C(C(=O)NCC(O)CO)C(I)C(C(=O)NCC(O)CO)C1I, CC(=O)N(CC(O)CN(C(C)=O)C1C(I)C(C(=O)NCC(O)CO)C(I)C(C(=O)NCC(O)CO)C1I)C1C(I)C(C(=O)NCC(O)CO)C(I)C(C(=O)NCC(O)CO)C1I",NBQNWMBBSKPBAY-UHFFFAOYSA-N
IODOPYRINE,4-IODO-;4-IODO-(SUP 131)I-ANTIPYRINE;4-IODOANTIPYRINE;ANTIPYRINE;ANTIPYRINE IODIDE;I-131;IODOANTIPYRINE;IODOANTIPYRINE I 131;IODOANTIPYRINE I-131;IODOPYRINE,CHEMBL2104814;CHEMBL24132,BRD:BRD-BRD-K69216798-001-01-9;BRD:BRD-K69216798-001-01-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,Cc1c(I)c(=O)n(-c2ccccc2)n1C;CC1C(I)C(=O)N(-C2CCCCC2)N1C,ZZOBLCHCPLOXCE-UHFFFAOYSA-N
IODODEXETIMIDE,IODODEXETIMIDE,,BRD:BRD-A46813902-001-01-6;BRD:BRD-BRD-A46813902-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,,,PHASE 2,,,NA,IC1CCC(CN2CCC(CC2)C2(CCC(=O)NC2=O)C2CCCCC2)CC1,
IODOPHENPROPIT,IODOPHENPROPIT,CHEMBL498770,BRD:BRD-BRD-K51918615-303-02-9;BRD:BRD-K51918615-303-02-9,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH3;HRH4,,,PRECLINICAL,,Small molecule,NA,IC1CCC(CCNC(=N)SCCCC2C[NH]CN2)CC1;N/C(=N/CCc1ccc(I)cc1)SCCCc1cnc[nH]1,UBHYDQAARZKHEZ-UHFFFAOYSA-N
ZOAQUIN,DIIODOHYDROXYQUIN;DIIODOHYDROXYQUINOLINE;DIODOQUIN;ENTERODIAMOEBINE;IODOQUINOL;IOQUIN;LANODOXIN;NSC-8704;QUINADOME;SEARLEQUIN;SS-578;YODOXIN;ZOAQUIN,CHEMBL86754,BRD:BRD-BRD-K75855670-001-14-2;BRD:BRD-K75855670-001-14-2,rep_primary;rep_single_dose,ANTISEPTIC,,AMEBIASIS,,LAUNCHED,,Small molecule,-1,Oc1c(I)cc(I)c2cccnc12;OC1C(I)CC(I)C2CCCNC12,UXZFQZANDVDGMM-UHFFFAOYSA-N
WIN-39424,EXYPAQUE;IOHEXOL;IOHEXOLUM;NSC-759636;OMNIPAQUE;OMNIPAQUE 12;OMNIPAQUE 140;OMNIPAQUE 180;OMNIPAQUE 210;OMNIPAQUE 240;OMNIPAQUE 300;OMNIPAQUE 350;OMNIPAQUE 70;OMNIPAQUE 9;ORALTAG;WIN 39424;WIN-39424,CHEMBL1200455,BRD:BRD-A60217728-001-11-2;BRD:BRD-BRD-A60217728-001-11-2,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,CONTRAST AGENT,,LAUNCHED,,Small molecule,4,CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I;CC(=O)N(CC(O)CO)C1C(I)C(C(=O)NCC(O)CO)C(I)C(C(=O)NCC(O)CO)C1I,NTHXOOBQLCIOLC-UHFFFAOYSA-N
RO16-0154,I-123;IOMAZENIL;IOMAZENIL (123 I);IOMAZENIL (123I);IOMAZENIL I 123;IOMAZENIL I-123;RO 16-0154;RO-16-0154;RO16-0154,CHEMBL2105020;CHEMBL2110679,BRD:BRD-K00075696-001-02-9,rep_single_dose,,,,,,,Small molecule,2,CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2,FRIZVHMAECRUBR-UHFFFAOYSA-N
SQ-13396,"IOPAMIDOL;IOPAMIDOL-200;IOPAMIDOL-250;IOPAMIDOL-300;IOPAMIDOL-370;IOPAMIRON;ISOVUE;ISOVUE-128;ISOVUE-200;ISOVUE-250;ISOVUE-300;ISOVUE-370;ISOVUE-M 200;ISOVUE-M 300;SCANLUX-300;SCANLUX-370;SQ 13,396;SQ-13396",CHEMBL1200932,BRD:BRD-BRD-K75868704-001-05-3;BRD:BRD-K75868704-001-05-3,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,CONTRAST AGENT,,LAUNCHED,,Small molecule,4,C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I;C[C@H](O)C(=O)NC1C(I)C(C(=O)NC(CO)CO)C(I)C(C(=O)NC(CO)CO)C1I,XQZXYNRDCRIARQ-LURJTMIESA-N
IOPANIC-ACID,IOPANIC-ACID,,BRD:BRD-A42628519-001-12-4;BRD:BRD-BRD-A42628519-001-12-4,rep_primary;rep_single_dose,THYROID HORMONE INHIBITOR,,,,PRECLINICAL,,,NA,CCC(CC1C(I)CC(I)C(N)C1I)C(O)=O,
IOPODIC-ACID,IOPODIC-ACID,,BRD:BRD-BRD-K51956333-001-03-8;BRD:BRD-K51956333-001-03-8,rep_primary;rep_single_dose,,,CONTRAST AGENT,,LAUNCHED,,,NA,CN(C)\C=N\C1C(I)CC(I)C(CCC(O)=O)C1I,
OPTIRAY 350,IOVERSOL;MP 328;MP-328;OPTIRAY;OPTIRAY 160;OPTIRAY 240;OPTIRAY 300;OPTIRAY 320;OPTIRAY 350,CHEMBL1200614,BRD:BRD-A65818372-001-05-3;BRD:BRD-BRD-A65818372-001-05-3,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,CONTRAST AGENT,,LAUNCHED,,Small molecule,4,O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I;OCCN(C(=O)CO)C1C(I)C(C(=O)NCC(O)CO)C(I)C(C(=O)NCC(O)CO)C1I,AMDBBAQNWSUWGN-UHFFFAOYSA-N
IOWH032,IOWH-032;IOWH032,CHEMBL4297392,BRD:BRD-BRD-K84892605-001-01-1;BRD:BRD-K84892605-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,CFTR CHANNEL ANTAGONIST,CFTR,,,PHASE 2,,Small molecule,2,O=C(NCc1ccc(Oc2ccccc2)cc1)c1nc(-c2cc(Br)c(O)c(Br)c2)no1;OC1C(BR)CC(CC1BR)-C1NOC(N1)C(=O)NCC1CCC(OC2CCCCC2)CC1,DSFNLJXHXBIKDS-UHFFFAOYSA-N
IOX-2,AK176060;IOX 2;IOX-2,,GDSC1:1230,gdsc,,,,,,,,NA,,
IOX1,IOX1,,BRD:BRD-K70751730-001-10-4,rep_single_dose,HISTONE DEMETHYLASE INHIBITOR,EGLN1;KDM3A;KDM4C;KDM6B,,,,,,NA,,
IOX2,IOX2,,BRD:BRD-BRD-K98251413-001-04-0;BRD:BRD-K98251413-001-04-0;GDSC1:1230,gdsc;rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,EGLN1;KDM2A;KDM5C,,,PRECLINICAL,,,NA,"OC(=O)CNC(=O)C1C(O)C2CCCCC2N(CC2CCCCC2)C1=O, OC(=O)CNC(=O)C1C(O)C2CCCCC2N(CC2CCCCC2)C1=O",
IOXAGLIC-ACID,IOXAGLIC-ACID,,BRD:BRD-BRD-K79124250-001-08-9;BRD:BRD-K79124250-001-08-9,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,CONTRAST AGENT,,LAUNCHED,,,NA,CNC(=O)C1C(I)C(N(C)C(C)=O)C(I)C(C(=O)NCC(=O)NC2C(I)C(C(O)=O)C(I)C(C(=O)NCCO)C2I)C1I,
OXILAN-350,IOXILAN;IOXITOL;LOXILAN;NSC-760056;OXILAN;OXILAN-300;OXILAN-350,CHEMBL1201075,BRD:BRD-A09370961-001-01-0;BRD:BRD-BRD-A09370961-001-01-0,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,ANGIOGRAPHY,,LAUNCHED,,Small molecule,4,CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I;CC(=O)N(CC(O)CO)C1C(I)C(C(=O)NCCO)C(I)C(C(=O)NCC(O)CO)C1I,UUMLTINZBQPNGF-UHFFFAOYSA-N
IPA-3,IPA 3;IPA-3,,GDSC1:176,gdsc,,,,,,,,NA,,
IPAG,IPAG,,BRD:BRD-BRD-K82421491-001-02-6;BRD:BRD-K82421491-001-02-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,IC1CCC(NC(=N)NC2C3CC4CC(C3)CC2C4)CC1,
IPI549,IPI549,,BRD:BRD-K00003385-001-01-9,rep_single_dose,PI3K INHIBITOR,,,,,,,NA,,
IPIDACRINE,IPIDACRINE,CHEMBL130880,BRD:BRD-BRD-K66896231-001-08-1;BRD:BRD-K66896231-001-08-1,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE,,,PHASE 3,,Small molecule,-1,Nc1c2c(nc3c1CCC3)CCCC2;NC1C2CCCC2NC2CCCCC12,YLUSMKAJIQOXPV-UHFFFAOYSA-N
IPR-456,IPR-456,,CTRP:660084,ctrp,,,,,,,,NA,,
IPRAGLIFLOZIN-L-PROLINE,IPRAGLIFLOZIN-L-PROLINE,,BRD:BRD-BRD-K51247865-001-01-2;BRD:BRD-K51247865-001-01-2,rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,SLC5A2,DIABETES MELLITUS,,LAUNCHED,,,NA,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1CCC(F)C(CC2CC3CCCCC3S2)C1,
IPRATROPIUM ION,IPRATROPIUM;IPRATROPIUM CATION;IPRATROPIUM ION,CHEMBL1621597,BRD:BRD-A47449001-004-13-7;BRD:BRD-BRD-A47449001-004-13-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,"BRONCHOSPASM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BRONCHITIS, EMPHYSEMA",,LAUNCHED,,Small molecule,4,"CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2;CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1CCCCC1, CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1CCCCC1, CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1CCCCC1",OEXHQOGQTVQTAT-BHIXFJMTSA-N
OSTIVONE,7-ISOPROPOXYISOFLAVONE;IPRIFLAVONE;NSC-755888;OSTEN;OSTIVONE,CHEMBL165790,BRD:BRD-BRD-K93618743-001-21-0;BRD:BRD-K93618743-001-21-0,rep_primary;rep_single_dose,BONE RESORPTION INHIBITOR,,OSTEOPOROSIS,,LAUNCHED,,Small molecule,-1,"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1;CC(C)OC1CCC2C(C1)OCC(-C1CCCCC1)C2=O, CC(C)OC1CCC2C(C1)OCC(-C1CCCCC1)C2=O",SFBODOKJTYAUCM-UHFFFAOYSA-N
MARSILID,IPRONIAZID;IPRONIAZIDE;MARSILID,CHEMBL92401,BRD:BRD-BRD-K88568253-011-19-9;BRD:BRD-K88568253-011-19-9,rep_multi_dose;rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,,,WITHDRAWN,,Small molecule,4,CC(C)NNC(=O)c1ccncc1;CC(C)NNC(=O)C1CCNCC1,NYMGNSNKLVNMIA-UHFFFAOYSA-N
IPSAPIRONE,IPSAPIRONE,CHEMBL8412,BRD:BRD-BRD-K90574421-001-03-5;BRD:BRD-K90574421-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,,,PHASE 3,,Small molecule,-1,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1;O=C1N(CCCCN2CCN(CC2)C2NCCCN2)S(=O)(=O)C2CCCCC12,TZJUVVIWVWFLCD-UHFFFAOYSA-N
SR-47436,APROVEL;AVAPRO;BMS-186295;IFIRMASTA;IRBESARTAN;IRBESARTAN BMS;IRBESARTAN TEVA;IRBESARTAN ZENTIVA;KARVEA;NSC-758696;SABERVEL;SARBEVEL;SR 47436;SR-47436,CHEMBL1513,BRD:BRD-BRD-K60038276-001-09-0;BRD:BRD-K60038276-001-09-0,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1;JUN;SLC10A1,"HYPERTENSION, DIABETIC NEPHROPATHY",,LAUNCHED,,Small molecule,4,"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1;CCCCC1=NC2(CCCC2)C(=O)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCCCC1=NC2(CCCC2)C(=O)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1",YOSHYTLCDANDAN-UHFFFAOYSA-N
IRGANOX-1010,IRGANOX-1010,,BRD:BRD-K00004549-001-01-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
IRGD-PEPTIDE,IRGD-PEPTIDE,,BRD:BRD-K00003335-001-01-9,rep_single_dose,INTEGRIN SIGNALING ACTIVATOR,,,,,,,NA,,
NSC-728073,BIOTECAN;CAMPTOSAR;IRINOTECAN;NSC-728073,CHEMBL481,BRD:BRD-BRD-K08547377-394-03-5;BRD:BRD-K08547377-001-04-4;BRD:BRD-K08547377-001-05-1;BRD:BRD-K08547377-394-03-5;GDSC2:1088,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF TOPOISOMERASE 1,TOP1;TOP1A;TOP1MT,COLORECTAL CANCER,,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF TOPOISOMERASE 1', 'TOPOISOMERASE INHIBITOR'}, defaulting to 'INHIBITOR OF TOPOISOMERASE 1'
Multiple values for repurposing_target: {'TOP1;TOP1MT', 'TOP1A'}, taking the union",Small molecule,4,"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC;CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(OC(=O)N3CCC(CC3)N3CCCCC3)CC12, CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(OC(=O)N3CCC(CC3)N3CCCCC3)CC12, CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(OC(=O)N3CCC(CC3)N3CCCCC3)CC12, CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(OC(=O)N3CCC(CC3)N3CCCCC3)CC12, CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(OC(=O)N3CCC(CC3)N3CCCCC3)CC12, CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(OC(=O)N3CCC(CC3)N3CCCCC3)CC12, CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(OC(=O)N3CCC(CC3)N3CCCCC3)CC12",UWKQSNNFCGGAFS-XIFFEERXSA-N
U-101440E,"(+)-IRINOTECAN;CAMPTO;CAMPTOSAR;CPT-11;DQ-2805;IRINOTECAN HYDROCHLORIDE;IRINOTECAN HYDROCHLORIDE ANHYDROUS;IRINOTECAN HYDROCHLORIDE HYDRATE;IRINOTECAN HYDROCHLORIDE TRIHYDRATE;IRINOTECAN MONOHYDROCHLORIDE TRIHYDRATE;IRINOTECANUM;NSC-759878;ONIVYDE;U-101,440E;U-101440E",CHEMBL1200512;CHEMBL3989514;CHEMBL541887,GDSC2:1088,gdsc,,,,,,,Small molecule,4,CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O;CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O,KLEAIHJJLUAXIQ-JDRGBKBRSA-N;OHNBIIZWIUBGTK-NYPSMHOZSA-N
IRL-2500,IRL-2500,,BRD:BRD-BRD-K98357249-001-02-9;BRD:BRD-K98357249-001-02-9,rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRB,,,PRECLINICAL,,,NA,CN([C@H](CC1CCC(CC1)-C1CCCCC1)C(=O)N[C@@H](CC1C[NH]C2CCCCC12)C(O)=O)C(=O)C1CC(C)CC(C)C1,
STX64,667 COUMATE;667-COUMATE;BN 83495;BN-83495;BN83495;IROSUSTAT;STX 64;STX-64;STX64,CHEMBL286738,BRD:BRD-BRD-K87777313-001-02-2;BRD:BRD-K87777313-001-02-2,rep_primary;rep_single_dose,STEROID SULFATASE INHIBITOR,CA2;STS,,,PHASE 2,,Small molecule,2,NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3;NS(=O)(=O)OC1CCC2C3CCCCCC3C(=O)OC2C1,DSLPMJSGSBLWRE-UHFFFAOYSA-N
NSC-759836,IRSOGLADINE;IRSOGLADINE MALEATE;NSC-759836,CHEMBL136497,BRD:BRD-BRD-K74195153-050-12-1;BRD:BRD-K74195153-050-12-1,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,1,"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1;NC1NC(N)NC(N1)-C1CC(CL)CCC1CL, NC1NC(N)NC(N1)-C1CC(CL)CCC1CL, NC1NC(N)NC(N1)-C1CC(CL)CCC1CL",ATCGGEJZONJOCL-UHFFFAOYSA-N
ISAMOLTANE,ISAMOLTAN;ISAMOLTANE,CHEMBL27077,BRD:BRD-A26845397-051-01-9;BRD:BRD-BRD-A26845397-051-01-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,HTR1A;HTR1B,,,PHASE 1,,Small molecule,-1,CC(C)NCC(O)COc1ccccc1-n1cccc1;CC(C)NCC(O)COC1CCCCC1-N1CCCC1,XVTVPGKWYHWYAD-UHFFFAOYSA-N
ISAVUCONAZOLE,BAL-4815;CRESEMBA;ISAVUCONAZOLE,CHEMBL409153,BRD:BRD-A17009129-001-01-3;BRD:BRD-BRD-A17009129-001-01-3,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP3A4,,,PHASE 3,,Small molecule,4,C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1cc(F)ccc1F;C[C@@H](C1NC(CS1)-C1CCC(CC1)C#N)C(O)(CN1CNCN1)C1CC(F)CCC1F,DDFOUSQFMYRUQK-RCDICMHDSA-N
NSC-760406,ISAXONINE;NSC-760406,CHEMBL1740513,BRD:BRD-BRD-K95957366-001-02-6;BRD:BRD-K95957366-001-02-6,rep_primary;rep_single_dose,NERVE GROWTH FACTOR AGONIST,,,,WITHDRAWN,,Small molecule,4,CC(C)Nc1ncccn1;CC(C)NC1NCCCN1,FTCYIGBVOHNHCD-UHFFFAOYSA-N
ISBUFYLLINE,ISBUFYLLINE,CHEMBL1453416,BRD:BRD-BRD-K06762493-001-08-1;BRD:BRD-K06762493-001-08-1,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,PHASE 2,,Small molecule,-1,CC(C)Cn1cnc2c1c(=O)n(C)c(=O)n2C;CC(C)CN1CNC2N(C)C(=O)N(C)C(=O)C12,WHUWQSQEVISUMC-UHFFFAOYSA-N
SCH-21420,HAPA-B;ISEPAMICIN;ISEPAMICIN SULFATE;SCH 21420;SCH-21420,CHEMBL272080,BRD:BRD-BRD-K74759733-065-01-4;BRD:BRD-K74759733-065-01-4,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,"PNEUMONIA, PERITONITIS",,LAUNCHED,,Small molecule,-1,"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN)OC[C@]1(C)O;CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)NC(=O)[C@@H](O)CN)OC[C@]1(C)O, CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)NC(=O)[C@@H](O)CN)OC[C@]1(C)O",UDIIBEDMEYAVNG-ZKFPOVNWSA-N
MK-8591,ISLATRAVIR;ISLATRAVIR ANHYDROUS;MK-8591,CHEMBL517231,BRD:BRD-K00079205-001-02-9,rep_single_dose,,,,,,,Small molecule,3,C#C[C@]1(CO)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O,IKKXOSBHLYMWAE-QRPMWFLTSA-N
ISO-1,ISO-1,,BRD:BRD-A94055480-001-02-9,rep_single_dose,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,MIF,,,,,,NA,,
NSC-23517,BENZAMELID;CICLOFORME;CYCLOFORM;CYCLOGESIN;ISOBUTAMBEN;ISOBUTYL P-AMINOBENZOATE;ISOCAINE;NSC-23517,CHEMBL1985617,BRD:BRD-BRD-K96714749-001-01-0;BRD:BRD-K96714749-001-01-0,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,,,PRECLINICAL,,Small molecule,-1,CC(C)COC(=O)c1ccc(N)cc1;CC(C)COC(=O)C1CCC(N)CC1,PUYOAVGNCWPANW-UHFFFAOYSA-N
ISOBUTYRAMIDE,ISOBUTYRAMIDE,CHEMBL352219,BRD:BRD-BRD-K54057105-001-01-2;BRD:BRD-K54057105-001-01-2,rep_primary;rep_single_dose,GENE EXPRESSION STIMULANT,HBE1;HBG1,,,PHASE 2,,Small molecule,NA,CC(C)C(N)=O,WFKAJVHLWXSISD-UHFFFAOYSA-N
TRAVOGYN,"ISOCONAZOLE;ISOCONAZOLE NITRATE;MICONAZOLE 2,6-ISOMER;R 15,454;R-15,454;R-15,454 [AS NITRATE SALT];R-15454;TRAVOGYN",CHEMBL1571863,BRD:BRD-A93353767-008-02-2;BRD:BRD-BRD-A93353767-008-02-2,rep_primary;rep_single_dose,FUNGAL LANOSTEROL DEMETHYLASE INHIBITOR,CYP17A1,GRAM-POSITIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1;CLC1CCC(C(CN2CCNC2)OCC2C(CL)CCCC2CL)C(CL)C1,MPIPASJGOJYODL-UHFFFAOYSA-N
ISODIBUT,ISODIBUT,,BRD:BRD-BRD-K60241851-001-11-9;BRD:BRD-K60241851-001-11-9,rep_primary;rep_single_dose,ALDEHYDE REDUCTASE INHIBITOR,,,,PHASE 2,,,NA,"OC(=O)CCCN1C(=O)C2CCCC3CCCC(C1=O)C23, OC(=O)CCCN1C(=O)C2CCCC3CCCC(C1=O)C23",
WIN3406,DILABRON;ETYPRENALINE;ISOETARINE;ISOETHARINE;NEOISUPREL;WIN 3406;WIN-3046;WIN-3406;WIN3406,CHEMBL1201213,BRD:BRD-A24587114-066-22-5;BRD:BRD-BRD-A24587114-066-22-5,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2,"BRONCHOSPASM, ASTHMA",,LAUNCHED,,Small molecule,4,"CCC(NC(C)C)C(O)c1ccc(O)c(O)c1;CCC(NC(C)C)C(O)C1CCC(O)C(O)C1, CCC(NC(C)C)C(O)C1CCC(O)C(O)C1, CCC(NC(C)C)C(O)C1CCC(O)C(O)C1",HUYWAWARQUIQLE-UHFFFAOYSA-N
ISOEVODIAMINE,ISOEVODIAMINE,,CTRP:594664,ctrp,,,,,,,,NA,,
ISOFLOXYTHEPIN,ISOFLOXYTHEPIN,,BRD:BRD-A07704283-001-01-3;BRD:BRD-BRD-A07704283-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,PHASE 2,,,NA,CC(C)C1CCC2SC3CC(F)CCC3CC(N3CCN(CCO)CC3)C2C1,
ISOFLUPREDONE-ACETATE,ISOFLUPREDONE-ACETATE,,BRD:BRD-BRD-K29173907-001-09-2;BRD:BRD-K29173907-001-09-2,rep_multi_dose;rep_primary;rep_single_dose,,NR3C1,,,PRECLINICAL,,,NA,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,
ISOFLURANE,AERRANE;COMPOUND 469;COMPOUND-469;FORANE;ISOFLURANE,CHEMBL1256,BRD:BRD-A31564021-001-01-8;BRD:BRD-BRD-A31564021-001-01-8,rep_primary;rep_single_dose,INHALED ANAESTHETIC,ATP2C1;ATP5D;CALM1;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GLRA1;GLRB;GRIA1;KCNA1;KCNK10;KCNK18;KCNK2;KCNK3;KCNK9,GENERAL ANAESTHETIC,,LAUNCHED,,Small molecule,4,"FC(F)OC(Cl)C(F)(F)F;FC(F)OC(CL)C(F)(F)F, FC(F)OC(CL)C(F)(F)F",PIWKPBJCKXDKJR-UHFFFAOYSA-N
NSC-727370,DYFLOS;FLOROPRYL;FLUOSTIGMINE;ISOFLUROPHATE;NSC-727370,CHEMBL1025,BRD:BRD-K56575995-001-03-0,rep_single_dose,CHOLINESTERASE INHIBITOR,ACHE;BCHE,,,,,Small molecule,4,CC(C)OP(=O)(F)OC(C)C,MUCZHBLJLSDCSD-UHFFFAOYSA-N
ISOGUVACINE,ISOGUVACINE,CHEMBL39071,BRD:BRD-BRD-K66480997-003-10-0;BRD:BRD-K66480997-003-10-0,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRR1;GABRR2;GABRR3,,,PRECLINICAL,,Small molecule,NA,O=C(O)C1=CCNCC1;OC(=O)C1=CCNCC1,KRVDMABBKYMBHG-UHFFFAOYSA-N
NSC-46708,FEMA NO. 4675;ISOLEUCINE;L-ISOLEUCINE;NSC-46708,CHEMBL1233584,BRD:BRD-A02232681-001-01-8;BRD:BRD-BRD-A02232681-001-01-8,rep_primary;rep_single_dose,,ACADSB;BCAT1;BCAT2;IARS;IARS2,,,LAUNCHED,,Small molecule,2,CC[C@H](C)[C@H](N)C(=O)O;CCC(C)C(N)C(O)=O,AGPKZVBTJJNPAG-WHFBIAKZSA-N
ISOLIQUIRITIGENIN,ISOLIQUIRITIGENIN,CHEMBL129795,BRD:BRD-BRD-K33583600-001-16-1;BRD:BRD-K33583600-001-16-1;CTRP:25393,ctrp;rep_primary;rep_single_dose,GUANYLATE CYCLASE ACTIVATOR,GABBR1,,,PRECLINICAL,,Small molecule,NA,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O;OC1CCC(CC1)\C=C\C(=O)C1CCC(O)CC1O,DXDRHHKMWQZJHT-FPYGCLRLSA-N
OCTANIL,ISOMETHEPTENE;ISOMETHEPTENE-MUCATE;ISONYL;OCTANIL,CHEMBL1697841,BRD:BRD-A64743628-001-01-5;BRD:BRD-BRD-A64743628-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,,ADRA1A;SLC18A2,HEADACHE,,LAUNCHED,,Small molecule,4,CNC(C)CCC=C(C)C,XVQUOJBERHHONY-UHFFFAOYSA-N
TISIODRAZIDA,ARMAZID;ARMAZIDE;ATCOTIBINE;CEDIN;COTINAZIN;DIANICOTYL;DOW-ISONIAZID;ERALON;ERTUBAN;HIDRASONIL;HYDRAZID;HYZYD;IPCAZIDE;ISCOTIN;ISIDRINA;ISOBICINA;ISONIAZID;ISONIAZIDUM;ISONICOTAN;ISONICOTINYLHYDRAZINE;LANIAZID;MYBASAN;NEUMANDIN;NICOTIBINE;NSC-9659;NYDRAZID;RIMIFON;STANOZIDE;TEEBACONIN;TISIODRAZIDA,CHEMBL64,BRD:BRD-BRD-K87202646-001-32-6,rep_primary,FABI INHIBITOR,CYP1A2;CYP2C19;CYP2C8;CYP2E1;CYP3A4,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,"NNC(=O)c1ccncc1;NNC(=O)C1CCNCC1, NNC(=O)C1CCNCC1",QRXWMOHMRWLFEY-UHFFFAOYSA-N
ISONICOTINOHYDROXAMIC ACID,ISONICOTINOHYDROXAMIC ACID,,CTRP:478694,ctrp,,,,,,,,NA,,
ISOPENTYL-4-METHOXYCINNAMATE,ISOPENTYL-4-METHOXYCINNAMATE,,BRD:BRD-K37851352-001-02-9,rep_single_dose,,,,,,,,NA,,
VAPO-N-ISO,(-)-ISOPROTERENOL;(R)-;A-21;ALEUDRIN;ALUDRINE;ASIPRENOL;ASMALAR;ASSIPRENOL;BELLASTHMAN;ISONORIN;ISOPRENALINE;ISOPROPYDRIN;ISOPROTERENOL;ISOPROTERENOL DL-FORM;ISOPROTERENOL L-FORM;ISORENIN;ISUPREN;L-;L-ISOPRENALINE;LEVISOPRENALINE;NEO-EPININE;NEODRENAL;NOVODRIN;NSC-33791;NSC-9975;PROTERNOL;RESPIFRAL;SAVENTRINE;VAPO-N-ISO,CHEMBL1160723;CHEMBL434,BRD:BRD-A04322457-003-17-9;BRD:BRD-BRD-A04322457-003-17-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2;ADRB3;MAPK1;PIK3R1;PIK3R2;PIK3R3,"BRADYCARDIA, HEART BLOCK, ASTHMA",,LAUNCHED,,Small molecule,4,"CC(C)NCC(O)c1ccc(O)c(O)c1;CC(C)NCC(O)C1CCC(O)C(O)C1, CC(C)NCC(O)C1CCC(O)C(O)C1, CC(C)NCC(O)C1CCC(O)C(O)C1, CC(C)NCC(O)C1CCC(O)C(O)C1",JWZZKOKVBUJMES-UHFFFAOYSA-N
ISOPROPAMIDE-IODIDE,ISOPROPAMIDE-IODIDE,,BRD:BRD-BRD-K14127446-005-22-7;BRD:BRD-K14127446-005-22-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM3;CHRM4,"PEPTIC ULCER DISEASE (PUD), GASTROINTESTINAL ACIDOSIS",,LAUNCHED,,,NA,CC(C)[N+](C)(CCC(C(N)=O)(C1CCCCC1)C1CCCCC1)C(C)C,
ISOPROPYL-MYRISTATE,ISOPROPYL-MYRISTATE,,BRD:BRD-BRD-K13409143-001-01-9;BRD:BRD-K13409143-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,,,COSMETIC,,LAUNCHED,,,NA,"CCCCCCCCCCCCCC(=O)OC(C)C, CCCCCCCCCCCCCC(=O)OC(C)C",
ISOPROPYL-PALMITATE,ISOPROPYL-PALMITATE,,BRD:BRD-BRD-K30758549-001-01-8;BRD:BRD-K30758549-001-01-8,rep_primary;rep_single_dose,COSMETIC MOISTURIZER,,COSMETIC,,LAUNCHED,,,NA,"CCCCCCCCCCCCCCCC(=O)OC(C)C, CCCCCCCCCCCCCCCC(=O)OC(C)C",
RONACARE ISOQUERCETIN,(-)-;3-GLUCOSYLQUERCETIN;CONTIGOSIDE B;FEMA NO. 4225;GLUCOSYL-3-QUERCETIN;HIRSUTRIN;ISOQUERCETIN;ISOQUERCITRIN;ISOQUERCITROSIDE;ISOTRIFOLIIN;ISOTRIFOLIN;NSC-115918;NSC-407304;QUERCETIN 3-D-GLUCOSIDE;QUERCETIN 3-O-GLUCOPYRANOSIDE;QUERCETIN 3-O-GLUCOSIDE;QUERCETIN 3.BETA.-GLUCOSIDE;QUERCETIN GLUCOSIDE;QUERCETIN-3-GLUCOSE;QUERCETIN-3-O-GLUCOSIDE;QUERCETOL 3-MONOGLUCOSIDE;RONACARE ISOQUERCETIN,CHEMBL250450,BRD:BRD-K73991644-001-07-9,rep_single_dose,ANTIOXIDANT,,,,,,Small molecule,2,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,OVSQVDMCBVZWGM-QSOFNFLRSA-N
"ISOQUINOLINE,-6,7-DIMETHOXY-1-METHYL-1,2,3,4-TETRAHYDRO,","ISOQUINOLINE,-6,7-DIMETHOXY-1-METHYL-1,2,3,4-TETRAHYDRO,",,BRD:BRD-A75140635-003-10-9;BRD:BRD-BRD-A75140635-003-10-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC1CC2CCNC(C)C2CC1OC,
ISOSORBIDE-MONONITRATE,ISOSORBIDE-MONONITRATE,,BRD:BRD-BRD-K82225283-001-03-1;BRD:BRD-K82225283-001-03-1,rep_primary;rep_single_dose,NITRIC OXIDE STIMULANT,GUCY1A2;GUCY1A3;GUCY1B2;GUCY1B3,"ANGINA PECTORIS, CORONARY ARTERY DISEASE (CAD)",,LAUNCHED,,,NA,O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O,
ISOSTEVIOL,ISOSTEVIOL,CHEMBL462653,BRD:BRD-A96529864-001-01-3;BRD:BRD-BRD-A96529864-001-01-3,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,NA,C[C@]12C[C@@]3(CC1=O)CC[C@H]1[C@@](C)(CCC[C@@]1(C)C(O)=O)C3CC2;C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)O)(CC1=O)C2,KFVUFODCZDRVSS-XGBBNYNSSA-N
WY-24377,"ISOTIQUIMIDE;WY-24,377;WY-24377",CHEMBL2107405,BRD:BRD-A02933148-001-01-8;BRD:BRD-BRD-A02933148-001-01-8,rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,-1,CC1CCNC2C(CCCC12)C(N)=S;Cc1ccnc2c1CCCC2C(N)=S,PWPWEYFVLITGNU-UHFFFAOYSA-N
NSC-402555,ISOVALERAMIDE;NFS-1776;NFS1776;NSC-402555,CHEMBL171066,BRD:BRD-BRD-K90069354-001-03-7;BRD:BRD-K90069354-001-03-7,rep_primary;rep_single_dose,ALCOHOL DEHYDROGENASE INHIBITOR,,,,PHASE 2,,Small molecule,-1,"CC(C)CC(N)=O;CC(C)CC(N)=O, CC(C)CC(N)=O, CC(C)CC(N)=O, CC(C)CC(N)=O",SANOUVWGPVYVAV-UHFFFAOYSA-N
ISOX,ISOX,,CTRP:632907,ctrp,,,,,,,,NA,,
ISOX:BORTEZOMIB (250:1 MOL/MOL),ISOX:BORTEZOMIB (250:1 MOL/MOL),,CTRP:660173,ctrp,,,,,,,,NA,,
P-720549,ARTIL;HP 549;HP-549;ISOXEPAC;NSC-300907;OLOPATADINE RELATED COMPOUND C;P 720549;P-720549,CHEMBL33211,BRD:BRD-BRD-K92116564-001-01-4;BRD:BRD-K92116564-001-01-4,rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,PHASE 2,,Small molecule,-1,O=C(O)Cc1ccc2c(c1)C(=O)c1ccccc1CO2;OC(=O)CC1CCC2OCC3CCCCC3C(=O)C2C1,QFGMXJOBTNZHEL-UHFFFAOYSA-N
W-8495,ISOXICAM;MAXICAM;NSC-758436;W 8495;W-8495,CHEMBL53292,BRD:BRD-A75552914-001-15-0;BRD:BRD-BRD-A75552914-001-15-0,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,WITHDRAWN,,Small molecule,4,"Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1;CN1C(C(=O)NC2CC(C)ON2)C(=O)C2CCCCC2S1(=O)=O, CN1C(C(=O)NC2CC(C)ON2)C(=O)C2CCCCC2S1(=O)=O",YYUAYBYLJSNDCX-UHFFFAOYSA-N
ISOXSUPRINE,DILATOR;ISOXSUPRINE,CHEMBL1197051,BRD:BRD-A16700644-003-04-4;BRD:BRD-BRD-A16700644-003-04-4,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,"RAYNAUD'S DISEASE, ARTERIOSCLEROSIS, BUERGER'S DISEASE",,LAUNCHED,,Small molecule,4,CC(COC1CCCCC1)NC(C)[C@H](O)C1CCC(O)CC1;CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1,BMUKKTUHUDJSNZ-UHFFFAOYSA-N
SB-715992-S,CK-0238273;CK0238273;ISPINESIB MESILATE;ISPINESIB MESYLATE;SB-715992-S,CHEMBL2347651,GDSC1:208,gdsc,,,,,,,Small molecule,-1,CS(=O)(=O)O.Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1,MRKSDPIHUJSKRA-HZPIKELBSA-N
PRESCAL,DYNACIRC;DYNACIRC CR;ISRADIPINE;ISRODIPINE;NSC-759892;PN 200-110;PN-200-110;PRESCAL,CHEMBL1648,BRD:BRD-A90799790-001-19-9;BRD:BRD-BRD-A90799790-001-19-9,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1D;CACNA1F;CACNA1H;CACNA1S;CACNA2D1;CACNA2D2;CACNB2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12;COC(=O)C1=C(C)NC(C)=C(C1C1CCCC2NONC12)C(=O)OC(C)C, COC(=O)C1=C(C)NC(C)=C(C1C1CCCC2NONC12)C(=O)OC(C)C, COC(=O)C1=C(C)NC(C)=C(C1C1CCCC2NONC12)C(=O)OC(C)C, COC(=O)C1=C(C)NC(C)=C(C1C1CCCC2NONC12)C(=O)OC(C)C",HMJIYCCIJYRONP-UHFFFAOYSA-N
ISRIB,ISRIB,,BRD:BRD-K12826175-001-02-4,rep_single_dose,"EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR, PERK INHIBITOR",EIF2A;EIF2AK3,,,,,,NA,,
PST-2744,"(E,Z)-ISTAROXIME;ISTAROXIME;PST-2744",CHEMBL2093999;CHEMBL3989692,BRD:BRD-BRD-K95412502-003-01-5;BRD:BRD-K95412502-003-01-5,rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP1A1,,,PHASE 2,,Small molecule,2,C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C\C(CC[C@]34C)=N\OCCN)[C@@H]1CCC2=O;C[C@]12CCC(=NOCCN)C[C@@H]1C(=O)C[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,MPYLDWFDPHRTEG-IFVNMTGRSA-N
NOURIAST,ISTRADEFYLLINE;KW-6002;NOURIANZ;NOURIAST,CHEMBL431770,BRD:BRD-BRD-K87774949-001-03-9;BRD:BRD-K87774949-001-03-9;CTRP:687694,ctrp;rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,"PARKINSON'S DISEASE, DYSKINESIA",,LAUNCHED,,Small molecule,4,"CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O;CCN1C2NC(\C=C\C3CCC(OC)C(OC)C3)N(C)C2C(=O)N(CC)C1=O, CCN1C2NC(\C=C\C3CCC(OC)C(OC)C3)N(C)C2C(=O)N(CC)C1=O, CCN1C2NC(\C=C\C3CCC(OC)C(OC)C3)N(C)C2C(=O)N(CC)C1=O, CCN1C2NC(\C=C\C3CCC(OC)C(OC)C3)N(C)C2C(=O)N(CC)C1=O, CCN1C2NC(\C=C\C3CCC(OC)C(OC)C3)N(C)C2C(=O)N(CC)C1=O",IQVRBWUUXZMOPW-PKNBQFBNSA-N
ISX-9,ISX-9,,BRD:BRD-K53903639-001-01-3,rep_single_dose,NEURAL STEM CELL INDUCER,NEUROD1,,,,,,NA,,
IT1T,IT1T,,BRD:BRD-K73499906-300-02-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR4,,,,,,NA,,
ITACITINIB,INCB-039110;INCB-39110;INCB039110;ITACITINIB,CHEMBL3622820,BRD:BRD-BRD-K67482377-001-01-8;BRD:BRD-K67482377-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,JAK1,,,PHASE 2,,Small molecule,3,FC1C(CCNC1C(F)(F)F)C(=O)N1CCC(CC1)N1CC(CC#N)(C1)N1CC(CN1)-C1NCNC2[NH]CCC12;N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1,KTBSXLIQKWEBRB-UHFFFAOYSA-N
ITD-1,ITD-1,,BRD:BRD-A56690687-001-02-9,rep_single_dose,TGF BETA RECEPTOR INHIBITOR,TGFBR2,,,,,,NA,,
ITE,ITE,,BRD:BRD-BRD-K60298136-001-03-3;BRD:BRD-K60298136-001-03-3,rep_primary;rep_single_dose,ARYL HYDROCARBON RECEPTOR AGONIST,AHR,,,PRECLINICAL,,,NA,COC(=O)C1CSC(N1)C(=O)C1C[NH]C2CCCCC12,
ITI214,ITI214,,BRD:BRD-BRD-K77987496-011-01-9;BRD:BRD-K77987496-011-01-9,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE1A,,,PHASE 1,,,NA,CN1C2=N[C@@H]3CCC[C@@H]3N2C2NN(CC3CCC(CC3)-C3CCCC(F)N3)C(NC3CCCCC3)C2C1=O,
NSC-759643,ITOPRIDE;NSC-759643,CHEMBL2107457,BRD:BRD-BRD-K96740444-001-02-1;BRD:BRD-K96740444-001-02-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CHRM3;DRD2,"DYSPEPSIA, GASTROPARESIS, HEARTBURN, NAUSEA, VOMITING, ANOREXIA",,LAUNCHED,,Small molecule,3,COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC;COC1CCC(CC1OC)C(=O)NCC1CCC(OCCN(C)C)CC1,QQQIECGTIMUVDS-UHFFFAOYSA-N
TRIASPORIN,"CANDISTAT;CANDITRAL;CLADOSAL 100;FUNGITRAXX;ITRAC;ITRACONAZOLE;ITRALEK;ITRAZOLE;ITRIZOLE;NSC-759239;ONMEL;ORUNGAL;R 51,211;R-51211;SEMPERA;SPHERAZOLE CR;SPHERAZOLE IR;SPORAMELT;SPORANOS;SPORANOX;SPORANOX I.V.;SPORANOX-PULSE;SPORONOX;TOLSURA;TRACONAL;TRIASPORIN",CHEMBL64391,BRD:BRD-A23067620-300-01-3;BRD:BRD-BRD-A23067620-300-01-3;CTRP:63349,ctrp;rep_multi_dose;rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP51A1,"ONYCHOMYCOSIS, HISTOPLASMOSIS, BLASTOMYCOSIS, ASPERGILLOSIS",,LAUNCHED,,Small molecule,4,"CCC(C)N1NCN(-C2CCC(CC2)N2CCN(CC2)C2CCC(OC[C@H]3CO[C@@](CN4CNCN4)(O3)C3CCC(CL)CC3CL)CC2)C1=O, CCC(C)N1NCN(-C2CCC(CC2)N2CCN(CC2)C2CCC(OC[C@H]3CO[C@@](CN4CNCN4)(O3)C3CCC(CL)CC3CL)CC2)C1=O, CCC(C)N1NCN(-C2CCC(CC2)N2CCN(CC2)C2CCC(OC[C@H]3CO[C@@](CN4CNCN4)(O3)C3CCC(CL)CC3CL)CC2)C1=O;CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O",VHVPQPYKVGDNFY-UHFFFAOYSA-N
ITX3,ITX3,,BRD:BRD-K36515744-001-03-5,rep_single_dose,GEF INHIBITOR,TRIO,,,,,,NA,,
ITX5061,ITX5061,,BRD:BRD-K76911699-003-03-9,rep_single_dose,SR-BI INHIBITOR,,,,,,,NA,,
IU1,IU1,,BRD:BRD-BRD-K45841694-001-11-7;BRD:BRD-K45841694-001-11-7;CTRP:272805,ctrp;rep_primary;rep_single_dose,UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR,USP14,,,PRECLINICAL,,,NA,"CC1CC(C(=O)CN2CCCC2)C(C)N1-C1CCC(F)CC1, CC1CC(C(=O)CN2CCCC2)C(C)N1-C1CCC(F)CC1, CC1CC(C(=O)CN2CCCC2)C(C)N1-C1CCC(F)CC1",
S-16257-2,AMG 998;AMG-998;CORLANOR;CORLENTOR;IVABRADINE;IVABRADINE HCL;IVABRADINE HYDROCHLORIDE;PROCORALAN;S 16257;S-16257;S-16257-2,CHEMBL2145077;CHEMBL471737,BRD:BRD-BRD-K31385749-003-01-3;BRD:BRD-K31385749-003-01-3,rep_primary;rep_single_dose,"HCN CHANNEL ANTAGONIST, POTASSIUM CHANNEL BLOCKER, SODIUM CHANNEL BLOCKER",HCN1;HCN3;HCN4,ANGINA PECTORIS,,LAUNCHED,,Small molecule,4,COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2.Cl;COC1CC2C[C@@H](CN(C)CCCN3CCC4CC(OC)C(OC)CC4CC3=O)C2CC1OC,HLUKNZUABFFNQS-ZMBIFBSDSA-N
VX-770,IVACAFTOR;KALYDECO;VX-770,CHEMBL2010601,BRD:BRD-BRD-K52818472-001-02-2;BRD:BRD-K52818472-001-02-2,rep_primary;rep_single_dose,CFTR CHANNEL POTENTIATOR,CFTR,CYSTIC FIBROSIS,,LAUNCHED,,Small molecule,4,CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O;CC(C)(C)C1CC(C(NC(=O)C2C[NH]C3CCCCC3C2=O)CC1O)C(C)(C)C,PURKAOJPTOLRMP-UHFFFAOYSA-N
ZIMECTERIN,"22,23-DIHYDRO C-076B1;22,23-DIHYDROABAMECTIN;22,23-DIHYDROAVERMECTIN B1;22,23-DIHYDROAVERMECTIN B1A;ACAREXX;BIMECTIN;BOVINET;CARDOMEC;CARDOTEK 30;CD-5024;CD5024;CEVAMEC;DIHYDROAVERMECTIN B1A;EQUIMEC;EQVALAN;HEARTGARD;HEARTGUARD;HYVERMECTIN;IVECTIN;IVERMECTIN;IVERMECTIN B1A;IVERMECTIN COMPONENT B1A;IVERTIN;IVOMEC;IVOSINT;JETAMEC;L 640471;L-640471;MECTIZAN;MK 933;MK-933;NORAMECTIN;NOROMECTIN;NSC-755843;ORAMEC;PANDEX;PHOENECTIN;SKLICE;SOOLANTRA;STROMECTOL;UVEMEC;VERMIC;VETMEC;ZIMECTERIN",CHEMBL1200633,BRD:BRD-BRD-K85554912-001-06-3;BRD:BRD-BRD-K85554912-001-08-9;BRD:BRD-K85554912-001-06-3;BRD:BRD-K85554912-001-08-9,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,CHRNA7;GABRB3;GLRA3;P2RX7,"GASTROINTESTINAL ROUNDWORMS, LUNGWORMS, CATTLE GRUBS, MITES, LICE, HORN FLIES",,LAUNCHED,,Unknown,4,"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O;CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2, CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2, CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2, CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2",SPBDXSGPUHCETR-JFUDTMANSA-N
TIBSOVO,AG-120;IVOSIDENIB;TIBSOVO,CHEMBL3989958,BRD:BRD-BRD-K93073858-001-01-1;BRD:BRD-K93073858-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,ISOCITRATE DEHYDROGENASE INHIBITOR,IDH1,ACUTE MYELOID LEUKEMIA (AML),,LAUNCHED,,Small molecule,4,FC1CNCC(C1)N([C@H](C(=O)NC1CC(F)(F)C1)C1CCCCC1CL)C(=O)[C@@H]1CCC(=O)N1C1CC(CCN1)C#N;N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,WIJZXSAJMHAVGX-DHLKQENFSA-N
IWP-L6,IWP-L6,,BRD:BRD-BRD-K53234107-001-01-6;BRD:BRD-K53234107-001-01-6,rep_primary;rep_single_dose,PORCUPINE INHIBITOR,PORCN,,,PRECLINICAL,,,NA,O=C(CSC1NC2CCSC2C(=O)N1-C1CCCCC1)NC1CCC(CN1)-C1CCCCC1,
NSC-747973,AZAEPOTHILONE B;BMS 247550-01;BMS-247550;BMS-247550-01;IXABEPILONE;IXEMPRA;IXEMPRA KIT;NSC-747973,CHEMBL1201752,BRD:BRD-BRD-K03601870-001-01-2;BRD:BRD-K03601870-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,MICROTUBULE STABILIZING AGENT,TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8,BREAST CANCER,,LAUNCHED,,Small molecule,4,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C1CSC(C)N1;C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1,FABUFPQFXZVHFB-PVYNADRNSA-N
NINLARO,IXAZOMIB;MLN-2238;MLN-9708 FREE BASE;MLN2238;NINLARO,CHEMBL2141296,BRD:BRD-BRD-K78659596-001-03-9;BRD:BRD-K78659596-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,PROTEASOME INHIBITOR,,MULTIPLE MYELOMA,,LAUNCHED,,Small molecule,4,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O;CC(C)C[C@H](NC(=O)CNC(=O)C1CC(CL)CCC1CL)B(O)O,MXAYKZJJDUDWDS-LBPRGKRZSA-N
IXAZOMIB-CITRATE,IXAZOMIB-CITRATE,,BRD:BRD-A66419424-001-02-4;BRD:BRD-BRD-A66419424-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,PROTEASOME INHIBITOR,,MULTIPLE MYELOMA,,LAUNCHED,,,NA,CC(C)C[C@H](NC(=O)CNC(=O)C1CC(CL)CCC1CL)B1OC(=O)CC(CC(O)=O)(O1)C(O)=O,
J147,J-147;J147,CHEMBL2387144,BRD:BRD-K00004699-001-01-9,rep_single_dose,BDNF INDUCER,,,,,,Small molecule,1,COc1cccc(/C=N/N(C(=O)C(F)(F)F)c2ccc(C)cc2C)c1,HYMZAYGFKNNHDN-SSDVNMTOSA-N
JD-5037,JD-5037,,BRD:BRD-K00003271-001-01-9,rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,,,,,,,NA,,
OPNURASIB,JDQ 443;JDQ-443;JDQ443;NVP-JDQ-443;NVP-JDQ443;OPNURASIB,CHEMBL5077861,BRD:BRD-K00126788-001-01-9,oncref_2,INHIBITOR OF KRAS-G12C,KRAS,,,,,Small molecule,3,C=CC(=O)N1CC2(CC(n3nc(-c4ccc5c(cnn5C)c4)c(-c4c(Cl)c(C)cc5[nH]ncc45)c3C)C2)C1,AZUYLZMQTIKGSC-UHFFFAOYSA-N
RTI-JDTIC,JDTIC;RTI-JDTIC,CHEMBL415247,BRD:BRD-BRD-K95837862-300-01-7;BRD:BRD-K95837862-300-01-7,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRK1,,,PHASE 1,,Small molecule,1,CC(C)[C@@H](CN1CC[C@](C)([C@@H](C)C1)C1CCCC(O)C1)NC(=O)[C@H]1CC2CCC(O)CC2CN1;CC(C)[C@@H](CN1CC[C@@](C)(c2cccc(O)c2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1,ZLVXBBHTMQJRSX-VMGNSXQWSA-N
JHW-007,JHW-007,,BRD:BRD-K32892871-003-02-9,rep_single_dose,DOPAMINE REUPTAKE INHIBITOR,SLC6A3,,,,,,NA,,
JI-101,ANGIOGENESIS INHIBITOR JI-101;CGI-1842;JI-101,CHEMBL3545155,BRD:BRD-K00003209-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,Small molecule,2,COc1ccc(Br)cc1NC(=O)Nc1cccc2c1ccn2Cc1ccnc(N)c1,ZXBFYBLSJMEBEP-UHFFFAOYSA-N
JIB04,JIB04,,BRD:BRD-BRD-K76180386-001-01-6;BRD:BRD-K76180386-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,HISTONE LYSINE DEMETHYLASE INHIBITOR,KDM4E,,,PRECLINICAL,,,NA,"CLC1CCC(N\N=C(/C2CCCCC2)C2CCCCN2)NC1, CLC1CCC(N\N=C(/C2CCCCC2)C2CCCCN2)NC1, CLC1CCC(N\N=C(/C2CCCCC2)C2CCCCN2)NC1",
JK-184,JK-184,,BRD:BRD-BRD-K38860038-001-01-2;BRD:BRD-K38860038-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,HEDGEHOG PATHWAY INHIBITOR,,,,PRECLINICAL,,,NA,"CCOC1CCC(NC2NC(CS2)-C2C(C)NC3CCCCN23)CC1, CCOC1CCC(NC2NC(CS2)-C2C(C)NC3CCCCN23)CC1, CCOC1CCC(NC2NC(CS2)-C2C(C)NC3CCCCN23)CC1",
JNJ-10191584,JNJ-10191584,,BRD:BRD-BRD-K15086322-050-01-3;BRD:BRD-K15086322-050-01-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH4,,,PRECLINICAL,,,NA,"CN1CCN(CC1)C(=O)C1NC2CCC(CL)CC2[NH]1, CN1CCN(CC1)C(=O)C1NC2CCC(CL)CC2[NH]1",
JNJ-10397049,JNJ-10397049,,BRD:BRD-K61721596-001-01-0,rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR1;HCRTR2,,,,,,NA,,
JNJ-16259685,JNJ-16259685,,BRD:BRD-BRD-K25596805-001-01-8;BRD:BRD-K25596805-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM1,,,PRECLINICAL,,,NA,"CO[C@H]1CC[C@H](CC1)C(=O)C1CCC2NC3OCCCC3CC2C1, CO[C@H]1CC[C@H](CC1)C(=O)C1CCC2NC3OCCCC3CC2C1",
JNJ-1661010,JNJ-1661010,,BRD:BRD-BRD-K47376733-001-08-1;BRD:BRD-K47376733-001-08-1,rep_primary;rep_single_dose,FAAH INHIBITOR,FAAH,,,PRECLINICAL,,,NA,"O=C(NC1CCCCC1)N1CCN(CC1)C1NC(NS1)-C1CCCCC1, O=C(NC1CCCCC1)N1CCN(CC1)C1NC(NS1)-C1CCCCC1",
JNJ-17203212,JNJ-17203212,,BRD:BRD-BRD-K51770398-001-01-9;BRD:BRD-K51770398-001-01-9,rep_primary;rep_single_dose,TRPV ANTAGONIST,TRPV1,,,PRECLINICAL,,,NA,"FC(F)(F)C1CCC(NC(=O)N2CCN(CC2)C2NCCCC2C(F)(F)F)NC1, FC(F)(F)C1CCC(NC(=O)N2CCN(CC2)C2NCCCC2C(F)(F)F)NC1",
QUISINOSTAT HYDROCHLORIDE,JNJ 26481585;JNJ-26481585;JNJ-26481585-AAC;QUISINOSTAT;QUISINOSTAT HYDROCHLORIDE,CHEMBL2105763;CHEMBL3039527,BRD:BRD-BRD-K83837640-001-04-8;BRD:BRD-K83837640-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC10;HDAC11;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9;MDM2,,,PHASE 2,,Small molecule,-1,Cl.Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21;CN1CC(CNCC2CCN(CC2)C2NCC(CN2)C(=O)NO)C2CCCCC12,TWNOICNTTFKOHQ-UHFFFAOYSA-N
SERDEMETAN,JNJ-26854165;SERDEMETAN,CHEMBL2137530,GDSC1:1133,gdsc,,,,,,,Small molecule,1,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,CEGSUKYESLWKJP-UHFFFAOYSA-N
JNJ-26990990,JNJ-26990990,,BRD:BRD-BRD-K24864897-001-01-0;BRD:BRD-K24864897-001-01-0,rep_primary;rep_single_dose,ANTICONVULSANT,,,,PHASE 2,,,NA,NS(=O)(=O)NCC1CSC2CCCCC12,
JNJ-27141491,JNJ-27141491,,BRD:BRD-K41895652-001-02-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR2,,,,,,NA,,
JNJ-37822681,JNJ-37822681,CHEMBL3234237,BRD:BRD-BRD-K31802667-001-01-9;BRD:BRD-K31802667-001-01-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2,,,PHASE 2,,Small molecule,2,FC1CCC(CN2CCC(CC2)NC2CCC(NN2)C(F)(F)F)CC1F;Fc1ccc(CN2CCC(Nc3ccc(C(F)(F)F)nn3)CC2)cc1F,UVUYWJWYRLJHEN-UHFFFAOYSA-N
JNJ-38877605,JNJ-38877605,CHEMBL2133806,BRD:BRD-BRD-K02123250-001-06-7;BRD:BRD-K02123250-001-06-7,rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,MET,,,PHASE 1,,Small molecule,1,Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1;CN1CC(CN1)-C1CCC2NNC(N2N1)C(F)(F)C1CCC2NCCCC2C1,JRWCBEOAFGHNNU-UHFFFAOYSA-N
OMO-1,JNJ-38877618;JNJ38877618;OMO 1;OMO-1,CHEMBL5095255,BRD:BRD-K00003094-001-01-9,rep_single_dose,C-MET INHIBITOR,,,,,,Small molecule,1,FC(F)(c1ccc2ncccc2c1)c1nnc2ccc(-c3ccncc3)nn12,KOAWAWHSMVKCON-UHFFFAOYSA-N
JNJ39758979,JNJ 39758979;JNJ-39758979;JNJ39758979,CHEMBL3236549,BRD:BRD-K00003403-001-01-9,rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,CC(C)c1cc(N2CC[C@@H](N)C2)nc(N)n1,COOGVHJHSCBOQT-MRVPVSSYSA-N
JNJ-40411813,ADX-71149;JNJ-40411813,CHEMBL3337527,BRD:BRD-BRD-K55029398-001-01-6;BRD:BRD-K55029398-001-01-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM2,,,PHASE 2,,Small molecule,2,CCCCn1ccc(N2CCC(c3ccccc3)CC2)c(Cl)c1=O;CCCCN1CCC(N2CCC(CC2)C2CCCCC2)C(CL)C1=O,HYOGJHCDLQSAHX-UHFFFAOYSA-N
JNJ-42041935,JNJ-42041935,,BRD:BRD-BRD-K01036220-001-01-0;BRD:BRD-K01036220-001-01-0,rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,PDK2,,,PRECLINICAL,,,NA,OC(=O)C1CNN(C1)-C1NC2CC(CL)C(OC(F)(F)F)CC2[NH]1,
JNJ-42165279,JNJ-42165279,CHEMBL4297294,BRD:BRD-BRD-K70330032-001-01-1;BRD:BRD-K70330032-001-01-1,rep_primary;rep_single_dose,FAAH INHIBITOR,FAAH,,,PHASE 2,,Small molecule,2,FC1(F)OC2CCC(CN3CCN(CC3)C(=O)NC3CNCCC3CL)CC2O1;O=C(Nc1cnccc1Cl)N1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1,YWGYNGCRVZLMCS-UHFFFAOYSA-N
JNJ-47965567,JNJ-47965567,,BRD:BRD-K83547600-001-02-9,rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX7,,,,,,NA,,
JNJ-5207852,JNJ-5207852,CHEMBL129542,BRD:BRD-K27889527-001-10-9,rep_single_dose,,,,,,,Small molecule,NA,c1cc(OCCCN2CCCCC2)ccc1CN1CCCCC1,PTKHFRNHJULJKT-UHFFFAOYSA-N
JNJ-54175446,JNJ-54175446,CHEMBL4079239,BRD:BRD-K00004575-001-01-9,rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,,,,,,Small molecule,2,C[C@@H]1c2nnn(-c3ncc(F)cn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl,CWFVVQFVGMFTBD-SECBINFHSA-N
JNJ-63533054,JNJ-63533054,,BRD:BRD-BRD-K19482962-001-01-8;BRD:BRD-K19482962-001-01-8,rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,GPR139,,,PRECLINICAL,,,NA,C[C@H](NC(=O)CNC(=O)C1CCCC(CL)C1)C1CCCCC1,
ONAMETOSTAT,JNJ-64619178;JNJ64619178;ONAMETOSTAT,CHEMBL4249337,BRD:BRD-K30421675-001-04-9,rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,,,,,,Small molecule,1,Nc1nc2cc(CC[C@H]3C[C@@H](n4ccc5c(N)ncnc54)[C@H](O)[C@@H]3O)ccc2cc1Br,DBSMLQTUDJVICQ-CJODITQLSA-N
JNJ-678,JNJ-678,,BRD:BRD-K00004600-001-01-9,rep_single_dose,RSV FUSION INHIBITOR,,,,,,,NA,,
JNJ-7706621,JNJ-7706621,CHEMBL191003,BRD:BRD-BRD-K11636097-001-03-1;BRD:BRD-K11636097-001-03-1,rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,AURKA;AURKB;CDK1;CDK2,,,PRECLINICAL,,Small molecule,NA,NC1NC(NC2CCC(CC2)S(N)(=O)=O)NN1C(=O)C1C(F)CCCC1F;Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,KDKUVYLMPJIGKA-UHFFFAOYSA-N
JNJ-7777120,JNJ-7777120,CHEMBL129198,BRD:BRD-BRD-K17774839-001-02-9;BRD:BRD-K17774839-001-02-9,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH4,,,PRECLINICAL,,Small molecule,NA,"CN1CCN(C(=O)c2cc3cc(Cl)ccc3[nH]2)CC1;CN1CCN(CC1)C(=O)C1CC2CC(CL)CCC2[NH]1, CN1CCN(CC1)C(=O)C1CC2CC(CL)CCC2[NH]1",HUQJRYMLJBBEDO-UHFFFAOYSA-N
JNJ38877605,JNJ38877605,,GDSC1:284,gdsc,,,,,,,,NA,,
JNK INHIBITOR VIII,JNK INHIBITOR VIII,,GDSC1:1043,gdsc,,,,,,,,NA,,
TURIMYCIN A5,EN-141;IOSALIDE;JOMYBEL;JOSAMINA;JOSAMYCIN;JOSAMYCIN PROPIONATE;KITASAMYCIN A3;LEUCOMYCIN A3;TURIMYCIN A5,CHEMBL224436,BRD:BRD-BRD-K25837718-001-03-8;BRD:BRD-K25837718-001-03-8,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,BRONCHITIS,,LAUNCHED,,Small molecule,3,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O;CO[C@H]1[C@@H](CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C)OC(C)=O,XJSFLOJWULLJQS-NGVXBBESSA-N
JPH203,JPH203,,BRD:BRD-K00003340-300-01-9,rep_single_dose,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,,,,,,,NA,,
JQ-1,JQ-1,,CTRP:616354;GDSC1:1218;GDSC1:163;GDSC2:2172,ctrp;gdsc,,,,,,,,NA,,
JQ-1:CARBOPLATIN (1:1 MOL/MOL),JQ-1:CARBOPLATIN (1:1 MOL/MOL),,CTRP:660247,ctrp,,,,,,,,NA,,
JQ-1:MK-0752 (1:1 MOL/MOL),JQ-1:MK-0752 (1:1 MOL/MOL),,CTRP:660253,ctrp,,,,,,,,NA,,
JQ-1:NAVITOCLAX (2:1 MOL/MOL),JQ-1:NAVITOCLAX (2:1 MOL/MOL),,CTRP:660252,ctrp,,,,,,,,NA,,
JQ-1:UNC0638 (2:1 MOL/MOL),JQ-1:UNC0638 (2:1 MOL/MOL),,CTRP:660129,ctrp,,,,,,,,NA,,
JQ-1:VORINOSTAT (2:1 MOL/MOL),JQ-1:VORINOSTAT (2:1 MOL/MOL),,CTRP:660823,ctrp,,,,,,,,NA,,
JQ1,(+)-JQ-1;JQ1,,GDSC1:1218;GDSC1:163;GDSC2:2172,gdsc,,,,,,,,NA,,
JQ1-(+),JQ1-(+),,BRD:BRD-BRD-K54606188-001-13-1;BRD:BRD-K54606188-001-13-1,rep_multi_dose;rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD4;BRDT,,,PRECLINICAL,,,NA,"CC1SC-2C(C1C)C(=N[C@@H](CC(=O)OC(C)(C)C)C1NNC(C)N-21)C1CCC(CL)CC1, CC1SC-2C(C1C)C(=N[C@@H](CC(=O)OC(C)(C)C)C1NNC(C)N-21)C1CCC(CL)CC1",
JQ12,JQ12,,GDSC1:164,gdsc,,,,,,,,NA,,
JTC-801,JTC-801,,BRD:BRD-BRD-K17705806-003-04-4;BRD:BRD-K17705806-003-04-4,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRL1,,,PHASE 2,,,NA,"CCC1CCC(OCC2CCCCC2C(=O)NC2CCC3NC(C)CC(N)C3C2)CC1, CCC1CCC(OCC2CCCCC2C(=O)NC2CCC3NC(C)CC(N)C3C2)CC1, CCC1CCC(OCC2CCCCC2C(=O)NC2CCC3NC(C)CC(N)C3C2)CC1",
JTE-013,JTE-013,,BRD:BRD-K43330982-001-04-9,rep_single_dose,LYSOPHOSPHOLIPID RECEPTOR ANTAGONIST,P2RY10;S1PR2,,,,,,NA,,
JTE-607,JTE-607,,BRD:BRD-BRD-K81405859-300-01-4;BRD:BRD-K81405859-300-01-4,rep_multi_dose;rep_primary;rep_single_dose,CYTOKINE PRODUCTION INHIBITOR,IL10;IL1B;IL6;TNF,,,PHASE 2,,,NA,"CCOC(=O)[C@H](CC1CCCCC1)NC(=O)C1CC(CL)C(OCCN2CCN(C)CC2)C(CL)C1O, CCOC(=O)[C@H](CC1CCCCC1)NC(=O)C1CC(CL)C(OCCN2CCN(C)CC2)C(CL)C1O",
JTE-907,JTE-907,,BRD:BRD-BRD-K63150726-001-02-1;BRD:BRD-K63150726-001-02-1,rep_primary;rep_single_dose,CANNABINOID RECEPTOR INVERSE AGONIST,CNR2,,,PHASE 1,,,NA,"CCCCCOC1C(OC)CCC2CC(C(=O)NCC3CCC4OCOC4C3)C(=O)[NH]C12, CCCCCOC1C(OC)CCC2CC(C(=O)NCC3CCC4OCOC4C3)C(=O)[NH]C12",
JW-480,JW-480,,CTRP:660227,ctrp,,,,,,,,NA,,
JW-55,JW-55,,BRD:BRD-BRD-K53328210-001-04-4;BRD:BRD-K53328210-001-04-4;CTRP:682993,ctrp;rep_primary;rep_single_dose,TANKYRASE INHIBITOR,TNKS;TNKS2,,,PRECLINICAL,,,NA,COC1CCC(CC1)C1(CNC(=O)C2CCC(NC(=O)C3CCCO3)CC2)CCOCC1,
JW-642,JW-642,,BRD:BRD-K48424871-001-04-9,rep_single_dose,MONOACYLGLYCEROL LIPASE INHIBITOR,MGLL,,,,,,NA,,
JW-67,JW-67,,BRD:BRD-BRD-K24554037-001-08-3;BRD:BRD-K24554037-001-08-3,rep_primary;rep_single_dose,WNT PATHWAY INHIBITOR,APC;AXIN1;GSK3B,,,PRECLINICAL,,,NA,O=C1NC2CCCCC2C11OCC2(CO1)COC1(OC2)C(=O)NC2CCCCC12,
JW-7-24-1,JW-7-24-1,,GDSC1:256,gdsc,,,,,,,,NA,,
JW-7-52-1,JW-7-52-1,,GDSC1:83,gdsc,,,,,,,,NA,,
JW-74,JW-74,,BRD:BRD-BRD-K75664313-001-02-6;BRD:BRD-K75664313-001-02-6;CTRP:676728,ctrp;rep_primary;rep_single_dose,"TANKYRASE INHIBITOR, WNT SIGNALING INHIBITOR",TNKS;TNKS2,,,PRECLINICAL,"Multiple values for MOA: {'WNT SIGNALING INHIBITOR, TANKYRASE INHIBITOR', 'TANKYRASE INHIBITOR, WNT SIGNALING INHIBITOR'}, defaulting to 'TANKYRASE INHIBITOR, WNT SIGNALING INHIBITOR'",,NA,"COC1CCC(CC1)-N1C(SCC2NC(NO2)-C2CCC(C)CC2)NNC1-C1CCNCC1, COC1CCC(CC1)-N1C(SCC2NC(NO2)-C2CCC(C)CC2)NNC1-C1CCNCC1",
JWZ-5-13,JWZ-5-13,,BRD:BRD-U00115420-001-01-9,oncref_1,VHL-BASED DEGRADER OF CDK7,CDK7,,,,,,NA,,
JX-401,JX-401,,BRD:BRD-BRD-K05464208-001-05-7;BRD:BRD-K05464208-001-05-7,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK14,,,PRECLINICAL,,,NA,"COC1CC(SC)CCC1C(=O)N1CCC(CC2CCCCC2)CC1, COC1CC(SC)CCC1C(=O)N1CCC(CC2CCCCC2)CC1",
JZL-184,JZL-184,,BRD:BRD-BRD-K45446451-001-05-0;BRD:BRD-K45446451-001-05-0,rep_multi_dose;rep_primary;rep_single_dose,MONOACYLGLUCEROL LIPASE INHIBITOR,MGLL,,,PRECLINICAL,,,NA,"OC(C1CCN(CC1)C(=O)OC1CCC(CC1)[N+]([O-])=O)(C1CCC2OCOC2C1)C1CCC2OCOC2C1, OC(C1CCN(CC1)C(=O)OC1CCC(CC1)[N+]([O-])=O)(C1CCC2OCOC2C1)C1CCC2OCOC2C1",
JZL-195,JZL-195,,BRD:BRD-BRD-K38875233-001-03-9;BRD:BRD-K38875233-001-03-9,rep_primary;rep_single_dose,"FAAH INHIBITOR, MONOACYLGLYCEROL LIPASE INHIBITOR",FAAH;MGLL,,,PRECLINICAL,,,NA,[O-][N+](=O)C1CCC(OC(=O)N2CCN(CC3CCCC(OC4CCCCC4)C3)CC2)CC1,
K-858,K-858,,BRD:BRD-A67748489-001-10-0;BRD:BRD-BRD-A67748489-001-10-0,rep_multi_dose;rep_primary;rep_single_dose,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,KIF11,,,PRECLINICAL,,,NA,CC(=O)NC1=NN(C(C)=O)C(C)(S1)C1CCCCC1,
K-MAP,K-MAP,,BRD:BRD-A45906415-001-01-9;BRD:BRD-BRD-A45906415-001-01-9,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,OCC1OC(NC2CCC(CC2)C(O)=O)C(O)C(O)C1O,
K-RAS(G12C)-INHIBITOR-12,K-RAS(G12C)-INHIBITOR-12,,BRD:BRD-K90756851-001-01-1,rep_single_dose,K-RAS INHIBITOR,KRAS,,,,,,NA,,
K-RAS(G12C)-INHIBITOR-6,K-RAS(G12C)-INHIBITOR-6,,BRD:BRD-BRD-K26305185-001-02-1;BRD:BRD-K26305185-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,K-RAS INHIBITOR,,,,PRECLINICAL,,,NA,"SCCCC(=O)NC1CCN(CC1)C(=O)COC1CCC(CL)CC1CL, SCCCC(=O)NC1CCN(CC1)C(=O)COC1CCC(CL)CC1CL",
K-STROPHANTHIDIN,K-STROPHANTHIDIN,,BRD:BRD-A55312468-001-04-7;BRD:BRD-BRD-A55312468-001-04-7,rep_multi_dose;rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP1A1,,,PHASE 2,,,NA,C[C@]12CCC3C(CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]1(O)CCC2C1=CC(=O)OC1,
K02288,K02288,,BRD:BRD-BRD-K58568447-001-01-1;BRD:BRD-K58568447-001-01-1,rep_primary;rep_single_dose,BONE MORPHOGENIC PROTEIN INHIBITOR,BMP1,,,PRECLINICAL,,,NA,"COC1CC(CC(OC)C1OC)-C1CC(CNC1N)-C1CCCC(O)C1, COC1CC(CC(OC)C1OC)-C1CC(CNC1N)-C1CCCC(O)C1, COC1CC(CC(OC)C1OC)-C1CC(CNC1N)-C1CCCC(O)C1",
K145,K145,,BRD:BRD-K12106308-003-01-9,rep_single_dose,SPHINGOSINE KINASE INHIBITOR,SPHK2,,,,,,NA,,
TRIFOLITIN,KAEMPFEROL;KEMPFEROL;PELARGIDENOLON;POPULNETIN;RHAMNOLUTEIN;RHAMNOLUTIN;ROBIGENIN;SWARTZIOL;TRIFOLITIN,CHEMBL150,BRD:BRD-BRD-K12807006-001-18-5;BRD:BRD-K12807006-001-18-5,rep_primary;rep_single_dose,"BONE RESORPTION INHIBITOR, ESTROGEN-RELATED RECEPTOR INVERSE AGONIST",AKR1B1;ALOX15B;ALOX5;AR;CYP1B1;GLO1;HSD17B1;UGT3A1,,,PRECLINICAL,,Small molecule,NA,"O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12;OC1CCC(CC1)-C1OC2CC(O)CC(O)C2C(=O)C1O, OC1CCC(CC1)-C1OC2CC(O)CC(O)C2C(=O)C1O, OC1CCC(CC1)-C1OC2CC(O)CC(O)C2C(=O)C1O",IYRMWMYZSQPJKC-UHFFFAOYSA-N
KAF156,GANAPLACIDE;GNF 156;GNF-156;KAF 156;KAF-156;KAF156,CHEMBL2058833,BRD:BRD-K00004578-001-01-9,rep_single_dose,ANTIMALARIAL AGENT,,,,,,Small molecule,2,CC1(C)c2nc(-c3ccc(F)cc3)c(Nc3ccc(F)cc3)n2CCN1C(=O)CN,BUPRVECGWBHCQV-UHFFFAOYSA-N
KAINIC-ACID,KAINIC-ACID,,BRD:BRD-BRD-K52459018-001-09-1;BRD:BRD-K52459018-001-09-1,rep_primary;rep_single_dose,KAINATE RECEPTOR AGONIST,GRIA1;GRIK1;GRIK2;GRIK3;GRIK4;GRIK5,,,PRECLINICAL,,,NA,CC(=C)[C@H]1CN[C@@H]([C@H]1CC(O)=O)C(O)=O,
PUERARIN 80 MM,DAIDZEIN 8-C-GLUCOSIDE;KAKONEIN;NPI 031G;NSC-380711;PUERARIN;PUERARIN 80 MM,CHEMBL486386,BRD:BRD-A07815743-001-01-1;BRD:BRD-BRD-A07815743-001-01-1,rep_primary;rep_single_dose,"GABA RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",,,,PHASE 2,,Small molecule,2,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12;OCC1OC(C(O)C(O)C1O)C1C(O)CCC2C1OCC(-C1CCC(O)CC1)C2=O,HKEAFJYKMMKDOR-VPRICQMDSA-N
KARENITECIN,KARENITECIN,CHEMBL1743260,BRD:BRD-K00003176-001-01-9,rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,,,Small molecule,3,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CC[Si](C)(C)C)cccc3nc2-1,SYXGVIWFCCQOEK-VWLOTQADSA-N
KARTOGENIN,KARTOGENIN,,BRD:BRD-K27584835-001-02-9,rep_single_dose,CHONDROCYTE DIFFERENTIATION STIMULATOR,FLNA,,,,,,NA,,
KASUGAMYCIN,KASUGAMYCIN,CHEMBL1631109,BRD:BRD-K91644281-311-02-9,rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,,,,,Small molecule,NA,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]2O)[C@@H](N)C[C@@H]1NC(=N)C(=O)O,PVTHJAPFENJVNC-MHRBZPPQSA-N
KB NB 142-70,KB NB 142-70,,GDSC1:407,gdsc,,,,,,,,NA,,
KB-0742 (DIHYDROCHLORIDE),KB-0742 (DIHYDROCHLORIDE),,BRD:BRD-K00010521-300-02-9,rep_single_dose,,,,,,,,NA,,
KB-R7943,KB-R7943,,BRD:BRD-BRD-K17743697-066-03-6;BRD:BRD-K17743697-066-03-6,rep_primary;rep_single_dose,SODIUM/CALCIUM EXCHANGE INHIBITOR,SLC8A1;TRPC3;TRPC5;TRPC6,,,PRECLINICAL,,,NA,"NC(=N)SCCC1CCC(OCC2CCC(CC2)[N+]([O-])=O)CC1, NC(=N)SCCC1CCC(OCC2CCC(CC2)[N+]([O-])=O)CC1",
KB-SRC-4,KB-SRC-4,,BRD:BRD-BRD-K88154110-001-01-0;BRD:BRD-K88154110-001-01-0,rep_primary;rep_single_dose,SRC INHIBITOR,SRC,,,PRECLINICAL,,,NA,NC1NCNC2N(NC(-C3CCC(CL)CC3)C12)-C1CCCC(C1)-C1CNNN1CC1CCCC(C1)-C1CCCCC1,
KBG,KBG,,BRD:BRD-A00376169-001-01-6;BRD:BRD-BRD-A00376169-001-01-6,rep_primary;rep_single_dose,NEPRILYSIN INHIBITOR,MME,,,PHASE 2,,,NA,OC1O[C@@H]2COC(O[C@H]2[C@H](O)[C@H]1O)C1CCCCC1,
KD-023,KD-023,,BRD:BRD-BRD-K71164191-001-01-0;BRD:BRD-K71164191-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,ACAT INHIBITOR,ACACA;ACACB,,,PHASE 2,,,NA,CCCCCCCCCCCCCCOC1CCC(O1)C(O)=O,
SLX-2119 FREE BASE,BELUMOSUDIL;KD-025;KD025;ROCK2 INHIBITOR KD025;SLX-2119;SLX-2119 FREE BASE,CHEMBL2005186,BRD:BRD-BRD-K88506063-001-01-8;BRD:BRD-K88506063-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK2,,,PHASE 2,,Small molecule,4,CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1;CC(C)NC(=O)COC1CCCC(C1)-C1NC(NC2CCC3[NH]NCC3C2)C2CCCCC2N1,GKHIVNAUVKXIIY-UHFFFAOYSA-N
KENPAULLONE,KENPAULLONE,CHEMBL296586,BRD:BRD-BRD-K37312348-001-15-0;BRD:BRD-K37312348-001-15-0,rep_multi_dose;rep_primary;rep_single_dose,"CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",CCNB1;CDK1;CDK5;GSK3B,,,PRECLINICAL,,Small molecule,NA,"BRC1CCC2[NH]C-3C(CC(=O)NC4CCCCC-34)C2C1, BRC1CCC2[NH]C-3C(CC(=O)NC4CCCCC-34)C2C1;O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1",QQUXFYAWXPMDOE-UHFFFAOYSA-N
SUFREXAL,"KETANSERIN;KETANSERIN TARTRATE;KJK 945;NSC-758959;PERKETAN;R 49945;R-41,468;R-41468;R-49945;SEREPRESS;SUFREXAL",CHEMBL51,BRD:BRD-BRD-K49671696-045-08-5;BRD:BRD-K49671696-045-08-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;DRD1;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C;HTR5A;HTR7;SLC18A1;SLC18A2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"FC1CCC(CC1)C(=O)C1CCN(CCN2C(=O)[NH]C3CCCCC3C2=O)CC1, FC1CCC(CC1)C(=O)C1CCN(CCN2C(=O)[NH]C3CCCCC3C2=O)CC1, FC1CCC(CC1)C(=O)C1CCN(CCN2C(=O)[NH]C3CCCCC3C2=O)CC1;O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1",FPCCSQOGAWCVBH-UHFFFAOYSA-N
XOLEGEL,"(-)-(2S,4R)-KETOCONAZOLE;(2S,4R)-;2S,4R KETOCONAZOLE;2S,4R-KETOCONAZOLE;COR-003;COR003;DAKTARIN GOLD;DAKTARIN INTENSIV;DANDRAZOL;DANDRID;DIO-902;EXTINA;J02AB02;KETOCONAZOLE;KETOCONAZOLUM;KETOPINE;KETOSIDIN;KETOZOLE;LEVOKETOCONAZOLE;NIZORAL;NIZORAL A-D;NIZORAL ANTI-DANDRUFF;NIZORELLE;NORMOCORT;NSC-317629;PANFUNGOL;R 41,400;R-41400;RECORLEV;XOLEGEL",CHEMBL157101;CHEMBL295698,BRD:BRD-A38350138-001-04-9;BRD:BRD-BRD-A38350138-001-04-9,rep_multi_dose;rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,AR;CYP19A1;CYP21A2;KCNA10,SEBORRHEIC DERMATITIS,,LAUNCHED,,Small molecule,4,"CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1;CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1;CC(=O)N1CCN(CC1)C1CCC(OC[C@H]2CO[C@@](CN3CCNC3)(O2)C2CCC(CL)CC2CL)CC1, CC(=O)N1CCN(CC1)C1CCC(OC[C@H]2CO[C@@](CN3CCNC3)(O2)C2CCC(CL)CC2CL)CC1, CC(=O)N1CCN(CC1)C1CCC(OC[C@H]2CO[C@@](CN3CCNC3)(O2)C2CCC(CL)CC2CL)CC1, CC(=O)N1CCN(CC1)C1CCC(OCC2CO[C@@](CN3CCNC3)(O2)C2CCC(CL)CC2CL)CC1",XMAYWYJOQHXEEK-UHFFFAOYSA-N;XMAYWYJOQHXEEK-ZEQKJWHPSA-N
KETOHEXOKINASE-INHIBITOR-1,KETOHEXOKINASE-INHIBITOR-1,,BRD:BRD-K00003341-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,,NA,,
VALKET 200 RETARD,"(RS)-KETOPROFEN;(S)-;(S)-KETOPROFEN;19583RP;ACTRON;ACTRON KETOPROFEN;ALRHEUMAT;ANEOL;ARVELES;AXORID;CAPISTEN;DEXKETOPROFEN;FENOKET 200;HYDRATROPIC ACID;IDEA-033;ISO-K;JOMETHID XL;KERAL;KETOCID 200;KETONAL;KETOPROFEN;KETORIN;KETOTARD 200 XL;KETOVAIL;KETOZIP 200 XL;LARAFEN;LARAFEN CR;M-BENZOYL-;NEXCEDE;NSC-758144;ORUDIS;ORUDIS 100;ORUDIS KT;ORUVAIL;ORUVAIL 100;ORUVAIL 150;ORUVAIL 200;ORUVAIL IM;POWERGEL;R.P. 19,583;R.P. 19583;RP-19583;RU-4733;SECTOR;TILOKET;TILOKET CR;VALKET 200 RETARD",CHEMBL571;CHEMBL75435,BRD:BRD-A97739905-001-26-5;BRD:BRD-BRD-A97739905-001-26-5,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,CXCR1;PTGS1;PTGS2;SLC5A8,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS",,LAUNCHED,,Small molecule,4,"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1;CC(C(O)=O)C1CCCC(C1)C(=O)C1CCCCC1, CC(C(O)=O)C1CCCC(C1)C(=O)C1CCCCC1",DKYWVDODHFEZIM-UHFFFAOYSA-N
KETOROLAC,KETOROLAC,CHEMBL469,BRD:BRD-A40639672-234-18-0;BRD:BRD-BRD-A40639672-234-18-0,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,LAUNCHED,,Small molecule,4,"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O;OC(=O)C1CCN2C1CCC2C(=O)C1CCCCC1, OC(=O)C1CCN2C1CCC2C(=O)C1CCCCC1, OC(=O)C1CCN2C1CCC2C(=O)C1CCCCC1",OZWKMVRBQXNZKK-UHFFFAOYSA-N
KETOTIFEN,(R)-KETOTIFEN;KETOTIFEN,CHEMBL534,BRD:BRD-BRD-K28936863-051-33-0,rep_primary,"HISTAMINE RECEPTOR AGONIST, LEUKOTRIENE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",HRH1;PDE4A;PDE4B;PDE4C;PDE4D;PDE7A;PDE7B;PDE8A;PDE8B;PGD,ITCHING,,LAUNCHED,,Small molecule,4,"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1;CN1CCC(CC1)=C1C2CCSC2C(=O)CC2CCCCC12, CN1CCC(CC1)=C1C2CCSC2C(=O)CC2CCCCC12, CN1CCC(CC1)=C1C2CCSC2C(=O)CC2CCCCC12",ZCVMWBYGMWKGHF-UHFFFAOYSA-N
THIOUREIDOBUTYRONITRILE,4-ISOTHIOUREIDOBUTYRONITRILE;KEVETRIN;NSC-525990;THIOUREIDOBUTYRONITRILE,CHEMBL4297540,BRD:BRD-BRD-K61339991-003-01-8;BRD:BRD-K61339991-003-01-8,rep_primary;rep_single_dose,P53 ACTIVATOR,,,,PHASE 1,,Small molecule,2,N#CCCCSC(=N)N;NC(=N)SCCCC#N,PRDJGNVQBVXXEO-UHFFFAOYSA-N
KF-38789,KF-38789,,BRD:BRD-A54927599-001-16-9;BRD:BRD-BRD-A54927599-001-16-9,rep_multi_dose;rep_primary;rep_single_dose,P SELECTIN INHIBITOR,SELP,,,PRECLINICAL,,,NA,"COC1CCC(C2CC(=NCCS2)C2C(O)CC(C)OC2=O)C(OC)C1, COC1CCC(C2CC(=NCCS2)C2C(O)CC(C)OC2=O)C(OC)C1",
KG-5,KG-5,,BRD:BRD-BRD-K90747162-001-01-4;BRD:BRD-K90747162-001-01-4,rep_primary;rep_single_dose,RAF INHIBITOR,BRAF;FLT3;KIT;PDGFRB,,,PRECLINICAL,,,NA,CSC1NC(N)CC(OC2CCC(CC2)-C2NNC(NC3CCCC(C3)C(F)(F)F)[NH]2)N1,
KH-CB19,KH-CB19,,CTRP:660085,ctrp,,,,,,,,NA,,
VISCARDAN,AMMIVIN;CORONIN;KHELLIN;KHELLOYD;NSC-25509;NSC-37744;VISCARDAN,CHEMBL44746,BRD:BRD-BRD-K80353807-001-25-3;BRD:BRD-K80353807-001-25-3,rep_primary;rep_single_dose,VASODILATOR,,,,PHASE 2,,Small molecule,-1,"COC1C2CCOC2C(OC)C2OC(C)CC(=O)C12, COC1C2CCOC2C(OC)C2OC(C)CC(=O)C12;COc1c2occc2c(OC)c2c(=O)cc(C)oc12",HSMPDPBYAYSOBC-UHFFFAOYSA-N
KHK-IN-1,KHK-IN-1,,BRD:BRD-K84605263-003-01-6,rep_single_dose,HEXOKINASE INHIBITOR,KHK,,,,,,NA,,
KHS-101,KHS-101,,BRD:BRD-BRD-K78978711-003-01-3;BRD:BRD-K78978711-003-01-3,rep_primary;rep_single_dose,NEURAL STEM CELL INDUCER,TACC3,,,PRECLINICAL,,,NA,CC(C)CNC1CCNC(NCC2CSC(N2)-C2CCCCC2)N1,
KHS101,KHS101,,CTRP:660819,ctrp,,,,,,,,NA,,
KI-16425,KI-16425,,BRD:BRD-A25569250-001-03-3;BRD:BRD-BRD-A25569250-001-03-3,rep_multi_dose;rep_primary;rep_single_dose,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,LPAR1;LPAR3,,,PRECLINICAL,,,NA,CC(OC(=O)NC1C(C)NOC1-C1CCC(CSCCC(O)=O)CC1)C1CCCCC1CL,
KI-20227,KI-20227,,BRD:BRD-A88787317-001-01-0;BRD:BRD-BRD-A88787317-001-01-0,rep_primary;rep_single_dose,C-FMS INHIBITOR,CSF1R;KDR;KIT;PDGFRB,,,PRECLINICAL,,,NA,COC1CC(OC2CCNC3CC(OC)C(OC)CC23)CCC1NC(=O)NC(C)C1NCCS1,
KI-8751,KI-8751,,BRD:BRD-BRD-K47150025-001-05-3;BRD:BRD-K47150025-001-05-3,rep_multi_dose;rep_primary;rep_single_dose,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",KDR,,,PRECLINICAL,,,NA,"COC1CC2NCCC(OC3CCC(NC(=O)NC4CCC(F)CC4F)C(F)C3)C2CC1OC, COC1CC2NCCC(OC3CCC(NC(=O)NC4CCC(F)CC4F)C(F)C3)C2CC1OC, COC1CC2NCCC(OC3CCC(NC(=O)NC4CCC(F)CC4F)C(F)C3)C2CC1OC",
KI16198,KI16198,,BRD:BRD-A94323479-001-02-8;BRD:BRD-BRD-A94323479-001-02-8,rep_primary;rep_single_dose,LIPOPROTEIN ANTAGONIST,LPA,,,PRECLINICAL,,,NA,COC(=O)CCSCC1CCC(CC1)-C1ONC(C)C1NC(=O)OC(C)C1CCCCC1CL,
KI8751,KI8751,,CTRP:375560,ctrp,,,,,,,,NA,,
KIFUNENSINE,KIFUNENSINE,CHEMBL1233851,BRD:BRD-BRD-K02898090-001-02-7;BRD:BRD-K02898090-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,MANNOSIDASE INHIBITOR,MAN1B1;MAN2A1,,,PHASE 1,,Small molecule,NA,O=C1N[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)N2C1=O;OC[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H]2NC(=O)C(=O)N12,OIURYJWYVIAOCW-PQMKYFCFSA-N
KIN001-013,KIN001-013,,GDSC1:52,gdsc,,,,,,,,NA,,
KIN001-019,CGP 60474;CGP60474;KIN001-019,,GDSC1:53,gdsc,,,,,,,,NA,,
KIN001-021,CGP-082996;CINK4;KIN001-021,,GDSC1:54,gdsc,,,,,,,,NA,,
KIN001-042,KIN001-042,,GDSC1:289,gdsc,,,,,,,,NA,,
KIN001-102,AKT INHIBITOR VIII;AKTI-1/2;KIN001-102,,GDSC1:171;GDSC1:228,gdsc,,,,,,,,NA,,
KIN001-111,A-770041;KIN001-111,,GDSC1:55,gdsc,,,,,,,,NA,,
KIN001-112,KIN001-112,,GDSC1:56,gdsc,,,,,,,,NA,,
KIN001-127,BMS-509744;ITK INHIBITOR;KIN001-127,,GDSC1:63,gdsc,,,,,,,,NA,,
KIN001-128,CMK;KIN001-128,,GDSC1:64,gdsc,,,,,,,,NA,,
KIN001-135,GSK-319347A;GSK319347A;IKK-3 INHIBITOR;KIN001-135,CHEMBL373751,GDSC1:91,gdsc,,,,,,,Small molecule,NA,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC,LDTAHRLHGHFHKP-UHFFFAOYSA-N
KIN001-139,A-443654;A-4436554;KIN001-139,CHEMBL379300,GDSC1:86,gdsc,,,,,,,Small molecule,NA,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,YWTBGJGMTBHQTM-IBGZPJMESA-N
KIN001-173,AS-605240;AS605240;KIN001-173,,GDSC1:224,gdsc,,,,,,,,NA,,
PONATINIB HYDROCHLORIDE,AP-24534;AP-24534 HCL;AP24534;AP24534 HCL;ICLUSIG;KIN001-192;PONATINIB;PONATINIB HYDROCHLORIDE,CHEMBL1171837;CHEMBL2105708,GDSC1:155,gdsc,,,,,,,Small molecule,4,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl,BWTNNZPNKQIADY-UHFFFAOYSA-N
KIN001-204,JNK INHIBITOR 9L;JNK-9L;KIN001-204,,GDSC1:157,gdsc,,,,,,,,NA,,
KIN001-206,HG6-64-1;KIN001-206,,GDSC1:159,gdsc,,,,,,,,NA,,
KIN001-236,KIN001-236,,GDSC1:286,gdsc,,,,,,,,NA,,
KIN001-242,FMK;KIN001-242,,GDSC1:231,gdsc,,,,,,,,NA,,
KIN001-260,ACHP;BAYER IKKB INHIBITOR;KIN001-260,,GDSC1:290,gdsc,,,,,,,,NA,,
KIN001-266,KIN001-266,,GDSC1:291,gdsc,,,,,,,,NA,,
KIN001-270,CDK9 INHIBITOR;CDK9-IN-1;KIN001-270,,GDSC1:345,gdsc,,,,,,,,NA,,
KINETIN,KINETIN,CHEMBL228792,BRD:BRD-BRD-K65667145-001-14-0;BRD:BRD-K65667145-001-14-0,rep_primary;rep_single_dose,CELL DIVISION INDUCER,,SUNBURN,,LAUNCHED,,Small molecule,NA,C(NC1NCNC2[NH]CNC12)C1CCCO1;c1coc(CNc2ncnc3[nH]cnc23)c1,QANMHLXAZMSUEX-UHFFFAOYSA-N
KL-001,KL-001,,BRD:BRD-A94580299-001-10-4;BRD:BRD-BRD-A94580299-001-10-4,rep_primary;rep_single_dose,PROTEASOME INHIBITOR,CRY1;CRY2,,,PRECLINICAL,,,NA,CS(=O)(=O)N(CC(O)CN1C2CCCCC2C2CCCCC12)CC1CCCO1,
PTX-008,CALIXARENE 0118;KM-0118;OTX-008;OTX008;PTX-008,CHEMBL221186,BRD:BRD-K00005245-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,Small molecule,1,CN(C)CCNC(=O)COc1c2cccc1Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)C2,CQVAQQNDZCZBSU-UHFFFAOYSA-N
KME-4,KME-4,,BRD:BRD-K00004747-001-01-9,rep_single_dose,PROSTAGLANDIN INHIBITOR,,,,,,,NA,,
KML29,KML29,,BRD:BRD-BRD-K46734292-001-03-6;BRD:BRD-K46734292-001-03-6,rep_primary;rep_single_dose,MONOACYLGLUCEROL LIPASE INHIBITOR,MGLL,,,PRECLINICAL,,,NA,OC(C1CCN(CC1)C(=O)OC(C(F)(F)F)C(F)(F)F)(C1CCC2OCOC2C1)C1CCC2OCOC2C1,
KN-62,KN-62,,BRD:BRD-A81177136-001-12-7;BRD:BRD-BRD-A81177136-001-12-7,rep_primary;rep_single_dose,"CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR, PURINERGIC RECEPTOR ANTAGONIST",AKT1;CAMK2A;CHEK1;LCK;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;P2RX7;PRKCA;ROCK1;RPS6KB1;SGK1,,,PRECLINICAL,,,NA,CN(C(CC1CCC(OS(=O)(=O)C2CCCC3CNCCC23)CC1)C(=O)N1CCN(CC1)C1CCCCC1)S(=O)(=O)C1CCCC2CNCCC12,
KN-93,KN-93,,BRD:BRD-BRD-K93480852-003-01-0;BRD:BRD-K93480852-003-01-0,rep_primary;rep_single_dose,CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR,CAMK2A,,,PRECLINICAL,,,NA,"COC1CCC(CC1)S(=O)(=O)N(CCO)C1CCCCC1CN(C)C\C=C\C1CCC(CL)CC1, COC1CCC(CC1)S(=O)(=O)N(CCO)C1CCCCC1CN(C)C\C=C\C1CCC(CL)CC1, COC1CCC(CC1)S(=O)(=O)N(CCO)C1CCCCC1CN(C)C\C=C\C1CCC(CL)CC1",
KO-143,KO-143,,CTRP:418172,ctrp,,,,,,,,NA,,
KO143,KO143,,BRD:BRD-BRD-K64642496-001-04-0;BRD:BRD-K64642496-001-04-0,rep_primary;rep_single_dose,BCRP INHIBITOR,ABCB1;ABCC1,,,PRECLINICAL,,,NA,"COC1CCC2C3C[C@@H]4N([C@@H](CC(C)C)C3[NH]C2C1)C(=O)[C@H](CCC(=O)OC(C)(C)C)NC4=O, COC1CCC2C3C[C@@H]4N([C@@H](CC(C)C)C3[NH]C2C1)C(=O)[C@H](CCC(=O)OC(C)(C)C)NC4=O",
KOBE2602,KOBE2602,,GDSC1:563,gdsc,,,,,,,,NA,,
KOJIC ACID,5-HYDROXY-2-(HYDROXYMETHYL)-4-PYRONE;KOJIC ACID,CHEMBL287556,BRD:BRD-K20878815-001-06-9,rep_single_dose,,,,,,,Small molecule,NA,O=c1cc(CO)occ1O,BEJNERDRQOWKJM-UHFFFAOYSA-N
SN-1212,DHDAC;KP-1212;KP1212;SN-1212,CHEMBL3086524,BRD:BRD-BRD-K46690591-001-01-2;BRD:BRD-K46690591-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,NC1=NC(=O)N([C@H]2C[C@H](O)[C@@H](CO)O2)CN1;NC1=NC(=O)N(CN1)[C@H]1C[C@@H](O)[C@@H](CO)O1,LAOLDMMWVYDDID-KVQBGUIXSA-N
KPT-185,KPT-185,,BRD:BRD-BRD-K71467466-001-02-3;BRD:BRD-K71467466-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,EXPORTIN ANTAGONIST,XPO1,,,PRECLINICAL,,,NA,COC1CC(CC(C1)C(F)(F)F)-C1NCN(\C=C/C(=O)OC(C)C)N1,
KPT-276,KPT-276,,BRD:BRD-BRD-K75352575-001-01-3;BRD:BRD-K75352575-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,EXPORTIN ANTAGONIST,XPO1,,,PRECLINICAL,,,NA,FC(F)(F)C1CC(CC(C1)C(F)(F)F)-C1NCN(N1)\C=C/C(=O)N1CC(F)(F)C1,
PAK4-IN-1,KPT 9274;KPT-9274;PADNARSERTIB;PAK4-IN-1,CHEMBL4297467,BRD:BRD-K00004701-001-01-9,rep_single_dose,NAMPT INHIBITOR,,,,,,Small molecule,1,Nc1ccc(/C=C/C(=O)NCc2cc3cc(-c4ccc(C(=O)N5CCC(F)(F)CC5)cc4)cc(-c4ccc(F)cc4)c3o2)cn1,MRFOPLWJZULAQD-SWGQDTFXSA-N
KPT185,KPT185,,CTRP:660935,ctrp,,,,,,,,NA,,
KR-33494,KR-33494,,BRD:BRD-K00004587-001-01-9,rep_single_dose,CELL DEATH INHIBITOR,,,,,,,NA,,
KRAS (G12C) INHIBITOR-12,GTPL8020;KRAS (G12C) INHIBITOR-12,,GDSC2:1855,gdsc,,,,,,,,NA,,
KRCA-0008,KRCA-0008,,BRD:BRD-K40604024-001-02-9,rep_single_dose,ALK INIHIBITOR,ALK,,,,,,NA,,
KRN633,K00589A;KRN-633;KRN633,CHEMBL406381,BRD:BRD-BRD-K90993449-001-02-7;BRD:BRD-K90993449-001-02-7,rep_primary;rep_single_dose,VEGFR INHIBITOR,FLT1;FLT4;KDR,,,PRECLINICAL,,Small molecule,1,CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl;CCCNC(=O)NC1CCC(OC2NCNC3CC(OC)C(OC)CC23)CC1CL,VPBYZLCHOKSGRX-UHFFFAOYSA-N
TIVOZANIB HYDROCHLORIDE MONOHYDRATE,ASP-4130;AV 951;AV-951;FOTIVDA;KIL-8951;KIL8951;KRN-951;TIVOZANIB;TIVOZANIB HYDROCHLORIDE;TIVOZANIB HYDROCHLORIDE MONOHYDRATE,CHEMBL1289494;CHEMBL2105756,GDSC1:312,gdsc,,,,,,,Small molecule,4,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC.Cl.O,RQXMKRRBJITKRN-UHFFFAOYSA-N
KS-176,KS-176,,BRD:BRD-BRD-K81053848-001-01-0;BRD:BRD-K81053848-001-01-0,rep_primary;rep_single_dose,BCRP INHIBITOR,ABCG2,,,PRECLINICAL,,,NA,OCCC1CCC(NC(=O)C2CCCCC2NC(=O)C2CCC(CC2)[N+]([O-])=O)CC1,
KT-433,KT-433,,BRD:BRD-BRD-K66437909-001-01-0;BRD:BRD-K66437909-001-01-0,rep_primary;rep_single_dose,URICOSURIC AGENT,,,,PHASE 2,,,NA,CCC1OC2CCCCC2C1C(=O)C1CCC(OCC(O)=O)CC1,
KU 0060648,KU 0060648,,CTRP:632119,ctrp,,,,,,,,NA,,
KU-0063794,KU-0063794,,BRD:BRD-BRD-K67566344-001-07-5;BRD:BRD-K67566344-001-07-5;CTRP:606363,ctrp;rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PRECLINICAL,,,NA,"COC1CCC(CC1CO)-C1CCC2C(NC(NC2N1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1, COC1CCC(CC1CO)-C1CCC2C(NC(NC2N1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1",
KU-60019,KU-60019,,BRD:BRD-BRD-K36016295-001-04-5;BRD:BRD-K36016295-001-04-5;CTRP:660411,ctrp;rep_primary;rep_single_dose,ATM KINASE INHIBITOR,ATM,,,PRECLINICAL,,,NA,"C[C@H]1CN(CC(=O)NC2CCC3SC4C(CC3C2)CCCC4-C2CC(=O)CC(O2)N2CCOCC2)C[C@@H](C)O1, C[C@H]1CN(CC(=O)NC2CCC3SC4C(CC3C2)CCCC4-C2CC(=O)CC(O2)N2CCOCC2)C[C@@H](C)O1, C[C@H]1CN(CC(=O)NC2CCC3SC4C(CC3C2)CCCC4-C2CC(=O)CC(O2)N2CCOCC2)C[C@@H](C)O1",
KU14R,KU14R,,BRD:BRD-A38747044-001-02-3;BRD:BRD-BRD-A38747044-001-02-3,rep_primary;rep_single_dose,IMIDAZOLINE RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,"CCC1(CC2CCCCC2O1)C1NCC[NH]1, CCC1(CC2CCCCC2O1)C1NCC[NH]1",
KU55933,KU55933,,GDSC1:1030;GDSC2:1030,gdsc,,,,,,,,NA,,
KUROMANIN,KUROMANIN,CHEMBL257839,BRD:BRD-BRD-K51337109-003-01-3;BRD:BRD-K51337109-003-01-3,rep_primary;rep_single_dose,RIBOSYL CYCLASE INHIBITOR,CD38,,,PRECLINICAL,,Small molecule,NA,OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O;OC[C@H]1O[C@@H](OC2CC3C(O)CC(O)CC3[O+]C2-C2CCC(O)C(O)C2)[C@H](O)[C@@H](O)[C@@H]1O,RKWHWFONKJEUEF-GQUPQBGVSA-O
KW-2449,KW 2449;KW-2449,CHEMBL1908397,BRD:BRD-BRD-K21718444-001-06-8;BRD:BRD-K21718444-001-06-8;CTRP:660413,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"ABL KINASE INHIBITOR, AURORA KINASE INHIBITOR, FLT3 INHIBITOR",ABL1;AURKA;AURKB;FLT3,,,PHASE 1,,Small molecule,1,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1;O=C(N1CCNCC1)C1CCC(CC1)\C=C\C1N[NH]C2CCCCC12,YYLKKYCXAOBSRM-JXMROGBWSA-N
KW-2478,KW 2478;KW-2478,CHEMBL4297298;CHEMBL4300557,BRD:BRD-BRD-K41213548-001-02-0;BRD:BRD-K41213548-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,,,,PHASE 1/PHASE 2,,Small molecule,1,CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC;CCC1C(O)CC(O)C(C(=O)C2CCC(OCCN3CCOCC3)C(OC)C2)C1CC(=O)N(CCOC)CCOC;CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC.Cl,CKMGYWHSTADSIG-UHFFFAOYSA-N;VFUXSYAXEKYYMB-UHFFFAOYSA-N
ROLOFYLLINE,KW 3902;KW-3902;MK-7418;ROLOFYLLINE,CHEMBL52333,BRD:BRD-A95683721-001-03-8;BRD:BRD-BRD-A95683721-001-03-8,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PHASE 3,,Small molecule,3,CCCn1c(=O)c2nc(C34CC5CC(CC3C5)C4)[nH]c2n(CCC)c1=O;CCCN1C2NC([NH]C2C(=O)N(CCC)C1=O)C12CC3CC1CC(C2)C3,PJBFVWGQFLYWCB-UHFFFAOYSA-N
TIRBANIBULIN,KLISYRI;KX-01;KX-2-391;KX-2391;KX2-391;KX2391;TIRBANIBULIN,CHEMBL571546,BRD:BRD-BRD-K29968218-001-03-2;BRD:BRD-K29968218-001-03-2;CTRP:660779,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"SRC INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",SRC,,,PHASE 2,,Small molecule,4,O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1;O=C(CC1CCC(CN1)-C1CCC(OCCN2CCOCC2)CC1)NCC1CCCCC1,HUNGUWOZPQBXGX-UHFFFAOYSA-N
KY02111,KY02111,,BRD:BRD-BRD-K13302470-001-02-7;BRD:BRD-K13302470-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,WNT PATHWAY INHIBITOR,DKK1,,,PRECLINICAL,,,NA,"COC1CCC(CCC(=O)NC2NC3CCC(CL)CC3S2)CC1OC, COC1CCC(CCC(=O)NC2NC3CCC(CL)CC3S2)CC1OC",
KYNURENIC-ACID,KYNURENIC-ACID,,BRD:BRD-BRD-K85872723-001-15-9;BRD:BRD-K85872723-001-15-9,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GPR35;GRIN1;GRIN2A;GRIN2B,,,PRECLINICAL,,,NA,"OC(=O)C1CC(O)C2CCCCC2N1, OC(=O)C1CC(O)C2CCCCC2N1",
L-(+)-RHAMNOSE-MONOHYDRATE,L-(+)-RHAMNOSE-MONOHYDRATE,,BRD:BRD-A86354194-002-01-7;BRD:BRD-BRD-A86354194-002-01-7,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,C[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O,
L-152804,L-152804,,BRD:BRD-A42553870-001-14-3;BRD:BRD-BRD-A42553870-001-14-3,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPY5R,,,PRECLINICAL,,,NA,"CC1(C)CC(=O)C(C2C3CCCCC3OC3=C2C(=O)CC(C)(C)C3)C(=O)C1, CC1(C)CC(=O)C(C2C3CCCCC3OC3=C2C(=O)CC(C)(C)C3)C(=O)C1",
L-161982,L-161982,,BRD:BRD-BRD-K39733634-001-02-6;BRD:BRD-K39733634-001-02-6,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGER4,,,PRECLINICAL,,,NA,"CCCCC1NN(-C2CCCCC2C(F)(F)F)C(=O)N1CC1CCC(CC1)-C1CCCCC1S(=O)(=O)NC(=O)C1SCCC1C, CCCCC1NN(-C2CCCCC2C(F)(F)F)C(=O)N1CC1CCC(CC1)-C1CCCCC1S(=O)(=O)NC(=O)C1SCCC1C",
L-165041,L-165041,,BRD:BRD-BRD-K98372770-001-08-2;BRD:BRD-K98372770-001-08-2,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARD,,,PRECLINICAL,,,NA,"CCCC1C(OCCCOC2CCC(OCC(O)=O)CC2)CCC(C(C)=O)C1O, CCCC1C(OCCCOC2CCC(OCC(O)=O)CC2)CCC(C(C)=O)C1O",
L-168049,L-168049,,BRD:BRD-BRD-K18036262-001-02-8;BRD:BRD-K18036262-001-02-8,rep_primary;rep_single_dose,GLUCAGON RECEPTOR ANTAGONIST,GCGR,,,PRECLINICAL,,,NA,"CCCOC1CCC(BR)CC1-C1CC([NH]C1-C1CCNCC1)-C1CCC(CL)CC1, CCCOC1CCC(BR)CC1-C1CC([NH]C1-C1CCNCC1)-C1CCC(CL)CC1",
LY-365260,L-365260;LY-365260,CHEMBL9387,BRD:BRD-BRD-K34277641-001-01-2;BRD:BRD-K34277641-001-01-2,rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKAR;CCKBR;KCNQ1,,,PHASE 2,,Small molecule,NA,Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1;CN1C2CCCCC2C(=N[C@@H](NC(=O)NC2CCCC(C)C2)C1=O)C1CCCCC1,KDFQABSFVYLGPM-QFIPXVFZSA-N
L-368899,L-368899,,BRD:BRD-A43930669-003-02-8;BRD:BRD-BRD-A43930669-003-02-8,rep_primary;rep_single_dose,OXYTOCIN RECEPTOR ANTAGONIST,AVPR1A;AVPR2;OXTR,,,PHASE 1,,,NA,"CC1CCCCC1N1CCN(CC1)S(=O)(=O)CC12CCC(C[C@@H]1NC(=O)[C@@H](N)CCS(C)(=O)=O)C2(C)C, CC1CCCCC1N1CCN(CC1)S(=O)(=O)CC12CCC(C[C@@H]1NC(=O)[C@@H](N)CCS(C)(=O)=O)C2(C)C",
"L-655,708","L-655,708",,BRD:BRD-BRD-K13474508-001-01-2;BRD:BRD-K13474508-001-01-2,rep_primary;rep_single_dose,GABA RECEPTOR INVERSE AGONIST,GABRA1;GABRA2;GABRA3;GABRA5;GABRG2,,,PRECLINICAL,,,NA,"CCOC(=O)C1NCN-2C1[C@@H]1CCCN1C(=O)C1CC(OC)CCC-21, CCOC(=O)C1NCN-2C1[C@@H]1CCCN1C(=O)C1CC(OC)CCC-21",
L-655240,L-655240,,BRD:BRD-BRD-K89402695-001-02-3;BRD:BRD-K89402695-001-02-3,rep_primary;rep_single_dose,THROMBOXANE RECEPTOR ANTAGONIST,PTGES,,,PHASE 1,,,NA,"CC1C(CC(C)(C)C(O)=O)N(CC2CCC(CL)CC2)C2CCC(F)CC12, CC1C(CC(C)(C)C(O)=O)N(CC2CCC(CL)CC2)C2CCC(F)CC12",
L-670596,L-670596,,BRD:BRD-A85472596-001-02-2;BRD:BRD-BRD-A85472596-001-02-2,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,CS(=O)(=O)C1CCC(CN2C3C(CC(O)=O)CCCC3C3CC(F)CC(F)C23)CC1,
L-685458,L-685458,,CTRP:411717,ctrp,,,,,,,,NA,,
L-689560,L-689560,,BRD:BRD-K74284736-001-04-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,,,,NA,,
L-693403,L-693403,,BRD:BRD-BRD-K83322645-050-01-9;BRD:BRD-K83322645-050-01-9,rep_primary;rep_single_dose,"SIGMA RECEPTOR AGONIST, SIGMA RECEPTOR ANTAGONIST",DRD2;SIGMAR1,,,PRECLINICAL,,,NA,C(N1CCC2(CCC3CCCCC23)CC1)C1CCCCC1,
L-694247,L-694247,CHEMBL39317,BRD:BRD-K18816859-001-06-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D,,,,,Small molecule,NA,CS(=O)(=O)Nc1ccc(Cc2noc(-c3ccc4[nH]cc(CCN)c4c3)n2)cc1,HKXMQLISPYELRD-UHFFFAOYSA-N
L-701252,L-701252,,BRD:BRD-BRD-K10176267-001-03-3;BRD:BRD-K10176267-001-03-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1,,,PRECLINICAL,,,NA,OC1C(C(=O)C2CC2)C(=O)[NH]C2CC(CL)CCC12,
L-701324,L-701324,,BRD:BRD-BRD-K08109516-001-07-8;BRD:BRD-K08109516-001-07-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,PRECLINICAL,,,NA,"OC1C(-C2CCCC(OC3CCCCC3)C2)C(=O)[NH]C2CC(CL)CCC12, OC1C(-C2CCCC(OC3CCCCC3)C2)C(=O)[NH]C2CC(CL)CCC12",
"L-732,138","L-732,138",,BRD:BRD-BRD-K37952347-001-01-4;BRD:BRD-K37952347-001-01-4,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1;TACR2,,,PRECLINICAL,,,NA,"CC(=O)N[C@H](CC1C[NH]C2CCCCC12)C(=O)OCC1CC(CC(C1)C(F)(F)F)C(F)(F)F, CC(=O)N[C@H](CC1C[NH]C2CCCCC12)C(=O)OCC1CC(CC(C1)C(F)(F)F)C(F)(F)F",
L-733060,L-733060,,BRD:BRD-BRD-K15791587-003-02-5;BRD:BRD-K15791587-003-02-5,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1,,,PRECLINICAL,,,NA,FC(F)(F)C1CC(CO[C@H]2CCCN[C@H]2C2CCCCC2)CC(C1)C(F)(F)F,
L-741742,L-741742,,BRD:BRD-BRD-K13211965-003-02-8;BRD:BRD-K13211965-003-02-8,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD3;DRD4;SCN1A;SCN3A,,,PRECLINICAL,,,NA,CC1C(NOC1-C1CCC(CL)CC1)C1CCN(CCC2CCCCC2)CC1,
L-745870,L-745870,CHEMBL267014,BRD:BRD-BRD-K05528470-305-02-2;BRD:BRD-K05528470-305-02-2,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD2;DRD3;DRD4;HTR1A;HTR2A;HTR6;HTR7,,,PRECLINICAL,,Small molecule,NA,"CLC1CCC(CC1)N1CCN(CC2C[NH]C3NCCCC23)CC1, CLC1CCC(CC1)N1CCN(CC2C[NH]C3NCCCC23)CC1;Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1",OGJGQVFWEPNYSB-UHFFFAOYSA-N
L-755507,L-755507,CHEMBL12998,BRD:BRD-K39359968-001-03-9,rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2;ADRB3,,,,,Small molecule,NA,CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1,NYYJKMXNVNFOFQ-MHZLTWQESA-N
L-760735,L-760735,,BRD:BRD-K30425481-003-02-9,rep_single_dose,TACHYKININ ANTAGONIST,TACR1,,,,,,NA,,
L-778123,"L-778,123;L-778123",CHEMBL279433;CHEMBL4297396,BRD:BRD-BRD-K10958118-003-01-5;BRD:BRD-K10958118-003-01-5,rep_primary;rep_single_dose,FARNESYLTRANSFERASE INHIBITOR,FNTA;FNTB;PGGT1B,,,PHASE 1,,Small molecule,1,Cl.N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1;CLC1CCCC(C1)N1CCN(CC2CNCN2CC2CCC(CC2)C#N)CC1=O;N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1,JNUGFGAVPBYSHF-UHFFFAOYSA-N;YNBSQYGTJLIPJS-UHFFFAOYSA-N
L-798106,"L-798,106;L-798106",,BRD:BRD-BRD-K43905307-001-01-2;BRD:BRD-K43905307-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGER3,,,PRECLINICAL,,,NA,"COC1CCC(BR)CC1S(=O)(=O)NC(=O)\C=C\C1CCCCC1CC1CCC2CCCCC2C1, COC1CCC(BR)CC1S(=O)(=O)NC(=O)\C=C\C1CCCCC1CC1CCC2CCCCC2C1",
L-838417,L-838417,,BRD:BRD-BRD-K46647427-001-02-0;BRD:BRD-K46647427-001-02-0,rep_primary;rep_single_dose,GABA RECEPTOR PARTIAL AGONIST,GABRA1;GABRA2;GABRA3;GABRA5,,,PRECLINICAL,,,NA,CN1NCNC1COC1NN2C(NNC2CC1C(C)(C)C)-C1CC(F)CCC1F,
VX-105,ARGININE;ARGININE BUTANOATE;ARGININE BUTYRATE;BUTANOATE (3:4);HQK-1004;L-ARGININE;METHYL ESTER;METHYL P-TOLUENESULFONYL-L-ARGININATE;N1-TOSYL-L-ARGININE METHYL ESTER;N2-((4-METHYLPHENYL)SULFONYL)-;NSC-206269;TAME (PHARMACEUTICAL);VX 105;VX-105,CHEMBL1485;CHEMBL4297982;CHEMBL44752,BRD:BRD-BRD-K76811153-003-01-3;BRD:BRD-K76811153-003-01-3,rep_primary;rep_single_dose,NITRIC OXIDE PRECURSOR,ARG2;ASL;ASS1;AZIN2;GPRC6A;NOS2;NOS3;SLC7A1;SLC7A3;SLC7A4,"CONGESTIVE HEART FAILURE, HYPERTENSION, CORONARY ARTERY DISEASE (CAD), CLAUDICATION, SENILE DEMENTIA, ERECTILE DYSFUNCTION, INFERTILITY, COMMON COLD",,LAUNCHED,,Unknown,2,N[C@H](CCCNC(N)=N)C(O)=O,
L-ASPARAGINE-N-HYDROXY,L-ASPARAGINE-N-HYDROXY,,BRD:BRD-BRD-K82178523-001-01-6;BRD:BRD-K82178523-001-01-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,N[C@@H](CC(=O)NO)C(O)=O,
L-ASPARTIC-ACID,L-ASPARTIC-ACID,,BRD:BRD-BRD-K97163964-001-03-3;BRD:BRD-K97163964-001-03-3,rep_primary;rep_single_dose,METALLIC RADICAL FORMATION STIMULANT,ACY1;ACY3;ADSS;ADSSL1;ASNS;ASPA;ASPH;ASRGL1;ASS1;CAD;DARS;DARS2;GOT1;GOT2;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;LYZ;PAICS;RNASE1;SLC1A1;SLC25A12;SLC25A13,,,LAUNCHED,,,NA,"N[C@@H](CC(O)=O)C(O)=O, N[C@@H](CC(O)=O)C(O)=O",
NSC-27425,CITRULLINE;L-CITRULLINE;NSC-27425,CHEMBL444814,BRD:BRD-A12237696-001-04-2;BRD:BRD-BRD-A12237696-001-04-2,rep_primary;rep_single_dose,NITRIC OXIDE STIMULANT,ASS1;DDAH1;DDAH2;GPRC6A;NOS1;NOS2;NOS3;OTC;PADI1;PADI2;PADI3;PADI4;PADI6,"HYPERTENSION, ERECTILE DYSFUNCTION",,LAUNCHED,,Small molecule,3,NC(=O)NCCC[C@H](N)C(=O)O;NC(CCCNC(N)=O)C(O)=O,RHGKLRLOHDJJDR-BYPYZUCNSA-N
L-CYSTEINESULFINIC-ACID,L-CYSTEINESULFINIC-ACID,,BRD:BRD-A25800195-001-02-2;BRD:BRD-BRD-A25800195-001-02-2,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM1;GRM5;GSR;HMGCS2;PAPOLA;PRDX2,,,PRECLINICAL,,,NA,N[C@@H](CS(O)=O)C(O)=O,
L-CYSTINE,L-CYSTINE,,BRD:BRD-A15397381-001-02-5;BRD:BRD-BRD-A15397381-001-02-5,rep_primary;rep_single_dose,,CTNS;SLC3A1;SLC7A11;SLC7A9,,,LAUNCHED,,,NA,"NC(CSSCC(N)C(O)=O)C(O)=O, NC(CSSCC(N)C(O)=O)C(O)=O, N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O",
L-ERGOTHIONEINE,L-ERGOTHIONEINE,,BRD:BRD-BRD-K26341917-001-01-3;BRD:BRD-K26341917-001-01-3,rep_primary;rep_single_dose,FREE RADICAL SCAVENGER,,,,PHASE 2,,,NA,C[N+](C)(C)[C@@H](CC1C[NH]C(=S)[NH]1)C(O)=O,
L-GLUTAMIC-ACID,L-GLUTAMIC-ACID,,BRD:BRD-BRD-K62309135-001-05-2;BRD:BRD-K62309135-001-05-2,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,AADAT;AASS;ABAT;ALDH18A1;ASNS;BCAT1;BCAT2;CCBL2;DNPEP;EARS2;ENPEP;EPRS;FOLH1;FPGS;FTCD;GAD1;GAD2;GATB;GCLC;GCLM;GGCX;GLS;GLS2;GLUD1;GLUD2;GLUL;GMPS;GOT1;GOT2;GPT;GPT2;GRIA1;GRIA2;GRIA3;GRIA4;GRID1;GRID2;GRIK1;GRIK2;GRIK3;GRIK4;GRIK5;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B;GRM1;GRM2;GRM3;GRM4;GRM6;GRM7;GRM8;LGSN;NADSYN1;NAGS;OPLAH;PFAS;PGCP;PSAT1;SLC1A1;SLC1A2;SLC1A3;SLC1A6;SLC1A7;SLC25A18;SLC25A22;SLC7A11;TAT,,,LAUNCHED,,,NA,N[C@@H](CCC(O)=O)C(O)=O,
L-HYDROXYPROLINE,L-HYDROXYPROLINE,,BRD:BRD-A12454076-001-01-9;BRD:BRD-BRD-A12454076-001-01-9,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,OC1CNC(C1)C(O)=O,
L-KYNURENINE,L-KYNURENINE,CHEMBL498416,BRD:BRD-K20497775-001-06-9,rep_single_dose,ARYL HYDROCARBON RECEPTOR AGONIST,,,,,,Small molecule,1,Nc1ccccc1C(=O)C[C@H](N)C(=O)O,YGPSJZOEDVAXAB-QMMMGPOBSA-N
RACEMETHIONINE,L-METHIONINE;METHIONINE;NSC-22946;RACEMETHIONINE,CHEMBL42336,BRD:BRD-BRD-K06502269-001-02-6;BRD:BRD-K06502269-001-02-6,rep_primary;rep_single_dose,VOLTAGE-GATED CALCIUM CHANNEL LIGAND,BHMT;BHMT2;METAP2;MTR;MTRR,,,LAUNCHED,,Small molecule,4,CSCC[C@H](N)C(=O)O;CSCC[C@H](N)C(O)=O,FFEARJCKVFRZRR-BYPYZUCNSA-N
NG-NITRO-L-ARGININE METHYL ESTER,L-NAME;NG-NITRO-L-ARGININE METHYL ESTER,CHEMBL7890,BRD:BRD-BRD-K33141550-003-05-7;BRD:BRD-K33141550-003-05-7,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS3,,,PHASE 2/PHASE 3,,Small molecule,2,"COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O, COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O;COC(=O)[C@@H](N)CCCNC(=N)N[N+](=O)[O-]",KCWZGJVSDFYRIX-YFKPBYRVSA-N
L-NIL,L-NIL,CHEMBL7889,BRD:BRD-BRD-K60036103-003-01-6;BRD:BRD-K60036103-003-01-6,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS1;NOS2;NOS3,,,PRECLINICAL,,Small molecule,NA,CC(=N)NCCCC[C@H](N)C(=O)O;CC(=N)NCCCC[C@H](N)C(O)=O,ONYFNWIHJBLQKE-ZETCQYMHSA-N
L-PHENYLISOPROPYLADENOSINE,L-PHENYLISOPROPYLADENOSINE,,BRD:BRD-K25521961-001-06-9,rep_single_dose,,,,,,,,NA,,
L-PROLINE,L-PROLINE,,BRD:BRD-BRD-K01666412-001-02-0;BRD:BRD-K01666412-001-02-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,EPRS;L3HYPDH;P3H1;P3H2;P3H3;P4HA1;P4HA2;PARS2;PPIA;PPIB;PPIC;PPIF;PPIG;PPIH;PRODH;PROSC;PYCR1;PYCR2;PYCRL;SLC6A14;SLC6A7,,,LAUNCHED,,,NA,OC(=O)[C@@H]1CCCN1,
L-QUISQUALIC-ACID,L-QUISQUALIC-ACID,,BRD:BRD-BRD-K92404805-001-07-0;BRD:BRD-K92404805-001-07-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,FOLH1;GRIA2;GRIK1;GRIK2;GRM1;GRM2;GRM3;GRM5;GRM7;GRM8,,,PRECLINICAL,,,NA,N[C@@H](CN1OC(=O)[NH]C1=O)C(O)=O,
THEANINE,L-THEANINE;NSC-21308;THEANINE,CHEMBL3039113,BRD:BRD-A08715367-001-01-7;BRD:BRD-BRD-A08715367-001-01-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,LAUNCHED,,Small molecule,3,CCNC(=O)CC[C@H](N)C(=O)O;CCNC(=O)CCC(N)C(O)=O,DATAGRPVKZEWHA-YFKPBYRVSA-N
MOAB C225,ABP-494;C-225;C225;CETUXIMAB;CETUXIMAB (GENETICAL RECOMBINATION);CETUXIMAB BIOSIMILAR (ABP-494);CMAB-009;CMAB009;ERBITUX;IMC-225;IMC-C225;L01XC06;MOAB C225,CHEMBL1201577,GDSC1:1114,gdsc,,,,,,,Antibody,4,,
TRANDATE,AH-5158A FREE BASE;IBIDOMIDE;LABETALOL;NORMODYNE;NORMOZIDE;SCH-15719W FREE BASE;TRANDATE,CHEMBL429,BRD:BRD-A07440155-003-25-4;BRD:BRD-BRD-A07440155-003-25-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRB1;ADRB2,HYPERTENSION,,LAUNCHED,,Small molecule,4,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1;CC(CCC1CCCCC1)NCC(O)C1CCC(O)C(C1)C(N)=O,SGUAFYQXFOLMHL-UHFFFAOYSA-N
NSC-7773,"3,3'-DIAMINO-;3,3'-IMINOBISPROPYLAMINE;3,3'-IMINODIPROPYLAMINE;4-AZAHEPTAMETHYLENEDIAMINE;CALDINE;DIPROPYLAMINE;DIPROPYLENETRIAMINE;GR 43659X;GR-43659X;LACIDIPINE;MOLAP;MOTENS;NSC-7773",CHEMBL460291,BRD:BRD-BRD-K43586850-001-02-9;BRD:BRD-K43586850-001-02-9,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C,HYPERTENSION,,LAUNCHED,,Small molecule,4,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C;CCOC(=O)C1=C(C)NC(C)=C(C1C1CCCCC1\C=C\C(=O)OC(C)(C)C)C(=O)OCC,GKQPCPXONLDCMU-CCEZHUSRSA-N
LACITOL,LACITOL,,BRD:BRD-BRD-K40787673-001-02-1;BRD:BRD-K40787673-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,"LAXATIVE, OSMOSIS STIMULANT",,CONSTIPATION,,LAUNCHED,"Multiple values for MOA: {'OSMOSIS STIMULANT', 'LAXATIVE, OSMOSIS STIMULANT'}, defaulting to 'LAXATIVE, OSMOSIS STIMULANT'",,NA,"OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO, OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO",
VIMPAT,(R)-LACOSAMIDE 1;ADD 243037;ADD-243037;ERLOSAMIDE;LACOSAMIDE;LACOSAMIDE CV;SPM 927;SPM-927;VIMPAT,CHEMBL58323,BRD:BRD-BRD-K68232650-001-02-2;BRD:BRD-K68232650-001-02-2,rep_primary;rep_single_dose,"COLLAPSIN RESPONSE MEDIATOR PROTEIN INHIBITOR, COLLAPSIN RESPONSE MEDIATOR PROTEIN STIMULANT, SODIUM CHANNEL BLOCKER",SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,Small molecule,4,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1;COC[C@@H](NC(C)=O)C(=O)NCC1CCCCC1,VPPJLAIAVCUEMN-GFCCVEGCSA-N
REGULOSE,4-GALACTOSYL FRUCTOSE;ACILAC;BIFITERAL;CEPHULAC;CHOLAC;CHRONULAC;CONSTILAC;CONSTULOSE;DUPHALAC;DUPHALAC DRY;E966;ENULOSE;EVALOSE;GENERLAC;HEPTALAC;LACTULOSE;LACTULOSE JP17;LAXILOSE;LAXOSE ORANGE;LEMLAX;NSC-757082;OSMOLAX;PORTALAC;REGULOSE,CHEMBL1237068;CHEMBL296306,BRD:BRD-BRD-K77258318-001-04-6;BRD:BRD-K77258318-001-04-6,rep_primary;rep_single_dose,LAXATIVE,,PORTAL-SYSTEMIC ENCEPHALOPATHY (PSE),,LAUNCHED,,Small molecule,4,OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O;OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,JCQLYHFGKNRPGE-FCVZTGTOSA-N
LAFLUNIMUS,LAFLUNIMUS,CHEMBL142218,BRD:BRD-K00076962-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,Cc1cc(NC(=O)/C(C#N)=C(\O)C2CC2)ccc1C(F)(F)F,GDHFOVCRYCPOTK-QBFSEMIESA-N
LAFUTIDINE,LAFUTIDINE,CHEMBL1742461,BRD:BRD-A67516570-001-02-8;BRD:BRD-BRD-A67516570-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,"DUODENAL ULCER DISEASE, PEPTIC ULCER DISEASE (PUD)",,LAUNCHED,,Small molecule,3,O=C(C[S+]([O-])Cc1ccco1)NC/C=C\COc1cc(CN2CCCCC2)ccn1;O=C(CS(=O)CC1CCCO1)NC\C=C/COC1CC(CN2CCCCC2)CCN1,KMZQAVXSMUKBPD-DJWKRKHSSA-N
ZEFFIX,(-)-;BCH 189;EPIVIR;EPIVIR-HBV;GR 109714X;GR-109714X;LAMIVUDINE;LAMIVUDINE TEVA;LAMIVUDINUM;NSC-760061;VIROLAM;ZEFFIX,CHEMBL141,BRD:BRD-BRD-K02992638-001-11-8;BRD:BRD-K02992638-001-11-8,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,"HUMAN IMMUNODEFICIENCY VIRUS (HIV-1), ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), HEPATITIS B",,LAUNCHED,,Small molecule,4,"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1;NC1CCN(C2CSC(CO)O2)C(=O)N1, NC1CCN([C@@H]2CS[C@H](CO)O2)C(=O)N1",JTEGQNOMFQHVDC-NKWVEPMBSA-N
NSC-759171,BW 430C;BW-430C;LAMICTAL;LAMICTAL CD;LAMICTAL ODT;LAMICTAL XR;LAMOTRIGINE;NSC-759171,CHEMBL741,BRD:BRD-BRD-K93460210-001-23-7;BRD:BRD-K93460210-001-23-7,rep_primary;rep_single_dose,"SEROTONIN RECEPTOR ANTAGONIST, SODIUM CHANNEL BLOCKER",SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,"EPILEPSY, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,4,"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1;NC1NNC(C(N)N1)-C1CCCC(CL)C1CL, NC1NNC(C(N)N1)-C1CCCC(CL)C1CL",PYZRQGJRPPTADH-UHFFFAOYSA-N
LY3314814,AZD-3293;AZD3293;LANABECESTAT;LY-3314814;LY3314814,CHEMBL3989948,BRD:BRD-K00003387-001-01-9,rep_single_dose,BETA SECRETASE INHIBITOR,,,,,,Small molecule,3,CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](OC)CC2)C3)c1,WKDNQONLGXOZRG-HRNNMHKYSA-N
LANATOSIDE-C,LANATOSIDE-C,,BRD:BRD-A64242993-001-05-6;BRD:BRD-BRD-A64242993-001-05-6,rep_multi_dose;rep_primary;rep_single_dose,CARDIAC GLYCOSIDE,,,,PRECLINICAL,,,NA,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](OC(C)=O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)C(CCC3C2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,
ONO-1101,AOP-200704;AOP200704;LANDIOLOL;LDLL-600;LDLL600;ONO-1101,CHEMBL1742466,BRD:BRD-BRD-K86436199-003-01-3;BRD:BRD-K86436199-003-01-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1,CARDIAC ARRYTHMIA,,LAUNCHED,,Small molecule,3,CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1;CC1(C)OC[C@@H](COC(=O)CCC2CCC(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)CC2)O1,WMDSZGFJQKSLLH-RBBKRZOGSA-N
LANIFIBRANOR,IVA-337;IVA337;LANIFIBRANOR,CHEMBL4091374,BRD:BRD-K00003462-001-01-9,rep_single_dose,PPAR RECEPTOR AGONIST,,,,,,Small molecule,3,O=C(O)CCCc1cc2cc(Cl)ccc2n1S(=O)(=O)c1ccc2ncsc2c1,OQDQIFQRNZIEEJ-UHFFFAOYSA-N
LANOCONAZOLE,ASTAT;LANOCONAZOLE,CHEMBL1555126,BRD:BRD-A54275602-001-01-0;BRD:BRD-BRD-A54275602-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,,FUNGAL INFECTION,,LAUNCHED,,Small molecule,-1,CLC1CCCCC1C1CS\C(S1)=C(\C#N)N1CCNC1;N#C/C(=C1/SCC(c2ccccc2Cl)S1)n1ccnc1,ZRTQSJFIDWNVJW-WYMLVPIESA-N
ZOTON,(R)-;(R)-LANSOPRAZOLE;A-65006;AG-1749;AGOPTON;DEXILANT;DEXILANT SOLUTAB;DEXLANSOPRAZOLE;KAPIDEX;LANSOPRAZOLE;LANSOPRAZOLE R-FORM;LANSOX;LANZOPRAZOLE;LANZOR;LIMPIDEX;NSC-758638;NSC-758710;OGAST;OGASTORO;OPIREN;PREVACID;PREVACID 24 HR;PREVACID DELAYED RELEASE;PREVACID IV;PREVACID SOLUTAB;PREVONCO;T-168390;TAK-390;TAKEPRON;ZOTON,CHEMBL1201863;CHEMBL480,BRD:BRD-A49172652-001-27-1;BRD:BRD-BRD-A49172652-001-27-1,rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP4A;ATP4B,HEARTBURN,,LAUNCHED,,Small molecule,4,"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1;CC1C(OCC(F)(F)F)CCNC1CS(=O)C1NC2CCCCC2[NH]1, CC1C(OCC(F)(F)F)CCNC1CS(=O)C1NC2CCCCC2[NH]1, CC1C(OCC(F)(F)F)CCNC1CS(=O)C1NC2CCCCC2[NH]1",MJIHNNLFOKEZEW-UHFFFAOYSA-N
TYVERB,GSK-572016;GW-2016;GW-572016;GW-572016X;GW572016;LAPATINIB;TYVERB,CHEMBL554,BRD:BRD-BRD-K19687926-379-07-4;BRD:BRD-K19687926-001-04-1;BRD:BRD-K19687926-001-05-8;BRD:BRD-K19687926-001-08-2;BRD:BRD-K19687926-379-07-4;CTRP:634309;GDSC1:119;GDSC2:1558,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF EGFR AND ERBB2,EGFR;ERBB2,BREAST CANCER,,LAUNCHED,"Multiple values for MOA: {'EGFR INHIBITOR', 'INHIBITOR OF EGFR AND ERBB2'}, defaulting to 'INHIBITOR OF EGFR AND ERBB2'",Small molecule,4,"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1;CS(=O)(=O)CCNCC1CCC(O1)-C1CCC2NCNC(NC3CCC(OCC4CCCC(F)C4)C(CL)C3)C2C1, CS(=O)(=O)CCNCC1CCC(O1)-C1CCC2NCNC(NC3CCC(OCC4CCCC(F)C4)C(CL)C3)C2C1, CS(=O)(=O)CCNCC1CCC(O1)-C1CCC2NCNC(NC3CCC(OCC4CCCC(F)C4)C(CL)C3)C2C1",BCFGMOOMADDAQU-UHFFFAOYSA-N
LAPPACONITE,LAPPACONITE,,BRD:BRD-A05906449-004-01-1;BRD:BRD-BRD-A05906449-004-01-1,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,,,,PHASE 2,,,NA,CCN1C[C@@]2(CC[C@@H](OC)[C@@]34[C@H]5C[C@H]6[C@H](OC)[C@]5(O)[C@](O)(C[C@@H]6OC)[C@H](C[C@H]23)C14)OC(=O)C1CCCCC1NC(C)=O,
TV-5600 FREE ACID,ABR-215062;ABR-215062 FREE ACID;LAQUINIMOD;TV-5600 FREE ACID,CHEMBL66092,BRD:BRD-BRD-K60918217-001-03-8;BRD:BRD-K60918217-001-03-8,rep_primary;rep_single_dose,IMMUNOSUPPRESSANT,CXCL2,,,PHASE 3,,Small molecule,3,"CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1;CCN(C(=O)C1C(O)C2C(CL)CCCC2N(C)C1=O)C1CCCCC1, CCN(C(=O)C1C(O)C2C(CL)CCCC2N(C)C1=O)C1CCCCC1",GKWPCEFFIHSJOE-UHFFFAOYSA-N
LARAZOTIDE-ACETATE,LARAZOTIDE-ACETATE,,BRD:BRD-K00003469-015-01-9,rep_single_dose,TIGHT JUNCTION REGULATOR,,,,,,,NA,,
MK-0524,CORDAPTIVE;LAROPIPRANT;MK-0524,CHEMBL426559,BRD:BRD-BRD-K48894757-001-01-8;BRD:BRD-K48894757-001-01-8,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGDR;PTGDR2;PTGER1;PTGER2;PTGER3;PTGFR;PTGIR;TBXA2R,CHOLESTEROL,,LAUNCHED,,Small molecule,4,CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3;CS(=O)(=O)C1CC(F)CC2C3CC[C@H](CC(O)=O)C3N(CC3CCC(CL)CC3)C12,NXFFJDQHYLNEJK-CYBMUJFWSA-N
LOXO-101,ARRY-470;BAY-2757556;BAY2757556;LAROTRECTINIB;LOXO-101,CHEMBL3889654,BRD:BRD-BRD-K36574127-001-01-3;BRD:BRD-K36574127-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,TROPOMYOSIN RECEPTOR KINASE INHIBITOR,NTRK1;NTRK2;NTRK3,,,PHASE 2,,Small molecule,4,O[C@H]1CCN(C1)C(=O)NC1CNN2CCC(NC12)N1CCC[C@@H]1C1CC(F)CCC1F;O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1,NYNZQNWKBKUAII-KBXCAEBGSA-N
LAS101057,LAS-101057;LAS101057,CHEMBL1672627,BRD:BRD-K00079404-001-02-9,rep_single_dose,,,,,,,Small molecule,1,O=C(Nc1cnc(-c2ccncc2F)c(-c2cccnc2)n1)C1CC1,XUYURJQIMYCWBB-UHFFFAOYSA-N
RO-22985,LASALOCID;LASALOCID A;NSC-243048;RO 2-2985;RO-2-2985;RO-22985,CHEMBL145347,BRD:BRD-A72711497-236-03-8;BRD:BRD-BRD-A72711497-236-03-8,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL PERMEABILITY INDUCER,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)[C@H]1O[C@](CC)([C@H]2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C;CC[C@H](C1OC(CC)(C[C@@H]1C)C1CC[C@](O)(CC)[C@H](C)O1)C(=O)C(C)[C@@H](O)[C@H](C)CCC1CCC(C)C(O)C1C(O)=O,BBMULGJBVDDDNI-OWKLGTHSSA-N
LY573144,COL-144;LASMIDITAN;LY573144,CHEMBL3039520,BRD:BRD-K00003178-003-01-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,,,,,,Small molecule,4,CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1,XEDHVZKDSYZQBF-UHFFFAOYSA-N
LASOFOXIFENE,LASOFOXIFENE,CHEMBL328190,BRD:BRD-M93148412-001-02-6,rep_single_dose,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),ESR1;ESR2,,,,,Small molecule,4,Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1,GXESHMAMLJKROZ-IAPPQJPRSA-N
XELPROS,LATANOPROST;LATANOPROST (ISOPROPYL ESTER);MONOPOST;PHXA-41;PHXA41;T-2345;T2345;XA-41;XA41;XALATAN;XELPROS,CHEMBL1051,BRD:BRD-BRD-K10961822-001-05-1;BRD:BRD-K10961822-001-05-1,rep_multi_dose;rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,PTGFR,"OCULAR HYPERTENSION, GLAUCOMA",,LAUNCHED,,Small molecule,4,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O;CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1CCCCC1,GGXICVAJURFBLW-CEYXHVGTSA-N
VYZULTA,BOL-303259-X;LATANOPROSTENE BUNOD;NCX 116;NCX-116;PF-3187207;VESNEO;VYZULTA,CHEMBL2364612,BRD:BRD-K00029604-001-02-9,rep_single_dose,,,,,,,Small molecule,4,O=C(CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O)OCCCCO[N+](=O)[O-],LOVMMUBRQUFEAH-UIEAZXIASA-N
PF-01913539,DIMEBOLIN;DIMEBON;LATREPIRDINE;PF-01913539,CHEMBL589390,BRD:BRD-BRD-K55703048-001-07-7;BRD:BRD-K55703048-001-07-7,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,HRH1;HTR6,,,PHASE 3,,Small molecule,3,"Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1;CN1CCC2C(C1)C1CC(C)CCC1N2CCC1CCC(C)NC1, CN1CCC2C(C1)C1CC(C)CCC1N2CCC1CCC(C)NC1, CN1CCC2C(C1)C1CC(C)CCC1N2CCC1CCC(C)NC1",JNODQFNWMXFMEV-UHFFFAOYSA-N
LAURIC-DIETHANOLAMIDE,LAURIC-DIETHANOLAMIDE,,BRD:BRD-BRD-K11548689-001-01-6;BRD:BRD-K11548689-001-01-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCCCCCCCCCCC(=O)N(CCO)CCO,
N-DODECYL-.EPSILON.-CAPROLACTAM,1-N-DODECYLAZACYCLOHEPTAN-2-ONE;AZONE;LAUROCAPRAM;N-0252;N-DODECYL-.EPSILON.-CAPROLACTAM,CHEMBL76591,BRD:BRD-BRD-K35698076-001-01-2;BRD:BRD-K35698076-001-01-2,rep_primary;rep_single_dose,,,,,PHASE 3,,Small molecule,-1,CCCCCCCCCCCCN1CCCCCC1=O,AXTGDCSMTYGJND-UHFFFAOYSA-N
RO-196327,LAZABEMIDE;RO 19-6327/000;RO-196327,CHEMBL279390,BRD:BRD-BRD-K51486818-003-02-8;BRD:BRD-K51486818-003-02-8,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOB,,,PHASE 3,,Small molecule,-1,"NCCNC(=O)c1ccc(Cl)cn1;NCCNC(=O)C1CCC(CL)CN1, NCCNC(=O)C1CCC(CL)CN1",JZXRLKWWVNUZRB-UHFFFAOYSA-N
YH25448,C-18112003-G;GNS-1480;GNS1480;JNJ-73841937-AAA;LAZERTINIB;YH-25448;YH25448,CHEMBL4558324,BRD:BRD-K00003501-001-01-9,rep_single_dose,TYROSINE KINASE INHIBITOR,,,,,,Small molecule,3,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,RRMJMHOQSALEJJ-UHFFFAOYSA-N
LB-100,LB 100;LB-100,CHEMBL4297300,BRD:BRD-A73709786-001-01-3;BRD:BRD-BRD-A73709786-001-01-3,rep_primary;rep_single_dose,PROTEIN PHOSPHATASE INHIBITOR,,,,PHASE 1,,Small molecule,2,"CN1CCN(C(=O)C2C(C(=O)O)[C@H]3CC[C@@H]2O3)CC1;CN1CCN(CC1)C(=O)C1[C@H]2CC[C@H](O2)C1C(O)=O, CN1CCN(CC1)C(=O)C1C2CCC(O2)C1C(O)=O, CN1CCN(CC1)C(=O)C1C2CCC(O2)C1C(O)=O",JUQMLSGOTNKJKI-IZUQBHJASA-N
LB42708,LB42708,,BRD:BRD-BRD-K18834913-001-01-1;BRD:BRD-K18834913-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,FARNESYLTRANSFERASE INHIBITOR,,,,PRECLINICAL,,,NA,"BRC1CCC(CN2CNCC2CN2CC(C(=O)N3CCOCC3)C(C2)-C2CCCC3CCCCC23)CC1, BRC1CCC(CN2CNCC2CN2CC(C(=O)N3CCOCC3)C(C2)-C2CCCC3CCCCC23)CC1, BRC1CCC(CN2CNCC2CN2CC(C(=O)N3CCOCC3)C(C2)-C2CCCC3CCCCC23)CC1",
PANOBINOSTAT HYDRATE,FARYDAK;LBH-589;LBH589;PANOBINOSTAT;PANOBINOSTAT HYDRATE,CHEMBL483254,CTRP:54210,ctrp,,,,,,,Small molecule,4,Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,FPOHNWQLNRZRFC-ZHACJKMWSA-N
PANOBINOSTAT LACTATE ANHYDROUS,FARYDAK;LBH-589;LBH589;PANOBINOSTAT;PANOBINOSTAT HYDRATE;PANOBINOSTAT LACTATE;PANOBINOSTAT LACTATE ANHYDROUS,CHEMBL3545368;CHEMBL483254,GDSC1:438,gdsc,,,,,,,Small molecule,4,CC(O)C(=O)O.Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,XVDWNSFFSMWXJJ-ASTDGNLGSA-N
NVP-LCL 161,LCL 161;LCL-161;LCL161;NVP-LCL 161,CHEMBL2431768,BRD:BRD-BRD-K08248804-001-01-8;BRD:BRD-K08248804-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,XIAP INHIBITOR,BIRC2;XIAP,,,PHASE 2,,Small molecule,2,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C1NC(CS1)C(=O)C1CCC(F)CC1;CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,UFPFGVNKHCLJJO-SSKFGXFMSA-N
NVP-LCL 161,LCL 161;LCL-161;LCL161;NVP-LCL 161,CHEMBL2431768,GDSC1:439;GDSC2:1557,gdsc,,,,,,,Small molecule,2,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1,UFPFGVNKHCLJJO-SSKFGXFMSA-N
LCQ908,LCQ908,,BRD:BRD-BRD-K20008181-001-01-3;BRD:BRD-K20008181-001-01-3,rep_primary;rep_single_dose,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,DGAT1,,,PHASE 3,,,NA,OC(=O)C[C@H]1CC[C@@H](CC1)C1CCC(CC1)-C1CCC(NC2CCC(NC2)C(F)(F)F)CN1,
LDC1267,LDC1267,,BRD:BRD-BRD-K44715996-001-01-0;BRD:BRD-K44715996-001-01-0,rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,AXL;MERTK;TYRO3,,,PRECLINICAL,,,NA,CCOC1CN(NC1C(=O)NC1CCC(OC2CCNC3CC(OC)C(OC)CC23)C(F)C1)-C1CCC(F)CC1C,
LDN-193189,LDN-193189,,GDSC1:478,gdsc,,,,,,,,NA,,
LDN-212854,LDN-212854,,BRD:BRD-BRD-K59831625-001-01-6;BRD:BRD-K59831625-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,BONE MORPHOGENIC PROTEIN INHIBITOR,ABL1;ACVR1;RIPK2,,,PRECLINICAL,,,NA,"C1CN(CCN1)C1CCC(CC1)-C1CNC2C(CNN2C1)-C1CCCC2NCCCC12, C1CN(CCN1)C1CCC(CC1)-C1CNC2C(CNN2C1)-C1CCCC2NCCCC12",
LDN-27219,LDN-27219,,BRD:BRD-K51485109-001-02-9,rep_single_dose,TISSUE TRANSGLUTAMINASE INHIBITOR,TGM2,,,,,,NA,,
LDN-57444,LDN-57444,,BRD:BRD-BRD-K94485812-001-02-9;BRD:BRD-K94485812-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR,,,,PRECLINICAL,,,NA,"CC(=O)O\N=C1\C(=O)N(CC2CC(CL)CCC2CL)C2CCC(CL)CC12, CC(=O)O\N=C1\C(=O)N(CC2CC(CL)CCC2CL)C2CCC(CL)CC12, CC(=O)O\N=C1\C(=O)N(CC2CC(CL)CCC2CL)C2CCC(CL)CC12",
LDN193189,LDN193189,,BRD:BRD-K04853698-376-01-4,rep_single_dose,BONE MORPHOGENIC PROTEIN INHIBITOR,ACVR1;BMPR1A,,,,,,NA,,
LE-135,LE-135,,BRD:BRD-BRD-K06593056-001-04-8;BRD:BRD-K06593056-001-04-8;CTRP:375354,ctrp;rep_multi_dose;rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARB,,,PRECLINICAL,,,NA,"CN1C2CC3C(CC2N=C(C2CCC(CC2)C(O)=O)C2CCCCC12)C(C)(C)CCC3(C)C, CN1C2CC3C(CC2N=C(C2CCC(CC2)C(O)=O)C2CCCCC12)C(C)(C)CCC3(C)C",
LEDIPASVIR ACETONATE,GS-5885;LEDIPASVIR;LEDIPASVIR ACETONATE,CHEMBL2374220,BRD:BRD-BRD-K05446112-001-01-8;BRD:BRD-K05446112-001-01-8,rep_primary;rep_single_dose,HCV INHIBITOR,,HEPATITIS C,,LAUNCHED,,Small molecule,4,COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C1NCC([NH]1)-C1CCC2-C3CCC(CC3C(F)(F)C2C1)-C1CCC2NC([NH]C2C1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C;COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C,VRTWBAAJJOHBQU-KMWAZVGDSA-N
RIBOCICLIB,LEE 011;LEE-011;LEE-011A;LEE011;LEE011A;NVP-LEE011;RIBOCICLIB,CHEMBL3545110,BRD:BRD-BRD-K36788280-001-01-2;BRD:BRD-K36788280-001-01-2;BRD:BRD-K36788280-001-06-9;GDSC2:1632,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF CDK4 AND CDK6,CDK4;CDK6,BREAST CANCER,,LAUNCHED,"Multiple values for MOA: {'CDK INHIBITOR', 'INHIBITOR OF CDK4 AND CDK6'}, defaulting to 'INHIBITOR OF CDK4 AND CDK6'",Small molecule,4,"CN(C)C(=O)C1CC2CNC(NC3CCC(CN3)N3CCNCC3)NC2N1C1CCCC1, CN(C)C(=O)C1CC2CNC(NC3CCC(CN3)N3CCNCC3)NC2N1C1CCCC1, CN(C)C(=O)C1CC2CNC(NC3CCC(CN3)N3CCNCC3)NC2N1C1CCCC1;CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1",RHXHGRAEPCAFML-UHFFFAOYSA-N
LEFAMULIN,BC-3781;LEFAMULIN,CHEMBL3291398,BRD:BRD-K00071589-001-01-9,rep_single_dose,,,,,,,Small molecule,4,C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CC[C@@H](N)C[C@H]2O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,KPVIXBKIJXZQJX-FCEONZPQSA-N
SULOL,ARAVA;HWA-486;L04AA13;LEFLUNOMIDE;LEFLUNOMIDE MEDAC;LEFLUNOMIDE RATIOPHARM;LEFLUNOMIDE TEVA;LEFLUNOMIDE WINTHROP;NSC-677411;NSC-759864;REPSO;SU-101;SU101;SULOL,CHEMBL960,BRD:BRD-BRD-K78692225-001-24-5;BRD:BRD-K78692225-001-24-5;GDSC2:1578,gdsc;rep_primary;rep_single_dose,"DIHYDROOROTATE DEHYDROGENASE INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",AHR;DHODH;PTK2B,RHEUMATOID ARTHRITIS,,LAUNCHED,,Small molecule,4,"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1;CC1ONCC1C(=O)NC1CCC(CC1)C(F)(F)F, CC1ONCC1C(=O)NC1CCC(CC1)C(F)(F)F, CC1ONCC1C(=O)NC1CCC(CC1)C(F)(F)F",VHOGYURTWQBHIL-UHFFFAOYSA-N
LEMBOREXANT,DAYVIGO;E-2006;E2006;LEMBOREXANT,CHEMBL3545367,BRD:BRD-BRD-K78666663-001-01-6;BRD:BRD-K78666663-001-01-6,rep_primary;rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR1;HCRTR2,,,PHASE 3,,Small molecule,4,CC1NCC(OC[C@]2(C[C@H]2C(=O)NC2CCC(F)CN2)C2CCCC(F)C2)C(C)N1;Cc1ncc(OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1,MUGXRYIUWFITCP-PGRDOPGGSA-N
SYP-1512,CC-5013;CDC-501;LENALIDOMIDE;NSC-747972;REVLIMID;SYP-1512,CHEMBL848,BRD:BRD-A17883755-001-06-1;BRD:BRD-A17883755-001-13-9;BRD:BRD-BRD-A17883755-001-06-1;GDSC1:1020,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,MOLECULAR GLUE AND BINDER OF CRBN,CDH5;CRBN;CUL4A;PTGS2;TNF;TNFSF11,"MULTIPLE MYELOMA, MANTLE CELL LYMPHOMA (MCL), MYELODYSPLASTIC DISEASES (MDS)",,LAUNCHED,"Multiple values for MOA: {'MOLECULAR GLUE AND BINDER OF CRBN', 'ANTICANCER AGENT'}, defaulting to 'MOLECULAR GLUE AND BINDER OF CRBN'
Multiple values for repurposing_target: {'CRBN;CUL4A', 'CDH5;CRBN;PTGS2;TNF;TNFSF11'}, taking the union",Small molecule,4,NC1CCCC2C(=O)N(CC12)C1CCC(=O)NC1=O;Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,GOTYRUGSSMKFNF-UHFFFAOYSA-N
LENIOLISIB,CDZ-173 FREE BASE;CDZ-173-NX;CDZ173 FREE BASE;CDZ173-NX;LENIOLISIB,CHEMBL3643413,BRD:BRD-K00003261-001-01-9,rep_single_dose,PI3K INHIBITOR,,,,,,Small molecule,3,CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,MWKYMZXCGYXLPL-ZDUSSCGKSA-N
LENVIMA,E-7080;ER-203492-00;KISPLYX;LENVATINIB;LENVIMA,CHEMBL1289601,BRD:BRD-BRD-K39974922-001-04-3;BRD:BRD-K39974922-001-04-3;CTRP:628639,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"FGFR INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",FLT4;KDR,THYROID CANCER,,LAUNCHED,,Small molecule,4,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O;COC1CC2NCCC(OC3CCC(NC(=O)NC4CC4)C(CL)C3)C2CC1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N
LEONURINE,LEONURINE,CHEMBL1290284,BRD:BRD-K00004696-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,NA,COc1cc(C(=O)OCCCCNC(=N)N)cc(OC)c1O,WNGSUWLDMZFYNZ-UHFFFAOYSA-N
LEPTOMYCIN B,LEPTOMYCIN B,CHEMBL486133,CTRP:660086,ctrp,,,,,,,Small molecule,NA,CCC(=C/[C@H](C)C/C=C/C(C)=C/[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C/C(=O)O)/C=C/[C@@H]1OC(=O)C=C[C@@H]1C,YACHGFWEQXFSBS-XYERBDPFSA-N
NVP-LEQ506,LEQ 506;LEQ-506;LEQ506;NVP-LEQ-506;NVP-LEQ506,CHEMBL3133037,BRD:BRD-K00003269-001-01-9,rep_single_dose,G PROTEIN SIGNALING INHIBITOR,,,,,,Small molecule,1,Cc1c(Cc2ccccc2)nnc(N2CCN(c3cnc(C(C)(C)O)cn3)[C@H](C)C2)c1C,POERAARDVFVDLO-QGZVFWFLSA-N
LERCANIL,LERCANIDIPINE;LERCANIL,CHEMBL250270,BRD:BRD-A18992208-003-02-7;BRD:BRD-BRD-A18992208-003-02-7,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA2D1;CACNG1,HYPERTENSION,,LAUNCHED,,Small molecule,4,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1;COC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1CCCCC1)C1CCCCC1,ZDXUKAKRHYTAKV-UHFFFAOYSA-N
LERISETRON,LERISETRON,CHEMBL56900,BRD:BRD-BRD-K62398570-300-01-2;BRD:BRD-K62398570-300-01-2,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A,,,PHASE 3,,Small molecule,3,C(C1CCCCC1)N1C(NC2CCCCC12)N1CCNCC1;c1ccc(Cn2c(N3CCNCC3)nc3ccccc32)cc1,PWWDCRQZITYKDV-UHFFFAOYSA-N
UK-453061,"LERSIVIRINE;UK-453,061;UK-453061",CHEMBL571987,BRD:BRD-BRD-K03289534-001-01-4;BRD:BRD-K03289534-001-01-4,rep_primary;rep_single_dose,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,,,PHASE 2,,Small molecule,2,CCc1nn(CCO)c(CC)c1Oc1cc(C#N)cc(C#N)c1;CCC1NN(CCO)C(CC)C1OC1CC(CC(C1)C#N)C#N,MCPUZZJBAHRIPO-UHFFFAOYSA-N
ZURAMPIC,LESINURAD;RDEA 594;RDEA-594;RDEA594;ZURAMPIC,CHEMBL2105720,BRD:BRD-BRD-K75024268-001-01-0;BRD:BRD-K75024268-001-01-0,rep_primary;rep_single_dose,URIC ACID DIURETIC,SLC22A12,GOUT,,LAUNCHED,,Small molecule,4,O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12;OC(=O)CSC1NNC(BR)N1-C1CCC(C2CC2)C2CCCCC12,FGQFOYHRJSUHMR-UHFFFAOYSA-N
SPM-924,A-154475;A-154475.0;CEP-701;KT-555;KT-5555;KT5555;LESTAURTINIB;SP-924;SP924;SPM-924,CHEMBL603469,BRD:BRD-A27376179-001-01-3;BRD:BRD-BRD-A27376179-001-01-3;GDSC1:1024,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"FLT3 INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR, JAK INHIBITOR",FLT3;NTRK1,,,PHASE 3,,Small molecule,3,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O;C[C@]12OC(C[C@]1(O)CO)N1C3CCCCC3C3C4C(=O)NCC4C4C5CCCCC5N2C4C13,UIARLYUEJFELEN-LROUJFHJSA-N
LETEPRINIM,LETEPRINIM,CHEMBL2104345,BRD:BRD-BRD-K21612934-001-01-1;BRD:BRD-K21612934-001-01-1,rep_primary;rep_single_dose,NERVE GROWTH FACTOR AGONIST,,,,PHASE 2,,Small molecule,2,O=C(CCn1cnc2c(=O)[nH]cnc21)Nc1ccc(C(=O)O)cc1;OC(=O)C1CCC(NC(=O)CCN2CNC3C(O)NCNC23)CC1,JMPOIZCOJJMTHI-UHFFFAOYSA-N
PREVYMIS,AIC 246;AIC-246;AIC246;LETERMOVIR;MK-8228;PREVYMIS,CHEMBL1241951,BRD:BRD-BRD-K94288301-001-01-7;BRD:BRD-K94288301-001-01-7,rep_primary;rep_single_dose,CMV TERMINASE INHIBITOR,,,,PHASE 3,,Small molecule,4,COC1CCCC(C1)N1CCN(CC1)C1=NC2C(F)CCCC2[C@H](CC(O)=O)N1C1CC(CCC1OC)C(F)(F)F;COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1,FWYSMLBETOMXAG-QHCPKHFHSA-N
VISCOTIOL,LETOSTEINE;VISCOTIOL,CHEMBL2105044,BRD:BRD-A32597168-001-03-6;BRD:BRD-BRD-A32597168-001-03-6,rep_primary;rep_single_dose,MUCOLYTIC AGENT,,"BRONCHITIS, PNEUMONIA",,LAUNCHED,,Small molecule,-1,CCOC(=O)CSCCC1NC(C(=O)O)CS1;CCOC(=O)CSCCC1NC(CS1)C(O)=O,IKOCLISPVJZJEA-UHFFFAOYSA-N
LETRAZURIL,LETRAZURIL,CHEMBL2104819,BRD:BRD-K00003474-001-01-9,rep_single_dose,ANTIINFECTIVE DRUG,,,,,,Small molecule,1,N#CC(c1ccc(F)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl,XQKYUBTUOHHNDV-UHFFFAOYSA-N
NSC-759652,CGS 20267;CGS-20267;FEMARA;LETROZOLE;NSC-759652,CHEMBL1444,BRD:BRD-BRD-K88789588-001-14-9;BRD:BRD-K88789588-001-14-9,rep_multi_dose;rep_primary;rep_single_dose,AROMATASE INHIBITOR,CYP19A1,BREAST CANCER,,LAUNCHED,,Small molecule,4,"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1;N#CC1CCC(CC1)C(C1CCC(CC1)C#N)N1CNCN1, N#CC1CCC(CC1)C(C1CCC(CC1)C#N)N1CNCN1",HPJKCIUCZWXJDR-UHFFFAOYSA-N
LEUCOVORIN,LEUCOVORIN,CHEMBL1679,BRD:BRD-A75919782-399-02-6;BRD:BRD-BRD-A75919782-399-02-6,rep_multi_dose;rep_primary;rep_single_dose,FOLATE RECEPTOR LIGAND,TYMS,OSTEOSARCOMA,,LAUNCHED,,Small molecule,4,"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O;NC1NC(=O)C2N(C=O)C(CNC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2[NH]1, NC1NC(=O)C2N(C=O)C(CNC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2[NH]1, NC1NC(=O)C2N(C=O)C(CNC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2[NH]1",VVIAGPKUTFNRDU-ABLWVSNPSA-N
LEUCYLLEUCINE-METHYL-ESTER,LEUCYLLEUCINE-METHYL-ESTER,,BRD:BRD-BRD-K81136890-003-01-6;BRD:BRD-K81136890-003-01-6,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C,
TAP-144 FREE BASE,(-)-LEUPROLIDE;ABBOTT-43818 FREE BASE;CKD-841;LEUPORELIN;LEUPROLIDE;LEUPRORELIN;LEUPRORELIN SLOW RELEASE;NSC-377526;TAP-144 FREE BASE,CHEMBL1201199,BRD:BRD-BRD-K26323068-001-01-8;BRD:BRD-K26323068-001-01-8,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,GNRHR,PROSTATE CANCER,,LAUNCHED,,Protein,4,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1;CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC1C[NH]CN1)NC(=O)[C@@H]1CCC(=O)N1,GFIJNRVAKGFPGQ-LIJARHBVSA-N
VINKRISTIN,22-OXO-;22-OXOVINCALEUKOBLASTINE;37231;KYOCRISTINE;LEUCRISTINE;LEUROCRISTINE;LEUROCRISTINE SULFATE;LILLY-37231;MARQIBO;MARQIBO KIT;NOVOPHARM;NSC-67574;ONCOTCS;ONCOVIN;TECNOCRIS;VINCALEUKOBLASTINE;VINCASAR;VINCASAR PFS;VINCREX;VINCRISTIN;VINCRISTINE;VINCRISTINE SULFATE;VINCRISTINE SULFATE LIPOSOME;VINCRISTINE SULFATE PFS;VINCRISTINE SULPHATE;VINCRISTINI SULFAS;VINCRISUL;VINKRISTIN,CHEMBL501867;CHEMBL90555,BRD:BRD-BRD-K12251893-065-04-7;BRD:BRD-K12251893-065-01-3;BRD:BRD-K12251893-065-04-7;CTRP:62602;GDSC2:1818,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBA;TUBA4A;TUBB,ACUTE LYMPHOBLASTIC LEUKEMIA (ALL),,LAUNCHED,"Multiple values for MOA: {'TUBULIN POLYMERIZATION INHIBITOR', 'INHIBITOR OF TUBULIN'}, defaulting to 'TUBULIN POLYMERIZATION INHIBITOR'
Multiple values for repurposing_target: {'TUBA;TUBB', 'TUBA4A;TUBB'}, taking the union",Small molecule,4,"CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC;CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1",OGWKCGZFUXNPDA-XQKSVPLYSA-N
XOPENEX,ALBUTEROL (R)-FORM;ASF-1096;LEVALBUTEROL;LEVOSALBUTAMOL;R-SALBUTAMOL;XOPENEX,CHEMBL1002,BRD:BRD-BRD-K34469523-003-03-0;BRD:BRD-K34469523-003-03-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,BRONCHOSPASM,,LAUNCHED,,Small molecule,4,CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1;CC(C)(C)NC[C@H](O)C1CCC(O)C(CO)C1,NDAUXUAQIAJITI-LBPRGKRZSA-N
NALOXIPHAN,LEVALLORPHAN;LORFAN;NALOXIPHAN,CHEMBL1254682,BRD:BRD-BRD-K30634073-046-01-0;BRD:BRD-K30634073-046-01-0,rep_primary;rep_single_dose,"OPIOID ANTAGONIST, OPIOID RECEPTOR ANTAGONIST",CHRNA2;OPRM1,RESPIRATORY DEPRESSION,,LAUNCHED,"Multiple values for MOA: {'OPIOID ANTAGONIST, OPIOID RECEPTOR ANTAGONIST', 'OPIOID ANTAGONIST'}, defaulting to 'OPIOID ANTAGONIST, OPIOID RECEPTOR ANTAGONIST'",Small molecule,4,C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13;OC1CCC2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)C2C1,OZYUPQUCAUTOBP-QXAKKESOSA-N
TETRAMISOLE,(S)-;LEVAMISOLE;TCMDC-125847;TETRAMISOLE,CHEMBL1454,BRD:BRD-BRD-K73107279-003-12-5;BRD:BRD-K73107279-003-12-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,ALPL;ALPPL2;CHRNA3,,,WITHDRAWN,,Small molecule,4,"c1ccc([C@H]2CN3CCSC3=N2)cc1;C1CN2C[C@@H](N=C2S1)C1CCCCC1, C1CN2C[C@@H](N=C2S1)C1CCCCC1",HLFSDGLLUJUHTE-SNVBAGLBSA-N
S-AMLODIPINE,(S)-;AMLODIPINE;LEVAMLODIPINE;S-AMLODIPINE,CHEMBL2111097,BRD:BRD-K00005329-074-01-9,rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,,,Small molecule,4,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl,HTIQEAQVCYTUBX-KRWDZBQOSA-N
LEVCROMAKALIM,(-)-CROMAKALIM;BRL-38227;LEVCROMAKALIM,CHEMBL100,BRD:BRD-K24526313-001-17-7,rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNJ5,,,,,Small molecule,-1,CC1(C)Oc2ccc(C#N)cc2[C@@H](N2CCCC2=O)[C@@H]1O,TVZCRIROJQEVOT-CABCVRRESA-N
UCB-L059,AGB-101;DESITREND;ELEPSIA;ELEPSIA XR;KEPPRA;KEPPRA XR;LEVETIRACETAM;LEVETIRACETAM ACCORD;LEVETIRACETAM ACTAVIS;LEVETIRACETAM HOSPIRA;LEVETIRACETAM IN SODIUM CHLORIDE;LEVETIRACETAM SUN;LEVETIRACETAM TEVA;LEVETIRACETAME;MATEVER;N03AX14;NSC-760119;SPRITAM;UCB 22059;UCB L059;UCB-22059;UCB-L059,CHEMBL1286,BRD:BRD-BRD-K49404994-001-10-9;BRD:BRD-K49404994-001-10-9,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1B;SCN1A;SV2A,SEIZURES,,LAUNCHED,,Small molecule,4,"CC[C@@H](C(N)=O)N1CCCC1=O;CC[C@H](N1CCCC1=O)C(N)=O, CC[C@H](N1CCCC1=O)C(N)=O, CC[C@H](N1CCCC1=O)C(N)=O, CC[C@H](N1CCCC1=O)C(N)=O",HPHUVLMMVZITSG-LURJTMIESA-N
LEVO-PHENCYNONATE,LEVO-PHENCYNONATE,,BRD:BRD-A64698388-003-01-7;BRD:BRD-BRD-A64698388-003-01-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,,,LAUNCHED,,,NA,CN1CC2CCCC(C1)C2OC(=O)C(O)(C1CCCC1)C1CCCCC1,
LEVOBETAXOLOL,(S)-;BETAXOLOL;LEVOBETAXOLOL,CHEMBL1201274,BRD:BRD-K43883465-003-02-9,rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,,,,,Small molecule,4,CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1,NWIUTZDMDHAVTP-KRWDZBQOSA-N
LEVOBUNOLOL,(-)-;(S)-;BUNOLOL;LEVOBUNOLOL,CHEMBL1201237,BRD:BRD-BRD-K31812033-003-11-0;BRD:BRD-K31812033-003-11-0,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3,"GLAUCOMA, OCULAR HYPERTENSION",,LAUNCHED,,Small molecule,4,"CC(C)(C)NC[C@H](O)COC1CCCC2C(=O)CCCC12, CC(C)(C)NC[C@H](O)COC1CCCC2C(=O)CCCC12;CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O",IXHBTMCLRNMKHZ-LBPRGKRZSA-N
LEVOBUNOLOL-(+),LEVOBUNOLOL-(+),,BRD:BRD-BRD-K73323637-003-10-9;BRD:BRD-K73323637-003-10-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,CC(C)(C)NC[C@@H](O)COC1CCCC2C(=O)CCCC12,
LEVOBUNOLOL-(+/-),LEVOBUNOLOL-(+/-),,BRD:BRD-A46876182-003-02-8;BRD:BRD-BRD-A46876182-003-02-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,CC(C)(C)NCC(O)COC1CCCC2C(=O)CCCC12,
R-50547,LEVOCABASTINE;LIVOSTIN DIRECT;R-50547,CHEMBL1615438,BRD:BRD-BRD-K33453211-003-11-5;BRD:BRD-K33453211-003-11-5,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1;NTSR2,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1;C[C@@H]1CN(CC[C@]1(C(O)=O)C1CCCCC1)[C@H]1CC[C@](CC1)(C#N)C1CCC(F)CC1,ZCGOMHNNNFPNMX-KYTRFIICSA-N
VITAMIN BT,BICARNESINE;BIOCARN;CARNITINE;CARNITINE DL-FORM HYDROCHLORIDE;CARNITINE HCL;CARNITINE HYDROCHLORIDE;CARNITOR;CARNITOR SF;DL-;DL-CARNITINE HYDROCHLORIDE;LEVOCARNITINE;LEVOCARNITINE CHLORIDE;LEVOCARNITINE HCL;LEVOCARNITINE HYDROCHLORIDE;NSC-759132;ORISTAR LCH;VITAMIN BT,CHEMBL1149,BRD:BRD-BRD-K59647213-001-10-5;BRD:BRD-K59647213-001-10-5,rep_multi_dose;rep_primary;rep_single_dose,,CRAT;CROT,CARNITINE DEFICIENCY,,LAUNCHED,,Small molecule,4,"C[N+](C)(C)C[C@H](O)CC(=O)[O-];C[N+](C)(C)C[C@H](O)CC(O)=O, C[N+](C)(C)C[C@H](O)CC(O)=O",PHIQHXFUZVPYII-ZCFIWIBFSA-N
XYZAL,(-)-;(-)-CETIRIZINE;(R)-;(R)-CETIRIZINE;CETIRIZINE;CETIRIZINE (R)-FORM;LEVOCETIRIZINE;XAZAL;XYZAL,CHEMBL1201191,BRD:BRD-BRD-K27184429-300-01-3;BRD:BRD-K27184429-300-01-3,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,4,O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1;OC(=O)COCCN1CCN(CC1)[C@H](C1CCCCC1)C1CCC(CL)CC1,ZKLPARSLTMPFCP-OAQYLSRUSA-N
V-1512,BENDOPA;BROCADOPA;CVT-301;DOPAR;INBRIJA;LARODOPA;LEVODOPA;LEVODOPUM;NSC-118381;V-1512,CHEMBL1009,BRD:BRD-BRD-K34730807-001-17-6;BRD:BRD-K34730807-001-17-6,rep_primary;rep_single_dose,DOPAMINE PRECURSOR,DRD1;DRD2;DRD3;DRD4;DRD5;GPR143,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O;N[C@@H](CC1CCC(O)C(O)C1)C(O)=O, N[C@@H](CC1CCC(O)C(O)C1)C(O)=O, N[C@@H](CC1CCC(O)C(O)C1)C(O)=O",WTDRDQBEARUVNC-LURJTMIESA-N
RAPITUX,(-)-DROPROPIZINE;(S)-;(S)-(-)-DROPROPIZINE;(S)-ISOMER;DANKA;DIPROPIZINE;DROPROPIZINE;DROPROPIZINE S-FORM;L-DROPROPIZINE;LEVODROPROPIZINE;LEVOPRONT;LEVOTUSS;RAPITUX,CHEMBL1288810,BRD:BRD-BRD-K83551379-001-01-8;BRD:BRD-BRD-K83551379-001-02-6;BRD:BRD-K83551379-001-01-8;BRD:BRD-K83551379-001-02-6,rep_primary;rep_single_dose,ANTITUSSIVE,,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,3,"OC[C@@H](O)CN1CCN(c2ccccc2)CC1;OC[C@@H](O)CN1CCN(CC1)C1CCCCC1, OC[C@@H](O)CN1CCN(CC1)C1CCCCC1",PTVWPYVOOKLBCG-ZDUSSCGKSA-N
VOLEQUIN,(S)-;CRAVIT;DR-3355;EVOXIL;FLOXACIN;IQUIX;L-OFLOXACIN;LEVAQUIN;LEVOFLOXACIN;LEVOFLOXACIN (AS HEMIHYDRATE);LEVOFLOXACIN ANHYDROUS;LEVOFLOXACIN HEMIHYDRATE;LEVOFLOXACIN HYDRATE;NOFAXIN;NSC-758709;OFLOXACIN;OFLOXACIN S-(-)-FORM;OFLOXACIN S-(-)-FORM HEMIHYDRATE;OFTAQUIX;QUINSAIR;QUIXIN;RWJ-25213;TAVANIC;VOLEQUIN,CHEMBL33,BRD:BRD-BRD-K09471561-001-18-2;BRD:BRD-K09471561-001-18-2,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,"PNEUMONIA, SINUSITIS, BRONCHITIS, SKIN INFECTIONS, PROSTATITIS, URINARY TRACT INFECTIONS, PYELONEPHRITIS, ANTHRAX, PLAGUE",,LAUNCHED,,Small molecule,4,"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23;C[C@H]1COC2C(N3CCN(C)CC3)C(F)CC3C2N1CC(C(O)=O)C3=O, C[C@H]1COC2C(N3CCN(C)CC3)C(F)CC3C2N1CC(C(O)=O)C3=O",GSDSWSVVBLHKDQ-JTQLQIEISA-N
XP03,CL 36467;CL 39743;CL-36467;CL-39743;LEVOMEPROMAZINE;LEVOPROME;METHOTRIMEPRAZINE;N05AA02;NEOZINE;NIRVAN;NSC-226516;RP 7044;RP-7044;SK&F 5116;SK&F-5116;TISERCIN;XP-03;XP03,CHEMBL1764,BRD:BRD-BRD-K35559145-050-08-5;BRD:BRD-K35559145-050-08-5,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HTR2A;HTR2C,"PSYCHOSIS, SCHIZOPHRENIA, BIPOLAR DISORDER, NAUSEA, INSOMNIA",,LAUNCHED,,Small molecule,4,"COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2;COC1CCC2SC3CCCCC3N(C[C@H](C)CN(C)C)C2C1, COC1CCC2SC3CCCCC3N(C[C@H](C)CN(C)C)C2C1",VRQVVMDWGGWHTJ-CQSZACIVSA-N
LEVOMEQUITAZINE,LEVOMEQUITAZINE,,BRD:BRD-A67616246-001-07-9;BRD:BRD-BRD-A67616246-001-07-9,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,,,PHASE 2,,,NA,C(C1CN2CCC1CC2)N1C2CCCCC2SC2CCCCC12,
WY-5104,(-)-;ATHENTIA NEXT;BAY86-5028;EMERRES;EMERRES UNA;EZINELLE;FALLBACK SOLO;HER STYLE;ISTERANDA;JADELLE;JAYDESS;KYLEENA;LEVONELLE;LEVONELLE ONE STEP;LEVONELLE-2;LEVONORGESTREL;LEVONORGESTRELUM;LEVOSERT;LILETTA;MICROVAL;MIRENA;NORGESTON;NORGESTREL;NORGESTREL (-)-FORM;NORPLANT;NORPLANT II;NORPLANT SYSTEM;NSC-744007;OPCICON ONE-STEP;OVRETTE;PLAN B;PLAN B ONE-STEP;POSTINOR-2;SKYLA;UPOSTELLE;WY-5104,CHEMBL1389,BRD:BRD-BRD-K35189033-001-26-1;BRD:BRD-K35189033-001-26-1,rep_multi_dose;rep_primary;rep_single_dose,"ESTROGEN RECEPTOR AGONIST, GLUCOCORTICOID RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR AGONIST, PROGESTERONE RECEPTOR ANTAGONIST",AR;ESR1;PGR;SRD5A1,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC;CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C",WWYNJERNGUHSAO-XUDSTZEESA-N
SIMENDAN,(-)-OR-1259;(R)-;(R)-SIMENDAN;LEVOSIMENDAN;NSC-759644;OR-1259;SIMDAX;SIMENDAN,CHEMBL2051955,BRD:BRD-BRD-K03095347-001-06-1;BRD:BRD-K03095347-001-06-1,rep_primary;rep_single_dose,CALCIUM SENSITIZER,KCNJ11;KCNJ8;PDE3A;TNNC1,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,3,"C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1;C[C@@H]1CC(=O)NN=C1C1CCC(NN=C(C#N)C#N)CC1, C[C@@H]1CC(=O)NN=C1C1CCC(NN=C(C#N)C#N)CC1",WHXMKTBCFHIYNQ-SECBINFHSA-N
SULPIRIDE L-FORM,(-)-;(-)-SULPIRIDE;(S)-;L-SULPIRIDE;LESURIDE;LEVOBREN;LEVOPRAID;LEVOPRIDE;LEVOSULPIRIDE;S-(-)-SULPIRIDE;SULPIRIDE;SULPIRIDE L-FORM,CHEMBL267044,BRD:BRD-BRD-K51671335-001-10-6;BRD:BRD-K51671335-001-10-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CA1;CA12;CA7;DRD2;DRD3,"SCHIZOPHRENIA, PSYCHOSIS, ANXIETY, VERTIGO, DYSPEPSIA, IRRITABLE BOWEL SYNDROME, PREMATURE EJACULATION (PE)",,LAUNCHED,,Small molecule,2,"CCN1CCC[C@H]1CNC(=O)C1CC(CCC1OC)S(N)(=O)=O, CCN1CCC[C@H]1CNC(=O)C1CC(CCC1OC)S(N)(=O)=O, CCN1CCC[C@H]1CNC(=O)C1CC(CCC1OC)S(N)(=O)=O;CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC",BGRJTUBHPOOWDU-NSHDSACASA-N
THYROXINE,L-;L-THYROXINE;LEVOTHYROXIN;LEVOTHYROXINE;NSC-36397;SYNTHETIC LEVOTHYROXINE;THYROXINE,CHEMBL1624,BRD:BRD-BRD-K30685142-001-15-4;BRD:BRD-K30685142-001-15-4,rep_primary;rep_single_dose,THYROID HORMONE STIMULANT,THRA;THRB,MYXEDEMA COMA,,LAUNCHED,,Small molecule,4,"N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O;N[C@@H](CC1CC(I)C(OC2CC(I)C(O)C(I)C2)C(I)C1)C(O)=O, N[C@@H](CC1CC(I)C(OC2CC(I)C(O)C(I)C2)C(I)C1)C(O)=O, N[C@@H](CC1CC(I)C(OC2CC(I)C(O)C(I)C2)C(I)C1)C(O)=O, N[C@@H](CC1CC(I)C(OC2CC(I)C(O)C(I)C2)C(I)C1)C(O)=O",XUIIKFGFIJCVMT-LBPRGKRZSA-N
LFM-A13,LFM-A13,,BRD:BRD-A30655177-001-14-0;BRD:BRD-BRD-A30655177-001-14-0;GDSC1:192,gdsc;rep_primary;rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BTK,,,PRECLINICAL,,,NA,CC(=O)C(C#N)C(=O)NC1CC(BR)CCC1BR,
MB-11262,LGD-6972;MB-11262,CHEMBL4297469,BRD:BRD-K00003132-001-01-9,rep_single_dose,GLUCAGON RECEPTOR ANTAGONIST,,,,,,Small molecule,2,Cc1cc(C)c(-c2ccc(NC(=O)[C@H](Cc3ccc(C(=O)NCCS(=O)(=O)O)cc3)c3ccc(-c4ccc(C(C)(C)C)cc4)cc3)cc2)c(C)c1,HKJMCBYPVCGZFB-LDLOPFEMSA-N
WNT974,LGK-974;LGK974;WNT-974;WNT974,CHEMBL3188386,BRD:BRD-BRD-K16810791-001-01-0;BRD:BRD-K16810791-001-01-0;GDSC2:1598,gdsc;rep_primary;rep_single_dose,PORCUPINE INHIBITOR,PORCN,,,PHASE 2,,Small molecule,2,Cc1cc(-c2ncc(CC(=O)Nc3ccc(-c4cnccn4)cn3)cc2C)ccn1;CC1CC(CCN1)-C1NCC(CC(=O)NC2CCC(CN2)-C2CNCCN2)CC1C,XXYGTCZJJLTAGH-UHFFFAOYSA-N
WNT974,LGK-974;LGK974;WNT-974;WNT974,CHEMBL3188386,GDSC1:573;GDSC2:1598,gdsc,,,,,,,Small molecule,2,Cc1cc(-c2ncc(CC(=O)Nc3ccc(-c4cnccn4)cn3)cc2C)ccn1,XXYGTCZJJLTAGH-UHFFFAOYSA-N
LH846,LH846,,BRD:BRD-BRD-K47409078-001-02-6;BRD:BRD-K47409078-001-02-6,rep_primary;rep_single_dose,CASEIN KINASE INHIBITOR,CSNK1D,,,PRECLINICAL,,,NA,"CC1CC2SC(NC(=O)CC3CCCCC3)NC2CC1CL, CC1CC2SC(NC(=O)CC3CCCCC3)NC2CC1CL",
LHF-535,LHF-535,CHEMBL4537239,BRD:BRD-K00090654-001-01-9,rep_single_dose,,,,,,,Small molecule,1,CC(C)Oc1ccc(-n2cnc3cc(/C=C\c4ccc(C(C)(C)O)cc4)ccc32)cc1,DBNZTRPIBJSUIX-WAYWQWQTSA-N
R-75251,LIAROZOLE;LIAZAL;R-75251,CHEMBL389433,BRD:BRD-A57133765-300-01-7;BRD:BRD-BRD-A57133765-300-01-7,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP19A1;CYP26A1,,,PHASE 2/PHASE 3,,Small molecule,2,Clc1cccc(C(c2ccc3[nH]cnc3c2)n2ccnc2)c1;CLC1CCCC(C1)C(C1CCC2NC[NH]C2C1)N1CCNC1,UGFHIPBXIWJXNA-UHFFFAOYSA-N
STEDESA,(S)-;(S)-LICARBAZEPINE;10-HYDROXY-CARBAMAZEPINE;BIA 2-194;BIA-2-194;CGP-13751;ERELIB;ESLICARBAZEPINE;LICARBAZEPINE;PAZZUL;STEDESA,CHEMBL1067;CHEMBL315985,BRD:BRD-A22642447-001-01-9;BRD:BRD-BRD-A22642447-001-01-9,rep_primary;rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,SCN5A,,,PHASE 3,,Small molecule,4,"NC(=O)N1c2ccccc2C[C@H](O)c2ccccc21;NC(=O)N1C2CCCCC2CC(O)C2CCCCC12, NC(=O)N1C2CCCCC2CC(O)C2CCCCC12",BMPDWHIDQYTSHX-AWEZNQCLSA-N
LICOCHALCONE-A,LICOCHALCONE-A,,BRD:BRD-BRD-K26011976-001-01-0;BRD:BRD-K26011976-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,PTPN1,,,PHASE 3,,,NA,COC1CC(O)C(CC1C=CC(=O)C1CCC(O)CC1)C(C)(C)C=C,
LIK066,LICOGLIFLOZIN;LIK-066;LIK066,CHEMBL4297625,BRD:BRD-K00003504-001-01-9,rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,,,,,,Small molecule,2,CCc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc2c(c1)OCCO2,XFJAMQQAAMJFGB-ZQGJOIPISA-N
LICOSTINEL,ACEA 1021;ACEA-1021;LICOSTINEL,CHEMBL289832,BRD:BRD-K81881550-001-03-9,rep_single_dose,NMDA RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,O=c1[nH]c2cc(Cl)c(Cl)c([N+](=O)[O-])c2[nH]c1=O,CHFSOFHQIZKQCR-UHFFFAOYSA-N
LIDAMIDINE,LIDAMIDINE,CHEMBL448416,BRD:BRD-BRD-K68693535-001-03-4;BRD:BRD-K68693535-001-03-4,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,DIARRHEA,,LAUNCHED,,Small molecule,-1,CN=C(N)NC(=O)Nc1c(C)cccc1C;CNC(=N)NC(=O)NC1C(C)CCCC1C,RRHJHSBDJDZUGL-UHFFFAOYSA-N
ZTLIDO,ALGRX 3268;ALGRX-3268;ALPHACAINE;ANESTACON;DENTIPATCH;EMBOLEX;IONTOCAINE;LIDOCAINE;LIDOCAINUM;LIDOCATON;LIDODERM;LIDOPEN;LIGNOCAINE;LIGNOCAINE HCL;LIGNOSTAB;LMX 4;NSC-40030;OCTOCAINE;ORAQIX;SOLARCAINE;VAGISIL;XYLESTESIN;XYLOCAINE;XYLODASE;XYLOTOX;ZTLIDO,CHEMBL79,BRD:BRD-BRD-K52662033-003-21-2;BRD:BRD-K52662033-003-21-2,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,EGFR;SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,"ITCHING, ECZEMA, HEMORRHAGE",,LAUNCHED,,Small molecule,4,"CCN(CC)CC(=O)Nc1c(C)cccc1C;CCN(CC)CC(=O)NC1C(C)CCCC1C, CCN(CC)CC(=O)NC1C(C)CCCC1C",NNJVILVZKWQKPM-UHFFFAOYSA-N
R-7904,ANGEX;CLINIUM;LIDOFLAZINE;MCN-JR-7904;R 7904;R-7904,CHEMBL92870,BRD:BRD-BRD-K62996583-001-10-3;BRD:BRD-K62996583-001-10-3,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,SCN1A;SCN3A;SLC29A1,,,LAUNCHED,,Small molecule,4,Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1;CC1CCCC(C)C1NC(=O)CN1CCN(CCCC(C2CCC(F)CC2)C2CCC(F)CC2)CC1,ZBIAKUMOEKILTF-UHFFFAOYSA-N
LIFIRAFENIB,BEIGENE-283;BGB 283;BGB-283;LIFIRAFENIB,CHEMBL4209157,BRD:BRD-K00003275-001-01-9,rep_single_dose,RAF INHIBITOR,,,,,,Small molecule,1,O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4cc(C(F)(F)F)ccc4[nH]3)ccnc2N1,NGFFVZQXSRKHBM-FKBYEOEOSA-N
XIIDRA,LIFITEGRAST;SAR 1118;SAR-1118;SHP-606;SHP606;XIIDRA,CHEMBL2048028,BRD:BRD-K60265345-001-02-9,rep_single_dose,LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN NEGATIVE MODULATOR,,,,,,Small molecule,4,CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1,JFOZKMSJYSPYLN-QHCPKHFHSA-N
VK5211,LGD-4033;LIGANDROL;VK-5211;VK5211,CHEMBL3545356,BRD:BRD-K00091109-001-01-9,rep_single_dose,,,,,,,Small molecule,2,,
LIGUSTILIDE,(Z)-LIGUSTILIDE;LIGUSTILIDE,CHEMBL481246,BRD:BRD-K48875051-001-01-0,rep_single_dose,TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,TNF,,,,,Small molecule,NA,CCC/C=C1\OC(=O)C2=C1CCC=C2,IQVQXVFMNOFTMU-FLIBITNWSA-N
LIMAPROST-ALFADEX,LIMAPROST-ALFADEX,,BRD:BRD-BRD-K25015158-001-01-2;BRD:BRD-K25015158-001-01-2,rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,PTGER1,CLAUDICATION,,LAUNCHED,,,NA,"CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O, CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O",
LIMK1 INHIBITOR BMS4,LIMK1 INHIBITOR BMS4,,GDSC1:406,gdsc,,,,,,,,NA,,
LIMKI-3,LIMKI-3,,BRD:BRD-BRD-K75373031-001-01-7;BRD:BRD-K75373031-001-01-7,rep_primary;rep_single_dose,LIM KINASE INHIBITOR,LIMK1,,,PRECLINICAL,,,NA,CC(C)C(=O)NC1NCC(S1)-C1CC(NN1-C1C(CL)CCCC1CL)C(F)F,
LIMONIN,LIMONIN,CHEMBL517449,BRD:BRD-BRD-K05906022-001-05-1;BRD:BRD-K05906022-001-05-1,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@]54[C@]2(C)C(=O)C[C@@H]13;CC1(C)O[C@H]2CC(=O)OC[C@@]22[C@H]1CC(=O)[C@]1(C)[C@@H]2CC[C@@]2(C)[C@@H](OC(=O)[C@H]3O[C@@]123)C1CCOC1,KBDSLGBFQAGHBE-MSGMIQHVSA-N
TRAZENTA,BI 1356;BI 1356 BS;BI-1356;BI-1356-BS;BI-1356BS;BS 1356 BS;BS-1356-BS;LINAGLIPTIN;TRADJENTA;TRAJENTA;TRAZENTA,CHEMBL237500,BRD:BRD-BRD-K96550715-001-02-6;BRD:BRD-K96550715-001-02-6,rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C;CC#CCN1C(NC2N(C)C(=O)N(CC3NC(C)C4CCCCC4N3)C(=O)C12)N1CCC[C@@H](N)C1, CC#CCN1C(NC2N(C)C(=O)N(CC3NC(C)C4CCCCC4N3)C(=O)C12)N1CCC[C@@H](N)C1, CC#CCN1C(NC2N(C)C(=O)N(CC3NC(C)C4CCCCC4N3)C(=O)C12)N1CCC[C@@H](N)C1, CC#CCN1C(NC2N(C)C(=O)N(CC3NC(C)C4CCCCC4N3)C(=O)C12)N1CCC[C@@H](N)C1",LTXREWYXXSTFRX-QGZVFWFLSA-N
LINALOOL,LINALOOL,CHEMBL25306,BRD:BRD-A43082461-001-06-3;BRD:BRD-BRD-A43082461-001-06-3,rep_multi_dose;rep_primary;rep_single_dose,ANTICONVULSANT,,,,PHASE 1,,Small molecule,NA,C=CC(C)(O)CCC=C(C)C;CC(C)=CCCC(C)(O)C=C,CDOSHBSSFJOMGT-UHFFFAOYSA-N
LINAPRAZAN,AZD-0865;LINAPRAZAN,CHEMBL497011,BRD:BRD-K00003366-001-01-9,rep_single_dose,ATP-SENSITIVE POTASSIUM CHANNEL INHIBITOR,,,,,,Small molecule,-1,Cc1cccc(C)c1CNc1cc(C(=O)NCCO)cn2c(C)c(C)nc12,GHVIMBCFLRTFHI-UHFFFAOYSA-N
U-10149,"LINCOLNENSIN;LINCOMYCIN;U-10,149;U-10149",CHEMBL1447,BRD:BRD-BRD-K08033334-003-04-3;BRD:BRD-BRD-K81447180-003-21-4;BRD:BRD-K08033334-003-04-3;BRD:BRD-K81447180-003-21-4,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,ENTERITIS,,LAUNCHED,"Multiple values for structure_id: {'K08033334', 'K81447180'}, defaulting to None",Small molecule,4,"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1;CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]1O, CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@@H]([C@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O, CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]1O",OJMMVQQUTAEWLP-KIDUDLJLSA-N
ZYVOX,"LINEZOLID;PNU-100766;U-100,766;U-100766;ZYVOX",CHEMBL126,BRD:BRD-BRD-K66876909-001-12-6;BRD:BRD-K66876909-001-12-6,rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,MAOA;MAOB,"PNEUMONIA, SKIN INFECTIONS",,LAUNCHED,,Small molecule,4,"CC(=O)NC[C@H]1CN(C(=O)O1)C1CCC(N2CCOCC2)C(F)C1, CC(=O)NC[C@H]1CN(C(=O)O1)C1CCC(N2CCOCC2)C(F)C1, CC(=O)NC[C@H]1CN(C(=O)O1)C1CCC(N2CCOCC2)C(F)C1;CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1",TYZROVQLWOKYKF-ZDUSSCGKSA-N
RG-3635,A-741439;ABT-869;AL-39324;LINIFANIB;RG-3635,CHEMBL223360,BRD:BRD-BRD-K99749624-001-07-0;BRD:BRD-K99749624-001-07-0;CTRP:606033;GDSC1:277,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",CSF1;CSF1R;FLT1;FLT3;FLT4;KDR;KIT;PDGFRB;RET;TEK,,,PHASE 3,,Small molecule,3,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1;CC1CCC(F)C(NC(=O)NC2CCC(CC2)-C2CCCC3[NH]NC(N)C23)C1,MPVGZUGXCQEXTM-UHFFFAOYSA-N
LINOPIRDINE,DUP 996;DUP-996;LINOPIRDINE,CHEMBL319111,BRD:BRD-BRD-K59332007-300-02-7;BRD:BRD-K59332007-300-02-7,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNQ2;KCNQ3;KCNQ4;KCNQ5,,,PHASE 3,,Small molecule,-1,"O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1;O=C1N(C2CCCCC2C1(CC1CCNCC1)CC1CCNCC1)C1CCCCC1, O=C1N(C2CCCCC2C1(CC1CCNCC1)CC1CCNCC1)C1CCCCC1",YEJCDKJIEMIWRQ-UHFFFAOYSA-N
LINSIDOMINE,LINSIDOMINE,CHEMBL1189150,BRD:BRD-BRD-K86344238-003-04-6;BRD:BRD-K86344238-003-04-6,rep_primary;rep_single_dose,NITRIC OXIDE DONOR,,ERECTILE DYSFUNCTION,,LAUNCHED,,Small molecule,-1,"[NH-]c1c[n+](N2CCOCC2)no1;NC1C[N+](NO1)N1CCOCC1, NC1C[N+](NO1)N1CCOCC1",FKDHHVKWGRFRTG-UHFFFAOYSA-N
OSI-906AA,ASP-7487;LINSITINIB;OSI-906;OSI-906AA,CHEMBL1091644,BRD:BRD-BRD-K86118762-001-01-8;BRD:BRD-K86118762-001-01-8;CTRP:705300;GDSC1:185;GDSC2:1510,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,IGF-1 INHIBITOR,IGF1R;INSR;INSRR,,,PHASE 3,,Small molecule,3,"C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1;C[C@@]1(O)C[C@@H](C1)C1NC(-C2CCC3CCC(NC3C2)-C2CCCCC2)C2C(N)NCCN12, C[C@@]1(O)C[C@@H](C1)C1NC(-C2CCC3CCC(NC3C2)-C2CCCCC2)C2C(N)NCCN12",PKCDDUHJAFVJJB-VLZXCDOPSA-N
LINTOPRIDE,LINTOPRIDE,CHEMBL2106767,BRD:BRD-K00004744-001-01-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,CCN1CCN=C1CNC(=O)c1cc(Cl)c(N)cc1OC,MJCKISCWHDATBN-UHFFFAOYSA-N
TRIOSTAT,"(S)-;3,5,3'-TRIIODOTHYRONINE;ACTIVE) (6-11%);CYRONINE;CYTOMEL;DL-;DL-TRIIODOTHYRONINE;EUTHROID-0.5;EUTHROID-1;EUTHROID-2;EUTHROID-3;L-;LEVOTHYROXINE SODIUM RELATED COMPOUND LIOTHYRONINE;LIOTHYRONINE;NSC-80203;RATHYRONINE;TERTROXIN;THYROLAR-0.25;THYROLAR-0.5;THYROLAR-1;THYROLAR-2;THYROLAR-3;THYROLAR-5;TRIIODOTHYRONINE (T3 OR LIOTHYRONINE;TRIOSTAT",CHEMBL1544;CHEMBL789,BRD:BRD-BRD-K89152108-236-07-6;BRD:BRD-K89152108-236-07-6,rep_primary;rep_single_dose,THYROID HORMONE STIMULANT,THRA;THRB,"HYPOTHYROIDISM, MYXEDEMA COMA",,LAUNCHED,,Small molecule,4,"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O;N[C@@H](CC1CC(I)C(OC2CCC(O)C(I)C2)C(I)C1)C(O)=O, N[C@@H](CC1CC(I)C(OC2CCC(O)C(I)C2)C(I)C1)C(O)=O, N[C@@H](CC1CC(I)C(OC2CCC(O)C(I)C2)C(I)C1)C(O)=O",AUYYCJSJGJYCDS-LBPRGKRZSA-N
LIOTHYRONINE-(ISOMER),LIOTHYRONINE-(ISOMER),,BRD:BRD-BRD-K46428823-001-02-5;BRD:BRD-K46428823-001-02-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,N[C@H](CC1CC(I)C(OC2CCC(O)C(I)C2)C(I)C1)C(O)=O,
LIQUIRITIN,LIQUIRITIN,CHEMBL511995,BRD:BRD-K39084158-001-08-9,rep_single_dose,ANTIOXIDANT,,,,,,Small molecule,NA,O=C1C[C@@H](c2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2)Oc2cc(O)ccc21,DEMKZLAVQYISIA-ZRWXNEIDSA-N
RLY-4008,LIRAFUGRATINIB;RLY-4008,,BRD:BRD-K00126780-001-01-9,oncref_2,INHIBITOR OF FGFR2,FGFR2,,,,,,NA,,
VICTOZA,LIRAGLUTIDE;LIRAGLUTIDE (RDNA ORIGIN);LIRAGLUTIDE RECOMBINANT;NN-2211;NN-9924;NN2211;NN9924;NNC 90-1170;NNC-90-1170;SAXENDA;VICTOZA,CHEMBL4084119;CHEMBL4524066,BRD:BRD-A48274390-001-01-8;BRD:BRD-BRD-A48274390-001-01-8,rep_primary;rep_single_dose,GLP RECEPTOR AGONIST,GLP1R,"WEIGHT-LOSS AID, DIABETES MELLITUS",,LAUNCHED,,Protein,4,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(=O)O;CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1CCC(O)CC1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC1CCCCC1)NC(=O)C(NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(C)NC(=O)C(N)CC1CNC[NH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC1C[NH]C2CCCCC12)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O,YSDQQAXHVYUZIW-QCIJIYAXSA-N
ZEFNART,LIRANAFTATE;PIRITETRATE;ZEFNART,CHEMBL1591365,BRD:BRD-BRD-K35775715-001-03-1;BRD:BRD-K35775715-001-03-1,rep_primary;rep_single_dose,FUNGAL SQUALENE EPOXIDASE INHIBITOR,,FUNGAL INFECTION,,LAUNCHED,,Small molecule,-1,COc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCCC3)n1;COC1CCCC(N1)N(C)C(=S)OC1CCC2CCCCC2C1,VPHPQNGOVQYUMG-UHFFFAOYSA-N
LIRIMILAST,LIRIMILAST,CHEMBL1922282,BRD:BRD-BRD-K31339321-001-03-6;BRD:BRD-K31339321-001-03-6,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,PHASE 2,,Small molecule,-1,CS(=O)(=O)Oc1ccc2c(NC(N)=O)c(C(=O)c3ccc(Cl)cc3Cl)oc2c1;CS(=O)(=O)OC1CCC2C(NC(N)=O)C(OC2C1)C(=O)C1CCC(CL)CC1CL,YPFLFUJKZDAXRA-UHFFFAOYSA-N
LISADIMATE,GLYCERYL P-AMINOBENZOATE;GLYCERYL PABA;LISADIMATE,CHEMBL2106668,BRD:BRD-A76533773-001-01-9;BRD:BRD-BRD-A76533773-001-01-9,rep_primary;rep_single_dose,TOPICAL SUNSCREEN AGENT,,SUNSCREEN LOTION,,LAUNCHED,,Small molecule,-1,Nc1ccc(C(=O)OCC(O)CO)cc1;NC1CCC(CC1)C(=O)OCC(O)CO,WHQOKFZWSDOTQP-UHFFFAOYSA-N
ZESTRIL,ACEMIN;CARACE;LISINOPRIL;LISINOPRIL DIHYDRATE;LISINOPRIL HYDRATE;LISOPRESS;MK-521;NSC-751176;NSC-758151;PRINIVIL;QBRELIS;RANOLIP;ZESTRIL,CHEMBL1237;CHEMBL1729579;CHEMBL419213,BRD:BRD-BRD-K67966701-001-11-6;BRD:BRD-BRD-K67966701-001-12-4;BRD:BRD-K67966701-001-11-6;BRD:BRD-K67966701-001-12-4,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE;ACE2,"HYPERTENSION, CONGESTIVE HEART FAILURE, DIABETES MELLITUS",,LAUNCHED,,Small molecule,4,"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O;NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O;NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O;NCCCC[C@H](N[C@@H](CCC1CCCCC1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, NCCCC[C@H](N[C@@H](CCC1CCCCC1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, NCCCC[C@H](N[C@@H](CCC1CCCCC1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O",BAVDEDVBIHTHJQ-UVJOBNTFSA-N;CZRQXSDBMCMPNJ-ZUIPZQNBSA-N;RLAWWYSOJDYHDC-BZSNNMDCSA-N
PROTEC,(R)-;CT 1501R;CT-1501R;LISOFYLLINE;PROTEC,CHEMBL1411,BRD:BRD-A05334458-001-02-8;BRD:BRD-BRD-A05334458-001-02-8,rep_primary;rep_single_dose,"INTERLEUKIN RECEPTOR ANTAGONIST, STAT INHIBITOR",,,,PHASE 2,,Small molecule,2,C[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O;CC(O)CCCCN1C(=O)N(C)C2NCN(C)C2C1=O,NSMXQKNUPPXBRG-SECBINFHSA-N
REVANIL 200,LISURIDE;LISURIDE MALEATE;LYSURIDE;LYSURIDE MALEATE;REVANIL 200,CHEMBL157138,BRD:BRD-BRD-K67943528-050-01-4;BRD:BRD-K67943528-050-01-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA1A;ADRA2A;ADRA2B;ADRA2C;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C;HTR6,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3C[NH]C4CCCC(C2=C1)C34;CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,BKRGVLQUQGGVSM-KBXCAEBGSA-N
LITHIUM-ACETOACETATE,LITHIUM-ACETOACETATE,,BRD:BRD-BRD-K73234506-235-02-1;BRD:BRD-K73234506-235-02-1,rep_primary;rep_single_dose,,FAH,,,PRECLINICAL,,,NA,CC(=O)CC(O)=O,
LITHIUM-CITRATE,LITHIUM-CITRATE,,BRD:BRD-BRD-M41245765-001-04-2;BRD:BRD-M41245765-001-04-2,rep_primary;rep_single_dose,,,"BIPOLAR DISORDER, DEPRESSION",,LAUNCHED,,,NA,"[LI].[LI].[LI].OC(=O)CC(O)(CC(O)=O)C(O)=O, [LI].[LI].[LI].OC(=O)CC(O)(CC(O)=O)C(O)=O, [LI].[LI].[LI].OC(=O)CC(O)(CC(O)=O)C(O)=O",
LITHOCHOLIC-ACID,LITHOCHOLIC-ACID,,BRD:BRD-BRD-K04497194-001-02-1;BRD:BRD-K04497194-001-02-1,rep_primary;rep_single_dose,"FXR ANTAGONIST, VITAMIN D RECEPTOR AGONIST",GPBAR1;NR1H4;NR1I2;VDR,,,PRECLINICAL,,,NA,C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,
LY2523355,KF 89617;KF-89617;KF89617;LITRONESIB;LY 2523355;LY-2523355;LY2523355,CHEMBL2105661,BRD:BRD-BRD-K83029223-001-01-3;BRD:BRD-K83029223-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,KIF11,,,PHASE 2,,Small molecule,2,CCNCCS(=O)(=O)NC[C@]1(SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C)C1CCCCC1;CCNCCS(=O)(=O)NC[C@@]1(c2ccccc2)SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C,YVAFBXLHPINSIK-QHCPKHFHSA-N
WAY-VPA-985,CRTX 080;CRTX-080;LIXAR;LIXIVAPTAN;VPA 985;VPA-985;WAY-VPA-985,CHEMBL49429,BRD:BRD-BRD-K59391348-001-01-7;BRD:BRD-K59391348-001-01-7,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR ANTAGONIST,AVPR2,,,PHASE 3,,Small molecule,3,CC1CCC(F)CC1C(=O)NC1CCC(C(=O)N2CC3CCCN3CC3CCCCC23)C(CL)C1;Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1,PPHTXRNHTVLQED-UHFFFAOYSA-N
LJI308,LJI308,,GDSC2:2107,gdsc,,,,,,,,NA,,
LL-Z1640-2,(5Z)-7-OXOZEAENOL;5Z-7-OXOZEAENOL;LL-Z1640-2,,GDSC1:1242,gdsc,,,,,,,,NA,,
LM-22A4,LM-22A4,,BRD:BRD-BRD-K70404782-001-01-6;BRD:BRD-K70404782-001-01-6,rep_primary;rep_single_dose,TROPOMYOSIN RECEPTOR KINASE INHIBITOR,NTRK2,,,PRECLINICAL,,,NA,OCCNC(=O)C1CC(CC(C1)C(=O)NCCO)C(=O)NCCO,
LM11A-31,LM11A-31,,BRD:BRD-A04649065-001-01-7;BRD:BRD-BRD-A04649065-001-01-7,rep_primary;rep_single_dose,NEUROTROPHIC AGENT,NGFR,,,PHASE 1,,,NA,CCC(C)C(N)C(=O)NCCN1CCOCC1,
NVS-SM1,BRANAPLAM;LMI-070;LMI070;NVP-LMI070-NX;NVS-SM1,CHEMBL4290141,BRD:BRD-BRD-K08532119-001-01-5;BRD:BRD-K08532119-001-01-5,rep_primary;rep_single_dose,SURVIVAL MOTOR NEURON PROTEIN MODULATOR,SMN1,,,PHASE 1/PHASE 2,,Small molecule,2,CC1(C)CC(CC(C)(C)N1)OC1CCC(NN1)-C1CCC(CC1O)-C1CN[NH]C1;CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1,STWTUEAWRAIWJG-UHFFFAOYSA-N
LMK-235,LMK-235,,BRD:BRD-K49921286-001-02-6,rep_single_dose,HDAC INHIBITOR,HDAC4;HDAC5,,,,,,NA,,
SK&F 24529,LOBENDAZOLE;NSC-42044;SK&F 24529,CHEMBL2105088,BRD:BRD-BRD-K15834839-001-02-3;BRD:BRD-K15834839-001-02-3,rep_primary;rep_single_dose,ANTHELMINTIC AGENT,,,,PRECLINICAL,,Small molecule,-1,CCOC(=O)Nc1nc2ccccc2[nH]1;CCOC(=O)NC1NC2CCCCC2[NH]1,OKOVSTKGUBOSTB-UHFFFAOYSA-N
LOBENZARIT,LOBENZARIT,CHEMBL1986706,BRD:BRD-BRD-K55847762-304-01-7;BRD:BRD-K55847762-304-01-7,rep_primary;rep_single_dose,IMMUNOSUPPRESSANT,,RHEUMATOID ARTHRITIS,,LAUNCHED,,Small molecule,-1,O=C(O)c1ccccc1Nc1cc(Cl)ccc1C(=O)O;OC(=O)C1CCCCC1NC1CC(CL)CCC1C(O)=O,UGDPYGKWIHHBMB-UHFFFAOYSA-N
NSC-613792,F-DDA;LODENOSINE;NSC-613792,CHEMBL501916,BRD:BRD-K00004554-001-01-9,rep_single_dose,ANTIRETROVIRAL,,,,,,Small molecule,-1,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@@H]1F,KBEMFSMODRNJHE-JFWOZONXSA-N
U-42718,"LODOXAMIDE;LODOXAMIDE DIETHYL ESTER;LODOXAMIDE ETHYL;U-42,718;U-42718",CHEMBL1201266;CHEMBL2107161,BRD:BRD-BRD-K66937583-001-01-2;BRD:BRD-K66937583-001-01-2,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,VERNAL KERATOCONJUNCTIVITIS (VKC),,LAUNCHED,,Small molecule,-1,CCOC(=O)C(=O)Nc1cc(C#N)cc(NC(=O)C(=O)OCC)c1Cl;OC(=O)C(=O)NC1CC(CC(NC(=O)C(O)=O)C1CL)C#N,BNTAPIYHWPPFBW-UHFFFAOYSA-N
LOFEMIZOLE,LOFEMIZOLE,CHEMBL2111114,BRD:BRD-BRD-K06388517-001-01-2;BRD:BRD-K06388517-001-01-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,PHASE 3,,Small molecule,-1,Cc1[nH]cnc1-c1ccc(Cl)cc1;CC1NC[NH]C1-C1CCC(CL)CC1,MBKWNJVQSFBLQI-UHFFFAOYSA-N
LOFEXIDINE,(R)-;(S)-;DEXLOFEXIDINE;LEVLOFEXIDINE;LOFEXIDINE,CHEMBL17860;CHEMBL2106205;CHEMBL2107417,BRD:BRD-A02990301-003-06-6;BRD:BRD-BRD-A02990301-003-06-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A,OPIOID WITHDRAWAL,,LAUNCHED,,Small molecule,4,"C[C@@H](Oc1c(Cl)cccc1Cl)C1=NCCN1;C[C@H](Oc1c(Cl)cccc1Cl)C1=NCCN1;CC(Oc1c(Cl)cccc1Cl)C1=NCCN1;CC(OC1C(CL)CCCC1CL)C1=NCCN1, CC(OC1C(CL)CCCC1CL)C1=NCCN1",KSMAGQUYOIHWFS-SSDOTTSWSA-N;KSMAGQUYOIHWFS-UHFFFAOYSA-N;KSMAGQUYOIHWFS-ZETCQYMHSA-N
SC-47111A,LOMEFLOXACIN;MAXAQUIN;OKACYN;SC-47111A,CHEMBL561,BRD:BRD-A75850590-213-01-0;BRD:BRD-BRD-A75850590-213-01-0,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,"RESPIRATORY TRACT INFECTIONS, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21;CCN1CC(C(O)=O)C(=O)C2CC(F)C(N3CCNC(C)C3)C(F)C12, CCN1CC(C(O)=O)C(=O)C2CC(F)C(N3CCNC(C)C3)C(F)C12",ZEKZLJVOYLTDKK-UHFFFAOYSA-N
LOMEGUATRIB,LOMEGUATRIB,CHEMBL339133,BRD:BRD-BRD-K27955832-001-02-9;BRD:BRD-K27955832-001-02-9;CTRP:660207,ctrp;rep_multi_dose;rep_primary;rep_single_dose,O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INHIBITOR,MGMT,,,PHASE 2,,Small molecule,-1,"Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1;NC1NC(OCC2CC(BR)CS2)C2[NH]CNC2N1, NC1NC(OCC2CC(BR)CS2)C2[NH]CNC2N1",JUJPKFNFCWJBCX-UHFFFAOYSA-N
LOMERIZINE,LOMERIZINE,CHEMBL29188,BRD:BRD-BRD-K62858456-001-01-8;BRD:BRD-K62858456-001-01-8,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1B;SCN5A,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,-1,"COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC;COC1CCC(CN2CCN(CC2)C(C2CCC(F)CC2)C2CCC(F)CC2)C(OC)C1OC, COC1CCC(CN2CCN(CC2)C(C2CCC(F)CC2)C2CCC(F)CC2)C(OC)C1OC",JQSAYKKFZOSZGJ-UHFFFAOYSA-N
LOMITAPIDE,AEGR-733;BMS-201038;BMS-201038-01;LOJUXTA;LOMITAPIDE,CHEMBL354541,BRD:BRD-BRD-K92213669-001-01-3;BRD:BRD-K92213669-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,MICROSOMAL TRIGYLCERIDE TRANSFER PROTEIN INHIBITOR,MTTP,HYPERCHOLESTEROLEMIA,,LAUNCHED,,Small molecule,4,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2CCCCC2-C2CCC(CC2)C(F)(F)F)C2CCCCC2-C2CCCCC12;O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1,MBBCVAKAJPKAKM-UHFFFAOYSA-N
ZOKINVY,LONAFARNIB;SARASAR;SCH 66336;SCH-66336;SCH66336;ZOKINVY,CHEMBL298734,BRD:BRD-BRD-K41599323-001-02-3;BRD:BRD-K41599323-001-02-3;BRD:BRD-U00115421-001-01-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF FARNESYLTRANSFERASE A AND B,FNTA;FNTB;HRAS;KRAS;NRAS,,,PHASE 3,"Multiple values for MOA: {'FARNESYLTRANSFERASE INHIBITOR', 'INHIBITOR OF FARNESYLTRANSFERASE A AND B'}, defaulting to 'INHIBITOR OF FARNESYLTRANSFERASE A AND B'
Multiple values for repurposing_target: {'FNTA;FNTB', 'FNTA;HRAS;KRAS;NRAS'}, taking the union
Multiple values for structure_id: {'U00115421', 'K41599323'}, defaulting to None",Small molecule,4,NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1;NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3NCC(BR)CC3CCC3CC(CL)CC(BR)C23)CC1,DHMTURDWPRKSOA-RUZDIDTESA-N
RS-43179,LONAPALENE;RS-43179,CHEMBL36648,BRD:BRD-K00076155-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,COc1c(OC)c(OC(C)=O)c2cc(Cl)ccc2c1OC(C)=O,IFWMVQUGSGWCRP-UHFFFAOYSA-N
NSC-758419,DORIDAMINA;LONIDAMINE;NSC-741419;NSC-758419,CHEMBL1257030,BRD:BRD-BRD-K78513633-001-15-7;BRD:BRD-K78513633-001-15-7,rep_primary;rep_single_dose,GLUCOKINASE INHIBITOR,GCK,,,LAUNCHED,,Small molecule,3,"O=C(O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12;OC(=O)C1NN(CC2CCC(CL)CC2CL)C2CCCCC12, OC(=O)C1NN(CC2CCC(CL)CC2CL)C2CCCCC12, OC(=O)C1NN(CC2CCC(CL)CC2CL)C2CCCCC12, OC(=O)C1NN(CC2CCC(CL)CC2CL)C2CCCCC12",WDRYRZXSPDWGEB-UHFFFAOYSA-N
LOPERAMIDE,IMODIUM;LOPERAMIDE,CHEMBL841,BRD:BRD-BRD-K61250553-003-32-2;BRD:BRD-K61250553-003-32-2,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,CACNA1A;CALM1;OPRD1;OPRK1;OPRM1;POMC,DIARRHEA,,LAUNCHED,,Small molecule,4,"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1;CN(C)C(=O)C(CCN1CCC(O)(CC1)C1CCC(CL)CC1)(C1CCCCC1)C1CCCCC1, CN(C)C(=O)C(CCN1CCC(O)(CC1)C1CCC(CL)CC1)(C1CCCCC1)C1CCCCC1, CN(C)C(=O)C(CCN1CCC(O)(CC1)C1CCC(CL)CC1)(C1CCCCC1)C1CCCCC1",RDOIQAHITMMDAJ-UHFFFAOYSA-N
LOPINAVIRUM,"(S-(2S,4S,5S))-;A-157378-0;A-157378.0;ABT-378;ALUVIRAN;KALETRA;KOLETRA;LOPINAVIR;LOPINAVIR-;LOPINAVIRUM",CHEMBL729,BRD:BRD-BRD-K99451608-001-07-3;BRD:BRD-K99451608-001-07-3,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC1CCCCC1)NC(=O)COC1C(C)CCCC1C)CC1CCCCC1;Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,KJHKTHWMRKYKJE-SUGCFTRWSA-N
LY163892 MONOHYDRATE,LORABID;LORACARBEF;LORACARBEF HYDRATE;LORACARBEF MONOHYDRATE;LY-163892;LY-163892 MONOHYDRATE;LY163892 MONOHYDRATE,CHEMBL1013;CHEMBL1200610,BRD:BRD-K28935038-002-03-9,rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,,,Small molecule,4,N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1.O,GPYKKBAAPVOCIW-HSASPSRMSA-N
SCH-29851,ALAVERT;BAY76-2211;CHILDREN'S CLARITIN;CLARITIN;CLARITIN HIVES RELIEF;CLARITIN HIVES RELIEF REDITAB;CLARITIN REDITABS;CLARITIN-D;CLARITYN;CLARITYN RAPIDE;CLARITYNE;HAY-RITE;LORATADINE;LORATADINE REDIDOSE;NSC-758628;ROLETRA;SCH 29851;SCH-29851,CHEMBL998,BRD:BRD-BRD-K82795137-001-26-2;BRD:BRD-K82795137-001-26-2,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"ALLERGIC RHINITIS, ITCHING",,LAUNCHED,,Small molecule,4,"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1;CCOC(=O)N1CCC(CC1)=C1C2CCC(CL)CC2CCC2CCCNC12, CCOC(=O)N1CCC(CC1)=C1C2CCC(CL)CC2CCC2CCCNC12, CCOC(=O)N1CCC(CC1)=C1C2CCC(CL)CC2CCC2CCCNC12, CCOC(=O)N1CCC(CC1)=C1C2CCC(CL)CC2CCC2CCCNC12",JCCNYMKQOSZNPW-UHFFFAOYSA-N
WY-4036,ABBLORAZ;ATIVAN;LORAZ;LORAZEPAM;LORAZEPAM CIV;LORAZEPAM INTENSOL;LORAZEPAM PRESERVATIVE FREE;LOREEV XR;NSC-289758;TEMESTA;WY-4036,CHEMBL580,BRD:BRD-A11990600-001-03-4;BRD:BRD-BRD-A11990600-001-03-4,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;TSPO,STATUS EPILEPTICUS,,LAUNCHED,,Small molecule,4,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O;OC1N=C(C2CCCCC2CL)C2CC(CL)CCC2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N
LORCASERIN,LORCASERIN,CHEMBL360328,BRD:BRD-BRD-K55013654-003-02-3;BRD:BRD-K55013654-003-02-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2A;HTR2B;HTR2C,OBESITY,,LAUNCHED,,Small molecule,4,C[C@H]1CNCCC2CCC(CL)CC12;C[C@H]1CNCCc2ccc(Cl)cc21,XTTZERNUQAFMOF-QMMMGPOBSA-N
R-72063,LORECLEZOLE;R 72063;R-72063,CHEMBL1397886,BRD:BRD-BRD-K09659835-003-01-4;BRD:BRD-K09659835-003-01-4,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRB2;GABRB3,,,PHASE 2,,Small molecule,-1,Cl/C(=C\n1cncn1)c1ccc(Cl)cc1Cl;CL\C(=C/N1CNCN1)C1CCC(CL)CC1CL,XGLHZTBDUXXHOM-WMZJFQQLSA-N
LOREDIPLON,GF-015535-00;LOREDIPLON,CHEMBL3707317,BRD:BRD-BRD-K42066335-001-01-0;BRD:BRD-K42066335-001-01-0,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABRA1,,,PHASE 2,,Small molecule,-1,CN(C(C)=O)C1CC(CCC1F)-C1CCNC2C(CNN12)C(=O)C1CCCS1,
LORGLUMIDE,CR-1409;LORGLUMIDE,CHEMBL24938,BRD:BRD-A29854054-236-12-6;BRD:BRD-BRD-A29854054-236-12-6,rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKAR;CCKBR,,,PHASE 1,,Small molecule,-1,CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1;CCCCCN(CCCCC)C(=O)C(CCC(O)=O)NC(=O)C1CCC(CL)C(CL)C1,IEKOTSCYBBDIJC-UHFFFAOYSA-N
PF-06463922,LORBRENA;LORLATINIB;PF-06463922,CHEMBL3286830,BRD:BRD-BRD-K99879819-001-02-1;BRD:BRD-K99879819-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK,,,PHASE 2,,Small molecule,4,"C[C@H]1OC2CC(CNC2N)-C2C(CN(C)C(=O)C3CCC(F)CC13)NN(C)C2C#N, C[C@H]1OC2CC(CNC2N)-C2C(CN(C)C(=O)C3CCC(F)CC13)NN(C)C2C#N;C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21",IIXWYSCJSQVBQM-LLVKDONJSA-N
XEFO,CTX;LORCAM;LORNOXICAM;NSC-759620;RO 13-9297;RO-13-9297;RO-139297;XEFO,CHEMBL1569487,BRD:BRD-A90551241-001-10-8;BRD:BRD-BRD-A90551241-001-10-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"OSTEOARTHRITIS, SCIATA",,LAUNCHED,,Small molecule,4,"CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O;CN1C(C(=O)NC2CCCCN2)C(=O)C2SC(CL)CC2S1(=O)=O, CN1C(C(=O)NC2CCCCN2)C(=O)C2SC(CL)CC2S1(=O)=O",WLHQHAUOOXYABV-UHFFFAOYSA-N
NSC-758699,ALLISARTAN;ANGIZAAR;DUP-89;E-3174;EXP-3174;EXP3174;HGP-1405;HGP1405;LOSARTAN;LOSARTAN CARBOXYLIC ACID;LOSARTIC;LOZAP;NSC-758699,CHEMBL191,BRD:BRD-BRD-K76205745-237-16-5;BRD:BRD-K76205745-237-16-5;BRD:BRD-K76205745-237-22-9,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,"HYPERTENSION, DIABETIC NEPHROPATHY",,LAUNCHED,,Small molecule,4,"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1;CCCCC1NC(CL)C(CO)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCCCC1NC(CL)C(CO)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCCCC1NC(CL)C(CO)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1, CCCCC1NC(CL)C(CO)N1CC1CCC(CC1)-C1CCCCC1-C1NNN[NH]1",PSIFNNKUMBGKDQ-UHFFFAOYSA-N
LOSMAPIMOD,FTX-1821;FTX1821;GSK-AHAB;GSKAHAB;GW-856553;GW-856553X;GW856553;GW856553X;LOSMAPIMOD,CHEMBL1088752,BRD:BRD-BRD-K56195681-001-01-0;BRD:BRD-K56195681-001-01-0,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK14,,,PHASE 3,,Small molecule,3,Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1;CC1C(F)CC(CC1-C1CCC(CN1)C(=O)NCC(C)(C)C)C(=O)NC1CC1,KKYABQBFGDZVNQ-UHFFFAOYSA-N
RVT-501,E-6005;E6005;LOTAMILAST;RVT-501,CHEMBL3989967,BRD:BRD-K00003137-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,2,CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1,BBTFKAOFCSOZMB-UHFFFAOYSA-N
P-5604,AIREX;ALREX;CDDD 5604;CDDD-5604;EYSUVIS;HGP-1;INVELTYS;KPI-121;LOTEMAX;LOTEMAX SM;LOTEPREDNOL;LOTEPREDNOL ETABONATE;P-5604,CHEMBL1200865;CHEMBL1201389,BRD:BRD-BRD-K39983086-001-06-1;BRD:BRD-K39983086-001-06-1,rep_primary;rep_single_dose,"GLUCOCORTICOID RECEPTOR AGONIST, PHOSPHOLIPASE INHIBITOR",NR3C1,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,"CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C;CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCL, CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCL",DMKSVUSAATWOCU-HROMYWEYSA-N
LOTILANER (EMA EPAR: VETERINARY),CREDELIO;LOTILANER;LOTILANER (EMA EPAR: VETERINARY),CHEMBL3707310,BRD:BRD-K00084842-001-01-9,rep_single_dose,,,,,,,Small molecule,3,Cc1cc(C2=NO[C@@](c3cc(Cl)c(Cl)c(Cl)c3)(C(F)(F)F)C2)sc1C(=O)NCC(=O)NCC(F)(F)F,HDKWFBCPLKNOCK-SFHVURJKSA-N
SIVLOR,6.ALPHA.-METHYLCOMPACTIN;ALTOPREV;C10AA02;L-154803;LOVASTATIN;LOVASTATIN-;MEVACOR;MEVINACOR;MEVINACOR 10;MEVINACOR 40;MEVINOLIN;MEVLOR;MK-803;MONACOLIN K;NSC-758662;SIMVASTATIN IMPURITY;SIVLOR,CHEMBL503,BRD:BRD-BRD-K09416995-001-39-9;BRD:BRD-K09416995-001-39-9;CTRP:30620,ctrp;rep_multi_dose;rep_primary;rep_single_dose,HMGCR INHIBITOR,HDAC2;HMGCR;ITGAL;NR1I2,"CORONARY HEART DISEASE, MYOCARDIAL INFARCTION, HYPERCHOLESTEROLEMIA",,LAUNCHED,,Small molecule,4,"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12;CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21",PCZOHLXUXFIOCF-BXMDZJJMSA-N
SUM-3170,"ADASUVE;CL 62,362;CL-62362;LOXAPAC;LOXAPINE;LOXITANE;LOXITANE INTRAMUSCULAR [AS HYDROCHLORIDE];LOXITANE-C ORAL SUSPENSION [AS HYDROCHLORIDE];SUM 3170;SUM-3170",CHEMBL831,BRD:BRD-BRD-K39915878-036-24-4;BRD:BRD-K39915878-036-24-4,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA2A;ADRA2B;ADRA2C;ADRB1;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HRH2;HRH4;HTR1A;HTR1B;HTR1D;HTR1E;HTR2A;HTR2C;HTR3A;HTR5A;HTR6;HTR7;SLC6A2;SLC6A3;SLC6A4,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,"CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1;CN1CCN(CC1)C1=NC2CCCCC2OC2CCC(CL)CC12, CN1CCN(CC1)C1=NC2CCCCC2OC2CCC(CL)CC12",XJGVXQDUIWGIRW-UHFFFAOYSA-N
LOXISTATIN-ACID,LOXISTATIN-ACID,,BRD:BRD-BRD-K21937671-001-09-2;BRD:BRD-BRD-K21937671-001-10-0;BRD:BRD-K21937671-001-09-2;BRD:BRD-K21937671-001-10-0,rep_multi_dose;rep_primary;rep_single_dose,CYSTEINE PEPTIDASE INHIBITOR,CTSB,,,PRECLINICAL,,,NA,"CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O, CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O",
LOXOPROFEN SODIUM,LOXOPROFEN;LOXOPROFEN ACID;LOXOPROFEN SODIUM,CHEMBL19299,BRD:BRD-A43082555-001-01-1;BRD:BRD-A43082555-001-02-9;BRD:BRD-BRD-A43082555-001-01-1;BRD:BRD-BRD-A43082555-001-02-9,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",PTGS2,PAIN RELIEF,,LAUNCHED,,Small molecule,3,"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1;CC(C(O)=O)C1CCC(CC2CCCC2=O)CC1, CC(C(O)=O)C1CCC(CC2CCCC2=O)CC1",YMBXTVYHTMGZDW-UHFFFAOYSA-N
LP-533401,LP-533401,,BRD:BRD-K00004673-001-01-9,rep_single_dose,TRYPTOPHAN HYDROXYLASE INHIBITOR,,,,,,,NA,,
LPA2-ANTAGONIST-1,LPA2-ANTAGONIST-1,,BRD:BRD-BRD-K32322923-001-01-7;BRD:BRD-K32322923-001-01-7,rep_primary;rep_single_dose,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,LPAR2,,,PRECLINICAL,,,NA,C[C@@H](CN1CCN(CC1)S(=O)(=O)C1CCC(CL)C(CL)C1)NC1NCNC2C(C)CSC12,
LRRK2-IN-1,LRRK2-IN-1,,BRD:BRD-BRD-K01436366-001-22-2;BRD:BRD-K01436366-001-22-2;CTRP:607696,ctrp;rep_primary;rep_single_dose,LEUCINE RICH REPEAT KINASE INHIBITOR,LRRK2,,,PRECLINICAL,,,NA,"COC1CC(CCC1NC1NCC2N(C)C(=O)C3CCCCC3N(C)C2N1)C(=O)N1CCC(CC1)N1CCN(C)CC1, COC1CC(CCC1NC1NCC2N(C)C(=O)C3CCCCC3N(C)C2N1)C(=O)N1CCC(CC1)N1CCN(C)CC1",
LSN-2463359,LSN-2463359,,BRD:BRD-BRD-K79337272-001-01-6;BRD:BRD-K79337272-001-01-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM5,,,PRECLINICAL,,,NA,CC(C)NC(=O)C1CCC(CN1)C#CC1CCNCC1,
LSZ102,LSZ-102;LSZ102,CHEMBL4298014,BRD:BRD-K00004675-001-01-9,rep_single_dose,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),,,,,,Unknown,1,,
LTA,LTA,,BRD:BRD-BRD-K52914072-001-01-5;BRD:BRD-K52914072-001-01-5,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,N=C(NC1CCCCC1)C1CCCS1,
LTA4H-IN-1,LTA4H-IN-1,,BRD:BRD-K00091132-001-01-9,rep_single_dose,,,,,,,,NA,,
LTB4,LTB4,,BRD:BRD-BRD-K53124401-001-03-8;BRD:BRD-K53124401-001-03-8,rep_primary;rep_single_dose,LEUKOCYTE ACTIVATOR,LTB4R;LTB4R2,,,PHASE 2,,,NA,CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O,
RUXOTEMITIDE,KKWWKKW-.BETA.-PHENYL-FK-NH2;KKWWKKWDIPK-NH2;LTX 315;LTX-315;ONCOPORE;RUXOTEMITIDE,CHEMBL4297628,BRD:BRD-K00003300-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,Protein,2,NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(c1ccccc1)c1ccccc1)C(N)=O,GGAKLYWEFZCVIT-TVEKFXMRSA-N
LU-AA-47070,LU-AA-47070,,BRD:BRD-BRD-K83970940-001-01-0;BRD:BRD-K83970940-001-01-0,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA2A,,,PHASE 2,,,NA,CC(C)(C)CC(=O)NC1C(F)CC(CC1F)C(=O)\N=C1/SCCN1COP(O)(O)=O,
RU-0211,AMITIZA;LUBIPROSTONE;RU-0211,CHEMBL1201134,BRD:BRD-BRD-K33814251-001-01-4;BRD:BRD-BRD-K33814251-001-02-2;BRD:BRD-K33814251-001-01-4;BRD:BRD-K33814251-001-02-2,rep_primary;rep_single_dose,CHLORIDE CHANNEL ACTIVATOR,CLCN2,"CONSTIPATION, IRRITABLE BOWEL SYNDROME",,LAUNCHED,,Small molecule,4,"CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1;CCCCC(F)(F)C(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O, CCCCC(F)(F)C(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O",WGFOBBZOWHGYQH-MXHNKVEKSA-N
LUCANTHONE,LUCANTHONE,CHEMBL279014,BRD:BRD-K00003521-001-01-9,rep_single_dose,ENDONUCLEASE INHIBITOR,APEX1;TOP1;TOP2A,,,,,Small molecule,2,CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12,FBQPGGIHOFZRGH-UHFFFAOYSA-N
S-80881,AL-3810;CO-3810;E-3810;LUCITANIB;S 80881;S-80881,CHEMBL2220486,BRD:BRD-BRD-K31309378-001-01-5;BRD:BRD-K31309378-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,"FGFR INHIBITOR, VEGFR INHIBITOR",FGFR1;FLT1;KDR;KIT;PDGFRA;PDGFRB;RET,,,PHASE 2,,Small molecule,2,CNC(=O)C1CCCC2CC(CCC12)OC1CCNC2CC(OCC3(N)CC3)C(OC)CC12;CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,CUDVHEFYRIWYQD-UHFFFAOYSA-N
LUF-5834,LUF-5834,,BRD:BRD-BRD-K67079690-001-01-2;BRD:BRD-K67079690-001-01-2,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA2A;ADORA2B,,,PRECLINICAL,,,NA,NC1NC(SCC2NCC[NH]2)C(C#N)C(-C2CCC(O)CC2)C1C#N,
NSC-759097,CGA-184699;LUFENURON;NSC-759097,CHEMBL1364906,BRD:BRD-A71774530-001-05-9;BRD:BRD-BRD-A71774530-001-05-9,rep_primary;rep_single_dose,CHITIN INHIBITOR,,FLEA CONTROL,,LAUNCHED,,Small molecule,-1,FC(C(F)(F)F)C(F)(F)OC1CC(CL)C(NC(=O)NC(=O)C2C(F)CCCC2F)CC1CL;O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)C(F)(F)F)cc1Cl,PWPJGUXAGUPAHP-UHFFFAOYSA-N
PR-2699,LULICON;LULICONAZOLE;LUZU;NND-502;PR-2699,CHEMBL2105689,BRD:BRD-BRD-K71058253-001-01-9;BRD:BRD-K71058253-001-01-9,rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,,"TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS",,LAUNCHED,,Small molecule,4,CLC1CCC([C@@H]2CS\C(S2)=C(\C#N)N2CCNC2)C(CL)C1;N#C/C(=C1/SC[C@@H](c2ccc(Cl)cc2Cl)S1)n1ccnc1,YTAOBBFIOAEMLL-REQDGWNSSA-N
VX-809,LUMACAFTOR;VRT 826809;VRT-826809;VX 809;VX-809,CHEMBL2103870,BRD:BRD-BRD-K69236721-001-02-7;BRD:BRD-K69236721-001-02-7,rep_primary;rep_single_dose,CFTR CHANNEL AGONIST,CFTR,CYSTIC FIBROSIS,,LAUNCHED,,Small molecule,4,Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1;CC1CCC(NC(=O)C2(CC2)C2CCC3OC(F)(F)OC3C2)NC1-C1CCCC(C1)C(O)=O,UFSKUSARDNFIRC-UHFFFAOYSA-N
LUMATEPERONE,ITI 007;ITI-007;ITI-722;ITI007;LUMATEPERONE,CHEMBL3306803,BRD:BRD-BRD-K10031916-075-01-3;BRD:BRD-K10031916-075-01-3,rep_primary;rep_single_dose,"SEROTONIN RECEPTOR ANTAGONIST, DOPAMINE RECEPTOR MODULATOR",DRD2;HTR2A,,,PHASE 3,"Multiple values for MOA: {'DOPAMINE RECEPTOR MODULATOR, SEROTONIN RECEPTOR ANTAGONIST', 'SEROTONIN RECEPTOR ANTAGONIST, DOPAMINE RECEPTOR MODULATOR'}, defaulting to 'SEROTONIN RECEPTOR ANTAGONIST, DOPAMINE RECEPTOR MODULATOR'",Small molecule,4,"CN1CCN2[C@H]3CCN(CCCC(=O)C4CCC(F)CC4)C[C@H]3C3CCCC1C23, CN1CCN2[C@H]3CCN(CCCC(=O)C4CCC(F)CC4)C[C@H]3C3CCCC1C23;CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12",HOIIHACBCFLJET-SFTDATJTSA-N
PREXIGE,COX-189;LUMIRACOXIB;PREXIGE,CHEMBL404108,BRD:BRD-BRD-K26901728-001-06-2;BRD:BRD-K26901728-001-06-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,WITHDRAWN,,Small molecule,4,"Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1;CC1CCC(NC2C(F)CCCC2CL)C(CC(O)=O)C1, CC1CCC(NC2C(F)CCCC2CL)C(CC(O)=O)C1",KHPKQFYUPIUARC-UHFFFAOYSA-N
LUPANINE,LUPANINE,CHEMBL459396,BRD:BRD-A92826379-001-01-5;BRD:BRD-BRD-A92826379-001-01-5,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,INS,,,PHASE 1,,Small molecule,NA,O=C1CCC[C@@H]2[C@H]3C[C@@H](CN12)[C@@H]1CCCCN1C3;O=C1CCCC2C3CC(CN12)[C@@H]1CCCCN1C3,JYIJIIVLEOETIQ-XDQVBPFNSA-N
LURASIDONE,LATUDA;LURASIDONE,CHEMBL1237021,BRD:BRD-BRD-K51143828-003-03-1;BRD:BRD-K51143828-003-03-1,rep_multi_dose;rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA2A;ADRA2C;DRD2;HTR1A;HTR2A;HTR7,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1;O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1NSC2CCCCC12,PQXKDMSYBGKCJA-CVTJIBDQSA-N
ZEPZELCA,LURBINECTEDIN;PM-01183;PM-1183;PM01183;PM1183;TRYPTAMICIDIN;ZEPSYRE;ZEPZELCA,CHEMBL4297516,BRD:BRD-K00003211-001-01-9,rep_single_dose,DNA BINDING AGENT,,,,,,Small molecule,4,COc1ccc2[nH]c3c(c2c1)CCN[C@]31CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(C)c(OC)c3O)C[C@@H]([C@@H]1O)N2C)OCO4,YDDMIZRDDREKEP-HWTBNCOESA-N
LUSAPERIDONE,LUSAPERIDONE,CHEMBL162501,BRD:BRD-K00004742-001-01-9,rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,ZYXHQIPQIKTEDI-UHFFFAOYSA-N
S-888711,LUSUTROMBOPAG;MULPLETA;RSC888711;S-888711,CHEMBL2107831,BRD:BRD-K93228461-001-02-9,rep_single_dose,THROMBOPOIETIN RECEPTOR AGONIST,,,,,,Small molecule,4,CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC,NOZIJMHMKORZBA-KJCUYJGMSA-N
YAMA KARIYASU,CYANIDENON-1470;DIGITOFLAVONE;FLACITRAN;LUTEOLIN;LUTEOLINE;LUTEOLOL;SALIFAZIDE;WELD LAKE;YAMA KARIYASU,CHEMBL151,BRD:BRD-BRD-K05236810-001-19-0;BRD:BRD-K05236810-001-19-0,rep_primary;rep_single_dose,GLUCOSIDASE INHIBITOR,TOP1,,,PHASE 2,,Small molecule,2,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12;OC1CC(O)C2C(C1)OC(CC2=O)-C1CCC(O)C(O)C1,IQPNAANSBPBGFQ-UHFFFAOYSA-N
LUZINDOLE,LUZINDOLE,CHEMBL286615,BRD:BRD-K67013324-001-04-9,rep_single_dose,MELATONIN RECEPTOR ANTAGONIST,MTNR1A;MTNR1B,,,,,Small molecule,NA,CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12,WVVXBPKOIZGVNS-UHFFFAOYSA-N
LX1031,LX1031,,BRD:BRD-BRD-K32101625-001-01-6;BRD:BRD-K32101625-001-01-6,rep_primary;rep_single_dose,TRYPTOPHAN HYDROXYLASE INHIBITOR,TPH1,,,PHASE 2,,,NA,COC1CCCC(C1)-C1CCC(CC1)[C@@H](OC1CC(NC(N)N1)-C1CCC(C[C@H](N)C(O)=O)CC1)C(F)(F)F,
LX7101,LX-7101;LX7101,CHEMBL3356433,BRD:BRD-BRD-K21038058-001-01-9;BRD:BRD-K21038058-001-01-9,rep_primary;rep_single_dose,"LIM KINASE INHIBITOR, RHO ASSOCIATED KINASE INHIBITOR",LIMK2;ROCK1;ROCK2,,,PHASE 1/PHASE 2,,Small molecule,1,"Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12;CN(C)C(=O)OC1CCCC(NC(=O)C2(CN)CCN(CC2)C2NCNC3[NH]CC(C)C23)C1, CN(C)C(=O)OC1CCCC(NC(=O)C2(CN)CCN(CC2)C2NCNC3[NH]CC(C)C23)C1",PWPNYABQEOGNNC-UHFFFAOYSA-N
PAN-RAF INHIBITOR LXH254,LXH 254;LXH-254;LXH254;NAPORAFENIB;PAN-RAF INHIBITOR LXH254,CHEMBL4583691,BRD:BRD-K00003107-001-01-9;BRD:BRD-U00115422-001-01-9,oncref_1;rep_single_dose,"INHIBITOR OF BRAF, BRAF-V600E, AND CRAF",BRAF;CRAF,,,,"Multiple values for MOA: {'RAF INHIBITOR', 'INHIBITOR OF BRAF, BRAF-V600E, AND CRAF'}, defaulting to 'INHIBITOR OF BRAF, BRAF-V600E, AND CRAF'
Multiple values for structure_id: {'U00115422', 'K00003107'}, defaulting to None",Small molecule,2,Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1,UEPXBTCUIIGYCY-UHFFFAOYSA-N
WAY252623,LX-623;LX623;LXR-623;WAY-252623;WAY252623,CHEMBL456237,BRD:BRD-BRD-K54520417-001-01-2;BRD:BRD-K54520417-001-01-2,rep_primary;rep_single_dose,LXR AGONIST,AR;NR1H2;NR1H3;NR1I2;NR3C1,,,PHASE 1,,Small molecule,1,Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1;FC1CCC(CC1)-C1N(CC2CCC(F)CC2CL)NC2C(CCCC12)C(F)(F)F,KYWWJENKIMRJBI-UHFFFAOYSA-N
NVP-LXS-196,DAROVASERTIB;IDE-196;IDE196;LXS-196;LXS196;NVP-LXS-196,CHEMBL3982723,BRD:BRD-K00003425-001-01-9,rep_single_dose,PKC INHIBITOR,,,,,,Small molecule,2,CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1,XXJXHXJWQSCNPX-UHFFFAOYSA-N
NSC-613327,GEMCITABINE;GEMCITABINE (AS HYDROCHLORIDE);GEMCITABINE HCL;GEMCITABINE HYDROCHLORIDE;GEMZAR;INFUGEM;LY-188011;LY-188011 HYDROCHLORIDE;LY188011;LY188011 HYDROCHLORIDE;NSC-613327,CHEMBL1637;CHEMBL888,GDSC1:135;GDSC2:1190,gdsc,,,,,,,Small molecule,4,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,SDUQYLNIPVEERB-QPPQHZFASA-N
LY2157299,GALUNISERTIB;LY-2157299;LY2157299,CHEMBL2364611,CTRP:660431,ctrp,,,,,,,Small molecule,2,Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1,IVRXNBXKWIJUQB-UHFFFAOYSA-N
LY-2183240,LY-2183240,,CTRP:375496,ctrp,,,,,,,,NA,,
LY2090314,LY 2090314;LY-2090314;LY2090314,CHEMBL362558,BRD:BRD-BRD-K78055238-001-01-8;BRD:BRD-K78055238-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3B,,,PHASE 2,,Small molecule,2,FC1CC2CN(CCN3CC(C4=C(C(=O)NC4=O)C4CNC5CCCCN45)C(C1)C23)C(=O)N1CCCCC1;O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2,HRJWTAWVFDCTGO-UHFFFAOYSA-N
LY2109761,LY2109761,,BRD:BRD-BRD-K47557313-001-02-7;BRD:BRD-K47557313-001-02-7;GDSC2:1852,gdsc;rep_multi_dose;rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,TGFBR1;TGFBR2,,,PRECLINICAL,,,NA,C(CN1CCOCC1)OC1CCC2C(CCNC2C1)-C1C(NN2CCCC12)-C1CCCCN1,
POMAGLUMETAD METHIONIL,LY-2140023;LY-2140023 MONOHYDRATE;LY2140023;POMAGLUMETAD METHIONIL,CHEMBL2110730,BRD:BRD-BRD-K49519144-001-04-6;BRD:BRD-K49519144-001-04-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM3,,,PHASE 3,,Small molecule,3,"CSCC[C@H](N)C(=O)N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21;N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O, N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O",VOYCNOJFAJAILW-CAMHOICYSA-N
LY215490,LY215490,,BRD:BRD-BRD-K34313798-001-01-6;BRD:BRD-K34313798-001-01-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1;GRIA2;GRIA3;GRIA4;GRIK1,,,PHASE 1,,,NA,OC(=O)[C@@H]1C[C@H]2C[C@@H](CCC3NN[NH]N3)CC[C@H]2CN1,
LY2157299,GALUNISERTIB;LY-2157299;LY2157299,CHEMBL2364611,BRD:BRD-BRD-K78118466-001-03-3;BRD:BRD-K78118466-001-03-3,rep_multi_dose;rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,TGFBR1,,,PHASE 2/PHASE 3,,Small molecule,2,Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1;CC1CCCC(N1)-C1NN2CCCC2C1-C1CCNC2CCC(CC12)C(N)=O,IVRXNBXKWIJUQB-UHFFFAOYSA-N
LY2183240,LY2183240,,BRD:BRD-BRD-K37865504-001-04-1;BRD:BRD-K37865504-001-04-1,rep_multi_dose;rep_primary;rep_single_dose,"FAAH INHIBITOR, FAAH REUPTAKE INHIBITOR",FAAH,,,PRECLINICAL,,,NA,"CN(C)C(=O)N1NNNC1CC1CCC(CC1)-C1CCCCC1, CN(C)C(=O)N1NNNC1CC1CCC(CC1)-C1CCCCC1",
RALIMETINIB,LSN-2322600 FREE BASE;LSN2322600 FREE BASE;LY-2228820;LY2228820;LY22288220;RALIMETINIB,CHEMBL2364626,BRD:BRD-BRD-K59227464-334-02-4;BRD:BRD-K59227464-334-02-4,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK14,,,PHASE 2,,Small molecule,2,"CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)nc21;CC(C)(C)CN1C(N)NC2CCC(NC12)-C1[NH]C(NC1-C1CCC(F)CC1)C(C)(C)C, CC(C)(C)CN1C(N)NC2CCC(NC12)-C1[NH]C(NC1-C1CCC(F)CC1)C(C)(C)C",XPPBBJCBDOEXDN-UHFFFAOYSA-N
LY223982,LY223982,,BRD:BRD-BRD-K35367061-001-01-1;BRD:BRD-K35367061-001-01-1,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,LTB4R,,,PHASE 2,,,NA,COC1CCC(\C=C\CCCCOC2CCC(CC2CCC(O)=O)C(=O)C2CCCC(C2)C(O)=O)CC1,
LY225910,LY225910,,BRD:BRD-BRD-K33864865-001-02-5;BRD:BRD-K33864865-001-02-5,rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKBR,,,PRECLINICAL,,,NA,"CC(C)OC1CCCC(C1)-N1C(CCC2C[NH]C3CCC(BR)CC23)NC2CCCCC2C1=O, CC(C)OC1CCCC(C1)-N1C(CCC2C[NH]C3CCC(BR)CC23)NC2CCCCC2C1=O",
LY231617,LY231617,,BRD:BRD-K85804405-003-01-3,rep_single_dose,LIPID PEROXIDASE INHIBITOR,,,,,,,NA,,
LY2334737,LY-2334737;LY2334737,CHEMBL577711,BRD:BRD-BRD-K04993719-001-01-7;BRD:BRD-K04993719-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,"ANTITUMOR AGENT, RIBONUCLEOTIDE REDUCTASE INHIBITOR",,,,PHASE 1,,Small molecule,1,CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1;CCCC(CCC)C(=O)NC1CCN([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)C(=O)N1,MEOYFIHNRBNEPI-UXIGCNINSA-N
LY2365109,LY2365109,,BRD:BRD-BRD-K13888115-003-02-2;BRD:BRD-K13888115-003-02-2,rep_primary;rep_single_dose,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",SLC6A9,,,PRECLINICAL,"Multiple values for MOA: {'GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR', 'GLYCINE TRANSPORTER 1 INHIBITOR'}, defaulting to 'GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR'",,NA,"CN(CCOC1CCC(CC1C(C)(C)C)-C1CCC2OCOC2C1)CC(O)=O, CN(CCOC1CCC(CC1C(C)(C)C)-C1CCC2OCOC2C1)CC(O)=O",
TT-701,LY-2452473;LY2452473;OPK-88004;TT-701,CHEMBL3542265,BRD:BRD-BRD-K90171280-001-01-4;BRD:BRD-K90171280-001-01-4,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,,,PHASE 2,,Small molecule,2,CC(C)OC(=O)N[C@@H]1CC2C(C1)C1CC(CCC1N2CC1CCCCN1)C#N;CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1,IHIWYQYVBNODSV-KRWDZBQOSA-N
LY2510924,LY2510924,,BRD:BRD-K00003131-001-01-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,,,,NA,,
LY255283,LY255283,,BRD:BRD-BRD-K92492521-001-02-9;BRD:BRD-K92492521-001-02-9,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,LTB4R;LTB4R2,,,PRECLINICAL,,,NA,"CCC1CC(C(C)=O)C(O)CC1OCCCCCC(C)(C)C1NNN[NH]1, CCC1CC(C(C)=O)C(O)CC1OCCCCCC(C)(C)C1NNN[NH]1",
TERN-101,LY-2562175;LY2562175;TERN-101,CHEMBL3746388,BRD:BRD-K00075537-001-02-9,rep_single_dose,,,,,,,Small molecule,2,Cn1cc(C(=O)O)c2ccc(N3CCC(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)CC3)cc21,RPVDFHPBGBMWID-UHFFFAOYSA-N
LY2584702,LY 2584702;LY-2584702;LY2584702,CHEMBL3545076,BRD:BRD-BRD-K21833260-075-01-1;BRD:BRD-K21833260-075-01-1,rep_primary;rep_single_dose,RIBOSOMAL PROTEIN INHIBITOR,RPS6KB1,,,PHASE 1,,Small molecule,1,"Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1;CN1CC(NC1C1CCN(CC1)C1NCNC2[NH]NCC12)-C1CCC(F)C(C1)C(F)(F)F, CN1CC(NC1C1CCN(CC1)C1NCNC2[NH]NCC12)-C1CCC(F)C(C1)C(F)(F)F",FYXRSVDHGLUMHB-UHFFFAOYSA-N
RABUSERTIB,IC-83;LY-2603618;LY2603618;RABUSERTIB,CHEMBL3039517,BRD:BRD-BRD-K14109347-001-03-4;BRD:BRD-K14109347-001-03-4,rep_multi_dose;rep_primary;rep_single_dose,CHK INHIBITOR,CHEK1,,,PHASE 2,,Small molecule,2,"Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1;CC1CNC(NC(=O)NC2CC(BR)C(C)CC2OC[C@@H]2CNCCO2)CN1, CC1CNC(NC(=O)NC2CC(BR)C(C)CC2OC[C@@H]2CNCCO2)CN1",SYYBDNPGDKKJDU-ZDUSSCGKSA-N
PREXASERTIB,LY2606368;PREXASERTIB,CHEMBL3544911,BRD:BRD-BRD-K20463415-300-01-4;BRD:BRD-K20463415-300-01-4,rep_multi_dose;rep_primary;rep_single_dose,CHK INHIBITOR,CHEK1,,,PHASE 2,,Small molecule,2,"COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1;COC1CCCC(OCCCN)C1-C1CC(NC2CNC(CN2)C#N)N[NH]1, COC1CCCC(OCCCN)C1-C1CC(NC2CNC(CN2)C#N)N[NH]1",DOTGPNHGTYJDEP-UHFFFAOYSA-N
SY-004,GLOBALAGLIATIN;LY-2608204;LY2608204;SY-004,CHEMBL4297399,BRD:BRD-BRD-K12068470-001-02-5;BRD:BRD-BRD-K12068470-001-04-1;BRD:BRD-K12068470-001-02-5;BRD:BRD-K12068470-001-04-1,rep_multi_dose;rep_primary;rep_single_dose,GLUCOKINASE ACTIVATOR,GCK,,,PHASE 2,,Small molecule,2,"O=C(Nc1ncc(SCCN2CCCC2)s1)[C@]1(c2ccc(S(=O)(=O)C3CC3)cc2)C[C@H]1C1CCCCC1;O=C(NC1NCC(SCCN2CCCC2)S1)[C@@]1(C[C@H]1C1CCCCC1)C1CCC(CC1)S(=O)(=O)C1CC1, O=C(NC1NCC(SCCN2CCCC2)S1)[C@@]1(C[C@H]1C1CCCCC1)C1CCC(CC1)S(=O)(=O)C1CC1, O=C(NC1NCC(SCCN2CCCC2)S1)[C@@]1(C[C@H]1C1CCCCC1)C1CCC(CC1)S(=O)(=O)C1CC1",QIIVJLHCZUTGSD-CUBQBAPOSA-N
LY266097,LY266097,,BRD:BRD-A64004759-003-01-9;BRD:BRD-BRD-A64004759-003-01-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2B,,,PRECLINICAL,,,NA,COC1CCC(CC2NCCC3C2[NH]C2CCC(C)CC32)C(CL)C1OC,
LY2784544,GANDOTINIB;LY-2784544;LY2784544,CHEMBL2107823,BRD:BRD-BRD-K25630527-001-03-8;BRD:BRD-K25630527-001-03-8,rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,JAK2;JAK3,,,PHASE 2,,Small molecule,2,CC1CC(NC2CC(CN3CCOCC3)C3NC(C)C(CC4CCC(CL)CC4F)N3N2)[NH]N1;Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1,SQSZANZGUXWJEA-UHFFFAOYSA-N
LY2795050,LY2795050,,BRD:BRD-K00003195-001-01-9,rep_single_dose,OPIOID RECEPTOR ANTAGONIST,,,,,,,NA,,
MERESTINIB,LY-2801653;LY2801653;MERESTINIB,CHEMBL3545307,BRD:BRD-BRD-K18961567-001-01-1;BRD:BRD-K18961567-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,MET INHIBITOR,MET,,,PHASE 2,,Small molecule,2,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1;CC1CCC(C(=O)NC2CCC(OC3CC4CNN(C)C4CC3-C3CN[NH]C3)C(F)C2)C(=O)N1-C1CCC(F)CC1,QHADVLVFMKEIIP-UHFFFAOYSA-N
LY2811376,J3.079.793K;LY-2811376;LY2811376,CHEMBL2333941,BRD:BRD-BRD-K94534639-001-02-5;BRD:BRD-K94534639-001-02-5,rep_primary;rep_single_dose,BETA-SECRETASE INHIBITOR,BACE1,,,PHASE 1,,Small molecule,1,C[C@]1(CCSC(N)=N1)C1CC(C(F)CC1F)-C1CNCNC1;C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1,MJQMRGWYPNIERM-HNNXBMFYSA-N
LY2828360,LY-2828360;LY2828360,CHEMBL3139186,BRD:BRD-K00005249-001-01-9,rep_single_dose,CANNABINOID RECEPTOR AGONIST,,,,,,Small molecule,2,Cc1nc(N2CCN(C)CC2)c2nc(-c3ccccc3Cl)n(C3CCOCC3)c2n1,UCMNDPDJRSEZPL-UHFFFAOYSA-N
LY2857785,LY2857785,,BRD:BRD-K15382985-001-01-7,rep_single_dose,CDK INHIBITOR,CDK9,,,,,,NA,,
LY2874455,LY-2874455;LY2874455,CHEMBL3545264,BRD:BRD-BRD-K17203476-001-01-9;BRD:BRD-K17203476-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,FGFR ANTAGONIST,FGFR1;FGFR2;FGFR3;FGFR4;KDR,,,PHASE 1,,Small molecule,1,C[C@@H](OC1CCC2[NH]NC(\C=C\C3CNN(CCO)C3)C2C1)C1C(CL)CNCC1CL;CC(Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl,GKJCVYLDJWTWQU-DUXPYHPUSA-N
LY288513,LY288513,,BRD:BRD-K24675965-001-06-9,rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKBR,,,,,,NA,,
LY2886721,LY-2886721;LY2886721,CHEMBL2396989,BRD:BRD-BRD-K17953908-001-01-7;BRD:BRD-K17953908-001-01-7,rep_primary;rep_single_dose,BETA-SECRETASE INHIBITOR,BACE1,,,PHASE 1/PHASE 2,,Small molecule,1,NC1=N[C@]2(COC[C@@H]2CS1)C1CC(NC(=O)C2CCC(F)CN2)CCC1F;NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COC[C@H]2CS1,NIDRNVHMMDAAIK-YPMLDQLKSA-N
LY2922470,LY2922470,,BRD:BRD-K00091082-001-01-9,rep_single_dose,,,,,,,,NA,,
LY294002,LY294002,,BRD:BRD-BRD-K27305650-001-16-6;BRD:BRD-K27305650-001-16-6,rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR, DNA DEPENDENT PROTEIN KINASE INHIBITOR, PHOSPHODIESTERASE INHIBITOR, PLK INHIBITOR",AKT1;CHEK1;GSK3B;LCK;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG;PIM1;PLK1;PRKCA;PRKDC;ROCK1;RPS6KB1;SGK1,,,PRECLINICAL,"Multiple values for MOA: {'DNA DEPENDENT PROTEIN KINASE INHIBITOR, MTOR INHIBITOR, PHOSPHODIESTERASE INHIBITOR, PI3K INHIBITOR, PLK INHIBITOR', 'MTOR INHIBITOR, PI3K INHIBITOR, DNA DEPENDENT PROTEIN KINASE INHIBITOR, PHOSPHODIESTERASE INHIBITOR, PLK INHIBITOR'}, defaulting to 'MTOR INHIBITOR, PI3K INHIBITOR, DNA DEPENDENT PROTEIN KINASE INHIBITOR, PHOSPHODIESTERASE INHIBITOR, PLK INHIBITOR'
Multiple values for repurposing_target: {'AKT1;CHEK1;GSK3B;LCK;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG;PLK1;PRKCA;PRKDC;ROCK1;RPS6KB1;SGK1', 'AKT1;CHEK1;GSK3B;LCK;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG;PIM1;PLK1;PRKCA;PRKDC;ROCK1;RPS6KB1;SGK1'}, taking the union",,NA,"O=C1CC(OC2C(CCCC12)-C1CCCCC1)N1CCOCC1, O=C1CC(OC2C(CCCC12)-C1CCCCC1)N1CCOCC1, O=C1CC(OC2C(CCCC12)-C1CCCCC1)N1CCOCC1",
LY2940094,LY2940094,CHEMBL3545406,BRD:BRD-K00077386-001-02-9,rep_single_dose,,,,,,,Small molecule,2,,
LY2979165,HY-13239;LY-2979165;LY2979165,CHEMBL3544939;CHEMBL4303379,BRD:BRD-BRD-K68220839-413-02-8;BRD:BRD-K68220839-413-02-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM2,,,PHASE 1,,Small molecule,1,"C[C@H](N)C(=O)N[C@]1(C[C@@H](SC2NNC[NH]2)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O, C[C@H](N)C(=O)N[C@]1(C[C@@H](SC2NNC[NH]2)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O;C[C@H](N)C(=O)N[C@@]1(C(=O)O)C[C@@H](Sc2nnc[nH]2)[C@H]2[C@H](C(=O)O)[C@H]21",BBGHHIUQOKQCBW-LDZWZCGGSA-N
LY3000328,LY3000328,,BRD:BRD-BRD-K21070437-001-01-4;BRD:BRD-K21070437-001-01-4,rep_primary;rep_single_dose,CATHEPSIN INHIBITOR,CTSS,,,PHASE 1,,,NA,CNC(=O)O[C@H]1COC2CCC(CC2[C@@H]1NC(=O)C1CCC(F)CC1)N1CCN(CC1)C1COC1,
PAN-RAF INHIBITOR LY3009120,DP-4978;LY-3009120;LY3009120;PAN-RAF INHIBITOR LY3009120,CHEMBL3545195,BRD:BRD-BRD-K38385169-001-04-5;BRD:BRD-K38385169-001-04-5,rep_primary;rep_single_dose,RAF INHIBITOR,BRAF;RAF1,,,PHASE 1,,Small molecule,1,"CNC1NCC2CC(C(C)NC2N1)-C1CC(NC(=O)NCCC(C)(C)C)C(F)CC1C, CNC1NCC2CC(C(C)NC2N1)-C1CC(NC(=O)NCCC(C)(C)C)C(F)CC1C",
SAMOTOLISIB,LY 3023414;LY-3023414;LY3023414;SAMOTOLISIB,CHEMBL4297181,BRD:BRD-BRD-K82967180-001-01-6;BRD:BRD-K82967180-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,"PI3K INHIBITOR, MTOR INHIBITOR",MTOR,,,PHASE 2,"Multiple values for MOA: {'MTOR INHIBITOR, PI3K INHIBITOR', 'PI3K INHIBITOR, MTOR INHIBITOR'}, defaulting to 'PI3K INHIBITOR, MTOR INHIBITOR'",Small molecule,2,CO[C@@H](C)Cn1c(=O)n(C)c2cnc3ccc(-c4cncc(C(C)(C)O)c4)cc3c21;CO[C@@H](C)CN1C2C(CNC3CCC(CC23)-C2CNCC(C2)C(C)(C)O)N(C)C1=O,ACCFLVVUVBJNGT-AWEZNQCLSA-N
LY303511,LY303511,,BRD:BRD-BRD-K22385716-001-02-5;BRD:BRD-K22385716-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,"CASEIN KINASE INHIBITOR, MTOR INHIBITOR, PI3K INHIBITOR",BRD2;BRD3;BRD4,,,PRECLINICAL,,,NA,"O=C1CC(OC2C(CCCC12)-C1CCCCC1)N1CCNCC1, O=C1CC(OC2C(CCCC12)-C1CCCCC1)N1CCNCC1",
LY310762,LY310762,,BRD:BRD-BRD-K41194171-003-09-7;BRD:BRD-K41194171-003-09-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1D,,,PRECLINICAL,,,NA,CC1(C)C(=O)N(CCN2CCC(CC2)C(=O)C2CCC(F)CC2)C2CCCCC12,
LY311727,LY311727,,BRD:BRD-K00004565-001-01-9,rep_single_dose,PHOSPHOLIPASE INHIBITOR,,,,,,,NA,,
LY317615,DB-102;DB102;ENZASTAURIN;KINENZA;LY-317615;LY317615,CHEMBL300138,GDSC1:229,gdsc,,,,,,,Small molecule,3,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,AXRCEOKUDYDWLF-UHFFFAOYSA-N
LY3200882,LY 3200882;LY-3200882;LY3200882,CHEMBL4594432,BRD:BRD-K00003446-001-01-9,rep_single_dose,TGF BETA RECEPTOR INHIBITOR,,,,,,Small molecule,1,CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccn1,PNPFMWIDAKQFPY-UHFFFAOYSA-N
LY320135,LY320135,,BRD:BRD-BRD-K78637815-001-02-2;BRD:BRD-K78637815-001-02-2,rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1,,,PRECLINICAL,,,NA,COC1CCC(CC1)-C1OC2CC(OC)CCC2C1C(=O)C1CCC(CC1)C#N,
TEMUTERKIB,[14C]-LY3214996;LY 3214996;LY-3214996;LY3214996;TEMUTERKIB,CHEMBL4650285,BRD:BRD-K00003416-001-01-9,oncref_1;rep_single_dose,INHIBITOR OF ERK1 AND ERK2,MAPK1;MAPK2,,,,"Multiple values for MOA: {'INHIBITOR OF ERK1 AND ERK2', 'ERK INHIBITOR'}, defaulting to 'INHIBITOR OF ERK1 AND ERK2'",Small molecule,2,Cn1nccc1Nc1nccc(-c2cc3c(s2)C(C)(C)N(CCN2CCOCC2)C3=O)n1,JNPRPMBJODOFEC-UHFFFAOYSA-N
LY3295668,AK-01;LY-3295668;LY3295668,CHEMBL4594367,BRD:BRD-K00004722-001-01-9,rep_single_dose,AURORA KINASE INHIBITOR,,,,,,Unknown,1,,
LY334370,LY334370,,BRD:BRD-K00003451-001-01-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,,,,,,,NA,,
LY344864,LY344864,,BRD:BRD-BRD-K95899059-003-02-8;BRD:BRD-K95899059-003-02-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR7,,,PRECLINICAL,,,NA,"CN(C)[C@@H]1CCC2[NH]C3CCC(NC(=O)C4CCC(F)CC4)CC3C2C1, CN(C)[C@@H]1CCC2[NH]C3CCC(NC(=O)C4CCC(F)CC4)CC3C2C1",
LY364947,LY364947,,BRD:BRD-BRD-K06234293-001-04-2;BRD:BRD-K06234293-001-04-2,rep_multi_dose;rep_primary;rep_single_dose,"P38 MAPK INHIBITOR, TGF BETA RECEPTOR INHIBITOR",TGFBR1,,,PRECLINICAL,"Multiple values for MOA: {'TGF BETA RECEPTOR INHIBITOR, P38 MAPK INHIBITOR', 'P38 MAPK INHIBITOR, TGF BETA RECEPTOR INHIBITOR'}, defaulting to 'P38 MAPK INHIBITOR, TGF BETA RECEPTOR INHIBITOR'",,NA,"C1[NH]NC(C1-C1CCNC2CCCCC12)-C1CCCCN1, C1[NH]NC(C1-C1CCNC2CCCCC12)-C1CCCCN1, C1[NH]NC(C1-C1CCNC2CCCCC12)-C1CCCCN1",
LY404187,LY404187,,BRD:BRD-A50062753-001-02-9,rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRIA1;GRIA2;GRIA3;GRIA4,,,,,,NA,,
LY411575,LY411575,,BRD:BRD-BRD-K20013301-001-02-6;BRD:BRD-K20013301-001-02-6,rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,,,,PRECLINICAL,,,NA,C[C@H](NC(=O)[C@@H](O)C1CC(F)CC(F)C1)C(=O)N[C@H]1C2CCCCC2-C2CCCCC2N(C)C1=O,
LY450108,LY450108,,BRD:BRD-BRD-K54538117-001-01-7;BRD:BRD-K54538117-001-01-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,,,,PHASE 1,,,NA,C[C@@H](CNS(=O)(=O)C(C)C)C1CCC(NC(=O)C2CC(F)CC(F)C2)CC1,
LY456236,LY456236,,BRD:BRD-BRD-K87696786-003-04-4;BRD:BRD-K87696786-003-04-4,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM1,,,PRECLINICAL,,,NA,"COC1CCC(NC2NCNC3CCC(OC)CC23)CC1, COC1CCC(NC2NCNC3CCC(OC)CC23)CC1",
TOMATO LYCOPENE,(ALL-E)-LYCOPENE;(ALL-TRANS)-LYCOPENE;AEC LYCOPENE;ATERONON;BLAKESLEA TRISPORA;CI 75125;E-160D(III);E160D;FEMA NO. 4110;INS NO.160D(III);INS-160D(III);LYCOPENE;LYCOPENE FROM BLAKESLEA TRISPORA;LYCOPENE PREPARATION;LYCORED;MEXORYL SAQ;NSC-407322;REDIVIVO;SOLANORUBIN;TOMAT-O-RED;TOMATO LYCOPENE,CHEMBL501174,BRD:BRD-BRD-K37083340-001-02-3;BRD:BRD-K37083340-001-02-3,rep_primary;rep_single_dose,FREE RADICAL SCAVENGER,,,,PHASE 3,,Small molecule,3,CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(\C)CCC=C(C)C;CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(/C)CCC=C(C)C,OAIJSZIZWZSQBC-GYZMGTAESA-N
LYLAMINE,LYLAMINE,,BRD:BRD-K62289640-003-05-9,rep_single_dose,CANNABINOID RECEPTOR AGONIST,CNR1,,,,,,NA,,
OLAPARIB COMPONENT OF KEYLYNK-010,AZ-2281;AZ2281;AZD-2281;AZD2281;KEYLYNK-010 COMPONENT OLAPARIB;KU-0059436;KU-59436;LYNPARZA;NSC-747856;OLAPARIB;OLAPARIB COMPONENT OF KEYLYNK-010,CHEMBL521686,GDSC1:1017;GDSC1:1495;GDSC2:1017,gdsc,,,,,,,Small molecule,4,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,FDLYAMZZIXQODN-UHFFFAOYSA-N
VASOPRESSIN PIG,8-L-LYSINE;8-L-LYSINEVASOPRESSIN;DIAPID;L-8;LYPRESSIN;LYSINE VASOPRESSIN;VASOPRESSIN;VASOPRESSIN PIG,CHEMBL1200690,BRD:BRD-BRD-K93331255-001-02-0;BRD:BRD-K93331255-001-02-0,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR AGONIST,AVPR1A;AVPR1B;AVPR2,,,LAUNCHED,,Protein,4,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O;NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2CCC(O)CC2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,BJFIDCADFRDPIO-DZCXQCEKSA-N
M-14157,M-14157,,BRD:BRD-A96977263-001-03-7;BRD:BRD-BRD-A96977263-001-03-7,rep_primary;rep_single_dose,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,KCNQ1,,,PHASE 2,,,NA,CCCCCC(O)CCCC(O)=O,
M-25,M-25,,BRD:BRD-BRD-K51265828-001-01-0;BRD:BRD-K51265828-001-01-0,rep_primary;rep_single_dose,SMOOTHENED RECEPTOR ANTAGONIST,DHH;IHH;SMO,,,PRECLINICAL,,,NA,CCCC(CCC)C(=O)NCC1CCC2N(NCC2C1)-C1CCCCC1OC,
M-344,M-344,,BRD:BRD-BRD-K45528773-001-06-4;BRD:BRD-BRD-K45528773-001-07-2;BRD:BRD-K45528773-001-06-4;BRD:BRD-K45528773-001-07-2,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC8,,,PRECLINICAL,,,NA,"CN(C)C1CCC(CC1)C(=O)NCCCCCCC(=O)NO, CN(C)C1CCC(CC1)C(=O)NCCCCCCC(=O)NO, CN(C)C1CCC(CC1)C(=O)NCCCCCCC(=O)NO",
M-3M3FBS,M-3M3FBS,,BRD:BRD-BRD-K09635314-001-03-4;BRD:BRD-K09635314-001-03-4,rep_primary;rep_single_dose,PHOSPHOLIPASE ACTIVATOR,PLCB2;PLCB3;PLCD1;PLCG1;PLCG2,,,PRECLINICAL,,,NA,"CC1CC(C)C(C(C)C1)S(=O)(=O)NC1CCCC(C1)C(F)(F)F, CC1CC(C)C(C(C)C1)S(=O)(=O)NC1CCCC(C1)C(F)(F)F",
M-CHLOROPHENYLBIGUANIDE,M-CHLOROPHENYLBIGUANIDE,,BRD:BRD-BRD-K36965586-003-08-8;BRD:BRD-K36965586-003-08-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR3A;HTR3B,,,PRECLINICAL,,,NA,NC(=N)NC(=N)NC1CCCC(CL)C1,
M-THP,M-THP,,BRD:BRD-BRD-K91147684-001-01-5;BRD:BRD-K91147684-001-01-5,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,OC1CCCC(C1)-C1C2CCC(N2)C(-C2CCCC(O)C2)C2CCC([NH]2)C(-C2CCCC(O)C2)C2CCC(N2)C(-C2CCCC(O)C2)C2CCC1[NH]2,
M8-B,M8-B,,BRD:BRD-K90410034-003-02-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPM8,,,,,,NA,,
MABUPROFEN,ALDOSPRAY ANALGESICO;MABUPROFEN,CHEMBL2105154,BRD:BRD-A93683007-001-01-9;BRD:BRD-BRD-A93683007-001-01-9,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,CC(C)Cc1ccc(C(C)C(=O)NCCO)cc1;CC(C)CC1CCC(CC1)C(C)C(=O)NCCO,JVGUNCHERKJFCM-UHFFFAOYSA-N
MABUTEROL HYDROCHLORIDE,AMBUTEROL;MABUTEROL;MABUTEROL HYDROCHLORIDE,CHEMBL86749,BRD:BRD-A13116749-003-01-6;BRD:BRD-BRD-A13116749-003-01-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,,,LAUNCHED,,Small molecule,-1,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(C(F)(F)F)c1;CC(C)(C)NCC(O)C1CC(CL)C(N)C(C1)C(F)(F)F,JSJCTEKTBOKRST-UHFFFAOYSA-N
MACELIGNAN,MACELIGNAN,,BRD:BRD-BRD-K94948151-001-07-4;BRD:BRD-K94948151-001-07-4,rep_primary;rep_single_dose,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, ANTIOXIDANT",,,,PRECLINICAL,"Multiple values for MOA: {'ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, ANTIOXIDANT', 'ANTIOXIDANT, ANTIINFLAMMATORY AGENT'}, defaulting to 'ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, ANTIOXIDANT'",,NA,COC1CC(C[C@H](C)[C@H](C)CC2CCC3OCOC3C2)CCC1O,
SOLOREL,AEZS-130;ARD-07;EP-01572;EP-1572;EP01572;JMV 1843;JMV-1843;MACIMORELIN;MACRILEN;SOLOREL,CHEMBL278623,BRD:BRD-K00071596-019-01-9,rep_single_dose,,,,,,,Small molecule,4,CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O,UJVDJAPJQWZRFR-DHIUTWEWSA-N
OPSUMIT,ACT 064992;ACT-064992;MACITENTAN;OPSUMIT,CHEMBL2103873,BRD:BRD-BRD-K48812570-001-02-3;BRD:BRD-K48812570-001-02-3,rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA;EDNRB,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1;CCCNS(=O)(=O)NC1NCNC(OCCOC2NCC(BR)CN2)C1-C1CCC(BR)CC1, CCCNS(=O)(=O)NC1NCNC(OCCOC2NCC(BR)CN2)C1-C1CCC(BR)CC1",JGCMEBMXRHSZKX-UHFFFAOYSA-N
MACITENTAN-N-BUTYL-ANALOGUE,MACITENTAN-N-BUTYL-ANALOGUE,,BRD:BRD-K00003167-001-01-9,rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,,,,,,,NA,,
PBTZ169,MACOZINONE;PBTZ-169;PBTZ169,CHEMBL3330226,BRD:BRD-K16343284-001-02-9,rep_single_dose,DPRE1 INHIBITOR,,,,,,Small molecule,2,O=c1nc(N2CCN(CC3CCCCC3)CC2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12,BJDZBXGJNBMCAV-UHFFFAOYSA-N
MADECASSOSIDE,MADECASSOSIDE,,BRD:BRD-K00003328-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,,NA,,
MADRASIN,MADRASIN,,BRD:BRD-K48905682-001-11-1,rep_single_dose,CELL SPLICING INHIBITOR,,,,,,,NA,,
SULFAMYLON,4-HOMOSULFANILAMIDE;D06BA03;MAFENIDE;NSC-34632;SULFAMYLON,CHEMBL419,BRD:BRD-BRD-K30649484-003-13-7;BRD:BRD-K30649484-003-13-7,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA12;CA14;CA2;CA4;CA6;CA9,"FIRST-AID ANTIBIOTIC, SKIN INFECTIONS",,LAUNCHED,,Small molecule,4,NCC1CCC(CC1)S(N)(=O)=O;NCc1ccc(S(N)(=O)=O)cc1,TYMRLRRVMHJFTF-UHFFFAOYSA-N
MAGNOLOL,MAGNOLOL,CHEMBL180920,BRD:BRD-BRD-K26168087-001-09-7;BRD:BRD-K26168087-001-09-7,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,GABRA1;PPARG,,,PRECLINICAL,,Small molecule,NA,C=CCc1ccc(O)c(-c2cc(CC=C)ccc2O)c1;OC1CCC(CC=C)CC1-C1CC(CC=C)CCC1O,VVOAZFWZEDHOOU-UHFFFAOYSA-N
MALIC-ACID,MALIC-ACID,,BRD:BRD-A18396475-001-15-3;BRD:BRD-BRD-A18396475-001-15-3,rep_primary;rep_single_dose,,CS;ME2;PKD2L1,,,LAUNCHED,,,NA,"OC(CC(O)=O)C(O)=O, OC(CC(O)=O)C(O)=O",
NKK-105,HEPATION;KANTEC;MALOTILATE;NKK 105;NKK-105,CHEMBL1697754,BRD:BRD-BRD-K97884852-001-05-4;BRD:BRD-K97884852-001-05-4,rep_primary;rep_single_dose,PROTEIN SYNTHESIS STIMULANT,,HEPATIC CIRRHOSIS,,LAUNCHED,,Small molecule,-1,CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1,YPIQVCUJEKAZCP-UHFFFAOYSA-N
MALTOBIONIC-ACID,MALTOBIONIC-ACID,,BRD:BRD-BRD-K01624185-001-05-7;BRD:BRD-K01624185-001-05-7,rep_primary;rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,,COSMETIC,,LAUNCHED,,,NA,OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(O)=O,
MANDELIC-ACID,MANDELIC-ACID,,BRD:BRD-A91448670-001-08-9,rep_single_dose,,,,,,,,NA,,
MANGAFODIPIR,MANGAFODIPIR,CHEMBL1201301,BRD:BRD-K57365211-314-03-9,rep_single_dose,CONTRAST AGENT,,,,,,Small molecule,4,,
MANIDIPINE HYDROCHLORIDE,ARTEDIL;FRANIDIPINE;MANIDIPINE;MANIDIPINE 6300;MANIDIPINE HYDROCHLORIDE,CHEMBL1085699,BRD:BRD-A90695733-001-07-4;BRD:BRD-BRD-A90695733-001-07-4,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1D,HYPERTENSION,,LAUNCHED,,Small molecule,3,"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1;COC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1, COC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1, COC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1, COC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1",ANEBWFXPVPTEET-UHFFFAOYSA-N
MNA-715,FK-778;FK778;HMR 1715;HMR-1715;MANITIMUS;MNA-715,CHEMBL2107757,BRD:BRD-K00004729-001-01-9,rep_single_dose,DEHYDROGENASE INHIBITOR,,,,,,Small molecule,2,N#CCC/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1,OQUXVPJVBSENGK-QXMHVHEDSA-N
MANNITOL-D,MANNITOL-D,,BRD:BRD-BRD-K30374899-001-09-3;BRD:BRD-K30374899-001-09-3,rep_primary;rep_single_dose,DIURETIC,,"INTRACRANIAL PRESSURE, INTRAOCULAR PRESSURE, CONSTIPATION",,LAUNCHED,,,NA,"OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO, OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO",
MANUMYCIN A,MANUMYCIN A,CHEMBL285848,CTRP:50727,ctrp,,,,,,,Small molecule,NA,CCCC[C@@H](C)/C=C(C)/C=C(\C)C(=O)NC1=C[C@@](O)(/C=C/C=C/C=C/C(=O)NC2=C(O)CCC2=O)[C@@H]2O[C@@H]2C1=O,TWWQHCKLTXDWBD-MVTGTTCWSA-N
ZK-245186,BOL-303242-X;BOL-303242X;MAPRACORAT;ZK 245186;ZK-245186,CHEMBL2103876,BRD:BRD-K00077013-001-02-9,rep_single_dose,,,,,,,Small molecule,3,Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1,VJGFOYBQOIPQFY-XMMPIXPASA-N
MAPROTILINE,"BA-34,276 [AS HYDROCHLORIDE];BA-34,276 FREE BASE;BA-34276 FREE BASE;MAPROTILINE",CHEMBL21731,BRD:BRD-BRD-K25433859-003-25-4;BRD:BRD-K25433859-003-25-4,rep_multi_dose;rep_primary;rep_single_dose,"NOREPINEPHRINE REPUTAKE INHIBITOR, TRICYCLIC ANTIDEPRESSANT",ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD2;HRH1;HTR2A;HTR2C;HTR7;SLC6A2,"DEPRESSION, DYSTHYMIC DISORDER",,LAUNCHED,,Small molecule,4,"CNCCCC12CCC(C3CCCCC13)C1CCCCC21, CNCCCC12CCC(C3CCCCC13)C1CCCCC21, CNCCCC12CCC(C3CCCCC13)C1CCCCC21;CNCCCC12CCC(c3ccccc31)c1ccccc12",QSLMDECMDJKHMQ-UHFFFAOYSA-N
UK-427857,"CELSENTRI;MARAVIROC;REL-MARAVIROC;SELZENTRY;UK-427,857;UK-427857",CHEMBL1201187,BRD:BRD-A04352665-001-05-3;BRD:BRD-BRD-A04352665-001-05-3,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR5,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"CC(C)C1NNC(C)N1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1CCCCC1, CC(C)C1NNC(C)N1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1CCCCC1;Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1",GSNHKUDZZFZSJB-QYOOZWMWSA-N
RO 09-1168,MARBOCYL;MARBOFLOXACIN;RO 09-1168,CHEMBL478120,BRD:BRD-BRD-K71926323-001-13-8;BRD:BRD-BRD-K71926323-001-14-6;BRD:BRD-K71926323-001-13-8;BRD:BRD-K71926323-001-14-6,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,-1,"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCN4C)CC1;CN1CCN(CC1)C1C(F)CC2C3C1OCN(C)N3CC(C(O)=O)C2=O, CN1CCN(CC1)C1C(F)CC2C3C1OCN(C)N3CC(C(O)=O)C2=O, CN1CCN(CC1)C1C(F)CC2C3C1OCN(C)N3CC(C(O)=O)C2=O",BPFYOAJNDMUVBL-UHFFFAOYSA-N
MARIBAVIR,1263-W-94;1263W94;BW-1263W94;GW-257406X;LIVTENCITY;MARIBAVIR,CHEMBL515408,BRD:BRD-BRD-K59524082-001-01-3;BRD:BRD-K59524082-001-01-3,rep_primary;rep_single_dose,"CYTOMEGALOVIRUS INHIBITOR, PROTEIN KINASE INHIBITOR",PYGM,,,PHASE 3,,Small molecule,4,CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O;CC(C)NC1NC2CC(CL)C(CL)CC2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O,KJFBVJALEQWJBS-XUXIUFHCSA-N
TA-2516,BB 2516;BB-2516;GI 5712;GI-5712;KB-R 8898;MARIMASTAT;NSC-719333;TA 2516;TA-2516,CHEMBL279785,BRD:BRD-BRD-K21396683-001-04-8;BRD:BRD-K21396683-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,MMP1;MMP10;MMP11;MMP12;MMP13;MMP14;MMP15;MMP16;MMP17;MMP19;MMP2;MMP20;MMP21;MMP23A;MMP24;MMP25;MMP26;MMP27;MMP28;MMP3;MMP7;MMP8;MMP9,,,PHASE 3,,Small molecule,3,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N
MARINOPYRROLE A,MARINOPYRROLE A,,CTRP:666910,ctrp,,,,,,,,NA,,
MAROPITANT,MAROPITANT,CHEMBL2111099,BRD:BRD-BRD-K76594255-001-01-6;BRD:BRD-K76594255-001-01-6,rep_primary;rep_single_dose,NEUROKININ RECEPTOR ANTAGONIST,TACR1,VOMITING,,LAUNCHED,,Small molecule,-1,COc1ccc(C(C)(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1;COC1CCC(CC1CN[C@H]1C2CCN(CC2)[C@H]1C(C1CCCCC1)C1CCCCC1)C(C)(C)C,OMPCVMLFFSQFIX-CONSDPRKSA-N
MASIVIERA,AB-1010;AB1010;KINAVET;MASICAN;MASITINIB;MASITINIB MESILATE;MASITINIB MESYLATE;MASITINIB METHANESULFONATE;MASIVET;MASIVIERA,CHEMBL1908391,BRD:BRD-BRD-K71035033-001-07-1;BRD:BRD-K71035033-001-07-1;CTRP:606143;GDSC1:292,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, SRC INHIBITOR",FGFR3;KIT;PDGFRA;PDGFRB,MASTOCYTOMA,,LAUNCHED,,Small molecule,4,"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1;CN1CCN(CC2CCC(CC2)C(=O)NC2CCC(C)C(NC3NC(CS3)-C3CCCNC3)C2)CC1, CN1CCN(CC2CCC(CC2)C(=O)NC2CCC(C)C(NC3NC(CS3)-C3CCCNC3)C2)CC1",WJEOLQLKVOPQFV-UHFFFAOYSA-N
MASIVIERA,AB-1010;AB1010;KINAVET;MASICAN;MASITINIB;MASITINIB MESILATE;MASITINIB MESYLATE;MASITINIB METHANESULFONATE;MASIVET;MASIVIERA,CHEMBL1908391,GDSC1:292,gdsc,,,,,,,Small molecule,4,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,WJEOLQLKVOPQFV-UHFFFAOYSA-N
NSC-682984,ACTINEX;CHX-100;INSM-18;MASOPROCOL;MESO-NDGA;MESO-NORDIHYDROGUAIARETIC ACID;NORDIHYDROGUAIARETIC ACID;NSC-4291;NSC-682984,CHEMBL313972,BRD:BRD-A87130939-001-07-9;BRD:BRD-BRD-A87130939-001-07-9,rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,ALOX5,ACTINIC KERATOSIS (AK),,LAUNCHED,,Small molecule,4,C[C@H](Cc1ccc(O)c(O)c1)[C@@H](C)Cc1ccc(O)c(O)c1;CC(CC1CCC(O)C(O)C1)C(C)CC1CCC(O)C(O)C1,HCZKYJDFEPMADG-TXEJJXNPSA-N
MATRINE,MATRINE,CHEMBL204860,BRD:BRD-BRD-K25312248-001-01-5;BRD:BRD-K25312248-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRK1,,,PHASE 2,,Small molecule,NA,O=C1CCC[C@@H]2[C@@H]3CCCN4CCC[C@H](CN12)[C@@H]34;O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34,ZSBXGIUJOOQZMP-JLNYLFASSA-N
SAR-439152,CAMZYOS;MAVACAMTEN;MYK-461;SAR-439152,CHEMBL4297517,BRD:BRD-K00003497-001-01-9,rep_single_dose,MYOSIN INHIBITOR,,,,,,Small molecule,4,CC(C)n1c(=O)cc(N[C@@H](C)c2ccccc2)[nH]c1=O,RLCLASQCAPXVLM-NSHDSACASA-N
MAVATREP,JNJ-39439335;MAVATREP,CHEMBL2364618,BRD:BRD-K00003237-001-01-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,,,,,,Small molecule,1,CC(C)(O)c1ccccc1-c1ccc2[nH]c(/C=C/c3ccc(C(F)(F)F)cc3)nc2c1,ORDHXXHTBUZRCN-NTEUORMPSA-N
MAVOGLURANT,AFQ-056;AFQ056;MAVOGLURANT,CHEMBL3087515,BRD:BRD-BRD-K07790550-001-01-6;BRD:BRD-K07790550-001-01-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM5,,,PHASE 2,,Small molecule,2,COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1;COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#CC1CCCC(C)C1,ZFPZEYHRWGMJCV-ZHALLVOQSA-N
SCH-209579,"1ALPHA,25-DIHYDROXY-22-OXAVITAMIN D3;22-OXACALCITRIOL;MAXACALCITOL;OCT;OXAROL;PREZIOS;SCH 209579;SCH-209579",CHEMBL333950,BRD:BRD-BRD-K81332461-001-01-4;BRD:BRD-K81332461-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,HYPERPARATHYROIDISM,,LAUNCHED,,Small molecule,3,[2H]C([2H])([2H])C(O)(CCO[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C)C([2H])([2H])[2H];C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,DTXXSJZBSTYZKE-ZDQKKZTESA-N
MAYTANSINOL-ISOBUTYRATE,MAYTANSINOL-ISOBUTYRATE,,BRD:BRD-BRD-K15898725-001-01-7;BRD:BRD-K15898725-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CO[C@@H]1\C=C\C=C(C)\CC2CC(OC)C(CL)C(C2)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]2(C)O[C@H]2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2,
TERONAC,42-548;AN-448;MAGRILON;MAZANOR;MAZILDENE;MAZINDOL;MAZINDOL CIV;SAH-42548;SANOREX;TERENAC;TERONAC,CHEMBL781,BRD:BRD-A68464583-001-02-5;BRD:BRD-BRD-A68464583-001-02-5,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)",SLC6A2;SLC6A3;SLC6A4,DUCHENNE MUSCULAR DYSTROPHY (DMD),,LAUNCHED,,Small molecule,4,OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21;OC1(N2CCN=C2C2CCCCC12)C1CCC(CL)CC1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N
MBX-2982,MBX-2982,CHEMBL3260505,BRD:BRD-BRD-K32218650-001-01-6;BRD:BRD-K32218650-001-01-6,rep_primary;rep_single_dose,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,GPR119,,,PHASE 2,,Small molecule,2,CCc1cnc(N2CCC(c3nc(COc4ccc(-n5cnnn5)cc4)cs3)CC2)nc1;CCC1CNC(NC1)N1CCC(CC1)C1NC(COC2CCC(CC2)-N2CNNN2)CS1,NFTMKHWBOINJGM-UHFFFAOYSA-N
MC1568,MC1568,,BRD:BRD-K24031866-001-02-1,rep_single_dose,HDAC INHIBITOR,HDAC2,,,,,,NA,,
MCN-5652-(+/-),MCN-5652-(+/-),,BRD:BRD-K31168993-001-03-9,rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),,,,,,,NA,,
MCOPPB,MCOPPB,,BRD:BRD-BRD-K73276278-305-01-1;BRD:BRD-K73276278-305-01-1,rep_primary;rep_single_dose,"NOCICEPTIN/ORPHANIN FQ (NOP) RECEPTOR AGONIST, NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST",OPRL1,,,PRECLINICAL,"Multiple values for MOA: {'NOCICEPTIN/ORPHANIN FQ (NOP) RECEPTOR AGONIST', 'NOCICEPTIN/ORPHANIN FQ (NOP) RECEPTOR AGONIST, NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST'}, defaulting to 'NOCICEPTIN/ORPHANIN FQ (NOP) RECEPTOR AGONIST, NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST'",,NA,CC1(CCCCCCC1)N1CCC(CC1)N1C(NC2CCCCC12)[C@@H]1CCCNC1,
MCPP,MCPP,,BRD:BRD-BRD-K75844781-003-08-0;BRD:BRD-K75844781-003-08-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1D;HTR1E;HTR2A;HTR2B;HTR2C;HTR6,,,PHASE 2,,,NA,CLC1CCCC(C1)N1CCNCC1,
MD-920,MD-920,,BRD:BRD-BRD-K92758126-001-18-8;BRD:BRD-K92758126-001-18-8,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,AADACL2,,,PHASE 1,,,NA,C[C@@]12[C@H]3[C@H](C(O)=O)[C@@]45CC(=C)[C@@](O)(C4)CC[C@H]5[C@]3(OC1=O)C=C[C@@H]2O,
MDIVI-1,MDIVI-1,,BRD:BRD-BRD-K61128465-001-09-9;BRD:BRD-K61128465-001-09-9;CTRP:215497,ctrp;rep_primary;rep_single_dose,DYNAMIN INHIBITOR,DNM1,,,PRECLINICAL,,,NA,"COC1CC(C(CL)CC1CL)-N1C(=S)[NH]C2CCCCC2C1=O, COC1CC(C(CL)CC1CL)-N1C(=S)[NH]C2CCCCC2C1=O",
MDL-11939,"GLEMANSERIN;MDL 11,939;MDL-11,939;MDL-11939",CHEMBL18972,BRD:BRD-A62057054-001-03-1;BRD:BRD-BRD-A62057054-001-03-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C,,,PHASE 2,,Small molecule,-1,"OC(c1ccccc1)C1CCN(CCc2ccccc2)CC1;OC(C1CCN(CCC2CCCCC2)CC1)C1CCCCC1, OC(C1CCN(CCC2CCCCC2)CC1)C1CCCCC1",AXNGJCOYCMDPQG-UHFFFAOYSA-N
MDL-27531,MDL-27531,,BRD:BRD-K50888640-001-01-6,rep_single_dose,GLYCINE RECEPTOR AGONIST,,,,,,,NA,,
MDL-29951,MDL-29951,,BRD:BRD-BRD-K59753853-001-02-3;BRD:BRD-K59753853-001-02-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,FBP1,,,PRECLINICAL,,,NA,OC(=O)CCC1C([NH]C2CC(CL)CC(CL)C12)C(O)=O,
MDL-72832,MDL-72832,,BRD:BRD-A17453586-003-02-3;BRD:BRD-BRD-A17453586-003-02-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,,,PRECLINICAL,,,NA,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COC2CCCCC2O1,
MDL-73005EF,"BINOSPIRONE MESILATE;BINOSPIRONE MESYLATE;MDL 73,005EF;MDL-73005EF",CHEMBL2218891,BRD:BRD-A50764878-003-02-8;BRD:BRD-BRD-A50764878-003-02-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A,,,PHASE 1,,Small molecule,-1,CS(=O)(=O)O.O=C1CC2(CCCC2)CC(=O)N1CCNCC1COc2ccccc2O1;O=C1CC2(CCCC2)CC(=O)N1CCNCC1COC2CCCCC2O1,JXBLEDCYKVWLJI-UHFFFAOYSA-N
MDR-652,MDR-652,,BRD:BRD-K00091267-001-01-9,rep_single_dose,,,,,,,,NA,,
ME0328,ME-0328;ME0328,,BRD:BRD-A63444178-001-01-5;BRD:BRD-BRD-A63444178-001-01-5;BRD:BRD-BRD-K24283677-001-01-9;BRD:BRD-K24283677-001-01-9,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PARP3,,,PRECLINICAL,"Multiple values for MOA: {'PPAR RECEPTOR ANTAGONIST', 'PARP INHIBITOR'}, defaulting to 'PPAR RECEPTOR ANTAGONIST'
Multiple values for SMILES: {'C[C@H](NC(=O)CCC1NC2CCCCC2C(=O)[NH]1)C1CCCCC1', 'CC(NC(=O)CCC1NC(=O)C2CCCCC2[NH]1)C1CCCCC1'}, defaulting to 'C[C@H](NC(=O)CCC1NC2CCCCC2C(=O)[NH]1)C1CCCCC1'
Multiple values for structure_id: {'K24283677', 'A63444178'}, defaulting to None",,NA,C[C@H](NC(=O)CCC1NC2CCCCC2C(=O)[NH]1)C1CCCCC1,
ZHIHUANQING,"CHLORFENSON;EMVERM;K-6451;MEBENDAZOLE;MEBENDAZOLE POLYMORPH C;MEBENDAZOLUM;MEBENVET;NSC-184849;NSC-5618;ORTHOTRAN;OVEX;OVITELMIN;OVOCHLOR;PANTELMIN;R 17,635;R-17635;TELMIN;TELMINTIC;VERMICIDIN;VERMOX;ZHIHUANQING",CHEMBL685,BRD:BRD-BRD-K77987382-001-13-2;BRD:BRD-K77987382-001-13-2,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBA1A;TUBB;TUBB4B,"PINWORM, WHIPWORM, HOOKWORM, ASCARIASIS",,LAUNCHED,,Small molecule,4,COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1;COC(=O)NC1NC2CCC(CC2[NH]1)C(=O)C1CCCCC1,OPXLLQIJSORQAM-UHFFFAOYSA-N
MEBEVERINE,ARLUY;MEBEVERINE,CHEMBL282121,BRD:BRD-A09467419-003-22-4;BRD:BRD-BRD-A09467419-003-22-4,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,IRRITABLE BOWEL SYNDROME,,LAUNCHED,,Small molecule,4,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1;CCN(CCCCOC(=O)C1CCC(OC)C(OC)C1)C(C)CC1CCC(OC)CC1,VYVKHNNGDFVQGA-UHFFFAOYSA-N
OMERIL,BEXIDAL;FABAHISTIN;INCIDAL;MEBHYDROLIN;MEBHYDROLIN NAPADISILATE;MEBHYDROLIN NAPADISYLATE;NSC-757830;OMERIL,CHEMBL1625607,BRD:BRD-BRD-K29713308-001-01-7,rep_primary,ANTIHISTAMINE,,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,4,CN1CCC2C(C1)C1CCCCC1N2CC1CCCCC1;CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1,FQQIIPAOSKSOJM-UHFFFAOYSA-N
"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE","MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE",,BRD:BRD-BRD-K29713308-077-04-1,rep_primary,,,,,PRECLINICAL,,,NA,CN1CCC2C(C1)C1CCCCC1N2CC1CCCCC1,
TETRAMETHYLGLYCOLURIL,"1,3,4,6-TETRAMETHYL-;ADAPTOL;GLYCOLURIL;MEBICAR;MEBIKAR;TEMGICOLURIL;TETRAMETHYLGLYCOLURIL",CHEMBL3707390,BRD:BRD-BRD-K76606751-001-01-7;BRD:BRD-K76606751-001-01-7,rep_primary;rep_single_dose,ANXIOLYTIC,,ANXIETY,,LAUNCHED,,Small molecule,-1,CN1C(=O)N(C)C2C1N(C)C(=O)N2C;CN1C2C(N(C)C1=O)N(C)C(=O)N2C,XIUUSFJTJXFNGH-UHFFFAOYSA-N
SQ-26962,MEBROFENIN;SQ 26962;SQ-26962,CHEMBL1605443,BRD:BRD-BRD-K96691275-001-01-2;BRD:BRD-K96691275-001-01-2,rep_primary;rep_single_dose,,,DIAGNOSTIC AGENT,,LAUNCHED,,Small molecule,-1,Cc1cc(C)c(NC(=O)CN(CC(=O)O)CC(=O)O)c(C)c1Br;CC1CC(C)C(NC(=O)CN(CC(O)=O)CC(O)=O)C(C)C1BR,MHPZZZZLAQGTHT-UHFFFAOYSA-N
MECAMYLAMINE,MECAMYLAMINE,CHEMBL267936,BRD:BRD-A20119038-003-07-8;BRD:BRD-BRD-A20119038-003-07-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRNA1;CHRNA2;CHRNA3;CHRNA4;CHRNA6;CHRNA7;CHRNB4,HYPERTENSION,,LAUNCHED,"Multiple values for repurposing_target: {'CHRNA1;CHRNA2;CHRNA3;CHRNA4;CHRNA6;CHRNA7;CHRNB4', 'CHRNA1;CHRNA2;CHRNA3;CHRNA4;CHRNA6;CHRNA7'}, taking the union",Small molecule,4,CNC1(C)C2CCC(C2)C1(C)C,IMYZQPCYWPFTAG-UHFFFAOYSA-N
MECARBINE,MECARBINATE;MECARBINE,CHEMBL1881106,BRD:BRD-BRD-K28405228-001-06-7;BRD:BRD-K28405228-001-06-7,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CCOC(=O)c1c(C)n(C)c2ccc(O)cc12;CCOC(=O)C1C(C)N(C)C2CCC(O)CC12,YTBNTDMBGXAOCG-UHFFFAOYSA-N
NSC-757087,CHLORETHAZINE;CHLORMETHINE;MECHLORETHAMINE;MUSTARGEN;NITROGEN MUSTARD (HN 2);NSC-10107;NSC-128663;NSC-757087,CHEMBL427,BRD:BRD-BRD-K12829205-003-02-8;BRD:BRD-K12829205-003-02-8,rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,"HODGKIN'S LYMPHOMA, CHRONIC MYELOID LEUKEMIA (CML), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), POLYCYTHEMIA VERA, MYCOSIS, BRONCHOGENIC CARCINOMA",,LAUNCHED,,Small molecule,4,"CN(CCCl)CCCl;CN(CCCL)CCCL, CN(CCCL)CCCL, CN(CCCL)CCCL, CN(CCCL)CCCL, CN(CCCL)CCCL",HAWPXGHAZFHHAD-UHFFFAOYSA-N
MECLINERTANT,MECLINERTANT,,BRD:BRD-BRD-K25075681-001-02-0;BRD:BRD-K25075681-001-02-0,rep_primary;rep_single_dose,NEUROTENSIN RECEPTOR ANTAGONIST,NTSR1;NTSR2,,,PHASE 2/PHASE 3,,,NA,COC1CCCC(OC)C1-C1CC(NN1-C1CCNC2CC(CL)CCC12)C(=O)NC1(C2CC3CC(C2)CC1C3)C(O)=O,
NSC-169189,MECLIZINE;MECLOZINE;NSC-169189,CHEMBL1623,BRD:BRD-A50311610-300-10-4;BRD:BRD-BRD-A50311610-300-10-4,rep_multi_dose;rep_primary;rep_single_dose,CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) AGONIST,HRH1;NR1I3,"NAUSEA, VOMITING, MOTION SICKNESS",,LAUNCHED,,Small molecule,4,"Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1;CC1CCCC(CN2CCN(CC2)C(C2CCCCC2)C2CCC(CL)CC2)C1, CC1CCCC(CN2CCN(CC2)C(C2CCCCC2)C2CCC(CL)CC2)C1, CC1CCCC(CN2CCN(CC2)C(C2CCCCC2)C2CCC(CL)CC2)C1",OCJYIGYOJCODJL-UHFFFAOYSA-N
MECLOCYCLINE-SULFOSALICYLATE,MECLOCYCLINE-SULFOSALICYLATE,,BRD:BRD-A07600638-060-05-2;BRD:BRD-BRD-A07600638-060-05-2,rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,"ACNE VULGARIS (AV), SKIN INFECTIONS",,LAUNCHED,,,NA,"CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)C4C(O)CCC(CL)C4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)C4C(O)CCC(CL)C4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)C4C(O)CCC(CL)C4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O",
MECLOFENAMIC-ACID,MECLOFENAMIC-ACID,,BRD:BRD-BRD-K50398167-236-22-7;BRD:BRD-K50398167-236-22-7,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",ALOX5;CNR1;KCNQ2;KCNQ3;PTGS1;PTGS2,"JOINT PAIN, MUSCLE PAIN, RHEUMATOID ARTHRITIS, PRIMARY DYSMENORRHEA (PD)",,LAUNCHED,,,NA,CC1CCC(CL)C(NC2CCCCC2C(O)=O)C1CL,
PROSERYL,ANALUX;ANP-235;CENTROPHENOXINE;CETREXIN;CLOPHENOXATE;MECLOFENOXANE;MECLOFENOXATE;MECLOFENOXATE HYDROCHLORIDE;NSC-169411;PROSERYL,CHEMBL64545,BRD:BRD-BRD-K10314788-003-12-7;BRD:BRD-K10314788-003-12-7,rep_primary;rep_single_dose,NOOTROPIC AGENT,,"SENILE DEMENTIA, ALZHEIMER'S DISEASE",,LAUNCHED,,Small molecule,-1,CN(C)CCOC(=O)COc1ccc(Cl)cc1;CN(C)CCOC(=O)COC1CCC(CL)CC1,XZTYGFHCIAKPGJ-UHFFFAOYSA-N
METHYL ESTER OF CYSTEINE,MECYSTEINE;METHYL CYSTEINE;METHYL ESTER OF CYSTEINE,CHEMBL1622757,BRD:BRD-K81993098-003-15-0,rep_single_dose,ANALGESIC AGENT,,,,,,Small molecule,-1,COC(=O)C(N)CS,MCYHPZGUONZRGO-UHFFFAOYSA-N
PRECEDEX,(S)-;DEXMEDETOMIDINE;DOMITOR;MEDETOMIDINE;MPV-1440;PRECEDEX,CHEMBL778;CHEMBL77921,BRD:BRD-A21607826-003-05-1;BRD:BRD-BRD-A21607826-003-05-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C,SEDATIVE,,LAUNCHED,,Small molecule,4,"CC(C1C[NH]CN1)C1CCCC(C)C1C, CC(C1C[NH]CN1)C1CCCC(C)C1C, CC(C1C[NH]CN1)C1CCCC(C)C1C;Cc1cccc([C@H](C)c2c[nH]cn2)c1C",CUHVIMMYOGQXCV-NSHDSACASA-N
MEDICA-16,MEDICA-16,,BRD:BRD-BRD-K92908289-001-01-8;BRD:BRD-K92908289-001-01-8,rep_primary;rep_single_dose,ATP CITRASE LYASE INHIBITOR,FFAR1,,,PHASE 2,,,NA,CC(C)(CCCCCCCCCCC(C)(C)CC(O)=O)CC(O)=O,
WIN-49016,"MEDORINONE;WIN 49,016;WIN-49,016;WIN-49016",CHEMBL144399,BRD:BRD-BRD-K40715924-001-01-1;BRD:BRD-K40715924-001-01-1,rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,-1,Cc1nccc2[nH]c(=O)ccc12;CC1NCCC2[NH]C(=O)CCC12,OCCZJXAHSUCJSA-UHFFFAOYSA-N
MEDRONIC-ACID,MEDRONIC-ACID,,BRD:BRD-BRD-K94072573-001-09-9;BRD:BRD-K94072573-001-09-9,rep_primary;rep_single_dose,BONE RESORPTION INHIBITOR,,SKELETAL IMAGING AGENT,,LAUNCHED,,,NA,OP(O)(=O)CP(O)(O)=O,
TV-46046,ADGYN MEDRO;AMEN;CLIMANOR;CURRETAB;CYCRIN;DEPO-PROGEVERA;DEPO-PROVERA;DEPO-PROVERA ONCOLOGY;DEPO-SUBQ PROVERA 104;DEPOT-MEDROXYPROGESTERONE ACETATE;FARLUTAL;FARLUTAL 100;FARLUTAL 200;FARLUTAL 250;FARLUTAL 500;FARLUTAL INYECTABLE;G03AC06;LUNELLE;MEDROXIPROGESTERONE ACETATE;MEDROXYPROGESTERONE;MEDROXYPROGESTERONE 17-ACETATE;MEDROXYPROGESTERONE ACETATE;MEDROXYPROGESTERONI ACETAS;NSC-21171;NSC-26386;NSC-27408;PREMPRO;PROVERA;SAYANA PRESS;TV-46046,CHEMBL717,BRD:BRD-BRD-K99615199-001-18-5;BRD:BRD-K99615199-001-18-5,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,ESR1;PGR,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12;CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,PSGAAPLEWMOORI-PEINSRQWSA-N
MEDROXYPROGESTERONE-ACETATE,MEDROXYPROGESTERONE-ACETATE,,BRD:BRD-A61221616-001-04-3;BRD:BRD-BRD-A61221616-001-04-3,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,,CONTRACEPTIVE,,LAUNCHED,,,NA,"C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12, C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12",
U-8471,HYDROXYMESTERONE;MEDRYSONE;NSC-63278;U-8471,CHEMBL1201173,BRD:BRD-BRD-K56515112-001-21-6;BRD:BRD-K56515112-001-21-6,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,"CONJUNCTIVITIS, EPISCLERITIS",,LAUNCHED,,Small molecule,4,"C[C@H]1CC2C3CCC(C(C)=O)C3(C)CC(O)C2C2(C)CCC(=O)C=C12, C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)CCC(=O)C=C12;CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C",GZENKSODFLBBHQ-ILSZZQPISA-N
MEFENAMIC-ACID,MEFENAMIC-ACID,,BRD:BRD-BRD-K92778217-001-32-7;BRD:BRD-K92778217-001-32-7,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,KCNQ1;PTGS1;PTGS2;TRPM3,PRIMARY DYSMENORRHEA (PD),,LAUNCHED,,,NA,"CC1CCCC(NC2CCCCC2C(O)=O)C1C, CC1CCCC(NC2CCCCC2C(O)=O)C1C",
TIMODYNE,MEFEXADYNE;MEFEXAMIDE;NSC-757827;TIMODYNE,CHEMBL1368380,BRD:BRD-BRD-K20655524-003-12-0;BRD:BRD-K20655524-003-12-0,rep_multi_dose;rep_primary;rep_single_dose,PSYCHOACTIVE DRUG,,,,PRECLINICAL,,Small molecule,-1,CCN(CC)CCNC(=O)COc1ccc(OC)cc1;CCN(CC)CCNC(=O)COC1CCC(OC)CC1,HUNIPYLVUPMFCZ-UHFFFAOYSA-N
"WR 142,490","GNF-PF-5544;LARIAM;MEFAQUIN;MEFLOQUINE;NSC-758233;RO 21-5998;RO-215998;WR 142,490",CHEMBL416956,BRD:BRD-A89585551-003-16-6;BRD:BRD-BRD-A89585551-003-16-6,rep_primary;rep_single_dose,"ADENOSINE RECEPTOR ANTAGONIST, HEMOGLOBIN ANTAGONIST",ADORA2A;HBA1,MALARIA,,LAUNCHED,,Small molecule,4,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1;OC(C1CCCCN1)C1CC(NC2C(CCCC12)C(F)(F)F)C(F)(F)F,XEEQGYMUWCZPDN-UHFFFAOYSA-N
SC-10363,5071;BDH 1298;BDH-1298;CHRONOPIL;MEGACE;MEGACE ES;MEGESTEROL ACETATE;MEGESTROL;MEGESTROL 17.ALPHA.-ACETATE;MEGESTROL ACETATE;NSC-71423;OVABAN;SC 10363;SC-10363,CHEMBL1201139,BRD:BRD-K00004691-001-01-9,rep_single_dose,PROGESTERONE RECEPTOR AGONIST,,,,,,Small molecule,4,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,RQZAXGRLVPAYTJ-GQFGMJRRSA-N
MEGESTROL-ACETATE,MEGESTROL-ACETATE,,BRD:BRD-A35989968-001-04-2;BRD:BRD-BRD-A35989968-001-04-2;BRD:BRD-BRD-K19507340-001-22-1;BRD:BRD-K19507340-001-22-1,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,NR3C1;PGR,"ANOREXIA, CACHEXIA",,LAUNCHED,"Multiple values for structure_id: {'A35989968', 'K19507340'}, defaulting to None",,NA,"CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O, CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O, CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O",
MEGLITINIDE,MEGLITINIDE,CHEMBL149930,BRD:BRD-BRD-K51324732-001-01-0;BRD:BRD-K51324732-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,CCR2,,,PHASE 2,,Small molecule,-1,COc1ccc(Cl)cc1C(=O)NCCc1ccc(C(=O)O)cc1;COC1CCC(CL)CC1C(=O)NCCC1CCC(CC1)C(O)=O,SWLAMJPTOQZTAE-UHFFFAOYSA-N
NSC-7391,D(-)-N-METHYLGLUCAMINE;MEGLUMINE;MEGLUMINUM;METHYLGLUCAMINE;N-METHYLGLUCAMINE;N-METHYLSORBITYLAMINE;NSC-52907;NSC-7391,CHEMBL1200570,BRD:BRD-BRD-K28595280-001-04-5;BRD:BRD-K28595280-001-04-5,rep_primary;rep_single_dose,EXCIPIENT,,,,LAUNCHED,,Small molecule,4,"CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO;CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO, CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO, CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO",MBBZMMPHUWSWHV-BDVNFPICSA-N
NSC-361411,CB 337;CB-337;MEGLUTOL;NSC-361411,CHEMBL50444,BRD:BRD-K00495673-001-05-2,rep_single_dose,HMGCR INHIBITOR,HMGCR,,,,,Small molecule,-1,CC(O)(CC(=O)O)CC(=O)O,NPOAOTPXWNWTSH-UHFFFAOYSA-N
MEISOINDIGO,MEISOINDIGO,CHEMBL607535,BRD:BRD-BRD-K14529030-001-01-9;BRD:BRD-K14529030-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,STAT INHIBITOR,STAT3,,,PHASE 3,,Small molecule,NA,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21;CN1C(=O)\C(C2CCCCC12)=C1\C(=O)NC2CCCCC12,QNOCRUSVMMAKSC-CCEZHUSRSA-N
MEK1-2-INHIBITOR,MEK1-2-INHIBITOR,,BRD:BRD-BRD-K12244279-001-05-8;BRD:BRD-K12244279-001-05-8,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K2,,,PRECLINICAL,,,NA,"N\C(SC1CCC(N)CC1)=C(\C#N)C1CCCCC1C(F)(F)F, N\C(SC1CCC(N)CC1)=C(\C#N)C1CCCCC1C(F)(F)F",
TRAMETINIB DIMETHYL SULFOXIDE,GSK-1120212;GSK-1120212B;GSK1120212;GSK1120212B;JTP 74057;JTP-74057;MEKINIST;TMT-212;TMT212;TRAMETINIB;TRAMETINIB DIMETHYL SULFOXIDE,CHEMBL2103875;CHEMBL2105741,GDSC1:1372;GDSC2:1372,gdsc,,,,,,,Small molecule,4,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1.C[S+](C)[O-],OQUFJVRYDFIQBW-UHFFFAOYSA-N
MELANOTAN-II,MELANOTAN-II,,BRD:BRD-K75989555-001-02-9,rep_single_dose,MELANOCORTIN RECEPTOR AGONIST,,,,,,,NA,,
VYTALONIN,5-METHOXY N-ACETYL-TRYPTAMINE;BCI-049;CIRCADIN;GENERAL NUTRIT;HEALTH AID;HEIDADOUPPI;ICENIA;J5.258B;LIFE EXT;MELAPURE;MELATOL;MELATONIN;MELATONINE;MELOVINE;N-(2-(5-METHOXY-1H-INDOL-3-YL)ETHYL)ACETAMIDE;N-ACETYL-5-METHOXYTRYPTAMINE;NATROL;NATURE'S BLEND;NATURES BOUNTY;NSC-113928;NSC-302012;NSC-56423;QUALITY HEALTH;REGULIN;S.GARD;TARTROL;TRAVELAG;VESPRO;VYTALONIN,CHEMBL45,BRD:BRD-BRD-K97530723-001-20-9;BRD:BRD-K97530723-001-20-9,rep_primary;rep_single_dose,"MELATONIN RECEPTOR AGONIST, NITRIC OXIDE SYNTHASE INHIBITOR",ASMT;CALM1;CALR;EPX;ESR1;HTR2B;MPO;MTNR1A;MTNR1B;NQO2;RORB,SLEEP CYCLE SUPPORT,,LAUNCHED,,Small molecule,4,"COc1ccc2[nH]cc(CCNC(C)=O)c2c1;COC1CCC2[NH]CC(CCNC(C)=O)C2C1, COC1CCC2[NH]CC(CCNC(C)=O)C2C1, COC1CCC2[NH]CC(CCNC(C)=O)C2C1",DRLFMBDRBRZALE-UHFFFAOYSA-N
MELENGESTROL-ACETATE,MELENGESTROL-ACETATE,,BRD:BRD-A42746051-001-02-9;BRD:BRD-BRD-A42746051-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,CC(=O)O[C@]1(C(C)=O)C(=C)CC2C3C=C(C)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C,
MELEVODOPA,CHF-1301;LEVOMET;MELEVODOPA,CHEMBL1328898,BRD:BRD-BRD-K18749874-003-08-9;BRD:BRD-K18749874-003-08-9,rep_primary;rep_single_dose,"DOPAMINE PRECURSOR, DOPAMINE RECEPTOR AGONIST",DDC,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,1,"COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1;COC(=O)C(N)CC1CCC(O)C(O)C1, COC(=O)[C@@H](N)CC1CCC(O)C(O)C1",XBBDACCLCFWBSI-ZETCQYMHSA-N
MELFLUFEN (HYDROCHLORIDE),MELFLUFEN (HYDROCHLORIDE),,BRD:BRD-K00075584-003-02-9,rep_single_dose,,,,,,,,NA,,
VIVLODEX,ACTICAM;ANJESO;CONTACERA;COXICAM;EMDOCAM;FLEXICAM;INFLACAM;LOXICOM;MELFAX;MELOSUS;MELOVEM;MELOXICAM;MELOXIDOLOR;MELOXIDYL;MELOXIVET;MELOXORAL;METACAM;MOBIC;MOVATEC;N-1539;N1539;QMIIZ ODT;RECOCAM;REVITACAM;RHEUMOCAM;UH-AC 62XX;UH-AC-62 XX;UHAC-62XX;VIVLODEX,CHEMBL599,BRD:BRD-A84174393-236-07-1;BRD:BRD-BRD-A84174393-236-07-1,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"OSTEOARTHRITIS, RHEUMATOID ARTHRITIS",,LAUNCHED,,Small molecule,4,"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1;CN1C(C(=O)NC2NCC(C)S2)C(=O)C2CCCCC2S1(=O)=O, CN1C(C(=O)NC2NCC(C)S2)C(=O)C2CCCCC2S1(=O)=O, CN1C(C(=O)NC2NCC(C)S2)C(=O)C2CCCCC2S1(=O)=O",ZRVUJXDFFKFLMG-UHFFFAOYSA-N
METYLPERON,BUNIL;FG 5111;FG-5111;FLUBUPERONE;MELPERONE;METYLPERON,CHEMBL1531134,BRD:BRD-BRD-K92984783-003-05-7;BRD:BRD-K92984783-003-05-7,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",DRD2;HTR2A,PSYCHOSIS,,LAUNCHED,,Small molecule,3,"CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1;CC1CCN(CCCC(=O)C2CCC(F)CC2)CC1, CC1CCN(CCCC(=O)C2CCC(F)CC2)CC1",DKMFBWQBDIGMHM-UHFFFAOYSA-N
SK-15673,AIKERAN;ALANINE NITROGEN MUSTARD;ALKERAN;CB 3025;CB-3025;L-;L-PAM;L-PHENYLALANINE MUSTARD;L-SARCOLYSIN;MELFALAN;MELPHALAN;NCI-C04853;NSC-241286;NSC-8806;PHENYLALANINE MUSTARD;SARCOLYCIN;SK 15673;SK-15673,CHEMBL852,BRD:BRD-BRD-K87827419-001-16-8;BRD:BRD-K87827419-001-16-8,rep_multi_dose;rep_primary;rep_single_dose,"DNA ALKYLATING AGENT, DNA INHIBITOR",,MULTIPLE MYELOMA,,LAUNCHED,,Small molecule,4,"N[C@@H](CC1CCC(CC1)N(CCCL)CCCL)C(O)=O, N[C@@H](CC1CCC(CC1)N(CCCL)CCCL)C(O)=O;N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O",SGDBTWWWUNNDEQ-LBPRGKRZSA-N
MELUADRINE,MELUADRINE,CHEMBL2104709,BRD:BRD-A07164067-001-01-2;BRD:BRD-BRD-A07164067-001-01-2,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CC(C)(C)NC[C@H](O)c1ccc(O)cc1Cl;CC(C)(C)NCC(O)C1CCC(O)CC1CL,LIXBJWRFCNRAPA-NSHDSACASA-N
VALIOS,ACRESCENT;AKATINOL;AUXURA;BALAXUR;D-145;DRG-0267;EBIXA;FP-01;MARIXINO;MEMANTINE;MEMANTINE ACCORD;MEMANTINE HCL;MEMANTINE HYDROCHLORIDE;MEMANTINE LEK;MEMANTINE MERZ;MEMANTINE MYLAN;MEMANTINE RATIOPHARM;MEMARY;NAMENDA;NAMENDA XR;NEMDATINE;NSC-102290;NSC-757843;SUN-Y7017;VALIOS,CHEMBL1699;CHEMBL807,BRD:BRD-A79803969-003-16-1;BRD:BRD-BRD-A79803969-003-16-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,CHRFAM7A;DRD2;GRIN1;GRIN2A;GRIN2B;GRIN3A;HTR3A,"ALZHEIMER'S DISEASE, SENILE DEMENTIA",,LAUNCHED,,Small molecule,4,"CC12CC3CC(C)(C1)CC(N)(C3)C2, CC12CC3CC(C)(C1)CC(N)(C3)C2, CC12CC3CC(C)(C1)CC(N)(C3)C2;CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl",LDDHMLJTFXJGPI-UHFFFAOYSA-N
VITAMIN K3,"1,4-NAPHTHALENEDIONE;2-METHYL;KAPPAXIN;KAYQUINONE;MENADIONE;MENAPHTHENE;MENAPHTHONE;NSC-4170;VITAMIN K 3;VITAMIN K3",CHEMBL590,BRD:BRD-BRD-K78126613-001-28-5;BRD:BRD-K78126613-001-28-5,rep_multi_dose;rep_primary;rep_single_dose,"MITOCHONDRIAL DNA POLYMERASE INHIBITOR, PHOSPHATASE INHIBITOR",AOX1;BGLAP;F10;F2;F7;F9;GGCX;NQO1;NQO2;PROC;PROS1;PROZ;VKORC1;VKORC1L1,"ULCERATIVE COLITIS, DIARRHEA, HEADACHE, VARICOSE VEINS, RHEUMATOID ARTHRITIS",,LAUNCHED,,Small molecule,4,"CC1=CC(=O)c2ccccc2C1=O;CC1=CC(=O)C2CCCCC2C1=O, CC1=CC(=O)C2CCCCC2C1=O, CC1=CC(=O)C2CCCCC2C1=O",MJVAVZPDRWSRRC-UHFFFAOYSA-N
MENADIONE-BISULFITE,MENADIONE-BISULFITE,,BRD:BRD-A19777893-236-01-9;BRD:BRD-BRD-A19777893-236-01-9,rep_primary;rep_single_dose,VITAMIN K,GGCX;VKORC1;VKORC1L1,,,PHASE 2,,,NA,CC1(CC(=O)C2CCCCC2C1=O)S(O)(=O)=O,
SC 1749 [AS SODIUM SALT],GENABILIC ACID;GENABILIN;GENABILINE;MENBUTONE;METHONAPHTHONE;NSC-53969;SC 1749 [AS SODIUM SALT],CHEMBL1972268,BRD:BRD-BRD-K53852914-001-01-8;BRD:BRD-K53852914-001-01-8,rep_primary;rep_single_dose,,,BILE STIMULATION,,LAUNCHED,,Small molecule,-1,COc1ccc(C(=O)CCC(=O)O)c2ccccc12;COC1CCC(C(=O)CCC(O)=O)C2CCCCC12,FHGJSJFIQNQBCK-UHFFFAOYSA-N
QUINACRINE,ATABRINE;GNF-PF-5448;MEPACRINE;QUINACRINE,CHEMBL7568,BRD:BRD-A45889380-300-07-1;BRD:BRD-BRD-A45889380-300-07-1,rep_primary;rep_single_dose,"CYTOKINE PRODUCTION INHIBITOR, NFKB PATHWAY INHIBITOR, TP53 ACTIVATOR",PLA2G1B;PLA2G4A;PLA2G6;PLCL1,GIARDIASIS,,LAUNCHED,,Small molecule,2,"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12;CCN(CC)CCCC(C)NC1C2CCC(CL)CC2NC2CCC(OC)CC12, CCN(CC)CCCC(C)NC1C2CCC(CL)CC2NC2CCC(OC)CC12, CCN(CC)CCCC(C)NC1C2CCC(CL)CC2NC2CCC(OC)CC12",GPKJTRJOBQGKQK-UHFFFAOYSA-N
MEPARFYLON,MEPARFYLON,,BRD:BRD-A11662333-001-03-3;BRD:BRD-BRD-A11662333-001-03-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCC(C)(O)C#C,
PECAZINE,III-2318;LACUMIN;MEPASIN;MEPAZIN;MEPAZINE;MEPAZINE BASE;MEPRAZINE;MESAPIN;NOTHIAZINE;P-391;PACATAL;PACATAL BASE;PACATOL;PAKATAL;PAXITAL;PECATAL;PECAZINE,CHEMBL395110,BRD:BRD-A82772293-001-03-2;BRD:BRD-BRD-A82772293-001-03-2,rep_primary;rep_single_dose,MALT1 INHIBITOR (JH),MALT1,,,PHASE 2,,Small molecule,4,CN1CCCC(CN2C3CCCCC3SC3CCCCC23)C1;CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,CBHCDHNUZWWAPP-UHFFFAOYSA-N
MEPENZOLATE ION,MEPENZOLATE;MEPENZOLATE BROMIDE FREE BASE;MEPENZOLATE CATION;MEPENZOLATE ION,CHEMBL524004,BRD:BRD-A62421304-004-18-9;BRD:BRD-BRD-A62421304-004-18-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM3,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,4,"C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1CCCCC1)C1CCCCC1, C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1CCCCC1)C1CCCCC1;C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1",GKNPSSNBBWDAGH-UHFFFAOYSA-N
TOLSEROL,CRESOXYDIOL;DECONTRACTYL;MEPHENESIN;NSC-25234;TOLSEROL,CHEMBL229128,BRD:BRD-A55469827-001-07-4;BRD:BRD-BRD-A55469827-001-07-4,rep_primary;rep_single_dose,MUSCLE RELAXANT,,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,4,Cc1ccccc1OCC(O)CO;CC1CCCCC1OCC(O)CO,JWDYCNIAQWPBHD-UHFFFAOYSA-N
MEPHENTERMINE,MEPHENTERMINE,CHEMBL1201234,BRD:BRD-BRD-K18194590-065-08-0;BRD:BRD-K18194590-065-08-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;ADRB3,HYPOTENSION,,LAUNCHED,,Small molecule,4,CNC(C)(C)Cc1ccccc1;CNC(C)(C)CC1CCCCC1,RXQCGGRTAILOIN-UHFFFAOYSA-N
NSC-34652,MEPHENYTOIN;MESANTOIN;METHOIN;NSC-34652,CHEMBL861,BRD:BRD-A83937277-001-10-5;BRD:BRD-BRD-A83937277-001-10-5,rep_multi_dose;rep_primary;rep_single_dose,HYDANTOIN ANTIEPILEPTIC,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,Small molecule,4,CCC1(c2ccccc2)NC(=O)N(C)C1=O;CCC1(NC(=O)N(C)C1=O)C1CCCCC1,GMHKMTDVRCWUDX-UHFFFAOYSA-N
NSC-66283,MEPIROXOL;NSC-66283,CHEMBL1985503,BRD:BRD-BRD-K78299798-001-02-2;BRD:BRD-K78299798-001-02-2,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,"[O-][n+]1cccc(CO)c1;OCC1CCC[N+]([O-])C1, OCC1CCC[N+]([O-])C1",LQYJAVWWKTWWKN-UHFFFAOYSA-N
TEVACAINE,"(S)-;(S)-MEPIVACAINE;1-METHYL-;1-METHYL-2',6'-PIPECOLOXYLIDIDE;2',6'-PIPECOLOXYLIDIDE;APF-135;CARBOCAINE;CARBOPLYIN DENTAL;DEXIVACAINE;DL-MEPIVACAINE;MEPISV;MEPIVACAINE;POLOCAINE;POLOCAINE-MPF;TEVACAINE",CHEMBL1087;CHEMBL2104634,BRD:BRD-A03216249-003-24-3;BRD:BRD-BRD-A03216249-003-24-3,rep_multi_dose;rep_primary;rep_single_dose,"POTASSIUM CHANNEL BLOCKER, SODIUM CHANNEL BLOCKER",SCN10A,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,4,"Cc1cccc(C)c1NC(=O)C1CCCCN1C;CN1CCCCC1C(=O)NC1C(C)CCCC1C, CN1CCCCC1C(=O)NC1C(C)CCCC1C",INWLQCZOYSRPNW-UHFFFAOYSA-N
TRANMEP,AMOSENE;BAMATE;EQUANIL;MEPRIAM;MEPROBAMATE;MEPROBAMATE CIV;MEPROSPAN;MILTOWN;NEURAMATE;NSC-30418;TENAVOID;TRANMEP,CHEMBL979,BRD:BRD-BRD-K19180152-001-02-6;BRD:BRD-K19180152-001-02-6,rep_primary;rep_single_dose,,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ,ANXIETY,,LAUNCHED,,Small molecule,4,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N
MEPRYLCAINE,MEPRYLCAINE,CHEMBL127810,BRD:BRD-BRD-K65417056-003-10-1;BRD:BRD-K65417056-003-10-1,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,,,PRECLINICAL,,Small molecule,-1,CCCNC(C)(C)COC(=O)c1ccccc1;CCCNC(C)(C)COC(=O)C1CCCCC1,VXJABHHJLXLNMP-UHFFFAOYSA-N
MEPTAZINOL,IL-22811;MEPTAZINOL,CHEMBL314437,BRD:BRD-A02710418-003-11-8;BRD:BRD-BRD-A02710418-003-11-8,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,BCHE,PAIN RELIEF,,LAUNCHED,,Small molecule,4,"CCC1(c2cccc(O)c2)CCCCN(C)C1;CCC1(CCCCN(C)C1)C1CCCC(O)C1, CCC1(CCCCN(C)C1)C1CCCC(O)C1, CCC1(CCCCN(C)C1)C1CCCC(O)C1",JLICHNCFTLFZJN-UHFFFAOYSA-N
PYRILAMINE,MEPYRAMINE;NSC-13136;PYRILAMINE,CHEMBL511,BRD:BRD-BRD-K97564742-050-32-7;BRD:BRD-K97564742-050-32-7,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"COMMON COLD, MENSTRUAL PAIN",,LAUNCHED,,Small molecule,4,"COC1CCC(CC1)CN(CCN(C)C)C1CCCCN1, COC1CCC(CC1)CN(CCN(C)C)C1CCCCN1, COC1CCC(CC1)CN(CCN(C)C)C1CCCCN1;COc1ccc(CN(CCN(C)C)c2ccccn2)cc1",YECBIJXISLIIDS-UHFFFAOYSA-N
P-HYDROXYANISOLE,4-HYDROXYANISOLE;4-METHOXYPHENOL;4HA;BMS-181158;HQMME; HYDROXYQUINONE METHYL ETHER;LEUCOBASAL;LEUCODINE B;MECHINOLUM;MENTHYL ANTHRANILATE;MEQUINOL;NOVO-DERMOQUINONA;NSC-4960;P-GUAIACOL;P-HYDROXYANISOLE,CHEMBL544,BRD:BRD-BRD-K45216060-001-10-0;BRD:BRD-BRD-K45216060-001-11-8;BRD:BRD-K45216060-001-10-0;BRD:BRD-K45216060-001-11-8,rep_primary;rep_single_dose,,TYR,SKIN DEPIGMENTATION,,LAUNCHED,,Small molecule,4,"COc1ccc(O)cc1;COC1CCC(O)CC1, COC1CCC(O)CC1, COC1CCC(O)CC1",NWVVVBRKAWDGAB-UHFFFAOYSA-N
ONCOSTATIN K,AC-DE;ACTD;ACTINOMYCIN C1;ACTINOMYCIN D;ACTINOMYCIN I1;ACTINOMYCIN IV;ACTINOMYCIN X1;ACTINOMYCIN-D;COSMEGEN;COSMEGEN LYOVAC;DACTINOMYCIN;DACTINOMYCINUM;DILACTONE ACTINOMYCIN D ACID;GNF-PF-1977;GNF-PF-2290;LYOVAC;MERACTINOMYCIN;NCI-C04682;NSC-3053;ONCOSTATIN K,CHEMBL1554,GDSC2:1911,gdsc,,,,,,,Protein,4,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,RJURFGZVJUQBHK-IIXSONLDSA-N
MERBARONE,MERBARONE,CHEMBL1765797,BRD:BRD-BRD-K45152786-001-08-4;BRD:BRD-K45152786-001-08-4;BRD:BRD-K45152786-001-09-9,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A,,,PHASE 2,,Small molecule,NA,O=C(NC1CCCCC1)C1C(=O)NC(=S)NC1=O;O=C1NC(=S)NC(=O)C1C(=O)Nc1ccccc1,JARCFMKMOFFIGZ-UHFFFAOYSA-N
NSC-757381,MERBROMIN;MERBROMIN SODIUM;MERCUROCHROME;NSC-757381,CHEMBL3833381,BRD:BRD-BRD-K21771665-304-04-2;BRD:BRD-K21771665-304-04-2,rep_primary;rep_single_dose,ANTISEPTIC,,FIRST-AID ANTISEPTIC,,LAUNCHED,,Small molecule,4,O[HG]C1C(O)C(BR)CC2C(-C3CCCCC3C(O)=O)C3CC(BR)C(=O)CC3OC12,
XALUPRINE,6-MERCAPTOPURINE;6-MERCAPTOPURINE MONOHYDRATE;MERCAPTOPURINE;MERCAPTOPURINE ANHYDROUS;MERCAPTOPURINE HYDRATE;MERCAPTOPURINUM;NSC-755;NSC-759614;PURI-NETHOL;PURINETHOL;PURIXAN;XALUPRINE,CHEMBL1200751;CHEMBL1425,BRD:BRD-BRD-K91601245-001-12-0;BRD:BRD-K91601245-001-12-0,rep_multi_dose;rep_primary;rep_single_dose,"IMMUNOSUPPRESSANT, PROTEIN SYNTHESIS INHIBITOR, PURINE ANTAGONIST",HPRT1;IMPDH1;IMPDH2;PPAT,ACUTE LYMPHOBLASTIC LEUKEMIA (ALL),,LAUNCHED,,Small molecule,4,"O.S=c1[nH]cnc2nc[nH]c12;S=C1[NH]CNC2NC[NH]C12, S=C1[NH]CNC2NC[NH]C12",WFFQYWAAEWLHJC-UHFFFAOYSA-N
MERCAPTOSUCCINIC-ACID,MERCAPTOSUCCINIC-ACID,,BRD:BRD-A43435802-001-02-0;BRD:BRD-BRD-A43435802-001-02-0,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,"OC(=O)CC(S)C(O)=O, OC(=O)CC(S)C(O)=O",
MERCK60,MERCK60,,BRD:BRD-K04466929-001-12-9;CTRP:61674,ctrp;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2,,,,,,NA,,
RO5024048; R7128,"3',5'-DIISOBUTYRYL PSI 6130;MERICITABINE;PSI 6130 DIISOBUTYRATE;R 7128;R-7128;R7128;RG 7128;RO-5024048;RO5024048;RO5024048; R7128",CHEMBL562967,BRD:BRD-BRD-K69726595-001-01-2;BRD:BRD-K69726595-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,HCV INHIBITOR,,,,PHASE 2,,Small molecule,2,CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C;CC(C)C(=O)OC[C@H]1O[C@@H](N2CCC(N)NC2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C,MLESJYFEMSJZLZ-MAAOGQSESA-N
VX-497,"MERIMEPODIB;VI-21,497;VI-21497;VX-497",CHEMBL304087,BRD:BRD-BRD-K09372874-001-01-0;BRD:BRD-K09372874-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,IMPDH1,,,PHASE 2,,Small molecule,2,COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1;COC1CC(NC(=O)NC2CCCC(CNC(=O)O[C@H]3CCOC3)C2)CCC1-C1CNCO1,JBPUGFODGPKTDW-SFHVURJKSA-N
MERTANSINE,MAYTANSINOID DM 1;MAYTANSINOID DM1;MERTANSINE,CHEMBL4802230,BRD:BRD-K00003293-001-01-9,rep_single_dose,MICROTUBULE INHIBITOR,,,,,,Small molecule,-1,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCS)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,ANZJBCHSOXCCRQ-FKUXLPTCSA-N
SFROWASA,5-AMINO-2-HYDROXY-;APRISO;ASACOL;ASACOL HD;BENZOIC ACID;CANASA;COLTEC EC;DELZICOL;FISALAMINE;IIALDA;IPOCOL;LIALDA;MAX-002;MESALAMINE;MESALAZINE;MESALAZINE ;MESREN MR;MEZAVANT XL;NSC-38877;OCTASA;PENTASA;PENTASA SR;ROWASA;SALOFALK;SFROWASA,CHEMBL704,BRD:BRD-BRD-K28849549-001-13-4;BRD:BRD-K28849549-001-13-4,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",ALOX5;CHUK;IKBKB;MPO;PPARG;PTGS1;PTGS2,"ULCERATIVE COLITIS, INFLAMMATORY BOWEL DISEASE",,LAUNCHED,,Small molecule,4,"Nc1ccc(O)c(C(=O)O)c1;NC1CCC(O)C(C1)C(O)=O, NC1CCC(O)C(C1)C(O)=O, NC1CCC(O)C(C1)C(O)=O",KBOPZPXVLCULAV-UHFFFAOYSA-N
UROMITEXAN,COENZYME M SODIUM SALT;D 7093;D-7093;MESNA;MESNEX;MISTABRON;NSC-113891;UROMITEXAN,CHEMBL1098319;CHEMBL975,BRD:BRD-BRD-K49954789-001-02-9;BRD:BRD-K49954789-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,ANTIOXIDANT,,HEMORRHAGIC CYSTITIS,,LAUNCHED,,Small molecule,4,"O=S(=O)([O-])CCS.[Na+];OS(=O)(=O)CCS, OS(=O)(=O)CCS, OS(=O)(=O)CCS",XOGTZOOQQBDUSI-UHFFFAOYSA-M
TPS-23,LIDANAR;MESORIDAZINE;NC-123;NSC-186066;SERENTIL;THIORIDAZINE-2-SULFOXIDE;TPS-23,CHEMBL1088,BRD:BRD-A14395271-074-17-8;BRD:BRD-BRD-A14395271-074-17-8,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;HTR2A,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,"CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21;CN1CCCCC1CCN1C2CCCCC2SC2CCC(CC12)S(C)=O, CN1CCCCC1CCN1C2CCCCC2SC2CCC(CC12)S(C)=O, CN1CCCCC1CCN1C2CCCCC2SC2CCC(CC12)S(C)=O",SLVMESMUVMCQIY-UHFFFAOYSA-N
MESTINON,MESTINON,,BRD:BRD-BRD-K69688083-004-23-1;BRD:BRD-K69688083-004-23-1,rep_primary;rep_single_dose,CHOLINESTERASE INHIBITOR,ACHE;BCHE,MYASTHENIA GRAVIS,,LAUNCHED,,,NA,"CN(C)C(=O)OC1CCC[N+](C)C1, CN(C)C(=O)OC1CCC[N+](C)C1",
NSC-84032,33355;EE-3ME;EE3 ME;EE3-ME;EE3ME;EEI3ME;MESTRANOL;NSC-84032,CHEMBL1201151,BRD:BRD-BRD-K31920458-001-23-6;BRD:BRD-K31920458-001-23-6,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C;COC1CCC2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCC2C1, COC1CCC2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCC2C1",IMSSROKUHAOUJS-MJCUULBUSA-N
MESULERGINE,MESULERGINE,CHEMBL12314,BRD:BRD-BRD-K91336023-003-01-0;BRD:BRD-K91336023-003-01-0,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,HTR2A;HTR2B;HTR2C;HTR3A;HTR3B;HTR6;HTR7,,,PHASE 2,,Small molecule,-1,CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](CC3CN(C)C4CCCC2C34)N(C)C1;CN1C[C@@H](NS(=O)(=O)N(C)C)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,JLVHTNZNKOSCNB-YSVLISHTSA-N
NSC-3990,BS 749;BS-749;METACETAMOL;NSC-3990,CHEMBL9419,BRD:BRD-BRD-K16474819-001-09-6;BRD:BRD-K16474819-001-09-6,rep_primary;rep_single_dose,ANALGESIC AGENT,,,,PRECLINICAL,,Small molecule,-1,CC(=O)Nc1cccc(O)c1;CC(=O)NC1CCCC(O)C1,QLNWXBAGRTUKKI-UHFFFAOYSA-N
METACRESOL,METACRESOL,CHEMBL298312,BRD:BRD-BRD-K22518984-001-01-8;BRD:BRD-K22518984-001-01-8,rep_primary;rep_single_dose,,INS,,,LAUNCHED,,Small molecule,-1,Cc1cccc(O)c1;CC1CCCC(O)C1,RLSSMJSEOOYNOY-UHFFFAOYSA-N
METAMIZOLE,METAMIZOLE,,BRD:BRD-BRD-K76812510-236-14-8;BRD:BRD-K76812510-236-14-8,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, OPIOID RECEPTOR AGONIST",PTGS1,,,WITHDRAWN,,,NA,CN(CS(O)(=O)=O)C1C(C)N(C)N(-C2CCCCC2)C1=O,
"METAP2 INHIBITOR, A832234","METAP2 INHIBITOR, A832234",,GDSC1:410,gdsc,,,,,,,,NA,,
ORCIPRENALINE,METAPROTERENOL;ORCIPRENALINE,CHEMBL776,BRD:BRD-A07780951-001-08-9;BRD:BRD-A07780951-065-10-0;BRD:BRD-BRD-A07780951-001-08-9;BRD:BRD-BRD-A07780951-065-10-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,"BRONCHOSPASM, ASTHMA, BRONCHITIS, EMPHYSEMA",,LAUNCHED,,Small molecule,4,"CC(C)NCC(O)c1cc(O)cc(O)c1;CC(C)NCC(O)C1CC(O)CC(O)C1, CC(C)NCC(O)C1CC(O)CC(O)C1, CC(C)NCC(O)C1CC(O)CC(O)C1",LMOINURANNBYCM-UHFFFAOYSA-N
METARAMINOL,METARAMINOL,CHEMBL1201319,BRD:BRD-BRD-K96253961-046-03-1;BRD:BRD-K96253961-046-03-1,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A,HYPOTENSION,,LAUNCHED,,Small molecule,4,"C[C@H](N)[C@H](O)c1cccc(O)c1;C[C@H](N)[C@H](O)C1CCCC(O)C1, C[C@H](N)[C@H](O)C1CCCC(O)C1, C[C@H](N)[C@H](O)C1CCCC(O)C1",WXFIGDLSSYIKKV-RCOVLWMOSA-N
ML-246,METARRESTIN;ML-246,CHEMBL4594433,BRD:BRD-K31606909-001-03-9,rep_single_dose,,,,,,,Small molecule,1,N=c1c2c(-c3ccccc3)c(-c3ccccc3)n(Cc3ccccc3)c2ncn1[C@H]1CC[C@H](O)CC1,WSMXAUJFLWRPNT-DIVCQZSQSA-N
METATINIB,METATINIB,,BRD:BRD-BRD-K27182532-001-02-3;BRD:BRD-K27182532-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,BCR-ABL KINASE INHIBITOR,ABL1;BCR,,,PHASE 1,,,NA,NC1NCCC(OC2CCC(NC(=O)C3C[NH]CC(-C4CCC(F)CC4)C3=O)CC2F)C1CL,
ZORANE,AHR-438;FLEXURA;METAXALONE;NSC-170959;SKELAXIN;ZORANE,CHEMBL1079604,BRD:BRD-A94709349-001-08-3;BRD:BRD-BRD-A94709349-001-08-3,rep_primary;rep_single_dose,MUSCLE RELAXANT,,MUSCLE PAIN,,LAUNCHED,,Small molecule,4,Cc1cc(C)cc(OCC2CNC(=O)O2)c1;CC1CC(C)CC(OCC2CNC(=O)O2)C1,IMWZZHHPURKASS-UHFFFAOYSA-N
METAZOSIN,METAZOSIN,,BRD:BRD-A78277353-001-01-9;BRD:BRD-BRD-A78277353-001-01-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A,,,PHASE 2,,,NA,COC(C)C(=O)N1CCN(CC1)C1NC(N)C2CC(OC)C(OC)CC2N1,
METENKEPHALIN,METENKEPHALIN,,BRD:BRD-A38218502-001-01-2;BRD:BRD-BRD-A38218502-001-01-2,rep_primary;rep_single_dose,IMMUNOSTIMULANT,OPRD1,,,PHASE 2,,,NA,CSCCC(NC(=O)C(CC1CCCCC1)NC(=O)CNC(=O)CNC(=O)C(N)CC1CCC(O)CC1)C(O)=O,
NSC-755878,FI 6337;FI-6337;LISERDOL;MCE;METERGOLINE;NSC-755878,CHEMBL19215,BRD:BRD-A72309220-001-04-1;BRD:BRD-BRD-A72309220-001-04-1,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR5A;HTR6;HTR7,,,LAUNCHED,,Small molecule,4,"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21;CN1C[C@H](CNC(=O)OCC2CCCCC2)C[C@H]2[C@H]1CC1CN(C)C3CCCC2C13, CN1CC(CNC(=O)OCC2CCCCC2)C[C@@H]2C1CC1CN(C)C3CCCC2C13, CN1C[C@H](CNC(=O)OCC2CCCCC2)C[C@H]2[C@H]1CC1CN(C)C3CCCC2C13",WZHJKEUHNJHDLS-QTGUNEKASA-N
METFORMIN EXTENDED RELEASE,LA-6023;METFORMIN;METFORMIN EXTENDED RELEASE,CHEMBL1431,BRD:BRD-BRD-K79602928-003-19-9;BRD:BRD-K79602928-003-19-9,rep_primary;rep_single_dose,INSULIN SENSITIZER,ACACB;PRKAB1,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CN(C)C(=N)NC(=N)N;CN(C)C(=N)NC(N)=N, CN(C)C(=N)NC(N)=N, CN(C)C(=N)NC(N)=N",XZWYZXLIPXDOLR-UHFFFAOYSA-N
PROVOCHOLINE,METHACHOLINE;METHACHOLINE CATION;METHACHOLINE ION;PROVOCHOLINE,CHEMBL978,BRD:BRD-A18056626-003-22-3;BRD:BRD-BRD-A18056626-003-22-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM2;CHRM3;CHRM4,BRONCHIAL HYPERRESPONSIVENESS DIAGNOSTIC,,LAUNCHED,,Small molecule,4,CC(=O)OC(C)C[N+](C)(C)C;CC(C[N+](C)(C)C)OC(C)=O,NZWOPGCLSHLLPA-UHFFFAOYSA-N
MOTC,GS-2876;METACYCLINE;METHACYCLINE;MOTC,CHEMBL249837,BRD:BRD-A49035384-003-28-9;BRD:BRD-A49035384-003-30-5;BRD:BRD-BRD-A49035384-003-28-9;BRD:BRD-BRD-A49035384-003-30-5;BRD:BRD-K00003351-003-01-9,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,BRONCHITIS,,LAUNCHED,"Multiple values for structure_id: {'A49035384', 'K00003351'}, defaulting to None",Small molecule,4,"C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12;CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)C4C(O)CCCC4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)C4C(O)CCCC4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)C4C(O)CCCC4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)C4C(O)CCCC4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O",MHIGBKBJSQVXNH-IWVLMIASSA-N
METHANESULFONYL-FLUORIDE,METHANESULFONYL-FLUORIDE,,BRD:BRD-K53896891-001-01-2,rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE,,,,,,NA,,
METHANTHELINIUM,METHANTHELINE;METHANTHELINE CATION;METHANTHELINE ION;METHANTHELINIUM,CHEMBL1201264,BRD:BRD-K09859624-004-11-9,rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;HRH2,,,,,Small molecule,4,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21,GZHFODJQISUKAY-UHFFFAOYSA-N
THIONYLAN,A 3322;A-3322;METAPYRILENE;METHAPYRILENE;PYRINISTOL;RESTRYL;SEMIKON;SLEEPWELL;TENALIN;THIONYLAN,CHEMBL1411979,BRD:BRD-BRD-K47323024-003-24-4;BRD:BRD-K47323024-003-24-4,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,,,WITHDRAWN,,Small molecule,4,"CN(C)CCN(Cc1cccs1)c1ccccn1;CN(C)CCN(CC1CCCS1)C1CCCCN1, CN(C)CCN(CC1CCCS1)C1CCCCN1",HNJJXZKZRAWDPF-UHFFFAOYSA-N
NSC-27156,ENDIEMAL;GEMONIL;METHARBITAL;METHARBITAL CIII;METHARBITONE;NSC-27156,CHEMBL450,BRD:BRD-BRD-K88143662-001-01-5;BRD:BRD-K88143662-001-01-5,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,CHRNA4;CHRNA7;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GRIA2;GRIK2,EPILEPSY,,LAUNCHED,,Small molecule,4,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N
VVP808,L-584601;METHAZOLAMIDE;METHENAMIDE;NEPTAZANE;NEPTAZANEAT;NSC-758426;VVP-808;VVP808,CHEMBL19,BRD:BRD-BRD-K13356952-001-25-1;BRD:BRD-K13356952-001-25-1,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA1;CA12;CA14;CA2;CA4;CA7,"GLAUCOMA, INTRAOCULAR PRESSURE",,LAUNCHED,,Small molecule,4,"CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C;CC(=O)N=C1SC(NN1C)S(N)(=O)=O, CC(=O)N=C1SC(NN1C)S(N)(=O)=O, CC(=O)N=C1SC(NN1C)S(N)(=O)=O",FLOSMHQXBMRNHR-QPJJXVBHSA-N
UROTROPIN,AMINOFORM;E-239;E239;HEXAMETHYLENAMINE;HEXAMETHYLENE TETRAMINE;HEXAMETHYLENETETRAMINE;HEXAMINE;INS NO.239;INS-239;METHENAMINE;NSC-26346;NSC-403347;URITONE;UROTROPIN,CHEMBL1201270,BRD:BRD-BRD-K30114692-001-15-9;BRD:BRD-K30114692-001-15-9,rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,"C1N2CN3CN1CN(C2)C3;C1N2CN3CN1CN(C2)C3, C1N2CN3CN1CN(C2)C3",VKYKSIONXSXAKP-UHFFFAOYSA-N
METHIAZOLE,METHIAZOLE,,BRD:BRD-BRD-K02764365-001-13-6;BRD:BRD-K02764365-001-13-6,rep_multi_dose;rep_primary;rep_single_dose,ANTHELMINTIC AGENT,,,,PRECLINICAL,,,NA,COC(=O)NC1NC2CC(SC(C)C)CCC2[NH]1,
STAPHCILLIN,"2,6-DIMETHOXYPHENYL PENICILLIN;METHICILLIN;METICILLIN;STAPHCILLIN",CHEMBL575,BRD:BRD-BRD-K34388247-236-08-2;BRD:BRD-K34388247-236-08-2,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,,,LAUNCHED,,Small molecule,4,"COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O;COC1CCCC(OC)C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O, COC1CCCC(OC)C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O",RJQXTJLFIWVMTO-TYNCELHUSA-N
THIAMAZOLE,FAVISTAN;MERCAPTIZOLE;METHIMAZOLE;NSC-38608;TAPAZOLE;THIAMAZOLE,CHEMBL1515,BRD:BRD-BRD-K54416256-001-19-9;BRD:BRD-K54416256-001-19-9,rep_primary;rep_single_dose,ANTITHYROID AGENT,TPO,HYPERTHYROIDISM,,LAUNCHED,,Small molecule,4,"CN1CC[NH]C1=S, CN1CC[NH]C1=S;Cn1ccnc1S",PMRYVIKBURPHAH-UHFFFAOYSA-N
METHIOPRIL,METHIOPRIL,,BRD:BRD-A32172948-001-07-6;BRD:BRD-BRD-A32172948-001-07-6,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,,,PHASE 2,,,NA,CC1CCCC(N1C(=O)CCSC(C)=O)C(O)=O,
ROBAXIN-750,DELAXIN;FORBAXIN;METHOCARBAMOL;MIOLAXIN;NEURAXIN;NSC-170960;ROBAXIN;ROBAXIN-750,CHEMBL1201117,BRD:BRD-A31521121-001-26-4;BRD:BRD-BRD-A31521121-001-26-4,rep_multi_dose;rep_primary;rep_single_dose,MUSCLE RELAXANT,CA1,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,4,"COc1ccccc1OCC(O)COC(N)=O;COC1CCCCC1OCC(O)COC(N)=O, COC1CCCCC1OCC(O)COC(N)=O",GNXFOGHNGIVQEH-UHFFFAOYSA-N
METHOPRENE-(S),METHOPRENE-(S),,BRD:BRD-BRD-K34591242-001-04-3;BRD:BRD-K34591242-001-04-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC(C)(C)CCC[C@H](C)C\C=C\C(C)=C\C(=O)OC(C)C,
ZLATAL,(R)-;(R)-METHOTREXATE;ABITREXATE;ADX-2191;ADX-2191 SODIUM;AMETHOPTERIN;CL 14377;CL-14377;D-;D-AMETHOPTERIN;D-METHOTREXATE;DISODIUM METHOTREXATE;EBETREX;EMT-25299;EMTEXATE HIGH-POT;EMTEXATE PF;FOLEX;FOLEX PFS;MAXTREX;METHOTREXATE;METHOTREXATE (AS DISODIUM);METHOTREXATE DISODIUM;METHOTREXATE DISODIUM SALT;METHOTREXATE LPF;METHOTREXATE PRESERVATIVE FREE;METHOTREXATE SODIUM;METHOTREXATE SODIUM PRESERVATIVE FREE;METHOTREXATE SODIUM SALT;METHOTREXATUM;METHYLAMINOPTERIN;METOJECT;MEXATE;MEXATE-AQ;MEXATE-AQ PRESERVED;NSC-740;OTREXUP;OTREXUP PFS;R-9985;R-METHOTREXATE;RASUVO;REDITREX;RHEUMATREX;SODIUM SALT;TCMDC-123832;TCMDC-125488;TCMDC-125858;TREXALL;XATMEP;ZLATAL,CHEMBL3244648;CHEMBL34259,BRD:BRD-A55424491-001-19-9;BRD:BRD-BRD-A55424491-001-19-9;BRD:BRD-BRD-K59456551-001-22-6;BRD:BRD-K59456551-001-22-6;CTRP:30371;GDSC1:1008,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR,"GESTATIONAL CHORIOCARCINOMA, HYDATIDIFORM MOLE, ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), PSORIASIS, RHEUMATOID ARTHRITIS",,LAUNCHED,"Multiple values for structure_id: {'K59456551', 'A55424491'}, defaulting to None",Small molecule,4,"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1;CN(CC1CNC2NC(N)NC(N)C2N1)C1CCC(CC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CN(CC1CNC2NC(N)NC(N)C2N1)C1CCC(CC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CN(CC1CNC2NC(N)NC(N)C2N1)C1CCC(CC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CN(CC1CNC2NC(N)NC(N)C2N1)C1CCC(CC1)C(=O)NC(CCC(O)=O)C(O)=O",FBOZXECLQNJBKD-ZDUSSCGKSA-N
VASOXYL,METHOXAMINE;NRL-001;NRL001;VASOXYL,CHEMBL524,BRD:BRD-A39189014-003-22-7;BRD:BRD-BRD-A39189014-003-22-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D,HYPOTENSION,,LAUNCHED,,Small molecule,4,"COc1ccc(OC)c(C(O)C(C)N)c1;COC1CCC(OC)C(C1)C(O)C(C)N, COC1CCC(OC)C(C1)C(O)C(C)N",WJAJPNHVVFWKKL-UHFFFAOYSA-N
XANTHOTOXIN,8-METHOXSALEN;8-METHOXYPSORALEN;8-MOP;DELTASORALEN;MELADININE;METHOXSALEN;METOXALEN;NSC-45923;OXSORALEN;OXSORALEN-ULTRA;OXYPSORALEN;PUVALEN;PUVASORALEN-8;SM-88 COMPONENT METHOXSALEN;UVADEX;VITPSO;XANTHOTOXIN,CHEMBL416,BRD:BRD-BRD-K63430059-001-17-2;BRD:BRD-K63430059-001-17-2,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,CYP1A1;CYP1A2;CYP2A13;CYP2A6;CYP3A4,PSORIASIS,,LAUNCHED,,Small molecule,4,"COc1c2occc2cc2ccc(=O)oc12;COC1C2OCCC2CC2CCC(=O)OC12, COC1C2OCCC2CC2CCC(=O)OC12",QXKHYNVANLEOEG-UHFFFAOYSA-N
METHOXYAMINE,METHOXYAMINE,CHEMBL1213633,BRD:BRD-BRD-K79277568-003-04-7;BRD:BRD-K79277568-003-04-7,rep_primary;rep_single_dose,DNA REPAIR ENZYME INHIBITOR,APEX1,,,PHASE 2,,Small molecule,2,CON,GMPKIPWJBDOURN-UHFFFAOYSA-N
PENTRANE,ANALGIZER;ANECOTAN;DA-759;INHALAN;METHOXIFLURANE;METHOXY FLURANE;METHOXYFLURANE;METOFANE;NSC-110432;PENTHRANE;PENTHROX;PENTRANE,CHEMBL1341,BRD:BRD-BRD-K06152156-001-01-8;BRD:BRD-K06152156-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,MEMBRANE PERMEABILITY INHIBITOR,ATP2C1;ATP5D;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GLRA1;GLRB;GRIA1;KCNA1;MT-ND1,GENERAL ANAESTHETIC,,LAUNCHED,,Small molecule,4,"COC(F)(F)C(Cl)Cl;COC(F)(F)C(CL)CL, COC(F)(F)C(CL)CL",RFKMCNOHBTXSMU-UHFFFAOYSA-N
METHOXYPHENAMINE,METHOXYPHENAMINE,CHEMBL2010507,BRD:BRD-A21474126-001-01-6;BRD:BRD-BRD-A21474126-001-01-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,ASTHMA,,LAUNCHED,,Small molecule,4,CNC(C)Cc1ccccc1OC;CNC(C)CC1CCCCC1OC,OEHAYUOVELTAPG-UHFFFAOYSA-N
N-METHYLSCOPOLAMINE,(-)-N-METHYLSCOPOLAMINE;METHSCOPOLAMINE;METHSCOPOLAMINE CATION;METHSCOPOLAMINE ION;METHYLSCOPOLAMINE;N-METHYLHYOSCINE;N-METHYLSCOPOLAMINE,CHEMBL1201268;CHEMBL376897,BRD:BRD-A03932035-004-04-3;BRD:BRD-BRD-A03932035-004-04-3;BRD:BRD-BRD-K48619321-004-16-8;BRD:BRD-K48619321-004-16-8,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,"Multiple values for structure_id: {'K48619321', 'A03932035'}, defaulting to None",Small molecule,4,"C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12;C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1CCCCC1, C[N+]1(C)C2CC(CC1C1OC21)OC(=O)[C@@H](CO)C1CCCCC1, C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1CCCCC1",LZCOQTDXKCNBEE-IKIFYQGPSA-N
NSC-760075,CELONTIN;MESUXIMIDE;METHSUXIMIDE;NSC-760075,CHEMBL697,BRD:BRD-A57592049-001-01-6;BRD:BRD-BRD-A57592049-001-01-6,rep_primary;rep_single_dose,"T-TYPE CALCIUM CHANNEL BINDER, T-TYPE CALCIUM CHANNEL BLOCKER",CACNA1G;CACNA1H;CACNA1I,SEIZURES,,LAUNCHED,"Multiple values for MOA: {'T-TYPE CALCIUM CHANNEL BINDER, T-TYPE CALCIUM CHANNEL BLOCKER', 'T-TYPE CALCIUM CHANNEL BINDER'}, defaulting to 'T-TYPE CALCIUM CHANNEL BINDER, T-TYPE CALCIUM CHANNEL BLOCKER'",Small molecule,4,CN1C(=O)CC(C)(C1=O)C1CCCCC1;CN1C(=O)CC(C)(c2ccccc2)C1=O,AJXPJJZHWIXJCJ-UHFFFAOYSA-N
NSC-110431,AQUATENSEN;ENDURON;METHYCLOTHIAZIDE;NSC-110431,CHEMBL1577,BRD:BRD-A95340155-001-09-7;BRD:BRD-BRD-A95340155-001-09-7,rep_primary;rep_single_dose,CHLORIDE REABSORPTION INHIBITOR,CA1;CA2;CA4;SLC12A1;SLC12A3,"HYPERTENSION, EDEMA",,LAUNCHED,,Small molecule,4,CN1C(CCL)NC2CC(CL)C(CC2S1(=O)=O)S(N)(=O)=O;CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,CESYKOGBSMNBPD-UHFFFAOYSA-N
METHYL-AMINOLEVULINATE,METHYL-AMINOLEVULINATE,,BRD:BRD-K01292611-003-13-7,rep_single_dose,OXIDIZING AGENT,FCGR1A;FECH,,,,,,NA,,
METHYLATROPINE-NITRATE,METHYLATROPINE-NITRATE,,BRD:BRD-A52460047-001-01-3;BRD:BRD-BRD-A52460047-001-01-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,,,PRECLINICAL,,,NA,C[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)C1CCCCC1,
METHYLBENACTYZIUM-BROMIDE,METHYLBENACTYZIUM-BROMIDE,,BRD:BRD-K00003518-004-01-9,rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,,,,,,,NA,,
METHYLBENZETHONIUM-CHLORIDE,METHYLBENZETHONIUM-CHLORIDE,,BRD:BRD-K46531780-003-19-7,rep_single_dose,OTHER ANTIBIOTIC,,,,,,,NA,,
METHYLCOBALAMIN,MECOBALAMIN;METHYL B12;METHYLCOBALAMIN,CHEMBL2448537;CHEMBL4297672,BRD:BRD-K00003534-001-01-9,rep_single_dose,VITAMIN B,,,,,,Small molecule;Unknown,2,,
NSC-760080,.ALPHA.-METHYL-L-DOPA;(-)-.ALPHA.-METHYLDOPA;(S)-(-)-.ALPHA.-METHYLDOPA;ALDOMET;ALPHA-METHYLDOPA;ANHYDROUS;ANHYDROUS METHYLDOPA;BAYER-1440L;DOPAMET;J9.247I;L-.ALPHA.-METHYLDOPA;LEDERDOPA;MEDOMET;METALPHA 250;METALPHA 500;METHYLDOPA;METHYLDOPA (LEVOROTATORY);METHYLDOPA ANHYDROUS;METHYLDOPA HYDRATE;METHYLDOPA SESQUIHYDRATE;MK-351;NSC-169916;NSC-760080,CHEMBL459,BRD:BRD-BRD-K48578705-001-16-8;BRD:BRD-BRD-K48578705-001-17-6;BRD:BRD-K48578705-001-16-8;BRD:BRD-K48578705-001-17-6,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C;DDC,HYPERTENSION,,LAUNCHED,,Small molecule,4,"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O;C[C@](N)(CC1CCC(O)C(O)C1)C(O)=O, C[C@](N)(CC1CCC(O)C(O)C1)C(O)=O, C[C@](N)(CC1CCC(O)C(O)C1)C(O)=O, C[C@](N)(CC1CCC(O)C(O)C1)C(O)=O",CJCSPKMFHVPWAR-JTQLQIEISA-N
METHYLERGONOVINE,ERGOTYL;METHYLERGOMETRINE;METHYLERGONOVINE,CHEMBL1201356,BRD:BRD-BRD-K34685430-050-12-5;BRD:BRD-K34685430-050-12-5,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",DRD1;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C,"POSTPARTUM HEMORRHAGE (PPH), MIGRAINE HEADACHE",,LAUNCHED,,Small molecule,4,"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1;CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3C[NH]C4CCCC(C2=C1)C34, CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3C[NH]C4CCCC(C2=C1)C34",UNBRKDKAWYKMIV-QWQRMKEZSA-N
METHYLLYCANONITINE,METHYLLYCACONITINE;METHYLLYCANONITINE,CHEMBL510275,BRD:BRD-BRD-K43192255-048-03-6;BRD:BRD-K43192255-048-03-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRNA7,,,PRECLINICAL,,Small molecule,NA,"CCN1C[C@]2(COC(=O)c3ccccc3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@](O)([C@@H](OC)[C@H]23)[C@@H]14;CCN1C[C@]2(COC(=O)C3CCCCC3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@@](O)([C@@H](OC)[C@H]23)[C@@H]14, CCN1C[C@]2(COC(=O)C3CCCCC3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@@](O)([C@@H](OC)[C@H]23)[C@@H]14, CCN1C[C@]2(COC(=O)C3CCCCC3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@@](O)([C@@H](OC)[C@H]23)[C@@H]14",XLTANAWLDBYGFU-BVFBBISOSA-N
MRZ-2663,METHYLNALTREXONE;METHYLNALTREXONE CATION;METHYLNALTREXONE ION;MRZ-2663,CHEMBL1186579,BRD:BRD-BRD-K33732501-004-01-0;BRD:BRD-K33732501-004-01-0,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1,CONSTIPATION,,LAUNCHED,,Small molecule,4,C[N@@+]1(CC2CC2)CC[C@@]23[C@H]4OC5C2C(C[C@@H]1[C@@]3(O)CCC4=O)CCC5O;C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,JVLBPIPGETUEET-GAAHOAFPSA-O
TEGOSEPT M,E-218;E218;FEMA NO. 2710;INS NO.218;INS-218;KILLITOL;METHYL P-HYDROXYBENZOATE;METHYL P-OXYBENZOATE;METHYL PARABEN;METHYL PARABEN (E218);METHYL PARAHYDROXYBENZOATE;METHYLIS HYDROXYBENZOAS;METHYLPARABEN;METHYLPARABEN E218;MOLDEX;NSC-3827;NSC-406127;P-HYDROXYBENZOIC METHYL ESTER;PRESERVAL M;TEGOSEPT M,CHEMBL325372,BRD:BRD-K78321730-001-13-9,rep_single_dose,OTHER ANTIFUNGAL,,,,,,Small molecule,-1,COC(=O)c1ccc(O)cc1,LXCFILQKKLGQFO-UHFFFAOYSA-N
THREO-DL-METHYLPHENIDATE,CONCERTA;COTEMPLA XR-ODT;DAYTRANA;METHYLIN;METHYLPHENIDATE;METHYLPHENIDATE EXTENDED RELEASE;PRC-063;THREO-DL-METHYLPHENIDATE,CHEMBL796,BRD:BRD-A19585813-003-03-3;BRD:BRD-BRD-A19585813-003-03-3,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE-NOREPINEPHRINE REUPTAKE INHIBITOR,SLC6A2;SLC6A3;SLC6A4,"ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD), NARCOLEPSY",,LAUNCHED,,Small molecule,4,COC(=O)C(c1ccccc1)C1CCCCN1;COC(=O)C(C1CCCCN1)C1CCCCC1,DUGOZIWVEXMGBE-UHFFFAOYSA-N
URBASONE,"A-METHAPRED;J3.872E;MEDROL;MEDRONE;METHYLPREDNISOLONE;METHYLPREDNISOLONE 21-SUCCINATE SODIUM SALT;METHYLPREDNISOLONE SODIUM SUCCINATE;MIN-I-MIX;NSC-19987;NSC-48989;SOLU-MEDROL;SOLU-MEDRONE;U-67,590A;URBASONE",CHEMBL1201081;CHEMBL650,BRD:BRD-BRD-K35240538-001-26-2;BRD:BRD-K35240538-001-26-2,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,"HYPERCALCEMIA, THYROIDITIS, ANKYLOSING SPONDYLITIS, BURSITIS, OSTEOARTHRITIS, PSORIATIC ARTHRITIS, SEBORRHEIC DERMATITIS, MYCOSIS, ALLERGIC RHINITIS, PSORIASIS, ANEMIA, MULTIPLE SCLEROSIS, ULCERATIVE COLITIS, ENTERITIS",,LAUNCHED,,Small molecule,4,"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)[O-])[C@@]2(C)C=CC(=O)C=C12.[Na+];C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12, C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12, C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12",FQISKWAFAHGMGT-SGJOWKDISA-M
METHYLPREDNISOLONE-ACEPONATE,METHYLPREDNISOLONE-ACEPONATE,,BRD:BRD-BRD-K24452555-001-01-7;BRD:BRD-K24452555-001-01-7,rep_primary;rep_single_dose,"ANTI-INFLAMMATORY AGENT, GLUCOCORTICOID RECEPTOR AGONIST",NR3C1,"CONGENITAL ADRENAL HYPERPLASIA, THYROIDITIS, HYPERCALCEMIA, RHEUMATOID ARTHRITIS, BURSITIS, EPICONDYLITIS, ALLERGIC RHINITIS, ASTHMA, ULCERATIVE COLITIS, ENTERITIS, OSTEOARTHRITIS, PSORIASIS, MULTIPLE SCLEROSIS, ANEMIA",,LAUNCHED,,,NA,CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O,
METHYLPREDNISOLONE-SODIUM-SUCCINATE,METHYLPREDNISOLONE-SODIUM-SUCCINATE,,BRD:BRD-A45044890-236-02-3;BRD:BRD-BRD-A45044890-236-02-3,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,,"HYPERCALCEMIA, THYROIDITIS, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, SEBORRHEIC DERMATITIS, ASTHMA, ALLERGIC RHINITIS, SHINGLES, CONJUNCTIVITIS, ULCERATIVE COLITIS, ENTERITIS, ANEMIA, MULTIPLE SCLEROSIS, MYCOSIS",,LAUNCHED,,,NA,C[C@H]1CC2C3CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)C=CC(=O)C=C12,
METHYLSTAT,METHYLSTAT,,CTRP:667933,ctrp,,,,,,,,NA,,
THIMECIL,METHYLTHIOURACIL;NSC-193526;THIMECIL,CHEMBL1330588,BRD:BRD-BRD-K11900042-001-14-4;BRD:BRD-K11900042-001-14-4,rep_primary;rep_single_dose,,,HYPERTHYROIDISM,,LAUNCHED,,Small molecule,-1,"Cc1cc(=O)[nH]c(=S)[nH]1;CC1CC(=O)[NH]C(=S)[NH]1, CC1CC(=O)[NH]C(=S)[NH]1",HWGBHCRJGXAGEU-UHFFFAOYSA-N
SANSERT,DESERIL;METHYSERGIDE;SANSERT,CHEMBL1065;CHEMBL485253,BRD:BRD-K35941380-050-28-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR5A;HTR6;HTR7,,,,,Small molecule,NA,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,KPJZHOPZRAFDTN-ZRGWGRIASA-N
SD-17102,ARRESTEN;METICRANE;NSC-759309;SD 17102;SD-17102,CHEMBL1318341,BRD:BRD-BRD-K58265391-001-12-7;BRD:BRD-K58265391-001-12-7,rep_primary;rep_single_dose,DIURETIC,,EDEMA,,LAUNCHED,,Small molecule,-1,"Cc1cc2c(cc1S(N)(=O)=O)S(=O)(=O)CCC2;CC1CC2CCCS(=O)(=O)C2CC1S(N)(=O)=O, CC1CC2CCCS(=O)(=O)C2CC1S(N)(=O)=O",FNQQBFNIYODEMB-UHFFFAOYSA-N
VUAB6453 (SPOFA),"BETAMANN;BM-01.004;BM-01004;BM01.004;D,L-METIPRANOLOL;GLAULINE;METIPRANOLOL;METIPRANOLOL HCL;METIPRANOLOL HYDROCHLORIDE;OPTIPRANOLOL;VUAB-6453;VUAB6453;VUAB6453 (SPOFA)",CHEMBL1200947;CHEMBL1291,BRD:BRD-A99388803-001-01-5;BRD:BRD-BRD-A99388803-001-01-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,,,WITHDRAWN,,Small molecule,4,CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C;CC(C)NCC(O)COC1CC(C)C(OC(C)=O)C(C)C1C,BQIPXWYNLPYNHW-UHFFFAOYSA-N
RACEMETIROSINE,(S)-;DEMSER;L-588357-0;METIROSINE;METYROSINE;MK-781;RACEMETIROSINE,CHEMBL1200862,BRD:BRD-BRD-K83766205-001-03-8;BRD:BRD-K83766205-001-03-8,rep_primary;rep_single_dose,TYROSINE HYDROXYLASE INHIBITOR,TH,HYPERTENSION,,LAUNCHED,,Small molecule,4,C[C@](N)(Cc1ccc(O)cc1)C(=O)O;C[C@](N)(CC1CCC(O)CC1)C(O)=O,NHTGHBARYWONDQ-JTQLQIEISA-N
RO-8-6837,METHIOTEPIN;METHIOTHEPIN;METHIOTHEPINE;METITEPINE;NSC-759875;RO 8-6837;RO-8-6837,CHEMBL93240,BRD:BRD-A07932845-050-15-8;BRD:BRD-BRD-A07932845-050-15-8,rep_primary;rep_single_dose,ANTI-HCVE2,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR5A;HTR6;HTR7,,,PRECLINICAL,,Small molecule,-1,"CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2;CSC1CCC2SC3CCCCC3CC(N3CCN(C)CC3)C2C1, CSC1CCC2SC3CCCCC3CC(N3CCN(C)CC3)C2C1, CSC1CCC2SC3CCCCC3CC(N3CCN(C)CC3)C2C1",RLJFTICUTYVZDG-UHFFFAOYSA-N
METIXENE,ATOSIL;METHIXENE;METIXENE,CHEMBL1201342,BRD:BRD-A33711280-003-03-1;BRD:BRD-BRD-A33711280-003-03-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,CN1CCCC(CC2C3CCCCC3SC3CCCCC23)C1;CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1,MJFJKKXQDNNUJF-UHFFFAOYSA-N
TERPERAN,CLOPRA;CLOPRA-'YELLOW';ELIETEN;MAXOLON;METHOXYCLOPRAMIDE;METOCLOPRAMIDE;REGLAN;TERPERAN,CHEMBL86,BRD:BRD-BRD-K75641298-003-25-0;BRD:BRD-K75641298-003-25-0,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",CHRM1;DRD2;HTR3A;HTR3B;HTR4,"GASTROPARESIS, NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC;CCN(CC)CCNC(=O)C1CC(CL)C(N)CC1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N
METOCURINE ION,DIMETHYL TUBOCURARINE;DIMETHYLTUBOCURARINE;DIMETHYLTUBOCURARINIUM;METOCURINE;METOCURINE CATION;METOCURINE ION,CHEMBL1259,BRD:BRD-BRD-K16484091-001-01-1;BRD:BRD-K16484091-001-01-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM2;CHRNA2,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,4,COC1CCC2C[C@@H]3C4C(CC[N+]3(C)C)CC(OC)C(OC)C4OC3CCC(C[C@H]4C5CC(OC1C2)C(OC)CC5CC[N+]4(C)C)CC3;COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3,JFXBEKISTKFVAB-AJQTZOPKSA-N
ZAROXOLYN,DIULO;METAZOLINE;METENIX;METOLAZONE;METOZALONE;MYKROX;NORMELAN;NSC-759581;OLDREN;SR 720-22;SR-720-22;XURET;ZAROXOLYN,CHEMBL878,BRD:BRD-A61793559-001-15-6;BRD:BRD-BRD-A61793559-001-15-6,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,SLC12A3,"EDEMA, HYPERTENSION",,LAUNCHED,,Small molecule,4,"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C;CC1NC2CC(CL)C(CC2C(=O)N1C1CCCCC1C)S(N)(=O)=O, CC1NC2CC(CL)C(CC2C(=O)N1C1CCCCC1C)S(N)(=O)=O, CC1NC2CC(CL)C(CC2C(=O)N1C1CCCCC1C)S(N)(=O)=O",AQCHWTWZEMGIFD-UHFFFAOYSA-N
TCMDC-123931,METOPRINE;NSC-19494;NSC-7364;TCMDC-123931,CHEMBL264373,BRD:BRD-K77185060-001-08-9,rep_single_dose,,,,,,,Small molecule,-1,Cc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1,VQJHOPSWBGJHQS-UHFFFAOYSA-N
TOPROL-XL,(RS)-METOPROLOL;BEATROLOL;CGP-2175;DL-METOPROLOL;LOPRESSIDONE;METOPROLOL;METOPROLOL SLOW RELEASE;SEROKEN;TOPROL-XL,CHEMBL13,BRD:BRD-A03623303-045-09-5;BRD:BRD-BRD-A03623303-045-09-5,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,"HYPERTENSION, ANGINA PECTORIS, MYOCARDIAL INFARCTION",,LAUNCHED,,Small molecule,4,"COCCc1ccc(OCC(O)CNC(C)C)cc1;COCCC1CCC(OCC(O)CNC(C)C)CC1, COCCC1CCC(OCC(O)CNC(C)C)CC1, COCCC1CCC(OCC(O)CNC(C)C)CC1",IUBSYMUCCVWXPE-UHFFFAOYSA-N
METOXIBUTROPATE,METOXIBUTROPATE,,BRD:BRD-A71725768-001-01-3;BRD:BRD-BRD-A71725768-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,LAUNCHED,,,NA,COC1CCCCC1OC(=O)C(C)C1CCC(CC(C)C)CC1,
WIN-39103,AMIPAQUE;METRIZAMIDE;TELEBRIX 300;WIN 39103;WIN-39103,CHEMBL1200889;CHEMBL462394,BRD:BRD-A45543382-001-10-0;BRD:BRD-BRD-A45543382-001-10-0,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,CONTRAST AGENT,,LAUNCHED,,Small molecule,4,CC(=O)Nc1c(I)c(C(=O)N[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]2O)c(I)c(N(C)C(C)=O)c1I;CC(=O)Nc1c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c(I)c(N(C)C(C)=O)c1I;CN(C(C)=O)C1C(I)C(NC(C)=O)C(I)C(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)C1I,BAQCROVBDNBEEB-KSDLJXBFSA-N;BAQCROVBDNBEEB-UBYUBLNFSA-N
METRIZOIC-ACID,METRIZOIC-ACID,,BRD:BRD-BRD-K99241550-001-03-5;BRD:BRD-K99241550-001-03-5,rep_primary;rep_single_dose,RADIOPAQUE MEDIUM,,CONTRAST AGENT,,LAUNCHED,,,NA,"CN(C(C)=O)C1C(I)C(NC(C)=O)C(I)C(C(O)=O)C1I, CN(C(C)=O)C1C(I)C(NC(C)=O)C(I)C(C(O)=O)C1I",
ZYOMET,ACEA;ANABACT;BAY-5360;BAYER 5360;BAYER-5360;DEFLAMON;DRAZIFON;ELYZOL;FLAGYL;FLAGYL 375;FLAGYL COMPAK;FLAGYL ER;FLAGYL I.V. RTU IN PLASTIC CONTAINER;FLAGYL-400;FLAGYL-S;GINEFLAVIR;METRIC 21;METRO I.V.;METROCREAM;METROGEL;METROGEL-VAGINAL;METROLOTION;METROLYL;METROMIDOL;METRONIDAZOLE;METROSA;METROTOP;NEUTRATOP;NORITATE;NORZOL;NSC-50364;NSC-69587;NUVESSA;ORVAGIL;PROTOSTAT;ROSICED;ROZEX;RP 8823;RP-8823;SATRIC;VAGINYL;VANDAZOLE;ZADSTAT;ZIDOVAL;ZYOMET,CHEMBL137,BRD:BRD-BRD-K52020312-001-26-8;BRD:BRD-K52020312-001-26-8,rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,CYP2C9;CYP3A4,ROSACEA,,LAUNCHED,,Small molecule,4,"Cc1ncc([N+](=O)[O-])n1CCO;CC1NCC(N1CCO)[N+]([O-])=O, CC1NCC(N1CCO)[N+]([O-])=O",VAOCPAMSLUNLGC-UHFFFAOYSA-N
NSC-25265,METOPIRON;METOPIRONE;METYRAPONE;NSC-25265,CHEMBL934,BRD:BRD-BRD-K46862739-001-14-3;BRD:BRD-K46862739-001-14-3,rep_multi_dose;rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP11B1,ADRENAL DIAGNOSTIC AGENT,,LAUNCHED,,Small molecule,4,"CC(C)(C(=O)c1cccnc1)c1cccnc1;CC(C)(C(=O)C1CCCNC1)C1CCCNC1, CC(C)(C(=O)C1CCCNC1)C1CCCNC1, CC(C)(C(=O)C1CCCNC1)C1CCCNC1",FJLBFSROUSIWMA-UHFFFAOYSA-N
NSC-759322,MEVASTATIN;NSC-759322,CHEMBL54440,BRD:BRD-BRD-K94441233-001-13-0;BRD:BRD-BRD-K94441233-001-17-1;BRD:BRD-K94441233-001-13-0;BRD:BRD-K94441233-001-17-1,rep_multi_dose;rep_primary;rep_single_dose,HMGCR INHIBITOR,HMGCR,,,PRECLINICAL,,Small molecule,-1,"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12;CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21",AJLFOPYRIVGYMJ-INTXDZFKSA-N
MEXENEONE,MEXENEONE,,BRD:BRD-BRD-K18613660-001-05-5;BRD:BRD-K18613660-001-05-5,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC1CCC(C(=O)C2CCC(C)CC2)C(O)C1,
MEXILETINE,(RS)-MEXILETINE;DL-MEXILETINE;MEXILETINE,CHEMBL558,BRD:BRD-A64092382-003-18-3;BRD:BRD-BRD-A64092382-003-18-3,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,AHR;PLAU;SCN4A;SCN5A,"VENTRICULAR ARRHYTHMIAS, VENTRICULAR TACHYCARDIA (VT)",,LAUNCHED,"Multiple values for repurposing_target: {'AHR;PLAU;SCN4A;SCN5A', 'AHR;SCN4A;SCN5A'}, taking the union",Small molecule,4,"CC(N)COC1C(C)CCCC1C, CC(N)COC1C(C)CCCC1C, CC(N)COC1C(C)CCCC1C, CC(N)COC1C(C)CCCC1C;Cc1cccc(C)c1OCC(C)N",VLPIATFUUWWMKC-UHFFFAOYSA-N
MULTOCILLIN,BAY-F-1353;BAYPEN;MEZLOCILLIN;MULTOCILLIN,CHEMBL1731,BRD:BRD-BRD-K45114938-236-01-8;BRD:BRD-K45114938-236-01-8,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"GRAM-NEGATIVE BACTERIAL INFECTIONS, GRAM-POSITIVE BACTERIAL INFECTIONS",,LAUNCHED,,Small molecule,4,"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O;CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCN(C3=O)S(C)(=O)=O)C3CCCCC3)C(=O)N2[C@@H]1C(O)=O, CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCN(C3=O)S(C)(=O)=O)C3CCCCC3)C(=O)N2[C@@H]1C(O)=O",YPBATNHYBCGSSN-VWPFQQQWSA-N
MF-094,MF-094,,BRD:BRD-K00126474-001-01-9,oncref_2,INHIBITOR OF USP30,USP30,,,,,,NA,,
MF-101,MF-101,,BRD:BRD-BRD-K34328244-001-01-4;BRD:BRD-K34328244-001-01-4,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,CYP19A1;XDH,,,PHASE 3,,,NA,OC1CCC(CC1)[C@@H]1CC(=O)C2CCC(O)CC2O1,
MG-132,MG-132,CHEMBL64925,BRD:BRD-BRD-K60230970-001-14-2;BRD:BRD-BRD-K60230970-001-17-5;BRD:BRD-K60230970-001-17-5;CTRP:58948;GDSC1:9,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,PROTEASOME INHIBITOR,PSMB1,,,PRECLINICAL,,Protein,NA,"CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1;CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1CCCCC1)C=O, CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1CCCCC1)C=O, CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1CCCCC1)C=O",TZYWCYJVHRLUCT-VABKMULXSA-N
STILONIUM IODIDE,ELVETIL;M.G. 624;MG-624;STILONIUM IODIDE,CHEMBL1257065,BRD:BRD-K03128577-005-08-9,rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRNA7,,,,,Small molecule,-1,CC[N+](CC)(CC)CCOc1ccc(/C=C/c2ccccc2)cc1.[I-],RDTKUZXIHMTSJO-UEIGIMKUSA-M
MG132,LLL CPD;MG 132;MG132,,GDSC1:9,gdsc,,,,,,,,NA,,
MGCD265,GLESATINIB;MG-90265;MG-90265X;MG90265;MG90265GLY;MG90265H9;MG90265X;MGCD-265;MGCD265,CHEMBL3989914,BRD:BRD-BRD-K56277358-001-07-5;BRD:BRD-K56277358-001-07-5;CTRP:628622,ctrp;rep_multi_dose;rep_primary;rep_single_dose,VEGFR INHIBITOR,AXL;MET,,,PRECLINICAL,,Small molecule,2,CN1CNC(C1)-C1CC2NCCC(OC3CCC(NC(=S)NC(=O)CC4CCCCC4)CC3F)C2S1;COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1,YRCHYHRCBXNYNU-UHFFFAOYSA-N
MHP,MHP,,BRD:BRD-K00074484-001-02-9,rep_single_dose,,,,,,,,NA,,
MHY1485,MHY1485,,BRD:BRD-K26797311-001-07-9,oncref_2,"MTOR ACTIVATOR, AUTOPHAGY INHIBITOR",MTOR,,,,,,NA,,
MI-1,MI-1,,CTRP:185987,ctrp,,,,,,,,NA,,
MI-14,MI-14,,BRD:BRD-K26726854-001-02-9,rep_single_dose,PI4K INHIBITOR,PI4KB,,,,,,NA,,
MI-2,MI-2,,CTRP:687714,ctrp,,,,,,,,NA,,
TOLVON,J16.389I;MIANSERIN;TOLVON,CHEMBL6437,BRD:BRD-A19661776-003-27-6;BRD:BRD-BRD-A19661776-003-27-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;DRD1;DRD2;DRD3;DRD5;HRH1;HRH2;HRH4;HTR1A;HTR1F;HTR2A;HTR2B;HTR2C;HTR6;HTR7;OPRK1;SLC6A2;SLC6A3;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"CN1CCN2C(C1)C1CCCCC1CC1CCCCC21, CN1CCN2C(C1)C1CCCCC1CC1CCCCC21, CN1CCN2C(C1)C1CCCCC1CC1CCCCC21, CN1CCN2C(C1)C1CCCCC1CC1CCCCC21;CN1CCN2c3ccccc3Cc3ccccc3C2C1",UEQUQVLFIPOEMF-UHFFFAOYSA-N
MIBAMPATOR,LY 451395;LY-451395;LY451395;MIBAMPATOR,CHEMBL1277001,BRD:BRD-BRD-K42981054-001-01-9;BRD:BRD-K42981054-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,GRIA1,,,PHASE 2,,Small molecule,2,CC(C)S(=O)(=O)NC[C@H](C)c1ccc(-c2ccc(CCNS(C)(=O)=O)cc2)cc1;CC(C)S(=O)(=O)NC[C@H](C)C1CCC(CC1)-C1CCC(CCNS(C)(=O)=O)CC1,ULRDYYKSPCRXAJ-KRWDZBQOSA-N
POSICOR 50,MIBEFRADIL;POSICOR;POSICOR 100;POSICOR 50,CHEMBL45816,BRD:BRD-BRD-K09549677-300-03-4;BRD:BRD-K09549677-300-03-4,rep_multi_dose;rep_primary;rep_single_dose,T-TYPE CALCIUM CHANNEL BLOCKER,ANO1;CACNA1C;CACNA1D;CACNA1F;CACNA1G;CACNA1H;CACNA1I;CACNA1S;CACNB1;CACNB2;CACNB3;CACNB4;CATSPER1;CATSPER2;CATSPER3;CATSPER4,,,WITHDRAWN,,Small molecule,4,"COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C;COCC(=O)O[C@]1(CCN(C)CCCC2NC3CCCCC3[NH]2)CCC2CC(F)CCC2[C@@H]1C(C)C, COCC(=O)O[C@]1(CCN(C)CCCC2NC3CCCCC3[NH]2)CCC2CC(F)CCC2[C@@H]1C(C)C",HBNPJJILLOYFJU-VMPREFPWSA-N
MYCAMINE,MICAFUNGIN;MYCAMINE,CHEMBL457547,BRD:BRD-K40407248-001-04-9,rep_single_dose,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",,,,,,Small molecule,4,CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1,PIEUQSKUWLMALL-YABMTYFHSA-N
VUSION,CONOFITE;DERMAZOLE;DUMICOAT;LORAMYC;MICATIN;MICONAZOLE;MONISTAT;MONISTAT-3;MONISTAT-DERM;NSC-170986;ORAVIG;VUSION,CHEMBL91,BRD:BRD-A82396632-008-29-0;BRD:BRD-BRD-A82396632-008-29-0,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,KCNH2;KCNH6;KCNH7;KCNMA1;KCNMB1;KCNMB2;KCNMB3;KCNMB4;KCNN1;KCNN2;KCNN3;KCNN4;NOS2;NOS3;TRPM2;TRPV5,"YEAST INFECTION, ITCHING",,LAUNCHED,,Small molecule,4,"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1;CLC1CCC(COC(CN2CCNC2)C2CCC(CL)CC2CL)C(CL)C1, CLC1CCC(COC(CN2CCNC2)C2CCC(CL)CC2CL)C(CL)C1, CLC1CCC(COC(CN2CCNC2)C2CCC(CL)CC2CL)C(CL)C1, CLC1CCC(COC(CN2CCNC2)C2CCC(CL)CC2CL)C(CL)C1",BYBLEWFAAKGYCD-UHFFFAOYSA-N
SDZ-EAA-494,MIDAFOTEL;SDZ EAA 494;SDZ-EAA-494,CHEMBL90564,BRD:BRD-BRD-K45163704-001-01-5;BRD:BRD-K45163704-001-01-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,PHASE 3,,Small molecule,-1,"O=C(O)[C@H]1CN(C/C=C/P(=O)(O)O)CCN1;OC(=O)[C@H]1CN(C\C=C\P(O)(O)=O)CCN1, OC(=O)[C@H]1CN(C\C=C\P(O)(O)=O)CCN1",VZXMZMJSGLFKQI-ABVWVHJUSA-N
ST-1085,MIDODRINE;ST 1085;ST-1085,CHEMBL1201212,BRD:BRD-A79981887-003-16-4;BRD:BRD-BRD-A79981887-003-16-4,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D,HYPOTENSION,,LAUNCHED,,Small molecule,4,COc1ccc(OC)c(C(O)CNC(=O)CN)c1;COC1CCC(OC)C(C1)C(O)CNC(=O)CN,PTKSEFOSCHHMPD-UHFFFAOYSA-N
RYDAPT,CGP 41251;CGP-41251;MIDOSTAURIN;NSC-656576;NVP-PKC412;PKC 412;PKC-412;RYDAPT,CHEMBL608533,BRD:BRD-BRD-K13646352-001-03-8;BRD:BRD-K13646352-001-03-8;GDSC1:153,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"FLT3 INHIBITOR, KIT INHIBITOR, PKC INHIBITOR",FLT3;PRKCG,ACUTE MYELOID LEUKEMIA (AML),,LAUNCHED,,Small molecule,4,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3CCCCC3C3C4CNC(=O)C4C4C5CCCCC5N2C4C13)N(C)C(=O)C1CCCCC1;CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,BMGQWWVMWDBQGC-IIFHNQTCSA-N
RU486,KORLYM;MIFEGYNE;MIFEPREX;MIFEPRISTONE;NSC-759862;RU 38486;RU 486;RU-38486;RU-486;RU486,CHEMBL1276308,BRD:BRD-BRD-K37270826-001-27-6;BRD:BRD-BRD-K37270826-001-31-8;BRD:BRD-K37270826-001-27-6;BRD:BRD-K37270826-001-31-8,rep_multi_dose;rep_primary;rep_single_dose,"GLUCOCORTICOID RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR ANTAGONIST",AR;NR1I2;NR3C1;PGR,"HYPERGLYCEMIA, DIABETES MELLITUS",,LAUNCHED,,Small molecule,4,"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C;CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1CCC(CC1)N(C)C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1CCC(CC1)N(C)C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1CCC(CC1)N(C)C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1CCC(CC1)N(C)C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1CCC(CC1)N(C)C",VKHAHZOOUSRJNA-GCNJZUOMSA-N
SR-202,CLANICLOR;CLENICOR;MIFOBATE;SR-202,CHEMBL284768,BRD:BRD-A72066420-001-04-5;BRD:BRD-BRD-A72066420-001-04-5,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PPARG,,,PHASE 2,,Small molecule,-1,COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC;COP(=O)(OC)OC(C1CCC(CL)CC1)P(=O)(OC)OC,VQHUQHAPWMNBLP-UHFFFAOYSA-N
NSC-758702,BAY M 1099;BAY-M-1099;DIASTABOL;GLYSET;MIGLITOL;NSC-758702,CHEMBL1561,BRD:BRD-A63310107-001-04-8;BRD:BRD-BRD-A63310107-001-04-8,rep_primary;rep_single_dose,GLUCOSIDASE INHIBITOR,GAA;GANAB;GANC;MGAM,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO;OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO, OCCN1C[C@@H](O)[C@@H](O)C(O)C1CO, OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO",IBAQFPQHRJAVAV-ULAWRXDQSA-N
ZAVESCA,BUTYLDEOXYNOJIRIMYCIN;MIGLUSTAT;N-BUTYLDEOXYNOJIRIMYCIN;OGT 918;OGT-918;ZAVESCA,CHEMBL1029,BRD:BRD-BRD-K33251802-001-01-3;BRD:BRD-K33251802-001-01-3,rep_primary;rep_single_dose,GLYCOSYL TRANSFERASE INHIBITOR,UGCG,GAUCHER DISEASE,,LAUNCHED,,Small molecule,4,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,UQRORFVVSGFNRO-UTINFBMNSA-N
S64315,MIK-665;MIK665;S 64315;S-64315;S64315,CHEMBL4298096,BRD:BRD-K00005263-001-02-9,rep_single_dose,,,,,,,Unknown,1,,
MILACEMIDE,MILACEMIDE,CHEMBL75838,BRD:BRD-BRD-K64338723-001-01-6;BRD:BRD-K64338723-001-01-6,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOB,,,PHASE 3,,Small molecule,-1,CCCCCNCC(N)=O,GJNNXIYZWIZFRH-UHFFFAOYSA-N
MILADEMETAN,DS-3032;MDM2 INHIBITOR DS-3032;MILADEMETAN,CHEMBL4292264,BRD:BRD-K00003406-001-01-9,rep_single_dose,MDM INHIBITOR,,,,,,Small molecule,1,CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21,RYAYYVTWKAOAJF-QISPRATLSA-N
MILNACIPRAN,"(1S,2R)-;(1S,2R)-MILNACIPRAN;F 2695;F-2695;F2695;FETZIMA;IMPULSOR;LEVOMILNACIPRAN;MIDALCIPRAN;MILNACIPRAN",CHEMBL259209;CHEMBL99946,BRD:BRD-A15202882-003-02-7;BRD:BRD-BRD-A15202882-003-02-7,rep_primary;rep_single_dose,SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B;SLC6A2;SLC6A4,FIBROMYALGIA,,LAUNCHED,,Small molecule,4,"CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN;CCN(CC)C(=O)C1(c2ccccc2)CC1CN;CCN(CC)C(=O)C1(CC1CN)C1CCCCC1, CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C1CCCCC1",GJJFMKBJSRMPLA-DZGCQCFKSA-N;GJJFMKBJSRMPLA-UHFFFAOYSA-N
WIN-47203-2,"MILRILA;MILRINONE;NSC-760072;PRIMACOR;WIN 47,203-2;WIN-47203-2",CHEMBL189,BRD:BRD-BRD-K67080878-001-15-4;BRD:BRD-K67080878-001-15-4,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE2A;PDE3A;PDE3B;PDE5A,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,4,"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1;CC1[NH]C(=O)C(CC1-C1CCNCC1)C#N, CC1[NH]C(=O)C(CC1-C1CCNCC1)C#N",PZRHRDRVRGEVNW-UHFFFAOYSA-N
NSC-758968,D-18506;HDPC;IMPAVIDO;MILTEFOSINE;MILTEX;NSC-605583;NSC-758968,CHEMBL125,BRD:BRD-A31811760-001-06-7;BRD:BRD-BRD-A31811760-001-06-7,rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,PLA2G1B,LEISHMANIASIS,,LAUNCHED,,Small molecule,4,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C;CCCCCCCCCCCCCCCCOP(O)(=O)OCC[N+](C)(C)C,PQLXHQMOHUQAKB-UHFFFAOYSA-N
MIM-1,MIM 1;MIM-1,,GDSC2:1996,gdsc,,,,,,,,NA,,
MIM1,MIM1,,GDSC1:446;GDSC2:1996,gdsc,,,,,,,,NA,,
MINAPRINE,AGR-1240;BRANTUR;CANTOR;CB-30038;MINAPRINE,CHEMBL278819,BRD:BRD-BRD-K02867583-300-08-9;BRD:BRD-K02867583-300-08-9,rep_primary;rep_single_dose,SEROTONIN REUPTAKE INHIBITOR,ACHE;CHRM1;DRD1;DRD2;HTR2A;HTR2B;HTR2C;MAOA;SLC6A4,,,WITHDRAWN,,Small molecule,4,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1;CC1CC(NNC1NCCN1CCOCC1)-C1CCCCC1,LDMWSLGGVTVJPG-UHFFFAOYSA-N
SML0256,2-HYDROXYOLEIC ACID;2-OHOA;IDROXIOLEIC ACID;MINERVAL;NFX-88;NFX88;SML-0256;SML0256,CHEMBL4594452,BRD:BRD-A74347210-001-01-7;BRD:BRD-BRD-A74347210-001-01-7,rep_primary;rep_single_dose,FAAH INHIBITOR,,,,PHASE 1/PHASE 2,,Small molecule,2,CCCCCCCC\C=C/CCCCCCC(O)C(O)=O;CCCCCCCCC=CCCCCCCC(O)C(=O)O,JBSOOFITVPOOSY-UHFFFAOYSA-N
MINOCYCLINE,MINOCYCLINE,CHEMBL1434,BRD:BRD-A69651145-003-07-2;BRD:BRD-BRD-A69651145-003-07-2;BRD:BRD-K00003346-003-01-9,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,ALOX5;CASP1;CASP3;CYCS;IL1B;MMP9;VEGFA,"FEVER, RESPIRATORY TRACT INFECTIONS, PSITTACOSIS, TRACHOMA, CONJUNCTIVITIS, URETHRITIS, CHANCROID, TULAREMIA, CHOLERA, BRUCELLOSIS",,LAUNCHED,"Multiple values for structure_id: {'K00003346', 'A69651145'}, defaulting to None",Small molecule,4,"CN(C)[C@H]1[C@@H]2C[C@@H]3CC4C(CCC(O)C4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3CC4C(CCC(O)C4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3CC4C(CCC(O)C4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3CC4C(CCC(O)C4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3CC4C(CCC(O)C4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C;CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O",DYKFCLLONBREIL-KVUCHLLUSA-N
WOMEN'S ROGAINE,"ALOPEXIL;ALOSTIL;LONITEN;LONOLOX;MEN'S ROGAINE;MINODYL;MINOXIDIL;MINOXIDIL (FOR MEN);MINOXIDIL (FOR WOMEN);MINOXIDIL EXTRA STRENGTH (FOR MEN);MINOXIMEN;MINTOP;NORMOXIDIL;NSC-757106;PIERMINOX;PREXIDIL;REGAINE FOR MEN;REGAINE FOR WOMEN;ROGAINE;ROGAINE (FOR MEN);ROGAINE (FOR WOMEN);ROGAINE EXTRA STRENGTH (FOR MEN);THEROXIDIL;TRICOXIDIL;U-10,858;U-10858;WOMEN'S ROGAINE",CHEMBL802,BRD:BRD-BRD-K06902185-003-01-7;BRD:BRD-K06902185-003-01-7,rep_primary;rep_single_dose,"KATP ACTIVATOR, KIR6 CHANNEL (KATP) ACTIVATOR, VASODILATOR",ABCC9;KCNJ1;KCNJ10;KCNJ11;KCNJ8;PTGS1,ANDROGENETIC ALOPECIA,,LAUNCHED,,Small molecule,4,"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-];NC1CC(NC(N)[N+]1[O-])N1CCCCC1, NC1CC(NC(N)[N+]1[O-])N1CCCCC1, NC1CC(NC(N)[N+]1[O-])N1CCCCC1, NC1CC(NC(N)[N+]1[O-])N1CCCCC1, NC1CC(NC(N)[N+]1[O-])N1CCCCC1",ZFMITUMMTDLWHR-UHFFFAOYSA-N
PONSINOMYCIN,"3'',9-DIACETYLMYDECAMYCIN;9,3''-DI-O-ACETYLMIDECAMYCIN;ACECAMYCIN;MIDECAMYCIN ACETATE;MIDECAMYCIN DIACETATE;MIOCAMYCIN;MIOKAMYCIN;PONSINOMYCIN",CHEMBL1091024,BRD:BRD-BRD-K30764557-001-01-5;BRD:BRD-K30764557-001-01-5,rep_primary;rep_single_dose,OTHER ANTIBIOTIC,,"URINARY TRACT INFECTIONS, CHLAMYDIA",,LAUNCHED,,Small molecule,-1,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(C)=O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC;CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(C)=O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](OC(C)=O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C,GQNZGCARKRHPOH-RQIKCTSVSA-N
YM178,BETANIS;BETMIGA;MIRABEGRON;MYRBETRIQ;MYRBETRIQ GRANULES;YM-178;YM178,CHEMBL2095212,BRD:BRD-BRD-K47949423-001-03-1;BRD:BRD-K47949423-001-03-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1;ADRB2;ADRB3,URINARY INCONTINENCE,,LAUNCHED,,Small molecule,4,"Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1;NC1NC(CC(=O)NC2CCC(CCNC[C@H](O)C3CCCCC3)CC2)CS1, NC1NC(CC(=O)NC2CCC(CCNC[C@H](O)C3CCCCC3)CC2)CS1",PBAPPPCECJKMCM-IBGZPJMESA-N
RO-638695,CPHPC;GSK-2315698;GSK2315698;MIRIDESAP;RO 63-8695;RO-638695,CHEMBL25263,BRD:BRD-K00003434-001-01-9,rep_single_dose,AMYLOID PROTEIN INHIBITOR,,,,,,Small molecule,2,O=C(O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O,HZLAWYIBLZNRFZ-VXGBXAGGSA-N
MIRIN,MIRIN,CHEMBL570841,BRD:BRD-K55420858-001-01-0;GDSC1:1048;GDSC2:1048,gdsc;rep_single_dose,MRE11A EXONUCLEASE INHIBITOR,MRE11A,,,,,Small molecule,NA,N=C1NC(=O)/C(=C/c2ccc(O)cc2)S1,YBHQCJILTOVLHD-YVMONPNESA-N
SK3530 FREE BASE,MIRODENAFIL;SK-3530 FREE BASE;SK3530 FREE BASE,CHEMBL4297518,BRD:BRD-BRD-K82967685-300-01-2;BRD:BRD-K82967685-300-01-2,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A,ERECTILE DYSFUNCTION,,LAUNCHED,,Small molecule,1,CCCOC1CCC(CC1-C1NC2C(CCC)CN(CC)C2C(=O)[NH]1)S(=O)(=O)N1CCN(CCO)CC1;CCCOc1ccc(S(=O)(=O)N2CCN(CCO)CC2)cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1,MIJFNYMSCFYZNY-UHFFFAOYSA-N
MIROGABALIN-BESYLATE,MIROGABALIN-BESYLATE,,BRD:BRD-K00003484-074-01-9,rep_single_dose,CALCIUM CHANNEL ANTAGONIST,,,,,,,NA,,
ZISPIN,(S)-;(S)-6-AZAMIANSERIN;(S)-MIRTAZAPINE;(S)-ORG 3770;6-AZAMIANSERIN;AVANZA;ESMIRTAZAPINE;MIRATAZ;MIRTAZAPIN;MIRTAZAPINE;MIRTAZAPINE ANHYDROUS;NORSET;ORG 3770;ORG-3770;ORG-44-20;PROMYRTIL;REMERON;REMERON SOLTAB;REXER;ZISPIN,CHEMBL1366933;CHEMBL654,BRD:BRD-A64977602-001-15-9;BRD:BRD-BRD-A64977602-001-15-9,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;DRD1;DRD2;DRD3;DRD5;HRH1;HRH3;HTR2A;HTR2B;HTR2C;HTR3A;HTR7;OPRK1;SLC6A2;SLC6A3;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"CN1CCN2C(C1)C1CCCCC1CC1CCCNC21, CN1CCN2C(C1)C1CCCCC1CC1CCCNC21, CN1CCN2C(C1)C1CCCCC1CC1CCCNC21, CN1CCN2C(C1)C1CCCCC1CC1CCCNC21;CN1CCN2c3ncccc3Cc3ccccc3C2C1",RONZAEMNMFQXRA-UHFFFAOYSA-N
RO-70582,"MISONIDAZOLE;NSC-261,037;NSC-261037;RO 07-0582;RO 7-0582;RO-07-0582;RO-7-0582;RO-70582",CHEMBL42161,BRD:BRD-A16263897-001-06-6;BRD:BRD-BRD-A16263897-001-06-6,rep_primary;rep_single_dose,,,,,PHASE 3,,Small molecule,2,COCC(O)CN1CCNC1[N+]([O-])=O;COCC(O)Cn1ccnc1[N+](=O)[O-],OBBCSXFCDPPXOL-UHFFFAOYSA-N
TOPOGYNE,CYTOTEC;MISOPROSTOL;MYSODELLE;SC-29333;TOPOGYNE,CHEMBL606,BRD:BRD-A72351335-001-04-5;BRD:BRD-BRD-A72351335-001-04-5,rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,PTGER2;PTGER3;PTGER4;PTGIR,DUODENAL ULCER DISEASE,,LAUNCHED,,Small molecule,4,CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC;CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N
PKR-IN-1,AG-348;MITAPIVAT;PKR-IN-1,CHEMBL4299940,BRD:BRD-K00003136-001-01-9,rep_single_dose,PYRUVATE KINASE ISOZYME ACTIVATOR,,,,,,Small molecule,4,O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(CC2CC2)CC1,XAYGBKHKBBXDAK-UHFFFAOYSA-N
MITIGLINIDE,MITIGLINIDE,CHEMBL471498,BRD:BRD-BRD-K52959329-238-01-9;BRD:BRD-K52959329-238-01-9,rep_primary;rep_single_dose,INSULIN SECRETAGOGUE,ABCC8;KCNJ10;PPARG,DIABETES MELLITUS,,LAUNCHED,,Small molecule,3,O=C(O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1;OC(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)CC1CCCCC1,WPGGHFDDFPHPOB-BBWFWOEESA-N
NSC-347512,MITOFLAXONE;NSC-347512,CHEMBL443793,BRD:BRD-BRD-K35882976-001-04-7;BRD:BRD-K35882976-001-04-7,rep_primary;rep_single_dose,ANTITUMOR AGENT,VWF,,,PHASE 2,,Small molecule,-1,O=C(O)Cc1cccc2c(=O)cc(-c3ccccc3)oc12;OC(=O)CC1CCCC2C1OC(CC2=O)-C1CCCCC1,TZZNWMJZDWYJAZ-UHFFFAOYSA-N
UGN-102,AMETYCINE;JELMYTO;MITOCIN-C;MITOMYCIN;MITOMYCIN C;MITOMYCIN-C;MITOSOL;MITOZYTREX;MUAMYCIN;MUTAMYCIN;MYTOZYTREX;NSC-26980;UGN-101;UGN-102,CHEMBL105,CTRP:50732,ctrp,,,,,,,Small molecule,4,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,NWIBSHFKIJFRCO-WUDYKRTCSA-N
UGN-102,AMETYCINE;JELMYTO;MITOCIN-C;MITOMYCIN;MITOMYCIN C;MITOMYCIN-C;MITOSOL;MITOZYTREX;MUAMYCIN;MUTAMYCIN;MYTOZYTREX;NSC-26980;UGN-101;UGN-102,CHEMBL105,BRD:BRD-A48237631-001-04-8;BRD:BRD-BRD-A48237631-001-04-8;GDSC1:136,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"DNA ALKYLATING AGENT, DNA SYNTHESIS INHIBITOR",,"PANCREATIC CANCER, GASTRIC ADENOCARCINOMA",,LAUNCHED,,Small molecule,4,CO[C@@]12[C@@H]3NC3CN1C1=C([C@@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O;CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,NWIBSHFKIJFRCO-WUDYKRTCSA-N
MITOQUINONE ION,MITOQUINONE;MITOQUINONE CATION;MITOQUINONE ION,CHEMBL1229093,BRD:BRD-K00003362-066-01-9,rep_single_dose,ANTIOXIDANT,,,,,,Small molecule,2,COC1=C(OC)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=C(C)C1=O,OIIMUKXVVLRCAF-UHFFFAOYSA-N
OPEPRIM,"CB 313;CB-313;CHLODITAN;CHLODITHANE;LYSODREN;MITOTAN;MITOTANE;NSC-38721;O,P'-DDD;O,P'-DDD,O P'-TDE;O,P'-TDE;OPDDD;OPEPRIM",CHEMBL1670,BRD:BRD-A31204924-001-14-2,rep_single_dose,ANTINEOPLASTIC AGENT,CYP11A1;CYP11B1;ESR1,,,,,Small molecule,4,Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,JWBOIMRXGHLCPP-UHFFFAOYSA-N
NSC-301739,"CL 232,315;CL-232315;MISOSTOL;MITOXANTRONE;MITOXANTRONE DIHCL;MITOXANTRONE DIHYDROCHLORIDE;MITOXANTRONE HCL;MITOXANTRONE HYDROCHLORIDE;MITOZANTRONE;NOVANTRONE;NSC-279836;NSC-301739",CHEMBL1417019;CHEMBL58,BRD:BRD-BRD-K21680192-300-14-4;BRD:BRD-K21680192-300-14-4;GDSC2:1810,gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF TOPOISOMERASE,TOP2A;TOP2B,"MULTIPLE SCLEROSIS, PROSTATE CANCER, ACUTE MYELOID LEUKEMIA (AML)",,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF TOPOISOMERASE', 'TOPOISOMERASE INHIBITOR'}, defaulting to 'INHIBITOR OF TOPOISOMERASE'
Multiple values for repurposing_target: {'TOP2A', 'TOP2A;TOP2B'}, taking the union",Small molecule,4,"Cl.Cl.O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21;O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21;OCCNCCNC1CCC(NCCNCCO)C2C(=O)C3C(O)CCC(O)C3C(=O)C12, OCCNCCNC1CCC(NCCNCCO)C2C(=O)C3C(O)CCC(O)C3C(=O)C12, OCCNCCNC1CCC(NCCNCCO)C2C(=O)C3C(O)CCC(O)C3C(=O)C12",KKZJGLLVHKMTCM-UHFFFAOYSA-N;ZAHQPTJLOCWVPG-UHFFFAOYSA-N
MIVEBRESIB,ABBV-075;ABBV075;MIVEBRESIB,CHEMBL3987016,BRD:BRD-K00003356-001-01-9,rep_single_dose,BROMODOMAIN INHIBITOR,,,,,,Small molecule,1,CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1,RDONXGFGWSSFMY-UHFFFAOYSA-N
MIVOBULIN,MIVOBULIN,CHEMBL1233800,BRD:BRD-K39576764-071-01-6,rep_single_dose,MICROTUBULE INHIBITOR,,,,,,Small molecule,-1,CCOC(=O)Nc1cc2c(c(N)n1)N=C(c1ccccc1)[C@H](C)N2,XXBDOTXPQDVHIP-JTQLQIEISA-N
MIW-815,MIW-815,,BRD:BRD-K00003146-318-01-9,rep_single_dose,INTERFERON INDUCER,,,,,,,NA,,
MIZOLLEN,MIZOLASTINE;MIZOLLEN,CHEMBL94454,BRD:BRD-BRD-K21884483-001-03-7;BRD:BRD-K21884483-001-03-7,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"URTICARIA, ALLERGIC RHINITIS",,LAUNCHED,,Small molecule,4,CN(C1CCN(CC1)C1NC2CCCCC2N1CC1CCC(F)CC1)C1NCCC(=O)[NH]1;CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,PVLJETXTTWAYEW-UHFFFAOYSA-N
NSC-289637,BREDININ;MIZORIBINE;NSC-289637,CHEMBL245019,BRD:BRD-BRD-K88061624-001-21-4;BRD:BRD-K88061624-001-21-4,rep_primary;rep_single_dose,"IMMUNOSUPPRESSANT, INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR",IMPDH1,,,LAUNCHED,,Small molecule,3,"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O;NC(=O)C1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1O, NC(=O)C1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1O, NC(=O)C1NCN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1O",HZQDCMWJEBCWBR-UUOKFMHZSA-N
MJ-15,MJ-15,,BRD:BRD-K71315565-001-02-9,rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1,,,,,,NA,,
MK-0354,MK-0354,,BRD:BRD-BRD-K91405252-001-01-9;BRD:BRD-K91405252-001-01-9,rep_primary;rep_single_dose,NIACIN RECEPTOR AGONIST,HCAR2;HCAR3,,,PHASE 2,,,NA,C1CC2[NH]NC(-C3NNN[NH]3)C2C1,
MK-0429,MK-0429,,BRD:BRD-K00076647-001-02-9,rep_single_dose,,,,,,,,NA,,
MK0557,MK-0557;MK0557,CHEMBL595573,BRD:BRD-K00003190-001-01-9,rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,,,,,,Small molecule,3,O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21,RMYZIRFUCOMQRH-CAJLXGCNSA-N
MK-0608,MK-0608,,BRD:BRD-K00004557-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,,NA,,
MK-0752,MK-0752,CHEMBL4205422,BRD:BRD-BRD-K18850819-001-04-6;BRD:BRD-K18850819-001-04-6;CTRP:660332,ctrp;rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,,,,PHASE 1/PHASE 2,,Small molecule,1,O=C(O)CC[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1;OC(=O)CC[C@H]1CC[C@@](CC1)(C1CC(F)CCC1F)S(=O)(=O)C1CCC(CL)CC1,XCGJIFAKUZNNOR-QCKZDCLWSA-N
PF-05314882,MK-0773;PF-05314882,CHEMBL3545333,BRD:BRD-BRD-K38868394-001-01-3;BRD:BRD-K38868394-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,,,PHASE 2,,Small molecule,2,CN1[C@@H]2CC[C@H]3[C@@H]4CC[C@H](C(=O)NCC5NC6CCCNC6[NH]5)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C(F)C1=O;CN1C(=O)C(F)=C[C@]2(C)C3CC[C@@]4(C)C(CC[C@@H]4C(=O)NCc4nc5ncccc5[nH]4)C3CCC12,GBEUKTWTUSPHEE-PAWGCEJPSA-N
MK0812,MK-0812;MK0812,CHEMBL4297538,BRD:BRD-BRD-K14175878-001-01-6;BRD:BRD-K14175878-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR2,,,PHASE 2,,Small molecule,2,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCC2NCC(CC2C1)C(F)(F)F;CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](CN2CCc3ncc(C(F)(F)F)cc3C2)(C(C)C)C1,UNVWTBOGMHPKJM-CWKRKGSWSA-N
MK0893,MK-0893;MK0893,CHEMBL1933349,BRD:BRD-BRD-K16732600-001-01-7;BRD:BRD-K16732600-001-01-7,rep_primary;rep_single_dose,GLUCAGON RECEPTOR ANTAGONIST,GCGR,,,PHASE 2,,Small molecule,2,COc1ccc2cc(-c3cc(-c4cc(Cl)cc(Cl)c4)nn3[C@@H](C)c3ccc(C(=O)NCCC(=O)O)cc3)ccc2c1;COC1CCC2CC(CCC2C1)-C1CC(NN1[C@@H](C)C1CCC(CC1)C(=O)NCCC(O)=O)-C1CC(CL)CC(CL)C1,DNTVJEMGHBIUMW-IBGZPJMESA-N
MK0941,MK-0941;MK0941,CHEMBL3580737;CHEMBL4297302,BRD:BRD-K00079347-066-02-9,rep_single_dose,,,,,,,Small molecule,2,CCS(=O)(=O)c1ccc(Oc2cc(O[C@@H](C)CO)cc(C(=O)Nc3ccn(C)n3)c2)cn1.CS(=O)(=O)O,PIDNRTWDGDJKSQ-UQKRIMTDSA-N
MK-1064,MK 1064;MK-1064,CHEMBL3338866,BRD:BRD-K00003304-001-01-9,rep_single_dose,OREXIN RECEPTOR ANTAGONIST,,,,,,Small molecule,1,COc1ccc(CNC(=O)c2cc(-c3cncc(Cl)c3)cnc2-c2ccccn2)nc1OC,CKTWQGHVNRYNCM-UHFFFAOYSA-N
MK-1903,MK-1903,,BRD:BRD-K00004660-001-01-9,rep_single_dose,NIACIN RECEPTOR AGONIST,,,,,,,NA,,
MK2206,MK-2206;MK2206,CHEMBL1079175,BRD:BRD-BRD-K68065987-300-09-1;BRD:BRD-K68065987-300-09-1;CTRP:377381;GDSC1:1053;GDSC2:1053,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,AKT INHIBITOR,AKT1;AKT2;AKT3,,,PHASE 2,,Small molecule,2,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1;NC1(CCC1)C1CCC(CC1)-C1NC2CCN3C(N[NH]C3=O)C2CC1-C1CCCCC1,ULDXWLCXEDXJGE-UHFFFAOYSA-N
NGD-8243,MK-2295;MK-2295-005;NGD-8243,CHEMBL3545227,BRD:BRD-BRD-K43316319-001-01-8;BRD:BRD-K43316319-001-01-8,rep_primary;rep_single_dose,TRPV ANTAGONIST,TRPV1,,,PHASE 2,,Small molecule,2,FC(F)(F)C1CCC(NC2NCNC3CC(CCC23)-C2NCCCC2C(F)(F)F)CC1,
MK-2461,MK-2461,CHEMBL1822792,BRD:BRD-BRD-K56405753-001-02-4;BRD:BRD-K56405753-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,"FGFR INHIBITOR, VEGFR INHIBITOR",FGFR1;FGFR2;FGFR3;FLT1;FLT3;FLT4;KDR;MERTK;MET;MST1R;NTRK1;NTRK2;PDGFRB,,,PHASE 1/PHASE 2,,Small molecule,2,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1;CN(C[C@@H]1COCCO1)S(=O)(=O)NC1CCC2CCC3NCC(CC3C(=O)C2C1)-C1CNN(C)C1,JGEBLDKNWBUGRZ-HXUWFJFHSA-N
MK-2894,MK-2894,,BRD:BRD-K27983781-001-01-4,rep_single_dose,PROSTAGLANDIN INHIBITOR,PTGER4,,,,,,NA,,
MK3207,MK 3207;MK-3207;MK3207,CHEMBL1910936,BRD:BRD-BRD-K66911501-003-01-2;BRD:BRD-K66911501-003-01-2,rep_multi_dose;rep_primary;rep_single_dose,CALCITONIN ANTAGONIST,CALCA,,,PHASE 2,,Small molecule,2,FC1CC(F)CC(C1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)NC1CCC2C[C@]3(CC2C1)C(=O)NC1NCCCC31;O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21,AZAANWYREOQRFB-SETSBSEESA-N
MK-3697,MK-3697,,BRD:BRD-BRD-K95828359-001-01-0;BRD:BRD-K95828359-001-01-0,rep_primary;rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR2,,,PHASE 2,,,NA,COC1CCC(CNC(=O)C2CC(NCC2-C2NCCS2)-C2CNCC(C)C2)NC1OC,
MK-4074,MK-4074,,BRD:BRD-K00003482-001-01-9,rep_single_dose,ACETYL-COA CARBOXYLASE INHIBITOR,,,,,,,NA,,
ZL-2306,JNJ-64091742;MK-4827;MK4827;NIRAPARIB;ZEJULA;ZL-2306,CHEMBL1094636,BRD:BRD-BRD-K54955827-001-02-2;BRD:BRD-K54955827-001-02-2;GDSC2:1177,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF PARP1 AND PARP2,PARP1;PARP2,PRIMARY PERITONEAL CANCER (PPC),,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF PARP1 AND PARP2', 'PARP INHIBITOR'}, defaulting to 'INHIBITOR OF PARP1 AND PARP2'
Multiple values for repurposing_target: {'PARP1', 'PARP1;PARP2'}, taking the union",Small molecule,4,"NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12;NC(=O)C1CCCC2CN(NC12)-C1CCC(CC1)[C@@H]1CCCNC1, NC(=O)C1CCCC2CN(NC12)-C1CCC(CC1)[C@@H]1CCCNC1",PCHKPVIQAHNQLW-CQSZACIVSA-N
MK-5046,MK-5046,,BRD:BRD-K03886848-001-01-8,rep_single_dose,BOMBESIN RECEPTOR AGONIST,BRS3;GRPR;NMBR,,,,,,NA,,
VX-689,MK 5108;MK-5108;MK5108;VX-689,CHEMBL3182444,BRD:BRD-BRD-K53665955-001-03-0;BRD:BRD-K53665955-001-03-0,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB;AURKC,,,PHASE 1,,Small molecule,1,O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1;OC(=O)[C@@]1(CC2CCCC(NC3NCCS3)N2)CC[C@@H](CC1)OC1CCCC(CL)C1F,LCVIRAZGMYMNNT-UHFFFAOYSA-N
MK-571,L-660711;MK-571,CHEMBL15177,BRD:BRD-A73679382-236-01-8;BRD:BRD-BRD-A73679382-236-01-8,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,ABCC2;CYSLTR1,,,PHASE 2,,Small molecule,NA,CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1;CN(C)C(=O)CCSC(SCCC(O)=O)C1CCCC(\C=C\C2CCC3CCC(CL)CC3N2)C1,AXUZQJFHDNNPFG-UXBLZVDNSA-N
MK-6096,FILOREXANT;MK-6096,CHEMBL2107822,BRD:BRD-BRD-K03894385-001-01-1;BRD:BRD-K03894385-001-01-1,rep_primary;rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR1;HCRTR2,,,PHASE 2,,Small molecule,2,C[C@@H]1CC[C@@H](COC2CCC(F)CN2)CN1C(=O)C1CC(C)CCC1-C1NCCCN1;Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1,NPFDWHQSDBWQLH-QZTJIDSGSA-N
MK7246,MK-7246;MK7246,CHEMBL561132,BRD:BRD-K00003199-001-01-9,rep_single_dose,CRTH RECEPTOR ANTAGONIST,,,,,,Small molecule,1,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,JTCAGRAKUAAYDY-OAHLLOKOSA-N
MK7622,MK-7622;MK7622,CHEMBL4078588,BRD:BRD-K00003194-001-01-9,rep_single_dose,CHOLINERGIC RECEPTOR AGONIST,,,,,,Small molecule,2,Cc1ccc(Cc2cc3c(=O)n([C@H]4CCCC[C@@H]4O)cnc3c3ccccc23)cn1,JUVQLZBJFOGEEO-GOTSBHOMSA-N
MK8033,MK-8033;MK8033,CHEMBL2323775,BRD:BRD-BRD-K55512740-001-01-6;BRD:BRD-K55512740-001-01-6,rep_primary;rep_single_dose,C-MET INHIBITOR,MET,,,PHASE 1,,Small molecule,1,Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1;CN1CC(CN1)-C1CNC2CCC3CCC(CS(=O)(=O)NCC4CCCCN4)CC3C(=O)C2C1,VMJFTOSOFDEKTM-UHFFFAOYSA-N
MK-8245,MK-8245,CHEMBL1938870,BRD:BRD-BRD-K29656036-001-02-5;BRD:BRD-K29656036-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,STEAROYL-COA DESATURASE INHIBITOR,SCD,,,PHASE 2,,Small molecule,1,O=C(O)Cn1nnc(-c2cc(N3CCC(Oc4cc(F)ccc4Br)CC3)no2)n1;OC(=O)CN1NNC(N1)-C1CC(NO1)N1CCC(CC1)OC1CC(F)CCC1BR,UJEAABFSXKCSGI-UHFFFAOYSA-N
MK-8617,MK-8617,,BRD:BRD-K00003397-001-01-9,rep_single_dose,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,,,,,,,NA,,
MK-8745,MK-8745,,BRD:BRD-BRD-K25279140-001-01-5;BRD:BRD-K25279140-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA,,,PRECLINICAL,,,NA,FC1C(CL)CCCC1C(=O)N1CCN(CC2CCCC(NC3NCCS3)N2)CC1,
MK-886,MK-886,,BRD:BRD-K20168484-001-07-9,rep_single_dose,LIPOXYGENASE INHIBITOR,,,,,,,NA,,
SUVECALTAMIDE,CX-8998;JZP-385;JZP385;MK-8998;SUVECALTAMIDE,CHEMBL1684950,BRD:BRD-K86677390-001-02-9,rep_single_dose,T-TYPE CALCIUM CHANNEL BLOCKER,,,,,,Small molecule,2,CC(C)c1ccc(CC(=O)N[C@H](C)c2ccc(OCC(F)(F)F)cn2)cc1,IQIKXZMPPBEWAD-CQSZACIVSA-N
MK2-IN-1,MK2-IN-1,,BRD:BRD-K90316462-003-01-1,rep_single_dose,MAP KINASE INHIBITOR,MAPKAPK2,,,,,,NA,,
MK2206,MK 2206;MK-2206;MK2206,CHEMBL1079175,GDSC1:1053;GDSC2:1053,gdsc,,,,,,,Small molecule,2,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,ULDXWLCXEDXJGE-UHFFFAOYSA-N
ZL-2306,JNJ-64091742;MK-4827;MK4827;NIRAPARIB;ZEJULA;ZL-2306,CHEMBL1094636,GDSC2:1177,gdsc,,,,,,,Small molecule,4,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,PCHKPVIQAHNQLW-CQSZACIVSA-N
ML179,ML-179;ML179,,BRD:BRD-BRD-K77547509-001-03-3;BRD:BRD-K77547509-001-03-3,rep_primary;rep_single_dose,LIVER RECEPTOR HOMOLOG INVERSE AGONIST,NR5A2,,,PRECLINICAL,,,NA,FC(F)(F)C1CCCC(C1)N1CCN(CC1)C1CC(=O)N(C2CCCCC2)C(=O)[NH]1,
ML193,ML-193;ML193,,BRD:BRD-BRD-K27539181-001-08-5;BRD:BRD-K27539181-001-08-5,rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,GPR55,,,PRECLINICAL,,,NA,CC1NOC(NS(=O)(=O)C2CCC(NC(=O)C3CC(NC4C(C)CC(C)CC34)-C3CCCCN3)CC2)C1C,
ML213,ML-213;ML213,,BRD:BRD-A12633378-001-07-0;BRD:BRD-BRD-A12633378-001-07-0;BRD:BRD-K00004301-001-01-9,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNQ4,,,PRECLINICAL,"Multiple values for structure_id: {'K00004301', 'A12633378'}, defaulting to None",,NA,CC1CC(C)C(NC(=O)C2CC3CCC2C3)C(C)C1,
ML228,ML-228;ML228,,BRD:BRD-BRD-K44432556-001-05-5;BRD:BRD-K44432556-001-05-5,rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR ACTIVATOR,HIF1A,,,PRECLINICAL,,,NA,C(NC1NC(NNC1-C1CCCCC1)-C1CCCCN1)C1CCC(CC1)-C1CCCCC1,
ML277,ML-277;ML277,,BRD:BRD-BRD-K60020910-001-02-5;BRD:BRD-K60020910-001-02-5,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNQ1,,,PRECLINICAL,,,NA,COC1CCC(CC1)-C1CSC(NC(=O)[C@H]2CCCCN2S(=O)(=O)C2CCC(C)CC2)N1,
ML281,ML-281;ML281,,BRD:BRD-BRD-K48188942-001-03-7;BRD:BRD-K48188942-001-03-7,rep_primary;rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,STK33,,,PRECLINICAL,,,NA,CC(C)C1CCC(NC(=O)C2CCCS2)C(C1)-C1NC2CCCCC2[NH]C1=O,
ML323,ML-323;ML323,,BRD:BRD-BRD-K93942811-001-01-3;BRD:BRD-K93942811-001-01-3;GDSC2:1629,gdsc;rep_primary;rep_single_dose,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,USP1,,,PRECLINICAL,,,NA,CC(C)C1CCCCC1-C1NCC(C)C(NCC2CCC(CC2)-N2CCNN2)N1,
ML3403,ML-3403;ML3403,,BRD:BRD-A29014990-001-02-3;BRD:BRD-BRD-A29014990-001-02-3,rep_primary;rep_single_dose,MAP KINASE INHIBITOR,CYP3A4;MAPK11;MAPK12;MAPK14,,,PRECLINICAL,,,NA,CSC1NC(C([NH]1)-C1CCNC(NC(C)C2CCCCC2)C1)-C1CCC(F)CC1,
ML348,ML-348;ML348,,BRD:BRD-BRD-K81044214-001-06-4;BRD:BRD-K81044214-001-06-4,rep_primary;rep_single_dose,LYSOPHOSPHOLIPASE INHIBITOR,LYPLA1,,,PRECLINICAL,,,NA,FC(F)(F)C1CCC(CL)C(NC(=O)CN2CCN(CC2)C(=O)C2CCCO2)C1,
ML365,ML-365;ML365,,BRD:BRD-BRD-K02160913-001-02-7;BRD:BRD-K02160913-001-02-7,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNK3;KCNK9,,,PRECLINICAL,,,NA,COC1CCCCC1C(=O)NC1CCCC(NC(=O)C2CCCC(C)C2)C1,
ML9,ML-9;ML9,,BRD:BRD-BRD-K68402494-003-03-5;BRD:BRD-K68402494-003-03-5,rep_primary;rep_single_dose,MYOSIN LIGHT CHAIN KINASE INHIBITOR,TRPC6,,,PRECLINICAL,,,NA,"CLC1CCCC2C(CCCC12)S(=O)(=O)N1CCCNCC1, CLC1CCCC2C(CCCC12)S(=O)(=O)N1CCCNCC1",
ML006,ML006,,CTRP:17712,ctrp,,,,,,,,NA,,
ML029,ML029,,CTRP:350548,ctrp,,,,,,,,NA,,
ML031,ML031,,CTRP:96171,ctrp,,,,,,,,NA,,
ML050,ML050,,CTRP:153820,ctrp,,,,,,,,NA,,
ML083,ML083,,CTRP:255961,ctrp,,,,,,,,NA,,
ML10302,ML10302,,BRD:BRD-K69343602-003-02-9,rep_single_dose,SEROTONIN RECEPTOR PARTIAL AGONIST,HTR3A;HTR3B;HTR4,,,,,,NA,,
ML130,ML130,,BRD:BRD-BRD-K89306950-001-12-5;BRD:BRD-K89306950-001-12-5,rep_primary;rep_single_dose,NOD1 INHIBITOR,,,,PRECLINICAL,,,NA,"CC1CCC(CC1)S(=O)(=O)N1C(N)NC2CCCCC12, CC1CCC(CC1)S(=O)(=O)N1C(N)NC2CCCCC12",
ML133,ML133,,BRD:BRD-BRD-K33743361-003-02-6;BRD:BRD-K33743361-003-02-6,rep_multi_dose;rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,COC1CCC(CNCC2CCCC3CCCCC23)CC1,
ML141,ML141,,BRD:BRD-A28422330-001-11-9,rep_single_dose,GTPASE INHIBITOR,CDC42,,,,,,NA,,
ML161,ML161,,BRD:BRD-BRD-K59036917-001-16-7;BRD:BRD-K59036917-001-16-7,rep_primary;rep_single_dose,PROTEASE-ACTIVATED RECEPTOR INHIBITOR,,,,PRECLINICAL,,,NA,"CCCC(=O)NC1CCCC(NC(=O)C2CCCCC2BR)C1, CCCC(=O)NC1CCCC(NC(=O)C2CCCCC2BR)C1",
ML162,ML162,,CTRP:154846,ctrp,,,,,,,,NA,,
ML167,ML167,,BRD:BRD-BRD-K64835161-001-02-8;BRD:BRD-K64835161-001-02-8,rep_primary;rep_single_dose,"CLK INHIBITOR, DYRK INHIBITOR",CLK4;DYRK1B,,,PRECLINICAL,,,NA,CC1CCC(CNC2NCNC3CCC(CC23)-C2CCC(CO)O2)O1,
ML203,ML203,,CTRP:411816,ctrp,,,,,,,,NA,,
ML204,ML204,,BRD:BRD-BRD-K80021413-001-08-8;BRD:BRD-K80021413-001-08-8,rep_primary;rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPC4;TRPC5,,,PRECLINICAL,,,NA,CC1CC(NC2CCCCC12)N1CCCCC1,
ML210,ML210,,BRD:BRD-K01877528-001-20-9;CTRP:609110,ctrp;oncref_1,INHIBITOR OF GPX4,GPX4,,,,,,NA,,
ML218,ML218,,BRD:BRD-K92995792-003-03-9,rep_single_dose,T-TYPE CALCIUM CHANNEL BLOCKER,CACNA1G;CACNA1H;CACNA1I,,,,,,NA,,
ML239,ML239,,CTRP:609781,ctrp,,,,,,,,NA,,
ML258,ML258,,CTRP:660314,ctrp,,,,,,,,NA,,
ML298,ML298,,BRD:BRD-K24600306-003-02-9,rep_single_dose,PHOSPHOLIPASE INHIBITOR,PLD2,,,,,,NA,,
ML311,ML311,,CTRP:290356,ctrp,,,,,,,,NA,,
ML312,ML312,,CTRP:434195,ctrp,,,,,,,,NA,,
ML314,ML314,,BRD:BRD-BRD-K92606079-001-02-0;BRD:BRD-K92606079-001-02-0,rep_primary;rep_single_dose,NEUROTENSIN AGONIST,NTSR1,,,PRECLINICAL,,,NA,COC1CCCCC1N1CCN(CC1)C1NC(NC2CC(OC)C(OC)CC12)C1CC1,
ML320,ML320,,CTRP:659682,ctrp,,,,,,,,NA,,
ML324,ML324,,BRD:BRD-K25611237-001-02-1,rep_single_dose,HISTONE LYSINE DEMETHYLASE INHIBITOR,KDM4A,,,,,,NA,,
ML334 DIASTEREOMER,ML334 DIASTEREOMER,,CTRP:654278,ctrp,,,,,,,,NA,,
ML347,ML347,,BRD:BRD-BRD-K33892651-001-02-4;BRD:BRD-K33892651-001-02-4,rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ACVR1;ACVRL1;BMPR1A,,,PRECLINICAL,,,NA,"COC1CCC(CC1)-C1CNC2C(CNN2C1)-C1CCCC2NCCCC12, COC1CCC(CC1)-C1CNC2C(CNN2C1)-C1CCCC2NCCCC12",
VLX-1005,ML-355;ML355;VLX-1005,CHEMBL3113165,BRD:BRD-K15324227-001-02-9,rep_single_dose,,,,,,,Small molecule,1,COc1cccc(CNc2ccc(S(=O)(=O)Nc3nc4ccccc4s3)cc2)c1O,OWHBVKBNNRYMIN-UHFFFAOYSA-N
ML786,ML786,,BRD:BRD-K52644305-300-02-9,rep_single_dose,RAF INHIBITOR,BRAF;RAF1,,,,,,NA,,
PEVONEDISTAT,MLN 4924;MLN-4924;MLN-4924003;MLN4924;PEVONEDISTAT,CHEMBL1231160,GDSC1:1529;GDSC2:1529,gdsc,,,,,,,Small molecule,3,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,MPUQHZXIXSTTDU-QXGSTGNESA-N
MLN8054,MLN 8054;MLN-8054;MLN8054,CHEMBL259084,BRD:BRD-BRD-K83963101-001-06-9;BRD:BRD-K83963101-001-06-9,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA,,,PHASE 1,,Small molecule,1,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1;OC(=O)C1CCC(NC2NCC3CN=C(C4CC(CL)CCC4-C3N2)C2C(F)CCCC2F)CC1,HHFBDROWDBDFBR-UHFFFAOYSA-N
TAK-228,CB-228;INK-128;INK128;MLN-0128;MLN0128;SAPANISERTIB;TAK-228,CHEMBL3545097,BRD:BRD-BRD-K59317601-001-05-5;BRD:BRD-K59317601-001-05-5,rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR;PIK3CA;PIK3CD;PIK3CG,,,PHASE 2,,Small molecule,2,CC(C)N1NC(-C2CCC3OC(N)NC3C2)C2C(N)NCNC12;CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21,GYLDXIAOMVERTK-UHFFFAOYSA-N
TAK-117,AGN-PC-0DB6FL;INK1117;MLN-1117;MLN1117;SERABELISIB;TAK-117,CHEMBL3935857,BRD:BRD-BRD-K73877023-001-01-9;BRD:BRD-K73877023-001-01-9,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA,,,PHASE 1/PHASE 2,,Small molecule,2,Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1;NC1NC2CC(CCC2O1)-C1CCC2NCC(C(=O)N3CCOCC3)N2C1,BLGWHBSBBJNKJO-UHFFFAOYSA-N
NINLARO,IXAZOMIB;MLN-2238;MLN-9708 FREE BASE;MLN2238;NINLARO,CHEMBL2141296,CTRP:632873,ctrp,,,,,,,Small molecule,4,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,MXAYKZJJDUDWDS-LBPRGKRZSA-N
MLN2480,MLN2480,,BRD:BRD-BRD-K43410529-001-02-3;BRD:BRD-K43410529-001-02-3;CTRP:687579,ctrp;rep_primary;rep_single_dose,RAF INHIBITOR,,,,PHASE 1,,,NA,C[C@@H](NC(=O)C1NCNC(N)C1CL)C1NCC(S1)C(=O)NC1CC(C(CL)CN1)C(F)(F)F,
PEVONEDISTAT,MLN 4924;MLN-4924;MLN-4924003;MLN4924;PEVONEDISTAT,CHEMBL1231160,BRD:BRD-BRD-K67844266-003-01-9;BRD:BRD-K00003376-001-03-9;BRD:BRD-K67844266-003-01-9;CTRP:411809;GDSC1:1529;GDSC2:1529,ctrp;gdsc;oncref_2;rep_multi_dose;rep_primary;rep_single_dose,NEDD ACTIVATING ENZYME INHIBITOR,NAE1;UBA3,,,PHASE 2,"Multiple values for MOA: {'NEDD ACTIVATING ENZYME INHIBITOR', 'INHIBITOR OF NAE1'}, defaulting to 'NEDD ACTIVATING ENZYME INHIBITOR'
Multiple values for repurposing_target: {'NAE1;UBA3', 'NAE1'}, taking the union
Multiple values for structure_id: {'K00003376', 'K67844266'}, defaulting to None",Small molecule,3,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O;NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)N1CCC2C(N[C@H]3CCC4CCCCC34)NCNC12,MPUQHZXIXSTTDU-QXGSTGNESA-N
UAE INHIBITOR MLN7243,MLN-7243;MLN7243;TAK 243;TAK-243;UAE INHIBITOR MLN7243,CHEMBL4297405,BRD:BRD-K67844266-001-07-9;BRD:BRD-U00127223-001-01-9,oncref_2,INHIBITOR OF UAE,UBA1,,,,,Small molecule,1,NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O,KJDAGXLMHXUAGV-DGWLBADLSA-N
MLN8237,ALISERTIB;MLN 8237;MLN-8237;MLN8237,CHEMBL483158,GDSC1:431;GDSC2:1051,gdsc,,,,,,,Small molecule,3,COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O,ZLHFILGSQDJULK-UHFFFAOYSA-N
MM-102,MM-102,,BRD:BRD-BRD-K68474068-001-01-8;BRD:BRD-K68474068-001-01-8,rep_primary;rep_single_dose,WDR5/MLL INTERACTION INHIBITOR,,,,PRECLINICAL,,,NA,CCC(CC)(NC(=O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NC1(CCCC1)C(=O)NC(C1CCC(F)CC1)C1CCC(F)CC1,
MM-11253,MM-11253,,BRD:BRD-BRD-K98353094-001-01-6;BRD:BRD-K98353094-001-01-6,rep_primary;rep_single_dose,RETINOID RECEPTOR ANTAGONIST,RARG,,,PRECLINICAL,,,NA,CC1(C)CCC(C)(C)C2CC(CCC12)C1(SCCS1)C1CCC2CC(CCC2C1)C(O)=O,
MM-206,MM-206,,BRD:BRD-K00004622-001-01-9,rep_single_dose,STAT INHIBITOR,,,,,,,NA,,
MM77,MM77,,BRD:BRD-BRD-K50293352-300-02-1;BRD:BRD-K50293352-300-02-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A,,,PRECLINICAL,,,NA,COC1CCCCC1N1CCN(CCCCN2C(=O)CCC2=O)CC1,
MMPX,MMPX,,BRD:BRD-BRD-K56077740-001-09-2;BRD:BRD-K56077740-001-09-2,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,PRECLINICAL,,,NA,COCC1NC2N(CC(C)C)C(=O)N(C)C(=O)C2[NH]1,
MMV048,J3.367.891F;MMV-048;MMV-390048;MMV048,CHEMBL2041980,BRD:BRD-K78973789-001-02-9,rep_single_dose,PI4K INHIBITOR,,,,,,Small molecule,1,CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)c2)cc1,RTJQABCNNLMCJF-UHFFFAOYSA-N
MN-64,MN-64,,BRD:BRD-BRD-K16183658-001-01-4;BRD:BRD-K16183658-001-01-4;GDSC2:1854,gdsc;rep_primary;rep_single_dose,TANKYRASE INHIBITOR,TNKS,,,PRECLINICAL,,,NA,CC(C)C1CCC(CC1)-C1CC(=O)C2CCCCC2O1,
MNITMT,MNITMT,,BRD:BRD-BRD-K63151507-001-02-4;BRD:BRD-K63151507-001-02-4,rep_primary;rep_single_dose,LYMPHOCYTE INHIBITOR,,,,PRECLINICAL,,,NA,CN1CNNC1SC1C(NCN1C)[N+]([O-])=O,
"MNS-(3,4-METHYLENEDIOXY-NITROSTYRENE)","MNS-(3,4-METHYLENEDIOXY-NITROSTYRENE)",,BRD:BRD-BRD-K42205652-001-02-7,rep_primary,"SRC INHIBITOR, SYK INHIBITOR",SRC;SYK,,,PRECLINICAL,,,NA,"[O-][N+](=O)\C=C\C1CCC2OCOC2C1, [O-][N+](=O)\C=C\C1CCC2OCOC2C1",
TAK-788,AP-32788;AP32788;MOBOCERTINIB;TAK-788,CHEMBL4650319,BRD:BRD-K00069020-001-02-9,rep_single_dose,,,,,,,Small molecule,4,C=CC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,AZSRSNUQCUDCGG-UHFFFAOYSA-N
MOCETINOSTAT,MGCD-0103;MGCD0103;MOCETINOSTAT,CHEMBL272980,BRD:BRD-BRD-K16485616-001-08-9;BRD:BRD-K16485616-001-08-9,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC11;HDAC2;HDAC3,,,PHASE 2,,Small molecule,2,"Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1;NC1CCCCC1NC(=O)C1CCC(CNC2NCCC(N2)-C2CCCNC2)CC1, NC1CCCCC1NC(=O)C1CCC(CNC2NCCC(N2)-C2CCCNC2)CC1, NC1CCCCC1NC(=O)C1CCC(CNC2NCCC(N2)-C2CCCNC2)CC1",HRNLUBSXIHFDHP-UHFFFAOYSA-N
RO-111163000,AURORIX;GNF-PF-695;MANERIX;MOCLOBEMIDE;RO 11-1163/000;RO-111163000,CHEMBL86304,BRD:BRD-BRD-K07237224-001-19-6;BRD:BRD-K07237224-001-19-6,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,"DEPRESSION, ANXIETY",,LAUNCHED,,Small molecule,4,"CLC1CCC(CC1)C(=O)NCCN1CCOCC1, CLC1CCC(CC1)C(=O)NCCN1CCOCC1;O=C(NCCN1CCOCC1)c1ccc(Cl)cc1",YHXISWVBGDMDLQ-UHFFFAOYSA-N
MODALINE,MODALINE,CHEMBL2111121,BRD:BRD-BRD-K25317177-065-01-4;BRD:BRD-K25317177-065-01-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,Cc1nccnc1N1CCCCC1;CC1NCCNC1N1CCCCC1,BJHCGMHPEKLROM-UHFFFAOYSA-N
UNIVASC,MOEXIPRIL;RS-10085;UNIRETIC;UNIVASC,CHEMBL1165,BRD:BRD-BRD-K34441861-003-07-0;BRD:BRD-K34441861-003-07-0,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE;ACE2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O;CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1CC2CC(OC)C(OC)CC2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1CC2CC(OC)C(OC)CC2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1CC2CC(OC)C(OC)CC2C[C@H]1C(O)=O",UWWDHYUMIORJTA-HSQYWUDLSA-N
MOFEGILINE,MOFEGILINE,CHEMBL489079,BRD:BRD-BRD-K52598503-003-01-1;BRD:BRD-K52598503-003-01-1,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,,,PHASE 1,,Small molecule,-1,"NC/C(=C/F)CCc1ccc(F)cc1;NC\C(CCC1CCC(F)CC1)=C\F, NC\C(CCC1CCC(F)CC1)=C\F",VXLBSYHAEKDUSU-JXMROGBWSA-N
MOFEZOLAC,MOFEZOLAC,CHEMBL259972,BRD:BRD-BRD-K49372556-001-04-1;BRD:BRD-K49372556-001-04-1,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1,"RHEUMATOID ARTHRITIS, OSTEOPOROSIS",,LAUNCHED,,Small molecule,-1,COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1;COC1CCC(CC1)-C1NOC(CC(O)=O)C1-C1CCC(OC)CC1,DJEIHHYCDCTAAH-UHFFFAOYSA-N
NSC-759829,MOGUISTEINE;NSC-759829,CHEMBL146980,BRD:BRD-A87673115-001-04-1;BRD:BRD-BRD-A87673115-001-04-1,rep_primary;rep_single_dose,ATP-SENSITIVE POTASSIUM CHANNEL INHIBITOR,,,,PHASE 2,,Small molecule,-1,CCOC(=O)CC(=O)N1CCSC1COc1ccccc1OC;CCOC(=O)CC(=O)N1CCSC1COC1CCCCC1OC,WSYVIAQNTFPTBI-UHFFFAOYSA-N
MOLIDUSTAT,BAY 85-3934;BAY-85-3934;MOLIDUSTAT,CHEMBL3646118,BRD:BRD-BRD-K01291782-001-01-1;BRD:BRD-K01291782-001-01-1,rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,EGLN2,,,PHASE 2,,Small molecule,2,"O=c1c(-n2ccnn2)c[nH]n1-c1cc(N2CCOCC2)ncn1;O=C1C(C[NH]N1-C1CC(NCN1)N1CCOCC1)-N1CCNN1, O=C1C(C[NH]N1-C1CC(NCN1)N1CCOCC1)-N1CCNN1",IJMBOKOTALXLKS-UHFFFAOYSA-N
SPN-810,MOBAN;MOLINDONE;SPN-810,CHEMBL460,BRD:BRD-A65280694-003-13-7;BRD:BRD-BRD-A65280694-003-13-7,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CHRM1;DRD2;HRH1;HTR1A;HTR2A,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2;CCC1C(C)[NH]C2CCC(CN3CCOCC3)C(=O)C12,KLPWJLBORRMFGK-UHFFFAOYSA-N
MOLNUPIRAVIR,EIDD 1931-ISOPROPYL ESTER;EIDD-2801;MK-4482;MOLNUPIRAVIR,CHEMBL4650320,BRD:BRD-K00090621-001-02-9,rep_single_dose,,,,,,,Small molecule,3,CC(C)C(=O)OC[C@H]1O[C@@H](n2cc/c(=N\O)[nH]c2=O)[C@H](O)[C@@H]1O,HTNPEHXGEKVIHG-QCNRFFRDSA-N
NSC-757398,CAS 276;CAS-276;CORVASAL;CORVATON;CORVATON MITE;CORVATON RET;MOLSIDOMINE;MORSYDOMINE;NSC-757398,CHEMBL1256353;CHEMBL1329455,BRD:BRD-BRD-K63861289-001-19-6;BRD:BRD-K63861289-001-19-6,rep_primary;rep_single_dose,GUANYLATE CYCLASE STIMULANT,GUCY1A3,CORONARY ARTERY DISEASE (CAD),,LAUNCHED,,Small molecule,4,CCOC(=O)[N-]c1c[n+](N2CCOCC2)no1;CCOC(=O)NC1C[N+](NO1)N1CCOCC1,XLFWDASMENKTKL-UHFFFAOYSA-N
MOMETASONE-FUROATE,MOMETASONE-FUROATE,,BRD:BRD-BRD-K60640630-001-11-0;BRD:BRD-K60640630-001-11-0,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1CCCO1)C(=O)CCL, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(CL)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1CCCO1)C(=O)CCL",
MONASTROL,MONASTROL,CHEMBL236789,BRD:BRD-A78377521-001-05-5;BRD:BRD-BRD-A78377521-001-05-5,rep_primary;rep_single_dose,KINESIN INHIBITOR,KIF11,,,PRECLINICAL,,Small molecule,NA,"CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1;CCOC(=O)C1=C(C)NC(=S)NC1C1CCCC(O)C1, CCOC(=O)C1=C(C)NC(=S)NC1C1CCCC(O)C1",LOBCDGHHHHGHFA-UHFFFAOYSA-N
RUMENSIN [AS SODIUM SALT],67314;A-3823A;COBAN [AS SODIUM SALT];E714;MONENSIN;RUMENSIN [AS SODIUM SALT],CHEMBL256105,BRD:BRD-A06627858-236-03-0;BRD:BRD-BRD-A06627858-236-03-0,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL PERMEABILITY INDUCER,,,,LAUNCHED,,Small molecule,-1,"CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C, CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C, CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C;CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O3)O2)O1",GAOZTHIDHYLHMS-KEOBGNEYSA-N
MONEPANTEL,MONEPANTEL,CHEMBL256563,BRD:BRD-K00004607-001-01-9,rep_single_dose,MTOR INHIBITOR,,,,,,Small molecule,1,C[C@](C#N)(COc1cc(C#N)ccc1C(F)(F)F)NC(=O)c1ccc(SC(F)(F)F)cc1,WTERNLDOAPYGJD-SFHVURJKSA-N
P-BENZYLOXYPHENOL,BENOQUIN;MONOBENZONE;MONOBENZYL ETHER OF HYDROQUINONE;NSC-2132;P-(BENZYLOXY)PHENOL;P-BENZYLOXYPHENOL,CHEMBL1388,BRD:BRD-BRD-K54262262-001-09-0;BRD:BRD-K54262262-001-09-0,rep_multi_dose;rep_primary;rep_single_dose,MELANIN INHIBITOR,TYR,SKIN DEPIGMENTATION,,LAUNCHED,,Small molecule,4,"Oc1ccc(OCc2ccccc2)cc1;OC1CCC(OCC2CCCCC2)CC1, OC1CCC(OCC2CCCCC2)CC1, OC1CCC(OCC2CCCCC2)CC1, OC1CCC(OCC2CCCCC2)CC1",VYQNWZOUAUKGHI-UHFFFAOYSA-N
MONOCROTALINE,MONOCROTALINE,CHEMBL521035,BRD:BRD-K65508953-001-13-9,rep_single_dose,ANTITUMOR AGENT,,,,,,Small molecule,NA,C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23,QVCMHGGNRFRMAD-XFGHUUIASA-N
MONOOCTANOIN,CAPMUL 8210;MOCTANIN;MONOCTANOIN;MONOOCTANOIN,CHEMBL3301678;CHEMBL3304484,BRD:BRD-A48938994-001-14-1;BRD:BRD-BRD-A48938994-001-14-1,rep_primary;rep_single_dose,,,GALLSTONES,,LAUNCHED,,Small molecule,4,"CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC.CCCCCCCC(=O)OCC(O)CO.CCCCCCCCCC(=O)OCC(O)CO.OCC(O)CO;CCCCCCCC(=O)OCC(O)CO, CCCCCCCC(=O)OCC(O)CO",YTORMSBGFMQNEO-UHFFFAOYSA-N
MONOMETHYL-FUMARATE,MONOMETHYL-FUMARATE,,BRD:BRD-K00004695-001-01-9,rep_single_dose,,,,,,,,NA,,
MONOSODIUM-ALPHA-LUMINOL,MONOSODIUM-ALPHA-LUMINOL,,BRD:BRD-BRD-K52559566-001-02-9;BRD:BRD-K52559566-001-02-9,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,"NC1CCCC2C1C(=O)[NH][NH]C2=O, NC1CCCC2C1C(=O)[NH][NH]C2=O",
STEARIN,C16-18;C16-18 MONO-;CERASYNT SD;CERASYNT-SD;CITHROL GMS 0400;CREMOPHOR GMSK;CUTINA GMS;EASTMAN 600;FEMA NO. 2527;GLYCERIDES;GLYCEROL MONOSTEARATE;GLYCEROL STEARATE;GLYCEROLI MONOSTEARAS;GLYCERYL MONOPALMITOSTEARATE;GLYCERYL MONOSTEARATE;GLYCERYL STEARATE;IMWITOR 491;LONZEST GMS;MONO-;MONOGLYCERIDES;MONOSTEARIN;NIKKOL MGS-A;SORBON MG-100;STEARIN,CHEMBL255696,BRD:BRD-A31454688-001-01-6;BRD:BRD-BRD-A31454688-001-01-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO,VBICKXHEKHSIBG-UHFFFAOYSA-N
SINGULAIR,BRONDILAT;MK-476;MONTELUKAST;SINGULAIR,CHEMBL787,BRD:BRD-BRD-K69470111-236-08-9;BRD:BRD-K69470111-236-08-9,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,ALOX5;CYSLTR1,"ASTHMA, ALLERGIC RHINITIS, EXERCISE-INDUCED BRONCHOCONSTRICTION (EIB)",,LAUNCHED,,Small molecule,4,"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1;CC(C)(O)C1CCCCC1CC[C@@H](SCC1(CC(O)=O)CC1)C1CCCC(\C=C\C2CCC3CCC(CL)CC3N2)C1, CC(C)(O)C1CCCCC1CC[C@@H](SCC1(CC(O)=O)CC1)C1CCCC(\C=C\C2CCC3CCC(CL)CC3N2)C1, CC(C)(O)C1CCCCC1CC[C@@H](SCC1(CC(O)=O)CC1)C1CCCC(\C=C\C2CCC3CCC(CL)CC3N2)C1",UCHDWCPVSPXUMX-TZIWLTJVSA-N
MOPROLOL L-FORM,(-)-;(S)-;LEVOMOPROLOL;MOPROLOL;MOPROLOL L-FORM,CHEMBL156901;CHEMBL2106030,BRD:BRD-A51747092-003-03-0;BRD:BRD-BRD-A51747092-003-03-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,"HYPERTENSION, GLAUCOMA, ANXIETY",,LAUNCHED,,Small molecule,-1,COc1ccccc1OC[C@@H](O)CNC(C)C;COC1CCCCC1OCC(O)CNC(C)C,LFTFGCDECFPSQD-NSHDSACASA-N
MORICIZINE,EN-313;EN-313 FREE BASE;ETHMOZINE;MORACIZINE;MORICIZINE,CHEMBL1075,BRD:BRD-BRD-K21548250-003-19-1;BRD:BRD-K21548250-003-19-1,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN5A,VENTRICULAR ARRHYTHMIAS,,LAUNCHED,,Small molecule,4,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2;CCOC(=O)NC1CCC2SC3CCCCC3N(C(=O)CCN3CCOCC3)C2C1,FUBVWMNBEHXPSU-UHFFFAOYSA-N
MORANTEL,MORANTEL,CHEMBL1240978,BRD:BRD-K71454870-046-01-8,rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,,,Small molecule,-1,Cc1ccsc1/C=C/C1=NCCCN1C,NVEPPWDVLBMNMB-SNAWJCMRSA-N
NSC-19801,MORIN;NSC-19801,CHEMBL28626,BRD:BRD-BRD-K11590034-002-03-4;BRD:BRD-K11590034-002-03-4,rep_multi_dose;rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,ADORA2A;ESR2;FASN;MCL1;SLC22A12,,,PRECLINICAL,,Small molecule,NA,"O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12;OC1CCC(C(O)C1)-C1OC2CC(O)CC(O)C2C(=O)C1O, OC1CCC(C(O)C1)-C1OC2CC(O)CC(O)C2C(=O)C1O",YXOLAZRVSSWPPT-UHFFFAOYSA-N
MORPONIDAZOLE,MORINIDAZOLE;MORPONIDAZOLE,CHEMBL3884248,BRD:BRD-A40546373-001-01-8;BRD:BRD-BRD-A40546373-001-01-8,rep_primary;rep_single_dose,OTHER ANTIBIOTIC,CYP51A1,,,LAUNCHED,,Small molecule,-1,Cc1ncc([N+](=O)[O-])n1CC(O)CN1CCOCC1;CC1NCC(N1CC(O)CN1CCOCC1)[N+]([O-])=O,GAZGHCHCYRSPIV-UHFFFAOYSA-N
UP-164,MORNIFLUMATE;UP 164;UP-164,CHEMBL2105059,BRD:BRD-BRD-K38938675-001-01-4;BRD:BRD-K38938675-001-01-4,rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,FC(F)(F)C1CCCC(NC2NCCCC2C(=O)OCCN2CCOCC2)C1;O=C(OCCN1CCOCC1)c1cccnc1Nc1cccc(C(F)(F)F)c1,LDXSPUSKBDTEKA-UHFFFAOYSA-N
SKF-8898A,ABOB;MOROXYDINE;SKF 8898-A;SKF-8898-A;SKF-8898A,CHEMBL1490434,BRD:BRD-BRD-K57291914-003-09-4;BRD:BRD-K57291914-003-09-4,rep_primary;rep_single_dose,ANTIVIRAL,,INFLUENZA A VIRUS INFECTION,,LAUNCHED,,Small molecule,-1,"N=C(N)NC(=N)N1CCOCC1;NC(=N)NC(=N)N1CCOCC1, NC(=N)NC(=N)N1CCOCC1",KJHOZAZQWVKILO-UHFFFAOYSA-N
MORPHOTHIADIN,MORPHOTHIADIN,,BRD:BRD-K00003491-001-01-9,rep_single_dose,ANTIINFECTIVE DRUG,,,,,,,NA,,
MOSART,MOSAPRIDE;MOSART,CHEMBL60889,BRD:BRD-A39052811-048-11-0;BRD:BRD-BRD-A39052811-048-11-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR4,"HYPERTROPHIC GASTRITIS (GHG), GASTROESOPHAGEAL REFLUX DISEASE (GERD), DYSPEPSIA, IRRITABLE BOWEL SYNDROME",,LAUNCHED,,Small molecule,3,"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1;CCOC1CC(N)C(CL)CC1C(=O)NCC1CN(CC2CCC(F)CC2)CCO1, CCOC1CC(N)C(CL)CC1C(=O)NCC1CN(CC2CCC(F)CC2)CCO1",YPELFRMCRYSPKZ-UHFFFAOYSA-N
NAT-05-239,MOTAPIZONE;NAT-05-239,CHEMBL2104670,BRD:BRD-K00004657-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,-1,CC1CC(=O)NN=C1c1cc(-n2ccnc2)cs1,NPFVRBCDMFKOPY-UHFFFAOYSA-N
MOTESANIB,AMG 706;AMG-706;MOTESANIB,CHEMBL572881,BRD:BRD-BRD-K99616396-001-05-1;BRD:BRD-K99616396-001-05-1;GDSC1:1029,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",FLT1;FLT4;KDR;KIT,,,PHASE 3,,Small molecule,3,"CC1(C)CNC2CC(NC(=O)C3CCCNC3NCC3CCNCC3)CCC12, CC1(C)CNC2CC(NC(=O)C3CCCNC3NCC3CCNCC3)CCC12, CC1(C)CNC2CC(NC(=O)C3CCCNC3NCC3CCNCC3)CCC12, CC1(C)CNC2CC(NC(=O)C3CCCNC3NCC3CCNCC3)CCC12, CC1(C)CNC2CC(NC(=O)C3CCCNC3NCC3CCNCC3)CCC12;CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21",RAHBGWKEPAQNFF-UHFFFAOYSA-N
VTX-378,MOTOLIMOD;VTX-2337;VTX-378,CHEMBL3301618,BRD:BRD-BRD-K11785681-001-01-2;BRD:BRD-K11785681-001-01-2,rep_primary;rep_single_dose,TOLL-LIKE RECEPTOR AGONIST,TLR8,,,PHASE 1/PHASE 2,,Small molecule,2,CCCN(CCC)C(=O)C1=Cc2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2N=C(N)C1;CCCN(CCC)C(=O)C1=CC2CCC(CC2N=C(N)C1)-C1CCC(CC1)C(=O)N1CCCC1,QSPOQCXMGPDIHI-UHFFFAOYSA-N
MOXAVERINE,MOXAVERINE,CHEMBL2105060,BRD:BRD-BRD-K12742203-003-01-7;BRD:BRD-K12742203-003-01-7,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,SPASMS,,LAUNCHED,,Small molecule,2,CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1;CCC1CC2CC(OC)C(OC)CC2C(CC2CCCCC2)N1,MYCMTMIGRXJNSO-UHFFFAOYSA-N
NSC-760424,"CL 301,423;CL-301,423;CL-301423;MOXIDECTIN;MOXIDECTIN FOR VETERINARY USE;NSC-760424",CHEMBL2104415,BRD:BRD-BRD-K61988078-001-01-2;BRD:BRD-K61988078-001-01-2,rep_primary;rep_single_dose,CHLORIDE CHANNEL ANTAGONIST,,GASTROINTESTINAL PARASITES,,LAUNCHED,,Small molecule,4,CO/N=C1\C[C@]2(C[C@@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C4\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C;CO\N=C1\C[C@]2(C[C@@H]3C[C@@H](C\C=C(C)\C[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@@H]([C@H]1C)C(\C)=C\C(C)C,YZBLFMPOMVTDJY-LSGXYNIPSA-N
ZIMOXIN,AVELOX;AVELOX I.V.;AVELOX IV;MOXIFLOXACIN;VIGAMOX;ZIMOXIN,CHEMBL32,BRD:BRD-BRD-K66615216-003-14-8;BRD:BRD-K66615216-003-14-8,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,"SINUSITIS, BRONCHITIS, PNEUMONIA, SKIN INFECTIONS, INTRA-ABDOMINAL INFECTIONS",,LAUNCHED,,Small molecule,4,"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12;COC1C(N2C[C@@H]3CCCN[C@@H]3C2)C(F)CC2C1N(CC(C(O)=O)C2=O)C1CC1, COC1C(N2C[C@@H]3CCCN[C@@H]3C2)C(F)CC2C1N(CC(C(O)=O)C2=O)C1CC1",FABPRXSRWADJSP-MEDUHNTESA-N
THYMOXAMINE HYDROCHLORIDE,ACETOXYTHYMOXAMINE;CARLYTENE;ERECNOS;MOXISYLYTE;MOXISYLYTE HCL;MOXISYLYTE HYDROCHLORIDE;MOXIVIG;NSC-170448;THYMOXAMINE;THYMOXAMINE HCL;THYMOXAMINE HYDROCHLORIDE,CHEMBL159226,BRD:BRD-BRD-K81144366-003-19-7;BRD:BRD-K81144366-003-19-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,WITHDRAWN,,Small molecule,4,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C;CC(C)C1CC(OC(C)=O)C(C)CC1OCCN(C)C,VRYMTAVOXVTQEF-UHFFFAOYSA-N
PHYSIOTENS,BDF-5896;BDF5896;BE-5895;BE5895;CYNT;FISIOTENS;LY-326869;LY326869;MOXONIDINE;NORCYNT;NORMATENS;NUCYNT;PHYSIOTENS,CHEMBL19236,BRD:BRD-BRD-K77771411-003-10-7;BRD:BRD-K77771411-003-10-7,rep_primary;rep_single_dose,IMIDAZOLINE RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C,HYPERTENSION,,LAUNCHED,,Small molecule,4,"COc1nc(C)nc(Cl)c1NC1=NCCN1;COC1NC(C)NC(CL)C1NC1=NCCN1, COC1NC(C)NC(CL)C1NC1=NCCN1, COC1NC(C)NC(CL)C1NC1=NCCN1",WPNJAUFVNXKLIM-UHFFFAOYSA-N
MOZAVAPTANE,MOZAVAPTAN;MOZAVAPTANE,CHEMBL420762,BRD:BRD-A31095847-001-02-3;BRD:BRD-BRD-A31095847-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR ANTAGONIST,AVPR1A;AVPR1B;AVPR2,HYPONATREMIA,,LAUNCHED,,Small molecule,-1,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1;CN(C)C1CCCN(C(=O)C2CCC(NC(=O)C3CCCCC3C)CC2)C2CCCCC12,WRNXUQJJCIZICJ-UHFFFAOYSA-N
MP470,AMUVATINIB;HPK 56;HPK-56;HPK56;MP 470;MP-470;MP470,CHEMBL2103851,GDSC1:293,gdsc,,,,,,,Small molecule,2,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,FOFDIMHVKGYHRU-UHFFFAOYSA-N
MPEP,MPEP,,BRD:BRD-BRD-K60690191-001-03-3;BRD:BRD-K60690191-001-03-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM1;GRM4;GRM5,,,PRECLINICAL,,,NA,"CC1CCCC(N1)C#CC1CCCCC1, CC1CCCC(N1)C#CC1CCCCC1, CC1CCCC(N1)C#CC1CCCCC1",
MPI-0479605,MPI-0479605,,BRD:BRD-BRD-K45551181-001-02-1;BRD:BRD-K45551181-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,MITOTIC KINASE INHIBITOR,TTK,,,PRECLINICAL,,,NA,"CC1CC(CCC1NC1NC(NC2CCCCC2)C2[NH]CNC2N1)N1CCOCC1, CC1CC(CCC1NC1NC(NC2CCCCC2)C2[NH]CNC2N1)N1CCOCC1, CC1CC(CCC1NC1NC(NC2CCCCC2)C2[NH]CNC2N1)N1CCOCC1, CC1CC(CCC1NC1NC(NC2CCCCC2)C2[NH]CNC2N1)N1CCOCC1",
MPS-1-IN-1,MPS-1-IN-1,,GDSC1:294,gdsc,,,,,,,,NA,,
MPS-BAY-2A,MPS-BAY-2A,,BRD:BRD-K18530250-001-02-9,rep_single_dose,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,TTK,,,,,,NA,,
MPS1-IN-1,MPS1-IN-1,,BRD:BRD-K94853001-300-04-9,rep_single_dose,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,TTK,,,,,,NA,,
MPS1-IN-5,(-)-BAY-1161909;BAY 1161909;BAY-1161909;EMPESERTIB;MPS1-IN-5,CHEMBL4303241,BRD:BRD-K43812936-001-01-9,rep_single_dose,PROTEIN KINASE INHIBITOR,,,,,,Small molecule,1,COc1cc(S(C)(=O)=O)ccc1Nc1nc2ccc(-c3ccc(NC(=O)[C@H](C)c4ccc(F)cc4)cc3)cn2n1,NRJKIOCCERLIDG-GOSISDBHSA-N
MR-16728,MR-16728,,BRD:BRD-A30590053-003-02-9;BRD:BRD-BRD-A30590053-003-02-9,rep_primary;rep_single_dose,ACETYLCHOLINE RELEASE ENHANCER,,,,PRECLINICAL,,,NA,O=C(NCCCN1CCCCCC1)C(C1CCCCC1)C1CCCCC1,
MR-948,MR-948,,BRD:BRD-BRD-K84883208-001-01-1;BRD:BRD-K84883208-001-01-1,rep_primary;rep_single_dose,THROMBOXANE SYNTHASE INHIBITOR,TBXAS1,,,PHASE 1,,,NA,OCCC1CCC(OCCN2CCNC2)CC1,
MRK-016,MRK-016,,BRD:BRD-BRD-K44022883-001-01-7;BRD:BRD-K44022883-001-01-7,rep_primary;rep_single_dose,GABA RECEPTOR INVERSE AGONIST,GABRA1;GABRA2;GABRA3;GABRA5,,,PHASE 1,,,NA,"CC1CC(NO1)-C1NNCC2C(C(OCC3NCNN3C)NN12)C(C)(C)C, CC1CC(NO1)-C1NNCC2C(C(OCC3NCNN3C)NN12)C(C)(C)C",
MRK-409,MRK-409,,BRD:BRD-BRD-K57416838-001-01-1;BRD:BRD-K57416838-001-01-1,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,,,,PHASE 1,,,NA,"CN1NCNC1COC1NN2C(NNC2CC1C1CCC1)-C1C(F)CCCC1F, CN1NCNC1COC1NN2C(NNC2CC1C1CCC1)-C1C(F)CCCC1F",
MRK-560,MRK-560,CHEMBL1091513,BRD:BRD-K68795758-001-02-9,rep_single_dose,GAMMA SECRETASE INHIBITOR,APP,,,,,Small molecule,NA,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,WDZVWDXOIGQJIO-UHFFFAOYSA-N
MRS-1220,MRS-1220,,BRD:BRD-BRD-K37618799-001-03-0;BRD:BRD-K37618799-001-03-0,rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA2B;ADORA3,,,PRECLINICAL,,,NA,"CLC1CCC2NC(NC(=O)CC3CCCCC3)N3NC(NC3C2C1)-C1CCCO1, CLC1CCC2NC(NC(=O)CC3CCCCC3)N3NC(NC3C2C1)-C1CCCO1",
MRS-1334,MRS-1334,,BRD:BRD-A06784547-001-03-9,rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA3,,,,,,NA,,
MRS1845,MRS-1845;MRS1845,,BRD:BRD-A78093359-001-06-3;BRD:BRD-BRD-A78093359-001-06-3,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,CCOC(=O)C1=C(C)N(CC#C)C(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC,
MRS3777,MRS-3777;MRS3777,,BRD:BRD-BRD-K10575656-034-01-0;BRD:BRD-BRD-M86143595-034-03-4;BRD:BRD-K10575656-034-01-0;BRD:BRD-M86143595-034-03-4,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,"Multiple values for SMILES: {'C1CCC(CC1)NC1NC(OC2CCCCC2)NC2[NH]CNC12', 'C1CCC(CC1)NC1NC(OC2CCCCC2)NC2[NH]CNC12.C1CCC(CC1)NC1NC(OC2CCCCC2)NC2[NH]CNC12'}, defaulting to 'C1CCC(CC1)NC1NC(OC2CCCCC2)NC2[NH]CNC12.C1CCC(CC1)NC1NC(OC2CCCCC2)NC2[NH]CNC12'
Multiple values for repurposing_target: {'ADORA2A', 'ADORA1;ADORA2A;ADORA2B;ADORA3'}, taking the union
Multiple values for structure_id: {'K10575656', 'M86143595'}, defaulting to None",,NA,C1CCC(CC1)NC1NC(OC2CCCCC2)NC2[NH]CNC12.C1CCC(CC1)NC1NC(OC2CCCCC2)NC2[NH]CNC12,
MRT68921,MRT68921,,BRD:BRD-K00002753-001-02-9,oncref_2,INHIBITOR OF ULK1 AND ULK2,ULK1;ULK2,,,,,,NA,,
MRTX-1133,MRTX-1133,,BRD:BRD-U00115284-001-01-9,oncref_1,INHIBITOR OF KRAS-G12D,KRAS,,,,,,NA,,
MRTX-1257,MRTX-1257,,BRD:BRD-K00006887-001-02-9,oncref_1,INHIBITOR OF KRAS-G12C,KRAS,,,,,,NA,,
MRTX-1719,MRTX-1719,,BRD:BRD-U00115283-001-01-9,oncref_1,MTA-COOPERATIVE INHIBITOR OF PRMT5,PRMT5,,,,,,NA,,
MRTX-9768,MRTX-9768,,BRD:BRD-U00115282-001-01-9,oncref_1,MTA-COOPERATIVE INHIBITOR OF PRMT5,PRMT5,,,,,,NA,,
MRTX0902,MRTX0902,,BRD:BRD-K00126473-001-01-9,oncref_2,INHIBITOR OF SOS1,SOS1,,,,,,NA,,
MRTX1133,MRTX1133,,BRD:BRD-K00104122-001-01-9,rep_single_dose,,,,,,,,NA,,
UNC-2371A,MRX-2843;UNC-2371A,CHEMBL4650408,BRD:BRD-K00003417-001-01-9,rep_single_dose,MER TYROSINE KINASE INHIBITOR,,,,,,Unknown,1,,
SNDX-275,ENTINOSTAT;MS-27-275;MS-275;MS-275-27;SNDX-275,CHEMBL27759,GDSC1:88;GDSC2:1593,gdsc,,,,,,,Small molecule,3,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,INVTYAOGFAGBOE-UHFFFAOYSA-N
MS-424,MS-424,,BRD:BRD-K00004683-001-01-9,rep_single_dose,GLUTAMATE TRANSPORTER MODULATOR,,,,,,,NA,,
MS4078,MS4078,,BRD:BRD-U00114871-001-01-9,oncref_1,CERITINIB-BASED DEGRADER OF ALK,ALK,,,,,,NA,,
MSC2360844,IOA 244;IOA-244;IOA244;MSC-2360844;MSC2360844,CHEMBL3683575,BRD:BRD-K00091079-001-01-9,rep_single_dose,,,,,,,Small molecule,1,O=C(c1nn(-c2ccc(CN3CCOCC3)cc2)c2c1CS(=O)(=O)c1c(F)cccc1-2)N1CCOCC1,NFHSJYKXENYICE-UHFFFAOYSA-N
U-91325,CAY-10415;J730.386F;MITOGLITAZONE;MSD-9;MSDC-0160;PNU-91325;U-91325,CHEMBL146624,BRD:BRD-K00003381-001-01-9,rep_single_dose,INSULIN SENSITIZER,,,,,,Small molecule,2,CCc1ccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1,IRNJSRAGRIZIHD-UHFFFAOYSA-N
MSDC-0602K,MSDC-0602K,,BRD:BRD-K00004703-001-01-9,rep_single_dose,MITOCHONDRIAL PYRUVATE CARRIER MODULATOR,,,,,,,NA,,
MST-312,MST-312,,CTRP:411865;GDSC2:1930,ctrp;gdsc,,,,,,,,NA,,
MSX-122,MSX 122;MSX-122,CHEMBL3545330,BRD:BRD-BRD-K25143390-001-01-0;BRD:BRD-K25143390-001-01-0,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR4,,,PHASE 1,,Small molecule,1,C(NC1NCCCN1)C1CCC(CNC2NCCCN2)CC1;c1cnc(NCc2ccc(CNc3ncccn3)cc2)nc1,PXZXYRKDDXKDTK-UHFFFAOYSA-N
MTPG,MTPG,,BRD:BRD-A28329383-001-02-1;BRD:BRD-BRD-A28329383-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM2;GRM3,,,PRECLINICAL,,,NA,CC(N)(C(O)=O)C1CCC(CC1)-C1NNN[NH]1,
TAK-165,MUBRITINIB;TAK-165,CHEMBL1614707,BRD:BRD-BRD-K19061412-001-02-4;BRD:BRD-K19061412-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,EGFR;ERBB2,,,PHASE 1,,Small molecule,1,"FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1;FC(F)(F)C1CCC(\C=C\C2NC(COC3CCC(CCCCN4CCNN4)CC3)CO2)CC1, FC(F)(F)C1CCC(\C=C\C2NC(COC3CCC(CCCCN4CCNN4)CC3)CO2)CC1, FC(F)(F)C1CCC(\C=C\C2NC(COC3CCC(CCCCN4CCNN4)CC3)CO2)CC1",ZTFBIUXIQYRUNT-MDWZMJQESA-N
TURIXIN,BACTODERM;BACTROBAN;BRL 4910A;BRL 4910F;BRL-4910A;BRL-4910F;CALCIUM MUPIROCIN;CALCIUM MUPIROCIN DIHYDRATE;CALCIUM PSEUDOMONATE;CENTANY;MUPIROCIN;MUPIROCIN CALCIUM;MUPIROCIN CALCIUM ANHYDROUS;MUPIROCIN CALCIUM DIHYDRATE;MUPIROCIN CALCIUM HYDRATE;NSC-759182;PSEUDOMONIC ACID;TRANS-PSEUDOMONIC ACID;TURIXIN,CHEMBL2068726;CHEMBL3989715;CHEMBL719,BRD:BRD-BRD-K15262564-001-15-0;BRD:BRD-K15262564-001-15-0,rep_primary;rep_single_dose,ISOLEUCYL-TRNA SYNTHETASE INHIBITOR,,IMPETIGO,,LAUNCHED,,Small molecule,4,"C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O, C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O, C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O;C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O",MINDHVHHQZYEEK-HBBNESRFSA-N
PANTHERINE,AGARIN;MUSCIMOL;NSC-333569;PANTHERINE,CHEMBL273481,BRD:BRD-BRD-K60441002-001-04-8;BRD:BRD-K60441002-001-04-8,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRR1;GABRR2;GABRR3,,,PHASE 1,,Small molecule,1,NCc1cc(O)no1;NCC1CC(O)NO1,ZJQHPWUVQPJPQT-UHFFFAOYSA-N
MUT056399,MUT056399,,BRD:BRD-BRD-K72078047-001-01-7;BRD:BRD-K72078047-001-01-7,rep_primary;rep_single_dose,FABI INHIBITOR,,,,PHASE 1,,,NA,CCC1CC(O)C(OC2CCC(CC2F)C(N)=O)CC1F,
MW150,MW 150;MW-150;MW150,CHEMBL4129018,BRD:BRD-K00091273-001-01-9,rep_single_dose,,,,,,,Small molecule,2,CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccccc4c3)nn2)CC1,CIIVUDIZZJLXCN-UHFFFAOYSA-N
MY-5445,MY-5445,,BRD:BRD-BRD-K90524085-001-07-8;BRD:BRD-K90524085-001-07-8,rep_primary;rep_single_dose,"PHOSPHODIESTERASE INHIBITOR, PLATELET AGGREGATION INHIBITOR",PDE5A,,,PRECLINICAL,,,NA,"CLC1CCCC(NC2NNC(-C3CCCCC3)C3CCCCC23)C1, CLC1CCCC(NC2NNC(-C3CCCCC3)C3CCCCC23)C1",
MYCOPHENOLATE-MOFETIL,MYCOPHENOLATE-MOFETIL,,BRD:BRD-BRD-K92428153-001-04-4;BRD:BRD-K92428153-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,"DEHYDROGENASE INHIBITOR, INOSITOL MONOPHOSPHATASE INHIBITOR",IMPDH1;IMPDH2,ORGAN REJECTION,,LAUNCHED,,,NA,"COC1C(C)C2COC(=O)C2C(O)C1C\C=C(/C)CCC(=O)OCCN1CCOCC1, COC1C(C)C2COC(=O)C2C(O)C1C\C=C(/C)CCC(=O)OCCN1CCOCC1, COC1C(C)C2COC(=O)C2C(O)C1C\C=C(/C)CCC(=O)OCCN1CCOCC1",
MYCOPHENOLIC-ACID,MYCOPHENOLIC-ACID,,BRD:BRD-BRD-K63750851-001-20-7;BRD:BRD-K63750851-001-20-7,rep_multi_dose;rep_primary;rep_single_dose,"DEHYDROGENASE INHIBITOR, INOSITOL MONOPHOSPHATASE INHIBITOR",IMPDH1;IMPDH2,ORGAN REJECTION,,LAUNCHED,,,NA,"COC1C(C)C2COC(=O)C2C(O)C1C\C=C(/C)CCC(O)=O, COC1C(C)C2COC(=O)C2C(O)C1C\C=C(/C)CCC(O)=O, COC1C(C)C2COC(=O)C2C(O)C1C\C=C(/C)CCC(O)=O, COC1C(C)C2COC(=O)C2C(O)C1C\C=C(/C)CCC(O)=O",
NSC-407290,MYRICETIN;NSC-407290,CHEMBL164,BRD:BRD-BRD-K43149758-001-22-7;BRD:BRD-K43149758-001-22-7;CTRP:29985,ctrp;rep_primary;rep_single_dose,"ANDROGEN RECEPTOR AGONIST, CYTOCHROME P450 INHIBITOR",PIK3CG,,,PRECLINICAL,,Small molecule,NA,"O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12;OC1CC(O)C2C(C1)OC(-C1CC(O)C(O)C(O)C1)C(O)C2=O, OC1CC(O)C2C(C1)OC(-C1CC(O)C(O)C(O)C1)C(O)C2=O",IKMDFBPHZNJCSN-UHFFFAOYSA-N
MYRICITRIN,MYRICITRIN,CHEMBL454576,BRD:BRD-BRD-K29834313-001-01-4;BRD:BRD-K29834313-001-01-4,rep_primary;rep_single_dose,PKC INHIBITOR,NOS1;PRKCA,,,PRECLINICAL,,Small molecule,NA,C[C@@H]1O[C@@H](OC2C(OC3CC(O)CC(O)C3C2=O)-C2CC(O)C(O)C(O)C2)[C@@H](O)[C@H](O)[C@H]1O;C[C@H]1O[C@@H](Oc2c(-c3cc(O)c(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@@H](O)[C@@H](O)[C@@H]1O,DCYOADKBABEMIQ-FHAIKQJESA-N
MYRIOCIN,MYRIOCIN,CHEMBL55076,CTRP:417977,ctrp,,,,,,,Small molecule,NA,CCCCCCC(=O)CCCCCC/C=C/C[C@@H](O)[C@H](O)[C@@](N)(CO)C(=O)O,ZZIKIHCNFWXKDY-GNTQXERDSA-N
"N-(2-BROMO-6-FLUOROPHENYL)-4,5-DIHYDRO-1H-IMIDAZOL","N-(2-BROMO-6-FLUOROPHENYL)-4,5-DIHYDRO-1H-IMIDAZOL",,BRD:BRD-K00077192-001-02-9,rep_single_dose,,,,,,,,NA,,
N-(P-AMYLCINNAMOYL)-ANTHRANILIC-ACID,N-(P-AMYLCINNAMOYL)-ANTHRANILIC-ACID,,BRD:BRD-K77817104-001-02-9,rep_single_dose,PHOSPHOLIPASE INHIBITOR,,,,,,,NA,,
N-ACETYL-D-GLUCOSAMINE,N-ACETYL-D-GLUCOSAMINE,,BRD:BRD-BRD-K80653534-001-01-7;BRD:BRD-K80653534-001-01-7,rep_primary;rep_single_dose,,B4GALT1;B4GALT2;B4GALT3;B4GALT4;NAGK;NAGLU;NAGPA;RENBP,,,PHASE 2/PHASE 3,,,NA,CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,
N-ACETYL-TYROSINE,N-ACETYL-TYROSINE,,BRD:BRD-A24857382-001-03-4;BRD:BRD-BRD-A24857382-001-03-4,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,CC(=O)NC(CC1CCC(O)CC1)C(O)=O,
N-ACETYLCARNOSINE,N-ACETYLCARNOSINE,,BRD:BRD-BRD-K52523550-001-01-5;BRD:BRD-K52523550-001-01-5,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CC(=O)NCCC(=O)N[C@@H](CC1C[NH]CN1)C(O)=O,
N-ACETYLCYSTEINE AMIDE,N-ACETYLCYSTEINE AMIDE,,BRD:BRD-K00091105-001-01-9,rep_single_dose,,,,,,,,NA,,
N-ACETYLGLYCYL-D-GLUTAMIC-ACID,N-ACETYLGLYCYL-D-GLUTAMIC-ACID,,BRD:BRD-BRD-K28121004-001-01-1;BRD:BRD-K28121004-001-01-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,"CC(=O)NCC(=O)N[C@H](CCC(O)=O)C(O)=O, CC(=O)NCC(=O)N[C@H](CCC(O)=O)C(O)=O",
N-ACETYLMANNOSAMINE,DEX-M74;MANNAC;N-ACETYLMANNOSAMINE,CHEMBL1231391,BRD:BRD-A92872453-001-01-8;BRD:BRD-BRD-A92872453-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,,CHIT1,,,PHASE 1,,Small molecule,2,CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O;CC(=O)NC1[C@@H](O)OC(CO)[C@@H](O)[C@H]1O,OVRNDRQMDRJTHS-UOLFYFMNSA-N
N-ACETYLTRYPTAMINE,N-ACETYLTRYPTAMINE,,BRD:BRD-BRD-K73700643-001-11-2;BRD:BRD-K73700643-001-11-2,rep_primary;rep_single_dose,MELATONIN RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,"CC(=O)NCCC1C[NH]C2CCCCC12, CC(=O)NCCC1C[NH]C2CCCCC12",
N-ALPHA-METHYLHISTAMINE-DIHYDROCHLORIDE,N-ALPHA-METHYLHISTAMINE-DIHYDROCHLORIDE,,BRD:BRD-BRD-K64422603-300-02-7;BRD:BRD-K64422603-300-02-7,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH4,,,PHASE 3,,,NA,CNCCC1CNC[NH]1,
N-BENZYLNALTRINDOLE,N-BENZYLNALTRINDOLE,,BRD:BRD-A33514596-003-01-2;BRD:BRD-BRD-A33514596-003-01-2,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,OC1CCC2CC3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C1C(C[C@@]35O)C2CCCCC2N1CC1CCCCC1,
N-HYDROXYNICOTINAMIDE,N-HYDROXYNICOTINAMIDE,,BRD:BRD-BRD-K28030264-001-02-7;BRD:BRD-K28030264-001-02-7,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,ONC(=O)C1CCCNC1,
"N-METHYL-(-)EPHEDRINE-[1R,2S]","N-METHYL-(-)EPHEDRINE-[1R,2S]",,BRD:BRD-BRD-K82236108-001-04-9;BRD:BRD-K82236108-001-04-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,C[C@@H]([C@H](O)C1CCCCC1)N(C)C,
N-METHYLFORMAMIDE,N-METHYLFORMAMIDE,,BRD:BRD-K33445938-001-01-8,rep_single_dose,,,,,,,,NA,,
N-METHYLLIDOCAINE-IODIDE,N-METHYLLIDOCAINE-IODIDE,,BRD:BRD-BRD-K60060639-005-02-2;BRD:BRD-K60060639-005-02-2,rep_primary;rep_single_dose,ANTIARRHYTHMIC MEDICATION,,,,PRECLINICAL,,,NA,CC[N+](C)(CC)CC(=O)NC1C(C)CCCC1C,
N-METHYLQUIPAZINE,N-METHYLQUIPAZINE,,BRD:BRD-BRD-K62056274-332-01-8;BRD:BRD-K62056274-332-01-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1D;HTR2A;HTR2B;HTR2C;HTR3A;HTR3B;HTR6;SLC6A4,,,PRECLINICAL,,,NA,CN1CCN(CC1)C1CCC2CCCCC2N1,
N-MPPP,N-MPPP,,BRD:BRD-BRD-K93806173-003-01-8;BRD:BRD-K93806173-003-01-8,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,CN([C@H](CN1CCCC1)C1CCCCC1)C(=O)CC1CCCCC1,
N-SALICOYLAMINOPHENOL,N-SALICOYLAMINOPHENOL,,BRD:BRD-BRD-K39693230-001-01-2;BRD:BRD-K39693230-001-01-2,rep_primary;rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,,,,PRECLINICAL,,,NA,OC1CCC(NC(=O)C2CCCCC2O)CC1,
N-[2-(PIPERIDINYLAMINO)ETHYL]-4-IODOBENZAMIDE,N-[2-(PIPERIDINYLAMINO)ETHYL]-4-IODOBENZAMIDE,,BRD:BRD-BRD-K78844995-001-02-6;BRD:BRD-K78844995-001-02-6,rep_primary;rep_single_dose,SIGMA RECEPTOR LIGAND,,,,PRECLINICAL,,,NA,IC1CCC(CC1)C(=O)NCCN1CCCCC1,
N1-(B-D-RIBOFURANOSYL)-5-AMINOIMIDAZOLE-4-CARBOXAMIDE,AICA RIBONUCLEOTIDE;AICAR;N1-(B-D-RIBOFURANOSYL)-5-AMINOIMIDAZOLE-4-CARBOXAMIDE,,GDSC1:1001,gdsc,,,,,,,,NA,,
N20C,N20C,,BRD:BRD-BRD-K41143549-003-02-4;BRD:BRD-K41143549-003-02-4,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,NC(=O)CNCCC(C1CCCCC1)C1CCCCC1,
N6-CYCLOPENTYLADENOSINE,CCPA;CYCLOPENTYLADENOSINE;N6-CYCLOPENTYLADENOSINE,CHEMBL68738,BRD:BRD-BRD-K60150510-001-15-6;BRD:BRD-K60150510-001-15-6,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3;SLC29A1,,,PRECLINICAL,,Small molecule,NA,OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(NC3CCCC3)NCNC12,SQMWSBKSHWARHU-SDBHATRESA-N
N6-METHYLADENOSINE,N6-METHYLADENOSINE,,BRD:BRD-BRD-K81807412-001-10-6;BRD:BRD-K81807412-001-10-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CNC1NCNC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,
N6022,N-6022;N6022,CHEMBL1738699,BRD:BRD-BRD-K82522873-001-01-1;BRD:BRD-K82522873-001-01-1,rep_primary;rep_single_dose,ALCOHOL DEHYDROGENASE INHIBITOR,ADH5,,,PHASE 1/PHASE 2,,Small molecule,3,Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1;CC1CC(CCC1-N1C(CCC(O)=O)CCC1-C1CCC(CC1)-N1CCNC1)C(N)=O,YVPGZQLRPAGKLA-UHFFFAOYSA-N
N9-ISOPROPYLOLOMOUCINE,N9-ISOPROPYLOLOMOUCINE,,CTRP:45093,ctrp,,,,,,,,NA,,
NAB-2,NAB-2,,BRD:BRD-BRD-K36804890-001-01-9;BRD:BRD-K36804890-001-01-9,rep_primary;rep_single_dose,UBIQUITIN LIGASE TRANSPORT PROMOTER,NEDD4,,,PRECLINICAL,,,NA,CC1CCC(C)C(C1)-N1CNC2CC(CCC12)C(=O)NCC1CCCCC1CL,
RELIFEX,BRL 14777;BRL-14777;NABUMETONE;NSC-758623;RELAFEN;RELIFEX,CHEMBL1070,BRD:BRD-BRD-K65146499-001-27-9;BRD:BRD-K65146499-001-27-9,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS",,LAUNCHED,,Small molecule,4,"COc1ccc2cc(CCC(C)=O)ccc2c1;COC1CCC2CC(CCC(C)=O)CCC2C1, COC1CCC2CC(CCC(C)=O)CCC2C1",BLXXJMDCKKHMKV-UHFFFAOYSA-N
NSC-20272,.BETA.-NAD;CO-I;CODEHYDROGENASE;CODEHYDROGENASE I;COENZYME I;COZYMASE;DIPHOSPHOPYRIDINE NUCLEOTIDE;DPN;NAD;NAD+;NADIDE;NADIDUM;NICOTINAMIDE ADENINE DINUCLEOTIDE;NICOTINAMIDE ADININE DINUCLEOTIDE;NICOTINAMIDE-ADENINE DINUCLEOTIDE;NSC-20272,CHEMBL1234613,BRD:BRD-A11132253-001-08-2;BRD:BRD-BRD-A11132253-001-08-2,rep_multi_dose;rep_primary;rep_single_dose,ELECTRON ACCEPTOR,AHCY;AKR1A1;ALDH2;BLVRA;DHPS;DLD;GALE;HMGCR;HSD17B1;HSD17B4;IMPDH2;MGAM;P2RY11;SORD;TRPM2,,,LAUNCHED,,Small molecule,-1,NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1;NC(=O)C1CCC[N+](C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2CNC3C(N)NCNC23)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N
OPC-7251,ACUATIM;JINOFLOXACIN;NADIFLOXACIN;NSC-759622;OPC 7251;OPC-7251,CHEMBL363449,BRD:BRD-A24397426-001-10-4;BRD:BRD-BRD-A24397426-001-10-4,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,"ACNE VULGARIS (AV), SKIN INFECTIONS",,LAUNCHED,,Small molecule,3,"CC1CCc2c(N3CCC(O)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23;CC1CCC2C(N3CCC(O)CC3)C(F)CC3C2N1CC(C(O)=O)C3=O, CC1CCC2C(N3CCC(O)CC3)C(F)CC3C2N1CC(C(O)=O)C3=O",JYJTVFIEFKZWCJ-UHFFFAOYSA-N
NAFADOTRIDE,NAFADOTRIDE,CHEMBL286252,BRD:BRD-A71262238-001-08-4;BRD:BRD-BRD-A71262238-001-08-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3;HTR1A,,,PRECLINICAL,,Small molecule,NA,CCCCN1CCCC1CNC(=O)c1cc(C#N)c2ccccc2c1OC;CCCCN1CCCC1CNC(=O)C1CC(C#N)C2CCCCC2C1OC,IDZASIQMRGPBCQ-UHFFFAOYSA-N
NAFAMOSTAT,NAFAMOSTAT,CHEMBL273264,BRD:BRD-BRD-K06674495-334-03-2;BRD:BRD-K06674495-334-03-2,rep_primary;rep_single_dose,SERINE PROTEASE INHIBITOR,ASIC1;ASIC2;ASIC3;C1R;PRSS1;TPSAB1;TRPM7,,,LAUNCHED,,Small molecule,3,"N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1;NC(=N)NC1CCC(CC1)C(=O)OC1CCC2CC(CCC2C1)C(N)=N, NC(=N)NC1CCC(CC1)C(=O)OC1CCC2CC(CCC2C1)C(N)=N, NC(=N)NC1CCC(CC1)C(=O)OC1CCC2CC(CCC2C1)C(N)=N",MQQNFDZXWVTQEH-UHFFFAOYSA-N
UNIPEN,NAFCILLIN;NALLPEN;UNIPEN,CHEMBL1443,BRD:BRD-BRD-K18574842-236-17-7;BRD:BRD-BRD-K18574842-323-10-8;BRD:BRD-K18574842-236-17-7;BRD:BRD-K18574842-323-10-8,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,CYP1A2;CYP3A4;SLC22A6,GRAM-POSITIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O;CCOC1CCC2CCCCC2C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O, CCOC1CCC2CCCCC2C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O, CCOC1CCC2CCCCC2C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O",GPXLMGHLHQJAGZ-JTDSTZFVSA-N
PRAXILENE,CITOXID;DI-ACTANE;DROSUNAL;DUBIMAX;DUSODRIL;EU-1806;GEVATRAN;LS-121;NAFRONYL;NAFRONYL ACID OXALATE;NAFRONYL OXALATE;NAFTIDROFURYL;NAFTIDROFURYL HYDROGEN OXALATE;NAFTIDROFURYL OXALATE;NSC-225233;PRAXILENE,CHEMBL1439099;CHEMBL1443491;CHEMBL1620794,BRD:BRD-A67862938-034-14-9;BRD:BRD-BRD-A67862938-034-14-9,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,CLAUDICATION,,LAUNCHED,,Small molecule,-1,CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC1CCCO1.O=C(O)C(=O)O;CCN(CC)CCOC(=O)C(CC1CCCO1)CC1CCCC2CCCCC12,SSAJNPNVUYMUCI-UHFFFAOYSA-N
NAFTIFINE,AW-105-843;NAFT-500;NAFTIFINE,CHEMBL626,BRD:BRD-BRD-K74141488-003-11-2;BRD:BRD-K74141488-003-11-2,rep_multi_dose;rep_primary;rep_single_dose,FUNGAL SQUALENE EPOXIDASE INHIBITOR,SQLE,"TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS",,LAUNCHED,,Small molecule,4,"CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12;CN(C\C=C\C1CCCCC1)CC1CCCC2CCCCC12, CN(C\C=C\C1CCCCC1)CC1CCCC2CCCCC12",OZGNYLLQHRPOBR-DHZHZOJOSA-N
NSC-759293,FLIVAS;NAFTOPIDIL;NSC-759293,CHEMBL142635,BRD:BRD-A01787639-003-16-9;BRD:BRD-BRD-A01787639-003-16-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A,BENIGN PROSTATIC HYPERPLASIA (BPH),,LAUNCHED,,Small molecule,3,"COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1;COC1CCCCC1N1CCN(CC(O)COC2CCCC3CCCCC23)CC1, COC1CCCCC1N1CCN(CC(O)COC2CCCC3CCCCC23)CC1, COC1CCCCC1N1CCN(CC(O)COC2CCCC3CCCCC23)CC1, COC1CCCCC1N1CCN(CC(O)COC2CCCC3CCCCC23)CC1, COC1CCCCC1N1CCN(CC(O)COC2CCCC3CCCCC23)CC1, COC1CCCCC1N1CCN(CC(O)COC2CCCC3CCCCC23)CC1, COC1CCCCC1N1CCN(CC(O)COC2CCCC3CCCCC23)CC1",HRRBJVNMSRJFHQ-UHFFFAOYSA-N
NAKITERPIOSIN,NAKITERPIOSIN,,CTRP:417452,ctrp,,,,,,,,NA,,
NUBAIN,EN-2234A;INTAPAN;NALBUFINE HYDROCHLORIDE;NALBUPHINE;NALBUPHINE HCL;NALBUPHINE HYDROCHLORIDE;NSC-757829;NUBAIN,CHEMBL1201132;CHEMBL895,BRD:BRD-BRD-K66404838-310-01-1;BRD:BRD-K66404838-310-01-1,rep_primary;rep_single_dose,"OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST",OPRD1;OPRK1;OPRM1,PAIN RELIEF,,LAUNCHED,,Small molecule,4,"Cl.Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314;O[C@H]1CC[C@@]2(O)[C@H]3CC4CCC(O)C5O[C@@H]1[C@]2(CCN3CC1CCC1)C45, O[C@H]1CC[C@@]2(O)[C@H]3CC4CCC(O)C5O[C@@H]1[C@]2(CCN3CC1CCC1)C45;Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314",NETZHAKZCGBWSS-CEDHKZHLSA-N;YZLZPSJXMWGIFH-BCXQGASESA-N
NALFURAFINE,MT-9938;NALFURAFINE,CHEMBL267495,BRD:BRD-BRD-K89272869-003-01-8;BRD:BRD-K89272869-003-01-8,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRK1;OPRM1,UREMIC PRURITUS,,LAUNCHED,,Small molecule,3,CN([C@@H]1CC[C@@]2(O)[C@H]3CC4CCC(O)C5O[C@@H]1[C@]2(CCN3CC1CC1)C45)C(=O)\C=C\C1CCOC1;CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,XGZZHZMWIXFATA-UEZBDDGYSA-N
NALIDIXIC-ACID,NALIDIXIC-ACID,,BRD:BRD-BRD-K47886988-001-21-4;BRD:BRD-K47886988-001-21-4,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,URINARY TRACT INFECTIONS,,LAUNCHED,,,NA,"CCN1CC(C(O)=O)C(=O)C2CCC(C)NC12, CCN1CC(C(O)=O)C(=O)C2CCC(C)NC12",
SRD174,JF-1;JKB-121;NALMEFENE;NALMEFENE HYDROCHLORIDE DIHYDRATE;NALMEFENE HYDROCHLORIDE HYDRATE;NALMETRENE;ORF 1167;ORF 11676;ORF-1167;ORF-11676;REVEX;SELINCRO;SRD-174;SRD174,CHEMBL982,BRD:BRD-A72767275-003-01-6;BRD:BRD-BRD-A72767275-003-01-6,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1,RESPIRATORY DEPRESSION,,LAUNCHED,,Small molecule,4,"C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5;OC1CCC2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C(=C)CC[C@@]35O, OC1CCC2CC3N(CC4CC4)CCC45C(OC1C24)C(=C)CCC35O",WJBLNOPPDWQMCH-MBPVOVBZSA-N
NKTR-118,AZ-13337019;MOVENTIG;NALOXEGOL;NKTR-118,CHEMBL2219418,BRD:BRD-BRD-K41458421-034-01-6;BRD:BRD-K41458421-034-01-6,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRM1,CONSTIPATION,,LAUNCHED,,Small molecule,4,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5;COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4CCC(O)C5O[C@@H]1[C@]2(CCN3CC=C)C45,XNKCCCKFOQNXKV-ZRSCBOBOSA-N
SUBOXONE,DBL NALOXONE;NALONE;NALOXONE;NARCAN;NARCANTI;NSC-70413;SUBOXONE,CHEMBL80,BRD:BRD-BRD-K67511046-001-02-3;BRD:BRD-K67511046-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,CREB1;ESR1;OPRD1;OPRK1;OPRM1;TLR4,RESPIRATORY DEPRESSION,,LAUNCHED,,Small molecule,4,"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5;OC1CCC2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1C24)C(=O)CC[C@@]35O, OC1CCC2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1C24)C(=O)CC[C@@]35O, OC1CCC2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1C24)C(=O)CC[C@@]35O, OC1CCC2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1C24)C(=O)CC[C@@]35O",UZHSEJADLWPNLE-GRGSLBFTSA-N
NALOXONE-BENZOYLHYDRAZONE,NALOXONE-BENZOYLHYDRAZONE,,BRD:BRD-BRD-K70898774-001-03-5;BRD:BRD-K70898774-001-03-5,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRK1;OPRM1,,,PRECLINICAL,,,NA,"OC1CCC2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1C24)\C(CC[C@@]35O)=N\NC(=O)C1CCCCC1, OC1CCC2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1C24)\C(CC[C@@]35O)=N\NC(=O)C1CCCCC1, OC1CCC2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1C24)\C(CC[C@@]35O)=N\NC(=O)C1CCCCC1",
VIVITROL,CELUPAN;EN-1639A;EN-1639A [AS HYDROCHLORIDE];EN-1639A FREE BASE;NALTREXONE;NSC-758439;REVIA;TREXAL;TREXAN;VIVITROL,CHEMBL19019,BRD:BRD-BRD-K88172511-003-20-3;BRD:BRD-BRD-K88172511-003-21-1;BRD:BRD-K88172511-003-20-3;BRD:BRD-K88172511-003-21-1,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1;SIGMAR1,ABSTINENCE FROM ALCOHOL,,LAUNCHED,,Small molecule,4,"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5;OC1CCC2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C(=O)CC[C@@]35O, OC1CCC2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C(=O)CC[C@@]35O, OC1CCC2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C(=O)CC[C@@]35O",DQCKKXVULJGBQN-XFWGSAIBSA-N
NALTRIBEN,NALTRIBEN,CHEMBL100940,BRD:BRD-A19102171-066-01-4;BRD:BRD-BRD-A19102171-066-01-4,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1,,,PRECLINICAL,,Small molecule,NA,"Oc1ccc2c3c1O[C@H]1c4oc5ccccc5c4C[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314;OC1CCC2CC3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C1OC2CCCCC2C1C[C@@]35O, OC1CCC2CC3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C1OC2CCCCC2C1C[C@@]35O",ZHVWWEYETMPAMX-IFKAHUTRSA-N
NALTRINDOLE,NALTRINDOLE,CHEMBL567175,BRD:BRD-A47342814-003-01-8;BRD:BRD-BRD-A47342814-003-01-8,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1,,,PRECLINICAL,,Small molecule,NA,"Oc1ccc2c3c1O[C@H]1c4[nH]c5ccccc5c4C[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314;OC1CCC2CC3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C1[NH]C2CCCCC2C1C[C@@]35O, OC1CCC2CC3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C1[NH]C2CCCCC2C1C[C@@]35O",WIYUZYBFCWCCQJ-IFKAHUTRSA-N
NAMPT-IN-1,NAMPT-IN-1,,BRD:BRD-BRD-K18280217-001-01-0;BRD:BRD-K18280217-001-01-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC(C)(O)CS(=O)(=O)NC1CCC2CN(CCC2C1)C(=O)COC1CCCNC1,
NAN-190,NAN-190,CHEMBL8618,BRD:BRD-BRD-K69195780-004-08-4;BRD:BRD-K69195780-004-08-4,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;HTR1A;HTR1F,,,PRECLINICAL,,Small molecule,NA,COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1;COC1CCCCC1N1CCN(CCCCN2C(=O)C3CCCCC3C2=O)CC1,SJDOMIRMMUGQQK-UHFFFAOYSA-N
NANCHANGMYCIN,NANCHANGMYCIN,,BRD:BRD-A73871920-236-03-6;BRD:BRD-BRD-A73871920-236-03-6,rep_multi_dose;rep_primary;rep_single_dose,OTHER ANTIBIOTIC,,,,PRECLINICAL,,,NA,CO[C@H]1CCC(O[C@H]2CC(O[C@]3(O[C@H](C[C@@H]3C)C3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)[C@@H]2C)[C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@H](O3)[C@@H](C)\C=C(/C)C(=O)[C@H](C)C[C@H](C)C(O)=O)O2)O[C@@H]1C,
RS-3268R,DECA-DURABOLIN;DURABOLIN;NANDROLONE;NANDROLONE CIII;NANDROLONE CYCLOHEXYLPROPIONATE;NANDROLONE CYCLOTATE;NSC-3351;RS-3268R,CHEMBL2104906;CHEMBL757,BRD:BRD-BRD-K52080565-001-09-2;BRD:BRD-K52080565-001-09-2,rep_primary;rep_single_dose,IMIDAZOLINE RECEPTOR AGONIST,AR;CYP19A1;MAOA;MAOB,ANEMIA,,LAUNCHED,,Small molecule,-1,"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O;CC12C=CC(C(=O)O[C@H]3CC[C@H]4[C@@H]5CCC6=CC(=O)CC[C@@H]6[C@H]5CC[C@]34C)(CC1)CC2",REACBNMPQDINOF-YBBIQVIJSA-N
NANDROLONE-DECANOATE,NANDROLONE-DECANOATE,,BRD:BRD-BRD-K78352627-001-01-8;BRD:BRD-K78352627-001-01-8,rep_primary;rep_single_dose,ANDROGENIC STEROID,AR,,,PHASE 1,,,NA,"CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C, CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C",
NAPABUCASIN,"2-ACETYLFURANONAPHTHOQUINONE;2-ACETYLFURO-1,4-NAPHTHOQUINONE;BBI-608;BBI608;NAPABUCASIN",CHEMBL64130,BRD:BRD-BRD-K22064724-001-01-8;BRD:BRD-K22064724-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,STAT INHIBITOR,STAT3,,,PHASE 3,,Small molecule,3,"CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O;CC(=O)C1CC2C(O1)C(=O)C1CCCCC1C2=O, CC(=O)C1CC2C(O1)C(=O)C1CCCCC1C2=O",DPHUWDIXHNQOSY-UHFFFAOYSA-N
NAPAMEZOLE,NAPAMEZOLE,CHEMBL167493,BRD:BRD-K00004563-001-01-9,rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, MONOAMINE REUPTAKE INHIBITOR",,,,,,Small molecule,-1,C1=C(CC2=NCCN2)CCc2ccccc21,WETRBJOSGIDJHQ-UHFFFAOYSA-N
NAPHAZOLINE,NAFAZAIR;NAFAZOLIN;NAPHAZOLINE,CHEMBL761,BRD:BRD-BRD-K77641333-003-27-1;BRD:BRD-K77641333-003-27-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA2A,EYE IRRITATION,,LAUNCHED,,Small molecule,4,"C(C1=NCCN1)C1CCCC2CCCCC12, C(C1=NCCN1)C1CCCC2CCCCC12;c1ccc2c(CC3=NCCN3)cccc2c1",CNIIGCLFLJGOGP-UHFFFAOYSA-N
NAPHTHOQUINE-PHOSPHATE,NAPHTHOQUINE-PHOSPHATE,,BRD:BRD-BRD-K13664493-316-02-5;BRD:BRD-K13664493-316-02-5,rep_primary;rep_single_dose,ANTIMALARIAL AGENT,,,,LAUNCHED,,,NA,"CC(C)(C)NCC1CC(NC2CCNC3CC(CL)CCC23)C2CCCCC2C1O, CC(C)(C)NCC1CC(NC2CCNC3CC(CL)CCC23)C2CCCCC2C1O, CC(C)(C)NCC1CC(NC2CCNC3CC(CL)CCC23)C2CCCCC2C1O",
NAPIRIMUS,NAPIRIMUS,CHEMBL2105168,BRD:BRD-BRD-K91234829-001-01-7;BRD:BRD-K91234829-001-01-7,rep_primary;rep_single_dose,IMMUNOSUPPRESSANT,,,,PHASE 1,,Small molecule,-1,Cn1cc(C(=O)c2cccc3ccccc23)cc1C(=O)O;CN1CC(CC1C(O)=O)C(=O)C1CCCC2CCCCC12,CNUPQURTHORUGH-UHFFFAOYSA-N
VIMOVO,ALEVE;ANAPROX;ARTHROSIN 250;ARTHROSIN 250 EC;ARTHROSIN 500;ARTHROSIN 500 EC;CONDROTEC;EC-NAPROSYN;EQUIPROXEN;FEMINAX ULTRA;GRENOXAL;KENOSYN;LARAFLEX;NAPRATEC OP;NAPRELAN;NAPROSYN;NAPROSYN 375;NAPROSYN EC;NAPROXEN;NSC-750183;NSC-757239;NYCOPREN;PN400 COMPONENT NAPROXEN;PRANOXEN CONTINUS;PROSAID;RHEUFLEX 250;RHEUFLEX 500;RIMOXYN;RS-3540;STIRLESCENT;TIMPRON;TIMPRON 250 EC;TIMPRON 500 EC;VALROX;VIMOVO,CHEMBL154,BRD:BRD-BRD-K59197931-001-04-5;BRD:BRD-K59197931-001-04-5,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"PAIN RELIEF, RHEUMATOID ARTHRITIS, HEADACHE, TOOTHACHE, BACKACHE, MUSCLE PAIN, COMMON COLD, FEVER",,LAUNCHED,,Small molecule,4,"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1;COC1CCC2CC(CCC2C1)[C@H](C)C(O)=O, COC1CCC2CC(CCC2C1)[C@H](C)C(O)=O, COC1CCC2CC(CCC2C1)[C@H](C)C(O)=O, COC1CCC2CC(CCC2C1)[C@H](C)C(O)=O",CMWTZPSULFXXJA-VIFPVBQESA-N
NAQUOTINIB,ASP-8273;ASP8273;NAQUOTINIB,CHEMBL3663929,BRD:BRD-K64114733-066-03-9,rep_single_dose,EGFR INHIBITOR,,,,,,Small molecule,3,C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1,QKDCLUARMDUUKN-XMMPIXPASA-N
SALINOMYCIN,(4S)-;4-METHYL-;ANTIBIOTIC A-28086 FACTOR A;C-7819B;COMPD-79891;COMPOUND 79891;MONTEBAN;NARASIN;NARASIN A;SALINOMYCIN,CHEMBL2104423,BRD:BRD-A25608658-001-01-1;BRD:BRD-BRD-A25608658-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,CC[C@@H](C(=O)O)[C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@]3(C=C[C@@H](O)[C@]4(CC[C@@](C)([C@H]5CC[C@](O)(CC)[C@H](C)O5)O4)O3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C;CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)C4CC[C@](O)(CC)[C@H](C)O4)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@H]1C)C(O)=O,VHKXXVVRRDYCIK-CWCPJSEDSA-N
NARATRIPTAN HYDROCHLORIDE,AMERGE;GR 85548A;GR-85548A;NARAMIG;NARATRIPTAN;NARATRIPTAN HCL;NARATRIPTAN HYDROCHLORIDE,CHEMBL1200601;CHEMBL1278,BRD:BRD-BRD-K61337602-003-02-1;BRD:BRD-K61337602-003-02-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,"CNS(=O)(=O)CCC1CCC2[NH]CC(C3CCN(C)CC3)C2C1, CNS(=O)(=O)CCC1CCC2[NH]CC(C3CCN(C)CC3)C2C1;CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1.Cl",AWEZYKMQFAUBTD-UHFFFAOYSA-N
NARCICLASINE,NARCICLASINE,CHEMBL98745,CTRP:632243,ctrp,,,,,,,Small molecule,NA,O=C1N[C@@H]2C(=C[C@H](O)[C@@H](O)[C@H]2O)c2cc3c(c(O)c21)OCO3,LZAZURSABQIKGB-AEKGRLRDSA-N
NSC-11855,NARINGENIN;NSC-11855,CHEMBL9352,BRD:BRD-BRD-K08832567-001-11-5;BRD:BRD-K08832567-001-11-5,rep_primary;rep_single_dose,"AROMATASE INHIBITOR, TRPV ANTAGONIST",CYP19A1;CYP1B1;ESR2;GLO1;HSD17B1,,,PHASE 1,,Small molecule,NA,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21;OC1CCC(CC1)[C@@H]1CC(=O)C2C(O)CC(O)CC2O1,FTVWIRXFELQLPI-ZDUSSCGKSA-N
NARINGENINIC-ACID,NARINGENINIC-ACID,,BRD:BRD-BRD-K87122641-001-10-7;BRD:BRD-K87122641-001-10-7,rep_primary;rep_single_dose,,HCAR2;PTGR1,,,PHASE 1,,,NA,"OC(=O)\C=C\C1CCC(O)CC1, OC(=O)\C=C\C1CCC(O)CC1",
NARINGIN,NARINGIN,CHEMBL451532,BRD:BRD-BRD-K02953697-001-09-2;BRD:BRD-K02953697-001-09-2,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,SLCO1A2,,,PRECLINICAL,,Small molecule,NA,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2CC(O)C3C(=O)C[C@H](OC3C2)C2CCC(O)CC2)[C@H](O)[C@H](O)[C@H]1O;C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)cc3)CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,DFPMSGMNTNDNHN-ZPHOTFPESA-N
NARINGIN-DIHYDROCHALCONE,NARINGIN-DIHYDROCHALCONE,,BRD:BRD-BRD-K13511380-001-01-4;BRD:BRD-K13511380-001-01-4,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,,,,PRECLINICAL,,,NA,C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2CC(O)C(C(=O)CCC3CCC(O)CC3)C(O)C2)[C@H](O)[C@H](O)[C@H]1O,
SCH-900518,NARLAPREVIR;SCH 900518;SCH-900518,CHEMBL1255891,BRD:BRD-BRD-K38287497-001-01-2;BRD:BRD-K38287497-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,HCV INHIBITOR,,,,PHASE 2/PHASE 3,,Small molecule,3,CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1,RICZEKWVNZFTNZ-LFGITCQGSA-N
NAS-181,NAS-181,,BRD:BRD-K00004235-334-01-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1B,,,,,,NA,,
NASTORAZEPIDE,NASTORAZEPIDE,,BRD:BRD-BRD-K17295893-001-01-0;BRD:BRD-K17295893-001-01-0;BRD:BRD-K17295893-238-03-9,rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKBR,,,PHASE 2,,,NA,CC(C)(C)C(=O)CN1C2CCCCC2N(C[C@@H](NC(=O)NC2CCCC(C2)C(O)=O)C1=O)C1CCCCC1,
TENNECETIN,"ANTIBIOTIC A-5283;CL 12,625;CL-12625;DELVOCID;E-235;E235;INS NO.235;INS-235;MYCOPHYT;MYPROZINE;NATACYN;NATAMYCIN;NSC-759167;PIMAFUCIN;PIMARACIN;PIMARICIN;SYNOGIL;TENNECETIN",CHEMBL1200656,BRD:BRD-BRD-K90563805-001-02-6;BRD:BRD-K90563805-001-02-6,rep_primary;rep_single_dose,FUNGAL ERGOSTEROL INHIBITOR,,"CONJUNCTIVITIS, FUNGAL KERATOSIS, BLEPHARITIS",,LAUNCHED,,Small molecule,4,"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O;C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O",NCXMLFZGDNKEPB-FFPOYIOWSA-N
STARSIS,A-4166;AY-4166;AY4166;D-NATEGLINIDE;DJN 608;DJN-608;NATEGLINIDE;NSC-758695;SDZ DJN 608;SDZ-DJN-608;SENAGLINIDE;STARLIX;STARSIS,CHEMBL783,BRD:BRD-BRD-K44353683-001-08-3;BRD:BRD-K44353683-001-08-3,rep_primary;rep_single_dose,INSULIN SECRETAGOGUE,ABCC8;KCNJ10;KCNJ11;PPARG,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1CCCCC1)C(O)=O, CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](CC1CCCCC1)C(O)=O, CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1CCCCC1)C(O)=O, CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1CCCCC1)C(O)=O;CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1",OELFLUMRDSZNSF-BRWVUGGUSA-N
NAV-26,NAV-26,,BRD:BRD-A84202322-001-01-7;BRD:BRD-BRD-A84202322-001-01-7,rep_primary;rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,SCN9A,,,PRECLINICAL,,,NA,FC(F)(F)OC1CCC(CNC(=O)C2N(C3CCOCC3)C(=O)C3CCCCC23)CC1,
SCH527123,MK-7123;NAVARIXIN;NAVARIXIN MONOHYDRATE;PS-291822;PS291822;SCH 527123;SCH-527123;SCH527123,CHEMBL2103864;CHEMBL216981,BRD:BRD-BRD-K82850175-001-01-1;BRD:BRD-K82850175-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR1;CXCR2,,,PHASE 2,,Small molecule,2,CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1;CC[C@@H](NC1C(NC2CCCC(C(=O)N(C)C)C2O)C(=O)C1=O)C1CCC(C)O1;CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1.O,AFTCWZSEWTXWTL-BTQNPOSSSA-N;RXIUEIPPLAFSDF-CYBMUJFWSA-N
NAVITOCLAX:BIRINAPANT (1:1 MOL/MOL),NAVITOCLAX:BIRINAPANT (1:1 MOL/MOL),,CTRP:660172,ctrp,,,,,,,,NA,,
NAVITOCLAX:GEMCITABINE (1:1 MOL/MOL),NAVITOCLAX:GEMCITABINE (1:1 MOL/MOL),,CTRP:660225,ctrp,,,,,,,,NA,,
NAVITOCLAX:MST-312 (1:1 MOL/MOL),NAVITOCLAX:MST-312 (1:1 MOL/MOL),,CTRP:660222,ctrp,,,,,,,,NA,,
NAVITOCLAX:PIPERLONGUMINE (1:1 MOL/MOL),NAVITOCLAX:PIPERLONGUMINE (1:1 MOL/MOL),,CTRP:660284,ctrp,,,,,,,,NA,,
NAVITOCLAX:PLURIPOTIN (1:1 MOL/MOL),NAVITOCLAX:PLURIPOTIN (1:1 MOL/MOL),,CTRP:660246,ctrp,,,,,,,,NA,,
NAVITOCLAX:PLX-4032 (1:1 MOL/MOL),NAVITOCLAX:PLX-4032 (1:1 MOL/MOL),,CTRP:660219,ctrp,,,,,,,,NA,,
NAVITOCLAX:SORAFENIB (1:1 MOL/MOL),NAVITOCLAX:SORAFENIB (1:1 MOL/MOL),,CTRP:660283,ctrp,,,,,,,,NA,,
RO7077339-001,GDC-0919;IDO-IN-7;NAVOXIMOD;NLG-919;NLG919;RG-6078;RG6078;RO-7077339;RO7077339;RO7077339-001,CHEMBL3989951,BRD:BRD-K00078423-001-02-9,rep_single_dose,,,,,,,Small molecule,1,O[C@H](C[C@H]1c2c(F)cccc2-c2cncn21)[C@H]1CC[C@H](O)CC1,YGACXVRLDHEXKY-WXRXAMBDSA-N
NAZAGOLIDE,"(R,R)-PHNO;DOPAZINOL;NAXAGOLIDE;NAZAGOLIDE",CHEMBL69271,BRD:BRD-K00004670-001-01-9,rep_single_dose,DOPAMINE RECEPTOR AGONIST,,,,,,Small molecule,-1,CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,JCSREICEMHWFAY-HUUCEWRRSA-N
NB001,HTS-09836;NB-001;NB001,CHEMBL4297305,BRD:BRD-K00004647-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,3,Nc1ncnc2c1ncn2CCNCCCCCO,CVPTTZZCRDVGSU-UHFFFAOYSA-N
NBI-27914,NBI-27914,,BRD:BRD-BRD-K61177364-003-02-9;BRD:BRD-K61177364-003-02-9,rep_primary;rep_single_dose,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",CRHR1,,,PRECLINICAL,"Multiple values for MOA: {'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST', 'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST'}, defaulting to 'CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST'",,NA,"CCCN(CC1CC1)C1NC(C)NC(NC2C(CL)CC(CL)CC2CL)C1CL, CCCN(CC1CC1)C1NC(C)NC(NC2C(CL)CC(CL)CC2CL)C1CL",
NBI-74330-(+/-),NBI-74330-(+/-),,BRD:BRD-A86523169-001-01-0;BRD:BRD-BRD-A86523169-001-01-0,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR3,,,PRECLINICAL,,,NA,CCOC1CCC(CC1)-N1C(NC2NCCCC2C1=O)C(C)N(CC1CCCNC1)C(=O)CC1CCC(F)C(C1)C(F)(F)F,
NBI-98782,NBI-98782,,BRD:BRD-K15241725-001-02-9,rep_single_dose,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,,,,,,,NA,,
NBQX,NBQX,CHEMBL222519,BRD:BRD-BRD-K11796549-001-04-5;BRD:BRD-K11796549-001-04-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1;GRIA2;GRIA3;GRIA4;GRIK1;GRIN1;GRIN2A;GRIN2B,,,PRECLINICAL,,Small molecule,NA,"NS(=O)(=O)c1cccc2c1c([N+](=O)[O-])cc1nc(O)c(O)nc12;NS(=O)(=O)C1CCCC2C1C(CC1[NH]C(=O)C(=O)[NH]C21)[N+]([O-])=O, NS(=O)(=O)C1CCCC2C1C(CC1[NH]C(=O)C(=O)[NH]C21)[N+]([O-])=O, NS(=O)(=O)C1CCCC2C1C(CC1[NH]C(=O)C(=O)[NH]C21)[N+]([O-])=O",UQNAFPHGVPVTAL-UHFFFAOYSA-N
NCS-382,NCS-382,,BRD:BRD-A85025557-001-02-5;BRD:BRD-BRD-A85025557-001-02-5,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABBR1;GABBR2;SLC52A2,,,PRECLINICAL,,,NA,OC1C2CCCCC2CCC\C1=C/C(O)=O,
NCX-1015,NCX-1015,,BRD:BRD-K00004749-001-01-9,rep_single_dose,INTERLEUKIN SYTHESIS STIMULATOR,,,,,,,NA,,
NDD-094,NDD-094,,BRD:BRD-K00004664-001-01-9,rep_single_dose,,,,,,,,NA,,
NDT-9513727,NDT-9513727,,BRD:BRD-K17539220-001-02-9,rep_single_dose,COMPLEMENT ANTAGONIST,C5AR1,,,,,,NA,,
NE-100,NE-100,,BRD:BRD-BRD-K11443721-003-01-6;BRD:BRD-K11443721-003-01-6,rep_primary;rep_single_dose,SIGMA RECEPTOR ANTAGONIST,SIGMAR1,,,PHASE 2,,,NA,"CCCN(CCC)CCC1CCC(OC)C(OCCC2CCCCC2)C1, CCCN(CCC)CCC1CCC(OC)C(OCCC2CCCCC2)C1",
"R65,824","HYPOLOC;NARBIVOLOL;NEBILET;NEBIVOLOL;R-65824;R65,824",CHEMBL434394,BRD:BRD-BRD-K04956647-003-02-5;BRD:BRD-K04956647-003-02-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"O[C@H](CNC[C@@H](O)[C@@H]1CCC2CC(F)CCC2O1)[C@H]1CCC2CC(F)CCC2O1, O[C@H](CNC[C@@H](O)[C@@H]1CCC2CC(F)CCC2O1)[C@H]1CCC2CC(F)CCC2O1, O[C@H](CNC[C@@H](O)[C@@H]1CCC2CC(F)CCC2O1)[C@H]1CCC2CC(F)CCC2O1, OC(CNCC(O)C1CCC2CC(F)CCC2O1)C1CCC2CC(F)CCC2O1;OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1",KOHIRBRYDXPAMZ-UHFFFAOYSA-N
NEBRACETAM,NEBRACETAM,CHEMBL2104682,BRD:BRD-A51355958-003-01-9;BRD:BRD-BRD-A51355958-003-01-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1,,,PHASE 3,,Small molecule,-1,NCC1CC(=O)N(Cc2ccccc2)C1;NCC1CN(CC2CCCCC2)C(=O)C1,LCAFGJGYCUMTGS-UHFFFAOYSA-N
NECA,5'-N-ETHYLCARBOXAMIDOADENOSINE;NECA,CHEMBL464859,BRD:BRD-BRD-K14395568-001-16-3;BRD:BRD-K14395568-001-16-3,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3;HSP90B1,,,LAUNCHED,,Small molecule,NA,"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O;CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(N)NCNC12, CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CNC2C(N)NCNC12",JADDQZYHOWSFJD-FLNNQWSLSA-N
NECROSTATIN-1,NECROSTATIN-1,,BRD:BRD-A36318220-001-08-8;BRD:BRD-BRD-A36318220-001-08-8;CTRP:375435,ctrp;rep_primary;rep_single_dose,RIPK INHIBITOR,RIPK1,,,PRECLINICAL,,,NA,"CN1C(=S)NC(CC2C[NH]C3CCCCC23)C1=O, CN1C(=S)NC(CC2C[NH]C3CCCCC23)C1=O, CN1C(=S)NC(CC2C[NH]C3CCCCC23)C1=O, CN1C(=S)NC(CC2C[NH]C3CCCCC23)C1=O",
NECROSTATIN-2,NECROSTATIN-2,,BRD:BRD-BRD-K68851986-001-01-6;BRD:BRD-K68851986-001-01-6,rep_primary;rep_single_dose,"NECROPTOSIS INHIBITOR, RIPK INHIBITOR",RIPK2,,,PRECLINICAL,,,NA,CN1C(=O)N[C@H](CC2C[NH]C3C(CL)CCCC23)C1=O,
NECROSTATIN-7,NECROSTATIN-7,,CTRP:660201,ctrp,,,,,,,,NA,,
NECROSULFONAMIDE,NECROSULFONAMIDE,,CTRP:677522,ctrp,,,,,,,,NA,,
NSC-375101D,AQUPLA;CIS-DIAMMINE-GLYCOLATOPLATINUM;NEDAPLATIN;NSC-375101D,CHEMBL3137685,BRD:BRD-BRD-K73469236-001-01-8;BRD:BRD-K73469236-001-01-8,rep_primary;rep_single_dose,DNA INHIBITOR,,,,LAUNCHED,,Small molecule,3,"N[PT++]1(N)OCC(=O)O1, N[PT]1(N)OCC(=O)O1",
NEDOCROMIL,FPL 59002;FPL-59002;NEDOCROMIL,CHEMBL746,BRD:BRD-BRD-K64716392-001-01-3;BRD:BRD-K64716392-001-01-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,CYSLTR1;CYSLTR2;FPR1;HSP90AA1;PTGDR,"ITCHING, CONJUNCTIVITIS",,LAUNCHED,,Small molecule,4,"CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12;CCCC1C2OC(CC(=O)C2CC2C1N(CC)C(CC2=O)C(O)=O)C(O)=O, CCCC1C2OC(CC(=O)C2CC2C1N(CC)C(CC2=O)C(O)=O)C(O)=O, CCCC1C2OC(CC(=O)C2CC2C1N(CC)C(CC2=O)C(O)=O)C(O)=O",RQTOOFIXOKYGAN-UHFFFAOYSA-N
NEFAZODONE,NEFAZODONE,CHEMBL623,BRD:BRD-BRD-K90789829-001-07-8;BRD:BRD-K90789829-001-07-8,rep_primary;rep_single_dose,"ADRENERGIC INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN REUPTAKE INHIBITOR",ADRA1A;ADRA1B;ADRA2A;CYP3A4;HTR1A;HTR2A;HTR2C;SLC6A2;SLC6A3;SLC6A4,,,WITHDRAWN,,Small molecule,4,"CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1;CCC1NN(CCCN2CCN(CC2)C2CCCC(CL)C2)C(=O)N1CCOC1CCCCC1, CCC1NN(CCCN2CCN(CC2)C2CCCC(CL)C2)C(=O)N1CCOC1CCCCC1",VRBKIVRKKCLPHA-UHFFFAOYSA-N
NSC-759830,NEFIRACETAM;NSC-759830,CHEMBL260829,BRD:BRD-BRD-K65678996-001-05-5;BRD:BRD-K65678996-001-05-5,rep_multi_dose;rep_primary;rep_single_dose,"ACETYLCHOLINE RECEPTOR AGONIST, BENZODIAZEPINE RECEPTOR AGONIST",CHRM1,,,PHASE 3,,Small molecule,2,"Cc1cccc(C)c1NC(=O)CN1CCCC1=O;CC1CCCC(C)C1NC(=O)CN1CCCC1=O, CC1CCCC(C)C1NC(=O)CN1CCCC1=O, CC1CCCC(C)C1NC(=O)CN1CCCC1=O",NGHTXZCKLWZPGK-UHFFFAOYSA-N
NEFOPAM,NEFOPAM,CHEMBL465026,BRD:BRD-A78877355-001-03-0;BRD:BRD-BRD-A78877355-001-03-0,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,PAIN RELIEF,,LAUNCHED,,Small molecule,4,"CN1CCOC(c2ccccc2)c2ccccc2C1;CN1CCOC(C2CCCCC2)C2CCCCC2C1, CN1CCOC(C2CCCCC2)C2CCCCC2C1",RGPDEAGGEXEMMM-UHFFFAOYSA-N
NSC-759876,506U;506U78;ARRANON;ATRIANCE;ATTRIANCE;GW-506U78;MAY;NELARABINE;NELZARABINE;NSC-686673;NSC-755985;NSC-759876,CHEMBL1201112,BRD:BRD-BRD-K84466663-001-05-4;BRD:BRD-K84466663-001-05-4;CTRP:660391;GDSC2:1814,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"DNA SYNTHESIS INHIBITOR, T CELL INHIBITOR",POLA1,"ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)",,LAUNCHED,,Small molecule,4,COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O;COC1NC(N)NC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N
VIRACEPT,NELFINAVIR;NSC-747167;VIRACEPT,CHEMBL584,BRD:BRD-BRD-K74117820-066-10-8;BRD:BRD-K74117820-066-10-8,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,CYP1A2;CYP2B6;CYP2C19;CYP2C9;CYP2D6;CYP3A4;CYP3A7,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C;CC1C(O)CCCC1C(=O)N[C@@H](CSC1CCCCC1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N
NELOCIGUAT,NELOCIGUAT,,BRD:BRD-K00003315-001-01-9,rep_single_dose,GUANYLATE CYCLASE STIMULANT,,,,,,,NA,,
NELOTANSERIN,APD-125;APD125;NELOTANSERIN,CHEMBL598172,BRD:BRD-K00003466-001-01-9,rep_single_dose,SEROTONIN RECEPTOR INVERSE AGONIST,,,,,,Small molecule,2,COc1ccc(NC(=O)Nc2ccc(F)cc2F)cc1-c1c(Br)cnn1C,COSPVUFTLGQDQL-UHFFFAOYSA-N
SCH-40054,NEMAZOLINE;SCH 40054;SCH-40054,CHEMBL2110957,BRD:BRD-K00004662-001-01-9,rep_single_dose,"ADRENERGIC RECEPTOR AGONIST, ADRENERGIC RECEPTOR ANTAGONIST",,,,,,Small molecule,-1,Nc1c(Cl)cc(CC2=NCCN2)cc1Cl,FXNNRWAIGIEAST-UHFFFAOYSA-N
NEMIRALISIB,GSK-2269557;GSK-2269557 FREE BASE;GSK-2269557A;GSK2269557A;NEMIRALISIB,CHEMBL2216859,BRD:BRD-K00003285-001-01-9,rep_single_dose,,,,,,,Small molecule,2,CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1,MCIDWGZGWVSZMK-UHFFFAOYSA-N
NEMONAPRIDE,EMILACE;EMONAPRIDE;NEMONAPRIDE,CHEMBL20734,BRD:BRD-BRD-M80207679-001-01-5;BRD:BRD-M80207679-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3;DRD4,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,-1,"CNc1cc(OC)c(C(=O)NC2CCN(Cc3ccccc3)C2C)cc1Cl;CNC1CC(OC)C(CC1CL)C(=O)N[C@@H]1CCN(CC2CCCCC2)[C@@H]1C.CNC1CC(OC)C(CC1CL)C(=O)N[C@H]1CCN(CC2CCCCC2)[C@H]1C, CNC1CC(OC)C(CC1CL)C(=O)N[C@@H]1CCN(CC2CCCCC2)[C@@H]1C.CNC1CC(OC)C(CC1CL)C(=O)N[C@H]1CCN(CC2CCCCC2)[C@H]1C",KRVOJOCLBAAKSJ-UHFFFAOYSA-N
NEMOREXANT,ACT-541468;DARIDOREXANT;NEMOREXANT,CHEMBL4297590,BRD:BRD-K00003505-001-01-9,rep_single_dose,OREXIN RECEPTOR ANTAGONIST,,,,,,Small molecule,4,COc1ccc(-n2nccn2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1,NBGABHGMJVIVBW-QHCPKHFHSA-N
NEMORUBICIN,NEMORUBICIN,CHEMBL1232279,BRD:BRD-BRD-K51911221-001-01-2;BRD:BRD-K51911221-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1;TOP2A,,,PHASE 2,,Small molecule,-1,CO[C@@H]1CN(CCO1)[C@H]1C[C@H](O[C@H]2C[C@@](O)(CC3C(O)C4C(=O)C5CCCC(OC)C5C(=O)C4C(O)C23)C(=O)CO)O[C@@H](C)[C@H]1O;COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N2CCO[C@H](OC)C2)[C@H](O)[C@H](C)O1,CTMCWCONSULRHO-UHQPFXKFSA-N
PRAJMALIUM BITARTRATE,GT-1012;N-PROPYLAJMALINE BITARTRATE;N-PROPYLAJMALINIUM TARTRATE;NEO GILURYTHMAL;NEO-GILURYTMAL;NPA-P;NPAP;PRAJMALINE BITARTRATE;PRAJMALINE HYDROGEN TARTRATE;PRAJMALIUM BITARTRATE,CHEMBL3833388,BRD:BRD-A53539450-004-01-7;BRD:BRD-BRD-A53539450-004-01-7,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,4,CCC[N+]12[C@H](O)[C@@H](CC)[C@@H]3C[C@H]1[C@@H]1N(C)c4ccccc4[C@]14C[C@H]2[C@@H]3[C@H]4O.O=C([O-])C(O)C(O)C(=O)O;CCC[N+]12[C@H]3C[C@]45C(O)C3[C@@H](CC1[C@@H]4N(C)C1CCCCC51)[C@H](CC)[C@H]2O,VZAUGYDMVQSQAO-BAYLNNJJSA-M
NEOHESPERIDIN,NEOHESPERIDIN,CHEMBL506398,BRD:BRD-BRD-K96299080-001-02-7;BRD:BRD-K96299080-001-02-7,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,NA,COC1CC(O)CC(C1)[C@@H]1CC(=O)C2C(O)CC(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)CC2O1;COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)cc3O2)cc1O,ARGKVCXINMKCAZ-UZRWAPQLSA-N
NEOHESPERIDIN-DIHYDROCHALCONE,NEOHESPERIDIN-DIHYDROCHALCONE,,BRD:BRD-BRD-K61032563-001-02-9;BRD:BRD-K61032563-001-02-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC1CCC(CCC(=O)C2C(O)CC(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)CC2O)CC1O,
NEOPELTOLIDE,NEOPELTOLIDE,CHEMBL223238,CTRP:411774,ctrp,,,,,,,Small molecule,NA,CCC[C@@H]1C[C@H](OC)C[C@H](C)C[C@@H]2C[C@@H](OC(=O)/C=C\CCc3coc(/C=C\CNC(=O)OC)n3)C[C@H](CC(=O)O1)O2,YRSJLYCTJWNTMF-NRBUTUAXSA-N
NEOSTIGMINE ION,MIOSTIN;NEOSTIGMINE;NEOSTIGMINE (CATION);NEOSTIGMINE CATION;NEOSTIGMINE HYDROXIDE;NEOSTIGMINE ION,CHEMBL278020,BRD:BRD-BRD-K18922609-004-23-1;BRD:BRD-K18922609-004-23-1,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE,MYASTHENIA GRAVIS,,LAUNCHED,,Small molecule,4,"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1;CN(C)C(=O)OC1CCCC(C1)[N+](C)(C)C, CN(C)C(=O)OC1CCCC(C1)[N+](C)(C)C, CN(C)C(=O)OC1CCCC(C1)[N+](C)(C)C",ALWKGYPQUAPLQC-UHFFFAOYSA-N
NEVANAC,AHR-9434;AL-6515;ILEVRO;NEPAFENAC;NEVANAC,CHEMBL1021,BRD:BRD-BRD-K04112579-001-07-0;BRD:BRD-K04112579-001-07-0,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,EYE INFLAMMATION,,LAUNCHED,,Small molecule,4,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N;NC(=O)CC1CCCC(C(=O)C2CCCCC2)C1N,QEFAQIPZVLVERP-UHFFFAOYSA-N
SYN117,NEPICASTAT;SYN-117;SYN117,CHEMBL1188395,BRD:BRD-BRD-K09126848-003-01-9;BRD:BRD-K09126848-003-01-9,rep_primary;rep_single_dose,DOPAMINE BETA HYDROXYLASE INHIBITOR,DBH,,,PHASE 2,,Small molecule,2,"NCc1c[nH]c(=S)n1[C@H]1CCc2c(F)cc(F)cc2C1;NCC1C[NH]C(=S)N1[C@H]1CCC2C(F)CC(F)CC2C1, NCC1C[NH]C(=S)N1[C@H]1CCC2C(F)CC(F)CC2C1, NCC1C[NH]C(=S)N1[C@H]1CCC2C(F)CC(F)CC2C1",YZZVIKDAOTXDEB-JTQLQIEISA-N
NEPINALONE (HYDROCHLORIDE),NEPINALONE (HYDROCHLORIDE),,BRD:BRD-K00079018-003-02-9,rep_single_dose,,,,,,,,NA,,
WAY-179272,CDP-820;HKI-272;NERATINIB;WAY-179272,CHEMBL180022,BRD:BRD-BRD-K85606544-001-09-1;BRD:BRD-K85606544-001-09-1;CTRP:418038,ctrp;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2;KDR,,,PHASE 3,,Small molecule,4,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C;CCOC1CC2NCC(C#N)C(NC3CCC(OCC4CCCCN4)C(CL)C3)C2CC1NC(=O)\C=C\CN(C)C,JWNPDZNEKVCWMY-VQHVLOKHSA-N
NERBACADOL,NERBACADOL,CHEMBL2104808,BRD:BRD-BRD-K43647122-001-01-3;BRD:BRD-K43647122-001-01-3,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,PHASE 3,,Small molecule,-1,Cc1oncc1C(=O)N1CCCCC1;CC1ONCC1C(=O)N1CCCCC1,ZWNGSOLJLMBZFZ-UHFFFAOYSA-N
NERIDRONIC-ACID,NERIDRONIC-ACID,,BRD:BRD-BRD-K60212747-236-01-1;BRD:BRD-K60212747-236-01-1,rep_primary;rep_single_dose,BONE RESORPTION INHIBITOR,FDPS,"BRITTLE BONE DISEASE, PAGET'S DISEASE",,LAUNCHED,,,NA,NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,
NESBUVIR,HCV 796;HCV-796;NESBUVIR,CHEMBL1092581,BRD:BRD-BRD-K79989959-001-01-4;BRD:BRD-K79989959-001-01-4,rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,,,PHASE 2,,Small molecule,2,CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12;CNC(=O)C1C(OC2CC(N(CCO)S(C)(=O)=O)C(CC12)C1CC1)-C1CCC(F)CC1,WTDWVLJJJOTABN-UHFFFAOYSA-N
RHOPRESSA,AR-13324;NETARSUDIL DIMESYLATE;NETARSUDIL MESILATE;NETARSUDIL MESYLATE;RHOPRESSA,CHEMBL4594251,BRD:BRD-K00029607-334-02-9,rep_single_dose,,,,,,,Small molecule,4,CS(=O)(=O)O.CS(=O)(=O)O.Cc1ccc(C(=O)OCc2ccc([C@@H](CN)C(=O)Nc3ccc4cnccc4c3)cc2)c(C)c1,QQDRLKRHJOAQDC-FBHGDYMESA-N
NETICONAZOLE HYDROCHLORIDE,NETICONAZOLE;NETICONAZOLE HYDROCHLORIDE,CHEMBL2107447,BRD:BRD-K00074531-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,CCCCCOc1ccccc1/C(=C\SC)n1ccnc1,VWOIKFDZQQLJBJ-DTQAZKPQSA-N
NSC-759586,NETILMICIN;NETIRA;NSC-759586,CHEMBL1572,BRD:BRD-A59825838-326-01-4;BRD:BRD-BRD-A59825838-326-01-4,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,4,"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O;CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O, CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O, CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O, CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O",CIDUJQMULVCIBT-MQDUPKMGSA-N
RO-673189000,NETUPITANT;RO 67-3189/000;RO-67-3189;RO-673189000,CHEMBL206253,BRD:BRD-BRD-K97428065-001-01-2;BRD:BRD-K97428065-001-01-2,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1,"NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,Cc1ccccc1-c1cc(N2CCN(C)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;CN(C(=O)C(C)(C)C1CC(CC(C1)C(F)(F)F)C(F)(F)F)C1CNC(CC1-C1CCCCC1C)N1CCN(C)CC1,WAXQNWCZJDTGBU-UHFFFAOYSA-N
NEU2000,NEU2000,,BRD:BRD-K00003470-001-01-9,rep_single_dose,IONOTROPIC GLUTAMATE RECEPTOR ANTAGONIST,,,,,,,NA,,
NEURODAZINE,NEURODAZINE,,BRD:BRD-K22631935-001-02-7,rep_single_dose,NEUROGENESIS OF NON-PLURIPOTENT C2C12 MYOBLAST INDUCER,,,,,,,NA,,
NEURONAL DIFFERENTIATION INDUCER III,NEURONAL DIFFERENTIATION INDUCER III,,CTRP:411733,ctrp,,,,,,,,NA,,
NEUROPATHIAZOL,NEUROPATHIAZOL,,BRD:BRD-K28567778-001-02-7,rep_single_dose,NEURAL STEM CELL INDUCER,BMP2;LIF,,,,,,NA,,
PD132301-2,ATR-101;ATR-101 HYDROCHLORIDE;NEVANIMIBE HYDROCHLORIDE;PD 132301-02;PD-132301 HYDROCHLORIDE;PD-132301-02;PD-132301-2;PD132301-02;PD132301-2,CHEMBL542103,BRD:BRD-K00091091-003-01-9,rep_single_dose,,,,,,,Small molecule,2,CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(c2ccc(N(C)C)cc2)CCCC1.Cl,SDOOGTHIDFZUNM-UHFFFAOYSA-N
VIRAMUNE XR,ANHYDROUS;BIRG 0587;BIRG-0587;NEVIRAPINE;NEVIRAPINE ANHYDROUS;NEVIRAPINE TEVA;NEVIRAPINUM ANHYDROUS;NSC-641530;VIRAMUNE;VIRAMUNE XR,CHEMBL57,BRD:BRD-BRD-K15502390-001-20-9;BRD:BRD-K15502390-001-20-9,rep_primary;rep_single_dose,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,CYP1A2;CYP2A6;CYP2B6;CYP2C9;CYP2D6;CYP3A4;CYP3A5,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1;CC1CCNC2C1NC(=O)C1CCCNC1N2C1CC1, CC1CCNC2C1NC(=O)C1CCCNC1N2C1CC1",NQDJXKOVJZTUJA-UHFFFAOYSA-N
SORAFENIB,284461-73-0;BAY 43-9006;BAY-43-9006;NEXAVAR;SORAFENIB,CHEMBL1336,GDSC1:30;GDSC2:1085,gdsc,,,,,,,Small molecule,4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,MLDQJTXFUGDVEO-UHFFFAOYSA-N
NEXTURASTAT-A,NEXTURASTAT-A,,BRD:BRD-BRD-K70402238-001-02-8;BRD:BRD-K70402238-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC6,,,PRECLINICAL,,,NA,CCCCN(CC1CCC(CC1)C(=O)NO)C(=O)NC1CCCCC1,
NFKB-ACTIVATION-INHIBITOR-II,NFKB-ACTIVATION-INHIBITOR-II,,BRD:BRD-K83354763-001-07-9,rep_single_dose,NFKB PATHWAY INHIBITOR,RELA,,,,,,NA,,
NG-NITRO-ARGININE,NG-NITRO-ARGININE,,BRD:BRD-BRD-K89223384-001-05-2;BRD:BRD-K89223384-001-05-2,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS1;NOS2;NOS3,,,PHASE 1,,,NA,"N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O, N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O",
NG25,NG-25;NG25,,GDSC1:260,gdsc,,,,,,,,NA,,
NGB-2904,NGB-2904,,BRD:BRD-BRD-K05181084-003-03-7;BRD:BRD-K05181084-003-03-7,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD3,,,PRECLINICAL,,,NA,"CLC1CCCC(N2CCN(CCCCNC(=O)C3CCC-4C(CC5CCCCC-45)C3)CC2)C1CL, CLC1CCCC(N2CCN(CCCCNC(=O)C3CCC-4C(CC5CCCCC-45)C3)CC2)C1CL",
NGD-94-1,NGD-94-1,,BRD:BRD-BRD-K28639661-001-01-6;BRD:BRD-K28639661-001-01-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD4,,,PHASE 1,,,NA,C(N1CCN(CC1)C1NCCCN1)C1CNC([NH]1)-C1CCCCC1,
NGD-98-2,NGD-98-2,,BRD:BRD-K81779590-003-02-9,rep_single_dose,CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST,CRHR1,,,,,,NA,,
NGP555,NGP555,,BRD:BRD-K00003490-001-01-9,rep_single_dose,GAMMA SECRETASE MODULATOR,,,,,,,NA,,
NH125,NH125,,BRD:BRD-BRD-K31086665-005-04-6;BRD:BRD-K31086665-005-04-6,rep_multi_dose;rep_primary;rep_single_dose,EUKARYOTIC TRANSLATION ELONGATION FACTOR 2 INHIBITOR,,,,PRECLINICAL,,,NA,"CCCCCCCCCCCCCCCC[N+]1CCN(CC2CCCCC2)C1C, CCCCCCCCCCCCCCCC[N+]1CCN(CC2CCCCC2)C1C",
NHI-2,NHI-2,,BRD:BRD-K05653025-001-02-9,rep_single_dose,LACTATE DEHYDROGENASE INHIBITOR,LDHA,,,,,,NA,,
NI-57,NI-57,,BRD:BRD-BRD-K03042257-001-01-2;BRD:BRD-K03042257-001-01-2,rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD1;BRPF1;BRPF3,,,PRECLINICAL,,,NA,COC1CC(CCC1S(=O)(=O)NC1CCC2N(C)C(=O)C(C)CC2C1)C#N,
WAMPOCAP,ACIDUM NICOTINICUM;NIACIN;NIACIN EXTENDED RELEASE;NIACIN TD;NIACOR;NIASPAN;NIASPAN ER;NIASPAN TITRATION STARTER PACK;NICANGIN;NICOLAR;NICOTINATE;NICOTINIC ACID;NSC-169454;SIMCOR;VITAMIN B3;WAMPOCAP,CHEMBL573,BRD:BRD-BRD-K60237333-001-27-1;BRD:BRD-K60237333-001-27-1,rep_multi_dose;rep_primary;rep_single_dose,"NAD PRECURSOR, VITAMIN B",DGAT2;HCAR1;HCAR2;HCAR3;NNMT;QPRT,HYPERTRIGLYCERIDEMIA,,LAUNCHED,,Small molecule,4,"O=C(O)c1cccnc1;OC(=O)C1CCCNC1, OC(=O)C1CCCNC1, OC(=O)C1CCCNC1",PVNIIMVLHYAWGP-UHFFFAOYSA-N
NSC-124514,NIALAMIDE;NIAMID;NSC-124514,CHEMBL1256841,BRD:BRD-BRD-K12102668-001-25-5;BRD:BRD-K12102668-001-25-5,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,COMT;MAOA;MAOB,,,WITHDRAWN,,Small molecule,4,"O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1;O=C(CCNNC(=O)C1CCNCC1)NCC1CCCCC1, O=C(CCNNC(=O)C1CCNCC1)NCC1CCCCC1",NOIIUHRQUVNIDD-UHFFFAOYSA-N
NIBENTAN,NIBENTAN,,BRD:BRD-A85876464-001-01-5;BRD:BRD-BRD-A85876464-001-01-5,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,,,,PHASE 2,,,NA,CCN(CC)CCCCC(NC(=O)C1CCC(CC1)[N+]([O-])=O)C1CCCCC1,
NICAINOPROL,NICAINOPROL,CHEMBL2106788,BRD:BRD-K00003382-001-01-9,rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,,,,,,Small molecule,-1,CC(C)NCC(O)COc1cccc2c1N(C(=O)c1cccnc1)CCC2,AUIHHZBJBKRDIE-UHFFFAOYSA-N
NICARAVEN,ANTEVAS;NICARAVEN,CHEMBL1705525,BRD:BRD-A86871940-001-01-9;BRD:BRD-BRD-A86871940-001-01-9,rep_primary;rep_single_dose,FREE RADICAL SCAVENGER,,,,PHASE 3,,Small molecule,-1,CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1;CC(CNC(=O)C1CCCNC1)NC(=O)C1CCCNC1,KTXBOOWDLPUROC-UHFFFAOYSA-N
PERPIDINE,NICARDIPINE;NICARDIPINE (STN);PERPIDINE,CHEMBL1484,BRD:BRD-A26711594-003-10-6;BRD:BRD-BRD-A26711594-003-10-6,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,ADORA3;ADRA1A;ADRA1B;ADRA1D;CACNA1C;CACNA1D;CACNA2D1;CACNB2;CALM1;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;PDE1A;PDE1B,"CHRONIC STABLE ANGINA, HYPERTENSION",,LAUNCHED,,Small molecule,4,"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1;COC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCN(C)CC1CCCCC1, COC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCN(C)CC1CCCCC1",ZBBHBTPTTSWHBA-UHFFFAOYSA-N
VASOSPAN,CERGODUM;CIRCO-MAREN;DILASENIL;DURACEBROL;ERGOBEL;ERGOTOP;FI-6714;MEMOQ;NICERGOLENT;NICERGOLINE;NILOGRIN;NSC-150531;SERMION;VASOSPAN,CHEMBL1372950,BRD:BRD-BRD-K76810206-001-07-3;BRD:BRD-BRD-K76810206-001-08-1;BRD:BRD-K76810206-001-07-3;BRD:BRD-K76810206-001-08-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A,"RAYNAUD'S DISEASE, MIGRAINE HEADACHE, ATHEROSCLEROSIS, THROMBOSIS, RAYNAUD'S DISEASE, MIGRAINE HEADACHE, ATHEROSCLEROSIS, THROMBOSIS",,LAUNCHED,,Small molecule,4,"CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13;CO[C@]12C[C@@H](COC(=O)C3CNCC(BR)C3)CN(C)[C@@H]1CC1CN(C)C3CCCC2C13, CO[C@]12C[C@@H](COC(=O)C3CNCC(BR)C3)CN(C)[C@@H]1CC1CN(C)C3CCCC2C13",YSEXMKHXIOCEJA-FVFQAYNVSA-N
PERYCIT,NICERITROL;PENTAERITHRITOL TETRANICOTINATE;PERYCIT,CHEMBL1697762,BRD:BRD-BRD-K11256763-001-01-5;BRD:BRD-K11256763-001-01-5,rep_primary;rep_single_dose,NAD PRECURSOR,,HYPERLIPIDEMIA,,LAUNCHED,,Small molecule,-1,O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1;O=C(OCC(COC(=O)C1CCCNC1)(COC(=O)C1CCCNC1)COC(=O)C1CCCNC1)C1CCCNC1,KUEUWHJGRZKESU-UHFFFAOYSA-N
YOMESAN,ANHYDROUS;BAY 2353;BAY-2353;EX A LINT;LINTEX;NICLOCIDE;NICLOSAMIDE;NICLOSAMIDE (ANHYDROUS);NICLOSAMIDE ANHYDROUS;NICLOSAMIDUM ANHYDROUS;NICLOSIDE;NSC-178296;WR 46234;YOMESAN,CHEMBL1448,BRD:BRD-BRD-K35960502-001-20-0;BRD:BRD-K35960502-001-20-0;CTRP:32653,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"DNA REPLICATION INHIBITOR, STAT INHIBITOR",STAT3,TAPEWORM,,LAUNCHED,,Small molecule,4,"O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O;OC1CCC(CL)CC1C(=O)NC1CCC(CC1CL)[N+]([O-])=O, OC1CCC(CL)CC1C(=O)NC1CCC(CC1CL)[N+]([O-])=O",RJMUSRYZPJIFPJ-UHFFFAOYSA-N
NICODICOSAPENT,NICODICOSAPENT,,BRD:BRD-K00003262-001-01-9,rep_single_dose,STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) INHIBITOR,,,,,,,NA,,
SIGMART,IKOREL;NICORANDIL;SG-75;SIGMART,CHEMBL284906,BRD:BRD-BRD-K97752965-001-16-4;BRD:BRD-K97752965-001-16-4,rep_multi_dose;rep_primary;rep_single_dose,"NITRIC OXIDE DONOR, POTASSIUM CHANNEL ACTIVATOR",KCNJ11,ANGINA PECTORIS,,LAUNCHED,,Small molecule,4,"[O-][N+](=O)OCCNC(=O)C1CCCNC1, [O-][N+](=O)OCCNC(=O)C1CCCNC1, [O-][N+](=O)OCCNC(=O)C1CCCNC1, [O-][N+](=O)OCCNC(=O)C1CCCNC1;O=C(NCCO[N+](=O)[O-])c1cccnc1",LBHIOVVIQHSOQN-UHFFFAOYSA-N
PAPULEX,FREEDERM;NIACIN (AS NIACINAMIDE);NIACINAMID;NIACINAMIDE;NIATIN;NICAM;NICOBION;NICOTINAMIDE;NICOTINAMIDUM;NICOTINIC ACID AMIDE;NICOTYLAMIDE;NSC-13128;NSC-27452;PAPULEX,CHEMBL1140,BRD:BRD-BRD-K28912512-001-23-2;BRD:BRD-K28912512-001-23-2,rep_primary;rep_single_dose,PROTEIN SYNTHESIS STIMULANT,BST1;LDHA;PARP1;SIRT5,ACNE VULGARIS (AV),,LAUNCHED,,Small molecule,4,"NC(=O)c1cccnc1;NC(=O)C1CCCNC1, NC(=O)C1CCCNC1, NC(=O)C1CCCNC1",DFPAKSUCGFBDDF-UHFFFAOYSA-N
STUBIT,HABITROL;NICABATE;NICODERM;NICODERM CQ;NICOPASS;NICOPATCH;NICORETTE INVISI;NICOTINE;NICOTINELL CLASSIC;NICOTINELL SUPPORT;NICOTINELL TTS 10;NICOTINELL TTS 20;NICOTINELL TTS 30;NICOTROL;NICOTROL INHALER;NICOTROL NS;NIQUITIN;NIQUITIN CLR;NIQUITIN MINIS CHERRY;NIQUITIN MINIS MINT;NIQUITIN MINIS ORANGE;NIQUITIN MINT;NIQUITIN PRE-QUIT;NIQUITIN STRIPS MINT;PROSTEP;STOPPERS;STUBIT,CHEMBL3,BRD:BRD-A93695607-322-02-5;BRD:BRD-BRD-A93695607-322-02-5;BRD:BRD-BRD-K05395900-322-05-4;BRD:BRD-K05395900-322-05-4,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHAT;CHRNA10;CHRNA2;CHRNA3;CHRNA4;CHRNA5;CHRNA6;CHRNA7;CHRNA9;CHRNB2;CHRNB3;CHRNB4;CYP19A1;TBXAS1;TRPA1,SMOKING CESSATION,,LAUNCHED,"Multiple values for structure_id: {'A93695607', 'K05395900'}, defaulting to None",Small molecule,4,"CN1CCC[C@H]1c1cccnc1;CN1CCCC1C1CCCNC1, CN1CCC[C@H]1C1CCCNC1, CN1CCCC1C1CCCNC1",SNICXCGAKADSCV-JTQLQIEISA-N
NICOTINYL-ALCOHOL-TARTRATE,NICOTINYL-ALCOHOL-TARTRATE,,BRD:BRD-BRD-K76600340-045-04-9;BRD:BRD-K76600340-045-04-9,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,OCC1CCCNC1,
NIDA-41020,NIDA-41020,,BRD:BRD-BRD-K17617556-001-01-3;BRD:BRD-K17617556-001-01-3,rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1,,,PRECLINICAL,,,NA,COC1CCC(CC1)-C1C(C)C(NN1-C1CCC(CL)CC1CL)C(=O)NN1CCCCC1,
NIDUFEXOR,LMB763;NIDUFEXOR,CHEMBL4297626,BRD:BRD-K00091135-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Cn1nc(C(=O)N(Cc2ccccc2)Cc2ccc(C(=O)O)cc2)c2c1-c1cc(Cl)ccc1OC2,JYTIXGYXBIBOMN-UHFFFAOYSA-N
VASAD,ADALAT;ADALAT A.R.;ADALAT CC;ADALAT IC;ADALAT LA 20;ADALAT LA 30;ADALAT LA 60;ADALAT RET;ADALATE LP;ADANIF XL;ADIPINE MR 10;ADIPINE MR 20;ADIPINE XL;AFEDITAB CR;ANGIOPINE 10;ANGIOPINE 40 LA;ANGIOPINE 5;ANGIOPINE MR 10;ANGIOPINE MR 20;BAY A 1040;BAY-A-1040;CALANIF;CALCHAN MR 10;CALCHAN MR 20;CALCILAT;CARDILATE MR;CORACTEN;CORACTEN SR;CORACTEN XL;CORODAY MR;FORTIPINE LA40;GENALAT 10 RET;GENALAT 20 RET;HYPOLAR RET 10;HYPOLAR RET 20;HYPOLAR XL 30;KENTIPINE;KENTIPINE MR 10;KENTIPINE MR 20;NEOZIPINE XL;NIFE-WOLFF;NIFEDIPINE;NIFEDIPINE HYDROCHLORIDE;NIFEDIPINE SLOW RELEASE;NIFEDIPINUM;NIFEDIPRESS MR 10;NIFEDIPRESS MR 20;NIFEDOTARD 20 MR;NIFELEASE;NIFENSAR XL;NIFOPRESS MR;NIFOPRESS RET;NIMODREL MR 10;NIMODREL MR 20;NIMODREL XL;NIVATEN RET;NSC-757242;PROCARDIA;PROCARDIA XL;SLOFEDIPINE XL 30;SLOFEDIPINE XL 60;TENSIPINE MR 10;TENSIPINE MR 20;UNIPINE XL;VALNI 20 RET;VALNI XL;VASAD,CHEMBL193,BRD:BRD-K96354014-001-29-4,rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1D;CACNA1F;CACNA1H;CACNA1S;CACNA2D1;CACNB2;CALM1;GLRA1;GLRA3;GLRB;KCNA1;KCNA5;NR1I2;TRPM3,,,,,Small molecule,4,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],HYIMSNHJOBLJNT-UHFFFAOYSA-N
NIFEKALANT HYDROCHLORIDE,NIFEKALANT;NIFEKALANT HYDROCHLORIDE,CHEMBL360861,BRD:BRD-BRD-K32311154-001-01-0;BRD:BRD-K32311154-001-01-0,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,,"VENTRICULAR ARRHYTHMIAS, VENTRICULAR TACHYCARDIA (VT)",,LAUNCHED,,Small molecule,3,Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O;CN1C(NCCN(CCO)CCCC2CCC(CC2)[N+]([O-])=O)CC(=O)N(C)C1=O,OEBPANQZQGQPHF-UHFFFAOYSA-N
RACEMIC NIFENALOL,DL-INPEA;ISOPHENETHANOL;NIFENALOL;RACEMIC NIFENALOL,CHEMBL127349,BRD:BRD-A21280314-001-06-8;BRD:BRD-BRD-A21280314-001-06-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,,,LAUNCHED,,Small molecule,-1,CC(C)NCC(O)c1ccc([N+](=O)[O-])cc1;CC(C)NCC(O)C1CCC(CC1)[N+]([O-])=O,UAORFCGRZIGNCI-UHFFFAOYSA-N
NSC-758411,N-ANTIPYRINYLNICOTINAMIDE;NIAPYRIN;NICOPHEZON;NIFENAZONE;NSC-758411,CHEMBL1413176,BRD:BRD-BRD-K47407372-001-17-1;BRD:BRD-K47407372-001-17-1,rep_primary;rep_single_dose,ANALGESIC AGENT,,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,"Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C;CC1C(NC(=O)C2CCCNC2)C(=O)N(-C2CCCCC2)N1C, CC1C(NC(=O)C2CCCNC2)C(=O)N(-C2CCCCC2)N1C",BRZANEXCSZCZCI-UHFFFAOYSA-N
NIFLUMIC-ACID,NIFLUMIC-ACID,,BRD:BRD-BRD-K98763141-001-30-8;BRD:BRD-K98763141-001-30-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,ANO1;CLCN1;CLCNKA;CLCNKB;KCNQ1;PLA2G1B;PLA2G4A;PTGS1;PTGS2;UGT1A9,"JOINT PAIN, MUSCLE PAIN",,LAUNCHED,,,NA,"OC(=O)C1CCCNC1NC1CCCC(C1)C(F)(F)F, OC(=O)C1CCCNC1NC1CCCC(C1)C(F)(F)F",
SJ000287313,ERCEFURYL 200;NIFUROXAZIDE;NSC-759261;RC-27109;SJ000287313,CHEMBL244888,BRD:BRD-BRD-K68188368-001-09-4;BRD:BRD-K68188368-001-09-4,rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,"COLITIS, DIARRHEA",,LAUNCHED,,Small molecule,4,"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(O)cc1;OC1CCC(CC1)C(=O)N\N=C\C1CCC(O1)[N+]([O-])=O, OC1CCC(CC1)C(=O)N\N=C\C1CCC(O1)[N+]([O-])=O, OC1CCC(CC1)C(=O)N\N=C\C1CCC(O1)[N+]([O-])=O",YCWSUKQGVSGXJO-NTUHNPAUSA-N
NSC-759632,NIFURSOL;NSC-759632,CHEMBL485549,BRD:BRD-BRD-K85757157-001-01-7;BRD:BRD-K85757157-001-01-7,rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,,,LAUNCHED,,Small molecule,-1,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O;OC1C(CC(CC1[N+]([O-])=O)[N+]([O-])=O)C(=O)N\N=C\C1CCC(O1)[N+]([O-])=O,XXUXXCZCUGIGPP-WLRTZDKTSA-N
NIFURTIMOXUM,BAY 2502;BAY A2502;BAY-2502;BAY-A2502;BAYER 2502;BAYER-2502;DNDI1613515;LAMPIT;NIFURTIMOX;NIFURTIMOXUM,CHEMBL290960,BRD:BRD-A00100033-001-08-9;BRD:BRD-BRD-A00100033-001-08-9,rep_primary;rep_single_dose,DNA INHIBITOR,,"CHAGAS DISEASE, AFRICAN TRYPANOSOMIASIS",,LAUNCHED,,Small molecule,4,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1;CC1CS(=O)(=O)CCN1N=CC1CCC(O1)[N+]([O-])=O,ARFHIAQFJWUCFH-IZZDOVSWSA-N
NIGULDIPINE-(S)-(+),NIGULDIPINE-(S)-(+),,BRD:BRD-BRD-K59333713-003-02-0;BRD:BRD-K59333713-003-02-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A,,,PRECLINICAL,,,NA,"COC(=O)C1=C(C)NC(C)=C([C@H]1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1CCCCC1)C1CCCCC1, COC(=O)C1=C(C)NC(C)=C([C@H]1C1CCCC(C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1CCCCC1)C1CCCCC1",
NSC-130820,CARDITONIC;CORAMINE;NICETHAMIDE;NIKETHAMIDE;NIKETHYL;NSC-130820,CHEMBL2104607,BRD:BRD-BRD-K91544578-001-03-8;BRD:BRD-K91544578-001-03-8,rep_primary;rep_single_dose,IMMUNOSTIMULANT,,,,WITHDRAWN,,Small molecule,4,CCN(CC)C(=O)c1cccnc1;CCN(CC)C(=O)C1CCCNC1,NCYVXEGFNDZQCU-UHFFFAOYSA-N
TASIGNA,AMN 107;AMN-107;AMN107;NILOTINIB;NSC-747599;TASIGNA,CHEMBL255863,BRD:BRD-BRD-K81528515-001-13-8;BRD:BRD-K81528515-001-02-1;BRD:BRD-K81528515-001-13-8;CTRP:374749;GDSC1:1013;GDSC2:1013,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,"ABL KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR",ABL1;KIT;PDGFRA,CHRONIC MYELOID LEUKEMIA (CML),,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF BCR-ABL1, PDGFRA, AND KIT', 'ABL KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR'}, defaulting to 'ABL KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR'
Multiple values for repurposing_target: {'ABL1;KIT;PDGFRA', 'ABL1;KIT'}, taking the union",Small molecule,4,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1;CC1CN(CN1)-C1CC(NC(=O)C2CCC(C)C(NC3NCCC(N3)-C3CCCNC3)C2)CC(C1)C(F)(F)F,HHZIURLSWUIHRB-UHFFFAOYSA-N
RU-23908,ANADRON;NILANDRON;NILUTAMIDE;NSC-758683;RU 23908;RU-23908,CHEMBL1274,BRD:BRD-BRD-K23566484-001-15-1;BRD:BRD-K23566484-001-15-1,rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AR,PROSTATE CANCER,,LAUNCHED,,Small molecule,4,"CC1(C)NC(=O)N(C1=O)C1CCC(C(C1)C(F)(F)F)[N+]([O-])=O, CC1(C)NC(=O)N(C1=O)C1CCC(C(C1)C(F)(F)F)[N+]([O-])=O;CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O",XWXYUMMDTVBTOU-UHFFFAOYSA-N
SKF-102362,"CL 287,389;CL-287,389;CL-287389;DL-NILVADIPINE;ESCOR;FK 235;FK-235;FR-34235;NILVADIPINE;NIVADIL;NIVADIP;NIVADIPINE;SK&F 102,362;SKF-102362",CHEMBL517427,BRD:BRD-A84687895-001-03-2;BRD:BRD-BRD-A84687895-001-03-2,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1D;CACNA1S;CACNA2D1;CACNA2D3;CACNB2,"HYPERTENSION, CEREBRAL ARTERY OCCLUSION",,LAUNCHED,,Small molecule,3,"COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1;COC(=O)C1=C(NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC(C)C)C#N, COC(=O)C1=C(NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC(C)C)C#N",FAIIFDPAEUKBEP-UHFFFAOYSA-N
NIM811,NIM-811;NIM811,CHEMBL1688529,BRD:BRD-K00003331-001-01-9,oncref_1;rep_single_dose,CYCLOPHILIN AND MITOCHONDRIAL PERMEABILITY TRANSITION INHIBITOR,PPID,,,,"Multiple values for MOA: {'CYCLOPHILIN AND MITOCHONDRIAL PERMEABILITY TRANSITION INHIBITOR', 'MITOCHONDRIAL PERMEABILITY TRANSITION INHIBITOR'}, defaulting to 'CYCLOPHILIN AND MITOCHONDRIAL PERMEABILITY TRANSITION INHIBITOR'",Protein,2,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,RPJPZDVUUKWPGT-FOIHOXPVSA-N
R-805,AULIN;NIMESULIDE;NSC-758412;R 805;R-805,CHEMBL56367,BRD:BRD-BRD-K76775527-001-30-2;BRD:BRD-K76775527-001-30-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,LTF;PLA2G2E;PTGS1;PTGS2,"OSTEOARTHRITIS, MENSTRUAL PAIN",,LAUNCHED,,Small molecule,4,"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1;CS(=O)(=O)NC1CCC(CC1OC1CCCCC1)[N+]([O-])=O, CS(=O)(=O)NC1CCC(CC1OC1CCCCC1)[N+]([O-])=O, CS(=O)(=O)NC1CCC(CC1OC1CCCCC1)[N+]([O-])=O",HYWYRSMBCFDLJT-UHFFFAOYSA-N
PERIPLUM,ADMON;BAY E 9736;BAY-E-9736;NEMOTAN;NIMODIPINE;NIMODIPINE AP;NIMOTOP;NSC-758476;NYMALIZE;PERIPLUM,CHEMBL1428,BRD:BRD-A58048407-001-18-8;BRD:BRD-BRD-A58048407-001-18-8,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,AHR;CACNA1C;CACNA1D;CACNA1F;CACNA1S;CACNB1;CACNB2;CACNB3;CACNB4;CFTR;NR3C2,HEMORRHAGE,,LAUNCHED,,Small molecule,4,"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1;COCCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC(C)C, COCCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC(C)C, COCCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC(C)C",UIAGMCDKSXEBJQ-UHFFFAOYSA-N
NSC-107524,K-1900;NAXOGIN;NAXOGIN 500;NIMORAZOLE;NSC-107524,CHEMBL435966,BRD:BRD-BRD-K79145628-001-05-5;BRD:BRD-K79145628-001-05-5,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC),,LAUNCHED,,Small molecule,4,[O-][N+](=O)C1CNCN1CCN1CCOCC1;O=[N+]([O-])c1cncn1CCN1CCOCC1,MDJFHRLTPRPZLY-UHFFFAOYSA-N
NINGETINIB-TOSYLATE,NINGETINIB-TOSYLATE,,BRD:BRD-K00003476-075-01-9,rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,,,,,,,NA,,
VARGATEF,BIBF 1120;BIBF-1120;BIBF1120;INTEDANIB;NINTEDANIB;OFEV;VARGATEF,CHEMBL502835,BRD:BRD-BRD-K49075727-001-08-5;BRD:BRD-K49075727-001-08-5;CTRP:628601,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"FGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",FGFR1;FGFR2;FGFR3;FGFR4;FLT1;FLT4;KDR;PDGFRA;PDGFRB,IDIOPATHIC PULMONARY FIBROSIS (IPF),,LAUNCHED,,Small molecule,4,"COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1;COC(=O)C1CCC2C(NC(=O)\C2=C(/NC2CCC(CC2)N(C)C(=O)CN2CCN(C)CC2)C2CCCCC2)C1, COC(=O)C1CCC2C(NC(=O)\C2=C(/NC2CCC(CC2)N(C)C(=O)CN2CCN(C)CC2)C2CCCCC2)C1",XZXHXSATPCNXJR-ZIADKAODSA-N
NSC-136947,BA 32644;BA-32644;CIBA 32644BA;NIRIDAZOLE;NIRIDAZOLUM;NSC-136947,CHEMBL152632,BRD:BRD-BRD-K53123955-001-10-5;BRD:BRD-K53123955-001-10-5,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHOFRUCTOKINASE INHIBITOR,,SCHISTOSOMIASIS,,LAUNCHED,,Small molecule,-1,[O-][N+](=O)C1CNC(S1)N1CCNC1=O;O=C1NCCN1c1ncc([N+](=O)[O-])s1,RDXLYGJSWZYTFJ-UHFFFAOYSA-N
SYSCOR MR 30,BAY K 5552;BAY-K-5552;BAYMYCARD;GEOMATRIX 16E;NISOLDIPIN;NISOLDIPINE;NISOLDIPINE (STN);NSC-759106;SULAR;SYSCOR MR 10;SYSCOR MR 20;SYSCOR MR 30,CHEMBL1726,BRD:BRD-A84465106-001-09-5,rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1D;CACNA1F;CACNA1S,,,,,Small molecule,4,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],VKQFCGNPDRICFG-UHFFFAOYSA-N
NSC-283481,COMPOUND 89218;LY-94939;NISOXETINE;NSC-283481,CHEMBL295467,BRD:BRD-A95696066-003-13-8;BRD:BRD-BRD-A95696066-003-13-8,rep_multi_dose;rep_primary;rep_single_dose,NOREPINEPHRINE REUPTAKE INHIBITOR,SLC6A2;SLC6A3;SLC6A4,,,PHASE 1,,Small molecule,-1,CNCCC(Oc1ccccc1OC)c1ccccc1;CNCCC(OC1CCCCC1OC)C1CCCCC1,ITJNARMNRKSWTA-UHFFFAOYSA-N
NITARSONE,NITARSONE,,BRD:BRD-BRD-K56707426-001-02-0;BRD:BRD-K56707426-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,,,BLACKHEAD DISEASE,,LAUNCHED,,,NA,"O[AS](O)(=O)C1CCC(CC1)[N+]([O-])=O, O[AS](O)(=O)C1CCC(CC1)[N+]([O-])=O",
PH-5776,ALINIA;NITAZOXANIDE;NSC-697855;NSC-760057;PH 5776;PH-5776,CHEMBL1401,BRD:BRD-BRD-K96471533-001-09-0;BRD:BRD-K96471533-001-09-0,rep_primary;rep_single_dose,PYRUVATE FERREDOXIN OXIDOREDUCTASE INHIBITOR,,DIARRHEA,,LAUNCHED,,Small molecule,4,"CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1;CC(=O)OC1CCCCC1C(=O)NC1NCC(S1)[N+]([O-])=O, CC(=O)OC1CCCCC1C(=O)NC1NCC(S1)[N+]([O-])=O, CC(=O)OC1CCCCC1C(=O)NC1NCC(S1)[N+]([O-])=O, CC(=O)OC1CCCCC1C(=O)NC1NCC(S1)[N+]([O-])=O, CC(=O)OC1CCCCC1C(=O)NC1NCC(S1)[N+]([O-])=O",YQNQNVDNTFHQSW-UHFFFAOYSA-N
NITENPYRAM,NITENPYRAM,CHEMBL259728,BRD:BRD-BRD-K47887731-001-01-4;BRD:BRD-K47887731-001-01-4,rep_primary;rep_single_dose,,,FLEA CONTROL,,LAUNCHED,,Small molecule,NA,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC;CCN(CC1CCC(CL)NC1)C(\NC)=C\[N+]([O-])=O,CFRPSFYHXJZSBI-DHZHZOJOSA-N
NSC-45914,"2-ACETAMIDO-5-NITROTHIAZOLE;ACINITRAZOLE;AMINITROZOLE;CL 5,279;CL-5279;NITHIAMIDE;NSC-31539;NSC-45914",CHEMBL1872946,BRD:BRD-BRD-K39467894-001-05-9;BRD:BRD-BRD-K39467894-001-06-7;BRD:BRD-K39467894-001-05-9;BRD:BRD-K39467894-001-06-7,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,,,PRECLINICAL,,Small molecule,-1,"CC(=O)Nc1ncc([N+](=O)[O-])s1;CC(=O)NC1NCC(S1)[N+]([O-])=O, CC(=O)NC1NCC(S1)[N+]([O-])=O, CC(=O)NC1NCC(S1)[N+]([O-])=O",UJRRDDHEMZLWFI-UHFFFAOYSA-N
SC-0735,NITISINONE;NITYR;ORFADIN;SC-0735,CHEMBL1337,BRD:BRD-BRD-K01109406-001-03-7;BRD:BRD-K01109406-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,HYDROXYPHENYLPYRUVATE DIOXYGENASE INHIBITOR,HPD,TYROSINEMIA,,LAUNCHED,,Small molecule,4,"[O-][N+](=O)C1CC(CCC1C(=O)C1C(=O)CCCC1=O)C(F)(F)F, [O-][N+](=O)C1CC(CCC1C(=O)C1C(=O)CCCC1=O)C(F)(F)F;O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]",OUBCNLGXQFSTLU-UHFFFAOYSA-N
NSC-758466,BAY E 5009;BAY-E-5009;BAYOTENSIN;BAYPRESS;DEITEN;NIDREL;NITRENDIPINE;NITREPIN;NSC-758466,CHEMBL475534,BRD:BRD-A02006392-001-16-4;BRD:BRD-BRD-A02006392-001-16-4,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C;CACNA1D;CACNA1H;CACNA1S;CACNA2D1;CACNA2D2;CACNB2;CACNG1;KCNN4,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1;CCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC",PVHUJELLJLJGLN-UHFFFAOYSA-N
NITROCARAMIPHEN,NITROCARAMIPHEN,,BRD:BRD-BRD-K28453807-003-11-2;BRD:BRD-K28453807-003-11-2,rep_multi_dose;rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRM1,,,PRECLINICAL,,,NA,CCN(CC)CCOC(=O)C1(CCCC1)C1CCC(CC1)[N+]([O-])=O,
NITROFLURBIPROFEN,NITROFLURBIPROFEN,,BRD:BRD-K00004737-001-01-9,rep_single_dose,CYCLOOXYGENASE INHIBITOR,,,,,,,NA,,
NSC-44150,BERKFURIN;CEDURAN;DANTAFUR;FURADANTIN;FURALAN;GENFURA;IVADANTIN;MACROBID;MACROCRYSTALLINE;MACROCRYSTALS;MACRODANTIN;NITROFURANTOIN;NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS);NITROFURANTOIN ANHYDROUS;NITROFURANTOIN MACROCRYSTAL;NITROFURANTOIN MACROCRYSTALLINE;NITROFURANTOINUM ANHYDROUS;NSC-2107;NSC-44150,CHEMBL572,BRD:BRD-BRD-K76927775-001-11-8;BRD:BRD-K76927775-001-11-8,rep_primary;rep_single_dose,DNA INHIBITOR,,"URINARY TRACT INFECTIONS, PYELONEPHRITIS",,LAUNCHED,,Small molecule,4,"[O-][N+](=O)C1CCC(\C=N\N2CC(=O)NC2=O)O1, [O-][N+](=O)C1CCC(\C=N\N2CC(=O)NC2=O)O1, [O-][N+](=O)C1CCC(\C=N\N2CC(=O)NC2=O)O1;O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1",NXFQHRVNIOXGAQ-YCRREMRBSA-N
NSC-2100,ACTIN-N;FURACILIN;FURACIN;FURACINE;FURAZONE;NITROFURAL;NITROFURAZONE;NSC-1602;NSC-2100,CHEMBL869,BRD:BRD-BRD-K79092138-001-11-0;BRD:BRD-K79092138-001-11-0,rep_primary;rep_single_dose,BACTERIAL DNA INHIBITOR,,FIRST-AID ANTIBIOTIC,,LAUNCHED,,Small molecule,4,"NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1;NC(=O)N\N=C\C1CCC(O1)[N+]([O-])=O, NC(=O)N\N=C\C1CCC(O1)[N+]([O-])=O",IAIWVQXQOWNYOU-FPYGCLRLSA-N
NSC-60719,NITROMIDE;NSC-60719,CHEMBL1437065,BRD:BRD-BRD-K76381435-001-08-6;BRD:BRD-K76381435-001-08-6,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,NC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1;NC(=O)C1CC(CC(C1)[N+]([O-])=O)[N+]([O-])=O,UUKWKUSGGZNXGA-UHFFFAOYSA-N
ZINGA 300,ACINON;AXID;AXID AR;LY 139037;LY-139037;NIZATIDINE;NSC-759289;ZINGA 150;ZINGA 300,CHEMBL3183075,BRD:BRD-BRD-K73589491-001-11-2;BRD:BRD-K73589491-001-11-2,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,"DUODENAL ULCER DISEASE, EROSIVE ESOPHAGITIS (EE), ULCERATIVE ESOPHAGITIS (UE), GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,LAUNCHED,,Small molecule,4,"CN\C(NCCSCC1CSC(CN(C)C)N1)=C/[N+]([O-])=O, CN\C(NCCSCC1CSC(CN(C)C)N1)=C/[N+]([O-])=O;CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1",SGXXNSQHWDMGGP-UHFFFAOYSA-N
NIZOFENONE FUMARATE,NIZOFENONE;NIZOFENONE FUMARATE,CHEMBL2106822,BRD:BRD-BRD-K84011460-051-01-7;BRD:BRD-K84011460-051-01-7,rep_multi_dose;rep_primary;rep_single_dose,ION CHANNEL ANTAGONIST,,STROKE,,LAUNCHED,,Small molecule,-1,CCN(CC)Cc1nccn1-c1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1Cl;CCN(CC)CC1NCCN1-C1CCC(CC1C(=O)C1CCCCC1CL)[N+]([O-])=O,WZGBZLHGOVJDET-UHFFFAOYSA-N
NK-252,NK-252,,BRD:BRD-K47441935-001-02-9,rep_single_dose,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",NFE2L2,,,,,,NA,,
NKP-1339,IT-139;KP-1339;NKP-1339,CHEMBL4297410,BRD:BRD-BRD-K81645297-236-01-1;BRD:BRD-K81645297-236-01-1,rep_primary;rep_single_dose,HSP INHIBITOR,,,,PHASE 1,,Small molecule,1,"CL[RU+3](CL)(CL)(CL)([N+]1CC2CCCCC2[NH]1)[N+]1CC2CCCCC2[NH]1, CL[RU](CL)(CL)(CL)([N+]1CC2CCCCC2[NH]1)[N+]1CC2CCCCC2[NH]1",
NKY-80,NKY-80,,BRD:BRD-A75015151-001-08-9,rep_single_dose,ADENYLYL CYCLASE INHIBITOR,ADCY5,,,,,,NA,,
RO7077339-001,GDC-0919;IDO-IN-7;NAVOXIMOD;NLG-919;NLG919;RG-6078;RG6078;RO-7077339;RO7077339;RO7077339-001,CHEMBL3989951,BRD:BRD-A62133859-001-03-7;BRD:BRD-BRD-A62133859-001-03-7,rep_primary;rep_single_dose,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",IDO1,,,PHASE 1,,Small molecule,1,"O[C@H](C[C@H]1c2c(F)cccc2-c2cncn21)[C@H]1CC[C@H](O)CC1;OC(CC1C2CCCCC2-C2CNCN12)C1CCCCC1, OC(CC1C2CCCCC2-C2CNCN12)C1CCCCC1, OC(CC1C2CCCCC2-C2CNCN12)C1CCCCC1, OC(CC1C2CCCCC2-C2CNCN12)C1CCCCC1",YGACXVRLDHEXKY-WXRXAMBDSA-N
NM107,NM107,,BRD:BRD-A66966115-001-01-0;BRD:BRD-BRD-A66966115-001-01-0,rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,,,PHASE 2,,,NA,CC1(O)C(O)C(CO)OC1N1CCC(N)NC1=O,
NMDA,NMDA,,BRD:BRD-BRD-K62414032-001-12-0;BRD:BRD-K62414032-001-12-0,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,PRECLINICAL,,,NA,"CN[C@H](CC(O)=O)C(O)=O, CN[C@H](CC(O)=O)C(O)=O",
NMDI14,NMDI14,,BRD:BRD-A76106214-001-09-9,oncref_2,INHIBITOR OF SMG7-UPF1 INTERACTION,SMG7,,,,,,NA,,
PCM-075,NMS-1286937;NMS-P937;ONVANSERTIB;PCM-075,CHEMBL1094408;CHEMBL1738758,BRD:BRD-BRD-K83699324-001-01-1;BRD:BRD-K83699324-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,PLK INHIBITOR,FLT3;PLK1;PLK2;PLK3,,,PHASE 1,,Small molecule,2,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1;CN1CCN(CC1)C1CCC(OC(F)(F)F)C(NC2NCC3CCC4C(NN(CCO)C4-C3N2)C(N)=O)C1,QHLVBNKYJGBCQJ-UHFFFAOYSA-N
NMS-873,NMS-873,,BRD:BRD-BRD-K26253904-001-01-5;BRD:BRD-K26253904-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,ATPASE INHIBITOR,VCP,,,PRECLINICAL,,,NA,"CC1CC(OCC2NNC(SC3CCCC3)N2-C2CCCNC2)CCC1-C1CCC(CC1)S(C)(=O)=O, CC1CC(OCC2NNC(SC3CCCC3)N2-C2CCCNC2)CCC1-C1CCC(CC1)S(C)(=O)=O",
NMS-E973,NMS-E973,,BRD:BRD-BRD-K58770988-001-01-8;BRD:BRD-K58770988-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,,,,PRECLINICAL,,,NA,CN1CCC(CC1)NC(=O)C1CC(ON1)-C1C(O)CC(O)CC1OC1CCC(CC1)[N+]([O-])=O,
NMS-P715,NMS-P715,,BRD:BRD-BRD-K54170555-001-01-8;BRD:BRD-K54170555-001-01-8,rep_primary;rep_single_dose,PROTEIN KINASE INHIBITOR,,,,PRECLINICAL,,,NA,CCC1CCCC(CC)C1NC(=O)C1NN(C)C-2C1CCC1CNC(NC3CCC(CC3OC(F)(F)F)C(=O)NC3CCN(C)CC3)NC-21,
NN-DNJ,NN-DNJ,,BRD:BRD-K00004640-001-01-9,rep_single_dose,GLUCOSIDASE INHIBITOR,GBA,,,,,,NA,,
NNC-05-2090,NNC-05-2090,,BRD:BRD-BRD-K85015012-003-02-9;BRD:BRD-K85015012-003-02-9,rep_primary;rep_single_dose,"GABA UPTAKE INHIBITOR, GAT INHIBITOR",SLC6A12,,,PRECLINICAL,,,NA,"COC1CCCCC1C1(O)CCN(CCCN2C3CCCCC3C3CCCCC23)CC1, COC1CCCCC1C1(O)CCN(CCCN2C3CCCCC3C3CCCCC23)CC1",
NNC-55-0396,NNC-55-0396,,BRD:BRD-BRD-K78122587-300-02-7;BRD:BRD-K78122587-300-02-7,rep_primary;rep_single_dose,T-TYPE CALCIUM CHANNEL BLOCKER,CATSPER1;CATSPER2;CATSPER3;CATSPER4,,,PRECLINICAL,,,NA,"CC(C)[C@H]1C2CCC(F)CC2CC[C@@]1(CCN(C)CCCC1NC2CCCCC2[NH]1)OC(=O)C1CC1, CC(C)[C@H]1C2CCC(F)CC2CC[C@@]1(CCN(C)CCCC1NC2CCCCC2[NH]1)OC(=O)C1CC1",
NNC-63-0532,NNC-63-0532,,BRD:BRD-BRD-K72904818-001-01-1;BRD:BRD-K72904818-001-01-1,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRL1,,,PRECLINICAL,,,NA,"COC(=O)CN1CN(C2CCCCC2)C2(CCN(CC3CCCC4CCCCC34)CC2)C1=O, COC(=O)CN1CN(C2CCCCC2)C2(CCN(CC3CCCC4CCCCC34)CC2)C1=O",
NNC-711,NNC-711,,BRD:BRD-BRD-K42221274-003-07-7;BRD:BRD-K42221274-003-07-7,rep_primary;rep_single_dose,GABA UPTAKE INHIBITOR,SIGMAR1;SLC6A1,,,PRECLINICAL,,,NA,"OC(=O)C1=CCCN(CCON=C(C2CCCCC2)C2CCCCC2)C1, OC(=O)C1=CCCN(CCON=C(C2CCCCC2)C2CCCCC2)C1",
NSC-76751,NOBILETIN;NSC-76751,CHEMBL76447,BRD:BRD-BRD-K06753942-001-14-5;BRD:BRD-K06753942-001-14-5,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1,,,PRECLINICAL,,Small molecule,NA,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1OC;COC1CCC(CC1OC)-C1CC(=O)C2C(OC)C(OC)C(OC)C(OC)C2O1,MRIAQLRQZPPODS-UHFFFAOYSA-N
R-17934,"NOCODAZOLE;NSC-238159;R 17,934;R-17934",CHEMBL9514,BRD:BRD-BRD-K12539581-001-23-7;BRD:BRD-K12539581-001-23-7,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,HPGDS,,,PRECLINICAL,,Small molecule,-1,"COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1;COC(=O)NC1NC2CC(CCC2[NH]1)C(=O)C1CCCS1, COC(=O)NC1NC2CC(CCC2[NH]1)C(=O)C1CCCS1, COC(=O)NC1NC2CC(CCC2[NH]1)C(=O)C1CCCS1, COC(=O)NC1NC2CC(CCC2[NH]1)C(=O)C1CCCS1",KYRVNWMVYQXFEU-UHFFFAOYSA-N
NOLATREXED,NOLATREXED,CHEMBL320775,BRD:BRD-BRD-K36636143-001-01-0;BRD:BRD-K36636143-001-01-0,rep_primary;rep_single_dose,THYMIDYLATE SYNTHASE INHIBITOR,TYMS,,,PHASE 3,,Small molecule,3,Cc1ccc2nc(N)[nH]c(=O)c2c1Sc1ccncc1;CC1CCC2NC(N)NC(O)C2C1SC1CCNCC1,XHWRWCSCBDLOLM-UHFFFAOYSA-N
NOMEGESTROL-ACETATE,NOMEGESTROL-ACETATE,,BRD:BRD-BRD-K27351809-001-09-5;BRD:BRD-K27351809-001-09-5,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,CONTRACEPTIVE,,LAUNCHED,,,NA,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O,
NOMIFENSINE,LINAMIPHEN;NOMIFENSIN;NOMIFENSINE,CHEMBL273575,BRD:BRD-A29644307-050-17-0;BRD:BRD-BRD-A29644307-050-17-0,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, NORADRENALINE UPTAKE INHIBITOR",DRD2;MAOA;MAOB;MPO;SLC6A2;SLC6A3,,,WITHDRAWN,"Multiple values for MOA: {'DOPAMINE UPTAKE INHIBITOR, NORADRENALINE UPTAKE INHIBITOR', 'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, NORADRENALINE UPTAKE INHIBITOR'}, defaulting to 'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, NORADRENALINE UPTAKE INHIBITOR'",Small molecule,4,"CN1CC(C2CCCCC2)C2CCCC(N)C2C1, CN1CC(C2CCCCC2)C2CCCC(N)C2C1, CN1CC(C2CCCCC2)C2CCCC(N)C2C1;CN1Cc2c(N)cccc2C(c2ccccc2)C1",XXPANQJNYNUNES-UHFFFAOYSA-N
PSEUDOCAPSAICIN,AH-23491X;FEMA NO. 2787;HANSAPLAST;HYDROXYMETHOXYBENZYL PELARGONAMIDE;N-VANILLYLNONAMIDE;NONIVAMIDE;NONYLIC ACID VANILLYAMIDE;NSC-172795;PSEUDOCAPSAICIN,CHEMBL75124,BRD:BRD-BRD-K05907307-001-07-1;BRD:BRD-K05907307-001-07-1,rep_primary;rep_single_dose,TRPV AGONIST,TRPV1,"RHEUMATOID ARTHRITIS, MUSCLE PAIN",,LAUNCHED,,Small molecule,3,CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1;CCCCCCCCC(=O)NCC1CCC(O)C(OC)C1,RGOVYLWUIBMPGK-UHFFFAOYSA-N
TODAY SPONGE,C-FILM;CONCEPTROL;DELFEN;DOUBLE CHECK;DURAGEL;EMKO;GYGEL;GYNOL 11;GYNOL II;IGEPAL CO-630;INTERCEPT;NONOXINOL 9;NONOXINOLUM 9;NONOXYNOL 9;NONOXYNOL-9;NONOXYNOL-9.5;NONYLPHENOXYPOLYETHOXYETHANOL;NORFOX NP-9;NSC-758941;ORTHO-CREME;ORTHO-FORMS;PEG-9 NONYL PHENYL ETHER;PRELUDE;SEMICID;TERGITOL NP-9;TODAY;TODAY SPONGE,CHEMBL1410,BRD:BRD-BRD-K88625236-001-04-2;BRD:BRD-K88625236-001-04-2,rep_multi_dose;rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,"CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1;CCCCCCCCCC1CCC(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)CC1, CCCCCCCCCC1CCC(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)CC1, CCCCCCCCCC1CCC(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)CC1",FBWNMEQMRUMQSO-UHFFFAOYSA-N
NOR-BINALTORPHIMINE-DIHYDROCHLORIDE,NOR-BINALTORPHIMINE-DIHYDROCHLORIDE,,BRD:BRD-BRD-K36381762-300-02-7,rep_primary,OPIOID RECEPTOR ANTAGONIST,OPRD1;OPRK1;OPRM1,,,PRECLINICAL,,,NA,"OC1CCC2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C1[NH]C2[C@@H]4OC6C7C(C[C@H]8N(CC9CC9)CC[C@@]47[C@@]8(O)CC2C1C[C@@]35O)CCC6O, OC1CCC2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1C24)C1[NH]C2[C@@H]4OC6C7C(C[C@H]8N(CC9CC9)CC[C@@]47[C@@]8(O)CC2C1C[C@@]35O)CCC6O",
NORCYCLOBENZAPRINE,NORCYCLOBENZAPRINE,,BRD:BRD-BRD-K63165456-001-10-8;BRD:BRD-K63165456-001-10-8,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",,,,PRECLINICAL,,,NA,CNCCC=C1C2CCCCC2C=CC2CCCCC12,
RWJ-10553,DEACETYLNORGESTIMATE;EVRA;NORELGESTROMIN;ORTHO EVRA;RWJ-10553,CHEMBL1200807,BRD:BRD-BRD-K42504537-001-01-6;BRD:BRD-K42504537-001-01-6,rep_primary;rep_single_dose,,PGR,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC;CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(O)C#C,ISHXLNHNDMZNMC-VTKCIJPMSA-N
TARTRATE,(-)-NORADRENALINE;ADRENOR;AKTAMIN;ARTERENOL;BINODRENAL;LEVARTERENOL;LEVARTERENOL BITARTRATE;LEVOPHED;MONOHYDRATE;NOR ADRENALIN;NORADRENALINE;NORADRENALINE (AS TARTRATE);NORADRENALINE BITARTRATE;NORADRENALINE TARTRATE;NOREPINEPHRINE;NOREPINEPHRINE BITARTRATE;NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE;NOREPINEPHRINE BITARTRATE MONOHYDRATE;NOREPINEPHRINE D-BITARTRATE;NOREPINEPHRINE HYDROCHLORIDE;NSC-169106;NSC-757246;R-NOREPINEPHRINE;TARTRATE,CHEMBL1434513;CHEMBL1437,BRD:BRD-BRD-K87349682-347-03-8;BRD:BRD-K87349682-347-03-8,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;ADRB3;PAH;SLC18A1;SLC18A2,"HYPERTENSION, URTICARIA, HEADACHE, SEASONAL AFFECTIVE DISORDER",,LAUNCHED,,Small molecule,4,"NC[C@H](O)C1CCC(O)C(O)C1, NC[C@H](O)C1CCC(O)C(O)C1, NC[C@H](O)C1CCC(O)C(O)C1;NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O",LNBCGLZYLJMGKP-JZGIKJSDSA-N
UTOVLAN,ACTIVELLA;ANOVULE;AYGESTIN;CALLUNA VULGARIS;CALLUNA VULGARIS WHOLE;CAMILA;COMBIPATCH;ERRIN;FEMHRT;GESTEST;HEATHER;HEATHER WHOLE;INCASSIA;JENCYCLA;MENZOL;MICRONOR;MICRONOR HRT;NOR-QD;NORETHIDRONE;NORETHINDRONE;NORETHISTERON;NORETHISTERONE;NORETHISTERONUM;NORIDAY;NORLUTATE;NORLUTIN;NSC-9564;PRIMOLUT N;SC-4640;TRIELLA;UTOVLAN,CHEMBL1162,BRD:BRD-BRD-K92073408-001-15-7;BRD:BRD-BRD-K92073408-001-16-5;BRD:BRD-K92073408-001-15-7;BRD:BRD-K92073408-001-16-5,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,ENDOMETRIOSIS,,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C;C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C",VIKNJXKGJWUCNN-XGXHKTLJSA-N
NORETHINDRONE-ACETATE,NORETHINDRONE-ACETATE,,BRD:BRD-A09349126-001-10-7;BRD:BRD-BRD-A09349126-001-10-7,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,,"MENOPAUSE, OSTEOPOROSIS, VAGINAL ATROPHY",,LAUNCHED,,,NA,CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@]12C)C#C,
NORETHISTERONE-ENANTHATE,NORETHISTERONE-ENANTHATE,,BRD:BRD-BRD-K07625016-001-01-2;BRD:BRD-K07625016-001-01-2,rep_primary;rep_single_dose,CONTRACEPTIVE AGENT,,CONTRACEPTIVE,,LAUNCHED,,,NA,CCCCCCC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,
SC-4642,ENIDREL;NORETHYNODREL;NORETYNODREL;NSC-15432;SC-4642,CHEMBL1387,BRD:BRD-A00758722-001-04-9;BRD:BRD-BRD-A00758722-001-04-9,rep_multi_dose;rep_primary;rep_single_dose,PROGESTOGEN HORMONE,PGR,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,C[C@]12CCC3C(CCC4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C;C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C,ICTXHFFSOAJUMG-SLHNCBLASA-N
UTINOR,BACCIDAL;CHIBROXIN;MK-366;NORFLOXACIN;NOROXIN;NSC-757250;QUINABIC;UTINOR,CHEMBL9,BRD:BRD-BRD-K11196887-001-21-2;BRD:BRD-BRD-K11196887-001-22-0;BRD:BRD-K11196887-001-21-2;BRD:BRD-K11196887-001-22-0,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,"URINARY TRACT INFECTIONS, GONORRHEA, PROSTATITIS",,LAUNCHED,,Small molecule,4,"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21;CCN1CC(C(O)=O)C(=O)C2CC(F)C(CC12)N1CCNCC1, CCN1CC(C(O)=O)C(=O)C2CC(F)C(CC12)N1CCNCC1, CCN1CC(C(O)=O)C(=O)C2CC(F)C(CC12)N1CCNCC1",OGJPXUAPXNRGGI-UHFFFAOYSA-N
SEPROXETINE,(S)-;(S)-NORFLUOXETINE;NORFLUOXETINE;SEPROXETINE,CHEMBL1494;CHEMBL465123,BRD:BRD-A79769222-001-01-3;BRD:BRD-BRD-A79769222-001-01-3,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),HTR2B,,,PHASE 1,,Small molecule,-1,NCC[C@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1;NCCC(OC1CCC(CC1)C(F)(F)F)C1CCCCC1,WIQRCHMSJFFONW-HNNXBMFYSA-N
WY-5104,(-)-;ATHENTIA NEXT;BAY86-5028;DL-NORGESTREL;EMERRES;EMERRES UNA;EZINELLE;FALLBACK SOLO;FH-122A;HER STYLE;ISTERANDA;JADELLE;JAYDESS;KYLEENA;LEVONELLE;LEVONELLE ONE STEP;LEVONELLE-2;LEVONORGESTREL;LEVONORGESTRELUM;LEVOSERT;LILETTA;MICROVAL;MIRENA;NORGESTON;NORGESTREL;NORGESTREL (-)-FORM;NORPLANT;NORPLANT II;NORPLANT SYSTEM;NSC-744007;NSC-757251;OPCICON ONE-STEP;OPILL;OVRETTE;PLAN B;PLAN B ONE-STEP;POSTINOR-2;PREFEST;PREVIFEM;SH-70850;SH-850;SKYLA;SPRINTEC;TRI-PREVIFEM;TRI-SPRINTEC;UPOSTELLE;WY-3707;WY-5104,CHEMBL1389;CHEMBL2107797,BRD:BRD-A14886633-001-01-6;BRD:BRD-BRD-A14886633-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,AR;ESR1;PGR;SRD5A1,CONTRACEPTIVE,,LAUNCHED,"Multiple values for repurposing_target: {'AR;ESR1;PGR;SRD5A1', 'PGR'}, taking the union",Small molecule,4,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC;CC[C@]12CCC3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-XUDSTZEESA-N
NORNICOTINE,1'-DEMETHYLNICOTINE;3-(2-PYRROLIDINYL)-(S)-PYRIDINE;NICOTINE RELATED COMPOUND F;NORNICOTINE,CHEMBL1132,BRD:BRD-A24543851-001-05-7;BRD:BRD-BRD-A24543851-001-05-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,PRECLINICAL,,Small molecule,1,C1CNC(C1)C1CCCNC1;c1cncc(C2CCCN2)c1,MYKUKUCHPMASKF-UHFFFAOYSA-N
SESAVAL,ALLEGRON;AVENTYL;DESITRIPTILINA;LUMBECK;MOTIPRESS;MOTIVAL;NCI-169453;NORAMITRIPTYLINE;NORTRILEN;NORTRIPTYLINE;NSC-757234;PAMELOR;SESAVAL,CHEMBL445,BRD:BRD-BRD-K91263825-003-21-4;BRD:BRD-K91263825-003-21-4,rep_primary;rep_single_dose,TRICYCLIC ANTIDEPRESSANT,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;ADRB3;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD2;HRH1;HTR1A;HTR2A;HTR2C;HTR6;KCNJ10;PGRMC1;SIGMAR1;SLC6A2;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,CNCCC=C1C2CCCCC2CCC2CCCCC12;CNCCC=C1c2ccccc2CCc2ccccc21,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
TUSSCAPINE,(-)-.ALPHA.-NARCOTINE;(-)-NARCOTINE;METHOXYHYDRASTINE;NARCOTINE;NARCOTINUM;NOSCAPINE;NOSCAPINUM;NSC-5366;TUSSCAPINE,CHEMBL364713,BRD:BRD-BRD-K91301684-003-05-5;BRD:BRD-K91301684-003-05-5,rep_primary;rep_single_dose,"BRADYKININ RECEPTOR ANTAGONIST, TUBULIN POLYMERIZATION INHIBITOR",SIGMAR1,COUGH SUPPRESSANT,,LAUNCHED,,Small molecule,4,"COC1CCC2[C@H](OC(=O)C2C1OC)[C@@H]1N(C)CCC2CC3OCOC3C(OC)C12, COC1CCC2[C@@H](OC(=O)C2C1OC)[C@@H]1N(C)CCC2CC3OCOC3C(OC)C12, COC1CCC2[C@H](OC(=O)C2C1OC)[C@@H]1N(C)CCC2CC3OCOC3C(OC)C12;COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C",AKNNEGZIBPJZJG-MSOLQXFVSA-N
NOV-002,NOV-002,,BRD:BRD-BRD-K11411329-001-01-3;BRD:BRD-K11411329-001-01-3,rep_primary;rep_single_dose,,GSR;GSTM2,,,PHASE 3,,,NA,N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O,
VULCAMYCIN,ALBAMYCIN;ALBAMYCIN T;CALCIUM NOVOBIOCIN;CALCIUM SALT;CATHOMYCIN;MONOSODIUM SALT;NOVOBIOCIN;NOVOBIOCIN CALCIUM;NOVOBIOCIN MONOSODIUM SALT;NOVOBIOCIN SODIUM;NSC-2382;SODIUM NOVOBIOCIN;SPHEROMYCIN;VULCAMYCIN,CHEMBL3183453;CHEMBL3544972;CHEMBL36506,BRD:BRD-BRD-K85307935-236-09-5;BRD:BRD-BRD-K85307935-236-10-3;BRD:BRD-K85307935-236-09-5;BRD:BRD-K85307935-236-10-3,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,MASTITIS,,LAUNCHED,,Small molecule,4,"CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c([O-])c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C.[Na+];CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2CCC3C(O)C(NC(=O)C4CCC(O)C(CC=C(C)C)C4)C(=O)OC3C2C)OC1(C)C, CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2CCC3C(O)C(NC(=O)C4CCC(O)C(CC=C(C)C)C4)C(=O)OC3C2C)OC1(C)C, CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2CCC3C(O)C(NC(=O)C4CCC(O)C(CC=C(C)C)C4)C(=O)OC3C2C)OC1(C)C",WWPRGAYLRGSOSU-RNROJPEYSA-M
NP-G2-044,NP-G2-044,CHEMBL4297473,BRD:BRD-K00090625-001-01-9,rep_single_dose,,,,,,,Small molecule,1,Cc1occc1C(=O)Nc1nn(Cc2ccc(C(F)(F)F)cc2)c2ccccc12,XLLRLAABUFOJPC-UHFFFAOYSA-N
NPC-01,NPC-01,,BRD:BRD-BRD-K58277159-001-01-7;BRD:BRD-K58277159-001-01-7,rep_primary;rep_single_dose,STEROID,,,,PHASE 3,,,NA,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,
NPC-15199,NPC-15199,,BRD:BRD-BRD-K65275554-001-04-7;BRD:BRD-K65275554-001-04-7,rep_primary;rep_single_dose,ICAM1 ANTAGONIST,PPARG,,,PHASE 2,,,NA,CC(C)C[C@@H](NC(=O)OCC1C2CCCCC2-C2CCCCC12)C(O)=O,
NPC-26,NPC-26,,CTRP:609058,ctrp,,,,,,,,NA,,
NPK76-II-72-1,NPK76-II-72-1,,GDSC1:257,gdsc,,,,,,,,NA,,
NPPB,NPPB,,BRD:BRD-BRD-K89272762-001-12-7;BRD:BRD-K89272762-001-12-7,rep_primary;rep_single_dose,CHLORIDE CHANNEL BLOCKER,ANO1;CLCN2;CLCN7;TRPA1,,,PRECLINICAL,,,NA,"OC(=O)C1CC(CCC1NCCCC1CCCCC1)[N+]([O-])=O, OC(=O)C1CC(CCC1NCCCC1CCCCC1)[N+]([O-])=O",
NPS-2143,NPS-2143,,BRD:BRD-BRD-K75506300-001-01-6;BRD:BRD-K75506300-001-01-6,rep_primary;rep_single_dose,CALCIUM RECEPTOR ANTAGONIST,CASR,,,PRECLINICAL,,,NA,"CC(C)(CC1CCC2CCCCC2C1)NC[C@@H](O)COC1CCCC(CL)C1C#N, CC(C)(CC1CCC2CCCCC2C1)NC[C@@H](O)COC1CCCC(CL)C1C#N",
NPS-2407,NPS-2407,,BRD:BRD-K00004686-001-01-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,,,,NA,,
NPY-5RA972,NPY-5RA972,,BRD:BRD-BRD-K95600043-001-01-5;BRD:BRD-K95600043-001-01-5,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPY5R,,,PRECLINICAL,,,NA,"CC(C)N1C2CCCCC2C2C(C)C(NC(=O)N3CCOCC3)CCC12, CC(C)N1C2CCCCC2C2C(C)C(NC(=O)N3CCOCC3)CCC12",
NQDI-1,NQDI-1,,BRD:BRD-BRD-K61918008-001-07-1;BRD:BRD-K61918008-001-07-1,rep_primary;rep_single_dose,CASPASE INHIBITOR,CASP3,,,PRECLINICAL,,,NA,CCOC(=O)C1C(O)NC2CCCC3C(=O)C4CCCCC4-C1C23,
NRC-2694,NRC-2694,,BRD:BRD-K00076493-001-02-9,rep_single_dose,,,,,,,,NA,,
NS-018,ILGINATINIB;NS-018,CHEMBL3545217,BRD:BRD-BRD-K21865955-003-01-5;BRD:BRD-K21865955-003-01-5,rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2;JAK3;TYK2,,,PHASE 1/PHASE 2,,Small molecule,2,C[C@H](NC1CC(CC(NC2CNCCN2)N1)-C1CNN(C)C1)C1CCC(F)CC1,
NS-11394,NS-11394,,BRD:BRD-K00004548-001-01-9,rep_single_dose,GABA RECEPTOR AGONIST,,,,,,,NA,,
NS-1643,NS-1643,,BRD:BRD-K73738482-001-01-7,rep_single_dose,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,KCNH2;KCNH6;KCNMA1,,,,,,NA,,
NS-19504,NS-19504,,BRD:BRD-K03808106-001-02-9,rep_single_dose,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,KCNMA1,,,,,,NA,,
NS-309,NS-309,,BRD:BRD-K00004295-001-01-9,rep_single_dose,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,KCNN1;KCNN2;KCNN3;KCNN4,,,,,,NA,,
NS-3623,NS-3623,,BRD:BRD-K24434292-001-01-3,rep_single_dose,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,KCNH2,,,,,,NA,,
NS-5806,NS-5806,,BRD:BRD-K93314017-001-02-9,rep_single_dose,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,KCND3,,,,,,NA,,
NS-8593,NS-8593,,BRD:BRD-BRD-K34624869-003-01-6;BRD:BRD-K34624869-003-01-6,rep_primary;rep_single_dose,CALCIUM-ACTIVATED POTASSIUM CHANNEL MODULATOR,KCNN1;KCNN2;KCNN3,,,PRECLINICAL,,,NA,C1C[C@@H](NC2NC3CCCCC3[NH]2)C2CCCCC2C1,
NS-9283,NS-9283,,BRD:BRD-BRD-K40176866-001-01-6;BRD:BRD-K40176866-001-01-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,CHRNA4,,,PRECLINICAL,,,NA,N#CC1CCCC(C1)-C1NC(NO1)-C1CCCNC1,
RITA,NSC 652287;RITA,,BRD:BRD-BRD-K00317371-001-06-1;BRD:BRD-K00317371-001-06-1;BRD:BRD-K00317371-001-09-9;CTRP:375492,ctrp;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,CROSSLINKING PRODRUG VIA SULT1A1,MDM2;SULT1A1,,,PRECLINICAL,"Multiple values for MOA: {'CROSSLINKING PRODRUG VIA SULT1A1', 'MDM INHIBITOR'}, defaulting to 'CROSSLINKING PRODRUG VIA SULT1A1'
Multiple values for repurposing_target: {'MDM2', 'SULT1A1'}, taking the union",,NA,"OCC1CCC(S1)-C1CCC(O1)-C1CCC(CO)S1, OCC1CCC(S1)-C1CCC(O1)-C1CCC(CO)S1",
NSC 74859,NSC 74859,,CTRP:411734,ctrp,,,,,,,,NA,,
NSC-19630,MIRA 1;MIRA-1;MIRA1;NSC 19630;NSC-19630,,GDSC2:1931,gdsc,,,,,,,,NA,,
NSC-23766,NSC-23766,,BRD:BRD-A80213327-305-08-3;BRD:BRD-BRD-A80213327-305-08-3,rep_multi_dose;rep_primary;rep_single_dose,RAS GTPASE INHIBITOR,,,,PRECLINICAL,,,NA,"CCN(CC)CCCC(C)NC1NC(C)CC(NC2CCC3NC(C)CC(N)C3C2)N1, CCN(CC)CCCC(C)NC1NC(C)CC(NC2CCC3NC(C)CC(N)C3C2)N1, CCN(CC)CCCC(C)NC1NC(C)CC(NC2CCC3NC(C)CC(N)C3C2)N1, CCN(CC)CCCC(C)NC1NC(C)CC(NC2CCC3NC(C)CC(N)C3C2)N1",
UGN-102,AMETYCINE;JELMYTO;MITOCIN-C;MITOMYCIN;MITOMYCIN C;MITOMYCIN-C;MITOSOL;MITOZYTREX;MMC;MUAMYCIN;MUTAMYCIN;MYTOZYTREX;NSC-26980;UGN-101;UGN-102,CHEMBL105,GDSC1:136,gdsc,,,,,,,Small molecule,4,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,NWIBSHFKIJFRCO-WUDYKRTCSA-N
NSC-319726,NSC-319726,,BRD:BRD-BRD-K99170882-001-04-3;BRD:BRD-K99170882-001-04-3,rep_multi_dose;rep_primary;rep_single_dose,P53 ACTIVATOR,,,,PRECLINICAL,,,NA,"C\C(C1CCCCN1)=N/NC(=S)N1CCC1, C\C(C1CCCCN1)=N/NC(=S)N1CCC1, C\C(C1CCCCN1)=N/NC(=S)N1CCC1",
NSC-3852,NSC-3852,,BRD:BRD-BRD-K13169950-001-14-4;BRD:BRD-K13169950-001-14-4,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1,,,PRECLINICAL,,,NA,OC1CCC([N+][O-])C2CCCNC12,
NSC-405020,NSC-405020,,BRD:BRD-A67975844-001-01-8;BRD:BRD-BRD-A67975844-001-01-8,rep_primary;rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,MMP1,,,PRECLINICAL,,,NA,"CCCC(C)NC(=O)C1CCC(CL)C(CL)C1, CCCC(C)NC(=O)C1CCC(CL)C(CL)C1",
NSC-4644,NSC-4644,,BRD:BRD-BRD-K64874225-001-04-7;BRD:BRD-K64874225-001-04-7,rep_primary;rep_single_dose,"ACAT INHIBITOR, STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) INHIBITOR",PYGM,,,PHASE 2,,,NA,CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12,
NSC5844,NSC-5844;NSC5844,,BRD:BRD-BRD-K73799155-001-01-5;BRD:BRD-K73799155-001-01-5,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR AGONIST,CCR1,,,PRECLINICAL,,,NA,C(CNC1CCNC2CC(CL)CCC12)NC1CCNC2CC(CL)CCC12,
NSC-632839,NSC-632839,,BRD:BRD-BRD-K81197548-003-01-4;BRD:BRD-K81197548-003-01-4,rep_multi_dose;rep_primary;rep_single_dose,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,SENP2;USP1;USP2;USP7,,,PRECLINICAL,,,NA,"CC1CCC(CC1)\C=C1/CNC\C(C1=O)=C/C1CCC(C)CC1, CC1CCC(CC1)\C=C1/CNC\C(C1=O)=C/C1CCC(C)CC1",
NSC-636819,NSC-636819,,BRD:BRD-K61120504-001-01-6,rep_single_dose,HISTONE DEMETHYLASE INHIBITOR,KDM4A;KDM4B,,,,,,NA,,
NSC-663284,NSC-663284,,BRD:BRD-BRD-K03109492-001-02-2;BRD:BRD-K03109492-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,CDC INHIBITOR,CDC25A;CDC25B;CDC25C,,,PRECLINICAL,,,NA,"CLC1=C(NCCN2CCOCC2)C(=O)C2NCCCC2C1=O, CLC1=C(NCCN2CCOCC2)C(=O)C2NCCCC2C1=O",
NSC-697923,NSC-697923,,BRD:BRD-BRD-K20605374-001-05-4;BRD:BRD-K20605374-001-05-4,rep_multi_dose;rep_primary;rep_single_dose,UBIQUITIN-CONJUGATING ENZYME INHIBITOR,UBE2N,,,PRECLINICAL,,,NA,"CC1CCC(CC1)S(=O)(=O)C1CCC(O1)[N+]([O-])=O, CC1CCC(CC1)S(=O)(=O)C1CCC(O1)[N+]([O-])=O",
NSC-87877,NSC 87877;NSC-87877,,GDSC1:147,gdsc,,,,,,,,NA,,
NSC-9965,NSC-9965,,BRD:BRD-BRD-K49811169-004-06-6;BRD:BRD-K49811169-004-06-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRNA4;CHRNB2,,,PRECLINICAL,,,NA,CO[C@H]1CC=C2CCN3CCC4=C(CC(=O)OC4)[C@]23C1,
NSC19630,NSC19630,,CTRP:580922;GDSC2:1931,ctrp;gdsc,,,,,,,,NA,,
NSC23766,NSC23766,,CTRP:44503,ctrp,,,,,,,,NA,,
NSC30930,NSC30930,,CTRP:182395,ctrp,,,,,,,,NA,,
NSC319726,NSC319726,,GDSC1:461,gdsc,,,,,,,,NA,,
NSC48300,NSC48300,,CTRP:594399,ctrp,,,,,,,,NA,,
NSC632839,NSC632839,,CTRP:375594,ctrp,,,,,,,,NA,,
NSC95397,NSC95397,,CTRP:50715,ctrp,,,,,,,,NA,,
NSI-189,NSI-189,CHEMBL4302505,BRD:BRD-BRD-K74371986-001-01-7;BRD:BRD-K74371986-001-01-7,rep_primary;rep_single_dose,NEUROTROPHIC AGENT,,,,PHASE 2,,Small molecule,2,CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1;CC(C)CCNC1NCCCC1C(=O)N1CCN(CC2CCCCC2)CC1,DYTOQURYRYYNOR-UHFFFAOYSA-N
NSP-805,NSP-805,,BRD:BRD-K00004733-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,,NA,,
NTNCB,NTNCB,,BRD:BRD-A40413915-003-01-2;BRD:BRD-BRD-A40413915-003-01-2,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPY5R,,,PRECLINICAL,,,NA,[O-][N+](=O)C1CCCCC1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCC3CCCCC3C2)CC1,
NTRC-824,NTRC-824,,BRD:BRD-K07788774-001-02-9,rep_single_dose,NEUROTENSIN RECEPTOR ANTAGONIST,NTSR2,,,,,,NA,,
NTZDPA,NTZDPA,,BRD:BRD-BRD-K54708045-001-02-1;BRD:BRD-K54708045-001-02-1,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARG,,,PRECLINICAL,,,NA,"OC(=O)C1N(CC2CCC(CL)CC2)C2CCC(CL)CC2C1SC1CCCCC1, OC(=O)C1N(CC2CCC(CL)CC2)C2CCC(CL)CC2C1SC1CCCCC1",
NU-1025,NU-1025,,BRD:BRD-BRD-K48692744-001-02-0;BRD:BRD-K48692744-001-02-0,rep_primary;rep_single_dose,PARP INHIBITOR,PARP1,,,PRECLINICAL,,,NA,"CC1NC2C(O)CCCC2C(=O)[NH]1, CC1NC2C(O)CCCC2C(=O)[NH]1",
NU-2058,NU-2058,,BRD:BRD-K20976221-001-12-0,rep_single_dose,CYCLIN D INHIBITOR,CCNA2;CDK2,,,,,,NA,,
NU6027,NU-6027;NU6027,,BRD:BRD-BRD-K03294269-001-08-0;BRD:BRD-K03294269-001-08-0,rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CCNA2;CDK2,,,PRECLINICAL,,,NA,NC1NC(N)C([N+][O-])C(OCC2CCCCC2)N1,
NU-7026,NU-7026,,BRD:BRD-BRD-K09537769-001-04-0;BRD:BRD-K09537769-001-04-0,rep_primary;rep_single_dose,"DNA DEPENDENT PROTEIN KINASE INHIBITOR, MTOR INHIBITOR, PI3K INHIBITOR",PRKDC,,,PRECLINICAL,,,NA,"O=C1CC(OC2C3CCCCC3CCC12)N1CCOCC1, O=C1CC(OC2C3CCCCC3CCC12)N1CCOCC1, O=C1CC(OC2C3CCCCC3CCC12)N1CCOCC1",
NU-7441,NU-7441,,BRD:BRD-BRD-K00337317-001-06-6;BRD:BRD-K00337317-001-06-6,rep_primary;rep_single_dose,DNA DEPENDENT PROTEIN KINASE INHIBITOR,PRKDC,,,PRECLINICAL,,,NA,O=C1CC(OC2C(CCCC12)-C1CCCC2C3CCCCC3SC12)N1CCOCC1,
NU7441,KU-57788;NU-7432;NU-7741;NU7441,,GDSC1:1038;GDSC2:1038,gdsc,,,,,,,,NA,,
TI-31,NUCLOMEDONE;TEI-3096;TI-31,CHEMBL2106465,BRD:BRD-A96466199-001-01-4;BRD:BRD-BRD-A96466199-001-01-4,rep_primary;rep_single_dose,IMMUNOSUPPRESSANT,,,,PHASE 3,,Small molecule,-1,CLC1CCC(CC2C(=O)N=C3SCCN3C2=O)CC1;O=C1N=C2SCCN2C(=O)C1Cc1ccc(Cl)cc1,QSKVYHYMQQQAFS-UHFFFAOYSA-N
REBEMADLIN,NUTLIN-3;NUTLIN-3A;REBEMADLIN,CHEMBL191334,BRD:BRD-A12230535-001-06-7;BRD:BRD-A12230535-001-10-9;BRD:BRD-BRD-A12230535-001-06-7;CTRP:411722,ctrp;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF TP53/MDM2/4 INTERACTION,MDM2;MDM4;TP53,,,PRECLINICAL,"Multiple values for MOA: {'MDM INHIBITOR', 'INHIBITOR OF TP53/MDM2/4 INTERACTION'}, defaulting to 'INHIBITOR OF TP53/MDM2/4 INTERACTION'
Multiple values for repurposing_target: {'MDM2;TP53', 'MDM2;MDM4;TP53'}, taking the union",Small molecule,NA,"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1;COC1CCC(C2=NC(C(N2C(=O)N2CCNC(=O)C2)C2CCC(CL)CC2)C2CCC(CL)CC2)C(OC(C)C)C1, COC1CCC(C2=NC(C(N2C(=O)N2CCNC(=O)C2)C2CCC(CL)CC2)C2CCC(CL)CC2)C(OC(C)C)C1, COC1CCC(C2=N[C@@H]([C@@H](N2C(=O)N2CCNC(=O)C2)C2CCC(CL)CC2)C2CCC(CL)CC2)C(OC(C)C)C1",BDUHCSBCVGXTJM-WUFINQPMSA-N
NUTLIN-3A (-),NUTLIN-3A (-),,GDSC1:1047;GDSC2:1047,gdsc,,,,,,,,NA,,
NUVENZEPINE,NUVENZEPINE,CHEMBL2107170,BRD:BRD-K00004743-001-01-9,rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,CN1CCC(C(=O)N2c3ccccc3NC(=O)c3cccnc32)CC1,HPKYRXAEGNUARA-UHFFFAOYSA-N
NVP-231,NVP-231,,BRD:BRD-BRD-K01573278-001-02-1;BRD:BRD-K01573278-001-02-1;CTRP:660331,ctrp;rep_primary;rep_single_dose,CERAMIDASE INHIBITOR,CERK,,,PRECLINICAL,,,NA,"O=C(NC1NC2CCC(NC(=O)C34CC5CC(CC(C5)C3)C4)CC2S1)C1CCCCC1, O=C(NC1NC2CCC(NC(=O)C34CC5CC(CC(C5)C3)C4)CC2S1)C1CCCCC1",
NVP-ADW742,NVP-ADW742,,BRD:BRD-BRD-K15179513-001-03-4;BRD:BRD-K15179513-001-03-4;CTRP:660287;GDSC2:1932,ctrp;gdsc;rep_primary;rep_single_dose,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,IGF1R,,,PRECLINICAL,,,NA,"NC1NCNC2N(CC(-C3CCCC(OCC4CCCCC4)C3)C12)[C@H]1C[C@H](CN2CCCC2)C1, NC1NCNC2N(CC(-C3CCCC(OCC4CCCCC4)C3)C12)[C@H]1C[C@H](CN2CCCC2)C1, NC1NCNC2N(CC(-C3CCCC(OCC4CCCCC4)C3)C12)[C@H]1C[C@H](CN2CCCC2)C1",
NVP-AEW541,AEW 541;AEW-541;NVP-AEW 541;NVP-AEW541,CHEMBL551064,BRD:BRD-BRD-K24696047-001-02-3;BRD:BRD-K24696047-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,IGF-1 INHIBITOR,IGF1R;INSR,,,PRECLINICAL,,Small molecule,1,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1;NC1NCNC2N(CC(-C3CCCC(OCC4CCCCC4)C3)C12)[C@@H]1C[C@H](CN2CCC2)C1,USVCWSAJUAARAL-MEMLXQNLSA-N
VER-52296,LUMINESPIB;NVP-AUY-922;NVP-AUY922;NVP-AUY922-NX;VER-52296,CHEMBL252164,BRD:BRD-BRD-K41859756-001-06-8;BRD:BRD-K41859756-001-06-8;GDSC1:194;GDSC2:1559,gdsc;rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1;HSP90AB1,,,PHASE 2,,Small molecule,2,"CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1;CCNC(=O)C1NOC(C1-C1CCC(CN2CCOCC2)CC1)-C1CC(C(C)C)C(O)CC1O, CCNC(=O)C1NOC(C1-C1CCC(CN2CCOCC2)CC1)-C1CC(C(C)C)C(O)CC1O, CCNC(=O)C1NOC(C1-C1CCC(CN2CCOCC2)CC1)-C1CC(C(C)C)C(O)CC1O",NDAZATDQFDPQBD-UHFFFAOYSA-N
RTB101,BEZ-235;BEZ235;DACTOLISIB;NSC-751249;NVP-BEZ-235;NVP-BEZ235;NVP-BEZ235-NX;RTB-101;RTB101,CHEMBL1879463,BRD:BRD-BRD-K12184916-001-15-4;BRD:BRD-K12184916-001-15-4;BRD:BRD-K12184916-001-19-6;CTRP:348992;GDSC1:1057;GDSC2:1057,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",ATR;MTOR;PIK3CA;PIK3CD;PIK3CG,,,PHASE 2,,Small molecule,3,"Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21;CN1C2CNC3CCC(CC3C2N(-C2CCC(CC2)C(C)(C)C#N)C1=O)-C1CNC2CCCCC2C1, CN1C2CNC3CCC(CC3C2N(-C2CCC(CC2)C(C)(C)C#N)C1=O)-C1CNC2CCCCC2C1",JOGKUKXHTYWRGZ-UHFFFAOYSA-N
NVP-BHG712,NVP-BHG712,,BRD:BRD-BRD-K79259477-001-04-9;BRD:BRD-K79259477-001-04-9;GDSC1:295,gdsc;rep_multi_dose;rep_primary;rep_single_dose,EPHRIN INHIBITOR,EPHB4,,,PRECLINICAL,,,NA,CC1CCC(CC1NC1NC(NC2N(C)NCC12)-C1CCCNC1)C(=O)NC1CCCC(C1)C(F)(F)F,
NVP-BKM120,BKM-120;BKM-120NX;BKM120;BKM120-NX;BUPARLISIB;NVP-BKM-120;NVP-BKM120,CHEMBL2017974,GDSC2:1873,gdsc,,,,,,,Small molecule,3,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,CWHUFRVAEUJCEF-UHFFFAOYSA-N
NVP-BSK805,NVP-BSK805,,BRD:BRD-BRD-K02017404-300-06-2;BRD:BRD-K02017404-300-06-2;CTRP:660434,ctrp;rep_primary;rep_single_dose,JAK INHIBITOR,JAK2,,,PRECLINICAL,,,NA,"FC1CC(CC(F)C1CN1CCOCC1)-C1CCCC2NCC(NC12)-C1CNN(C1)C1CCNCC1, FC1CC(CC(F)C1CN1CCOCC1)-C1CCCC2NCC(NC12)-C1CNN(C1)C1CCNCC1",
NVP-BVU972,NVP-BVU972,,BRD:BRD-BRD-K77943374-001-02-8;BRD:BRD-K77943374-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,MET INHIBITOR,MET,,,PRECLINICAL,,,NA,CN1CC(CN1)-C1CCC2NCC(CC3CCC4NCCCC4C3)N2N1,
VIJOICE,ALPELISIB;BYL-719;BYL719;NVP-BYL719;PIQRAY;VIJOICE,CHEMBL2396661,GDSC2:1560,gdsc,,,,,,,Small molecule,4,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,STUWGJZDJHPWGZ-LBPRGKRZSA-N
NVP-DPP728,NVP-DPP728,,BRD:BRD-BRD-K77396579-300-01-0;BRD:BRD-K77396579-300-01-0,rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,,,PHASE 2,,,NA,O=C(CNCCNC1CCC(CN1)C#N)N1CCC[C@H]1C#N,
NVP-HSP990,NVP-HSP990,,BRD:BRD-BRD-K67915505-001-01-2;BRD:BRD-K67915505-001-01-2,rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1;HSP90AB1,,,PHASE 1,,,NA,COC1CCCC(N1)-C1CC(F)CCC1[C@H]1CC2NC(N)NC(C)C2C(=O)N1,
NVP-LAQ824,DACINOSTAT;LAQ-824;LAQ824;NVP-LAQ824,CHEMBL356066,GDSC1:200,gdsc,,,,,,,Small molecule,-1,O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO,BWDQBBCUWLSASG-MDZDMXLPSA-N
RIBOCICLIB SUCCINATE,BIROCICLIB;KISQALI;LEE-011;LEE-011-BBA;LEE-011A;LEE011;LEE011-BBA;LEE011A;NVP-LEE011;RIBOCICLIB;RIBOCICLIB SUCCINATE,CHEMBL3545110;CHEMBL3707266,GDSC2:1632,gdsc,,,,,,,Small molecule,4,CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1.O=C(O)CCC(=O)O,NHANOMFABJQAAH-UHFFFAOYSA-N
NVP-TAE226,NVP-TAE226,,BRD:BRD-BRD-K21025364-001-04-9;BRD:BRD-BRD-K21025364-001-05-6;BRD:BRD-K21025364-001-04-9;BRD:BRD-K21025364-001-05-6,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,PTK2,,,PRECLINICAL,,,NA,"CNC(=O)C1CCCCC1NC1NC(NC2CCC(CC2OC)N2CCOCC2)NCC1CL, CNC(=O)C1CCCCC1NC1NC(NC2CCC(CC2OC)N2CCOCC2)NCC1CL",
TAE-684,NVP-TAE684;TAE-684,CHEMBL509032,BRD:BRD-BRD-K50140147-001-10-1;BRD:BRD-K50140147-001-10-1;CTRP:606249;GDSC1:35,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK;INSR,,,PRECLINICAL,,Small molecule,NA,COC1CC(CCC1NC1NCC(CL)C(NC2CCCCC2S(=O)(=O)C(C)C)N1)N1CCC(CC1)N1CCN(C)CC1;COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,QQWUGDVOUVUTOY-UHFFFAOYSA-N
NVP-TNKS656,NVP-TNKS656,,BRD:BRD-K87454346-001-01-1,rep_single_dose,TANKYRASE INHIBITOR,TNKS2,,,,,,NA,,
NVPADW742,NVP ADW742;NVPADW742,,GDSC2:1932,gdsc,,,,,,,,NA,,
NVS-PAK1-1,NVS-PAK1-1,,BRD:BRD-BRD-K28132190-001-02-0;BRD:BRD-K28132190-001-02-0,rep_primary;rep_single_dose,P21 ACTIVATED KINASE INHIBITOR,PAK1,,,PRECLINICAL,,,NA,CC(C)NC(=O)N1CC[C@@H](C1)NC1=NC2CC(F)CCC2N(CC(F)F)C2CCC(CL)CC12,
OKN-007,"2,4-DISULFONYL PNB;CEROVIVE;DISUFENTON SODIUM;DISUFENTON SODIUM SALT;HPN-07;NXY-059;OKN-007",CHEMBL2107334,BRD:BRD-BRD-K46133855-304-03-8;BRD:BRD-K46133855-304-03-8,rep_primary;rep_single_dose,FREE RADICAL SCAVENGER,,,,PHASE 3,,Small molecule,3,"CC(C)(C)[N+]([O-])=Cc1ccc(S(=O)(=O)[O-])cc1S(=O)(=O)[O-].[Na+].[Na+];CC(C)(C)[N+](\[O-])=C\C1CCC(CC1S(O)(=O)=O)S(O)(=O)=O, CC(C)(C)[N+](\[O-])=C\C1CCC(CC1S(O)(=O)=O)S(O)(=O)=O",XLZOVRYBVCMCGL-UHFFFAOYSA-L
O-1918,O-1918,,BRD:BRD-BRD-K18316707-001-02-7;BRD:BRD-K18316707-001-02-7,rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,"COC1CC(C)CC(OC)C1[C@@H]1C=C(C)CC[C@H]1C(C)=C, COC1CC(C)CC(OC)C1[C@@H]1C=C(C)CC[C@H]1C(C)=C",
O-304,O-304,,BRD:BRD-K00003113-001-01-9,rep_single_dose,AMPK ACTIVATOR,,,,,,,NA,,
O-3M3FBS,O-3M3FBS,,BRD:BRD-BRD-K46384212-001-02-9;BRD:BRD-K46384212-001-02-9,rep_primary;rep_single_dose,PHOSPHOLIPASE ACTIVATOR,,,,PRECLINICAL,,,NA,"CC1CC(C)C(C(C)C1)S(=O)(=O)NC1CCCCC1C(F)(F)F, CC1CC(C)C(C(C)C1)S(=O)(=O)NC1CCCCC1C(F)(F)F",
O-6-BENZYLGUANINE,O-6-BENZYLGUANINE,,CTRP:345712,ctrp,,,,,,,,NA,,
O-ACETYL-L-SERINE,O-ACETYL-L-SERINE,,BRD:BRD-BRD-K63247785-001-01-5;BRD:BRD-K63247785-001-01-5,rep_primary;rep_single_dose,,PTGS1,,,PRECLINICAL,,,NA,CC(=O)OC[C@H](N)C(O)=O,
O-MERCAPTO-BENZOIC-ACID,O-MERCAPTO-BENZOIC-ACID,,BRD:BRD-BRD-K36998189-001-03-5;BRD:BRD-K36998189-001-03-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC(=O)C1CCCCC1S,
O6-BENZYLGUANINE,6-O-BENZYLGUANINE;NSC-637037;O(6)-BENZYLGUANINE;O6-BENZYLGUANINE,CHEMBL407874,BRD:BRD-BRD-K92041145-001-09-5;BRD:BRD-K92041145-001-09-5,rep_multi_dose;rep_primary;rep_single_dose,O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INHIBITOR,MGMT,,,PHASE 3,,Small molecule,3,NC1NC(OCC2CCCCC2)C2[NH]CNC2N1;Nc1nc(OCc2ccccc2)c2nc[nH]c2n1,KRWMERLEINMZFT-UHFFFAOYSA-N
OAC1,OAC1,,BRD:BRD-BRD-K10878147-001-02-2;BRD:BRD-K10878147-001-02-2,rep_primary;rep_single_dose,OCT ACTIVATOR,,,,PRECLINICAL,,,NA,"O=C(NC1CC2CC[NH]C2CN1)C1CCCCC1, O=C(NC1CC2CC[NH]C2CN1)C1CCCCC1",
OAC2,OAC2,,BRD:BRD-BRD-K18305454-001-07-4;BRD:BRD-K18305454-001-07-4,rep_primary;rep_single_dose,OCT ACTIVATOR,POU5F1,,,PRECLINICAL,,,NA,O=C(NC1CCC2[NH]CCC2C1)C1CCCCC1,
OBATOCLAX MESYLATE,GX-15-070MS;GX15-070;GX15-070MS;OBATOCLAX;OBATOCLAX MESILATE;OBATOCLAX MESYLATE,CHEMBL2107358;CHEMBL408194,BRD:BRD-BRD-K15600710-066-04-1;BRD:BRD-K15600710-066-04-1;BRD:BRD-K15600710-066-05-8;CTRP:606142;GDSC1:182;GDSC2:1068,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,BCL INHIBITOR,BCL2,,,PHASE 3,,Small molecule,3,"COC1=CC(=N\C\1=C/C1[NH]C(C)CC1C)C1CC2CCCCC2[NH]1, COC1=CC(=N\C\1=C/C1[NH]C(C)CC1C)C1CC2CCCCC2[NH]1;COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O",ZFKXDVMHNXPEIY-PEZBNFGJSA-N
OBATOCLAX MESYLATE,GX-15-070MS;GX15-070;GX15-070MS;OBATOCLAX;OBATOCLAX MESILATE;OBATOCLAX MESYLATE,CHEMBL2107358;CHEMBL408194,GDSC1:182;GDSC2:1068,gdsc,,,,,,,Small molecule,3,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C;COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,RFTSSZJZXOSICM-GRSHGNNSSA-N;ZFKXDVMHNXPEIY-PEZBNFGJSA-N
OBIDOXIME,OBIDOXIME,CHEMBL451635,BRD:BRD-BRD-K33588785-001-01-9;BRD:BRD-K33588785-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,CHOLINESTERASE REACTIVATOR,ACHE,"POISON ANTIDOTE, NERVE GAS POISONING",,LAUNCHED,,Small molecule,-1,O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1;O\N=C\C1CC[N+](COC[N+]2CCC(CC2)\C=N\O)CC1,HIGRLDNHDGYWQJ-UHFFFAOYSA-P
TIMAPIPRANT,CHF-6532;OC-000459;OC-459;OC000459;OC459;ODC-9101;TIMAPIPRANT,CHEMBL560993,BRD:BRD-BRD-K36463073-001-03-9;BRD:BRD-K36463073-001-03-9,rep_primary;rep_single_dose,CRTH RECEPTOR ANTAGONIST,PTGDR2,,,PHASE 2,,Small molecule,2,"Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(=O)O;CC1C(CC2CCC3CCCCC3N2)C2CC(F)CCC2N1CC(O)=O, CC1C(CC2CCC3CCCCC3N2)C2CC(F)CCC2N1CC(O)=O, CC1C(CC2CCC3CCCCC3N2)C2CC(F)CCC2N1CC(O)=O",FATGTHLOZSXOBC-UHFFFAOYSA-N
R-79598,OCAPERIDONE;R 79598;R-79598,CHEMBL2104619,BRD:BRD-K00003399-001-01-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,Cc1nc2c(C)cccn2c(=O)c1CCN1CCC(c2noc3cc(F)ccc23)CC1,ZZQNEJILGNNOEP-UHFFFAOYSA-N
OCINAPLON,"CL 273,547;CL-273547;OCINAPLON",CHEMBL2105199,BRD:BRD-BRD-K92581468-001-01-6;BRD:BRD-K92581468-001-01-6,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABRA1;GABRA2;GABRA3;GABRA5,,,PHASE 3,,Small molecule,-1,O=C(c1ccccn1)c1cnn2c(-c3ccncc3)ccnc12;O=C(C1CNN2C(CCNC12)-C1CCNCC1)C1CCCCN1,OQJFBUOFGHPMSR-UHFFFAOYSA-N
PF-03394197,JAK-I;JAKI;OCLACITINIB;PF 03394197;PF-03394197,CHEMBL2103874,BRD:BRD-K00084846-001-01-9,rep_single_dose,,,,,,,Small molecule,-1,CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1,HJWLJNBZVZDLAQ-HAQNSBGRSA-N
OCO-1112,OCO-1112,,BRD:BRD-BRD-K22097830-001-01-9;BRD:BRD-K22097830-001-01-9,rep_primary;rep_single_dose,CHOLESTEROL INHIBITOR,,,,PHASE 2,,,NA,CC(C)C1CCC(CC1)C(=O)NCCOC1CCC(CC1)C(O)=O,
OCTENIDINE,OCTENIDINE,CHEMBL1199480,BRD:BRD-BRD-K04568635-300-01-4;BRD:BRD-K04568635-300-01-4,rep_multi_dose;rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,,,,LAUNCHED,,Small molecule,2,CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(=NCCCCCCCC)cc2)cc1;CCCCCCCCN=C1CCN(CCCCCCCCCCN2CCC(CC2)=NCCCCCCCC)CC1,ZVXNYZWXUADSRV-UHFFFAOYSA-N
UVINUL MC80,2-ETHYLHEXYL P-METHOXYCINNAMATE;2-ETHYLHEXYL-P-METHOXYCINNAMATE;ESCALOL 557;ESCALOL 557NB;ESCALOL 557T;ETHYLHEXYL METHOXYCINNAMATE;ETHYLHEXYL P-METHOXYCINNAMATE;EUSOLEX 2292;EUSOLEX UV-PEARLS OMC;JEESCREEN OMC;NEO HELIOPAN AV;NSC-26466;OCINOXATE;OCTINOXATE;OCTYL METHOXYCINNAMATE;OCTYL P-METHOXYCINNAMATE;PARSOL;PARSOL MCX;PARSOL MCX-SA;PARSOL MOX;SOLAROM OMC;SUN CAPS 664;SUNSCREEN AV;TINOSORB OMC;UVINUL 3088;UVINUL MC 80;UVINUL MC 80N;UVINUL MC 90;UVINUL MC80,CHEMBL1200608;CHEMBL3183184,BRD:BRD-BRD-K19972289-001-01-4;BRD:BRD-K19972289-001-01-4,rep_primary;rep_single_dose,,,SUNSCREEN LOTION,,LAUNCHED,,Small molecule,4,CCCC[C@@H](CC)COC(=O)\C=C\C1CCC(OC)CC1;CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1,YBGZDTIWKVFICR-UHFFFAOYSA-N
UVINUL,ESCALOL;ETHYL HEXYL SALICYLATE;ETHYLHEXYL SALICYLATE;NEO HELIOPAN;NSC-46151;OCTISALATE;OCTYL SALICYLATE;UVINUL,CHEMBL1329203,BRD:BRD-BRD-K95161686-001-02-8;BRD:BRD-K95161686-001-02-8,rep_primary;rep_single_dose,,,SUNSCREEN LOTION,,LAUNCHED,,Small molecule,-1,CCCC[C@@H](CC)COC(=O)C1CCCCC1O;CCCCC(CC)COC(=O)c1ccccc1O,FMRHJJZUHUTGKE-UHFFFAOYSA-N
OCTOCRYLENE,NSC-760433;OCTOCRILENE;OCTOCRYLENE,CHEMBL1201147,BRD:BRD-BRD-K39023557-001-01-7;BRD:BRD-K39023557-001-01-7,rep_primary;rep_single_dose,,,SUNSCREEN LOTION,,LAUNCHED,,Small molecule,4,CCCC[C@@H](CC)COC(=O)C(C#N)=C(C1CCCCC1)C1CCCCC1;CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1,FMJSMJQBSVNSBF-UHFFFAOYSA-N
SKF-51,"1,5-DMHA;NSC-759813;OCTODRINE;SK&F 51;SKF-51",CHEMBL2105833,BRD:BRD-A37873789-003-02-9,rep_single_dose,ANTITUMOR AGENT,,,,,,Small molecule,-1,CC(C)CCCC(C)N,QNIVIMYXGGFTAK-UHFFFAOYSA-N
OCTOPAMINE,ND 50;ND-50;NSC-757399;OCTOPAMINE,CHEMBL53929,BRD:BRD-A14240607-003-26-1;BRD:BRD-BRD-A14240607-003-26-1,rep_multi_dose;rep_primary;rep_single_dose,TRACE AMINE ASSOCIATED RECEPTOR AGONIST,F10;TAAR1,,,PRECLINICAL,,Small molecule,-1,"NCC(O)c1ccc(O)cc1;NCC(O)C1CCC(O)CC1, NCC(O)C1CCC(O)CC1, NCC(O)C1CCC(O)CC1, NCC(O)C1CCC(O)CC1",QHGUCRYDKWKLMG-UHFFFAOYSA-N
SMS995,OCTREOTIDE;SANDOSTATIN;SMS 201-995;SMS-201-995;SMS-995;SMS995,CHEMBL1680,BRD:BRD-A64173453-015-02-3;BRD:BRD-BRD-A64173453-015-02-3,rep_primary;rep_single_dose,SOMATOSTATIN RECEPTOR AGONIST,SSTR1;SSTR2;SSTR3;SSTR5,"DIARRHEA, ACROMEGALY, CARCINOID TUMORS",,LAUNCHED,,Protein,4,"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O;CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)CC2CCCCC2)C(=O)NC(CC2CCCCC2)C(=O)NC(CC2C[NH]C3CCCCC23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1, CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)CC2CCCCC2)C(=O)NC(CC2CCCCC2)C(=O)NC(CC2C[NH]C3CCCCC23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1, CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)CC2CCCCC2)C(=O)NC(CC2CCCCC2)C(=O)NC(CC2C[NH]C3CCCCC23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1",DEQANNDTNATYII-OULOTJBUSA-N
ODANACATIB,MK-0822;MK0822;ODANACATIB,CHEMBL481611,BRD:BRD-BRD-K22822991-001-02-3;BRD:BRD-K22822991-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,CATHEPSIN INHIBITOR,CTSK,,,PHASE 3,,Small molecule,3,CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1;CC(C)(F)C[C@H](N[C@@H](C1CCC(CC1)-C1CCC(CC1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N,FWIVDMJALNEADT-SFTDATJTSA-N
ODM-203,ODM-203,,BRD:BRD-K00091101-001-01-9,rep_single_dose,,,,,,,,NA,,
OF-1,OF-1,,BRD:BRD-K92658264-001-02-9;GDSC2:1853,gdsc;rep_single_dose,BROMODOMAIN INHIBITOR,BRD1,,,,,,NA,,
VOLEQUIN,(S)-;CRAVIT;DL-8280;DR-3355;EVOXIL;EXOCIN;FLOXACIN;FLOXIN;FLOXIN OTIC;HOE 280;HOE-280;IQUIX;J01MA01;L-OFLOXACIN;LEVAQUIN;LEVOFLOXACIN;LEVOFLOXACIN (AS HEMIHYDRATE);LEVOFLOXACIN ANHYDROUS;LEVOFLOXACIN HEMIHYDRATE;LEVOFLOXACIN HYDRATE;NOFAXIN;NSC-727071;NSC-758178;NSC-758709;OCUFLOX;OFLOXACIN;OFLOXACIN S-(-)-FORM;OFLOXACIN S-(-)-FORM HEMIHYDRATE;OFTAQUIX;QUINSAIR;QUIXIN;RWJ-25213;TARIVID;TARIVID 400;TARIVID I.V.;TAVANIC;VISIREN;VOLEQUIN,CHEMBL33;CHEMBL4,BRD:BRD-A24228527-213-01-9;BRD:BRD-BRD-A24228527-213-01-9,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,"RESPIRATORY TRACT INFECTIONS, SINUSITIS, SKIN INFECTIONS, BONE AND JOINT INFECTIONS, INTRA-ABDOMINAL INFECTIONS, DIARRHEA, FEVER, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23;CC1COC2C(N3CCN(C)CC3)C(F)CC3C2N1CC(C(O)=O)C3=O, CC1COC2C(N3CCN(C)CC3)C(F)CC3C2N1CC(C(O)=O)C3=O",GSDSWSVVBLHKDQ-JTQLQIEISA-N
OG-L002,OG-L002,,BRD:BRD-BRD-K26349472-001-01-3;BRD:BRD-K26349472-001-01-3,rep_primary;rep_single_dose,HISTONE LYSINE DEMETHYLASE INHIBITOR,KDM1A,,,PRECLINICAL,,,NA,"N[C@H]1C[C@@H]1C1CCC(CC1)-C1CCCC(O)C1, N[C@H]1C[C@@H]1C1CCC(CC1)-C1CCCC(O)C1",
OGERIN,OGERIN,,BRD:BRD-K00005341-001-01-9,rep_single_dose,G PROTEIN-COUPLED RECEPTOR MODULATOR,,,,,,,NA,,
OGLEMILAST,GRC 3845;OGLEMILAST,CHEMBL4297520,BRD:BRD-BRD-K92303087-001-01-6;BRD:BRD-K92303087-001-01-6,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,PHASE 2,,Small molecule,2,CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1;CS(=O)(=O)NC1CCC2OC3C(OC(F)F)CCC(C(=O)NC4C(CL)CNCC4CL)C3C2C1,OKFDRAHPFKMAJH-UHFFFAOYSA-N
OGLUFANIDE,NSC-334073;OGLUFANIDE,CHEMBL2111029,BRD:BRD-K00003164-001-01-9,rep_single_dose,VEGF ANTAGONIST,,,,,,Small molecule,3,N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,LLEUXCDZPQOJMY-AAEUAGOBSA-N
OICR-9429,OICR-9429,,BRD:BRD-K94083718-001-03-9,rep_single_dose,WDR5/MLL INTERACTION INHIBITOR,WDR5,,,,,,NA,,
OLANEXIDINE,OLANEXIDINE,CHEMBL1190262,BRD:BRD-K00074735-014-02-9,rep_single_dose,,,,,,,Small molecule,-1,CCCCCCCCNC(=N)NC(=N)NCc1ccc(Cl)c(Cl)c1,ZZQMUJGZCZTLQD-UHFFFAOYSA-N
ZYPREXA ZYDIS,ARKOLAMYL;LY-170053;LY170053;OLANSEK;OLANZAPINE;OLANZAPINE APOTEX;OLANZAPINE CIPLA;OLANZAPINE GLENMARK;OLANZAPINE MYLAN;OLANZAPINE TEVA;OLAZAX;OLAZAX DISPERZI;ZALASTA;ZYPREXA;ZYPREXA VELOTAB;ZYPREXA ZYDIS,CHEMBL715,BRD:BRD-BRD-K18895904-001-16-1;BRD:BRD-K18895904-001-16-1,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA2A;ADRA2B;ADRA2C;ADRB1;ADRB2;ADRB3;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;DRD5;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;HRH1;HRH2;HRH4;HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR3A;HTR5A;HTR6;HTR7,"SCHIZOPHRENIA, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,4,"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1;CN1CCN(CC1)C1=NC2CCCCC2NC2SC(C)CC12, CN1CCN(CC1)C1=NC2CCCCC2NC2SC(C)CC12, CN1CCN(CC1)C1=NC2CCCCC2NC2SC(C)CC12, CN1CCN(CC1)C1=NC2CCCCC2NC2SC(C)CC12",KVWDHTXUZHCGIO-UHFFFAOYSA-N
OLDA,OLDA,,BRD:BRD-BRD-K95523387-001-09-6;BRD:BRD-K95523387-001-09-6,rep_multi_dose;rep_primary;rep_single_dose,TRPV AGONIST,GPR119,,,PRECLINICAL,,,NA,CCCCCCCC\C=C/CCCCCCCC(=O)NCCC1CCC(O)C(O)C1,
OLEAMIDE,OCTADEC-9-ENOIC ACID AMIDE;OLEAMIDE,CHEMBL15927,BRD:BRD-BRD-K06644925-001-03-0;BRD:BRD-K06644925-001-03-0,rep_primary;rep_single_dose,CANNABINOID RECEPTOR AGONIST,HTR7;PLA2G2A,,,PRECLINICAL,,Small molecule,NA,CCCCCCCC/C=C\CCCCCCCC(N)=O;CCCCCCCC\C=C/CCCCCCCC(N)=O,FATBGEAMYMYZAF-KTKRTIGZSA-N
OLEANDRIN,ANVIRZEL;NSC-692219;OLEANDRIN,CHEMBL1075789;CHEMBL4285883,BRD:BRD-BRD-K98006098-001-01-6;BRD:BRD-K98006098-001-01-6,rep_primary;rep_single_dose,NA/K-ATPASE INHIBITOR,,,,PHASE 1,,Small molecule,1,CC(=O)O[C@H]1C[C@]2(O)[C@@H]3CC[C@@H]4C[C@@H](O[C@H]5C[C@H](O)[C@@H](O)[C@H](C)O5)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1C1=CC(=O)OC1;CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@@H](C5=CC(=O)OC5)[C@@H](OC(C)=O)C[C@]43O)C2)O[C@@H](C)[C@@H]1O;CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O,JLPDBLFIVFSOCC-XYXFTTADSA-N;QWTDCDSWAVIWER-VSBFTHSSSA-N
OLEANOLIC-ACID,OLEANOLIC-ACID,,BRD:BRD-BRD-K90647725-001-06-5;BRD:BRD-BRD-K90647725-001-07-3;BRD:BRD-K90647725-001-06-5;BRD:BRD-K90647725-001-07-3,rep_multi_dose;rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,GPBAR1,,,PRECLINICAL,,,NA,"CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O, CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O",
OLEOYLETHANOLAMINE,N-(2-HYDROXYETHYL)OLEAMIDE;N-OLEOYLETHANOLAMINE;N-OLEYLETHANOLAMINE;OLEOYL ETHANOLAMIDE;OLEOYLETHANOLAMIDE;OLEOYLETHANOLAMINE,CHEMBL280065,BRD:BRD-BRD-K66956375-001-11-3;BRD:BRD-K66956375-001-11-3,rep_multi_dose;rep_primary;rep_single_dose,"CANNABINOID RECEPTOR AGONIST, GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST, POTASSIUM CHANNEL BLOCKER, PPAR RECEPTOR AGONIST",CNR1;GPR119;GPR55;PPARA,,,PRECLINICAL,,Small molecule,NA,CCCCCCCC/C=C\CCCCCCCC(=O)NCCO;CCCCCCCC\C=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N
OLEUROPEIN,OLEUROPEIN,CHEMBL1911053,BRD:BRD-A00842753-001-01-9;BRD:BRD-BRD-A00842753-001-01-9,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,GPER1,,,PHASE 2,,Small molecule,NA,C/C=C1/[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)[C@H]1CC(=O)OCCc1ccc(O)c(O)c1;COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)\C(=C/C)C1CC(=O)OCCC1CCC(O)C(O)C1,RFWGABANNQMHMZ-ZCHJGGQASA-N
RUTAMYCIN A,26-DEMETHYL-;26-DEMETHYLOLIGOMYCIN A;A 272;A-272;OLIGOMYCIN A;OLIGOMYCIN D;RR 32705;RR NO. 32705;RR-32705;RUTAMYCIN;RUTAMYCIN A,CHEMBL1256136;CHEMBL3989875,CTRP:411869,ctrp,,,,,,,Small molecule,-1,CC[C@H]1/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@H]2C[C@@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)O[C@@H](CC1)[C@H]2C,LVWVMRBMGDJZLM-BONFEJLISA-N
OLIGOMYCIN-A,OLIGOMYCIN-A,,BRD:BRD-A81541225-001-06-8;BRD:BRD-BRD-A81541225-001-06-8,rep_multi_dose;rep_primary;rep_single_dose,"ATP SYNTHASE INHIBITOR, ATPASE INHIBITOR",ATP5A1,,,PRECLINICAL,,,NA,CCC1CCC2OC3(CC[C@@H](C)C(C[C@H](C)O)O3)[C@H](C)C(OC(=O)\C=C\[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)C\C=C\C=C\1)[C@H]2C,
OLINCIGUAT,IW-1701;IW1701;OLINCIGUAT,CHEMBL4297616,BRD:BRD-K00091274-001-01-9,rep_single_dose,,,,,,,Small molecule,2,NC(=O)[C@](O)(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)C(F)(F)F,YWQFJNWMWZMXRW-HXUWFJFHSA-N
RNH-6270,NSC-759810;OLMESARTAN;OLMESARTAN MEDOXOMIL IMPURITY;OLMESARTAN-;RNH-6270,CHEMBL1516,BRD:BRD-BRD-K83144676-001-09-5;BRD:BRD-K83144676-001-09-5,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,HYPERTENSION,,LAUNCHED,,Small molecule,3,"CCCC1NC(C(C(O)=O)N1CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1)C(C)(C)O, CCCC1NC(C(C(O)=O)N1CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1)C(C)(C)O, CCCC1NC(C(C(O)=O)N1CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1)C(C)(C)O, CCCC1NC(C(C(O)=O)N1CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1)C(C)(C)O;CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1",VTRAEEWXHOVJFV-UHFFFAOYSA-N
OLMESARTAN-MEDOXOMIL,OLMESARTAN-MEDOXOMIL,,BRD:BRD-BRD-K78485176-001-07-8;BRD:BRD-K78485176-001-07-8,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,HYPERTENSION,,LAUNCHED,,,NA,"CCCC1NC(C(C)(C)O)C(C(=O)OCC2OC(=O)OC2C)N1CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1, CCCC1NC(C(C)(C)O)C(C(=O)OCC2OC(=O)OC2C)N1CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1, CCCC1NC(C(C)(C)O)C(C(=O)OCC2OC(=O)OC2C)N1CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1",
OLMUTINIB,BI 1482694;BI-1482694;HM-61713;HM61713;OLMUTINIB,CHEMBL3786343,BRD:BRD-BRD-K60421517-001-01-4;BRD:BRD-K60421517-001-01-4,rep_primary;rep_single_dose,"EGFR INHIBITOR, BRUTON'S TYROSINE KINASE (BTK) INHIBITOR",BTK;EGFR,,,LAUNCHED,"Multiple values for MOA: {""BRUTON'S TYROSINE KINASE (BTK) INHIBITOR, EGFR INHIBITOR"", ""EGFR INHIBITOR, BRUTON'S TYROSINE KINASE (BTK) INHIBITOR""}, defaulting to ""EGFR INHIBITOR, BRUTON'S TYROSINE KINASE (BTK) INHIBITOR""",Small molecule,2,"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1;CN1CCN(CC1)C1CCC(NC2NC(OC3CCCC(NC(=O)C=C)C3)C3SCCC3N2)CC1, CN1CCN(CC1)C1CCC(NC2NC(OC3CCCC(NC(=O)C=C)C3)C3SCCC3N2)CC1",FDMQDKQUTRLUBU-UHFFFAOYSA-N
PD-126055,EMA-401;EMA401;OLODANRIGAN;PD-126055,CHEMBL34124,BRD:BRD-K00003151-001-01-9,rep_single_dose,ANGIOTENSIN ANTAGONIST,,,,,,Small molecule,2,COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2,GHBCIXGRCZIPNQ-MHZLTWQESA-N
OLOMUCINE,OLOMOUCINE;OLOMUCINE,CHEMBL280074,BRD:BRD-BRD-K82731415-001-07-0;BRD:BRD-K82731415-001-07-0,rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK5;MAPK1,,,PRECLINICAL,,Small molecule,NA,CN1CNC2C(NCC3CCCCC3)NC(NCCO)NC12;Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21,GTVPOLSIJWJJNY-UHFFFAOYSA-N
OPATANOL,AL-4943A;OLOPATADINE;OPATANOL,CHEMBL1189432,BRD:BRD-BRD-K67637637-003-12-6;BRD:BRD-K67637637-003-12-6,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1;S100A1;S100A12;S100A13;S100A2;S100B,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,"CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21;CN(C)CC\C=C1\C2CCCCC2COC2CCC(CC(O)=O)CC12, CN(C)CC\C=C1\C2CCCCC2COC2CCC(CC(O)=O)CC12",JBIMVDZLSHOPLA-LSCVHKIXSA-N
OLPRINONE,LOPRINONE;OLPRINONE,CHEMBL1474900,BRD:BRD-BRD-K20745393-003-01-0;BRD:BRD-K20745393-003-01-0,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,-1,Cc1[nH]c(=O)c(C#N)cc1-c1ccc2nccn2c1;CC1[NH]C(=O)C(CC1-C1CCC2NCCN2C1)C#N,JPAWFIIYTJQOKW-UHFFFAOYSA-N
OLSALAZINE,C. I. MORDANT YELLOW 5;DIPENTUM;OLSALAZINE,CHEMBL425,BRD:BRD-BRD-K57853941-304-02-5;BRD:BRD-K57853941-304-02-5,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,IFNG;TPMT,ULCERATIVE COLITIS,,LAUNCHED,,Small molecule,4,"O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O;OC(=O)C1CC(CCC1O)\N=N\C1CCC(O)C(C1)C(O)=O, OC(=O)C1CC(CCC1O)\N=N\C1CCC(O)C(C1)C(O)=O",QQBDLJCYGRGAKP-FOCLMDBBSA-N
OLTIPRAZ,NSC-347901;OLTIPRAZ,CHEMBL178459,BRD:BRD-BRD-K86972824-001-01-4;BRD:BRD-BRD-K86972824-001-02-2;BRD:BRD-K86972824-001-01-4;BRD:BRD-K86972824-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",ANG,,,PHASE 3,"Multiple values for MOA: {'NUCLEAR FACTOR ERYTHROID DERIVED, LIKE (NRF2) ACTIVATOR', 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'}, defaulting to 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'",Small molecule,3,"Cc1c(-c2cnccn2)ssc1=S;CC1C(SSC1=S)-C1CNCCN1, CC1C(SSC1=S)-C1CNCCN1",CKNAQFVBEHDJQV-UHFFFAOYSA-N
OLUMACOSTAT-GLASARETIL,OLUMACOSTAT-GLASARETIL,,BRD:BRD-K00004611-001-01-9,rep_single_dose,ACETYL-COA CARBOXYLASE INHIBITOR,,,,,,,NA,,
OLUTASIDENIB,FT-2102;OLUTASIDENIB,CHEMBL4297610,BRD:BRD-K00091092-001-01-9,rep_single_dose,,,,,,,Small molecule,1,C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O,NEQYWYXGTJDAKR-JTQLQIEISA-N
TCMDC-124289,NE-19550;OLVANIL;TCMDC-124289,CHEMBL76903,BRD:BRD-BRD-K31560319-001-01-5;BRD:BRD-K31560319-001-01-5,rep_primary;rep_single_dose,TRPV AGONIST,CNR1;GPR119;TRPV1,,,PRECLINICAL,,Small molecule,-1,"CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(O)c(OC)c1;CCCCCCCC\C=C/CCCCCCCC(=O)NCC1CCC(O)C(OC)C1, CCCCCCCC\C=C/CCCCCCCC(=O)NCC1CCC(O)C(OC)C1",OPZKBPQVWDSATI-KHPPLWFESA-N
SYNRIBO,CEFLATONIN;CGX-635;HOMOHARRINGTONIN;HOMOHARRINGTONINE;MYELOSTAT;NSC-141633;OMACETAXINE MEPESUCCINATE;OMAPRO;SYNRIBO,CHEMBL46286,CTRP:375219,ctrp,,,,,,,Small molecule,4,COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4,HYFHYPWGAURHIV-JFIAXGOJSA-N
OMACICLOVIR,2-HMHBG;A-182091.0;A-1820910;ABT-091;H2G;OMACICLOVIR,CHEMBL2105375,BRD:BRD-K00091117-001-01-9,rep_single_dose,,,,,,,Small molecule,-1,Nc1nc2c(ncn2C[C@H](CO)CCO)c(=O)[nH]1,SCBFBAWJWLXVHS-ZCFIWIBFSA-N
PTK 0796,AMADACYCLINE;BAY 73-6944;OMADACYCLINE;PTK 0796,CHEMBL1689772,BRD:BRD-K00003569-003-01-9,rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,,,,,Small molecule,4,CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,JEECQCWWSTZDCK-IQZGDKDPSA-N
OMAPATRILAT,BMS-186716;BMS-186716-01;OMAPATRILAT,CHEMBL289556,BRD:BRD-K00003265-001-01-9,rep_single_dose,METALLOPROTEINASE INHIBITOR,ACE;MME,,,,,Small molecule,-1,O=C(N[C@H]1CCS[C@H]2CCC[C@@H](C(=O)O)N2C1=O)[C@@H](S)Cc1ccccc1,LVRLSYPNFFBYCZ-VGWMRTNUSA-N
OMARIGLIPTIN,MK-3102;OMARIGLIPTIN,CHEMBL2105762,BRD:BRD-BRD-K14171291-001-01-4;BRD:BRD-K14171291-001-01-4,rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,,,LAUNCHED,,Small molecule,3,"CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2;CS(=O)(=O)N1CC2CN(CC2N1)[C@H]1CO[C@@H]([C@@H](N)C1)C1CC(F)CCC1F, CS(=O)(=O)N1CC2CN(CC2N1)[C@H]1CO[C@@H]([C@@H](N)C1)C1CC(F)CCC1F",MKMPWKUAHLTIBJ-ISTRZQFTSA-N
OMBITASVIR,ABT-267;OMBITASVIR,CHEMBL3127326,BRD:BRD-K11072003-001-02-4,rep_single_dose,HCV INHIBITOR,,,,,,Small molecule,4,COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C,PIDFDZJZLOTZTM-KHVQSSSXSA-N
OMBRABULIN,AC7700;AVE-8062;AVE8062;OMBRABULIN,CHEMBL572284,BRD:BRD-K00003267-003-01-9,rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,,,Small molecule,3,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO,IXWNTLSTOZFSCM-YVACAVLKSA-N
OMDM-2,OMDM-2,,BRD:BRD-BRD-K48830578-001-01-9;BRD:BRD-K48830578-001-01-9,rep_primary;rep_single_dose,FAAH INHIBITOR,GPR119,,,PRECLINICAL,,,NA,CCCCCCCC\C=C/CCCCCCCC(=O)N[C@@H](CO)CC1CCC(O)CC1,
OMECAMTIV-MECARBIL,OMECAMTIV-MECARBIL,,BRD:BRD-BRD-K36680103-001-01-6;BRD:BRD-K36680103-001-01-6,rep_primary;rep_single_dose,CARDIAC MYOSIN ACTIVATOR,MYBPC3,,,PHASE 2,,,NA,COC(=O)N1CCN(CC2CCCC(NC(=O)NC3CCC(C)NC3)C2F)CC1,
OMEGA-3-ACID-ESTERS,OMEGA-3-ACID-ESTERS,,BRD:BRD-BRD-K31139048-001-03-2;BRD:BRD-K31139048-001-03-2,rep_primary;rep_single_dose,CHOLESTEROL INHIBITOR,,,,LAUNCHED,,,NA,"CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC, CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC, CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC",
ZANPROL,(S)-;A02BC05;ANTRA;EMOZUL;ESOMEPRAZOLE;H 168/68;H-168/68;INEXIUM PARANOVA;LOSEC;LOSEC MUPS;MEZZOPRAM;MOPRAL;NEXIUM;NEXIUM CONTROL;NEXIUM I.V.;NSC-751450;NSC-759192;OMEPRAZOLE;OMEPRAZOLE S-FORM;OMERAN;PRILOSEC;VENTRA;ZANPROL,CHEMBL1201320;CHEMBL1503,BRD:BRD-A55962179-001-22-1;BRD:BRD-BRD-A55962179-001-22-1,rep_multi_dose;rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP4A;CLCN2,HEARTBURN,,LAUNCHED,,Small molecule,4,"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1;COC1CCC2NC([NH]C2C1)S(=O)CC1NCC(C)C(OC)C1C, COC1CCC2NC([NH]C2C1)S(=O)CC1NCC(C)C(OC)C1C, COC1CCC2NC([NH]C2C1)S(=O)CC1NCC(C)C(OC)C1C, COC1CCC2NC([NH]C2C1)S(=O)CC1NCC(C)C(OC)C1C",SUBDBMMJDZJVOS-UHFFFAOYSA-N
OMEPRAZOLE-MAGNESIUM,OMEPRAZOLE-MAGNESIUM,,BRD:BRD-A56892734-001-09-4;BRD:BRD-BRD-A56892734-001-09-4,rep_primary;rep_single_dose,PROTON PUMP INHIBITOR,ATP4A;ATP4B,"GASTROESOPHAGEAL REFLUX DISEASE (GERD), HEARTBURN",,LAUNCHED,,,NA,COC1CCC2N([MG]N3C(NC4CC(OC)CCC34)S(=O)CC3NCC(C)C(OC)C3C)C(NC2C1)S(=O)CC1NCC(C)C(OC)C1C,
OMEPRAZOLE-SULFIDE,OMEPRAZOLE-SULFIDE,,BRD:BRD-BRD-K69035426-001-01-3;BRD:BRD-K69035426-001-01-3,rep_primary;rep_single_dose,ATPASE INHIBITOR,,,,PHASE 1,,,NA,COC1CCC2NC(SCC3NCC(C)C(OC)C3C)[NH]C2C1,
OMIPALISIB,EX-8678;GSK-2126458;GSK2126458;GSK458;OMIPALISIB,CHEMBL1236962,GDSC1:283,gdsc,,,,,,,Small molecule,1,COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,CGBJSGAELGCMKE-UHFFFAOYSA-N
PG490-88,OMTRIPTOLIDE;PG490-88,CHEMBL2110669,BRD:BRD-K00003212-001-01-9,rep_single_dose,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,,,,,,Small molecule,-1,CC(C)[C@]12O[C@H]1[C@@H]1O[C@]13[C@]1(O[C@H]1C[C@H]1C4=C(CC[C@@]13C)C(=O)OC4)[C@@H]2OC(=O)CCC(=O)O,HROMYAWHLUOUPY-AHCCQAQQSA-N
ON-01500,ON-01500,,BRD:BRD-K55790047-001-02-9,rep_single_dose,APOPTOSIS STIMULANT,,,,,,,NA,,
ON123300,NARAZACICLIB;ON-123300;ON123300,CHEMBL3115681,BRD:BRD-K88554883-001-03-2,rep_single_dose,CDK INHIBITOR,CDK4;NUAK1;PDGFRB,,,,,Small molecule,1,CN1CCN(c2ccc(Nc3ncc4cc(C#N)c(=O)n(C5CCCC5)c4n3)cc2)CC1,VADOZMZXXRBXNY-UHFFFAOYSA-N
TIC10,DORDAVIPRONE;NSC-350625;ONC 201;ONC-201;ONC201;TIC-10;TIC10,CHEMBL4297310,BRD:BRD-BRD-K58529924-001-01-5;BRD:BRD-K58529924-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,"AKT INHIBITOR, MAP KINASE INHIBITOR",TNFSF10,,,PHASE 2,,Small molecule,3,Cc1ccccc1CN1C(=O)C2=C(CCN(Cc3ccccc3)C2)N2CCN=C12;CC1CCCCC1CN1C2=NCCN2C2=C(CN(CC3CCCCC3)CC2)C1=O,VLULRUCCHYVXOH-UHFFFAOYSA-N
ONCRASIN-1,ONCRASIN-1,,BRD:BRD-BRD-K43449605-001-01-0;BRD:BRD-K43449605-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,APOPTOSIS STIMULANT,,,,PRECLINICAL,,,NA,CLC1CCC(CN2CC(C=O)C3CCCCC23)CC1,
ZUPLENZ,A04AA01;DESMETHYLONDANSETRON;EUR-1025;GR-38032;GR-38032F;NSC-757870;ONDANSETRON;ZOFRAN;ZOFRAN ODT;ZUPLENZ,CHEMBL46,BRD:BRD-A19736161-001-06-7;BRD:BRD-BRD-A19736161-001-06-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A;HTR1B;HTR3A;HTR3B;HTR4;OPRM1,"NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,"CC1NCCN1CC1CCC2C(C1=O)C1CCCCC1N2C, CC1NCCN1CC1CCC2C(C1=O)C1CCCCC1N2C, CC1NCCN1CC1CCC2C(C1=O)C1CCCCC1N2C;Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O",FELGMEQIXOGIFQ-UHFFFAOYSA-N
TIRABRUTINIB,GS-4059;ONO-4059;ONO-4059(FREE BASE);TIRABRUTINIB,CHEMBL4071161,BRD:BRD-A13689093-001-01-8;BRD:BRD-BRD-A13689093-001-01-8;BRD:BRD-K00003197-001-02-9,rep_primary;rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BTK,,,PHASE 1,"Multiple values for structure_id: {'K00003197', 'A13689093'}, defaulting to None",Small molecule,2,CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1;NC1NCNC2N(C3CCCN(C3)C(=O)C=C)C(=O)N(-C3CCC(OC4CCCCC4)CC3)C12,SEJLPXCPMNSRAM-GOSISDBHSA-N
ONO-4817,ONO-4817,,BRD:BRD-BRD-K58894520-001-01-1;BRD:BRD-K58894520-001-01-1,rep_primary;rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,MMP8,,,PHASE 1,,,NA,CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)C1CCC(OC2CCCCC2)CC1,
ONO-8130,ONO-8130,,BRD:BRD-K76725781-001-02-9,rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGER1,,,,,,NA,,
ONO-AE3-208,ONO-AE3-208,,BRD:BRD-A80567330-001-01-7;BRD:BRD-BRD-A80567330-001-01-7,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGER4,,,PRECLINICAL,,,NA,CC(C(=O)NC1CC(CCC1CCCC(O)=O)C#N)C1CCC(F)C2CCCCC12,
ONX-0914,ONX-0914,,BRD:BRD-BRD-K60446698-001-01-2;BRD:BRD-K60446698-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,PROTEASOME INHIBITOR,,,,PRECLINICAL,,,NA,COC1CCC(C[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC2CCCCC2)C(=O)[C@]2(C)CO2)CC1,
OP-0595,OP-0595,,BRD:BRD-K00004708-001-01-9,rep_single_dose,BETA LACTAMASE INHIBITOR,,,,,,,NA,,
OPC-21268,OPC-21268,,BRD:BRD-BRD-K19426040-001-01-1;BRD:BRD-K19426040-001-01-1,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR ANTAGONIST,AVPR1A;AVPR2;OXTR,,,PHASE 1,,,NA,"CC(=O)NCCCOC1CCC(CC1)C(=O)N1CCC(CC1)N1C(=O)CCC2CCCCC12, CC(=O)NCCCOC1CCC(CC1)C(=O)N1CCC(CC1)N1C(=O)CCC2CCCCC12",
OPICAPONE,BIA 9-1067;BIA-9-1067;BIA-91067;ONGENTYS;OPICAPONE,CHEMBL1089318,BRD:BRD-BRD-K66192203-001-02-2;BRD:BRD-K66192203-001-02-2,rep_primary;rep_single_dose,CATECHOL O METHYLTRANSFERASE INHIBITOR,COMT,,,PHASE 3,,Small molecule,4,"Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(O)c(O)c([N+](=O)[O-])c2)n1;CC1C(CL)C(C)[N+]([O-])C(CL)C1-C1NOC(N1)-C1CC(O)C(O)C(C1)[N+]([O-])=O, CC1C(CL)C(C)[N+]([O-])C(CL)C1-C1NOC(N1)-C1CC(O)C(O)C(C1)[N+]([O-])=O",ASOADIZOVZTJSR-UHFFFAOYSA-N
OPIPRAMOL DURA,NSC-169867;OPIPRAMOL;OPIPRAMOL DURA,CHEMBL370753,BRD:BRD-BRD-K43786866-300-02-3;BRD:BRD-K43786866-300-02-3,rep_primary;rep_single_dose,SIGMA RECEPTOR AGONIST,,GENERALIZED ANXIETY DISORDER (GAD),,LAUNCHED,,Small molecule,3,OCCN1CCN(CCCN2C3CCCCC3C=CC3CCCCC23)CC1;OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1,YNZFUWZUGRBMHL-UHFFFAOYSA-N
PR-047,ONX 0912;ONX-0912;OPROZOMIB;PR-047,CHEMBL2103884,BRD:BRD-A36331462-001-02-1;BRD:BRD-BRD-A36331462-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,PROTEASOME INHIBITOR,,,,PHASE 1/PHASE 2,,Small molecule,1,COC[C@H](NC(=O)[C@H](COC)NC(=O)C1CNC(C)S1)C(=O)N[C@@H](CC1CCCCC1)C(=O)C1(C)CO1;COC[C@H](NC(=O)c1cnc(C)s1)C(=O)N[C@@H](COC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1,SWZXEVABPLUDIO-WSZYKNRRSA-N
OR-1896,OR-1896,,BRD:BRD-K86283245-001-03-9,rep_single_dose,,,,,,,,NA,,
OR-486,OR-486,,BRD:BRD-K18602506-001-09-9,rep_single_dose,CATECHOL O METHYLTRANSFERASE INHIBITOR,COMT,,,,,,NA,,
TSU-68,NSC-702827;ORANTINIB;SU-6668;TSU-68,CHEMBL274654,BRD:BRD-BRD-K55966568-001-05-4;BRD:BRD-K55966568-001-05-4,rep_multi_dose;rep_primary;rep_single_dose,"FGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",AURKA;AURKB;EGFR;FGFR1;FGFR2;KDR;PDGFRA;PDGFRB,,,PHASE 3,,Small molecule,3,"Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O;CC1[NH]C(\C=C2/C(=O)NC3CCCCC23)C(C)C1CCC(O)=O, CC1[NH]C(\C=C2/C(=O)NC3CCCCC23)C(C)C1CCC(O)=O, CC1[NH]C(\C=C2/C(=O)NC3CCCCC23)C(C)C1CCC(O)=O, CC1[NH]C(\C=C2/C(=O)NC3CCCCC23)C(C)C1CCC(O)=O",NHFDRBXTEDBWCZ-ZROIWOOFSA-N
ORBIFLOXACIN,NSC-758614;ORBAX;ORBIFLOXACIN,CHEMBL295433,BRD:BRD-BRD-K63001556-001-08-8;BRD:BRD-BRD-K63001556-001-09-6;BRD:BRD-K63001556-001-08-8;BRD:BRD-K63001556-001-09-6,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,-1,"C[C@@H]1CN(c2c(F)c(F)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1;C[C@H]1CN(C[C@@H](C)N1)C1C(F)C(F)C2C(C1F)N(CC(C(O)=O)C2=O)C1CC1, C[C@H]1CN(C[C@@H](C)N1)C1C(F)C(F)C2C(C1F)N(CC(C(O)=O)C2=O)C1CC1, C[C@H]1CN(C[C@@H](C)N1)C1C(F)C(F)C2C(C1F)N(CC(C(O)=O)C2=O)C1CC1",QIPQASLPWJVQMH-DTORHVGOSA-N
ORE1001,GL-1001;GL1001;MLN-4760;ORE-1001;ORE-1001 FREE ACID;ORE1001,CHEMBL429844,BRD:BRD-BRD-K67068943-001-01-0;BRD:BRD-K67068943-001-01-0,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE2,,,PHASE 1/PHASE 2,,Small molecule,1,CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O;CC(C)C[C@H](N[C@@H](CC1CNCN1CC1CC(CL)CC(CL)C1)C(O)=O)C(O)=O,NTCCRGGIJNDEAB-IRXDYDNUSA-N
ORG-12962,ORG-12962,,BRD:BRD-BRD-K07409305-001-01-1;BRD:BRD-K07409305-001-01-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2A;HTR2B;HTR2C,,,PHASE 2,,,NA,FC(F)(F)C1CCC(NC1CL)N1CCNCC1,
ORG-25543,ORG-25543,,BRD:BRD-BRD-K32853922-003-01-8;BRD:BRD-K32853922-003-01-8,rep_primary;rep_single_dose,GLYCINE TRANSPORTER INHIBITOR,GLRB;SLC6A5,,,PRECLINICAL,,,NA,COC1CC(CC(OC)C1OCC1CCCCC1)C(=O)NCC1(CCCC1)N(C)C,
ORG-26576,ORG-26576,,BRD:BRD-BRD-K40002998-001-01-5;BRD:BRD-K40002998-001-01-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,,,,PHASE 2,,,NA,O=C1N2CCC[C@H]2COC2NCCCC12,
ORG-27569,ORG-27569,,BRD:BRD-BRD-K57597776-001-01-2;BRD:BRD-K57597776-001-01-2,rep_primary;rep_single_dose,CANNABINOID RECEPTOR MODULATOR,CNR1,,,PRECLINICAL,,,NA,CCC1C([NH]C2CCC(CL)CC12)C(=O)NCCC1CCC(CC1)N1CCCCC1,
ORG-9768,ORG-9768,,BRD:BRD-BRD-K41434598-003-01-9;BRD:BRD-K41434598-003-01-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A,,,PHASE 1,,,NA,CC1(CN)CC2CCCCC2C1,
PURE ORIDONIN,ENT-ORIDONIN;ISODONOL;NSC-250682;ORIDONIN;ORIDONINE;PURE ORIDONIN,CHEMBL454570;CHEMBL4639672,BRD:BRD-BRD-K23925186-001-01-0;BRD:BRD-BRD-K23925186-001-02-8;BRD:BRD-K23925186-001-01-0;BRD:BRD-K23925186-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,BCL INHIBITOR,BCL2,,,PRECLINICAL,,Small molecule,-1,"C=C1C(=O)[C@]23C(O)[C@H]1CC[C@H]2[C@@]12CO[C@]3(O)[C@@H](O)[C@@H]1C(C)(C)CC[C@@H]2O;O[C@@H]1[C@H]2CC[C@@H]3[C@@]45CO[C@](O)(C[C@@H]4C(C)(C)CC[C@@H]5O)[C@@]13C(=O)C2=C, O[C@@H]1[C@H]2CC[C@@H]3[C@@]45CO[C@](O)(C[C@@H]4C(C)(C)CC[C@@H]5O)[C@@]13C(=O)C2=C",SDHTXBWLVGWJFT-UMXDBTPVSA-N
ORITAVANCIN,LY-333328;LY333328;ORITAVANCIN,CHEMBL1688530,BRD:BRD-A33352494-316-01-6;BRD:BRD-BRD-A33352494-316-01-6,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,SKIN INFECTIONS,,LAUNCHED,,Unknown,4,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O;CNC(CC(C)C)C(=O)NC1C(O)C2CCC(OC3CC4CC(OC5CCC(CC5CL)C(OC5CC(C)(N)C(O)C(C)O5)C5NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)C1CCC(O)C(C1)-C1C(O)CC(O)CC1C(NC5=O)C(O)=O)C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(NCC3CCC(CC3)-C3CCC(CL)CC3)C(O)C(C)O1)C(CL)C2,VHFGEBVPHAGQPI-LXKZPTCJSA-N
XENICAL,ALLI;BEACITA;LIPSTATIN;NSC-758881;ORLIPASTAT;ORLISTAT;RO 18-0647/002;RO-180647-002;RO-180647002;TETRAHYDROLIPSTATIN;XENICAL,CHEMBL175247,BRD:BRD-BRD-K63343048-001-12-2;BRD:BRD-K63343048-001-12-2,rep_primary;rep_single_dose,LIPASE INHIBITOR,CNR1;DAGLA;DAGLB;FASN;LIPF;PNLIP,WEIGHT-LOSS AID,,LAUNCHED,,Small molecule,4,"CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O;CCCCCCCCCCC[C@@H](C[C@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@@H](CC(C)C)NC=O, CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O, CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O",AHLBNYSZXLDEJQ-FWEHEUNISA-N
TRANS-CENTCHROMAN,CENTCHROMAN;CENTRON;ORMELOXIFENE;SAHELI;TRANS-CENTCHROMAN,CHEMBL154126,BRD:BRD-K00004639-001-01-9,rep_single_dose,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),,,,,,Small molecule,-1,COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1,XZEUAXYWNKYKPL-UHFFFAOYSA-N
TIBERAL,NSC-95075;ORNIDAZOLE;RO 7-0207;RO-7-0207;RO-70207;TIBERAL,CHEMBL1449676,BRD:BRD-A42759514-001-20-5;BRD:BRD-BRD-A42759514-001-20-5,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,PROTOZOAN INFECTION,,LAUNCHED,,Small molecule,4,"Cc1ncc([N+](=O)[O-])n1CC(O)CCl;CC1NCC(N1CC(O)CCL)[N+]([O-])=O, CC1NCC(N1CC(O)CCL)[N+]([O-])=O, CC1NCC(N1CC(O)CCL)[N+]([O-])=O",IPWKIXLWTCNBKN-UHFFFAOYSA-N
POR-8,8-L-ORNITHINEVASOPRESSIN;8-ORNITHINEVASOPRESSIN;ORN(8)-VASOPRESSIN;ORNIPRESSIN;ORNITHINE VASOPRESSIN;ORPRESSIN;POR 8;POR 8 SANDOZ;POR-8,CHEMBL1819440,BRD:BRD-K00003333-001-01-9,rep_single_dose,VASOCONSTRICTOR,,,,,,Protein,-1,NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,MUNMIGOEDGHVLE-LGYYRGKSSA-N
ORNITHINE,(L)-ISOMER;NSC-758894;ORNITHINE,CHEMBL446143,BRD:BRD-A13561534-003-02-0;BRD:BRD-BRD-A13561534-003-02-0,rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY MODULATOR,ARG1;ARG2;GATM;GPRC6A;OAT;OAZ1;OAZ2;OAZ3;OTC;SLC25A15;SLC25A2;SLC7A1;SLC7A2;SLC7A3;SLC7A4,,,LAUNCHED,,Small molecule,3,NCCC[C@H](N)C(=O)O;NCCCC(N)C(O)=O,AHLPHDHHMVZTML-BYPYZUCNSA-N
OROTIC-ACID,OROTIC-ACID,,BRD:BRD-BRD-K32572029-001-04-4;BRD:BRD-K32572029-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,,DHODH,,,PHASE 2,,,NA,"OC(=O)C1CC(=O)[NH]C(=O)[NH]1, OC(=O)C1CC(=O)[NH]C(=O)[NH]1",
ORPHENGESIC,DISIPAL;INVAGESIC;MEFENAMINE;MIALGIN;NORFLEX;NORGESIC;ORPHENADRIN;ORPHENADRINE;ORPHENGESIC,CHEMBL900,BRD:BRD-A53576514-048-14-3;BRD:BRD-BRD-A53576514-048-14-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,GRIN1;GRIN2D;GRIN3A;GRIN3B;HRH1;SCN10A;SLC6A2,MUSCLE PAIN,,LAUNCHED,,Small molecule,4,"Cc1ccccc1C(OCCN(C)C)c1ccccc1;CN(C)CCOC(C1CCCCC1)C1CCCCC1C, CN(C)CCOC(C1CCCCC1)C1CCCCC1C",QVYRGXJJSLMXQH-UHFFFAOYSA-N
TAK-700,ORTERONEL;TAK-700,CHEMBL1921976,BRD:BRD-BRD-K00674894-001-01-4;BRD:BRD-K00674894-001-01-4,rep_primary;rep_single_dose,"ANDROGEN BIOSYNTHESIS INHIBITOR, ANDROGEN RECEPTOR ANTAGONIST, CYTOCHROME P450 INHIBITOR",CYP17A1,,,PHASE 3,,Small molecule,3,CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1;CNC(=O)C1CCC2CC(CCC2C1)[C@]1(O)CCN2CNCC12,OZPFIJIOIVJZMN-SFHVURJKSA-N
ORY-1001,ORY-1001,,BRD:BRD-BRD-K59711701-300-02-1;BRD:BRD-K59711701-300-02-1,rep_primary;rep_single_dose,HISTONE LYSINE DEMETHYLASE INHIBITOR,KDM1A,,,PHASE 1/PHASE 2,,,NA,"NC1CCC(CC1)N[C@@H]1C[C@H]1C1CCCCC1, NC1CCC(CC1)N[C@@H]1C[C@H]1C1CCCCC1",
OSELTAMIVIR-CARBOXYLATE,OSELTAMIVIR-CARBOXYLATE,,BRD:BRD-BRD-K93767137-001-01-1;BRD:BRD-K93767137-001-01-1,rep_primary;rep_single_dose,NEURAMINIDASE INHIBITOR,,INFLUENZA A VIRUS INFECTION,,LAUNCHED,,,NA,CCC(CC)O[C@@H]1C=C(C[C@H](N)[C@H]1NC(C)=O)C(O)=O,
OSELTAMIVIR-PHOSPHATE,OSELTAMIVIR-PHOSPHATE,,BRD:BRD-BRD-K76011241-001-01-8;BRD:BRD-K76011241-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,NEURAMINIDASE INHIBITOR,CES1;NEU1;NEU2,INFLUENZA A VIRUS INFECTION,,LAUNCHED,,,NA,"CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1, CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1, CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1",
OSEMOZOTAN,MKC-242;MN-305;OSEMOZOTAN,CHEMBL1742408,BRD:BRD-BRD-K60371362-001-01-7;BRD:BRD-K60371362-001-01-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,,,PHASE 2/PHASE 3,,Small molecule,3,C(CNC[C@H]1COC2CCCCC2O1)COC1CCC2OCOC2C1;c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2,MEEQBDCQPIZMLY-HNNXBMFYSA-N
OSI 930 OSI930,OSI 930 OSI930,,GDSC1:298,gdsc,,,,,,,,NA,,
OSI-027,AEVI-006;ASP 7486;ASP-7486;CERC 006;CERC-006;OSI 027;OSI-027,CHEMBL3120215,BRD:BRD-BRD-K87124298-001-03-4;BRD:BRD-K87124298-001-03-4;CTRP:660433;GDSC1:299;GDSC2:1594,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PHASE 1,,Small molecule,2,"COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12;COC1CCCC2CC([NH]C12)-C1NC([C@H]2CC[C@@H](CC2)C(O)=O)N2NCNC(N)C12, COC1CCCC2CC([NH]C12)-C1NC([C@H]2CC[C@@H](CC2)C(O)=O)N2NCNC(N)C12",JROFGZPOBKIAEW-HAQNSBGRSA-N
OSI-420,OSI-420,,BRD:BRD-BRD-K73309154-003-02-8;BRD:BRD-K73309154-003-02-8,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PRECLINICAL,,,NA,COCCOC1CC2NCNC(NC3CCCC(C3)C#C)C2CC1OCCO,
OSI-906AA,ASP-7487;LINSITINIB;OSI-906;OSI-906AA,CHEMBL1091644,GDSC1:185;GDSC2:1510,gdsc,,,,,,,Small molecule,3,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,PKCDDUHJAFVJJB-VLZXCDOPSA-N
OSI-930,OSI 930;OSI-930,CHEMBL1614710,BRD:BRD-BRD-K25340465-001-11-1;BRD:BRD-K25340465-001-11-1;CTRP:628620;GDSC1:298,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"KIT INHIBITOR, VEGFR INHIBITOR",FLT1;KDR;KIT,,,PHASE 1,"Multiple values for repurposing_target: {'KDR;KIT', 'FLT1;KDR;KIT'}, taking the union",Small molecule,1,"FC(F)(F)OC1CCC(NC(=O)C2SCCC2NCC2CCNC3CCCCC23)CC1, FC(F)(F)OC1CCC(NC(=O)C2SCCC2NCC2CCNC3CCCCC23)CC1;O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12",FGTCROZDHDSNIO-UHFFFAOYSA-N
OSILODROSTAT,LCI-699;LCI-699-NX;LCI699;LCI699-NX;OSILODROSTAT,CHEMBL3099695,BRD:BRD-K00003210-001-01-9,rep_single_dose,CYTOCHROME P450 INHIBITOR,,,,,,Small molecule,4,N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1,USUZGMWDZDXMDG-CYBMUJFWSA-N
TAGRISSO,AZD-9291;AZD-9291 FREE BASE;AZD9291;MERELETINIB;OSIMERTINIB;TAGRISSO,CHEMBL3353410,BRD:BRD-BRD-K42805893-001-04-9;BRD:BRD-K42805893-001-04-9;GDSC2:1919,gdsc;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,,Small molecule,4,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C;COC1CC(N(C)CCN(C)C)C(NC(=O)C=C)CC1NC1NCCC(N1)-C1CN(C)C2CCCCC12,DUYJMQONPNNFPI-UHFFFAOYSA-N
TORE III,(DEAMINOHYDROXY) TOREMIFENE;FC-1271;FC-1271A;OSPEMIFENE;OSPHENA;SENSHIO;TORE III,CHEMBL2105395,BRD:BRD-BRD-K44184170-001-01-7;BRD:BRD-K44184170-001-01-7,rep_primary;rep_single_dose,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),ESR1;ESR2,"VAGINAL ATROPHY, DYSPAREUNIA, MENOPAUSE",,LAUNCHED,,Small molecule,4,OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1;OCCOC1CCC(CC1)C(\C1CCCCC1)=C(\CCCL)C1CCCCC1,LUMKNAVTFCDUIE-VHXPQNKSSA-N
OSTARINE,OSTARINE,,BRD:BRD-BRD-K29735307-001-02-9;BRD:BRD-K29735307-001-02-9,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,,,PHASE 3,,,NA,C[C@](O)(COC1CCC(CC1)C#N)C(=O)NC1CCC(C#N)C(C1)C(F)(F)F,
OSTHOL,OSTHOL,,BRD:BRD-BRD-K78294846-001-12-4;BRD:BRD-K78294846-001-12-4,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,COC1CCC2CCC(=O)OC2C1CC=C(C)C,
OT-R-ANTAGONIST-1,OT-R-ANTAGONIST-1,,BRD:BRD-BRD-K42009284-001-01-1;BRD:BRD-K42009284-001-01-1,rep_primary;rep_single_dose,OXYTOCIN RECEPTOR ANTAGONIST,AVPR1A;OXTR,,,PRECLINICAL,,,NA,CO\N=C1\C[C@H](N(C1)C(=O)C1CCC(CC1)-C1CCCCC1C)C(=O)NC[C@@H](O)C1CCCCC1,
XRP0673,FXV-673;FXV673;OTAMIXABAN;RPR-130673;RPR130673;XRP-0673;XRP0673,CHEMBL46618,BRD:BRD-BRD-K80082640-001-01-0;BRD:BRD-K80082640-001-01-0,rep_primary;rep_single_dose,COAGULATION FACTOR INHIBITOR,F10,,,PHASE 3,,Small molecule,3,COC(=O)[C@H](Cc1cccc(C(=N)N)c1)[C@@H](C)NC(=O)c1ccc(-c2cc[n+]([O-])cc2)cc1;COC(=O)[C@H](CC1CCCC(C1)C(N)=N)[C@@H](C)NC(=O)C1CCC(CC1)-C1CC[N+]([O-])CC1,PFGVNLZDWRZPJW-OPAMFIHVSA-N
OTENZEPAD,AF-DX 116;AF-DX-116;OTENZEPAD,CHEMBL17045,BRD:BRD-A00520476-001-07-4;BRD:BRD-BRD-A00520476-001-07-4,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,,,PHASE 3,,Small molecule,-1,"CCN(CC)CC1CCCCN1CC(=O)N1C2CCCCC2C(=O)NC2CCCNC12, CCN(CC)CC1CCCCN1CC(=O)N1C2CCCCC2C(=O)NC2CCCNC12;CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc21",UBRKDAVQCKZSPO-UHFFFAOYSA-N
VT-1161,OTESECONAZOLE;VIVJOA;VT-1161,CHEMBL3311228,BRD:BRD-K00077023-001-02-9,rep_single_dose,,,,,,,Small molecule,4,O[C@@](Cn1cnnn1)(c1ccc(F)cc1F)C(F)(F)c1ccc(-c2ccc(OCC(F)(F)F)cc2)cn1,IDUYJRXRDSPPRC-NRFANRHFSA-N
OTILONIUM ION,OCTYLONIUM;OTILONIUM;OTILONIUM CATION;OTILONIUM ION,CHEMBL1433361,BRD:BRD-BRD-K85337334-004-02-6;BRD:BRD-K85337334-004-02-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CACNA1C,IRRITABLE BOWEL SYNDROME,,LAUNCHED,,Small molecule,3,CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1;CCCCCCCCOC1CCCCC1C(=O)NC1CCC(CC1)C(=O)OCC[N+](C)(CC)CC,NQHNLNLJPDMBFN-UHFFFAOYSA-O
OTS167,OTS167,,BRD:BRD-BRD-K53417444-003-03-1;BRD:BRD-K53417444-003-03-1,rep_multi_dose;rep_primary;rep_single_dose,MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE INHIBITOR,MELK,,,PHASE 1,,,NA,CN(C)C[C@H]1CC[C@@H](CC1)NC1C(CNC2CCC(NC12)-C1CC(CL)C(O)C(CL)C1)C(C)=O,
OTS514,OTS514,,BRD:BRD-K38018935-001-01-1,rep_single_dose,TOPK INHIBITOR,,,,,,,NA,,
Y-803 ANHYDROUS,BIRABRESIB;MK-8628;OTX-015;OTX-015 ANHYDROUS;OTX015;OTX015 ANHYDROUS;Y-803 ANHYDROUS,CHEMBL3581647,GDSC2:1626,gdsc,,,,,,,Small molecule,2,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2,GNMUEVRJHCWKTO-FQEVSTJZSA-N
Y-803 ANHYDROUS,BIRABRESIB;MK-8628;OTX-015;OTX-015 ANHYDROUS;OTX015;OTX015 ANHYDROUS;Y-803 ANHYDROUS,CHEMBL3581647,BRD:BRD-BRD-K43471985-001-03-0;BRD:BRD-BRD-K43471985-001-05-5;BRD:BRD-K43471985-001-03-0;BRD:BRD-K43471985-001-05-5;GDSC2:1626,gdsc;rep_multi_dose;rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD2;BRD3;BRD4,,,PHASE 1/PHASE 2,,Small molecule,2,"CC1SC-2C(C1C)C(=N[C@@H](CC(=O)NC1CCC(O)CC1)C1NNC(C)N-21)C1CCC(CL)CC1, CC1SC-2C(C1C)C(=N[C@@H](CC(=O)NC1CCC(O)CC1)C1NNC(C)N-21)C1CCC(CL)CC1;Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2",GNMUEVRJHCWKTO-FQEVSTJZSA-N
STROPHOPERM,ACOCANTHERIN;ACOCANTHERIN OCTAHYDRATE;G-STROPHANTHIN;GRATUS STROPHANTHIN;NSC-25485;NSC-757425;OUABAIN;OUABAIN ANHYDROUS;OUABAIN OCTAHYDRATE;OUABAINE ARNAUD;PUROSTROPHAN;STRODIVAL;STROPHANTIN-G;STROPHOPERM,CHEMBL1889436;CHEMBL222863,BRD:BRD-BRD-K33277808-331-01-3;BRD:BRD-K33277808-331-01-3;CTRP:37190,ctrp;rep_multi_dose;rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP1A1,"HYPERTENSION, CARDIAC ARRYTHMIA",,LAUNCHED,,Small molecule,4,"C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O;C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O.O.O.O.O.O.O.O.O",TYBARJRCFHUHSN-DMJRSANLSA-N
OXA-06,OXA-06,,BRD:BRD-BRD-K98736329-300-01-5;BRD:BRD-K98736329-300-01-5,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK1;ROCK2,,,PRECLINICAL,,,NA,FC1CCCCC1CNCC1CCC(CC1)-C1CCNC2[NH]CCC12,
OXACEPROL,ACETYL HYDROXYPROLINE;JONCTUM;OXACEPROL,CHEMBL1407356;CHEMBL2105621,BRD:BRD-K65230684-001-06-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,-1,CC(=O)N1C[C@H](O)C[C@H]1C(=O)O;CC(=O)N1CC(O)C[C@H]1C(=O)O,BAPRUDZDYCKSOQ-GDVGLLTNSA-N;BAPRUDZDYCKSOQ-RITPCOANSA-N
PROSTAPHLIN,OXACILLIN;OXAZOCILLINE;PROSTAPHLIN,CHEMBL819,BRD:BRD-BRD-K96786677-236-02-4;BRD:BRD-BRD-K96786677-323-02-0;BRD:BRD-K96786677-236-02-4;BRD:BRD-K96786677-323-02-0,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,STAPHYLOCOCCAL INFECTIONS,,LAUNCHED,,Small molecule,4,"Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O;CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1CCCCC1, CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1CCCCC1, CC1ONC(C1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-C1CCCCC1",UWYHMGVUTGAWSP-JKIFEVAISA-N
XALIPLATIN,ELOXATIN;JM-83;L-OHP;MBP-426 (LIPOSOMAL OXALIPLATIN);NSC-266046;OXALIPLATIN;RP-54780;SR-96669;XALIPLATIN,CHEMBL414804,BRD:BRD-BRD-K78960041-001-03-2;BRD:BRD-BRD-K78960041-001-05-7;BRD:BRD-K78960041-001-03-2;BRD:BRD-K78960041-001-05-7;CTRP:375582;GDSC2:1089;GDSC2:1806,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,COLORECTAL CANCER,,LAUNCHED,,Small molecule,4,"O=C1O[PT]2(N[C@@H]3CCCC[C@H]3N2)OC1=O, O=C1O[PT]2(N[C@@H]3CCCC[C@H]3N2)OC1=O, O=C1O[PT]2(N[C@@H]3CCCC[C@H]3N2)OC1=O, O=C1O[PT]2(N[C@@H]3CCCC[C@H]3N2)OC1=O",
OXOSUCCINIC ACID,ANHYDROUS ENOL-OXALOACETATE;BIOEPG;NSC-77688;OXALOACETATE;OXALOACETIC ACID;OXOSUCCINIC ACID,CHEMBL1794791,BRD:BRD-BRD-K61279411-001-02-0;BRD:BRD-K61279411-001-02-0,rep_primary;rep_single_dose,GLUTAMATE RELEASE INHIBITOR,CS;SPR,,,PHASE 2/PHASE 3,,Small molecule,2,"O=C(O)CC(=O)C(=O)O;OC(=O)CC(=O)C(O)=O, OC(=O)CC(=O)C(O)=O",KHPXUQMNIQBQEV-UHFFFAOYSA-N
VANSIL,NSC-352888;OXAMNIQUINE;OXAMNIQUINUM;UK-4261;UK-4271;VANSIL,CHEMBL847,BRD:BRD-A04843135-001-09-9,rep_single_dose,,,,,,,Small molecule,4,CC(C)NCC1CCc2cc(CO)c([N+](=O)[O-])cc2N1,XCGYUJZMCCFSRP-UHFFFAOYSA-N
VASOROME,ANAVAR;LONAVAR;NSC-67068;OXANDRIN;OXANDROLONE;OXANDROLONE CIII;PROVITAR;SC 11585;SC-11585;VASOROME,CHEMBL1200436,BRD:BRD-BRD-K92467929-001-01-1;BRD:BRD-K92467929-001-01-1,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,AR,WEIGHT-GAIN AID,,LAUNCHED,,Small molecule,4,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C;C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,QSLJIVKCVHQPLV-PEMPUTJUSA-N
WY-21743,"DAYPRO;NSC-310839;OXAPROZIN;WY-21,743;WY-21743",CHEMBL1071,BRD:BRD-BRD-K25394294-001-14-9;BRD:BRD-K25394294-001-14-9,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"OSTEOARTHRITIS, RHEUMATOID ARTHRITIS",,LAUNCHED,,Small molecule,4,"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1;OC(=O)CCC1NC(C(O1)-C1CCCCC1)-C1CCCCC1, OC(=O)CCC1NC(C(O1)-C1CCCCC1)-C1CCCCC1",OFPXSFXSNFPTHF-UHFFFAOYSA-N
TINSET,"CELTECT;COBIONA;DASTEN;NSC-309710;OXATOMIDE;R 35,443;R-35443;TINSET",CHEMBL13828,BRD:BRD-BRD-K02079473-001-01-3;BRD:BRD-K02079473-001-01-3,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1;O=C1[NH]C2CCCCC2N1CCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1,BAINIUMDFURPJM-UHFFFAOYSA-N
ZAXOPAM,J3.308A;LEDERPAM;NSC-169448;OXAZEPAM;OXAZEPAM CIV;OXAZEPAM-;OXOZEPAM;SERAX;SERENID FTE;TEMAZEPAM IMPURITY;WY-3498;ZAXOPAM,CHEMBL568,BRD:BRD-A50049929-001-01-9;BRD:BRD-BRD-A50049929-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GABRR1;GABRR2;GABRR3,ANXIETY,,LAUNCHED,,Small molecule,4,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O;OC1N=C(C2CCCCC2)C2CC(CL)CCC2NC1=O,ADIMAYPTOBDMTL-UHFFFAOYSA-N
TRILEPTAL,GP-47680;KIN-493;NSC-758693;OXCARBAMAZEPINE;OXCARBAZEPINE;OXTELLAR XR;SPN-804;TRILEPTAL,CHEMBL1068,BRD:BRD-BRD-K04196797-001-24-4;BRD:BRD-K04196797-001-24-4,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,Small molecule,4,"NC(=O)N1C2CCCCC2CC(=O)C2CCCCC12, NC(=O)N1C2CCCCC2CC(=O)C2CCCCC12, NC(=O)N1C2CCCCC2CC(=O)C2CCCCC12;NC(=O)N1c2ccccc2CC(=O)c2ccccc21",CTRLABGOLIVAIY-UHFFFAOYSA-N
OXELAIDIN,OXELAIDIN,,BRD:BRD-BRD-K17977438-048-02-4;BRD:BRD-K17977438-048-02-4,rep_primary;rep_single_dose,ANTITUSSIVE,,COUGH SUPPRESSANT,,LAUNCHED,,,NA,"CCN(CC)CCOCCOC(=O)C(CC)(CC)C1CCCCC1, CCN(CC)CCOCCOC(=O)C(CC)(CC)C1CCCCC1, CCN(CC)CCOCCOC(=O)C(CC)(CC)C1CCCCC1",
WY-806,NSC-758444;OXETACAINE;OXETHAZAINE;STROCAIN;WY-806,CHEMBL127592,BRD:BRD-BRD-K56940463-001-13-8;BRD:BRD-K56940463-001-13-8,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,3,"CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1;CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1CCCCC1)C(C)(C)CC1CCCCC1, CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1CCCCC1)C(C)(C)CC1CCCCC1",FTLDJPRFCGDUFH-UHFFFAOYSA-N
OXF-BD-02,OXF-BD-02,,BRD:BRD-A73891132-001-02-9,rep_single_dose,BROMODOMAIN INHIBITOR,BRD4,,,,,,NA,,
SYNANTHIC,NSC-758943;OXFENDAZOLE;RS-8858;SYNANTHIC,CHEMBL42442,BRD:BRD-A33447119-001-10-8;BRD:BRD-BRD-A33447119-001-10-8,rep_primary;rep_single_dose,ANTHELMINTIC AGENT,,"LUNGWORMS, TAPEWORM, GASTROINTESTINAL ROUNDWORMS",,LAUNCHED,,Small molecule,2,"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1;COC(=O)NC1NC2CCC(CC2[NH]1)S(=O)C1CCCCC1, COC(=O)NC1NC2CCC(CC2[NH]1)S(=O)C1CCCCC1",BEZZFPOZAYTVHN-UHFFFAOYSA-N
UK-25842,"(S)-;(S)-(4-HYDROXYPHENYL)GLYCINE;4-HYDROXYPHENYLGLYCINE;L-2-(P-HYDROXYPHENYL)GLYCINE;OXFENICINE;UK-25,842;UK-25842",CHEMBL1232077,BRD:BRD-A86525947-001-01-4;BRD:BRD-BRD-A86525947-001-01-4,rep_primary;rep_single_dose,CARNITINE PALMITOYLTRANSFERASE INHIBITOR,CPT1A;CPT1B,,,PHASE 1,,Small molecule,-1,"N[C@@H](C(O)=O)C1CCC(O)CC1, NC(C(O)=O)C1CCC(O)CC1;N[C@H](C(=O)O)c1ccc(O)cc1",LJCWONGJFPCTTL-ZETCQYMHSA-N
SK&F 30310,ANTHELCIDE EQ;FILARIBITS PLUS;NSC-758459;OXIBENDAZOLE;SK&F 30310,CHEMBL1087630,BRD:BRD-BRD-K52075715-001-06-7;BRD:BRD-K52075715-001-06-7,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB;TUBB4B,STRONGYLES,,LAUNCHED,,Small molecule,-1,"CCCOc1ccc2[nH]c(NC(=O)OC)nc2c1;CCCOC1CCC2NC(NC(=O)OC)[NH]C2C1, CCCOC1CCC2NC(NC(=O)OC)[NH]C2C1",RAOCRURYZCVHMG-UHFFFAOYSA-N
OXIZOLE,OXICONAZOLE;OXISTAT;OXIZOLE,CHEMBL1262,BRD:BRD-BRD-K56104152-008-04-1;BRD:BRD-K56104152-008-04-1,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS",,LAUNCHED,,Small molecule,4,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1;CLC1CCC(CO\N=C(/CN2CCNC2)C2CCC(CL)CC2CL)C(CL)C1,QRJJEGAJXVEBNE-HKOYGPOVSA-N
OXINIACIC-ACID,OXINIACIC-ACID,,BRD:BRD-BRD-K20417253-001-01-9;BRD:BRD-K20417253-001-01-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"OC(=O)C1CCC[N+]([O-])C1, OC(=O)C1CCC[N+]([O-])C1",
R-4714,NSC-313681;OXIPEROMIDE;R 4714;R-4714,CHEMBL2059304,BRD:BRD-BRD-K78096648-001-05-7;BRD:BRD-K78096648-001-05-7,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,PHASE 2,,Small molecule,-1,O=c1[nH]c2ccccc2n1C1CCN(CCOc2ccccc2)CC1;OC1NC2CCCCC2N1C1CCN(CCOC2CCCCC2)CC1,NVDBBGBUTKLRSN-UHFFFAOYSA-N
OXIRACETAM,CGP 21690E;CGP-21690E;GNF-PF-1005;OXIRACETAM,CHEMBL36633,BRD:BRD-BRD-K50677762-001-01-5;BRD:BRD-K50677762-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,LAUNCHED,,Small molecule,2,NC(=O)CN1C[C@H](O)CC1=O;NC(=O)CN1CC(O)CC1=O,IHLAQQPQKRMGSS-UHFFFAOYSA-N
OXOLINIC-ACID,OXOLINIC-ACID,,BRD:BRD-BRD-K73394555-237-01-1;BRD:BRD-K73394555-237-01-1,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,,,PRECLINICAL,,,NA,CCN1CC(C(O)=O)C(=O)C2CC3OCOC3CC12,
OXONIC-ACID,OXONIC-ACID,,BRD:BRD-BRD-K31468676-237-01-8;BRD:BRD-K31468676-237-01-8,rep_multi_dose;rep_primary;rep_single_dose,URICASE INHIBITOR,,,,PRECLINICAL,,,NA,"OC(=O)C1NC(=O)[NH]C(=O)[NH]1, OC(=O)C1NC(=O)[NH]C(=O)[NH]1",
OXOTREMORINE-M,OXOTREMORINE-M,,BRD:BRD-BRD-K01942991-005-08-2;BRD:BRD-K01942991-005-08-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4,,,PRECLINICAL,,,NA,"C[N+](C)(C)CC#CCN1CCCC1=O, C[N+](C)(C)CC#CCN1CCCC1=O",
OXPRENOLOL,OXPRENOLOL,CHEMBL546,BRD:BRD-A43671941-003-11-9;BRD:BRD-BRD-A43671941-003-11-9,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,"ANGINA PECTORIS, HYPERTENSION, CARDIAC ARRYTHMIA",,LAUNCHED,,Small molecule,4,C=CCOc1ccccc1OCC(O)CNC(C)C;CC(C)NCC(O)COC1CCCCC1OCC=C,CEMAWMOMDPGJMB-UHFFFAOYSA-N
VIOSORB 110,ADVASTAB 45;BENZOPHENONE-3;NSC-7778;ONGROSTAB HMB;OXYBENZONE;TINOSORB B 3;UVINUL 40;UVINUL M40;VIOSORB 110,CHEMBL1625,BRD:BRD-BRD-K59037100-001-14-7;BRD:BRD-K59037100-001-14-7,rep_primary;rep_single_dose,LIPASE INHIBITOR,LIPE,SUNSCREEN LOTION,,LAUNCHED,,Small molecule,4,COc1ccc(C(=O)c2ccccc2)c(O)c1;COC1CCC(C(=O)C2CCCCC2)C(O)C1,DXGLGDHPHMLXJC-UHFFFAOYSA-N
OXYBUPROCAINE,BENOXINATE;CONJUCAIN;DORSACAIN;MONOFREE OXYBUPROCAINE;OXYBUCAINE;OXYBUPROCAINE,CHEMBL1200,BRD:BRD-BRD-K04185004-003-11-9;BRD:BRD-K04185004-003-11-9,rep_primary;rep_single_dose,LOCAL ANESTHETIC,SCN10A,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,4,"CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N;CCCCOC1CC(CCC1N)C(=O)OCCN(CC)CC, CCCCOC1CC(CCC1N)C(=O)OCCN(CC)CC, CCCCOC1CC(CCC1N)C(=O)OCCN(CC)CC",CMHHMUWAYWTMGS-UHFFFAOYSA-N
URIMIN,(-)-;(-)-OXYBUTYNIN;(R)-;(R)-OXYBUTYNIN;(S)-;ANTUROL;AROXYBUTYNIN;CONTIMIN 2.5;CONTIMIN 5;CYSTRIN;DITROPAN;DITROPAN XL;ESOXYBUTYNIN;KENTERA;LYRINEL XL;OXYBUTYNIN;OXYTROL;OXYTROL FOR WOMEN;PROMICTULINE;R-OXYBUTYNIN;URIMIN,CHEMBL1231;CHEMBL1394756;CHEMBL185434,BRD:BRD-A65013509-003-24-4;BRD:BRD-BRD-A65013509-003-24-4,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3,URINARY INCONTINENCE,,LAUNCHED,,Small molecule,4,"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1;CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1CCCCC1, CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1CCCCC1, CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1CCCCC1",XIQVNETUBQGFHX-UHFFFAOYSA-N
ZANILOX,DIPLIN;ICI 46683;ICI-46683;OXYCLOZANIDE;ZANIL;ZANILOX,CHEMBL2105450,BRD:BRD-BRD-K07283971-001-01-3;BRD:BRD-K07283971-001-01-3,rep_primary;rep_single_dose,,,FASCIOLIASIS,,LAUNCHED,,Small molecule,-1,O=C(Nc1cc(Cl)cc(Cl)c1O)c1c(O)c(Cl)cc(Cl)c1Cl;OC1C(CL)CC(CL)CC1NC(=O)C1C(O)C(CL)CC(CL)C1CL,JYWIYHUXVMAGLG-UHFFFAOYSA-N
OXYFEDRINE HYDROCHLORIDE,(-)-OXYFEDRINE;OXYFEDRINE;OXYFEDRINE HYDROCHLORIDE,CHEMBL1651913,BRD:BRD-BRD-K73027814-003-01-0;BRD:BRD-K73027814-003-01-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,ANGINA PECTORIS,,LAUNCHED,,Small molecule,-1,COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1;COC1CCCC(C1)C(=O)CCN[C@@H](C)[C@H](O)C1CCCCC1,GDYUVHBMFVMBAF-LIRRHRJNSA-N
OXYMATRINE,OXYMATRINE,CHEMBL458337,BRD:BRD-A57833392-001-01-7;BRD:BRD-BRD-A57833392-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,[O-][N+]12CCC[C@@H]3CN4[C@H](CCCC4=O)[C@H](CCC1)[C@@H]23;O=C1CCC[C@@H]2[C@H]3CCC[N+]4([O-])CCC[C@@H](CN12)[C@@H]34,XVPBINOPNYFXID-LHDUFFHYSA-N
OXYMETAZOLINE,NASACON;OCUCLEAR;OPERIL;OXYMETAZOLINE,CHEMBL762,BRD:BRD-BRD-K16195444-003-26-0;BRD:BRD-K16195444-003-26-0,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;HTR1B;HTR1D;HTR2C,NASAL CONGESTION,,LAUNCHED,,Small molecule,4,"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1;CC1CC(C(O)C(C)C1CC1=NCCN1)C(C)(C)C, CC1CC(C(O)C(C)C1CC1=NCCN1)C(C)(C)C, CC1CC(C(O)C(C)C1CC1=NCCN1)C(C)(C)C",WYWIFABBXFUGLM-UHFFFAOYSA-N
OXYPHENCYCLIMINE,OXYPHENCYCLIMINE,CHEMBL1495,BRD:BRD-A58193911-003-18-7;BRD:BRD-BRD-A58193911-003-18-7,rep_multi_dose;rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,4,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1;CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1CCCCC1,DUDKAZCAISNGQN-UHFFFAOYSA-N
VERIPAQUE,ACETALAX;ACETPHENOLISATIN;ISOCRIN;LAVEMA;NSC-117186;NSC-59687;OXYPHENISATIN ACETATE;OXYPHENISATIN DIACETATE;OXYPHENISATINE ACETATE;VERIPAQUE,CHEMBL1402684,GDSC2:1804,gdsc,,,,,,,Small molecule,4,CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)Nc3ccccc32)cc1,PHPUXYRXPHEJDF-UHFFFAOYSA-N
OXYPHENONIUM ION,OXYPHENONIUM;OXYPHENONIUM CATION;OXYPHENONIUM ION,CHEMBL1201286,BRD:BRD-A14208071-004-19-8;BRD:BRD-BRD-A14208071-004-19-8,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRM1;CHRM3,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,"Multiple values for repurposing_target: {'CHRM1;CHRM3', 'CHRM1'}, taking the union",Small molecule,4,CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1;CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1CCCCC1,GFRUPHOKLBPHTQ-UHFFFAOYSA-N
OXYPURINOL,NSC-76239;OXIPURINOL;OXYPURINOL,CHEMBL859,BRD:BRD-BRD-K31841515-001-07-8;BRD:BRD-K31841515-001-07-8,rep_primary;rep_single_dose,XANTHINE OXIDASE INHIBITOR,XDH,,,PHASE 2/PHASE 3,,Small molecule,4,O=C1[NH]C2N[NH]CC2C(=O)[NH]1;Oc1nc(O)c2cn[nH]c2n1,HXNFUBHNUDHIGC-UHFFFAOYSA-N
OXYQUINOLINE,J2.960B;NSC-2039;NSC-285166;NSC-402623;NSC-48037;NSC-54230;NSC-615011;NSC-82404;NSC-82405;NSC-82409;NSC-82410;NSC-82412;OXINE;OXYQUINOL;OXYQUINOLINE,CHEMBL310555,BRD:BRD-BRD-K66808046-065-03-7;BRD:BRD-K66808046-065-03-7,rep_multi_dose;rep_primary;rep_single_dose,CHELATING AGENT,METAP2,COSMETIC,,LAUNCHED,,Small molecule,-1,Oc1cccc2cccnc12;OC1CCCC2CCCNC12,MCJGNVYPOGVAJF-UHFFFAOYSA-N
TTA-121,1-DEAMINOOXYTOCIN;4-L-ASPARAGINE-;A 8999;A-8999;ALPHA-HYPOPHAMINE;ASPARTOCIN;DEAMINO-;DEAMINOOXYTOCIN;DEMOXYTOCIN;DESAMINO-OXYTOCIN;DESAMINOOXYTOCIN;ENDOPITUITRINA;INTERTOCINE S;ODA 914;ODA-914;ORASTHIN;OXYTOCIN;OXYTOCINUM;PITOCIN;SANDOPART;SYNTOCINON;SYNTOMETRINE;TNX-1900;TNX1900;TTA-121,CHEMBL2104384;CHEMBL395429;CHEMBL435716,BRD:BRD-BRD-K25243230-001-01-2;BRD:BRD-K25243230-001-01-2,rep_primary;rep_single_dose,OXYTOCIN RECEPTOR AGONIST,AVPR1A;AVPR1B;AVPR2;OXTR,LABOR INDUCTION,,LAUNCHED,,Protein,4,"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O;CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCC(O)CC2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O, CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCC(O)CC2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O",XNOPRXBHLZRZKH-DSZYJQQASA-N
OZAGREL SODIUM,KCT-0809;OZAGREL;OZAGREL SODIUM,CHEMBL11662,BRD:BRD-BRD-K53061490-003-13-9;BRD:BRD-K53061490-003-13-9,rep_primary;rep_single_dose,THROMBOXANE SYNTHASE INHIBITOR,TBXAS1,STROKE,,LAUNCHED,,Small molecule,3,"O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1;OC(=O)\C=C\C1CCC(CN2CCNC2)CC1, OC(=O)\C=C\C1CCC(CN2CCNC2)CC1, OC(=O)\C=C\C1CCC(CN2CCNC2)CC1",SHZKQBHERIJWAO-AATRIKPKSA-N
RPC1063,OZANIMOD;RPC-1063;RPC1063,CHEMBL3707247,BRD:BRD-BRD-K46625559-001-01-8;BRD:BRD-K46625559-001-01-8,rep_primary;rep_single_dose,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",S1PR1,,,PHASE 3,"Multiple values for MOA: {'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST', 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'}, defaulting to 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'",Small molecule,4,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N;CC(C)OC1CCC(CC1C#N)-C1NC(NO1)-C1CCCC2[C@H](CCC12)NCCO,XRVDGNKRPOAQTN-FQEVSTJZSA-N
XEPI,GF-001001-00;OZENOXACIN;T-3912;XEPI,CHEMBL3990047,BRD:BRD-K00003184-001-01-9,rep_single_dose,ANTIINFECTIVE DRUG,,,,,,Small molecule,4,CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C,XPIJWUTXQAGSLK-UHFFFAOYSA-N
OZOLINONE,GOEDECKE 3282;GOEDECKE 382;GOEDECKE-382;OZOLINONE,CHEMBL3989840,BRD:BRD-A72297358-001-01-8;BRD:BRD-BRD-A72297358-001-01-8,rep_primary;rep_single_dose,DIURETIC,,,,PHASE 3,,Small molecule,-1,CN1C(=O)C(N2CCCCC2)S/C1=C\C(=O)O;CN1C(=O)C(S\C1=C/C(O)=O)N1CCCCC1,NQFBZYYUAFJYNS-FPLPWBNLSA-N
P-22077,P 22077;P-22077,,GDSC2:1933,gdsc,,,,,,,,NA,,
P22077,P22077,,BRD:BRD-BRD-K97714174-001-01-3;BRD:BRD-K97714174-001-01-3;GDSC2:1933,gdsc;rep_multi_dose;rep_primary;rep_single_dose,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,USP7,,,PRECLINICAL,,,NA,"CC(=O)C1CC(C(SC2CCC(F)CC2F)S1)[N+]([O-])=O, CC(=O)C1CC(C(SC2CCC(F)CC2F)S1)[N+]([O-])=O",
RIVICICLIB,P 276-00 FREE BASE;P-276-00 FREE BASE;P276-00;RIVICICLIB,CHEMBL3545283,BRD:BRD-BRD-K51791723-003-01-7;BRD:BRD-K51791723-003-01-7,rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK4;CDK9,,,PHASE 2,,Small molecule,2,CN1CC[C@H]([C@@H]1CO)C1C(O)CC(O)C2C1OC(CC2=O)-C1CCCCC1CL;CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C1CO,QLUYMIVVAYRECT-UHFFFAOYSA-N
P5091,P5091,,BRD:BRD-BRD-K13606314-001-01-3;BRD:BRD-K13606314-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,USP7,,,PRECLINICAL,,,NA,CC(=O)C1CC(C(SC2CCCC(CL)C2CL)S1)[N+]([O-])=O,
P7C3,P7C3,,BRD:BRD-A09487507-001-03-9,rep_single_dose,NAMPT INHIBITOR,NAMPT,,,,,,NA,,
PA-452,PA-452,,BRD:BRD-BRD-K11428250-001-01-0;BRD:BRD-K11428250-001-01-0,rep_primary;rep_single_dose,RETINOID RECEPTOR ANTAGONIST,RXRA,,,PRECLINICAL,,,NA,CCCCCCOC1CC2C(CC1N(C)C1NCC(CN1)C(O)=O)C(C)(C)CCC2(C)C,
PRETOMANID,PA 824;PA-824;PA824;PRETOMANID,CHEMBL227875,BRD:BRD-BRD-K96671969-001-03-1;BRD:BRD-K96671969-001-03-1,rep_primary;rep_single_dose,NITRIC OXIDE DONOR,FASN,,,PHASE 3,,Small molecule,4,[O-][N+](=O)C1CN2C[C@@H](COC2N1)OCC1CCC(OC(F)(F)F)CC1;O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2,ZLHZLMOSPGACSZ-NSHDSACASA-N
PROCASPASE-ACTIVATING COMPOUND 1,PAC-1;PROCASPASE-ACTIVATING COMPOUND 1,CHEMBL591429,BRD:BRD-BRD-K92991072-001-04-9;BRD:BRD-K92991072-001-04-9;CTRP:411832;GDSC1:175,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,CASPASE ACTIVATOR,CASP3,,,PHASE 1,,Small molecule,1,"C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O;OC1C(CC=C)CCCC1\C=N\NC(=O)CN1CCN(CC2CCCCC2)CC1, OC1C(CC=C)CCCC1\C=N\NC(=O)CN1CCN(CC2CCCCC2)CC1, OC1C(CC=C)CCCC1\C=N\NC(=O)CN1CCN(CC2CCCCC2)CC1",YQNRVGJCPCNMKT-LFVJCYFKSA-N
YEWTAXAN,(-)-PACLITAXEL;ABI-007;ABI-007 COMPONENT PACLITAXEL;ABRAXANE;BMS 181339-01;BMS-181339-01;CAPXOL;CYCLOPAX;DHP 107;DHP-107;EBETAXEL;EMPAC;ENDOTAG 1;GENAXOL;GENETAXYL;GENEXOL;GENEXOL-PM;INTAXEL;LEP-ETU;MBT 0206;MBT-0206;MITOTAX;NK 105;NK-105;NSC-125973;ONCOGEL;ONXAL;ONXOL;PACITAXEL;PACLIEX;PACLITAXEL;PACLITAXEL (TAXUS CANADENSIS);PACLITAXOL;PAXENE;PLAXICEL;QW-8184;TAXALBIN;TAXOL;TAXOL 100;TAXOL A;TAXUS;TAXUS LIBERTE;TAXUS STENT;TOCOSOL PACLITAXEL;YEWTAXAN,CHEMBL428647,BRD:BRD-BRD-K62008436-001-22-1;BRD:BRD-K62008436-001-22-1;BRD:BRD-K62008436-001-23-9;BRD:BRD-U00115290-001-01-9;CTRP:26956;GDSC1:11;GDSC2:1080,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF MICROTUBULE ASSEMBLY,BCL2;MAP2;MAP4;MAPT;NR1I2;TLR4;TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8,"OVARIAN CANCER, BREAST CANCER, NON-SMALL CELL LUNG CANCER (NSCLC)",,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF MICROTUBULE ASSEMBLY', 'TUBULIN POLYMERIZATION INHIBITOR'}, defaulting to 'INHIBITOR OF MICROTUBULE ASSEMBLY'
Multiple values for repurposing_target: {'BCL2;MAP2;MAP4;MAPT;NR1I2;TLR4;TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8', 'TUBB'}, taking the union
Multiple values for repurposing_target: {'BCL2;MAP2;MAP4;MAPT;NR1I2;TLR4;TUBB;TUBB1', 'BCL2;MAP2;MAP4;MAPT;NR1I2;TLR4;TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8'}, taking the union
Multiple values for structure_id: {'U00115290', 'K62008436'}, defaulting to None",Small molecule,4,"CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3CCCCC3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1CCCCC1)C1CCCCC1, CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3CCCCC3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1CCCCC1)C1CCCCC1, CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3CCCCC3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1CCCCC1)C1CCCCC1, CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3CCCCC3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1CCCCC1)C1CCCCC1, CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3CCCCC3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1CCCCC1)C1CCCCC1;CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O",RCINICONZNJXQF-MZXODVADSA-N
PACOCF3,PACOCF3,,BRD:BRD-BRD-K05677083-001-05-4;BRD:BRD-K05677083-001-05-4,rep_primary;rep_single_dose,PHOSPHOLIPASE INHIBITOR,PLA2G4A,,,PRECLINICAL,,,NA,CCCCCCCCCCCCCCCC(=O)C(F)(F)F,
SB1518,ONX-0803;PACRITINIB;SB-1518;SB1518,CHEMBL2035187,BRD:BRD-BRD-K19034817-001-01-4;BRD:BRD-K19034817-001-01-4;BRD:BRD-K19034817-001-08-9,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,"FLT3 INHIBITOR, JAK INHIBITOR",FLT3;JAK1;JAK2;JAK3,,,PHASE 3,"Multiple values for MOA: {'FLT3 INHIBITOR, JAK INHIBITOR', 'INHIBITOR OF JAK2 AND FLT3'}, defaulting to 'FLT3 INHIBITOR, JAK INHIBITOR'
Multiple values for repurposing_target: {'FLT3;JAK1;JAK2;JAK3', 'FLT3;JAK2'}, taking the union",Small molecule,4,"C(CN1CCCC1)OC1CCC2NC3NCCC(N3)-C3CCCC(COC\C=C\COCC1C2)C3, C(CN1CCCC1)OC1CCC2NC3NCCC(N3)-C3CCCC(COC\C=C\COCC1C2)C3, C(CN1CCCC1)OC1CCC2NC3NCCC(N3)-C3CCCC(COC\C=C\COCC1C2)C3;C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2",HWXVIOGONBBTBY-ONEGZZNKSA-N
UCB1415943-000,PADSEVONIL;UCB-0942;UCB-1415943-000;UCB0942;UCB1415943-000,CHEMBL4297521,BRD:BRD-K00003493-001-01-9,rep_single_dose,ANTIEPILEPTIC,,,,,,Small molecule,3,COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1,DCXFIOLWWRXEQH-SSDOTTSWSA-N
PEONIFLORIN,NSC-178886;PAEONIFLORIN;PEONIFLORIN,CHEMBL1078549,BRD:BRD-K83631119-001-04-9,rep_single_dose,ANTICONVULSANT,,,,,,Small molecule,3,C[C@@]12C[C@@]3(O)O[C@@H](O1)[C@]1(COC(=O)c4ccccc4)[C@@H]3C[C@]12O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,YKRGDOXKVOZESV-QYDSDWLYSA-N
PAEONOL,PAEONOL,CHEMBL1079227,BRD:BRD-BRD-K94239562-001-05-5;BRD:BRD-K94239562-001-05-5,rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,PRECLINICAL,,Small molecule,NA,COc1ccc(C(C)=O)c(O)c1;COC1CCC(C(C)=O)C(O)C1,UILPJVPSNHJFIK-UHFFFAOYSA-N
PAFURAMIDINE,PAFURAMIDINE,CHEMBL319669,BRD:BRD-BRD-K68805147-001-01-8;BRD:BRD-K68805147-001-01-8,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,,,PHASE 3,,Small molecule,3,CONC(=N)c1ccc(-c2ccc(-c3ccc(C(=N)NOC)cc3)o2)cc1;CONC(=N)C1CCC(CC1)-C1CCC(O1)-C1CCC(CC1)C(=N)NOC,UKOQVLAXCBRRGH-UHFFFAOYSA-N
RP-62955,IP 456;IP-456;PAGOCLONE;RP 62955;RP-62955,CHEMBL2104745,BRD:BRD-K00003428-001-01-9,rep_single_dose,GABA RECEPTOR AGONIST,,,,,,Small molecule,2,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1,HIUPRQPBWVEQJJ-UHFFFAOYSA-N
PD-0332991,IBRANCE;PALBOCICLIB;PD-0332991,CHEMBL189963,BRD:BRD-BRD-K51313569-003-03-3;BRD:BRD-K51313569-001-06-0;BRD:BRD-K51313569-001-07-8;BRD:BRD-K51313569-003-03-3;GDSC1:1054;GDSC2:1054,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF CDK4 AND CDK6,CDK4;CDK6,BREAST CANCER,,LAUNCHED,"Multiple values for MOA: {'CDK INHIBITOR', 'INHIBITOR OF CDK4 AND CDK6'}, defaulting to 'INHIBITOR OF CDK4 AND CDK6'",Small molecule,4,"CC(=O)C1C(C)C2CNC(NC3CCC(CN3)N3CCNCC3)NC2N(C2CCCC2)C1=O, CC(=O)C1C(C)C2CNC(NC3CCC(CN3)N3CCNCC3)NC2N(C2CCCC2)C1=O;CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O",AHJRHEGDXFFMBM-UHFFFAOYSA-N
ZIO-201,"IFOSFAMIDE MUSTARD;IPM;ISOPHOSPHAMIDE MUSTARD;N,N'-BIS-(2-CHLOROETHYL)PHOSPHORIC ACID;NSC-297900;PALIFOSFAMIDE;ZIO-201",CHEMBL889,BRD:BRD-BRD-K12047401-001-01-5;BRD:BRD-K12047401-001-01-5,rep_primary;rep_single_dose,DNA ALKYLATING AGENT,,,,PHASE 3,,Small molecule,3,"O=P(O)(NCCCl)NCCCl;OP(=O)(NCCCL)NCCCL, OP(=O)(NCCCL)NCCCL",BKCJZNIZRWYHBN-UHFFFAOYSA-N
XEPLION,9-HYDROXYRISPERIDONE;9-HYDROXYRISPERIDONE-;INVEGA;NSC-759623;PALIPERIDONE;R-76477;RISPERIDONE IMPURITY;RO-76477;RO76477;TREVICTA;XEPLION,CHEMBL1621,BRD:BRD-A99888680-001-03-8;BRD:BRD-A99888680-001-04-6;BRD:BRD-BRD-A99888680-001-03-8;BRD:BRD-BRD-A99888680-001-04-6,rep_multi_dose;rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA2A;ADRA2B;ADRA2C;CYP2D6;CYP3A4;CYP3A5;DRD1;DRD2;DRD3;DRD4;HRH1;HTR1A;HTR1D;HTR2A;HTR2C,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,"CC1NC2C(O)CCCN2C(=O)C1CCN1CCC(CC1)C1NOC2CC(F)CCC12, CC1NC2C(O)CCCN2C(=O)C1CCN1CCC(CC1)C1NOC2CC(F)CCC12, CC1NC2C(O)CCCN2C(=O)C1CCN1CCC(CC1)C1NOC2CC(F)CCC12;Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O",PMXMIIMHBWHSKN-UHFFFAOYSA-N
PALMATINE-CHLORIDE,PALMATINE-CHLORIDE,,BRD:BRD-BRD-K58466253-003-14-0;BRD:BRD-K58466253-003-14-0,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE SYNTHESIS INHIBITOR,CYP3A4,,,PRECLINICAL,,,NA,COC1CC2CC[N+]3CC4C(OC)C(OC)CCC4CC3-C2CC1OC,
PALMITOLEIC-ACID,PALMITOLEIC-ACID,,BRD:BRD-BRD-K91356052-001-04-0;BRD:BRD-K91356052-001-04-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCCCCC\C=C/CCCCCCCC(O)=O,
PALMITOYLCARNITINE,PALMITOYLCARNITINE,,BRD:BRD-A77577770-003-08-9;BRD:BRD-BRD-A77577770-003-08-9,rep_primary;rep_single_dose,PROTEIN KINASE INHIBITOR,,,,PRECLINICAL,,,NA,CCCCCCCCCCCCCCCC(=O)OC(CC(O)=O)C[N+](C)(C)C,
PALMITOYLETHANOLAMIDE,AM 3112;FSD-201;IMPULSIN;LEVAGEN;LORAMINE P 256;N-(2-HYDROXYETHYL)-PALMITIDE;N(2-HYDROXYETHYL) PALMITIDE;N(2-HYDROXYETHYL)PALMITIDE;NSC-23320;PALMDROL PRODES;PALMIDROL;PALMITAMIDE MEA;PALMITIC ACID MONOETHANOLAMIDE;PALMITIC MONOETHANOLAMIDE;PALMITOYL ETHANOLAMIDE;PALMITOYLETHANOLAMIDE,CHEMBL417675,BRD:BRD-BRD-K68095457-001-10-1;BRD:BRD-K68095457-001-10-1,rep_multi_dose;rep_primary;rep_single_dose,CANNABINOID RECEPTOR AGONIST,CNR2;GPR119;GPR55,,,LAUNCHED,,Small molecule,3,"CCCCCCCCCCCCCCCC(=O)NCCO;CCCCCCCCCCCCCCCC(=O)NCCO, CCCCCCCCCCCCCCCC(=O)NCCO",HXYVTAGFYLMHSO-UHFFFAOYSA-N
PALMOSTATIN B,PALMOSTATIN B,CHEMBL1673415,CTRP:679844,ctrp,,,,,,,Small molecule,NA,CCCCCCCCCC[C@@H]1C(=O)O[C@H]1CCc1ccc(OC)c(OC)c1,ASVWFAVGLYUDFD-PMACEKPBSA-N
SG-00529,P-529;P529;PALOMID 529;PALOMID-529;SG 00529;SG-00529,CHEMBL2141712,BRD:BRD-A50998626-001-02-1;BRD:BRD-BRD-A50998626-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,"AKT INHIBITOR, MTOR INHIBITOR",MTOR,,,PHASE 1,,Small molecule,1,COc1ccc(COc2cc3oc(=O)c4cc(C(C)O)ccc4c3cc2OC)cc1;COC1CCC(COC2CC3OC(=O)C4CC(CCC4C3CC2OC)C(C)O)CC1,YEAHTLOYHVWAKW-UHFFFAOYSA-N
PALONOSETRON,(-)-PALONOSETRON;(3AS;3S)-;AUROTHIOGLUCOSE;NSC-743769;PALONOSETRON,CHEMBL1189679,BRD:BRD-BRD-K08924299-003-06-1;BRD:BRD-K08924299-003-06-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A,"NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2;O=C1N(C[C@H]2CCCC3CCCC1C23)[C@@H]1CN2CCC1CC2,CPZBLNMUGSZIPR-NVXWUHKLSA-N
PALOSURAN,ACT-058362;PALOSURAN,CHEMBL567303,BRD:BRD-BRD-K07682953-001-01-8;BRD:BRD-K07682953-001-01-8,rep_primary;rep_single_dose,UROTENSIN RECEPTOR ANTAGONIST,UTS2R,,,PHASE 2,,Small molecule,2,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1;CC1CC(NC(=O)NCCN2CCC(O)(CC3CCCCC3)CC2)C2CCCCC2N1,WYJCYXOCHXWTHG-UHFFFAOYSA-N
SOHONOS,CLM-001;IPN-60120;IPN60120;PALOVAROTENE;R-667;RG-667;RO-3300074;RO3300074;SOHONOS,CHEMBL2105648,BRD:BRD-BRD-K83794243-001-01-8;BRD:BRD-K83794243-001-01-8,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARG,,,PHASE 2,,Small molecule,3,CC1(C)CCC(C)(C)C2CC(\C=C\C3CCC(CC3)C(O)=O)C(CN3CCCN3)CC12;CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21,YTFHCXIPDIHOIA-DHZHZOJOSA-N
PAMABROM,PAMABROM,CHEMBL2104825;CHEMBL316160,BRD:BRD-M67659203-001-02-7,rep_single_dose,DIURETIC,,,,,,Small molecule,-1,CC(C)(N)CO.Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O;Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O,ATOTUUBRFJHZQG-UHFFFAOYSA-N;SKTFQHRVFFOHTQ-UHFFFAOYSA-N
PAMICOGREL,PAMICOGREL,CHEMBL2104947,BRD:BRD-K00075290-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,CCOC(=O)Cn1cccc1-c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1,ISCHOARKJADAKJ-UHFFFAOYSA-N
RIBODROAT,CGP-23339AE;PAMIDRONATE;PAMIDRONIC ACID;RIBODROAT,CHEMBL834,BRD:BRD-BRD-K58513245-304-02-7;BRD:BRD-K58513245-304-02-7,rep_primary;rep_single_dose,BONE RESORPTION INHIBITOR,FDPS,"HYPERCALCEMIA, PAGET'S DISEASE, BREAST CANCER, MULTIPLE MYELOMA",,LAUNCHED,,Small molecule,4,"NCCC(O)(P(=O)(O)O)P(=O)(O)O;NCCC(O)(P(O)(O)=O)P(O)(O)=O, NCCC(O)(P(O)(O)=O)P(O)(O)=O",WRUUGTRCQOWXEG-UHFFFAOYSA-N
PAMIPARIB,BGB-290;PAMIPARIB,CHEMBL4112930,BRD:BRD-K00003461-001-01-9,rep_single_dose,PARP INHIBITOR,,,,,,Small molecule,3,C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34,DENYZIUJOTUUNY-MRXNPFEDSA-N
PAVULON,PANCURONIUM;PAVULON,CHEMBL185073,BRD:BRD-BRD-K50817623-303-05-7;BRD:BRD-K50817623-303-05-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM2;CHRM3;CHRNA1;CHRNA2,"ENDOTRACHEAL INTUBATION, MUSCLE RELAXANT",,LAUNCHED,,Small molecule,4,"CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1, CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1;CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1",GVEAYVLWDAFXET-XGHATYIMSA-N
PANDACOSTAT,PANDACOSTAT,,CTRP:417098,ctrp,,,,,,,,NA,,
RS-533,CS-533;PANIPENEM;RS-533,CHEMBL339323,BRD:BRD-K00004671-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,-1,CC(=N)N1CC[C@H](SC2=C(C(=O)O)N3C(=O)[C@H]([C@@H](C)O)[C@H]3C2)C1,TYMABNNERDVXID-DLYFRVTGSA-N
PANOBINOSTAT HYDRATE,FARYDAK;LBH-589;LBH589;PANOBINOSTAT;PANOBINOSTAT HYDRATE,CHEMBL483254,BRD:BRD-BRD-K02130563-001-11-4;BRD:BRD-K02130563-001-11-4;GDSC1:438,gdsc;rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC4;HDAC6;HDAC7;HDAC8;HDAC9,MULTIPLE MYELOMA,,LAUNCHED,,Small molecule,4,"Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1;CC1[NH]C2CCCCC2C1CCNCC1CCC(\C=C\C(=O)NO)CC1, CC1[NH]C2CCCCC2C1CCNCC1CCC(\C=C\C(=O)NO)CC1, CC1[NH]C2CCCCC2C1CCNCC1CCC(\C=C\C(=O)NO)CC1, CC1[NH]C2CCCCC2C1CCNCC1CCC(\C=C\C(=O)NO)CC1",FPOHNWQLNRZRFC-ZHACJKMWSA-N
PANTETHINE,D-PANTETHINE;NSC-759269;PANTETHINE,CHEMBL2104786,BRD:BRD-BRD-K68764924-001-03-2;BRD:BRD-K68764924-001-03-2,rep_primary;rep_single_dose,COENZYME A PRECURSOR,,,,LAUNCHED,,Small molecule,3,"CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO;CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO, CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO, CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO, CC(C)(CO)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO",DJWYOLJPSHDSAL-ROUUACIJSA-N
ZOVANTA,ALTOPAN;BY 1023;BY-1023;NSC-759257;PANTOCID;PANTOLOC;PANTOLOC CONTROL;PANTOPRAZOLE;PANTOZOL;PROTIUM;PROTIUM I.V.;PROTONIX;SK-96022;SK&F 96022;SK&F-96022;SKF-96022;ZOVANTA,CHEMBL1502,BRD:BRD-A22380646-236-05-8;BRD:BRD-BRD-A22380646-236-05-8;BRD:BRD-K00003243-236-01-9,rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP4A,"GASTROESOPHAGEAL REFLUX DISEASE (GERD), EROSIVE ESOPHAGITIS (EE), ZOLLINGER-ELLISON SYNDROME",,LAUNCHED,"Multiple values for structure_id: {'K00003243', 'A22380646'}, defaulting to None",Small molecule,4,"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC;COC1CCNC(CS(=O)C2NC3CC(OC(F)F)CCC3[NH]2)C1OC, COC1CCNC(CS(=O)C2NC3CC(OC(F)F)CCC3[NH]2)C1OC, COC1CCNC(CS(=O)C2NC3CC(OC(F)F)CCC3[NH]2)C1OC",IQPSEEYGBUAQFF-UHFFFAOYSA-N
PANTOTHENIC-ACID,PANTOTHENIC-ACID,,BRD:BRD-BRD-K29392254-001-02-2;BRD:BRD-K29392254-001-02-2,rep_primary;rep_single_dose,COENZYME A PRECURSOR,,,,LAUNCHED,,,NA,"CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O, CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O, CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O",
PAOPA,PAOPA,,BRD:BRD-K18573821-001-03-9,rep_single_dose,DOPAMINE RECEPTOR MODULATOR,DRD2,,,,,,NA,,
PAPAVERINUM,NSC-136630;PAPAVERINE;PAPAVERINUM,CHEMBL19224,BRD:BRD-BRD-K15567136-003-27-2;BRD:BRD-K15567136-003-27-2,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE10A;PDE4B;PDE5A,"MYOCARDIAL INFARCTION, ANGINA PECTORIS, PULMONARY EMBOLISM (PE), COLITIS, VASCULAR SPASM",,LAUNCHED,,Small molecule,4,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC;COC1CCC(CC2NCCC3CC(OC)C(OC)CC23)CC1OC,XQYZDYMELSJDRZ-UHFFFAOYSA-N
PAQUINIMOD,ABR-215757;PAQUINIMOD,CHEMBL67776,BRD:BRD-K00003371-001-01-9,rep_single_dose,S100A9 INHIBITOR,,,,,,Small molecule,2,CCc1cccc2c1c(O)c(C(=O)N(CC)c1ccccc1)c(=O)n2C,DIKSYHCCYVYKRO-UHFFFAOYSA-N
TOLUENESULFONAMIDE,NSC-9908;P-;P-METHYLBENZENESULFONAMIDE;P-TOLUENESULFONAMIDE;P-TOLUENESULFONYLAMIDE;P-TOSYLAMIDE;PARA-TOLUENESULFONAMIDE;PARATOULENE SULFONAMIDE;TOLUENESULFONAMIDE,CHEMBL574,BRD:BRD-BRD-K62412084-001-07-1;BRD:BRD-K62412084-001-07-1,rep_primary;rep_single_dose,,CA12;CA2;CA6;CA9,,,PHASE 3,,Small molecule,3,CC1CCC(CC1)S(N)(=O)=O;Cc1ccc(S(N)(=O)=O)cc1,LMYRWZFENFIFIT-UHFFFAOYSA-N
VERMIDON,ABDINE;ACEPHEN;ACETAMINOPHEN;ALVEDON;ANGIERS;APAP;BIOCETAMOL;CALPOL;CALPOL SIX PLUS;CALPOL SIX PLUS FASTMELTS;CHILD LEMSIP;CUPANOL;DAFALGAN;DATRIL;DISPROL;DISPROL INFANT;DISPROL JNR;DISPROL PAED;DOLIPRANE;EFFERALGAN;FENNINGS;GALPAMOL;HEDEX;INFADROPS;INFANTS' FEVERALL;INJECTAPAP;JUNIOR PARAPAED;MANDANOL;MEDINOL;MEDINOL FOR CHILDREN;MEDINOL OVER 6;MEDINOL UNDER 6;MEDISED PLAIN;MIRADOL;N-ACETYL-P-AMINOPHENOL;NEOPAP;NSC-109028;NSC-3991;OFIRMEV;P-HYDROXY-ACETANILID;PALDESIC;PANADOL;PANADOL ACTIFAST;PANADOL ACTIFAST SOLB;PANADOL ADVAN;PANADOL JNR;PANADOL OA;PANALEVE;PANALEVE 6 PLUS;PARACETAMOL;PARACETAMOLUM;PARAMIN;PARAPAED JNR;PARAPAED SIX PLUS;PARAVICT;PERFALGAN;PHENAPHEN;PLACIDEX;RIMADOL;SALZONE;TIXYMOL;TRAMIL 500;TYLENOL;VERMIDON,CHEMBL112,BRD:BRD-BRD-K41524689-001-23-5;BRD:BRD-K41524689-001-23-5,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,FAAH;PTGS1;PTGS2;TRPV1,"PAIN RELIEF, FEVER",,LAUNCHED,,Small molecule,4,"CC(=O)Nc1ccc(O)cc1;CC(=O)NC1CCC(O)CC1, CC(=O)NC1CCC(O)CC1, CC(=O)NC1CCC(O)CC1",RZVAJINKPMORJF-UHFFFAOYSA-N
PARACHLOROPHENOL,PARACHLOROPHENOL,CHEMBL57053,BRD:BRD-BRD-K40992116-001-09-7;BRD:BRD-K40992116-001-09-7,rep_multi_dose;rep_primary;rep_single_dose,ANTIINFECTIVE DRUG,,,,LAUNCHED,,Small molecule,-1,Oc1ccc(Cl)cc1;OC1CCC(CL)CC1,WXNZTHHGJRFXKQ-UHFFFAOYSA-N
PARAXANTHINE(72%),NSC-400018;PARAXANTHINE;PARAXANTHINE(72%),CHEMBL1158,BRD:BRD-BRD-K24084088-001-11-3;BRD:BRD-K24084088-001-11-3,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,,,,PHASE 1,,Small molecule,0.5,Cn1c(=O)[nH]c2ncn(C)c2c1=O;CN1CNC2[NH]C(=O)N(C)C(=O)C12,QUNWUDVFRNGTCO-UHFFFAOYSA-N
TCMDC-131798,NSC-256420;PARBENDAZOLE;SK&F 29044;TCMDC-131798,CHEMBL528271,BRD:BRD-BRD-K02407574-001-09-7;BRD:BRD-K02407574-001-09-7;CTRP:28172,ctrp;rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB,,,PRECLINICAL,,Small molecule,-1,CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1;CCCCC1CCC2[NH]C(NC(=O)OC)NC2C1,YRWLZFXJFBZBEY-UHFFFAOYSA-N
PARCETASAL,MR-897;PARCETASAL,CHEMBL2105451,BRD:BRD-K00004740-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,-1,CC(=O)Nc1ccc(OC2(C)OC(=O)c3ccccc3O2)cc1,ZAPRLADYRFPQSH-UHFFFAOYSA-N
SLV308,DU 126891;DU-126891;PARDOPRUNOX;SLV 308;SLV-308;SLV308,CHEMBL2103832,BRD:BRD-BRD-K11851476-003-01-7;BRD:BRD-K11851476-003-01-7,rep_multi_dose;rep_primary;rep_single_dose,"SEROTONIN RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST",DRD2;DRD3;DRD4;HTR1A;HTR7,,,PHASE 3,"Multiple values for MOA: {'DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST', 'SEROTONIN RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST'}, defaulting to 'SEROTONIN RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST'",Small molecule,3,CN1CCN(c2cccc3[nH]c(=O)oc23)CC1;CN1CCN(CC1)C1CCCC2[NH]C(=O)OC12,YVPUUUDAZYFFQT-UHFFFAOYSA-N
XAPIT,PARECOXIB;RAYZON;SC-69124;XAPIT,CHEMBL1206690,BRD:BRD-BRD-K13800121-001-01-5;BRD:BRD-K13800121-001-01-5,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,LTF,PAIN RELIEF,,LAUNCHED,,Small molecule,4,CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1;CCC(=O)NS(=O)(=O)C1CCC(CC1)-C1C(C)ONC1-C1CCCCC1,TZRHLKRLEZJVIJ-UHFFFAOYSA-N
PARETHOXYCAINE,PARETHOXYCAINE,CHEMBL421669,BRD:BRD-K54799382-003-08-4,rep_single_dose,LOCAL ANESTHETIC,,,,,,Small molecule,-1,CCOc1ccc(C(=O)OCCN(CC)CC)cc1,OWWVHQUOYSPNNE-UHFFFAOYSA-N
PARGYLINE,EUTONYL;EUTRON;PARGYLINE,CHEMBL673,BRD:BRD-BRD-K83597974-003-22-2;BRD:BRD-K83597974-003-22-2,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,HYPERTENSION,,LAUNCHED,,Small molecule,4,C#CCN(C)Cc1ccccc1;CN(CC#C)CC1CCCCC1,DPWPWRLQFGFJFI-UHFFFAOYSA-N
ZEMPLAR,COMPOUND 49510;COMPOUND-49510;PARICALCITOL;ZEMPLAR,CHEMBL1200622,BRD:BRD-BRD-K60585088-001-01-5;BRD:BRD-K60585088-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,"CHRONIC KIDNEY DISEASE (CKD), HYPERTHYROIDISM",,LAUNCHED,,Small molecule,4,C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@]12C;C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1C[C@@H](O)C[C@H](O)C1,BPKAHTKRCLCHEA-UBFJEZKGSA-N
VERUPREVIR ANHYDROUS,ABT-450;PARITAPREVIR;VERUPREVIR;VERUPREVIR ANHYDROUS,CHEMBL3391662,BRD:BRD-BRD-K89920762-001-01-4;BRD:BRD-K89920762-001-01-4,rep_primary;rep_single_dose,HCV INHIBITOR,,HEPATITIS C,,LAUNCHED,,Small molecule,4,Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1;CC1CNC(CN1)C(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC1NC2CCCCC2C2CCCCC12)C(=O)NS(=O)(=O)C1CC1,UAUIUKWPKRJZJV-QPLHLKROSA-N
R-400,AMINOSIDIN;AMINOSIDINE;ANTIBIOTIC 503-3;ANTIBIOTIC SF 767B;ANTIBIOTIC SF-767B;CATENULIN;CRESTOMYCIN;ESTOMYCIN;GABROMYCIN;HYDROXYMYCIN;MONOMYCIN;MONOMYCIN A;NEOMYCIN E;PAROMOMYCIN;PAROMOMYCIN I;PAUCIMYCIN;QUINTOMYCIN C;R 400;R-400,CHEMBL370143,BRD:BRD-BRD-K36524108-065-04-0;BRD:BRD-K36524108-065-04-0,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,AMEBIASIS,,LAUNCHED,,Small molecule,4,"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O;NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O",UOZODPSAJZTQNH-LSWIJEOBSA-N
XETANOR,"(-)3S,4R-PAROXETINE;ARKETIS;AROTIN;BESITRAM;BRL 29060;BRL-29060;CASBOL;DAPAROX;FG-7051;FROSINOR;MOTIVAN;PAROGEN;PAROXETINE;PAXIL;PAXIL [AS HYDROCHLORIDE];PAXPAR;PEXEVA;XETANOR",CHEMBL490,BRD:BRD-BRD-K37991163-003-13-4;BRD:BRD-K37991163-003-13-4,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;HTR2A;SLC6A2;SLC6A4,"DEPRESSION, OBSESSIVE COMPULSIVE DISORDER (OCD), GENERALIZED ANXIETY DISORDER (GAD), PANIC DISORDERS, POSTTRAUMATIC STRESS DISORDER, SOCIAL ANXIETY DISORDER",,LAUNCHED,,Small molecule,4,"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1;FC1CCC(CC1)[C@@H]1CCNC[C@H]1COC1CCC2OCOC2C1, FC1CCC(CC1)[C@@H]1CCNC[C@H]1COC1CCC2OCOC2C1, FC1CCC(CC1)[C@@H]1CCNC[C@H]1COC1CCC2OCOC2C1",AHOUBRCZNHFOSL-YOEHRIQHSA-N
PAROXYPROPIONE,B-360;H 365;H-365;NSC-2834;P-HYDROXYPROPIOPHENONE;PAROXYPROPIONE,CHEMBL312311,BRD:BRD-BRD-K07441213-001-18-9;BRD:BRD-K07441213-001-18-9,rep_primary;rep_single_dose,GONADOTROPIN INHIBITOR,,,,LAUNCHED,,Small molecule,-1,CCC(=O)c1ccc(O)cc1;CCC(=O)C1CCC(O)CC1,RARSHUDCJQSEFJ-UHFFFAOYSA-N
PARSACLISIB,INCB-050465;INCB050465;PARSACLISIB,CHEMBL4297615,BRD:BRD-K00004594-001-01-9,rep_single_dose,PI3K INHIBITOR,,,,,,Small molecule,3,CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1,ZQPDJCIXJHUERQ-QWRGUYRKSA-N
PARTHENOLIDE,NSC-157035;PARTHENOLIDE,CHEMBL540445,BRD:BRD-BRD-K98548675-001-05-9;BRD:BRD-K98548675-001-05-9;CTRP:411792;GDSC1:89,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,,,,PHASE 1,,Small molecule,2,"C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1, C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1;C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21",KTEXNACQROZXEV-SLXBATTESA-N
PARTHENOLIDE-(-),PARTHENOLIDE-(-),,BRD:BRD-BRD-K34851558-001-02-3;BRD:BRD-K34851558-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,HDAC1,,,PRECLINICAL,,,NA,C\C1=C\CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,
PARTHENOLIDE-(ALTERNATE-STEREO),PARTHENOLIDE-(ALTERNATE-STEREO),,BRD:BRD-BRD-K28120222-001-08-4;BRD:BRD-K28120222-001-08-4,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,IKBKB;RELA,,,PRECLINICAL,,,NA,C\C1=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,
PASINIAZID,PASINIAZID,,BRD:BRD-BRD-K87202646-061-04-9,rep_primary,CYCLOOXYGENASE INHIBITOR,,TUBERCULOSIS,,LAUNCHED,,,NA,"NNC(=O)C1CCNCC1, NNC(=O)C1CCNCC1",
SOM230,PASIREOTIDE;SIGNIFOR;SOM 230;SOM-230;SOM230,CHEMBL3039583,BRD:BRD-BRD-K59715032-362-01-4;BRD:BRD-K59715032-362-01-4,rep_primary;rep_single_dose,SOMATOSTATIN RECEPTOR AGONIST,SSTR1;SSTR2;SSTR3;SSTR5,"CUSHING'S SYNDROME, ACROMEGALY",,LAUNCHED,,Protein,4,NCCCC[C@@H]1NC(=O)[C@@H](CC2C[NH]C3CCCCC23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2CCCCC2)NC(=O)[C@H](CC2CCC(OCC3CCCCC3)CC2)NC1=O)OC(=O)NCCN)C1CCCCC1;NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O,VMZMNAABQBOLAK-IXZCVAHUSA-N
PAT-1251,PAT-1251,CHEMBL4116649,BRD:BRD-K00003481-001-01-9,rep_single_dose,LYSYL OXIDASE INHIBITOR,,,,,,Small molecule,2,NCc1cc(Oc2cccc(C(=O)N3C[C@@H](O)[C@H](F)C3)c2)nc(C(F)(F)F)c1,ODGXXYXJORZPHE-ZIAGYGMSSA-N
PATUPILONE,(-)-EPOTHILONE B;EPITHILONE B;EPO 906;EPO 906A;EPO B;EPO-906;EPO-906A;EPO906;EPOB;EPOTHILONE B;GNF-PF-193;PATUPILONE,CHEMBL94657,GDSC1:201,gdsc,,,,,,,Small molecule,3,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,QXRSDHAAWVKZLJ-PVYNADRNSA-N
PAVINETANT,AZ-12472520;AZ12472520;AZ124752520;AZ4901;AZD 2624;AZD 4901;AZD-2624;AZD-4901;AZD2624;AZD4901;MLE-4901;MLE4901;PAVINETANT,CHEMBL3545233,BRD:BRD-K00003170-001-01-9,rep_single_dose,NEUROKININ RECEPTOR ANTAGONIST,,,,,,Small molecule,2,CC[C@H](NC(=O)c1c(NS(C)(=O)=O)c(-c2ccccc2)nc2ccccc12)c1ccccc1,QYTBBBAHNIWFOD-NRFANRHFSA-N
VOTRIENT,GW786034;NSC-752782;PAZOPANIB;VOTRIENT,CHEMBL477772,BRD:BRD-BRD-K74514084-001-03-9;BRD:BRD-K74514084-001-03-9;BRD:BRD-K74514084-003-09-2;CTRP:640265;GDSC1:199,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",CSF1R;FGF1;FGFR1;FGFR3;FLT1;FLT4;ITK;KDR;KIT;PDGFRA;PDGFRB;SH2B3,"RENAL CELL CARCINOMA (RCC), SOFT TISSUE SARCOMA (STS)",,LAUNCHED,,Small molecule,4,"Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O;CN(C1CCC2C(C)N(C)NC2C1)C1CCNC(NC2CCC(C)C(C2)S(N)(=O)=O)N1, CN(C1CCC2C(C)N(C)NC2C1)C1CCNC(NC2CCC(C)C(C2)S(N)(=O)=O)N1",CUIHSIWYWATEQL-UHFFFAOYSA-N
T-3761,PAZUFLOXACIN;T-3761,CHEMBL240163,BRD:BRD-BRD-K66412701-066-01-6;BRD:BRD-K66412701-066-01-6,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,,"PNEUMONIA, PERITONITIS, BACTERIAL SEPTICEMIA",,LAUNCHED,,Small molecule,3,C[C@H]1COC2C(C(F)CC3C2N1CC(C(O)=O)C3=O)C1(N)CC1;C[C@H]1COc2c(C3(N)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,XAGMUUZPGZWTRP-ZETCQYMHSA-N
SETOGEPRAM,FEZAGEPRAS;PBI-4050;SETOGEPRAM,CHEMBL4297635,BRD:BRD-K00003391-236-01-9,rep_single_dose,FREE FATTY ACID RECEPTOR AGONIST,,,,,,Small molecule,2,CCCCCc1cccc(CC(=O)O)c1,PEGQOIGYZLJMIB-UHFFFAOYSA-N
PBT-1033,PBT-1033,,BRD:BRD-K00004615-001-01-9,rep_single_dose,CHELATING AGENT,,,,,,,NA,,
PCA-4248,PCA-4248,,BRD:BRD-A29289453-001-04-7;BRD:BRD-BRD-A29289453-001-04-7,rep_primary;rep_single_dose,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,PTAFR,,,PHASE 1,,,NA,"COC(=O)C1=C(C)NC(C)=C(C1C)C(=O)OCCSC1CCCCC1, COC(=O)C1=C(C)NC(C)=C(C1C)C(=O)OCCSC1CCCCC1",
S78454,ABEXINOSTAT;CRA 024781;CRA 24781;CRA-024781;PCI 24781;PCI-24781;PZP-115891;PZP115891;S-78454;S78454,CHEMBL2103863,BRD:BRD-BRD-K12867552-001-04-7;BRD:BRD-K12867552-001-04-7,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC6,,,PHASE 1/PHASE 2,,Small molecule,3,CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12;CN(C)CC1C(OC2CCCCC12)C(=O)NCCOC1CCC(CC1)C(=O)NO,MAUCONCHVWBMHK-UHFFFAOYSA-N
PCI-27483,CRA-027483;PCI-27483,CHEMBL4297315,BRD:BRD-K00003213-001-01-9,rep_single_dose,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,,,,,,Small molecule,2,N=C(N)c1ccc2nc(-c3cc(CC(=O)N[C@@H](CC(=O)O)C(=O)O)cc(-c4cc(S(N)(=O)=O)ccc4O)c3O)[nH]c2c1,WDJHHCAKBRKCLW-IBGZPJMESA-N
PCI-29732,PCI-29732,,BRD:BRD-K71223042-001-03-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BTK,,,,,,NA,,
PCI-32765-00,CRA-032765;IBRUTINIB;IMBRUVICA;PC-32765;PCI 32765;PCI-32765;PCI-32765-00,CHEMBL1873475,GDSC2:1799,gdsc,,,,,,,Small molecule,4,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,XYFPWWZEPKGCCK-GOSISDBHSA-N
PCI-34051,PCI-34051,,BRD:BRD-BRD-K88742110-001-07-9;BRD:BRD-K88742110-001-07-9;GDSC2:1621,gdsc;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC10;HDAC6;HDAC8,,,PRECLINICAL,,,NA,"COC1CCC(CN2CCC3CCC(CC23)C(=O)NO)CC1, COC1CCC(CN2CCC3CCC(CC23)C(=O)NO)CC1, COC1CCC(CN2CCC3CCC(CC23)C(=O)NO)CC1",
PCO-400,PCO-400,,BRD:BRD-K52721684-001-04-8,rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNJ8,,,,,,NA,,
PCO371,PC-0371;PCO-371;PCO371,CHEMBL3976807,BRD:BRD-K00079290-001-02-9,rep_single_dose,,,,,,,Small molecule,1,Cc1cc(N2C(=O)NC(=O)C2(C)C)cc(C)c1CCS(=O)(=O)N1CCC2(CC1)N=C(c1ccc(OC(F)(F)F)cc1)NC2=O,LDZJFVOUPUFOHX-UHFFFAOYSA-N
PD 153035,PD 153035,,CTRP:52133,ctrp,,,,,,,,NA,,
PD-0325901,MIRDAMETINIB;PD 0325901;PD 03525901;PD 901;PD-0325901,CHEMBL507361,BRD:BRD-BRD-K49865102-001-08-4;BRD:BRD-K49865102-001-08-4;GDSC1:1060;GDSC2:1060,gdsc;rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1,,,PHASE 2,,Small molecule,2,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F;OC[C@@H](O)CONC(=O)C1CCC(F)C(F)C1NC1CCC(I)CC1F,SUDAHWBOROXANE-SECBINFHSA-N
PD-102807,PD-102807,,BRD:BRD-A89337244-001-02-9;BRD:BRD-BRD-A89337244-001-02-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM4,,,PRECLINICAL,,,NA,"CCOC(=O)C1C(C)[NH]C2CCC3OC4N(CCC5CC(OC)CCC45)CC3C12, CCOC(=O)C1C(C)[NH]C2CCC3OC4N(CCC5CC(OC)CCC45)CC3C12",
PD-118057,PD-118057,,BRD:BRD-K34657753-001-01-9,rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNH2,,,,,,NA,,
PD-123319,PD-123319,,BRD:BRD-BRD-K34713073-001-01-3;BRD:BRD-K34713073-001-01-3,rep_primary;rep_single_dose,ANGIOTENSIN ANTAGONIST,AGTR2,,,PHASE 1,,,NA,"CN(C)C1CCC(CN2CNC3CN([C@@H](CC23)C(O)=O)C(=O)C(C2CCCCC2)C2CCCCC2)CC1C, CN(C)C1CCC(CN2CNC3CN([C@@H](CC23)C(O)=O)C(=O)C(C2CCCCC2)C2CCCCC2)CC1C",
PD-128907,PD-128907,,BRD:BRD-BRD-K38797369-003-01-1;BRD:BRD-BRD-K62456038-003-07-1;BRD:BRD-K38797369-003-01-1;BRD:BRD-K62456038-003-07-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD2;DRD3,,,PRECLINICAL,"Multiple values for structure_id: {'K62456038', 'K38797369'}, defaulting to None",,NA,"CCCN1CCO[C@H]2[C@@H]1COC1CCC(O)CC21, CCCN1CCO[C@@H]2[C@@H]1COC1CCC(O)CC21, CCCN1CCO[C@H]2[C@H]1COC1CCC(O)CC21",
PD-153035,PD-153035,,BRD:BRD-BRD-K26603252-003-04-9;BRD:BRD-K26603252-003-04-9,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;KDR,,,PHASE 1,,,NA,COC1CC2NCNC(NC3CCCC(BR)C3)C2CC1OC,
PD-160170,PD-160170,,BRD:BRD-BRD-K12079898-001-02-6;BRD:BRD-K12079898-001-02-6,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPY1R,,,PRECLINICAL,,,NA,"CC(C)C1CCCCC1S(=O)(=O)C1CC(N)C2NCCCC2C1[N+]([O-])=O, CC(C)C1CCCCC1S(=O)(=O)C1CC(N)C2NCCCC2C1[N+]([O-])=O",
PD-161570,PD-161570,,BRD:BRD-K97152684-001-03-9,rep_single_dose,FGFR INHIBITOR,FGFR1,,,,,,NA,,
PD-166285,PD-166285,,BRD:BRD-K93217218-300-03-9,rep_single_dose,SRC INHIBITOR,EGFR;FGFR1;PDGFRB;PKMYT1;SRC;WEE1,,,,,,NA,,
PD-166793,PD-166793,,BRD:BRD-BRD-K60984070-001-01-0;BRD:BRD-K60984070-001-01-0,rep_primary;rep_single_dose,"COLLAGENASE INHIBITOR, METALLOPROTEINASE INHIBITOR",MMP13;MMP2;MMP3,,,PRECLINICAL,,,NA,"CC(C)[C@H](NS(=O)(=O)C1CCC(CC1)-C1CCC(BR)CC1)C(O)=O, CC(C)[C@H](NS(=O)(=O)C1CCC(CC1)-C1CCC(BR)CC1)C(O)=O",
PD-168393,PD-168393,,BRD:BRD-BRD-K17702546-001-03-2;BRD:BRD-K17702546-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2;SRC,,,PRECLINICAL,,,NA,BRC1CCCC(NC2NCNC3CCC(NC(=O)C=C)CC23)C1,
PD-168568,PD-168568,,BRD:BRD-A82013137-300-01-1;BRD:BRD-BRD-A82013137-300-01-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD4,,,PRECLINICAL,,,NA,CC1CCC(CC1C)N1CCN(CCC2NC(=O)C3CCCCC23)CC1,
PD-173074,PD-173074,CHEMBL189584,BRD:BRD-BRD-K97764662-001-17-3;BRD:BRD-K97764662-001-17-3;GDSC1:1049;GDSC2:1049,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"FGFR INHIBITOR, VEGFR INHIBITOR",FGFR1;FGFR2;FGFR3;FGFR4;FLT1;FLT4;KDR;PDGFRA;PDGFRB,,,PRECLINICAL,,Small molecule,NA,"CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1;CCN(CC)CCCCNC1NCC2CC(-C3CC(OC)CC(OC)C3)C(NC(=O)NC(C)(C)C)NC2N1, CCN(CC)CCCCNC1NCC2CC(-C3CC(OC)CC(OC)C3)C(NC(=O)NC(C)(C)C)NC2N1, CCN(CC)CCCCNC1NCC2CC(-C3CC(OC)CC(OC)C3)C(NC(=O)NC(C)(C)C)NC2N1",DXCUKNQANPLTEJ-UHFFFAOYSA-N
PD-173212,PD-173212,,BRD:BRD-K04426574-001-03-9,rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1B,,,,,,NA,,
PD-184352,212631-79-3;CI 1040;CI-1040;PD-18435;PD-184352,CHEMBL105442,GDSC1:1015,gdsc,,,,,,,Small molecule,2,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,GFMMXOIFOQCCGU-UHFFFAOYSA-N
PD-184352,CI 1040;CI-1040;PD-18435;PD-184352,CHEMBL105442,BRD:BRD-BRD-K05104363-001-10-0;BRD:BRD-K05104363-001-10-0;GDSC1:1015,gdsc;rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1;MAP3K1;MAP3K2,,,PHASE 2,,Small molecule,2,FC1CCC(C(=O)NOCC2CC2)C(NC2CCC(I)CC2CL)C1F;O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,GFMMXOIFOQCCGU-UHFFFAOYSA-N
PD-198306,PD-198306,,BRD:BRD-BRD-K88677950-001-03-9;BRD:BRD-K88677950-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,"MAP KINASE INHIBITOR, MEK INHIBITOR",MAP2K1;MAP2K2,,,PRECLINICAL,,,NA,CC1CC(I)CCC1NC1C(F)C(F)C(F)CC1C(=O)NOCC1CC1,
PD-318088,PD-318088,,BRD:BRD-A57798112-001-03-7;BRD:BRD-BRD-A57798112-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1,,,PRECLINICAL,,,NA,OCC(O)CONC(=O)C1CC(BR)C(F)C(F)C1NC1CCC(I)CC1F,
PD-407824,PD-407824,,BRD:BRD-BRD-K82823804-001-04-1;BRD:BRD-K82823804-001-04-1,rep_multi_dose;rep_primary;rep_single_dose,PKC INHIBITOR,WEE1,,,PRECLINICAL,,,NA,"OC1CCC2[NH]C3CC(C4C(=O)NC(=O)C4C3C2C1)-C1CCCCC1, OC1CCC2[NH]C3CC(C4C(=O)NC(=O)C4C3C2C1)-C1CCCCC1",
PD-81723,PD-81723,,BRD:BRD-K77951111-001-05-9,rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1,,,,,,NA,,
PD-98059,PD-98059,,BRD:BRD-BRD-K62810658-001-12-2;BRD:BRD-K62810658-001-12-2,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,AKT1;CHEK1;GSK3B;LCK;MAP2K1;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;PRKCA;RAF1;ROCK1;RPS6KB1;SGK1,,,PRECLINICAL,,,NA,"COC1CCCC(-C2CC(=O)C3CCCCC3O2)C1N, COC1CCCC(-C2CC(=O)C3CCCCC3O2)C1N, COC1CCCC(-C2CC(=O)C3CCCCC3O2)C1N",
PD0325901,MIRDAMETINIB;PD 0325901;PD 03525901;PD 901;PD-0325901;PD0325901,CHEMBL507361,GDSC1:1060;GDSC2:1060,gdsc,,,,,,,Small molecule,2,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,SUDAHWBOROXANE-SECBINFHSA-N
PD1-PDL-INHIBITOR-1,PD1-PDL-INHIBITOR-1,,BRD:BRD-BRD-K04032780-001-01-8;BRD:BRD-K04032780-001-01-8,rep_primary;rep_single_dose,PROGRAMMED DEATH LIGAND INHIBITOR,CD274,,,PRECLINICAL,,,NA,COC1CC(OCC2CCCC(-C3CCCCC3)C2C)CC(OC)C1CN1CCCC[C@H]1C(O)=O,
PD173074,PD 173074;PD173074,,GDSC1:1049;GDSC2:1049,gdsc,,,,,,,,NA,,
PD318088,PD318088,,CTRP:660410,ctrp,,,,,,,,NA,,
PDD-00017273,PDD-00017273,,BRD:BRD-K00021095-001-01-9,rep_single_dose,PARG INHIBITOR,,,,,,,NA,,
PDE10-IN-1,PDE10-IN-1,,BRD:BRD-BRD-K38145871-001-01-8;BRD:BRD-K38145871-001-01-8,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE10A,,,PRECLINICAL,,,NA,CC1C(NC2C3CCCNC3CCN12)[C@@H]1C[C@H]1C1NC2C(C)NCC(C)N2N1,
PDK1 INHIBITOR 7,KIN001-244;PDK1 INHIBITOR 7,,GDSC1:287,gdsc,,,,,,,,NA,,
PDK1 INHIBITOR AR-12,AR-12;OSU 03012;OSU-03012;OSU03012;PDK1 INHIBITOR AR-12,CHEMBL1650595,GDSC1:167,gdsc,,,,,,,Small molecule,1,NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1,YULUCECVQOCQFQ-UHFFFAOYSA-N
PDMP,PDMP,,CTRP:58472,ctrp,,,,,,,,NA,,
PDP-EA,PDP-EA,,BRD:BRD-BRD-K26358347-001-01-7;BRD:BRD-K26358347-001-01-7,rep_primary;rep_single_dose,FAAH ACTIVATOR,FAAH,,,PRECLINICAL,,,NA,CCCCCCCCCCCCCCCC1CCCC(OCC(=O)NCCO)C1,
PEFICITINIB,ASP-015K;ASP015K;JNJ-54781532;PEFICITINIB,CHEMBL3137308,BRD:BRD-A14577621-001-01-5;BRD:BRD-BRD-A14577621-001-01-5,rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2;JAK3,,,PHASE 3,,Small molecule,3,"NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2;NC(=O)C1CNC2[NH]CCC2C1N[C@H]1[C@H]2C[C@H]3C[C@@H]1C[C@](O)(C3)C2, NC(=O)C1CNC2[NH]CCC2C1N[C@@H]1C2C[C@@H]3C[C@H]1C[C@@](O)(C3)C2",DREIJXJRTLTGJC-ZLBJMMTISA-N
PEFLOXACIN,1589 RB;1589-RB;EU-5306;PEFLOXACIN,CHEMBL267648,BRD:BRD-BRD-K55034111-066-17-1;BRD:BRD-K55034111-066-17-1,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,"GASTROINTESTINAL INFECTIONS, URETHRITIS, GONORRHEA, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21;CCN1CC(C(O)=O)C(=O)C2CC(F)C(CC12)N1CCN(C)CC1, CCN1CC(C(O)=O)C(=O)C2CC(F)C(CC12)N1CCN(C)CC1",FHFYDNQZQSQIAI-UHFFFAOYSA-N
PELANSERIN,PELANSERIN,CHEMBL2110706,BRD:BRD-BRD-K96436774-001-01-8;BRD:BRD-K96436774-001-01-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A,,,PHASE 2,,Small molecule,-1,O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2ccccc2)CC1;O=C1[NH]C2CCCCC2C(=O)N1CCCN1CCN(CC1)C1CCCCC1,WPKPLSFHHBBLRY-UHFFFAOYSA-N
WAY-EKB-569,EKB-569;PELITINIB;WAY-EKB-569,CHEMBL607707,BRD:BRD-BRD-K08799216-001-05-3;BRD:BRD-K08799216-001-05-3;GDSC1:282,gdsc;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PHASE 2,,Small molecule,2,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C;CCOC1CC2NCC(C#N)C(NC3CCC(F)C(CL)C3)C2CC1NC(=O)\C=C\CN(C)C,WVUNYSQLFKLYNI-AATRIKPKSA-N
PELRINONE,PELRINONE,CHEMBL17125,BRD:BRD-K00004687-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,-1,Cc1nc(=O)c(C#N)c(NCc2cccnc2)[nH]1,NZXHFDXOCVIYLO-UHFFFAOYSA-N
PEMAFIBRATE,(R)-;(R)-K-13675;K-13675;PEMAFIBRATE,CHEMBL247951,BRD:BRD-K00003251-001-01-9,rep_single_dose,PPAR RECEPTOR AGONIST,,,,,,Small molecule,3,CC[C@@H](Oc1cccc(CN(CCCOc2ccc(OC)cc2)c2nc3ccccc3o2)c1)C(=O)O,ZHKNLJLMDFQVHJ-RUZDIDTESA-N
PEMFEXY,ALIMTA;LY-2315;LY-231514;LY231514;NSC-698037;PEMETREXED;PEMFEXY,CHEMBL225072,BRD:BRD-BRD-K32842773-434-01-8;BRD:BRD-K32842773-380-01-3;BRD:BRD-K32842773-434-01-8;GDSC1:428,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"DIHYDROFOLATE REDUCTASE INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",ATIC;DHFR;GART;TYMS,"NON-SMALL CELL LUNG CANCER (NSCLC), MESOTHELIOMA",,LAUNCHED,,Small molecule,4,"NC1NC(=O)C2C(CCC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C[NH]C2[NH]1, NC1NC(=O)C2C(CCC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C[NH]C2[NH]1, NC1NC(=O)C2C(CCC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C[NH]C2[NH]1, NC1NC(=O)C2C(CCC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C[NH]C2[NH]1, NC1NC(=O)C2C(CCC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C[NH]C2[NH]1, NC1NC(=O)C2C(CCC3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C[NH]C2[NH]1;Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1",WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
PERMIROLAST,PEMIROLAST;PEMIROX;PERMIROLAST,CHEMBL1201198,BRD:BRD-BRD-K31731454-237-02-5;BRD:BRD-K31731454-237-02-5;BRD:BRD-K31731454-237-04-9,rep_primary;rep_single_dose,MEDIATOR RELEASE INHIBITOR,HRH1,ASTHMA,,LAUNCHED,,Small molecule,4,"Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12;CC1CCCN2C1NCC(-C1NNN[NH]1)C2=O, CC1CCCN2C1NCC(-C1NNN[NH]1)C2=O",HIANJWSAHKJQTH-UHFFFAOYSA-N
PENBUTOLOL,LEVATOL;PENBUTOLOL,CHEMBL1290,BRD:BRD-BRD-K55705469-065-01-0;BRD:BRD-K55705469-065-01-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;HTR1A;HTR1B,HYPERTENSION,,LAUNCHED,,Small molecule,4,CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1;CC(C)(C)NC[C@H](O)COC1CCCCC1C1CCCC1,KQXKVJAGOJTNJS-HNNXBMFYSA-N
VECTAVIR,BRL-39123;DENAVIR;FENISTIL;NSC-759624;PENCICLOVIR;VECTAVIR,CHEMBL1540,BRD:BRD-BRD-K47780086-001-07-9;BRD:BRD-K47780086-001-07-9,rep_primary;rep_single_dose,DNA DIRECTED DNA POLYMERASE INHIBITOR,,COLD SORE,,LAUNCHED,,Small molecule,4,"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1;NC1NC(O)C2NCN(CCC(CO)CO)C2N1, NC1NC(O)C2NCN(CCC(CO)CO)C2N1, NC1NC(O)C2NCN(CCC(CO)CO)C2N1",JNTOCHDNEULJHD-UHFFFAOYSA-N
SEMAP,"MCN-JR-16,341;MCN-JR-16341;MICEFAL;NSC-759179;PENFLURIDOL;R 16,341;R-16341;SEMAP",CHEMBL47050,BRD:BRD-BRD-K15409150-001-05-8;BRD:BRD-K15409150-001-05-8,rep_multi_dose;rep_primary;rep_single_dose,T-TYPE CALCIUM CHANNEL BLOCKER,CACNA1G,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,-1,"OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1;OC1(CCN(CCCC(C2CCC(F)CC2)C2CCC(F)CC2)CC1)C1CCC(CL)C(C1)C(F)(F)F, OC1(CCN(CCCC(C2CCC(F)CC2)C2CCC(F)CC2)CC1)C1CCC(CL)C(C1)C(F)(F)F",MDLAAYDRRZXJIF-UHFFFAOYSA-N
PENICILLAMINE-(D),PENICILLAMINE-(D),,BRD:BRD-BRD-K17518951-001-03-0;BRD:BRD-K17518951-001-03-0,rep_multi_dose;rep_primary;rep_single_dose,CHELATING AGENT,,"WILSON'S DISEASE, RHEUMATOID ARTHRITIS, CYSTINURIA",,LAUNCHED,,,NA,"CC(C)(S)[C@@H](N)C(O)=O, CC(C)(S)[C@@H](N)C(O)=O",
PENICILLIN-V-POTASSIUM,PENICILLIN-V-POTASSIUM,,BRD:BRD-BRD-K43966364-237-04-8;BRD:BRD-K43966364-237-04-8,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"PNEUMONIA, EAR INFECTIONS, SKIN INFECTIONS, THROAT INFECTIONS, CHOLERA, SCARLET FEVER",,LAUNCHED,,,NA,CC1(C)S[C@@H]2[C@H](NC(=O)COC3CCCCC3)C(=O)N2[C@H]1C(O)=O,
PENTACOSANOIC-ACID,PENTACOSANOIC-ACID,,BRD:BRD-BRD-K48996094-001-01-3;BRD:BRD-K48996094-001-01-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCCCCCCCCCCCCCCCCCCCCCCCC(O)=O,
PEPTAVLON,"AY-6608;ICI 50,123;ICI-50123;NSC-367746;PENTAGASTRIN;PEPTAVLON",CHEMBL1328,BRD:BRD-BRD-K78789465-001-01-6;BRD:BRD-BRD-K78789465-001-02-4;BRD:BRD-K78789465-001-01-6;BRD:BRD-K78789465-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,CCK RECEPTOR AGONIST,CCKBR,"ANACIDITY DIAGNOSTIC, GASTRIC HYPERSECRETION DIAGNOSTIC, ANACIDITY DIAGNOSTIC, GASTRIC HYPERSECRETION DIAGNOSTIC",,LAUNCHED,,Small molecule,4,"CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O;CSCC[C@H](NC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1CCCCC1)C(N)=O, CSCC[C@H](NC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1CCCCC1)C(N)=O",NEYNJQRKHLUJRU-DZUOILHNSA-N
RP-2512 FREE BASE,GNF-PF-3680;MB 800 [AS ISETHIONATE];MB 800 FREE BASE;MB-800;MB-800 (AS ISETHIONATE);MB-800 FREE BASE;MP-601205;NEBUPENT [AS ISETHIONATE];NSC-9921;PENTACARINAT;PENTACARINAT [AS ISETHIONATE];PENTAM 300;PENTAM 300 [AS ISETHIONATE];PENTAMIDINE;PENTAMIDINE ISETIONATE;RP 2512 [AS ISETHIONATE);RP 2512 FREE BASE;RP-2512;RP-2512 FREE BASE,CHEMBL55,BRD:BRD-BRD-K13183738-317-10-2;BRD:BRD-K13183738-317-10-2,rep_multi_dose;rep_primary;rep_single_dose,ANTI-PNEUMOCYSTIS AGENT,TRDMT1,PNEUMONIA,,LAUNCHED,,Small molecule,4,"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1;NC(=N)C1CCC(OCCCCCOC2CCC(CC2)C(N)=N)CC1, NC(=N)C1CCC(OCCCCCOC2CCC(CC2)C(N)=N)CC1",XDRYMKDFEDOLFX-UHFFFAOYSA-N
PENTETIC-ACID,PENTETIC-ACID,,BRD:BRD-BRD-K40621224-001-06-7;BRD:BRD-K40621224-001-06-7,rep_primary;rep_single_dose,CHELATING AGENT,PGD,,,PHASE 2,,,NA,OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O,
PENTOBARBITONE,MEBUBARBITAL;MEBUMAL;NEMBUTAL;NSC-28708;PENTOBARBITAL;PENTOBARBITAL CALCIUM;PENTOBARBITAL CII;PENTOBARBITONE,CHEMBL448,BRD:BRD-A44448661-001-04-8;BRD:BRD-BRD-A44448661-001-04-8,rep_primary;rep_single_dose,"BARBITURATE ANTIEPILEPTIC, GABA RECEPTOR MODULATOR",CHRNA4;CHRNA7;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GRIA2;GRIK2;GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D;GRIN3A;GRIN3B,,,WITHDRAWN,,Small molecule,4,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N
PENTOLONIUM,ANSOLYSEN;PENTOLINIUM;PENTOLINIUM CATION;PENTOLINIUM ION;PENTOLONIUM,CHEMBL1271,BRD:BRD-BRD-K44942604-346-05-4;BRD:BRD-K44942604-346-05-4,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRNA10;CHRNA3;CHRNA4;CHRNB4,HYPERTENSION,,LAUNCHED,,Small molecule,4,"C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1;C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1, C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1",XSBSKEQEUFOSDD-UHFFFAOYSA-N
YK-176,CI-825;DEOXYCOFORMYCIN;NIPENT;NSC-218321;PD 81565;PD-81565;PENTOSTATIN;YK-176,CHEMBL1580,BRD:BRD-BRD-K91543828-001-02-0;BRD:BRD-K91543828-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,"ADENOSINE DEAMINASE INHIBITOR, RIBONUCLEOTIDE REDUCTASE INHIBITOR",ADA,HAIRY CELL LEUKEMIA,,LAUNCHED,,Small molecule,4,"OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O;OC[C@H]1O[C@H](C[C@@H]1O)N1CNC2[C@H](O)CNC=NC12, OC[C@H]1O[C@H](CC1O)N1CNC2[C@H](O)CNC=NC12",FPVKHBSQESCIEP-JQCXWYLXSA-N
TRENTAL 400,BL 191;BL-191;C04AD03;NEOTREN MR;NSC-637086;NSC-758481;OXPENTIFYLLINE;OXYPENTIFYLLINE;PENTOXIFYLLINE;PENTOXIL;PENTOXIPHYLLIN;TRENTAL;TRENTAL 100;TRENTAL 400,CHEMBL628,BRD:BRD-BRD-K57569181-001-27-5;BRD:BRD-K57569181-001-27-5,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,ADORA1;ADORA2A;ADORA2B;ADRA2B;NT5E;PDE10A;PDE1A;PDE1B;PDE1C;PDE2A;PDE3A;PDE3B;PDE4A;PDE4B;PDE4C;PDE4D;PDE5A;PDE6A;PDE6B;PDE6C;PDE6D;PDE6G;PDE6H;PDE7A;PDE7B;PDE8A;PDE8B;PDE9A;TNF,CLAUDICATION,,LAUNCHED,,Small molecule,4,"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O;CC(=O)CCCCN1C(=O)N(C)C2NCN(C)C2C1=O, CC(=O)CCCCN1C(=O)N(C)C2NCN(C)C2C1=O",BYPFEZZEUUWMEJ-UHFFFAOYSA-N
PENTYLENETETRAZOLE,CARDIAZOL;CARDIOZOL;CENAZOL;CORANORMOL;CORAZOLE;CORYVET;KORAZOL;KORAZOLE;LEPTAZOL;LEPTAZOLE;METRAZOL;METRAZOLE;NSC-5729;NSC-66489;PENTAMETHYLENETETRAZOL;PENTAMETHYLENETETRAZOLE;PENTETRAZOL;PENTYLENETETRAZOL;PENTYLENETETRAZOLE,CHEMBL116943,BRD:BRD-BRD-K57718010-001-11-9;BRD:BRD-K57718010-001-11-9,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,,,,WITHDRAWN,,Small molecule,2,"C1CCc2nnnn2CC1;C1CCC2NNNN2CC1, C1CCC2NNNN2CC1, C1CCC2NNNN2CC1",CWRVKFFCRWGWCS-UHFFFAOYSA-N
PEPOSERTIB,M-3814;M3814;MSC 2490484A;MSC-2490484A;MSC2490484A;NEDISERTIB;PEPOSERTIB,CHEMBL4297629,BRD:BRD-K00003426-001-01-9,rep_single_dose,DNA DEPENDENT PROTEIN KINASE INHIBITOR,,,,,,Small molecule,1,COc1ccc([C@@H](O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1,MOWXJLUYGFNTAL-DEOSSOPVSA-N
PEPSTATIN A,NSC-272671;PEPSTATIN;PEPSTATIN A,CHEMBL296588,BRD:BRD-BRD-K13571841-001-14-4;BRD:BRD-K13571841-001-14-4,rep_multi_dose;rep_primary;rep_single_dose,ASPARTIC PROTEASE INHIBITOR,CTSB;CTSD;CTSL;REN,,,PRECLINICAL,,Small molecule,-1,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O;CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C,FAXGPCHRFPCXOO-LXTPJMTPSA-N
RWJ-270201,BCX-1812;PERAMIVIR;PERAMIVIR HYDRATE;PERAMIVIR TRIHYDRATE;RAPIACTA;RAPIVAB;RWJ-270201,CHEMBL139367;CHEMBL3989402,BRD:BRD-BRD-K00519864-341-03-3;BRD:BRD-K00519864-341-03-3,rep_primary;rep_single_dose,NEURAMINIDASE INHIBITOR,,INFLUENZA A VIRUS INFECTION,,LAUNCHED,,Small molecule,4,"CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N;CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O, CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O",XRQDFNLINLXZLB-CKIKVBCHSA-N
PERAMPANEL,E-2007;E2007;ER-155055-90;FYCOMPA;PERAMPANEL,CHEMBL1214124,BRD:BRD-BRD-K41438959-001-01-7;BRD:BRD-K41438959-001-01-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1;GRIA2;GRIA3;GRIA4,SEIZURES,,LAUNCHED,,Small molecule,4,N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O;O=C1C(CC(CN1-C1CCCCC1)-C1CCCCN1)-C1CCCCC1C#N,PRMWGUBFXWROHD-UHFFFAOYSA-N
PERCHLOZONE,PERCHLOZONE,,BRD:BRD-BRD-K86435560-001-01-0;BRD:BRD-K86435560-001-01-0,rep_primary;rep_single_dose,,,TUBERCULOSIS,,LAUNCHED,,,NA,NC(=S)NN=CC1CCNCC1,
PERETINOIN,NIK-333;PERETINOIN,CHEMBL4303228,BRD:BRD-BRD-K99431849-001-01-7;BRD:BRD-K99431849-001-01-7,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RXRA,,,PHASE 3,,Small molecule,3,"CC(C)=CCC/C(C)=C/CC/C(C)=C/C=C/C(C)=C/C(=O)O;CC(C)=CCC\C(C)=C\CC\C(C)=C\C=C\C(C)=C\C(O)=O, CC(C)=CCC\C(C)=C\CC\C(C)=C\C=C\C(C)=C\C(O)=O",UUBHZHZSIKRVIV-KCXSXWJSSA-N
PERFLUOROTRI-N-PROPYLAMINE,PERFLUAMINE;PERFLUOROTRI-N-PROPYLAMINE,CHEMBL2104877,BRD:BRD-BRD-K16758059-001-01-8;BRD:BRD-K16758059-001-01-8,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,FC(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F,JAJLKEVKNDUJBG-UHFFFAOYSA-N
PFOB,IMAGENT;N-PERFLUOROOCTYL BROMIDE;PERFLUBRON;PERFLUOROCAPRYLYL BROMIDE;PERFLUOROCTYL BROMIDE;PERFLUOROOCTYLBROMIDE;PFOB,CHEMBL1200866,BRD:BRD-BRD-K92988025-001-01-9;BRD:BRD-K92988025-001-01-9,rep_primary;rep_single_dose,CONTRAST AGENT,,CONTRAST AGENT,,LAUNCHED,,Small molecule,4,"FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br;FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)BR, FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)BR",WTWWXOGTJWMJHI-UHFFFAOYSA-N
PERFLUOROHEXYLOCTANE,PERFLUOROHEXYLOCTANE,,BRD:BRD-K00004546-001-01-9,rep_single_dose,,,,,,,,NA,,
PERGOLIDE,PERGOLIDE,CHEMBL531,BRD:BRD-BRD-K60770992-066-25-0;BRD:BRD-K60770992-066-25-0,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C,,,WITHDRAWN,,Small molecule,4,"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21;CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC1C[NH]C3CCCC2C13, CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC1C[NH]C3CCCC2C13",YEHCICAEULNIGD-MZMPZRCHSA-N
PERHEXILINE,PERHEXILINE,CHEMBL75880,BRD:BRD-A19633847-050-32-1;BRD:BRD-BRD-A19633847-050-32-1,rep_primary;rep_single_dose,CARNITINE PALMITOYLTRANSFERASE INHIBITOR,CPT1A;CPT2,ANGINA PECTORIS,,LAUNCHED,,Small molecule,4,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1;C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,CYXKNKQEMFBLER-UHFFFAOYSA-N
SKF-20716,NEULACTIL;NSC-758641;PERICIAZINE;PERICYAZINE;PROPERICIAZINE;RP 8909;RP-8909;SKF 20716;SKF-20716,CHEMBL251940,BRD:BRD-K89669299-001-04-9,rep_single_dose,,,,,,,Small molecule,4,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,LUALIOATIOESLM-UHFFFAOYSA-N
PERIFOSINE,KRX-0401;NSC-639966;PERIFOSINE,CHEMBL372764,BRD:BRD-A89082344-001-08-7;BRD:BRD-BRD-A89082344-001-08-7,rep_primary;rep_single_dose,AKT INHIBITOR,AKT1,,,PHASE 3,,Small molecule,3,"CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1;CCCCCCCCCCCCCCCCCCOP(O)(=O)OC1CC[N+](C)(C)CC1, CCCCCCCCCCCCCCCCCCOP(O)(=O)OC1CC[N+](C)(C)CC1, CCCCCCCCCCCCCCCCCCOP(O)(=O)OC1CC[N+](C)(C)CC1",SZFPYBIJACMNJV-UHFFFAOYSA-N
PERILLYL-ALCOHOL,PERILLYL-ALCOHOL,,BRD:BRD-A13323580-001-04-8;BRD:BRD-BRD-A13323580-001-04-8,rep_primary;rep_single_dose,"APOPTOSIS STIMULANT, FARNESYLTRANSFERASE INHIBITOR",FNTA,,,PHASE 2,,,NA,"CC(=C)C1CCC(CO)=CC1, CC(=C)C1CCC(CO)=CC1",
S-9490,MCN-A-2833;PERINDOPRIL;S-9490,CHEMBL1581,BRD:BRD-BRD-K92731339-227-04-9;BRD:BRD-K92731339-227-04-9,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,"HYPERTENSION, MYOCARDIAL INFARCTION, CORONARY ARTERY DISEASE (CAD)",,LAUNCHED,,Small molecule,4,"CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC;CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC, CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC",IPVQLZZIHOAWMC-QXKUPLGCSA-N
PEROSPIRONE,PEROSPIRONE,CHEMBL1472975,BRD:BRD-BRD-K85503079-001-02-8;BRD:BRD-K85503079-001-02-8,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",DRD2;DRD3;DRD4,"SCHIZOPHRENIA, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,-1,"O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1;O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)C1NSC2CCCCC12, O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)C1NSC2CCCCC12",FBVFZWUMDDXLLG-HDICACEKSA-N
TRILAFON-LA,CHLORPIPRAZINE;DECENTAN;ETAPERAZINE;FENTAZIN;NSC-150866;PERPHENAZINE;PERPHENAZINE FENDIZOATE;PERPHENAZINE MALEATE;TRILAFON;TRILAFON-LA,CHEMBL567,BRD:BRD-BRD-K10995081-001-27-9;BRD:BRD-K10995081-001-27-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CALM1;DRD1;DRD2;HRH1;HTR2A;HTR2C;HTR6;HTR7,"SCHIZOPHRENIA, NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,"OCCN1CCN(CCCN2C3CCCCC3SC3CCC(CL)CC23)CC1, OCCN1CCN(CCCN2C3CCCCC3SC3CCC(CL)CC23)CC1, OCCN1CCN(CCCN2C3CCCCC3SC3CCC(CL)CC23)CC1;OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1",RGCVKNLCSQQDEP-UHFFFAOYSA-N
PERUVOSIDE,CANNOGENIN .ALPHA.-L-THEVETOSIDE;CANNOGENIN THEVETOSIDE;ENCORDIN;PERUVOSID;PERUVOSIDE,CHEMBL1075790,BRD:BRD-A72716251-001-01-5;BRD:BRD-BRD-A72716251-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,CARDIAC GLYCOSIDE,,,,PHASE 1,,Small molecule,-1,CO[C@H]1[C@@H](O)C(C)O[C@@H](O[C@H]2CC[C@@]3(C=O)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C3=CC(=O)OC3)C2)C1O;CO[C@H]1[C@H](O)[C@H](O[C@H]2CC[C@@]3(C=O)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)O[C@@H](C)[C@@H]1O,PMTSPAGBAFCORP-HBUONDEYSA-N
PERZINFOTEL,EAA-090;PERZINFOTEL,CHEMBL452461,BRD:BRD-BRD-K04643877-001-03-2;BRD:BRD-K04643877-001-03-2,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1;GRIN2A;GRIN2B,,,PHASE 2,,Small molecule,2,O=c1c2c(c1=O)N(CCP(=O)(O)O)CCCN2;OP(O)(=O)CCN1CCCNC2C1C(=O)C2=O,BDABGOLMYNHHTR-UHFFFAOYSA-N
PETCM,PETCM,,BRD:BRD-A93477898-001-04-2;BRD:BRD-BRD-A93477898-001-04-2,rep_multi_dose;rep_primary;rep_single_dose,CASPASE ACTIVATOR,CASP3,,,PRECLINICAL,,,NA,OC(CC1CCNCC1)C(CL)(CL)CL,
RO5459072,PETESICATIB;RG-7625;RG7625;RO-5459072;RO5459072,CHEMBL4297638,BRD:BRD-K00091277-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Cn1cc(-c2ccc(S(=O)(=O)[C@@H]3C[C@@H](C(=O)NC4(C#N)CC4)N(C(=O)C4(C(F)(F)F)CC4)C3)c(C(F)(F)F)c2)cn1,KXAAIORSMACJSI-AEFFLSMTSA-N
PEXACERFONT,BMS-562086;BMS562086;CRF1 ANTAGONIST;DPC-A69448;PEXACERFONT,CHEMBL482950,BRD:BRD-K00073864-001-02-9,rep_single_dose,,,,,,,Small molecule,3,CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12,LBWQSAZEYIZZCE-SNVBAGLBSA-N
PLX3397,CML-261;PEXIDARTINIB;PLX-3397;PLX3397,CHEMBL3813873,BRD:BRD-BRD-K54519451-001-02-9;BRD:BRD-K54519451-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,CSF1R;FLT3;KIT,,,PHASE 3,,Small molecule,4,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1;FC(F)(F)C1CCC(CNC2CCC(CC3C[NH]C4NCC(CL)CC34)CN2)CN1,JGWRKYUXBBNENE-UHFFFAOYSA-N
PEXMETINIB,ARRY-614;PEXMETINIB,CHEMBL3991932,BRD:BRD-BRD-K53405000-001-02-8;BRD:BRD-K53405000-001-02-8,rep_primary;rep_single_dose,"MAP KINASE INHIBITOR, TIE TYROSINE KINASE INHIBITOR",MAPK14;TEK,,,PHASE 1,"Multiple values for MOA: {'TIE TYROSINE KINASE INHIBITOR, MAP KINASE INHIBITOR', 'MAP KINASE INHIBITOR, TIE TYROSINE KINASE INHIBITOR'}, defaulting to 'MAP KINASE INHIBITOR, TIE TYROSINE KINASE INHIBITOR'",Small molecule,1,"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1;CC1CCC(CC1)-N1NC(CC1NC(=O)NCC1CC(F)CCC1OC1CCC2N(CCO)NCC2C1)C(C)(C)C, CC1CCC(CC1)-N1NC(CC1NC(=O)NCC1CC(F)CCC1OC1CCC2N(CCO)NCC2C1)C(C)(C)C",LNMRSSIMGCDUTP-UHFFFAOYSA-N
PF 03716556,PF 03716556,,BRD:BRD-K00091129-001-01-9,rep_single_dose,,,,,,,,NA,,
PF 04531083,PF 04531083,,BRD:BRD-K00076501-001-02-9,rep_single_dose,,,,,,,,NA,,
PF-0008066573,PALBOCICLIB ISETHIOLATE;PALBOCICLIB ISETHIONATE;PD 0332991-0054;PD-0332991-0054;PD-03329910054;PD0332991;PF-00080665-73;PF-0008066573,CHEMBL2364621,GDSC1:1054;GDSC2:1054,gdsc,,,,,,,Small molecule,2,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O.O=S(=O)(O)CCO,LYYVFHRFIJKPOV-UHFFFAOYSA-N
VIZIMPRO,DACOMITINIB;DACOMITINIB HYDRATE;DACOMITINIB MONOHYDRATE;PF-00299804;PF-00299804-03;VIZIMPRO,CHEMBL2105719;CHEMBL2110732,GDSC1:363,gdsc,,,,,,,Small molecule,4,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O,BSPLGGCPNTZPIH-IPZCTEOASA-N
PF-562271 BESILATE,PF 562271;PF-00562271;PF-562271;PF-562271 BESILATE,CHEMBL1084546,GDSC1:158,gdsc,,,,,,,Small molecule,1,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,MZDKLVOWGIOKTN-UHFFFAOYSA-N
RUCAPARIB PHOSPHATE,AG 014699;AG-014699;AG-14447;AG-14699;AG014699;PF-01367338;PF01367338;RUCAPARIB;RUCAPARIB PHOSPHATE,CHEMBL1173055;CHEMBL2105733,GDSC1:1175,gdsc,,,,,,,Small molecule,1,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1.O=P(O)(O)O,FCCGJTKEKXUBFZ-UHFFFAOYSA-N
PF-02413873,PF-02413873,,BRD:BRD-K00004632-001-01-9,rep_single_dose,PROGESTERONE RECEPTOR ANTAGONIST,,,,,,,NA,,
PF-2545920,MARDEPODECT;MP-10;PF-02545920;PF-2545920,CHEMBL562318,BRD:BRD-BRD-K31519811-001-02-2;BRD:BRD-K31519811-001-02-2,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE10A,,,PHASE 2,,Small molecule,2,Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1;CN1CC(C(N1)-C1CCC(OCC2CCC3CCCCC3N2)CC1)-C1CCNCC1,AZEXWHKOMMASPA-UHFFFAOYSA-N
PF-03049423,PF-03049423,CHEMBL591501,BRD:BRD-BRD-K07070922-001-01-4;BRD:BRD-K07070922-001-01-4,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A,,,PHASE 2,,Small molecule,2,CCCOCCn1c(=O)c(N2CCN(CCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21;CCCOCCN1C2CC(NCC2NC(N2CCN(CCO)CC2)C1=O)-C1CCC(OC)NC1,MNLNAGRCHNMKKJ-UHFFFAOYSA-N
PF-3084014,NIROGACESTAT;PF 03084014;PF 3084014;PF-03084014;PF-3084014,CHEMBL1770916,BRD:BRD-BRD-K61691541-001-01-1;BRD:BRD-K61691541-001-01-1,rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,,,,PHASE 2,,Small molecule,3,CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1;CCC[C@H](N[C@H]1CCC2CC(F)CC(F)C2C1)C(=O)NC1CN(CN1)C(C)(C)CNCC(C)(C)C,VFCRKLWBYMDAED-REWPJTCUSA-N
PF-3463275,PF-03463275;PF-3463275,CHEMBL563251,BRD:BRD-K00075673-001-02-9,rep_single_dose,,,,,,,Small molecule,2,CN1C[C@@H]2[C@H](C1)[C@H]2CN(Cc1ccc(F)c(Cl)c1)C(=O)c1cn(C)cn1,KYLOBHXXQOZRKK-FICVDOATSA-N
PF-3758309,PF-03758309;PF-3758309,CHEMBL3128043,BRD:BRD-BRD-K37764012-001-04-1;BRD:BRD-K37764012-001-04-1,rep_multi_dose;rep_primary;rep_single_dose,P21 ACTIVATED KINASE INHIBITOR,PAK4,,,PHASE 1,,Small molecule,1,Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1;CN(C)C[C@@H](NC(=O)N1CC2C(NC3NC(C)NC4CCSC34)N[NH]C2C1(C)C)C1CCCCC1,AYCPARAPKDAOEN-LJQANCHMSA-N
PF-3814735,PF 03814735;PF 3814735;PF-03814735;PF-3814735,CHEMBL3545078,BRD:BRD-BRD-K68747584-001-02-0;BRD:BRD-K68747584-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB,,,PHASE 1,,Small molecule,1,"CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C1CC(NC3NCC(C(NC4CCC4)N3)C(F)(F)F)CCC21, CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C1CC(NC3NCC(C(NC4CCC4)N3)C(F)(F)F)CCC21",
PF-3882845,PF-03882845;PF-3882845,CHEMBL3545175,BRD:BRD-BRD-K51041191-001-01-4;BRD:BRD-K51041191-001-01-4;BRD:BRD-K51041191-001-02-9,rep_primary;rep_single_dose,MINERALOCORTICOID RECEPTOR ANTAGONIST,,,,PHASE 1,,Small molecule,1,OC(=O)C1CCC2C3=C(CCC2C1)[C@H](C1CCCC1)N(N3)C1CCC(C#N)C(CL)C1,
PF-4136309,INCB-8761;INCB8761;PF-04136309;PF-4136309,CHEMBL4650501,BRD:BRD-BRD-K94420399-001-01-9;BRD:BRD-K94420399-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,PHASE 2,,Unknown,2,O[C@]1(CC[C@@H](CC1)N[C@H]1CCN(C1)C(=O)CNC(=O)C1CCCC(C1)C(F)(F)F)C1CCC(CN1)-C1NCCCN1,
PF-4217903,MET TYROSINE KINASE INHIBITOR PF-04217903;PF-04217903;PF-4217903,CHEMBL2001019,BRD:BRD-BRD-K73319509-001-08-0;BRD:BRD-K73319509-001-08-0,rep_multi_dose;rep_primary;rep_single_dose,C-MET INHIBITOR,MET,,,PHASE 1,,Small molecule,1,OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1;OCCN1CC(CN1)-C1CNC2NNN(CC3CCC4NCCCC4C3)C2N1,PDMUGYOXRHVNMO-UHFFFAOYSA-N
PF-04418948,PF-04418948,CHEMBL3286797,BRD:BRD-BRD-K54871792-001-02-2;BRD:BRD-K54871792-001-02-2,rep_primary;rep_single_dose,PROSTAGLANDIN INHIBITOR,PTGER2,,,PHASE 1,,Small molecule,1,"COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1;COC1CCC2CC(OCC3(CN(C3)C(=O)C3CCC(F)CC3)C(O)=O)CCC2C1, COC1CCC2CC(OCC3(CN(C3)C(=O)C3CCC(F)CC3)C(O)=O)CCC2C1",LWJGMYMNSNVCEM-UHFFFAOYSA-N
PF-04447943,PF-04447943,CHEMBL2179105,BRD:BRD-BRD-K50031829-001-01-6;BRD:BRD-K50031829-001-01-6,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE9A,,,PHASE 2,,Small molecule,2,C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1;C[C@@H]1CN(CC2NCCCN2)C[C@H]1C1NC2N(NCC2C(=O)[NH]1)C1CCOCC1,IWXUVYOOUMLUTQ-CZUORRHYSA-N
PF-4457845,PF-04457845;PF-4457845,CHEMBL1651534,BRD:BRD-BRD-K86816506-001-01-8;BRD:BRD-K86816506-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,FAAH INHIBITOR,FAAH,,,PHASE 2,,Small molecule,2,FC(F)(F)C1CCC(OC2CCCC(C=C3CCN(CC3)C(=O)NC3CCCNN3)C2)NC1;O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,BATCTBJIJJEPHM-UHFFFAOYSA-N
PF-4620110,PF-04620110;PF-4620110,CHEMBL1835919,BRD:BRD-BRD-K30550578-001-01-3;BRD:BRD-K30550578-001-01-3,rep_primary;rep_single_dose,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,DGAT1,,,PHASE 1,,Small molecule,1,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2;NC1NCNC2OCCN(C3CCC(CC3)[C@H]3CC[C@H](CC(O)=O)CC3)C(=O)C12,GEVVQZHMFVFGLN-HDJSIYSDSA-N
PF-4691502,PF-04691502;PF-4691502,CHEMBL1234354,BRD:BRD-BRD-K07310275-001-02-5;BRD:BRD-K07310275-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",MTOR;PIK3CA,,,PHASE 2,,Small molecule,2,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1;COC1CCC(CN1)-C1CC2C(C)NC(N)NC2N([C@H]2CC[C@@H](CC2)OCCO)C1=O,XDLYKKIQACFMJG-WKILWMFISA-N
PF-04885614,PF-04885614,,BRD:BRD-K92435527-001-03-9,rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,SCN10A,,,,,,NA,,
PF-04937319,PF-04937319,CHEMBL2165615,BRD:BRD-BRD-K27755542-001-01-6;BRD:BRD-K27755542-001-01-6,rep_primary;rep_single_dose,GLUCOKINASE ACTIVATOR,GCK,,,PHASE 2,,Small molecule,2,Cc1cnc(NC(=O)c2cc(Oc3cnc(C(=O)N(C)C)nc3)c3cc(C)oc3c2)cn1;CN(C)C(=O)C1NCC(OC2CC(CC3OC(C)CC23)C(=O)NC2CNC(C)CN2)CN1,MASKQITXHVYVFL-UHFFFAOYSA-N
PF-04995274,PF-04995274,CHEMBL2152922,BRD:BRD-K00004635-001-01-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,,,,,,Small molecule,1,OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1,WLLOFQROROXOMO-GOSISDBHSA-N
PF-05089771,PF-05089771,CHEMBL3545171,BRD:BRD-K00003145-001-01-9,rep_single_dose,SODIUM CHANNEL BLOCKER,,,,,,Small molecule,2,,
PF-05175157,PF-05175157,CHEMBL3359265,BRD:BRD-K00002423-001-02-9,rep_single_dose,ACETYL-COA CARBOXYLASE INHIBITOR,,,,,,Small molecule,2,Cc1nc2ccc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2[nH]1,BDXXSFOJPYSYOC-UHFFFAOYSA-N
PF-999,PF-05180999;PF-999,CHEMBL3092562,BRD:BRD-K00003097-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,1,Cc1nc(-c2cnn(C)c2-c2ccc(C(F)(F)F)cn2)c2c(N3CCC3)ncnn12,CLGCHUKGBICQTE-UHFFFAOYSA-N
PF-5190457,PF-05190457;PF-5190457,CHEMBL3287218,BRD:BRD-BRD-K02554563-001-01-6;BRD:BRD-K02554563-001-01-6,rep_primary;rep_single_dose,GROWTH HORMONE SECRETAGOGUE RECEPTOR INVERSE AGONIST,GHSR,,,PHASE 2,,Small molecule,2,Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1;CC1CN2CC(CC(=O)N3CCC4(CN(C4)[C@@H]4CCC5CC(CCC45)-C4CC(C)NCN4)CC3)NC2S1,ZIUDADZJCKGWKR-AREMUKBSSA-N
PKI-587,GEDATOLISIB;PF-05212384;PKI-587,CHEMBL592445,BRD:BRD-BRD-K07955840-001-02-3;BRD:BRD-K07955840-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",MTOR;PIK3CA,,,PHASE 2,,Small molecule,3,"CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1;CN(C)C1CCN(CC1)C(=O)C1CCC(NC(=O)NC2CCC(CC2)-C2NC(NC(N2)N2CCOCC2)N2CCOCC2)CC1, CN(C)C1CCN(CC1)C(=O)C1CCC(NC(=O)NC2CCC(CC2)-C2NC(NC(N2)N2CCOCC2)N2CCOCC2)CC1, CN(C)C1CCN(CC1)C(=O)C1CCC(NC(=O)NC2CCC(CC2)-C2NC(NC(N2)N2CCOCC2)N2CCOCC2)CC1",DWZAEMINVBZMHQ-UHFFFAOYSA-N
PF-06260414,PF-06260414,CHEMBL4297476,BRD:BRD-K00004644-001-01-9,rep_single_dose,ANDROGEN RECEPTOR MODULATOR,,,,,,Small molecule,1,C[C@@H]1CNS(=O)(=O)N(c2ccc3c(C#N)nccc3c2)C1,ZKAVFOXYJCREBQ-SNVBAGLBSA-N
PF06273340,PF-06273340;PF06273340,CHEMBL4212531,BRD:BRD-K00004638-001-01-9,rep_single_dose,TYROSINE KINASE RECEPTOR INHIBITOR,,,,,,Small molecule,1,CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cn3)c2)c2cnc(N)nc21,BPIWZDNVMQQBQX-UHFFFAOYSA-N
PF-06282999,PF-06282999,CHEMBL3633460,BRD:BRD-K00003279-001-01-9,rep_single_dose,MYELOPEROXIDASE INHIBITOR,,,,,,Small molecule,1,COc1ccc(Cl)cc1-c1cc(=O)[nH]c(=S)n1CC(N)=O,ICYNYWFGIDGBRD-UHFFFAOYSA-N
PF-6305591,PF-06305591;PF-6305591,CHEMBL4297317,BRD:BRD-K00004712-001-01-9,rep_single_dose,SODIUM CHANNEL BLOCKER,,,,,,Small molecule,1,C[C@@H](C(N)=O)[C@H](N)c1nc2ccc(C(C)(C)C)cc2[nH]1,APWZIFIAVVFPNT-PELKAZGASA-N
PF-06409577,PF-06409577,,BRD:BRD-K00003731-001-01-9,rep_single_dose,PROTEIN KINASE ACTIVATOR,,,,,,,NA,,
PF-06412562,PF-06412562,,BRD:BRD-K00004652-001-01-9,rep_single_dose,DOPAMINE RECEPTOR PARTIAL AGONIST,,,,,,,NA,,
PF-06447475,PF-06447475,,BRD:BRD-BRD-K83114366-001-02-8;BRD:BRD-K83114366-001-02-8,rep_primary;rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,LRRK2,,,PRECLINICAL,,,NA,"N#CC1CCCC(C1)-C1C[NH]C2NCNC(N3CCOCC3)C12, N#CC1CCCC(C1)-C1C[NH]C2NCNC(N3CCOCC3)C12",
PF-06459988,PF-06459988,CHEMBL3786098,BRD:BRD-K00003311-001-01-9,rep_single_dose,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,,,,,,Small molecule,2,C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](OC)C1,ODMXWZROLKITMS-RISCZKNCSA-N
PF-06463922,LORBRENA;LORLATINIB;PF-06463922,CHEMBL3286830,BRD:BRD-A23124853-001-01-4;BRD:BRD-BRD-A23124853-001-01-4,rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,ALK;FES;ROS1,,,PHASE 2,,Small molecule,4,C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21;CC1OC2CC(CNC2N)-C2C(CN(C)C(=O)C3CCC(F)CC13)NN(C)C2C#N,IIXWYSCJSQVBQM-LLVKDONJSA-N
ZIMLOVISERTIB,PF 06650833;PF-06650833;ZIMLOVISERTIB,CHEMBL4081711,BRD:BRD-K00003296-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,Small molecule,2,CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12,JKDGKIBAOAFRPJ-ZBINZKHDSA-N
RITLECITINIB,PF-06651600;RITLECITINIB,CHEMBL4085457,BRD:BRD-K47084954-001-02-9,rep_single_dose,JAK INHIBITOR,,,,,,Small molecule,3,C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C,CBRJPFGIXUFMTM-WDEREUQCSA-N
PF-06747775,EGFR T790M INHIBITOR PF-06747775;MAVELERTINIB;PF-06747775,CHEMBL3989970,BRD:BRD-K00004648-001-01-9,rep_single_dose,EGFR INHIBITOR,,,,,,Small molecule,2,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F,JYIUNVOCEFIUIU-GHMZBOCLSA-N
PF-06751979,PF-06751979,CHEMBL4297807,BRD:BRD-K00004598-001-01-9,rep_single_dose,BETA SECRETASE INHIBITOR,,,,,,Unknown,1,,
PF-06840003,PF-06840003,CHEMBL4086143,BRD:BRD-K00003400-001-01-9,rep_single_dose,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",,,,,,Small molecule,1,O=C1CC(c2c[nH]c3ccc(F)cc23)C(=O)N1,MXKLDYKORJEOPR-UHFFFAOYSA-N
PF-06873600,EBVACICLIB;PF-06873600,CHEMBL4446357,BRD:BRD-K00004750-001-01-9;BRD:BRD-K00004750-001-03-9,oncref_2;rep_single_dose,"INHIBITOR OF CDK2, CDK4, AND CDK6",CDK2;CDK4;CDK6,,,,"Multiple values for MOA: {'CDK INHIBITOR', 'INHIBITOR OF CDK2, CDK4, AND CDK6'}, defaulting to 'INHIBITOR OF CDK2, CDK4, AND CDK6'",Small molecule,2,C[C@@]1(O)CCC[C@H]1n1c(=O)c(C(F)F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21,QIEKHLDZKRQLLN-FOIQADDNSA-N
PF-06928215,PF-06928215,,BRD:BRD-K00005326-001-01-9,rep_single_dose,CYCLIC GMP-AMP SYNTHASE INHIBITOR,,,,,,,NA,,
PF06952229,PF 06952229;PF-06952229;PF06952229,CHEMBL5095192,BRD:BRD-K00091071-001-01-9,rep_single_dose,,,,,,,Small molecule,1,CC(C)c1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccncc1C(=O)NC(CO)CO,IPBLCOKXDQHSQW-UHFFFAOYSA-N
PF-07104091,PF-07104091,,BRD:BRD-K00126469-001-01-9,oncref_2,INHIBITOR OF CDK2,CDK2,,,,,,NA,,
PF-184,PF-184,,CTRP:660208,ctrp,,,,,,,,NA,,
PF-3274167,PF-3274167,,BRD:BRD-BRD-K31417912-001-01-9;BRD:BRD-K31417912-001-01-9,rep_primary;rep_single_dose,OXYTOCIN RECEPTOR ANTAGONIST,AVPR1A;OXTR,,,PHASE 2,,,NA,COCC1NNC(N2CC(C2)OC2CCC(F)CC2CL)N1-C1CCC(OC)NC1,
PF-3758309,PF-03758309;PF-3758309,CHEMBL3128043,CTRP:687953,ctrp,,,,,,,Small molecule,1,Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1,AYCPARAPKDAOEN-LJQANCHMSA-N
PF-3845,PF-3845,,BRD:BRD-BRD-K68997413-001-05-1;BRD:BRD-K68997413-001-05-1,rep_multi_dose;rep_primary;rep_single_dose,FAAH INHIBITOR,FAAH,,,PRECLINICAL,,,NA,"FC(F)(F)C1CCC(OC2CCCC(CC3CCN(CC3)C(=O)NC3CCCNC3)C2)NC1, FC(F)(F)C1CCC(OC2CCCC(CC3CCN(CC3)C(=O)NC3CCCNC3)C2)NC1",
PF-4191834,PF-04191834;PF-4191834,CHEMBL4297416,BRD:BRD-K00004633-001-01-9,rep_single_dose,LIPOXYGENASE INHIBITOR,,,,,,Small molecule,2,Cn1nccc1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1,DVNQWYLVSNPCJZ-UHFFFAOYSA-N
PF-429242,PF-429242,,BRD:BRD-K11821338-300-02-9,rep_single_dose,SREBP INHIBITOR,MBTPS1,,,,,,NA,,
PF-431396,PF-431396,,BRD:BRD-BRD-K93788137-001-04-1;BRD:BRD-K93788137-001-04-1,rep_primary;rep_single_dose,FOCAL ADHESION KINASE INHIBITOR,PTK2;PTK2B,,,PRECLINICAL,,,NA,CN(C1CCCCC1CNC1NC(NC2CCC3NC(=O)CC3C2)NCC1C(F)(F)F)S(C)(=O)=O,
PF-4708671,PF-4708671,,BRD:BRD-BRD-K14711741-001-02-1;BRD:BRD-K14711741-001-02-1;GDSC1:1129;GDSC2:1129,gdsc;rep_primary;rep_single_dose,RIBOSOMAL PROTEIN INHIBITOR,RPS6KB1,,,PRECLINICAL,,,NA,"CCC1CNCNC1N1CCN(CC1)CC1NC2CC(CCC2[NH]1)C(F)(F)F, CCC1CNCNC1N1CCN(CC1)CC1NC2CC(CCC2[NH]1)C(F)(F)F",
PF477736,PF 477736;PF-00477736;PF-477736;PF-736;PF477736,CHEMBL3545137,BRD:BRD-BRD-K03063480-001-05-8;BRD:BRD-BRD-K03063480-001-06-6;BRD:BRD-K03063480-001-05-8;BRD:BRD-K03063480-001-06-6;BRD:BRD-K03063480-001-08-9,oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF CHEK1,CHEK1;CHEK2,,,PHASE 1,"Multiple values for MOA: {'INHIBITOR OF CHEK1', 'CHK INHIBITOR'}, defaulting to 'INHIBITOR OF CHEK1'
Multiple values for repurposing_target: {'CHEK1;CHEK2', 'CHEK1'}, taking the union",Small molecule,1,"Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1;CN1CC(CN1)-C1[NH]C2CC(NC(=O)[C@H](N)C3CCCCC3)CC3C2C1CN[NH]C3=O, CN1CC(CN1)-C1[NH]C2CC(NC(=O)[C@H](N)C3CCCCC3)CC3C2C1CN[NH]C3=O, CN1CC(CN1)-C1[NH]C2CC(NC(=O)[C@H](N)C3CCCCC3)CC3C2C1CN[NH]C3=O",YFNWWNRZJGMDBR-UHFFFAOYSA-N
PF-4800567,PF-4800567,,BRD:BRD-BRD-K43428468-003-04-0;BRD:BRD-K43428468-003-04-0,rep_primary;rep_single_dose,CASEIN KINASE INHIBITOR,CSNK1D;CSNK1E,,,PRECLINICAL,,,NA,NC1NCNC2N(NC(COC3CCCC(CL)C3)C12)C1CCOCC1,
PF-4800567 HYDROCHLORIDE,PF-4800567 HYDROCHLORIDE,,CTRP:688962,ctrp,,,,,,,,NA,,
PF-4981517,PF-4981517,,BRD:BRD-BRD-K78318619-001-02-7;BRD:BRD-K78318619-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP3A4,,,PRECLINICAL,,,NA,CC1CCC(CC1)-C1C(CNN1C)-C1NN(C)C2NCNC(N3CC[C@@H](C3)N3CCCCC3)C12,
PF-514273,PF-514273,,BRD:BRD-K00004642-001-01-9,rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,,,,,,,NA,,
PF-5274857,PF-5274857,,BRD:BRD-BRD-K40302533-001-02-9;BRD:BRD-K40302533-001-02-9,rep_primary;rep_single_dose,SMOOTHENED RECEPTOR ANTAGONIST,SMO,,,PRECLINICAL,,,NA,"CC1CNC(C(C)C1)-C1CC(NCC1CL)N1CCN(CC1)C(=O)CCS(C)(=O)=O, CC1CNC(C(C)C1)-C1CC(NCC1CL)N1CCN(CC1)C(=O)CCS(C)(=O)=O",
PF-543,PF-543,,CTRP:660073;GDSC1:408,ctrp;gdsc,,,,,,,,NA,,
PF-562271 BESILATE,PF 562271;PF-00562271;PF-562271;PF-562271 BESILATE,CHEMBL1084546,BRD:BRD-BRD-K99545815-001-06-3;BRD:BRD-K99545815-001-06-3;GDSC1:158,gdsc;rep_multi_dose;rep_primary;rep_single_dose,FOCAL ADHESION KINASE INHIBITOR,PTK2;PTK2B,,,PHASE 1,,Small molecule,1,"CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O;CN(C1NCCCC1CNC1NC(NC2CCC3NC(=O)CC3C2)NCC1C(F)(F)F)S(C)(=O)=O, CN(C1NCCCC1CNC1NC(NC2CCC3NC(=O)CC3C2)NCC1C(F)(F)F)S(C)(=O)=O, CN(C1NCCCC1CNC1NC(NC2CCC3NC(=O)CC3C2)NCC1C(F)(F)F)S(C)(=O)=O, CN(C1NCCCC1CNC1NC(NC2CCC3NC(=O)CC3C2)NCC1C(F)(F)F)S(C)(=O)=O",MZDKLVOWGIOKTN-UHFFFAOYSA-N
PF-573228,PF-573228,,BRD:BRD-BRD-K79239947-001-06-8;BRD:BRD-K79239947-001-06-8;BRD:BRD-U00115423-001-01-9;CTRP:660075,ctrp;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,FOCAL ADHESION KINASE INHIBITOR,CDK1;CDK2;CDK7;FAK;GSK3B;IKBKB,,,PRECLINICAL,"Multiple values for MOA: {'FOCAL ADHESION KINASE INHIBITOR', 'INHIBITOR OF FAK'}, defaulting to 'FOCAL ADHESION KINASE INHIBITOR'
Multiple values for repurposing_target: {'FAK', 'CDK1;CDK2;CDK7;GSK3B;IKBKB'}, taking the union
Multiple values for structure_id: {'U00115423', 'K79239947'}, defaulting to None",,NA,"CS(=O)(=O)C1CCCC(CNC2NC(NC3CCC4NC(=O)CCC4C3)NCC2C(F)(F)F)C1, CS(=O)(=O)C1CCCC(CNC2NC(NC3CCC4NC(=O)CCC4C3)NCC2C(F)(F)F)C1",
PF-670462,PF-670462,,BRD:BRD-BRD-K96295391-300-01-7;BRD:BRD-K96295391-300-01-7,rep_primary;rep_single_dose,CASEIN KINASE INHIBITOR,CSNK1D;CSNK1E,,,PRECLINICAL,,,NA,"NC1NCCC(N1)-C1C(NCN1C1CCCCC1)-C1CCC(F)CC1, NC1NCCC(N1)-C1C(NCN1C1CCCCC1)-C1CCC(F)CC1",
PF-750,PF-750,,BRD:BRD-K83213911-001-08-9;CTRP:411719,ctrp;rep_single_dose,FAAH INHIBITOR,FAAH,,,,,,NA,,
PF-8380,PF-8380,,BRD:BRD-K50865540-001-02-3,rep_single_dose,AUTOTAXIN INHIBITOR,ENPP2,,,,,,NA,,
PF-915275,PF-915275,,BRD:BRD-BRD-K18289362-001-02-2;BRD:BRD-K18289362-001-02-2,rep_primary;rep_single_dose,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,HSD11B1,,,PHASE 1,,,NA,"NC1CCCC(NS(=O)(=O)C2CCC(CC2)-C2CCC(CC2)C#N)N1, NC1CCCC(NS(=O)(=O)C2CCC(CC2)-C2CCC(CC2)C#N)N1",
PF4708671,PF 4708671;PF4708671,,GDSC1:1129;GDSC2:1129,gdsc,,,,,,,,NA,,
PFI-1,PFI-1,,BRD:BRD-BRD-K13094524-001-07-5;BRD:BRD-K13094524-001-07-5;GDSC1:1219,gdsc;rep_multi_dose;rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,BRD4,,,PRECLINICAL,,,NA,"COC1CCCCC1S(=O)(=O)NC1CCC2NC(=O)N(C)CC2C1, COC1CCCCC1S(=O)(=O)NC1CCC2NC(=O)N(C)CC2C1, COC1CCCCC1S(=O)(=O)NC1CCC2NC(=O)N(C)CC2C1",
PFI-3,PFI-3,,BRD:BRD-K61524559-001-04-7;GDSC1:1530;GDSC2:1620,gdsc;rep_single_dose,BROMODOMAIN INHIBITOR,PBRM1;SMARCA4,,,,,,NA,,
PFI-4,PFI-4,,BRD:BRD-K13106865-001-02-9,rep_single_dose,BROMODOMAIN INHIBITOR,BRPF1,,,,,,NA,,
PFI-6,PFI-6,,BRD:BRD-K00126494-001-01-9,oncref_2,INHIBITOR OF MLLT1 AND MLLT3,MLLT1;MLLT3,,,,,,NA,,
PFI3,AOB2221;PFI 3;PFI3,,GDSC2:1620,gdsc,,,,,,,,NA,,
PFK-015,PFK-015,,BRD:BRD-BRD-K95573441-001-01-2;BRD:BRD-K95573441-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHOFRUCTOKINASE INHIBITOR,PFKFB3,,,PHASE 1,,,NA,"O=C(\C=C\C1CCC2CCCCC2N1)C1CCNCC1, O=C(\C=C\C1CCC2CCCCC2N1)C1CCNCC1",
PFK-158,PFK-158,CHEMBL4303611,BRD:BRD-BRD-K28010364-001-01-0;BRD:BRD-K28010364-001-01-0,rep_primary;rep_single_dose,PHOSPHOFRUCTOKINASE INHIBITOR,PFKFB3,,,PHASE 1,,Small molecule,1,FC(F)(F)C1CCC2CCC(\C=C\C(=O)C3CCNCC3)NC2C1;O=C(/C=C/c1ccc2ccc(C(F)(F)F)cc2n1)c1ccncc1,IAJOMYABKVAZCN-AATRIKPKSA-N
PG-9,PG-9,,BRD:BRD-A70268693-050-01-2;BRD:BRD-BRD-A70268693-050-01-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,CC(C(=O)OC1CC2CCC(C1)N2C)C1CCC(BR)CC1,
PGL5001,AS-602801;AS602801;BENTAMAPIMOD;PGL-5001;PGL5001,CHEMBL3545213,BRD:BRD-A53813595-001-01-8;BRD:BRD-BRD-A53813595-001-01-8,rep_primary;rep_single_dose,JNK INHIBITOR,MAPK10;MAPK8;MAPK9,,,PHASE 2,,Small molecule,2,"N#CC(c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1)c1nc2ccccc2s1;N#CC(C1NC2CCCCC2S1)C1CCNC(OCC2CCC(CN3CCOCC3)CC2)N1, N#CC(C1NC2CCCCC2S1)C1CCNC(OCC2CCC(CN3CCOCC3)CC2)N1, N#CC(C1NC2CCCCC2S1)C1CCNC(OCC2CCC(CN3CCOCC3)CC2)N1",XCPPIJCBCWUBNT-UHFFFAOYSA-N
PHA-797804,PH-797804;PHA-797804,CHEMBL1088751,BRD:BRD-BRD-K95880107-001-02-4;BRD:BRD-K95880107-001-02-4,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK11;MAPK14,,,PHASE 2,,Small molecule,2,CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1;CNC(=O)C1CCC(C)C(C1)-N1C(C)CC(OCC2CCC(F)CC2F)C(BR)C1=O,KCAJXIDMCNPGHZ-UHFFFAOYSA-N
PHA-543613,"J3.179.420J;PHA-00543613;PHA-543,613;PHA-543613",CHEMBL214268,BRD:BRD-K00004641-001-01-9,rep_single_dose,NICOTINIC RECEPTOR AGONIST,,,,,,Small molecule,1,O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1,IPKZCLGGYKRDES-ZDUSSCGKSA-N
PHA-568487,PHA-568487,,BRD:BRD-K48053228-051-02-9,rep_single_dose,NICOTINIC RECEPTOR AGONIST,CHRNA7,,,,,,NA,,
TCMDC-125885,PHA-665752;TCMDC-125885,CHEMBL450786,BRD:BRD-BRD-K95435023-001-08-5;BRD:BRD-BRD-K95435023-001-10-1;BRD:BRD-K95435023-001-08-5;BRD:BRD-K95435023-001-10-1;GDSC1:6,gdsc;rep_multi_dose;rep_primary;rep_single_dose,C-MET INHIBITOR,MET,,,PRECLINICAL,,Small molecule,NA,"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1;CC1[NH]C(\C=C2/C(=O)NC3CCC(CC23)S(=O)(=O)CC2C(CL)CCCC2CL)C(C)C1C(=O)N1CCC[C@@H]1CN1CCCC1, CC1[NH]C(\C=C2/C(=O)NC3CCC(CC23)S(=O)(=O)CC2C(CL)CCCC2CL)C(C)C1C(=O)N1CCC[C@@H]1CN1CCCC1, CC1[NH]C(\C=C2/C(=O)NC3CCC(CC23)S(=O)(=O)CC2C(CL)CCCC2CL)C(C)C1C(=O)N1CCC[C@@H]1CN1CCCC1, CC1[NH]C(\C=C2/C(=O)NC3CCC(CC23)S(=O)(=O)CC2C(CL)CCCC2CL)C(C)C1C(=O)N1CCC[C@@H]1CN1CCCC1",OYONTEXKYJZFHA-SSHUPFPWSA-N
PHA-680632,PHA-680632,CHEMBL363160,BRD:BRD-BRD-K09443272-001-03-3;BRD:BRD-K09443272-001-03-3,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB;AURKC,,,PRECLINICAL,,Small molecule,NA,CCC1CCCC(CC)C1NC(=O)N1CC2[NH]NC(NC(=O)C3CCC(CC3)N3CCN(C)CC3)C2C1;CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1,OBWNXGOQPLDDPS-UHFFFAOYSA-N
PHA-767491,PHA-767491,,BRD:BRD-BRD-K50000283-001-04-4;BRD:BRD-K50000283-001-04-4,rep_multi_dose;rep_primary;rep_single_dose,CDC INHIBITOR,CDK1;RPS6KB1,,,PRECLINICAL,,,NA,"O=C1NCCC2[NH]C(CC12)-C1CCNCC1, O=C1NCCC2[NH]C(CC12)-C1CCNCC1",
PHA-793887,PHA-793887,CHEMBL1230607,BRD:BRD-BRD-K64800655-001-07-4;BRD:BRD-K64800655-001-07-4;CTRP:640007;GDSC1:301,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK4;CDK5;CDK7;CDK9,,,PHASE 1,,Small molecule,1,"CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C;CC(C)CC(=O)NC1N[NH]C2C1CN(C(=O)C1CCN(C)CC1)C2(C)C, CC(C)CC(=O)NC1N[NH]C2C1CN(C(=O)C1CCN(C)CC1)C2(C)C",HUXYBQXJVXOMKX-UHFFFAOYSA-N
PHA-848125,MILCICLIB;PHA 848125;PHA-848125,CHEMBL564829,BRD:BRD-BRD-K60997853-001-02-3;BRD:BRD-K60997853-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,"CDK INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR",CDK2;CDK4;CDK7;NTRK1,,,PHASE 2,,Small molecule,2,CNC(=O)C1NN(C)C-2C1C(C)(C)CC1CNC(NC3CCC(CC3)N3CCN(C)CC3)NC-21;CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,RXZMYLDMFYNEIM-UHFFFAOYSA-N
PHA665752,PHA 665752;PHA665752,,GDSC1:6,gdsc,,,,,,,,NA,,
PHA793887,PHA 793887;PHA793887,,GDSC1:301,gdsc,,,,,,,,NA,,
PHCCC,PHCCC,,BRD:BRD-A59709458-001-01-8;BRD:BRD-BRD-A59709458-001-01-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRM1;GRM4,,,PRECLINICAL,,,NA,"O\N=C1/C2CC2(OC2CCCCC12)C(=O)NC1CCCCC1, O\N=C1/C2CC2(OC2CCCCC12)C(=O)NC1CCCCC1",
PHENACAINE,PHENACAINE,CHEMBL127123,BRD:BRD-BRD-K81092066-311-01-6;BRD:BRD-K81092066-311-01-6,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,LOCAL ANESTHETIC,,LAUNCHED,,Small molecule,-1,CCOc1ccc(/N=C(\C)Nc2ccc(OCC)cc2)cc1;CCOC1CCC(NC(C)=NC2CCC(OCC)CC2)CC1,QXDAEKSDNVPFJG-UHFFFAOYSA-N
PHENURONE,NSC-39458;PHENACEMIDE;PHENURONE,CHEMBL918,BRD:BRD-BRD-K40905133-001-04-9;BRD:BRD-K40905133-001-04-9,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,"EPILEPSY, SEIZURES",,LAUNCHED,,Small molecule,4,NC(=O)NC(=O)Cc1ccccc1;NC(=O)NC(=O)CC1CCCCC1,XPFRXWCVYUEORT-UHFFFAOYSA-N
PHENAZETIN,ACETAMIDE;ACETOPHENETIDIN;ACETPHENETIDIN;FENIDINA;KALMIN;N-(4-ETHOXYPHENOL)-;NSC-7651;P-ACETOPHENETIDIDE;PHENACETIN;PHENACETIN MELTING POINT STANDARD;PHENACETINUM;PHENAZETIN,CHEMBL16073,BRD:BRD-BRD-K38323065-001-19-9;BRD:BRD-K38323065-001-19-9,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1,,,WITHDRAWN,,Small molecule,4,"CCOc1ccc(NC(C)=O)cc1;CCOC1CCC(NC(C)=O)CC1, CCOC1CCC(NC(C)=O)CC1",CPJSUEIXXCENMM-UHFFFAOYSA-N
PHENAZONE,ANTIPYRIN;ANTIPYRINE;ANTIPYRINUM;NSC-7945;PHENAZON;PHENAZONE,CHEMBL277474,BRD:BRD-BRD-K46937689-001-15-0;BRD:BRD-K46937689-001-15-0,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,PAIN RELIEF,,LAUNCHED,,Small molecule,4,"Cc1cc(=O)n(-c2ccccc2)n1C;CC1CC(=O)N(-C2CCCCC2)N1C, CC1CC(=O)N(-C2CCCCC2)N1C",VEQOALNAAJBPNY-UHFFFAOYSA-N
PHENAZOPYRIDINE,NSC-145895;PHENAZOPYRIDINE,CHEMBL1242,BRD:BRD-BRD-K76304753-003-20-3;BRD:BRD-BRD-K76304753-003-21-1;BRD:BRD-K76304753-003-20-3;BRD:BRD-K76304753-003-21-1,rep_primary;rep_single_dose,LOCAL ANESTHETIC,SCN1A,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,"Nc1ccc(/N=N/c2ccccc2)c(N)n1;NC1CCC(\N=N\C2CCCCC2)C(N)N1, NC1CCC(\N=N\C2CCCCC2)C(N)N1, NC1CCC(\N=N\C2CCCCC2)C(N)N1",QPFYXYFORQJZEC-FOCLMDBBSA-N
PHENELZINE,NARDIL;PHENELZINE,CHEMBL1089,BRD:BRD-BRD-K87024524-065-17-7;BRD:BRD-K87024524-065-17-7,rep_multi_dose;rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,ABAT;AOC3;GAD2;GPT;GPT2;MAOA;MAOB;SLC6A2;SLC6A3;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"NNCCc1ccccc1;NNCCC1CCCCC1, NNCCC1CCCCC1, NNCCC1CCCCC1",RMUCZJUITONUFY-UHFFFAOYSA-N
PHENFORMIN,PHENFORMIN,CHEMBL170988,BRD:BRD-BRD-K11399644-003-11-3;BRD:BRD-K11399644-003-11-3;GDSC1:196,gdsc;rep_primary;rep_single_dose,AMPK ACTIVATOR,KCNJ8;PRKAA1,,,WITHDRAWN,,Small molecule,4,"N=C(N)NC(=N)NCCc1ccccc1;NC(=N)NC(=N)NCCC1CCCCC1, NC(=N)NC(=N)NCCC1CCCCC1, NC(=N)NC(=N)NCCC1CCCCC1",ICFJFFQQTFMIBG-UHFFFAOYSA-N
PHENYLINDANEDIONE,DANILONE;DINDEVAN;HEDULIN;NSC-41693;PHENINDIONE;PHENYLINDANEDIONE,CHEMBL711,BRD:BRD-BRD-K70592963-001-31-6;BRD:BRD-K70592963-001-31-6,rep_primary;rep_single_dose,VITAMIN K ANTAGONIST,VKORC1,DEEP VEIN THROMBOSIS (DVT),,LAUNCHED,,Small molecule,4,"O=C1C(C(=O)C2CCCCC12)C1CCCCC1, O=C1C(C(=O)C2CCCCC12)C1CCCCC1, O=C1C(C(=O)C2CCCCC12)C1CCCCC1, O=C1C(C(=O)C2CCCCC12)C1CCCCC1, O=C1C(C(=O)C2CCCCC12)C1CCCCC1, O=C1C(C(=O)C2CCCCC12)C1CCCCC1;O=C1c2ccccc2C(=O)C1c1ccccc1",NFBAXHOPROOJAW-UHFFFAOYSA-N
TRIPOTON,NSC-47965;PHENIRAMINE;PROPHENIRAMINE;PROPHENPYRIDAMINE;PYRITON;TRIPOTON,CHEMBL1193,BRD:BRD-A23072235-050-18-5;BRD:BRD-BRD-A23072235-050-18-5,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,4,"CN(C)CCC(c1ccccc1)c1ccccn1;CN(C)CCC(C1CCCCC1)C1CCCCN1, CN(C)CCC(C1CCCCC1)C1CCCCN1",IJHNSHDBIRRJRN-UHFFFAOYSA-N
YELLOW,"ALOPHEN;EX-LAX;FEEN-A-MINT GUM;PHENOLPHTHALEIN;PHENOLPHTHALEIN, YELLOW;PRULET;YELLOW",CHEMBL2109222;CHEMBL63857,BRD:BRD-BRD-K19227686-001-18-6;BRD:BRD-K19227686-001-18-6,rep_primary;rep_single_dose,INDICATOR DYE,UGT1A9,,,WITHDRAWN,,Unknown,-1,OC1CCC(CC1)C1(OC(=O)C2CCCCC12)C1CCC(O)CC1,
PHENOSULFOPHTHALEIN,NSC-10459;PHENOL RED;PHENOLSULFONPHTHALEIN;PHENOLSULPHONPHTHALEIN;PHENOSULFOPHTHALEIN,CHEMBL258921,BRD:BRD-BRD-K79892937-001-02-5;BRD:BRD-K79892937-001-02-5,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21;OC1CCC(CC1)C1(OS(=O)(=O)C2CCCCC12)C1CCC(O)CC1,BELBBZDIHDAJOR-UHFFFAOYSA-N
THIODIPHENYLAMINE,10H-PHENOTHIAZINE;CONTAVERM;DANIKOROPA;ENT 38;ENT-38;FENOVERM;NEMAZINE;NSC-2037;PHENOTHIAZINE;PHENTHIAZINE;THIODIPHENYLAMINE,CHEMBL828,BRD:BRD-BRD-K59597909-001-17-6;BRD:BRD-K59597909-001-17-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,PRECLINICAL,,Small molecule,-1,"c1ccc2c(c1)Nc1ccccc1S2;N1C2CCCCC2SC2CCCCC12, N1C2CCCCC2SC2CCCCC12, N1C2CCCCC2SC2CCCCC12",WJFKNYWRSNBZNX-UHFFFAOYSA-N
SUMITHRIN,D-PHENOTRHIN;FULL MARKS;HEGOR ANTIPOUX;NSC-758668;PHENOTHRIN;S-2539F;SUMITHRIN,CHEMBL1322884,BRD:BRD-A22106989-001-05-0;BRD:BRD-BRD-A22106989-001-05-0,rep_primary;rep_single_dose,,,LICE,,LAUNCHED,,Small molecule,4,"CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C;CC(C)=CC1C(C(=O)OCC2CCCC(OC3CCCCC3)C2)C1(C)C, CC(C)=CC1C(C(=O)OCC2CCCC(OC3CCCCC3)C2)C1(C)C",SBNFWQZLDJGRLK-UHFFFAOYSA-N
SPANTOL,MH-532;NSC-44682;NSC-50538;NSC-64270;PHENPROBAMATE;SPANTOL,CHEMBL1079576,BRD:BRD-BRD-K22009844-001-12-5;BRD:BRD-K22009844-001-12-5,rep_primary;rep_single_dose,MUSCLE RELAXANT,,"ANXIETY, MUSCLE RELAXANT",,LAUNCHED,,Small molecule,-1,NC(=O)OCCCc1ccccc1;NC(=O)OCCCC1CCCCC1,CAMYKONBWHRPDD-UHFFFAOYSA-N
RO-1-4849,BS-7565;FENCUMAR;LIQUAMAR;MARCOUMAR;MARCUMAR;PHENPROCOUMAROL;PHENPROCOUMAROLE;PHENPROCOUMON;PHENPROCUMONE;RO-1-4849,CHEMBL1465;CHEMBL16694,BRD:BRD-A49838158-001-01-1;BRD:BRD-BRD-A49838158-001-01-1,rep_primary;rep_single_dose,VITAMIN K ANTAGONIST,VKORC1,"THROMBOSIS, PULMONARY EMBOLISM (PE)",,LAUNCHED,,Small molecule,4,CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O;CCC(C1CCCCC1)C1C(O)C2CCCCC2OC1=O,DQDAYGNAKTZFIW-UHFFFAOYSA-N
R-PHENSERINE,(+)-;ANVS-401;ANVS401;BUNTANETAP;BUNTANETAP ;PHENSERINE;POSIPHEN;R-PHENSERINE,CHEMBL4297417;CHEMBL74926,BRD:BRD-BRD-K46580984-001-03-6;BRD:BRD-K46580984-001-03-6,rep_primary;rep_single_dose,"ACETYLCHOLINESTERASE INHIBITOR, BETA AMYLOID SYNTHESIS INHIBITOR",ACHE;BCHE,,,PHASE 3,,Small molecule,3,"CN1CC[C@]2(C)[C@H]1N(C)C1CCC(OC(=O)NC3CCCCC3)CC21, CN1CC[C@]2(C)[C@H]1N(C)C1CCC(OC(=O)NC3CCCCC3)CC21;CN1CC[C@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@H]12",PBHFNBQPZCRWQP-AZUAARDMSA-N
SUCCITIMAL,1-METHYL-3-PHENYLSUCCINIMIDE;EPIMID;LIFENE;MILONTIN;MILONTON;MIRONTIN;N-METHYL-3-PHENYLPYRROLIDINEDIONE;NSC-760079;PHENSUXIMID;PHENSUXIMIDE;PM-334;RACEMIC PHENSUXIMIDE;SUCCITIMAL,CHEMBL797,BRD:BRD-A18043272-001-09-9;BRD:BRD-BRD-A18043272-001-09-9,rep_primary;rep_single_dose,SUCCINIMIDE ANTIEPILEPTIC,CACNA1G;CACNA1H;CACNA1I,SEIZURES,,LAUNCHED,,Small molecule,4,CN1C(=O)CC(C1=O)C1CCCCC1;CN1C(=O)CC(c2ccccc2)C1=O,WLWFNJKHKGIJNW-UHFFFAOYSA-N
QSIVA,DUROMINE;IONAMIN;NSC-759163;PHENTERMINE;PHENTERMINE RESIN;PHENTERMINE RESIN 30;PHENTERMINE RESIN COMPLEX;QSIVA,CHEMBL1574,BRD:BRD-BRD-K96319534-003-03-9;BRD:BRD-K96319534-003-03-9,rep_primary;rep_single_dose,"DOPAMINE UPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",MAOA;MAOB;SLC6A2;SLC6A3;SLC6A4,WEIGHT-LOSS AID,,LAUNCHED,,Small molecule,4,CC(C)(N)Cc1ccccc1;CC(C)(N)CC1CCCCC1,DHHVAGZRUROJKS-UHFFFAOYSA-N
PHENTOLAMINE,PHENTOLAMIN;PHENTOLAMINE,CHEMBL597,BRD:BRD-BRD-K90333595-003-21-4;BRD:BRD-K90333595-003-21-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C,"PHEOCHROMOCYTOMA, HYPERTENSION",,LAUNCHED,,Small molecule,4,"CC1CCC(CC1)N(CC1=NCCN1)C1CCCC(O)C1, CC1CCC(CC1)N(CC1=NCCN1)C1CCCC(O)C1, CC1CCC(CC1)N(CC1=NCCN1)C1CCCC(O)C1, CC1CCC(CC1)N(CC1=NCCN1)C1CCCC(O)C1;Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1",MRBDMNSDAVCSSF-UHFFFAOYSA-N
PHENYL-AMINOSALICYLATE,PHENYL-AMINOSALICYLATE,,BRD:BRD-BRD-K73157543-001-04-1;BRD:BRD-K73157543-001-04-1,rep_primary;rep_single_dose,,,TUBERCULOSIS,,LAUNCHED,,,NA,NC1CCC(C(=O)OC2CCCCC2)C(O)C1,
PHENYL-SALICYLATE,PHENYL-SALICYLATE,,BRD:BRD-K44091963-001-04-9,rep_single_dose,ANTISEPTIC,,,,,,,NA,,
PHENYLACETYLGLUTAMINE,PHENYLACETYLGLUTAMINE,,BRD:BRD-BRD-K70592483-001-01-0;BRD:BRD-K70592483-001-01-0,rep_primary;rep_single_dose,"DNA METHYLASE INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",,,,PHASE 2,,,NA,NC(=O)CC[C@H](NC(=O)CC1CCCCC1)C(O)=O,
PHENYLBENZIMIDAZOLE-SULFONIC-ACID,PHENYLBENZIMIDAZOLE-SULFONIC-ACID,,BRD:BRD-BRD-K02729857-001-01-9;BRD:BRD-K02729857-001-01-9,rep_primary;rep_single_dose,,,SUNSCREEN LOTION,,LAUNCHED,,,NA,OS(=O)(=O)C1CCC2[NH]C(NC2C1)-C1CCCCC1,
ZOLAPHEN,AMBENE;ANTADOL;ARTRIZIN;AZOLID;BIZOLIN;BUTACOTE;BUTADION;BUTADIONA;BUTAJECT;BUTAPIRAZOL;BUTATRON;BUTAZOLIDIN;BUTOZ;BUZON;DIPHEBUZOL;DIPHENYLBUTAZONE;ECOBUTAZONE;ELMEDAL;EQUIPALAZONE;EQUIPHAR;EXRHEUDON N;FENIBUTAZONA;FENIBUTOL;FENYLBUTAZON;FLEXAZONE;G-13871;INTRABUTAZONE;INTRAZONE;MEPHA-BUTAZON;NSC-25134;PHEBUZINE;PHENYLBUTAZONE;PHENYZENE;PRO-BUTE;R-3-ZON;ROBIZONE-V;SHIGRODIN;TEVCODYNE;UZONE;ZOLAPHEN,CHEMBL101,BRD:BRD-BRD-K10843433-001-22-7;BRD:BRD-BRD-K10843433-001-23-5;BRD:BRD-K10843433-001-22-7;BRD:BRD-K10843433-001-23-5,rep_multi_dose;rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",PTGIS;PTGS1;PTGS2,,,WITHDRAWN,,Small molecule,4,"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O;CCCCC1C(=O)N(N(C1=O)C1CCCCC1)C1CCCCC1, CCCCC1C(=O)N(N(C1=O)C1CCCCC1)C1CCCCC1, CCCCC1C(=O)N(N(C1=O)C1CCCCC1)C1CCCCC1",VYMDGNCVAMGZFE-UHFFFAOYSA-N
PHENYLBUTYRATE,PHENYLBUTYRATE,,BRD:BRD-BRD-K67102207-236-07-7;BRD:BRD-K67102207-236-07-7,rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1,UREA CYCLE DISORDERS,,LAUNCHED,,,NA,"OC(=O)CCCC1CCCCC1, OC(=O)CCCC1CCCCC1, OC(=O)CCCC1CCCCC1, OC(=O)CCCC1CCCCC1",
R(-)-MEZATON,(-)-PHENYLEPHRINE;(R)-;(R)-PHENYLEPHRINE;AB-101 (PHENYLEPHRINE);CYCLOMYDRIL;DUO-MEDIHALER;J8.601K;M-OXEDRINE;M-SYMPATHOL;M-SYMPATOL;M-SYNEPHRINE;META-SYNEPHRINE;METASYNEPHRINE;PHENYLEPHRINE;PHENYLEPHRINE MINIMS;R(-)-MEZATON,CHEMBL1215,BRD:BRD-BRD-K73381542-003-23-4;BRD:BRD-K73381542-003-23-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D,"NASAL CONGESTION, HEMORRHOIDS, HYPOTENSION",,LAUNCHED,,Small molecule,4,"CNC[C@H](O)c1cccc(O)c1;CNC[C@H](O)C1CCCC(O)C1, CNC[C@H](O)C1CCCC(O)C1, CNC[C@H](O)C1CCCC(O)C1",SONNWYBIRXJNDC-VIFPVBQESA-N
PHENYLMERCURIC-ACETATE,PHENYLMERCURIC-ACETATE,,BRD:BRD-BRD-K74193284-001-04-8;BRD:BRD-K74193284-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,OTHER ANTIFUNGAL,,,,PRECLINICAL,,,NA,CC(=O)O[HG]C1CCCCC1,
PHENYLMETHYLSULFONYL-FLUORIDE,PHENYLMETHYLSULFONYL-FLUORIDE,,BRD:BRD-K33422401-001-06-4,rep_single_dose,SERINE PROTEASE INHIBITOR,,,,,,,NA,,
PHENYLPIRACETAM,PHENYLPIRACETAM,,BRD:BRD-A65683612-001-07-7;BRD:BRD-BRD-A65683612-001-07-7,rep_primary;rep_single_dose,NORADRENALINE UPTAKE INHIBITOR,,"ANXIETY, FATIGUE, DEPRESSION",,LAUNCHED,,,NA,NC(=O)CN1CC(CC1=O)C1CCCCC1,
ZENTROPIL,DILABID;DILANTIN;DILANTIN-125;DILANTIN-30;DIPHENYLHYDANTOIN;EPAMIN;HYDANTOL;LEPITOIN;NSC-8722;PHENTYTOIN;PHENYTEK;PHENYTEX;PHENYTOIN;PHENYTOINUM;SM-88 COMPONENT PHENYTOIN;ZENTROPIL,CHEMBL16,BRD:BRD-BRD-K55930204-236-24-3;BRD:BRD-K55930204-236-24-3,rep_primary;rep_single_dose,HYDANTOIN ANTIEPILEPTIC,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,Small molecule,4,"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1;O=C1NC(=O)C(N1)(C1CCCCC1)C1CCCCC1, O=C1NC(=O)C(N1)(C1CCCCC1)C1CCCCC1, O=C1NC(=O)C(N1)(C1CCCCC1)C1CCCCC1",CXOFVDLJLONNDW-UHFFFAOYSA-N
PHIKAN-083,PHIKAN-083,,BRD:BRD-K44400149-003-02-9,rep_single_dose,P53 STABILIZING AGENT,TP53,,,,,,NA,,
PHLORETIN,"2',4,4',6'-TETRAHYDROXY-DIHYDROCHALCONE;2',4,4',6'-TETRAHYDROXYDIHYDROCHALCONE;PHLORETIN",CHEMBL45068,BRD:BRD-BRD-K15563106-001-18-0;BRD:BRD-K15563106-001-18-0;CTRP:24173,ctrp;rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,AQP9;CLCN3;SLC23A1,,,LAUNCHED,,Small molecule,NA,O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O;OC1CCC(CCC(=O)C2C(O)CC(O)CC2O)CC1,VGEREEWJJVICBM-UHFFFAOYSA-N
PHLORIZIN,PHLORIDZIN;PHLORIZIN,CHEMBL245067,BRD:BRD-BRD-K24601397-001-01-1;BRD:BRD-K24601397-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,SLC5A1;SLC5A11;SLC5A2;SLC5A3,,,PRECLINICAL,,Small molecule,NA,O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O;OC[C@H]1O[C@@H](OC2CC(O)CC(O)C2C(=O)CCC2CCC(O)CC2)[C@@H](O)[C@@H](O)[C@@H]1O,IOUVKUPGCMBWBT-QNDFHXLGSA-N
SYM-TRIHYDROXYBENZENE,"BENEZENE-1,3,5-TRIOL;DILOSPAN S;NSC-1572;PHLOROGLUCIN;PHLOROGLUCINOL;SPASFON;SPASFON-LYOC;SYM-TRIHYDROXYBENZENE",CHEMBL473159,BRD:BRD-BRD-K00405906-001-01-9;BRD:BRD-K00405906-001-01-9,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,4,Oc1cc(O)cc(O)c1;OC1CC(O)CC(O)C1,QCDYQQDYXPDABM-UHFFFAOYSA-N
PHORTRESS,PHORTRESS,,BRD:BRD-BRD-K74558903-300-01-5;BRD:BRD-K74558903-300-01-5,rep_primary;rep_single_dose,ARYL HYDROCARBON RECEPTOR LIGAND,AHR,,,PHASE 1,,,NA,CC1CC(CCC1NC(=O)[C@@H](N)CCCCN)-C1NC2CC(F)CCC2S1,
PHOSPHOLIPIDS EGG,PHOSPHATIDYLCHOLINE;PHOSPHOLIPIDS EGG,CHEMBL503481,BRD:BRD-BRD-U51753822-000-01-1;BRD:BRD-U51753822-000-01-1,rep_primary;rep_single_dose,,PCTP,"HEPATITIS B, HEPATITIS C, ECZEMA, GALLBLADDER DISEASE, CHOLESTEROL, PREMENSTRUAL SYNDROME",,LAUNCHED,,Small molecule,3,", CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC;CCCCCCCCCCCCCCSCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CSCCCCCCCCCCCCCC",ZZWQHNRGJQENEP-KXQOOQHDSA-N
PHP-501,PHP-501,,BRD:BRD-K07460388-019-02-9,rep_single_dose,GABA RECEPTOR ANTAGONIST,GABRA1;GABRB2;GABRG2,,,,,,NA,,
PHT-427,PHT-427,,BRD:BRD-BRD-K59745944-001-02-0;BRD:BRD-K59745944-001-02-0,rep_primary;rep_single_dose,"AKT INHIBITOR, PYRUVATE DEHYDROGENASE INHIBITOR",AKT2;PDPK1,,,PRECLINICAL,,,NA,"CCCCCCCCCCCCC1CCC(CC1)S(=O)(=O)NC1NNCS1, CCCCCCCCCCCCC1CCC(CC1)S(=O)(=O)NC1NNCS1, CCCCCCCCCCCCC1CCC(CC1)S(=O)(=O)NC1NNCS1",
THALAMYD,NSC-163977;PHTHALYLSULFACETAMIDE;PHTHALYLSULPHACETAMIDE;TALSIGEL;THALAMYD,CHEMBL2106951,BRD:BRD-BRD-K77115421-001-02-6;BRD:BRD-K77115421-001-02-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,"CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2C(=O)O)cc1;CC(=O)NS(=O)(=O)C1CCC(NC(=O)C2CCCCC2C(O)=O)CC1, CC(=O)NS(=O)(=O)C1CCC(NC(=O)C2CCCCC2C(O)=O)CC1, CC(=O)NS(=O)(=O)C1CCC(NC(=O)C2CCCCC2C(O)=O)CC1, CC(=O)NS(=O)(=O)C1CCC(NC(=O)C2CCCCC2C(O)=O)CC1",SNWQKAWITMVCQW-UHFFFAOYSA-N
THALAZOLE,NSC-66454;NSC-683525;PHTHALYLSULFATHIAZOLE;PHTHALYLSULFHATHIAZOLE;PHTHALYLSULPHATHIAZOLE;SULFAPHTALYLTHIAZOL;SULFATHALIDINE;THALAZOLE,CHEMBL1524273,BRD:BRD-BRD-K64659768-001-12-8;BRD:BRD-K64659768-001-12-8,rep_primary;rep_single_dose,DIHYDROPTEROATE SYNTHETASE INHIBITOR,,"DYSENTRY, COLITIS",,LAUNCHED,,Small molecule,4,"O=C(O)c1ccccc1C(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1;OC(=O)C1CCCCC1C(=O)NC1CCC(CC1)S(=O)(=O)NC1NCCS1, OC(=O)C1CCCCC1C(=O)NC1CCC(CC1)S(=O)(=O)NC1NCCS1",PBMSWVPMRUJMPE-UHFFFAOYSA-N
PHTPP,PHTPP,,BRD:BRD-BRD-K76568384-001-02-2;BRD:BRD-K76568384-001-02-2,rep_primary;rep_single_dose,ESTROGEN RECEPTOR ANTAGONIST,ESR2,,,PRECLINICAL,,,NA,"OC1CCC(CC1)-C1C(NN2C(CC(NC12)C(F)(F)F)C(F)(F)F)-C1CCCCC1, OC1CCC(CC1)-C1C(NN2C(CC(NC12)C(F)(F)F)C(F)(F)F)-C1CCCCC1",
PHYSOSTIGMINE,(-)-PHYSOSTIGMINE;COGMINE;ESERIN;ESERINE;ESERINUM;MCV-4484;NSC-30782;PHYSOSTIGMINE,CHEMBL94,BRD:BRD-BRD-K25650355-065-02-0;BRD:BRD-K25650355-065-02-0,rep_primary;rep_single_dose,"ACETYLCHOLINESTERASE INHIBITOR, CHOLINESTERASE INHIBITOR",ACHE;BCHE,"HYPOTENSION, ALZHEIMER'S DISEASE, GLAUCOMA, GASTROPARESIS",,LAUNCHED,"Multiple values for MOA: {'CHOLINESTERASE INHIBITOR', 'ACETYLCHOLINESTERASE INHIBITOR, CHOLINESTERASE INHIBITOR'}, defaulting to 'ACETYLCHOLINESTERASE INHIBITOR, CHOLINESTERASE INHIBITOR'",Small molecule,4,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C;CNC(=O)OC1CCC2N(C)[C@H]3N(C)CC[C@@]3(C)C2C1,PIJVFDBKTWXHHD-HIFRSBDPSA-N
PHYTOSPHINGOSINE,PHYTOSPHINGOSINE,CHEMBL236036,BRD:BRD-BRD-K05048137-001-03-9;BRD:BRD-K05048137-001-03-9,rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,NA,CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO,AERBNCYCJBRYDG-KSZLIROESA-N
PI-103,PI-103,CHEMBL573339,BRD:BRD-BRD-K67868012-001-07-6;BRD:BRD-K67868012-001-07-6;CTRP:411742;GDSC1:302,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG;PRKDC,,,PRECLINICAL,,Small molecule,NA,"Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1;OC1CCCC(C1)-C1NC(N2CCOCC2)C2OC3NCCCC3C2N1, OC1CCCC(C1)-C1NC(N2CCOCC2)C2OC3NCCCC3C2N1",TUVCWJQQGGETHL-UHFFFAOYSA-N
PI-828,PI-828,,BRD:BRD-BRD-K97365803-001-02-1;BRD:BRD-K97365803-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,,,,PRECLINICAL,,,NA,"NC1CCC(CC1)-C1CCCC2C1OC(CC2=O)N1CCOCC1, NC1CCC(CC1)-C1CCCC2C1OC(CC2=O)N1CCOCC1, NC1CCC(CC1)-C1CCCC2C1OC(CC2=O)N1CCOCC1",
PI103,PI 103;PI103,,GDSC1:302,gdsc,,,,,,,,NA,,
PQR309,BIMIRALISIB;NC-B5;NCB5;PI3K-IN-2;PQR-309;PQR309,CHEMBL4084907,BRD:BRD-BRD-K62374002-001-01-5;BRD:BRD-K62374002-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,,,,PHASE 2,,Small molecule,2,NC1CC(C(CN1)-C1NC(NC(N1)N1CCOCC1)N1CCOCC1)C(F)(F)F;Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,ADGGYDAFIHSYFI-UHFFFAOYSA-N
PI3KD-IN-2,PI3KD-IN-2,,BRD:BRD-K00004592-001-01-9,rep_single_dose,PI3K INHIBITOR,,,,,,,NA,,
PI4KIII-BETA-INHIBITOR-1,PI4KIII-BETA-INHIBITOR-1,,BRD:BRD-BRD-K75528696-001-01-2;BRD:BRD-K75528696-001-01-2,rep_primary;rep_single_dose,PI4K INHIBITOR,PI4K2B,,,PRECLINICAL,,,NA,COC1CCC(CC1S(=O)(=O)NC1CCC(O)CC1)-C1SC(NC(=O)C(C)(C)C)NC1C,
PIBENZIMOL,PIBENZIMOL,,BRD:BRD-BRD-K17026858-001-01-2;BRD:BRD-BRD-K79132813-001-09-0;BRD:BRD-K17026858-001-01-2;BRD:BRD-K79132813-001-09-0,rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,,,PHASE 2,"Multiple values for structure_id: {'K17026858', 'K79132813'}, defaulting to None",,NA,"C1CCC2[NH]C(NC2C1)-C1NC2CCCCC2[NH]1, CN1CCN(CC1)C1CCC2NC([NH]C2C1)-C1CCC2NC([NH]C2C1)-C1CCC(O)CC1",
SB-207266,PIBOSEROD;SB-207266,CHEMBL356359,BRD:BRD-BRD-K02750403-001-01-4;BRD:BRD-K02750403-001-01-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2B;HTR4,,,PHASE 2,,Small molecule,2,"CCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1;CCCCN1CCC(CNC(=O)C2C3OCCCN3C3CCCCC23)CC1, CCCCN1CCC(CNC(=O)C2C3OCCCN3C3CCCCC23)CC1",KVCSJPATKXABRQ-UHFFFAOYSA-N
PIBRENTASVIR,A-1325912.0;ABT-530;PIBRENTASVIR,CHEMBL3545123,BRD:BRD-K00071592-001-01-9;BRD:BRD-K00076315-001-02-9,rep_single_dose,,,,,,"Multiple values for structure_id: {'K00076315', 'K00071592'}, defaulting to None",Small molecule,4,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc([C@H]3CC[C@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)[nH]c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)c(F)cc2[nH]1)[C@@H](C)OC,VJYSBPDEJWLKKJ-NLIMODCCSA-N
PICARTAMIDE,PICARTAMIDE,CHEMBL100424,BRD:BRD-A71765060-001-01-4;BRD:BRD-BRD-A71765060-001-01-4,rep_primary;rep_single_dose,H+/K+-ATPASE INHIBITOR,ATP4A,,,PHASE 2,,Small molecule,-1,CNC(=S)C1(c2ccccn2)CCCS1;CNC(=S)C1(CCCS1)C1CCCCN1,ITNLONMDUMHEOK-UHFFFAOYSA-N
PICEATANNOL,NSC-365798;PICEATANNOL,CHEMBL69863,BRD:BRD-BRD-K91509126-001-23-6;BRD:BRD-K91509126-001-23-6,rep_primary;rep_single_dose,SYK INHIBITOR,ATP5A1;ATP5B;ATP5C1;IRF3,,,PRECLINICAL,,Small molecule,NA,"Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1;OC1CC(O)CC(C1)\C=C\C1CCC(O)C(O)C1, OC1CC(O)CC(C1)\C=C\C1CCC(O)C(O)C1, OC1CC(O)CC(C1)\C=C\C1CCC(O)C(O)C1",CDRPUGZCRXZLFL-OWOJBTEDSA-N
RPR-73401,PICLAMILAST;RP 73401;RP-73041;RP-73401;RP73401;RPR-73401,CHEMBL42126,BRD:BRD-BRD-K47642186-001-01-3;BRD:BRD-K47642186-001-01-3,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A;PDE4B;PDE4C;PDE4D,,,PHASE 2,,Small molecule,-1,"COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1;COC1CCC(CC1OC1CCCC1)C(=O)NC1C(CL)CNCC1CL, COC1CCC(CC1OC1CCCC1)C(=O)NC1C(CL)CNCC1CL",RRRUXBQSQLKHEL-UHFFFAOYSA-N
PICOLAMINE,NSC-59706;PICOLAMINE,CHEMBL1988272,BRD:BRD-BRD-K68653965-001-01-1;BRD:BRD-K68653965-001-01-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,NCc1cccnc1;NCC1CCCNC1,HDOUGSFASVGDCS-UHFFFAOYSA-N
PICOLINICI-ACID,PICOLINATE;PICOLINICI-ACID,,GDSC2:1635,gdsc,,,,,,,,NA,,
PICONOL,NSC-760363;PICONOL,CHEMBL2103981,BRD:BRD-BRD-K28492574-001-01-6;BRD:BRD-K28492574-001-01-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,OCc1ccccn1;OCC1CCCCN1,SHNUBALDGXWUJI-UHFFFAOYSA-N
PICOTAMIDE,G-137;NSC-304384;PICOTAMIDE,CHEMBL1257015,BRD:BRD-BRD-K67277431-002-10-5;BRD:BRD-K67277431-002-10-5,rep_primary;rep_single_dose,"THROMBOXANE RECEPTOR ANTAGONIST, THROMBOXANE SYNTHASE INHIBITOR",TBXA2R,THROMBOSIS,,LAUNCHED,,Small molecule,4,COc1ccc(C(=O)NCc2cccnc2)cc1C(=O)NCc1cccnc1;COC1CCC(CC1C(=O)NCC1CCCNC1)C(=O)NCC1CCCNC1,KYWCWBXGRWWINE-UHFFFAOYSA-N
PICROTIN,PICROTIN,CHEMBL478523,BRD:BRD-A91822151-001-05-0;BRD:BRD-BRD-A91822151-001-05-0,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABRA1;GABRR1;GLRA1;GLRA2;GLRA3;GLRB,,,PHASE 2,,Small molecule,NA,CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C;CC(C)(O)C1C2OC(=O)C1C1(O)CC3OC33C(=O)OC2C13C,RYEFFICCPKWYML-QCGISDTRSA-N
PICROTOXININ,PICROTOXININ,CHEMBL47244,BRD:BRD-BRD-K36461289-001-05-8;BRD:BRD-K36461289-001-05-8,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GLRA1;GLRA2;GLRA3;GLRB;HTR3A;HTR3B,,,PRECLINICAL,,Small molecule,NA,C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C;CC(=C)[C@@H]1[C@H]2OC(=O)[C@H]1[C@]1(O)C[C@H]3O[C@]33C(=O)O[C@H]2[C@]13C,PIMZUZSSNYHVCU-YKWPQBAZSA-N
PIDOLIC-ACID,PIDOLIC-ACID,,BRD:BRD-BRD-K57313110-001-06-8;BRD:BRD-K57313110-001-06-8,rep_primary;rep_single_dose,,ADAM28;AMY1A;AMY2A;AMY2B;ANG;CCL8;HCRT;IGLC1;KRTAP5-2;TFF2;VEGFA,XEROSIS CUTIS,,LAUNCHED,,,NA,OC(=O)[C@@H]1CCC(=O)N1,
PILIMOD,NSC-759841;PIDOTIMOD;PILIMOD,CHEMBL1488165,BRD:BRD-BRD-K44442813-001-12-9;BRD:BRD-K44442813-001-12-9,rep_primary;rep_single_dose,"INTERFERON RECEPTOR AGONIST, INTERLEUKIN RECEPTOR AGONIST",,IMMUNE ADJUVANT,,LAUNCHED,,Small molecule,-1,"O=C1CC[C@@H](C(=O)N2CSC[C@H]2C(=O)O)N1;OC(=O)[C@@H]1CSCN1C(=O)[C@@H]1CCC(=O)N1, OC(=O)[C@@H]1CSCN1C(=O)[C@@H]1CCC(=O)N1",UUTKICFRNVKFRG-WDSKDSINSA-N
PIFITHRIN-ALPHA,PIFITHRIN-ALPHA,,CTRP:50747,ctrp,,,,,,,,NA,,
PIFITHRIN-CYCLIC,PIFITHRIN-CYCLIC,,BRD:BRD-BRD-K31792052-004-02-7;BRD:BRD-K31792052-004-02-7,rep_primary;rep_single_dose,TP53 INHIBITOR,TP53,,,PRECLINICAL,,,NA,CC1CCC(CC1)-C1CN2C3CCCCC3SC2N1,
PIFITHRIN-MU,PIFITHRIN-MU,,BRD:BRD-BRD-K96799727-001-06-6;BRD:BRD-K96799727-001-06-6;CTRP:375596,ctrp;rep_primary;rep_single_dose,HSP INHIBITOR,HSPA1A;TP53,,,PRECLINICAL,,,NA,"NS(=O)(=O)C#CC1CCCCC1, NS(=O)(=O)C#CC1CCCCC1, NS(=O)(=O)C#CC1CCCCC1",
PIK-293,PIK-293,,BRD:BRD-BRD-K30977212-001-02-8;BRD:BRD-K30977212-001-02-8,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PRECLINICAL,,,NA,CC1CCCCC1-N1C(CN2NCC3C(N)NCNC23)NC2CCCC(C)C2C1=O,
PIK-294,PIK-294,,BRD:BRD-BRD-K50631926-001-02-3;BRD:BRD-K50631926-001-02-3,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CB;PIK3CD;PIK3CG,,,PRECLINICAL,,,NA,CC1CCCCC1-N1C(CN2NC(-C3CCCC(O)C3)C3C(N)NCNC23)NC2CCCC(C)C2C1=O,
PIK-75,PIK-75,,BRD:BRD-BRD-K49371609-003-03-8;BRD:BRD-K49371609-003-03-8,rep_multi_dose;rep_primary;rep_single_dose,"DNA PROTEIN KINASE INHIBITOR, PI3K INHIBITOR",PIK3CA;PIK3CB;PIK3CD;PIK3CG;PRKDC,,,PRECLINICAL,,,NA,CN(\N=C\C1CNC2CCC(BR)CN12)S(=O)(=O)C1CC(CCC1C)[N+]([O-])=O,
PIK-93,PIK-93,,BRD:BRD-BRD-K29395450-001-06-8;BRD:BRD-K29395450-001-06-8;CTRP:660774;GDSC1:303,ctrp;gdsc;rep_primary;rep_single_dose,PI3K INHIBITOR,PI4KB;PIK3C3;PIK3CG,,,PRECLINICAL,,,NA,CC(=O)NC1NC(C)C(S1)-C1CCC(CL)C(C1)S(=O)(=O)NCCO,
PIK93,PIK 93;PIK93,,GDSC1:303,gdsc,,,,,,,,NA,,
PIKAMILONE,PIKAMILONE,,BRD:BRD-BRD-K56691760-001-01-2;BRD:BRD-K56691760-001-01-2,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,OC(=O)CCCNC(=O)C1CCCNC1,
PIKETOPROFEN,CALMATEL;PIKETOPROFEN,CHEMBL2106966,BRD:BRD-A85548292-001-01-8;BRD:BRD-BRD-A85548292-001-01-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,CC(C(=O)NC1CC(C)CCN1)C1CCCC(C1)C(=O)C1CCCCC1;Cc1ccnc(NC(=O)C(C)c2cccc(C(=O)c3ccccc3)c2)c1,ASFKKFRSMGBFRO-UHFFFAOYSA-N
XL147,PILARALISIB;SAR-245408;SAR245408;XL-147;XL147,CHEMBL3218575;CHEMBL3360203,BRD:BRD-BRD-K49456274-001-01-9;BRD:BRD-K49456274-001-01-9;GDSC1:372,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,,,,PHASE 2,,Small molecule,2,COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1;COC1CCC(CL)C(NC2NC3CCCCC3NC2NS(=O)(=O)C2CCCC(NC(=O)C(C)(C)N)C2)C1,QINPEPAQOBZPOF-UHFFFAOYSA-N
SYNCARPINE,OCUCARPINE;OCUSERT PILO;OCUSERT PILO-20;OCUSERT PILO-40;PILOCARPINE;PILOCARPINUM;PILOCARPOL;PILOKARPIN;SPERSACARPINE;SYNCARPINE,CHEMBL550,BRD:BRD-BRD-K85090592-008-22-7;BRD:BRD-K85090592-008-22-7,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,"GLAUCOMA, HYPERTENSION",,LAUNCHED,,Small molecule,4,"CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C;CC[C@H]1[C@@H](CC2CNCN2C)COC1=O, CC[C@H]1[C@@H](CC2CNCN2C)COC1=O, CC[C@H]1[C@@H](CC2CNCN2C)COC1=O, CC[C@H]1[C@@H](CC2CNCN2C)COC1=O",QCHFTSOMWOSFHM-WPRPVWTQSA-N
PILSICAINIDE HYDROCHLORIDE,PILSICAINIDE;PILSICAINIDE HYDROCHLORIDE,CHEMBL163238,BRD:BRD-BRD-K83245588-001-01-4;BRD:BRD-K83245588-001-01-4,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN5A,CARDIAC ARRYTHMIA,,LAUNCHED,,Small molecule,-1,Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2;CC1CCCC(C)C1NC(=O)CC12CCCN1CCC2,BCQTVJKBTWGHCX-UHFFFAOYSA-N
PIM-1-INHIBITOR-2,PIM-1-INHIBITOR-2,,BRD:BRD-K48832421-001-03-9,rep_single_dose,PIM KINASE INHIBITOR,PIM1,,,,,,NA,,
PIM-447,LGH-447;LGH447;NVP-LGH477;PIM 447;PIM KINASE INHIBITOR LGH447;PIM-447,CHEMBL3545194,BRD:BRD-K00003280-300-01-9,rep_single_dose,PIM KINASE INHIBITOR,,,,,,Small molecule,1,,
PIMAVANSERIN,PIMAVANSERIN,CHEMBL2111101,BRD:BRD-BRD-K83405785-001-01-5;BRD:BRD-K83405785-001-01-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR INVERSE AGONIST,DRD2;HTR2A,,,LAUNCHED,,Small molecule,4,CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1;CC(C)COC1CCC(CNC(=O)N(CC2CCC(F)CC2)C2CCN(C)CC2)CC1,RKEWSXXUOLRFBX-UHFFFAOYSA-N
SDZ-ASM-981,(-)-PIMECROLIMUS;ELIDEL;PIMECROLIMUS;SDZ ASM 981;SDZ ASM-981;SDZ-ASM 981;SDZ-ASM-981,CHEMBL1200686,BRD:BRD-BRD-K92107055-001-01-9;BRD:BRD-K92107055-001-01-9,rep_primary;rep_single_dose,CALCINEURIN INHIBITOR,FKBP1A;MTOR,ECZEMA,,LAUNCHED,,Small molecule,4,CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC;CC[C@@H]1\C=C(C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(\C)=C\[C@@H]1CC[C@H](CL)[C@@H](C1)OC,KASDHRXLYQOAKZ-XDSKOBMDSA-N
PIMETIXENE,BP 400;BP-400;CALMIXENE;NSC-757828;PIMETHIXENE;PIMETIXENE,CHEMBL152408,BRD:BRD-BRD-K88090157-050-10-8;BRD:BRD-K88090157-050-10-8,rep_primary;rep_single_dose,ANTIHISTAMINE,,"ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD), ANXIETY, SLEEP CYCLE SUPPORT, ALLERGIC RHINITIS",,LAUNCHED,,Small molecule,-1,CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1;CN1CCC(CC1)=C1C2CCCCC2SC2CCCCC12,NZLVRVYNQYGMAB-UHFFFAOYSA-N
VETMEDIN,ACARDI;DL-PIMOBENDAN;PIMOBENDAN;PIMOBENDANE;RACEMIC PIMOBENDAN;UD-CG-115;UD-CG-115BS;UDCG-115;VETMEDIN,CHEMBL24646,BRD:BRD-A84575140-001-02-4;BRD:BRD-BRD-A84575140-001-02-4,rep_primary;rep_single_dose,"CALCIUM SENSITIZER, PHOSPHODIESTERASE INHIBITOR",PDE3A,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,-1,COc1ccc(-c2nc3cc(C4=NNC(=O)CC4C)ccc3[nH]2)cc1;COC1CCC(CC1)-C1NC2CC(CCC2[NH]1)C1=NNC(=O)CC1C,GLBJJMFZWDBELO-UHFFFAOYSA-N
VX-787 ANHYDROUS BASE,JNJ - 63623872 - ZCD;JNJ-63623872;JNJ-63623872-ZCD;JNJ-872;JNJ63623872;JNJ872;PIMODIVIR;VX -787;VX-787;VX-787 ANHYDROUS BASE,CHEMBL3318007,BRD:BRD-K00003127-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,3,O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,JGPXDNKSIXAZEQ-SBBZOCNPSA-N
RO-038799,NSC-380540;PD 126675;PD-126675;PIMONIDAZOLE;RO 03-8799;RO-03-8799;RO-038799,CHEMBL58752,BRD:BRD-A67521319-001-01-6;BRD:BRD-BRD-A67521319-001-01-6,rep_primary;rep_single_dose,,,,,PHASE 3,,Small molecule,2,O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1;OC(CN1CCCCC1)CN1CCNC1[N+]([O-])=O,WVWOOAYQYLJEFD-UHFFFAOYSA-N
R-6238,MCN-JR-6238;NSC-170984;ORAP;PIMOZIDE;R 623;R 6238;R-623;R-6238,CHEMBL1423,BRD:BRD-BRD-K01292756-001-25-0;BRD:BRD-K01292756-001-25-0,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CACNA1I;CALM1;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HTR1A;HTR2A;KCNA10;KCNH2,TOURETTE'S DISORDER,,LAUNCHED,,Small molecule,4,"FC1CCC(CC1)C(CCCN1CCC(CC1)N1C2CCCCC2[NH]C1=O)C1CCC(F)CC1, FC1CCC(CC1)C(CCCN1CCC(CC1)N1C2CCCCC2[NH]C1=O)C1CCC(F)CC1, FC1CCC(CC1)C(CCCN1CCC(CC1)N1C2CCCCC2[NH]C1=O)C1CCC(F)CC1, FC1CCC(CC1)C(CCCN1CCC(CC1)N1C2CCCCC2[NH]C1=O)C1CCC(F)CC1;O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1",YVUQSNJEYSNKRX-UHFFFAOYSA-N
SULFOPIN,PIN1-3;SULFOPIN,,BRD:BRD-U00115292-001-01-9,oncref_1,INHIBITOR OF PIN1,PIN1,,,,,,NA,,
PINDAC,NSC-759588;PINACIDIL;PINACIDIL HYDRATE;PINACIDIL MONOHYDRATE;PINDAC,CHEMBL1159;CHEMBL1200338,BRD:BRD-A43882281-001-15-5;BRD:BRD-BRD-A43882281-001-15-5,rep_primary;rep_single_dose,"ATP CHANNEL ACTIVATOR, POTASSIUM CHANNEL ACTIVATOR",ABCC8;ABCC9,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CC(N/C(=N\C#N)Nc1ccncc1)C(C)(C)C;CC(N/C(=N\C#N)Nc1ccncc1)C(C)(C)C.O;CC(N\C(NC1CCNCC1)=N\C#N)C(C)(C)C, CC(N\C(NC1CCNCC1)=N\C#N)C(C)(C)C",AFJCNBBHEVLGCZ-UHFFFAOYSA-N;IVVNZDGDKPTYHK-UHFFFAOYSA-N
PINAVERIUM ION,PINAVERIUM;PINAVERIUM CATION;PINAVERIUM ION,CHEMBL1909324,BRD:BRD-A70998768-004-01-1;BRD:BRD-BRD-A70998768-004-01-1,rep_primary;rep_single_dose,T-TYPE CALCIUM CHANNEL BLOCKER,CACNA1C,IRRITABLE BOWEL SYNDROME,,LAUNCHED,,Small molecule,4,COC1CC(BR)C(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)CC1OC;COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC,DDHUTBKXLWCZCO-UHFFFAOYSA-N
PINCAINIDE,PINCAINIDE,CHEMBL1867802,BRD:BRD-BRD-K90727284-001-05-0;BRD:BRD-K90727284-001-05-0,rep_primary;rep_single_dose,ANTIARRHYTHMIC,,,,PHASE 1,,Small molecule,-1,Cc1cccc(C)c1NC(=O)CN1CCCCCC1;CC1CCCC(C)C1NC(=O)CN1CCCCCC1,RJOUHGWLHPOQSA-UHFFFAOYSA-N
VISKEN,(RS)-PINDOLOL;APO-PINDOL;BETADREN;BETAPINDOL;BLOCKLIN-L;CALVISKEN;CARVISKEN;DECRETEN;DL-LB-46;DL-PINDOLOL;DURAPINDOL;GLAUCO-VISKEN;LB-46;NSC-757276;PECTOBLOC;PINBETOL;PINDOLOL;PRINODOLOL;PYNASTIN;VISKEN,CHEMBL500,BRD:BRD-A97701745-001-16-0;BRD:BRD-BRD-A97701745-001-16-0,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;HTR1A;HTR1B;HTR2A;HTR2B,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CC(C)NCC(O)COc1cccc2[nH]ccc12;CC(C)NCC(O)COC1CCCC2[NH]CCC12, CC(C)NCC(O)COC1CCCC2[NH]CCC12, CC(C)NCC(O)COC1CCCC2[NH]CCC12",JZQKKSLKJUAGIC-UHFFFAOYSA-N
PINDOLOL-(-),PINDOLOL-(-),,BRD:BRD-K95598440-001-10-9,rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",HTR1A,,,,,,NA,,
PINITOL B,3-O-METHYL-;3-O-METHYL-D-CHIRO-INOSITOL;CATHRTOMANNITOL;D-3-O-METHYL-CHIRO-INOSITOL;D-CHIRO-;D-CHIRO-INOSITOL;D-PINITOL;INOSITOL;INZITOL;MATEZIT;METHYLINOSITOL;NDI 18;NIC5-15;NSC-128700;PINIOL;PINITOL;PINITOL B,CHEMBL493737,BRD:BRD-A69275535-001-01-5;BRD:BRD-BRD-A69275535-001-01-5,rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,,,,PHASE 2,,Small molecule,2,CO[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O;COC1C(O)[C@@H](O)C(O)C(O)[C@H]1O,DSCFFEYYQKSRSV-KLJZZCKASA-N
PINOCEMBRIN,(2S)-PINOCEMBRIN;DIHYDROCHRYSIN;GALANGIN FLAVANONE;NSC-279005;NSC-43318;PINOCEMBRIN,CHEMBL399910,BRD:BRD-BRD-K94689771-001-09-0;BRD:BRD-K94689771-001-09-0,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP1B1,,,PHASE 2,,Small molecule,2,O=C1C[C@@H](c2ccccc2)Oc2cc(O)cc(O)c21;OC1CC(O)C2C(=O)C[C@H](OC2C1)C1CCCCC1,URFCJEUYXNAHFI-ZDUSSCGKSA-N
PINOMETOSTAT ANHYDROUS,EPZ-005676;EPZ-5676;EPZ5676;PINOMETOSTAT;PINOMETOSTAT ANHYDROUS,CHEMBL3414626,GDSC2:1563,gdsc,,,,,,,Small molecule,1,CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)[C@H]1C[C@@H](CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1,LXFOLMYKSYSZQS-LURJZOHASA-N
ZACTOS,ACTOS;AD-4833;DUETACT;GLUSTIN;PIOGLITAZONE;U-72107;ZACTOS,CHEMBL595,BRD:BRD-A48430263-003-17-2;BRD:BRD-BRD-A48430263-003-17-2,rep_primary;rep_single_dose,"INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",PPARG;TRPM3,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1;CCC1CCC(CCOC2CCC(CC3SC(=O)NC3=O)CC2)NC1, CCC1CCC(CCOC2CCC(CC3SC(=O)NC3=O)CC2)NC1, CCC1CCC(CCOC2CCC(CC3SC(=O)NC3=O)CC2)NC1, CCC1CCC(CCOC2CCC(CC3SC(=O)NC3=O)CC2)NC1",HYAFETHFCAUJAY-UHFFFAOYSA-N
R-3345,FLOROPIPAMIDE;NSC-759178;PIPAMPERONE;PIPAMPERONE HYDROCHLORIDE;PIPANEPERONE;R 3345;R-3345,CHEMBL440294,BRD:BRD-BRD-K26801045-001-02-9;BRD:BRD-K26801045-001-02-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;HRH1;HTR1A;HTR1B;HTR1D;HTR2A,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,3,NC(=O)C1(CCN(CCCC(=O)C2CCC(F)CC2)CC1)N1CCCCC1;NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,AXKPFOAXAHJUAG-UHFFFAOYSA-N
PIPECURONIUM,PIPECURONIUM,CHEMBL1201206,BRD:BRD-A21544762-303-01-5;BRD:BRD-BRD-A21544762-303-01-5,rep_primary;rep_single_dose,NEUROMUSCULAR BLOCKER,CHRM2;CHRM3;CHRNA2,ANESTHETIC,,LAUNCHED,,Small molecule,4,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1;CC(=O)OC1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,OWWLUIWOFHMHOQ-XGHATYIMSA-N
PIPEMIDIC-ACID,PIPEMIDIC-ACID,,BRD:BRD-BRD-K08999871-213-01-5;BRD:BRD-K08999871-213-01-5,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,,NA,CCN1CC(C(O)=O)C(=O)C2CNC(NC12)N1CCNCC1,
PIPENZOLATE ION,PIPENZOLATE;PIPENZOLATE CATION;PIPENZOLATE ION,CHEMBL1393947;CHEMBL1619528,BRD:BRD-A53561827-004-23-1;BRD:BRD-BRD-A53561827-004-23-1,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRM1,SPASMS,,LAUNCHED,,Small molecule,4,"CC[N+]1(C)CCCC(C1)OC(=O)C(O)(C1CCCCC1)C1CCCCC1, CC[N+]1(C)CCCC(C1)OC(=O)C(O)(C1CCCCC1)C1CCCCC1;CC[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1",WPUKUEMZZRVAKZ-UHFFFAOYSA-N
QUIDE,NSC-760067;PC-1421;PIPERACETAZINE;QUIDE,CHEMBL1584,BRD:BRD-BRD-K16277217-001-10-9;BRD:BRD-K16277217-001-10-9,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2;CC(=O)C1CCC2SC3CCCCC3N(CCCN3CCC(CCO)CC3)C2C1,BTFMCMVEUCGQDX-UHFFFAOYSA-N
T-1220,"CL 227,193;CL-227193;ISIPEN;NSC-757277;PENMALIN;PENTACILLIN;PIPERACIL;PIPERACILLIN;PIPERACILLIN (AS SODIUM);PIPERACILLIN HYDRATE;PIPERACILLIN MONOHYDRATE;PIPERACILLIN SODIUM;PIPERACILLIN SODIUM SALT;PIPRACIL;PIPRIL;T-1220",CHEMBL1200820;CHEMBL702,BRD:BRD-BRD-K86873305-236-14-7;BRD:BRD-K86873305-236-14-7,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"INTRA-ABDOMINAL INFECTIONS, SKIN INFECTIONS, PELVIC INFLAMMATORY DISEASE, PNEUMONIA",,LAUNCHED,,Small molecule,4,"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)[O-])c2ccccc2)C(=O)C1=O.[Na+];CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C2CCCCC2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C2CCCCC2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C2CCCCC2)C(=O)C1=O, CCN1CCN(C(=O)NC(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C2CCCCC2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C2CCCCC2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C2CCCCC2)C(=O)C1=O",WCMIIGXFCMNQDS-IDYPWDAWSA-M
PIPERAQUINE-PHOSPHATE,PIPERAQUINE-PHOSPHATE,,BRD:BRD-BRD-K27382019-418-01-9;BRD:BRD-K27382019-418-01-9,rep_primary;rep_single_dose,ANTIMALARIAL AGENT,,MALARIA,,LAUNCHED,,,NA,CLC1CCC2C(CCNC2C1)N1CCN(CCCN2CCN(CC2)C2CCNC3CC(CL)CCC23)CC1,
WORMEX,ANTEPAR;ASCALIX;ECTODYNE;EXPELIX;INS UMULINE RAPIDE;PIPERAZINE;WORMEX,CHEMBL1412,BRD:BRD-BRD-K13249881-001-02-3;BRD:BRD-K13249881-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRB3,GASTROINTESTINAL ROUNDWORMS,,LAUNCHED,,Small molecule,4,C1CNCCN1,GLUUGHFHXGJENI-UHFFFAOYSA-N
PIPERAZINEDIONE,"DIKETOPIPERAZINE;PIPERAZINE-2,5-DIONE;PIPERAZINEDIONE",CHEMBL125229,BRD:BRD-BRD-K95941975-001-01-5;BRD:BRD-K95941975-001-01-5,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,,,PHASE 2,,Small molecule,NA,O=C1CNC(=O)CN1,BXRNXXXXHLBUKK-UHFFFAOYSA-N
PIPERIDOLATE,1087-A.N.;JB-305;PIPERIDOLATE,CHEMBL1474977;CHEMBL1623992,BRD:BRD-A97479839-003-13-3;BRD:BRD-BRD-A97479839-003-13-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,SPASMS,,LAUNCHED,,Small molecule,4,CCN1CCC[C@@H](OC(=O)C(c2ccccc2)c2ccccc2)C1;CCN1CCCC(C1)OC(=O)C(C1CCCCC1)C1CCCCC1;CCN1CCCC(OC(=O)C(c2ccccc2)c2ccccc2)C1,KTHVBAZBLKXIHZ-LJQANCHMSA-N;KTHVBAZBLKXIHZ-UHFFFAOYSA-N
PIPERINE,BIOPERINE;FEMA NO. 2909;NSC-21727;PIPERINE,CHEMBL43185,BRD:BRD-BRD-K59522102-001-14-6;BRD:BRD-BRD-K59522102-001-15-3;BRD:BRD-K59522102-001-14-6;BRD:BRD-K59522102-001-15-3,rep_multi_dose;rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB;TRPV1,,,PHASE 1,,Small molecule,2,"O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1;O=C(\C=C\C=C\C1CCC2OCOC2C1)N1CCCCC1, O=C(\C=C\C=C\C1CCC2OCOC2C1)N1CCCCC1, O=C(\C=C\C=C\C1CCC2OCOC2C1)N1CCCCC1",MXXWOMGUGJBKIW-YPCIICBESA-N
PIPERLONGUMINE,PIPERLONGUMINE,,CTRP:39782;GDSC1:1243,ctrp;gdsc,,,,,,,,NA,,
PIPERLONGUMINE:MST-312 (1:1 MOL/MOL),PIPERLONGUMINE:MST-312 (1:1 MOL/MOL),,CTRP:660224,ctrp,,,,,,,,NA,,
PIPERONYL-BUTOXIDE,PIPERONYL-BUTOXIDE,,BRD:BRD-BRD-K76452401-001-03-6;BRD:BRD-K76452401-001-03-6,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,,LICE,,LAUNCHED,,,NA,CCCCOCCOCCOCC1CC2OCOC2CC1CCC,
PIPLARTINE,PIPLARTINE,CHEMBL465843,GDSC1:1243,gdsc,,,,,,,Small molecule,NA,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,VABYUUZNAVQNPG-BQYQJAHWSA-N
VERCYTE,A-8103;NSC-25154;PIPOBROMAN;VERCYTE,CHEMBL1585,BRD:BRD-K15656090-001-07-3,rep_single_dose,DNA ALKYLATING AGENT,,,,,,Small molecule,4,O=C(CCBr)N1CCN(C(=O)CCBr)CC1,NJBFOOCLYDNZJN-UHFFFAOYSA-N
PIPOFEZINE,PIPOFEZINE,CHEMBL1886755,BRD:BRD-K00003317-312-01-9,rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),,,,,,Small molecule,-1,CN1CCN(c2cc3c(nn2)Oc2ccccc2N3C)CC1,SDYYIRPAZHJOLM-UHFFFAOYSA-N
RP-19552,19552 RP;IL-19552;PIPORTIL;PIPORTIL DEPOT;PIPOTHIAZINE;PIPOTIAZINE;PIPOTIAZINE PALMITATE;PIPOTIAZINE PALMITIC ESTER;RP 19552;RP-19552,CHEMBL2106439;CHEMBL398880,BRD:BRD-K00004560-001-01-9,rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD2;HTR1A;HTR2A,,,,,Small molecule,4,CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,KTOYYUONFQWSMW-UHFFFAOYSA-N
PIPOTIAZINE-PALMITATE,PIPOTIAZINE-PALMITATE,,BRD:BRD-BRD-K48429278-001-01-3;BRD:BRD-K48429278-001-01-3,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",DRD1;DRD2;HTR1A;HTR2A,,,LAUNCHED,,,NA,CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2C3CCCCC3SC3CCC(CC23)S(=O)(=O)N(C)C)CC1,
PIRACETAM,CL-871;GABACET;MYOCALM;NOOTROP;NOOTROP 1200;NOOTROP 400;NOOTROP 800;NOOTROPIL;NSC-758191;PIRACETAM,CHEMBL36715,BRD:BRD-BRD-K19456237-001-27-6;BRD:BRD-K19456237-001-27-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,GRIA1;GRIA2;GRIA3;GRIA4,SENILE DEMENTIA,,LAUNCHED,,Small molecule,4,"NC(=O)CN1CCCC1=O;NC(=O)CN1CCCC1=O, NC(=O)CN1CCCC1=O",GMZVRMREEHBGGF-UHFFFAOYSA-N
PIRENOXINE,CATALIN-K;PIRENOXINE,CHEMBL1372341,BRD:BRD-BRD-K65992024-001-01-5;BRD:BRD-K65992024-001-01-5,rep_primary;rep_single_dose,AGE INHIBITOR,,CATARACTS,,LAUNCHED,,Small molecule,-1,O=C(O)c1cc(O)c2c3nc4ccccc4oc-3cc(=O)c2n1;OC(=O)C1CC(O)C2C3NC4CCCCC4OC3CC(=O)C2N1,OKPNYGAWTYOBFZ-UHFFFAOYSA-N
R-47465,"NSC-760095;PIRENPERONE;R-47,465;R-47465",CHEMBL18331,BRD:BRD-BRD-K25224017-001-25-0;BRD:BRD-K25224017-001-25-0,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR7,,,PRECLINICAL,,Small molecule,-1,Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1;CC1NC2CCCCN2C(=O)C1CCN1CCC(CC1)C(=O)C1CCC(F)CC1,HXCNRYXBZNHDNE-UHFFFAOYSA-N
PIRENZEPINE,ACI-91;GASTRI P;GASTROZEPIN;PIRENZEPINE,CHEMBL9967,BRD:BRD-BRD-K89375097-300-08-8;BRD:BRD-K89375097-300-08-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,4,CN1CCN(CC(=O)N2C3CCCCC3C(=O)NC3CCCNC23)CC1;CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,RMHMFHUVIITRHF-UHFFFAOYSA-N
S-734118,ARELIX;ARLIX;HOE 118;HOE-118;PIRETANIDE;S 73 4118;S-73-4118;S-734118,CHEMBL349803,BRD:BRD-BRD-K87990216-001-10-2;BRD:BRD-K87990216-001-10-2,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,SLC12A1;SLC12A2,"HYPERTENSION, EDEMA",,LAUNCHED,,Small molecule,4,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1;NS(=O)(=O)C1CC(CC(N2CCCC2)C1OC1CCCCC1)C(O)=O,UJEWTUDSLQGTOA-UHFFFAOYSA-N
PIRFENIDONE,AMR-69;ESBRIET;NSC-748456;PIRESPA;PIRFENIDONE,CHEMBL1256391,BRD:BRD-BRD-K96862998-001-15-5;BRD:BRD-K96862998-001-15-5,rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,FURIN;TNF,IDIOPATHIC PULMONARY FIBROSIS (IPF),,LAUNCHED,,Small molecule,4,"Cc1ccc(=O)n(-c2ccccc2)c1;CC1CCC(=O)N(C1)-C1CCCCC1, CC1CCC(=O)N(C1)-C1CCCCC1",ISWRGOKTTBVCFA-UHFFFAOYSA-N
TRIVASTAL LP,ET-495;EU-4200;PIRIBEDIL;TRIVASTAL;TRIVASTAL LP,CHEMBL1371770,BRD:BRD-BRD-K47936004-003-11-4;BRD:BRD-K47936004-003-11-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA1A;ADRA2A;ADRA2C;DRD2;DRD3;DRD4;HTR1A;HTR2B,"PARKINSON'S DISEASE, DIZZINESS",,LAUNCHED,,Small molecule,4,C(N1CCN(CC1)C1NCCCN1)C1CCC2OCOC2C1;c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N
PIRICAPIRON,PIRICAPIRON,,BRD:BRD-A04203391-001-08-3;BRD:BRD-BRD-A04203391-001-08-3,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",HTR2A,,,PHASE 2,,,NA,CC1(C)C2CCC1(C)C(=O)N(CCCCN1CCN(CC1)C1CCCCN1)C2=O,
PIRINIXIC-ACID,PIRINIXIC-ACID,,BRD:BRD-BRD-K01902415-001-11-7;BRD:BRD-K01902415-001-11-7,rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARA,,,PRECLINICAL,,,NA,"CC1CCCC(NC2CC(CL)NC(SCC(O)=O)N2)C1C, CC1CCCC(NC2CC(CL)NC(SCC(O)=O)N2)C1C, CC1CCCC(NC2CC(CL)NC(SCC(O)=O)N2)C1C",
PIRLINDOLE,PIRAZIDOL;PIRLINDOLE,CHEMBL32350,BRD:BRD-A54490543-066-11-9;BRD:BRD-BRD-A54490543-066-11-9,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA,DEPRESSION,,LAUNCHED,,Small molecule,-1,Cc1ccc2c(c1)c1c3n2CCNC3CCC1;CC1CCC2N3CCNC4CCCC(C34)C2C1,IWVRVEIKCBFZNF-UHFFFAOYSA-N
PIRMENOL,PIRMENOL,CHEMBL432103,BRD:BRD-K00003530-003-01-9,rep_single_dose,ACETYLCHOLINE RECEPTOR INHIBITOR,,,,,,Small molecule,-1,CC1CCCC(C)N1CCCC(O)(c1ccccc1)c1ccccn1,APUDBKTWDCXQJA-UHFFFAOYSA-N
R-77975,PIRODAVIR;R 77975;R-77975,CHEMBL298019,BRD:BRD-BRD-K22261391-001-01-2;BRD:BRD-K22261391-001-01-2,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,CCOC(=O)c1ccc(OCCC2CCN(c3ccc(C)nn3)CC2)cc1;CCOC(=O)C1CCC(OCCC2CCN(CC2)C2CCC(C)NN2)CC1,KCHIOGFOPPOUJC-UHFFFAOYSA-N
PIROMIDIC-ACID,PIROMIDIC-ACID,,BRD:BRD-BRD-K37682401-001-09-3;BRD:BRD-BRD-K37682401-213-01-1;BRD:BRD-K37682401-001-09-3;BRD:BRD-K37682401-213-01-1,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,,,PHASE 2,,,NA,"CCN1CC(C(O)=O)C(=O)C2CNC(NC12)N1CCCC1, CCN1CC(C(O)=O)C(=O)C2CNC(NC12)N1CCCC1, CCN1CC(C(O)=O)C(=O)C2CNC(NC12)N1CCCC1",
PIROZIP 20,"BREXIDOL;CP-16,171;CP-16171;FELDENE;FELDENE 20;FELDENE P;FLAMATROL;KENTENE;LARAPAM;NSC-666076;PIROFLAM 10;PIROFLAM 20;PIROXICAM;PIROZIP 10;PIROZIP 20",CHEMBL527,BRD:BRD-A57382968-001-29-0;BRD:BRD-BRD-A57382968-001-29-0,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"OSTEOARTHRITIS, RHEUMATOID ARTHRITIS",,LAUNCHED,,Small molecule,4,"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O;CN1C(C(=O)NC2CCCCN2)C(=O)C2CCCCC2S1(=O)=O, CN1C(C(=O)NC2CCCCN2)C(=O)C2CCCCC2S1(=O)=O, CN1C(C(=O)NC2CCCCN2)C(=O)C2CCCCC2S1(=O)=O",QYSPLQLAKJAUJT-UHFFFAOYSA-N
PIROXIMONE,"MDL 19,205;MDL-19205;PIROXIMONE",CHEMBL58355,BRD:BRD-BRD-K71977764-001-01-2;BRD:BRD-K71977764-001-01-2,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A,,,PHASE 2,,Small molecule,-1,CCc1[nH]c(=O)[nH]c1C(=O)c1ccncc1;CCC1[NH]C(O)NC1C(=O)C1CCNCC1,OQGWJZOWLHWFME-UHFFFAOYSA-N
PIROZADIL,PIROZADIL,CHEMBL2106888,BRD:BRD-K00004581-001-01-9,rep_single_dose,HYPOLIPIDEMIC,,,,,,Small molecule,-1,COc1cc(C(=O)OCc2cccc(COC(=O)c3cc(OC)c(OC)c(OC)c3)n2)cc(OC)c1OC,DIIBXMIIOQXTHW-UHFFFAOYSA-N
SQ-13847,PIRQUINOZOL;SO 13847;SO-13847;SQ 13847;SQ-13847,CHEMBL2106923,BRD:BRD-BRD-K63651590-001-01-3;BRD:BRD-K63651590-001-01-3,rep_primary;rep_single_dose,HISTAMINE RELEASE INHIBITOR,,,,PHASE 1,,Small molecule,-1,O=c1[nH]c2ccccc2c2cc(CO)nn12;OCC1CC2C3CCCCC3[NH]C(=O)N2N1,XLUKOGNIEDDIMV-UHFFFAOYSA-N
PITAVASTATIN,ITAVASTATIN;NSC-760423;PITAVASTATIN,CHEMBL1201753,BRD:BRD-BRD-K75958547-238-01-0;BRD:BRD-K75958547-238-01-0;BRD:BRD-K75958547-238-04-9,rep_multi_dose;rep_primary;rep_single_dose,HMGCR INHIBITOR,HMGCR,HYPERLIPIDEMIA,,LAUNCHED,,Small molecule,4,"O[C@H](C[C@H](O)\C=C\C1C(NC2CCCCC2C1-C1CCC(F)CC1)C1CC1)CC(O)=O, O[C@H](C[C@H](O)\C=C\C1C(NC2CCCCC2C1-C1CCC(F)CC1)C1CC1)CC(O)=O;O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1",VGYFMXBACGZSIL-MCBHFWOFSA-N
PITSTOP2,PITSTOP2,,CTRP:660985,ctrp,,,,,,,,NA,,
SELEXID,AMDINOCILLIN PIVOXIL;COACTABS;PIVMECILLINAM;PIVMECILLINAM HYDROCHLORIDE;RO 10-9071;RO-10-9071;SELEXID,CHEMBL1650818,BRD:BRD-BRD-K67100011-003-06-3;BRD:BRD-K67100011-003-06-3,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,"URINARY TRACT INFECTIONS, GRAM-NEGATIVE BACTERIAL INFECTIONS",,LAUNCHED,,Small molecule,4,"CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O, CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O, CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O;CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](/N=C/N3CCCCCC3)[C@H]2SC1(C)C",NPGNOVNWUSPMDP-UTEPHESZSA-N
SANDOMIGRAN,BC-105;PIZOTIFEN;PIZOTYLINE;SANDOMIGRAN,CHEMBL294951,BRD:BRD-BRD-K75958195-037-09-4;BRD:BRD-K75958195-037-09-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A;HTR2A;HTR2C,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,-1,"CN1CCC(=C2c3ccccc3CCc3sccc32)CC1;CN1CCC(CC1)=C1C2CCSC2CCC2CCCCC12, CN1CCC(CC1)=C1C2CCSC2CCC2CCCCC12",FIADGNVRKBPQEU-UHFFFAOYSA-N
PJ-34,PJ-34,,BRD:BRD-BRD-K11853856-001-01-7;BRD:BRD-K11853856-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,EEF2;PARP1;PARP15;PARP3,,,PRECLINICAL,,,NA,"CN(C)CC(=O)NC1CCC2[NH]C(=O)C3CCCCC3C2C1, CN(C)CC(=O)NC1CCC2[NH]C(=O)C3CCCCC3C2C1, CN(C)CC(=O)NC1CCC2[NH]C(=O)C3CCCCC3C2C1",
PK-11195,PK-11195,CHEMBL481537,BRD:BRD-A41451487-001-11-2;BRD:BRD-BRD-A41451487-001-11-2,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR ANTAGONIST,TSPO,,,PHASE 1,,Small molecule,NA,"CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2Cl)n1;CCC(C)N(C)C(=O)C1CC2CCCCC2C(N1)-C1CCCCC1CL, CCC(C)N(C)C(=O)C1CC2CCCCC2C(N1)-C1CCCCC1CL",RAVIZVQZGXBOQO-UHFFFAOYSA-N
PK-44,PK-44,,BRD:BRD-K04035716-011-02-9,rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,,,,,,NA,,
PK-THPP,PK-THPP,,BRD:BRD-BRD-K44043890-001-01-4;BRD:BRD-K44043890-001-01-4,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNK9,,,PRECLINICAL,,,NA,CCCC(=O)C1CCN(CC1)C1NCNC2CCN(CC12)C(=O)C1CCC(CC1)-C1CCCCC1,
RYDAPT,BENZOYLSTAUROSPORINE;CGP 41251;CGP-41251;MIDOSTAURIN;NSC-656576;NVP-PKC412;PKC 412;PKC-412;PKC412;RYDAPT,CHEMBL608533,GDSC1:153,gdsc,,,,,,,Small molecule,4,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,BMGQWWVMWDBQGC-IIFHNQTCSA-N
PKI-166,CGP-75166;NVP-PKI166;PKI 166;PKI-166,CHEMBL1963502,BRD:BRD-BRD-K10115470-001-01-8;BRD:BRD-K10115470-001-01-8,rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PHASE 1,,Small molecule,1,C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1;C[C@@H](NC1NCNC2[NH]C(CC12)-C1CCC(O)CC1)C1CCCCC1,XRYJULCDUUATMC-CYBMUJFWSA-N
PKI-179,PKI-179,CHEMBL1258517,BRD:BRD-A28467416-002-01-0;BRD:BRD-BRD-A28467416-002-01-0,rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",MTOR,,,PHASE 1,,Small molecule,1,O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1;O=C(NC1CCNCC1)NC1CCC(CC1)-C1NC(NC(N1)N1CCOCC1)N1C2CCC1COC2,WXUUCRLKXQMWRY-UHFFFAOYSA-N
PL-DI,PL-DI,,CTRP:609440,ctrp,,,,,,,,NA,,
PLATIN,PLATIN,,CTRP:375395,ctrp,,,,,,,,NA,,
PLATINOL-AQ,(SP-4-2)-DIAMMINEDICHLOROPLATINUM;CIS-DDP;CIS-DIAMMINEDICHLOROPLATINUM;CIS-DIAMMINEDICHLOROPLATINUM II;CIS-DIAMMINEDICHLOROPLATINUM(II);CIS-DIAMMINEPLATINUM(II) DICHLORIDE;CIS-PLATIN;CIS-PLATINUM II;CISPLATIN;CISPLATINUM;FAULDISCIPLA;INT-230-6 COMPONENT CISPLATIN;INT230-6 COMPONENT CISPLATIN;LIPLACIS;NSC-119875;PEYRONE'S SALT;PLATINOL;PLATINOL-AQ,CHEMBL11359,GDSC1:1005;GDSC2:1005,gdsc,,,,,,,Small molecule,4,,
WIN-63843,PLECONARIL;VP 63843;VP-63843;WIN 63843;WIN-63843,CHEMBL29609,BRD:BRD-BRD-K27625831-001-02-9;BRD:BRD-K27625831-001-02-9,rep_primary;rep_single_dose,,,,,PHASE 3,,Small molecule,2,"Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1;CC1CC(CCCOC2C(C)CC(CC2C)-C2NOC(N2)C(F)(F)F)ON1, CC1CC(CCCOC2C(C)CC(CC2C)-C2NOC(N2)C(F)(F)F)ON1",KQOXLKOJHVFTRN-UHFFFAOYSA-N
SID 791,AMD 3100;AMD3100;JM 3100;MOZOBIL;PLERIXAFOR;PLERIXAFOR HYDROCHLORIDE;PLERIXAFOR OCTAHYDROCHLORIDE;SID 791,CHEMBL18442,BRD:BRD-BRD-K33240821-001-06-2;BRD:BRD-K33240821-001-06-2;BRD:BRD-K33240821-400-02-5,rep_multi_dose;rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,ACKR3;CCR4;CXCR4,"NON-HODGKIN LYMPHOMA (NHL), MULTIPLE MYELOMA",,LAUNCHED,,Small molecule,4,"C(N1CCCNCCNCCCNCC1)C1CCC(CN2CCCNCCNCCCNCC2)CC1, C(N1CCCNCCNCCCNCC1)C1CCC(CN2CCCNCCNCCCNCC2)CC1, C(N1CCCNCCNCCCNCC1)C1CCC(CN2CCCNCCNCCCNCC2)CC1, C(N1CCCNCCNCCCNCC1)C1CCC(CN2CCCNCCNCCCNCC2)CC1;c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1",YIQPUIGJQJDJOS-UHFFFAOYSA-N
PLINABULIN,NPI-2358;PLINABULIN,CHEMBL1096380,BRD:BRD-BRD-K99498722-001-02-6;BRD:BRD-K99498722-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,PHASE 3,,Small molecule,3,"CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O;CC(C)(C)C1[NH]CNC1\C=C1/[NH]C(=O)\C(=C\C2CCCCC2)[NH]C1=O, CC(C)(C)C1[NH]CNC1\C=C1/[NH]C(=O)\C(=C\C2CCCCC2)[NH]C1=O, CC(C)(C)C1[NH]CNC1\C=C1/[NH]C(=O)\C(=C\C2CCCCC2)[NH]C1=O",UNRCMCRRFYFGFX-TYPNBTCFSA-N
PLOVAMER-ACETATE,PLOVAMER-ACETATE,,BRD:BRD-A20781140-001-01-7;BRD:BRD-BRD-A20781140-001-01-7,rep_primary;rep_single_dose,,TAT;TH;YARS;YARS2,,,PHASE 2,,,NA,"NC(CC1CCC(O)CC1)C(O)=O, NC(CC1CCC(O)CC1)C(O)=O",
PLUMBAGIN,NSC-236613;NSC-688284;PCUR-101;PLUMBAGIN,CHEMBL295316,BRD:BRD-K36137799-001-06-9,rep_single_dose,ANTICANCER AGENT,,,,,,Small molecule,1,CC1=CC(=O)c2c(O)cccc2C1=O,VCMMXZQDRFWYSE-UHFFFAOYSA-N
PLURIPOTIN,PLURIPOTIN,,CTRP:411833,ctrp,,,,,,,,NA,,
PLURISIN-1,PLURISIN-#1;PLURISIN-1,,BRD:BRD-BRD-K99149715-001-01-6;BRD:BRD-K99149715-001-01-6,rep_primary;rep_single_dose,STEAROYL-COA DESATURASE INHIBITOR,SCD,,,PRECLINICAL,,,NA,"O=C(NNC1CCCCC1)C1CCNCC1, O=C(NNC1CCCCC1)C1CCNCC1, O=C(NNC1CCCCC1)C1CCNCC1",
PLX 4720,PLX 4720,,GDSC1:1036;GDSC1:1371;GDSC2:1036,gdsc,,,,,,,,NA,,
ZELBORAF,PLX-4032;PLX4032;RG 7204;RG-7204;RO 5185426;RO-51-85426;RO-5185426;VEMURAFENIB;ZELBORAF,CHEMBL1229517,CTRP:649420,ctrp,,,,,,,Small molecule,4,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,GPXBXXGIAQBQNI-UHFFFAOYSA-N
PLX4720,PLX-4720;PLX4720,CHEMBL1230020,BRD:BRD-BRD-K16478699-001-09-2;BRD:BRD-K16478699-001-09-2;CTRP:606256;GDSC1:1036;GDSC1:1371;GDSC2:1036,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,RAF INHIBITOR,BRAF;KDR,,,PRECLINICAL,,Small molecule,NA,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F;CCCS(=O)(=O)NC1CCC(F)C(C(=O)C2C[NH]C3NCC(CL)CC23)C1F,YZDJQTHVDDOVHR-UHFFFAOYSA-N
ZELBORAF,PLX-4032;PLX4032;RG 7204;RG-7204;RO 5185426;RO-51-85426;RO-5185426;VEMURAFENIB;ZELBORAF,CHEMBL1229517,BRD:BRD-BRD-K56343971-001-10-6;BRD:BRD-K56343971-001-10-6;BRD:BRD-K56343971-001-14-8;BRD:BRD-K56343971-001-19-9,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF BRAF-V600E,BRAF;RAF1,MELANOMA,,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF BRAF-V600E', 'RAF INHIBITOR'}, defaulting to 'INHIBITOR OF BRAF-V600E'
Multiple values for repurposing_target: {'BRAF', 'BRAF;RAF1'}, taking the union",Small molecule,4,"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F;CCCS(=O)(=O)NC1CCC(F)C(C(=O)C2C[NH]C3NCC(CC23)-C2CCC(CL)CC2)C1F, CCCS(=O)(=O)NC1CCC(F)C(C(=O)C2C[NH]C3NCC(CC23)-C2CCC(CL)CC2)C1F, CCCS(=O)(=O)NC1CCC(F)C(C(=O)C2C[NH]C3NCC(CC23)-C2CCC(CL)CC2)C1F",GPXBXXGIAQBQNI-UHFFFAOYSA-N
PLX51107,PLX51107,,BRD:BRD-K00003099-001-01-9,rep_single_dose,BROMODOMAIN INHIBITOR,,,,,,,NA,,
PLX647,PLX647,,BRD:BRD-K79294107-300-02-9,rep_single_dose,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,CSF1R;KIT,,,,,,NA,,
PLX8394,FORE-8394;FORE8394;PLX 8394;PLX-8394;PLX8394,CHEMBL4303729,BRD:BRD-BRD-K53723268-001-01-3;BRD:BRD-K53723268-001-01-3;BRD:BRD-U00115428-001-01-9,oncref_1;rep_primary;rep_single_dose,"INHIBITOR OF BRAF, BRAF-V600E, AND CRAF",BRAF;CRAF,,,PHASE 1/PHASE 2,"Multiple values for MOA: {'SERINE/THREONINE KINASE INHIBITOR', 'INHIBITOR OF BRAF, BRAF-V600E, AND CRAF'}, defaulting to 'INHIBITOR OF BRAF, BRAF-V600E, AND CRAF'
Multiple values for repurposing_target: {'BRAF;CRAF', 'BRAF'}, taking the union
Multiple values for structure_id: {'K53723268', 'U00115428'}, defaulting to None",Small molecule,1,F[C@@H]1CCN(C1)S(=O)(=O)NC1CCC(F)C(C(=O)C2C[NH]C3NCC(CC23)-C2CNC(NC2)C2CC2)C1F;O=C(c1c(F)ccc(NS(=O)(=O)N2CC[C@@H](F)C2)c1F)c1c[nH]c2ncc(-c3cnc(C4CC4)nc3)cc12,YYACLQUDUDXAPA-MRXNPFEDSA-N
VIREAD,GS-1278;GS-4331-05;GS-4331-05-;GSK-548470;GSK548470;PMPA;PMPA PRODRUG;PMPA-PRODRUG;TENOFOVIR;TENOFOVIR DF;TENOFOVIR DISOPROXIL FUMARATE;TENOFOVIRI DISOPROXILI FUMARAS;VIREA;VIREAD,CHEMBL1486;CHEMBL3989702,BRD:BRD-A74387232-001-02-5;BRD:BRD-BRD-A74387232-001-02-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,FOLH1,,,PRECLINICAL,,Small molecule,4,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O;OC(=O)CCC(CP(O)(O)=O)C(O)=O,VCMJCVGFSROFHV-WZGZYPNHSA-N
PNU-120596,PNU-120596,,BRD:BRD-BRD-K71731651-001-04-3;BRD:BRD-K71731651-001-04-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA7,,,PRECLINICAL,,,NA,"COC1CC(OC)C(NC(=O)NC2CC(C)ON2)CC1CL, COC1CC(OC)C(NC(=O)NC2CC(C)ON2)CC1CL, COC1CC(OC)C(NC(=O)NC2CC(C)ON2)CC1CL",
PNU-142633,PNU-142633,,BRD:BRD-BRD-K81616657-001-01-4;BRD:BRD-K81616657-001-01-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1D,,,PHASE 2,,,NA,CNC(=O)C1CCC2[C@H](CCN3CCN(CC3)C3CCC(CC3)C(N)=O)OCCC2C1,
PNU-177864,PNU-177864,,BRD:BRD-K04635846-003-02-9,rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD3,,,,,,NA,,
PNU-22394,PNU-22394,CHEMBL6557,BRD:BRD-BRD-K16551401-003-03-4;BRD:BRD-K16551401-003-03-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2A;HTR2B;HTR2C;MAOA;MAOB,,,PHASE 2,,Small molecule,NA,Cn1c2c(c3ccccc31)CCNCC2;CN1C2CCNCCC2C2CCCCC12,ZBXDOQWPGBISAR-UHFFFAOYSA-N
PNU-282987,PNU-282987,CHEMBL177611,BRD:BRD-BRD-K28863208-001-02-0;BRD:BRD-K28863208-001-02-0,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR AGONIST,CHRNA7,,,PRECLINICAL,,Small molecule,NA,"CLC1CCC(CC1)C(=O)N[C@H]1CN2CCC1CC2, CLC1CCC(CC1)C(=O)N[C@H]1CN2CCC1CC2;O=C(N[C@H]1CN2CCC1CC2)c1ccc(Cl)cc1",WECKJONDRAUFDD-ZDUSSCGKSA-N
PNU-37883,PNU-37883,,BRD:BRD-BRD-K12769093-003-01-3;BRD:BRD-K12769093-003-01-3,rep_primary;rep_single_dose,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,,,,PRECLINICAL,,,NA,"C1CCC(CC1)N\C(N1CCOCC1)=N\C12CC3CC(CC(C3)C1)C2, C1CCC(CC1)N\C(N1CCOCC1)=N\C12CC3CC(CC(C3)C1)C2",
PNU-74654,PNU-74654,,BRD:BRD-BRD-K30707190-001-04-1;BRD:BRD-K30707190-001-04-1,rep_primary;rep_single_dose,BETA-CATENIN INHIBITOR,CTNNB1;TCF4,,,PRECLINICAL,,,NA,"CC1CCC(\C=N\NC(=O)C2CCCCC2OC2CCCCC2)O1, CC1CCC(\C=N\NC(=O)C2CCCCC2OC2CCCCC2)O1",
POCAPAVIR,POCAPAVIR,,BRD:BRD-K00003464-001-01-9,rep_single_dose,ENTEROVIRUS CAPSID INHIBITOR,,,,,,,NA,,
WARTICON,CONDYLINE;CONDYLOX;NSC-24818;PODOFILOX;PODOPHYLLOTOXIN;WARTICON,CHEMBL61,BRD:BRD-BRD-K47869605-001-32-0;BRD:BRD-K47869605-001-32-0,rep_multi_dose;rep_primary;rep_single_dose,"MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",IGF1R;TOP2A;TUBA4A;TUBB,GENITAL WARTS,,LAUNCHED,,Small molecule,4,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC;COC1CC(CC(OC)C1OC)[C@H]1[C@@H]2[C@H](COC2=O)[C@@H](O)C2CC3OCOC3CC12,YJGVMLPVUAXIQN-XVVDYKMHSA-N
PODOPHYLLOTOXIN BROMIDE,PODOPHYLLOTOXIN BROMIDE,,GDSC2:1825,gdsc,,,,,,,,NA,,
Z-103,CARNOSINE;POLAPREZINC;Z 103;Z-103,CHEMBL242948,BRD:BRD-K00003535-001-01-9,rep_single_dose,CHELATING AGENT,,,,,,Small molecule,2,NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O,CQOVPNPJLQNMDC-ZETCQYMHSA-N
VARITHENA,ASCLERA;POLIDOCANOL;POLYOXYL 9 LAURYL ETHER;VARITHENA,CHEMBL1231723,BRD:BRD-BRD-K35798650-001-01-4;BRD:BRD-K35798650-001-01-4,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,VARICOSE VEINS,,LAUNCHED,,Small molecule,4,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,ONJQDTZCDSESIW-UHFFFAOYSA-N
TRANS-POLYDATIN,(E)-PICEID;(E)-POLYDATIN;PICEID;POLYDATIN;RESVERATROL 3-.BETA.-MONO-D-GLUCOSIDE;TRANS-PICEID;TRANS-POLYDATIN,CHEMBL142652,BRD:BRD-BRD-K43236057-001-07-1;BRD:BRD-K43236057-001-07-1,rep_multi_dose;rep_primary;rep_single_dose,ICAM1 EXPRESSION INHIBITOR,ICAM1,,,PHASE 2,,Small molecule,2,"OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O;OC[C@H]1O[C@@H](OC2CC(O)CC(\C=C\C3CCC(O)CC3)C2)[C@H](O)[C@@H](O)[C@@H]1O, OC[C@H]1O[C@@H](OC2CC(O)CC(\C=C\C3CCC(O)CC3)C2)[C@H](O)[C@@H](O)[C@@H]1O",HSTZMXCBWJGKHG-CUYWLFDKSA-N
POLYINOSINE,POLYINOSINE,,BRD:BRD-A67531813-001-01-6;BRD:BRD-BRD-A67531813-001-01-6,rep_primary;rep_single_dose,IMMUNOSTIMULANT,ADSSL1;HPRT1;IMPDH2;PYGM,,,PRECLINICAL,,,NA,OC1C(COP(O)(O)=O)OC(C1O)N1CNC2C(O)NCNC12,
POLYMYXIN B NONAPEPTIDE (TFA),POLYMYXIN B NONAPEPTIDE (TFA),,BRD:BRD-K00091270-459-01-9,rep_single_dose,,,,,,,,NA,,
POLYMYXIN-B-SULFATE,POLYMYXIN-B-SULFATE,,BRD:BRD-A08641215-065-05-5,rep_single_dose,BACTERIAL PERMEABILITY INDUCER,,,,,,,NA,,
RENESE,NEPHRIL;NSC-108161;P-2525;POLYTHIAZIDE;RENESE,CHEMBL1587,BRD:BRD-A15739803-001-01-0;BRD:BRD-BRD-A15739803-001-01-0,rep_primary;rep_single_dose,SODIUM/CHLORIDE COTRANSPORTER INHIBITOR,SLC12A3,"EDEMA, CONGESTIVE HEART FAILURE, HEPATIC CIRRHOSIS, NEPHROTIC SYNDROME, ACUTE GLOMERULONEPHRITIS (AGN), CHRONIC RENAL FAILURE, HYPERTENSION",,LAUNCHED,,Small molecule,4,CN1C(CSCC(F)(F)F)NC2CC(CL)C(CC2S1(=O)=O)S(N)(=O)=O;CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,CYLWJCABXYDINA-UHFFFAOYSA-N
POMALYST,ACTIMID;CC-4047;IMID 3;IMID-3;IMNOVID;POMALIDOMIDE;POMALYST,CHEMBL43452,BRD:BRD-A12994259-001-02-1;BRD:BRD-BRD-A12994259-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,"ANGIOGENESIS INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",CRBN;PTGS2;TNF,MULTIPLE MYELOMA,,LAUNCHED,,Small molecule,4,NC1CCCC2C(=O)N(C3CCC(=O)NC3=O)C(=O)C12;Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,UVSMNLNDYGZFPF-UHFFFAOYSA-N
PONATINIB,AP-24534;AP24534;ICLUSIG;PONATINIB,CHEMBL1171837,BRD:BRD-BRD-K44227013-001-06-4;BRD:BRD-K44227013-001-06-4;GDSC1:155,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"BCR-ABL KINASE INHIBITOR, FLT3 INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",ABL1;BCR;FGFR1;FGFR2;FGFR3;FGFR4;FLT3;KDR;KIT;LCK;LYN;PDGFRA;RET;SRC;TEK,"CHRONIC MYELOID LEUKEMIA (CML), ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)",,LAUNCHED,,Small molecule,4,"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12;CN1CCN(CC2CCC(NC(=O)C3CCC(C)C(C3)C#CC3CNC4CCCNN34)CC2C(F)(F)F)CC1, CN1CCN(CC2CCC(NC(=O)C3CCC(C)C(C3)C#CC3CNC4CCCNN34)CC2C(F)(F)F)CC1",PHXJVRSECIGDHY-UHFFFAOYSA-N
PONVORY,ACT-128800;PONESIMOD;PONVORY,CHEMBL1096146,BRD:BRD-BRD-K44030614-001-01-6;BRD:BRD-K44030614-001-01-6,rep_primary;rep_single_dose,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",S1PR1,,,PHASE 3,"Multiple values for MOA: {'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST', 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'}, defaulting to 'SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST'",Small molecule,4,CCC/N=C1\S/C(=C\c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C;CCC\N=C1/S\C(=C/C2CCC(OC[C@H](O)CO)C(CL)C2)C(=O)N1C1CCCCC1C,LPAUOXUZGSBGDU-STDDISTJSA-N
SCH-56592,(-)-POSACONAZOLE;NOXAFIL;NOXAFIL POWDERMIX KIT;POSACONAZOLE;SCH 56592;SCH-56592,CHEMBL1397,BRD:BRD-BRD-K06222852-001-03-2;BRD:BRD-K06222852-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,CYP3A4,OROPHARYNGEAL CANDIDIASIS,,LAUNCHED,,Small molecule,4,"CC[C@@H]([C@H](C)O)N1NCN(-C2CCC(CC2)N2CCN(CC2)C2CCC(OC[C@@H]3CO[C@](CN4CNCN4)(C3)C3CCC(F)CC3F)CC2)C1=O, CC[C@@H]([C@H](C)O)N1NCN(-C2CCC(CC2)N2CCN(CC2)C2CCC(OC[C@@H]3CO[C@](CN4CNCN4)(C3)C3CCC(F)CC3F)CC2)C1=O;CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O",RAGOYPUPXAKGKH-XAKZXMRKSA-N
POTASSIUM-CANRENOATE,POTASSIUM-CANRENOATE,,BRD:BRD-BRD-K46556543-001-01-4;BRD:BRD-BRD-K46556543-237-10-5;BRD:BRD-K46556543-001-01-4;BRD:BRD-K46556543-237-10-5,rep_primary;rep_single_dose,MINERALOCORTICOID RECEPTOR ANTAGONIST,NR3C2,EDEMA,,LAUNCHED,,,NA,"C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O, C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O, C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O",
POTASSIUM-IODIDE,POTASSIUM-IODIDE,,BRD:BRD-M55321172-001-03-3,rep_single_dose,,,,,,,,NA,,
POTASSIUM-P-AMINOBENZOATE,POTASSIUM-P-AMINOBENZOATE,,BRD:BRD-BRD-K58497451-237-10-7;BRD:BRD-K58497451-237-10-7,rep_primary;rep_single_dose,,,"SCLERODERMA, DERMATOMYOSITIS, PEYRONIE'S DISEASE",,LAUNCHED,,,NA,NC1CCC(CC1)C(O)=O,
POZANICLINE,A-87089.0;A-870890;ABT-089;POZANICLINE,CHEMBL127071,BRD:BRD-BRD-K79803033-300-01-3;BRD:BRD-K79803033-300-01-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRNA4;CHRNB2,,,PHASE 2,,Small molecule,2,Cc1ncccc1OC[C@@H]1CCCN1;CC1NCCCC1OC[C@@H]1CCCN1,YRVIKLBSVVNSHF-JTQLQIEISA-N
PP-1,PP-1,,BRD:BRD-BRD-K47598052-001-15-8;BRD:BRD-K47598052-001-15-8,rep_multi_dose;rep_primary;rep_single_dose,SRC INHIBITOR,HCK;RET,,,PRECLINICAL,,,NA,"CC1CCC(CC1)-C1NN(C2NCNC(N)C12)C(C)(C)C, CC1CCC(CC1)-C1NN(C2NCNC(N)C12)C(C)(C)C",
PP-121,PP-121,,BRD:BRD-BRD-K81801188-001-02-8;BRD:BRD-K81801188-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,ABL1;EGFR;HCK;KDR;MTOR;PDGFRA;PIK3CA;PIK3CB;PIK3CD;PIK3CG;PRKDC;SRC,,,PRECLINICAL,,,NA,"C1CCC(C1)N1NC(-C2CNC3[NH]CCC3C2)C2C(N)NCNC12, C1CCC(C1)N1NC(-C2CNC3[NH]CCC3C2)C2C(N)NCNC12",
PP-2,PP-2,,BRD:BRD-BRD-K95785537-001-23-1;BRD:BRD-K95785537-001-23-1,rep_multi_dose;rep_primary;rep_single_dose,SRC INHIBITOR,ABL1;LCK;LYN;RIPK2;SRC,,,PRECLINICAL,,,NA,"CC(C)(C)N1NC(-C2CCC(CL)CC2)C2C(N)NCNC12, CC(C)(C)N1NC(-C2CCC(CL)CC2)C2C(N)NCNC12, CC(C)(C)N1NC(-C2CCC(CL)CC2)C2C(N)NCNC12",
PP242,PP242,,BRD:BRD-BRD-K87112191-001-04-5;BRD:BRD-K87112191-001-04-5,rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR;PASK,,,PRECLINICAL,,,NA,"CC(C)N1NC(-C2CC3CC(O)CCC3[NH]2)C2C(N)NCNC12, CC(C)N1NC(-C2CC3CC(O)CCC3[NH]2)C2C(N)NCNC12, CC(C)N1NC(-C2CC3CC(O)CCC3[NH]2)C2C(N)NCNC12",
PPT,PPT,,BRD:BRD-BRD-K00312224-001-09-5;BRD:BRD-K00312224-001-09-5,rep_multi_dose;rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1,,,PRECLINICAL,,,NA,"CCCC1C(NN(C1-C1CCC(O)CC1)-C1CCC(O)CC1)-C1CCC(O)CC1, CCCC1C(NN(C1-C1CCC(O)CC1)-C1CCC(O)CC1)-C1CCC(O)CC1",
PPY-A,PPY-A,,BRD:BRD-BRD-K72514671-001-01-4;BRD:BRD-K72514671-001-01-4,rep_primary;rep_single_dose,ABL KINASE INHIBITOR,ABL1;BCR,,,PRECLINICAL,,,NA,COC1CCCCC1-C1C[NH]C2NCC(CC12)-C1CNCC(C1)C(=O)N(C)C,
PQ-401,PQ-401,,BRD:BRD-BRD-K67537649-001-04-5;BRD:BRD-K67537649-001-04-5,rep_multi_dose;rep_primary;rep_single_dose,IGF-1 INHIBITOR,IGF1R,,,PRECLINICAL,,,NA,"COC1CCC(CL)CC1NC(=O)NC1CC(C)NC2CCCCC12, COC1CCC(CL)CC1NC(=O)NC1CC(C)NC2CCCCC12, COC1CCC(CL)CC1NC(=O)NC1CC(C)NC2CCCCC12",
PR-619,PR-619,,BRD:BRD-BRD-K54395039-001-01-7;BRD:BRD-K54395039-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,DUB INHIBITOR,,,,PRECLINICAL,,,NA,"NC1NC(N)C(SC#N)CC1SC#N, NC1NC(N)C(SC#N)CC1SC#N",
PRACTOLOL,"[3-(4-ACETYLAMINO-PHENOXY)-2-HYDROXY-PROPYL]-ISOPROPYL-AMMONIUM;AY-21,011;AY-21011;DALZIC;ERALDIN;I.C.I. 50,172;I.C.I.-50,172;ICI-50172;PRACTOLOL",CHEMBL6995,BRD:BRD-A41304429-001-14-8;BRD:BRD-BRD-A41304429-001-14-8,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1,,,WITHDRAWN,,Small molecule,4,"CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1;CC(C)NCC(O)COC1CCC(NC(C)=O)CC1, CC(C)NCC(O)COC1CCC(NC(C)=O)CC1",DURULFYMVIFBIR-UHFFFAOYSA-N
PRADEFOVIR,PRADEFOVIR,CHEMBL2096895,BRD:BRD-K00003119-066-01-9,rep_single_dose,CYTOCHROME P450 ACTIVATOR,,,,,,Small molecule,3,Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1,GWNHAOBXDGOXRR-HJFSHJIFSA-N
PRALATREXATE,FOLOTYN;NSC-754230;PDX;PRALATREXATE,CHEMBL1201746,BRD:BRD-A74914197-001-02-9;BRD:BRD-BRD-A74914197-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR;TYMS,PERIPHERAL T-CELL LYMPHOMA (PTCL),,LAUNCHED,,Small molecule,4,C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1;NC1NC(N)C2NC(CC(CC#C)C3CCC(CC3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2N1,OGSBUKJUDHAQEA-WMCAAGNKSA-N
PRALIDOXIME ION,ATNAA;DUODOTE;PRALIDOXIME;PRALIDOXIME CATION;PRALIDOXIME ION,CHEMBL1420,BRD:BRD-BRD-K84281997-003-08-4;BRD:BRD-K84281997-003-08-4,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE;BCHE,ORGANOPHOSPHATE POISONING,,LAUNCHED,,Small molecule,4,"C[N+]1CCCCC1\C=N\O, C[N+]1CCCCC1\C=N\O, C[N+]1CCCCC1\C=N\O;C[n+]1ccccc1C=NO",JBKPUQTUERUYQE-UHFFFAOYSA-O
PRALIDOXIME-CHLORIDE,PRALIDOXIME-CHLORIDE,,BRD:BRD-BRD-K24221957-003-01-6;BRD:BRD-K24221957-003-01-6,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE;BCHE,RESPIRATORY DEPRESSION,,LAUNCHED,,,NA,C[N+]1CCCCC1C[N+][O-],
PRALMORELIN,GHRP-2;KP-102;PRALMORELIN,CHEMBL106593,BRD:BRD-K00004629-001-01-9,rep_single_dose,GROWTH HORMONE RELEASING PEPTIDE LIGAND AGONIST,,,,,,Protein,-1,C[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O,HRNLPPBUBKMZMT-RDRUQFPZSA-N
U-98528E,MIRAPEXIN;NELIPRAX;NSC-760426;OPRYMEA;PIPEXUS;PRAMIPEXOLE;SUD-919CL2Y;SUD919CL2Y;U-98528E,CHEMBL301265,BRD:BRD-BRD-K06388322-312-02-6;BRD:BRD-K06388322-312-02-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,"CCCN[C@H]1CCc2nc(N)sc2C1;CCCN[C@H]1CCC2NC(N)SC2C1, CCCN[C@H]1CCC2NC(N)SC2C1, CCCN[C@H]1CCC2NC(N)SC2C1",FASDKYOPVNHBLU-ZETCQYMHSA-N
PRAMIRACETAM,PRAMIRACETAM,CHEMBL159776,BRD:BRD-BRD-K21123171-001-02-9;BRD:BRD-K21123171-001-02-9,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,LAUNCHED,,Small molecule,-1,CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,ZULJGOSFKWFVRX-UHFFFAOYSA-N
PRAMOXINE,PRAMOCAINE;PRAMOXINE,CHEMBL1198,BRD:BRD-BRD-K46523383-003-22-9;BRD:BRD-K46523383-003-22-9,rep_primary;rep_single_dose,TOPICAL ANESTHETIC,,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,Small molecule,4,"CCCCOc1ccc(OCCCN2CCOCC2)cc1;CCCCOC1CCC(OCCCN2CCOCC2)CC1, CCCCOC1CCC(OCCCN2CCOCC2)CC1",DQKXQSGTHWVTAD-UHFFFAOYSA-N
PRANIDIPINE,ACALAS;FRC-8411;OPC-13340;PRANIDIPINE,CHEMBL1096842,BRD:BRD-A68083442-001-01-6;BRD:BRD-BRD-A68083442-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1C,,,PHASE 2,,Small molecule,-1,COC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1;COC(=O)C1=C(C)NC(C)=C(C1C1CCCC(C1)[N+]([O-])=O)C(=O)OC\C=C\C1CCCCC1,XTFPDGZNWTZCMF-DHZHZOJOSA-N
SB-205312,AZLAIRE;CCN 00401;CCN-00401;ONO 1078;ONO-1078;PRANLUKAST;RS 411;RS-411;SB 205312;SB-205312,CHEMBL21333,BRD:BRD-BRD-K97045029-001-02-7;BRD:BRD-BRD-K97045029-001-04-3;BRD:BRD-K97045029-001-02-7;BRD:BRD-K97045029-001-04-3,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,CYSLTR1;CYSLTR2;IL5;MUC2;NFKB1;RNASE3;TNF,"BRONCHOSPASM, ASTHMA, BRONCHOSPASM, ASTHMA",,LAUNCHED,,Small molecule,3,"O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1;O=C(NC1CCCC2C1OC(CC2=O)-C1NNN[NH]1)C1CCC(OCCCCC2CCCCC2)CC1, O=C(NC1CCCC2C1OC(CC2=O)-C1NNN[NH]1)C1CCC(OCCCCC2CCCCC2)CC1",NBQKINXMPLXUET-UHFFFAOYSA-N
PYRANOPROFEN,ELICAPRIC;NSC-759832;PRANOPROFEN;PYRANOPROFEN,CHEMBL367463,BRD:BRD-A64610707-001-04-4;BRD:BRD-BRD-A64610707-001-04-4,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,"CC(C(=O)O)c1ccc2c(c1)Cc1cccnc1O2;CC(C(O)=O)C1CCC2OC3NCCCC3CC2C1, CC(C(O)=O)C1CCC2OC3NCCCC3CC2C1, CC(C(O)=O)C1CCC2OC3NCCCC3CC2C1",TVQZAMVBTVNYLA-UHFFFAOYSA-N
PRASTERONE-ACETATE,PRASTERONE-ACETATE,,BRD:BRD-A20758144-001-04-5;BRD:BRD-BRD-A20758144-001-04-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC(=O)O[C@H]1CC[C@]2(C)C3CC[C@@]4(C)C(CCC4=O)C3CC=C2C1,
PRASUGREL,EFIENT;LY-640315;NSC-759625;PRASUGREL,CHEMBL1201772,BRD:BRD-A83029242-001-05-3;BRD:BRD-BRD-A83029242-001-05-3,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RY12,"MYOCARDIAL INFARCTION, ACUTE CORONARY SYNDROME (ACS)",,LAUNCHED,,Small molecule,4,"CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2;CC(=O)OC1CC2CN(CCC2S1)C(C(=O)C1CC1)C1CCCCC1F, CC(=O)OC1CC2CN(CCC2S1)C(C(=O)C1CC1)C1CCCCC1F, CC(=O)OC1CC2CN(CCC2S1)C(C(=O)C1CC1)C1CCCCC1F, CC(=O)OC1CC2CN(CCC2S1)C(C(=O)C1CC1)C1CCCCC1F",DTGLZDAWLRGWQN-UHFFFAOYSA-N
PRAVADOLINE,PRAVADOLINE,CHEMBL13178,BRD:BRD-BRD-K46209126-001-06-4;BRD:BRD-K46209126-001-06-4,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,CNR1;CNR2,,,PRECLINICAL,,Small molecule,-1,COc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3ccccc23)cc1;COC1CCC(CC1)C(=O)C1C(C)N(CCN2CCOCC2)C2CCCCC12,MEUQWHZOUDZXHH-UHFFFAOYSA-N
PRAVATOR,C10AA03;PRAVACHOL;PRAVASTATIN;PRAVATOR,CHEMBL1144,BRD:BRD-BRD-K60511616-236-08-9;BRD:BRD-K60511616-236-08-9,rep_primary;rep_single_dose,HMGCR INHIBITOR,HMGCR;SLCO1B1,"HYPERCHOLESTEROLEMIA, MYOCARDIAL INFARCTION, HYPERLIPIDEMIA",,LAUNCHED,,Small molecule,4,"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21;CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12, CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)C12, CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12",TUZYXOIXSAXUGO-PZAWKZKUSA-N
PRAZIQUANTELUM,"(-)-;(-)-PRAZIQUANTEL;(R)-;(R)-(-)-PRAZIQUANTEL;(R)-PRAZIQUANTEL;ARPRAZIQUANTEL;BILTRICIDE;CESOL;CESTOCUR;CISTICID;CYSTICIDE;DRONCIT;EMBAY 8440;EMBAY-8440;L-PRAZIQUANTEL;L-PZQ;MSC-2499550A;MSC2499550A;NSC-757285;PRAZIQUANTEL;PRAZIQUANTEL, (R)-;PRAZIQUANTELUM",CHEMBL1235551;CHEMBL976,BRD:BRD-A21858158-001-23-5;BRD:BRD-BRD-A21858158-001-23-5,rep_primary;rep_single_dose,ANTHELMINTIC AGENT,,"GASTROINTESTINAL PARASITES, CYSTIC HYDATID DISEASE, SCHISTOSOMIASIS",,LAUNCHED,,Small molecule,4,"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1;O=C(C1CCCCC1)N1CC2N(CCC3CCCCC23)C(=O)C1, O=C(C1CCCCC1)N1CC2N(CCC3CCCCC23)C(=O)C1",FSVJFNAIGNNGKK-UHFFFAOYSA-N
PRAZOSIN,CP-12299;CP-122991;PRAZOSIN,CHEMBL2,BRD:BRD-BRD-K49111258-003-29-7;BRD:BRD-K49111258-003-29-7,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;KCNH2;KCNH6;KCNH7,HYPERTENSION,,LAUNCHED,,Small molecule,4,"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC;COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1CCCO1, COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1CCCO1, COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1CCCO1, COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1CCCO1",IENZQIKPVFGBNW-UHFFFAOYSA-N
PRE-084,PRE-084,,BRD:BRD-BRD-K57304726-003-06-9;BRD:BRD-K57304726-003-06-9,rep_primary;rep_single_dose,SIGMA RECEPTOR AGONIST,SIGMAR1,,,PRECLINICAL,,,NA,"O=C(OCCN1CCOCC1)C1(CCCCC1)C1CCCCC1, O=C(OCCN1CCOCC1)C1(CCCCC1)C1CCCCC1",
PRECLAMOL,(-)-3PPP;PRECLAMOL,CHEMBL7549,BRD:BRD-BRD-K02908048-003-06-4;BRD:BRD-K02908048-003-06-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD2,,,PHASE 2,,Small molecule,-1,CCCN1CCC[C@@H](C1)C1CCCC(O)C1;CCCN1CCC[C@@H](c2cccc(O)c2)C1,HTSNFXAICLXZMA-CYBMUJFWSA-N
VERDESO,CORTALONE;DEKOTIL;DELTA-CORTEF;DELTACORTRIL;DELTALONE;DESOWEN;DILACORT;FERNISOLONE-P;HYDELTRA;HYDELTRA-TBA;METI-DERM;METICORTELONE;NEO-DELTA-CORTEF;NSC-9120;NSC-9900;PEVANTI;POLY-PRED;PRECORTISYL;PRECORTISYL FTE;PRED-G;PREDNISOLONE;PRELONE;SCHERIPROCT;SERVISONE;STERANE;TRIDESILON;VERDESO,CHEMBL131,BRD:BRD-A27887842-001-04-0;BRD:BRD-BRD-A27887842-001-04-0,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;NR3C2;SERPINA6,"CONJUNCTIVITIS, ROSACEA, PUNCTATE KERATITIS, SHINGLES, IRITIS, CYCLITIS",,LAUNCHED,,Small molecule,4,"C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO;C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO",OIGNJSKKLXVSLS-VWUMJDOOSA-N
PREDNISOLONE-ACETATE,PREDNISOLONE-ACETATE,,BRD:BRD-A01643550-001-04-9;BRD:BRD-BRD-A01643550-001-04-9;BRD:BRD-BRD-K45664306-001-19-6;BRD:BRD-K45664306-001-19-6,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,"CONJUNCTIVITIS, ROSACEA, PUNCTATE KERATITIS, SHINGLES, IRITIS, CYCLITIS",,LAUNCHED,"Multiple values for structure_id: {'A01643550', 'K45664306'}, defaulting to None",,NA,"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3[C@@H](O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C",
PREDNISOLONE-HEMISUCCINATE,PREDNISOLONE-HEMISUCCINATE,,BRD:BRD-A78391468-001-02-8;BRD:BRD-BRD-A78391468-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,,,PRECLINICAL,,,NA,C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O,
PREDNISOLONE-SODIUM-PHOSPHATE,PREDNISOLONE-SODIUM-PHOSPHATE,,BRD:BRD-A94523291-304-02-7;BRD:BRD-BRD-A94523291-304-02-7,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1,"ALLERGIC RHINITIS, ASTHMA, CONTACT DERMATITIS, MYCOSIS, LUPUS, HYPERCALCEMIA, THYROIDITIS, CONGENITAL ADRENAL HYPERPLASIA, MULTIPLE SCLEROSIS, ULCERATIVE COLITIS, ENTERITIS, THROMBOCYTHEMIA, PNEUMONIA, ASTHMA, MENINGITIS, PSORIATIC ARTHRITIS, RHEUMATOID ARTHRITIS",,LAUNCHED,,,NA,C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O,
PREDNISOLONE-TEBUTATE,PREDNISOLONE-TEBUTATE,,BRD:BRD-A53151380-001-01-2;BRD:BRD-BRD-A53151380-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,LAUNCHED,,,NA,CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C,
SUPERCORTIL,3EN3HG4WSW;CORTAN;CORTANCYL;DECORTIN;DECORTISYL;DEHYDROCORTISONE;DELTA-DOME;DELTASONE;FERNISONE;LIQUID PRED;LODOTRA;METACORTANDRACIN;METICORTEN;NSC-10023;ORASONE;PARACORT;PREDNICEN-M;PREDNISONE;PREDNISONE ANHYDROUS;PREDNISONE INTENSOL;PREDNISONE TABLETS;RAYOS;SERVISONE;STERAPRED;SUPERCORTIL,CHEMBL635,BRD:BRD-BRD-K85883481-001-25-7;BRD:BRD-K85883481-001-25-7,rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,HSD11B1;NR3C1,"CONGENITAL ADRENAL HYPERPLASIA, HYPERCALCEMIA, RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, BURSITIS, OSTEOARTHRITIS, EPICONDYLITIS, DERMATOMYOSITIS, PSORIASIS, MYCOSIS, CONJUNCTIVITIS, ANEMIA, ULCERATIVE COLITIS, ENTERITIS, MULTIPLE SCLEROSIS, MENINGITIS",,LAUNCHED,,Small molecule,4,"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO;C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO",XOFYZVNMUHMLCC-ZPOLXVRWSA-N
YNP-1807,ALZAIN;AXALID;CI-1008;LECAENT;LYRICA;LYRICA CR;NSC-759256;PD-144723;PREGABALIN;PREGABALIN MYLAN;PREGABALIN SANDOZ;PREGABALIN SANDOZ GMBH;PREGABALIN ZENTIVA;REWISCA;VRONOGABIC;YNP-1807,CHEMBL1059,BRD:BRD-BRD-K66786476-001-01-3;BRD:BRD-K66786476-001-01-3,rep_primary;rep_single_dose,VOLTAGE-GATED CALCIUM CHANNEL LIGAND,CACNA1A;CACNA1B;CACNA1C;CACNA1D;CACNA1E;CACNA1F;CACNA1G;CACNA1H;CACNA1I;CACNA1S;CACNA2D1;CACNA2D2;CACNA2D3;CACNA2D4;CACNB1;CACNB2;CACNB3;CACNB4;CACNG1;CACNG2;CACNG3;CACNG4;CACNG5;CACNG6;CACNG7;CACNG8,"PERIPHERAL NEUROPATHY, SEIZURES, FIBROMYALGIA, POSTHERPETIC NEURALGIA",,LAUNCHED,,Small molecule,4,"CC(C)C[C@H](CN)CC(=O)O;CC(C)C[C@H](CN)CC(O)=O, CC(C)C[C@H](CN)CC(O)=O",AYXYPKUFHZROOJ-ZETCQYMHSA-N
SKF-6455,ELTANOLONE;KABI 2213;KABI-2213;NSC-82867;PREGNAN-3.ALPHA.-OL-20-ONE;PREGNANOLONE;SKF-6455,CHEMBL210952,BRD:BRD-A03204438-001-01-2;BRD:BRD-BRD-A03204438-001-01-2,rep_primary;rep_single_dose,GABA RECEPTOR POSITIVE ALLOSTERIC MODULATOR,,,,PHASE 2,,Small molecule,-1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C;CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,AURFZBICLPNKBZ-YZRLXODZSA-N
PREGNENOLONE SUCCINATE,ARTHENOLONE;ENELONE;FORMULA 405;NSC-1616;NSC-18158;NSC-759188;PREGNENOLONE;PREGNENOLONE SUCCINATE,CHEMBL2105373;CHEMBL253363,BRD:BRD-BRD-K43880410-001-14-4;BRD:BRD-K43880410-001-14-4,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,CYP17A1;SULT2B1,,,LAUNCHED,,Small molecule,3,"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C, CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C;CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C",OZZAYJQNMKMUSD-DMISRAGPSA-N
PREGNENOLONE-SUCCINATE,PREGNENOLONE-SUCCINATE,,BRD:BRD-A35912562-001-02-8;BRD:BRD-BRD-A35912562-001-02-8,rep_primary;rep_single_dose,GABA RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,CYP17A1,,,PRECLINICAL,,,NA,CC(=O)[C@H]1CCC2C3CC=C4C[C@H](CC[C@]4(C)C3CC[C@]12C)OC(=O)CCC(O)=O,
SCH-420814,MK-3814;PRELADENANT;SCH 420814;SCH-420814,CHEMBL240624,BRD:BRD-BRD-K46290096-001-01-1;BRD:BRD-K46290096-001-01-1,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PHASE 3,,Small molecule,3,COCCOC1CCC(CC1)N1CCN(CCN2NCC3C2NC(N)N2NC(NC32)-C2CCCO2)CC1;COCCOc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)cc1,DTYWJKSSUANMHD-UHFFFAOYSA-N
PRENYLAMINE LACTATE,B-436;PRENYLAMINE;PRENYLAMINE LACTATE,CHEMBL24072,BRD:BRD-A10662413-043-11-2;BRD:BRD-BRD-A10662413-043-11-2,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CALM1;MYLK2,,,WITHDRAWN,,Small molecule,4,CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1;CC(CC1CCCCC1)NCCC(C1CCCCC1)C1CCCCC1,IFFPICMESYHZPQ-UHFFFAOYSA-N
PRESATOVIR,GS-5806;PRESATOVIR,CHEMBL3410450,BRD:BRD-BRD-K45906612-001-01-8;BRD:BRD-K45906612-001-01-8,rep_primary;rep_single_dose,RSV FUSION INHIBITOR,,,,PHASE 2,,Small molecule,2,Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1CC[C@H](N)C1;CC1CN2NC(CC2NC1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)C1CC(CL)CCC1NS(C)(=O)=O,GOFXWTVKPWJNGD-UWJYYQICSA-N
PRI724,"(S,S)-ICG-001;FOSCENVIVINT;PRI-724;PRI724",CHEMBL4297813,BRD:BRD-K00091108-001-01-9,rep_single_dose,,,,,,,Unknown,2,,
PRIDINOL MESILATE,C-238;NSC-23016;PRIDINOL;PRIDINOL MESILATE,CHEMBL404215,BRD:BRD-BRD-K17565903-066-23-1;BRD:BRD-K17565903-066-23-1,rep_primary;rep_single_dose,MUSCLE RELAXANT,,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,-1,"OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1;OC(CCN1CCCCC1)(C1CCCCC1)C1CCCCC1, OC(CCN1CCCCC1)(C1CCCCC1)C1CCCCC1",RQXCLMGKHJWMOA-UHFFFAOYSA-N
PRIDOPIDINE,ACR-16;ACR16;FR-310826;FR310826;HUNTEXIL;PRIDOPIDINE,CHEMBL596802,BRD:BRD-K00003473-001-01-9,rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,3,CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1,YGKUEOZJFIXDGI-UHFFFAOYSA-N
PROPITOCAINE,ASTRA-1512;ASTRA-1515;CITANEST;NSC-40027;PRILOCAINE;PROPITOCAINE,CHEMBL1194,BRD:BRD-A53952395-003-25-1;BRD:BRD-BRD-A53952395-003-25-1,rep_primary;rep_single_dose,LOCAL ANESTHETIC,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,ANESTHETIC,,LAUNCHED,,Small molecule,4,"CCCNC(C)C(=O)Nc1ccccc1C;CCCNC(C)C(=O)NC1CCCCC1C, CCCNC(C)C(=O)NC1CCCCC1C",MVFGUOIZUNYYSO-UHFFFAOYSA-N
PRIMA-1,PRIMA-1,,CTRP:50131,ctrp,,,,,,,,NA,,
PRIMA-1-MET,PRIMA-1-MET,,CTRP:594663,ctrp,,,,,,,,NA,,
PRIMA-1MET,PRIMA 1MET;PRIMA-1MET,,GDSC2:1131,gdsc,,,,,,,,NA,,
PRIMA1,PRIMA1,,BRD:BRD-BRD-K15318909-001-10-5;BRD:BRD-K15318909-001-10-5,rep_primary;rep_single_dose,TP53 INHIBITOR,ACHE,,,PRECLINICAL,,,NA,"OCC1(CO)N2CCC(CC2)C1=O, OCC1(CO)N2CCC(CC2)C1=O",
WR-2975,KANAPRIM;MALIRIDE;NEO-QUIPENYL;NSC-27296;PRIMACHIN;PRIMAQUINE;SN-13272;WR-2975,CHEMBL506,BRD:BRD-A55913614-316-09-6;BRD:BRD-BRD-A55913614-316-09-6,rep_multi_dose;rep_primary;rep_single_dose,"ANTIMALARIAL AGENT, DNA INHIBITOR",KRT7;NQO2,MALARIA,,LAUNCHED,,Small molecule,4,"COc1cc(NC(C)CCCN)c2ncccc2c1;COC1CC(NC(C)CCCN)C2NCCCC2C1, COC1CC(NC(C)CCCN)C2NCCCC2C1",INDBQLZJXZLFIT-UHFFFAOYSA-N
RESIMATIL,LEPIMIDIN;LEPSIRAL;LISKANTIN;MYSOLINE;NEUROSYN;NSC-41701;PRIMACLONE;PRIMIDONE;RESIMATIL,CHEMBL856,BRD:BRD-BRD-K32247306-001-29-4;BRD:BRD-K32247306-001-29-4,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,CHRNA4;CHRNA7;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GRIA2;GRIK2;SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,Small molecule,4,"CCC1(C(=O)NCNC1=O)C1CCCCC1, CCC1(C(=O)NCNC1=O)C1CCCCC1, CCC1(C(=O)NCNC1=O)C1CCCCC1;CCC1(c2ccccc2)C(=O)NCNC1=O",DQMZLTXERSFNPB-UHFFFAOYSA-N
PRINABEREL,ERB-041;PF-00913086;PRINABEREL,CHEMBL450940,BRD:BRD-BRD-K87316765-001-01-4;BRD:BRD-K87316765-001-01-4,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR2;NCOA1,,,PHASE 2,,Small molecule,2,C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12;OC1CC(C=C)C2OC(NC2C1)-C1CCC(O)C(F)C1,MQIMZDXIAHJKQP-UHFFFAOYSA-N
PRINOMASTAT,AG-3340;AG3340;KB-R-9896;PRINOMASTAT,CHEMBL75094,BRD:BRD-K00003122-001-01-9,rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,,,,,,Small molecule,3,CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO,YKPYIPVDTNNYCN-INIZCTEOSA-N
PRIRALFINAMIDE,PRIRALFINAMIDE,,BRD:BRD-BRD-K01662324-001-01-8;BRD:BRD-K01662324-001-01-8,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,CACNA1B,,,PHASE 3,,,NA,"C[C@H](NCC1CCC(OCC2CCCCC2F)CC1)C(N)=O, C[C@H](NCC1CCC(OCC2CCCCC2F)CC1)C(N)=O",
PRISOTINOL,PRISOTINOL,CHEMBL2106875,BRD:BRD-K00004547-001-01-9,rep_single_dose,,,,,,,Small molecule,-1,CC(C)NC(C)Cc1ccc(O)cn1,WQRPBKUCJBWQRT-UHFFFAOYSA-N
PRITELIVIR,AIC-316;AIC316;PRITELIVIR,CHEMBL4069597,BRD:BRD-BRD-K25204779-001-01-1;BRD:BRD-K25204779-001-01-1,rep_primary;rep_single_dose,HELICASE PRIMASE INHIBITOR,,,,PHASE 2,,Small molecule,3,Cc1nc(N(C)C(=O)Cc2ccc(-c3ccccn3)cc2)sc1S(N)(=O)=O;CN(C(=O)CC1CCC(CC1)-C1CCCCN1)C1NC(C)C(S1)S(N)(=O)=O,IVZKZONQVYTCKC-UHFFFAOYSA-N
PRL-3 INHIBITOR I,PRL-3 INHIBITOR I,,CTRP:411727,ctrp,,,,,,,,NA,,
PRLX-93936,PRLX-93936,,BRD:BRD-K00004604-001-01-9,rep_single_dose,VOLTAGE-DEPENDENT ANION SELECTIVE CHANNEL PROTEIN INHIBITOR,,,,,,,NA,,
RILZABRUTINIB,PRN-1008;PRN1008;RILZABRUTINIB,CHEMBL3702854,BRD:BRD-K00004599-001-01-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,Small molecule,3,CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1,LCFFREMLXLZNHE-GBOLQPHISA-N
PRN1371,PRN 1371;PRN-1371;PRN1371,CHEMBL4068509,BRD:BRD-K00003430-001-01-9,rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,,,,,,Small molecule,1,C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1,PUIXMSRTTHLNKI-UHFFFAOYSA-N
PROACIPIMOX,PROACIPIMOX,,BRD:BRD-BRD-K53605365-001-01-4;BRD:BRD-K53605365-001-01-4,rep_primary;rep_single_dose,CHOLESTEROL INHIBITOR,,,,PHASE 1,,,NA,COCC1C[N+]([O-])C(C)CN1,
PROADIFEN,PROADIFEN,CHEMBL282567,BRD:BRD-BRD-K46317332-003-17-8;BRD:BRD-K46317332-003-17-8,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS1,,,PRECLINICAL,,Small molecule,-1,"CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1;CCCC(C(=O)OCCN(CC)CC)(C1CCCCC1)C1CCCCC1, CCCC(C(=O)OCCN(CC)CC)(C1CCCCC1)C1CCCCC1, CCCC(C(=O)OCCN(CC)CC)(C1CCCCC1)C1CCCCC1",SNTQPLDRUZOSDP-UHFFFAOYSA-N
PROBENECIDUM,BENEMID;BENURYL;HC 5006;NSC-18786;P-(DIPROPYLSULFAMOYL)BENZOIC ACID;PROBALAN;PROBAMPICIN;PROBECID;PROBENATE;PROBENECID;PROBENECIDUM,CHEMBL897,BRD:BRD-BRD-K95237249-001-26-5;BRD:BRD-K95237249-001-26-5,rep_primary;rep_single_dose,URICOSURIC BLOCKER,PANX1;SLC22A11;SLC22A6;SLC22A8;SLCO1C1,"HYPERURICEMIA, GOUT",,LAUNCHED,,Small molecule,4,"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1;CCCN(CCC)S(=O)(=O)C1CCC(CC1)C(O)=O, CCCN(CCC)S(=O)(=O)C1CCC(CC1)C(O)=O, CCCN(CCC)S(=O)(=O)C1CCC(CC1)C(O)=O",DBABZHXKTCFAPX-UHFFFAOYSA-N
SINLESTAL,BISBID;DH-581;LORELCO;LURSELLE;NSC-652160;NSC-86225;PROBUCOL;SINLESTAL,CHEMBL608,BRD:BRD-BRD-K72029282-001-22-0;BRD:BRD-K72029282-001-22-0,rep_primary;rep_single_dose,ATHEROGENESIS INHIBITOR,ABCA1;ABCB11;CES1,CORONARY ARTERY DISEASE (CAD),,LAUNCHED,,Small molecule,4,"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1;CC(C)(SC1CC(C(O)C(C1)C(C)(C)C)C(C)(C)C)SC1CC(C(O)C(C1)C(C)(C)C)C(C)(C)C, CC(C)(SC1CC(C(O)C(C1)C(C)(C)C)C(C)(C)C)SC1CC(C(O)C(C1)C(C)(C)C)C(C)(C)C",FYPMFJGVHOHGLL-UHFFFAOYSA-N
SP 100 (PHARMACEUTICAL),NOVOCAINAMIDE;NSC-27461;PROCAINAMIDE;PROCAN;PROCANBID;PROCAPAN;PRONESTYL;PRONESTYL-SR;SP 100 (PHARMACEUTICAL),CHEMBL640,BRD:BRD-BRD-K75089421-003-24-5;BRD:BRD-K75089421-003-24-5,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,DNMT1;SCN5A,"VENTRICULAR ARRHYTHMIAS, VENTRICULAR TACHYCARDIA (VT)",,LAUNCHED,,Small molecule,4,CCN(CC)CCNC(=O)c1ccc(N)cc1;CCN(CC)CCNC(=O)C1CCC(N)CC1,REQCZEXYDRLIBE-UHFFFAOYSA-N
PROCAINE,NOVOCAIN;NSC-169497;PROCAINE,CHEMBL569,BRD:BRD-BRD-K24616672-003-20-1;BRD:BRD-K24616672-003-20-1,rep_primary;rep_single_dose,HMGCR INHIBITOR,CHRNA2;GRIN3A;HTR3A;KCNMA1;KCNMB1;KCNMB2;KCNMB3;KCNMB4;KCNN1;KCNN2;KCNN3;KCNN4;MAOA;MAOB;RYR1;RYR2;SCN10A;SLC6A3,ANESTHETIC,,LAUNCHED,,Small molecule,4,"CCN(CC)CCOC(=O)c1ccc(N)cc1;CCN(CC)CCOC(=O)C1CCC(N)CC1, CCN(CC)CCOC(=O)C1CCC(N)CC1",MFDFERRIHVXMIY-UHFFFAOYSA-N
RO-4-6467 FREE BASE,MATULANE;PROCARBACINE;PROCARBAZINE;RO-4-6467;RO-4-6467 FREE BASE,CHEMBL1321,CTRP:28183,ctrp,,,,,,,Small molecule,4,CNNCc1ccc(C(=O)NC(C)C)cc1,CPTBDICYNRMXFX-UHFFFAOYSA-N
PROCATEROL,MEPTIN;PROCATEROL,CHEMBL160519,BRD:BRD-BRD-K78666826-003-01-6;BRD:BRD-K78666826-003-01-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,ASTHMA,,LAUNCHED,,Small molecule,3,"CC[C@H](NC(C)C)[C@H](O)C1CCC(O)C2[NH]C(=O)CCC12, CC[C@H](NC(C)C)[C@H](O)C1CCC(O)C2[NH]C(=O)CCC12;CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12",FKNXQNWAXFXVNW-UHFFFAOYSA-N
STEMETIL EFF,COMPAZINE;COMPRO;PROCHLORPERAZINE;PROCHLORPERAZINE MESILATE;PROCHLORPERAZINE MESYLATE;STEMETIL EFF,CHEMBL728,BRD:BRD-BRD-K19352500-070-12-4;BRD:BRD-K19352500-070-12-4;CTRP:33166,ctrp;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD2;DRD3;DRD4,"NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,"CN1CCN(CCCN2C3CCCCC3SC3CCC(CL)CC23)CC1, CN1CCN(CCCN2C3CCCCC3SC3CCC(CL)CC23)CC1, CN1CCN(CCCN2C3CCCCC3SC3CCC(CL)CC23)CC1, CN1CCN(CCCN2C3CCCCC3SC3CCC(CL)CC23)CC1;CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1",WIKYUJGCLQQFNW-UHFFFAOYSA-N
PROPAZOL,AL-1241;ESTIMULOCEL;NSC-35790;PROCODAZOLE;PROPAZOL,CHEMBL596009,BRD:BRD-BRD-K54824716-001-04-0;BRD:BRD-K54824716-001-04-0,rep_primary;rep_single_dose,IMMUNOSTIMULANT,,,,PRECLINICAL,,Small molecule,-1,"O=C(O)CCc1nc2ccccc2[nH]1;OC(=O)CCC1NC2CCCCC2[NH]1, OC(=O)CCC1NC2CCCCC2[NH]1",XYWJNTOURDMTPI-UHFFFAOYSA-N
PROCYANIDIN-B-2,PROCYANIDIN-B-2,,BRD:BRD-BRD-K72093555-001-01-0;BRD:BRD-K72093555-001-01-0,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,"O[C@H]1CC2C(O)CC(O)C([C@@H]3[C@@H](O)[C@H](OC4CC(O)CC(O)C34)C3CCC(O)C(O)C3)C2O[C@@H]1C1CCC(O)C(O)C1, O[C@H]1CC2C(O)CC(O)C([C@@H]3[C@@H](O)[C@H](OC4CC(O)CC(O)C34)C3CCC(O)C(O)C3)C2O[C@@H]1C1CCC(O)C(O)C1",
VAGOSIN,ELORINE;KEMADRINE;LERGINE;NSC-169103;PROCYCLIDINE;TRICOLOID;VAGOSIN,CHEMBL86715,BRD:BRD-A31800922-003-25-1;BRD:BRD-BRD-A31800922-003-25-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4,"PARKINSONISM, PARKINSON'S DISEASE, AKATHISIA, DYSTONIA",,LAUNCHED,,Small molecule,4,"OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1;OC(CCN1CCCC1)(C1CCCCC1)C1CCCCC1, OC(CCN1CCCC1)(C1CCCCC1)C1CCCCC1",WYDUSKDSKCASEF-UHFFFAOYSA-N
PROCYSTEINE,KOPROSTEINE;L-2-OXO-4-THIAZOLIDINECARBOXYLIC ACID;OXOTHIAZOLIDINECARBOXYLIC ACID;PROCYSTEINE,CHEMBL442218,BRD:BRD-BRD-K92413528-001-06-9;BRD:BRD-K92413528-001-06-9,rep_primary;rep_single_dose,GLUTATHIONE SYNTHASE STIMULANT,,,,PHASE 3,,Small molecule,2,O=C1N[C@H](C(=O)O)CS1;OC(=O)[C@@H]1CSC(=O)N1,BMLMGCPTLHPWPY-REOHCLBHSA-N
REVIMMUNE,B-518;CICLOFOSFAMIDE;CYCLOBLASTIN;CYCLOPHOSPHAMID;CYCLOPHOSPHAMIDE;CYCLOPHOSPHAMIDE ANHYDROUS;CYCLOPHOSPHAMIDE HYDRATE;CYCLOPHOSPHAMIDE MONOHYDRATE;CYCLOPHOSPHAMIDUM;CYCLOPHOSPHANE;CYCLOPHOSPHANUM;CYCLOSTIN;CYTOPHOSPHAN;CYTOPHOSPHANE;CYTOXAN;CYTOXAN (LYOPHILIZED);ENDOXAN;ENDOXAN MONOHYDRATE;ENDOXANA;LYOPHILIZED CYTOXAN;NEOSAR;NSC-26271;NSC-756711;PROCYTOX;REVIMMUNE,CHEMBL1200796,GDSC2:1512,gdsc,,,,,,,Small molecule,4,O.O=P1(N(CCCl)CCCl)NCCCO1,PWOQRKCAHTVFLB-UHFFFAOYSA-N
PROFLAVINE-HEMISULFATE,PROFLAVINE-HEMISULFATE,,BRD:BRD-BRD-K68408467-065-01-8;BRD:BRD-K68408467-065-01-8,rep_multi_dose;rep_primary;rep_single_dose,TOPICAL ANESTHETIC,F2,,,PHASE 2,,,NA,NC1CCC2CC3CCC(N)CC3NC2C1,
UTROGESTAN,CRINONE;CYCLOGEST;ENDOMETRIN;GESTEROL;LUTIGEST;MICRONIZED;MILPROSA;NSC-64377;NSC-9704;PROCHIEVE;PROGESTA-CARE;PROGESTASERT;PROGESTERONE;PROGESTERONUM;PROGESTIN;PROMETRIUM;REGUMATE;SERENITY FOR WOMEN;SYNGESTRONE;U 3672;UTROGESTAN,CHEMBL103,BRD:BRD-BRD-K64994968-001-32-5;BRD:BRD-K64994968-001-32-5,rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,CATSPER1;CATSPER2;CATSPER3;CATSPER4;CYP17A1;ESR1;NR3C2;OPRK1;PGR;TRPC5,"INFERTILITY, AMENORRHEA",,LAUNCHED,,Small molecule,4,"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C;CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C, CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C",RJKFOVLPORLFTN-LEKSSAKUSA-N
XYLAMIDE,BINOSIDE;CR-242;DL-PROGLUMIDE;GASTROTOPIC;MIDELID;MILID;NSC-757841;NULSA;PROGLUMIDE;PROMID;ULCUTIN;W-5219;XYLAMIDE,CHEMBL316561,BRD:BRD-A44863528-001-13-2;BRD:BRD-BRD-A44863528-001-13-2,rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKAR;CCKBR,,,WITHDRAWN,,Small molecule,4,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1;CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1CCCCC1,DGMKFQYCZXERLX-UHFFFAOYSA-N
SN-12837,336-U-50;336U50;CHLORGUANIDE;CHLORGUANIDE HYDROCHLORIDE;CHLOROGUANIDE;CHLOROGUANIDE HYDROCHLORIDE;CHLOROQUANIL;DIGUANYL;DRINUPAL;GUANATOL;GW AH7673A;GW-AH7673A;GWAH7673A;M-4888;NSC-12977;NSC-26614;PALUDRINE;PALUSIL;PROGUANIL;PROGUANIL CHLORIDE;PROGUANIL HCL;PROGUANIL HYDROCHLORIDE;PROGUANILI HYDROCHLORIDUM;RP-3359;SN-12837,CHEMBL1201059;CHEMBL1377,BRD:BRD-BRD-K28183345-003-11-4;BRD:BRD-K28183345-003-11-4,rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR,MALARIA,,LAUNCHED,,Small molecule,4,CC(C)NC(=N)NC(=N)NC1CCC(CL)CC1;CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1.Cl,SARMGXPVOFNNNG-UHFFFAOYSA-N
PROLYLLEUCYLGLYCINAMIDE,PROLYLLEUCYLGLYCINAMIDE,,BRD:BRD-A09911125-001-01-4;BRD:BRD-BRD-A09911125-001-01-4,rep_primary;rep_single_dose,MELANOCYTE-STIMULATING HORMONE RELEASE INHIBITOR,,,,PHASE 2,,,NA,CC(C)CC(NC(=O)C1CCCN1)C(=O)NCC(N)=O,
PROMAZINE,COMBELEN;NSC-31447;PROMAZINE,CHEMBL564,BRD:BRD-BRD-K06980535-003-25-9;BRD:BRD-K06980535-003-25-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;HRH1;HTR2A;HTR2C,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,"CN(C)CCCN1C2CCCCC2SC2CCCCC12, CN(C)CCCN1C2CCCCC2SC2CCCCC12;CN(C)CCCN1c2ccccc2Sc2ccccc21",ZGUGWUXLJSTTMA-UHFFFAOYSA-N
ZIPAN-50,DIMAPP;DIPHERGAN;FARGAN;MYMETHAZINE FORTIS;NSC-30321;PHENERGAN;PHENERGAN NIGHTIME;PHENHALAL;PHENSEDYL;PROAZAMINE;PROCIT;PROMETAZIN;PROMETH FORTIS;PROMETH PLAIN;PROMETHACON;PROMETHAZINE;PROMETHAZINE HYDROCHLORIDE;PROMETHAZINE HYDROCHLORIDE PLAIN;PROMETHAZINE PLAIN;PROMETHEGAN;PROTAZINE;PROTHAZIN;Q-MAZINE;REMSED;RP-3277;SARANTIHIST;SOMINEX;VALLERGINE;ZIPAN-25;ZIPAN-50,CHEMBL1200750;CHEMBL643,BRD:BRD-A46335897-003-27-8;BRD:BRD-BRD-A46335897-003-27-8,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,ADRA1A;CALM1;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD2;HRH1;HTR2A,"SEDATIVE, ALLERGIC RHINITIS",,LAUNCHED,,Small molecule,4,"CC(CN1C2CCCCC2SC2CCCCC12)N(C)C, CC(CN1C2CCCCC2SC2CCCCC12)N(C)C;CC(CN1c2ccccc2Sc2ccccc21)N(C)C;CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl",PWWVAXIEGOYWEE-UHFFFAOYSA-N;XXPDBLUZJRXNNZ-UHFFFAOYSA-N
PRONETHALOL,AY 6204 [AS HYDROCHLORIDE];AY-6204 HCL;DL-PRONETHALOL;GNF-PF-2670;ICI 38174 [AS HYDROCHLORIDE];INETOL;NAPHTHYLISOPROTERENOL;NETHALIDE;PRONETALOL;PRONETHALOL,CHEMBL16476,BRD:BRD-A87715314-003-14-4;BRD:BRD-BRD-A87715314-003-14-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,WITHDRAWN,,Small molecule,4,"CC(C)NCC(O)c1ccc2ccccc2c1;CC(C)NCC(O)C1CCC2CCCCC2C1, CC(C)NCC(O)C1CCC2CCCCC2C1",HRSANNODOVBCST-UHFFFAOYSA-N
PROPACETAMOL,PROPACETAMOL,CHEMBL1851805,BRD:BRD-BRD-K54496168-003-01-2;BRD:BRD-K54496168-003-01-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,"FEVER, PAIN RELIEF",,LAUNCHED,,Small molecule,-1,CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1;CCN(CC)CC(=O)OC1CCC(NC(C)=O)CC1,QTGAJCQTLIRCFL-UHFFFAOYSA-N
RYTHMOL,GNF-PF-4594;PROPAFENON HEXAL;PROPAFENONE;RYTHMOL,CHEMBL631,BRD:BRD-A26334849-001-06-2;BRD:BRD-BRD-A26334849-001-06-2,rep_primary;rep_single_dose,ANTIARRHYTHMIC,ADRB1;ADRB2;KCNA5;KCNH2;SCN5A,"ATRIAL FIBRILLATION (AF), VENTRICULAR TACHYCARDIA (VT), VENTRICULAR ARRHYTHMIAS",,LAUNCHED,,Small molecule,4,"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1;CCCNCC(O)COC1CCCCC1C(=O)CCC1CCCCC1, CCCNCC(O)COC1CCCCC1C(=O)CCC1CCCCC1",JWHAUXFOSRPERK-UHFFFAOYSA-N
PROPAGERMANIUM,NSC-267004;PROPAGERMANIUM,CHEMBL2109214,BRD:BRD-K53382462-001-02-0,rep_single_dose,"CCR AGONIST, INTERFERON RECEPTOR AGONIST",CCR2,,,,,Small molecule,2,,
PROPANTHELINE ION,PROPANTHELINE;PROPANTHELINE CATION;PROPANTHELINE ION,CHEMBL1180725,BRD:BRD-BRD-K90885812-004-24-2;BRD:BRD-K90885812-004-24-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,4,CC(C)[N+](C)(CCOC(=O)C1C2CCCCC2OC2CCCCC12)C(C)C;CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,VVWYOYDLCMFIEM-UHFFFAOYSA-N
PROPENTOPHYLLINE,HWA 285;HWA-285;NSC-752424;PROPENTOFYLLINE;PROPENTOPHYLLINE,CHEMBL1079905,BRD:BRD-BRD-K59273480-001-10-6;BRD:BRD-K59273480-001-10-6,rep_primary;rep_single_dose,"ADENOSINE REUPTAKE INHIBITOR, PHOSPHODIESTERASE INHIBITOR",PDE1A,STROKE,,LAUNCHED,,Small molecule,-1,CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C;CCCN1CNC2N(C)C(=O)N(CCCCC(C)=O)C(=O)C12,RBQOQRRFDPXAGN-UHFFFAOYSA-N
PROPIVERINE HYDROCHLORIDE,DETRUNORM;DETRUNORM XL;MICTONETTEN;MICTONORM;NSC-172140;PROPIVERINE;PROPIVERINE HYDROCHLORIDE,CHEMBL1078261,BRD:BRD-BRD-K91244729-003-01-3;BRD:BRD-K91244729-003-01-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,URINARY INCONTINENCE,,LAUNCHED,,Small molecule,4,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1;CCCOC(C(=O)OC1CCN(C)CC1)(C1CCCCC1)C1CCCCC1,QPCVHQBVMYCJOM-UHFFFAOYSA-N
RAPINOVET,"2,6-BIS(1-METHYLETHYL);DIPRIVAN;DISOPRIVAN;DISOPROFOL;FRESOFOL;ICI 35-868;ICI 35,868;ICI-35868;ICI35,868;LIPURO;NSC-5105;PHENOL;PROPOFOL;RAPINOVET",CHEMBL526,BRD:BRD-BRD-K82255054-001-15-9;BRD:BRD-K82255054-001-15-9,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,FAAH;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;SCN2A;SCN4A,ANESTHETIC,,LAUNCHED,,Small molecule,4,"CC(C)c1cccc(C(C)C)c1O;CC(C)C1CCCC(C(C)C)C1O, CC(C)C1CCCC(C(C)C)C1O",OLBCVFGFOZPWHH-UHFFFAOYSA-N
PROPOXUR,NSC-379584;PROPOXUR,CHEMBL446060,BRD:BRD-BRD-K08231299-001-08-1;BRD:BRD-K08231299-001-08-1,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,CNC(=O)Oc1ccccc1OC(C)C;CNC(=O)OC1CCCCC1OC(C)C,ISRUGXGCCGIOQO-UHFFFAOYSA-N
PROPOXYCAINE,PROPOXYCAINE,CHEMBL1195,BRD:BRD-BRD-K18250272-003-11-0;BRD:BRD-K18250272-003-11-0,rep_multi_dose;rep_primary;rep_single_dose,LOCAL ANESTHETIC,,ANESTHETIC,,LAUNCHED,,Small molecule,4,CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC;CCCOC1CC(N)CCC1C(=O)OCCN(CC)CC,CAJIGINSTLKQMM-UHFFFAOYSA-N
REDUCOR,.BETA.-PROPRANOLOL;(R)-;AY-64043-;BETALONG;DEXPROPRANOLOL;DL-PROPRANOLOL;EUPROVASIN;INDERAL;INDERIDE-40/25;INDERIDE-80/25;PROPRANOLOL;PROPRASYLYT;REDUCOR,CHEMBL27;CHEMBL275742,BRD:BRD-A10070317-003-28-3;BRD:BRD-BRD-A10070317-003-28-3,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,"HYPERTENSION, ANGINA PECTORIS, MIGRAINE HEADACHE",,LAUNCHED,,Small molecule,4,"CC(C)NCC(O)COc1cccc2ccccc12;CC(C)NCC(O)COC1CCCC2CCCCC12, CC(C)NCC(O)COC1CCCC2CCCCC12, CC(C)NCC(O)COC1CCCC2CCCCC12",AQHHHDLHHXJYJD-UHFFFAOYSA-N
PROPRANOLOL-(R),PROPRANOLOL-(R),,BRD:BRD-BRD-K92830582-003-10-5;BRD:BRD-K92830582-003-10-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB2;ADRB3,,,PRECLINICAL,,,NA,CC(C)NC[C@@H](O)COC1CCCC2CCCCC12,
PROPRANOLOL-(S),PROPRANOLOL-(S),,BRD:BRD-BRD-K13994703-003-15-8;BRD:BRD-K13994703-003-15-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3;HTR1A;HTR1B;HTR5A;SLC10A1,,,PRECLINICAL,,,NA,"CC(C)NC[C@H](O)COC1CCCC2CCCCC12, CC(C)NC[C@H](O)COC1CCCC2CCCCC12",
PROPYLENE-GLYCOL,PROPYLENE-GLYCOL,,BRD:BRD-A19232309-001-08-6,rep_single_dose,,,,,,,,NA,,
PROPYLHEXEDRINE L-FORM,(-)-PROPYLHEXEDRINE;(S)-;BENZEDREX;DL-PROPYLHEXEDRINE;DRISTAN INHALER;EVENTIN;HYDROMETHAMPHETAMINE;L-PROPYLHEXEDRINE;LEVOPROPYLHEXEDRINE;NSC-32410;PROPYLHEXEDRINE;PROPYLHEXEDRINE DL-FORM;PROPYLHEXEDRINE L-FORM,CHEMBL2105014;CHEMBL2105275,BRD:BRD-A35667010-001-01-8;BRD:BRD-BRD-A35667010-001-01-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,SLC18A2;TAAR1,"NASAL CONGESTION, FEVER, ALLERGIC RHINITIS",,LAUNCHED,,Small molecule,-1,CN[C@@H](C)CC1CCCCC1;CNC(C)CC1CCCCC1,JCRIVQIOJSSCQD-VIFPVBQESA-N
TEGOSEPT P,E216;FEMA NO. 2951;NIPAGIN P;NIPASOL;NIPAZOL;NSC-23515;NSC-8511;PARABEN P;PARATEXIN P;PROPAGIN;PROPYL P-HYDROXYBENZOATE;PROPYL PARA-HYDROXYBENZOATE;PROPYL PARABEN;PROPYL PARAHYDROXYBENZOATE;PROPYLIS HYDROXYBENZOAS;PROPYLPARABEN;PROPYLPARABEN E216;TEGOSEPT P,CHEMBL194014,BRD:BRD-K60783397-001-12-9,rep_single_dose,,,,,,,Small molecule,-1,CCCOC(=O)c1ccc(O)cc1,QELSKZZBTMNZEB-UHFFFAOYSA-N
THYREOSTAT II,NSC-6498;NSC-70461;PROPACIL;PROPYLTHIOURACIL;PROTHYRAN;THYREOSTAT;THYREOSTAT II,CHEMBL1518,BRD:BRD-BRD-K48168960-001-19-2;BRD:BRD-K48168960-001-19-2,rep_primary;rep_single_dose,THYROID PEROXIDASE INHIBITOR,DIO1;TPO,"HYPERTHYROIDISM, GRAVE'S DISEASE, GOITER",,LAUNCHED,,Small molecule,4,"CCCc1cc(=O)[nH]c(=S)[nH]1;CCCC1CC(=O)[NH]C(=S)[NH]1, CCCC1CC(=O)[NH]C(=S)[NH]1",KNAHARQHSZJURB-UHFFFAOYSA-N
YOSHIPYRIN,ISOPROPYLANTIPYRINE;PROPYPHENAZONE;YOSHIPYRIN,CHEMBL28318,BRD:BRD-K06520168-001-03-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,-1,Cc1c(C(C)C)c(=O)n(-c2ccccc2)n1C,PXWLVJLKJGVOKE-UHFFFAOYSA-N
PROQUAZONE,43-715;ARTHREX;PROQUAZONE,CHEMBL268501,BRD:BRD-BRD-K54339150-001-01-8;BRD:BRD-K54339150-001-01-8,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,LAUNCHED,,Small molecule,-1,CC(C)N1C2CC(C)CCC2C(NC1=O)-C1CCCCC1;Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1,JTIGKVIOEQASGT-UHFFFAOYSA-N
PROSCILLARIDIN-A,PROSCILLARIDIN-A,,BRD:BRD-A11815689-001-01-1;BRD:BRD-BRD-A11815689-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,,,"CONGESTIVE HEART FAILURE, CARDIAC ARRYTHMIA",,LAUNCHED,,,NA,C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CCC3=C2)C2CCC(=O)OC2)C(O)C(O)[C@H]1O,
TREVINTIX,EKTEBIN;NSC-758962;PETEHA;PROTHIONAMIDE;PROTIONAMIDE;PROTIONAMIDUM;RP 9778;RP-9778;TH-1321;TREVINTIX,CHEMBL1378024,BRD:BRD-BRD-K75360161-001-18-0;BRD:BRD-K75360161-001-18-0,rep_primary;rep_single_dose,,,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,"CCCc1cc(C(N)=S)ccn1;CCCC1CC(CCN1)C(S)=N, CCCC1CC(CCN1)C(S)=N",VRDIULHPQTYCLN-UHFFFAOYSA-N
TRH-CAMBRIDGE,5-OXO-PRO-HIS-PRO-NH2;A-38579;ABBOTT-38579;LOPREMONE;NSC-760113;PROTIRELIN;PROTIRELIN TARTRATE;RELEFACT TRH;SYNTHETIC;SYNTHETIC TRH;THYPINONE;THYREL TRH;THYROID RELEASING HORMONE;THYROLIBERIN;THYROTROPIN RELEASING HORMONE;THYROTROPIN-RELEASING FACTOR;THYROTROPIN-RELEASING HORMONE;TRH-CAMBRIDGE,CHEMBL1472,BRD:BRD-A16997652-001-02-3;BRD:BRD-BRD-A16997652-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,THYROTROPIN RELEASING HORMONE RECEPTOR AGONIST,TRHR,THYROID FUNCTION DIAGNOSTIC,,LAUNCHED,,Protein,4,NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1;NC(=O)C1CCCN1C(=O)C(CC1C[NH]CN1)NC(=O)C1CCC(=O)N1,XNSAINXGIQZQOO-SRVKXCTJSA-N
PROTRIPTYLINE,PROTRIPTYLINE,CHEMBL668,BRD:BRD-BRD-K42098891-003-20-5;BRD:BRD-K42098891-003-20-5,rep_primary;rep_single_dose,TRICYCLIC ANTIDEPRESSANT,SLC6A2;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,CNCCCC1C2CCCCC2C=CC2CCCCC12;CNCCCC1c2ccccc2C=Cc2ccccc21,BWPIARFWQZKAIA-UHFFFAOYSA-N
PROXODOLOL,PROXODOLOL,,BRD:BRD-A29944538-003-08-3;BRD:BRD-BRD-A29944538-003-08-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,LAUNCHED,,,NA,CC1NOC(COC2CCCCC2OCC(O)CNC(C)(C)C)N1,
PROXYFAN,PROXIFAN;PROXYFAN,CHEMBL19173,BRD:BRD-BRD-K77171813-034-01-8;BRD:BRD-K77171813-034-01-8,rep_primary;rep_single_dose,HISTAMINE RECEPTOR MODULATOR,HRH3,,,PRECLINICAL,,Small molecule,NA,"C(COCC1CCCCC1)CC1CNC[NH]1, C(COCC1CCCCC1)CC1CNC[NH]1;c1ccc(COCCCc2c[nH]cn2)cc1",WNWALBVQAAIULR-UHFFFAOYSA-N
PROXYMETACAINE HYDROCHLORIDE,AK-TAINE;ALCAINE;KAINAIR;NSC-759896;OPHTHAINE;OPHTHETIC;PARACAINE;PROPARACAINE;PROPARACAINE HCL;PROPARACAINE HYDROCHLORIDE;PROXYMETACAINE;PROXYMETACAINE HYDROCHLORIDE,CHEMBL1196;CHEMBL1200464,BRD:BRD-BRD-K79116891-003-15-1;BRD:BRD-K79116891-003-15-1,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A;SCN5A,ANESTHETIC,,LAUNCHED,,Small molecule,4,"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N.Cl;CCCOC1CCC(CC1N)C(=O)OCCN(CC)CC, CCCOC1CCC(CC1N)C(=O)OCCN(CC)CC",BFUUJUGQJUTPAF-UHFFFAOYSA-N
THEAN,PROXYPHYLLINE;THEAN,CHEMBL37390,BRD:BRD-A28887267-001-19-3;BRD:BRD-BRD-A28887267-001-19-3,rep_primary;rep_single_dose,,,ASTHMA,,LAUNCHED,,Small molecule,4,CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C;CC(O)CN1CNC2N(C)C(=O)N(C)C(=O)C12,KYHQZNGJUGFTGR-UHFFFAOYSA-N
PRT-2607,BIIB-057;P505-15;PRT-062607;PRT-2607,CHEMBL3545138,GDSC2:1631,gdsc,,,,,,,Small molecule,1,,
PRT062070,PRT062070,,BRD:BRD-BRD-K25835157-001-01-4;BRD:BRD-K25835157-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,"JAK INHIBITOR, SYK INHIBITOR",SYK,,,PHASE 1,,,NA,"CCS(=O)(=O)N1CCN(CC1)C1CCC(NC2NCC(C(N)=O)C(NC3CC3)N2)CC1, CCS(=O)(=O)N1CCN(CC1)C1CCC(NC2NCC(C(N)=O)C(NC3CC3)N2)CC1, CCS(=O)(=O)N1CCN(CC1)C1CCC(NC2NCC(C(N)=O)C(NC3CC3)N2)CC1",
PRT062607,PRT062607,,BRD:BRD-BRD-K53734668-003-02-0;BRD:BRD-BRD-K53734668-003-04-6;BRD:BRD-K53734668-003-02-0;BRD:BRD-K53734668-003-04-6;GDSC2:1631,gdsc;rep_multi_dose;rep_primary;rep_single_dose,SYK INHIBITOR,FGR;MAP3K9;SYK,,,PHASE 2,,,NA,"N[C@H]1CCCC[C@H]1NC1NCC(C(N)=O)C(NC2CCCC(C2)-N2NCCN2)N1, N[C@H]1CCCC[C@H]1NC1NCC(C(N)=O)C(NC2CCCC(C2)-N2NCCN2)N1",
RESOLOR,PRUCALOPRIDE;R-093877;R093877;RESOLOR,CHEMBL117287,BRD:BRD-BRD-K33681278-036-01-2;BRD:BRD-K33681278-036-01-2,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR4,CONSTIPATION,,LAUNCHED,,Small molecule,4,"COCCCN1CCC(CC1)NC(=O)C1CC(CL)C(N)C2CCOC12, COCCCN1CCC(CC1)NC(=O)C1CC(CL)C(N)C2CCOC12;COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1",ZPMNHBXQOOVQJL-UHFFFAOYSA-N
PRUVEL,NM-441;NM441;NSC-759833;PRULIFLOXACIN;PRUVEL,CHEMBL422648,BRD:BRD-A92341659-001-04-0;BRD:BRD-BRD-A92341659-001-04-0,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,"URINARY TRACT INFECTIONS, BRONCHITIS, DIARRHEA",,LAUNCHED,,Small molecule,3,"Cc1oc(=O)oc1CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)c2n3C(C)S2)CC1;CC1SC2C(C(O)=O)C(=O)C3CC(F)C(CC3N12)N1CCN(CC2OC(=O)OC2C)CC1, CC1SC2C(C(O)=O)C(=O)C3CC(F)C(CC3N12)N1CCN(CC2OC(=O)OC2C)CC1",PWNMXPDKBYZCOO-UHFFFAOYSA-N
PRUVANSERIN,EMD 390920;EMD-281014;EMD-390920;LSN-2422347;LSN2422347;LY-2420586;LY-2422347;LY-2422347 FREE BASE;LY2420586;LY2422347;PRUVANSERIN,CHEMBL1215661,BRD:BRD-BRD-K43837174-003-01-3;BRD:BRD-K43837174-003-01-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2C,,,PHASE 2,,Small molecule,2,"FC1CCC(CCN2CCN(CC2)C(=O)C2CCCC3C(C[NH]C23)C#N)CC1, FC1CCC(CCN2CCN(CC2)C(=O)C2CCCC3C(C[NH]C23)C#N)CC1;N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)cccc12",AQRLDDAFYYAIJP-UHFFFAOYSA-N
PRX-07034,PRX-07034,,BRD:BRD-K00004616-001-01-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,,,,NA,,
PRX-08066,PRX-08066,CHEMBL4297322;CHEMBL513994,BRD:BRD-BRD-K16757695-050-02-5;BRD:BRD-K16757695-050-02-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2B,,,PHASE 2,,Small molecule,2,FC1CCC(CN2CCC(CC2)NC2NCNC3SC(CL)CC23)CC1C#N;N#Cc1cc(CN2CCC(Nc3ncnc4sc(Cl)cc34)CC2)ccc1F;N#Cc1cc(CN2CCC(Nc3ncnc4sc(Cl)cc34)CC2)ccc1F.O=C(O)/C=C/C(=O)O,IENZFHBNCRQMNP-UHFFFAOYSA-N;RPYIKXHIQXRXEM-WLHGVMLRSA-N
PS178990,PS178990,,BRD:BRD-BRD-K99092662-001-01-1;BRD:BRD-K99092662-001-01-1,rep_primary;rep_single_dose,ANDROGEN RECEPTOR MODULATOR,AR,,,PHASE 1,,,NA,CC1C(CCC(C#N)C1CL)N1C(=O)[C@@H]2[C@H](O)CCN2C1=O,
PSB-06126,PSB-06126,,BRD:BRD-BRD-K71266197-236-02-7;BRD:BRD-K71266197-236-02-7,rep_primary;rep_single_dose,NTPDASE INHIBITOR,ENTPD3,,,PRECLINICAL,,,NA,NC1C2C(=O)C3CCCCC3C(=O)C2C(NC2CCCC3CCCCC23)CC1S(O)(=O)=O,
PSB-11,PSB-11,,BRD:BRD-BRD-K10177585-003-02-4;BRD:BRD-K10177585-003-02-4,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA3,,,PRECLINICAL,,,NA,"CC[C@@H]1CN2C(=N1)C1[NH]C(NC1N(C)C2=O)-C1CCCCC1, CC[C@@H]1CN2C(=N1)C1[NH]C(NC1N(C)C2=O)-C1CCCCC1",
PSB-1115,PSB-1115,,BRD:BRD-BRD-K49027941-001-01-1;BRD:BRD-K49027941-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2B;ADORA3,,,PRECLINICAL,,,NA,"CCCN1C(=O)[NH]C2NC([NH]C2C1=O)-C1CCC(CC1)S(O)(=O)=O, CCCN1C(=O)[NH]C2NC([NH]C2C1=O)-C1CCC(CC1)S(O)(=O)=O",
PSB-36,PSB-36,,BRD:BRD-A70407468-001-02-0;BRD:BRD-BRD-A70407468-001-02-0,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,,,NA,"CCCCN1C(=O)N(CCCO)C2NC([NH]C2C1=O)C12CC3CC1CC(C2)C3, CCCCN1C(=O)N(CCCO)C2NC([NH]C2C1=O)C12CC3CC1CC(C2)C3",
PSB-603,PSB-603,,BRD:BRD-BRD-K05419687-001-01-0;BRD:BRD-K05419687-001-01-0,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,,,NA,CCCN1C(=O)[NH]C2NC([NH]C2C1=O)-C1CCC(CC1)S(=O)(=O)N1CCN(CC1)C1CCC(CL)CC1,
PSI-6130,PSI-6130,,BRD:BRD-BRD-K07798980-001-01-9;BRD:BRD-K07798980-001-01-9,rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,,,PHASE 1,,,NA,C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1CCC(N)NC1=O,
PSI-697,PSI-697,CHEMBL219046,BRD:BRD-K00003192-001-01-9,rep_single_dose,P SELECTIN INHIBITOR,,,,,,Small molecule,1,O=C(O)c1c(O)c(Cc2ccc(Cl)cc2)nc2c3c(ccc12)CCCC3,DIEPFYNZGUUVHD-UHFFFAOYSA-N
SOVALDI,GS-7977;GS7977;PSI-7976;PSI-7977;SOFOSBUVIR;SOVALDI,CHEMBL1259059,BRD:BRD-BRD-K05674516-001-01-7;BRD:BRD-BRD-K05674516-001-02-5;BRD:BRD-K05674516-001-01-7;BRD:BRD-K05674516-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,"HCV INHIBITOR, RNA POLYMERASE INHIBITOR",,HEPATITIS C,,PRECLINICAL,"Multiple values for MOA: {'HCV INHIBITOR', 'HCV INHIBITOR, RNA POLYMERASE INHIBITOR'}, defaulting to 'HCV INHIBITOR, RNA POLYMERASE INHIBITOR'
Multiple values for MOA: {'HCV INHIBITOR', 'RNA POLYMERASE INHIBITOR', 'HCV INHIBITOR, RNA POLYMERASE INHIBITOR'}, defaulting to 'HCV INHIBITOR, RNA POLYMERASE INHIBITOR'
Multiple values for Phase: {'PRECLINICAL', 'LAUNCHED'}, defaulting to 'PRECLINICAL'",Small molecule,4,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1;CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](N2CCC(=O)[NH]C2=O)[C@](C)(F)[C@@H]1O)OC1CCCCC1,TTZHDVOVKQGIBA-IQWMDFIBSA-N
PSNCBAM-1,PSNCBAM-1,,BRD:BRD-K33502629-001-02-9,rep_single_dose,CANNABINOID RECEPTOR MODULATOR,CNR1,,,,,,NA,,
PSORALEN,FICUSIN;NSC-404562;PSORALEN,CHEMBL164660,BRD:BRD-BRD-K47264279-001-08-9;BRD:BRD-K47264279-001-08-9,rep_primary;rep_single_dose,,MAOA;MAOB,"PSORIASIS, ECZEMA, VITILIGO",,LAUNCHED,,Small molecule,1,O=c1ccc2cc3ccoc3cc2o1;O=C1CCC2CC3CCOC3CC2O1,ZCCUUQDIBDJBTK-UHFFFAOYSA-N
PT2385,PT-2385;PT2385,,BRD:BRD-BRD-K20850787-001-01-6;BRD:BRD-K20850787-001-01-6,oncref_2;rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,EPAS1;HIF2A,,,PHASE 1,"Multiple values for MOA: {'HYPOXIA INDUCIBLE FACTOR INHIBITOR', 'ANTAGONIST OF HIF2A'}, defaulting to 'HYPOXIA INDUCIBLE FACTOR INHIBITOR'
Multiple values for repurposing_target: {'HIF2A', 'EPAS1'}, taking the union",,NA,CS(=O)(=O)C1CCC(OC2CC(F)CC(C2)C#N)C2CC(F)(F)[C@@H](O)C12,
PT2399,PT2399,,BRD:BRD-K00090636-001-01-9;BRD:BRD-K00090636-001-02-9,oncref_2;rep_single_dose,INHIBITOR OF HIF2A AND ARNT INTERACTION,HIF2A,,,,,,NA,,
PTC-028,PTC-028,,BRD:BRD-K00010388-001-01-9,rep_single_dose,BMI-1 INHIBITOR,,,,,,,NA,,
PTC-209,PTC-209,,BRD:BRD-BRD-K83834509-001-01-1;BRD:BRD-K83834509-001-01-1;BRD:BRD-K83834509-001-04-9,rep_multi_dose;rep_primary;rep_single_dose,BMI-1 INHIBITOR,,,,PRECLINICAL,,,NA,"COC1CC(BR)C(NC2NC(CS2)-C2C(C)NC3NCCCN23)C(BR)C1, COC1CC(BR)C(NC2NC(CS2)-C2C(C)NC3NCCCN23)C(BR)C1, COC1CC(BR)C(NC2NC(CS2)-C2C(C)NC3NCCCN23)C(BR)C1",
UNESBULIN,BMI1 INHIBITOR PTC596;PTC 596;PTC-596;PTC596;UNESBULIN,CHEMBL4594353,BRD:BRD-K00090626-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Cc1nc2ccc(F)cc2n1-c1nc(N)c(F)c(Nc2ccc(C(F)(F)F)cc2)n1,TWLWOOPCEXYVBE-UHFFFAOYSA-N
TRANS-PTEROSTILBENE,"(E)-;4-(3,5-DIMETHOXYSTYRYL)PHENOL;PTEROSTILBEN;PTEROSTILBENE;TRANS-PTEROSTILBENE",CHEMBL83527,BRD:BRD-BRD-K53097745-001-01-5;BRD:BRD-K53097745-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PPAR RECEPTOR AGONIST",PTGS2,,,PHASE 2/PHASE 3,,Small molecule,2,COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1;COC1CC(OC)CC(C=CC2CCC(O)CC2)C1,VLEUZFDZJKSGMX-ONEGZZNKSA-N
PTI-428,NESOLICAFTOR;NESOLICITOR;PTI-428,CHEMBL4297479,BRD:BRD-K00091089-001-01-9,rep_single_dose,,,,,,,Small molecule,2,C[C@@H](O)c1nnc([C@H]2C[C@H](NC(=O)c3cc(-c4ccccc4)no3)C2)o1,XPEHHUISIBFLHX-RAIGVLPGSA-N
ZELAVESPIB,PU-H 71;PU-H-71;PU-H71;PUH-71;ZELAVESPIB,CHEMBL200102,BRD:BRD-BRD-K36529613-001-02-6;BRD:BRD-K36529613-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1,,,PHASE 1,,Small molecule,1,CC(C)NCCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21;CC(C)NCCCN1C(SC2CC3OCOC3CC2I)NC2C(N)NCNC12,SUPVGFZUWFMATN-UHFFFAOYSA-N
PUERARIN 80 MM,DAIDZEIN 8-C-GLUCOSIDE;KAKONEIN;NPI 031G;NSC-380711;PUERARIN;PUERARIN 80 MM,CHEMBL486386,BRD:BRD-BRD-K89048337-001-06-9;BRD:BRD-K89048337-001-06-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,PHASE 2,,Small molecule,2,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12;OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1C(O)CCC2C1OCC(-C1CCC(O)CC1)C2=O,HKEAFJYKMMKDOR-VPRICQMDSA-N
PUMOSETRAG,DDP733;PUMOSETRAG,CHEMBL1643880,BRD:BRD-BRD-K44164034-003-01-1;BRD:BRD-K44164034-003-01-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR3A;HTR4,,,PHASE 2,,Small molecule,2,O=C(N[C@H]1CN2CCC1CC2)c1c[nH]c2ccsc2c1=O;OC1C(CNC2CCSC12)C(=O)N[C@H]1CN2CCC1CC2,AFUWQWYPPZFWCO-LBPRGKRZSA-N
PURMORPHAMINE,PURMORPHAMINE,CHEMBL1221984,BRD:BRD-BRD-K73397362-001-06-6;BRD:BRD-K73397362-001-06-6;CTRP:52576,ctrp;rep_primary;rep_single_dose,SMOOTHENED RECEPTOR AGONIST,SMO,,,PRECLINICAL,,Small molecule,NA,"C1CCC(CC1)N1CNC2C(NC3CCC(CC3)N3CCOCC3)NC(OC3CCCC4CCCCC34)NC12, C1CCC(CC1)N1CNC2C(NC3CCC(CC3)N3CCOCC3)NC(OC3CCCC4CCCCC34)NC12, C1CCC(CC1)N1CNC2C(NC3CCC(CC3)N3CCOCC3)NC(OC3CCCC4CCCCC34)NC12;c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1",FYBHCRQFSFYWPY-UHFFFAOYSA-N
TCMDC-123493,"3123-L;3123L;CL 13,900;CL-13900;GNF-PF-2016;P-638;PUROMYCIN;TCMDC-123493",CHEMBL469912,BRD:BRD-A28970875-300-04-9;BRD:BRD-BRD-A28970875-300-04-9,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,NHP2L1;RPL10L;RPL11;RPL13A;RPL15;RPL19;RPL23;RPL23A;RPL26L1;RPL3;RPL37;RPL8;RSL24D1,,,PRECLINICAL,,Small molecule,-1,COC1CCC(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)OC([C@@H]2O)N2CNC3C(NCNC23)N(C)C)CC1;COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1,RXWNCPJZOCPEPQ-NVWDDTSBSA-N
PURVALANOL-A,PURVALANOL-A,,BRD:BRD-BRD-K50836978-001-02-5;BRD:BRD-K50836978-001-02-5,rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK4;CDK5;CSNK1G3;RPS6KA1;SRC,,,PRECLINICAL,,,NA,"CC(C)[C@H](CO)NC1NC(NC2CCCC(CL)C2)C2NCN(C(C)C)C2N1, CC(C)[C@H](CO)NC1NC(NC2CCCC(CL)C2)C2NCN(C(C)C)C2N1",
PURVALANOL-B,PURVALANOL-B,,BRD:BRD-BRD-K41564320-001-02-0;BRD:BRD-K41564320-001-02-0,rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,CDK2;CDK4;CDK5;MAPK1;MAPK3;SRPK2,,,PRECLINICAL,,,NA,"CC(C)[C@H](CO)NC1NC(NC2CCC(C(O)=O)C(CL)C2)C2NCN(C(C)C)C2N1, CC(C)[C@H](CO)NC1NC(NC2CCC(C(O)=O)C(CL)C2)C2NCN(C(C)C)C2N1",
PUTRESCINE,NSC-60545;PUTRESCINE,CHEMBL46257,BRD:BRD-K75282878-300-05-3,rep_single_dose,TISSUE TRANSGLUTAMINASE INHIBITOR,AMD1;KCNJ4;ODC1,,,,,Small molecule,3,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N
PX-12,PX-12,CHEMBL406050,BRD:BRD-A56592690-001-04-3;BRD:BRD-BRD-A56592690-001-04-3;CTRP:609124,ctrp;rep_primary;rep_single_dose,THIOREDOXIN INHIBITOR,CNR1;TXN;TXNRD1,,,PHASE 2,"Multiple values for repurposing_target: {'CNR1;TXN;TXNRD1', 'TXN;TXNRD1'}, taking the union",Small molecule,2,CCC(C)SSc1ncc[nH]1;CCC(C)SSC1NCC[NH]1,BPBPYQWMFCTCNG-UHFFFAOYSA-N
PX-478,PX 478;PX-478,CHEMBL4297816,BRD:BRD-A26835809-300-01-3;BRD:BRD-BRD-A26835809-300-01-3,rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,,,,PHASE 1,,Unknown,1,NC(CC1CCC(CC1)[N+]([O-])(CCCL)CCCL)C(O)=O,
PXD101,BELEODAQ;BELINOSTAT;NSC-726630;NSC726630;PX-105684;PXD-101;PXD101,CHEMBL408513,GDSC1:274,gdsc,,,,,,,Small molecule,4,O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,NCNRHFGMJRPRSK-MDZDMXLPSA-N
PYM50028,PYM50028,,BRD:BRD-BRD-K62277907-001-01-6;BRD:BRD-K62277907-001-01-6,rep_primary;rep_single_dose,NEUROTROPHIC AGENT,,,,PHASE 2,,,NA,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@]11CC[C@H](C)CO1,
PYR-41,PYR-41,,CTRP:660202,ctrp,,,,,,,,NA,,
PYRANTEL,KONVERMEX;PYRANTEL,CHEMBL1626223,BRD:BRD-BRD-K82118441-001-03-7;BRD:BRD-K82118441-001-03-7,rep_primary;rep_single_dose,"ACETYLCHOLINE RECEPTOR AGONIST, NICOTINIC RECEPTOR AGONIST",,"GASTROINTESTINAL ROUNDWORMS, GASTROINTESTINAL ROUNDWORMS",,LAUNCHED,"Multiple values for MOA: {'ACETYLCHOLINE RECEPTOR AGONIST, NICOTINIC RECEPTOR AGONIST', 'NICOTINIC RECEPTOR AGONIST'}, defaulting to 'ACETYLCHOLINE RECEPTOR AGONIST, NICOTINIC RECEPTOR AGONIST'",Small molecule,4,CN1CCCN=C1/C=C/c1cccs1;OC(=O)C1CC2CCCCC2C(CC2C(O)C(CC3CCCCC23)C(O)=O)C1O,YSAUAVHXTIETRK-AATRIKPKSA-N
PYRANTEL-PAMOATE,PYRANTEL-PAMOATE,,BRD:BRD-K20672254-046-05-4,rep_single_dose,NEUROMUSCULAR BLOCKER,,,,,,,NA,,
ZINAMIDE,.ALPHA.-PYRAZINAMIDE;ALDINAMID;ALDINAMIDE;D-50;EPRAZIN;FARMIZINA;ISOPAS;MK-56;NOVAMID;NSC-14911;PIRAZIMIDA;PIRAZINAMID;PIRILENE;PYRAFAT;PYRAMIZADE;PYRAZIDE;PYRAZINAMIDE;PYRAZINAMIDUM;PYRAZINE CARBOXYLAMIDE;PYRAZINECARBOXAMIDE;ROZIDE;TEBRAZID;UNIPYRANAMIDE;ZINAMIDE,CHEMBL614,BRD:BRD-BRD-K28667793-001-28-1;BRD:BRD-K28667793-001-28-1,rep_primary;rep_single_dose,FATTY ACID SYNTHASE INHIBITOR,FASN,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,"NC(=O)c1cnccn1;NC(=O)C1CNCCN1, NC(=O)C1CNCCN1",IPEHBUMCGVEMRF-UHFFFAOYSA-N
PYRAZINOYLGUANIDINE,PYRAZINOYLGUANIDINE,,BRD:BRD-BRD-K61693562-300-01-7;BRD:BRD-K61693562-300-01-7,rep_primary;rep_single_dose,DIURETIC,,,,PHASE 1,,,NA,NC(=N)NC(=O)C1CNCCN1,
PYRAZOLANTHRONE,PYRAZOLANTHRONE,,BRD:BRD-BRD-K01567962-001-23-0;BRD:BRD-K01567962-001-23-0;CTRP:44511,ctrp;rep_primary;rep_single_dose,JNK INHIBITOR,MAPK10;MAPK8;MAPK8IP1;MAPK9;TTK,,,PRECLINICAL,,,NA,"O=C1C2CCCCC2-C2N[NH]C3CCCC1C23, O=C1C2CCCCC2-C2N[NH]C3CCCC1C23",
PYRETHRINS,PYRETHRINS,CHEMBL2096637,BRD:BRD-K00010129-001-01-9,rep_single_dose,,,,,,,Small molecule,4,C=C/C=C\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(\C)C(=O)OC)C2(C)C)CC1=O.C=C/C=C\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O,VXSIXFKKSNGRRO-MXOVTSAMSA-N
PYRIDOSTATIN,PYRIDOSTATIN,CHEMBL2349416,GDSC2:2044,gdsc,,,,,,,Small molecule,NA,NCCOc1cc(C(=O)Nc2cc(OCCN)c3ccccc3n2)nc(C(=O)Nc2cc(OCCN)c3ccccc3n2)c1,VGHSATQVJCTKEF-UHFFFAOYSA-N
PYRIDOXALDEHYDE,PIRIDOXAL;PYRIDOXAL;PYRIDOXALDEHYDE,CHEMBL102970,BRD:BRD-BRD-K76204040-001-03-8;BRD:BRD-K76204040-001-03-8,rep_primary;rep_single_dose,,PDXK,EPILEPSY,,LAUNCHED,,Small molecule,3,Cc1ncc(CO)c(C=O)c1O;CC1NCC(CO)C(C=O)C1O,RADKZDMFGJYCBB-UHFFFAOYSA-N
PYRIDOXAL-ISONICOTINOYL-HYDRAZONE,PYRIDOXAL-ISONICOTINOYL-HYDRAZONE,,BRD:BRD-BRD-K42019693-001-01-5;BRD:BRD-K42019693-001-01-5,rep_primary;rep_single_dose,APOPTOSIS STIMULANT,,,,PHASE 2,,,NA,CC1NCC(CO)C(\C=N\NC(=O)C2CCNCC2)C1O,
PYRIDOXYLAMINE,MONOHYDROCHLORIDE;NSC-21278;PYRIDORIN;PYRIDOXAMINE;PYRIDOXAMINE DIHYDROCHLORIDE;PYRIDOXAMINE HCL;PYRIDOXAMINE HYDROCHLORIDE;PYRIDOXYLAMINE,CHEMBL4298078;CHEMBL593019,BRD:BRD-BRD-K96669468-300-01-1;BRD:BRD-K96669468-300-01-1,rep_primary;rep_single_dose,AGE INHIBITOR,,,,PHASE 3,,Small molecule,2,Cc1ncc(CO)c(CN)c1O;CC1NCC(CO)C(CN)C1O,NHZMQXZHNVQTQA-UHFFFAOYSA-N
VITAMIN V6,ADERMINE;HEXA-BETALIN;HEXABIONE;M.V.I.-12;NSC-759148;PYRIDOXINE;PYRIDOXINE (VIT B6);PYRIDOXOL;VITAMIN B-6;VITAMIN B6;VITAMIN V6,CHEMBL1364,BRD:BRD-BRD-K14349461-003-13-1;BRD:BRD-K14349461-003-13-1,rep_primary;rep_single_dose,VITAMIN B,DDC;PDXK,VITAMIN B6 DEFICIENCY,,LAUNCHED,,Small molecule,4,"Cc1ncc(CO)c(CO)c1O;CC1NCC(CO)C(CO)C1O, CC1NCC(CO)C(CO)C1O",LXNHXLLTXMVWPM-UHFFFAOYSA-N
WR-2978,CHLORIDIN;CHLORIDINE;DARAPRIM;GNF-PF-5586;MALACIDE;NSC-3061;PYRIMETHAMINE;PYRIMETHAMINUM;RP-4753;TCMDC-123831;TCMDC-125860;WR-2978,CHEMBL36,BRD:BRD-BRD-K88429204-001-35-1;BRD:BRD-K88429204-001-35-1;GDSC1:71,gdsc;rep_multi_dose;rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR;SLC47A1,MALARIA,,LAUNCHED,,Small molecule,4,"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1;CCC1NC(N)NC(N)C1-C1CCC(CL)CC1, CCC1NC(N)NC(N)C1-C1CCC(CL)CC1, CCC1NC(N)NC(N)C1-C1CCC(CL)CC1, CCC1NC(N)NC(N)C1-C1CCC(CL)CC1",WKSAUQYGYAYLPV-UHFFFAOYSA-N
PYRINTEGRIN,PYRINTEGRIN,,BRD:BRD-K94659840-001-02-9,rep_single_dose,INTEGRIN SIGNALING ACTIVATOR,,,,,,,NA,,
PYRIPROXYFEN,PYRIPROXYFEN,CHEMBL1883234,BRD:BRD-K00084847-001-01-9,rep_single_dose,,,,,,,Small molecule,NA,CC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1,NHDHVHZZCFYRSB-UHFFFAOYSA-N
PYRITHIONE-ZINC,PYRITHIONE-ZINC,,BRD:BRD-BRD-K16136380-001-01-7;BRD:BRD-K16136380-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,ATP SYNTHASE INHIBITOR,KCNQ1;KCNQ2;KCNQ4;KCNQ5,DANDRUFF,,LAUNCHED,,,NA,"O1[N+]2CCCCC2S[ZN]11O[N+]2CCCCC2S1, O1[N+]2CCCCC2S[ZN]11O[N+]2CCCCC2S1, O1[N+]2CCCCC2S[ZN]11O[N+]2CCCCC2S1",
PYRITHYLDIONE,NSC-89733;PYRITHYLDIONE,CHEMBL1722501,BRD:BRD-BRD-K36116267-001-15-3;BRD:BRD-K36116267-001-15-3,rep_primary;rep_single_dose,PSYCHOACTIVE DRUG,,,,WITHDRAWN,,Small molecule,-1,CCC1(CC)C(=O)C=CNC1=O;CCC1(CC)C(=O)NC=CC1=O,NZASCBIBXNPDMH-UHFFFAOYSA-N
PYRITINOL,NSC-759229;PYRITHIOXIN;PYRITHIOXINE;PYRITHIOXINE HYDROCHLORIDE;PYRITINOL,CHEMBL488093,BRD:BRD-BRD-K82181219-001-04-3;BRD:BRD-K82181219-001-04-3,rep_multi_dose;rep_primary;rep_single_dose,,,"RHEUMATOID ARTHRITIS, SENILE DEMENTIA",,LAUNCHED,,Small molecule,3,Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O;CC1NCC(CSSCC2CNC(C)C(O)C2CO)C(CO)C1O,SIXLXDIJGIWWFU-UHFFFAOYSA-N
PYRONARIDINE,MALARIDINE;PYRONARIDINE,CHEMBL35228,BRD:BRD-BRD-K73132780-001-01-2;BRD:BRD-K73132780-001-01-2,rep_primary;rep_single_dose,ANTIMALARIAL AGENT,,,,PHASE 3,,Small molecule,3,"COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1;COC1CCC2NC3CC(CL)CCC3C(NC3CC(CN4CCCC4)C(O)C(CN4CCCC4)C3)C2N1, COC1CCC2NC3CC(CL)CCC3C(NC3CC(CN4CCCC4)C(O)C(CN4CCCC4)C3)C2N1",DJUFPMUQJKWIJB-UHFFFAOYSA-N
SHR-1258,PYROTINIB;SHR-1258,CHEMBL3544956,BRD:BRD-K00003463-001-01-9;BRD:BRD-K00003463-001-03-9,oncref_2;rep_single_dose,PAN-HER RECEPTOR TYROSINE KINASE INHIBITOR,EGFR;ERBB2;ERBB4,,,,"Multiple values for MOA: {'KINASE INHIBITOR', 'PAN-HER RECEPTOR TYROSINE KINASE INHIBITOR'}, defaulting to 'PAN-HER RECEPTOR TYROSINE KINASE INHIBITOR'",Small molecule,3,,
PYROXAMIDE,OCTANEDIOIC ACID HYDROXYAMIDE PYRIDIN-3-YLAMIDE;PYROXAMIDE,CHEMBL353581,BRD:BRD-BRD-K11663430-001-02-3;BRD:BRD-K11663430-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1,,,PHASE 1,,Small molecule,1,"O=C(CCCCCCC(=O)Nc1cccnc1)NO;ONC(=O)CCCCCCC(=O)NC1CCCNC1, ONC(=O)CCCCCCC(=O)NC1CCCNC1, ONC(=O)CCCCCCC(=O)NC1CCCNC1",PTJGLFIIZFVFJV-UHFFFAOYSA-N
PZ-2891,PZ-2891,,BRD:BRD-K00005336-001-01-9,rep_single_dose,PANTOTHENATE KINASE ACTIVATOR,,,,,,,NA,,
TELACEBEC,Q-203;Q203;TELACEBEC,CHEMBL3298910,BRD:BRD-BRD-K59853741-001-01-9;BRD:BRD-K59853741-001-01-9,rep_primary;rep_single_dose,ATP SYNTHASE INHIBITOR,,,,PHASE 1,,Small molecule,2,CCC1NC2CCC(CL)CN2C1C(=O)NCC1CCC(CC1)N1CCC(CC1)C1CCC(OC(F)(F)F)CC1;CCc1nc2ccc(Cl)cn2c1C(=O)NCc1ccc(N2CCC(c3ccc(OC(F)(F)F)cc3)CC2)cc1,OJICYBSWSZGRFB-UHFFFAOYSA-N
QL-VIII-58,QL-VIII-58,,GDSC1:1166,gdsc,,,,,,,,NA,,
QL-X-138,QL-X-138,,GDSC1:331,gdsc,,,,,,,,NA,,
QL-XI-92,QL-XI-92,,GDSC1:329,gdsc,,,,,,,,NA,,
QL-XII-47,QL-XII-47,,GDSC1:235,gdsc,,,,,,,,NA,,
QL-XII-61,QL-XII-61,,GDSC1:1203,gdsc,,,,,,,,NA,,
QS-11,QS-11,,CTRP:609681,ctrp,,,,,,,,NA,,
QS11,944328-88-5;QS11,,GDSC1:151,gdsc,,,,,,,,NA,,
RO-136438006,QUAZINONE;RO 13-6438/006;RO-13-6438;RO-136438;RO-136438006,CHEMBL320341,BRD:BRD-BRD-K63631219-001-01-6;BRD:BRD-K63631219-001-01-6,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A;PDE3B,,,PHASE 2,,Small molecule,-1,C[C@@H]1C(=O)NC2=Nc3cccc(Cl)c3CN21;CC1C(O)NC2NC3CCCC(CL)C3CN12,BHZFZYLBVSWUMT-ZCFIWIBFSA-N
XANTHAURINE,3'-HYDROXYKAEMPFEROL;C.I. 75670;C.I. NATURAL RED 1;CI-75670;CORVITIN;CYANIDENOLON 1522;KORVITIN;LDN 0052529;LDN-0052529;LIPOFLAVON;MELETIN;NSC 57655;NSC 9219;NSC-57655;NSC-9219;QUERCETIN;QUERCETIN (CONSTITUENT OF GINKGO);QUERCETINE;QUERCETOL;QUERTIN;QUERTINE;SOPHORETIN;XANTHAURINE,CHEMBL50,BRD:BRD-BRD-K97399794-001-15-3;BRD:BRD-K97399794-001-15-3,rep_primary;rep_single_dose,POLAR AUXIN TRANSPORT INHIBITOR,ATP5A1;ATP5B;ATP5C1;HCK;HIBCH;PIK3CG;PIM1;STK17B;UGT3A1,"FATIGUE, ALLERGIC RHINITIS, DROWSINESS",,LAUNCHED,,Small molecule,3,"O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12;OC1CC(O)C2C(C1)OC(-C1CCC(O)C(O)C1)C(O)C2=O, OC1CC(O)C2C(C1)OC(-C1CCC(O)C(O)C1)C(O)C2=O, OC1CC(O)C2C(C1)OC(-C1CCC(O)C(O)C1)C(O)C2=O, OC1CC(O)C2C(C1)OC(-C1CCC(O)C(O)C1)C(O)C2=O, OC1CC(O)C2C(C1)OC(-C1CCC(O)C(O)C1)C(O)C2=O",REFJWTPEDVJJIY-UHFFFAOYSA-N
ZALURON XL,ATROLAK XL;BIQUELLE XL;BRANCICO XL;EBESQUE XL;MINTRELEQ XL;NORSIC;NSC-758918;PSYQUET XL;QUETIAPINE;QUETIAPINE EXTENDED RELEASE;SEOTIAPIM XL;SEROQUEL;SEROQUEL XL;SONDATE XL;TENPROLIDE XL;ZALURON XL,CHEMBL716,BRD:BRD-BRD-K68867920-051-11-5;BRD:BRD-K68867920-051-11-5,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2C;HTR3A;HTR6;HTR7;SLC6A2,"SCHIZOPHRENIA, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,4,"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1;OCCOCCN1CCN(CC1)C1=NC2CCCCC2SC2CCCCC12, OCCOCCN1CCN(CC1)C1=NC2CCCCC2SC2CCCCC12, OCCOCCN1CCN(CC1)C1=NC2CCCCC2SC2CCCCC12",URKOMYMAXPYINW-UHFFFAOYSA-N
QUIFLAPON,L-686708;MK-591;QUIFLAPON,CHEMBL16596,BRD:BRD-BRD-K39503511-001-03-9;BRD:BRD-K39503511-001-03-9,rep_primary;rep_single_dose,LEUKOTRIENE SYNTHESIS INHIBITOR,ALOX5;ALOX5AP,,,PHASE 2,,Small molecule,-1,CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12;CC(C)(C)SC1C(CC(C)(C)C(O)=O)N(CC2CCC(CL)CC2)C2CCC(OCC3CCC4CCCCC4N3)CC12,NZOONKHCNQFYCI-UHFFFAOYSA-N
QUINAGOLIDE,NORPROLAC;QUINAGOLIDE,CHEMBL2218861;CHEMBL290962,BRD:BRD-BRD-K02995728-003-01-9;BRD:BRD-K02995728-003-01-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD2,HYPERPROLACTINEMIA,,LAUNCHED,,Small molecule,2,CCCN1C[C@@H](NS(=O)(=O)N(CC)CC)C[C@@H]2Cc3c(O)cccc3C[C@H]21;CCCN1C[C@H](C[C@@H]2CC3C(O)CCCC3C[C@@H]12)NS(=O)(=O)N(CC)CC;CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,GDFGTRDCCWFXTG-UHFFFAOYSA-N;GDFGTRDCCWFXTG-ZIFCJYIRSA-N
QUINAPRIL,C09AA06;CI-906;QUINAPRIL,CHEMBL1592,BRD:BRD-BRD-K72222507-003-16-8;BRD:BRD-K72222507-003-16-8,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,"HYPERTENSION, CONGESTIVE HEART FAILURE, ANGIOEDEMA",,LAUNCHED,,Small molecule,4,"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O;CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1CC2CCCCC2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1CC2CCCCC2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1CC2CCCCC2C[C@H]1C(O)=O",JSDRRTOADPPCHY-HSQYWUDLSA-N
QUINELORANE,QUINELORANE,CHEMBL155731,BRD:BRD-BRD-K13261168-300-01-0;BRD:BRD-K13261168-300-01-0,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD2;DRD3,,,PHASE 3,,Small molecule,-1,CCCN1CCC[C@@H]2CC3NC(N)NCC3C[C@@H]12;CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@H]21,TUFADSGTJUOBEH-ZWNOBZJWSA-N
W-3566,ESTROVIS;NSC-759637;QUINESTROL;W 3566;W-3566,CHEMBL1201165,BRD:BRD-A16439188-001-01-1;BRD:BRD-BRD-A16439188-001-01-1,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ESR1,MENOPAUSE,,LAUNCHED,,Small molecule,4,C[C@]12CCC3C(CCC4CC(OC5CCCC5)CCC34)C1CC[C@@]2(O)C#C;C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C,PWZUUYSISTUNDW-VAFBSOEGSA-N
QUINETHAZONE,CHINETHAZONE;HYDROMOX;NSC-759904;QUINETHAZONE,CHEMBL1532,BRD:BRD-A59303141-001-10-4;BRD:BRD-BRD-A59303141-001-10-4,rep_multi_dose;rep_primary;rep_single_dose,THIAZIDE DIURETIC,CA1;CA2;SLC12A1;SLC12A2;SLC12A3,HYPERTENSION,,LAUNCHED,,Small molecule,4,CCC1NC(=O)C2CC(C(CL)CC2N1)S(N)(=O)=O;CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,AGMMTXLNIQSRCG-UHFFFAOYSA-N
TCMDC-131239,".BETA.-QUINIDINE;(8R,9S)-QUINIDINE;AVP-786 COMPONENT QUINIDINE SULFATE;CARDIOQUIN;CIN-QUIN;CONCHININ;CONQUININE;DURAQUIN;GNF-PF-5459;KINIDIN;NSC-10004;PITAYINE;QUINACT;QUINAGLUTE;QUINALAN;QUINATIME;QUINICARDINE;QUINIDEX;QUINIDEX EXTENTABS;QUINIDINE;QUINIDINE SULFATE;QUINIDINE SULFATE ANHYDROUS;QUINIDINE SULFATE COMPONENT OF AVP-786;QUINIDINE SULFATE DIHYDRATE;QUINIDINE SULFATE HYDRATE;QUINIDINE SULPHATE;QUINIDINE SULPHATE ANHYDROUS;QUINIDINE SULPHATE DIHYDRATE;QUINIDINI SULFAS;QUINORA;SULFATE (2:1) (SALT);TCMDC-131239",CHEMBL1294;CHEMBL21578;CHEMBL3707183,BRD:BRD-BRD-K59632282-052-03-1;BRD:BRD-K59632282-052-03-1,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,KCNA5;KCNA7;KCNH1;KCNH2;KCNH5;KCNK1;KCNK6;SCN5A;SLC29A4,"MALARIA, ATRIAL FIBRILLATION (AF), VENTRICULAR ARRHYTHMIAS",,LAUNCHED,,Small molecule,NA,C=C[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12;COC1CCC2NCCC([C@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)C2C1,LOUPRKONTZGTKE-NBGVHYBESA-N
WR297608,"(8S,9R)-6'-METHOXYCINCHONAN-9-OL;ANHYDROUS;ANHYDROUS QUININE BISULFATE;ANHYDROUS QUININE HYDROBROMIDE;ANHYDROUS QUININE SULFATE;BIQUINATE;CHININUM PURUM;CHININUM SALICYLICUM;CHININUM SULPHURICUM;FEMA NO. 2975;FEMA NO. 2977;GLS 1200;GLS-1200;GLS1200;MONOHBR;MONOHYDROBROMIDE;MONOSALICYLATE;NSC-192949;NSC-5362;NSC-757298;PHOSPHATE (3:2) (SALT);QUALAQUIN;QUINAMM;QUINATE;QUININE;QUININE BISULFATE;QUININE BISULFATE ANHYDROUS;QUININE BISULFATE HEPTAHYDRATE;QUININE BISULPHATE HEPTAHYDRATE;QUININE HBR;QUININE HEMISULFATE ANHYDROUS;QUININE HYDROBROMIDE;QUININE HYDROBROMIDE ANHYDROUS;QUININE HYDROBROMIDE MONOHYDRATE;QUININE HYDROGEN SULFATE;QUININE PHOSPHATE;QUININE SALICYLATE;QUININE SULFATE;QUININE SULFATE (2:1);QUININE SULFATE ANHYDROUS;QUININE SULFATE DIHYDRATE;QUININE SULFATE HYDRATE;QUININE SULPHATE;QUININI BISULFAS;REZQUIN;SULFATE (1:1) (SALT);SULFATE (2:1) (SALT);WR297608",CHEMBL170;CHEMBL2146083;CHEMBL2146084;CHEMBL2146105;CHEMBL2359966;CHEMBL3707329,BRD:BRD-BRD-K07940445-310-02-9;BRD:BRD-K07940445-310-02-9,rep_primary;rep_single_dose,HEMOZOIN BIOCRYSTALLIZATION INHIBITOR,GP9;KCNB2;KCNN4;SLC29A4,MALARIA,,LAUNCHED,,Small molecule,4,"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12;COC1CCC2NCCC([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)C2C1, COC1CCC2NCCC([C@@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)C2C1",LOUPRKONTZGTKE-WZBLMQSHSA-N
QUININE-ETHYL-CARBONATE,QUININE-ETHYL-CARBONATE,,BRD:BRD-BRD-K97028990-001-04-4;BRD:BRD-K97028990-001-04-4,rep_primary;rep_single_dose,,,MALARIA,,LAUNCHED,,,NA,CCOC(=O)O[C@H]([C@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)C1CCNC2CCC(OC)CC12,
QUINOLINIC-ACID,QUINOLINIC-ACID,,BRD:BRD-BRD-K51885093-001-11-2;BRD:BRD-K51885093-001-11-2,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,OC(=O)C1CCCNC1C(O)=O,
QUINPIROL-(-),QUINPIROL-(-),,BRD:BRD-BRD-K26548821-003-10-5;BRD:BRD-K26548821-003-10-5,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD1;DRD2;DRD3;DRD4;HTR1A;HTR2A;HTR2B;HTR2C,,,PHASE 2,,,NA,"CCCN1CCC[C@@H]2CC3N[NH]CC3C[C@@H]12, CCCN1CCC[C@@H]2CC3N[NH]CC3C[C@@H]12",
QUIPAZINE,QUIPAZINE,CHEMBL18772,BRD:BRD-BRD-K77925998-050-14-3;BRD:BRD-K77925998-050-14-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1D;HTR2A;HTR2B;HTR2C;HTR3A;HTR3B;HTR6;SLC6A4,,,PRECLINICAL,,Small molecule,-1,"c1ccc2nc(N3CCNCC3)ccc2c1;C1CN(CCN1)C1CCC2CCCCC2N1, C1CN(CCN1)C1CCC2CCCCC2N1, C1CN(CCN1)C1CCC2CCCCC2N1",XRXDAJYKGWNHTQ-UHFFFAOYSA-N
QUIZARTINIB,AC-010220;AC-220;AC010220;AC220;ASP-2689;QUIZARTINIB,CHEMBL576982,BRD:BRD-BRD-K93918653-001-08-9;BRD:BRD-K93918653-001-08-9;CTRP:640011;GDSC1:254,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,FLT3 INHIBITOR,CSF1R;FLT3;KIT;PDGFRA;PDGFRB;RET,,,PHASE 3,,Small molecule,3,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1;CC(C)(C)C1CC(NC(=O)NC2CCC(CC2)-C2CN3C(N2)SC2CC(OCCN4CCOCC4)CCC32)NO1,CVWXJKQAOSCOAB-UHFFFAOYSA-N
QW-BI-011,QW-BI-011,,CTRP:362063,ctrp,,,,,,,,NA,,
QX-222,QX-222,,BRD:BRD-BRD-K40782193-003-02-9;BRD:BRD-K40782193-003-02-9,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,CC1CCCC(C)C1NC(=O)C[N+](C)(C)C,
QX-314,QX-314,,BRD:BRD-BRD-K56596464-004-10-7;BRD:BRD-K56596464-004-10-7,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,MAPK14;TGFBR1,,,PRECLINICAL,,,NA,"CC[N+](CC)(CC)CC(=O)NC1C(C)CCCC1C, CC[N+](CC)(CC)CC(=O)NC1C(C)CCCC1C",
R-121919,R-121919,,BRD:BRD-K00004717-001-01-9,rep_single_dose,CRF RECEPTOR ANTAGONIST,,,,,,,NA,,
R-1479,4'-AZIDOCYTIDINE;R-1479,CHEMBL393857,BRD:BRD-BRD-K28442028-001-01-3;BRD:BRD-K28442028-001-01-3,rep_primary;rep_single_dose,HCV INHIBITOR,,,,PHASE 1,,Small molecule,-1,[N-]=[N+]=N[C@]1(CO)O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O;NC1CCN([C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@H]2O)C(=O)N1,ODLGMSQBFONGNG-JVZYCSMKSA-N
R-1485,R-1485,,BRD:BRD-BRD-K96418224-300-01-8;BRD:BRD-K96418224-300-01-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR6,,,PHASE 1,,,NA,FC1CCCCC1S(=O)(=O)N1CCOC2C(CCCC12)N1CCNCC1,
R-1487,R 1487;R-1487,CHEMBL1230122;CHEMBL1766582,BRD:BRD-K00004710-001-01-9,rep_single_dose,P38 MAPK INHIBITOR,,,,,,Small molecule,1,Cl.Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21;Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21,KKKRKRMVJRHDMG-UHFFFAOYSA-N;RQHSAIGGUWVOBG-UHFFFAOYSA-N
R-268712,R-268712,,BRD:BRD-K83904070-001-02-9,rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,TGFBR1,,,,,,NA,,
W-5845,BEMCENTINIB;BGB 324;BGB-324;BGB324;CS-1046;HY-15150;KB-80319;QC-11751;R 428;R-428;R428;SYN-1131;SYN1131;W-5845,CHEMBL3809489,BRD:BRD-BRD-K14870255-001-02-3;BRD:BRD-K14870255-001-02-3,rep_primary;rep_single_dose,AXL KINASE INHIBITOR,AXL,,,PHASE 1,,Small molecule,2,Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2;NC1NC(NC2CCC3CC[C@@H](CCC3C2)N2CCCC2)NN1-C1CC2CCCC3CCCCC3-C2NN1,KXMZDGSRSGHMMK-VWLOTQADSA-N
R-59022,R-59022,,BRD:BRD-BRD-K54665485-001-07-9;BRD:BRD-K54665485-001-07-9,rep_primary;rep_single_dose,"DIACYLGLYCEROL KINASE INHIBITOR, PROTEIN KINASE INHIBITOR",DGKA,,,PRECLINICAL,,,NA,"CC1NC2SCCN2C(=O)C1CCN1CCC(CC1)=C(C1CCCCC1)C1CCC(F)CC1, CC1NC2SCCN2C(=O)C1CCN1CCC(CC1)=C(C1CCCCC1)C1CCC(F)CC1",
R-96544,R-96544,,BRD:BRD-BRD-K15588452-003-02-7;BRD:BRD-K15588452-003-02-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A,,,PRECLINICAL,,,NA,"COC1CCCC(CCC2CCCCC2OCC[C@@H]2C[C@@H](O)CN2C)C1, COC1CCCC(CCC2CCCCC2OCC[C@@H]2C[C@@H](O)CN2C)C1",
R112,R112,,BRD:BRD-K23902832-001-01-7,rep_single_dose,SYK INHIBITOR,SYK,,,,,,NA,,
ZARNESTRA,NSC-702818;R-11577;R-115777;R115777;TIPIFARNIB;ZARNESTRA,CHEMBL289228,BRD:BRD-BRD-K62965247-001-04-9;BRD:BRD-K62965247-001-04-9;BRD:BRD-U00115426-001-01-9;GDSC1:204,gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF FARNESYLTRANSFERASE A AND B,FNTA;FNTB,,,PHASE 3,"Multiple values for MOA: {'FARNESYLTRANSFERASE INHIBITOR', 'INHIBITOR OF FARNESYLTRANSFERASE A AND B'}, defaulting to 'INHIBITOR OF FARNESYLTRANSFERASE A AND B'
Multiple values for structure_id: {'U00115426', 'K62965247'}, defaulting to None",Small molecule,3,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C;CN1CNCC1[C@@](N)(C1CCC(CL)CC1)C1CCC2N(C)C(=O)CC(-C3CCCC(CL)C3)C2C1,PLHJCIYEEKOWNM-HHHXNRCGSA-N
R306465,JNJ-16241199;R-306465;R306465,CHEMBL609583,BRD:BRD-BRD-K86687746-001-01-3;BRD:BRD-K86687746-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,,,,PHASE 1,,Small molecule,1,O=C(NO)c1cnc(N2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1;ONC(=O)C1CNC(NC1)N1CCN(CC1)S(=O)(=O)C1CCC2CCCCC2C1,MUTBJZVSRNUIHA-UHFFFAOYSA-N
R406,R406,,BRD:BRD-BRD-K20285085-001-07-1;BRD:BRD-BRD-K20285085-074-04-5;BRD:BRD-K20285085-001-07-1;BRD:BRD-K20285085-074-04-5,rep_multi_dose;rep_primary;rep_single_dose,SYK INHIBITOR,RET;SYK,,,PHASE 1,,,NA,"COC1CC(NC2NCC(F)C(NC3CCC4OC(C)(C)C(=O)NC4N3)N2)CC(OC)C1OC, COC1CC(NC2NCC(F)C(NC3CCC4OC(C)(C)C(=O)NC4N3)N2)CC(OC)C1OC, COC1CC(NC2NCC(F)C(NC3CCC4OC(C)(C)C(=O)NC4N3)N2)CC(OC)C1OC",
W-5845,BEMCENTINIB;BGB 324;BGB-324;BGB324;CS-1046;HY-15150;KB-80319;QC-11751;R 428;R-428;R428;SYN-1131;SYN1131;W-5845,CHEMBL2023349;CHEMBL3809489,CTRP:660993,ctrp,,,,,,,Small molecule,2,Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,KXMZDGSRSGHMMK-VWLOTQADSA-N
R547,R547,,BRD:BRD-BRD-K52233191-001-02-4;BRD:BRD-K52233191-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK4;CDK7,,,PHASE 1,,,NA,COC1CCC(F)C(F)C1C(=O)C1CNC(NC2CCN(CC2)S(C)(=O)=O)NC1N,
RABEPRAZOLE,(R)-;ACIPHEX;DEXRABEPRAZOLE;E-3810 (PPI);E3810;ERALOC;LY-307640;LY307640;PARIPRAZOLE;RABEPRAZOLE,CHEMBL1219;CHEMBL1615209,BRD:BRD-A39390670-236-10-7;BRD:BRD-BRD-A39390670-236-10-7,rep_multi_dose;rep_primary;rep_single_dose,"ATPASE INHIBITOR, GASTRIN INHIBITOR",ATP4A,"GASTROESOPHAGEAL REFLUX DISEASE (GERD), DUODENAL ULCER DISEASE, ZOLLINGER-ELLISON SYNDROME",,LAUNCHED,,Small molecule,4,"COCCCOc1ccnc(C[S@@+]([O-])c2nc3ccccc3[nH]2)c1C;COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C;COCCCOC1CCNC(CS(=O)C2NC3CCCCC3[NH]2)C1C, COCCCOC1CCNC(CS(=O)C2NC3CCCCC3[NH]2)C1C, COCCCOC1CCNC(CS(=O)C2NC3CCCCC3[NH]2)C1C, COCCCOC1CCNC(CS(=O)C2NC3CCCCC3[NH]2)C1C",YREYEVIYCVEVJK-RUZDIDTESA-N;YREYEVIYCVEVJK-UHFFFAOYSA-N
TIORFIX,ACETORPHAN;HIDRASEC;NSC-759828;RACECADOTRIL;TIORFAN;TIORFIX,CHEMBL2103772,BRD:BRD-A08187463-001-12-9;BRD:BRD-BRD-A08187463-001-12-9,rep_multi_dose;rep_primary;rep_single_dose,ENKEPHALINASE INHIBITOR,MME,DIARRHEA,,LAUNCHED,,Small molecule,4,"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1;CC(=O)SCC(CC1CCCCC1)C(=O)NCC(=O)OCC1CCCCC1, CC(=O)SCC(CC1CCCCC1)C(=O)NCC(=O)OCC1CCCCC1",ODUOJXZPIYUATO-UHFFFAOYSA-N
RACLOPRIDE,RACLOPRIDE,CHEMBL8809,BRD:BRD-BRD-K04111260-001-10-0;BRD:BRD-K04111260-001-10-0,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3;HTR1A,,,LAUNCHED,,Small molecule,1,"CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC;CCN1CCC[C@H]1CNC(=O)C1C(O)C(CL)CC(CL)C1OC, CCN1CCC[C@H]1CNC(=O)C1C(O)C(CL)CC(CL)C1OC",WAOQONBSWFLFPE-VIFPVBQESA-N
RACTOPAMINE,RACTOPAMINE,CHEMBL509336,BRD:BRD-A86414188-003-01-5;BRD:BRD-BRD-A86414188-003-01-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,,,LAUNCHED,,Small molecule,-1,"CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1;CC(CCC1CCC(O)CC1)NCC(O)C1CCC(O)CC1, CC(CCC1CCC(O)CC1)NCC(O)C1CCC(O)CC1",YJQZYXCXBBCEAQ-UHFFFAOYSA-N
VOSILASARM,RAD-140;RAD140;TESTOLONE;VOSILASARM,CHEMBL1672635,BRD:BRD-K00003169-001-01-9,rep_single_dose,ANDROGEN RECEPTOR MODULATOR,,,,,,Small molecule,1,Cc1c(N[C@@H](c2nnc(-c3ccc(C#N)cc3)o2)[C@H](C)O)ccc(C#N)c1Cl,XMBUPPIEVAFYHO-KPZWWZAWSA-N
RADAFAXINE,RADAFAXINE,CHEMBL1172928,BRD:BRD-BRD-K13394247-003-01-4;BRD:BRD-K13394247-003-01-4,rep_primary;rep_single_dose,DOPAMINE-NOREPINEPHRINE REUPTAKE INHIBITOR,SLC6A3,,,PHASE 2,,Small molecule,2,C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1;C[C@@H]1NC(C)(C)CO[C@@]1(O)C1CCCC(CL)C1,RCOBKSKAZMVBHT-TVQRCGJNSA-N
RX-O1_667,RADEZOLID;RX-01_667;RX-013;RX-103;RX-1741;RX-O1_667,CHEMBL455461,BRD:BRD-BRD-K84683831-001-01-0;BRD:BRD-K84683831-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,"BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR, BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR",,,,PHASE 2,,Small molecule,2,CC(=O)NC[C@H]1CN(C(=O)O1)C1CCC(C(F)C1)-C1CCC(CNCC2CNN[NH]2)CC1;CC(=O)NC[C@H]1CN(c2ccc(-c3ccc(CNCc4cnn[nH]4)cc3)c(F)c2)C(=O)O1,BTTNOGHPGJANSW-IBGZPJMESA-N
RGH-896,RADIPRODIL;RGH-896,CHEMBL182066,BRD:BRD-K00005328-001-01-9,rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,O=C(Nc1ccc2nc(O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1,GKGRZLGAQZPEHO-UHFFFAOYSA-N
RADOTINIB,IY5511;RADOTINIB,CHEMBL4297524,BRD:BRD-K00004716-001-01-9,rep_single_dose,BCR-ABL KINASE INHIBITOR,,,,,,Small molecule,3,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cnccn5)n4)c3)cc(C(F)(F)F)c2)cn1,DUPWHXBITIZIKZ-UHFFFAOYSA-N
RAF265,CHIR-265;NVP-RAF265;RAF 265;RAF-265;RAF265,CHEMBL558752,BRD:BRD-BRD-K93123848-001-04-1;BRD:BRD-K93123848-001-04-1;CTRP:660414,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"RAF INHIBITOR, VEGFR INHIBITOR",BRAF,,,PHASE 2,,Small molecule,2,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21;CN1C(NC2CCC(CC2)C(F)(F)F)NC2CC(OC3CCNC(C3)-C3NCC([NH]3)C(F)(F)F)CCC12,YABJJWZLRMPFSI-UHFFFAOYSA-N
RAF709,RAF709,,BRD:BRD-K00010389-001-01-9,rep_single_dose,RAF INHIBITOR,,,,,,,NA,,
RALINEPAG,APD-811;APD811;RALINEPAG,CHEMBL3301604,BRD:BRD-K00003227-001-01-9,rep_single_dose,IP1 PROSTACYCLIN RECEPTOR AGONIST,,,,,,Small molecule,3,O=C(O)COC[C@H]1CC[C@H](COC(=O)N(c2ccccc2)c2ccc(Cl)cc2)CC1,NPDKXVKJRHPDQT-IYARVYRRSA-N
RAXETO,EVIDEN;EVISTA;J22.982B;KEOXIFENE;LY-139481;NSC-747974;RALOXIFENE;RALOXIPHENE;RAXETO,CHEMBL81,BRD:BRD-BRD-K63828191-003-32-1;BRD:BRD-K63828191-003-32-1,rep_multi_dose;rep_primary;rep_single_dose,"ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",ESR1;ESR2,"OSTEOPOROSIS, BREAST CANCER",,LAUNCHED,,Small molecule,4,"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12;OC1CCC(CC1)-C1SC2CC(O)CCC2C1C(=O)C1CCC(OCCN2CCCCC2)CC1, OC1CCC(CC1)-C1SC2CC(O)CCC2C1C(=O)C1CCC(OCCN2CCCCC2)CC1, OC1CCC(CC1)-C1SC2CC(O)CCC2C1C(=O)C1CCC(OCCN2CCCCC2)CC1, OC1CCC(CC1)-C1SC2CC(O)CCC2C1C(=O)C1CCC(OCCN2CCCCC2)CC1",GZUITABIAKMVPG-UHFFFAOYSA-N
RALTEGRAVIR,ISENTRESS;MK-0518;RALTEGRAVIR,CHEMBL254316,BRD:BRD-BRD-K05658747-001-02-9;BRD:BRD-K05658747-001-02-9,rep_primary;rep_single_dose,HIV INTEGRASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1;CC1NNC(O1)C(=O)NC(C)(C)C1NC(C(=O)NCC2CCC(F)CC2)C(O)C(=O)N1C, CC1NNC(O1)C(=O)NC(C)(C)C1NC(C(=O)NCC2CCC(F)CC2)C(O)C(=O)N1C",CZFFBEXEKNGXKS-UHFFFAOYSA-N
ZD1694,RALTITREXED;TOMUDEX;ZD-16;ZD-1694;ZD1694,CHEMBL225071,BRD:BRD-BRD-K89839824-001-05-3;BRD:BRD-K89839824-001-05-3,rep_multi_dose;rep_primary;rep_single_dose,THYMIDYLATE SYNTHASE INHIBITOR,FPGS;TYMS,MESOTHELIOMA,,LAUNCHED,,Small molecule,4,"Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1;CN(CC1CCC2[NH]C(C)NC(=O)C2C1)C1CCC(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CN(CC1CCC2[NH]C(C)NC(=O)C2C1)C1CCC(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O",IVTVGDXNLFLDRM-HNNXBMFYSA-N
RAMATROBAN,BAY U 3405;BAY-U-3405;BAYNAS;EN 137774;EN-137774;RAMATROBAN,CHEMBL361812,BRD:BRD-BRD-K08586861-001-01-1;BRD:BRD-K08586861-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGDR2;TBXA2R,"CORONARY ARTERY DISEASE (CAD), ASTHMA",,LAUNCHED,,Small molecule,2,O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2;OC(=O)CCN1C2CC[C@H](CC2C2CCCCC12)NS(=O)(=O)C1CCC(F)CC1,LDXDSHIEDAPSSA-OAHLLOKOSA-N
TAK375,RAMELTEON;ROZEREM;TAK-375;TAK375,CHEMBL1218,BRD:BRD-BRD-K28761891-001-10-1;BRD:BRD-K28761891-001-10-1,rep_primary;rep_single_dose,MELATONIN RECEPTOR AGONIST,MTNR1A;MTNR1B,INSOMNIA,,LAUNCHED,,Small molecule,4,"CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3;CCC(=O)NCC[C@@H]1CCC2CCC3OCCC3C12, CCC(=O)NCC[C@@H]1CCC2CCC3OCCC3C12",YLXDSYKOBKBWJQ-LBPRGKRZSA-N
RAMIFENAZONE,ISOPROPYLAMINOANTIPYRINE;ISOPYRINE;NSC-758621;RAMIFENAZONE,CHEMBL157337,BRD:BRD-BRD-K85333151-003-13-4;BRD:BRD-K85333151-003-13-4,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,"PAIN RELIEF, FEVER",,LAUNCHED,,Small molecule,-1,"CC(C)NC1C(C)N(C)N(-C2CCCCC2)C1=O, CC(C)NC1C(C)N(C)N(-C2CCCCC2)C1=O;Cc1c(NC(C)C)c(=O)n(-c2ccccc2)n1C",XOZLRRYPUKAKMU-UHFFFAOYSA-N
VESDIL,ALTACE;C09AA05;CARDACE;CORPRIL;DELIX;ECATOR;HOE 498;HOE-498;HOPACE;LOPACE;NSC-758933;PRAMACE;RAMACE;RAMIPRES;RAMIPRIL;RANACE;TRIATEC;TRITACE;UNIPRIL;VESDIL,CHEMBL1168,BRD:BRD-BRD-K89348303-001-14-7;BRD:BRD-K89348303-001-14-7,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21;CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O",HDACQVRGBOVJII-JBDAPHQKSA-N
RAMOSETRON,RAMOSETRON,CHEMBL1643895,BRD:BRD-BRD-K85046107-003-01-2;BRD:BRD-K85046107-003-01-2,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A,"NAUSEA, VOMITING, IRRITABLE BOWEL SYNDROME",,LAUNCHED,,Small molecule,3,Cn1cc(C(=O)[C@@H]2CCc3[nH]cnc3C2)c2ccccc21;CN1CC(C(=O)[C@@H]2CCC3NC[NH]C3C2)C2CCCCC12,NTHPAPBPFQJABD-LLVKDONJSA-N
RANIRESTAT,AS-3201;RANIRESTAT,CHEMBL132846;CHEMBL334830,BRD:BRD-BRD-K50489389-001-01-8;BRD:BRD-K50489389-001-01-8,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,AKR1B1,,,PHASE 3,,Small molecule,3,FC1CC(BR)CCC1CN1C(=O)C2CCCN2[C@@]2(CC(=O)NC2=O)C1=O;O=C1C[C@@]2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1cccn12;O=C1CC2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1cccn12,QCVNMNYRNIMDKV-QGZVFWFLSA-N;QCVNMNYRNIMDKV-UHFFFAOYSA-N
ZANTAC,NSC-757851;RANITIDINE;TRITEC;ZANTAC,CHEMBL1790041,BRD:BRD-BRD-K70505054-003-12-4;BRD:BRD-K70505054-003-12-4,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,HEARTBURN,,LAUNCHED,,Small molecule,4,"CN\C(NCCSCC1CCC(CN(C)C)O1)=C/[N+]([O-])=O, CN\C(NCCSCC1CCC(CN(C)C)O1)=C/[N+]([O-])=O, CN\C(NCCSCC1CCC(CN(C)C)O1)=C/[N+]([O-])=O, CN\C(NCCSCC1CCC(CN(C)C)O1)=C/[N+]([O-])=O;CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1",VMXUWOKSQNHOCA-UHFFFAOYSA-N
RANITIDINE (HYDROCHLORIDE),RANITIDINE (HYDROCHLORIDE),,BRD:BRD-K76687997-003-07-9,rep_single_dose,,,,,,,,NA,,
RS-43285-003,ASPRUZYO;ASPRUZYO SPRINKLE;CVT-303;NSC-759100;RAN D;RANEXA;RANOLAZINE;RS-43285-003,CHEMBL1404,BRD:BRD-A97674275-001-11-8;BRD:BRD-BRD-A97674275-001-11-8,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A;SCN4A;SCN5A;SCN9A,CHRONIC STABLE ANGINA,,LAUNCHED,,Small molecule,4,"COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1;COC1CCCCC1OCC(O)CN1CCN(CC(=O)NC2C(C)CCCC2C)CC1, COC1CCCCC1OCC(O)CN1CCN(CC(=O)NC2C(C)CCCC2C)CC1, COC1CCCCC1OCC(O)CN1CCN(CC(=O)NC2C(C)CCCC2C)CC1, COC1CCCCC1OCC(O)CN1CCN(CC(=O)NC2C(C)CCCC2C)CC1",XKLMZUWKNUAPSZ-UHFFFAOYSA-N
RAS INHIBITOR ABD-7,RAS INHIBITOR ABD-7,,BRD:BRD-K00126787-001-01-9,oncref_2,RAS-EFFECTOR PPI INHIBITOR,HRAS;KRAS;NRAS,,,,,,NA,,
TV-1030,AGN-1135;AZILECT;NSC-759639;RASAGILINE;TV-1030,CHEMBL887,BRD:BRD-BRD-K58114536-001-01-6;BRD:BRD-K58114536-001-01-6,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,BCL2;MAOB,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,"C#CCN[C@@H]1CCC2CCCCC12, C#CCN[C@@H]1CCC2CCCCC12, C#CCN[C@@H]1CCC2CCCCC12, C#CCN[C@@H]1CCC2CCCCC12;C#CCN[C@@H]1CCc2ccccc21",RUOKEQAAGRXIBM-GFCCVEGCSA-N
RAUWOLSCINE,RAUWOLSCINE,CHEMBL10347,BRD:BRD-K77474816-003-15-9,rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A;ADRA2B;ADRA2C;HTR1B;HTR1D;HTR1E;HTR2B,,,,,Small molecule,NA,COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2CC[C@@H]1O,BLGXFZZNTVWLAY-DIRVCLHFSA-N
RG-7842,GDC-0994;GDC0994;RAVOXERTINIB;RG-7842,CHEMBL3544964,BRD:BRD-BRD-K86309810-001-01-5;BRD:BRD-K86309810-001-01-5,rep_primary;rep_single_dose,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,MAPK1;MAPK3,,,PHASE 1,,Small molecule,1,Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1;CN1NCCC1NC1NCCC(N1)-C1CCN([C@H](CO)C2CCC(CL)C(F)C2)C(=O)C1,RZUOCXOYPYGSKL-GOSISDBHSA-N
RAVUCONAZOLE,BMS-207147;ER-30346;RAVUCONAZOLE,CHEMBL294029,BRD:BRD-BRD-K03503561-001-01-4;BRD:BRD-K03503561-001-01-4,rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,,,,PHASE 2,,Small molecule,1,C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F;C[C@@H](C1NC(CS1)-C1CCC(CC1)C#N)[C@](O)(CN1CNCN1)C1CCC(F)CC1F,OPAHEYNNJWPQPX-RCDICMHDSA-N
RBC8,RBC8,,BRD:BRD-A67036568-001-03-9,rep_single_dose,RAL GTPASE INHIBITOR,RALA;RALB,,,,,,NA,,
REFAMETINIB,BAY 869766;BAY 8697661;BAY-86-9766;BAY-869766;BAY-8697661;BAY86-9766;RDEA 119;RDEA-119;RDEA119;REFAMETINIB,CHEMBL1236682,GDSC1:1014;GDSC1:1526,gdsc,,,,,,,Small molecule,2,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1,RDSACQWTXKSHJT-NSHDSACASA-N
REBATOR,MUCOSTA;NSC-758955;OPC-12759;PROAMIPIDE;REBAMIPIDE;REBATOR,CHEMBL1697771,BRD:BRD-A15909516-001-06-6;BRD:BRD-BRD-A15909516-001-06-6,rep_primary;rep_single_dose,FREE RADICAL SCAVENGER,FPR1,"PEPTIC ULCER DISEASE (PUD), GASTRITIS",,LAUNCHED,,Small molecule,3,"O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1;OC(=O)C(CC1CC(=O)[NH]C2CCCCC12)NC(=O)C1CCC(CL)CC1, OC(=O)C(CC1CC(=O)[NH]C2CCCCC12)NC(=O)C1CCC(CL)CC1",ALLWOAVDORUJLA-UHFFFAOYSA-N
REBASTINIB,DCC-2036;DCC-2036 FREE BASE;DP-1919;REBASTINIB,CHEMBL1738757,BRD:BRD-BRD-K76694128-001-05-0;BRD:BRD-K76694128-001-05-0,rep_primary;rep_single_dose,"BCR-ABL KINASE INHIBITOR, TIE TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",ABL1;BCR;FGR;FLT3;HCK;LYN;SRC,,,PHASE 1,,Small molecule,2,"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1;CNC(=O)C1CC(OC2CCC(NC(=O)NC3CC(NN3-C3CCC4NCCCC4C3)C(C)(C)C)C(F)C2)CCN1, CNC(=O)C1CC(OC2CCC(NC(=O)NC3CC(NN3-C3CCC4NCCCC4C3)C(C)(C)C)C(F)C2)CCN1, CNC(=O)C1CC(OC2CCC(NC(=O)NC3CC(NN3-C3CCC4NCCCC4C3)C(C)(C)C)C(F)C2)CCN1, CNC(=O)C1CC(OC2CCC(NC(=O)NC3CC(NN3-C3CCC4NCCCC4C3)C(C)(C)C)C(F)C2)CCN1",WVXNSAVVKYZVOE-UHFFFAOYSA-N
"S,S-REBOXETINE","(S,S)-REBOXETINE;EDRONAX;ESREBOXETINE;REBOXETINE;S,S-REBOXETINE",CHEMBL14370;CHEMBL180101,BRD:BRD-BRD-M39350793-334-01-1;BRD:BRD-M39350793-334-01-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,SLC6A2,DEPRESSION,,LAUNCHED,,Small molecule,3,"CCOC1CCCCC1O[C@@H]([C@H]1CNCCO1)C1CCCCC1.CCOC1CCCCC1O[C@H]([C@@H]1CNCCO1)C1CCCCC1, CCOC1CCCCC1O[C@@H]([C@H]1CNCCO1)C1CCCCC1, CCOC1CCCCC1OC(C1CNCCO1)C1CCCCC1, CCOC1CCCCC1O[C@@H]([C@H]1CNCCO1)C1CCCCC1.CCOC1CCCCC1O[C@H]([C@@H]1CNCCO1)C1CCCCC1;CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1",CBQGYUDMJHNJBX-OALUTQOASA-N
ZD-2171,AZD 2171;AZD-2171;AZD2171;CEDIRANIB;RECENTIN;ZD-2171,CHEMBL491473,GDSC2:1922,gdsc,,,,,,,Small molecule,3,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,XXJWYDDUDKYVKI-UHFFFAOYSA-N
RECILISIB,EX-RAD;ON 01210;ON 01210.NA;ON-01210;RECILISIB,CHEMBL2219421,BRD:BRD-K00075424-001-02-9,rep_single_dose,,,,,,,Small molecule,1,O=C(O)c1ccc(/C=C/S(=O)(=O)Cc2ccc(Cl)cc2)cc1,KBEKQQJUNVQLDZ-MDZDMXLPSA-N
REFAMETINIB,BAY 869766;BAY 8697661;BAY-86-9766;BAY-869766;BAY-8697661;BAY86-9766;RDEA 119;RDEA-119;RDEA119;REFAMETINIB,CHEMBL1236682,BRD:BRD-BRD-K85751432-001-03-3;BRD:BRD-K85751432-001-03-3;GDSC1:1014;GDSC1:1526,gdsc;rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1;MAP2K2,,,PHASE 2,,Small molecule,2,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1;COC1CC(F)C(F)C(NC2CCC(I)CC2F)C1NS(=O)(=O)C1(C[C@H](O)CO)CC1,RDSACQWTXKSHJT-NSHDSACASA-N
REGADENOSON MONOHYDRATE,CVT-3146;LEXISCAN;RAPISCAN;REGADENOSON;REGADENOSON HYDRATE;REGADENOSON MONOHYDRATE,CHEMBL317052;CHEMBL3989695,BRD:BRD-A78341343-001-01-6;BRD:BRD-BRD-A78341343-001-01-6,rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,MYOCARDIAL PERFUSION IMAGING (MPI),,LAUNCHED,,Small molecule,4,CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1;CNC(=O)C1CNN(C1)-C1NC(N)C2NCN([C@@H]3O[C@H](CO)C(O)C3O)C2N1,LZPZPHGJDAGEJZ-AKAIJSEGSA-N
STIVARGA,BAY 73-4506;BAY 73-4506 MONOHYDRATE;BAY-73-4506;BAY-734506;REGORAFENIB;REGORAFENIB ANHYDROUS;REGORAFENIB HYDRATE;REGORAFENIB MONOHYDRATE;STIVARGA,CHEMBL1946170,BRD:BRD-BRD-K16730910-001-07-3;BRD:BRD-K16730910-001-07-3;CTRP:628613,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"FGFR INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAF INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",ABL1;BRAF;DDR2;EPHA2;FGFR1;FGFR2;FLT1;FLT4;FRK;KDR;KIT;MAPK11;NTRK1;PDGFRA;PDGFRB;RAF1;RET;TEK,"COLORECTAL CANCER, GASTROINTESTINAL STROMAL TUMORS (GIST)",,LAUNCHED,,Small molecule,4,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1;CNC(=O)C1CC(OC2CCC(NC(=O)NC3CCC(CL)C(C3)C(F)(F)F)C(F)C2)CCN1,FNHKPVJBJVTLMP-UHFFFAOYSA-N
TDI-0134,RELCOVAPTAN;SR 49059;SR-49059;TDI 0134;TDI-0134,CHEMBL419667,BRD:BRD-BRD-K96720755-001-02-6;BRD:BRD-K96720755-001-02-6,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR ANTAGONIST,AVPR1A;AVPR1B;AVPR2;OXTR,,,PHASE 2,,Small molecule,2,"COC1CCC(CC1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(C2CC(CL)CCC12)C1CCCCC1CL, COC1CCC(CC1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(C2CC(CL)CCC12)C1CCCCC1CL;COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@](O)(c3ccccc3Cl)[C@@H]2C(=O)N2CCC[C@H]2C(N)=O)cc1OC",CEBYCSRFKCEUSW-NAYZPBBASA-N
RELEBACTAM MONOHYDRATE,(-)-RELEBACTAM MONOHYDRATE;MK-7655;MK-7655 MONOHYDRATE;RELEBACTAM;RELEBACTAM HYDRATE;RELEBACTAM MONOHYDRATE,CHEMBL3112741;CHEMBL3301605,BRD:BRD-BRD-K63018010-001-01-7;BRD:BRD-K63018010-001-01-7,rep_primary;rep_single_dose,BETA LACTAMASE INHIBITOR,,,,PHASE 3,,Small molecule,4,O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O;OS(=O)(=O)ON1[C@H]2CN([C@@H](CC2)C(=O)NC2CCNCC2)C1=O,TWFRCSHLWKJBQH-UXQCFNEQSA-N
TAK-385,ORGOVYX;RELUGOLIX;TAK-385,CHEMBL1800159,BRD:BRD-K00003216-001-01-9,rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,,,,,,Small molecule,4,CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,AOMXMOCNKJTRQP-UHFFFAOYSA-N
REMACEMIDE,AR-R-12924;FPL-12924;PR-934-423;PR-934423A;REMACEMIDE,CHEMBL25843,BRD:BRD-A36074203-003-07-6;BRD:BRD-BRD-A36074203-003-07-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1,,,PHASE 3,,Small molecule,-1,CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1;CC(CC1CCCCC1)(NC(=O)CN)C1CCCCC1,YSGASDXSLKIKOD-UHFFFAOYSA-N
VEKLURY,GS 5734;GS-5734;REMDESIVIR;VEKLURY,CHEMBL4065616,BRD:BRD-K00071599-001-02-9,rep_single_dose,,,,,,,Small molecule,4,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1,RWWYLEGWBNMMLJ-YSOARWBDSA-N
SHP-141,NSC-748492;REMETINOSTAT;SHP-141,CHEMBL3707219,BRD:BRD-K00004584-001-01-9,rep_single_dose,HDAC INHIBITOR,,,,,,Small molecule,2,COC(=O)c1ccc(OC(=O)CCCCCCC(=O)NO)cc1,XDZAHHULFQIBFE-UHFFFAOYSA-N
REMIMAZOLAM,BYFAVO;CNS 7056;CNS-7056;ONO-2745;REMIMAZOLAM,CHEMBL4297526,BRD:BRD-BRD-K89413285-074-01-5;BRD:BRD-K89413285-074-01-5,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABBR1,,,PHASE 3,,Small molecule,4,COC(=O)CC[C@@H]1N=C(C2CCCCN2)C2CC(BR)CCC2-N2C(C)CNC12;COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21,CYHWMBVXXDIZNZ-KRWDZBQOSA-N
REMODELIN,REMODELIN,,BRD:BRD-K75349868-001-03-9,rep_single_dose,TRANSFERASE INHIBITOR,NAT10,,,,,,NA,,
REMOGLIFLOZIN ETABONATE,BHV-091009;GSK-189075;GSK-189075A;GSK189075;GSK189075A;REMOGLIFLOZIN ETABONATE,CHEMBL2028665,BRD:BRD-K00090650-001-01-9,rep_single_dose,,,,,,,Small molecule,2,CCOC(=O)OC[C@H]1O[C@@H](Oc2nn(C(C)C)c(C)c2Cc2ccc(OC(C)C)cc2)[C@H](O)[C@@H](O)[C@@H]1O,UAOCLDQAQNNEAX-ABMICEGHSA-N
ROXIAM,A 33547;A-33547;FLA 731;FLA-731(-);REMOXIPRIDE;ROXIAM,CHEMBL22242,BRD:BRD-BRD-K54094468-003-11-1;BRD:BRD-K54094468-003-11-1,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3;DRD4;HTR2A;SIGMAR1,,,WITHDRAWN,,Small molecule,4,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC;CCN1CCC[C@H]1CNC(=O)C1C(OC)CCC(BR)C1OC,GUJRSXAPGDDABA-NSHDSACASA-N
REPAGLINIDE,A10BX02;AG-EE 623 ZW;AG-EE-623-ZW;AG-EE-623ZW;AGEE-623ZW;ENYGLID;NOVONORM;NSC-759893;PRANDIN;REPAGLINIDE,CHEMBL1272,BRD:BRD-BRD-K82846253-001-15-4;BRD:BRD-K82846253-001-15-4,rep_multi_dose;rep_primary;rep_single_dose,INSULIN SECRETAGOGUE,ABCC8;KCNJ11;PPARG,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O;CCOC1CC(CC(=O)N[C@@H](CC(C)C)C2CCCCC2N2CCCCC2)CCC1C(O)=O, CCOC1CC(CC(=O)N[C@@H](CC(C)C)C2CCCCC2N2CCCCC2)CCC1C(O)=O, CCOC1CC(CC(=O)N[C@@H](CC(C)C)C2CCCCC2N2CCCCC2)CCC1C(O)=O, CCOC1CC(CC(=O)N[C@@H](CC(C)C)C2CCCCC2N2CCCCC2)CCC1C(O)=O",FAEKWTJYAYMJKF-QHCPKHFHSA-N
REPERTAXIN,DF 1681Y;DF-1681Y;DF1681Y;REPARIXIN;REPERTAXIN,CHEMBL191413,BRD:BRD-BRD-K58486055-001-02-7;BRD:BRD-K58486055-001-02-7,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR1;CXCR2,,,PHASE 3,,Small molecule,3,CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1;CC(C)CC1CCC(CC1)[C@@H](C)C(=O)NS(C)(=O)=O,KQDRVXQXKZXMHP-LLVKDONJSA-N
REPLIGEN 136,REPLIGEN 136,,CTRP:628408,ctrp,,,,,,,,NA,,
TRX-0005,REPOTRECTINIB;TPX-0005;TRX-0005,CHEMBL4298138,BRD:BRD-K00003447-001-01-9,rep_single_dose,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,,,,,,Small molecule,1,C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1,FIKPXCOQUIZNHB-WDEREUQCSA-N
REPSOX,REPSOX,,BRD:BRD-BRD-K80480517-001-02-4;BRD:BRD-K80480517-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,TGFBR1,,,PRECLINICAL,,,NA,"CC1CCCC(N1)-C1N[NH]CC1-C1CCC2NCCCC2N1, CC1CCCC(N1)-C1N[NH]CC1-C1CCC2NCCCC2N1",
TAK-242,CLI-095;RESATORVID;TAK-242,CHEMBL225157,BRD:BRD-BRD-K61567297-001-01-9;BRD:BRD-K61567297-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,"TOLL-LIKE RECEPTOR ANTAGONIST, TOLL-LIKE RECEPTOR INHIBITOR",TLR4,,,PHASE 3,"Multiple values for MOA: {'TOLL-LIKE RECEPTOR ANTAGONIST, TOLL-LIKE RECEPTOR INHIBITOR', 'TOLL-LIKE RECEPTOR ANTAGONIST'}, defaulting to 'TOLL-LIKE RECEPTOR ANTAGONIST, TOLL-LIKE RECEPTOR INHIBITOR'",Small molecule,3,"CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl;CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)NC1CCC(F)CC1CL, CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)NC1CCC(F)CC1CL",LEEIJTHMHDMWLJ-CQSZACIVSA-N
SERPIVITE,APOPLON;ENT-50146;HISERPIA;NSC-237659;NSC-59272;RAU-SED;RESERPINE;RESERPINUM;SANDRIL;SERPALAN;SERPANRAY;SERPASIL;SERPATE;SERPIVITE,CHEMBL772,BRD:BRD-BRD-K95921201-001-14-6;BRD:BRD-K95921201-001-14-6,rep_primary;rep_single_dose,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,SLC18A1;SLC18A2,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CO[C@H]1[C@@H](C[C@@H]2CN3CCC4C([NH]C5CC(OC)CCC45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1CC(OC)C(OC)C(OC)C1, CO[C@H]1[C@@H](C[C@@H]2CN3CCC4C([NH]C5CC(OC)CCC45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1CC(OC)C(OC)C(OC)C1, CO[C@H]1[C@@H](C[C@@H]2CN3CCC4C([NH]C5CC(OC)CCC45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1CC(OC)C(OC)C(OC)C1, CO[C@H]1[C@@H](C[C@@H]2CN3CCC4C([NH]C5CC(OC)CCC45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1CC(OC)C(OC)C(OC)C1;COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC",QEVHRUUCFGRFIF-MDEJGZGSSA-N
RESIBUFOGENIN,BUFOGENIN;NSC-90783;RESIBUFOGENIN,CHEMBL250172,BRD:BRD-BRD-K25970317-001-01-6;BRD:BRD-K25970317-001-01-6,rep_primary;rep_single_dose,NA/K-ATPASE INHIBITOR,,,,PHASE 2,,Small molecule,-1,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)C[C@H]3O[C@]132;C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@]11O[C@@H]1C[C@@H]2C1CCC(=O)OC1,ATLJNLYIJOCWJE-CWMZOUAVSA-N
S-28463,CD-11301;CD11301;R-848;RESIQUIMOD;S-28463,CHEMBL383322,BRD:BRD-BRD-K76210423-001-01-6;BRD:BRD-K76210423-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,TOLL-LIKE RECEPTOR AGONIST,TLR7;TLR8,,,PHASE 3,,Small molecule,2,"CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O;CCOCC1NC2C(N)NC3CCCCC3C2N1CC(C)(C)O, CCOCC1NC2C(N)NC3CCCCC3C2N1CC(C)(C)O",BXNMTOQRYBFHNZ-UHFFFAOYSA-N
VIA-3196,MGL-3196;RESMETIROM;VIA-3196,CHEMBL3261331,BRD:BRD-K00003123-001-01-9,rep_single_dose,THYROID HORMONE RECEPTOR AGONIST,,,,,,Small molecule,3,CC(C)c1cc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)n[nH]c1=O,FDBYIYFVSAHJLY-UHFFFAOYSA-N
RESMINOSTAT,4SC-201;BYK-408740;BYK408740;RAS-2410;RAS2410;RESMINOSTAT,CHEMBL4296717,BRD:BRD-BRD-K28822270-001-01-1;BRD:BRD-K28822270-001-01-1;BRD:BRD-K28822270-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC3;HDAC6;HDAC8,,,PHASE 2,,Small molecule,2,"CN(C)CC1CCC(CC1)S(=O)(=O)N1CCC(C1)\C=C\C(=O)NO, CN(C)CC1CCC(CC1)S(=O)(=O)N1CCC(C1)\C=C\C(=O)NO;CN(C)Cc1ccc(S(=O)(=O)n2ccc(/C=C/C(=O)NO)c2)cc1",FECGNJPYVFEKOD-VMPITWQZSA-N
TILLODERM,"BENZENE-1,3-DIOL;C.I. OXIDATION BASE 31;C.I.-76505;D.D.D.;FEMA NO. 3589;NSC-1571;RESORCIN;RESORCINOL;RESORCINUM;TILLODERM",CHEMBL24147,BRD:BRD-BRD-K74190368-001-04-3;BRD:BRD-K74190368-001-04-3,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,CA12;CA14;CA2;PTGS1,"ACNE VULGARIS (AV), ECZEMA, PSORIASIS, SEBORRHEIC DERMATITIS",,LAUNCHED,,Small molecule,4,Oc1cccc(O)c1;OC1CCCC(O)C1,GHMLBKRAJCXXBS-UHFFFAOYSA-N
TRANS-RESVERATROL,"(E)-5-(P-HYDROXYSTYRYL)RESORCINOL;(E)-RESVERATROL;3,5,4'-TRIHYDROXY-TRANS-STILBENE;BIA 6-512;BIA-6-512;BIOFORT;CA 1201;CUSPIDATIN;MELINJO RESVERATROL 20;NSC-327430;POLYGONIN;RESVERATROL;RESVERATROL P 5;RESVERATROL(E)-FORM;RESVIDA;SRT 501M;TRANS-RESVERATROL",CHEMBL165,BRD:BRD-BRD-K80738081-001-46-8;BRD:BRD-K80738081-001-46-8,rep_primary;rep_single_dose,"CYTOCHROME P450 INHIBITOR, SIRT ACTIVATOR",CSNK2A1;NQO2;PTGS1;PTGS2,,,LAUNCHED,,Small molecule,3,"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;OC1CCC(CC1)\C=C\C1CC(O)CC(O)C1, OC1CCC(CC1)\C=C\C1CC(O)CC(O)C1, OC1CCC(CC1)\C=C\C1CC(O)CC(O)C1, OC1CCC(CC1)\C=C\C1CC(O)CC(O)C1, OC1CCC(CC1)\C=C\C1CC(O)CC(O)C1",LUKBXSAWLPMMSZ-OWOJBTEDSA-N
SP2086,RETAGLIPTIN;SP-2086;SP2086,CHEMBL4297435,BRD:BRD-K00003118-011-01-9,rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,,,,,,Small molecule,3,COC(=O)c1nc(C(F)(F)F)n2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2,WIIAMRXFUJLYEF-SNVBAGLBSA-N
SB-275833,AITABAX;ALTABAX;ALTARGO;NSC-759885;RETAPAMULIN;SB 275833;SB-275833,CHEMBL1658,BRD:BRD-BRD-K33082088-001-03-3;BRD:BRD-K33082088-001-03-3,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,IMPETIGO,,LAUNCHED,,Small molecule,4,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C;C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2C[C@H]3CC[C@@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,STZYTFJPGGDRJD-NHUWBDDWSA-N
WAY-143841,AWD-21360;AWD21-360;D-23129;EZOGABINE;GKE-841;GW-582892X;GW582892X;POTIGA;RETIGABINE;TROBALT;WAY-143841,CHEMBL41355,BRD:BRD-BRD-K89917372-001-01-2;BRD:BRD-K89917372-001-01-2,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNQ1;KCNQ2;KCNQ3;KCNQ4;KCNQ5,EPILEPSY,,LAUNCHED,,Small molecule,4,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N;CCOC(=O)NC1CCC(NCC2CCC(F)CC2)CC1N,PCOBBVZJEWWZFR-UHFFFAOYSA-N
RETINALDEHYDE,RETINALDEHYDE,,BRD:BRD-BRD-K79884267-001-01-4;BRD:BRD-K79884267-001-01-4,rep_primary;rep_single_dose,,,COSMETIC,,LAUNCHED,,,NA,CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=O,
REV-901,REV-5901;REV-901,CHEMBL8747,BRD:BRD-A68281735-001-18-6;BRD:BRD-BRD-A68281735-001-18-6,rep_primary;rep_single_dose,"LEUKOTRIENE RECEPTOR ANTAGONIST, LIPOXYGENASE INHIBITOR",ALOX5,,,PHASE 2,,Small molecule,NA,CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1;CCCCCC(O)C1CCCC(OCC2CCC3CCCCC3N2)C1,JRLOEMCOOZSCQP-UHFFFAOYSA-N
YUPELRI,GSK-1160724;GSK1160724;REVEFENACIN;TD-4208;YUPELRI,CHEMBL3833319,BRD:BRD-K00003198-001-01-9,rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,,,,,,Small molecule,4,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,FYDWDCIFZSGNBU-UHFFFAOYSA-N
REVERSAN,REVERSAN,,BRD:BRD-BRD-K79700588-001-09-7;BRD:BRD-K79700588-001-09-7,rep_primary;rep_single_dose,MRP INHIBITOR,ABCC1,,,PRECLINICAL,,,NA,O=C(NCCCN1CCOCC1)C1CNN2C(CC(NC12)-C1CCCCC1)-C1CCCCC1,
REVERSINE,REVERSINE,CHEMBL188343,BRD:BRD-K77286328-001-03-7,rep_single_dose,AURORA KINASE INHIBITOR,AURKB;INCENP;MAP2K1,,,,,Small molecule,NA,c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1,ZFLJHSQHILSNCM-UHFFFAOYSA-N
SYP-1512,CC-5013;CDC-501;LENALIDOMIDE;NSC-747972;REVLIMID;SYP-1512,CHEMBL848,GDSC1:1020,gdsc,,,,,,,Small molecule,4,Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,GOTYRUGSSMKFNF-UHFFFAOYSA-N
REYNOUTRIN,REYNOUTRIN,CHEMBL488198,BRD:BRD-K00005343-001-01-9,rep_single_dose,ANTIOXIDANT,,,,,,Small molecule,NA,O=c1c(O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,PZZRDJXEMZMZFD-BWYUNELBSA-N
RG-108,RG-108,,CTRP:411831,ctrp,,,,,,,,NA,,
RG-7621,GDC0941;RG-7621,,GDSC1:1058;GDSC1:1527;GDSC2:1058,gdsc,,,,,,,,NA,,
RG108,RG108,,BRD:BRD-BRD-K89391146-001-08-0;BRD:BRD-K89391146-001-08-0,rep_multi_dose;rep_primary;rep_single_dose,DNA METHYLTRANSFERASE INHIBITOR,DNMT1;DNMT3B,,,PRECLINICAL,,,NA,"OC(=O)[C@H](CC1C[NH]C2CCCCC12)N1C(=O)C2CCCCC2C1=O, OC(=O)[C@H](CC1C[NH]C2CCCCC12)N1C(=O)C2CCCCC2C1=O",
RG2833,RG2833,,BRD:BRD-BRD-K02389548-001-02-5;BRD:BRD-K02389548-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC3,,,PHASE 1,,,NA,"CC1CCC(CC1)C(=O)NCCCCCC(=O)NC1CCCCC1N, CC1CCC(CC1)C(=O)NCCCCCC(=O)NC1CCCCC1N",
RG4733,RG4733,,BRD:BRD-BRD-K22024824-001-03-7;BRD:BRD-K22024824-001-03-7,rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,PSEN1,,,PHASE 2,,,NA,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1C2CCCCC2-C2CCCCC2NC1=O,
RO5045337,MDM2 ANTAGONIST RO5045337;R 7112;RG-7112;RG7112;RO-5045337;RO5045337,CHEMBL2386346,BRD:BRD-A78210457-001-01-5;BRD:BRD-BRD-A78210457-001-01-5,rep_primary;rep_single_dose,MDM INHIBITOR,MDM2,,,PHASE 1,,Small molecule,1,CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1;CCOC1CC(CCC1C1=NC(C)(C2CCC(CL)CC2)C(C)(N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)C1CCC(CL)CC1)C(C)(C)C,QBGKPEROWUKSBK-QPPIDDCLSA-N
RG7604,GDC0032;RG7604,,GDSC2:1561,gdsc,,,,,,,,NA,,
RG7800,RG7800,,BRD:BRD-K00004590-001-01-9,rep_single_dose,RNA SPLICING MODIFIER,,,,,,,NA,,
RG7834,RG7834,,BRD:BRD-K00004573-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,,NA,,
RGB-286638,RGB 286638;RGB-286638,CHEMBL3545083,BRD:BRD-BRD-K20986415-001-01-8;BRD:BRD-K20986415-001-01-8,rep_primary;rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK3;CDK4;CDK5;CDK6;CDK7;CDK9;FLT3;GSK3B;JAK2;MAP3K7;MAPK9,,,PHASE 1,,Small molecule,1,"COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1;COCCN1CCN(CC2CCC(CC2)-C2N[NH]C3-C4CCCC(NC(=O)NN5CCOCC5)C4C(=O)C23)CC1, COCCN1CCN(CC2CCC(CC2)-C2N[NH]C3-C4CCCC(NC(=O)NN5CCOCC5)C4C(=O)C23)CC1",XLSYZSRXVVCHLS-UHFFFAOYSA-N
RGFP966,RGFP966,,BRD:BRD-BRD-K61688984-001-02-9;BRD:BRD-K61688984-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC3,,,PRECLINICAL,,,NA,NC1CC(F)CCC1NC(=O)\C=C\C1CNN(C\C=C\C2CCCCC2)C1,
SB-742881,ABEQUOLIXRON;RGX-104;SB-742881,CHEMBL573677,BRD:BRD-K00004597-001-01-9,rep_single_dose,LXR AGONIST,,,,,,Small molecule,1,C[C@H](CCOc1cccc(CC(=O)O)c1)N(Cc1cccc(C(F)(F)F)c1Cl)CC(c1ccccc1)c1ccccc1,ZLJZDYOBXVOTSA-XMMPIXPASA-N
RHC-80267,RHC-80267,,BRD:BRD-BRD-K56047318-001-06-3;BRD:BRD-K56047318-001-06-3,rep_primary;rep_single_dose,TRIACYLGLYCEROL LIPASE INHIBITOR,DAGLA;DAGLB,,,PRECLINICAL,,,NA,"O=C(NCCCCCCNC(=O)ON=C1CCCCC1)ON=C1CCCCC1, O=C(NCCCCCCNC(=O)ON=C1CCCCC1)ON=C1CCCCC1",
RHEIN,RHEIN,CHEMBL418068,BRD:BRD-BRD-K27335680-001-10-0;BRD:BRD-K27335680-001-10-0,rep_primary;rep_single_dose,,HSP90AA1,,,PHASE 1,,Small molecule,NA,O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O;OC(=O)C1CC(O)C2C(=O)C3C(O)CCCC3C(=O)C2C1,FCDLCPWAQCPTKC-UHFFFAOYSA-N
RHEOCHRYSIDIN,RHEOCHRYSIDIN,,BRD:BRD-BRD-K67772619-001-05-1;BRD:BRD-K67772619-001-05-1,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,PTPN1,,,PRECLINICAL,,,NA,COC1CC(O)C2C(=O)C3C(O)CC(C)CC3C(=O)C2C1,
RHODAMINE-123,RHODAMINE-123,,BRD:BRD-BRD-K47169076-003-01-6;BRD:BRD-K47169076-003-01-6,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,COC(=O)C1CCCCC1-C1C2CCC(N)CC2[O+]C2CC(N)CCC12,
RI-1,RI-1,,BRD:BRD-BRD-K79555887-001-01-0;BRD:BRD-K79555887-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,,RAD51,,,PRECLINICAL,,,NA,CLC1=C(N2CCOCC2)C(=O)N(C1=O)C1CCC(CL)C(CL)C1,
VIRAZOLE,COPEGUS;COTRONAK;NSC-163039;REBETOL;RIBAPAK;RIBASPHERE;RIBAVARIN;RIBAVIRIN;RIBAVIRIN BIOPARTNERS;RIBAVIRIN MYLAN;RIBAVIRIN TEVA;RIBOFLURANOSYL CARBOXAMIDE;SCH 18908;SCH-18908;TRIBAVIRIN;VIRAMID;VIRAZID;VIRAZOLE,CHEMBL1643,BRD:BRD-BRD-K60369935-001-18-3;BRD:BRD-K60369935-001-18-3,rep_multi_dose;rep_primary;rep_single_dose,ANTIVIRAL,ADK;ENPP1;IMPDH1;IMPDH2;NT5C2,HEPATITIS C,,LAUNCHED,,Small molecule,4,"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1;NC(=O)C1NCN(N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O, NC(=O)C1NCN(N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O, NC(=O)C1NCN(N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O",IWUCXVSUMQZMFG-AFCXAGJDSA-N
RIBITOL,RIBITOL,,BRD:BRD-BRD-K49313711-001-05-4;BRD:BRD-K49313711-001-05-4,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC[C@H](O)[C@H](O)[C@H](O)CO,
VITAMIN-B2,BISULASE;C.I. 50900;C.I. FOOD YELLOW 15;E-101(III);E-B2;E101;FLAVAXIN;FREEDA;INS NO. 101(I);INS NO.101(III);INS-101(III);LACTO-FLAVIN;LACTOFLAVIN;NCI-0033298;NSC-33298;RIBOFLAVIN;RIBOFLAVIN (VIT B2);RIBOFLAVIN TETRABUTYRATE;RIBOFLAVINE;RIBOFLAVINUM;RUSSUPTERIDINE YELLOW III;VITAMIN B 2;VITAMIN B-2;VITAMIN B2;VITAMIN B2 (AS RIBOFLAVIN);VITAMIN G;VITAMIN-B2,CHEMBL1534,BRD:BRD-BRD-K70246307-001-04-1;BRD:BRD-BRD-K92760278-001-07-3;BRD:BRD-K70246307-001-04-1;BRD:BRD-K92760278-001-07-3,rep_multi_dose;rep_primary;rep_single_dose,"VITAMIN B, VITAMIN B2",BLVRB;RFK,JAUNDICE,,LAUNCHED,"Multiple values for MOA: {'VITAMIN B2', 'VITAMIN B, VITAMIN B2'}, defaulting to 'VITAMIN B, VITAMIN B2'
Multiple values for structure_id: {'K70246307', 'K92760278'}, defaulting to None",Small molecule,4,"Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C;CC1CC2NC3C(NC(=O)[NH]C3=O)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C2CC1C, CC1CC2NC3C(NC(=O)[NH]C3=O)N(C[C@H](O)[C@H](O)[C@H](O)CO)C2CC1C, CC1CC2NC3C(NC(=O)[NH]C3=O)N(C[C@H](O)[C@H](O)[C@H](O)CO)C2CC1C",AUNGANRZJHBGPY-SCRDCRAPSA-N
RIBOFLAVIN-TETRABUTYRATE,RIBOFLAVIN-TETRABUTYRATE,,BRD:BRD-K74227494-001-03-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
RIBOSTAMYCIN SULFATE,NSC-138925;RIBOSTAMYCIN;RIBOSTAMYCIN SULFATE,CHEMBL221572,BRD:BRD-BRD-K55188888-065-01-2;BRD:BRD-K55188888-065-01-2,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,P4HB,"HUMAN IMMUNODEFICIENCY VIRUS (HIV-1), HUMAN IMMUNODEFICIENCY VIRUS (HIV-1)",,LAUNCHED,,Small molecule,-1,"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NCC1OC(OC2C(N)CC(N)C(O)C2OC2OC(CO)C(O)C2O)C(N)C(O)C1O;NC[C@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O",NSKGQURZWSPSBC-VVPCINPTSA-N
SMT19969,RIDINILAZOLE;SMT-19969;SMT19969,CHEMBL3753858,BRD:BRD-K77897005-001-02-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,3,c1cc(-c2nc3cc(-c4ccc5[nH]c(-c6ccncc6)nc5c4)ccc3[nH]2)ccn1,UHQFBTAJFNVZIV-UHFFFAOYSA-N
RIFABUTIN,ANSAMYCIN;LM 427;LM-427;MYCOBUTIN;RIFABUTIN,CHEMBL444633,BRD:BRD-BRD-K30563334-001-02-9;BRD:BRD-K30563334-001-02-9,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,HSP90AA1;HSP90B1,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O;CO[C@H]1\C=C\O[C@@]2(C)OC3C(C2=O)C2C(C(O)C3C)C(O)C(NC(=O)\C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C1=NC3(CCN(CC(C)C)CC3)N=C21,ATEBXHFBFRCZMA-VXTBVIBXSA-N
RIMACTANE,ABRIFAM;BA 411661E;BA-41166E;EREMFAT;L-5103;L-5103 LEPETIT;L-5103-LEPETIT;NIH-10782;NSC-113926;RIFADIN;RIFADINE;RIFALDAZINE;RIFALDIN;RIFAMPICIN;RIFAMPICINUM;RIFAMPIN;RIFAMYCIN AMP;RIFAPIAM;RIFAPRODIN;RIFOLDIN;RIMACTAN;RIMACTANE,CHEMBL374478,BRD:BRD-A23603052-001-03-2;BRD:BRD-BRD-A23603052-001-03-2;BRD:BRD-BRD-K01507359-001-22-9;BRD:BRD-K01507359-001-22-9,rep_multi_dose;rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,NR1I2;SLCO1A2;SLCO1B1;SLCO1B3,"TUBERCULOSIS, MENINGITIS",,LAUNCHED,"Multiple values for structure_id: {'K01507359', 'A23603052'}, defaulting to None",Small molecule,4,"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C;CO[C@H]1\C=C\O[C@@]2(C)OC3C(C2=O)C2C(O)C(\C=N\N4CCN(C)CC4)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)C2C(O)C3C, CO[C@H]1\C=C\O[C@@]2(C)OC3C(C2=O)C2C(O)C(C=NN4CCN(C)CC4)C(NC(=O)\C(C)=C/C=C/C(C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](OC(C)=O)[C@@H]1C)C(O)C2C(O)C3C, CO[C@H]1\C=C\O[C@@]2(C)OC3C(C2=O)C2C(O)C(\C=N\N4CCN(C)CC4)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)C2C(O)C3C",JQXXHWHPUNPDRT-WLSIYKJHSA-N
RIFAMYCIN-SV,RIFAMYCIN-SV,,BRD:BRD-BRD-K13277760-001-01-2;BRD:BRD-K13277760-001-01-2,rep_primary;rep_single_dose,RNA SYNTHESIS INHIBITOR,,,,PHASE 3,,,NA,CO[C@H]1C=CO[C@@]2(C)OC3C(C2=O)C2C(O)CC(NC(=O)\C(C)=C/C=C\[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]([C@H]1C)C(=O)OC)C(O)C2C(O)C3C,
RIFAPENTINE,ANTIBIOTIC DL-473IT;DL-473;KTC-1;MDL 473;MDL-473;PRIFITIN;PRIFTIN;R-77-3;R-773;RIFAPENTIN;RIFAPENTINE,CHEMBL1660,BRD:BRD-BRD-K28346421-001-06-8;BRD:BRD-K28346421-001-06-8,rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,CYP2C8;CYP2C9;CYP3A4,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C;CO[C@H]1\C=C\O[C@@]2(C)OC3C(C2=O)C2C(O)C(\C=N\N4CCN(CC4)C4CCCC4)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)C2C(O)C3C, CO[C@H]1\C=C\O[C@@]2(C)OC3C(C2=O)C2C(O)C(\C=N\N4CCN(CC4)C4CCCC4)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)C2C(O)C3C, CO[C@H]1\C=C\O[C@@]2(C)OC3C(C2=O)C2C(O)C(\C=N\N4CCN(CC4)C4CCCC4)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)C2C(O)C3C",WDZCUPBHRAEYDL-GZAUEHORSA-N
XIFAXSAN,L-105;NORMIX;NSC-758957;RIFACOL;RIFAMYCIN L 105;RIFAXIDIN;RIFAXIMIN;TARGAXAN;XIFAXAN;XIFAXANTA;XIFAXSAN,CHEMBL1617,BRD:BRD-BRD-K92838188-001-01-9;BRD:BRD-K92838188-001-01-9,rep_primary;rep_single_dose,RNA SYNTHESIS INHIBITOR,NR1I2,"DIARRHEA, IRRITABLE BOWEL SYNDROME, HEPATIC ENCEPHALOPATHY (HE)",,LAUNCHED,,Small molecule,4,"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C;CO[C@H]1C=CO[C@@]2(C)OC3C(C2=O)C2C4NC5CC(C)CCN5C4C(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)C2C(O)C3C, CO[C@H]1C=CO[C@@]2(C)OC3C(C2=O)C2C4NC5CC(C)CCN5C4C(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)C2C(O)C3C",NZCRJKRKKOLAOJ-XRCRFVBUSA-N
RIGOSERTIB,ON 01910;RIGOSERTIB,CHEMBL1241855,BRD:BRD-BRD-K55187425-236-05-2;BRD:BRD-K55187425-236-05-2;CTRP:660397,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"CELL CYCLE INHIBITOR, PLK INHIBITOR",PLK1,,,PHASE 3,,Small molecule,3,"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1;COC1CC(OC)C(\C=C\S(=O)(=O)CC2CCC(OC)C(NCC(O)=O)C2)C(OC)C1, COC1CC(OC)C(\C=C\S(=O)(=O)CC2CCC(OC)C(NCC(O)=O)C2)C(OC)C1, COC1CC(OC)C(\C=C\S(=O)(=O)CC2CCC(OC)C(NCC(O)=O)C2)C(OC)C1",OWBFCJROIKNMGD-BQYQJAHWSA-N
SB-659032,RILAPLADIB;SB-659032,CHEMBL2104981,BRD:BRD-K00004676-001-01-9,rep_single_dose,PHOSPHOLIPASE INHIBITOR,,,,,,Small molecule,2,COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1,NNBGCSGCRSCFEA-UHFFFAOYSA-N
RILMENIDINE,HYPERIUM;RILMENIDINE,CHEMBL289480,BRD:BRD-BRD-K01638814-011-01-4;BRD:BRD-K01638814-011-01-4,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR AGONIST, IMIDAZOLINE RECEPTOR AGONIST",ADRA2A,HYPERTENSION,,LAUNCHED,,Small molecule,3,"C1CC1C(NC1=NCCO1)C1CC1, C1CC1C(NC1=NCCO1)C1CC1;C1COC(NC(C2CC2)C2CC2)=N1",CQXADFVORZEARL-UHFFFAOYSA-N
TMC278,EDURANT;R 278474;R-278474;R278474;RILPIVIRINE;TMC-278;TMC278,CHEMBL175691,BRD:BRD-BRD-K06240250-001-01-6;BRD:BRD-K06240250-001-01-6,rep_primary;rep_single_dose,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,NR1I2;SCN10A,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1;CC1CC(\C=C\C#N)CC(C)C1NC1CCNC(NC2CCC(CC2)C#N)N1,YIBOMRUWOWDFLG-ONEGZZNKSA-N
TIGLUTIK KIT,BHV-0223;EXSERVAN;NSC-753433;NSC-759823;RILUTEK;RILUZOLE;RP 54274;RP-54274;TEGLUTIK;TIGLUTIK;TIGLUTIK KIT,CHEMBL744,BRD:BRD-BRD-K21283037-001-21-5;BRD:BRD-K21283037-001-21-5,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE INHIBITOR,KCNK10;KCNK2;KCNK4;KCNN4;SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A;SLC7A11,AMYOTROPHIC LATERAL SCLEROSIS (ALS),,LAUNCHED,,Small molecule,4,"Nc1nc2ccc(OC(F)(F)F)cc2s1;NC1NC2CCC(OC(F)(F)F)CC2S1, NC1NC2CCC(OC(F)(F)F)CC2S1, NC1NC2CCC(OC(F)(F)F)CC2S1",FTALBRSUTCGOEG-UHFFFAOYSA-N
SMP-114,RIMACALIB;SMP-114,CHEMBL2107772,BRD:BRD-K00076949-001-02-9,rep_single_dose,,,,,,,Small molecule,2,C[C@@H](c1ccc(-c2ccccc2)c(F)c1)c1cc(NC(=N)N2CCOCC2)on1,MYTIJGWONQOOLC-HNNXBMFYSA-N
RIMANTADINE,RIMANTADIN;RIMANTADINE,CHEMBL959,BRD:BRD-A75479906-001-02-4;BRD:BRD-BRD-A75479906-001-02-4,rep_primary;rep_single_dose,"ANTIVIRAL, RNA SYNTHESIS INHIBITOR",,INFLUENZA A VIRUS INFECTION,,LAUNCHED,,Small molecule,4,"CC(N)C12CC3CC(CC(C3)C1)C2;CC(N)C12CC3CC(CC(C3)C1)C2, CC(N)C12CC3CC(CC(C3)C1)C2",UBCHPRBFMUDMNC-UHFFFAOYSA-N
RIMCAZOLE,BW 234U;BW-234U;RIMCAZOLE,CHEMBL275707,BRD:BRD-BRD-K70490179-300-01-2;BRD:BRD-K70490179-300-01-2,rep_primary;rep_single_dose,SIGMA RECEPTOR ANTAGONIST,SIGMAR1,,,PHASE 1,,Small molecule,-1,C[C@@H]1CN(CCCn2c3ccccc3c3ccccc32)C[C@H](C)N1;C[C@H]1CN(CCCN2C3CCCCC3C3CCCCC23)C[C@@H](C)N1,GUDVQJXODNJRIJ-CALCHBBNSA-N
RIMEPORIDE,RIMEPORIDE,CHEMBL2107802,BRD:BRD-K00004645-001-01-9,rep_single_dose,SODIUM/HYDROGEN EXCHANGER INHIBITOR,,,,,,Small molecule,1,Cc1cc(S(C)(=O)=O)c(S(C)(=O)=O)cc1C(=O)NC(=N)N,GROMEQPXDKRRIE-UHFFFAOYSA-N
VEXOL,ORG 6216;ORG-6216;RIMEXOLON;RIMEXOLONE;VEXOL,CHEMBL1200617,BRD:BRD-BRD-K31627533-001-09-5;BRD:BRD-K31627533-001-09-5,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;SERPINA6,ANTERIOR UVEITIS,,LAUNCHED,,Small molecule,4,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C;CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,QTTRZHGPGKRAFB-OOKHYKNYSA-N
ZIMULTI,ACOMPLIA;RIMONABANT;SR-14171;SR-141716;SR-141716A;SR141716;ZIMULTI,CHEMBL111,BRD:BRD-BRD-K13296708-001-05-8;BRD:BRD-K13296708-001-05-8,rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1;GPR55,,,WITHDRAWN,,Small molecule,4,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1;CC1C(NN(C1-C1CCC(CL)CC1)-C1CCC(CL)CC1CL)C(=O)NN1CCCCC1,JZCPYUJPEARBJL-UHFFFAOYSA-N
RIOCIGUAT,ADEMPAS;BAY 63-2521;BAY-63-2521;RIOCIGUAT,CHEMBL2107834,BRD:BRD-BRD-K84783599-001-01-0;BRD:BRD-K84783599-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,GUANYLATE CYCLASE STIMULANT,GUCY1A2;GUCY1A3;GUCY1B2;GUCY1B3,HYPERTENSION,,LAUNCHED,,Small molecule,4,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N;COC(=O)N(C)C1C(N)NC(NC1N)-C1NN(CC2CCCCC2F)C2NCCCC12,WXXSNCNJFUAIDG-UHFFFAOYSA-N
RYODIPINE,FORIDON;RIODIPINE;RYODIPINE,CHEMBL1891684,BRD:BRD-BRD-K36379990-001-01-1;BRD:BRD-K36379990-001-01-1,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,PHASE 2,,Small molecule,-1,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1OC(F)F;COC(=O)C1=C(C)NC(C)=C(C1C1CCCCC1OC(F)F)C(=O)OC,AZVFIZVKGSPGPK-UHFFFAOYSA-N
RIODOXOL,RIODOXOL,,BRD:BRD-K48963429-001-01-9,rep_single_dose,OTHER ANTIBIOTIC,,,,,,,NA,,
RIPASUDIL,RIPASUDIL,CHEMBL3426621,BRD:BRD-BRD-K53814070-310-01-3;BRD:BRD-K53814070-310-01-3,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK1;ROCK2,"GLAUCOMA, OCULAR HYPERTENSION",,LAUNCHED,,Small molecule,3,C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12;C[C@H]1CNCCCN1S(=O)(=O)C1CCCC2CNCC(F)C12,QSKQVZWVLOIIEV-NSHDSACASA-N
RIPAZEPAM,CL-683;RIPAZEPAM,CHEMBL159298,BRD:BRD-BRD-K57427145-001-01-6;BRD:BRD-K57427145-001-01-6,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1,,,PHASE 2,,Small molecule,-1,CCn1nc(C)c2c1C(c1ccccc1)=NCC(=O)N2;CCN1NC(C)C2NC(=O)CN=C(C12)C1CCCCC1,YFHYNLHGFKXAIQ-UHFFFAOYSA-N
RIPRETINIB,DCC-2618;QINLOCK;RIPRETINIB,CHEMBL4216467,BRD:BRD-K00005241-001-01-9,rep_single_dose,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,,,,,,Small molecule,4,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,CEFJVGZHQAGLHS-UHFFFAOYSA-N
RO7034067,EVRYSDI;RG-7916;RG7916;RISDIPLAM;RO-7034067;RO7034067,CHEMBL4297528,BRD:BRD-K00003506-001-01-9,rep_single_dose,RNA SPLICING INHIBITOR,,,,,,Small molecule,4,Cc1cn2nc(-c3cc(=O)n4cc(N5CCNC6(CC6)C5)ccc4n3)cc(C)c2n1,ASKZRYGFUPSJPN-UHFFFAOYSA-N
RISEDRONIC ACID,ACTONEL;M05BA07;NE-58095;RIDRON;RISEDRONATE;RISEDRONIC ACID,CHEMBL923,BRD:BRD-K05185389-001-02-6,rep_single_dose,OSTEOCLAST INHIBITOR,FDPS,,,,,Small molecule,4,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,IIDJRNMFWXDHID-UHFFFAOYSA-N
RISLENEMDAZ,(-)-;CERC-301;MK-0657;RISLENEMDAZ,CHEMBL2068839,BRD:BRD-K00003471-001-01-9,rep_single_dose,IONOTROPIC GLUTAMATE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H](F)C2)cc1,RECBFDWSXWAXHY-IAGOWNOFSA-N
RISPERIDONE,"LY-03004;LY03004;N05AX08;NSC-759895;PERSERIS;PERSERIS KIT;R 64 766;R-64-766;R-64,766;R-64766;RCN-3028;RCN3028;RISPERDAL;RISPERDAL CONSTA;RISPERDAL CONSTA LONG ACTING;RISPERDAL M;RISPERDAL M-TAB;RISPERDAL QUICKLET;RISPERIDONE",CHEMBL85,BRD:BRD-BRD-K53857191-001-22-7;BRD:BRD-K53857191-001-22-7,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;DRD1;DRD2;DRD3;DRD4;HRH1;HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2C;HTR6;HTR7,"SCHIZOPHRENIA, BIPOLAR DISORDER, IRRITABILITY",,LAUNCHED,,Small molecule,4,"CC1NC2CCCCN2C(=O)C1CCN1CCC(CC1)C1NOC2CC(F)CCC12, CC1NC2CCCCN2C(=O)C1CCN1CCC(CC1)C1NOC2CC(F)CCC12;Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2",RAPZEAPATHNIPO-UHFFFAOYSA-N
TISERTON,"NSC-758470;R 55,667;R-55667;RITANSERIN;TISERTON",CHEMBL267777,BRD:BRD-BRD-K40887525-001-21-9;BRD:BRD-K40887525-001-21-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C;HTR5A;HTR6;HTR7,,,PHASE 3,,Small molecule,2,"Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1;CC1NC2SCCN2C(=O)C1CCN1CCC(CC1)=C(C1CCC(F)CC1)C1CCC(F)CC1, CC1NC2SCCN2C(=O)C1CCN1CCC(CC1)=C(C1CCC(F)CC1)C1CCC(F)CC1, CC1NC2SCCN2C(=O)C1CCN1CCC(CC1)=C(C1CCC(F)CC1)C1CCC(F)CC1",JUQLTPCYUFPYKE-UHFFFAOYSA-N
RITODRINE,DU-21220;RITODRINE,CHEMBL785;CHEMBL83063,BRD:BRD-A59174698-003-18-5;BRD:BRD-BRD-A59174698-003-18-5;BRD:BRD-BRD-K14003026-003-09-0;BRD:BRD-K14003026-003-09-0,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,PREMATURE LABOR,,LAUNCHED,"Multiple values for structure_id: {'K14003026', 'A59174698'}, defaulting to None",Small molecule,4,"C[C@@H](NCCC1CCC(O)CC1)[C@@H](O)C1CCC(O)CC1, C[C@@H](NCCC1CCC(O)CC1)[C@@H](O)C1CCC(O)CC1, CC(NCCC1CCC(O)CC1)C(O)C1CCC(O)CC1;C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1;CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1",IOVGROKTTNBUGK-SJCJKPOMSA-N;IOVGROKTTNBUGK-UHFFFAOYSA-N
VIRITON,A-84538;ABBOTT-84538;ABT-538;EMPETUS;NORVIR;NSC-693184;RITOMUNE;RITONAVIR;RITONAVIR RELATED COMPOUNDS MIXTURE;RITONAVIRUM;RITOVIR;VIEKIRAX;VIRITON,CHEMBL163,BRD:BRD-BRD-K51485625-001-08-4;BRD:BRD-K51485625-001-08-4,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,CYP1A2;CYP2B6;CYP2C19;CYP2C8;CYP2C9;CYP2D6;CYP2E1;CYP3A4;CYP3A5;CYP3A7,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,CC(C)[C@H](NC(=O)N(C)CC1CSC(N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1CCCCC1)NC(=O)OCC1CNCS1)CC1CCCCC1;CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,NCDNCNXCDXHOMX-XGKFQTDJSA-N
TRANS-METANICOTINE,(E)-METANICOTINE;RIVANICLINE;TC-2403;TRANS-METANICOTINE,CHEMBL132966,BRD:BRD-BRD-K79966802-034-01-2;BRD:BRD-K79966802-034-01-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA4;CHRNB2;CXCL8,,,PHASE 2,,Small molecule,-1,CNCC/C=C/c1cccnc1;CNCC\C=C\C1CCCNC1,JUOSGGQXEBBCJB-GORDUTHDSA-N
XARELTO,BAY 59-7939;BAY-59-7939;JNJ-39039039;JNJ39039039;RIVAROXABAN;XARELTO,CHEMBL198362,BRD:BRD-BRD-K37130656-001-04-6;BRD:BRD-K37130656-001-04-6,rep_primary;rep_single_dose,COAGULATION FACTOR INHIBITOR,F10,"STROKE, SYSTEMIC EMBOLISM, ATRIAL FIBRILLATION (AF), DEEP VEIN THROMBOSIS (DVT), PULMONARY EMBOLISM (PE)",,LAUNCHED,,Small molecule,4,"CLC1CCC(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1CCC(CC1)N1CCOCC1=O, CLC1CCC(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1CCC(CC1)N1CCOCC1=O;O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1",KGFYHTZWPPHNLQ-AWEZNQCLSA-N
VOLEZE,ALZEST;ELUDEN;ENA-713;ENA-713D;ERASTIG;EXELON;KERSTIPON;NIMVASTID;ONO-2540;PROMETAX;RIVASTIGMINE;RIVASTIGMINE HEXAL;RIVASTIGMINE SANDOZ;RIVASTIGMINE TEVA;SDZ-212-713;SDZ-212713;SDZ-ENA-713;SOMNITON;VOLEZE,CHEMBL636,BRD:BRD-BRD-K10706131-046-03-6;BRD:BRD-K10706131-046-03-6,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE;BCHE,"ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, SENILE DEMENTIA",,LAUNCHED,,Small molecule,4,"CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1;CCN(C)C(=O)OC1CCCC(C1)[C@H](C)N(C)C, CCN(C)C(=O)OC1CCCC(C1)[C@H](C)N(C)C, CCN(C)C(=O)OC1CCCC(C1)[C@H](C)N(C)C, CCN(C)C(=O)OC1CCCC(C1)[C@H](C)N(C)C",XSVMFMHYUFZWBK-NSHDSACASA-N
RIZATRIPTAN,L-705126;MAXALT;MAXALT-MLT;MK-462;MK-462 FREE BASE;RIZATRIPTAN,CHEMBL905,BRD:BRD-BRD-K75699339-057-08-1;BRD:BRD-K75699339-057-08-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,"CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12;CN(C)CCC1C[NH]C2CCC(CN3CNCN3)CC12, CN(C)CCC1C[NH]C2CCC(CN3CNCN3)CC12, CN(C)CCC1C[NH]C2CCC(CN3CNCN3)CC12, CN(C)CCC1C[NH]C2CCC(CN3CNCN3)CC12",ULFRLSNUDGIQQP-UHFFFAOYSA-N
RKI-1447,RKI-1447,,BRD:BRD-BRD-K19333160-001-01-3;BRD:BRD-K19333160-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,CDC42BPA;DMPK;LIMK1;MYLK;PAK1;PKN1;ROCK1;ROCK2,,,PRECLINICAL,,,NA,"OC1CCCC(CNC(=O)NC2NC(CS2)-C2CCNCC2)C1, OC1CCCC(CNC(=O)NC2NC(CS2)-C2CCNCC2)C1",
RMC-0331,RM-023;RMC-0331,,BRD:BRD-U00115424-001-01-9,oncref_1,INHIBITOR OF THE KRAS-SOS1 INTERACTION,KRAS;SOS1,,,,,,NA,,
RMC-4550,RMC-4550,,BRD:BRD-K00010386-001-01-9,rep_single_dose,SHIP2 PHOSPHATASE INHIBITOR,,,,,,,NA,,
RMC4550,RMC4550,,BRD:BRD-U00115410-001-01-9,oncref_1,INHIBITOR OF SHP2,PTPN11,,,,,,NA,,
RN-1,RN-1,,BRD:BRD-K41415459-300-02-9,rep_single_dose,HISTONE DEMETHYLASE INHIBITOR,KDM1A,,,,,,NA,,
RN-1734,RN-1734,,BRD:BRD-BRD-K95581532-001-01-5;BRD:BRD-K95581532-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,TRPV ANTAGONIST,TRPV4,,,PRECLINICAL,,,NA,"CC(C)NCCN(C(C)C)S(=O)(=O)C1CCC(CL)CC1CL, CC(C)NCCN(C(C)C)S(=O)(=O)C1CCC(CL)CC1CL",
RN-1747,RN-1747,,BRD:BRD-BRD-K45519571-001-01-8;BRD:BRD-K45519571-001-01-8,rep_primary;rep_single_dose,TRPV AGONIST,TRPV4,,,PRECLINICAL,,,NA,"[O-][N+](=O)C1CC(CL)CCC1S(=O)(=O)N1CCN(CC2CCCCC2)CC1, [O-][N+](=O)C1CC(CL)CCC1S(=O)(=O)N1CCN(CC2CCCCC2)CC1",
RO-04-5595,RO-04-5595,,BRD:BRD-A63546914-003-02-0;BRD:BRD-BRD-A63546914-003-02-0,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN2B,,,PRECLINICAL,,,NA,"COC1CC2CCN(C)C(CCC3CCC(CL)CC3)C2CC1O, COC1CC2CCN(C)C(CCC3CCC(CL)CC3)C2CC1O",
RO-08-2750,RO-08-2750,,BRD:BRD-BRD-K00486786-001-02-2;BRD:BRD-K00486786-001-02-2,rep_primary;rep_single_dose,NGF BINDING INHIBITOR,NGF;NGFR,,,PRECLINICAL,"Multiple values for repurposing_target: {'NGF;NGFR', 'NGF'}, taking the union",,NA,CC1CC2NC3C(NC(=O)[NH]C3=O)N(C)C2CC1C=O,
RO-10-5824,RO-10-5824,,BRD:BRD-BRD-K79684402-300-02-8;BRD:BRD-K79684402-300-02-8,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD4,,,PRECLINICAL,,,NA,"CC1NCC(CN2CCC(=CC2)C2CCCCC2)C(N)N1, CC1NCC(CN2CCC(=CC2)C2CCCCC2)C(N)N1",
RO-106-9920,RO-106-9920,,BRD:BRD-A53134341-001-03-2;BRD:BRD-BRD-A53134341-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,,,,PRECLINICAL,,,NA,"O=S(C1CCCCC1)C1CCC2NNNN2N1, O=S(C1CCCCC1)C1CCC2NNNN2N1",
RO-1138452,RO-1138452,,BRD:BRD-BRD-K77220725-003-01-5;BRD:BRD-K77220725-003-01-5,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGIR,,,PRECLINICAL,,,NA,CC(C)OC1CCC(CC2CCC(NC3=NCCN3)CC2)CC1,
RO-15-4513,RO-15-4513,,BRD:BRD-BRD-K82823076-001-02-6;BRD:BRD-K82823076-001-02-6,rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB2;GABRG2,,,PRECLINICAL,,,NA,CCOC(=O)C1NCN-2C1CN(C)C(=O)C1CC(CCC-21)N=[N+]=[N-],
RO-19-4605,RO-19-4605,,BRD:BRD-BRD-K80778372-001-02-5;BRD:BRD-K80778372-001-02-5,rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,GABRA1;GABRA2;GABRA3;GABRA5,,,PRECLINICAL,,,NA,"CN1CC2C(NCN2-C2CCSC2C1=O)C(=O)OC(C)(C)C, CN1CC2C(NCN2-C2CCSC2C1=O)C(=O)OC(C)(C)C",
RO-20-1724,RO-20-1724,,BRD:BRD-A07207424-001-13-2;BRD:BRD-BRD-A07207424-001-13-2,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A;PDE4A;PDE4B;PDE4C;PDE4D,,,PRECLINICAL,,,NA,"CCCCOC1CC(CC2CNC(=O)N2)CCC1OC, CCCCOC1CC(CC2CNC(=O)N2)CCC1OC",
RO-25-6981,RO-25-6981,,BRD:BRD-BRD-K51541829-050-01-0;BRD:BRD-K51541829-050-01-0,rep_primary;rep_single_dose,"GLUTAMATE RECEPTOR ANTAGONIST, MONAMINE TRANSPORTER MODULATOR",GRIN2B,,,PRECLINICAL,,,NA,"C[C@@H](CN1CCC(CC2CCCCC2)CC1)[C@@H](O)C1CCC(O)CC1, C[C@@H](CN1CCC(CC2CCCCC2)CC1)[C@@H](O)C1CCC(O)CC1",
RO-28-1675,RO-28-1675,,BRD:BRD-BRD-K21672174-001-03-0;BRD:BRD-K21672174-001-03-0,rep_primary;rep_single_dose,GLUCOKINASE ACTIVATOR,GCK,,,PRECLINICAL,,,NA,CS(=O)(=O)C1CCC(CC1)[C@@H](CC1CCCC1)C(=O)NC1NCCS1,
RO-3,RO-3,,BRD:BRD-BRD-K00354853-001-01-2;BRD:BRD-K00354853-001-01-2,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RX3,,,PRECLINICAL,,,NA,COC1CC(CC2CNC(N)NC2N)C(CC1OC)C(C)C,
RO-3306,RO-3306,,BRD:BRD-BRD-K78373679-001-03-7;BRD:BRD-K78373679-001-03-7;GDSC1:1052;GDSC2:1052,gdsc;rep_primary;rep_single_dose,CDK INHIBITOR,CDK1,,,PRECLINICAL,,,NA,O=C1N=C(NCC2CCCS2)S\C1=C/C1CCC2NCCCC2C1,
RO-48-6791,RO-48-6791,,BRD:BRD-K00004572-001-01-9,rep_single_dose,GABA RECEPTOR MODULATOR,,,,,,,NA,,
RO-48-8071,RO-48-8071,,BRD:BRD-BRD-K55192287-051-01-1;BRD:BRD-K55192287-051-01-1,rep_primary;rep_single_dose,OXIDOSQUALENE CYCLASE INHIBITOR,LSS,,,PRECLINICAL,,,NA,"CN(CCCCCCOC1CCC(C(=O)C2CCC(BR)CC2)C(F)C1)CC=C, CN(CCCCCCOC1CCC(C(=O)C2CCC(BR)CC2)C(F)C1)CC=C",
RO4987655,CH-4987655;RO 4987655;RO-4987655;RO4987655,CHEMBL1614766,BRD:BRD-BRD-K64538373-001-01-4;BRD:BRD-K64538373-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1,,,PHASE 1,,Small molecule,1,O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F;OCCONC(=O)C1CC(CN2OCCCC2=O)C(F)C(F)C1NC1CCC(I)CC1F,FIMYFEGKMOCQKT-UHFFFAOYSA-N
RO5028442,RO-5028442;RO5028442,CHEMBL3416885,BRD:BRD-K00003149-001-01-9,rep_single_dose,VASOPRESSIN RECEPTOR ANTAGONIST,,,,,,Small molecule,1,CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21,QZXVLRCMAHJVIP-UHFFFAOYSA-N
RO-5126766,RO-5126766,,BRD:BRD-BRD-K82804538-001-01-0;BRD:BRD-K82804538-001-01-0,rep_primary;rep_single_dose,"MEK INHIBITOR, RAF INHIBITOR",BRAF;MAP2K1;MAP2K2;RAF1,,,PHASE 1,"Multiple values for MOA: {'RAF INHIBITOR, MEK INHIBITOR', 'MEK INHIBITOR, RAF INHIBITOR'}, defaulting to 'MEK INHIBITOR, RAF INHIBITOR'",,NA,"CNS(=O)(=O)NC1NCCC(CC2C(C)C3CCC(OC4NCCCN4)CC3OC2=O)C1F, CNS(=O)(=O)NC1NCCC(CC2C(C)C3CCC(OC4NCCCN4)CC3OC2=O)C1F, CNS(=O)(=O)NC1NCCC(CC2C(C)C3CCC(OC4NCCCN4)CC3OC2=O)C1F",
RO-5263397,RO-5263397,,BRD:BRD-K00004623-001-01-9,rep_single_dose,TRACE AMINE ASSOCIATED RECEPTOR AGONIST,,,,,,,NA,,
RO-60-0175,RO-60-0175,,BRD:BRD-BRD-K28007504-051-01-2;BRD:BRD-K28007504-051-01-2,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2A;HTR2B;HTR2C,,,PRECLINICAL,,,NA,"C[C@H](N)CN1CCC2CC(F)C(CL)CC12, C[C@H](N)CN1CCC2CC(F)C(CL)CC12",
RO-61-8048,RO-61-8048,,BRD:BRD-BRD-K12639498-001-01-3;BRD:BRD-K12639498-001-01-3,rep_primary;rep_single_dose,KYNURENINE 3-MONOOXYGENASE INHIBITOR,KMO,,,PRECLINICAL,,,NA,"COC1CCC(CC1OC)S(=O)(=O)NC1NC(CS1)-C1CCCC(C1)[N+]([O-])=O, COC1CCC(CC1OC)S(=O)(=O)NC1NC(CS1)-C1CCCC(C1)[N+]([O-])=O",
RO-67-7476,RO-67-7476,,BRD:BRD-K91333421-001-02-9,rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM1,,,,,,NA,,
RO-90-7501,RO-90-7501,,BRD:BRD-BRD-K58299615-001-03-5;BRD:BRD-K58299615-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,APP,,,PRECLINICAL,,,NA,"NC1CCC(CC1)-C1NC2CCC(CC2[NH]1)-C1NC2CCC(N)CC2[NH]1, NC1CCC(CC1)-C1NC2CCC(CC2[NH]1)-C1NC2CCC(N)CC2[NH]1",
RO-9187,RO-9187,,BRD:BRD-BRD-K57284066-001-01-6;BRD:BRD-K57284066-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,HCV INHIBITOR,,,,PRECLINICAL,,,NA,NC1CCN([C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@@H]2O)C(=O)N1,
RO4929097,RG 4733;RG-4733;RO 4929097;RO-4929097;RO4929097,CHEMBL4297422,CTRP:687577,ctrp,,,,,,,Small molecule,2,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2-c2ccccc21,OJPLJFIFUQPSJR-INIZCTEOSA-N
ROBALZOTAN,AZD-7371;NAD-299;ROBALZOTAN,CHEMBL1628569,BRD:BRD-BRD-K26169680-003-01-9;BRD:BRD-K26169680-003-01-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A,,,PHASE 2,,Small molecule,2,NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2;NC(=O)C1CCC(F)C2OC[C@@H](CC12)N(C1CCC1)C1CCC1,MQTUXRKNJYPMCG-CYBMUJFWSA-N
ROCILETINIB,AVL-301;CNX-419;CO-1686;CS-1631;ROCILETINIB,CHEMBL3545308,BRD:BRD-BRD-K33610132-001-02-9;BRD:BRD-K33610132-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PHASE 3,,Small molecule,3,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1;COC1CC(CCC1NC1NCC(C(NC2CCCC(NC(=O)C=C)C2)N1)C(F)(F)F)N1CCN(CC1)C(C)=O,HUFOZJXAKZVRNJ-UHFFFAOYSA-N
ROCURONIUM ION,ROCURONIUM;ROCURONIUM CATION;ROCURONIUM ION,CHEMBL1201244,BRD:BRD-BRD-K43305603-004-02-8;BRD:BRD-K43305603-004-02-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM2;CHRNA2;HTR3A,ANESTHETIC,,LAUNCHED,,Small molecule,4,"C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1;CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1, CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1",YXRDKMPIGHSVRX-OOJCLDBCSA-N
VIOXX,M01AH02;MK-0966;MK-966;MK0966;NSC-720256;NSC-758705;ROFECOXIB;TRM-201;TRM201;VIOXX,CHEMBL122,BRD:BRD-BRD-K21733600-001-14-1;BRD:BRD-K21733600-001-14-1,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,ELN;PTGS2,,,WITHDRAWN,,Small molecule,4,"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1;CS(=O)(=O)C1CCC(CC1)C1=C(C(=O)OC1)C1CCCCC1, CS(=O)(=O)C1CCC(CC1)C1=C(C(=O)OC1)C1CCCCC1, CS(=O)(=O)C1CCC(CC1)C1=C(C(=O)OC1)C1CCCCC1, CS(=O)(=O)C1CCC(CC1)C1=C(C(=O)OC1)C1CCCCC1, CS(=O)(=O)C1CCC(CC1)C1=C(C(=O)OC1)C1CCCCC1",RZJQGNCSTQAWON-UHFFFAOYSA-N
ZORYVE,ARQ-151;B-9302-107;B9302-107;BY-217;BY217;BYK-20869;BYK20869;DALIRESP;DAXAS;ROFLUMILAST;ZORYVE,CHEMBL193240,BRD:BRD-BRD-K03194791-001-04-8;BRD:BRD-K03194791-001-04-8,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A;PDE4B;PDE4C;PDE4D,"CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BRONCHITIS",,LAUNCHED,,Small molecule,4,FC(F)OC1CCC(CC1OCC1CC1)C(=O)NC1C(CL)CNCC1CL;O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,MNDBXUUTURYVHR-UHFFFAOYSA-N
VARUBY,ROLAPITANT;VARUBY,CHEMBL3707331,BRD:BRD-K00003175-001-01-9,rep_single_dose,NEUROKININ RECEPTOR ANTAGONIST,,,,,,Small molecule,4,C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,FIVSJYGQAIEMOC-ZGNKEGEESA-N
ZK-62771,"(R,S)-ROLIPRAM;NSC-760125;ROLIPRAM;SB-95952;ZK 62 711;ZK-62711;ZK-62771",CHEMBL63,BRD:BRD-A34255068-001-34-5;BRD:BRD-BRD-A34255068-001-34-5,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,PHASE 3,,Small molecule,2,"COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1;COC1CCC(CC1OC1CCCC1)C1CNC(=O)C1, COC1CCC(CC1OC1CCCC1)C1CNC(=O)C1, COC1CCC(CC1OC1CCCC1)C1CNC(=O)C1, COC1CCC(CC1OC1CCCC1)C1CNC(=O)C1",HJORMJIFDVBMOB-UHFFFAOYSA-N
ROLIPRAM-S(+),ROLIPRAM-S(+),,BRD:BRD-BRD-K65856711-001-04-4,rep_primary,PHOSPHODIESTERASE INHIBITOR,,,,PRECLINICAL,,,NA,"COC1CCC(CC1OC1CCCC1)[C@H]1CNC(=O)C1, COC1CCC(CC1OC1CCCC1)[C@H]1CNC(=O)C1",
ROLUPERIDONE,FMI;MIN-101 FREE BASE;ROLUPERIDONE,CHEMBL4297605,BRD:BRD-K00003283-001-01-9,rep_single_dose,,,,,,,Small molecule,3,O=C(CN1CCC(CN2Cc3ccccc3C2=O)CC1)c1ccc(F)cc1,RNRYULFRLCBRQS-UHFFFAOYSA-N
ROLZIRACETAM,CI-911;NSC-122751;ROLZIRACETAM,CHEMBL51396,BRD:BRD-BRD-K38564664-001-01-1;BRD:BRD-K38564664-001-01-1,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,O=C1CCC2CCC(=O)N12,IEZDOKQWPWZVQF-UHFFFAOYSA-N
ROMIDEPSIN,CHROMADAX;DEPSIPEPTIDE;FK-228;FK228;FR-901228;FR901228;ISTODAX;NSC-630176;ROMIDEPSIN,CHEMBL343448,BRD:BRD-BRD-K61397605-001-03-4;BRD:BRD-K61397605-001-03-4,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9,CUTANEOUS T-CELL LYMPHOMA (CTCL),,LAUNCHED,,Protein,4,C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O;C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,OHRURASPPZQGQM-GCCNXGTGSA-N
RONIDAZOLE,NSC-757865;RONIDAZOLE,CHEMBL290299,BRD:BRD-BRD-K94266545-001-24-1;BRD:BRD-K94266545-001-24-1,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,"HISTOMONIASIS, DYSENTRY",,LAUNCHED,,Small molecule,-1,"Cn1c([N+](=O)[O-])cnc1COC(N)=O;CN1C(COC(N)=O)NCC1[N+]([O-])=O, CN1C(COC(N)=O)NCC1[N+]([O-])=O",PQFRTXSWDXZRRS-UHFFFAOYSA-N
SK&F 101468,NSC-758917;REQUIP;ROPINIROLE;SK&F 101468,CHEMBL589,BRD:BRD-BRD-K15933101-003-06-1;BRD:BRD-K15933101-003-06-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C,"PARKINSON'S DISEASE, RESTLESS LEG SYNDROME",,LAUNCHED,,Small molecule,4,"CCCN(CCC)CCc1cccc2c1CC(=O)N2;CCCN(CCC)CCC1CCCC2NC(=O)CC12, CCCN(CCC)CCC1CCCC2NC(=O)CC12",UHSKFQJFRQCDBE-UHFFFAOYSA-N
TLC590,ROPIVACAINE;ROPIVICAINE;TLC-590;TLC590,CHEMBL1077896,BRD:BRD-BRD-K50938786-003-11-8;BRD:BRD-K50938786-003-11-8,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN10A,ANESTHETIC,,LAUNCHED,,Small molecule,4,CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C;CCCN1CCCC[C@H]1C(=O)NC1C(C)CCCC1C,ZKMNUMMKYBVTFN-HNNXBMFYSA-N
ROQUINIMEX,FCF 89;FCF-89;LINOMIDE;LS 2616;LS-2616;ROQUINIMEX,CHEMBL11672,BRD:BRD-BRD-K03384561-001-02-7;BRD:BRD-K03384561-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,"ANGIOGENESIS INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",,,,PHASE 3,,Small molecule,-1,CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1;CN(C(=O)C1C(O)C2CCCCC2N(C)C1=O)C1CCCCC1,SGOOQMRIPALTEL-UHFFFAOYSA-N
SCH-14947,4'-DEOXY-;4'-DEOXYCIRRAMYCIN A1;CIRRAMYCIN A1;JUVENIMICIN A3;M-4365A2;NSC-175150;ROSAMICIN;ROSARAMICIN;SCH 14947;SCH-14947,CHEMBL8965,BRD:BRD-K00004538-001-01-9,rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,,,,,Small molecule,-1,CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/[C@]2(C)O[C@H]2[C@@H]1C,IUPCWCLVECYZRV-JZMZINANSA-N
SELICICLIB,AL-39256;CYC-202;NSC-701554;R-ROSCOVITINE;ROSCOVITIN;ROSCOVITINE;SELICICLIB,CHEMBL14762,BRD:BRD-BRD-K07691486-001-15-5;BRD:BRD-K07691486-001-15-5;BRD:BRD-K07691486-001-19-7;GDSC1:110,gdsc;rep_multi_dose;rep_primary;rep_single_dose,CDK INHIBITOR,CDK2;CDK9,,,PHASE 2,,Small molecule,2,"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1;CC[C@H](CO)NC1NC(NCC2CCCCC2)C2NCN(C(C)C)C2N1, CC[C@H](CO)NC1NC(NCC2CCCCC2)C2NCN(C(C)C)C2N1",BTIHMVBBUGXLCJ-OAHLLOKOSA-N
ROSE-BENGAL-LACTONE,ROSE-BENGAL-LACTONE,,BRD:BRD-BRD-K36163066-304-02-4;BRD:BRD-K36163066-304-02-4,rep_primary;rep_single_dose,COLORING AGENT,,STAINING AGENT,,LAUNCHED,,,NA,OC1C(I)CC2C(OC3C(I)C(O)C(I)CC3C22OC(=O)C3C2C(CL)C(CL)C(CL)C3CL)C1I,
TDZ-01,AVANDAMET;AVANDARYL;AVANDIA;BRL-49653;GAUDIL;NSC-758698;REZULT;ROSIGLITAZONE;ROSIGLIZOLE;ROSVEL;TDZ-01,CHEMBL121,BRD:BRD-A97437073-050-14-5;BRD:BRD-BRD-A97437073-050-14-5,rep_primary;rep_single_dose,"INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",ACSL4;FFAR1;PPARG;TRPC5;TRPM3,,,WITHDRAWN,,Small molecule,4,"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1;CN(CCOC1CCC(CC2SC(=O)NC2=O)CC1)C1CCCCN1, CN(CCOC1CCC(CC2SC(=O)NC2=O)CC1)C1CCCCN1, CN(CCOC1CCC(CC2SC(=O)NC2=O)CC1)C1CCCCN1, CN(CCOC1CCC(CC2SC(=O)NC2=O)CC1)C1CCCCN1, CN(CCOC1CCC(CC2SC(=O)NC2=O)CC1)C1CCCCN1",YASAKCUCGLMORW-UHFFFAOYSA-N
ROSIPTOR,AQX-1125;AQX-1125 FREE BASE;ROSIPTOR,CHEMBL3989954,BRD:BRD-K00003494-001-01-9,rep_single_dose,SHIP1 PHOSPHATASE ACTIVATOR,,,,,,Small molecule,3,C=C1CC[C@H]2[C@H](CN)[C@@H]([C@@]3(C)CC[C@H](O)C[C@@H]3CO)CC[C@]12C,MDEJTPWQNNMAQF-BVMLLJBZSA-N
ROSMARINIC-ACID,ROSMARINIC-ACID,,BRD:BRD-BRD-K20313525-001-04-6;BRD:BRD-K20313525-001-04-6,rep_primary;rep_single_dose,GABA TRANSAMINASE INHIBITOR,MCL1;TYR,,,LAUNCHED,,,NA,OC(=O)[C@@H](CC1CCC(O)C(O)C1)OC(=O)\C=C\C1CCC(O)C(O)C1,
WINURON,"ACROSOXACIN;ERACINE;ERADACIL;ERADACIN;ERADICIN;NSC-146617;ROSOXACIN;ROXADYL;WIN 35,213;WIN-35213;WINOXACIN;WINURON",CHEMBL291157,BRD:BRD-BRD-K49841478-001-01-6;BRD:BRD-K49841478-001-01-6,rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,CCn1cc(C(=O)O)c(=O)c2ccc(-c3ccncc3)cc21;CCN1CC(C(O)=O)C(=O)C2CCC(CC12)-C1CCNCC1,XBPZXDSZHPDXQU-UHFFFAOYSA-N
ROSTAFUROXINE,ROSTAFUROXINE,,BRD:BRD-BRD-K11672787-001-01-5;BRD:BRD-K11672787-001-01-5,rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP1A1,,,PHASE 2,,,NA,"C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1CCOC1, C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1CCOC1",
ZD4522,CRESTON;ROSUVASTATIN;X-PLENDED;ZD-4522;ZD4522,CHEMBL1496,BRD:BRD-BRD-K82941592-238-04-5;BRD:BRD-K82941592-238-04-5;BRD:BRD-K82941592-238-07-9,rep_primary;rep_single_dose,HMGCR INHIBITOR,HMGCR,"HYPERLIPIDEMIA, DYSLIPIDEMIA, HYPERTRIGLYCERIDEMIA, HYPERCHOLESTEROLEMIA, ATHEROSCLEROSIS",,LAUNCHED,,Small molecule,4,"CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O;CC(C)C1NC(NC(-C2CCC(F)CC2)C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O, CC(C)C1NC(NC(-C2CCC(F)CC2)C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O",BPRHUIZQVSMCRT-VEUZHWNKSA-N
SPM-962,LEGANTO;NEUPRO;ROTIGOTINE;SPM 962;SPM-962,CHEMBL1303,BRD:BRD-BRD-K91111634-001-01-2;BRD:BRD-K91111634-001-01-2,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,ADRA2B;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A,"PARKINSON'S DISEASE, RESTLESS LEG SYNDROME",,LAUNCHED,,Small molecule,4,"CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1;CCCN(CCC1CCCS1)[C@H]1CCC2C(O)CCCC2C1, CCCN(CCC1CCCS1)[C@H]1CCC2C(O)CCCC2C1",KFQYTPMOWPVWEJ-INIZCTEOSA-N
TETRAHYDROPALMATINE L-FORM,(-)-;(-)-CORYDALIS B;(-)-ROTUNDINE;(-)-TETRAHYDROPALMATINE;CASEANINE;DL-;GINDARINE;HYNDARINE;L-;L-TETRAHYDROPALMATINE;LEVO-TETRAHYDROPALMATINE;ROTUNDINE;TETRAHYDROPALMATINE;TETRAHYDROPALMATINE L-FORM,CHEMBL487182,BRD:BRD-BRD-K35719256-001-02-6;BRD:BRD-K35719256-001-02-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,DRD1;DRD2;DRD3;HTR1A,,,LAUNCHED,,Small molecule,2,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2;COC1CC2CCN3CC4C(C[C@H]3C2CC1OC)CCC(OC)C4OC,AEQDJSLRWYMAQI-KRWDZBQOSA-N
ROVAZOLAC,ALX-101;ROVAZOLAC,CHEMBL4297218,BRD:BRD-K00003502-001-01-9,rep_single_dose,LXR AGONIST,,,,,,Small molecule,2,CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1,ZUMNJDGBYXHASJ-UHFFFAOYSA-N
ROXARSONE,ROXARSONE,CHEMBL1321154,BRD:BRD-BRD-K22685337-001-13-4;BRD:BRD-K22685337-001-13-4,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,WEIGHT-GAIN AID,,LAUNCHED,,Small molecule,NA,O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O;OC1CCC(CC1[N+]([O-])=O)[AS](O)(O)=O,XMVJITFPVVRMHC-UHFFFAOYSA-N
ROXATIDINE-ACETATE,ROXATIDINE-ACETATE,,BRD:BRD-BRD-K81855038-003-13-9;BRD:BRD-K81855038-003-13-9,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,"ZOLLINGER-ELLISON SYNDROME, EROSIVE ESOPHAGITIS (EE), GASTROESOPHAGEAL REFLUX DISEASE (GERD), GASTRITIS",,LAUNCHED,,,NA,"CC(=O)OCC(=O)NCCCOC1CCCC(CN2CCCCC2)C1, CC(=O)OCC(=O)NCCCOC1CCCC(CN2CCCCC2)C1, CC(=O)OCC(=O)NCCCOC1CCCC(CN2CCCCC2)C1",
RULIDE,NSC-758443;ROXITHROMYCIN;RU 28965;RU 965;RU-28965;RU-965;RULID;RULIDE,CHEMBL1214185,BRD:BRD-BRD-K38684403-001-05-4;BRD:BRD-K38684403-001-05-4,rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,ABCB1;MLNR,"RESPIRATORY TRACT INFECTIONS, URINARY TRACT INFECTIONS, SKIN INFECTIONS",,LAUNCHED,,Small molecule,4,"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O;CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O",RXZBMPWDPOLZGW-XMRMVWPWSA-N
RP-001,RP-001,,BRD:BRD-A29148886-003-02-9,rep_single_dose,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,S1PR1,,,,,,NA,,
RP-54745,RP-54745,,BRD:BRD-K00073937-001-02-9,rep_single_dose,,,,,,,,NA,,
RP-6306,RP-6306,CHEMBL5095288,BRD:BRD-K00126480-001-01-9,oncref_2,INHIBITOR OF PKMYT1,PKMYT1,,,,,Unknown,1,,
RQ-00203078,RQ-00203078,,BRD:BRD-K87973152-001-02-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPM8,,,,,,NA,,
RS-0481,RS-0481,,BRD:BRD-A00055058-001-01-0;BRD:BRD-BRD-A00055058-001-01-0,rep_primary;rep_single_dose,IMMUNOSTIMULANT,,,,PHASE 2,,,NA,CC(NC(=O)C1CSCN1C(=O)C1CCCCC1)C1CCCCC1,
RS-100329,RS-100329,,BRD:BRD-BRD-K08640512-003-02-3;BRD:BRD-K08640512-003-02-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1D,,,PRECLINICAL,,,NA,CC1C[NH]C(=O)N(CCCN2CCN(CC2)C2CCCCC2OCC(F)(F)F)C1=O,
RS-102221,"RS-102,221;RS-102221",CHEMBL88402,BRD:BRD-BRD-K87048468-003-02-7;BRD:BRD-K87048468-003-02-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C,,,PRECLINICAL,,Small molecule,NA,"COc1cc(OC)c(C(=O)CCCCN2CCC3(CC2)NC(=O)NC3=O)cc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1;COC1CC(OC)C(CC1NS(=O)(=O)C1CCC(CC1)C(F)(F)F)C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O, COC1CC(OC)C(CC1NS(=O)(=O)C1CCC(CC1)C(F)(F)F)C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O, COC1CC(OC)C(CC1NS(=O)(=O)C1CCC(CC1)C(F)(F)F)C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O",HZZZZODVDSHQRG-UHFFFAOYSA-N
RS-102895,RS-102895,,BRD:BRD-BRD-K83063356-003-02-5;BRD:BRD-K83063356-003-02-5,rep_primary;rep_single_dose,CCR ANTAGONIST,CCR2,,,PRECLINICAL,,,NA,"FC(F)(F)C1CCC(CCN2CCC3(CC2)OC(=O)NC2CCCCC32)CC1, FC(F)(F)C1CCC(CCN2CCC3(CC2)OC(=O)NC2CCCCC32)CC1",
RS-127445,RS-127445,,BRD:BRD-BRD-K90825648-001-02-0;BRD:BRD-K90825648-001-02-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C,,,PHASE 1,,,NA,CC(C)C1CC(NC(N)N1)-C1CCC(F)C2CCCCC12,
RS-16566,RS-16566,,BRD:BRD-BRD-K80725821-300-02-9;BRD:BRD-K80725821-300-02-9,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,PRECLINICAL,,,NA,CC(C)N1CNC2C(CC(CL)CC12)C(=O)N[C@H]1CN2CCC1CC2,
RS-17053,RS-17053,,BRD:BRD-BRD-K76840893-003-02-5;BRD:BRD-K76840893-003-02-5,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1D,,,PRECLINICAL,,,NA,"CC(C)(CC1C[NH]C2CCC(CL)CC12)NCCOC1CCCCC1OCC1CC1, CC(C)(CC1C[NH]C2CCC(CL)CC12)NCCOC1CCCCC1OCC1CC1",
RS-23597-190,RS-23597-190,,BRD:BRD-BRD-K01868942-003-02-7;BRD:BRD-K01868942-003-02-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR4,,,PRECLINICAL,,,NA,COC1CC(N)C(CL)CC1C(=O)OCCCN1CCCCC1,
RS-39604,RS-39604,,BRD:BRD-BRD-K20742498-003-02-9;BRD:BRD-K20742498-003-02-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR4,,,PRECLINICAL,,,NA,COC1CC(COC2CC(N)C(CL)CC2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)CC(OC)C1,
RS-45041-190,RS-45041-190,,BRD:BRD-BRD-K26160755-003-02-6;BRD:BRD-K26160755-003-02-6,rep_primary;rep_single_dose,IMIDAZOLINE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,CLC1CCCC2CN(CC12)C1=NCCN1,
RS-504393,RS-504393,,BRD:BRD-BRD-K87510569-001-02-8;BRD:BRD-K87510569-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCL2;CCR2,,,PRECLINICAL,,,NA,CC1OC(NC1CCN1CCC2(CC1)OC(=O)NC1CCC(C)CC21)-C1CCCCC1,
RS-56812,RS-56812,,BRD:BRD-BRD-K20714604-003-02-9;BRD:BRD-K20714604-003-02-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR PARTIAL AGONIST,HTR3A,,,PRECLINICAL,,,NA,CN1CC(C(=O)C(=O)N[C@H]2CN3CCC2CC3)C2CCCCC12,
RS-67333,RS-67333,,BRD:BRD-BRD-K46142322-003-02-4;BRD:BRD-K46142322-003-02-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR PARTIAL AGONIST,HTR4,,,PRECLINICAL,,,NA,CCCCN1CCC(CCC(=O)C2CC(CL)C(N)CC2OC)CC1,
RS-67506,RS-67506,,BRD:BRD-BRD-K50018155-003-02-1;BRD:BRD-K50018155-003-02-1,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR PARTIAL AGONIST,HTR4,,,PRECLINICAL,,,NA,COC1CC(N)C(CL)CC1C(=O)CCC1CCN(CCNS(C)(=O)=O)CC1,
RS-79948,RS-79948,,BRD:BRD-BRD-K86600316-003-02-0;BRD:BRD-K86600316-003-02-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A,,,PRECLINICAL,,,NA,CCS(=O)(=O)N1CCC[C@@H]2CN3CCC4CC(OC)CCC4[C@@H]3C[C@H]12,
RSV604,A-60444;RSV 604;RSV-604;RSV604,CHEMBL223402,BRD:BRD-BRD-K30159788-001-01-9;BRD:BRD-K30159788-001-01-9,rep_primary;rep_single_dose,RSV REPLICATION INHIBITOR,,,,PHASE 2,,Small molecule,2,FC1CCCCC1NC(=O)N[C@H]1N=C(C2CCCCC2)C2CCCCC2NC1=O;O=C(Nc1ccccc1F)N[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O,MTPVBMVUENFFLL-HXUWFJFHSA-N
RTA-408,OMAVELOXOLONE;RTA 408;RTA-408,CHEMBL4303525,BRD:BRD-BRD-K56211775-001-03-8;BRD:BRD-K56211775-001-03-8,rep_primary;rep_single_dose,NITRIC OXIDE PRODUCTION INHIBITOR,NFE2L2,,,PHASE 2,,Small molecule,2,"CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2, CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2, CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2;CC1(C)CC[C@]2(NC(=O)C(C)(F)F)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1",RJCWBNBKOKFWNY-IDPLTSGASA-N
RTRAIL,RTRAIL,,GDSC1:1261,gdsc,,,,,,,,NA,,
RU-28318,RU-28318,,BRD:BRD-BRD-K37687387-237-01-7;BRD:BRD-K37687387-237-01-7,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,NR3C2,,,PHASE 2,,,NA,CCC[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]3(O)CCC(O)=O)[C@H]12,
RU-58841,RU-58841,CHEMBL9337,BRD:BRD-BRD-K62762455-001-01-3;BRD:BRD-K62762455-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,AR,,,PHASE 2,,Small molecule,NA,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCCCO;CC1(C)N(CCCCO)C(=O)N(C1=O)C1CCC(C#N)C(C1)C(F)(F)F,ARBYGDBJECGMGA-UHFFFAOYSA-N
RU-SKI 43,RU-SKI 43,,GDSC1:576,gdsc,,,,,,,,NA,,
RU-SKI-43,RU-SKI-43,,BRD:BRD-A33603104-003-02-9,rep_single_dose,HEDGEHOG PATHWAY INHIBITOR,HHAT,,,,,,NA,,
VALRUBICIN IMPURITY,ADRIABLASTIN;ADRIAMYCIN;ADRIBLASTINA;DOXIL;DOXORUBICIN;DOXORUBICIN-;DOXORUBICINE;EPIRUBICIN HYDROCHLORIDE IMPURITY;HYDROXYDAUNORUBICIN;NSC-123127;NSC-759155;RUBEX;VALRUBICIN IMPURITY,CHEMBL53463,GDSC1:133,gdsc,,,,,,,Small molecule,4,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,AOJJSUZBOXZQNB-TZSSRYMLSA-N
RUBITECAN,9-NC;9-NITRO-20-(S)-CAMPTOTHECIN;9-NITRO-20(S)-CAMPTOTHECIN;9-NITROCAMPTOTHECIN;RFS 2000;RFS-2000;RFS2000;RUBITECAN,CHEMBL77305,BRD:BRD-BRD-K79821389-001-03-5;BRD:BRD-K79821389-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,PHASE 3,,Small molecule,3,CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCCC([N+]([O-])=O)C4CC3CN1C2=O;CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1,VHXNKPBCCMUMSW-FQEVSTJZSA-N
RUBOXISTAURIN,ARXXANT;LY-333531;RUBOXISTAURIN,CHEMBL91829,BRD:BRD-K27677357-003-04-9,rep_single_dose,PKC INHIBITOR,,,,,,Small molecule,3,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,ZCBUQCWBWNUWSU-SFHVURJKSA-N
RUCAPARIB,AG-014699;AG-14447;RUCAPARIB,CHEMBL1173055,BRD:BRD-BRD-K88560311-011-06-3;BRD:BRD-K88560311-011-06-3;GDSC1:1175,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,PARP1;PARP2,,,PHASE 3,,Small molecule,4,"CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1;CNCC1CCC(CC1)-C1[NH]C2CC(F)CC3C(=O)NCCC1C23, CNCC1CCC(CC1)-C1[NH]C2CC(F)CC3C(=O)NCCC1C23",HMABYWSNWIZPAG-UHFFFAOYSA-N
RUCINOL,N-BUTYLRESORCINOL;RUCINOL,CHEMBL450195,BRD:BRD-BRD-K61036791-001-01-6;BRD:BRD-K61036791-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,TYROSINASE INHIBITOR,TYR,,,PHASE 1,,Small molecule,NA,CCCCc1ccc(O)cc1O;CCCCC1CCC(O)CC1O,CSHZYWUPJWVTMQ-UHFFFAOYSA-N
RUFINAMIDE,60231/4;BANZEL;CGP 33101;CGP-33101;E-2080;E2080;INOVELON;RUF 331;RUF-331;RUFINAMIDE,CHEMBL1201754,BRD:BRD-BRD-K20079257-001-09-6;BRD:BRD-K20079257-001-09-6,rep_primary;rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,GRM5;SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,,Small molecule,4,NC(=O)c1cn(Cc2c(F)cccc2F)nn1;NC(=O)C1CN(CC2C(F)CCCC2F)NN1,POGQSBRIGCQNEG-UHFFFAOYSA-N
RUFLOXACIN,MF 934;NSC-759835;RUFLOXACIN,CHEMBL295619,BRD:BRD-BRD-K62374253-001-07-8;BRD:BRD-K62374253-001-07-8,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,-1,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1;CN1CCN(CC1)C1C(F)CC2C3C1SCCN3CC(C(O)=O)C2=O,NJCJBUHJQLFDSW-UHFFFAOYSA-N
UR-12592,RUPATADINE;UR-12592,CHEMBL91397,BRD:BRD-BRD-K98004573-051-02-8;BRD:BRD-K98004573-051-02-8,rep_primary;rep_single_dose,"HISTAMINE RECEPTOR ANTAGONIST, PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST",HRH1;PTAFR,"ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,3,Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1;CC1CNCC(CN2CCC(CC2)=C2C3CCC(CL)CC3CCC3CCCNC23)C1,WUZYKBABMWJHDL-UHFFFAOYSA-N
RUPINTRIVIR,AG-7088;AG7088;RUPINTRIVIR,CHEMBL20210,BRD:BRD-K00075060-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1,CAYJBRBGZBCZKO-BHGBQCOSSA-N
RUTAECARPINE,RUTAECARPINE,CHEMBL85139,BRD:BRD-BRD-K94723713-001-10-6;BRD:BRD-K94723713-001-10-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,,,PRECLINICAL,,Small molecule,NA,O=c1c2ccccc2nc2n1CCc1c-2[nH]c2ccccc12;O=C1N2CCC3C([NH]C4CCCCC34)-C2NC2CCCCC12,ACVGWSKVRYFWRP-UHFFFAOYSA-N
YUNXIANGGAN,BIRUTAN;C.I. 75730;GLOBULARIACITRIN;ILIXANTHIN;MYRTICOLORIN;NOVARRUTINA;NSC-115918;NSC-9220;OSYRITRIN;PALIUROSIDE;QUERCETIN 3-RUTINOSIDE;QUERCETIN-3-O-RUTINOSIDE;RUTIN;RUTOSIDE;SOPHORIN;TANRUTIN;VIOLAQUERCETRIN;YUNXIANGGAN,CHEMBL226335,BRD:BRD-BRD-K20482099-001-09-4;BRD:BRD-BRD-K20482099-001-11-0;BRD:BRD-K20482099-001-09-4;BRD:BRD-K20482099-001-11-0,rep_multi_dose;rep_primary;rep_single_dose,"ANTIOXIDANT, CAPILLARY STABILIZING AGENT, NITRIC OXIDE SCAVENGER",AKR1C3,"JOINT PAIN, NASAL CONGESTION, CONSTIPATION, IRRITABILITY, ALLERGIC RHINITIS",,LAUNCHED,,Small molecule,2,"C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O;C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3C(OC4CC(O)CC(O)C4C3=O)-C3CCC(O)C(O)C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3C(OC4CC(O)CC(O)C4C3=O)-C3CCC(O)C(O)C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3C(OC4CC(O)CC(O)C4C3=O)-C3CCC(O)C(O)C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O",IKGXIBQEEMLURG-NVPNHPEKSA-N
RUXOLITINIB PHOSPHATE,INC-424;INC424;INCB-018424;INCB-018424 PHOSPHATE;INCB-018424 SALT;INCB-18424;INCB-18424 PHOSPHATE;INCB018424;INCB018424 PHOSPHATE;INCB018424 SALT;JAKAFI;JAKAVI;OPZELURA;RUXOLITINIB;RUXOLITINIB (AS PHOSPHATE);RUXOLITINIB MONOPHOSPHATE;RUXOLITINIB PHOSPHATE,CHEMBL1789941;CHEMBL1795071,GDSC1:206;GDSC2:1507,gdsc,,,,,,,Small molecule,4,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1;N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O,HFNKQEVNSGCOJV-OAHLLOKOSA-N;JFMWPOCYMYGEDM-XFULWGLBSA-N
RUXOLITINIB-(S),RUXOLITINIB-(S),,BRD:BRD-BRD-K19601669-001-03-5;BRD:BRD-K19601669-001-03-5,rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2,,,PRECLINICAL,,,NA,N#CC[C@@H](C1CCCC1)N1CC(CN1)-C1NCNC2[NH]CCC12,
RV1729,RV1729,,BRD:BRD-K00004579-001-01-9,rep_single_dose,PI3K INHIBITOR,,,,,,,NA,,
RVX000222,1044870-39-4;APABETALONE;RVX-000222;RVX-208;RVX000222,CHEMBL2393130,GDSC2:1625,gdsc,,,,,,,Small molecule,3,COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1,NETXMUIMUZJUTB-UHFFFAOYSA-N
RWJ-21757,7-ALLYL-8-OXOGUANOSINE;LOXORIBINE;RWJ 21757;RWJ-21757,CHEMBL292008,BRD:BRD-BRD-K00091711-001-01-2;BRD:BRD-K00091711-001-01-2,rep_primary;rep_single_dose,TOLL-LIKE RECEPTOR AGONIST,TLR7,,,PHASE 1,,Small molecule,-1,"C=CCn1c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c21;NC1NC2N([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C(=O)N(CC=C)C2C(=O)[NH]1, NC1NC2N([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C(=O)N(CC=C)C2C(=O)[NH]1, NC1NC2N([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C(=O)N(CC=C)C2C(=O)[NH]1",VDCRFBBZFHHYGT-IOSLPCCCSA-N
RWJ-50271,RWJ-50271,,BRD:BRD-BRD-K94623186-001-01-5;BRD:BRD-K94623186-001-01-5,rep_primary;rep_single_dose,INTEGRIN INHIBITOR,ICAM1,,,PRECLINICAL,,,NA,CC1C(CNN1-C1NC(CS1)-C1CCCC(C1)C(F)(F)F)C(=O)NCCCO,
RWJ67657,JNJ-3026582;JNJ3026582;RWJ-67657;RWJ67657,CHEMBL190333,BRD:BRD-BRD-K07074923-001-01-5;BRD:BRD-K07074923-001-01-5,rep_primary;rep_single_dose,MAP KINASE INHIBITOR,MAPK14;PTGS2,,,PHASE 1,,Small molecule,1,"OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1;OCCC#CC1NC(C(-C2CCNCC2)N1CCCC1CCCCC1)-C1CCC(F)CC1, OCCC#CC1NC(C(-C2CCNCC2)N1CCCC1CCCCC1)-C1CCC(F)CC1",QSUSKMBNZQHHPA-UHFFFAOYSA-N
TV-1360,FLUOROCYCLOPENTENYLCYTOSINE;RODUCITABINE;RX-3117;TV-1360,CHEMBL2064455,BRD:BRD-BRD-K66213167-001-01-2;BRD:BRD-K66213167-001-01-2,rep_primary;rep_single_dose,"DNA SYNTHESIS INHIBITOR, CDK INHIBITOR",CDK2;DNMT1,,,PHASE 1/PHASE 2,"Multiple values for MOA: {'CDK INHIBITOR, DNA SYNTHESIS INHIBITOR', 'DNA SYNTHESIS INHIBITOR, CDK INHIBITOR'}, defaulting to 'DNA SYNTHESIS INHIBITOR, CDK INHIBITOR'",Small molecule,1,"Nc1ccn([C@@H]2C(F)=C(CO)[C@@H](O)[C@H]2O)c(=O)n1;NC1CCN([C@H]2[C@H](O)[C@H](O)C(CO)=C2F)C(=O)N1, NC1CCN([C@H]2[C@H](O)[C@H](O)C(CO)=C2F)C(=O)N1",QLLGKCJUPWYJON-HLTSFMKQSA-N
RX-821002,RX-821002,,BRD:BRD-A65597028-003-07-3;BRD:BRD-BRD-A65597028-003-07-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C,,,PRECLINICAL,,,NA,"COC1(COC2CCCCC2O1)C1=NCCN1, COC1(COC2CCCCC2O1)C1=NCCN1",
RYUVIDINE,RYUVIDINE,,BRD:BRD-BRD-K06426971-001-02-7;BRD:BRD-K06426971-001-02-7,rep_multi_dose;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,CDK2;CDK4,,,PRECLINICAL,,,NA,"CC1NC2C(S1)C(=O)C=C(NC1CCC(C)CC1)C2=O, CC1NC2C(S1)C(=O)C=C(NC1CCC(C)CC1)C2=O",
S-07662,S-07662,,BRD:BRD-K37635256-001-02-9,rep_single_dose,CAR ANTAGONIST,NR1I3,,,,,,NA,,
S-111,S-111,,BRD:BRD-BRD-K60005752-001-01-9;BRD:BRD-K60005752-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,PARP1,,,PHASE 2,,,NA,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C,
S-14506,S-14506,,BRD:BRD-BRD-K46766488-003-02-0;BRD:BRD-K46766488-003-02-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,,,PRECLINICAL,,,NA,"COC1CCC2CCCC(N3CCN(CCNC(=O)C4CCC(F)CC4)CC3)C2C1, COC1CCC2CCCC(N3CCN(CCNC(=O)C4CCC(F)CC4)CC3)C2C1",
S-17092,S-17092,,BRD:BRD-K00004618-001-01-9,rep_single_dose,PROLYL ENDOPEPTIDASE INHIBITOR,,,,,,,NA,,
S-3304,S 3304;S-3304,CHEMBL297792,BRD:BRD-K00003475-001-01-9,rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,,,,,,Small molecule,1,Cc1ccc(C#Cc2ccc(S(=O)(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)O)s2)cc1,YWCLDDLVLSQGSZ-JOCHJYFZSA-N
S-38093,S-38093,,BRD:BRD-K00003455-001-01-9,rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,,,,,,NA,,
S-ISOPROPYLISOTHIOUREA,S-ISOPROPYLISOTHIOUREA,,BRD:BRD-BRD-K10673031-004-02-0;BRD:BRD-K10673031-004-02-0,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS3,,,PRECLINICAL,,,NA,CC(C)SC(N)=N,
S-METHYLCYSTEINE,S-METHYLCYSTEINE,,BRD:BRD-BRD-K63123526-001-01-2;BRD:BRD-K63123526-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,,CTSD;MGMT,,,PHASE 1,,,NA,"CSC[C@H](N)C(O)=O, CSC[C@H](N)C(O)=O",
S-NITROSOGLUTATHIONE,S-NITROSOGLUTATHIONE,CHEMBL63507,BRD:BRD-BRD-K94780074-001-06-7;BRD:BRD-K94780074-001-06-7,rep_primary;rep_single_dose,NITRIC OXIDE STIMULANT,PTPN1,,,PHASE 1,,Small molecule,NA,"N[C@@H](CCC(=O)N[C@@H](CS[N+][O-])C(=O)NCC(O)=O)C(O)=O, N[C@@H](CCC(=O)N[C@@H](CS[N+][O-])C(=O)NCC(O)=O)C(O)=O;N[C@@H](CCC(=O)N[C@@H](CSN=O)C(=O)NCC(=O)O)C(=O)O",HYHSBSXUHZOYLX-WDSKDSINSA-N
S-SULFO-L-CYSTEINE-SODIUM-SALT,S-SULFO-L-CYSTEINE-SODIUM-SALT,,BRD:BRD-BRD-K59527975-236-01-8,rep_primary,GLUTAMATE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,N[C@@H](CSS(O)(=O)=O)C(O)=O,
S-TRITYL-L-CYSTEINE,NSC-83265;S-TRITYL-L-CYSTEINE,CHEMBL392695,BRD:BRD-K09774593-001-02-9;GDSC1:41,gdsc;rep_single_dose,MITOTIC KINESIN INHIBITOR,,,,,,Small molecule,NA,N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O,DLMYFMLKORXJPO-FQEVSTJZSA-N
S15535,S15535,,BRD:BRD-K00004653-001-01-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,,,,,,,NA,,
S18986,S18986,,BRD:BRD-BRD-K02501528-001-01-1;BRD:BRD-K02501528-001-01-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,GRIA1;GRIA2;GRIA3;GRIA4,,,PHASE 2,,,NA,O=S1(=O)N[C@H]2CCCN2C2CCCCC12,
S1P1-AGONIST-III,S1P1-AGONIST-III,,BRD:BRD-K12745498-001-03-4,rep_single_dose,SPHINGOSINE KINASE INHIBITOR,S1PR1,,,,,,NA,,
S26948,S26948,,BRD:BRD-BRD-K48826825-001-01-8;BRD:BRD-K48826825-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,PPAR RECEPTOR AGONIST,PPARG,,,PRECLINICAL,,,NA,"COC(=O)C(CC1CCC(OCCN2C3CCC(CC3SC2=O)C(=O)C2CCCCC2)CC1)C(=O)OC, COC(=O)C(CC1CCC(OCCN2C3CCC(CC3SC2=O)C(=O)C2CCCCC2)CC1)C(=O)OC",
S4,S4,,BRD:BRD-K96798615-001-02-9,rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA12;CA9,,,,,,NA,,
S49076,S49076,,BRD:BRD-K00003147-001-01-9,rep_single_dose,TYROSINE KINASE INHIBITOR,,,,,,,NA,,
S55746,BCL-201;BCL201;S 055746;S 55746;S-055746;S-55746;S55746,CHEMBL4650448,BRD:BRD-K00091090-001-01-9,rep_single_dose,,,,,,,Unknown,1,,
S63845,S63845,,BRD:BRD-K91876515-001-03-9,rep_single_dose,MCL1 INHIBITOR,,,,,,,NA,,
SA-47,SA-47,,BRD:BRD-K99819791-001-02-9,rep_single_dose,FAAH INHIBITOR,FAAH,,,,,,NA,,
SABUTOCLAX,BI-97C1;SABUTOCLAX,,GDSC2:1849,gdsc,,,,,,,,NA,,
SWEETA,BENZOSULFINIDE;E-954(I);E954;GLUSIDE;INS NO.954(I);INS-954(I);NSC-5349;SACCHARIN;SACCHARINUM;SWEETA,CHEMBL310671,BRD:BRD-BRD-K46493214-001-06-7;BRD:BRD-K46493214-001-06-7,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,CA1;CA12;CA2;CA9,,,LAUNCHED,,Small molecule,3,O=C1NS(=O)(=O)C2CCCCC12;O=C1NS(=O)(=O)c2ccccc21,CVHZOJJKTDOEJC-UHFFFAOYSA-N
SACLOFEN,SACLOFEN,,BRD:BRD-A24122750-001-03-7;BRD:BRD-BRD-A24122750-001-03-7,rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABBR1;GABBR2;KCTD12;KCTD16;KCTD8,,,PRECLINICAL,,,NA,NCC(CS(O)(=O)=O)C1CCC(CL)CC1,
SACUBITRIL,AHU-377;AHU377;SACUBITRIL,CHEMBL3137301,BRD:BRD-BRD-K91456750-238-01-7;BRD:BRD-K91456750-238-01-7,rep_primary;rep_single_dose,NEPRILYSIN INHIBITOR,MME,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,4,"CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O;CCOC(=O)[C@H](C)C[C@@H](CC1CCC(CC1)-C1CCCCC1)NC(=O)CCC(O)=O, CCOC(=O)[C@H](C)C[C@@H](CC1CCC(CC1)-C1CCCCC1)NC(=O)CCC(O)=O",PYNXFZCZUAOOQC-UTKZUKDTSA-N
SACUBITRILAT,LBQ-657;LBQ657;SACUBITRILAT,CHEMBL417007,BRD:BRD-K00003252-001-01-9,rep_single_dose,NEPRILYSIN INHIBITOR,,,,,,Small molecule,-1,C[C@H](C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O)C(=O)O,DOBNVUFHFMVMDB-BEFAXECRSA-N
XADAGO,EMD 1195686;EMD-1195686;SAFINAMIDE;XADAGO,CHEMBL396778,BRD:BRD-BRD-K92613113-066-02-7;BRD:BRD-K92613113-066-02-7,rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, GLUTAMATE INHIBITOR, MONOAMINE OXIDASE INHIBITOR",MAOB,PARKINSON'S DISEASE,,LAUNCHED,"Multiple values for MOA: {'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, GLUTAMATE INHIBITOR, MONOAMINE OXIDASE INHIBITOR', 'DOPAMINE UPTAKE INHIBITOR, GLUTAMATE INHIBITOR, MONOAMINE OXIDASE INHIBITOR'}, defaulting to 'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, GLUTAMATE INHIBITOR, MONOAMINE OXIDASE INHIBITOR'",Small molecule,4,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O;C[C@H](NCC1CCC(OCC2CCCC(F)C2)CC1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N
SPC-100270,DIHYDROSPINGOSINE;DL-ERYTHRO-DIHYDROSPHINGOSINE;NSC-714503;SAFINGOL;SAFINGOL HYDROCHLORIDE;SPC-100270,CHEMBL1442934;CHEMBL448741,BRD:BRD-BRD-K93944989-001-08-0;BRD:BRD-K93944989-001-08-0,rep_primary;rep_single_dose,PKC INHIBITOR,TRPM3,,,PHASE 1,,Small molecule,1,CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO;CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO,OTKJDMGTUTTYMP-ROUUACIJSA-N
SAG,SAG,,BRD:BRD-K99433989-001-02-9,rep_single_dose,SMOOTHENED RECEPTOR AGONIST,SMO;TRPC6,,,,,,NA,,
SAL003,SAL003,,BRD:BRD-A45869167-001-10-0;BRD:BRD-BRD-A45869167-001-10-0,rep_primary;rep_single_dose,EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR,EIF2A,,,PRECLINICAL,,,NA,"CLC1CCC(CC1)NC(=S)NC(C(CL)(CL)CL)NC(=O)\C=C\C1CCCCC1, CLC1CCC(CC1)NC(=S)NC(C(CL)(CL)CL)NC(=O)\C=C\C1CCCCC1, CLC1CCC(CC1)NC(=S)NC(C(CL)(CL)CL)NC(=O)\C=C\C1CCCCC1",
SALAZODINE,SALAZODINE,CHEMBL2105427,BRD:BRD-BRD-K15045219-001-01-8;BRD:BRD-K15045219-001-01-8,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,COc1ccc(NS(=O)(=O)c2ccc(/N=N/c3ccc(O)c(C(=O)O)c3)cc2)nn1;COC1CCC(NS(=O)(=O)C2CCC(CC2)N=NC2CCC(O)C(C2)C(O)=O)NN1,YFUATOCFMCWUEH-FMQUCBEESA-N
SALERMIDE,SALERMIDE,CHEMBL597845,CTRP:616352,ctrp,,,,,,,Small molecule,NA,CC(C(=O)Nc1cccc(/N=C/c2c(O)ccc3ccccc23)c1)c1ccccc1,HQSSEGBEYORUBY-WPWMEQJKSA-N
SALERMIDE:PLX-4032 (12:1 MOL/MOL),SALERMIDE:PLX-4032 (12:1 MOL/MOL),,CTRP:660269,ctrp,,,,,,,,NA,,
SALICYL ALCOHOL GLUCOSIDE,D-(-)-SALICIN;D-SALICIN;D(-)-SALICIN;NSC-5751;SALICIN;SALICINUM;SALICOSIDE;SALICYL ALCOHOL GLUCOSIDE,CHEMBL462997,BRD:BRD-BRD-K64614248-001-12-3;BRD:BRD-K64614248-001-12-3,rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,PHASE 1,,Small molecule,-1,"OC[C@H]1O[C@@H](OC2CCCCC2CO)[C@H](O)[C@@H](O)[C@@H]1O, OC[C@H]1O[C@@H](OC2CCCCC2CO)[C@H](O)[C@@H](O)[C@@H]1O;OCc1ccccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O",NGFMICBWJRZIBI-UJPOAAIJSA-N
SALICYL-ALCOHOL,SALICYL-ALCOHOL,,BRD:BRD-BRD-K08493205-001-04-9;BRD:BRD-K08493205-001-04-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OCC1CCCCC1O,
SALICYLAMIDE,NSC-3115;SALICYLAMIDE,CHEMBL27577,BRD:BRD-BRD-K81130846-001-17-4;BRD:BRD-K81130846-001-17-4,rep_primary;rep_single_dose,ANALGESIC AGENT,,"PAIN RELIEF, FEVER",,LAUNCHED,,Small molecule,-1,NC(=O)c1ccccc1O;NC(=O)C1CCCCC1O,SKZKKFZAGNVIMN-UHFFFAOYSA-N
SALICYLANILIDE,SALICYLANILIDE,CHEMBL82970,BRD:BRD-BRD-K83036479-001-09-2;BRD:BRD-K83036479-001-09-2,rep_primary;rep_single_dose,OTHER ANTIBIOTIC,,,,PRECLINICAL,,Small molecule,-1,"O=C(Nc1ccccc1)c1ccccc1O;OC1CCCCC1C(=O)NC1CCCCC1, OC1CCCCC1C(=O)NC1CCCCC1",WKEDVNSFRWHDNR-UHFFFAOYSA-N
SALICYLIC-ACID,SALICYLIC-ACID,,BRD:BRD-BRD-K93632104-001-17-2,rep_primary,CYCLOOXYGENASE INHIBITOR,AKR1C1;PTGS1;PTGS2,ACNE VULGARIS (AV),,LAUNCHED,,,NA,OC(=O)C1CCCCC1O,
SALIDROSIDE,SALIDROSIDE,CHEMBL465208,BRD:BRD-BRD-K66030860-001-03-6;BRD:BRD-K66030860-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,APP,,,PRECLINICAL,,Small molecule,NA,"OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O;OC[C@H]1O[C@@H](OCCC2CCC(O)CC2)[C@H](O)[C@@H](O)[C@@H]1O, OC[C@H]1O[C@@H](OCCC2CCC(O)CC2)[C@H](O)[C@@H](O)[C@@H]1O",ILRCGYURZSFMEG-RKQHYHRCSA-N
SALINOMYCIN,(4S)-;4-METHYL-;ANTIBIOTIC A-28086 FACTOR A;C-7819B;COMPD-79891;COMPOUND 79891;E716;MONTEBAN;NARASIN;NARASIN A;PROCOXACIN;SALINOMYCIN,CHEMBL1208572;CHEMBL2104423,BRD:BRD-A28301258-001-03-0;BRD:BRD-A28301258-001-04-8;BRD:BRD-BRD-A28301258-001-03-0;BRD:BRD-BRD-A28301258-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C;CC[C@@H](C(=O)O)[C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@]3(C=C[C@@H](O)[C@]4(CC[C@@](C)([C@H]5CC[C@](O)(CC)[C@H](C)O5)O4)O3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C;CC[C@H](C1CC[C@H](C)C(O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)C1O[C@@]2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O, CC[C@H](C1CC[C@H](C)C(O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)C1O[C@@]2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O, CC[C@H](C1CC[C@H](C)C(O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)C1O[C@@]2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O",KQXDHUJYNAXLNZ-XQSDOZFQSA-N;VHKXXVVRRDYCIK-CWCPJSEDSA-N
SALIRASIB,FTS;SALIRASIB,CHEMBL23293,BRD:BRD-BRD-K98453471-001-01-7;BRD:BRD-K98453471-001-01-7,rep_primary;rep_single_dose,MTOR INHIBITOR,TRPA1,,,PHASE 2,,Small molecule,2,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O;CC(C)=CCC\C(C)=C\CC\C(C)=C\CSC1CCCCC1C(O)=O,WUILNKCFCLNXOK-CFBAGHHKSA-N
SALUBRINAL,SALUBRINAL,CHEMBL180127,BRD:BRD-A45107007-001-03-4;BRD:BRD-BRD-A45107007-001-03-4;GDSC1:111,gdsc;rep_primary;rep_single_dose,EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR,EIF2S1,,,PRECLINICAL,,Small molecule,NA,"CLC(CL)(CL)C(NC(=O)\C=C\C1CCCCC1)NC(=S)NC1CCCC2CCCNC12, CLC(CL)(CL)C(NC(=O)\C=C\C1CCCCC1)NC(=S)NC1CCCC2CCCNC12, CLC(CL)(CL)C(NC(=O)\C=C\C1CCCCC1)NC(=S)NC1CCCC2CCCNC12, CLC(CL)(CL)C(NC(=O)\C=C\C1CCCCC1)NC(=S)NC1CCCC2CCCNC12;O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl",LCOIAYJMPKXARU-VAWYXSNFSA-N
SALVIANOLIC-ACID-A,SALVIANOLIC-ACID-A,,BRD:BRD-K00005247-001-01-9,rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,,,,,,,NA,,
SALVIANOLIC-ACID-B,SALVIANOLIC-ACID-B,,BRD:BRD-BRD-K18898553-001-01-1;BRD:BRD-K18898553-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,"EGFR INHIBITOR, METALLOPROTEINASE INHIBITOR",MMP9,,,PHASE 2,"Multiple values for MOA: {'METALLOPROTEINASE INHIBITOR, EGFR INHIBITOR', 'EGFR INHIBITOR, METALLOPROTEINASE INHIBITOR'}, defaulting to 'EGFR INHIBITOR, METALLOPROTEINASE INHIBITOR'",,NA,OC(=O)[C@@H](CC1CCC(O)C(O)C1)OC(=O)\C=C\C1CCC(O)C2O[C@H]([C@H](C(=O)O[C@H](CC3CCC(O)C(O)C3)C(O)=O)C12)C1CCC(O)C(O)C1,
SALVINORIN-A,SALVINORIN-A,,BRD:BRD-BRD-K19284129-001-02-6;BRD:BRD-K19284129-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRD1;OPRK1;OPRM1,,,PHASE 1,,,NA,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)C1CCOC1,
SAM-315,SAM-315,,BRD:BRD-K00004553-001-01-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,,,,NA,,
SAMERIDINE,SAMERIDINE,CHEMBL2104504,BRD:BRD-K00004552-001-01-9,rep_single_dose,OPIOID RECEPTOR MODULATOR,,,,,,Small molecule,-1,CCCCCCN1CCC(C(=O)N(C)CC)(c2ccccc2)CC1,TYWUGCGYWNSRPS-UHFFFAOYSA-N
SANAZOLE,SANAZOLE,,BRD:BRD-BRD-K37747025-001-08-2;BRD:BRD-K37747025-001-08-2,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,COCCNC(=O)CN1CNC(N1)[N+]([O-])=O,
SANCYCLINE,6-DEMETHYL-6-DEOXYTETRACYCLINE;BONOMYCIN;GS 2147;GS-2147;NORCYCLINE;SANCYCLINE,CHEMBL2009312,BRD:BRD-K00003242-001-01-9,rep_single_dose,ANTITUMOR AGENT,,,,,,Small molecule,-1,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4C[C@H]3C[C@@H]12,XDVCLKFLRAWGIT-ADOAZJKMSA-N
SANGIVAMYCIN,SANGIVAMYCIN,CHEMBL101892,BRD:BRD-A64064900-001-02-3;BRD:BRD-BRD-A64064900-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,,,PHASE 1,,Small molecule,NA,NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12;NC(=O)C1CN(C2OC(CO)[C@H](O)[C@@H]2O)C2NCNC(N)C12,OBZJZDHRXBKKTJ-JTFADIMSSA-N
SANGUINARIUM-CHLORIDE,SANGUINARIUM-CHLORIDE,,BRD:BRD-BRD-K66898851-003-03-3;BRD:BRD-K66898851-003-03-3,rep_primary;rep_single_dose,APOPTOSIS STIMULANT,CASP3,,,PHASE 1,,,NA,"C[N+]1CC2C3OCOC3CCC2C2CCC3CC4OCOC4CC3C12, C[N+]1CC2C3OCOC3CCC2C2CCC3CC4OCOC4CC3C12",
SANT-1,SANT-1,,BRD:BRD-BRD-K99741577-001-01-7;BRD:BRD-K99741577-001-01-7,rep_primary;rep_single_dose,SMOOTHENED RECEPTOR ANTAGONIST,SHH;SMO,,,PRECLINICAL,,,NA,"CC1NN(C(C)C1\C=N\N1CCN(CC2CCCCC2)CC1)-C1CCCCC1, CC1NN(C(C)C1\C=N\N1CCN(CC2CCCCC2)CC1)-C1CCCCC1, CC1NN(C(C)C1\C=N\N1CCN(CC2CCCCC2)CC1)-C1CCCCC1",
SANT-2,SANT-2,,BRD:BRD-BRD-K35781423-001-01-6;BRD:BRD-K35781423-001-01-6,rep_primary;rep_single_dose,SMOOTHENED RECEPTOR ANTAGONIST,SHH;SMO,,,PRECLINICAL,,,NA,"CCOC1CC(CC(OCC)C1OCC)C(=O)NC1CCC(CL)C(C1)-C1NC2CCCCC2[NH]1, CCOC1CC(CC(OCC)C1OCC)C(=O)NC1CCC(CL)C(C1)-C1NC2CCCCC2[NH]1",
SAPACITABINE,CS-682;CYC-682;CYC682;SAPACITABINE,CHEMBL2105681,BRD:BRD-K00003214-001-01-9,rep_single_dose,DNA SYNTHESIS INHIBITOR,,,,,,Small molecule,3,CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1,LBGFKUUHOPIEMA-PEARBKPGSA-N
SAPITINIB,AZD-8931;AZD8931;SAPITINIB,CHEMBL2408045,GDSC2:1549,gdsc,,,,,,,Small molecule,2,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,DFJSJLGUIXFDJP-UHFFFAOYSA-N
TETRAHYDROBIOPTERIN,6R-BH4;DAPROPTERIN;DAPROTERIN;R-THBP;SAPROPTERIN;TETRAHYDROBIOPTERIN,CHEMBL1201774,BRD:BRD-BRD-K36859431-300-02-3;BRD:BRD-K36859431-300-02-3,rep_primary;rep_single_dose,PHENYLALANINE 4-HYDROXYLASE STIMULANT,NOS3;PAH;TH;TPH1,HYPERPHENYLALANINEMIA (HPA),,LAUNCHED,,Small molecule,4,"C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)[nH]c(=O)c2N1;C[C@H](O)[C@H](O)[C@H]1CNC2NC(N)NC(O)C2N1, C[C@H](O)[C@H](O)[C@H]1CNC2NC(N)NC(O)C2N1, C[C@H](O)[C@H](O)[C@H]1CNC2NC(N)NC(O)C2N1",FNKQXYHWGSIFBK-RPDRRWSUSA-N
SCH-52852,FORTOVASE;INVIRASE;RO 31-8959/000;RO-31-8959;SAQUINAVIR;SAQUINAVIRUM;SCH-52852,CHEMBL114,BRD:BRD-A26690767-066-01-9;BRD:BRD-BRD-A26690767-066-01-9,rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,CYP3A4,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1;CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC(N)=O)NC(=O)C1CCC2CCCCC2N1, CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@@H](O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC(N)=O)NC(=O)C1CCC2CCCCC2N1",QWAXKHKRTORLEM-UGJKXSETSA-N
XL765,SAR-245409;SAR245409;VOXTALISIB;XL-765;XL765,CHEMBL3545366,BRD:BRD-BRD-K75308783-001-07-0;BRD:BRD-K75308783-001-07-0,rep_primary;rep_single_dose,PI3K INHIBITOR,MTOR;PIK3CG,,,PHASE 1/PHASE 2,,Small molecule,2,CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21;COC1CC(NC2NC3CCCCC3NC2NS(=O)(=O)C2CCC(NC(=O)C3CCC(C)C(OC)C3)CC2)CC(OC)C1,RGHYDLZMTYDBDT-UHFFFAOYSA-N
SAR260301,SAR-260301;SAR260301,CHEMBL3545008,BRD:BRD-K00073070-001-02-9,rep_single_dose,,,,,,,Small molecule,1,,
TG101348,FEDRATINIB;SAR-302503;SAR302503;TG-101348;TG101348,CHEMBL1287853,GDSC1:306,gdsc,,,,,,,Small molecule,4,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,JOOXLOJCABQBSG-UHFFFAOYSA-N
SAR125844,SAR 125844;SAR-125844;SAR125844,CHEMBL3545325,BRD:BRD-K00078317-001-02-9,rep_single_dose,,,,,,,Small molecule,2,,
SAR131675,SAR131675,,BRD:BRD-BRD-K38904395-001-02-3;BRD:BRD-K38904395-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,VEGFR INHIBITOR,FLT4,,,PRECLINICAL,,,NA,CCN1C(N)C(C(=O)NC)C(=O)C2CCC(NC12)C#C[C@@](C)(O)COC,
SAR405,SAR405,,BRD:BRD-BRD-K72868067-001-02-4;BRD:BRD-K72868067-001-02-4,rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3C3,,,PRECLINICAL,,,NA,C[C@@H]1COCCN1C1CC(=O)N2CC[C@H](N(CC3CNCC(CL)C3)C2N1)C(F)(F)F,
SAR405838,MI-77301;SAR 405838;SAR-405838;SAR405838,CHEMBL2381408,BRD:BRD-A16035238-001-01-7;BRD:BRD-BRD-A16035238-001-01-7,rep_primary;rep_single_dose,MDM INHIBITOR,MDM2,,,PHASE 1,,Small molecule,1,"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12;CC(C)(C)C[C@H]1N[C@H]([C@H](C2CCCC(CL)C2F)[C@@]11C(=O)NC2CC(CL)CCC12)C(=O)N[C@H]1CC[C@H](O)CC1, CC(C)(C)C[C@H]1N[C@H]([C@H](C2CCCC(CL)C2F)[C@@]11C(=O)NC2CC(CL)CCC12)C(=O)N[C@H]1CC[C@H](O)CC1, CC(C)(C)CC1NC(C(C2CCCC(CL)C2F)C11C(=O)NC2CC(CL)CCC12)C(=O)NC1CCC(O)CC1",IDKAKZRYYDCJDU-HBMMIIHUSA-N
SAR407899,SAR-407899;SAR407899,CHEMBL3545341,BRD:BRD-BRD-K56912469-003-02-0;BRD:BRD-K56912469-003-02-0,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK1,,,PHASE 2,,Small molecule,2,"Cl.O=c1[nH]ccc2cc(OC3CCNCC3)ccc12;O=C1[NH]CCC2CC(OC3CCNCC3)CCC12, O=C1[NH]CCC2CC(OC3CCNCC3)CCC12",KMNVOGVCCZNVNU-UHFFFAOYSA-N
SAR439859,AMCENESTRANT;SAR-439859;SAR439859,CHEMBL4475463,BRD:BRD-K00091093-001-01-9,rep_single_dose,,,,,,,Small molecule,3,O=C(O)c1ccc2c(c1)CCCC(c1ccc(Cl)cc1Cl)=C2c1ccc(O[C@H]2CCN(CCCF)C2)cc1,KISZAGQTIXIVAR-VWLOTQADSA-N
SARACATINIB,AZ-10353926;AZD-0530;AZD0530;SARACATINIB,CHEMBL217092,BRD:BRD-BRD-K19540840-001-09-4;BRD:BRD-K19540840-001-09-4;CTRP:606035;GDSC1:38,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,SRC INHIBITOR,ABL1;LCK;SRC;YES1,,,PHASE 2/PHASE 3,,Small molecule,3,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1;CN1CCN(CCOC2CC(OC3CCOCC3)C3C(NC4C5OCOC5CCC4CL)NCNC3C2)CC1,OUKYUETWWIPKQR-UHFFFAOYSA-N
SARAFLOXACIN,ABBOTT-57135;SARAFLOXACIN,CHEMBL37858,BRD:BRD-BRD-K08525451-003-05-2;BRD:BRD-K08525451-003-05-2,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,,,LAUNCHED,,Small molecule,-1,"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O;OC(=O)C1CN(-C2CCC(F)CC2)C2CC(N3CCNCC3)C(F)CC2C1=O, OC(=O)C1CN(-C2CCC(F)CC2)C2CC(N3CCNCC3)C(F)CC2C1=O",XBHBWNFJWIASRO-UHFFFAOYSA-N
SARCOSINE,METHYLAMINO-ACETIC ACID;SARCOSINE,CHEMBL304383,BRD:BRD-BRD-K51263939-001-08-6;BRD:BRD-K51263939-001-08-6,rep_primary;rep_single_dose,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",SLC6A9,,,PHASE 2,"Multiple values for MOA: {'GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR', 'GLYCINE TRANSPORTER 1 INHIBITOR'}, defaulting to 'GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR'",Small molecule,2,CNCC(=O)O;CNCC(O)=O,FSYKKLYZXJSNPZ-UHFFFAOYSA-N
SARDOMOZIDE,SARDOMOZIDE,CHEMBL65789,BRD:BRD-K00003165-300-01-9,rep_single_dose,S-ADENOSYLMETHIONINE DECARBOXYLASE INHIBITOR,,,,,,Small molecule,-1,N=C(N)c1cccc2c1CC/C2=N\N=C(N)N,CYPGNVSXMAUSJY-CXUHLZMHSA-N
SR-48968,SAREDUTANT;SR-48968,CHEMBL308148,BRD:BRD-K00091297-001-01-9,rep_single_dose,,,,,,,Small molecule,3,CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1,PGKXDIMONUAMFR-AREMUKBSSA-N
SARI-59-801,SARI-59-801,,BRD:BRD-A92448440-001-01-3;BRD:BRD-BRD-A92448440-001-01-3,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,CCC1NOC(C)C1-C1[NH]C2CCCCC2C1C(O)CN(C)C,
SAROGLITAZAR,SAROGLITAZAR,CHEMBL4297530,BRD:BRD-K79878800-239-02-9,rep_single_dose,PPAR RECEPTOR AGONIST,PPARA;PPARG,,,,,Small molecule,3,CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O,MRWFZSLZNUJVQW-DEOSSOPVSA-N
SIMPARICA,PF-6450567;SAROLANER;SIMPARICA,CHEMBL3137302,BRD:BRD-K00084848-001-01-9,rep_single_dose,,,,,,,Small molecule,-1,CS(=O)(=O)CC(=O)N1CC2(C1)OCc1cc(C3=NO[C@@](c4cc(Cl)c(F)c(Cl)c4)(C(F)(F)F)C3)ccc12,FLEFKKUZMDEUIP-QFIPXVFZSA-N
SARPOGRELATE HYDROCHLORIDE,SARPOGRELATE;SARPOGRELATE HYDROCHLORIDE,CHEMBL52939,BRD:BRD-A34358106-003-01-6;BRD:BRD-BRD-A34358106-003-01-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C,"DIABETES MELLITUS, ANGINA PECTORIS, RAYNAUD'S DISEASE, ATHEROSCLEROSIS, BUERGER'S DISEASE",,LAUNCHED,,Small molecule,3,"COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1;COC1CCCC(CCC2CCCCC2OCC(CN(C)C)OC(=O)CCC(O)=O)C1, COC1CCCC(CCC2CCCCC2OCC(CN(C)C)OC(=O)CCC(O)=O)C1",FFYNAVGJSYHHFO-UHFFFAOYSA-N
SASAPYRINE,BIMOLECULAR ESTER;DISALCID;DISALICYCLIC ACID;NSC-49171;SALICYLIC ACID;SALICYLSALICYLIC ACID;SALSALATE;SASAPYRINE,CHEMBL154111,BRD:BRD-BRD-K48892307-001-04-1;BRD:BRD-K48892307-001-04-1,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,PTGS1;PTGS2,"OSTEOARTHRITIS, RHEUMATOID ARTHRITIS",,LAUNCHED,,Small molecule,4,"O=C(Oc1ccccc1C(=O)O)c1ccccc1O;OC(=O)C1CCCCC1OC(=O)C1CCCCC1O, OC(=O)C1CCCCC1OC(=O)C1CCCCC1O",WVYADZUPLLSGPU-UHFFFAOYSA-N
SATRAPLATIN,BMS-182751;BMY-45594;JM-216;NSC-744226;SATRAPLATIN,CHEMBL3833367,BRD:BRD-BRD-K42497885-001-01-1;BRD:BRD-K42497885-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,,,,PHASE 3,,Small molecule,3,"NC1CCCCC1.CC(=O)O[PT+4](C)(C)(CL)(CL)OC(C)=O, CC(=O)O[PT](N)(CL)(CL)(NC1CCCCC1)OC(C)=O",
VOLITINIB,AZD-6094;AZD6094;HMPL-504;SAVOLITINIB;VOLITINIB,CHEMBL3334567,BRD:BRD-K98028353-001-02-8;GDSC2:1936,gdsc;oncref_1;rep_multi_dose;rep_single_dose,INHIBITOR OF MET,MET,,,PHASE 2,"Multiple values for MOA: {'INHIBITOR OF MET', 'C-MET INHIBITOR'}, defaulting to 'INHIBITOR OF MET'",Small molecule,3,"C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21;C[C@@H](C1CCC2NCCN2C1)N1NNC2NCC(NC12)-C1CNN(C)C1, C[C@@H](C1CCC2NCCN2C1)N1NNC2NCC(NC12)-C1CNN(C)C1",XYDNMOZJKOGZLS-NSHDSACASA-N
SAXAGLIPTIN MONOHYDRATE,BMS-477118;BMS-477118-11;NSC-760407;ONGLYZA;SAXAGLIPTIN;SAXAGLIPTIN HYDRATE;SAXAGLIPTIN MONOHYDRATE,CHEMBL2103745;CHEMBL385517,BRD:BRD-A81513827-001-03-6;BRD:BRD-BRD-A81513827-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2;N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2.O,AFNTWHMDBNQQPX-NHKADLRUSA-N
SB-200646,SB-200646,,BRD:BRD-BRD-K77677632-003-02-6;BRD:BRD-K77677632-003-02-6,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2B;HTR2C,,,PRECLINICAL,,,NA,"CN1CCC2CC(NC(=O)NC3CCCNC3)CCC12, CN1CCC2CC(NC(=O)NC3CCCNC3)CCC12",
SB-202190,SB-202190,CHEMBL278041,BRD:BRD-BRD-K54330070-001-15-4;BRD:BRD-K54330070-001-15-4,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,AKT1;ALOX5;CHEK1;GSK3B;LCK;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;PRKCA;ROCK1;RPS6KB1;SGK1,,,PRECLINICAL,,Small molecule,NA,"Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1;OC1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1, OC1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1, OC1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1",QHKYPYXTTXKZST-UHFFFAOYSA-N
SB-203186,SB-203186,,BRD:BRD-BRD-K27141178-003-07-3;BRD:BRD-K27141178-003-07-3,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR4,,,PRECLINICAL,,,NA,O=C(OCCN1CCCCC1)C1C[NH]C2CCCCC12,
SB-203580,SB-203580,CHEMBL10,BRD:BRD-A37704979-001-10-7;BRD:BRD-BRD-A37704979-001-10-7,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,AKT1;ALOX5;CHEK1;CYP2D6;CYP3A4;GAK;GSK3B;LCK;MAPK1;MAPK10;MAPK11;MAPK12;MAPK14;MAPK8;MAPK9;PRKCA;RAF1;RIPK2;ROCK1;RPS6KB1;SGK1;SRC;TNF,,,PRECLINICAL,,Small molecule,NA,"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1;CS(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1, CS(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1, CS(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1, CS(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1, CS(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1, CS(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCNCC1)-C1CCC(F)CC1",CDMGBJANTYXAIV-UHFFFAOYSA-N
SB-205384,SB-205384,,BRD:BRD-A22707317-001-10-8;BRD:BRD-BRD-A22707317-001-10-8,rep_multi_dose;rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABRA3;GABRA5;GABRA6,,,PRECLINICAL,,,NA,"CC#CCOC(=O)C1C(C)NC2SC3CC(O)CCC3C2C1N, CC#CCOC(=O)C1C(C)NC2SC3CC(O)CCC3C2C1N",
SB-206553,SB-206553,,BRD:BRD-BRD-K36395411-003-02-2;BRD:BRD-K36395411-003-02-2,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C,,,PRECLINICAL,,,NA,"CN1CCC2CC3N(CCC3CC12)C(=O)NC1CCCNC1, CN1CCC2CC3N(CCC3CC12)C(=O)NC1CCCNC1",
SB-216641,SB-216641,,BRD:BRD-BRD-K30867024-003-03-3;BRD:BRD-K30867024-003-03-3,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C,,,PRECLINICAL,,,NA,COC1CCC(NC(=O)C2CCC(CC2)-C2CCC(CC2C)-C2NOC(C)N2)CC1OCCN(C)C,
SB-216763,SB-216763,CHEMBL102714,BRD:BRD-BRD-K59184148-001-21-6;BRD:BRD-K59184148-001-21-6;GDSC1:1025;GDSC2:1025,gdsc;rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,CCNA2;CDK2;GSK3A;GSK3B,,,PRECLINICAL,,Small molecule,NA,"CN1CC(C2=C(C(=O)NC2=O)C2CCC(CL)CC2CL)C2CCCCC12, CN1CC(C2=C(C(=O)NC2=O)C2CCC(CL)CC2CL)C2CCCCC12;Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21",JCSGFHVFHSKIJH-UHFFFAOYSA-N
SB-218078,SB-218078,,BRD:BRD-A06352508-001-03-7;BRD:BRD-BRD-A06352508-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,CHK INHIBITOR,CHEK1,,,PRECLINICAL,,,NA,"O=C1NC(=O)C2C1C1C3CCCCC3N3C4CCC(O4)N4C5CCCCC5C2C4C13, O=C1NC(=O)C2C1C1C3CCCCC3N3C4CCC(O4)N4C5CCCCC5C2C4C13",
SB-218795,SB-218795,,BRD:BRD-BRD-K61097567-001-08-5;BRD:BRD-K61097567-001-08-5,rep_multi_dose;rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR3,,,PRECLINICAL,,,NA,"COC(=O)[C@H](NC(=O)C1CC(NC2CCCCC12)-C1CCCCC1)C1CCCCC1, COC(=O)[C@H](NC(=O)C1CC(NC2CCCCC12)-C1CCCCC1)C1CCCCC1",
SB-221284,SB-221284,,BRD:BRD-BRD-K14807180-001-02-5;BRD:BRD-K14807180-001-02-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C,,,PRECLINICAL,,,NA,CSC1CC2CCN(C(=O)NC3CCCNC3)C2CC1C(F)(F)F,
SB-222200,SB-222200,CHEMBL10284,BRD:BRD-BRD-K04414442-001-08-3;BRD:BRD-K04414442-001-08-3,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR3,,,PRECLINICAL,,Small molecule,NA,"CC[C@H](NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1;CC[C@H](NC(=O)C1C(C)C(NC2CCCCC12)-C1CCCCC1)C1CCCCC1, CC[C@H](NC(=O)C1C(C)C(NC2CCCCC12)-C1CCCCC1)C1CCCCC1",MQNYRKWJSMQECI-QFIPXVFZSA-N
SB-225002,SB-225002,,BRD:BRD-BRD-K61323504-001-04-0;BRD:BRD-K61323504-001-04-0;CTRP:52123,ctrp;rep_multi_dose;rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR2,,,PRECLINICAL,,,NA,"OC1CC(CCC1NC(=O)NC1CCCCC1BR)[N+]([O-])=O, OC1CC(CCC1NC(=O)NC1CCCCC1BR)[N+]([O-])=O",
SB-228357,SB-228357,,BRD:BRD-BRD-K15424032-001-03-6;BRD:BRD-K15424032-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C,,,PRECLINICAL,,,NA,"COC1CC2CCN(C(=O)NC3CC(F)CC(C3)-C3CCCNC3)C2CC1C(F)(F)F, COC1CC2CCN(C(=O)NC3CC(F)CC(C3)-C3CCCNC3)C2CC1C(F)(F)F",
SB-2343,SB-2343,,BRD:BRD-BRD-K98795921-001-01-7;BRD:BRD-K98795921-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PHASE 1,,,NA,CC(C)N1C(C)NC2C(NC(NC12)N1CCOCC1)-C1CNC(N)NC1,
SB-239063,SB-239063,,BRD:BRD-BRD-K82091397-001-03-0;BRD:BRD-K82091397-001-03-0,rep_multi_dose;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK11;MAPK14;PTGS2,,,PRECLINICAL,,,NA,COC1NCCC(N1)-C1C(NCN1[C@H]1CC[C@H](O)CC1)-C1CCC(F)CC1,
SB-242235,SB-242235,CHEMBL95692,BRD:BRD-BRD-K19412355-001-01-0;BRD:BRD-K19412355-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,HSPB1;MAPK14,,,PHASE 1,,Small molecule,NA,COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1;COC1NCCC(N1)-C1C(NCN1C1CCNCC1)-C1CCC(F)CC1,PDTYLGXVBIWRIM-UHFFFAOYSA-N
SB-243213,SB-243213,CHEMBL14460,BRD:BRD-BRD-K99968849-300-01-4;BRD:BRD-K99968849-300-01-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR INVERSE AGONIST,HTR2A;HTR2B;HTR2C;HTR6,,,PHASE 1,,Small molecule,NA,Cc1cc2c(cc1C(F)(F)F)N(C(=O)Nc1ccc(Oc3cccnc3C)nc1)CC2;CC1CC2CCN(C(=O)NC3CCC(OC4CCCNC4C)NC3)C2CC1C(F)(F)F,ZETBBVYSBABLHL-UHFFFAOYSA-N
SB-258585,SB-258585,,BRD:BRD-BRD-K80639402-003-02-9;BRD:BRD-K80639402-003-02-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR6,,,PRECLINICAL,,,NA,COC1CCC(NS(=O)(=O)C2CCC(I)CC2)CC1N1CCN(C)CC1,
SB-268262,SB-268262,,BRD:BRD-A91031770-001-01-8;BRD:BRD-BRD-A91031770-001-01-8,rep_primary;rep_single_dose,CALCITONIN ANTAGONIST,CALCA,,,PRECLINICAL,,,NA,CN(C(=O)C1CCC(C(C1)[N+]([O-])=O)S(=O)C1NCCS1)C1CCCCC1C,
SB-269970,SB-269970,,BRD:BRD-BRD-K24201553-003-11-5;BRD:BRD-K24201553-003-11-5,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR7,,,PRECLINICAL,,,NA,"CC1CCN(CC[C@H]2CCCN2S(=O)(=O)C2CCCC(O)C2)CC1, CC1CCN(CC[C@H]2CCCN2S(=O)(=O)C2CCCC(O)C2)CC1, CC1CCN(CC[C@H]2CCCN2S(=O)(=O)C2CCCC(O)C2)CC1",
SB-271046,SB-271046,,BRD:BRD-BRD-K82467063-001-02-7;BRD:BRD-K82467063-001-02-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR6,,,PHASE 1,,,NA,"COC1CCC(NS(=O)(=O)C2SC3CCC(CL)CC3C2C)CC1N1CCNCC1, COC1CCC(NS(=O)(=O)C2SC3CCC(CL)CC3C2C)CC1N1CCNCC1",
SB-297006,SB-297006,,BRD:BRD-K16107558-001-02-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR3,,,,,,NA,,
SB-328437,SB-328437,,BRD:BRD-BRD-K78720403-001-01-6;BRD:BRD-K78720403-001-01-6,rep_primary;rep_single_dose,CCR ANTAGONIST,,,,PRECLINICAL,,,NA,"COC(=O)[C@H](CC1CCC(CC1)[N+]([O-])=O)NC(=O)C1CCCC2CCCCC12, COC(=O)[C@H](CC1CCC(CC1)[N+]([O-])=O)NC(=O)C1CCCC2CCCCC12",
SB-334867,SB-334867,,BRD:BRD-BRD-K41567364-001-04-6;BRD:BRD-K41567364-001-04-6,rep_primary;rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR1;HCRTR2,,,PRECLINICAL,,,NA,"CC1NC2CCC(NC(=O)NC3CCNC4CCCNC34)CC2O1, CC1NC2CCC(NC(=O)NC3CCNC4CCCNC34)CC2O1",
SB-366791,SB-366791,,BRD:BRD-BRD-K61536336-001-01-7;BRD:BRD-K61536336-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,TRPV ANTAGONIST,TRPV1,,,PRECLINICAL,,,NA,"COC1CCCC(NC(=O)\C=C\C2CCC(CL)CC2)C1, COC1CCCC(NC(=O)\C=C\C2CCC(CL)CC2)C1",
SB-399885,SB-399885,CHEMBL1210710,BRD:BRD-BRD-K03988082-001-01-7;BRD:BRD-K03988082-001-01-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR6,,,PRECLINICAL,,Small molecule,NA,COC1CCC(CC1N1CCNCC1)S(=O)(=O)NC1CC(CL)CC(CL)C1OC;COc1ccc(S(=O)(=O)Nc2cc(Cl)cc(Cl)c2OC)cc1N1CCNCC1,ATKZKAYWARYLBW-UHFFFAOYSA-N
SB-408124,SB-408124,,BRD:BRD-BRD-K53913732-001-05-9;BRD:BRD-K53913732-001-05-9,rep_primary;rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR1;HCRTR2,,,PRECLINICAL,,,NA,"CN(C)C1CCC(NC(=O)NC2CC(C)NC3C(F)CC(F)CC23)CC1, CN(C)C1CCC(NC(=O)NC2CC(C)NC3C(F)CC(F)CC23)CC1, CN(C)C1CCC(NC(=O)NC2CC(C)NC3C(F)CC(F)CC23)CC1, CN(C)C1CCC(NC(=O)NC2CC(C)NC3C(F)CC(F)CC23)CC1",
SB-415286,SB-415286,,BRD:BRD-BRD-K76805682-001-15-9;BRD:BRD-K76805682-001-15-9,rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3A;GSK3B;RPS6KB1,,,PRECLINICAL,,,NA,"OC1CCC(NC2=C(C(=O)NC2=O)C2CCCCC2[N+]([O-])=O)CC1CL, OC1CCC(NC2=C(C(=O)NC2=O)C2CCCCC2[N+]([O-])=O)CC1CL, OC1CCC(NC2=C(C(=O)NC2=O)C2CCCCC2[N+]([O-])=O)CC1CL",
SB-431542,SB-431542,CHEMBL440084,BRD:BRD-BRD-K67298865-001-09-0;BRD:BRD-K67298865-001-09-0;CTRP:50753,ctrp;rep_multi_dose;rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,ACVR1C;TGFBR1,,,PRECLINICAL,,Small molecule,NA,"NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1;NC(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCCCN1)-C1CCC2OCOC2C1, NC(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCCCN1)-C1CCC2OCOC2C1, NC(=O)C1CCC(CC1)-C1NC(C([NH]1)-C1CCCCN1)-C1CCC2OCOC2C1",FHYUGAJXYORMHI-UHFFFAOYSA-N
SB-452533,SB-452533,,BRD:BRD-K03665769-001-02-9,rep_single_dose,TRPV ANTAGONIST,TRPV1,,,,,,NA,,
SB-505124,SB-505124,,BRD:BRD-BRD-K40109029-001-02-9;BRD:BRD-K40109029-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,ALK TYROSINE KINASE RECEPTOR INHIBITOR,TGFBR1,,,PRECLINICAL,,,NA,CC1CCCC(N1)-C1[NH]C(NC1-C1CCC2OCOC2C1)C(C)(C)C,
SB-525334,SB-525334,,BRD:BRD-BRD-K37720887-001-07-8;BRD:BRD-K37720887-001-07-8;CTRP:639962,ctrp;rep_multi_dose;rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,TGFBR1,,,PRECLINICAL,,,NA,"CC1CCCC(N1)-C1[NH]C(NC1-C1CCC2NCCNC2C1)C(C)(C)C, CC1CCCC(N1)-C1[NH]C(NC1-C1CCC2NCCNC2C1)C(C)(C)C",
SB590885,SB-590885;SB590885,CHEMBL477989,BRD:BRD-BRD-K78809024-001-05-7;BRD:BRD-K78809024-001-05-7;GDSC1:1061,gdsc;rep_multi_dose;rep_primary;rep_single_dose,RAF INHIBITOR,BRAF,,,PRECLINICAL,,Small molecule,NA,"CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1;CN(C)CCOC1CCC(CC1)-C1NC(C([NH]1)-C1CCC2C(CC\C2=N/O)C1)-C1CCNCC1, CN(C)CCOC1CCC(CC1)-C1NC(C([NH]1)-C1CCC2C(CC\C2=N/O)C1)-C1CCNCC1, CN(C)CCOC1CCC(CC1)-C1NC(C([NH]1)-C1CCC2C(CC\C2=N/O)C1)-C1CCNCC1",MLSAQOINCGAULQ-QFMPWRQOSA-N
SB-612111,SB-612111,,BRD:BRD-K08333979-003-02-9,rep_single_dose,NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST,OPRL1,,,,,,NA,,
SB-649868,GSK649868;SB-649868,CHEMBL1272307,BRD:BRD-K00003485-001-01-9,rep_single_dose,OREXIN RECEPTOR ANTAGONIST,,,,,,Small molecule,2,Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1,ZJXIUGNEAIHSBI-IBGZPJMESA-N
SB-657510,SB-657510,,BRD:BRD-BRD-K95292280-001-01-3;BRD:BRD-K95292280-001-01-3,rep_multi_dose;rep_primary;rep_single_dose,UROTENSIN RECEPTOR ANTAGONIST,UTS2R,,,PRECLINICAL,,,NA,"COC1CC(BR)C(CC1OC)S(=O)(=O)NC1CCC(CL)C(O[C@@H]2CCN(C)C2)C1, COC1CC(BR)C(CC1OC)S(=O)(=O)NC1CCC(CL)C(O[C@@H]2CCN(C)C2)C1",
SB-683698,SB-683698,,BRD:BRD-BRD-K24968862-001-01-0;BRD:BRD-K24968862-001-01-0,rep_primary;rep_single_dose,INTEGRIN ANTAGONIST,ITGA4;ITGAV;ITGB1;ITGB7,,,PHASE 1,,,NA,COC1CCCC(OC)C1-C1CCC(C[C@H](NC(=O)C2C(CL)CCCC2CL)C(O)=O)CC1,
SB-705498,GSK705498;SB-705498,CHEMBL207433,BRD:BRD-BRD-K65991129-001-02-9;BRD:BRD-K65991129-001-02-9,rep_primary;rep_single_dose,TRPV ANTAGONIST,TRPV1,,,PHASE 2,,Small molecule,2,FC(F)(F)C1CCC(NC1)N1CC[C@H](C1)NC(=O)NC1CCCCC1BR;O=C(Nc1ccccc1Br)N[C@@H]1CCN(c2ccc(C(F)(F)F)cn2)C1,JYILLRHXRVTRSH-GFCCVEGCSA-N
SB-706375,SB-706375,,BRD:BRD-BRD-K68633027-001-01-9;BRD:BRD-K68633027-001-01-9,rep_primary;rep_single_dose,UROTENSIN RECEPTOR ANTAGONIST,UTS2R,,,PRECLINICAL,,,NA,COC1CC(BR)C(CC1OC)S(=O)(=O)NC1CCC(C(O[C@@H]2CCN(C)C2)C1)C(F)(F)F,
SB-742457,GSK-742457;GSK742457;INTEPIRDINE;RVT-101;SB-742457,CHEMBL1083390,BRD:BRD-BRD-K78941306-001-02-4;BRD:BRD-K78941306-001-02-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR6,,,PHASE 3,,Small molecule,3,"O=S(=O)(C1CCCCC1)C1CNC2C(CCCC2C1)N1CCNCC1, O=S(=O)(C1CCCCC1)C1CNC2C(CCCC2C1)N1CCNCC1;O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1",JJZFWROHYSMCMU-UHFFFAOYSA-N
SB-743921 FREE BASE,SB 743921;SB-743921;SB-743921 FREE BASE,CHEMBL2325429,BRD:BRD-BRD-K68532323-003-02-8;BRD:BRD-K68532323-003-02-8;CTRP:660238,ctrp;rep_multi_dose;rep_primary;rep_single_dose,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,KIF11,,,PHASE 1/PHASE 2,,Small molecule,1,"CC(C)[C@@H](N(CCCN)C(=O)C1CCC(C)CC1)C1OC2CC(CL)CCC2C(=O)C1CC1CCCCC1, CC(C)[C@@H](N(CCCN)C(=O)C1CCC(C)CC1)C1OC2CC(CL)CCC2C(=O)C1CC1CCCCC1;Cc1ccc(C(=O)N(CCCN)[C@@H](c2oc3cc(Cl)ccc3c(=O)c2Cc2ccccc2)C(C)C)cc1",PGXYIBJJCLWJST-MUUNZHRXSA-N
SB-747651A,SB-747651A,,BRD:BRD-BRD-K49597925-300-01-9;BRD:BRD-K49597925-300-01-9,rep_primary;rep_single_dose,KINASE INHIBITOR,AKT1;AKT3;ROCK1;RPS6KA5;RPS6KB1,,,PRECLINICAL,,,NA,CCN1C(NC2CNCC(CNC3CCNCC3)C12)-C1NONC1N,
SB-756050,SB-050;SB-756050,CHEMBL4303545,BRD:BRD-BRD-K45168550-001-01-9;BRD:BRD-K45168550-001-01-9,rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,GPBAR1,,,PHASE 1,,Small molecule,1,COC1CCC(CC1OC)S(=O)(=O)N1CCCN(CC1)S(=O)(=O)C1CCC(OC)C(OC)C1;COc1ccc(S(=O)(=O)N2CCCN(S(=O)(=O)c3ccc(OC)c(OC)c3)CC2)cc1OC,GJUFPAZNBPFNRI-UHFFFAOYSA-N
SB-772077B,SB-772077B,,BRD:BRD-BRD-K49110935-300-01-9;BRD:BRD-K49110935-300-01-9,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK1;ROCK2,,,PRECLINICAL,,,NA,CCN1C(NC2CNCC(C(=O)N3CC[C@H](N)C3)C12)-C1NONC1N,
SB939,PRACINOSTAT;SB 939;SB-939;SB939,CHEMBL1851943,BRD:BRD-BRD-K86797399-001-04-4;BRD:BRD-BRD-K86797399-001-05-1;BRD:BRD-K86797399-001-04-4;BRD:BRD-K86797399-001-05-1,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC10;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC9,,,PHASE 2,"Multiple values for repurposing_target: {'HDAC1;HDAC10;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC9', 'HDAC1;HDAC10;HDAC3;HDAC4;HDAC5;HDAC9'}, taking the union",Small molecule,3,"CCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC;CCCCC1NC2CC(CCC2N1CCN(CC)CC)\C=C\C(=O)NO, CCCCC1NC2CC(CCC2N1CCN(CC)CC)\C=C\C(=O)NO",JHDKZFFAIZKUCU-ZRDIBKRKSA-N
SB216763,SB 216763;SB216763,,GDSC1:1025;GDSC2:1025,gdsc,,,,,,,,NA,,
SB505124,SB 505124;SB505124,,GDSC1:1194;GDSC1:476;GDSC2:1194,gdsc,,,,,,,,NA,,
SB52334,SB 52334;SB-52334;SB52334,,GDSC1:304,gdsc,,,,,,,,NA,,
SB590885,SB-590885;SB590885,CHEMBL477989,GDSC1:1061,gdsc,,,,,,,Small molecule,NA,CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1,MLSAQOINCGAULQ-QFMPWRQOSA-N
SBE-13,SBE-13,,BRD:BRD-BRD-K71667152-003-09-8;BRD:BRD-K71667152-003-09-8,rep_primary;rep_single_dose,PLK INHIBITOR,PLK1,,,PRECLINICAL,,,NA,COC1CCC(CCNCC2CCC(OCC3CCC(CL)NC3)C(OC)C2)CC1OC,
SBHA,SBHA,,BRD:BRD-K54729176-001-03-9,rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC3,,,,,,NA,,
SBI-115,SBI-115,,BRD:BRD-K00005340-001-01-9,rep_single_dose,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,,,,,,,NA,,
SC-10,SC-10,,BRD:BRD-BRD-K05361803-001-03-9;BRD:BRD-K05361803-001-03-9,rep_primary;rep_single_dose,PROTEIN KINASE ACTIVATOR,PRKCA,,,PRECLINICAL,,,NA,CCCCCCCNS(=O)(=O)C1CCCC2C(CL)CCCC12,
VIDOFLUDIMUS,4SC-101;IMU-838;NSC-717824;SC-12267;SC12267;VIDOFLUDIMUS,CHEMBL197194,BRD:BRD-BRD-K40797222-001-01-8;BRD:BRD-K40797222-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,IL17A,,,PHASE 2,,Small molecule,3,COc1cccc(-c2ccc(NC(=O)C3=C(C(=O)O)CCC3)c(F)c2)c1;COC1CCCC(C1)-C1CCC(NC(=O)C2=C(CCC2)C(O)=O)C(F)C1,XPRDUGXOWVXZLL-UHFFFAOYSA-N
SC-144,SC-144,,BRD:BRD-BRD-K55305701-001-01-2;BRD:BRD-K55305701-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,P GLYCOPROTEIN INHIBITOR,,,,PRECLINICAL,,,NA,"FC1CCC2C(C1)NC(NNC(=O)C1CNCCN1)C1CCCN21, FC1CCC2C(C1)NC(NNC(=O)C1CNCCN1)C1CCCN21, FC1CCC2C(C1)NC(NNC(=O)C1CNCCN1)C1CCCN21",
SC-19220,SC-19220,,BRD:BRD-BRD-K52512893-001-08-9;BRD:BRD-K52512893-001-08-9,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGER1,,,PRECLINICAL,,,NA,"CC(=O)NNC(=O)N1CC2CCCCC2OC2CCC(CL)CC12, CC(=O)NNC(=O)N1CC2CCCCC2OC2CCC(CL)CC12",
SC-236,SC-236,,BRD:BRD-BRD-K76365178-001-01-5;BRD:BRD-K76365178-001-01-5,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS2,,,PRECLINICAL,,,NA,NS(=O)(=O)C1CCC(CC1)-N1NC(CC1-C1CCC(CL)CC1)C(F)(F)F,
SC-51089,SC-51089,,BRD:BRD-K62715847-003-02-9,rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,PTGER1,,,,,,NA,,
SC-560,SC-560,CHEMBL26915,BRD:BRD-BRD-K14767410-001-02-3;BRD:BRD-K14767410-001-02-3,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1,,,PRECLINICAL,,Small molecule,NA,"COc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1;COC1CCC(CC1)-N1NC(CC1-C1CCC(CL)CC1)C(F)(F)F, COC1CCC(CC1)-N1NC(CC1-C1CCC(CL)CC1)C(F)(F)F",PQUGCKBLVKJMNT-UHFFFAOYSA-N
SC-9,SC-9,,BRD:BRD-BRD-K25875056-001-02-0;BRD:BRD-K25875056-001-02-0,rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE ACTIVATOR,PRKCA,,,PRECLINICAL,,,NA,"CLC1CCCC2C(CCCC12)S(=O)(=O)NCCCCCCC1CCCCC1, CLC1CCCC2C(CCCC12)S(=O)(=O)NCCCCCCC1CCCCC1",
SC79,SC79,,BRD:BRD-K00126778-001-01-9,oncref_2,ACTIVATOR OF AKT,AKT1;AKT2;AKT3,,,,,,NA,,
SCABERTOPIN,SCABERTOPIN,,BRD:BRD-K00005327-001-01-9,rep_single_dose,ANTICANCER AGENT,,,,,,,NA,,
SCH-202676,SCH-202676,,BRD:BRD-K29562203-004-12-9,rep_single_dose,G PROTEIN-COUPLED RECEPTOR MODULATOR,CHRM1;CHRM2;DRD1;DRD2,,,,,,NA,,
SCH-221510,SCH-221510,,BRD:BRD-K00004286-001-01-9,rep_single_dose,NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST,OPRL1,,,,,,NA,,
SCH-23390,SCH-23390,CHEMBL62,BRD:BRD-BRD-K45435259-003-11-1;BRD:BRD-K45435259-003-11-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD5;HTR2C;KCNJ4;KCNJ6,,,PRECLINICAL,,Small molecule,NA,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1;CN1CCC2CC(CL)C(O)CC2[C@H](C1)C1CCCCC1,GOTMKOSCLKVOGG-OAHLLOKOSA-N
SCH-28080,SCH-28080,,BRD:BRD-BRD-K55748775-001-02-2;BRD:BRD-K55748775-001-02-2,rep_primary;rep_single_dose,ATPASE INHIBITOR,ATP4A,,,PHASE 1,,,NA,CC1NC2C(OCC3CCCCC3)CCCN2C1CC#N,
SCH-51344,SCH-51344,,BRD:BRD-K02460719-001-02-9,rep_single_dose,MTH1 INHIBITOR,NUDT1,,,,,,NA,,
SCH-529074,SCH-529074,,CTRP:609062,ctrp,,,,,,,,NA,,
SCH-58261,SCH-58261,CHEMBL17127,BRD:BRD-BRD-K81225797-001-02-3;BRD:BRD-K81225797-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,,Small molecule,NA,"Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12;NC1NC2N(CCC3CCCCC3)NCC2C2NC(NN12)-C1CCCO1, NC1NC2N(CCC3CCCCC3)NCC2C2NC(NN12)-C1CCCO1",UTLPKQYUXOEJIL-UHFFFAOYSA-N
SCH-79797,SCH-79797,,CTRP:375264,ctrp,,,,,,,,NA,,
SCH-900776,MK-8776;SCH 900776;SCH-900776,CHEMBL2386889,BRD:BRD-BRD-K75009076-001-02-1;BRD:BRD-K75009076-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,CHK INHIBITOR,CDK2;CHEK1,,,PHASE 2,,Small molecule,2,"Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1;CN1CC(CN1)-C1CNN2C(N)C(BR)C(NC12)[C@@H]1CCCNC1, CN1CC(CN1)-C1CNN2C(N)C(BR)C(NC12)[C@@H]1CCCNC1",GMIZZEXBPRLVIV-SECBINFHSA-N
SCH727965,DINACICLIB;MK-7965;SCH 727965;SCH-727-965;SCH-727965;SCH727965,CHEMBL2103840,GDSC2:1180,gdsc,,,,,,,Small molecule,3,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,PIMQWRZWLQKKBJ-SFHVURJKSA-N
SCH772984,CS-1421;SCH772984,,GDSC2:1564,gdsc,,,,,,,,NA,,
SCH900776,MK-8776;SCH 900776;SCH-900776;SCH900776,CHEMBL2386889,GDSC2:2046,gdsc,,,,,,,Small molecule,2,Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1,GMIZZEXBPRLVIV-SECBINFHSA-N
SCHISANDRIN-B,SCHISANDRIN-B,,BRD:BRD-BRD-K86294588-001-01-9;BRD:BRD-K86294588-001-01-9,rep_primary;rep_single_dose,ANTIOXIDANT,ATR,,,PRECLINICAL,,,NA,COC1CC2C[C@H](C)[C@@H](C)CC3CC4OCOC4C(OC)C3-C2C(OC)C1OC,
SCHISANDROL-B,SCHISANDROL-B,,BRD:BRD-BRD-K18878288-001-06-4;BRD:BRD-K18878288-001-06-4,rep_primary;rep_single_dose,LIPID PEROXIDASE INHIBITOR,,,,PHASE 3,,,NA,"COC1CC2C[C@](C)(O)[C@@H](C)CC3CC4OCOC4C(OC)C3-C2C(OC)C1OC, COC1CC2C[C@](C)(O)[C@@H](C)CC3CC4OCOC4C(OC)C3-C2C(OC)C1OC",
SCLAREOL,SCLAREOL,CHEMBL294740,BRD:BRD-A23127772-001-02-3;BRD:BRD-BRD-A23127772-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,NA,C=C[C@](C)(O)CC[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2CC[C@@]1(C)O;CC(O)(CC[C@H]1[C@](C)(O)CCC2C(C)(C)CCC[C@]12C)C=C,XVULBTBTFGYVRC-HHUCQEJWSA-N
SCLAREOLIDE,SCLAREOLIDE,,BRD:BRD-BRD-K72925150-001-11-1;BRD:BRD-K72925150-001-11-1,rep_primary;rep_single_dose,OTHER ANTIFUNGAL,,,,LAUNCHED,,,NA,"C[C@@]12CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]1CC(=O)O2, C[C@@]12CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]1CC(=O)O2",
SCMC-LYS,SCMC-LYS,,BRD:BRD-BRD-K33809398-001-01-8;BRD:BRD-K33809398-001-01-8,rep_primary;rep_single_dose,MUCOLYTIC AGENT,GSTP1,,,LAUNCHED,,,NA,"N[C@@H](CSCC(O)=O)C(O)=O, N[C@@H](CSCC(O)=O)C(O)=O",
SCOPINE,SCOPINE,,BRD:BRD-BRD-K75923785-003-02-1;BRD:BRD-K75923785-003-02-1,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,"CN1[C@H]2C[C@H](O)C[C@@H]1[C@H]1O[C@@H]21, CN1[C@H]2C[C@H](O)C[C@@H]1[C@H]1O[C@@H]21",
TRANSDERM SCOP,ISOPTPO HYOSCINE;SCOPOLAMINE;TRANSDERM SCOP,CHEMBL1187846;CHEMBL569713,BRD:BRD-BRD-K64990126-004-01-1;BRD:BRD-K64990126-004-01-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,"MOTION SICKNESS, VOMITING, NAUSEA",,LAUNCHED,,Small molecule,4,"CN1[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12;CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1CCCCC1, CN1[C@H]2C[C@H](C[C@@H]1[C@@H]1O[C@H]21)OC(=O)[C@H](CO)C1CCCCC1, CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1CCCCC1",STECJAGHUSJQJN-FWXGHANASA-N
SCOPOLAMINE-N-OXIDE,SCOPOLAMINE-N-OXIDE,,BRD:BRD-A49906757-004-09-8;BRD:BRD-BRD-A49906757-004-09-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;SI,,,PRECLINICAL,,,NA,C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1CCCCC1,
SCP-1,SCP-1,,BRD:BRD-BRD-K20548681-001-01-3;BRD:BRD-K20548681-001-01-3,rep_primary;rep_single_dose,ANALGESIC AGENT,,,,PHASE 1,,,NA,OC1CCC(NC(=O)CN2C(=O)C3CCCCC3S2(=O)=O)CC1,
SJ000016636,GNF-PF-2024;SCRIPTAID;SJ000016636,CHEMBL96051,BRD:BRD-BRD-K22503835-001-11-0;BRD:BRD-K22503835-001-11-0,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9,,,PRECLINICAL,,Small molecule,NA,"O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO;ONC(=O)CCCCCN1C(=O)C2CCCC3CCCC(C1=O)C23, ONC(=O)CCCCCN1C(=O)C2CCCC3CCCC(C1=O)C23",JTDYUFSDZATMKU-UHFFFAOYSA-N
SCS,SCS,,BRD:BRD-BRD-K78496197-001-03-9;BRD:BRD-K78496197-001-03-9,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"OC1CCCCC1\C=N\NC(=O)C1CCCCC1O, OC1CCCCC1\C=N\NC(=O)C1CCCCC1O",
SD0006,SD-0006;SD-06;SD0006,CHEMBL1090173,BRD:BRD-K00003093-001-01-9,rep_single_dose,P38 MAPK INHIBITOR,,,,,,Small molecule,1,O=C(CO)N1CCC(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1,CATQHDWESBRRQA-UHFFFAOYSA-N
SD-169,SD-169,,BRD:BRD-BRD-K91904471-001-02-4;BRD:BRD-K91904471-001-02-4,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK14,,,PRECLINICAL,,,NA,NC(=O)C1CCC2[NH]CCC2C1,
SD-208,SD-208,,BRD:BRD-BRD-K24566386-001-01-9;BRD:BRD-K24566386-001-01-9,rep_primary;rep_single_dose,TGF BETA RECEPTOR INHIBITOR,TGFBR1,,,PRECLINICAL,,,NA,"FC1CCC(CL)CC1-C1NC(NC2CCNCC2)C2NCCNC2N1, FC1CCC(CL)CC1-C1NC(NC2CCNCC2)C2NCCNC2N1",
SD-2590,SD-2590,,BRD:BRD-K51102532-003-02-9,rep_single_dose,MATRIX METALLOPROTEASE INHIBITOR,MMP1;MMP13;MMP2,,,,,,NA,,
SDM25N,SDM25N,,BRD:BRD-A75769826-003-02-1;BRD:BRD-BRD-A75769826-003-02-1,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,OPRD1,,,PRECLINICAL,,,NA,"CC(=C)CN1CC[C@@]23[C@H]4OC5C2C(CC1[C@]3(O)CC1C4[NH]C2CCCCC12)CCC5O, CC(=C)CN1CC[C@@]23[C@H]4OC5C2C(CC1[C@]3(O)CC1C4[NH]C2CCCCC12)CCC5O, CC(=C)CN1CC[C@@]23[C@H]4OC5C2C(CC1[C@]3(O)CC1C4[NH]C2CCCCC12)CCC5O",
SDZ-205-557,SDZ-205-557,,BRD:BRD-BRD-K15868788-003-07-7;BRD:BRD-K15868788-003-07-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A;HTR3B,,,PRECLINICAL,,,NA,CCN(CC)CCOC(=O)C1CC(CL)C(N)CC1OC,
SDZ-21009,SDZ-21009,,BRD:BRD-A15530910-001-02-1;BRD:BRD-BRD-A15530910-001-02-1,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",HTR1A;HTR1B,,,PRECLINICAL,,,NA,CC(C)OC(=O)C1CC2C(OCC(O)CNC(C)(C)C)CCCC2[NH]1,
SDZ-220-040,SDZ-220-040,,BRD:BRD-K82266792-001-03-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1,,,,,,NA,,
SDZ-220-581,SDZ-220-581,,BRD:BRD-BRD-K27168049-001-02-8;BRD:BRD-K27168049-001-02-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN1,,,PRECLINICAL,,,NA,"N[C@@H](CC1CC(CP(O)(O)=O)CC(C1)-C1CCCCC1CL)C(O)=O, N[C@@H](CC1CC(CP(O)(O)=O)CC(C1)-C1CCCCC1CL)C(O)=O",
SDZ-MKS 492,SDZ-MKS 492,,BRD:BRD-K00076721-001-02-9,rep_single_dose,,,,,,,,NA,,
SDZ-NKT-343,SDZ-NKT-343,,BRD:BRD-BRD-K65820248-001-01-8;BRD:BRD-K65820248-001-01-8,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR1,,,PHASE 1,,,NA,"CN(CC1CCCCC1)C(=O)[C@H](CC1CCC2CCCCC2C1)NC(=O)[C@@H]1CCCN1C(=O)NC1CCCCC1[N+]([O-])=O, CN(CC1CCCCC1)C(=O)[C@H](CC1CCC2CCCCC2C1)NC(=O)[C@@H]1CCCN1C(=O)NC1CCCCC1[N+]([O-])=O",
SDZ-SER-082,SDZ-SER-082,,BRD:BRD-K31339597-051-03-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C,,,,,,NA,,
SDZ-WAG-994,SDZ-WAG-994,,BRD:BRD-BRD-K39558284-001-01-2;BRD:BRD-K39558284-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1,,,PHASE 2,,,NA,"CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1CNC2C(NC3CCCCC3)NCNC12, CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1CNC2C(NC3CCCCC3)NCNC12",
SE-METHYLSELENOCYSTEINE,SE-METHYLSELENOCYSTEINE,,BRD:BRD-BRD-K74227499-001-01-1;BRD:BRD-K74227499-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,"C[SE]C[C@H](N)C(O)=O, C[SE]C[C@H](N)C(O)=O",
SECALCIFEROL,"24;24(R),25-(OH)2D3;25-DIHYDROXYCHOLECALCIFEROL;OSTEO D;SECALCIFEROL",CHEMBL1590076,BRD:BRD-BRD-K02965577-001-03-4;BRD:BRD-K02965577-001-03-4,rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,BONE FRACTURE,,LAUNCHED,,Small molecule,-1,C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C;C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CC[C@@H](O)C(C)(C)O)CC[C@@H]12,FCKJYANJHNLEEP-XRWYNYHCSA-N
W-2354,NSC-294833;SECLAZONE;W-2352;W-2354,CHEMBL2105593,BRD:BRD-A53472930-001-01-7;BRD:BRD-BRD-A53472930-001-01-7,rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,PHASE 1,,Small molecule,-1,CLC1CCC2OC3CCON3C(=O)C2C1;O=C1c2cc(Cl)ccc2OC2CCON12,XWXVKXXKKLBDDJ-UHFFFAOYSA-N
SP2577,SECLIDEMSTAT;SP-2577;SP2577,CHEMBL4297641,BRD:BRD-K00003454-001-01-9,rep_single_dose,HISTONE DEMETHYLASE INHIBITOR,,,,,,Small molecule,1,C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCN(C)CC2)c1)c1cc(Cl)ccc1O,MVSQDUZRRVBYLA-HYARGMPZSA-N
SYM-1219,DEPROZOL;FLAGENTYL;NSC-759812;ORNIDAZOLE METABOLITE M4;PM-185184;RP 14539;RP-14539;SABIMA;SECNIDAL;SECNIDAZOLE;SECNIDAZOLE ANHYDROUS;SECNOL;SOLOSEC;SYM-1219,CHEMBL498847,BRD:BRD-A70083328-001-23-5;BRD:BRD-A70083328-001-24-3;BRD:BRD-BRD-A70083328-001-23-5;BRD:BRD-BRD-A70083328-001-24-3,rep_multi_dose;rep_primary;rep_single_dose,"ACETYLCHOLINESTERASE INHIBITOR, MICROTUBULE INHIBITOR",,PROTOZOAN INFECTION,,LAUNCHED,,Small molecule,4,"CC(O)CN1C(C)NCC1[N+]([O-])=O, CC(O)CN1C(C)NCC1[N+]([O-])=O, CC(O)CN1C(C)NCC1[N+]([O-])=O;Cc1ncc([N+](=O)[O-])n1CC(C)O",KPQZUUQMTUIKBP-UHFFFAOYSA-N
SECOISOLARICIRESINOL-(-),SECOISOLARICIRESINOL-(-),,BRD:BRD-BRD-K91733562-001-05-0;BRD:BRD-K91733562-001-05-0,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC1CC(C[C@@H](CO)[C@H](CO)CC2CCC(O)C(OC)C2)CCC1O,
SECOISOLARICIRESINOL-DIGLUCOSIDE,SECOISOLARICIRESINOL-DIGLUCOSIDE,,BRD:BRD-BRD-K77320845-001-01-2;BRD:BRD-K77320845-001-01-2,rep_primary;rep_single_dose,ANTIOXIDANT,,,,PHASE 2,,,NA,COC1CC(C[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC2CCC(O)C(OC)C2)CCC1O,
SECURININE,(-)-SECURININE;L-SECURININE;NSC-107413;SECURINAN-11-ONE;SECURININ;SECURININE,CHEMBL303062,BRD:BRD-BRD-K49071277-001-04-7;BRD:BRD-K49071277-001-04-7,rep_multi_dose;rep_primary;rep_single_dose,"GABA RECEPTOR ANTAGONIST, TP53 ACTIVATOR",GABRA1,,,PRECLINICAL,,Small molecule,-1,O=C1C=C2C=C[C@@H]3C[C@@]2(O1)[C@H]1CCCCN31;O=C1O[C@@]23C[C@@H](C=CC2=C1)N1CCCC[C@H]31,SWZMSZQQJRKFBP-WZRBSPASSA-N
SEGESTERONE-ACETATE,SEGESTERONE-ACETATE,,BRD:BRD-K00003150-001-01-9,rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,,,,,,NA,,
SEL120-34A (MONOHYDROCHLORIDE),SEL120-34A (MONOHYDROCHLORIDE),,BRD:BRD-K00091121-003-01-9,rep_single_dose,,,,,,,,NA,,
SELADELPAR,MBX-8025;RWJ-800025;SELADELPAR,CHEMBL230158,BRD:BRD-K00003284-236-01-9,rep_single_dose,PPAR RECEPTOR AGONIST,,,,,,Small molecule,3,CCO[C@H](COc1ccc(C(F)(F)F)cc1)CSc1ccc(OCC(=O)O)c(C)c1,JWHYSEDOYMYMNM-QGZVFWFLSA-N
UK-124114,"REVOLUTION;SELAMECTIN;UK-124,114;UK-124114",CHEMBL1908325,BRD:BRD-A58564983-001-04-6;BRD:BRD-BRD-A58564983-001-04-6,rep_multi_dose;rep_primary;rep_single_dose,NEMATOCIDE,,FLEA CONTROL,,LAUNCHED,,Small molecule,-1,CO[C@H]1C[C@H](O[C@@H]2/C(C)=C/C[C@@H]3C[C@@H](C[C@]4(CC[C@H](C)[C@@H](C5CCCCC5)O4)O3)OC(=O)[C@@H]3C=C(C)/C(=N/O)[C@H]4OC/C(=C\C=C\[C@@H]2C)[C@]43O)O[C@@H](C)[C@@H]1O;CO[C@H]1CC(O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4C(=N/O)\C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(CC[C@H](C)[C@H](O2)C2CCCCC2)C5)[C@]34O)O[C@@H](C)C1O,AFJYYKSVHJGXSN-XHKIUTQPSA-N
ZELAPAR,ELDEPRYL;EMSAM;L-SELEGILINE;SELEGILINE;ZELAPAR,CHEMBL972,BRD:BRD-A28545468-003-16-6;BRD:BRD-BRD-A28545468-003-16-6,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,PARKINSON'S DISEASE,,LAUNCHED,,Small molecule,4,C#CCN(C)[C@H](C)Cc1ccccc1;CC(CC1CCCCC1)N(C)CC#C,MEZLKOACVSPNER-GFCCVEGCSA-N
SETHOTOPE,"75SE;L-;NSC-760370;RADIOSELENOMETHIONINE 75 SE;SE-75;SELENOMETHIONINE;SELENOMETHIONINE (75 SE);SELENOMETHIONINE (75SE);SELENOMETHIONINE (75SE) INJECTION;SELENOMETHIONINE SE 75;SELENOMETHIONINE SE-75;SELENOMETHIONINE,SE-75;SETHOTOPE",CHEMBL113178;CHEMBL1201054,BRD:BRD-BRD-K74664543-213-01-2;BRD:BRD-K74664543-213-01-2,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,4,"C[75Se]CC[C@H](N)C(=O)O;C[SE]CCC(N)C(O)=O, C[SE]CC[C@H](N)C(O)=O, C[SE]CC[C@H](N)C(O)=O",RJFAYQIBOAGBLC-ZEMBQCNESA-N
UCB5857,SELETALISIB;UCB-5857;UCB5857,CHEMBL4297648,BRD:BRD-K00003228-001-01-9,rep_single_dose,PI3K INHIBITOR,,,,,,Small molecule,2,[O-][n+]1cccc(-c2nc3c(Cl)cccc3cc2[C@@H](Nc2ncnc3cccnc23)C(F)(F)F)c1,LNLJHGXOFYUARS-OAQYLSRUSA-N
UPTRAVI,ACT-293987;NS-304;SELEXIPAG;UPTRAVI,CHEMBL238804,BRD:BRD-BRD-K21191422-001-01-5;BRD:BRD-K21191422-001-01-5,rep_primary;rep_single_dose,"PLATELET AGGREGATION INHIBITOR, IP1 PROSTACYCLIN RECEPTOR AGONIST",PTGIR,,,PHASE 3,"Multiple values for MOA: {'IP1 PROSTACYCLIN RECEPTOR AGONIST, PLATELET AGGREGATION INHIBITOR', 'PLATELET AGGREGATION INHIBITOR, IP1 PROSTACYCLIN RECEPTOR AGONIST'}, defaulting to 'PLATELET AGGREGATION INHIBITOR, IP1 PROSTACYCLIN RECEPTOR AGONIST'",Small molecule,4,"CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1;CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1CNC(-C2CCCCC2)C(N1)-C1CCCCC1, CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1CNC(-C2CCCCC2)C(N1)-C1CCCCC1",QXWZQTURMXZVHJ-UHFFFAOYSA-N
SELICICLIB,AL-39256;CYC-202;NSC-701554;R-ROSCOVITINE;ROSCOVITIN;ROSCOVITINE;SELICICLIB,CHEMBL14762,GDSC1:110,gdsc,,,,,,,Small molecule,2,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,BTIHMVBBUGXLCJ-OAHLLOKOSA-N
XPOVIO,KPT-330;SELINEXOR;XPOVIO,CHEMBL3545185,BRD:BRD-BRD-K21361524-001-01-1;BRD:BRD-K21361524-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,EXPORTIN ANTAGONIST,XPO1,,,PHASE 2/PHASE 3,,Small molecule,4,FC(F)(F)C1CC(CC(C1)C(F)(F)F)-C1NCN(\C=C/C(=O)NNC2CNCCN2)N1;O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1,DEVSOMFAQLZNKR-RJRFIUFISA-N
SELISISTAT,EX 527;SELISISTAT,,GDSC1:341,gdsc,,,,,,,,NA,,
SELITRECTINIB,LOXO-195;SELITRECTINIB,CHEMBL4297627,BRD:BRD-K00003441-001-01-9,rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,,,,,,Small molecule,1,C[C@@H]1CCc2ncc(F)cc2[C@H]2CCCN2c2ccn3ncc(c3n2)C(=O)N1,OEBIHOVSAMBXIB-SJKOYZFVSA-N
SELONSERTIB,GS-4997;SELONSERTIB,CHEMBL3916717,BRD:BRD-K00003274-001-01-9,rep_single_dose,MAP KINASE ACTIVATOR,,,,,,Small molecule,3,Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1,YIDDLAAKOYYGJG-UHFFFAOYSA-N
SELPERCATINIB,LOXO-292;LY-3527723;LY3527723;RET INHIBITOR LOXO-292;RETEVMO;SELPERCATINIB,CHEMBL4559134,BRD:BRD-K00091095-001-01-9,rep_single_dose,,,,,,,Small molecule,4,COc1ccc(CN2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1,XIIOFHFUYBLOLW-UHFFFAOYSA-N
SELTOREXANT,JNJ-42847922;MIN-202;SELTOREXANT,CHEMBL3597971,BRD:BRD-K00073947-001-02-9,rep_single_dose,,,,,,,Small molecule,3,Cc1cc(C)nc(N2CC3CN(C(=O)c4c(F)cccc4-n4nccn4)CC3C2)n1,SQOCEMCKYDVLMM-UHFFFAOYSA-N
SELUMETINIB,ARRY-142886;ARRY-886;AZD-6244;AZD6244;SELUMETINIB,CHEMBL1614701,BRD:BRD-BRD-K57080016-001-15-9;BRD:BRD-K57080016-001-15-9;CTRP:348991;GDSC1:1062;GDSC1:1498,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1,,,PHASE 3,,Small molecule,4,"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21;CN1CNC2C(F)C(NC3CCC(BR)CC3CL)C(CC12)C(=O)NOCCO, CN1CNC2C(F)C(NC3CCC(BR)CC3CL)C(CC12)C(=O)NOCCO",CYOHGALHFOKKQC-UHFFFAOYSA-N
SELUMETINIB:BRD-A02303741 (4:1 MOL/MOL),SELUMETINIB:BRD-A02303741 (4:1 MOL/MOL),,CTRP:660178,ctrp,,,,,,,,NA,,
SELUMETINIB:DECITABINE (4:1 MOL/MOL),SELUMETINIB:DECITABINE (4:1 MOL/MOL),,CTRP:660249,ctrp,,,,,,,,NA,,
SELUMETINIB:GDC-0941 (4:1 MOL/MOL),SELUMETINIB:GDC-0941 (4:1 MOL/MOL),,CTRP:660174,ctrp,,,,,,,,NA,,
SELUMETINIB:JQ-1 (4:1 MOL/MOL),SELUMETINIB:JQ-1 (4:1 MOL/MOL),,CTRP:660177,ctrp,,,,,,,,NA,,
SELUMETINIB:MK-2206 (8:1 MOL/MOL),SELUMETINIB:MK-2206 (8:1 MOL/MOL),,CTRP:660218,ctrp,,,,,,,,NA,,
SELUMETINIB:NAVITOCLAX (8:1 MOL/MOL),SELUMETINIB:NAVITOCLAX (8:1 MOL/MOL),,CTRP:660248,ctrp,,,,,,,,NA,,
SELUMETINIB:PIPERLONGUMINE (8:1 MOL/MOL),SELUMETINIB:PIPERLONGUMINE (8:1 MOL/MOL),,CTRP:660220,ctrp,,,,,,,,NA,,
SELUMETINIB:PLX-4032 (8:1 MOL/MOL),SELUMETINIB:PLX-4032 (8:1 MOL/MOL),,CTRP:660133,ctrp,,,,,,,,NA,,
SELUMETINIB:TRETINOIN (2:1 MOL/MOL),SELUMETINIB:TRETINOIN (2:1 MOL/MOL),,CTRP:660175,ctrp,,,,,,,,NA,,
SELUMETINIB:UNC0638 (4:1 MOL/MOL),SELUMETINIB:UNC0638 (4:1 MOL/MOL),,CTRP:660281,ctrp,,,,,,,,NA,,
SELUMETINIB:VORINOSTAT (8:1 MOL/MOL),SELUMETINIB:VORINOSTAT (8:1 MOL/MOL),,CTRP:660176,ctrp,,,,,,,,NA,,
SEMAGACESTAT,LY-450139;LY450139;SEMAGACESTAT,CHEMBL520733,BRD:BRD-BRD-K81957469-001-01-0;BRD:BRD-K81957469-001-01-0;CTRP:660341,ctrp;rep_primary;rep_single_dose,GAMMA SECRETASE INHIBITOR,PSEN1,,,PHASE 3,,Small molecule,3,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc21;CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C2CCCCC2CCN(C)C1=O,PKXWXXPNHIWQHW-RCBQFDQVSA-N
SEMAPIMOD TETRAHYDROCHLORIDE,AXD-455;CNI-1493;CPSI-2364 FREE BASE;SEMAPIMOD;SEMAPIMOD HYDROCHLORIDE;SEMAPIMOD TETRAHYDROCHLORIDE,CHEMBL2107779,BRD:BRD-BRD-K21237892-376-01-3;BRD:BRD-K21237892-376-01-3,rep_primary;rep_single_dose,"CYTOKINE PRODUCTION INHIBITOR, P38 MAPK INHIBITOR",MAPK14,,,PHASE 2,,Small molecule,2,C/C(=N\NC(=N)N)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(/C(C)=N/NC(=N)N)cc(/C(C)=N/NC(=N)N)c2)cc(/C(C)=N/NC(=N)N)c1;NC(=N)NNC(=C)C1CC(NC(=O)CCCCCCCCC(=O)NC2CC(CC(C2)C(=C)NNC(N)=N)C(=C)NNC(N)=N)CC(C1)C(=C)NNC(N)=N,PWDYHMBTPGXCSN-VCBMUGGBSA-N
SU5416,NSC-696819;SEMAXANIB;SEMAXINIB;SU-5416;SU005416;SU5416,CHEMBL276711,BRD:BRD-BRD-K63504947-001-15-4;BRD:BRD-K63504947-001-14-7;BRD:BRD-K63504947-001-15-4,rep_multi_dose;rep_primary;rep_single_dose,VEGFR INHIBITOR,FGFR1;FLT1;KDR;KIT;PDGFRA;PDGFRB;RET,,,PHASE 3,,Small molecule,3,"Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1;CC1CC(C)C(\C=C2/C(=O)NC3CCCCC23)[NH]1, CC1CC(C)C(\C=C2/C(=O)NC3CCCCC23)[NH]1, CC1CC(C)C(\C=C2/C(=O)NC3CCCCC23)[NH]1, CC1CC(C)C(\C=C2/C(=O)NC3CCCCC23)[NH]1",WUWDLXZGHZSWQZ-WQLSENKSSA-N
SEN-1269,SEN-1269,,BRD:BRD-BRD-K70614402-001-01-0;BRD:BRD-K70614402-001-01-0,rep_primary;rep_single_dose,BETA AMYLOID INHIBITOR,APP,,,PRECLINICAL,,,NA,CN(C)C1CCCC(OC2CNC(NC3CCCC(O)C3)NC2)C1,
SENAPARIB,IMP-4297;IMP4297;SENAPARIB,CHEMBL4802152,BRD:BRD-K00090647-001-01-9,rep_single_dose,,,,,,,Small molecule,2,O=C(c1cc(Cn2c(=O)[nH]c(=O)c3c(F)cccc32)ccc1F)N1CCN(c2ncccn2)CC1,VBTUJTGLLREMNW-UHFFFAOYSA-N
SENICAPOC,ICA-17043;PF-05416266;SENICAPOC,CHEMBL405821,BRD:BRD-BRD-K21295289-001-01-6;BRD:BRD-K21295289-001-01-6,rep_primary;rep_single_dose,INTERMEDIATE CONDUCTANCE POTASSIUM CHANNEL BLOCKER,KCNN4,,,PHASE 3,,Small molecule,3,NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1;NC(=O)C(C1CCCCC1)(C1CCC(F)CC1)C1CCC(F)CC1,SCTZUZTYRMOMKT-UHFFFAOYSA-N
SENNOSIDE-A,SENNOSIDE-A,,BRD:BRD-A30370660-001-04-1;BRD:BRD-BRD-A30370660-001-04-1,rep_primary;rep_single_dose,GLYCOSIDE AGONIST,,CONSTIPATION,,LAUNCHED,,,NA,OC[C@H]1O[C@H](OC2CCCC3C([C@H]4C5CCCC(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C5C(=O)C5C(O)CC(CC45)C(O)=O)C4CC(CC(O)C4C(=O)C23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O,
SEOCALCITOL,CB-1089;EB-1089;SEOCALCITOL,CHEMBL1908376,BRD:BRD-BRD-K28456624-001-01-1;BRD:BRD-K28456624-001-01-1,rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,,,PHASE 3,,Small molecule,3,"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/C=C/C(O)(CC)CC)CC[C@@H]23)C[C@@H](O)C[C@@H]1O;CCC(O)(CC)\C=C\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, CCC(O)(CC)\C=C\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C",LVLLALCJVJNGQQ-SEODYNFXSA-N
SEP-227900,SEP-227900,,BRD:BRD-BRD-K49504902-001-01-6;BRD:BRD-K49504902-001-01-6,rep_primary;rep_single_dose,D-AMINO ACID OXIDASE INHIBITOR,DAO,,,PHASE 1,,,NA,OC(=O)C1CC2OCCC2[NH]1,
YM155,SEPANTRONIUM BROMIDE;YM 155;YM-155;YM155,CHEMBL2105734,BRD:BRD-BRD-K76703230-004-03-3;BRD:BRD-BRD-K76703230-004-04-1;BRD:BRD-K76703230-001-02-1;BRD:BRD-K76703230-004-03-3;BRD:BRD-K76703230-004-04-1;CTRP:417979;GDSC1:268;GDSC2:1941,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose, SUBSTRATE FOR SLC35F2 AND EXPORTED BY ABCB1;DNA DAMAGING AGENT,BIRC5;SLC35F2,,,PHASE 2,"Multiple values for MOA: {'SURVIVIN INHIBITOR', 'DNA DAMAGING AGENT; SUBSTRATE FOR SLC35F2 AND EXPORTED BY ABCB1'}, defaulting to 'DNA DAMAGING AGENT; SUBSTRATE FOR SLC35F2 AND EXPORTED BY ABCB1'
Multiple values for repurposing_target: {'BIRC5', 'SLC35F2'}, taking the union",Small molecule,2,"COCC[n+]1c2c(n(Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O.[Br-];COCCN1C2C(C(=O)C3CCCCC3C2=O)[N+](CC2CNCCN2)C1C, COCCN1C2C(C(=O)C3CCCCC3C2=O)[N+](CC2CNCCN2)C1C",QBIYUDDJPRGKNJ-UHFFFAOYSA-M
SERATRODAST,A-73001;AA-2414;ABBOTT 73001;ABBOTT-73001;ABT-001;BRONICA;NSC-759640;SERATRODAST,CHEMBL70972,BRD:BRD-A60765580-001-03-4,rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,TBXA2R,,,,,Small molecule,-1,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O,ZBVKEHDGYSLCCC-UHFFFAOYSA-N
SERDEMETAN,JNJ-26854165;SERDEMETAN,CHEMBL2137530,BRD:BRD-BRD-K65924316-001-03-1;BRD:BRD-K65924316-001-03-1;CTRP:418164;GDSC1:1133,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,MDM INHIBITOR,MDM2,,,PHASE 1,,Small molecule,1,"C(CC1C[NH]C2CCCCC12)NC1CCC(NC2CCNCC2)CC1, C(CC1C[NH]C2CCCCC12)NC1CCC(NC2CCNCC2)CC1;c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1",CEGSUKYESLWKJP-UHFFFAOYSA-N
SERDEMETAN:SCH-529074 (1:1 MOL/MOL),SERDEMETAN:SCH-529074 (1:1 MOL/MOL),,CTRP:660132,ctrp,,,,,,,,NA,,
THROMBOTONIN,5-HT;5-HYDROXYTRYPTAMINE;ENTERAMINE;SEROTONIN;THROMBOTONIN,CHEMBL39,BRD:BRD-BRD-K38580127-003-15-4;BRD:BRD-K38580127-003-15-4,rep_primary;rep_single_dose,GROWTH FACTOR RECEPTOR ACTIVATOR,DRD1;DRD5;HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR3A;HTR3B;HTR4;HTR5A;HTR6;HTR7;SLC36A1,"ANXIETY, DEPRESSION, SLEEPLESSNESS",,LAUNCHED,,Small molecule,3,"NCCc1c[nH]c2ccc(O)cc12;NCCC1C[NH]C2CCC(O)CC12, NCCC1C[NH]C2CCC(O)CC12, NCCC1C[NH]C2CCC(O)CC12",QZAYGJVTTNCVMB-UHFFFAOYSA-N
SERTACONAZOLE,(R)-;ARASERTACONAZOLE;DEMOFIX;ERTACZO;FI-7045;SERTACONAZOLE,CHEMBL1201196;CHEMBL1410877,BRD:BRD-A95939040-001-01-2;BRD:BRD-BRD-A95939040-001-01-2,rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,,TINEA PEDIS,,LAUNCHED,,Small molecule,4,Clc1ccc([C@H](Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1;Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1;CLC1CCC(C(CN2CCNC2)OCC2CSC3C(CL)CCCC23)C(CL)C1,JLGKQTAYUIMGRK-IBGZPJMESA-N;JLGKQTAYUIMGRK-UHFFFAOYSA-N
ZERDOL,LU 23-174;LU-23-174;SERDOLECT;SERLECT;SERTINDOLE;ZERDOL,CHEMBL12713,BRD:BRD-BRD-K69116396-001-04-1;BRD:BRD-K69116396-001-04-1,rep_multi_dose;rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA1D;DRD2;DRD3;DRD4;HRH1;HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2C;HTR6;KCNH2,,,WITHDRAWN,,Small molecule,4,FC1CCC(CC1)-N1CC(C2CCN(CCN3CCNC3=O)CC2)C2CC(CL)CCC12;O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,GZKLJWGUPQBVJQ-UHFFFAOYSA-N
SERTRALINE,SERTRALINE,CHEMBL809,BRD:BRD-BRD-K82036761-003-20-3;BRD:BRD-K82036761-003-20-3,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),SLC6A3;SLC6A4,"DEPRESSION, OBSESSIVE COMPULSIVE DISORDER (OCD), PANIC DISORDERS, POSTTRAUMATIC STRESS DISORDER, PREMENSTRUAL SYNDROME, SOCIAL ANXIETY DISORDER",,LAUNCHED,,Small molecule,4,"CN[C@H]1CC[C@@H](C2CCC(CL)C(CL)C2)C2CCCCC12, CN[C@H]1CC[C@@H](C2CCC(CL)C(CL)C2)C2CCCCC12, CN[C@H]1CC[C@@H](C2CCC(CL)C(CL)C2)C2CCCCC12, CN[C@H]1CC[C@@H](C2CCC(CL)C(CL)C2)C2CCCCC12;CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21",VGKDLMBJGBXTGI-SJCJKPOMSA-N
SESAMIN,SESAMIN,CHEMBL252915,BRD:BRD-BRD-K11631773-001-10-8;BRD:BRD-K11631773-001-10-8,rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,"c1cc2c(cc1[C@H]1OC[C@H]3[C@@H]1CO[C@@H]3c1ccc3c(c1)OCO3)OCO2;C1OC2CCC(CC2O1)[C@H]1OC[C@H]2[C@@H]1CO[C@@H]2C1CCC2OCOC2C1, C1OC2CCC(CC2O1)[C@H]1OC[C@H]2[C@@H]1CO[C@@H]2C1CCC2OCOC2C1",PEYUIKBAABKQKQ-AFHBHXEDSA-N
SETIPIPRANT,ACT-129968;KYTH-105;SETIPIPRANT,CHEMBL2386081,BRD:BRD-BRD-K24497734-001-01-6;BRD:BRD-K24497734-001-01-6,rep_primary;rep_single_dose,PROSTAGLANDIN INHIBITOR,PTGDR2,,,PHASE 3,,Small molecule,3,O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)c1cccc3ccccc13)CC2;OC(=O)CN1C2CCN(CC2C2CC(F)CCC12)C(=O)C1CCCC2CCCCC12,IHAXLPDVOWLUOS-UHFFFAOYSA-N
SETIPTILINE MALEATE,ORG 8282;SETIPTILINE;SETIPTILINE MALEATE,CHEMBL2104895,BRD:BRD-BRD-K36732695-001-01-9;BRD:BRD-K36732695-001-01-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,HRH1;HTR2A;HTR2C,DEPRESSION,,LAUNCHED,,Small molecule,-1,CN1CCC2=C(C1)c1ccccc1Cc1ccccc12;CN1CCC2=C(C1)C1CCCCC1CC1CCCCC21,GVPIXRLYKVFFMK-UHFFFAOYSA-N
SETMELANOTIDE,BIM-22493;RM-493;SETMELANOTIDE,CHEMBL3301624,BRD:BRD-K00003298-001-01-9,rep_single_dose,MELANOCORTIN RECEPTOR AGONIST,,,,,,Protein,4,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](C)NC1=O,HDHDTKMUACZDAA-PHNIDTBTSA-N
SEVELAMER ANHYDROUS,RENAGEL;RENVELA;SEVELAMER;SEVELAMER ANHYDROUS,CHEMBL1201798,BRD:BRD-BRD-U45393375-000-01-6;BRD:BRD-U45393375-000-01-6,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHATE ANTAGONIST,,CHRONIC KIDNEY DISEASE (CKD),,LAUNCHED,,Small molecule,4,", NCC=C.CLCC1CO1;C=CCN.ClCC1CO1",ZNSIZMQNQCNRBW-UHFFFAOYSA-N
ULTANE,MR-6S4;MR6S4;NSC-760367;SEVOCALM;SEVOFLO;SEVOFLURANE;SEVORANE;SOJOURN;ULTANE,CHEMBL1200694,BRD:BRD-BRD-K05638300-001-01-2;BRD:BRD-K05638300-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,ATP2C1;ATP5D;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GLRA1;GLRB;GRIA1;KCNA1;KCNK10;KCNK18;KCNK2;KCNK3;KCNK9;MT-ND1,ANESTHETIC,,LAUNCHED,,Small molecule,4,"FCOC(C(F)(F)F)C(F)(F)F;FCOC(C(F)(F)F)C(F)(F)F, FCOC(C(F)(F)F)C(F)(F)F",DFEYYRMXOJXZRJ-UHFFFAOYSA-N
SEW-2871,SEW-2871,,BRD:BRD-BRD-K15601958-001-03-9;BRD:BRD-K15601958-001-03-9,rep_primary;rep_single_dose,LYSOPHOSPHOLIPID RECEPTOR AGONIST,S1PR1,,,PRECLINICAL,,,NA,FC(F)(F)C1SC(CC1-C1CCCCC1)-C1NC(NO1)-C1CCCC(C1)C(F)(F)F,
SF-11,SF-11,,BRD:BRD-K42629487-001-09-9,rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,MCOLN3;NPY2R,,,,,,NA,,
SGC-0946,SGC-0946,,BRD:BRD-BRD-K69577666-001-01-3;BRD:BRD-K69577666-001-01-3,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,,,,PRECLINICAL,,,NA,"CC(C)N(CCCNC(=O)NC1CCC(CC1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CC(BR)C2C(N)NCNC12, CC(C)N(CCCNC(=O)NC1CCC(CC1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CC(BR)C2C(N)NCNC12",
SGC-707,SGC-707,,BRD:BRD-K86718786-001-03-9,rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,PRMT3,,,,,,NA,,
SGC-CBP30,SGC-CBP30,,BRD:BRD-BRD-K24821794-001-01-4;BRD:BRD-K24821794-001-01-4,rep_primary;rep_single_dose,BROMODOMAIN INHIBITOR,CREBBP;EP300,,,PRECLINICAL,,,NA,"COC1CCC(CCC2NC3CC(CCC3N2C[C@H](C)N2CCOCC2)-C2C(C)NOC2C)CC1CL, COC1CCC(CCC2NC3CC(CCC3N2C[C@H](C)N2CCOCC2)-C2C(C)NOC2C)CC1CL",
SGC0946,SGC0946,,GDSC1:1264,gdsc,,,,,,,,NA,,
SGI-1027,SGI-1027,,BRD:BRD-BRD-K61228301-001-01-2;BRD:BRD-K61228301-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,DNA METHYLTRANSFERASE INHIBITOR,DNMT1;DNMT3A;DNMT3B,,,PRECLINICAL,,,NA,CC1CC(NC2CCC(NC(=O)C3CCC(NC4CCNC5CCCCC45)CC3)CC2)NC(N)N1,
SGI-1776,SGI-1776,CHEMBL1952329,BRD:BRD-BRD-K80700417-001-04-2;BRD:BRD-K80700417-001-04-2,rep_multi_dose;rep_primary;rep_single_dose,PIM KINASE INHIBITOR,FLT3;PIM1;PIM2;PIM3,,,PHASE 1,,Small molecule,1,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1;CN1CCC(CNC2CCC3NCC(-C4CCCC(OC(F)(F)F)C4)N3N2)CC1,MHXGEROHKGDZGO-UHFFFAOYSA-N
SGS742,CGP-36742;LU-AE-58479;SGS 742;SGS-742;SGS742,CHEMBL112797,BRD:BRD-K00004650-001-01-9,rep_single_dose,GABA RECEPTOR ANTAGONIST,GABBR1;GABBR2,,,,,Small molecule,2,CCCCP(=O)(O)CCCN,ONNMDRQRSGKZCN-UHFFFAOYSA-N
SGX523,SGX-523;SGX523,CHEMBL1236107,BRD:BRD-BRD-K19477839-001-07-6;BRD:BRD-K19477839-001-07-6;BRD:BRD-K19477839-001-10-9;CTRP:635882,ctrp;oncref_2;rep_primary;rep_single_dose,HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR,MET,,,PHASE 1,"Multiple values for MOA: {'INHIBITOR OF MET', 'HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR'}, defaulting to 'HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR'",Small molecule,1,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1;CN1CC(CN1)-C1CCC2NNC(SC3CCC4NCCCC4C3)N2N1,BCZUAADEACICHN-UHFFFAOYSA-N
SHA-68,SHA-68,,BRD:BRD-A63344375-001-01-8;BRD:BRD-BRD-A63344375-001-01-8,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPSR1,,,PRECLINICAL,,,NA,FC1CCC(CNC(=O)N2CCN3C(C2)C(OC3=O)(C2CCCCC2)C2CCCCC2)CC1,
SHIKIMIC-ACID,SHIKIMIC-ACID,,BRD:BRD-A92096630-001-02-8;BRD:BRD-BRD-A92096630-001-02-8,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,O[C@@H]1CC(=CC(O)C1O)C(O)=O,
SHIKONIN,ANCHUSIN;SHIKONIN,CHEMBL9470,GDSC1:170,gdsc,,,,,,,Small molecule,NA,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,NEZONWMXZKDMKF-SNVBAGLBSA-N
SHP099,SHP099,,BRD:BRD-BRD-K00818915-003-01-8;BRD:BRD-K00818915-003-01-8,rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,PTPN11,,,PRECLINICAL,,,NA,CC1(N)CCN(CC1)C1CNC(C(N)N1)-C1CCCC(CL)C1CL,
SIB-1553A,SIB-1553A,,BRD:BRD-A79052425-003-01-5;BRD:BRD-BRD-A79052425-003-01-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNB4,,,PHASE 2,,,NA,CN1CCCC1CCSC1CCC(O)CC1,
SIB-1757,SIB-1757,,BRD:BRD-BRD-K98157055-001-10-9;BRD:BRD-K98157055-001-10-9,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM5,,,PRECLINICAL,,,NA,CC1CCC(O)C(N=NC2CCCCC2)N1,
SIB-1893,SIB-1893,,BRD:BRD-K14561059-001-06-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM4;GRM5,,,,,,NA,,
VRT-1353385,EB-8018;EB8018;SIBOFIMLOC;VRT-1353385,CHEMBL4594305,BRD:BRD-K00090658-001-01-9,rep_single_dose,,,,,,,Small molecule,1,CC(=O)N1CCC2(CC1)c1cc(C#C[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)ccc1-c1ccc(C#C[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)cc12,SFHMWDMKUYVSQJ-VECBPBMLSA-N
SIBUTRAMINE,BUTRAMIN;CF-ALLI;MEDARIA;RACEMIC SIBUTRAMINE;REDUCTIL;SIBUTRAMINE,CHEMBL1419,BRD:BRD-A23359898-003-10-0;BRD:BRD-BRD-A23359898-003-10-0,rep_primary;rep_single_dose,SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),SLC6A2;SLC6A3;SLC6A4,,,WITHDRAWN,,Small molecule,4,"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1;CC(C)CC(N(C)C)C1(CCC1)C1CCC(CL)CC1, CC(C)CC(N(C)C)C1(CCC1)C1CCC(CL)CC1",UNAANXDKBXWMLN-UHFFFAOYSA-N
SID 26681509,SID 26681509,,CTRP:411731,ctrp,,,,,,,,NA,,
SID-7969543,SID-7969543,,BRD:BRD-A43885598-001-08-1;BRD:BRD-BRD-A43885598-001-08-1,rep_multi_dose;rep_primary;rep_single_dose,STEROIDOGENIC FACTOR ANTAGONIST,NR5A1,,,PRECLINICAL,,,NA,"CCOC(=O)C(C)OC1CCCC2C1CCN(CC(=O)NC1CCC3OCCOC3C1)C2=O, CCOC(=O)C(C)OC1CCCC2C1CCN(CC(=O)NC1CCC3OCCOC3C1)C2=O",
SKF-94836,SIGUAZODAN;SK&F 94836;SKF-94836,CHEMBL1256712,BRD:BRD-A62071884-001-04-6;BRD:BRD-BRD-A62071884-001-04-6,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE3A,,,PHASE 1,,Small molecule,-1,"CN/C(=N\c1ccc(C2=NNC(=O)CC2C)cc1)NC#N;CN\C(NC#N)=N/C1CCC(CC1)C1=NNC(=O)CC1C, CN\C(NC#N)=N/C1CCC(CC1)C1=NNC(=O)CC1C",NUHPODZZKHQQET-UHFFFAOYSA-N
VIZARSIN,APHRODIL;HIP-0908;HIP0908;NIPATRA;PATREX;REVATIO;SILDENAFIL;SILDENAFIL ACTAVIS;SILDENAFIL RATIOPHARM;SILDENAFIL TEVA;UK-92480;VIAGRA;VIZARSIN,CHEMBL192,BRD:BRD-BRD-K79759585-048-04-8;BRD:BRD-K79759585-048-04-8;CTRP:27872,ctrp;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A;PDE6G;PDE6H;SLCO1B1;SLCO1B3,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12;CCCC1NN(C)C2C1NC([NH]C2=O)-C1CC(CCC1OCC)S(=O)(=O)N1CCN(C)CC1, CCCC1NN(C)C2C1NC([NH]C2=O)-C1CC(CCC1OCC)S(=O)(=O)N1CCN(C)CC1, CCCC1NN(C)C2C1NC([NH]C2=O)-C1CC(CCC1OCC)S(=O)(=O)N1CCN(C)CC1",BNRNXUUZRGQAQC-UHFFFAOYSA-N
SILYMARIN,LEGALON;SILIBIN;SILIBININ;SILIBININ A-SILIBININ B MIXT.;SILLIVER;SILYBIN;SILYBINE;SILYMARIN,CHEMBL9509,BRD:BRD-BRD-K80353138-001-12-1;BRD:BRD-K80353138-001-12-1,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,ALOX5,HEPATIC CIRRHOSIS,,LAUNCHED,,Small molecule,3,"COc1cc(C2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O;COC1CC(CCC1O)[C@H]1OC2CC(CCC2O[C@@H]1CO)[C@H]1OC2CC(O)CC(O)C2C(=O)[C@@H]1O, COC1CC(CCC1O)[C@H]1OC2CC(CCC2O[C@@H]1CO)[C@H]1OC2CC(O)CC(O)C2C(=O)[C@@H]1O, COC1CC(CCC1O)[C@H]1OC2CC(CCC2O[C@@H]1CO)[C@H]1OC2CC(O)CC(O)C2C(=O)[C@@H]1O",SEBFKMXJBCUCAI-DBMPWETRSA-N
SILMITASERTIB,CX 4945;CX-4945;CX-4945 FREE ACID;CX4945;SILMITASERTIB,CHEMBL1230165,CTRP:660421,ctrp,,,,,,,Small molecule,2,O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,MUOKSQABCJCOPU-UHFFFAOYSA-N
UROREC,KAD-3213;KMD-3213;KSO-0400;RAPAFLO;RAPILIF;SILODAL;SILODOSIN;SILODYX;URIEF;UROREC,CHEMBL24778,BRD:BRD-BRD-K10906636-001-02-9;BRD:BRD-K10906636-001-02-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D,BENIGN PROSTATIC HYPERPLASIA (BPH),,LAUNCHED,,Small molecule,4,"C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F;C[C@H](CC1CC2CCN(CCCO)C2C(C1)C(N)=O)NCCOC1CCCCC1OCC(F)(F)F, C[C@H](CC1CC2CCN(CCCO)C2C(C1)C(N)=O)NCCOC1CCCCC1OCC(F)(F)F",PNCPYILNMDWPEY-QGZVFWFLSA-N
SILVER-SULFADIAZINE,SILVER-SULFADIAZINE,,BRD:BRD-BRD-K68379918-001-01-1;BRD:BRD-K68379918-001-01-1,rep_primary;rep_single_dose,PABA ANTAGONIST,,SEPSIS,,LAUNCHED,,,NA,"NC1CCC(CC1)S(=O)(=O)N([AG])C1NCCCN1, NC1CCC(CC1)S(=O)(=O)N([AG])C1NCCCN1",
TMC435350,OLYSIO;SIMEPREVIR;TMC 435;TMC 435350;TMC-435;TMC-435350;TMC435;TMC435350,CHEMBL501849,BRD:BRD-A68493689-001-01-9;BRD:BRD-BRD-A68493689-001-01-9,rep_primary;rep_single_dose,HCV INHIBITOR,CYP1A2;CYP3A4,HEPATITIS C,,LAUNCHED,,Small molecule,4,COC1CCC2C(O[C@@H]3C[C@@H]4C(C3)C(=O)N(C)CCCC\C=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)CC(NC2C1C)-C1NC(CS1)C(C)C;COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C,JTZZSQYMACOLNN-VDWJNHBNSA-N
TAK931F,SIMUROSERTIB;TAK 931;TAK-931;TAK931F,CHEMBL4297644,BRD:BRD-K00004727-001-01-9,rep_single_dose,KINASE INHIBITOR,,,,,,Small molecule,2,Cc1n[nH]cc1-c1cc2nc([C@@H]3CC4CCN3CC4)[nH]c(=O)c2s1,XGVXKJKTISMIOW-ZDUSSCGKSA-N
ZOCOR HEART-PRO,C10AA01;FLOLIPID;LACERSA;MK-0733;MK-733;NSC-758706;RANZOLONT;SIMVADOR;SIMVASTATIN;SIMVASTATIN HYDROXY ACID;SYNVINOLIN;ZOCOR;ZOCOR HEART-PRO,CHEMBL1064,BRD:BRD-BRD-K22134346-001-22-3;BRD:BRD-BRD-K22134346-001-24-9;BRD:BRD-K22134346-001-22-3;BRD:BRD-K22134346-001-24-9;CTRP:27894,ctrp;rep_multi_dose;rep_primary;rep_single_dose,HMGCR INHIBITOR,HMGCR;ITGB2,"HYPERCHOLESTEROLEMIA, CORONARY HEART DISEASE, MYOCARDIAL INFARCTION, STROKE, HYPERLIPIDEMIA",,LAUNCHED,,Small molecule,4,"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12;CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21",RYMZZMVNJRMUDD-HGQWONQESA-N
SQ-19844,CCK C-TERMINAL OCTAPEPTIDE;CCK-8;CHOLECYSTOKININ;CHOLECYSTOKININ C-TERMINAL OCTAPEPTIDE;KINEVAC;PANCREOZYMIN (CHOLECYSTOKININ);SINCALIDE;SQ 19844;SQ-19844,CHEMBL1121,BRD:BRD-K00003334-001-01-9,rep_single_dose,CHOLECYSTOKININ AGONIST,,,,,,Protein,4,CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,IZTQOLKUZKXIRV-YRVFCXMDSA-N
SINEFUNGIN,COMPOUND 57926;LILLY 57926;LY-57926;SINEFUNGIN,CHEMBL1214186,BRD:BRD-K91100918-001-03-8,rep_single_dose,"DNA METHYLTRANSFERASE INHIBITOR, RNA SYNTHESIS INHIBITOR",CARM1,,,,,Small molecule,-1,Nc1ncnc2c1ncn2[C@@H]1O[C@H](C[C@@H](N)CC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O,LMXOHSDXUQEUSF-YECHIGJVSA-N
SINOMENINE,SINOMENINE,CHEMBL248095,BRD:BRD-BRD-K83459933-001-05-4;BRD:BRD-K83459933-001-05-4,rep_primary;rep_single_dose,ANGIOGENESIS INHIBITOR,,,,PRECLINICAL,,Small molecule,NA,COC1=C[C@@H]2[C@@H]3Cc4ccc(OC)c(O)c4[C@]2(CCN3C)CC1=O;COC1=C[C@@H]2[C@@H]3CC4CCC(OC)C(O)C4[C@]2(CCN3C)CC1=O,INYYVPJSBIVGPH-QHRIQVFBSA-N
SINULARIN,SINULARIN,,GDSC2:1838,gdsc,,,,,,,,NA,,
SIPATRIGINE,619-C-89;619C89;SIPATRIGINE,CHEMBL28854,BRD:BRD-BRD-K53195974-001-01-9;BRD:BRD-K53195974-001-01-9,rep_primary;rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,CACNA1D;SCN10A;SCN1A;SCN3A;SCN4A;SCN5A;SCN9A,,,PHASE 2,,Small molecule,-1,"CN1CCN(c2ncc(-c3cc(Cl)cc(Cl)c3Cl)c(N)n2)CC1;CN1CCN(CC1)C1NCC(C(N)N1)-C1CC(CL)CC(CL)C1CL, CN1CCN(CC1)C1NCC(C(N)N1)-C1CC(CL)CC(CL)C1CL",PDOCBJADCWMDGL-UHFFFAOYSA-N
SIPONIMOD,BAF-312;BAF312;NVP-BAF312-NX;SIPONIMOD,CHEMBL2336071,BRD:BRD-BRD-K62384160-001-02-0;BRD:BRD-K62384160-001-02-0,rep_primary;rep_single_dose,"SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, SPHINGOSINE PHOSPHATE RECEPTOR MODULATOR",S1PR1,,,PHASE 3,"Multiple values for MOA: {'SPHINGOSINE PHOSPHATE RECEPTOR MODULATOR', 'SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, SPHINGOSINE PHOSPHATE RECEPTOR MODULATOR'}, defaulting to 'SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, SPHINGOSINE PHOSPHATE RECEPTOR MODULATOR'",Small molecule,4,"CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1;CCC1CC(CCC1CN1CC(C1)C(O)=O)C(\C)=N\OCC1CCC(C2CCCCC2)C(C1)C(F)(F)F, CCC1CC(CCC1CN1CC(C1)C(O)=O)C(\C)=N\OCC1CCC(C2CCCCC2)C(C1)C(F)(F)F",KIHYPELVXPAIDH-HNSNBQBZSA-N
SIRAMESINE,SIRAMESINE,CHEMBL61479,BRD:BRD-BRD-K51333959-003-01-3;BRD:BRD-K51333959-003-01-3,rep_primary;rep_single_dose,SIGMA RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D,,,PHASE 2,,Small molecule,-1,Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1;FC1CCC(CC1)-N1CC(CCCCN2CCC3(CC2)OCC2CCCCC32)C2CCCCC12,XWAONOGAGZNUSF-UHFFFAOYSA-N
SIREMADLIN,HDM 201;HDM-201;HDM201;NVP-HDM 201;SIREMADLIN,CHEMBL3653256,BRD:BRD-K65480835-001-02-9,rep_single_dose,MDM INHIBITOR,,,,,,Small molecule,2,COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,AGBSXNCBIWWLHD-FQEVSTJZSA-N
WY-090217,AY-22989;FYARRO;HYFTOR;L04AA10;NPC-12G;NSC-226080;RAPALIMUS;RAPAMUNE;RAPAMYCIN;SIROLIMUS;SM-88 COMPONENT SIROLIMUS;WY-090217,CHEMBL413,BRD:BRD-A79768653-001-12-0;BRD:BRD-BRD-A79768653-001-12-0;BRD:BRD-BRD-K84937637-001-09-9;BRD:BRD-K84937637-001-09-9;CTRP:56703;GDSC1:3;GDSC2:1084,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,FGF2;FKBP1A;MTOR,"ORGAN REJECTION, LYMPHANGIOLEIOMYOMATOSIS",,LAUNCHED,"Multiple values for structure_id: {'K84937637', 'A79768653'}, defaulting to None",Small molecule,4,"CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O, CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O, COC1CC(CC(C)C2CC(=O)C(C)\C=C(C)\C(O)C(OC)C(=O)C(C)CC(C)\C=C\C=C\C=C(C)\C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1O, CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O;CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C",QFJCIRLUMZQUOT-HPLJOQBZSA-N
SIROLIMUS:BORTEZOMIB (250:1 MOL/MOL),SIROLIMUS:BORTEZOMIB (250:1 MOL/MOL),,CTRP:660134,ctrp,,,,,,,,NA,,
SIRREAL-2,SIRREAL-2,,BRD:BRD-BRD-K16472653-001-01-6;BRD:BRD-K16472653-001-01-6,rep_primary;rep_single_dose,SIRT INHIBITOR,SIRT2,,,PRECLINICAL,,,NA,CC1CC(C)NC(SCC(=O)NC2NCC(CC3CCCC4CCCCC34)S2)N1,
SIS3,SIS3,,BRD:BRD-K38905597-003-02-9,rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,SMAD3;TGFBR1,,,,,,NA,,
SITAFLOXACIN SESQUIHYDRATE,DU-6859A;SITAFLOXACIN;SITAFLOXACIN HYDRATE;SITAFLOXACIN SESQUIHYDRATE,CHEMBL108821;CHEMBL3989504,BRD:BRD-BRD-K10836013-001-01-3;BRD:BRD-K10836013-001-01-3,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,BURULI ULCER,,LAUNCHED,,Small molecule,2,N[C@@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn([C@@H]4C[C@@H]4F)c3c2Cl)CC12CC2.O;N[C@@H]1CN(CC11CC1)C1C(F)CC2C(C1CL)N(CC(C(O)=O)C2=O)[C@@H]1C[C@@H]1F,ANCJYRJLOUSQBW-JJZGMWGRSA-N
SITAGLIPTIN,JANUVIA;LEZ-763;LEZ763;MK-0431;SITAGLIPTIN,CHEMBL1422,BRD:BRD-BRD-K19416115-001-05-3;BRD:BRD-K19416115-001-05-3;CTRP:58442,ctrp;rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"N[C@@H](CC(=O)N1CCN2C(C1)NNC2C(F)(F)F)CC1CC(F)C(F)CC1F, N[C@@H](CC(=O)N1CCN2C(C1)NNC2C(F)(F)F)CC1CC(F)C(F)CC1F;N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F",MFFMDFFZMYYVKS-SECBINFHSA-N
TBC-11251,IPI-1040;SITAXENTAN;SITAXSENTAN;TBC-11251,CHEMBL282724,BRD:BRD-BRD-K63806092-236-02-6;BRD:BRD-K63806092-236-02-6;BRD:BRD-K63806092-236-06-9,rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA;EDNRB,,,WITHDRAWN,"Multiple values for repurposing_target: {'EDNRA;EDNRB', 'EDNRA'}, taking the union",Small molecule,4,"Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2;CC1NOC(NS(=O)(=O)C2CCSC2C(=O)CC2CC3OCOC3CC2C)C1CL, CC1NOC(NS(=O)(=O)C2CCSC2C(=O)CC2CC3OCOC3CC2C)C1CL, CC1NOC(NS(=O)(=O)C2CCSC2C(=O)CC2CC3OCOC3CC2C)C1CL, CC1NOC(NS(=O)(=O)C2CCSC2C(=O)CC2CC3OCOC3CC2C)C1CL",PHWXUGHIIBDVKD-UHFFFAOYSA-N
SITRAVATINIB,MG-516;MG-91516;MGCD-516;MGCD516;SITRAVATINIB,CHEMBL3989926,BRD:BRD-K00003238-001-01-9,rep_single_dose,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,,,,,,Small molecule,3,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1,WLAVZAAODLTUSW-UHFFFAOYSA-N
SIVELESTAT,LY-544349;LY544349;ONO-5046;SIVELESTAT,CHEMBL76688,BRD:BRD-BRD-K02152879-414-02-1;BRD:BRD-K02152879-414-02-1,rep_primary;rep_single_dose,ELASTASE INHIBITOR,CELA1;ELANE,ACUTE LUNG INJURY,,LAUNCHED,,Small molecule,3,"CC(C)(C)C(=O)OC1CCC(CC1)S(=O)(=O)NC1CCCCC1C(=O)NCC(O)=O, CC(C)(C)C(=O)OC1CCC(CC1)S(=O)(=O)NC1CCCCC1C(=O)NCC(O)=O, CC(C)(C)C(=O)OC1CCC(CC1)S(=O)(=O)NC1CCCCC1C(=O)NCC(O)=O;CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1",BTGNGJJLZOIYID-UHFFFAOYSA-N
SJ-172550,SJ-172550,,CTRP:416777,ctrp,,,,,,,,NA,,
SJ733,SJ-733;SJ733,CHEMBL4207489,BRD:BRD-K34798115-001-02-9,rep_single_dose,ATPASE INHIBITOR,,,,,,Small molecule,2,N#Cc1cc(NC(=O)[C@H]2c3ccccc3C(=O)N(CC(F)(F)F)[C@@H]2c2cccnc2)ccc1F,VKCPFWKTFZAOTO-LEWJYISDSA-N
UP-2001,BN-2629;NSC-694501;SG-2000;SJG 136;SJG-136;SP-2001;UP-2001,CHEMBL16498,BRD:BRD-K00003173-001-01-9,rep_single_dose,DNA INTERCALATING AGENT,,,,,,Small molecule,2,C=C1C[C@H]2C=Nc3cc(OCCCOc4cc5c(cc4OC)C(=O)N4CC(=C)C[C@H]4C=N5)c(OC)cc3C(=O)N2C1,RWZVMMQNDHPRQD-SFTDATJTSA-N
SK&F-10047-(+),SK&F-10047-(+),,BRD:BRD-A47364545-003-02-6;BRD:BRD-BRD-A47364545-003-02-6,rep_primary;rep_single_dose,SIGMA RECEPTOR AGONIST,SIGMAR1,,,PHASE 1,,,NA,C[C@H]1C2CC3CCC(O)CC3[C@@]1(C)CCN2CC=C,
SKA-31,SKA-31,,BRD:BRD-BRD-K67304264-001-08-5;BRD:BRD-K67304264-001-08-5,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNN4,,,PRECLINICAL,,,NA,"NC1NC2C(CCC3CCCCC23)S1, NC1NC2C(CCC3CCCCC23)S1",
SKEPINONE-L,SKEPINONE-L,,BRD:BRD-BRD-K83607951-001-02-2;BRD:BRD-K83607951-001-02-2;CTRP:688799,ctrp;rep_multi_dose;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK14,,,PRECLINICAL,,,NA,OC[C@@H](O)COC1CCC2CCC3CC(NC4CCC(F)CC4F)CCC3C(=O)C2C1,
SKF-38393,NCG-C00093856-01;SK-38393;SK-383933;SK&F-38393;SK&F-383933;SKF-38393,CHEMBL286080,BRD:BRD-A88548664-004-02-7;BRD:BRD-BRD-A88548664-004-02-7,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,CALY;DRD1;DRD5,,,PRECLINICAL,,Small molecule,NA,Oc1cc2c(cc1O)C(c1ccccc1)CNCC2;OC1CC2CCNCC(C3CCCCC3)C2CC1O,JUDKOGFHZYMDMF-UHFFFAOYSA-N
SKF-77434,SKF-77434,,BRD:BRD-A64227845-004-09-3;BRD:BRD-BRD-A64227845-004-09-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD1,,,PRECLINICAL,,,NA,OC1CC2CCN(CC=C)CC(C3CCCCC3)C2CC1O,
SKF-81297,SKF-81297,,BRD:BRD-A09828896-004-11-0;BRD:BRD-BRD-A09828896-004-11-0,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD1;DRD5,,,PRECLINICAL,,,NA,"OC1CC2C(CNCCC2C(CL)C1O)C1CCCCC1, OC1CC2C(CNCCC2C(CL)C1O)C1CCCCC1",
SKF-83566,SKF-83566,,BRD:BRD-A52588987-004-08-2;BRD:BRD-BRD-A52588987-004-08-2,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD5,,,PRECLINICAL,,,NA,"CN1CCC2CC(BR)C(O)CC2C(C1)C1CCCCC1, CN1CCC2CC(BR)C(O)CC2C(C1)C1CCCCC1",
SKF-86002,SKF-86002,,BRD:BRD-BRD-K96809896-300-02-3;BRD:BRD-K96809896-300-02-3,rep_primary;rep_single_dose,P38 MAPK INHIBITOR,ALOX5;MAPK14,,,PRECLINICAL,,,NA,FC1CCC(CC1)-C1NC2SCCN2C1-C1CCNCC1,
SKF-89976A,SKF-89976A,,BRD:BRD-A49046702-003-08-3;BRD:BRD-BRD-A49046702-003-08-3,rep_primary;rep_single_dose,GABA UPTAKE INHIBITOR,SLC6A1,,,PRECLINICAL,,,NA,"OC(=O)C1CCCN(CCC=C(C2CCCCC2)C2CCCCC2)C1, OC(=O)C1CCCN(CCC=C(C2CCCCC2)C2CCCCC2)C1",
SKF-96365,SKF-96365,,BRD:BRD-A72703248-003-04-9;BRD:BRD-BRD-A72703248-003-04-9,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CYP3A4;PKD2;TRPC1;TRPC3;TRPC4;TRPC5;TRPV2,,,PRECLINICAL,,,NA,COC1CCC(CCCOC(CN2CCNC2)C2CCC(OC)CC2)CC1,
SKI-606,BOSULIF;BOSUTINIB;BOSUTINIB (AS MONOHYDRATE);BOSUTINIB HYDRATE;BOSUTINIB MONOHYDRATE;SK-606;SKI-606,CHEMBL288441,GDSC1:1019,gdsc,,,,,,,Small molecule,4,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N
SKI-II,SKI-II,,BRD:BRD-BRD-K20755323-001-05-9;BRD:BRD-K20755323-001-05-9;CTRP:375366,ctrp;rep_multi_dose;rep_primary;rep_single_dose,SPHINGOSINE KINASE INHIBITOR,SPHK1,,,PRECLINICAL,,,NA,"OC1CCC(NC2NC(CS2)-C2CCC(CL)CC2)CC1, OC1CCC(NC2NC(CS2)-C2CCC(CL)CC2)CC1, OC1CCC(NC2NC(CS2)-C2CCC(CL)CC2)CC1",
SKLB-1028,SKLB-1028,,BRD:BRD-K00004690-001-01-9,rep_single_dose,"ABL KINASE INHIBITOR, EGFR INHIBITOR, FLT3 INHIBITOR",,,,,,,NA,,
SKLB1002,SKLB1002,,BRD:BRD-BRD-K29895144-001-01-0;BRD:BRD-K29895144-001-01-0,rep_primary;rep_single_dose,VEGFR INHIBITOR,KDR,,,PRECLINICAL,,,NA,COC1CC2NCNC(SC3NNC(C)S3)C2CC1OC,
SL0101,SL 0101-1;SL-0101;SL0101,,GDSC1:1039,gdsc,,,,,,,,NA,,
SLV-319-(+/-),SLV-319-(+/-),,BRD:BRD-A54228901-001-01-7;BRD:BRD-BRD-A54228901-001-01-7,rep_primary;rep_single_dose,CANNABINOID RECEPTOR ANTAGONIST,CNR1;DRD2;HTR1A,,,PHASE 2,,,NA,C\N=C(\NS(=O)(=O)C1CCC(CL)CC1)N1CC(C(=N1)C1CCC(CL)CC1)C1CCCCC1,
SLV320,DERENOFYLLINE;SLV-320;SLV320,CHEMBL592435,BRD:BRD-BRD-K34445261-001-02-2;BRD:BRD-K34445261-001-02-2,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PHASE 2,,Small molecule,2,"O[C@H]1CC[C@@H](CC1)NC1NC(NC2[NH]CCC12)-C1CCCCC1, O[C@H]1CC[C@@H](CC1)NC1NC(NC2[NH]CCC12)-C1CCCCC1;OC1CCC(Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1",RBZNJGHIKXAKQE-UHFFFAOYSA-N
SM-108,SM-108,,BRD:BRD-BRD-K70053378-001-01-1;BRD:BRD-K70053378-001-01-1,rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,"NC(=O)C1[NH]CNC1O, NC(=O)C1[NH]CNC1O",
SM-164,SM-164,,BRD:BRD-K06191411-001-02-5,rep_single_dose,XIAP INHIBITOR,BIRC2;BIRC3;XIAP,,,,,,NA,,
SM-21,SM-21,,BRD:BRD-A92933783-050-01-6;BRD:BRD-BRD-A92933783-050-01-6,rep_primary;rep_single_dose,SIGMA RECEPTOR ANTAGONIST,PGRMC1,,,PRECLINICAL,,,NA,CCC(OC1CCC(CL)CC1)C(=O)OC1CC2CCC(C1)N2C,
SMER-28,SMER-28,,BRD:BRD-BRD-K08478539-001-13-8;BRD:BRD-K08478539-001-13-8,rep_primary;rep_single_dose,AUTOPHAGY INDUCER,SNCA,,,PRECLINICAL,,,NA,BRC1CCC2NCNC(NCC=C)C2C1,
SMER-3,SMER-3,,CTRP:660286,ctrp,,,,,,,,NA,,
SMI-4A,SMI-4A,,BRD:BRD-BRD-K70159787-001-01-1;BRD:BRD-K70159787-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,PIM KINASE INHIBITOR,PIM1,,,PRECLINICAL,,,NA,FC(F)(F)C1CCCC(C1)\C=C1\SC(=O)NC1=O,
SN-38,7-ETHYL-10-HYDROXY-;7-ETHYL-10-HYDROXY-CAMPTOTHECIN;7-ETHYL-10-HYDROXYCAMPTOTHECIN;CAMPTOTHECIN;IRINOTECAN RELATED COMPOUND B;IT-141;NK 012;NK-012;NK012;SN 38;SN-38,CHEMBL837,GDSC1:1494,gdsc,,,,,,,Small molecule,2,CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,FJHBVJOVLFPMQE-QFIPXVFZSA-N
SN-2,SN-2,,BRD:BRD-A64319165-001-07-0;BRD:BRD-BRD-A64319165-001-07-0,rep_primary;rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,MCOLN3,,,PRECLINICAL,,,NA,CC1CC(C)C(C2=NOC3C4CCC(C4)C23)C(C)C1,
SN38,7-ETHYL-10-HYDROXY-;7-ETHYL-10-HYDROXY-CAMPTOTHECIN;7-ETHYL-10-HYDROXYCAMPTOTHECIN;CAMPTOTHECIN;IRINOTECAN RELATED COMPOUND B;IT-141;NK 012;NK-012;NK012;SN 38;SN-38;SN38,CHEMBL837,BRD:BRD-BRD-K89561498-001-01-7;BRD:BRD-K89561498-001-01-7;BRD:BRD-K89561498-001-02-5;BRD:BRD-U00115289-001-01-9;CTRP:375637;GDSC1:1494,ctrp;gdsc;oncref_1;rep_multi_dose;rep_primary;rep_single_dose,INHIBITOR OF TOPOISOMERASE 1,TOP1;TOP1A,COLORECTAL CANCER,,LAUNCHED,"Multiple values for MOA: {'INHIBITOR OF TOPOISOMERASE 1', 'TOPOISOMERASE INHIBITOR'}, defaulting to 'INHIBITOR OF TOPOISOMERASE 1'
Multiple values for repurposing_target: {'TOP1A', 'TOP1'}, taking the union",Small molecule,2,"CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC;CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(O)CC12, CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(O)CC12, CCC1C2CN3C(CC4C(COC(=O)[C@]4(O)CC)C3=O)-C2NC2CCC(O)CC12",FJHBVJOVLFPMQE-QFIPXVFZSA-N
SN-6,SN-6,,BRD:BRD-A14316475-001-02-3;BRD:BRD-BRD-A14316475-001-02-3,rep_primary;rep_single_dose,SODIUM/CALCIUM EXCHANGE INHIBITOR,,,,PRECLINICAL,,,NA,"CCOC(=O)C1CSC(N1)CC1CCC(OCC2CCC([N+]([O-])=O)CC2)CC1, CCOC(=O)C1CSC(N1)CC1CCC(OCC2CCC([N+]([O-])=O)CC2)CC1",
SNAP,SNAP,,BRD:BRD-A67006024-001-04-8;BRD:BRD-BRD-A67006024-001-04-8,rep_primary;rep_single_dose,NITRIC OXIDE DONOR,PTPN1,,,PHASE 2,,,NA,"CC(=O)NC(C(O)=O)C(C)(C)S[N+][O-], CC(=O)NC(C(O)=O)C(C)(C)S[N+][O-]",
SNAP-94847,SNAP-94847,,BRD:BRD-BRD-K49702221-003-01-6;BRD:BRD-K49702221-003-01-6,rep_primary;rep_single_dose,,ADRA1A;DRD2,,,PRECLINICAL,,,NA,"CC(C)C(=O)NC1CCC(C)C(C1)C1CCN(CC2CCC(OC3CCC(F)C(F)C3)CC2)CC1, CC(C)C(=O)NC1CCC(C)C(C1)C1CCN(CC2CCC(OC3CCC(F)C(F)C3)CC2)CC1",
SNC-80,SNC-80,CHEMBL13470,BRD:BRD-BRD-K29546239-001-02-3;BRD:BRD-K29546239-001-02-3,rep_primary;rep_single_dose,,OPRD1,,,PRECLINICAL,,Small molecule,NA,"C=CCN1C[C@H](C)N([C@H](c2ccc(C(=O)N(CC)CC)cc2)c2cccc(OC)c2)C[C@H]1C;CCN(CC)C(=O)C1CCC(CC1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)C1CCCC(OC)C1, CCN(CC)C(=O)C1CCC(CC1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)C1CCCC(OC)C1",KQWVAUSXZDRQPZ-UMTXDNHDSA-N
SNDX5613,REVUMENIB SESQUIFUMARATE;SNDX 5613;SNDX-50613;SNDX-5613;SNDX50613;SNDX5613,CHEMBL4650278,BRD:BRD-K00090651-001-01-9,rep_single_dose,,,,,,,Small molecule,1,CCN(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(C[C@H]3CC[C@H](NS(=O)(=O)CC)CC3)CC2)C1)C(C)C.CCN(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(C[C@H]3CC[C@H](NS(=O)(=O)CC)CC3)CC2)C1)C(C)C.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O,AXNUWYROYVRYIM-OQIJCFCCSA-N
SNG-1153,SNG-1153,,BRD:BRD-K75016267-001-02-9,rep_single_dose,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),ESR1,,,,,,NA,,
SNS-032,BMS-387032;BMS387032;SNS 032;SNS-032,CHEMBL296468,CTRP:606254,ctrp,,,,,,,Small molecule,1,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,OUSFTKFNBAZUKL-UHFFFAOYSA-N
SNS-314 MESYLATE,SNS 314;SNS-314;SNS-314 MESYLATE,CHEMBL482767;CHEMBL518051,BRD:BRD-BRD-K71512533-066-02-8;BRD:BRD-K71512533-066-02-8,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB;AURKC,,,PHASE 1,,Small molecule,NA,"CLC1CCCC(NC(=O)NC2NCC(CCNC3NCNC4CCSC34)S2)C1, CLC1CCCC(NC(=O)NC2NCC(CCNC3NCNC4CCSC34)S2)C1;CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1",FYCODPVDEFFWSR-UHFFFAOYSA-N
SNX 2112,SNX 2112,,GDSC1:328,gdsc,,,,,,,,NA,,
SNX-2112,PF-04928473;SNX-2112,CHEMBL560895,BRD:BRD-BRD-K71281111-001-04-3;BRD:BRD-K71281111-001-04-3;CTRP:362338;GDSC1:328,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,,,,PHASE 1,,Small molecule,-1,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](O)CC4)c3)c2C1;CC1(C)CC2C(C(NN2-C2CCC(C(N)=O)C(N[C@H]3CC[C@H](O)CC3)C2)C(F)(F)F)C(=O)C1,ZFVRYNYOPQZKDG-MQMHXKEQSA-N
SNX-2112:BORTEZOMIB (250:1 MOL/MOL),SNX-2112:BORTEZOMIB (250:1 MOL/MOL),,CTRP:660251,ctrp,,,,,,,,NA,,
SNX-5422,PF-04929113;PF-4929113;SNX 5422;SNX-5422,CHEMBL1195136,BRD:BRD-BRD-K73197500-001-02-2;BRD:BRD-K73197500-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1;HSP90AB1,,,PHASE 1/PHASE 2,"Multiple values for repurposing_target: {'HSP90AA1', 'HSP90AA1;HSP90AB1'}, taking the union",Small molecule,2,"CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](OC(=O)CN)CC4)c3)c2C1;CC1(C)CC2C(C(NN2-C2CCC(C(N)=O)C(N[C@H]3CC[C@@H](CC3)OC(=O)CN)C2)C(F)(F)F)C(=O)C1, CC1(C)CC2C(C(NN2-C2CCC(C(N)=O)C(N[C@H]3CC[C@@H](CC3)OC(=O)CN)C2)C(F)(F)F)C(=O)C1, CC1(C)CC2C(C(NN2-C2CCC(C(N)=O)C(N[C@H]3CC[C@@H](CC3)OC(=O)CN)C2)C(F)(F)F)C(=O)C1",AVDSOVJPJZVBTC-CTYIDZIISA-N
SOBETIROME,GC-1;QRX-431;SOBETIROME,CHEMBL107400,BRD:BRD-BRD-K85406984-001-01-0;BRD:BRD-K85406984-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,THYROID HORMONE RECEPTOR AGONIST,THRA;THRB,,,PHASE 1,,Small molecule,1,"CC(C)C1CC(CC2C(C)CC(OCC(O)=O)CC2C)CCC1O, CC(C)C1CC(CC2C(C)CC(OCC(O)=O)CC2C)CCC1O;Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1",QNAZTOHXCZPOSA-UHFFFAOYSA-N
TZT-1027,AURISTATIN PE;SOBLIDOTIN;TZT-1027,CHEMBL3989512,BRD:BRD-K00003174-001-01-9,rep_single_dose,MICROTUBULE INHIBITOR,,,,,,Small molecule,2,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C,DZMVCVHATYROOS-ZBFGKEHZSA-N
SOBUZOXANE,SOBUZOXANE,CHEMBL1256871,BRD:BRD-K87595680-001-05-9,rep_single_dose,TOPOISOMERASE INHIBITOR,,,,,,Small molecule,-1,CC(C)COC(=O)OCN1C(=O)CN(CCN2CC(=O)N(COC(=O)OCC(C)C)C(=O)C2)CC1=O,OCOKWVBYZHBHLU-UHFFFAOYSA-N
SODIUM-ASCORBATE,SODIUM-ASCORBATE,,BRD:BRD-A67265925-236-02-6,rep_single_dose,,,,,,,,NA,,
SODIUM-BUTYRATE,SODIUM-BUTYRATE,,BRD:BRD-BRD-K05878375-236-05-7;BRD:BRD-K05878375-236-05-7,rep_primary;rep_single_dose,HDAC INHIBITOR,BCHE;FFAR2;FFAR3;HDAC1;HDAC2;HDAC3;HDAC8,,,PHASE 2,,,NA,"CCCC(O)=O, CCCC(O)=O",
SODIUM-DANSHENSU,SODIUM-DANSHENSU,,BRD:BRD-A93699261-236-03-4;BRD:BRD-BRD-A93699261-236-03-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"OC(CC1CCC(O)C(O)C1)C(O)=O, OC(CC1CCC(O)C(O)C1)C(O)=O",
SODIUM-DODECYL-SULFATE,SODIUM-DODECYL-SULFATE,,BRD:BRD-M58433298-001-02-4,rep_single_dose,,ALB,,,,,,NA,,
SODIUM-GLUCOHEPTONATE,SODIUM-GLUCOHEPTONATE,,BRD:BRD-BRD-K35952844-236-01-6,rep_primary,,,,,LAUNCHED,,,NA,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O,
SODIUM-GLUCONATE,SODIUM-GLUCONATE,,BRD:BRD-BRD-M54096567-001-01-9;BRD:BRD-M54096567-001-01-9,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,"OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O, [NA].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O, [NA].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O",
SODIUM-GUALENATE,SODIUM-GUALENATE,,BRD:BRD-BRD-K80043866-236-01-1;BRD:BRD-K80043866-236-01-1,rep_primary;rep_single_dose,ANTACID,,,,LAUNCHED,,,NA,CC(C)C1CCC(C)C2C(CC(C)C2C1)S(O)(=O)=O,
SODIUM-MONOFLUOROPHOSPHATE,SODIUM-MONOFLUOROPHOSPHATE,,BRD:BRD-BRD-K99308954-304-02-4;BRD:BRD-K99308954-304-02-4,rep_primary;rep_single_dose,,PYGM,CAVITIES,,LAUNCHED,,,NA,"OP(O)(F)=O, OP(O)(F)=O, OP(O)(F)=O",
SODIUM-NITRITE,SODIUM-NITRITE,,BRD:BRD-K61230716-236-03-5,rep_single_dose,NITRIC OXIDE DONOR,,,,,,,NA,,
SODIUM-NITROPRUSSIDE,SODIUM-NITROPRUSSIDE,,BRD:BRD-K00003606-380-01-9,rep_single_dose,NITRIC OXIDE DONOR,,,,,,,NA,,
SODIUM-ORTHOVANADATE,SODIUM-ORTHOVANADATE,,BRD:BRD-K60600693-314-03-2,rep_single_dose,,,,,,,,NA,,
SODIUM-OXYBATE,SODIUM-OXYBATE,,BRD:BRD-BRD-K82166906-236-02-8;BRD:BRD-K82166906-236-02-8,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRB1;HCAR1;SLC52A2,NARCOLEPSY,,LAUNCHED,,,NA,OCCCC(O)=O,
SODIUM-PICOSULFATE,SODIUM-PICOSULFATE,,BRD:BRD-BRD-K77251551-304-02-9;BRD:BRD-K77251551-304-02-9,rep_primary;rep_single_dose,,,CONSTIPATION,,LAUNCHED,,,NA,OS(=O)(=O)OC1CCC(CC1)C(C1CCC(OS(O)(=O)=O)CC1)C1CCCCN1,
SODIUM-SALICYLATE,SODIUM-SALICYLATE,,BRD:BRD-BRD-K93632104-001-18-0,rep_primary,PROSTANOID RECEPTOR ANTAGONIST,ASIC3;PTGS1;PTGS2,"FEVER, PAIN RELIEF",,LAUNCHED,,,NA,"OC(=O)C1CCCCC1O, OC(=O)C1CCCCC1O",
SODIUM-STIBOGLUCONATE,SODIUM-STIBOGLUCONATE,,BRD:BRD-A60786380-412-01-5;BRD:BRD-BRD-A60786380-412-01-5,rep_multi_dose;rep_primary;rep_single_dose,TYROSINE PHOSPHATASE INHIBITOR,PTPN6;TOP1,LEISHMANIASIS,,LAUNCHED,,,NA,OCC(O)C1O[SB]2(O)(O[SB]34(O)OC(C(O)CO)C(O3)C(O4)C(O)=O)OC1C(O2)C(O)=O,
SODIUM-TANSHINONE-II-A-SULFONATE,SODIUM-TANSHINONE-II-A-SULFONATE,,BRD:BRD-BRD-K84798689-236-02-9;BRD:BRD-K84798689-236-02-9,rep_multi_dose;rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,,,,PHASE 2,,,NA,CC1C2C(OC1S(O)(=O)=O)-C1CCC3C(CCCC3(C)C)C1C(=O)C2=O,
SODIUM-TETRADECYL-SULFATE,SODIUM-TETRADECYL-SULFATE,,BRD:BRD-A55664972-236-02-6;BRD:BRD-BRD-A55664972-236-02-6;BRD:BRD-BRD-K84544951-236-01-0;BRD:BRD-K84544951-236-01-0,rep_primary;rep_single_dose,,PROC;PROS1,"VARICOSE VEINS, VARICOSE VEINS",,LAUNCHED,"Multiple values for structure_id: {'K84544951', 'A55664972'}, defaulting to None",,NA,"CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O, CCCCCCCCCCCCCCOS(O)(=O)=O",
SU-88,SOFALCONE;SOLON;SU-88,CHEMBL1441961,BRD:BRD-BRD-K01039503-001-01-2;BRD:BRD-K01039503-001-01-2,rep_primary;rep_single_dose,MUCUS PROTECTING AGENT,CBR1,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,-1,CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1;CC(C)=CCOC1CCC(\C=C\C(=O)C2CCC(OCC=C(C)C)CC2OCC(O)=O)CC1,GFWRVVCDTLRWPK-KPKJPENVSA-N
SOFOSBUVIR-IMPURITY-M,SOFOSBUVIR-IMPURITY-M,,BRD:BRD-K00003527-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,,NA,,
YF476,NETAZEPIDE;SOGRAZEPIDE;YF-476;YF476,CHEMBL324547,BRD:BRD-K00004608-001-01-9,rep_single_dose,GASTRIN INHIBITOR,,,,,,Protein,2,CNc1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,YDZYKNJZCVIKPP-VWLOTQADSA-N
SOLAMARGINE,SOLAMARGINE,CHEMBL443114,BRD:BRD-A65562236-001-01-2;BRD:BRD-BRD-A65562236-001-01-2,rep_primary;rep_single_dose,APOPTOSIS INHIBITOR,,,,PHASE 3,,Small molecule,NA,C[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C;CC1C2C(CC3C4CC=C5CC(CCC5(C)C4CCC23C)OC2OC(CO)C(OC3OC(C)C(O)C(O)C3O)C(O)C2OC2OC(C)C(O)C(O)C2O)OC11CCC(C)CN1,MBWUSSKCCUMJHO-ZGXDEBHDSA-N
SOLCITINIB,G-154578;G154578;GLPG-0778;GLPG-0788;GLPG0778;GSK-2586184;GSK-2586184A;GSK2586184A;SOLCITINIB,CHEMBL3301606,BRD:BRD-BRD-K69215269-001-01-1;BRD:BRD-K69215269-001-01-1,rep_primary;rep_single_dose,JAK INHIBITOR,JAK1,,,PHASE 1,,Small molecule,2,CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1;CC1(C)CN(C1)C(=O)C1CCC(CC1)-C1CCCC2NC(NC(=O)C3CC3)NN12,MPYACSQFXVMWNO-UHFFFAOYSA-N
SOLIFENACIN-SUCCINATE,SOLIFENACIN-SUCCINATE,,BRD:BRD-BRD-K24723746-036-02-5;BRD:BRD-K24723746-036-02-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,"URINARY INCONTINENCE, URINARY FREQUENCY",,LAUNCHED,,,NA,"O=C(O[C@H]1CN2CCC1CC2)N1CCC2CCCCC2[C@@H]1C1CCCCC1, O=C(O[C@H]1CN2CCC1CC2)N1CCC2CCCCC2[C@@H]1C1CCCCC1",
SOLITHROMYCIN,CEM 101;CEM-101;OP 1068;OP-1068;SOLITHROMYCIN,CHEMBL1232510;CHEMBL1240704,BRD:BRD-BRD-K32256160-001-01-9;BRD:BRD-K32256160-001-01-9,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,,,PHASE 3,,Small molecule,3,CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCN3CC(NN3)-C3CCCC(N)C3)C(=O)O[C@]12C)OC;CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C;CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)C[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C,IXXFZUPTQVDPPK-ZAWHAJPISA-N;QHOXYVNRQLJLAO-FDCTVVDYSA-N
YKP-10A,ADX-N-05;JZP-110;JZP-110 HYDROCHLORIDE;R-228060;SKL-N-05;SOLRIAMFETOL;SOLRIAMFETOL HYDROCHLORIDE;SUNOSI;YKP-10A,CHEMBL4297212;CHEMBL4297620,BRD:BRD-K00004707-001-01-9,rep_single_dose,DOPAMINE REUPTAKE INHIBITOR,,,,,,Small molecule,4,NC(=O)OC[C@H](N)Cc1ccccc1,UCTRAOBQFUDCSR-SECBINFHSA-N
SOMANTADINE,SOMANTADINE,CHEMBL2111145,BRD:BRD-BRD-K85764479-003-01-0;BRD:BRD-K85764479-003-01-0,rep_primary;rep_single_dose,ANTIVIRAL,,,,PHASE 1,,Small molecule,-1,CC(C)(N)CC12CC3CC(CC(C3)C1)C2,OWKXRDQRMTVCEX-UHFFFAOYSA-N
SRIF-14,SOMATOSTATIN;SOMATOSTATIN-14;SRIF-14,CHEMBL1823872,BRD:BRD-BRD-K14681867-001-01-6;BRD:BRD-K14681867-001-01-6,rep_primary;rep_single_dose,SOMATOSTATIN RECEPTOR AGONIST,OPRD1;OPRM1;SSTR1;SSTR2;SSTR3;SSTR4;SSTR5,HEMORRHAGE,,LAUNCHED,,Protein,3,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2C[NH]C3CCCCC23)NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2CCCCC2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N;C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O,NHXLMOGPVYXJNR-ATOGVRKGSA-N
U-101387,SONEPIPRAZOLE;U-101387,CHEMBL69759,BRD:BRD-K69857269-001-03-9,rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,NS(=O)(=O)c1ccc(N2CCN(CC[C@@H]3OCCc4ccccc43)CC2)cc1,WNUQCGWXPNGORO-NRFANRHFSA-N
SONIDEGIB,ERISMODEGIB;LDE 225;LDE-225;LDE225;NVP-LDE 225;NVP-LDE-225;NVP-LDE225;SONIDEGIB,CHEMBL2105737,BRD:BRD-BRD-K19796430-001-05-6;BRD:BRD-K19796430-001-05-6,rep_multi_dose;rep_primary;rep_single_dose,SMOOTHENED RECEPTOR ANTAGONIST,SMO,BASAL CELL CARCINOMA (BCC),,LAUNCHED,,Small molecule,4,"C[C@H]1CN(C[C@@H](C)O1)C1CCC(NC(=O)C2CCCC(-C3CCC(OC(F)(F)F)CC3)C2C)CN1, C[C@H]1CN(C[C@@H](C)O1)C1CCC(NC(=O)C2CCCC(-C3CCC(OC(F)(F)F)CC3)C2C)CN1;Cc1c(C(=O)Nc2ccc(N3C[C@@H](C)O[C@@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1",VZZJRYRQSPEMTK-CALCHBBNSA-N
SOPHOCARPINE,SOPHOCARPINE,CHEMBL377725,BRD:BRD-BRD-K66845263-001-03-0;BRD:BRD-K66845263-001-03-0,rep_primary;rep_single_dose,,,,,PHASE 3,,Small molecule,NA,"O=C1C=CC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34;O=C1C=CC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34, O=C1C=CC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34, O=C1C=CC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34",AAGFPTSOPGCENQ-JLNYLFASSA-N
SORAFENIB,BAY 43-9006;BAY-43-9006;NEXAVAR;SORAFENIB,CHEMBL1336,BRD:BRD-BRD-K23984367-075-15-2;BRD:BRD-K23984367-001-07-5;BRD:BRD-K23984367-075-15-2;CTRP:349006;GDSC1:30;GDSC2:1085,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAF INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRAF;DDR2;FGFR1;FLT1;FLT3;FLT4;KDR;KIT;PDGFRB;RAF1;RET,"RENAL CELL CARCINOMA (RCC), THYROID CANCER, HEPATOCELLULAR CARCINOMA (HCC)",,LAUNCHED,,Small molecule,4,"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1;CNC(=O)C1CC(OC2CCC(NC(=O)NC3CCC(CL)C(C3)C(F)(F)F)CC2)CCN1, CNC(=O)C1CC(OC2CCC(NC(=O)NC3CCC(CL)C(C3)C(F)(F)F)CC2)CCN1",MLDQJTXFUGDVEO-UHFFFAOYSA-N
SORAPRAZAN,SORAPRAZAN,CHEMBL2105502,BRD:BRD-K00004585-001-01-9,rep_single_dose,PROTON PUMP INHIBITOR,,,,,,Small molecule,-1,COCCO[C@@H]1c2ccn3c(C)c(C)nc3c2N[C@H](c2ccccc2)[C@H]1O,PWILYDZRJORZDR-MISYRCLQSA-N
SORBIC-ACID,SORBIC-ACID,,BRD:BRD-BRD-K55892330-001-01-8;BRD:BRD-K55892330-001-01-8,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC=CC=CC(O)=O,
SORBINIL,"CP-45,634;CP-45634;NSC-355082;SORBINIL",CHEMBL266497,BRD:BRD-A89164055-001-03-3;BRD:BRD-BRD-A89164055-001-03-3,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,AKR1B1,,,PHASE 3,,Small molecule,3,FC1CCC2OCCC3(NC(=O)NC3=O)C2C1;O=C1NC(=O)[C@@]2(CCOc3ccc(F)cc32)N1,LXANPKRCLVQAOG-NSHDSACASA-N
SORBITOL-,7B5697N;D-;D-GLUCITOL;D-GLUCITOL SYRUP;D-SORBITOL;E 420;E-420(I);E420;FEMA NO. 3029;GLUCITOL;INS NO.420(I);INS-420(I);ISOMALT IMPURITY;NEOSORB P 60W;NSC-25944;SORBITOL;SORBITOL (E420);SORBITOL SOLUTIONS;SORBITOL-,CHEMBL1682,BRD:BRD-BRD-K66035042-001-10-1;BRD:BRD-K66035042-001-10-1,rep_primary;rep_single_dose,MUCOLYTIC AGENT,,,,LAUNCHED,,Small molecule,4,"OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO;OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO, OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO",FBPFZTCFMRRESA-JGWLITMVSA-N
SOTAGLIFLOZIN,LP-802034;LX-4211;LX4211;SAR-439954;SAR439954;SOTAGLIFLOZIN,CHEMBL3039507,BRD:BRD-BRD-K05850076-001-01-5;BRD:BRD-K05850076-001-01-5,rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,SLC5A1;SLC5A2,,,PHASE 3,,Small molecule,4,CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1;CCOC1CCC(CC2CC(CCC2CL)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)CC1,QKDRXGFQVGOQKS-CRSSMBPESA-N
SOTALOL,(S)-;(S)-SOTALOL;BETAPACE;C07AA07;D-;D-SOTALOL;DAROB MITE;DEXSOTALOL;DL-SOTALOL;L-SOTALOL;MJ-1999;SORINE;SOTALOL,CHEMBL252312;CHEMBL471,BRD:BRD-A33168282-003-18-0;BRD:BRD-BRD-A33168282-003-18-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;KCNH2,"ATRIAL FIBRILLATION (AF), VENTRICULAR ARRHYTHMIAS",,LAUNCHED,,Small molecule,4,"CC(C)NC[C@@H](O)c1ccc(NS(C)(=O)=O)cc1;CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1;CC(C)NCC(O)C1CCC(NS(C)(=O)=O)CC1, CC(C)NCC(O)C1CCC(NS(C)(=O)=O)CC1, CC(C)NCC(O)C1CCC(NS(C)(=O)=O)CC1",ZBMZVLHSJCTVON-GFCCVEGCSA-N;ZBMZVLHSJCTVON-UHFFFAOYSA-N
SOTRASTAURIN,AEB-071;AEB071;NVP-AEB071;SOTRASTAURIN,CHEMBL565612,BRD:BRD-BRD-K16761703-001-03-8;BRD:BRD-K16761703-001-03-8;CTRP:661032,ctrp;rep_primary;rep_single_dose,PKC INHIBITOR,PRKCA;PRKCB;PRKCD;PRKCE;PRKCH;PRKCQ,,,PHASE 2,,Small molecule,2,CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1;CN1CCN(CC1)C1NC(C2=C(C(=O)NC2=O)C2C[NH]C3CCCCC23)C2CCCCC2N1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N
SP-100030,SP-100030,,BRD:BRD-K71900389-001-02-9,rep_single_dose,NFKB PATHWAY INHIBITOR,JUN;NFKB1,,,,,,NA,,
SP-141,SP-141,,BRD:BRD-BRD-K28571773-001-01-6;BRD:BRD-K28571773-001-01-6,rep_primary;rep_single_dose,UBIQUITIN LIGASE INHIBITOR,MDM2,,,PRECLINICAL,,,NA,COC1CCC2[NH]C3C(NCCC3C2C1)-C1CCCC2CCCCC12,
SP-420,SP-420,CHEMBL1092665,BRD:BRD-BRD-K23005288-001-01-8;BRD:BRD-K23005288-001-01-8,rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,2,COCCOCCOC1CCC(C2=N[C@](C)(CS2)C(O)=O)C(O)C1;COCCOCCOc1ccc(C2=N[C@@](C)(C(=O)O)CS2)c(O)c1,YASYAEVZKXPYIZ-MRXNPFEDSA-N
SPAGLUMIC-ACID,SPAGLUMIC-ACID,,BRD:BRD-BRD-K68405354-001-06-4;BRD:BRD-BRD-K68405354-001-07-2;BRD:BRD-K68405354-001-06-4;BRD:BRD-K68405354-001-07-2,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM3,"ALLERGIC CONJUNCTIVITIS, ALLERGIC RHINITIS",,LAUNCHED,,,NA,"CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O",
ZAGAM,AT-4140;CI-978;NSC-759641;SPARA;SPARFLOXACIN;ZAGAM,CHEMBL850,BRD:BRD-BRD-K07612980-001-05-3;BRD:BRD-BRD-K07612980-001-07-9;BRD:BRD-K07612980-001-05-3;BRD:BRD-K07612980-001-07-9,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,,,WITHDRAWN,,Small molecule,4,"C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1;C[C@H]1CN(C[C@@H](C)N1)C1C(F)C(N)C2C(C1F)N(CC(C(O)=O)C2=O)C1CC1, C[C@H]1CN(C[C@@H](C)N1)C1C(F)C(N)C2C(C1F)N(CC(C(O)=O)C2=O)C1CC1, C[C@H]1CN(C[C@@H](C)N1)C1C(F)C(N)C2C(C1F)N(CC(C(O)=O)C2=O)C1CC1",DZZWHBIBMUVIIW-DTORHVGOSA-N
SPARSENTAN,PS-433540;PS433540;RE-021;SPARSENTAN,CHEMBL539423,BRD:BRD-K00003253-001-01-9,rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,,,,,,Small molecule,3,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1,WRFHGDPIDHPWIQ-UHFFFAOYSA-N
SPARTEINE-(+),SPARTEINE-(+),,BRD:BRD-K38203080-001-01-2,rep_single_dose,,,,,,,,NA,,
SPARTEINE-(-),SPARTEINE-(-),,BRD:BRD-K86872788-065-01-5,rep_single_dose,,,,,,,,NA,,
SPARTEINE-SULFATE,SPARTEINE-SULFATE,,BRD:BRD-BRD-K32847234-065-04-6;BRD:BRD-K32847234-065-04-6,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,C1CCN2C[C@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1,
SPAUTIN-1,SPAUTIN-1,,BRD:BRD-K84964099-001-03-9;CTRP:657183,ctrp;rep_single_dose,DEUBIQUITINASE INHIBITOR,USP10;USP13,,,,,,NA,,
SPERMIDINE,SPERMIDINE,CHEMBL19612,BRD:BRD-BRD-K40438880-305-06-6;BRD:BRD-K40438880-305-06-6,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR MODULATOR,KCNJ4;TXNRD1,,,PRECLINICAL,,Small molecule,3,NCCCCNCCCN,ATHGHQPFGPMSJY-UHFFFAOYSA-N
SPERMINE,"4,9-DIAZADODECAMETHYLENEDIAMINE;ACTILIP SP-91;GEROTINE;MUSCULAMINE;NEURIDINE;NSC-268508;SPERMINE",CHEMBL23194,BRD:BRD-BRD-K18375018-376-02-3;BRD:BRD-K18375018-376-02-3,rep_multi_dose;rep_primary;rep_single_dose,,CA14;CA4;CA6;CA9;CASR;GRIN1;GRIN2A;KCNJ4;ODC1;SMOX;SMS;TRPM4;TRPM5,,,PRECLINICAL,,Small molecule,0.5,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N
SPHINGOSINE KINASE 1 INHIBITOR II,SPHINGOSINE KINASE 1 INHIBITOR II,,GDSC1:408,gdsc,,,,,,,,NA,,
SPHINGOSYLPHOSPHORYLCHOLINE,SPHINGOSYLPHOSPHORYLCHOLINE,,BRD:BRD-A35379661-001-04-6;BRD:BRD-BRD-A35379661-001-04-6,rep_primary;rep_single_dose,GENE EXPRESSION STIMULANT,GPR12,,,PRECLINICAL,,,NA,CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(=O)OCC[N+](C)(C)C,
XDE-105,BLACKHAWK;COMFORTIS;DE-105;EXTINOSAD;LY-232105;NATROBA;NATROVA;NATURALYTE;PP-105;SPINOSAD;SPINOSAD (EMA EPAR: VETERINARY);SPINOSYNS SPINOSAD;SPINTOR;XDE-105,CHEMBL2040681;CHEMBL4297065,BRD:BRD-K00080753-001-01-9,rep_single_dose,,,,,,,Small molecule,4,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C(C)[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@H]3[C@@H]4C[C@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@H]4C=C[C@H]3C2CC(=O)O1,JFLRKDZMHNBDQS-UCQUSYKYSA-N
SPIROPITAN,NSC-170983;R 5147;R-5147;SPIPERONE;SPIROPITAN,CHEMBL267930,BRD:BRD-BRD-K55468218-001-26-1;BRD:BRD-K55468218-001-26-1,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;DRD1;DRD2;DRD3;DRD4;DRD5;HTR1A;HTR1D;HTR2A;HTR2B;HTR2C;HTR6;HTR7,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,-1,"FC1CCC(CC1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1CCCCC1, FC1CCC(CC1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1CCCCC1;O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1",DKGZKTPJOSAWFA-UHFFFAOYSA-N
U-62066,SPIRADOLINE;U-62066,CHEMBL118865;CHEMBL70586,BRD:BRD-BRD-K28192623-066-08-1;BRD:BRD-K28192623-066-08-1,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRK1,,,PHASE 2,,Small molecule,NA,CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1)C(=O)CC1CCC(CL)C(CL)C1;CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1,NYKCGQQJNVPOLU-ONTIZHBOSA-N
SPIRAMYCIN I,ACETYLSPIRAMYCIN;IL 5902;IL-5902;NSC-55926;NSC-64393;NSC-758472;ROVAMICINA;ROVAMYCIN;ROVAMYCINE;ROVAMYCINE 250;RP 5337;RP-5337;SELECTOMYCIN;SPIRAMYCIN;SPIRAMYCIN I,CHEMBL453514,BRD:BRD-A67305656-001-01-5;BRD:BRD-BRD-A67305656-001-01-5,rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,"TOXOPLASMOSIS, SOFT TISSUE INFECTION",,LAUNCHED,,Small molecule,4,"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O;CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C, CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C, CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C",ACTOXUHEUCPTEW-CEUOBAOPSA-N
SPIRAPRIL HYDROCHLORIDE,RENORMAX;SCH 33844;SCH-33844;SPIRAPRIL HCL;SPIRAPRIL HYDROCHLORIDE,CHEMBL1200831,BRD:BRD-K00074789-001-02-9,rep_single_dose,,,,,,,Small molecule,4,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2.Cl,CLDOLNORSLLQDI-OOAIBONUSA-N
VEROSPIRONE,ABBOLACTONE;ALDACTONE;CAROSPIR;DIATENSEC;GX SPIRONOL;LARACTONE;NSC-150399;SC-9420;SPIRETIC;SPIROCTAN 100;SPIROCTAN 25;SPIROCTAN 50;SPIRONOLACTONE;SPIRONOLACTONE CEVA;SPIRONOLACTONUM;SPIROSPARE 100;SPIROSPARE 25;VEROSPIRONE,CHEMBL1393,BRD:BRD-BRD-K90027355-001-13-3;BRD:BRD-BRD-K90027355-001-19-0;BRD:BRD-K90027355-001-13-3;BRD:BRD-K90027355-001-19-0,rep_multi_dose;rep_primary;rep_single_dose,MINERALOCORTICOID RECEPTOR ANTAGONIST,AR;CACNA1A;CACNA1B;CACNA1C;CACNA1D;CACNA1F;CACNA1G;CACNA1H;CACNA1I;CACNA1S;CACNA2D1;CACNA2D2;CACNA2D3;CACNB1;CACNB2;CACNB3;CACNB4;CACNG1;CYP11B2;NR3C1;NR3C2;PGR;SHBG,"HYPERALDOSTERONISM, CONGESTIVE HEART FAILURE, HEPATIC CIRRHOSIS, NEPHROTIC SYNDROME, HYPERTENSION, HYPOKALEMIA",,LAUNCHED,,Small molecule,4,"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12, CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12, CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12, CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12;CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12",LXMSZDCAJNLERA-ZHYRCANASA-N
SPIROXATRINE,NSC-665322;R 5188;R-5188;SPIROXAMIDE;SPIROXATRINE,CHEMBL300555,BRD:BRD-A72483914-001-03-7;BRD:BRD-BRD-A72483914-001-03-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;HTR1A;HTR2B,,,PRECLINICAL,,Small molecule,-1,O=C1NCN(C2CCCCC2)C11CCN(CC2COC3CCCCC3O2)CC1;O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccccc3O1)CC2,JVGBTTIJPBFLTE-UHFFFAOYSA-N
SPIZOFURONE,AG-629;SPIZOFURONE,CHEMBL18098,BRD:BRD-BRD-K94934625-001-01-5;BRD:BRD-K94934625-001-01-5,rep_primary;rep_single_dose,,,,,WITHDRAWN,,Small molecule,-1,CC(=O)c1ccc2c(c1)C(=O)C1(CC1)O2;CC(=O)C1CCC2OC3(CC3)C(=O)C2C1,SETMGIIITGNLAS-UHFFFAOYSA-N
SPM-924,A-154475;A-154475.0;CEP-701;KT-555;KT-5555;KT5555;LESTAURTINIB;SP-924;SP924;SPM-924,CHEMBL603469,GDSC1:1024,gdsc,,,,,,,Small molecule,3,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,UIARLYUEJFELEN-LROUJFHJSA-N
SPP86,SPP-86;SPP86,,BRD:BRD-BRD-K63253858-001-01-5;BRD:BRD-K63253858-001-01-5,rep_primary;rep_single_dose,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,RET,,,PRECLINICAL,,,NA,CC(C)N1NC(C#CC2CCCCC2)C2C(N)NCNC12,
SPP301,AVOSENTAN;RO 67-0565;RO-67-0565;RO670565;SPP-301;SPP301,CHEMBL3989834,BRD:BRD-BRD-K19203487-001-01-4;BRD:BRD-K19203487-001-01-4,rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA,,,PHASE 3,,Small molecule,3,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccncc2)nc1OC;COC1CCCCC1OC1C(NS(=O)(=O)C2CCC(C)CN2)NC(NC1OC)-C1CCNCC1,YBWLTKFZAOSWSM-UHFFFAOYSA-N
SPRYCEL,BMS-354825;BMS-354825 HYDRATE;BMS-354825-03;DASATINIB;DASATINIB ANHYDROUS;DASATINIB HYDRATE;DASATINIB MONOHYDRATE;NSC-759877;SPRYCEL,CHEMBL1421,GDSC1:51;GDSC2:1079,gdsc,,,,,,,Small molecule,4,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N
SQ109,NSC-722041;SQ-109;SQ109,CHEMBL561057,BRD:BRD-A08772153-001-02-4;BRD:BRD-BRD-A08772153-001-02-4,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,FDFT1,,,PHASE 3,,Small molecule,2,"CC(C)=CCC/C(C)=C/CNCCNC1C2CC3CC(C2)CC1C3;CC(C)=CCC\C(C)=C\CNCCNC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2, CC(C)=CCC\C(C)=C\CNCCNC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2",JFIBVDBTCDTBRH-REZTVBANSA-N
SQ-22536,SQ-22536,,BRD:BRD-A56987319-001-12-9;BRD:BRD-BRD-A56987319-001-12-9,rep_primary;rep_single_dose,ADENYLYL CYCLASE INHIBITOR,ADCY1,,,PRECLINICAL,,,NA,"NC1NCNC2N(CNC12)C1CCCO1, NC1NCNC2N(CNC12)C1CCCO1",
SQUALAMINE,SQUALAMINE,CHEMBL444929,BRD:BRD-K00003215-043-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,3,CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@@H](NCCCNCCCCN)CC[C@]4(C)[C@H]3CC[C@]12C)OS(=O)(=O)O,UIRKNQLZZXALBI-MSVGPLKSSA-N
SQUARIC-ACID-DIBUTYL-ESTER,SQUARIC-ACID-DIBUTYL-ESTER,,BRD:BRD-K00004684-001-01-9,rep_single_dose,OXIDATIVE STRESS INDUCER,,,,,,,NA,,
SR 146131,SR 146131,,BRD:BRD-K00076260-001-02-9,rep_single_dose,,,,,,,,NA,,
SR-1078,SR-1078,,BRD:BRD-K26501486-001-02-9,rep_single_dose,RETINOID RECEPTOR AGONIST,RORA;RORC,,,,,,NA,,
SR-140333,NOLPITANTIUM;NOLPITANTIUM CATION;NOLPITANTIUM ION;SR-140333,CHEMBL1178725,BRD:BRD-BRD-K60931454-003-01-3;BRD:BRD-K60931454-003-01-3,rep_primary;rep_single_dose,NEUROKININ RECEPTOR ANTAGONIST,TACR1,,,PHASE 2,,Small molecule,2,CC(C)Oc1cccc(CC(=O)N2CCC[C@](CC[N+]34CCC(c5ccccc5)(CC3)CC4)(c3ccc(Cl)c(Cl)c3)C2)c1;CC(C)OC1CCCC(CC(=O)N2CCC[C@@](CC[N+]34CCC(CC3)(CC4)C3CCCCC3)(C2)C2CCC(CL)C(CL)C2)C1,RPDFDSQFBCJTDY-GAQXSTBRSA-N
SR-1664,SR-1664,,BRD:BRD-K62814487-001-03-0,rep_single_dose,PPAR RECEPTOR LIGAND,PPARG,,,,,,NA,,
SR-2211,SR-2211,,BRD:BRD-K11641193-001-03-9,rep_single_dose,RETINOID RECEPTOR INVERSE AGONIST,RORC,,,,,,NA,,
SR-2640,SR-2640,CHEMBL18132,BRD:BRD-BRD-K62562723-003-02-7;BRD:BRD-K62562723-003-02-7,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,CYSLTR1,,,PHASE 2,,Small molecule,NA,"O=C(O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1;OC(=O)C1CCCCC1NC1CCCC(OCC2CCC3CCCCC3N2)C1, OC(=O)C1CCCCC1NC1CCCC(OCC2CCC3CCCCC3N2)C1",LMPZHLXYBWGGNT-UHFFFAOYSA-N
SR-27897,LINTITRIPT;SR-27897,CHEMBL249973,BRD:BRD-BRD-K35629949-001-02-0;BRD:BRD-K35629949-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKAR,,,PHASE 2,,Small molecule,-1,"O=C(O)Cn1c(C(=O)Nc2nc(-c3ccccc3Cl)cs2)cc2ccccc21;OC(=O)CN1C(CC2CCCCC12)C(=O)NC1NC(CS1)-C1CCCCC1CL, OC(=O)CN1C(CC2CCCCC12)C(=O)NC1NC(CS1)-C1CCCCC1CL",ILNRQFBVVQUOLP-UHFFFAOYSA-N
SR-31747,SR-31747,,BRD:BRD-K00074858-003-02-9,rep_single_dose,,,,,,,,NA,,
SR-3306,SR-3306,,BRD:BRD-BRD-K60952143-001-01-0;BRD:BRD-K60952143-001-01-0,rep_primary;rep_single_dose,JNK INHIBITOR,MAPK10;MAPK8;MAPK9,,,PRECLINICAL,,,NA,CC1CCC(CN1)-C1NCN(N1)-C1CCC(NC2NCCC(N2)-C2CCCC(C2)N2CCOCC2)CC1,
SR-33805,SR-33805,,BRD:BRD-BRD-K43002771-034-01-6;BRD:BRD-K43002771-034-01-6,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,PHASE 1,,,NA,"COC1CCC(CCN(C)CCCOC2CCC(CC2)S(=O)(=O)C2C(C(C)C)C3CCCCC3N2C)CC1OC, COC1CCC(CCN(C)CCCOC2CCC(CC2)S(=O)(=O)C2C(C(C)C)C3CCCCC3N2C)CC1OC",
SR-3576,SR-3576,,BRD:BRD-BRD-K50378376-001-01-8;BRD:BRD-K50378376-001-01-8,rep_primary;rep_single_dose,JNK INHIBITOR,MAPK10,,,PRECLINICAL,,,NA,COC1CC(NC(=O)C2CCCC(C2)-N2CC(NC(=O)NC3CCCC(C)C3)CN2)CC(OC)C1OC,
SR-3677,SR-3677,CHEMBL521179,BRD:BRD-A86468475-300-02-9,rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK2,,,,,Small molecule,NA,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,OQWZIAVXCYIZNN-UHFFFAOYSA-N
SR-57227A,SR-57227A,,BRD:BRD-BRD-K09397065-003-06-1;BRD:BRD-K09397065-003-06-1,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR3A,,,PHASE 2,,,NA,NC1CCN(CC1)C1CCCC(CL)N1,
SR-59230A,SR-59230A,,BRD:BRD-BRD-K35430135-003-02-3;BRD:BRD-K35430135-003-02-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3,,,PRECLINICAL,,,NA,"CCC1CCCCC1OC[C@@H](O)CN[C@H]1CCCC2CCCCC12, CCC1CCCCC1OC[C@@H](O)CN[C@H]1CCCC2CCCCC12",
SR-95639A,SR-95639A,,BRD:BRD-BRD-K19309090-300-05-5;BRD:BRD-K19309090-300-05-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1,,,PRECLINICAL,,,NA,C(CN1CCOCC1)NC1CC2CCCC3CCCCC3-C2NN1,
SR-II-138A,SR-II-138A,,CTRP:411770,ctrp,,,,,,,,NA,,
SR1001,SR1001,,CTRP:660317,ctrp,,,,,,,,NA,,
SR8278,SR8278,,CTRP:668858,ctrp,,,,,,,,NA,,
SRC-KINASE-INHIBITOR-I,SRC-KINASE-INHIBITOR-I,,BRD:BRD-BRD-K50495309-001-02-0;BRD:BRD-K50495309-001-02-0,rep_primary;rep_single_dose,SRC INHIBITOR,CSK;LCK;RIPK2,,,PRECLINICAL,,,NA,"COC1CC2NCNC(NC3CCC(OC4CCCCC4)CC3)C2CC1OC, COC1CC2NCNC(NC3CCC(OC4CCCCC4)CC3)C2CC1OC",
SRPIN340,SRPIN340,,BRD:BRD-BRD-K62621335-001-01-7;BRD:BRD-K62621335-001-01-7,rep_primary;rep_single_dose,SERINE ARGININE PROTEIN KINASE INHIBITOR,SRPK1;SRPK2,,,PRECLINICAL,,,NA,"FC(F)(F)C1CCC(N2CCCCC2)C(NC(=O)C2CCNCC2)C1, FC(F)(F)C1CCC(N2CCCCC2)C(NC(=O)C2CCNCC2)C1",
SRT-1720,SRT-1720,,CTRP:411820,ctrp,,,,,,,,NA,,
SRT1720,SRT1720,,BRD:BRD-BRD-K95926480-003-03-6;BRD:BRD-K95926480-003-03-6,rep_multi_dose;rep_primary;rep_single_dose,SIRT ACTIVATOR,SIRT1,,,PRECLINICAL,,,NA,O=C(NC1CCCCC1-C1CN2C(CN3CCNCC3)CSC2N1)C1CNC2CCCCC2N1,
SRT2104,SRT-2104;SRT2104,CHEMBL4297436,BRD:BRD-BRD-K48452630-001-01-8;BRD:BRD-K48452630-001-01-8,rep_primary;rep_single_dose,SIRT ACTIVATOR,SIRT1,,,PHASE 2,,Small molecule,2,"Cc1nc(-c2cccnc2)sc1C(=O)Nc1ccccc1-c1cn2c(CN3CCOCC3)csc2n1;CC1NC(SC1C(=O)NC1CCCCC1-C1CN2C(CN3CCOCC3)CSC2N1)-C1CCCNC1, CC1NC(SC1C(=O)NC1CCCCC1-C1CN2C(CN3CCOCC3)CSC2N1)-C1CCCNC1",LAMQVIQMVKWXOC-UHFFFAOYSA-N
SSR180711C,"J2.849.107G;SSR-180,711;SSR-180711;SSR180711;SSR180711C",CHEMBL559478,BRD:BRD-BRD-K02782351-003-01-5;BRD:BRD-K00004316-003-01-9;BRD:BRD-K02782351-003-01-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA7,,,PHASE 2,"Multiple values for structure_id: {'K02782351', 'K00004316'}, defaulting to None",Small molecule,2,BRC1CCC(OC(=O)N2CCN3CCC2CC3)CC1;O=C(Oc1ccc(Br)cc1)N1CCN2CCC1CC2,RXLOZRCLQMJJLC-UHFFFAOYSA-N
SSR128129E,SSR128129E,,BRD:BRD-BRD-K65890018-236-01-1;BRD:BRD-K65890018-236-01-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC1C(C)C(C(=O)C2CCC(N)C(C2)C(O)=O)N2CCCCC12,
SSR240612,SSR240612,,BRD:BRD-K00003186-003-01-9,rep_single_dose,BRADYKININ RECEPTOR ANTAGONIST,,,,,,,NA,,
SSTR5 ANTAGONIST 1,SSTR5 ANTAGONIST 1,,BRD:BRD-K00091080-001-01-9,rep_single_dose,,,,,,,,NA,,
ST1535,ST-1535;ST1535,CHEMBL197669,BRD:BRD-K00004706-001-01-9,rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,,,,,,Small molecule,1,CCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1,CYYQMAWUIRPCNW-UHFFFAOYSA-N
ST-1859,ST-1859,,BRD:BRD-BRD-K73524797-001-01-1;BRD:BRD-K73524797-001-01-1,rep_primary;rep_single_dose,ANTIAMYLOIDOGENIC AGENT,,,,PHASE 1,,,NA,OC1CCC2CCCCC2C1CC1C(O)CCC2CCCCC12,
ST-2825,ST-2825,,BRD:BRD-BRD-K68470841-001-01-0;BRD:BRD-K68470841-001-01-0,rep_primary;rep_single_dose,MYELOID DIFFERENTIATION PRIMARY RESPONSE INHIBITOR,MYD88,,,PRECLINICAL,,,NA,NC(=O)[C@H]1CCS[C@@H]2C[C@]3(CCCN3C(=O)CC3CCC(NC(=O)COC4CCC(CL)CC4CL)CC3)C(=O)N12,
ST-91,ST-91,,BRD:BRD-BRD-K18905250-003-02-4;BRD:BRD-K18905250-003-02-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,"CCC1CCCC(CC)C1N=C1NCCN1, CCC1CCCC(CC)C1N=C1NCCN1",
STA-5326,APILIMOD;STA 5326;STA-5326,CHEMBL4297643,BRD:BRD-BRD-K41783120-001-02-8;BRD:BRD-K41783120-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,INTERLEUKIN SYNTHESIS INHIBITOR,IL12A,,,PHASE 2,,Small molecule,2,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1;CC1CCCC(\C=N\NC2CC(NC(OCCC3CCCCN3)N2)N2CCOCC2)C1,HSKAZIJJKRAJAV-KOEQRZSOSA-N
WINSTROL DEPOT,ANDROSTANAZOL;ANDROSTANAZOLE;NSC-233046;NSC-43193;STANOZOLOL;STANOZOLOL CIII;STROMBA;TEVABOLIN;WIN 14833;WIN-14833;WINSTROL;WINSTROL DEPOT,CHEMBL2079587,BRD:BRD-BRD-K46791647-001-01-2;BRD:BRD-K46791647-001-01-2,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,AR,ANEMIA,,LAUNCHED,,Small molecule,4,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC5[NH]NCC5C[C@]4(C)[C@H]3CC[C@]12C;C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,LKAJKIOFIWVMDJ-IYRCEVNGSA-N
STAT3-INHIBITOR-VI,STAT3-INHIBITOR-VI,,BRD:BRD-K40853697-001-20-5,rep_single_dose,STAT INHIBITOR,STAT3,,,,,,NA,,
STATIL,STATIL,,BRD:BRD-K68332390-001-04-9,rep_single_dose,ALDOSE REDUCTASE INHIBITOR,,,,,,,NA,,
STATTIC,STATTIC,,BRD:BRD-BRD-K17061841-001-03-5;BRD:BRD-K17061841-001-03-5,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,[O-][N+](=O)C1CCC2C=CS(=O)(=O)C2C1,
STAUROSPORINE,STAUROSPORINE,CHEMBL388978,CTRP:50769,ctrp,,,,,,,Small molecule,NA,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,HKSZLNNOFSGOKW-FYTWVXJKSA-N
ZERIT XR,BMY-27857;D-4T;D4T;NSC-163661;NSC-759897;SANILVUDINE;STAVUDINE;STAVUDINE (D4T);STAVUDINE (DT4);STAVUDINUM;ZERIT;ZERIT XR,CHEMBL991,BRD:BRD-BRD-K93880783-001-26-6;BRD:BRD-K93880783-001-26-6,rep_primary;rep_single_dose,"DNA DIRECTED DNA POLYMERASE INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"CC1CN([C@@H]2O[C@H](CO)C=C2)C(=O)[NH]C1=O, CC1CN([C@@H]2O[C@H](CO)C=C2)C(=O)[NH]C1=O, CC1CN([C@@H]2O[C@H](CO)C=C2)C(=O)[NH]C1=O;Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O",XNKLLVCARDGLGL-JGVFFNPUSA-N
STEMREGENIN 1,STEMREGENIN 1,,CTRP:609063,ctrp,,,,,,,,NA,,
STEMREGENIN-1,STEMREGENIN-1,,BRD:BRD-BRD-K36739687-001-03-0;BRD:BRD-K36739687-001-03-0,rep_multi_dose;rep_primary;rep_single_dose,ARYL HYDROCARBON RECEPTOR ANTAGONIST,AHR,,,PRECLINICAL,,,NA,CC(C)N1CNC2C(NCCC3CCC(O)CC3)NC(NC12)-C1CSC2CCCCC12,
TIOFACIC,BRONCO-PLUS;PROSTENOGLYCINE;STEPRONIN;TIASE;TIOFACIC,CHEMBL2107531,BRD:BRD-A04506385-001-01-2;BRD:BRD-BRD-A04506385-001-01-2,rep_primary;rep_single_dose,MUCOLYTIC AGENT,,,,LAUNCHED,,Small molecule,-1,CC(SC(=O)c1cccs1)C(=O)NCC(=O)O;CC(SC(=O)C1CCCS1)C(=O)NCC(O)=O,JNYSEDHQJCOWQU-UHFFFAOYSA-N
STETADERM,STETADERM,,BRD:BRD-BRD-K93900986-001-15-0;BRD:BRD-K93900986-001-15-0,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@]12C,
STF-118804,STF-118804,,BRD:BRD-BRD-K39171998-001-01-1;BRD:BRD-K39171998-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,NAMPT INHIBITOR,NAMPT,,,PRECLINICAL,,,NA,"CC1OC(NC1CS(=O)(=O)C1CCC(C)CC1)-C1CCC(CC1)C(=O)NCC1CCCNC1, CC1OC(NC1CS(=O)(=O)C1CCC(C)CC1)-C1CCC(CC1)C(=O)NCC1CCCNC1",
STF-31,STF-31,,BRD:BRD-BRD-K22477529-001-02-7;BRD:BRD-K22477529-001-02-7;CTRP:652975,ctrp;rep_primary;rep_single_dose,NAMPT INHIBITOR,NAMPT;SLC2A1,,,PRECLINICAL,,,NA,CC(C)(C)C1CCC(CC1)S(=O)(=O)NCC1CCC(CC1)C(=O)NC1CCCNC1,
STF-62247,STF-62247,,BRD:BRD-BRD-K85479953-001-11-3;BRD:BRD-K85479953-001-11-3;GDSC1:258,gdsc;rep_primary;rep_single_dose,AUTOPHAGY INDUCER,,,,PRECLINICAL,,,NA,"CC1CCCC(NC2NC(CS2)-C2CCNCC2)C1, CC1CCCC(NC2NC(CS2)-C2CCNCC2)C1",
STF62247,STF62247,,GDSC1:258,gdsc,,,,,,,,NA,,
VIBRIOMYCIN,ABIOCINE;CHEMFORM;DIHYDRO-;DIHYDROSTREPTOMYCIN;GEROX;NSC-14083;STREPCEN;STREPTOMYCIN;VIBRIOMYCIN,CHEMBL1950576;CHEMBL372795,BRD:BRD-BRD-K07166362-330-02-8;BRD:BRD-K07166362-330-02-8,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,TUBERCULOSIS,,LAUNCHED,,Small molecule,4,"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O, CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O, CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O;CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O",ASXBYYWOLISCLQ-HZYVHMACSA-N
ZANOSAR,NSC-37917;NSC-85998;STREPTOZOCIN;STREPTOZOTOCIN;STZ;U-9889;ZANOSAR,CHEMBL1651906,BRD:BRD-BRD-K34411947-001-12-5;BRD:BRD-K34411947-001-12-5,rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,SLC2A2,PANCREATIC CANCER,,LAUNCHED,,Small molecule,4,"CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)NC1[C@@H](O)OC(CO)[C@@H](O)[C@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O;CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O",ZSJLQEPLLKMAKR-YDEIVXIUSA-N
STRONTIUM-RANELATE,STRONTIUM-RANELATE,,BRD:BRD-K83146339-001-04-0,rep_single_dose,"BONE FORMATION STIMULANT, BONE RESORPTION INHIBITOR",CASR,,,,,,NA,,
SULPHATE (2:1),MONONITRATE;NITRATE (1:1);NSC-5365;PHOSPHATE (1:1);STRYCHNIDIN-10-ONE;STRYCHNINE;STRYCHNINE HEMISULPHATE SALT;STRYCHNINE NITRATE;STRYCHNINE PHOSPHATE;STRYCHNINE SULFATE;STRYCHNINE SULPHATE;STRYCHNINUM;STRYCHNINUM NITRICUM;SULFATE (2:1);SULPHATE (2:1),CHEMBL2103753;CHEMBL2146114;CHEMBL227934;CHEMBL612118,BRD:BRD-A09094913-065-01-0;BRD:BRD-BRD-A09094913-065-01-0,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;CHRNA10;CHRNA9;GLRA1;GLRA2;GLRA3;GLRB,,,PRECLINICAL,,Small molecule,-1,O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46.O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46.O=S(=O)(O)O;O=C1CC2OCC=C3CN4CC[C@@]56C4C[C@@H]3[C@@H]2C5N1C1CCCCC61,GOOCRIHPADOQAS-ZNUXJMJHSA-N
SU11274,SU-11274;SU11274,,BRD:BRD-BRD-K02965346-001-07-5;BRD:BRD-K02965346-001-07-5;CTRP:606586;GDSC1:285,ctrp;gdsc;rep_primary;rep_single_dose,"HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR, TYROSINE KINASE INHIBITOR",MET,,,PRECLINICAL,,,NA,"CN(C1CCCC(CL)C1)S(=O)(=O)C1CCC2NC(=O)\C(=C/C3[NH]C(C)C(C(=O)N4CCN(C)CC4)C3C)C2C1, CN(C1CCCC(CL)C1)S(=O)(=O)C1CCC2NC(=O)\C(=C/C3[NH]C(C)C(C(=O)N4CCN(C)CC4)C3C)C2C1",
SU014813,SU014813,,BRD:BRD-BRD-K75911534-001-01-6;BRD:BRD-K75911534-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,"PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",KDR,,,PHASE 2,,,NA,CC1[NH]C(\C=C2\C(=O)NC3CCC(F)CC23)C(C)C1C(=O)NC[C@H](O)CN1CCOCC1,
SU16F,SU16F,,BRD:BRD-K91106808-001-03-9,rep_single_dose,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,PDGFRB,,,,,,NA,,
SU3327,SU3327,,BRD:BRD-BRD-K32730239-001-01-0;BRD:BRD-K32730239-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,JNK INHIBITOR,MAPK8,,,PRECLINICAL,,,NA,"NC1NNC(SC2NCC(S2)[N+]([O-])=O)S1, NC1NNC(SC2NCC(S2)[N+]([O-])=O)S1",
SU9516,SU-9516;SU9516,CHEMBL258805,BRD:BRD-K94883909-001-17-7,rep_single_dose,CDK INHIBITOR,CDK1;CDK2;CDK4;CDK5,,,,,Small molecule,1,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,QNUKRWAIZMBVCU-WCIBSUBMSA-N
SUBSTANCE-P,SUBSTANCE-P,,BRD:BRD-BRD-K23106423-001-01-0;BRD:BRD-K23106423-001-01-0,rep_primary;rep_single_dose,NEUROKININ RECEPTOR ANTAGONIST,TACR1;TACR2;TACR3,,,PHASE 1,,,NA,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,
SUCCINIC-ACID,SUCCINIC-ACID,,BRD:BRD-BRD-K45238818-001-02-6;BRD:BRD-K45238818-001-02-6,rep_primary;rep_single_dose,,ALDH5A1;ASPH;BBOX1;HSD17B6;OXCT1;OXCT2;P3H1;P3H2;P3H3;P4HA1;P4HA2;PLOD1;PLOD3;SDHA;SDHB;SDHC;SDHD;SLC13A1;SLC13A2;SLC13A3;SLC25A10;SUCLA2;SUCLG1;SUCLG2;SUCNR1;TMLHE,,,LAUNCHED,,,NA,OC(=O)CCC(O)=O,
SUCCINOBUCOL,AGI-1067;SUCCINOBUCOL,CHEMBL83626,BRD:BRD-K00003183-001-01-9,rep_single_dose,ANTIOXIDANT,VCAM1,,,,,Small molecule,3,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(OC(=O)CCC(=O)O)c(C(C)(C)C)c1,RKSMVPNZHBRNNS-UHFFFAOYSA-N
SUCCINYLSULFATHIAZOLE,SUCCINYLSULFATHIAZOLE,CHEMBL1484857,BRD:BRD-BRD-K01950558-001-14-7;BRD:BRD-K01950558-001-14-7,rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR,,,PHASE 2,,Small molecule,-1,O=C(O)CCC(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1;OC(=O)CCC(=O)NC1CCC(CC1)S(=O)(=O)NC1NCCS1,SKVLYVHULOWXTD-UHFFFAOYSA-N
TRICHLOROGALACTOSUCROSE,"1',4',6'-TRICHLORO-GALACTOSUCROSE;4,1',6'-TRICHLOROGALACTOSUCROSE;ASPASVIT;E-955;INS NO.955;INS-955;NSC-759272;SAN SWEET SA 8020;SANSWEET SU 100;SPLENDA;SUCRALOSE;SUCRAZIT;TRICHLOROGALACTOSUCROSE",CHEMBL2107529,BRD:BRD-BRD-K58968598-001-03-6;BRD:BRD-K58968598-001-03-6,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,3,"OC[C@@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H](O)[C@H]1Cl;OC[C@H]1O[C@H](O[C@]2(CCL)O[C@H](CCL)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1CL, OC[C@H]1O[C@H](O[C@]2(CCL)O[C@H](CCL)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1CL",BAQAVOSOZGMPRM-KBFHZYTNSA-N
SUCROSE,GNE-410;NSC-406942;S-67F;SUCROSE,CHEMBL253582,BRD:BRD-K74724920-001-02-4,rep_single_dose,,ACTA1;ATOX1;C22ORF28;LYZ,,,,,Small molecule,4,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,CZMRCDWAGMRECN-UGDNZRGBSA-N
SUCROSE-OCTAACETATE,FEMA NO. 3038;NSC-1695;SUCROSE OCTA-ACETATE;SUCROSE OCTAACETATE;SUCROSE-OCTAACETATE,CHEMBL2105790,BRD:BRD-BRD-K01294196-001-01-5;BRD:BRD-K01294196-001-01-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,CC(=O)OC[C@H]1O[C@@](COC(C)=O)(O[C@H]2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,ZIJKGAXBCRWEOL-SAXBRCJISA-N
SUFENTANYL,"IDS-NS-001;R 30,730;R-30730;SUFENTANIL;SUFENTANYL",CHEMBL658,BRD:BRD-BRD-K21547160-001-01-4;BRD:BRD-K21547160-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR MODULATOR,OPRD1;OPRK1;OPRM1,ANESTHETIC,,LAUNCHED,,Small molecule,4,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1;CCC(=O)N(C1CCCCC1)C1(COC)CCN(CCC2CCCS2)CC1,GGCSSNBKKAUURC-UHFFFAOYSA-N
TAK-013,SUFUGOLIX;TAK-013,CHEMBL22055,BRD:BRD-K00004582-001-01-9,rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)Cc2ccccc2)c(=O)n(-c2ccccc2)c(=O)n3Cc2c(F)cccc2F)cc1,UCQSBGOFELXYIN-UHFFFAOYSA-N
SUGAMMADEX,SUGAMMADEX,CHEMBL2111107,BRD:BRD-K00003322-363-01-9,rep_single_dose,NEUROMUSCULAR BLOCKADE REVERSAL AGENT,,,,,,Oligosaccharide,4,O=C(O)CCSC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)C(O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]9CSCCC(=O)O)O[C@@H]8CSCCC(=O)O)O[C@@H]7CSCCC(=O)O)O[C@@H]6CSCCC(=O)O)O[C@@H]5CSCCC(=O)O)O[C@@H]4CSCCC(=O)O)O[C@@H]3CSCCC(=O)O,WHRODDIHRRDWEW-ZWYCLXBASA-N
SULBACTAM,CP-45899;CP-458992;NSC-759886;SULBACTAM,CHEMBL403,BRD:BRD-BRD-K44133266-001-10-0;BRD:BRD-K44133266-001-10-0,rep_primary;rep_single_dose,BETA LACTAMASE INHIBITOR,,"SKIN INFECTIONS, INTRA-ABDOMINAL INFECTIONS, GYNECOLOGIC INFECTIONS",,LAUNCHED,,Small molecule,4,"CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O, CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O, CC1(C)C(N2[C@@H](CC2=O)S1(=O)=O)C(O)=O, CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O;CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O",FKENQMMABCRJMK-RITPCOANSA-N
SULBACTAM-PIVOXIL,SULBACTAM-PIVOXIL,,BRD:BRD-A63431791-001-01-9;BRD:BRD-BRD-A63431791-001-01-9,rep_primary;rep_single_dose,BETA LACTAMASE INHIBITOR,,SKIN INFECTIONS,,LAUNCHED,,,NA,CC(C)(C)C(=O)OCOC(=O)C1N2C(CC2=O)S(=O)(=O)C1(C)C,
SULBENTINE,D 47;DIBENZATHIONE;DIBENZTHION;NSC-150555;SULBENTINE,CHEMBL151803,BRD:BRD-BRD-K72384124-001-08-0;BRD:BRD-K72384124-001-08-0,rep_primary;rep_single_dose,OTHER ANTIFUNGAL,,,,PRECLINICAL,,Small molecule,-1,S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1;S=C1SCN(CC2CCCCC2)CN1CC1CCCCC1,QFVAWNPSRQWSDU-UHFFFAOYSA-N
YOUVITAN,BISIBUTHIAMINE;SULBUTIAMINE;YOUVITAN,CHEMBL2105813,BRD:BRD-BRD-K12539416-001-01-4;BRD:BRD-K12539416-001-01-4,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,ASTHENIA,,LAUNCHED,,Small molecule,-1,C/C(=C(\CCOC(=O)C(C)C)SS/C(CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N;CC(C)C(=O)OCC\C(SS\C(CCOC(=O)C(C)C)=C(/C)N(CC1CNC(C)NC1N)C=O)=C(\C)N(CC1CNC(C)NC1N)C=O,CKHJPWQVLKHBIH-ZDSKVHJSSA-N
SULCONAZOLE,EXELDERM;SULCONAZOLE,CHEMBL1221,BRD:BRD-A70649075-008-30-8;BRD:BRD-BRD-A70649075-008-30-8,rep_multi_dose;rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,,"TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS",,LAUNCHED,,Small molecule,4,"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1;CLC1CCC(CSC(CN2CCNC2)C2CCC(CL)CC2CL)CC1, CLC1CCC(CSC(CN2CCNC2)C2CCC(CL)CC2CL)CC1",AFNXATANNDIXLG-UHFFFAOYSA-N
TRIPLE SULFA (SULFABENZAMIDE),NSC-74587;SULFABENZAMIDE;SULFABENZAMIDE (TRIPLE SULFA);TRIPLE SULFA (SULFABENZAMIDE),CHEMBL1243,BRD:BRD-BRD-K59983611-001-21-9;BRD:BRD-K59983611-001-21-9,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,,,LAUNCHED,,Small molecule,4,NC1CCC(CC1)S(=O)(=O)NC(=O)C1CCCCC1;Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1,PBCZLFBEBARBBI-UHFFFAOYSA-N
UROSULFAN,EUVERNIL;N-SULFANILYLCARBAMIDE;NSC-78438;SULFACARBAMIDE;SULFAUREA;SULPHAUREA;URACTYL;URAMID;URENIL;UROMIDE;UROSULFAN,CHEMBL139877,BRD:BRD-BRD-K13486660-001-01-0;BRD:BRD-K13486660-001-01-0,rep_primary;rep_single_dose,,,,,WITHDRAWN,,Small molecule,4,NC(=O)NS(=O)(=O)c1ccc(N)cc1;NC(=O)NS(=O)(=O)C1CCC(N)CC1,WVAKABMNNSMCDK-UHFFFAOYSA-N
UROSULFON,BLEPH-10;BLEPH-30;CETAMIDE;FML-S;KLARON;NSC-63871;OCUSULF-10;OCUSULF-30;SULF-10;SULF-15;SULFACEL-15;SULFACETAMIDE;SULFACETAMIDE (TRIPLE SULFA);SULFACETAMIDUM;SULFAIR-15;SULPHACETAMIDE;SULSTER;SULTEN-10;TRIPLE SULFA (SULFACETAMIDE);UROSULFON,CHEMBL455,BRD:BRD-BRD-K21520694-236-02-6;BRD:BRD-K21520694-236-02-6,rep_primary;rep_single_dose,PABA ANTAGONIST,,CONJUNCTIVITIS,,LAUNCHED,,Small molecule,4,"CC(=O)NS(=O)(=O)c1ccc(N)cc1;CC(=O)NS(=O)(=O)C1CCC(N)CC1, CC(=O)NS(=O)(=O)C1CCC(N)CC1",SKIVFJLNDNKQPD-UHFFFAOYSA-N
SULPHACHLORPYRIDAZINE,NEFROSUL;NSC-757858;SONILYN;SULFACHLOROPYRIDAZINE;SULFACHLOROPYRIDIZINE;SULFACHLORPYRIDAZINE;SULPHACHLORPYRIDAZINE,CHEMBL1443577,BRD:BRD-BRD-K32021043-001-14-3;BRD:BRD-K32021043-001-14-3,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,-1,NC1CCC(CC1)S(=O)(=O)NC1CCC(CL)NN1;Nc1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1,XOXHILFPRYWFOD-UHFFFAOYSA-N
THERMAZENE,"ADIAZINE;ALTREET-AG;COCO-DIAZINE;DERMAZIN;DIAZYL;FLAMAZINE;FLAMMACERIUM;NSC-35600;SILDAFLO;SILVADENE;SILVAZINE;SILVER;SILVER SULFADIAZINE;SILVER SULPHADIAZINE;SSD;SSD AF;SULFACOMBIN;SULFADIAZINE;SULFADIAZINE (TRISULFAPYRIMIDINES);SULFADIAZINE SILVER;SULFADIAZINE SILVER SALT;SULFADIAZINE, SILVER;SULFADIAZINUM ARGENTUM;SULFAPYRIMIDINE;SULFOLEX;SULPHADIAZINE;THERMAZENE",CHEMBL1382627;CHEMBL439,BRD:BRD-BRD-K32273377-001-17-9;BRD:BRD-K32273377-001-17-9,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,"MALARIA, MENINGITIS, URINARY TRACT INFECTIONS, CONJUNCTIVITIS, TRACHOMA, CHANCROID",,LAUNCHED,,Small molecule,4,"NC1CCC(CC1)S(=O)(=O)NC1NCCCN1, NC1CCC(CC1)S(=O)(=O)NC1NCCCN1, NC1CCC(CC1)S(=O)(=O)NC1NCCCN1;Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Ag+];Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1",SEEPANYCNGTZFQ-UHFFFAOYSA-N;UEJSSZHHYBHCEL-UHFFFAOYSA-N
WR-4073,FANASIL;FANASULF;FANZIL;J21.373J;NSC-759319;RO 4-4393;RO-4-4393;RO-44393;SULFADOXIN;SULFADOXINE;SULFADOXINUM;SULFORTHAMIDINE;SULPHADOXINE;SULPHORMETHOXINE;WR-4073,CHEMBL1539,BRD:BRD-BRD-K55250441-001-13-0;BRD:BRD-K55250441-001-13-0,rep_primary;rep_single_dose,DIHYDROPTEROATE SYNTHASE INHIBITOR,,MALARIA,,LAUNCHED,,Small molecule,4,"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC;COC1NCNC(NS(=O)(=O)C2CCC(N)CC2)C1OC, COC1NCNC(NS(=O)(=O)C2CCC(N)CC2)C1OC",PJSFRIWCGOHTNF-UHFFFAOYSA-N
SULSOXIN,ENTUSIL;ERYZOLE;GANTRISIN;NEAZOLIN;NSC-13120;NSC-683536;PEDIAZOLE;SOSOL;SOXAZOLE;SULFAFURAZOLE;SULFALAR;SULFISOXAZOLE;SULPHAFURAZOLE;SULSOXIN,CHEMBL453,BRD:BRD-BRD-K50859149-001-19-5;BRD:BRD-K50859149-001-19-5,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C;CC1NOC(NS(=O)(=O)C2CCC(N)CC2)C1C, CC1NOC(NS(=O)(=O)C2CCC(N)CC2)C1C, CC1NOC(NS(=O)(=O)C2CCC(N)CC2)C1C",NHUHCSRWZMLRLA-UHFFFAOYSA-N
SULPHAGUANIDINE,GPPE SUSP FTE;GUANIMYCIN;NSC-14041;SULFAGUANIDINE;SULPHAGUANIDINE,CHEMBL338802,BRD:BRD-BRD-K45086103-001-15-5;BRD:BRD-BRD-K45086103-001-16-3;BRD:BRD-K45086103-001-15-5;BRD:BRD-K45086103-001-16-3,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,"N=C(N)NS(=O)(=O)c1ccc(N)cc1;NC(=N)NS(=O)(=O)C1CCC(N)CC1, NC(=N)NS(=O)(=O)C1CCC(N)CC1, NC(=N)NS(=O)(=O)C1CCC(N)CC1",BRBKOPJOKNSWSG-UHFFFAOYSA-N
SUMEDIN,MESULFA;METHYPYRIMAL;NSC-27259;SULFAMERAZINE;SULFAMERAZINE (TRISULFAPYRIMIDINES);SULFAMETHYLDIAZINE;SULPHAMERAZINE;SUMEDIN,CHEMBL438,BRD:BRD-BRD-K93524252-001-24-7;BRD:BRD-K93524252-001-24-7,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,"COCCIDIOSIS, CHOLERA",,LAUNCHED,,Small molecule,4,"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1;CC1CCNC(NS(=O)(=O)C2CCC(N)CC2)N1, CC1CCNC(NS(=O)(=O)C2CCC(N)CC2)N1",QPPBRPIAZZHUNT-UHFFFAOYSA-N
ULTRAX,AHR-857;BAY-5400;BAYRENA;NSC-683528;NSC-757874;SH-613;SULFAMETER;SULFAMETHOXYDIAZINE;SULFAMETHOXYPYRIMIDINE;SULFAMETIN;SULFAMETOXYDIAZINE;SULLA;SULPHAMETHOXYDIAZINE;ULTRAX,CHEMBL1200359,BRD:BRD-BRD-K87492696-001-16-5;BRD:BRD-K87492696-001-16-5,rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,"COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1;COC1CNC(NS(=O)(=O)C2CCC(N)CC2)NC1, COC1CNC(NS(=O)(=O)C2CCC(N)CC2)NC1",GPTONYMQFTZPKC-UHFFFAOYSA-N
SULFAMIDINE,BN-2409;NSC-67457;NSC-683529;SMZ-MED 454;SULFADIMERAZINE;SULFADIMETHYLPYRIMIDINE;SULFADIMIDINE;SULFADIMIDINUM;SULFAMETHAZINE;SULFAMETHAZINE (TRISULFAPYRIMIDINES);SULFAMEZATHINE;SULFAMEZATHINE ('S-MEZ');SULFAMIDINE,CHEMBL446,BRD:BRD-BRD-K11640013-001-15-8;BRD:BRD-BRD-K11640013-236-10-1;BRD:BRD-K11640013-001-15-8;BRD:BRD-K11640013-236-10-1,rep_multi_dose;rep_primary;rep_single_dose,PABA ANTAGONIST,,"ENTERITIS, ENTERITIS",,LAUNCHED,,Small molecule,4,"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1;CC1CC(C)NC(NS(=O)(=O)C2CCC(N)CC2)N1, CC1CC(C)NC(NS(=O)(=O)C2CCC(N)CC2)N1, CC1CC(C)NC(NS(=O)(=O)C2CCC(N)CC2)N1",ASWVTGNCAZCNNR-UHFFFAOYSA-N
UROLUCOSIL,METHAZOL;MICROSUL;NSC-757327;PROKLAR;SULFAMETHIZOLE;SULPHAMETHIZOLE;SULPHAMETHYLTHIADIAZOLE;TETRACID;THIOSULFIL;UROLUCOSIL,CHEMBL1191,BRD:BRD-BRD-K31682896-001-24-0;BRD:BRD-K31682896-001-24-0,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1;CC1NNC(NS(=O)(=O)C2CCC(N)CC2)S1, CC1NNC(NS(=O)(=O)C2CCC(N)CC2)S1",VACCAVUAMIDAGB-UHFFFAOYSA-N
UROBAK,ACETYLSULFAMETHOXAZOLE;GANTANOL;GANTANOL-DS;NSC-147832;RO 4-2130;RO-4-2130;SINOMIN;STX-608;SULFAMETHOXAZOLE;SULFAMETHOXAZOLE SODIUM;SULFAMETHOXAZOLUM;SULPHAMETHOXAZOLE;SUPHAMETHOXAZOLE;UROBAK,CHEMBL443,BRD:BRD-BRD-K28494619-001-28-2;BRD:BRD-K28494619-001-28-2,rep_primary;rep_single_dose,PABA ANTAGONIST,,"PNEUMONIA, ENTERITIS, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1;CC1CC(NS(=O)(=O)C2CCC(N)CC2)NO1, CC1CC(NS(=O)(=O)C2CCC(N)CC2)NO1",JLKIGFTWXXRPMT-UHFFFAOYSA-N
SULPHAMETHOXYPYRIDAZINE,CL-13494;DEPOVERNIL;LEDERKYN;MIDICEL;NSC-757875;RETASULPHINE;SUCCINYLSULFATHI;SULFAMETHOXYPYRIDAZINE;SULFAMETHOXYPYRIDAZINUM;SULFASUXIDINE;SULPHAMETHOXYPYRIDAZINE,CHEMBL268869,BRD:BRD-BRD-K00938507-001-17-8;BRD:BRD-K00938507-001-17-8,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,,,WITHDRAWN,,Small molecule,4,"COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1;COC1CCC(NS(=O)(=O)C2CCC(N)CC2)NN1, COC1CCC(NS(=O)(=O)C2CCC(N)CC2)NN1",VLYWMPOKSSWJAL-UHFFFAOYSA-N
SULFAMETOPYRAZINE,AS-18908;KELFIZINA;KELFIZINE W;LONGUM;NSC-110433;SULFALENE;SULFAMETHOPYRAZINE;SULFAMETHOXYPYRAZINE;SULFAMETOPYRAZINE,CHEMBL1525826,BRD:BRD-BRD-K17205817-001-06-1;BRD:BRD-K17205817-001-06-1,rep_primary;rep_single_dose,PABA ANTAGONIST,,"MALARIA, URINARY TRACT INFECTIONS, RESPIRATORY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,COc1nccnc1NS(=O)(=O)c1ccc(N)cc1;COC1NCCNC1NS(=O)(=O)C1CCC(N)CC1,KXRZBTAEDBELFD-UHFFFAOYSA-N
SULFAMONOMETHOXINE,DAIMETON;NSC-757862;SULFAMONOMETHOXINE,CHEMBL462990,BRD:BRD-BRD-K14116214-001-09-6;BRD:BRD-K14116214-001-09-6,rep_primary;rep_single_dose,BACTERIAL ANTIFOLATE,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,-1,COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1;COC1CC(NS(=O)(=O)C2CCC(N)CC2)NCN1,WMPXPUYPYQKQCX-UHFFFAOYSA-N
SULPHAMOXOLE,NSC-683535;SULFAMOXOLE;SULPHAMOXOLE,CHEMBL2105399,BRD:BRD-BRD-K19742012-001-02-3;BRD:BRD-K19742012-001-02-3,rep_primary;rep_single_dose,PABA ANTAGONIST,,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,-1,"Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C;CC1NC(NS(=O)(=O)C2CCC(N)CC2)OC1C, CC1NC(NS(=O)(=O)C2CCC(N)CC2)OC1C",CYFLXLSBHQBMFT-UHFFFAOYSA-N
SULPHANILAMIDUM,ANILINE-P-SULFONIC AMIDE;NSC-7618;P-AMINOBENZENESULFAMIDE;P-AMINOBENZENESULFONAMIDE;PRONTOSIL I;PRONTYLIN;STREPTOCID;SULFAMINE;SULFANILAMIDE;SULFONAMIDE;SULPHANILAMIDUM,CHEMBL21,BRD:BRD-BRD-K02594908-001-16-4;BRD:BRD-K02594908-001-16-4,rep_multi_dose;rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CYP2C19;CYP2C9;CYP2D6;CYP2E1;CYP3A4,VULVOVAGINAL CANDIDIASIS,,LAUNCHED,,Small molecule,4,"NC1CCC(CC1)S(N)(=O)=O, NC1CCC(CC1)S(N)(=O)=O;Nc1ccc(S(N)(=O)=O)cc1",FDDDEECHVMSUSB-UHFFFAOYSA-N
SULFANITRAN,NSC-217299;NSC-77120;SULFANITRAN,CHEMBL493636,BRD:BRD-BRD-K76845197-001-05-4;BRD:BRD-K76845197-001-05-4,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,CC(=O)NC1CCC(CC1)S(=O)(=O)NC1CCC(CC1)[N+]([O-])=O;CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)cc1,GWBPFRGXNGPPMF-UHFFFAOYSA-N
SULPHAPHENAZOLE,NSC-757859;ORISULF;SULFABID;SULFAFENAZOL;SULFAPHENAZOLE;SULPHAPHENAZOLE,CHEMBL1109,BRD:BRD-BRD-K10671814-001-14-8;BRD:BRD-K10671814-001-14-8,rep_primary;rep_single_dose,DIHYDROPTEROATE SYNTHETASE INHIBITOR,DHPS,URINARY TRACT INFECTIONS,,LAUNCHED,,Small molecule,4,NC1CCC(CC1)S(=O)(=O)NC1CCNN1-C1CCCCC1;Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,QWCJHSGMANYXCW-UHFFFAOYSA-N
SULPHAPYRIDINE,COCCOCLASE;CONCORD 693;DAGENAN;EUBASIN;NSC-41791;NSC-4753;PIRIDAZOL;SULFANILAMIDOPYRIDINE;SULFAPYRIDINE;SULPHAPYRIDINE,CHEMBL700,BRD:BRD-BRD-K41406082-001-16-2;BRD:BRD-K41406082-001-16-2,rep_primary;rep_single_dose,PABA ANTAGONIST,,,,LAUNCHED,,Small molecule,4,"NC1CCC(CC1)S(=O)(=O)NC1CCCCN1, NC1CCC(CC1)S(=O)(=O)NC1CCCCN1;Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1",GECHUMIMRBOMGK-UHFFFAOYSA-N
SULFAQUINOXALINE,NSC-41805;SULFAQUINOXALINE,CHEMBL1437847,BRD:BRD-BRD-K71133585-236-14-4;BRD:BRD-K71133585-236-14-4,rep_primary;rep_single_dose,VITAMIN K ANTAGONIST,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,NC1CCC(CC1)S(=O)(=O)NC1CNC2CCCCC2N1;Nc1ccc(S(=O)(=O)Nc2cnc3ccccc3n2)cc1,NHZLNPMOSADWGC-UHFFFAOYSA-N
UCINE,AZULFIDINE;AZULFIDINE EN;AZULFIDINE EN-TABS;BENZOSULFA;COLIZINE;NSC-203730;NSC-667219;S.A.S.;S.A.S.-500;SALAZOPYRIN;SALAZOPYRIN E.C.;SALAZOPYRIN-EN;SALAZOSULFAPYRIDINE;SALICYLAZOSULFAPYRIDINE;SAS-500;SULFASALAZINE;SULFASALAZINUM;SULFASALAZOPYRIDINE;SULPHASALAZINE;UCINE,CHEMBL421,BRD:BRD-BRD-K10670311-001-15-5;BRD:BRD-K10670311-001-15-5,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,ACAT1;ALOX5;CHUK;IKBKB;PLA2G1B;PPARG;PTGS1;PTGS2;SLC46A1;SLC7A11;TBXAS1,ULCERATIVE COLITIS,,LAUNCHED,,Small molecule,4,"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O;OC(=O)C1CC(CCC1O)\N=N\C1CCC(CC1)S(=O)(=O)NC1CCCCN1, OC(=O)C1CC(CCC1O)\N=N\C1CCC(CC1)S(=O)(=O)NC1CCCCN1, OC(=O)C1CC(CCC1O)\N=N\C1CCC(CC1)S(=O)(=O)NC1CCCCN1",NCEXYHBECQHGNR-QZQOTICOSA-N
TRIPLE SULFA (SULFATHIAZOLE),NSC-31812;NSC-683531;SULFATHIAZOLE;SULFATHIAZOLE (TRIPLE SULFA);SULPHATHIAZOLE;THIAZAMIDE;TRIPLE SULFA (SULFATHIAZOLE),CHEMBL437,BRD:BRD-BRD-K14705039-001-16-4;BRD:BRD-K14705039-001-16-4,rep_primary;rep_single_dose,DIHYDROPTEROATE SYNTHASE INHIBITOR,,,,LAUNCHED,,Small molecule,4,"NC1CCC(CC1)S(=O)(=O)NC1NCCS1, NC1CCC(CC1)S(=O)(=O)NC1NCCS1;Nc1ccc(S(=O)(=O)Nc2nccs2)cc1",JNMRHUJNCSQMMB-UHFFFAOYSA-N
SURUFATINIB,HMPL-012;SULFATINIB;SURUFATINIB,CHEMBL4297190,BRD:BRD-K00003125-001-01-9,rep_single_dose,TYROSINE KINASE INHIBITOR,,,,,,Small molecule,3,Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1,TTZSNFLLYPYKIL-UHFFFAOYSA-N
SULPHINPYRAZONE,ANTURAN;ANTURANE;NSC-75925;SULFINPYRAZONE;SULPHINPYRAZONE,CHEMBL832,BRD:BRD-A36217750-001-16-3;BRD:BRD-BRD-A36217750-001-16-3,rep_primary;rep_single_dose,URICOSURIC BLOCKER,ABCC1;ABCC2;FPR1;SLC22A12,GOUT,,LAUNCHED,,Small molecule,4,O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1;O=C1C(CCS(=O)C2CCCCC2)C(=O)N(N1C1CCCCC1)C1CCCCC1,MBGGBVCUIVRRBF-UHFFFAOYSA-N
SULFISOMIDIN,SULFISOMIDIN,,BRD:BRD-K52416806-001-05-9,rep_single_dose,ANTIBACTERIAL,,,,,,,NA,,
SULFORAPHANE,(-)-SULFORAPHANE;(R)-;(R)-SULFORAPHANE;4-(METHYLSULFINYL)BUTYL ISOTHIOCYANATE;SULFORAPHANE,CHEMBL48802,BRD:BRD-A58955223-001-03-8;BRD:BRD-BRD-A58955223-001-03-8,rep_primary;rep_single_dose,"ANTICANCER AGENT, ARYL HYDROCARBON RECEPTOR ANTAGONIST",NFE2L2,,,PHASE 2,,Small molecule,3,C[S+]([O-])CCCCN=C=S;CS(=O)CCCCN=C=S,SUVMJBTUFCVSAD-UHFFFAOYSA-N
SULINDAC,ARTHROCINE;ARTRIBID;CLINORIL;MK-231;NSC-757344;SULINDAC,CHEMBL15770,BRD:BRD-A13946108-001-17-1;BRD:BRD-BRD-A13946108-001-17-1,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,AKR1B1;MAPK3;PPARD;PTGDR2;PTGS1;PTGS2,"OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS",,LAUNCHED,,Small molecule,4,"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1;CC1=C(CC(O)=O)C2CC(F)CCC2C\1=C/C1CCC(CC1)S(C)=O, CC1=C(CC(O)=O)C2CC(F)CCC2C\1=C/C1CCC(CC1)S(C)=O, CC1=C(CC(O)=O)C2CC(F)CCC2C\1=C/C1CCC(CC1)S(C)=O, CC1=C(CC(O)=O)C2CC(F)CCC2C\1=C/C1CCC(CC1)S(C)=O",MLKXDPUZXIRXEP-MFOYZWKCSA-N
VIOSORB 111,BENZOPHENONE-4;ESCALOL 577;MS 40;NSC-60584;NSC-760350;SEESORB 101S;SPECTRA-SORB UV 284;SULFISOBENZONE;SULISOBENZONE;SUNGARD;SYNTASE 230;UVASORB S 5;UVINUL D 5030;UVINUL MS 40;UVINUL MS-40;VIOSORB 111,CHEMBL2059073,BRD:BRD-BRD-K38602774-001-03-2;BRD:BRD-K38602774-001-03-2,rep_primary;rep_single_dose,,,SUNSCREEN LOTION,,LAUNCHED,,Small molecule,-1,"COc1cc(O)c(C(=O)c2ccccc2)cc1S(=O)(=O)O;COC1CC(O)C(CC1S(O)(=O)=O)C(=O)C1CCCCC1, COC1CC(O)C(CC1S(O)(=O)=O)C(=O)C1CCCCC1",CXVGEDCSTKKODG-UHFFFAOYSA-N
VARDAX,AR-L-115;AR-L-115BS;NSC-757867;SULMAZOLE;VARDAX,CHEMBL286020,BRD:BRD-A22081593-001-11-1;BRD:BRD-BRD-A22081593-001-11-1,rep_multi_dose;rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,,,,PHASE 1,,Small molecule,-1,COc1cc([S+](C)[O-])ccc1-c1nc2cccnc2[nH]1;COC1CC(CCC1-C1NC2NCCCC2[NH]1)S(C)=O,XMFCOYRWYYXZMY-UHFFFAOYSA-N
SULMETOZINE,SULMETOZINE,,BRD:BRD-BRD-K29570907-001-07-3;BRD:BRD-K29570907-001-07-3,rep_primary;rep_single_dose,GASTRIN INHIBITOR,GAST,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,,NA,COC1CC(CC(OC)C1OC)C(=S)N1CCOCC1,
SULODENE,BEMPERIL;CEREBRO;CIRCLETON;CP-556S;DULASI;DULOCTIL;EUVASAL;FLUVERSIN;FLUVISCO;HEMOANTIN;IANGENE;LOCTIDON;LOCTON;MJF 12637;MJF-12637;OCTAMET;POLIVASAL;SUDIL;SULOCTIDIL;SULOCTON;SULODENE,CHEMBL404849;CHEMBL588119,BRD:BRD-A34205397-001-04-5;BRD:BRD-BRD-A34205397-001-04-5,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,WITHDRAWN,,Small molecule,4,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1;CCCCCCCCNC(C)C(O)C1CCC(SC(C)C)CC1,BFCDFTHTSVTWOG-UHFFFAOYSA-N
SULOL,ARAVA;HWA-486;L04AA13;LEFLUNOMIDE;LEFLUNOMIDE MEDAC;LEFLUNOMIDE RATIOPHARM;LEFLUNOMIDE TEVA;LEFLUNOMIDE WINTHROP;NSC-677411;NSC-759864;REPSO;SU-101;SU101;SULOL,CHEMBL960,GDSC2:1578,gdsc,,,,,,,Small molecule,4,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,VHOGYURTWQBHIL-UHFFFAOYSA-N
SULOPENEM,"CP-70,429;CP-70429;SULOPENEM",CHEMBL1908305,BRD:BRD-K00004713-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,3,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@H]3CC[S@@+]([O-])C3)S[C@H]12,FLSUCZWOEMTFAQ-PRBGKLEPSA-N
SULPHADIMETHOXINE,MADRIBON;NSC-683544;NSC-757860;SULFADIMETHOXINE;SULPHADIMETHOXINE,CHEMBL62193,BRD:BRD-BRD-K71125014-001-27-1;BRD:BRD-K71125014-001-27-1,rep_primary;rep_single_dose,DIHYDROPTEROATE SYNTHETASE INHIBITOR,,,,LAUNCHED,,Small molecule,4,"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1;COC1CC(NS(=O)(=O)C2CCC(N)CC2)NC(OC)N1, COC1CC(NS(=O)(=O)C2CCC(N)CC2)NC(OC)N1",ZZORFUFYDOWNEF-UHFFFAOYSA-N
SULPIRIDE L-FORM,(-)-;(-)-SULPIRIDE;(S)-;DOGMATYL;DOLMATIL;L-SULPIRIDE;LESURIDE;LEVOBREN;LEVOPRAID;LEVOPRIDE;LEVOSULPIRIDE;N05AL01;NSC-757850;RD-1403;S-(-)-SULPIRIDE;SULPIRIDE;SULPIRIDE L-FORM,CHEMBL26;CHEMBL267044,BRD:BRD-A55272860-001-14-6;BRD:BRD-A55272860-001-15-3;BRD:BRD-BRD-A55272860-001-14-6;BRD:BRD-BRD-A55272860-001-15-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,"SCHIZOPHRENIA, SCHIZOPHRENIA",,LAUNCHED,,Small molecule,2,"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC;CCN1CCCC1CNC(=O)C1CC(CCC1OC)S(N)(=O)=O, CCN1CCCC1CNC(=O)C1CC(CCC1OC)S(N)(=O)=O, CCN1CCCC1CNC(=O)C1CC(CCC1OC)S(N)(=O)=O",BGRJTUBHPOOWDU-NSHDSACASA-N
VD-1827,"BACIMEX;CP-49,952;CP-49952;SULTAMICILLIN;SULTAMICILLIN TOSILATE;SULTAMICILLIN TOSYLATE;UNACID;UNASYN;VD-1827",CHEMBL506110,BRD:BRD-K00004694-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,4,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OCOC(=O)[C@@H]1N2C(=O)C[C@H]2S(=O)(=O)C1(C)C,OPYGFNJSCUDTBT-PMLPCWDUSA-N
TROLONE,CONADIL;OSPOLOT;RIKER 594;RIKER-594;SULTHIAME;SULTIAME;TROLONE,CHEMBL328560,BRD:BRD-K00003488-001-01-9,rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA2,,,,,Small molecule,4,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,HMHVCUVYZFYAJI-UHFFFAOYSA-N
SULTOPRIDE HYDROCHLORIDE,SULTOPRIDE;SULTOPRIDE HYDROCHLORIDE,CHEMBL277945,BRD:BRD-K00003312-003-01-9,rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,UNRHXEPDKXPRTM-UHFFFAOYSA-N
SUMANIROLE,PNU-95666;PNU-95666E;SUMANIROLE,CHEMBL419792,BRD:BRD-BRD-K30485548-050-01-6;BRD:BRD-K30485548-050-01-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,DRD2,,,PHASE 3,,Small molecule,3,CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1;CN[C@@H]1CC2CCCC3NC(O)N(C1)C23,RKZSNTNMEFVBDT-MRVPVSSYSA-N
TOSYMRA,DFN-11;DFN-11 (SUMATRIPTAN INJECTION);IMITREX;N02CC01;SUMATRIPTAN;TOSYMRA,CHEMBL128,BRD:BRD-BRD-K50938287-036-13-8;BRD:BRD-K50938287-036-13-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR5A;HTR6;HTR7,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1;CNS(=O)(=O)CC1CCC2[NH]CC(CCN(C)C)C2C1, CNS(=O)(=O)CC1CCC2[NH]CC(CCN(C)C)C2C1, CNS(=O)(=O)CC1CCC2[NH]CC(CCN(C)C)C2C1, CNS(=O)(=O)CC1CCC2[NH]CC(CCN(C)C)C2C1",KQKPFRSPSRPDEB-UHFFFAOYSA-N
SUN-11602,SUN-11602,,BRD:BRD-K71250460-001-02-9,rep_single_dose,FIBROBLAST GROWTH FACTOR MIMETIC,FGFR1,,,,,,NA,,
SUTENT,NSC-736511;NSC-750690;SU-011248;SU-11248;SU011248;SUNITINIB;SUTENT,CHEMBL535,BRD:BRD-BRD-K42828737-044-09-0;BRD:BRD-K42828737-001-03-3;BRD:BRD-K42828737-044-09-0;CTRP:374750;GDSC1:5,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",CSF1R;FGFR1;FLT1;FLT3;FLT4;KDR;KIT;PDGFRA;PDGFRB;RET,"GASTROINTESTINAL STROMAL TUMORS (GIST), RENAL CELL CARCINOMA (RCC), NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET)",,LAUNCHED,,Small molecule,4,"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C;CCN(CC)CCNC(=O)C1C(C)[NH]C(\C=C2/C(=O)NC3CCC(F)CC23)C1C, CCN(CC)CCNC(=O)C1C(C)[NH]C(\C=C2/C(=O)NC3CCC(F)CC23)C1C, CCN(CC)CCNC(=O)C1C(C)[NH]C(\C=C2/C(=O)NC3CCC(F)CC23)C1C, CCN(CC)CCNC(=O)C1C(C)[NH]C(\C=C2/C(=O)NC3CCC(F)CC23)C1C",WINHZLLDWRZWRT-ATVHPVEESA-N
TOPALGIC,"NSC-303611;P-(2-THENOYL)HYDRATROPIC ACID;P-2-THENOYLHYDRATROPIC ACID;PROFENAL;R-25,061;R-25061;RACEMIC SUPROFEN;SRENDAM;SULPROLTIN;SUPROFEN;SUTOPROFEN;TN-762;TOPALGIC",CHEMBL956,BRD:BRD-A34006693-001-15-4;BRD:BRD-BRD-A34006693-001-15-4,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,WITHDRAWN,,Small molecule,4,"CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1;CC(C(O)=O)C1CCC(CC1)C(=O)C1CCCS1, CC(C(O)=O)C1CCC(CC1)C(=O)C1CCCS1",MDKGKXOCJGEUJW-UHFFFAOYSA-N
SURAMINE,FARMA;FARMA-939;FOURNEAU;METARET;NAGANOL;NSC-34936;SURAMIN;SURAMINE,CHEMBL265502,BRD:BRD-BRD-K70327167-348-13-4;BRD:BRD-K70327167-348-13-4,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,F2;FSHR;P2RY1;P2RY11;P2RY13;P2RY2;PLA2G2A;RYR1;RYR2;SIRT5,"AFRICAN TRYPANOSOMIASIS, ONCHOCERCIASIS",,LAUNCHED,,Small molecule,3,"Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1;CC1CCC(CC1NC(=O)C1CCCC(NC(=O)NC2CCCC(C2)C(=O)NC2CC(CCC2C)C(=O)NC2CCC(C3CC(CC(C23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C1)C(=O)NC1CCC(C2CC(CC(C12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O, CC1CCC(CC1NC(=O)C1CCCC(NC(=O)NC2CCCC(C2)C(=O)NC2CC(CCC2C)C(=O)NC2CCC(C3CC(CC(C23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C1)C(=O)NC1CCC(C2CC(CC(C12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O",FIAFUQMPZJWCLV-UHFFFAOYSA-N
SURITOZOLE,"MDL 26,479;MDL-26479;SURITOZOLE",CHEMBL278764,BRD:BRD-BRD-K98557884-001-01-6;BRD:BRD-K98557884-001-01-6,rep_primary;rep_single_dose,GABA RECEPTOR INVERSE AGONIST,GABBR1,,,PHASE 2,,Small molecule,-1,Cn1nc(-c2cccc(F)c2)n(C)c1=S;CN1NC(-C2CCCC(F)C2)N(C)C1=S,IWDUZEHNLHFBRZ-UHFFFAOYSA-N
SUTENT,NSC-736511;NSC-750690;PHA-290940AD;SU-010398;SU-011248;SU-011248 L-MALATE SALT;SU-11248;SU010398;SU011248;SU011248 L-MALATE SALT;SUNITINIB;SUNITINIB L-MALATE;SUNITINIB MALATE;SUTENT,CHEMBL1567;CHEMBL535,GDSC1:5,gdsc,,,,,,,Small molecule,4,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C;CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O,LBWFXVZLPYTWQI-IPOVEDGCSA-N;WINHZLLDWRZWRT-ATVHPVEESA-N
U-100480,NSC-742407;OXAZOLIDININONE;PNU-100480;SUTEZOLID;U 100480;U-100480,CHEMBL288149,BRD:BRD-BRD-K86670086-001-02-5;BRD:BRD-K86670086-001-02-5,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,,,PHASE 2,,Small molecule,2,CC(=O)NC[C@H]1CN(C(=O)O1)C1CCC(N2CCSCC2)C(F)C1;CC(=O)NC[C@H]1CN(c2ccc(N3CCSCC3)c(F)c2)C(=O)O1,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N
SUVOREXANT,BELSOMRA;MK-4305;MK4305;SUVOREXANT,CHEMBL1083659,BRD:BRD-BRD-K94293891-001-01-3;BRD:BRD-K94293891-001-01-3,rep_primary;rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR1;HCRTR2,INSOMNIA,,LAUNCHED,,Small molecule,4,C[C@@H]1CCN(CCN1C(=O)C1CC(C)CCC1-N1NCCN1)C1NC2CC(CL)CCC2O1;Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1,JYTNQNCOQXFQPK-MRXNPFEDSA-N
SUXIBUZONE,NSC-757866;SUXIBUZONE,CHEMBL1414320,BRD:BRD-BRD-K78815826-001-14-6;BRD:BRD-K78815826-001-14-6,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,"JOINT PAIN, MUSCLE PAIN",,LAUNCHED,,Small molecule,-1,"CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O;CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)C1CCCCC1)C1CCCCC1, CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)C1CCCCC1)C1CCCCC1",ONWXNHPOAGOMTG-UHFFFAOYSA-N
TRIDOLGOSIR,SWAINSONINE;TRIDOLGOSIR,CHEMBL371197,BRD:BRD-BRD-K15170068-001-03-2;BRD:BRD-K15170068-001-03-2,rep_primary;rep_single_dose,ALPHA MANNOSIDASE INHIBITOR,MAN2A1,,,PHASE 2,,Small molecule,-1,O[C@@H]1CN2CCC[C@@H](O)[C@@H]2[C@@H]1O;O[C@H]1[C@H]2[C@H](O)CCCN2C[C@H]1O,FXUAIOOAOAVCGD-WCTZXXKLSA-N
SX-011,SX-011,,BRD:BRD-BRD-K45385835-001-02-4;BRD:BRD-K45385835-001-02-4,rep_primary;rep_single_dose,MAP KINASE INHIBITOR,MAPK14,,,PRECLINICAL,,,NA,"CN(C)C(=O)C(=O)C1CN(C)C2CC(CL)C(CC12)C(=O)N1CCC(CC2CCC(F)CC2)CC1, CN(C)C(=O)C(=O)C1CN(C)C2CC(CL)C(CC12)C(=O)N1CCC(CC2CCC(F)CC2)CC1",
SX-682,SX-682,CHEMBL4297480,BRD:BRD-K00091103-001-01-9,rep_single_dose,,,,,,,Small molecule,1,O=C(Nc1ccc(F)cc1)c1cnc(SCc2cc(OC(F)(F)F)ccc2B(O)O)nc1,SDUDZBCEHIZMFZ-UHFFFAOYSA-N
SY-640,SY-640,,BRD:BRD-K00004665-001-01-9,rep_single_dose,,,,,,,,NA,,
SYK INHIBITOR,BAY-613606;SYK INHIBITOR,,GDSC1:178,gdsc,,,,,,,,NA,,
SYM-2081,"2S,4R-4-METHYLGLUTAMATE;SYM-2081",CHEMBL288166,BRD:BRD-BRD-K72106461-001-02-1;BRD:BRD-K72106461-001-02-1,rep_primary;rep_single_dose,KAINATE RECEPTOR ANTAGONIST,GRIK1;GRIK2;GRIK3;GRIK4;GRIK5;SLC1A2,,,PRECLINICAL,,Small molecule,NA,C[C@H](C[C@H](N)C(=O)O)C(=O)O;C[C@H](C[C@H](N)C(O)=O)C(O)=O,KRKRAOXTGDJWNI-DMTCNVIQSA-N
SYM-2206,SYM-2206,,BRD:BRD-A77218119-001-03-5;BRD:BRD-BRD-A77218119-001-03-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1;GRIA2;GRIA3;GRIA4,,,PRECLINICAL,,,NA,"CCCNC(=O)N1N=C(C2CCC(N)CC2)C2CC3OCOC3CC2C1C, CCCNC(=O)N1N=C(C2CCC(N)CC2)C2CC3OCOC3CC2C1C",
SYNTHENATE,ADVANTRA Z;ANALEPTIN;DL-SYNEPHRINE;ETHAPHENE;NSC-166285;NSC-170956;OXEDRINE;P-SYNEPHRINE;PARASYMPATOL;S-38537-9;SIMPALON;SYNEPHRIN;SYNEPHRINE;SYNTHENATE,CHEMBL33720,BRD:BRD-A04327189-001-15-1;BRD:BRD-A04327189-003-03-3;BRD:BRD-BRD-A04327189-001-15-1;BRD:BRD-BRD-A04327189-003-03-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A,,,LAUNCHED,,Small molecule,-1,"CNCC(O)c1ccc(O)cc1;CNCC(O)C1CCC(O)CC1, CNCC(O)C1CCC(O)CC1, CNCC(O)C1CCC(O)CC1, CNCC(O)C1CCC(O)CC1, CNCC(O)C1CCC(O)CC1",YRCWQPVGYLYSOX-UHFFFAOYSA-N
SZ4TA2,SZ4TA2,,CTRP:688138,ctrp,,,,,,,,NA,,
T-0070907,T-0070907,,BRD:BRD-BRD-K31843556-001-04-1;BRD:BRD-K31843556-001-04-1,rep_primary;rep_single_dose,PPAR RECEPTOR ANTAGONIST,PPARG,,,PRECLINICAL,,,NA,"[O-][N+](=O)C1CCC(CL)C(C1)C(=O)NC1CCNCC1, [O-][N+](=O)C1CCC(CL)C(C1)C(=O)NC1CCNCC1, [O-][N+](=O)C1CCC(CL)C(C1)C(=O)NC1CCNCC1",
T-0156,T-0156,,BRD:BRD-BRD-K63516691-003-02-0;BRD:BRD-K63516691-003-02-0,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A,,,PRECLINICAL,,,NA,"COC(=O)C1C(-C2CC(OC)C(OC)C(OC)C2)C2CCNC(OCC3NCCCN3)C2C(=O)N1CC1CCNC(C)C1, COC(=O)C1C(-C2CC(OC)C(OC)C(OC)C2)C2CCNC(OCC3NCCCN3)C2C(=O)N1CC1CCNC(C)C1",
T-025,T-025,,BRD:BRD-K16605796-001-01-9,rep_single_dose,CLK INHIBITOR,,,,,,,NA,,
T-0901317,T-0901317,,BRD:BRD-BRD-K23383398-001-09-9;BRD:BRD-K23383398-001-09-9,rep_primary;rep_single_dose,LXR AGONIST,NCOA1;NCOA2;NR1H2;NR1H3;NR1I2;RXRB,,,PRECLINICAL,,,NA,"OC(C1CCC(CC1)N(CC(F)(F)F)S(=O)(=O)C1CCCCC1)(C(F)(F)F)C(F)(F)F, OC(C1CCC(CC1)N(CC(F)(F)F)S(=O)(=O)C1CCCCC1)(C(F)(F)F)C(F)(F)F, OC(C1CCC(CC1)N(CC(F)(F)F)S(=O)(=O)C1CCCCC1)(C(F)(F)F)C(F)(F)F",
T-1095,T-1095,,BRD:BRD-K00004631-001-01-9,rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,,,,,,,NA,,
T-1101 (TOSYLATE),T-1101 (TOSYLATE),,BRD:BRD-K00091066-075-01-9,rep_single_dose,,,,,,,,NA,,
T-5224,T-5224,,BRD:BRD-BRD-K84925803-001-01-9;BRD:BRD-K84925803-001-01-9,rep_primary;rep_single_dose,AP INHIBITOR,JUN,,,PHASE 2,,,NA,OC(=O)CCC1CC(CCC1OCC1CCC2C(O)NOC2C1)C(=O)C1CCC(OC2CCCC2)CC1O,
T-5601640,T-5601640,,BRD:BRD-BRD-K83492904-001-01-9;BRD:BRD-K83492904-001-01-9,rep_primary;rep_single_dose,LIM KINASE INHIBITOR,LIMK2,,,PRECLINICAL,,,NA,CC1CC(ON1)C(=O)NC1CCCC(C1)C(=O)NC1CCCC(C1)C(F)(F)F,
T807,FLORTAUCIPIR;T-807;T807,CHEMBL3546271,BRD:BRD-K00003402-001-01-9,rep_single_dose,PET RADIOTRACER,,,,,,Small molecule,4,Fc1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1,GETAAWDSFUCLBS-UHFFFAOYSA-N
TA-01,TA-01,,BRD:BRD-BRD-K79856806-001-01-0;BRD:BRD-K79856806-001-01-0,rep_primary;rep_single_dose,"CASEIN KINASE INHIBITOR, MAP KINASE INHIBITOR",CSNK1D;CSNK1E;MAPK14,,,PRECLINICAL,,,NA,FC1CCC(CC1)-C1NC([NH]C1-C1CCNCC1)-C1C(F)CCCC1F,
TABIMORELIN,NN-703;NN703;NNC-26-0703;TABIMORELIN,CHEMBL281764,BRD:BRD-BRD-K53600683-051-01-5;BRD:BRD-K53600683-051-01-5,rep_primary;rep_single_dose,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,GHSR,,,PHASE 2,,Small molecule,2,CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)/C=C/CC(C)(C)N;CNC(=O)[C@@H](CC1CCCCC1)N(C)C(=O)[C@@H](CC1CCC2CCCCC2C1)N(C)C(=O)\C=C\CC(C)(C)N,WURGZWOTGMLDJP-ZCYANPAGSA-N
TACALCITOL,"1.ALPHA.,24-DIHYDROXYVITAMIN D3;BONALFA;CURATODERM;TACALCITOL",CHEMBL2105611,BRD:BRD-BRD-K73237276-001-01-0;BRD:BRD-K73237276-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN D RECEPTOR AGONIST,VDR,"PSORIASIS, CHAPPED LIPS",,LAUNCHED,,Small molecule,4,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CC[C@@H](O)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O;CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,BJYLYJCXYAMOFT-RSFVBTMBSA-N
TACEDINALINE,CI-994;GOE 5549;GOE-5549;PD 123654;PD-123654;TACEDINALINE,CHEMBL235191,BRD:BRD-BRD-K52313696-001-12-3;BRD:BRD-K52313696-001-12-3;CTRP:54200,ctrp;rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1,,,PHASE 3,,Small molecule,3,"CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1;CC(=O)NC1CCC(CC1)C(=O)NC1CCCCC1N, CC(=O)NC1CCC(CC1)C(=O)NC1CCCCC1N",VAZAPHZUAVEOMC-UHFFFAOYSA-N
TACRINE,TACRINAL;TACRINE,CHEMBL95,BRD:BRD-BRD-K81473089-003-26-1;BRD:BRD-K81473089-003-26-1,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,ACHE;BCHE,ALZHEIMER'S DISEASE,,LAUNCHED,,Small molecule,4,"Nc1c2c(nc3ccccc13)CCCC2;NC1C2CCCCC2NC2CCCCC12, NC1C2CCCCC2NC2CCCCC12, NC1C2CCCCC2NC2CCCCC12",YLJREFDVOIBQDA-UHFFFAOYSA-N
VIVADEX,ADOPORT;ADVAGRAF;ASTAGRAF XL;CAPEXION;ENVARSUS;ENVARSUS XR;FK 506;FK-506;FK506;FR-900506;FR900506;MODIGRAF;NSC-758659;PERIXIS;PROGRAF;PROTOPIC;TACNI;TACROLIMUS;TACROLIMUS HYDRATE;TACROLIMUS MONOHYDRATE;VIVADEX,CHEMBL269732;CHEMBL3989887,BRD:BRD-BRD-K69608737-001-10-2;BRD:BRD-K69608737-001-10-2;CTRP:50737,ctrp;rep_multi_dose;rep_primary;rep_single_dose,CALCINEURIN INHIBITOR,FKBP1A,ORGAN REJECTION,,LAUNCHED,,Small molecule,4,"C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC.O;CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC, CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC, CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC",NWJQLQGQZSIBAF-MLAUYUEBSA-N
TRANS-TADALAFIL,ADCIRCA;CIALIS;IC-351;IC351;LY-450190;LY450190;NSC-750236;NSC-759172;TADALAFIL;TADALAFIL MYLAN;TADLIQ;TRANS-TADALAFIL,CHEMBL779,BRD:BRD-BRD-K93645900-001-11-3;BRD:BRD-K93645900-001-11-3,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE11A;PDE5A,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O;CN1CC(=O)N2[C@H](CC3C([NH]C4CCCCC34)[C@H]2C2CCC3OCOC3C2)C1=O, CN1CC(=O)N2[C@H](CC3C([NH]C4CCCCC34)[C@H]2C2CCC3OCOC3C2)C1=O",WOXKDUGGOYFFRN-IIBYNOLFSA-N
TAE684,NVP-TAE 684;NVP-TAE684;TAE-684;TAE684,CHEMBL509032,GDSC1:35,gdsc,,,,,,,Small molecule,NA,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,QQWUGDVOUVUTOY-UHFFFAOYSA-N
TAFAMIDIS-MEGLUMINE,TAFAMIDIS-MEGLUMINE,,BRD:BRD-BRD-K23728141-001-01-2;BRD:BRD-K23728141-001-01-2,rep_primary;rep_single_dose,TRANSTHYRETIN AMYLOID INHIBITOR,TTR,FAMILIAL AMYLOID POLYNEUROPATHY (FAP),,LAUNCHED,,,NA,OC(=O)C1CCC2NC(OC2C1)-C1CC(CL)CC(CL)C1,
WR 238605,SB-252263-AAB;TAFENOQUINE;WR 238605,CHEMBL298470,BRD:BRD-A78965079-036-01-8;BRD:BRD-BRD-A78965079-036-01-8,rep_primary;rep_single_dose,ANTIMALARIAL AGENT,,,,PHASE 3,,Small molecule,4,COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1;COC1CC(C)C2C(OC3CCCC(C3)C(F)(F)F)C(OC)CC(NC(C)CCCN)C2N1,LBHLFPGPEGDCJG-UHFFFAOYSA-N
TAFINLAR,DABRAFENIB;DABRAFENIB MESILATE;DABRAFENIB MESYLATE;GSK-2118436;GSK-2118436 METHANESULFONATE SALT;GSK-2118436A;GSK-2118436B;GSK-2118436B MESYLATE;GSK-2118436B METHANESULFONATE SALT;GSK2118436;GSK2118436A;GSK2118436B;METHANE SULFONATE SALT;TAFINLAR,CHEMBL2028663;CHEMBL2105729,GDSC1:1373;GDSC2:1373,gdsc,,,,,,,Small molecule,4,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1;CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O,BFSMGDJOXZAERB-UHFFFAOYSA-N;YKGMKSIHIVVYKY-UHFFFAOYSA-N
ZIOPTAN,AFP-168;MK-2452;SAFLUTAN;TAFLUPROST;ZIOPTAN,CHEMBL1963683,BRD:BRD-K65059905-001-02-9,rep_single_dose,PROSTAGLANDIN INHIBITOR,PTGFR,,,,,Small molecule,4,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COc2ccccc2)[C@H](O)C[C@@H]1O,WSNODXPBBALQOF-VEJSHDCNSA-N
TAGATOSE,D-TAGATOSE;TAGATOSE,CHEMBL1236183,BRD:BRD-A73556557-001-06-4;BRD:BRD-BRD-A73556557-001-06-4;BRD:BRD-BRD-K89588135-001-01-9;BRD:BRD-K89588135-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHORYLASE INHIBITOR,PYGL,,,PHASE 3,"Multiple values for structure_id: {'K89588135', 'A73556557'}, defaulting to None",Small molecule,3,"O=C(CO)[C@@H](O)[C@@H](O)[C@H](O)CO;OCC(O)C(O)C(O)C(=O)CO, OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO, OC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O, OCC(O)C(O)C(O)C(=O)CO, OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO",BJHIKXHVCXFQLS-PQLUHFTBSA-N
TAGRISSO,AZD 9291;AZD-9291;AZD-9291 FREE BASE;AZD-9291 MESYLATE;AZD9291;AZD9291 MESYLATE;MERELETINIB;MERELETINIB MESILATE;MERELETINIB MESYLATE;OSIMERTINIB;OSIMERTINIB MESILATE;OSIMERTINIB MESYLATE;TAGRISSO,CHEMBL3353410;CHEMBL3545063,GDSC2:1919,gdsc,,,,,,,Small molecule,4,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C;C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.CS(=O)(=O)O,DUYJMQONPNNFPI-UHFFFAOYSA-N;FUKSNUHSJBTCFJ-UHFFFAOYSA-N
TAK-715,KIN001-201;TAK 715;TAK-715,CHEMBL363648,GDSC1:221,gdsc,,,,,,,Small molecule,2,CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1,HEKAIDKUDLCBRU-UHFFFAOYSA-N
TAK-063,BALIPODECT;TAK-063,CHEMBL3989972,BRD:BRD-BRD-K57155378-001-01-1;BRD:BRD-K57155378-001-01-1,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE10A,,,PHASE 2,,Small molecule,2,COc1cn(-c2ccc(-n3cccn3)cc2F)nc(-c2ccnn2-c2ccccc2)c1=O;COC1CN(NC(-C2CCNN2-C2CCCCC2)C1=O)-C1CCC(CC1F)-N1CCCN1,KVHRYLNQDWXAGI-UHFFFAOYSA-N
TAK-071,TAK-071,CHEMBL4594351,BRD:BRD-K00091106-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Cc1c(Cc2ccc(-n3cccn3)cc2)cc2c(c1F)CN([C@H]1COCC[C@@H]1O)C2=O,WFSARWQASFQZMG-VXKWHMMOSA-N
TAK-220,TAK-220,,BRD:BRD-BRD-K38793468-001-01-4;BRD:BRD-K38793468-001-01-4,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR5,,,PHASE 1,,,NA,CC(=O)N1CCC(CC1)C(=O)N(CCCN1CCC(CC2CCC(CC2)C(N)=O)CC1)C1CCC(C)C(CL)C1,
TAK285,TAK 285;TAK-285;TAK285,CHEMBL1614725,BRD:BRD-BRD-K80343549-001-02-6;BRD:BRD-K80343549-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,ERBB2,,,PHASE 1,,Small molecule,1,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21;CC(C)(O)CC(=O)NCCN1CCC2NCNC(NC3CCC(OC4CCCC(C4)C(F)(F)F)C(CL)C3)C12,ZYQXEVJIFYIBHZ-UHFFFAOYSA-N
TAK-593,TAK 593;TAK-593,CHEMBL2180604,BRD:BRD-BRD-K67262033-001-01-0;BRD:BRD-K67262033-001-01-0,rep_primary;rep_single_dose,VEGFR INHIBITOR,PDGFRA,,,PHASE 1,,Small molecule,1,Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1;CC1CC(C(=O)NC2CC(OC3CCC4NC(NC(=O)C5CC5)CN4N3)CCC2C)N(C)N1,DZFZXPPHBWCXPQ-UHFFFAOYSA-N
TAK-632,TAK-632,,BRD:BRD-BRD-K31866293-001-01-6;BRD:BRD-K31866293-001-01-6,oncref_2;rep_multi_dose;rep_primary;rep_single_dose,PAN RAF INHIBITOR,BRAF;RAF1,,,PRECLINICAL,"Multiple values for MOA: {'PAN RAF INHIBITOR', 'RAF INHIBITOR'}, defaulting to 'PAN RAF INHIBITOR'
Multiple values for repurposing_target: {'BRAF', 'BRAF;RAF1'}, taking the union",,NA,FC1CCC(OC2CCC3NC(NC(=O)C4CC4)SC3C2C#N)CC1NC(=O)CC1CCCC(C1)C(F)(F)F,
TAK-659,MIVAVOTINIB CITRATE;TAK 659;TAK-659,CHEMBL4594253,BRD:BRD-K71500795-003-02-9,rep_single_dose,SPLEEN ASSOCIATED TYROSINE KINASE INHIBITOR,,,,,,Small molecule,2,Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1.O=C(O)CC(O)(CC(=O)O)C(=O)O,ZVPYVZMKBQYKQG-ZVWHLABXSA-N
TAK-715,TAK 715;TAK-715,CHEMBL363648,BRD:BRD-BRD-K52751261-001-06-1;BRD:BRD-K52751261-001-06-1;GDSC1:221,gdsc;rep_multi_dose;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK14,,,PHASE 2,,Small molecule,2,"CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1;CCC1NC(C(S1)-C1CCNC(NC(=O)C2CCCCC2)C1)-C1CCCC(C)C1, CCC1NC(C(S1)-C1CCNC(NC(=O)C2CCCCC2)C1)-C1CCCC(C)C1",HEKAIDKUDLCBRU-UHFFFAOYSA-N
TAK733,MEK INHIBITOR TAK-733;TAK 733;TAK-733;TAK733,CHEMBL1615025,BRD:BRD-BRD-K26667523-001-02-5;BRD:BRD-K26667523-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,MAP2K1,,,PHASE 1,,Small molecule,1,"Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21;CN1C2NCN(C[C@@H](O)CO)C(=O)C2C(NC2CCC(I)CC2F)C(F)C1=O, CN1C2NCN(C[C@@H](O)CO)C(=O)C2C(NC2CCC(I)CC2F)C(F)C1=O",RCLQNICOARASSR-SECBINFHSA-N
TAK-779,TAK-779,,BRD:BRD-K00003155-003-01-9,rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,,,,NA,,
TAK875,FASIGLIFAM;FASIGLIFAM HEMIHYDRATE;FASIGLIFAM HYDRATE;TAK-875;TAK-875 ANHYDROUS;TAK875,CHEMBL1829174,BRD:BRD-BRD-K58501140-002-01-0;BRD:BRD-K58501140-002-01-0,rep_primary;rep_single_dose,INSULIN SECRETAGOGUE,FFAR1,,,PHASE 3,,Small molecule,3,CC1CC(OCCCS(C)(=O)=O)CC(C)C1-C1CCCC(COC2CCC3[C@H](CC(O)=O)COC3C2)C1;Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1,BZCALJIHZVNMGJ-HSZRJFAPSA-N
TAK-901,TAK-901,CHEMBL3544932,BRD:BRD-BRD-K01683783-001-02-6;BRD:BRD-K01683783-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKB,,,PHASE 1,,Small molecule,1,CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1;CCS(=O)(=O)C1CCCC(C1)-C1CC(C(=O)NC2CCN(C)CC2)C(C)C2[NH]C3NCC(C)CC3C12,WKDACQVEJIVHMZ-UHFFFAOYSA-N
TAK960,TAK-960;TAK960,CHEMBL2392545,BRD:BRD-BRD-K48059512-003-01-0;BRD:BRD-K48059512-003-01-0,rep_primary;rep_single_dose,PLK INHIBITOR,PLK1,,,PHASE 1,,Small molecule,1,"COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C;COC1CC(C(=O)NC2CCN(C)CC2)C(F)CC1NC1NCC2N(C)C(=O)C(F)(F)CN(C3CCCC3)C2N1, COC1CC(C(=O)NC2CCN(C)CC2)C(F)CC1NC1NCC2N(C)C(=O)C(F)(F)CN(C3CCCC3)C2N1",GWRSATNRNFYMDI-UHFFFAOYSA-N
TALADEGIB,LY-2940680;LY2940680;TALADEGIB,CHEMBL2142592,BRD:BRD-BRD-K50498985-001-03-3;BRD:BRD-K50498985-001-03-3,rep_primary;rep_single_dose,SMOOTHENED RECEPTOR ANTAGONIST,DHH;IHH;SMO,,,PHASE 2,,Small molecule,2,CN(C(=O)c1ccc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1;CN(C1CCN(CC1)C1NNC(-C2CCNN2C)C2CCCCC12)C(=O)C1CCC(F)CC1C(F)(F)F,SZBGQDXLNMELTB-UHFFFAOYSA-N
TALAMPANEL,(-)-TALAMPANEL;GYKI-53773;LY-300164;LY300164;TALAMPANEL,CHEMBL61872,BRD:BRD-BRD-K80359953-001-01-3;BRD:BRD-K80359953-001-01-3,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIA1;GRIA2;GRIA3;GRIA4,,,PHASE 2,,Small molecule,2,"C[C@@H]1CC2CC3OCOC3CC2C(=NN1C(C)=O)C1CCC(N)CC1, C[C@@H]1CC2CC3OCOC3CC2C(=NN1C(C)=O)C1CCC(N)CC1;CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C[C@H]1C)OCO3",JACAAXNEHGBPOQ-LLVKDONJSA-N
TALAPORFIN,TALAPORFIN,CHEMBL2111186,BRD:BRD-K00004965-342-01-9,rep_single_dose,PHOTOSENSITIZING AGENT,,,,,,Small molecule,3,C=Cc1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)O)C(=O)O)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)[C@@H](CCC(=O)O)[C@@H]3C,VSEIDZLLWQQJGK-WSUYNKMOSA-N
TALAROZOLE,R-115866;R115866;RAMBAZOLE;TALAROZOLE,CHEMBL459505,BRD:BRD-A95755460-001-01-3;BRD:BRD-BRD-A95755460-001-01-3,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP26A1,,,PHASE 2,,Small molecule,2,CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1;CCC(CC)C(C1CCC(NC2NC3CCCCC3S2)CC1)N1CNCN1,SNFYYXUGUBUECJ-UHFFFAOYSA-N
TALAZOPARIB,BMN 673;BMN-673;LT-673;TALAZOPARIB,CHEMBL3137320,BRD:BRD-BRD-K95142244-001-01-5;BRD:BRD-K95142244-001-01-5;GDSC1:1259;GDSC2:1259,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,PARP2,,,PHASE 3,,Small molecule,4,CN1NCNC1[C@@H]1[C@H](NC2CC(F)CC3C2C1N[NH]C3=O)C1CCC(F)CC1;Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,HWGQMRYQVZSGDQ-HZPDHXFCSA-N
TALCUM POWDER,E-553(III);HUASHIFEN;INS NO.553(III);INS-553(III);PULVIS TALCI;PURIFIED TALC;SCLEROSOL;STERITALC;TALC;TALC POWDER;TALCUM;TALCUM POWDER,CHEMBL3989756;CHEMBL3990276,BRD:BRD-BRD-M92352362-002-02-3;BRD:BRD-M92352362-002-02-3,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,4,"O.O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O;O=[MG].O=[MG].O=[MG].O=[SI]=O.O=[SI]=O.O=[SI]=O.O=[SI]=O, O=[MG].O=[MG].O=[MG].O=[SI]=O.O=[SI]=O.O=[SI]=O.O=[SI]=O",FPAFDBFIGPHWGO-UHFFFAOYSA-N
TALINOLOL,TALINOLOL,CHEMBL152067,BRD:BRD-A94276798-001-01-4;BRD:BRD-BRD-A94276798-001-01-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1,HYPERTENSION,,LAUNCHED,,Small molecule,1,CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1;CC(C)(C)NCC(O)COC1CCC(NC(=O)NC2CCCCC2)CC1,MXFWWQICDIZSOA-UHFFFAOYSA-N
TALIPEXOLE,TALIPEXOLE,CHEMBL279085,BRD:BRD-BRD-K75615183-300-03-9;BRD:BRD-K75615183-300-03-9,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST",ADRA2A;DRD2;HTR3A,GENITIAL HERPES,,LAUNCHED,,Small molecule,-1,"C=CCN1CCc2nc(N)sc2CC1;NC1NC2CCN(CC=C)CCC2S1, NC1NC2CCN(CC=C)CCC2S1, NC1NC2CCN(CC=C)CCC2S1, NC1NC2CCN(CC=C)CCC2S1",DHSSDEDRBUKTQY-UHFFFAOYSA-N
TALMAPIMOD,SCIO 469;SCIO-469;TALMAPIMOD,CHEMBL514201,BRD:BRD-BRD-K17555800-003-01-5;BRD:BRD-K17555800-003-01-5;BRD:BRD-K17555800-003-02-3,rep_multi_dose;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,IL1B;MAPK11;MAPK14;MT-CO2;TNF,,,PHASE 2,"Multiple values for repurposing_target: {'IL1B;MAPK11;MAPK14;MT-CO2;TNF', 'MAPK11;MAPK14'}, taking the union",Small molecule,2,"C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)c1cc2c(C(=O)C(=O)N(C)C)cn(C)c2cc1Cl;C[C@H]1CN([C@H](C)CN1CC1CCC(F)CC1)C(=O)C1CC2C(CN(C)C2CC1CL)C(=O)C(=O)N(C)C, C[C@H]1CN([C@H](C)CN1CC1CCC(F)CC1)C(=O)C1CC2C(CN(C)C2CC1CL)C(=O)C(=O)N(C)C, C[C@H]1CN([C@H](C)CN1CC1CCC(F)CC1)C(=O)C1CC2C(CN(C)C2CC1CL)C(=O)C(=O)N(C)C",ZMELOYOKMZBMRB-DLBZAZTESA-N
TALNETANT,SB-2234;SB-223412;TALNETANT,CHEMBL10188,BRD:BRD-BRD-K47095176-001-01-6;BRD:BRD-K47095176-001-01-6,rep_primary;rep_single_dose,TACHYKININ ANTAGONIST,TACR2;TACR3,,,PHASE 2,,Small molecule,2,CC[C@H](NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1;CC[C@H](NC(=O)C1C(O)C(NC2CCCCC12)-C1CCCCC1)C1CCCCC1,BIAVGWDGIJKWRM-FQEVSTJZSA-N
TALNIFLUMATE,BA 7602-06;BA-7602-06;SOMALGEN;TALNIFLUMATE,CHEMBL1081506,BRD:BRD-A98378129-001-02-2;BRD:BRD-BRD-A98378129-001-02-2,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,CLCA1,PAIN RELIEF,,LAUNCHED,,Small molecule,-1,"FC(F)(F)C1CCCC(NC2NCCCC2C(=O)OC2OC(=O)C3CCCCC23)C1, FC(F)(F)C1CCCC(NC2NCCCC2C(=O)OC2OC(=O)C3CCCCC23)C1;O=C1OC(OC(=O)c2cccnc2Nc2cccc(C(F)(F)F)c2)c2ccccc21",ANMLJLFWUCQGKZ-UHFFFAOYSA-N
TALOPRAM,TALOPRAM,CHEMBL299233,BRD:BRD-A02532772-003-01-7;BRD:BRD-BRD-A02532772-003-01-7,rep_primary;rep_single_dose,ADRENERGIC INHIBITOR,SLC6A2,,,PHASE 2,,Small molecule,-1,CNCCCC1(c2ccccc2)OC(C)(C)c2ccccc21;CNCCCC1(OC(C)(C)C2CCCCC12)C1CCCCC1,LJBBMCNHIUJBDU-UHFFFAOYSA-N
TALSACLIDINE,TALSACLIDINE,CHEMBL2111051,BRD:BRD-K00004651-001-01-9,rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,,,Small molecule,2,C#CCO[C@H]1CN2CCC1CC2,XVFJONKUSLSKSW-JTQLQIEISA-N
TALTIRELIN,TA-0910;TALTIRELIN,CHEMBL2107016,BRD:BRD-BRD-K93869735-001-01-1;BRD:BRD-K93869735-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,THYROTROPIN RELEASING HORMONE RECEPTOR AGONIST,TRHR,SPINOCEREBELLAR ATAXIA,,LAUNCHED,,Protein,-1,CN1C(=O)C[C@@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@H]2C(N)=O)NC1=O;CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC1CNC[NH]1)C(=O)N1CCC[C@H]1C(N)=O,LQZAIAZUDWIVPM-SRVKXCTJSA-N
TALTOBULIN,HTI-286;TALTOBULIN,CHEMBL182319,BRD:BRD-BRD-K87512222-019-01-7;BRD:BRD-K87512222-019-01-7,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,,,,PHASE 1,,Small molecule,-1,CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](C(C)C)\C=C(/C)C(O)=O)C(C)(C)C)C(C)(C)C1CCCCC1;CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](/C=C(\C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1,CNTMOLDWXSVYKD-PSRNMDMQSA-N
TAMATINIB,R-406;R940406;TAMATINIB,CHEMBL475251,CTRP:417818,ctrp,,,,,,,Small molecule,2,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,NHHQJBCNYHBUSI-UHFFFAOYSA-N
TAME,TAME,,BRD:BRD-BRD-K72231366-001-02-3;BRD:BRD-K72231366-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1CCC(C)CC1,
TOS-80T,AM-80;AM80;AMNOID;INNO-507;NSC-608000;OP-01;RR-110;SY-1425;TAMIBAROTENE;TM-411;TOS-80T,CHEMBL25202,BRD:BRD-BRD-K36627727-001-05-4;BRD:BRD-K36627727-001-05-4,rep_multi_dose;rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA;RARB,ACUTE PROMYELOCYTIC LEUKEMIA (APL),,LAUNCHED,,Small molecule,3,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21;CC1(C)CCC(C)(C)C2CC(NC(=O)C3CCC(CC3)C(O)=O)CCC12,MUTNCGKQJGXKEM-UHFFFAOYSA-N
TAMINADENANT,TAMINADENANT,,BRD:BRD-K00004682-001-01-9,rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,,,,,,,NA,,
TAMOXIFEN,ICI-46474;ICI-47699;MAMMATON;NOLVADEX;NOVALDEX;NSC-727681;SOLTAMOX;TAMOPLEX;TAMOXIFEN,CHEMBL83,BRD:BRD-BRD-K93754473-048-20-2;BRD:BRD-K93754473-048-20-2;CTRP:26972;GDSC1:1199;GDSC2:1199,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,"ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",EBP;ESR1;ESR2;GPER1;PRKCA;PRKCB;PRKCD;PRKCE;PRKCG;PRKCI;PRKCQ;PRKCZ,BREAST CANCER,,LAUNCHED,,Small molecule,4,"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1;CC\C(C1CCCCC1)=C(/C1CCCCC1)C1CCC(OCCN(C)C)CC1, CC\C(C1CCCCC1)=C(/C1CCCCC1)C1CCC(OCCN(C)C)CC1, CC\C(C1CCCCC1)=C(/C1CCCCC1)C1CCC(OCCN(C)C)CC1, CC\C(C1CCCCC1)=C(/C1CCCCC1)C1CCC(OCCN(C)C)CC1, CC\C(C1CCCCC1)=C(/C1CCCCC1)C1CCC(OCCN(C)C)CC1",NKANXQFJJICGDU-QPLCGJKRSA-N
TAMSULOSIN,HGP-0412;HIP-1402;HIP1402;TAMSULON;TAMSULOSIN,CHEMBL836,BRD:BRD-BRD-K74339692-001-01-9;BRD:BRD-K74339692-001-01-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D,BENIGN PROSTATIC HYPERPLASIA (BPH),,LAUNCHED,,Small molecule,4,"CCOC1CCCCC1OCCN[C@H](C)CC1CCC(OC)C(C1)S(N)(=O)=O, CCOC1CCCCC1OCCN[C@H](C)CC1CCC(OC)C(C1)S(N)(=O)=O;CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1",DRHKJLXJIQTDTD-OAHLLOKOSA-N
TANAPROGET,NSP-989;TANAPROGET,CHEMBL539163,BRD:BRD-BRD-K99604664-001-01-1;BRD:BRD-K99604664-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR AGONIST,PGR,,,PHASE 2,,Small molecule,-1,"Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(C)OC(=S)N2;CN1C(CCC1-C1CCC2NC(=S)OC(C)(C)C2C1)C#N, CN1C(CCC1-C1CCC2NC(=S)OC(C)(C)C2C1)C#N",PYVFWTPEBMRKSR-UHFFFAOYSA-N
TANDOSPIRONE,TANDOSPIRONE,CHEMBL274047,BRD:BRD-BRD-K65904673-001-01-4;BRD:BRD-K65904673-001-01-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,"GENERALIZED ANXIETY DISORDER (GAD), DYSTHYMIC DISORDER",,LAUNCHED,,Small molecule,-1,"O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1;O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(CC1)C1NCCCN1, O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(CC1)C1NCCCN1",CEIJFEGBUDEYSX-FZDBZEDMSA-N
TANDUTINIB,CT 53518;CT-53518;CT53518;MLN-0518;MLN-518;NSC-759851;TANDUTINIB,CHEMBL124660,BRD:BRD-BRD-K89162000-001-06-4;BRD:BRD-K89162000-001-06-4;CTRP:464458,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",CSF1R;FLT3;KIT;PDGFD;PDGFRB,,,PHASE 2,,Small molecule,2,"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1;COC1CC2C(NCNC2CC1OCCCN1CCCCC1)N1CCN(CC1)C(=O)NC1CCC(OC(C)C)CC1, COC1CC2C(NCNC2CC1OCCCN1CCCCC1)N1CCN(CC1)C(=O)NC1CCC(OC(C)C)CC1",UXXQOJXBIDBUAC-UHFFFAOYSA-N
TANESPIMYCIN,17-AAG;17AAG;BMS-722782;CNF-1010;CNF1010;KOS-953;NSC-330507;TANESPIMYCIN,CHEMBL109480,BRD:BRD-BRD-K81473043-001-14-6;BRD:BRD-K81473043-001-14-6;BRD:BRD-K81473043-001-19-5;CTRP:50134;GDSC1:1026,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1,,,PHASE 3,,Small molecule,3,"C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O;CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O, CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O",AYUNIORJHRXIBJ-TXHRRWQRSA-N
TANESPIMYCIN:BORTEZOMIB (250:1 MOL/MOL),TANESPIMYCIN:BORTEZOMIB (250:1 MOL/MOL),,CTRP:660221,ctrp,,,,,,,,NA,,
TANESPIMYCIN:GEMCITABINE (1:1 MOL/MOL),TANESPIMYCIN:GEMCITABINE (1:1 MOL/MOL),,CTRP:660216,ctrp,,,,,,,,NA,,
TANGERITIN,TANGERITIN,,BRD:BRD-BRD-K25186396-001-09-6;BRD:BRD-K25186396-001-09-6,rep_primary;rep_single_dose,CELL CYCLE INHIBITOR,,,,PRECLINICAL,,,NA,COC1CCC(CC1)-C1CC(=O)C2C(OC)C(OC)C(OC)C(OC)C2O1,
TANNIC-ACID,TANNIC-ACID,,BRD:BRD-K01584643-001-04-9,rep_single_dose,PARG INHIBITOR,ANO1,,,,,,NA,,
TANSHINONE-I,TANSHINONE-I,,BRD:BRD-BRD-K34073885-001-09-3;BRD:BRD-K34073885-001-09-3,rep_multi_dose;rep_primary;rep_single_dose,AP INHIBITOR,IFNG,,,PHASE 2,,,NA,"CC1COC-2C1C(=O)C(=O)C1C-2CCC2C(C)CCCC12, CC1COC-2C1C(=O)C(=O)C1C-2CCC2C(C)CCCC12",
TANSHINONE-IIA,TANSHINONE-IIA,,BRD:BRD-BRD-K00141480-001-15-4;BRD:BRD-K00141480-001-15-4,rep_primary;rep_single_dose,"ANTI-INFLAMMATORY AGENT, INTERLEUKIN INHIBITOR",IL1B;NR1I2;TNF,,,PHASE 2/PHASE 3,,,NA,"CC1COC-2C1C(=O)C(=O)C1C-2CCC2C1CCCC2(C)C, CC1COC-2C1C(=O)C(=O)C1C-2CCC2C1CCCC2(C)C",
TAPENTADOL,BN 200 (BASE);BN-200;CG-5503;CG5503;CG5503 (BASE);CG5503 IR;NSC-759619;TAPENTADOL,CHEMBL1201776,BRD:BRD-BRD-K25699529-003-01-1;BRD:BRD-K25699529-003-01-1,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,HTR3A;OPRD1;OPRK1;OPRM1;SLC6A2;SLC6A4,"ACUTE PAIN, MUSCLE PAIN",,LAUNCHED,,Small molecule,4,"CC[C@@H]([C@@H](C)CN(C)C)C1CCCC(O)C1, CC[C@H]([C@@H](C)CN(C)C)C1CCCC(O)C1, CC[C@H]([C@@H](C)CN(C)C)C1CCCC(O)C1;CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C",KWTWDQCKEHXFFR-SMDDNHRTSA-N
WBI-1001,BENVITIMOD;GSK-2894512;GSK2894512;TAPINAROF;VTAMA;WBI-1001,CHEMBL259571,BRD:BRD-K00003498-001-01-9,rep_single_dose,ARYL HYDROCARBON RECEPTOR AGONIST,,,,,,Small molecule,4,CC(C)c1c(O)cc(/C=C/c2ccccc2)cc1O,ZISJNXNHJRQYJO-CMDGGOBGSA-N
TAPRENEPAG,TAPRENEPAG,CHEMBL2107783,BRD:BRD-BRD-K88854110-001-01-5;BRD:BRD-K88854110-001-01-5,rep_primary;rep_single_dose,PROSTAGLANDIN RECEPTOR AGONIST,PTGER2,,,PHASE 2,,Small molecule,-1,O=C(O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)c1;OC(=O)COC1CCCC(CN(CC2CCC(CC2)-N2CCCN2)S(=O)(=O)C2CCCNC2)C1,MFFBXYNKZHTCEY-UHFFFAOYSA-N
TARAFENACIN,SVT-40776;TARAFENACIN,CHEMBL1779046,BRD:BRD-BRD-K59390331-045-01-5;BRD:BRD-K59390331-045-01-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM3,,,PHASE 2,,Small molecule,2,FC1CCCC(C1)N(CC1CC(F)C(F)C(F)C1)C(=O)O[C@H]1CN2CCC1CC2;O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1,UXZDMXYRRQJIBJ-IBGZPJMESA-N
TARANABANT,MK-0364;MK-0634;MK0364;TARANABANT,CHEMBL220360,BRD:BRD-BRD-K35169477-001-01-9;BRD:BRD-K35169477-001-01-9,rep_primary;rep_single_dose,CANNABINOID RECEPTOR INVERSE AGONIST,CNR1,,,PHASE 3,,Small molecule,3,C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1;C[C@H](NC(=O)C(C)(C)OC1CCC(CN1)C(F)(F)F)[C@@H](CC1CCC(CL)CC1)C1CCCC(C1)C#N,QLYKJCMUNUWAGO-GAJHUEQPSA-N
TARCEVA,"CP-358,774;CP-358774;CP-35877401;ERLOTINIB;OSI-774;R-1415;RG-1415;RO-508231;TARCEVA",CHEMBL553,GDSC1:1;GDSC2:1168,gdsc,,,,,,,Small molecule,4,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,AAKJLRGGTJKAMG-UHFFFAOYSA-N
TILARGININE,.OMEGA.-N-METHYLARGININE;L-NMMA;NG-METHYLARGININE;NG-MONOMETHYL-L-ARGININE;OMEGA-N-METHYLARGININE;OMEGA-N-METHYLATED ARGININE;TARGININE;TILARGININE,CHEMBL256147,BRD:BRD-BRD-K59506194-015-04-9;BRD:BRD-K59506194-015-04-9,rep_primary;rep_single_dose,NITRIC OXIDE SYNTHASE INHIBITOR,NOS3,,,PHASE 3,,Small molecule,3,CNC(=N)NCCC[C@H](N)C(=O)O;CNC(=N)NCCC[C@H](N)C(O)=O,NTNWOCRCBQPEKQ-YFKPBYRVSA-N
TARGREXIN,BEXAROTENE;BEXAROTENUM;LG-100069;LG100069;LGD-1069;LGD1069;NSC-747528;TARGRET;TARGRETIN;TARGRETINE;TARGRETYN;TARGREXIN,CHEMBL1023,GDSC1:186,gdsc,,,,,,,Small molecule,4,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N
XR9576,TARIQUIDAR;XR-9576;XR9576,CHEMBL348475,BRD:BRD-BRD-K09353376-001-03-9;BRD:BRD-K09353376-001-03-9,rep_primary;rep_single_dose,P GLYCOPROTEIN INHIBITOR,ABCB1,,,PHASE 3,,Small molecule,3,"COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2;COC1CC2CCN(CCC3CCC(NC(=O)C4CC(OC)C(OC)CC4NC(=O)C4CNC5CCCCC5C4)CC3)CC2CC1OC, COC1CC2CCN(CCC3CCC(NC(=O)C4CC(OC)C(OC)CC4NC(=O)C4CNC5CCCCC5C4)CC3)CC2CC1OC",LGGHDPFKSSRQNS-UHFFFAOYSA-N
TARTARIC-ACID,TARTARIC-ACID,,BRD:BRD-K36474365-001-09-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
TAS-103,TAS-103,,BRD:BRD-BRD-K09426783-300-01-0;BRD:BRD-K09426783-300-01-0,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1,,,PHASE 1,,,NA,CN(C)CCNC1NC2CC(O)CCC2C2-C3CCCCC3C(=O)C12,
TAS-116,PIMITESPIB;TAS 116;TAS-116,CHEMBL3661115,BRD:BRD-K00074122-001-02-9,rep_single_dose,,,,,,,Small molecule,1,CCc1cc(C(N)=O)ccc1-n1nc(C(C)C)c2c(-n3cnc(-c4cnn(C)c4)c3)ccnc21,NVVPMZUGELHVMH-UHFFFAOYSA-N
TAS4464,TAS4464,,BRD:BRD-K00091290-001-01-9,rep_single_dose,,,,,,,,NA,,
TASIGNA,AMN 107;AMN-107;AMN107;NILOTINIB;NILOTINIB (AS HYDROCHLORIDE);NILOTINIB HYDROCHLORIDE;NILOTINIB HYDROCHLORIDE ANHYDROUS;NILOTINIB HYDROCHLORIDE HYDRATE;NILOTINIB HYDROCHLORIDE MONOHYDRATE;NSC-747599;TASIGNA,CHEMBL1201740;CHEMBL255863,GDSC1:1013;GDSC2:1013,gdsc,,,,,,,Small molecule,4,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1;Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1.Cl.O,HHZIURLSWUIHRB-UHFFFAOYSA-N;YCBPQSYLYYBPDW-UHFFFAOYSA-N
VEC-162,"BMS-214,778;BMS-214778;HETLIOZ;HETLIOZ LQ;TASIMELTEON;VEC-162",CHEMBL2103822,BRD:BRD-BRD-K62971431-001-01-9;BRD:BRD-K62971431-001-01-9,rep_primary;rep_single_dose,MELATONIN RECEPTOR AGONIST,MTNR1A;MTNR1B,NON-24-HOUR SLEEP-WAKE DISORDER,,LAUNCHED,,Small molecule,4,CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2;CCC(=O)NC[C@@H]1C[C@H]1C1CCCC2OCCC12,PTOIAAWZLUQTIO-GXFFZTMASA-N
TASISULAM,LY-573636;LY573636;TASISULAM,CHEMBL2110587,BRD:BRD-BRD-K42495768-001-01-7;BRD:BRD-K42495768-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,APOPTOSIS STIMULANT,,,,PHASE 3,,Small molecule,3,CLC1CCC(C(=O)NS(=O)(=O)C2CCC(BR)S2)C(CL)C1;O=C(NS(=O)(=O)c1ccc(Br)s1)c1ccc(Cl)cc1Cl,WWONFUQGBVOKOF-UHFFFAOYSA-N
TASQUINIMOD,TASQUINIMOD,CHEMBL2107784,BRD:BRD-BRD-K14653796-001-01-1;BRD:BRD-K14653796-001-01-1,rep_primary;rep_single_dose,"ANGIOGENESIS INHIBITOR, S100A9 INHIBITOR",HDAC4,,,PHASE 3,,Small molecule,3,COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C;COC1CCCC2N(C)C(=O)C(C(=O)N(C)C3CCC(CC3)C(F)(F)F)C(O)C12,ONDYALNGTUAJDX-UHFFFAOYSA-N
TASULDINE,TASULDINE,CHEMBL358392,BRD:BRD-BRD-K10415035-001-04-4;BRD:BRD-K10415035-001-04-4,rep_primary;rep_single_dose,MUCOLYTIC AGENT,,,,PHASE 3,,Small molecule,-1,"C(SC1NCCCN1)C1CCCNC1, C(SC1NCCCN1)C1CCCNC1;c1cnc(SCc2cccnc2)nc1",HMCTXMOKMWELFJ-UHFFFAOYSA-N
TAURINE,2-AMINO-;AMINOETHYLSULFONIC ACID;ETHANESULFONIC ACID;FEMA NO. 3813;NSC-32428;O-DUE;TAURATE;TAURINE,CHEMBL239243,BRD:BRD-BRD-K51474575-001-10-4;BRD:BRD-K51474575-001-10-4,rep_multi_dose;rep_primary;rep_single_dose,ANTIOXIDANT,,"ANXIETY, IRRITABILITY, SLEEPLESSNESS",,LAUNCHED,,Small molecule,4,"NCCS(=O)(=O)O;NCCS(O)(=O)=O, NCCS(O)(=O)=O",XOAAWQZATWQOTB-UHFFFAOYSA-N
TAUROCHOLATE,TAUROCHOLATE,,BRD:BRD-BRD-K81062487-001-05-8;BRD:BRD-K81062487-001-05-8,rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,CEL;FABP6;SLCO1C1,,,PHASE 1,,,NA,C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,
TAUROGLYCOCHOLATE,TAUROGLYCOCHOLATE,,BRD:BRD-K00003523-236-01-9,rep_single_dose,MEMBRANE PERMEABILITY ENHANCER,,,,,,,NA,,
TAVABOROLE,AN-2690;AN2690;KERYDIN;TAVABOROLE,CHEMBL443052,BRD:BRD-BRD-K76713213-001-02-1;BRD:BRD-K76713213-001-02-1,rep_primary;rep_single_dose,LEUCYL-TRNA SYNTHETASE INHIBITOR,,ONYCHOMYCOSIS,,LAUNCHED,,Small molecule,4,"OB1OCC2CC(F)CCC12, OB1OCC2CC(F)CCC12;OB1OCc2cc(F)ccc21",LFQDNHWZDQTITF-UHFFFAOYSA-N
TAVILERMIDE,MIM-D3;TAVILERMIDE,CHEMBL3544981,BRD:BRD-K00003254-001-01-9,rep_single_dose,TYROSINE KINASE PARTIAL AGONIST,,,,,,Protein,3,NCCCC[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc([N+](=O)[O-])ccc2OCC[C@@H](C(=O)NCC(=O)O)NC1=O,DVJXNXPFYJIACK-ULQDDVLXSA-N
TAXIFOLIN,NSC-2801;TAXIFOLIN,CHEMBL337309,BRD:BRD-BRD-K94649603-001-10-6;BRD:BRD-K94649603-001-10-6,rep_primary;rep_single_dose,OPIOID RECEPTOR ANTAGONIST,ADIPOR2,,,PHASE 2,,Small molecule,NA,"O[C@@H]1[C@H](OC2CC(O)CC(O)C2C1=O)C1CCC(O)C(O)C1, O[C@@H]1[C@H](OC2CC(O)CC(O)C2C1=O)C1CCC(O)C(O)C1;O=C1c2c(O)cc(O)cc2OC(c2ccc(O)c(O)c2)C1O",CXQWRCVTCMQVQX-UHFFFAOYSA-N
YEWTAXAN,(-)-PACLITAXEL;ABI-007;ABI-007 COMPONENT PACLITAXEL;ABRAXANE;BMS 181339-01;BMS-181339-01;CAPXOL;CYCLOPAX;DHP 107;DHP-107;EBETAXEL;EMPAC;ENDOTAG 1;GENAXOL;GENETAXYL;GENEXOL;GENEXOL-PM;INTAXEL;LEP-ETU;MBT 0206;MBT-0206;MITOTAX;NK 105;NK-105;NSC-125973;ONCOGEL;ONXAL;ONXOL;PACITAXEL;PACLIEX;PACLITAXEL;PACLITAXEL (TAXUS CANADENSIS);PACLITAXOL;PAXENE;PLAXICEL;PRAXEL;QW-8184;TAXALBIN;TAXOL;TAXOL 100;TAXOL A;TAXUS;TAXUS LIBERTE;TAXUS STENT;TOCOSOL PACLITAXEL;YEWTAXAN,CHEMBL428647,GDSC1:11;GDSC2:1080,gdsc,,,,,,,Small molecule,4,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,RCINICONZNJXQF-MZXODVADSA-N
XRP6976,BIND 014;CKD-810;DOCEFREZ;DOCETAXEL;DOCETAXEL (AS TRIHYDRATE);DOCETAXEL ANHYDROUS;DOCETAXEL HYDRATE;DOCETAXEL TRIHYDRATE;NSC-628503;RP 56976;RP-56976;TAXCEUS;TAXOTERE;XRP6976,CHEMBL3545252;CHEMBL92,GDSC1:1007;GDSC2:1007;GDSC2:1819,gdsc,,,,,,,Small molecule,4,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,XCDIRYDKECHIPE-QHEQPUDQSA-N
ZORAC,AGN 190168;AGN-190168;ARAZLO;AVAGE;FABIOR;IDP-123;TAZAROTENE;TAZORAC;ZORAC,CHEMBL1657,BRD:BRD-BRD-K76841105-001-04-7;BRD:BRD-K76841105-001-04-7,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA;RARB;RARG;RXRB,"COSMETIC, SUNSCREEN LOTION",,LAUNCHED,,Small molecule,4,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1;CCOC(=O)C1CCC(NC1)C#CC1CCC2SCCC(C)(C)C2C1,OGQICQVSFDPSEI-UHFFFAOYSA-N
YTR-830H,"CL 298,741;CL-298741;NSC-759887;TAZOBACTAM;YTR-830H",CHEMBL404,BRD:BRD-A18611368-001-01-5;BRD:BRD-BRD-A18611368-001-01-5,rep_primary;rep_single_dose,BETA LACTAMASE INHIBITOR,,PNEUMONIA,,LAUNCHED,,Small molecule,4,C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O;C[C@]1(CN2CCNN2)C(N2C(CC2=O)S1(=O)=O)C(O)=O,LPQZKKCYTLCDGQ-WEDXCCLWSA-N
TBA-354,TBA 354;TBA-354,CHEMBL1630563,BRD:BRD-BRD-K56405978-001-01-5;BRD:BRD-K56405978-001-01-5,rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,1,[O-][N+](=O)C1CN2C[C@@H](COC2N1)OCC1CCC(NC1)-C1CCC(OC(F)(F)F)CC1;O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)C2,ZXSGSFMORAILEY-HNNXBMFYSA-N
TBOA-(DL),TBOA-(DL),,BRD:BRD-BRD-M77041484-001-01-8;BRD:BRD-M77041484-001-01-8,rep_primary;rep_single_dose,EXCITATORY AMINO ACID TRANSPORTER INHIBITOR,SLC1A1;SLC1A2;SLC1A3;SLC1A6;SLC1A7,,,PRECLINICAL,,,NA,"N[C@@H]([C@H](OCC1CCCCC1)C(O)=O)C(O)=O.N[C@H]([C@@H](OCC1CCCCC1)C(O)=O)C(O)=O, N[C@@H]([C@H](OCC1CCCCC1)C(O)=O)C(O)=O.N[C@H]([C@@H](OCC1CCCCC1)C(O)=O)C(O)=O, N[C@@H]([C@H](OCC1CCCCC1)C(O)=O)C(O)=O.N[C@H]([C@@H](OCC1CCCCC1)C(O)=O)C(O)=O",
TC-A-2317,TC-A-2317,,BRD:BRD-A12147465-003-02-9,rep_single_dose,AURORA KINASE INHIBITOR,AURKA,,,,,,NA,,
TC-ASK-10,TC-ASK-10,,BRD:BRD-BRD-K29660062-300-01-2;BRD:BRD-K29660062-300-01-2,rep_primary;rep_single_dose,MAP KINASE INHIBITOR,MAP3K5;MAP3K6,,,PRECLINICAL,,,NA,CC(C)(C)C1CCC(CC1)C(=O)NC1CN2CC(CCC2N1)-N1CCNC1,
TC-E-5002,TC-E-5002,,BRD:BRD-BRD-K15256258-001-01-3;BRD:BRD-K15256258-001-01-3,rep_primary;rep_single_dose,HISTONE DEMETHYLASE INHIBITOR,KDM2A;KDM4A;KDM4C;KDM5A;KDM6A;KDM7A;PHF8,,,PRECLINICAL,,,NA,"ON(CCC(O)=O)C(=O)CCCCCCCCC1CC1, ON(CCC(O)=O)C(=O)CCCCCCCCC1CC1",
TC-E-5006,TC-E-5006,,BRD:BRD-A66521565-001-01-8;BRD:BRD-BRD-A66521565-001-01-8,rep_primary;rep_single_dose,GAMMA SECRETASE MODULATOR,APP,,,PRECLINICAL,,,NA,CC(C(O)=O)C1CCC(C(N2CCC(C)CC2)C2CCC(F)CC2)C(C1)-C1CCC(CC1)C(F)(F)F,
TC-F-2,TC-F-2,,BRD:BRD-BRD-K26041695-001-02-5;BRD:BRD-K26041695-001-02-5,rep_primary;rep_single_dose,FAAH INHIBITOR,FAAH,,,PRECLINICAL,,,NA,CCN1C2CCCCC2N([C@H]2CCCN(C2)C2NCCC(N2)-C2CC3CCCCC3O2)C1=O,
TC-FPR-43,TC-FPR-43,,BRD:BRD-BRD-K16497916-001-01-6;BRD:BRD-K16497916-001-01-6,rep_primary;rep_single_dose,FORMYL PEPTIDE RECEPTOR AGONIST,FPR2,,,PRECLINICAL,,,NA,CC(C)C1C(NC(=O)NC2CCC(CL)CC2)C(=O)N(-C2CCCCC2)N1C,
TC-G-1000,TC-G-1000,,BRD:BRD-K27010807-050-02-9,rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C,,,,,,NA,,
TC-G-1004,TC-G-1004,,BRD:BRD-K76989898-001-02-9,rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA2A,,,,,,NA,,
TC-G-1005,TC-G-1005,,BRD:BRD-K16939217-001-02-9,rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,GPBAR1,,,,,,NA,,
TC-G-1008,TC-G-1008,,BRD:BRD-BRD-K87199310-001-01-4;BRD:BRD-K87199310-001-01-4,rep_primary;rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,GPR39,,,PRECLINICAL,,,NA,CNC1NC(NCC2CCC(NS(C)(=O)=O)CC2CL)CC(N1)-C1CCCCN1,
TC-H-106,TC-H-106,,BRD:BRD-K45044657-001-01-4,rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC8,,,,,,NA,,
TC-I-15,TC-I-15,,BRD:BRD-BRD-K17621556-001-01-5;BRD:BRD-K17621556-001-01-5,rep_primary;rep_single_dose,INTEGRIN INHIBITOR,ITGA2;ITGB1,,,PRECLINICAL,,,NA,CC1(C)SCN([C@@H]1C(=O)N[C@@H](CNC(=O)NCC1CCCCC1)C(O)=O)S(=O)(=O)C1CCCCC1,
TC-I-2000,TC-I-2000,,BRD:BRD-A83792282-001-01-6;BRD:BRD-BRD-A83792282-001-01-6,rep_primary;rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPM8,,,PRECLINICAL,,,NA,FC1CCC(NC(=O)N2CCC3CCCCC3C2C2CCC(CC2)C(F)(F)F)CC1,
TC-I-2014,TC-I-2014,,BRD:BRD-K05262258-001-02-9,rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPM8,,,,,,NA,,
TC-LPA5-4,TC-LPA5-4,,BRD:BRD-BRD-K32031961-001-01-7;BRD:BRD-K32031961-001-01-7,rep_primary;rep_single_dose,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,LPAR5,,,PRECLINICAL,,,NA,COC1CCCC(C1)-N1NC(CC1-C1CCC(C2CCCCC2)C(CL)C1)C(O)=O,
TC-MPS1-12,TC-MPS1-12,,BRD:BRD-BRD-K76792630-001-01-2;BRD:BRD-K76792630-001-01-2,rep_primary;rep_single_dose,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,TTK,,,PRECLINICAL,,,NA,CC(C)(C)NC1NC(NC2CCC(CC2)C(N)=O)CC(N)C1C#N,
TC-N-1752,TC-N-1752,,BRD:BRD-BRD-K78161388-001-01-2;BRD:BRD-K78161388-001-01-2,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN9A,,,PRECLINICAL,,,NA,CC(=O)NC1CCCC(NC2NCNC(N2)N2CCC(CC2)OCC2CCC(OC(F)(F)F)CC2)C1C,
TC-NTR1-17,TC-NTR1-17,,BRD:BRD-BRD-K79608170-001-02-1;BRD:BRD-K79608170-001-02-1,rep_primary;rep_single_dose,NEUROTENSIN AGONIST,NTSR1,,,PRECLINICAL,,,NA,COC1CCCC(OC)C1-C1CC(NN1-C1CCNC2CC(CL)CCC12)C(=O)N[C@@H](CC(C)C)C(O)=O,
TC-O-9311,TC-O-9311,,BRD:BRD-K54297077-001-02-9,rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,GPR139,,,,,,NA,,
TC-OT-39,TC-OT-39,,BRD:BRD-BRD-K55013981-001-01-3;BRD:BRD-K55013981-001-01-3,rep_primary;rep_single_dose,"OXYTOCIN RECEPTOR AGONIST, VASOPRESSIN RECEPTOR AGONIST",AVPR1A;OXT,,,PRECLINICAL,,,NA,CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCC1CCC(CC1C)C(=O)N1CC2CNN(C)C2NC2CCCCC12,
TC-S-7003,TC-S-7003,,BRD:BRD-K34362291-001-02-9,rep_single_dose,SRC INHIBITOR,LCK,,,,,,NA,,
TC-S-7004,TC-S-7004,,BRD:BRD-BRD-K89517477-001-01-4;BRD:BRD-K89517477-001-01-4,rep_primary;rep_single_dose,DYRK INHIBITOR,DYRK1A;DYRK1B,,,PRECLINICAL,,,NA,COC1NCC2CC(C(=O)NC3CC(CCC3CL)C(=O)NCC3CCCC(CL)C3)C(=O)[NH]C2N1,
TC-S-7005,TC-S-7005,,BRD:BRD-BRD-K89584803-001-01-9;BRD:BRD-K89584803-001-01-9,rep_primary;rep_single_dose,PLK INHIBITOR,PLK2,,,PRECLINICAL,,,NA,C[C@H](NC1CC2C(NOC2CN1)-C1CCC2OCOC2C1)C1CCCCC1,
TC-S-7006,TC-S-7006,,BRD:BRD-K51776215-001-03-9,rep_single_dose,MAP KINASE INHIBITOR,MAP3K8,,,,,,NA,,
TC-S-7009,TC-S-7009,,BRD:BRD-BRD-K21894922-001-01-9;BRD:BRD-K21894922-001-01-9,rep_primary;rep_single_dose,HYPOXIA INDUCIBLE FACTOR INHIBITOR,EPAS1,,,PRECLINICAL,,,NA,[O-][N+](=O)C1C(NC2CC(F)CC(CL)C2)CCC2NONC12,
TC-SP-14,TC-SP-14,,BRD:BRD-K87461578-001-02-9,rep_single_dose,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,S1PR1,,,,,,NA,,
TC1,TC1,,BRD:BRD-A13964793-001-02-6;BRD:BRD-BRD-A13964793-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,BETA-SECRETASE INHIBITOR,BACE1,,,PRECLINICAL,,,NA,OC12C3C4C5C3C(C3C5CC4C13)N2CCC1CCCC(F)C1,
TC2559,TC2559,,BRD:BRD-BRD-K24227647-364-01-5;BRD:BRD-K24227647-364-01-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA4,,,PRECLINICAL,,,NA,"CCOC1CNCC(\C=C\CCNC)C1, CCOC1CNCC(\C=C\CCNC)C1",
TCN201,TCN201,,BRD:BRD-BRD-K09787262-001-01-9;BRD:BRD-K09787262-001-01-9,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN2A,,,PRECLINICAL,,,NA,"FC1CCC(CC1CL)S(=O)(=O)NCC1CCC(CC1)C(=O)NNC(=O)C1CCCCC1, FC1CCC(CC1CL)S(=O)(=O)NCC1CCC(CC1)C(=O)NNC(=O)C1CCCCC1",
TCN238,TCN238,,BRD:BRD-K77915400-001-01-6,rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM4,,,,,,NA,,
TCS2002,TCS-2002;TCS2002,,BRD:BRD-A50028488-001-01-6;BRD:BRD-BRD-A50028488-001-01-6;BRD:BRD-K00004294-001-01-9,rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3B,,,PRECLINICAL,"Multiple values for structure_id: {'A50028488', 'K00004294'}, defaulting to None",,NA,"CC1NNC(O1)-C1CCC2OCC(-C3CCC(CC3)S(C)=O)C2C1, CC1NNC(O1)-C1CCC2OCC(-C3CCC(CC3)S(C)=O)C2C1",
TCS-21311,TCS-21311,,BRD:BRD-K49461364-001-01-0,rep_single_dose,JAK INHIBITOR,JAK3,,,,,,NA,,
TCS-2210,TCS-2210,,BRD:BRD-K19958299-001-02-9,rep_single_dose,NEURAL STEM CELL INDUCER,,,,,,,NA,,
TCS-2314,TCS-2314,,BRD:BRD-BRD-K55216666-001-01-4;BRD:BRD-K55216666-001-01-4,rep_primary;rep_single_dose,INTEGRIN INHIBITOR,ITGA4;ITGB1,,,PRECLINICAL,,,NA,CC1CCCCC1NC(=O)NC1CCC(CC(=O)N2CCOC[C@H]2C(=O)N2CCC(CC(O)=O)CC2)CC1,
TCS-3035,TCS-3035,,BRD:BRD-K81935556-001-02-9,rep_single_dose,G PROTEIN-COUPLED RECEPTOR AGONIST,GPR35,,,,,,NA,,
TCS-359,TCS-359,,BRD:BRD-BRD-K81376179-001-04-8;BRD:BRD-K81376179-001-04-8,rep_primary;rep_single_dose,FLT3 INHIBITOR,FLT3,,,PRECLINICAL,,,NA,"COC1CCC(CC1OC)C(=O)NC1SC2CCCCC2C1C(N)=O, COC1CCC(CC1OC)C(=O)NC1SC2CCCCC2C1C(N)=O, COC1CCC(CC1OC)C(=O)NC1SC2CCCCC2C1C(N)=O, COC1CCC(CC1OC)C(=O)NC1SC2CCCCC2C1C(N)=O",
TCS-5861528,TCS-5861528,,BRD:BRD-A16560607-001-02-5;BRD:BRD-BRD-A16560607-001-02-5,rep_primary;rep_single_dose,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,TRPA1,,,PRECLINICAL,,,NA,CCC(C)C1CCC(NC(=O)CN2CNC3N(C)C(=O)N(C)C(=O)C23)CC1,
TCS-HDAC6-20B,TCS-HDAC6-20B,,BRD:BRD-BRD-K68358632-001-01-0;BRD:BRD-K68358632-001-01-0,rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC6,,,PRECLINICAL,,,NA,CC(C)C(=O)SCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)NC12CC3CC(CC(C3)C1)C2,
TCS-OX2-29,TCS-OX2-29,,BRD:BRD-K29424831-003-01-3,rep_single_dose,OREXIN RECEPTOR ANTAGONIST,HCRTR2,,,,,,NA,,
TCS-PIM-1-1,TCS-PIM-1-1,,BRD:BRD-BRD-K08902330-001-01-3;BRD:BRD-K08902330-001-01-3,rep_primary;rep_single_dose,PIM KINASE INHIBITOR,PIM1,,,PRECLINICAL,,,NA,OC1CCC(BR)CC1-C1CC(-C2CCCCC2)C(C#N)C(=O)[NH]1,
TCV-309,TCV-309,,BRD:BRD-K00003278-003-01-9,rep_single_dose,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,,,,,,,NA,,
TD139,GB-0139;GB0139;OLITIGALTIN;TD 139;TD-139;TD139,CHEMBL4297442,BRD:BRD-K00003308-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,2,OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O,YGIDGBAHDZEYMT-MQFIMZJJSA-N
TEBANICLINE (DIHYDROCHLORIDE),TEBANICLINE (DIHYDROCHLORIDE),,BRD:BRD-K00091289-300-01-9,rep_single_dose,,,,,,,,NA,,
TEBIPENEM,LJC-11036;TEBIPENEM,CHEMBL576981,BRD:BRD-BRD-K06900071-001-01-2;BRD:BRD-K06900071-001-01-2,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,CNR1,"PNEUMONIA, OTITIS",,LAUNCHED,,Small molecule,1,C[C@@H](O)[C@@H]1[C@@H]2[C@H](C)C(SC3CN(C3)C3=NCCS3)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C;C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SC3CN(C4=NCCS4)C3)[C@H](C)[C@H]12,GXXLUDOKHXEFBQ-YJFSRANCSA-N
TECADENOSON,CVT-510;TECADENOSON,CHEMBL392149,BRD:BRD-K00003289-001-01-9,rep_single_dose,ADENOSINE RECEPTOR AGONIST,ADORA1,,,,,Small molecule,2,OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@H](O)[C@@H]1O,OESBDSFYJMDRJY-BAYCTPFLSA-N
TECALCET,TECALCET,CHEMBL292376,BRD:BRD-BRD-K41662846-003-01-5;BRD:BRD-K41662846-003-01-5,rep_primary;rep_single_dose,CALCIUM-SENSING RECEPTOR AGONIST,CASR,,,PHASE 2,,Small molecule,2,"COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1;COC1CCCC(C1)[C@@H](C)NCCCC1CCCCC1CL, COC1CCCC(C1)[C@@H](C)NCCCC1CCCCC1CL",ZVQUCWXZCKWZBP-CQSZACIVSA-N
TECARFARIN,ATI-5923;TECARFARIN,CHEMBL2105664,BRD:BRD-K00079520-001-02-9,rep_single_dose,,,,,,,Small molecule,3,CC(OC(=O)c1ccc(Cc2c(O)c3ccccc3oc2=O)cc1)(C(F)(F)F)C(F)(F)F,QFLNTQDOVCLQKW-UHFFFAOYSA-N
TECASTEMIZOLE,NORASTEMIZOLE;NORASTEMIZOLE (TRIVIAL NAME);R-43512;TECASTEMIZOLE,CHEMBL61301,BRD:BRD-BRD-K48195801-001-01-6;BRD:BRD-K48195801-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,KCNH2,,,PHASE 3,,Small molecule,-1,FC1CCC(CN2C(NC3CCNCC3)NC3CCCCC23)CC1;Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1,SFOVDSLXFUGAIV-UHFFFAOYSA-N
TPOXX,SIGA-246;ST 246;ST-246;TECOVIRIMAT;TECOVIRIMAT MONOHYDRATE;TPOXX,CHEMBL1242629;CHEMBL1257073,BRD:BRD-BRD-K24312986-001-01-2;BRD:BRD-K24312986-001-01-2,rep_primary;rep_single_dose,ORTHOPOXVIRUS EGRESS INHIBITOR,,,,PHASE 3,,Small molecule,4,FC(F)(F)C1CCC(CC1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O;O=C(NN1C(=O)[C@@H]2[C@@H]3C=C[C@@H]([C@H]4C[C@@H]34)[C@@H]2C1=O)c1ccc(C(F)(F)F)cc1,CSKDFZIMJXRJGH-VWLPUNTISA-N
TR-700,SIVEXTRO;TEDIZOLID;TOREZOLID;TR-700,CHEMBL1257051,BRD:BRD-BRD-K59436580-001-01-7;BRD:BRD-K59436580-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,SKIN INFECTIONS,,LAUNCHED,,Small molecule,4,Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1;CN1NNC(N1)-C1CCC(CN1)-C1CCC(CC1F)N1C[C@H](CO)OC1=O,XFALPSLJIHVRKE-GFCCVEGCSA-N
TEDIZOLID-PHOSPHATE,TEDIZOLID-PHOSPHATE,,BRD:BRD-BRD-K89121095-001-01-7;BRD:BRD-K89121095-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,SKIN INFECTIONS,,LAUNCHED,,,NA,"CN1NNC(N1)-C1CCC(CN1)-C1CCC(CC1F)N1C[C@H](COP(O)(O)=O)OC1=O, CN1NNC(N1)-C1CCC(CN1)-C1CCC(CC1F)N1C[C@H](COP(O)(O)=O)OC1=O, CN1NNC(N1)-C1CCC(CN1)-C1CCC(CC1F)N1C[C@H](COP(O)(O)=O)OC1=O",
TEFINOSTAT,TEFINOSTAT,CHEMBL4297582,BRD:BRD-K00091118-001-01-9,rep_single_dose,,,,,,,Small molecule,1,O=C(CCCCCCC(=O)Nc1ccc(CN[C@H](C(=O)OC2CCCC2)c2ccccc2)cc1)NO,GLNWREBYRLDPQP-MHZLTWQESA-N
ZELMAC,HTF 919;SDZ-HTF-919;TEGASEROD;ZELMAC,CHEMBL76370,BRD:BRD-BRD-K88743730-050-04-1;BRD:BRD-K88743730-050-04-1,rep_primary;rep_single_dose,SEROTONIN RECEPTOR PARTIAL AGONIST,HTR2A;HTR2B;HTR2C;HTR4,,,WITHDRAWN,,Small molecule,4,"CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12;CCCCCNC(=N)N\N=C\C1C[NH]C2CCC(OC)CC12, CCCCCNC(=N)N\N=C\C1C[NH]C2CCC(OC)CC12, CCCCCNC(=N)N\N=C\C1C[NH]C2CCC(OC)CC12",IKBKZGMPCYNSLU-RGVLZGJSSA-N
TEGLICAR,TEGLICAR,CHEMBL1231506,BRD:BRD-K00074712-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,CCCCCCCCCCCCCCNC(=O)N[C@H](CC(=O)[O-])C[N+](C)(C)C,BMZYTDRMCBZVNH-HXUWFJFHSA-N
TEGOBUVIR,GS-333126;GS-9190;TEGOBUVIR,CHEMBL1957287,BRD:BRD-BRD-K26701552-001-01-8;BRD:BRD-K26701552-001-01-8,rep_primary;rep_single_dose,"HCV INHIBITOR, PROTEASE INHIBITOR",,,,PHASE 3,,Small molecule,2,Fc1ccccc1-c1nc2ccn(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)nn3)cc-2n1;FC1CCCCC1-C1NC2CCN(CC3CCC(NN3)-C3CCC(CC3C(F)(F)F)C(F)(F)F)CC2N1,XBEQSQDCBSKCHJ-UHFFFAOYSA-N
TEIJIN-COMPOUND-1,TEIJIN-COMPOUND-1,,BRD:BRD-BRD-K51528698-003-01-4;BRD:BRD-K51528698-003-01-4,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR2,,,PRECLINICAL,,,NA,FC(F)(F)C1CCCC(C1)C(=O)NCC(=O)N[C@@H]1CCN(CC2CCC(CL)CC2)C1,
VX-950,INCIVEK;INCIVO;LY 570310;LY-570310;MP 424;MP-424;TELAPREVIR;VRT 111950;VRT-111950;VX 950;VX-950,CHEMBL231813,BRD:BRD-BRD-K72912098-001-02-3;BRD:BRD-K72912098-001-02-3,rep_primary;rep_single_dose,HCV INHIBITOR,CTSA;PGR,HEPATITIS C,,LAUNCHED,,Protein,4,"CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1;CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1CNCCN1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1, CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1CNCCN1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1",BBAWEDCPNXPBQM-GDEBMMAJSA-N
TELATINIB,BAY 57-9352;BAY-57-9352;BAY-579352;TELATINIB,CHEMBL2079588,BRD:BRD-BRD-K84564571-001-02-4;BRD:BRD-K84564571-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",KDR,,,PHASE 2,,Small molecule,2,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1;CNC(=O)C1CC(COC2NNC(NC3CCC(CL)CC3)C3CCOC23)CCN1,QFCXANHHBCGMAS-UHFFFAOYSA-N
TELEVANCIN,TELAVANCIN;TELEVANCIN,CHEMBL507870,BRD:BRD-K00085355-001-01-9,rep_single_dose,,,,,,,Small molecule,4,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,ONUMZHGUFYIKPM-MXNFEBESSA-N
TYZEKA,2'-DEOXY-L-THYMIDINE;LDT-600;LDT600;NV-02B;SEBIVO;TELBIVUDINE;TYZEKA,CHEMBL374731,BRD:BRD-BRD-K15976406-001-03-3;BRD:BRD-K15976406-001-03-3,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,TK2,HEPATITIS B,,LAUNCHED,,Small molecule,4,Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O;CC1CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)[NH]C1=O,IQFYYKKMVGJFEH-CSMHCCOUSA-N
TELCAGEPANT,MK-0974;MK0974;TELCAGEPANT,CHEMBL236593,BRD:BRD-BRD-K91159026-001-01-7;BRD:BRD-K91159026-001-01-7,rep_primary;rep_single_dose,CALCITONIN ANTAGONIST,CALCRL;RAMP1,,,PHASE 3,,Small molecule,3,FC1CCCC([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)N3C4CCCNC4[NH]C3=O)C(=O)N(CC(F)(F)F)C2)C1F;O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(=O)[nH]c3ncccc32)CC1,CGDZXLJGHVKVIE-DNVCBOLYSA-N
TELENZEPINE,NSC-758679;TELENZEPINE,CHEMBL253978,BRD:BRD-BRD-K06147391-300-06-8;BRD:BRD-K06147391-300-06-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,,,PHASE 3,,Small molecule,1,"Cc1scc2c1N(C(=O)CN1CCN(C)CC1)c1ccccc1NC2=O;CN1CCN(CC(=O)N2C3C(C)SCC3C(=O)NC3CCCCC23)CC1, CN1CCN(CC(=O)N2C3C(C)SCC3C(=O)NC3CCCCC23)CC1",VSWPGAIWKHPTKX-UHFFFAOYSA-N
TELITHROMYCIN,HMR 3647;HMR-3647;KETEK;LEVVIAX;NSC-758940;TELITHROMYCIN,CHEMBL1136,BRD:BRD-A94008949-001-01-9;BRD:BRD-BRD-A94008949-001-01-9,rep_primary;rep_single_dose,"BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR, BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR",CYP1A2;CYP2D6;CYP3A4;CYP3A5;CYP3A7,PNEUMONIA,,LAUNCHED,,Small molecule,4,"CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C;CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]2N(CCCCN3CNC(C3)-C3CCCNC3)C(=O)O[C@]12C)OC, CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCN3CNC(C3)-C3CCCNC3)C(=O)O[C@]12C)OC",LJVAJPDWBABPEJ-PNUFFHFMSA-N
TELMESTEINE,REOLASE;TELMESTEINE,CHEMBL2107621,BRD:BRD-A05523972-001-01-5;BRD:BRD-BRD-A05523972-001-01-5,rep_primary;rep_single_dose,MUCOLYTIC AGENT,,,,LAUNCHED,,Small molecule,-1,CCOC(=O)N1CSC[C@H]1C(=O)O;CCOC(=O)N1CSCC1C(O)=O,XBJWOGLKABXFJE-YFKPBYRVSA-N
TOLURA,BIBR 277 SE;BIBR-277;BIBR-277 SE;BIBR-277-SE;BIBR-277SE;C09CA07;KINZALMONO;MICARDIS;PRITOR;SEMINTRA;TELMISARTAN;TELMISARTAN ACTAVIS;TELMISARTAN TEVA;TOLURA,CHEMBL1017,BRD:BRD-BRD-K73999723-001-11-3;BRD:BRD-K73999723-001-11-3,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1;PPARG,HYPERTENSION,,LAUNCHED,,Small molecule,4,"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1;CCCC1NC2C(C)CC(CC2N1CC1CCC(CC1)-C1CCCCC1C(O)=O)-C1NC2CCCCC2N1C, CCCC1NC2C(C)CC(CC2N1CC1CCC(CC1)-C1CCCCC1C(O)=O)-C1NC2CCCCC2N1C, CCCC1NC2C(C)CC(CC2N1CC1CCC(CC1)-C1CCCCC1C(O)=O)-C1NC2CCCCC2N1C",RMMXLENWKUUMAY-UHFFFAOYSA-N
TELOMERASE INHIBITOR IX,MST 312;MST312;TELOMERASE INHIBITOR IX,,GDSC2:1930,gdsc,,,,,,,,NA,,
TELOTRISTAT,LP 778902;LP-778902;TELOTRISTAT,CHEMBL2103855,BRD:BRD-BRD-K63178091-001-01-1;BRD:BRD-K63178091-001-01-1,rep_primary;rep_single_dose,TRYPTOPHAN HYDROXYLASE INHIBITOR,TPH1,,,LAUNCHED,,Small molecule,4,Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1;CC1CCN(N1)-C1CC(CL)CCC1[C@@H](OC1CC(NC(N)N1)-C1CCC(C[C@H](N)C(O)=O)CC1)C(F)(F)F,NCLGDOBQAWBXRA-PGRDOPGGSA-N
TELOTRISTAT-ETHYL,TELOTRISTAT-ETHYL,,BRD:BRD-BRD-K94559059-091-01-6;BRD:BRD-K94559059-091-01-6,rep_multi_dose;rep_primary;rep_single_dose,TRYPTOPHAN HYDROXYLASE INHIBITOR,TPH1,DIARRHEA,,LAUNCHED,,,NA,"CCOC(=O)[C@@H](N)CC1CCC(CC1)-C1CC(O[C@H](C2CCC(CL)CC2-N2CCC(C)N2)C(F)(F)F)NC(N)N1, CCOC(=O)[C@@H](N)CC1CCC(CC1)-C1CC(O[C@H](C2CCC(CL)CC2-N2CCC(C)N2)C(F)(F)F)NC(N)N1, CCOC(=O)[C@@H](N)CC1CCC(CC1)-C1CC(O[C@H](C2CCC(CL)CC2-N2CCC(C)N2)C(F)(F)F)NC(N)N1",
TELRATOLIMOD,3M-052;MEDI 9197;MEDI-9197;MEDI9197;TELRATOLIMOD,CHEMBL4297631,BRD:BRD-K00004596-001-01-9,rep_single_dose,TOLL-LIKE RECEPTOR AGONIST,,,,,,Small molecule,1,CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c(N)nc3ccccc3c21,RRTPWQXEERTRRK-UHFFFAOYSA-N
TEMANOGREL,APD-791;APD791;TEMANOGREL,CHEMBL1084617,BRD:BRD-K00003467-001-01-9,rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,,,,,,Small molecule,2,COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1,ZEOQUKRCASTCFR-UHFFFAOYSA-N
WY-3917,(RS)-TEMAZEPAM;KENTEPAM;NORMISON;NSC-246303;RESTORIL;TEMAZ;TEMAZEPAM;TEMAZEPAM CIV;WY-3917,CHEMBL967,BRD:BRD-A93093700-001-02-9;BRD:BRD-BRD-A93093700-001-02-9,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GABRR1;GABRR2;GABRR3;TSPO,,,WITHDRAWN,,Small molecule,4,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21;CN1C2CCC(CL)CC2C(=NC(O)C1=O)C1CCCCC1,SEQDDYPDSLOBDC-UHFFFAOYSA-N
TEMEPHOS,27165;ABATE;ABATHION;AC-52160;AZAI-SS;BIOTHION;BIOTHON;DIFENPHOS;DIFOS;DIPHOS;ECOPRO 1707;EI-52160;ENT-27165;LAVIFOS;NEPHIS;NSC-755842;PROCIDA;TEMEFOS;TEMEPHOS,CHEMBL1355821,BRD:BRD-K51805276-001-10-9,rep_single_dose,CHOLINESTERASE INHIBITOR,,,,,,Small molecule,-1,COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1,WWJZWCUNLNYYAU-UHFFFAOYSA-N
TEMOCAPRIL,TEMOCAPRIL,CHEMBL2110627,BRD:BRD-BRD-K10784860-003-02-3;BRD:BRD-K10784860-003-02-3,rep_multi_dose;rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,"HYPERTENSION, CONGESTIVE HEART FAILURE, DIABETIC NEPHROPATHY, CORONARY ARTERY DISEASE (CAD)",,LAUNCHED,,Small molecule,-1,CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)C1CCCS1;CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@H](c2cccs2)CN(CC(=O)O)C1=O,FIQOFIRCTOWDOW-BJLQDIEVSA-N
TEMOZOLOMIDE,CCRG-81045;M-39831;M&B 39831;M&B-39831;METHAZOLASTONE;MK-7365;NSC-362856;SCH 52365;SCH-52365;TEMODAL;TEMODAR;TEMOMEDAC;TEMOZOLOMIDE,CHEMBL810,GDSC1:1375;GDSC2:1375,gdsc,,,,,,,Small molecule,4,Cn1nnc2c(C(N)=O)ncn2c1=O,BPEGJWRSRHCHSN-UHFFFAOYSA-N
TEMOPORFIN,EF-9;EF9;FOSCAN;MTHPC;TEMOPORFIN,CHEMBL383675,BRD:BRD-BRD-K63712959-001-01-8;BRD:BRD-K63712959-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,RADICAL FORMATION STIMULANT,,HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC),,LAUNCHED,,Small molecule,4,Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc2CC4)C=C3)c1;OC1CCCC(C1)-C1C2CCC(N2)C(-C2CCCC(O)C2)C2CCC([NH]2)C(-C2CCCC(O)C2)C2CCC(N2)C(-C2CCCC(O)C2)C2CCC1[NH]2,KSXLETNRCMCRAQ-LWQDQPMZSA-N
TEMOZOLOMIDE,CCRG-81045;M-39831;M&B 39831;M&B-39831;METHAZOLASTONE;MK-7365;NSC-362856;SCH 52365;SCH-52365;TEMODAL;TEMODAR;TEMOMEDAC;TEMOZOLOMIDE,CHEMBL810,BRD:BRD-BRD-K32107296-001-16-9;BRD:BRD-K32107296-001-16-9;CTRP:351043;GDSC1:1375;GDSC2:1375,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,MGMT,"GLIOBLASTOMA, ASTROCYTOMA",,LAUNCHED,,Small molecule,4,"Cn1nnc2c(C(N)=O)ncn2c1=O;CN1NNC2C(NCN2C1=O)C(N)=O, CN1NNC2C(NCN2C1=O)C(N)=O, CN1NNC2C(NCN2C1=O)C(N)=O, CN1NNC2C(NCN2C1=O)C(N)=O",BPEGJWRSRHCHSN-UHFFFAOYSA-N
ZJ-701,4-OXYPIPERIDOL;MBM-02;NSC-142784;SPJ-701;TANOL;TEMPOL;ZJ-701,CHEMBL607023,BRD:BRD-BRD-K95053546-001-01-9;BRD:BRD-BRD-K95053546-001-02-7;BRD:BRD-BRD-K95053546-001-03-5;BRD:BRD-K95053546-001-01-9;BRD:BRD-K95053546-001-02-7;BRD:BRD-K95053546-001-03-5,rep_primary;rep_single_dose,FREE RADICAL SCAVENGER,,,,PHASE 2,,Small molecule,2,"CC1(C)CC(O)CC(C)(C)N1[O];CC1(C)CC(O)CC(C)(C)N1O, CC1(C)CC(O)CC(C)(C)N1O, CC1(C)CC(O)CC(C)(C)N1O",UZFMOKQJFYMBGY-UHFFFAOYSA-N
TORISEL,CCI-779;TEMSIROLIMUS;TORISEL,CHEMBL1201182,BRD:BRD-BRD-K42898655-001-01-8;BRD:BRD-K42898655-001-01-8;CTRP:660358;GDSC1:1016,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,RENAL CELL CARCINOMA (RCC),,LAUNCHED,,Small molecule,4,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1OC(=O)C(C)(CO)CO;CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,CBPNZQVSJQDFBE-FUXHJELOSA-N
TEN-010,TEN-010,,BRD:BRD-K00005242-001-01-9,rep_single_dose,BROMODOMAIN INHIBITOR,,,,,,,NA,,
TENALISIB,TENALISIB,CHEMBL4297584,BRD:BRD-K00003263-001-01-9,rep_single_dose,PI3K INHIBITOR,,,,,,Small molecule,2,CC[C@H](Nc1ncnc2[nH]cnc12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1,HDXDQPRPFRKGKZ-INIZCTEOSA-N
TENAPANOR,AZD-1722;KHK-7791;KHK7791;TENAPANOR,CHEMBL3304485,BRD:BRD-K00003201-001-01-9,rep_single_dose,SODIUM/HYDROGEN EXCHANGER INHIBITOR,,,,,,Small molecule,4,CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1,DNHPDWGIXIMXSA-CXNSMIOJSA-N
TU199,TENATOPRAZOLE;TU-199;TU199,CHEMBL1475252,BRD:BRD-A42270467-001-04-4;BRD:BRD-BRD-A42270467-001-04-4,rep_primary;rep_single_dose,ATPASE INHIBITOR,IDO1,,,PHASE 2,,Small molecule,2,COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2n1;COC1CCC2[NH]C(NC2N1)S(=O)CC1NCC(C)C(OC)C1C,ZBFDAUIVDSSISP-UHFFFAOYSA-N
TENELIGLIPTIN,MP-513;TENELIGLIPTIN,CHEMBL2147777,BRD:BRD-BRD-K48068743-001-01-6;BRD:BRD-K48068743-001-01-6,rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,DIABETES MELLITUS,,LAUNCHED,,Small molecule,3,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1;CC1CC(N2CCN(CC2)[C@@H]2CN[C@@H](C2)C(=O)N2CCSC2)N(N1)-C1CCCCC1,WGRQANOPCQRCME-PMACEKPBSA-N
TENIDAP,"CP-66,248;CP-66248;TENIDAP",CHEMBL1908355,BRD:BRD-A87479750-001-02-7;BRD:BRD-BRD-A87479750-001-02-7,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,KCNJ4;PTGS1,,,PHASE 3,,Small molecule,-1,"NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21;NC(=O)N1C(=O)C(C(=O)C2CCCS2)C2CC(CL)CCC12, NC(=O)N1C(=O)C(C(=O)C2CCCS2)C2CC(CL)CCC12",LXIKEPCNDFVJKC-QXMHVHEDSA-N
VUMON,NSC-122819;TENIPOSIDE;VM-26;VM26;VUMON,CHEMBL452231,BRD:BRD-A35588707-001-05-5;BRD:BRD-BRD-A35588707-001-05-5;BRD:BRD-BRD-K10362825-001-03-4;BRD:BRD-K10362825-001-03-4;BRD:BRD-K10362825-001-04-2;CTRP:27871;GDSC2:1809,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A;TOP2B,ACUTE LYMPHOBLASTIC LEUKEMIA (ALL),,LAUNCHED,"Multiple values for structure_id: {'K10362825', 'A35588707'}, defaulting to None",Small molecule,4,"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O;COC1CC(CC(OC)C1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@H](O[C@H]3[C@H](O)[C@H]2O)C2CCCS2)C2CC3OCOC3CC12, COC1CC(CC(OC)C1O)[C@H]1[C@@H]2C(COC2=O)C(O[C@@H]2O[C@@H]3CO[C@H](OC3[C@H](O)[C@H]2O)C2CCCS2)C2CC3OCOC3CC12, COC1CC(CC(OC)C1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@H](O[C@H]3[C@H](O)[C@H]2O)C2CCCS2)C2CC3OCOC3CC12",NRUKOCRGYNPUPR-QBPJDGROSA-N
VIREAD,ATRIPLA;GS-1275;GS-1278;GS-4331-05;GS-4331-05-;GSK-548470;GSK548470;PMP-A;PMPA;PMPA PRODRUG;PMPA-PRODRUG;TENOFOVIR;TENOFOVIR DF;TENOFOVIR DISOPROXIL FUMARATE;TENOFOVIRI DISOPROXILI FUMARAS;TRUVADA;VIREA;VIREAD,CHEMBL1486;CHEMBL3989702;CHEMBL483,BRD:BRD-BRD-K15891719-001-05-1;BRD:BRD-K15891719-001-05-1,rep_primary;rep_single_dose,"HIV INTEGRASE INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",,"HUMAN IMMUNODEFICIENCY VIRUS (HIV-1), HEPATITIS B",,LAUNCHED,,Small molecule,4,"C[C@H](CN1CNC2C(N)NCNC12)OCP(O)(O)=O, C[C@H](CN1CNC2C(N)NCNC12)OCP(O)(O)=O, C[C@H](CN1CNC2C(N)NCNC12)OCP(O)(O)=O;CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O",VCMJCVGFSROFHV-WZGZYPNHSA-N
TENOFOVIR-ALAFENAMIDE,TENOFOVIR-ALAFENAMIDE,,BRD:BRD-A25988899-001-01-6,rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,,,,,,NA,,
TENOFOVIR-DISOPROXIL,TENOFOVIR-DISOPROXIL,,BRD:BRD-BRD-K61868322-050-01-7;BRD:BRD-K61868322-050-01-7,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,CYP1A2,"HUMAN IMMUNODEFICIENCY VIRUS (HIV-1), HEPATITIS B",,LAUNCHED,,,NA,"CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1CNC2C(N)NCNC12)OCOC(=O)OC(C)C, CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1CNC2C(N)NCNC12)OCOC(=O)OC(C)C",
TENOVIN-1,TENOVIN-1,,BRD:BRD-BRD-K05977823-001-05-3;BRD:BRD-K05977823-001-05-3,rep_primary;rep_single_dose,"SIRT INHIBITOR, TP53 ACTIVATOR",SIRT1,,,PRECLINICAL,,,NA,"CC(=O)NC1CCC(NC(=S)NC(=O)C2CCC(CC2)C(C)(C)C)CC1, CC(=O)NC1CCC(NC(=S)NC(=O)C2CCC(CC2)C(C)(C)C)CC1, CC(=O)NC1CCC(NC(=S)NC(=O)C2CCC(CC2)C(C)(C)C)CC1",
TENOVIN-6,TENOVIN-6,,BRD:BRD-BRD-K13949769-001-01-7;BRD:BRD-K13949769-001-01-7;GDSC1:342,gdsc;rep_multi_dose;rep_primary;rep_single_dose,SIRT INHIBITOR,SIRT1;SIRT2;SIRT3,,,PRECLINICAL,,,NA,"CN(C)CCCCC(=O)NC1CCC(NC(=S)NC(=O)C2CCC(CC2)C(C)(C)C)CC1, CN(C)CCCCC(=O)NC1CCC(NC(=S)NC(=O)C2CCC(CC2)C(C)(C)C)CC1",
TILCOTIL,MOBIFLEX;NSC-758397;RO 12-0068;RO 12-0068/000;RO-120068000;TENOXICAM;TILCOTIL,CHEMBL302795,BRD:BRD-A22844106-001-26-0;BRD:BRD-BRD-A22844106-001-26-0,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ANKYLOSING SPONDYLITIS, TENDINITIS, BURSITIS, PERIARTHRITIS",,LAUNCHED,,Small molecule,4,"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O;CN1C(C(=O)NC2CCCCN2)C(=O)C2SCCC2S1(=O)=O, CN1C(C(=O)NC2CCCCN2)C(=O)C2SCCC2S1(=O)=O",LZNWYQJJBLGYLT-UHFFFAOYSA-N
XP23829,PPC-06;TEPILAMIDE FUMARATE;XP-23829;XP23829,CHEMBL3989961,BRD:BRD-K00074843-001-02-9,rep_single_dose,,,,,,,Small molecule,2,CCN(CC)C(=O)COC(=O)/C=C/C(=O)OC,AKUGRXRLHCCENI-VOTSOKGWSA-N
ZUBRIN,ORF 20485;ORF-20485;RWJ 20485;RWJ-20485;TEPOXALIN;ZUBRIN,CHEMBL316040,BRD:BRD-BRD-K89714990-001-01-5;BRD:BRD-K89714990-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR",ALOX5,"RHEUMATOID ARTHRITIS, HIP DYSPLASIA",,LAUNCHED,,Small molecule,-1,"COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1;COC1CCC(CC1)-N1NC(CCC(=O)N(C)O)CC1-C1CCC(CL)CC1, COC1CCC(CC1)-N1NC(CCC(=O)N(C)O)CC1-C1CCC(CL)CC1",XYKWNRUXCOIMFZ-UHFFFAOYSA-N
TEPP-46,TEPP-46,,BRD:BRD-K01826017-001-02-9,rep_single_dose,PYRUVATE KINASE ISOZYME ACTIVATOR,PKM,,,,,,NA,,
TEPRENONE,E-0671;GERANYLGERANYLACETONE;SELBEX;TEPRENONE,CHEMBL3989432;CHEMBL79686,BRD:BRD-BRD-K11510141-001-01-8;BRD:BRD-K11510141-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,MUCUS PROTECTING AGENT,,COSMETIC,,LAUNCHED,,Small molecule,3,"CC(=O)CC/C=C(/C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C.CC(=O)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C;CC(=O)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C;CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C, CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C, CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C, CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C",DJAHKBBSJCDSOZ-AJLBTXRUSA-N;HUCXKZBETONXFO-NJFMWZAGSA-N
TERAMEPROCOL,EM 1421;EM-1421;TERAMEPROCOL,CHEMBL90983,BRD:BRD-BRD-K76788410-001-01-6;BRD:BRD-K76788410-001-01-6,rep_primary;rep_single_dose,LIPOXYGENASE INHIBITOR,BIRC5;CDK1,,,PHASE 1/PHASE 2,,Small molecule,1,COc1ccc(C[C@@H](C)[C@@H](C)Cc2ccc(OC)c(OC)c2)cc1OC;COC1CCC(C[C@H](C)[C@H](C)CC2CCC(OC)C(OC)C2)CC1OC,ORQFDHFZSMXRLM-IYBDPMFKSA-N
TERAZOSIN,HYTRIN;TERAZOSABB;TERAZOSIN,CHEMBL611,BRD:BRD-A22256192-003-22-7;BRD:BRD-BRD-A22256192-003-22-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;KCNH2;KCNH6;KCNH7,"BENIGN PROSTATIC HYPERPLASIA (BPH), HYPERTENSION",,LAUNCHED,,Small molecule,4,"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC;COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1CCCO1, COC1CC2NC(NC(N)C2CC1OC)N1CCN(CC1)C(=O)C1CCCO1",VCKUSRYTPJJLNI-UHFFFAOYSA-N
TERBINAFINE HYDROCHLORIDE,LAMISIL;LAMISIL AT;SF 86-327;SF-86-327;TDT-067;TERBINAFINE;TERBINAFINE HYDROCHLORIDE,CHEMBL822,BRD:BRD-BRD-K68132782-003-13-8;BRD:BRD-K68132782-003-13-8,rep_primary;rep_single_dose,FUNGAL SQUALENE EPOXIDASE INHIBITOR,SQLE,"TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS",,LAUNCHED,,Small molecule,4,"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12;CN(C\C=C\C#CC(C)(C)C)CC1CCCC2CCCCC12, CN(C\C=C\C#CC(C)(C)C)CC1CCCC2CCCCC12, CN(C\C=C\C#CC(C)(C)C)CC1CCCC2CCCCC12",DOMXUEMWDBAQBQ-WEVVVXLNSA-N
TERBUTALINE,ASTHMASIAN;BRETHAIRE;BRETHINE;BRICANYL;TERBUTALIN;TERBUTALINE,CHEMBL1760,BRD:BRD-A50157456-065-20-6;BRD:BRD-BRD-A50157456-065-20-6,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,"BRONCHOSPASM, BRONCHITIS, EMPHYSEMA",,LAUNCHED,,Small molecule,4,"CC(C)(C)NCC(O)c1cc(O)cc(O)c1;CC(C)(C)NCC(O)C1CC(O)CC(O)C1, CC(C)(C)NCC(O)C1CC(O)CC(O)C1",XWTYSIMOBUGWOL-UHFFFAOYSA-N
TERCIPRAZINE,TERCIPRAZINE,CHEMBL2107617,BRD:BRD-A11725667-001-01-8;BRD:BRD-BRD-A11725667-001-01-8,rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,-1,C#CC1(OCC(O)CN2CCN(c3cccc(C(F)(F)F)c3)CC2)CCCCC1;OC(COC1(CCCCC1)C#C)CN1CCN(CC1)C1CCCC(C1)C(F)(F)F,SDKXUWMRKYQIFU-UHFFFAOYSA-N
TRIACONAZOLE,"FUNGISTAT;GYNO-TERAZOL;NSC-331942;PANLOMYC;R 42470;R-42,470;R-42470;TERAZOL;TERAZOL 3;TERAZOL 7;TERCONAZOLE;TERCOSPOR;TERMAYAZOLE;TRIACONAZOLE",CHEMBL1306,BRD:BRD-BRD-K86204871-001-16-2;BRD:BRD-K86204871-001-16-2,rep_multi_dose;rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,,VULVOVAGINAL CANDIDIASIS,,LAUNCHED,,Small molecule,4,"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1;CC(C)N1CCN(CC1)C1CCC(OC[C@H]2CO[C@@](CN3CNCN3)(O2)C2CCC(CL)CC2CL)CC1, CC(C)N1CCN(CC1)C1CCC(OC[C@@H]2CO[C@](CN3CNCN3)(O2)C2CCC(CL)CC2CL)CC1",BLSQLHNBWJLIBQ-OZXSUGGESA-N
TRILUDAN FTE,ANTIHISTAMINE;HISTAFEN;HISTAFEN 120;NSC-665802;NSC-758627;RMI 9918;RMI-9918;SELDANE;TERFENADINE;TERFENOR;TERFENOR FTE;TERFEX;TERFINAX 120;TERFINAX 60;TRILUDAN;TRILUDAN FTE,CHEMBL17157,BRD:BRD-A06352418-001-25-9;BRD:BRD-BRD-A06352418-001-25-9,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;HRH1;KCNH1;KCNH2,,,WITHDRAWN,,Small molecule,4,"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1;CC(C)(C)C1CCC(CC1)C(O)CCCN1CCC(CC1)C(O)(C1CCCCC1)C1CCCCC1, CC(C)(C)C1CCC(CC1)C(O)CCCN1CCC(CC1)C(O)(C1CCCCC1)C1CCCCC1, CC(C)(C)C1CCC(CC1)C(O)CCCN1CCC(CC1)C(O)(C1CCCCC1)C1CCCCC1",GUGOEEXESWIERI-UHFFFAOYSA-N
TERGURIDE,TELURON;TERGURIDE,CHEMBL73151,BRD:BRD-A89207210-001-01-6;BRD:BRD-BRD-A89207210-001-01-6,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA2A;ADRA2B;ADRA2C;DRD2;DRD3;DRD4;HTR1A;HTR1B;HTR1D;HTR2A;HTR2B;HTR2C,,,LAUNCHED,,Small molecule,-1,CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1;CCN(CC)C(=O)N[C@H]1CC2C(CC3C[NH]C4CCCC2C34)N(C)C1,JOAHPSVPXZTVEP-YXJHDRRASA-N
TERIFLUNOMIDE,A77 1726;AUBAGIO;HMR-1726;HMR1726;LEFLUNOMIDE RELATED COMPOUND B;LEFLUNOMIDE RELATED COMPOUND B RS;TERIFLUNOMIDE,CHEMBL973,BRD:BRD-A42699921-001-02-8;BRD:BRD-A42699921-001-03-6;BRD:BRD-BRD-A42699921-001-02-8;BRD:BRD-BRD-A42699921-001-03-6,rep_multi_dose;rep_primary;rep_single_dose,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,DHODH,MULTIPLE SCLEROSIS,,LAUNCHED,,Small molecule,4,"C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1;CC(=O)C(C#N)C(=O)NC1CCC(CC1)C(F)(F)F, CC(=O)C(C#N)C(=O)NC1CCC(CC1)C(F)(F)F, CC(=O)C(C#N)C(=O)NC1CCC(CC1)C(F)(F)F",UTNUDOFZCWSZMS-YFHOEESVSA-N
VARIQUEL,GLYCYLPRESSIN;GLYPRESSIN;TERLIPRESSIN;TERLIPRESSIN ACETATE;TERLIVAZ;VARIQUEL,CHEMBL2135460,BRD:BRD-BRD-K73451719-001-01-2;BRD:BRD-K73451719-001-01-2,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR AGONIST,AVPR1A;AVPR1B;AVPR2,HYPOTENSION,,LAUNCHED,,Protein,4,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O;NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CC2CCC(O)CC2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,BENFXAYNYRLAIU-QSVFAHTRSA-N
TERODILINE,TERODILINE,CHEMBL363295,BRD:BRD-A33479817-003-03-7;BRD:BRD-BRD-A33479817-003-03-7,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,,,,PHASE 3,,Small molecule,4,CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C;CC(CC(C1CCCCC1)C1CCCCC1)NC(C)(C)C,UISARWKNNNHPGI-UHFFFAOYSA-N
TEROXIRONE,.ALPHA.-TRIGLYCIDYL ISOCYANURATE;ALPHATGI;GATGI;HENKEL'S COMPOUND;NSC-296934;TEROXIRONE,CHEMBL453863,BRD:BRD-A39935389-001-05-9;BRD:BRD-BRD-A39935389-001-05-9,rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,,,PHASE 1,,Small molecule,-1,O=c1n(CC2CO2)c(=O)n(CC2CO2)c(=O)n1CC1CO1;O=C1N(CC2CO2)C(=O)N(CC2CO2)C(=O)N1CC1CO1,OUPZKGBUJRBPGC-UHFFFAOYSA-N
TRIPLION,S18886;TERUTROBAN;TRIPLION,CHEMBL2107786,BRD:BRD-BRD-K43975632-001-01-1;BRD:BRD-K43975632-001-01-1,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,TBXA2R,,,PHASE 3,,Small molecule,3,Cc1ccc2c(c1CCC(=O)O)CC[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)C2;CC1CCC2C[C@@H](CCC2C1CCC(O)=O)NS(=O)(=O)C1CCC(CL)CC1,HWEOXFSBSQIWSY-MRXNPFEDSA-N
TESAGLITAZAR,AR-H-039242;AR-H039242XX;AZ-242;BR-44608;GALIDA;TESAGLITAZAR,CHEMBL282686,BRD:BRD-BRD-K15507868-001-03-7;BRD:BRD-K15507868-001-03-7,rep_primary;rep_single_dose,"INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",PPARA;PPARG,,,PHASE 3,,Small molecule,3,"CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O;CCO[C@@H](CC1CCC(OCCC2CCC(OS(C)(=O)=O)CC2)CC1)C(O)=O, CCO[C@@H](CC1CCC(OCCC2CCC(OS(C)(=O)=O)CC2)CC1)C(O)=O",CXGTZJYQWSUFET-IBGZPJMESA-N
TESTOLACTONE CIII,FLUDESTRIN;NSC-23759;SQ 9538;SQ-9538;TEOLIT;TESLAC;TESTOLACTONE;TESTOLACTONE CIII,CHEMBL1571,BRD:BRD-BRD-K69636617-001-01-7;BRD:BRD-K69636617-001-01-7,rep_primary;rep_single_dose,AROMATASE INHIBITOR,CYP19A1,BREAST CANCER,,LAUNCHED,,Small molecule,4,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)OC(=O)CC[C@@H]12;C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC(=O)O2,BPEWUONYVDABNZ-DZBHQSCQSA-N
VOGELXO,ANDRIOL;ANDRODERM;ANDROGEL;ANDROGEL 1%;ANDROPATCH;AVEED;AXIRON;DELATESTRYL;FORTESTA;INTRINSA;JATENZO;KYZATREX;MK-3033;NATESTO;NEBIDO;NSC-9700;ORG 538;ORG-538;RESTANDOL;RESTANDOL TESTOCAP;STRIANT;STRIANT SR;TESTIM;TESTIM 1%;TESTODERM;TESTODERM TTS;TESTOGEL;TESTOPATCH;TESTOPEL;TESTORAL;TESTOSTERONE;TESTOSTERONE 17.BETA.-UNDECYLATE;TESTOSTERONE CIII;TESTOSTERONE UNDECANOATE;TESTOSTERONE UNDECYLATE;TLANDO;TOSTRAN;TSX-011;UNDECANOATE (ESTER);UNDESTOR;VOGELXO,CHEMBL2107067;CHEMBL386630,BRD:BRD-A55393291-001-09-9;BRD:BRD-BRD-A55393291-001-09-9,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,AR,HYPOGONADISM,,LAUNCHED,,Small molecule,4,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O;C[C@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@@H]2O,MUMGGOZAMZWBJJ-DYKIIFRCSA-N
XYOSTED (AUTOINJECTOR),ANDROTARDYL;DELATESTRYL;NSC-17591;PRIMOTESTON DEPOT;TESTOSTERONE ENANTATE;TESTOSTERONE ENANTHATE;TESTOSTERONE ENANTHATE CIII;TESTOSTERONE HEPTANOATE;TESTOSTERONE-ENANTHATE;TESTOSTERONI ENANTAS;XYOSTED;XYOSTED (AUTOINJECTOR),CHEMBL1200335,BRD:BRD-BRD-K89657519-001-01-8;BRD:BRD-K89657519-001-01-8,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,AR,HYPOGONADISM,,LAUNCHED,,Small molecule,4,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,VOCBWIIFXDYGNZ-IXKNJLPQSA-N
TESTOSTERONE-PROPIONATE,TESTOSTERONE-PROPIONATE,,BRD:BRD-A48720949-001-04-0;BRD:BRD-BRD-A48720949-001-04-0,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,AR,,,LAUNCHED,,,NA,CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,
UNDESTOR,ANDRIOL;AVEED;JATENZO;KYZATREX;MK-3033;NEBIDO;ORG 538;ORG-538;RESTANDOL;RESTANDOL TESTOCAP;TESTOSTERONE;TESTOSTERONE 17.BETA.-UNDECYLATE;TESTOSTERONE UNDECANOATE;TESTOSTERONE UNDECYLATE;TESTOSTERONE-UNDECANOATE;TLANDO;TSX-011;UNDECANOATE (ESTER);UNDESTOR,CHEMBL2107067,BRD:BRD-BRD-K70650177-001-01-7;BRD:BRD-K70650177-001-01-7,rep_primary;rep_single_dose,ANDROGEN RECEPTOR AGONIST,AR,HYPOGONADISM,,LAUNCHED,,Small molecule,4,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,UDSFVOAUHKGBEK-CNQKSJKFSA-N
TETOMILAST,OPC-6535;TETOMILAST,CHEMBL332750,BRD:BRD-K00004564-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4D,,,,,Small molecule,3,CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC,XDBHURGONHZNJF-UHFFFAOYSA-N
XENAZINE 25,NITOMAN;NSC-169886;REVOCON;RO 1-9569;RO-1-9569;RO-19569;TETMODIS;TETRABENAZINE;XENAZINE;XENAZINE 25,CHEMBL117785,BRD:BRD-BRD-K95739795-001-03-7;BRD:BRD-K95739795-001-03-7,rep_primary;rep_single_dose,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,DRD2;SLC18A1;SLC18A2,"CHOLERA, HUNTINGTON'S DISEASE",,LAUNCHED,,Small molecule,4,"COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2;COC1CC2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3C2CC1OC, COC1CC2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3C2CC1OC",MKJIEFSOBYUXJB-UHFFFAOYSA-N
TETRACAINE,AMETHOCAINE;AMETOP;DICAINE;MEDIHALER-TETRACAINE;METRASPRAY;PONTOCAINE;TETRACAINE,CHEMBL698,BRD:BRD-BRD-K45071273-003-25-6;BRD:BRD-K45071273-003-25-6,rep_primary;rep_single_dose,MEMBRANE INTEGRITY INHIBITOR,SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,ANESTHETIC,,LAUNCHED,,Small molecule,4,"CCCCNc1ccc(C(=O)OCCN(C)C)cc1;CCCCNC1CCC(CC1)C(=O)OCCN(C)C, CCCCNC1CCC(CC1)C(=O)OCCN(C)C",GKCBAIGFKIBETG-UHFFFAOYSA-N
VETQUAMYCIN,ACHROMYCIN;ACHROMYCIN V;CYCLOPAR;E701;ECONOMYCIN;LIQUAMYCIN;NSC-108579;PANMYCIN;SUPRAMYCIN;SUSTAMYCIN;TETRABID ORGANON;TETRACYCLINE;TETRACYN;VETQUAMYCIN,CHEMBL1440,BRD:BRD-A34788695-003-10-2;BRD:BRD-BRD-A34788695-003-10-2;BRD:BRD-K00003352-003-01-9,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,PRNP,"RESPIRATORY TRACT INFECTIONS, PNEUMONIA, SKIN INFECTIONS, URINARY TRACT INFECTIONS, ACNE VULGARIS (AV), PLAGUE, PSITTACOSIS",,LAUNCHED,"Multiple values for structure_id: {'K00003352', 'A34788695'}, defaulting to None",Small molecule,4,"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12;CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCCC4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCCC4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCCC4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCCC4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCCC4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4C(O)CCCC4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O",OFVLGDICTFRJMM-WESIUVDSSA-N
TETRADECYLTHIOACETIC-ACID,TETRADECYLTHIOACETIC-ACID,,BRD:BRD-BRD-K47539947-001-03-7;BRD:BRD-K47539947-001-03-7,rep_primary;rep_single_dose,LIPID PEROXIDASE INHIBITOR,,,,PHASE 2,,,NA,CCCCCCCCCCCCCCSCC(O)=O,
TETRAETHYLENEPENTAMINE,TETRAETHYLENEPENTAMINE,,BRD:BRD-BRD-K41298358-395-03-4;BRD:BRD-K41298358-395-03-4,rep_primary;rep_single_dose,SUPEROXIDE DISMUTASE INHIBITOR,SOD1;SOD2,,,PHASE 2/PHASE 3,,,NA,"NCCNCCNCCNCCN, NCCNCCNCCNCCN",
TETRAHYDROPAPAVERINE,TETRAHYDROPAPAVERINE,CHEMBL160919,BRD:BRD-A91831168-003-02-5;BRD:BRD-BRD-A91831168-003-02-5,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,NA,COC1CCC(CC2NCCC3CC(OC)C(OC)CC23)CC1OC;COc1ccc(CC2NCCc3cc(OC)c(OC)cc32)cc1OC,YXWQTVWJNHKSCC-UHFFFAOYSA-N
U-23284,NSC-112907;NSC-112907-D;TETRAHYDROURIDINE;U-23284,CHEMBL1236475,BRD:BRD-A86248581-001-01-4;BRD:BRD-BRD-A86248581-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,CYTIDINE DEAMINASE INHIBITOR,CDA,,,PHASE 2,,Small molecule,2,O=C1N[C@H](O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(O)NC1=O,UCKYOOZPSJFJIZ-FMDGEEDCSA-N
TYZINE,CALTHEON;TETRAHYDROZOLINE;TETRYZOLINE;TYZINE,CHEMBL1266,BRD:BRD-A28856712-003-26-0;BRD:BRD-BRD-A28856712-003-26-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,EYE IRRITATION,,LAUNCHED,,Small molecule,4,"c1ccc2c(c1)CCCC2C1=NCCN1;C1CN=C(N1)C1CCCC2CCCCC12, C1CN=C(N1)C1CCCC2CCCCC12",BYJAVTDNIXVSPW-UHFFFAOYSA-N
TETRAMETHYLTHIURAM-MONOSULFIDE,BIS(DIMETHYLAMINETHIOCARBONYL)MONOSULFIDE;TETRAMETHYLTHIURAM-MONOSULFIDE,CHEMBL571700,BRD:BRD-BRD-K36889451-001-01-1;BRD:BRD-K36889451-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,NA,CN(C)C(=S)SC(=S)N(C)C,REQPQFUJGGOFQL-UHFFFAOYSA-N
TETRAMISOLE,"(R)-;(S)-;ASCAVERM;DEXAMISOLE;LEVAMISOLE;LEVAMISOLE DL-FORM;NSC-102063;R 12,563 [AS HYDROCHLORIDE];R-8299;TCMDC-125847;TETRAMISOLE",CHEMBL1369896;CHEMBL1454;CHEMBL277775,BRD:BRD-A46393198-003-16-6;BRD:BRD-BRD-A46393198-003-16-6,rep_primary;rep_single_dose,IMMUNOSTIMULANT,ALPPL2;CHRNA3,GASTROINTESTINAL PARASITES,,LAUNCHED,,Small molecule,4,"c1ccc([C@@H]2CN3CCSC3=N2)cc1;c1ccc([C@H]2CN3CCSC3=N2)cc1;c1ccc(C2CN3CCSC3=N2)cc1;C1CN2CC(N=C2S1)C1CCCCC1, C1CN2CC(N=C2S1)C1CCCCC1",HLFSDGLLUJUHTE-JTQLQIEISA-N;HLFSDGLLUJUHTE-SNVBAGLBSA-N;HLFSDGLLUJUHTE-UHFFFAOYSA-N
TETRANDRINE,TETRANDRINE,,BRD:BRD-BRD-K08078237-001-19-8;BRD:BRD-K08078237-001-19-8,rep_multi_dose;rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,SLC6A3,,,PRECLINICAL,,,NA,"COC1CCC2C[C@@H]3N(C)CCC4CC(OC)C(OC)C(OC5CC6[C@H](CC7CCC(OC1C2)CC7)N(C)CCC6CC5OC)C34, COC1CCC2C[C@@H]3N(C)CCC4CC(OC)C(OC)C(OC5CC6[C@H](CC7CCC(OC1C2)CC7)N(C)CCC6CC5OC)C34",
TETRAZOL-5-YL-GLYCINE-(RS),TETRAZOL-5-YL-GLYCINE-(RS),,BRD:BRD-A14757586-001-04-9,rep_single_dose,GLUTAMATE RECEPTOR AGONIST,GRIN1;GRIN2A;GRIN2B;GRIN2C;GRIN2D,,,,,,NA,,
TETRINDOLE,TETRINDOLE,,BRD:BRD-A52660433-066-02-1;BRD:BRD-BRD-A52660433-066-02-1,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA,,,PHASE 3,,,NA,"C1CCC(CC1)C1CCC2N3CCNC4CCCC(C34)C2C1, C1CCC(CC1)C1CCC2N3CCNC4CCCC(C34)C2C1",
VX-661,TEZACAFTOR;VX-661,CHEMBL3544914,BRD:BRD-BRD-K97101532-001-02-8;BRD:BRD-K97101532-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,CFTR CHANNEL AGONIST,,CYSTIC FIBROSIS,,LAUNCHED,,Small molecule,4,CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO;CC(C)(CO)C1CC2CC(NC(=O)C3(CC3)C3CCC4OC(F)(F)OC4C3)C(F)CC2N1C[C@@H](O)CO,MJUVRTYWUMPBTR-MRXNPFEDSA-N
TFC-007,TFC-007,,BRD:BRD-BRD-K57708067-001-01-3;BRD:BRD-K57708067-001-01-3,rep_primary;rep_single_dose,PROSTAGLANDIN INHIBITOR,HPGDS,,,PRECLINICAL,,,NA,O=C(NC1CCC(CC1)N1CCC(CC1)C(=O)N1CCOCC1)C1CNC(OC2CCCCC2)NC1,
TG-003,TG-003,,BRD:BRD-BRD-K97072811-001-11-4;BRD:BRD-K97072811-001-11-4,rep_primary;rep_single_dose,CLK INHIBITOR,CLK1;CLK4;DYRK1A;DYRK1B,,,PRECLINICAL,,,NA,CCN1\C(SC2CCC(OC)CC12)=C\C(C)=O,
ZOTIRACICLIB,EX 45;EX45;SB-1317;SB-1317 FREE BASE;SB1317;TG-02;TG02;ZOTIRACICLIB,CHEMBL1944698,BRD:BRD-BRD-K14560436-001-01-4;BRD:BRD-K14560436-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,"CDK INHIBITOR, FLT3 INHIBITOR, JAK INHIBITOR",CDK1;CDK2;CDK7;CDK9;FLT3;JAK2,,,PHASE 1,,Small molecule,1,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1;CN1C\C=C\CCOC2CCCC(C2)-C2CCNC(NC3CCCC(C1)C3)N2,VXBAJLGYBMTJCY-NSCUHMNNSA-N
TG-100-115,TG-100-115,,CTRP:606470,ctrp,,,,,,,,NA,,
TG-100572,TG-100572,,BRD:BRD-BRD-K18424115-003-01-3;BRD:BRD-K18424115-003-01-3,rep_multi_dose;rep_primary;rep_single_dose,"SRC INHIBITOR, VEGFR INHIBITOR",KDR;SRC,,,PRECLINICAL,,,NA,CC1CC(CC2NNC(NC3CCC(OCCN4CCCC4)CC3)NC12)-C1CC(O)CCC1CL,
TG-100713,TG-100713,,BRD:BRD-BRD-K46392623-001-02-5;BRD:BRD-K46392623-001-02-5,rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,,,,PRECLINICAL,,,NA,NC1NC(N)C2NC(CNC2N1)-C1CCCC(O)C1,
TG-100801,TG-100801,,BRD:BRD-BRD-K12735121-001-01-4;BRD:BRD-K12735121-001-01-4,rep_primary;rep_single_dose,"SRC INHIBITOR, VEGFR INHIBITOR",CSK;FGFR1;FLT1;FLT4;KDR;SRC,,,PHASE 2,"Multiple values for repurposing_target: {'FGFR1;FLT1;KDR;SRC', 'CSK;FGFR1;FLT1;FLT4;KDR;SRC'}, taking the union",,NA,CC1CC(CC2NNC(NC3CCC(OCCN4CCCC4)CC3)NC12)-C1CC(OC(=O)C2CCCCC2)CCC1CL,
TG-101209,TG-101209,,BRD:BRD-BRD-K39841531-001-02-1;BRD:BRD-K39841531-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,JAK2;JAK3,,,PRECLINICAL,,,NA,CN1CCN(CC1)C1CCC(NC2NCC(C)C(NC3CCCC(C3)S(=O)(=O)NC(C)(C)C)N2)CC1,
TG100-115,TG100-115,CHEMBL230011,BRD:BRD-BRD-K64785675-001-04-0;BRD:BRD-K64785675-001-04-0,rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CB;PIK3CD;PIK3CG,,,PHASE 1/PHASE 2,,Small molecule,2,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1;NC1NC(N)C2NC(-C3CCCC(O)C3)C(NC2N1)-C1CCCC(O)C1,UJIAQDJKSXQLIT-UHFFFAOYSA-N
UMBRALISIB TOSYLATE,RP-5307;TGR-1202;TGR-1202 (4-METHYLBENZENESULFONATE);UKONIQ;UMBRALISIB TOSYLATE,CHEMBL3989869,BRD:BRD-BRD-K52579889-001-01-9;BRD:BRD-K52579889-001-01-9,rep_primary;rep_single_dose,PI3K INHIBITOR,,,,PHASE 3,,Small molecule,4,CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F.Cc1ccc(S(=O)(=O)O)cc1;CC(C)OC1CCC(CC1F)-C1NN([C@@H](C)C2OC3CCC(F)CC3C(=O)C2-C2CCCC(F)C2)C2NCNC(N)C12,KYJWUPZPSXZEPG-NTISSMGPSA-N
TGX-221,TGX-221,,BRD:BRD-A41692738-001-07-6;BRD:BRD-BRD-A41692738-001-07-6;CTRP:606356;GDSC1:94,ctrp;gdsc;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CB;PIK3CD,,,PRECLINICAL,,,NA,"CC(NC1CCCCC1)C1CC(C)CN2C1NC(CC2=O)N1CCOCC1, CC(NC1CCCCC1)C1CC(C)CN2C1NC(CC2=O)N1CCOCC1",
TGX221,TGX 221;TGX221,,GDSC1:94,gdsc,,,,,,,,NA,,
TH-302,EVOFOSFAMIDE;HAP-302;TH-302,CHEMBL260046,BRD:BRD-BRD-K20958582-001-01-4;BRD:BRD-K20958582-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,DNA ALKYLATING AGENT,,,,PHASE 3,,Small molecule,3,CN1C(COP(=O)(NCCBR)NCCBR)CNC1[N+]([O-])=O;Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-],UGJWRPJDTDGERK-UHFFFAOYSA-N
TH588,TH-588;TH588,,BRD:BRD-BRD-K01054709-001-01-3;BRD:BRD-K01054709-001-01-3,rep_primary;rep_single_dose,MTH1 INHIBITOR,NUDT1,,,PRECLINICAL,,,NA,NC1NC(NC2CC2)CC(N1)-C1CCCC(CL)C1CL,
THAL-SNS-032,THAL-SNS-032,,BRD:BRD-U00115425-001-01-9,oncref_1,IMID-BASED DEGRADER OF CDK9,CDK9,,,,,,NA,,
THALOMID,.ALPHA.-PHTHALIMIDOGLUTARIMIDE;CELGENE;CONTERGAN;DISTAVAL;K-17;MYRIN;N-PHTHALYLGLUTAMIC ACID IMIDE;NEUROSEDYN;NSC-527179;NSC-66847;PANTOSEDIV;PHARMION;SOFTENON;TALIDEX;THALED;THALIDOMIDE;THALIDOMIDE ;THALOMID,CHEMBL468,BRD:BRD-A93255169-001-28-3;BRD:BRD-BRD-A93255169-001-28-3;CTRP:24197,ctrp;rep_primary;rep_single_dose,TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,CRBN;FGFR2;NFKB1;ORM1;ORM2;PTGS2;TNF,,,LAUNCHED,,Small molecule,4,"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1;O=C1N(C2CCC(=O)NC2=O)C(=O)C2CCCCC12, O=C1N(C2CCC(=O)NC2=O)C(=O)C2CCCCC12",UEJJHQNACJXSKW-UHFFFAOYSA-N
THAPSIGARGIN,CAPRYLIC ACID;EDENOR C 8-98-100;FEMA NO. 2799;KORTACID-0899;N-OCTANOIC ACID;NSC-5024;OCTANOIC ACID;PRIFAC-2901;SODIUM CAPRYLATE;SODIUM OCTANOATE;SODIUM SALT;THAPSIGARGIN,CHEMBL324846;CHEMBL557076;CHEMBL96926,GDSC1:180,gdsc,,,,,,,Small molecule,2,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O;CCCCCCCC(=O)[O-].[Na+];CCCCCCCC(=O)O,BYKRNSHANADUFY-UHFFFAOYSA-M;IXFPJGBNCFXKPI-FSIHEZPISA-N;WWZKQHOCKIZLMA-UHFFFAOYSA-N
THEAFLAVIN,THEAFLAVIN,CHEMBL346119,BRD:BRD-K60842365-001-03-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,NA,O=c1c(O)cc([C@H]2Oc3cc(O)cc(O)c3C[C@H]2O)cc2c([C@H]3Oc4cc(O)cc(O)c4C[C@H]3O)cc(O)c(O)c12,IPMYMEWFZKHGAX-ZKSIBHASSA-N
XILIERTINIB,HMPL-309;THELIATINIB;XILIERTINIB,CHEMBL3545180,BRD:BRD-K00091285-001-01-9,rep_single_dose,,,,,,,Small molecule,1,,
XANTHEOSE,DIUROBROMINE;FEMA NO. 3591;NSC-5039;SANTHEOSE;SC-15090;THEOBROMINE;THEOBROMINE(20%);THEOBROMINUM;THEOSALVOSE;XANTHEOSE,CHEMBL1114,BRD:BRD-BRD-K34888156-213-01-4;BRD:BRD-K34888156-213-01-4,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,ADORA1;ADORA2A;PDE4B,,,LAUNCHED,,Small molecule,3,"Cn1cnc2c1c(=O)[nH]c(=O)n2C;CN1CNC2N(C)C(=O)[NH]C(=O)C12, CN1CNC2N(C)C(=O)[NH]C(=O)C12",YAPQBXQYLJRXSA-UHFFFAOYSA-N
UNIPHYLLIN CONTINUS,"ACCURBRON;AEROLATE;AEROLATE III;AEROLATE JR;AEROLATE SR;ANHYDROUS;AQUAPHYLLIN;BRONKODYL;DIMETHYLXANTHINE;DOXOPHYLLINE METABOLITE M3;DURAPHYL;ELIXICON;ELIXOMIN;ELIXOPHYLLIN;ELIXOPHYLLIN SR;LABID;LANOPHYLLIN;LASMA;NSC-2066;NSC-757346;NUELIN;NUELIN SA;NUELIN SA-250;PRO-VENT;QUIBRON;QUIBRON-T;QUIBRON-T/SR;RESPBID;SLO-BID;SLO-PHYLLIN;SOMOPHYLLIN-CRT;SOMOPHYLLIN-T;SUSTAIRE;T-PHYL;THEO-24;THEO-DUR;THEOBID;THEOBID JR.;THEOCHRON;THEOCIN;THEOCLEAR L.A.-130;THEOCLEAR L.A.-260;THEOCLEAR-100;THEOCLEAR-200;THEOCLEAR-80;THEOGRAD;THEOLAIR;THEOLAIR-SR;THEOLIXIR;THEOPHYL;THEOPHYL-225;THEOPHYL-SR;THEOPHYLLINE;THEOPHYLLINE ANHYDROUS;THEOPHYLLINE MELTING POINT STANDARD;THEOPHYLLINE MONOHYDRATE;THEOPHYLLINE-SR;THEOPHYLLINE,ANHYDROUS;THEOVENT;UNI-DUR;UNIPHYL;UNIPHYLLIN CONTINUS",CHEMBL190,BRD:BRD-BRD-K97799481-001-16-0,rep_primary,ADENOSINE RECEPTOR ANTAGONIST,,"ASTHMA, EMPHYSEMA, BRONCHITIS",,LAUNCHED,,Small molecule,4,Cn1c(=O)c2[nH]cnc2n(C)c1=O;CN1C2NC[NH]C2C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N
THIAMET-G,THIAMET-G,,BRD:BRD-BRD-K38380126-001-01-4;BRD:BRD-K38380126-001-01-4,rep_primary;rep_single_dose,GLCNAC PHOSPHOTRANSFERASE INHIBITOR,MGEA5,,,PRECLINICAL,,,NA,"CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1, CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1",
VITANEURIN,ANEURINE;APATATE DRAPE;BEIVON;BETAMIN;BETAXIN;BETHIAMIN;ORYZANIN;THIACOAT;THIAMIN;THIAMINE;THIAMINE (VIT B1);THIAMINE MONOCHLORIDE;VITAMIN B 1;VITAMIN B-1;VITANEURIN,CHEMBL1547;CHEMBL1588,BRD:BRD-BRD-K95785345-300-14-8;BRD:BRD-K95785345-300-14-8,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN B,SLC19A2;SLC19A3;TPK1,THIAMINE DEFICIENCY,,LAUNCHED,,Small molecule,4,"CC1C(CCO)SC[N+]1CC1CNC(C)NC1N, CC1C(CCO)SC[N+]1CC1CNC(C)NC1N;Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.[Cl-]",MYVIATVLJGTBFV-UHFFFAOYSA-M
WIN-5063-2,ARMAI;DEXTROSULPHENIDOL;NSC-522822;THIAMPHENICOL;THIAMPHENICOL AMINOACETATE HYDROCHLORIDE;THIOCYMETIN;THIOPHENICOL;WIN 5063-2;WIN-5063-2,CHEMBL1236282,BRD:BRD-BRD-K79711234-001-18-3;BRD:BRD-K79711234-001-18-3,rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,PELVIC INFLAMMATORY DISEASE,,LAUNCHED,,Small molecule,1,"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1;CS(=O)(=O)C1CCC(CC1)[C@@H](O)[C@@H](CO)NC(=O)C(CL)CL, CS(=O)(=O)C1CCC(CC1)[C@@H](O)[C@@H](CO)NC(=O)C(CL)CL",OTVAEFIXJLOWRX-NXEZZACHSA-N
THIAZOVIVIN,THIAZOVIVIN,,BRD:BRD-BRD-K03164761-001-02-1;BRD:BRD-K03164761-001-02-1,rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,,,,PRECLINICAL,,,NA,O=C(NCC1CCCCC1)C1CSC(NC2CCNCN2)N1,
TORECAN,THIETHYLPERAZINE;TORECAN,CHEMBL1378,BRD:BRD-BRD-K69600043-328-05-5;BRD:BRD-K69600043-328-05-5,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD2;DRD4,NAUSEA,,LAUNCHED,,Small molecule,4,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2;CCSC1CCC2SC3CCCCC3N(CCCN3CCN(C)CC3)C2C1,XCTYLCDETUVOIP-UHFFFAOYSA-N
THIOCOLCHICOSIDE,COLTRAMYL;COLTRAX;MIOREL;MUSCO-RIL;NSC-147755;THIOCOLCHICINE 2-GLUCOSIDE ANALOG;THIOCOLCHICINE GLYCOSIDE;THIOCOLCHICOSIDE,CHEMBL1705373,BRD:BRD-BRD-K26619122-001-02-1;BRD:BRD-K26619122-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,GABA RECEPTOR ANTAGONIST,GABRA1;GABRB2;GABRG2;GLRA1;GLRB,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,3,COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1C(NC(C)=O)CC2;COC1C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC2CC[C@H](NC(C)=O)C3CC(=O)C(SC)CCC3-C2C1OC,LEQAKWQJCITZNK-MSQQGMGVSA-N
THIOCTIC-ACID,THIOCTIC-ACID,,BRD:BRD-A16347691-001-13-1;BRD:BRD-BRD-A16347691-001-13-1,rep_primary;rep_single_dose,REDUCING AGENT,ACHE;LIAS;LIPT1;PTGS2;SLC5A6,,,LAUNCHED,,,NA,OC(=O)CCCCC1CCSS1,
THIODIGLYCOL,"2,2'-THIODIETHANOL;NSC-6289;THIODIGLYCOL",CHEMBL444480,BRD:BRD-BRD-K54521836-001-02-1;BRD:BRD-K54521836-001-02-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,OCCSCCO,YODZTKMDCQEPHD-UHFFFAOYSA-N
TIOGUANINE HEMIHYDRATE,ANHYDROUS;LANVIS;NSC-752;NSC-76504;TABLOID;THIOGUANINE;THIOGUANINE ANHYDROUS;THIOGUANINE HEMIHYDRATE;TIOGUANINE;TIOGUANINE HEMIHYDRATE,CHEMBL727,BRD:BRD-BRD-K49350383-001-13-7;BRD:BRD-K49350383-001-13-7;BRD:BRD-K49350383-001-14-5,rep_multi_dose;rep_primary;rep_single_dose,PURINE ANTAGONIST,IMPDH1;IMPDH2,ACUTE MYELOID LEUKEMIA (AML),,LAUNCHED,,Small molecule,4,"Nc1nc2[nH]cnc2c(=S)[nH]1;NC1NC2NC[NH]C2C(=S)[NH]1, NC1NC2NC[NH]C2C(=S)[NH]1, NC1NC2NC[NH]C2C(=S)[NH]1",WYWHKKSPHMUBEB-UHFFFAOYSA-N
THIOMERSALATE,ETHYLMERCURY SODIUM SALT;MERCUROTHIOLATE;MERFAMIN;MERTHIOLATE;MERTORGAN;MERZONIN;NSC-4794;SODIUM ETHYLMERCURITHIOSALICYLATE;THIMEROSAL;THIOMERSAL;THIOMERSALATE,CHEMBL508338,BRD:BRD-BRD-K61443650-236-13-1;BRD:BRD-K61443650-236-13-1,rep_multi_dose;rep_primary;rep_single_dose,OTHER ANTIBIOTIC,OXCT1,,,LAUNCHED,,Small molecule,4,CC[HG]SC1CCCCC1C(O)=O,
THIOPERAMIDE,THIOPERAMIDE,CHEMBL260374,BRD:BRD-BRD-K63874012-001-02-9;BRD:BRD-K63874012-001-02-9,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH3;HRH4,,,PRECLINICAL,,Small molecule,NA,"S=C(NC1CCCCC1)N1CCC(c2cnc[nH]2)CC1;S=C(NC1CCCCC1)N1CCC(CC1)C1C[NH]CN1, S=C(NC1CCCCC1)N1CCC(CC1)C1C[NH]CN1",QKDDJDBFONZGBW-UHFFFAOYSA-N
THIOPHANATE,NSC-170810;THIOPHANATE,CHEMBL2103777,BRD:BRD-BRD-K90168339-001-08-6;BRD:BRD-K90168339-001-08-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,"CCOC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OCC;COC(=O)NC(=S)NC1CCCCC1NC(=S)NC(=O)OC, COC(=O)NC(=S)NC1CCCCC1NC(=S)NC(=O)OC",YFNCATAIYKQPOO-UHFFFAOYSA-N
THIOPROPERAZINE,THIOPROPERAZINE,CHEMBL609109,BRD:BRD-BRD-K08619574-334-05-4;BRD:BRD-K08619574-334-05-4,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;DRD1;DRD2;HTR1A;HTR2A,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,-1,CN(C)S(=O)(=O)C1CCC2SC3CCCCC3N(CCCN3CCN(C)CC3)C2C1;CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,VZYCZNZBPPHOFY-UHFFFAOYSA-N
TP-21,DL-THIORIDAZINE;MELLARIL;MELLARIL-S;MELLERETTE;MELLERIL;NOVORIDAZINE;RIDERIL;SONAPAX;THIORIDAZINE;THIORIDAZINE PROLONGATUM;THIORIL;TP-21,CHEMBL479,BRD:BRD-A84481105-003-31-3;BRD:BRD-BRD-A84481105-003-31-3,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HTR1A;HTR2A;HTR2C;HTR6;HTR7;KCNH2,,,WITHDRAWN,,Small molecule,4,"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2;CSC1CCC2SC3CCCCC3N(CCC3CCCCN3C)C2C1, CSC1CCC2SC3CCCCC3N(CCC3CCCCN3C)C2C1",KLBQZWRITKRQQV-UHFFFAOYSA-N
THIOSTREPTON A,BRYAMYCIN;GARGON;NSC-170365;NSC-81722;THIACTIN;THIOSTREPTON;THIOSTREPTON 1;THIOSTREPTON A,CHEMBL1236460;CHEMBL2303629;CHEMBL468719,BRD:BRD-BRD-K58049875-001-04-7;BRD:BRD-K58049875-001-04-7,rep_multi_dose;rep_primary;rep_single_dose,"FOXM1 INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",FOXM1,MASTITIS,,LAUNCHED,,Unknown,-1,"C=C(NC(=O)C(=C)NC(=O)c1csc(C2=N[C@@H]3c4csc(n4)[C@H]4NC(=O)c5csc(n5)[C@H]([C@](C)(O)[C@@H](C)O)NC(=O)[C@H]5CSC(=N5)/C(=C/C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c5csc(n5)[C@]3(CC2)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)N[C@@H]2C=Cc3c([C@H](C)O)cc(nc3[C@H]2O)C(=O)O[C@@H]4C)n1)C(N)=O;CCC(C)C1NC2C=CC3C(CC(NC3C2O)C(=O)OC(C)C2NC(=O)C3CSC(N3)C(NC(=O)C3CSC(=N3)\C(NC(=O)C(NC(=O)C3CSC(N3)C3(CCC(=NC3C3CSC2N3)C2NC(CS2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C/C)C(C)(O)C(C)O)C(C)O, CC[C@H](C)[C@@H]1N[C@@H]2C=CC3C(CC(NC3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)C3CSC(N3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)C3CSC(N3)[C@]3(CCC(=N[C@@H]3C3CSC2N3)C2NC(CS2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O, CC[C@H](C)[C@@H]1N[C@@H]2C=CC3C(CC(NC3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)C3CSC(N3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)C3CSC(N3)[C@]3(CCC(=N[C@@H]3C3CSC2N3)C2NC(CS2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O, CC[C@H](C)[C@@H]1N[C@@H]2C=CC3C(CC(NC3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)C3CSC(N3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)C3CSC(N3)[C@]3(CCC(=N[C@@H]3C3CSC2N3)C2NC(CS2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O, CC[C@H](C)[C@@H]1N[C@@H]2C=CC3C(CC(NC3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)C3CSC(N3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)C3CSC(N3)[C@]3(CCC(=N[C@@H]3C3CSC2N3)C2NC(CS2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O",NSFFHOGKXHRQEW-AIHSUZKVSA-N
THIOTEPA,NSC-6396;TEPADINA;THIOPLEX;THIOTEPA,CHEMBL671,BRD:BRD-K09631521-001-12-3,rep_multi_dose;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP2B6;CYP3A4,"BREAST CANCER, OVARIAN CANCER, BLADDER CANCER",,LAUNCHED,,Small molecule,4,"S=P(N1CC1)(N1CC1)N1CC1;S=P(N1CC1)(N1CC1)N1CC1, S=P(N1CC1)(N1CC1)N1CC1, S=P(N1CC1)(N1CC1)N1CC1",FOCVUCIESVLUNU-UHFFFAOYSA-N
TIOTIXENE,(Z)-THIOTHIXENE;CIS-THIOTHIXENE;CP-12252-1;NAVANE;NSC-108165;ORBINAMON;P-4657 B;P-4657B;THIOTHIXENE;THIOTHIXENE CIS-ISOMER;TIOTIXENE,CHEMBL1201,BRD:BRD-BRD-K97309399-001-09-4;BRD:BRD-K97309399-001-09-4,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD1;DRD2;HRH1;HTR2A,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,CN(C)S(=O)(=O)C1CCC2SC3CCCCC3\C(=C/CCN3CCN(C)CC3)C2C1;CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,GFBKORZTTCHDGY-UWVJOHFNSA-N
THIRAM,NSC-1771;NSC-49512;NSC-59637;NSC-622696;REZIFILM;SQ 1489;SQ-1489;THIRAM,CHEMBL120563,BRD:BRD-BRD-K29254801-001-14-7;BRD:BRD-K29254801-001-14-7,rep_multi_dose;rep_primary;rep_single_dose,,JAK2,CONTACT DERMATITIS,,LAUNCHED,,Small molecule,-1,CN(C)C(=S)SSC(=S)N(C)C,KUAZQDVKQLNFPE-UHFFFAOYSA-N
THK5351,THK5351,,BRD:BRD-K00003401-001-01-9,rep_single_dose,PET RADIOTRACER,,,,,,,NA,,
TONZONIUM,THONZONIUM;THONZONIUM CATION;THONZONIUM ION;TONZONIUM,CHEMBL1201322,BRD:BRD-BRD-K13387373-004-14-5;BRD:BRD-K13387373-004-14-5,rep_multi_dose;rep_primary;rep_single_dose,ATPASE INHIBITOR,,,,LAUNCHED,,Small molecule,4,"CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1;CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1CCC(OC)CC1)C1NCCCN1, CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1CCC(OC)CC1)C1NCCCN1",IOYZYMQFUSNATM-UHFFFAOYSA-N
TONAMIL,THONZYLAMINE;TONAMIL,CHEMBL1623738,BRD:BRD-BRD-K88405679-003-03-1;BRD:BRD-K88405679-003-03-1,rep_primary;rep_single_dose,ANTIHISTAMINE,,ITCHING,,LAUNCHED,,Small molecule,-1,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1;COC1CCC(CN(CCN(C)C)C2NCCCN2)CC1,GULNIHOSWFYMRN-UHFFFAOYSA-N
THREO-2-METHYLISOCITRATE-(DL),THREO-2-METHYLISOCITRATE-(DL),,BRD:BRD-M01344114-348-01-0,rep_single_dose,ISOCITRATE LYASE SUBSTRATE,,,,,,,NA,,
ZADAXIN,THYMALFASIN;THYMOSIN ALPHA1;THYMOSINS THYMALFASIN;ZADAXIN,CHEMBL2103979,BRD:BRD-K00004602-001-01-9,rep_single_dose,IMMUNE RESPONSE MODULATOR,,,,,,Protein,3,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O,NZVYCXVTEHPMHE-ZSUJOUNUSA-N
TP-5,ARG-LYS-ASP-VAL-TYR;HG-THYMOPENTIN;IMMUNOX;NSC-760116;ORF 15244;ORF-15244;ORISTAR THYMOPENTIN;PENTAPEPTIDE-1;SH-PENTAPEPTIDE-1;SINTOMODULINA;THYMOPENTIN;THYMOPOETIN 32-36-PENTAPEPTIDE;THYMOPOIETIN 32-36;THYMOPOIETIN PENTAPEPTIDE;TIMUNOX;TP-5,CHEMBL156025,BRD:BRD-K43977121-001-06-9,rep_single_dose,IMMUNE RESPONSE STIMULATOR,,,,,,Protein,3,CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O,PSWFFKRAVBDQEG-YGQNSOCVSA-N
THZ-2-102-1,THZ-2-102-1,,GDSC1:346,gdsc,,,,,,,,NA,,
THZ-2-49,THZ-2-49,,GDSC1:344,gdsc,,,,,,,,NA,,
THZ1,THZ1,,BRD:BRD-BRD-K66401437-001-03-3;BRD:BRD-K66401437-001-03-3,rep_primary;rep_single_dose,CDK INHIBITOR,CDK7,,,PRECLINICAL,,,NA,CN(C)C\C=C\C(=O)NC1CCC(CC1)C(=O)NC1CCCC(NC2NCC(CL)C(N2)-C2C[NH]C3CCCCC23)C1,
THZ1-R,THZ1-R,,BRD:BRD-BRD-K02135007-001-01-8;BRD:BRD-K02135007-001-01-8,rep_primary;rep_single_dose,CDK INHIBITOR,CDK7,,,PRECLINICAL,,,NA,CN(C)CCCC(=O)NC1CCC(CC1)C(=O)NC1CCCC(NC2NCC(CL)C(N2)-C2C[NH]C3CCCCC23)C1,
THZ2,THZ2,,BRD:BRD-BRD-K95902121-001-01-0;BRD:BRD-K95902121-001-01-0,rep_primary;rep_single_dose,CDK INHIBITOR,CDK7,,,PRECLINICAL,,,NA,CN(C)C\C=C\C(=O)NC1CCCC(C1)C(=O)NC1CCCC(NC2NCC(CL)C(N2)-C2C[NH]C3CCCCC23)C1,
THZ531,THZ531,,BRD:BRD-K00104123-001-01-9,rep_single_dose,,,,,,,,NA,,
TIABENDAZOLE,E233;EQUIZOLE;LOMBRISTOP;MINTEZOL;MINZOLUM;MK-360;NEMAPAN;NSC-525040;NSC-90507;OMNIZOLE;PITRIZET;THIABENDAZOLE;THIABENZOLE;TIABENDAZOLE,CHEMBL625,BRD:BRD-BRD-K77695569-001-30-0;BRD:BRD-K77695569-001-30-0,rep_primary;rep_single_dose,ANGIOGENESIS INHIBITOR,,"GASTROINTESTINAL ROUNDWORMS, HOOKWORM",,LAUNCHED,,Small molecule,4,"c1ccc2[nH]c(-c3cscn3)nc2c1;C1NC(CS1)-C1NC2CCCCC2[NH]1, C1NC(CS1)-C1NC2CCCCC2[NH]1",WJCNZQLZVWNLKY-UHFFFAOYSA-N
TIAGABINE,A-70569-1;ABBOTT-70569;ABBOTT-70569 FREE BASE;ABBOTT-70569-1;ABBOTT-705691 FREE BASE;ABT-569;ABT-569 FREE BASE;GABITRIL;NNC-05-0328;NNC-050328 FREE BASE;NO-05-0328;NO-050328 FREE BASE;TIAGABINE,CHEMBL1027,BRD:BRD-BRD-K60160658-003-11-2;BRD:BRD-K60160658-003-11-2,rep_multi_dose;rep_primary;rep_single_dose,GABA UPTAKE INHIBITOR,SLC6A1,SEIZURES,,LAUNCHED,,Small molecule,4,"Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C;CC1CCSC1C(=CCCN1CCC[C@H](C1)C(O)=O)C1SCCC1C, CC1CCSC1C(=CCCN1CCC[C@H](C1)C(O)=O)C1SCCC1C",PBJUNZJWGZTSKL-MRXNPFEDSA-N
TPI-1062,JNJ-39823277;S-1574;STABLON;TIANEPTINE;TPI-1062,CHEMBL1289110,BRD:BRD-A53077924-001-01-2;BRD:BRD-BRD-A53077924-001-01-2,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE ENHANCER (SSRE),OPRD1;OPRK1;OPRM1,"DEPRESSION, ASTHMA, IRRITABLE BOWEL SYNDROME",,LAUNCHED,,Small molecule,3,"CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O;CN1C2CCCCC2C(NCCCCCCC(O)=O)C2CCC(CL)CC2S1(=O)=O, CN1C2CCCCC2C(NCCCCCCC(O)=O)C2CCC(CL)CC2S1(=O)=O, CN1C2CCCCC2C(NCCCCCCC(O)=O)C2CCC(CL)CC2S1(=O)=O, CN1C2CCCCC2C(NCCCCCCC(O)=O)C2CCC(CL)CC2S1(=O)=O, CN1C2CCCCC2C(NCCCCCCC(O)=O)C2CCC(CL)CC2S1(=O)=O, CN1C2CCCCC2C(NCCCCCCC(O)=O)C2CCC(CL)CC2S1(=O)=O",JICJBGPOMZQUBB-UHFFFAOYSA-N
TIAPRIDE,NSC-758225;TIAPRIDE,CHEMBL84158,BRD:BRD-BRD-K57432881-003-21-8;BRD:BRD-K57432881-003-21-8,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3,"DYSKINESIA, ABSTINENCE FROM ALCOHOL, PSYCHOSIS",,LAUNCHED,,Small molecule,3,CCN(CC)CCNC(=O)C1CC(CCC1OC)S(C)(=O)=O;CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,JTVPZMFULRWINT-UHFFFAOYSA-N
TIAPROFENIC-ACID,TIAPROFENIC-ACID,,BRD:BRD-A72988804-001-11-1;BRD:BRD-BRD-A72988804-001-11-1,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,RHEUMATOID ARTHRITIS,,LAUNCHED,,,NA,"CC(C(O)=O)C1CCC(S1)C(=O)C1CCCCC1, CC(C(O)=O)C1CCC(S1)C(=O)C1CCCCC1",
TIARAMIDE,RHC 2592A;RHC-2592A;TIALAMIDE;TIARAMIDE,CHEMBL274239,BRD:BRD-BRD-K27293958-001-01-5;BRD:BRD-K27293958-001-01-5,rep_primary;rep_single_dose,ANTI-INFLAMMATORY AGENT,,ASTHMA,,LAUNCHED,,Small molecule,-1,O=C(Cn1c(=O)sc2ccc(Cl)cc21)N1CCN(CCO)CC1;OCCN1CCN(CC1)C(=O)CN1C2CC(CL)CCC2SC1=O,HTJXMOGUGMSZOG-UHFFFAOYSA-N
TIBOLONE,LIVIAL;NSC-759898;ORG OD 14;ORG-OD 14;TIBOLONE,CHEMBL2103774,BRD:BRD-A82522119-001-01-7;BRD:BRD-BRD-A82522119-001-01-7,rep_primary;rep_single_dose,"ANDROGEN RECEPTOR AGONIST, ESTROGEN RECEPTOR AGONIST, PROGESTERONE RECEPTOR AGONIST",ESR1,ENDOMETRIOSIS,,LAUNCHED,,Small molecule,4,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12;C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C,WZDGZWOAQTVYBX-XOINTXKNSA-N
TIC10,DORDAVIPRONE;NSC-350625;ONC 201;ONC-201;ONC201;TIC-10;TIC10,CHEMBL4297310,BRD:BRD-BRD-K19939891-001-05-4;BRD:BRD-K19939891-001-05-4,rep_primary;rep_single_dose,"AKT INHIBITOR, TRAIL MODULATOR",AKT1;MAPK1,,,PHASE 2,,Small molecule,3,"Cc1ccccc1CN1C(=O)C2=C(CCN(Cc3ccccc3)C2)N2CCN=C12;CC1CCCCC1CN1CC2=C(CCN(CC3CCCCC3)C2=O)N2CCN=C12, CC1CCCCC1CN1C2=NCCN2C(=O)C2=C1CCN(CC1CCCCC1)C2",VLULRUCCHYVXOH-UHFFFAOYSA-N
TICAGRELOR,AR-C126532XX;AZD-6140;AZD6140;BRILINTA;BRILIQUE;POSSIA;TICAGRELOR,CHEMBL398435,BRD:BRD-BRD-K44974079-001-01-3;BRD:BRD-K44974079-001-01-3,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RY12,"ACUTE CORONARY SYNDROME (ACS), MYOCARDIAL INFARCTION",,LAUNCHED,,Small molecule,4,CCCSC1NC(N[C@@H]2C[C@@H]2C2CCC(F)C(F)C2)C2NNN([C@@H]3C[C@H](OCCO)[C@H](O)[C@H]3O)C2N1;CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,OEKWJQXRCDYSHL-FNOIDJSQSA-N
TICLOPIDINE,TICLOPIDIN-PUREN;TICLOPIDINE,CHEMBL833,BRD:BRD-BRD-K00603606-003-24-0;BRD:BRD-K00603606-003-24-0,rep_primary;rep_single_dose,PURINERGIC RECEPTOR ANTAGONIST,P2RY12,"THROMBOSIS, STROKE",,LAUNCHED,,Small molecule,4,"Clc1ccccc1CN1CCc2sccc2C1;CLC1CCCCC1CN1CCC2SCCC2C1, CLC1CCCCC1CN1CCC2SCCC2C1",PHWBOXQYWZNQIN-UHFFFAOYSA-N
ZENTYLOR NYPTA,NP-031112;NP-12;NP031112;TIDEGLUSIB;ZENTYLOR NYPTA,CHEMBL3545157,BRD:BRD-BRD-K81330143-001-04-8;BRD:BRD-K81330143-001-04-8,rep_multi_dose;rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3B,,,PHASE 2,,Small molecule,2,"O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1;O=C1SN(-C2CCCC3CCCCC23)C(=O)N1CC1CCCCC1, O=C1SN(-C2CCCC3CCCCC23)C(=O)N1CC1CCCCC1",PMJIHLSCWIDGMD-UHFFFAOYSA-N
TIE2-KINASE-INHIBITOR,TIE2-KINASE-INHIBITOR,,BRD:BRD-A92800748-001-05-5;BRD:BRD-BRD-A92800748-001-05-5,rep_primary;rep_single_dose,TIE TYROSINE KINASE INHIBITOR,KDR;MAPK14,,,PRECLINICAL,,,NA,COC1CCC2CC(CCC2C1)-C1NC([NH]C1-C1CCNCC1)-C1CCC(CC1)S(C)=O,
TIENILIC-ACID,TIENILIC-ACID,,BRD:BRD-BRD-K34098590-001-02-1;BRD:BRD-K34098590-001-02-1,rep_primary;rep_single_dose,"SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR, CYTOCHROME P450 INHIBITOR",CYP2C9;SLC12A1,,,WITHDRAWN,"Multiple values for MOA: {'CYTOCHROME P450 INHIBITOR, SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR', 'SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR, CYTOCHROME P450 INHIBITOR'}, defaulting to 'SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR, CYTOCHROME P450 INHIBITOR'",,NA,OC(=O)COC1CCC(C(=O)C2CCCS2)C(CL)C1CL,
TIFENAZOXIDE,NN-414;TIFENAZOXIDE,CHEMBL135191,BRD:BRD-BRD-K20568871-001-01-1;BRD:BRD-K20568871-001-01-1,rep_primary;rep_single_dose,ATP-SENSITIVE POTASSIUM CHANNEL AGONIST,ABCC8;KCNJ11,,,PHASE 1,,Small molecule,-1,CC1(CC1)NC1=NS(=O)(=O)C2SC(CL)CC2N1;CC1(NC2=NS(=O)(=O)c3sc(Cl)cc3N2)CC1,KYSFUHHFTIGRJN-UHFFFAOYSA-N
WAY-GAR-936,TIGECYCLINE;TYGACIL;WAY-GAR-936,CHEMBL376140,BRD:BRD-K00003349-001-01-9;CTRP:659993,ctrp;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,,,,,Small molecule,4,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,FPZLLRFZJZRHSY-HJYUBDRYSA-N
ZUPREVO,TILDIPIROSIN;ZUPREVO,CHEMBL3039509,BRD:BRD-K00073880-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2CCCCC2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CN1CCCCC1,HNDXPZPJZGTJLJ-UEJFNEDBSA-N
TILETAMINE,TILETAMINE,CHEMBL2110703,BRD:BRD-A30582499-003-05-1;BRD:BRD-BRD-A30582499-003-05-1,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,ANESTHETIC,,LAUNCHED,,Small molecule,-1,CCNC1(c2cccs2)CCCCC1=O;CCNC1(CCCCC1=O)C1CCCS1,QAXBVGVYDCAVLV-UHFFFAOYSA-N
TILMICOSIN,EL-870;EL870;LY-177370;LY177370;MICOTIL;NSC-759584;TILMICOSIN,CHEMBL1908333,BRD:BRD-BRD-K26634012-001-04-9;BRD:BRD-K26634012-001-04-9,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,BOVINE RESPIRATORY DISEASE (BRD),,LAUNCHED,,Small molecule,-1,"CC[C@@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC, CC[C@@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC;CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2C[C@H](C)C[C@H](C)C2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC",JTSDBFGMPLKDCD-XVFHVFLVSA-N
TILORONE,AMIXIN IC;TILORONE,CHEMBL47298,BRD:BRD-BRD-K34568562-001-04-3;BRD:BRD-K34568562-001-04-3,rep_primary;rep_single_dose,INTERFERON INDUCER,,"INFLUENZA A VIRUS INFECTION, DIARRHEA, HEPATITIS B, MULTIPLE SCLEROSIS, URINARY TRACT INFECTIONS, VIRUS HERPES SIMPLEX (HSV), HEPATITIS C",,LAUNCHED,,Small molecule,-1,CCN(CC)CCOC1CCC2-C3CCC(OCCN(CC)CC)CC3C(=O)C2C1;CCN(CC)CCOc1ccc2c(c1)C(=O)c1cc(OCCN(CC)CC)ccc1-2,MPMFCABZENCRHV-UHFFFAOYSA-N
TILUDRONIC ACID,SKELID;SR 41319;SR-41319;TILUDRONATE;TILUDRONIC ACID,CHEMBL1350,BRD:BRD-BRD-K10845183-304-01-6;BRD:BRD-K10845183-304-01-6,rep_multi_dose;rep_primary;rep_single_dose,"BONE RESORPTION INHIBITOR, OSTEOCLAST INHIBITOR",ATP6V1A;MMP2;PTPN1,NAVICULAR SYNDROME,,LAUNCHED,,Small molecule,4,O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O;OP(O)(=O)C(SC1CCC(CL)CC1)P(O)(O)=O,DKJJVAGXPKPDRL-UHFFFAOYSA-N
TIMOFIBRATE,TIMOFIBRATE,CHEMBL2106730,BRD:BRD-A64406146-001-01-2;BRD:BRD-BRD-A64406146-001-01-2,rep_primary;rep_single_dose,"CHOLESTEROL INHIBITOR, LIPASE CLEARING FACTOR INHIBITOR",LPL,,,PHASE 2,,Small molecule,-1,CC(C)(Oc1ccc(Cl)cc1)C(=O)N1CSCC1C(=O)O;CC(C)(OC1CCC(CL)CC1)C(=O)N1CSCC1C(O)=O,QSNOWCXXECLALL-UHFFFAOYSA-N
TIOPEX,BETIM;BETIMOL;BLOCADREN;GLAU-OPT;GLAUCOL;ISTALOL;NYOGEL;TIMOLOL;TIMOLOL ANHYDROUS;TIMOLOL HEMIHYDRATE;TIMOPTIC;TIMOPTIC-XE;TIOPEX,CHEMBL499,BRD:BRD-BRD-K30421593-050-04-9;BRD:BRD-K30421593-050-04-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2,"OCULAR HYPERTENSION, GLAUCOMA",,LAUNCHED,,Small molecule,4,"CC(C)(C)NC[C@@H](O)COC1NSNC1N1CCOCC1, CC(C)(C)NC[C@H](O)COC1NSNC1N1CCOCC1, CC(C)(C)NC[C@H](O)COC1NSNC1N1CCOCC1;CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1",BLJRIMJGRPQVNF-JTQLQIEISA-N
TIMONACIC,HEPACOM;NORGAMEN;NSC-25855;TIMONACIC,CHEMBL358722,BRD:BRD-A38592941-001-02-7;BRD:BRD-BRD-A38592941-001-02-7,rep_primary;rep_single_dose,ANTIOXIDANT,ANXA5,,,LAUNCHED,,Small molecule,-1,O=C(O)C1CSCN1;OC(=O)C1CSCN1,DZLNHFMRPBPULJ-UHFFFAOYSA-N
TINAZOLINE,TINAZOLINE,CHEMBL2107015,BRD:BRD-K00004663-001-01-9,rep_single_dose,ADRENERGIC RECEPTOR AGONIST,,,,,,Small molecule,-1,c1ccc2c(SC3=NCCN3)c[nH]c2c1,JENBDJGHNIOHAJ-UHFFFAOYSA-N
TRIMONASE,"CP-12,574;CP-12574;FASIGIN;FASIGYN;HAISIGYN;NSC-758189;SYMPLOTAN;TINDAMAX;TINIDAZOLE;TRICOLAM;TRIMONASE",CHEMBL1220,BRD:BRD-BRD-K89125793-001-26-0;BRD:BRD-K89125793-001-26-0,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,"GIARDIASIS, AMEBIASIS, BACTERIAL VAGINOSIS, TRICHOMONIASIS",,LAUNCHED,,Small molecule,4,"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C;CCS(=O)(=O)CCN1C(C)NCC1[N+]([O-])=O, CCS(=O)(=O)CCN1C(C)NCC1[N+]([O-])=O, CCS(=O)(=O)CCN1C(C)NCC1[N+]([O-])=O",HJLSLZFTEKNLFI-UHFFFAOYSA-N
Y-3642,NSC-158555;TINORIDINE;TINORIDINE HYDROCHLORIDE;Y 3642;Y-3642,CHEMBL592943,BRD:BRD-K84313779-003-03-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,Small molecule,3,CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2,PFENFDGYVLAFBR-UHFFFAOYSA-N
VAGISTAT-1,"NSC-759169;TIOCONAZOLE;TROSYL;TZ-3;UK-20,349;UK-20349;VAGISTAT;VAGISTAT-1",CHEMBL1200438,BRD:BRD-A33084557-001-06-6;BRD:BRD-BRD-A33084557-001-06-6,rep_primary;rep_single_dose,STEROL DEMETHYLASE INHIBITOR,CYP51A1,YEAST INFECTION,,LAUNCHED,,Small molecule,4,"Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1;CLC1SCCC1COC(CN1CCNC1)C1CCC(CL)CC1CL, CLC1SCCC1COC(CN1CCNC1)C1CCC(CL)CC1CL",QXHHHPZILQDDPS-UHFFFAOYSA-N
TIOGUANINE HEMIHYDRATE,ANHYDROUS;LANVIS;NSC-752;NSC-76504;TABLOID;THIOGUANINE;THIOGUANINE ANHYDROUS;THIOGUANINE HEMIHYDRATE;TIOGUANINE;TIOGUANINE HEMIHYDRATE,CHEMBL727,BRD:BRD-BRD-K75649340-001-13-1;BRD:BRD-K75649340-001-13-1,rep_multi_dose;rep_primary;rep_single_dose,PURINE ANTAGONIST,,,,PHASE 2,,Small molecule,4,NC1NC(S)C2NCN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2N1;Nc1nc2[nH]cnc2c(=S)[nH]1,WYWHKKSPHMUBEB-UHFFFAOYSA-N
TIOPRONIN,(R)-;ACADIONE;CAPTIMER;DEXTIOPRONIN;NSC-760416;THIOLA;THIOLA EC;TIOPRONIN,CHEMBL1314;CHEMBL2106444,BRD:BRD-A85295731-001-06-4;BRD:BRD-BRD-A85295731-001-06-4,rep_primary;rep_single_dose,"CHELATING AGENT, REDUCING AGENT",,KIDNEY STONES,,LAUNCHED,,Small molecule,4,"C[C@@H](S)C(=O)NCC(=O)O;CC(S)C(=O)NCC(=O)O;CC(S)C(=O)NCC(O)=O, CC(S)C(=O)NCC(O)=O, CC(S)C(=O)NCC(O)=O, CC(S)C(=O)NCC(O)=O, CC(S)C(=O)NCC(O)=O",YTGJWQPHMWSCST-GSVOUGTGSA-N;YTGJWQPHMWSCST-UHFFFAOYSA-N
TIOTIDINE,"ICI 125,211;ICI-125,211;ICI-125211;TIOTIDINE",CHEMBL269646,BRD:BRD-BRD-K15071410-001-01-1;BRD:BRD-K15071410-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,,,PHASE 2,,Small molecule,-1,"C/N=C(/NC#N)NCCSCc1csc(NC(=N)N)n1;CN\C(NCCSCC1CSC(N=C(N)N)N1)=N/C#N, CN\C(NCCSCC1CSC(N=C(N)N)N1)=N/C#N",YDDXVAXDYKBWDX-UHFFFAOYSA-N
TIOTROPIUM ION,BRALTUS;SPIRIVA;SPIRIVA RESPIMAT;TIOTROPIUM;TIOTROPIUM CATION;TIOTROPIUM ION,CHEMBL1182657;CHEMBL1900528,BRD:BRD-BRD-K62782754-337-02-5;BRD:BRD-K62782754-337-02-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3,"CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BRONCHITIS, EMPHYSEMA",,LAUNCHED,,Small molecule,4,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12;C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(C1CCCS1)C1CCCS1,LERNTVKEWCAPOY-DZZGSBJMSA-N
TIOXOLONE,NSC-758240;THIOXOLONE;TIOXOLONE,CHEMBL442687,BRD:BRD-BRD-K41876534-001-13-7;BRD:BRD-K41876534-001-13-7,rep_multi_dose;rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA2,,,PRECLINICAL,,Small molecule,-1,"O=c1oc2cc(O)ccc2s1;OC1CCC2SC(=O)OC2C1, OC1CCC2SC(=O)OC2C1",SLYPOVJCSQHITR-UHFFFAOYSA-N
TIPELUKAST,KCA-757;MN-001;TIPELUKAST,CHEMBL2104988,BRD:BRD-K00004627-001-01-9,rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,,,,,,Small molecule,2,CCCc1c(SCCCOc2ccc(C(C)=O)c(OCCCC(=O)O)c2CCC)ccc(C(C)=O)c1O,KPWYNAGOBXLMSE-UHFFFAOYSA-N
TIPEPIDINE (HYDROCHLORIDE),TIPEPIDINE (HYDROCHLORIDE),,BRD:BRD-K00075727-003-02-9,rep_single_dose,,,,,,,,NA,,
TIPIFARNIB-P1,TIPIFARNIB-P1,,CTRP:417417,ctrp,,,,,,,,NA,,
TIPIFARNIB-P2,TIPIFARNIB-P2,,CTRP:417416,ctrp,,,,,,,,NA,,
TPI (FREEBASE),MA-1;TIPIRACIL;TPI (FREEBASE),CHEMBL235668,BRD:BRD-BRD-K11973162-003-01-8;BRD:BRD-K11973162-003-01-8,rep_multi_dose;rep_primary;rep_single_dose,THYMIDINE PHOSPHORYLASE INHIBITOR,TYMP,COLORECTAL CANCER,,LAUNCHED,,Small molecule,4,CLC1C(CN2CCCC2=N)[NH]C(=O)[NH]C1=O;N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl,QQHMKNYGKVVGCZ-UHFFFAOYSA-N
TIPLAXTININ,TIPLAXTININ,,BRD:BRD-BRD-K30882994-001-01-6;BRD:BRD-K30882994-001-01-6,rep_primary;rep_single_dose,PLASMINOGEN ACTIVATOR INHIBITOR,SERPINE1,,,PHASE 1,,,NA,"OC(=O)C(=O)C1CN(CC2CCCCC2)C2CCC(CC12)-C1CCC(OC(F)(F)F)CC1, OC(=O)C(=O)C1CN(CC2CCCCC2)C2CCC(CC12)-C1CCC(OC(F)(F)F)CC1",
U-140690,APTIVUS;TIPRANAVIR;U-140690,CHEMBL222559,BRD:BRD-A10039652-001-01-2;BRD:BRD-BRD-A10039652-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,HIV PROTEASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"CCC[C@@]1(CCC2CCCCC2)CC(=O)C([C@H](CC)C2CCCC(NS(=O)(=O)C3CCC(CN3)C(F)(F)F)C2)C(=O)O1, CCC[C@@]1(CCC2CCCCC2)CC(=O)C([C@H](CC)C2CCCC(NS(=O)(=O)C3CCC(CN3)C(F)(F)F)C2)C(=O)O1;CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1",SUJUHGSWHZTSEU-FYBSXPHGSA-N
TIPRENOLOL,TIPRENOLOL,CHEMBL2111163,BRD:BRD-A73566563-001-01-6;BRD:BRD-BRD-A73566563-001-01-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3,,,PHASE 2,,Small molecule,-1,CSc1ccccc1OCC(O)CNC(C)C;CSC1CCCCC1OCC(O)CNC(C)C,CSUNLSYSEQIDMO-UHFFFAOYSA-N
TIQUIZIUM ION,TIQUIZIUM;TIQUIZIUM CATION;TIQUIZIUM ION,CHEMBL1872078;CHEMBL4301292,BRD:BRD-BRD-K77552740-004-01-0;BRD:BRD-K77552740-004-01-0,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,,SPASMS,,LAUNCHED,,Small molecule,-1,C[N@+]12CCCC[C@@H]1CCC(C2)=C(C1CCCS1)C1CCCS1;C[N+]12CCCCC1CCC(=C(c1cccs1)c1cccs1)C2,ZGSDGGRVFIYKKE-UHFFFAOYSA-N
TIRACIZINE,TIRACIZINE,CHEMBL1625260,BRD:BRD-BRD-K75250001-001-01-3;BRD:BRD-K75250001-001-01-3,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN5A,,,WITHDRAWN,,Small molecule,-1,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CN(C)C)c1ccccc1CC2;CCOC(=O)NC1CCC2CCC3CCCCC3N(C(=O)CN(C)C)C2C1,KJAMZCVTJDTESW-UHFFFAOYSA-N
WIN-59075,NSC-130181;SR-259075;SR259075;TIRAPAZAMINE;WIN 59075;WIN-59075,CHEMBL50882,BRD:BRD-BRD-K92968657-001-01-6;BRD:BRD-K92968657-001-01-6,rep_multi_dose;rep_primary;rep_single_dose,DNA INHIBITOR,,,,PHASE 3,,Small molecule,3,"Nc1n[n+]([O-])c2ccccc2[n+]1[O-];NC1N[N+]([O-])C2CCCCC2[N+]1[O-], NC1N[N+]([O-])C2CCCCC2[N+]1[O-]",ORYDPOVDJJZGHQ-UHFFFAOYSA-N
TIRASEMTIV,CK-2017357;CK2017357;TIRASEMTIV,CHEMBL3039529,BRD:BRD-BRD-K51087630-001-01-6;BRD:BRD-K51087630-001-01-6,rep_primary;rep_single_dose,TROPONIN ACTIVATOR,,,,PHASE 2,,Small molecule,3,C#Cc1cnc2nc(O)n(C(CC)CC)c2n1;CCC(CC)N1C2NC(CNC2[NH]C1=O)C#C,RSQGZEAXODVTOL-UHFFFAOYSA-N
TRIIODOTHYROACETIC ACID,"3,5,3'-TRIIODOTHYROACETATE;LEVOTHYROXINE SODIUM IMPURITY;NSC-759294;OR T3-ACETIC ACID-;T3-ACETIC ACID;TIRACANA;TIRATRICOL;TRIAC;TRIIODOTHYROACETIC ACID",CHEMBL41632,BRD:BRD-BRD-K61236135-001-08-2;BRD:BRD-K61236135-001-08-2,rep_primary;rep_single_dose,THYROID HORMONE STIMULANT,THRA;THRB,REFETOFF SYNDROME,,LAUNCHED,,Small molecule,2,"O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1;OC(=O)CC1CC(I)C(OC2CCC(O)C(I)C2)C(I)C1, OC(=O)CC1CC(I)C(OC2CCC(O)C(I)C2)C(I)C1",UOWZUVNAGUAEQC-UHFFFAOYSA-N
TIROFIBAN,AGGRASTAT;AGRASTAT;L-700462;MK-383;TIROFIBAN,CHEMBL916,BRD:BRD-BRD-K37872686-003-01-9;BRD:BRD-K37872686-003-01-9,rep_primary;rep_single_dose,"PLATELET AGGREGATION INHIBITOR, STRUCTURAL GLYCOPROTEIN ANTAGONIST",ITGA2B;ITGB3,"MYOCARDIAL INFARCTION, REFACTORY ANGINA",,LAUNCHED,,Small molecule,4,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O;CCCCS(=O)(=O)N[C@@H](CC1CCC(OCCCCC2CCNCC2)CC1)C(O)=O,COKMIXFXJJXBQG-NRFANRHFSA-N
TITANOCENE-DICHLORIDE,TITANOCENE-DICHLORIDE,,BRD:BRD-BRD-K60284353-001-01-3;BRD:BRD-K60284353-001-01-3,rep_primary;rep_single_dose,APOPTOSIS STIMULANT,,,,PHASE 2,,,NA,CL[TI](CL)(C1C=CC=C1)C1C=CC=C1,
TIVANTINIB,ARQ 197;ARQ-197;TIVANTINIB,CHEMBL2103882,BRD:BRD-BRD-K33379087-001-07-5;BRD:BRD-K33379087-001-07-5;CTRP:687406,ctrp;rep_multi_dose;rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,MET,,,PHASE 3,,Small molecule,3,O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12;O=C1NC(=O)[C@H]([C@@H]1C1C[NH]C2CCCCC12)C1CN2CCCC3CCCC1C23,UCEQXRCJXIVODC-PMACEKPBSA-N
TIVOZANIB,ASP-4130;AV-951;FOTIVDA;KIL-8951;KIL8951;KRN-951;TIVOZANIB,CHEMBL1289494,BRD:BRD-BRD-K53414658-001-08-2;BRD:BRD-K53414658-001-08-2;CTRP:418170;GDSC1:312,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,VEGFR INHIBITOR,FLT1;FLT4;KDR;KIT;PDGFRA;PDGFRB,,,PHASE 3,,Small molecule,4,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC;COC1CC2NCCC(OC3CCC(NC(=O)NC4CC(C)ON4)C(CL)C3)C2CC1OC,SPMVMDHWKHCIDT-UHFFFAOYSA-N
ZANAFLEX,TIZANIDINE;ZANAFLEX,CHEMBL1079,BRD:BRD-BRD-K06335600-003-20-7;BRD:BRD-K06335600-003-20-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C;NISCH,SPASMS,,LAUNCHED,,Small molecule,4,"Clc1ccc2nsnc2c1NC1=NCCN1;CLC1CCC2NSNC2C1NC1=NCCN1, CLC1CCC2NSNC2C1NC1=NCCN1, CLC1CCC2NSNC2C1NC1=NCCN1",XFYDIVBRZNQMJC-UHFFFAOYSA-N
TK216,TK216,,BRD:BRD-K00090646-001-01-9,rep_single_dose,,,,,,,,NA,,
TL-1-85,TL-1-85,,GDSC1:261,gdsc,,,,,,,,NA,,
TL-2-105,TL-2-105,,GDSC1:211,gdsc,,,,,,,,NA,,
TMC-353121,TMC-353121,,BRD:BRD-BRD-K66097663-001-01-8;BRD:BRD-K66097663-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,RSV FUSION INHIBITOR,,,,PHASE 2,,,NA,CC1CCC(CCCO)C(NCC2CCC3NC(NCCCN4CCOCC4)N(CC4NC(C)CCC4O)C3C2)C1,
TMC647055,TMC-647055;TMC647055,CHEMBL2043025,BRD:BRD-BRD-K49659468-436-01-2;BRD:BRD-K49659468-436-01-2,rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,,,,PHASE 2,,Small molecule,2,COC1CCC2-C3C(C4CCCCC4)C4CCC5CC4N3CC(=CC2C1)C(=O)N(C)CCOCCN(C)S(=O)(=O)NC5=O;COc1ccc2c(c1)C=C1Cn3c-2c(C2CCCCC2)c2ccc(cc23)C(=O)NS(=O)(=O)N(C)CCOCCN(C)C1=O,UOBYJVFBFSLCTQ-UHFFFAOYSA-N
TMN-355,TMN-355,,BRD:BRD-K24527118-001-02-9,rep_single_dose,CYCLOPHILIN INHIBITOR,PPIA,,,,,,NA,,
TMPH,TMPH,,BRD:BRD-BRD-K49119234-003-02-6;BRD:BRD-K49119234-003-02-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"CCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1, CCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1",
TMS,TMS,,BRD:BRD-BRD-K96233303-001-01-9;BRD:BRD-K96233303-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"COC1CCC(\C=C\C2CC(OC)CC(OC)C2)C(OC)C1, COC1CCC(\C=C\C2CC(OC)CC(OC)C2)C(OC)C1",
TMX-4116,TMX-4116,,BRD:BRD-K00093879-001-02-9,oncref_2,CK1A DEGRADER,CK1A;CRBN,,,,,,NA,,
TNP-470,AGM-1470;NSC-642492;O-CHLOROACETYLCARBAMOYLFUMAGILLOL;TNP-470,CHEMBL424278,BRD:BRD-BRD-K53597484-001-02-7;BRD:BRD-K53597484-001-02-7,rep_primary;rep_single_dose,METHIONINE AMINOPEPTIDASE INHIBITOR,METAP2,,,PHASE 2,,Small molecule,2,CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCL;CO[C@@H]1[C@H](OC(=O)NC(=O)CCl)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,MSHZHSPISPJWHW-PVDLLORBSA-N
TO901317,T0901317;T091317;TO-901317;TO901317,CHEMBL62136,GDSC1:333,gdsc,,,,,,,Small molecule,NA,O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,SGIWFELWJPNFDH-UHFFFAOYSA-N
VANTOBRA,47663;AKTOB;BETHKIS;BRAMITOB;KITABIS PAK;NEBCIN;NEBICIN;NEBRAMYCIN;NEBRAMYCIN FACTOR 6;NEBRAMYCIN VI;NEBRIS;NSC-180514;OBRAMYCIN;TOBI;TOBI PODHALER;TOBRADEX;TOBRADEX ST;TOBRALEX;TOBRAMYCIN;TOBRAVISC;TOBREX;TYMBRINEB;VANTOBRA,CHEMBL1747,BRD:BRD-BRD-K05619559-001-12-7;BRD:BRD-K05619559-001-12-7,rep_primary;rep_single_dose,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,,"BACTERIAL SEPTICEMIA, RESPIRATORY TRACT INFECTIONS, MENINGITIS, SKIN INFECTIONS, URINARY TRACT INFECTIONS",,LAUNCHED,,Small molecule,4,"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O, NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O;NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O",NLVFBUXFDBBNBW-PBSUHMDJSA-N
W-36095,TOCAINIDE;W-36095,CHEMBL1762,BRD:BRD-A92670106-003-05-4;BRD:BRD-BRD-A92670106-003-05-4,rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCN5A,CARDIAC ARRYTHMIA,,LAUNCHED,,Small molecule,4,CC(N)C(=O)NC1C(C)CCCC1C;Cc1cccc(C)c1NC(=O)C(C)N,BUJAGSGYPOAWEI-UHFFFAOYSA-N
TOCERANIB,PALLADIA;PHA-291639;TOCERANIB,CHEMBL13608,BRD:BRD-BRD-K62040061-001-01-0;BRD:BRD-K62040061-001-01-0;BRD:BRD-K62040061-011-02-7,rep_multi_dose;rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,FLT1;FLT3;KDR;PDGFRA;PDGFRB,"CUTANEOUS MAST CELL TUMORS, CUTANEOUS MAST CELL TUMORS",,LAUNCHED,,Small molecule,-1,"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1;CC1[NH]C(\C=C2/C(=O)NC3CCC(F)CC23)C(C)C1C(=O)NCCN1CCCC1, CC1[NH]C(\C=C2/C(=O)NC3CCC(F)CC23)C(C)C1C(=O)NCCN1CCCC1, CC1[NH]C(\C=C2/C(=O)NC3CCC(F)CC23)C(C)C1C(=O)NCCN1CCCC1",SRSGVKWWVXWSJT-ATVHPVEESA-N
TODRALAZINE HYDROCHLORIDE,BT 621 [AS HYDROCHLORIDE];CEPH [AS HYDROCHLORIDE];ECARAZINE HYDROCHLORIDE;NSC-757868;TODRALAZINE;TODRALAZINE HYDROCHLORIDE,CHEMBL1079787,BRD:BRD-BRD-K68553471-003-12-3;BRD:BRD-K68553471-003-12-3,rep_primary;rep_single_dose,ANTIHYPERTENSIVE AGENT,,,,LAUNCHED,,Small molecule,-1,CCOC(=O)NNc1nncc2ccccc12;CCOC(=O)NNC1NNCC2CCCCC12,WGZDBVOTUVNQFP-UHFFFAOYSA-N
TOFACITINIB,"550;CP 690550;CP- 690 550;CP-690;CP-690 FREE BASE;CP-690-550;CP-690,550;CP-690,550 FREE BASE;CP-690550;CP-690550 FREE BASE;CP690,550;CP690550;TASOCITINIB;TOFACITINIB",CHEMBL221959,BRD:BRD-BRD-K31283835-048-04-4;BRD:BRD-K31283835-048-04-4,rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2;JAK3;TYK2,RHEUMATOID ARTHRITIS,,LAUNCHED,,Small molecule,4,"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12;C[C@@H]1CCN(C[C@@H]1N(C)C1NCNC2[NH]CCC12)C(=O)CC#N, C[C@@H]1CCN(C[C@@H]1N(C)C1NCNC2[NH]CCC12)C(=O)CC#N, C[C@@H]1CCN(C[C@@H]1N(C)C1NCNC2[NH]CCC12)C(=O)CC#N",UJLAWZDWDVHWOW-YPMHNXCESA-N
TOFISOPAM,EMANDAXIN;TOFISOPAM,CHEMBL404216,BRD:BRD-BRD-K94830213-001-01-3;BRD:BRD-K94830213-001-01-3,rep_primary;rep_single_dose,"PHOSPHODIESTERASE INHIBITOR, CYTOCHROME P450 INHIBITOR",CYP3A4;PDE10A;PDE2A;PDE3A;PDE4A,"ANXIETY, ABSTINENCE FROM ALCOHOL",,LAUNCHED,"Multiple values for MOA: {'CYTOCHROME P450 INHIBITOR, PHOSPHODIESTERASE INHIBITOR', 'PHOSPHODIESTERASE INHIBITOR, CYTOCHROME P450 INHIBITOR'}, defaulting to 'PHOSPHODIESTERASE INHIBITOR, CYTOCHROME P450 INHIBITOR'",Small molecule,-1,CCC1=C(C)NN=C(C2CCC(OC)C(OC)C2)C2CC(OC)C(OC)CC12;CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21,RUJBDQSFYCKFAA-UHFFFAOYSA-N
TOFOGLIFLOZIN MONOHYDRATE,CSG 452;CSG-452;CSG452;R-7201;RO-4998452;RO4998452;TOFOGLIFLOZIN;TOFOGLIFLOZIN HYDRATE;TOFOGLIFLOZIN MONOHYDRATE,CHEMBL2105711;CHEMBL2110731,BRD:BRD-BRD-K96344439-002-02-7;BRD:BRD-K96344439-002-02-7,rep_multi_dose;rep_primary;rep_single_dose,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,GCK,"DIABETES MELLITUS, DIABETES MELLITUS",,LAUNCHED,,Small molecule,3,"CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1.O;CCC1CCC(CC2CCC3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3C2)CC1, CCC1CCC(CC2CCC3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3C2)CC1",ZXOCGDDVNPDRIW-NHFZGCSJSA-N
TOLAMOLOL,TOLAMOLOL,CHEMBL418192,BRD:BRD-A60498477-001-01-2;BRD:BRD-BRD-A60498477-001-01-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB1;ADRB2;ADRB3,,,PHASE 3,,Small molecule,-1,Cc1ccccc1OCC(O)CNCCOc1ccc(C(N)=O)cc1;CC1CCCCC1OCC(O)CNCCOC1CCC(CC1)C(N)=O,SKQDKFOTIPJUSV-UHFFFAOYSA-N
U-17835,NSC-70762;TOLAZAMIDE;TOLINASE;U-17835,CHEMBL817,BRD:BRD-BRD-K32164935-001-30-8;BRD:BRD-K32164935-001-30-8,rep_primary;rep_single_dose,ATP CHANNEL BLOCKER,ABCC8;KCNJ1;KCNJ10;KCNJ11,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CC1CCC(CC1)S(=O)(=O)NC(=O)NN1CCCCCC1, CC1CCC(CC1)S(=O)(=O)NC(=O)NN1CCCCCC1, CC1CCC(CC1)S(=O)(=O)NC(=O)NN1CCCCCC1;Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1",OUDSBRTVNLOZBN-UHFFFAOYSA-N
TOLAZOLINE,NSC-35110;PRISCOLINE;TOLAZINE;TOLAZOLINE,CHEMBL770,BRD:BRD-BRD-K46211610-003-26-7;BRD:BRD-K46211610-003-26-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA2A;ADRA2B;ADRA2C;HRH1;HRH2,REVERSE SEDATIVE,,LAUNCHED,,Small molecule,4,"C(C1=NCCN1)C1CCCCC1, C(C1=NCCN1)C1CCCCC1;c1ccc(CC2=NCCN2)cc1",JIVZKJJQOZQXQB-UHFFFAOYSA-N
WILLBUTAMIDE,1-BUTYL-3-(P-TOLYLSULFONYL)UREA;ARKOZAL;BUTAMIDE;DIABETAMID;GLYCONON;IPOGLICONE;NSC-23813;NSC-87833;ORINASE;PRAMIDEX;RASTINON;TOLBUTAMIDE;TOLBUTAMIDUM;WILLBUTAMIDE,CHEMBL782,BRD:BRD-BRD-K85119730-001-28-9;BRD:BRD-K85119730-001-28-9,rep_primary;rep_single_dose,ATP CHANNEL BLOCKER,ABCC8;KCNJ1;KCNJ11;KCNJ8,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1;CCCCNC(=O)NS(=O)(=O)C1CCC(C)CC1, CCCCNC(=O)NS(=O)(=O)C1CCC(C)CC1",JLRGJRBPOGGCBT-UHFFFAOYSA-N
TOLCAPONE,RO 40-7592;RO-40-7592;RO-407592;TASMAR;TOLCAPONE,CHEMBL1324,BRD:BRD-BRD-K10852020-001-04-5;BRD:BRD-BRD-K10852020-001-05-2;BRD:BRD-K10852020-001-04-5;BRD:BRD-K10852020-001-05-2,rep_primary;rep_single_dose,CATECHOL O METHYLTRANSFERASE INHIBITOR,COMT,,,WITHDRAWN,,Small molecule,4,"Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1;CC1CCC(CC1)C(=O)C1CC(O)C(O)C(C1)[N+]([O-])=O, CC1CCC(CC1)C(=O)C1CC(O)C(O)C(C1)[N+]([O-])=O",MIQPIUSUKVNLNT-UHFFFAOYSA-N
TOLFENAMIC-ACID,TOLFENAMIC-ACID,,BRD:BRD-BRD-K50133271-001-18-7;BRD:BRD-K50133271-001-18-7,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",,MIGRAINE HEADACHE,,LAUNCHED,,,NA,"CC1C(CL)CCCC1NC1CCCCC1C(O)=O, CC1C(CL)CCCC1NC1CCCCC1C(O)=O",
TOLIMIDONE,"CP-26,154;CP-26154;MLR-1023;NSC-314335;TOLIMIDONE",CHEMBL8030,BRD:BRD-BRD-K41772907-001-01-2;BRD:BRD-K41772907-001-01-2,rep_primary;rep_single_dose,SRC ACTIVATOR,LYN;SRC,,,PHASE 2,,Small molecule,2,"Cc1cccc(Oc2cnc(=O)[nH]c2)c1;CC1CCCC(OC2CNC(=O)[NH]C2)C1, CC1CCCC(OC2CNC(=O)[NH]C2)C1",HJQILFPVRNHTIG-UHFFFAOYSA-N
TOLMETIN,MCN-2559;TOLECTIN;TOLMETIN,CHEMBL1020,BRD:BRD-BRD-K82562631-236-04-6;BRD:BRD-K82562631-236-04-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"RHEUMATOID ARTHRITIS, OSTEOARTHRITIS",,LAUNCHED,,Small molecule,4,"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1;CC1CCC(CC1)C(=O)C1CCC(CC(O)=O)N1C, CC1CCC(CC1)C(=O)C1CCC(CC(O)=O)N1C",UPSPUYADGBWSHF-UHFFFAOYSA-N
TRITIN,AFTATE;DR. SCHOLL'S ATHLETE'S FOOT SPRAY;MYCIL;NSC-233648;SCH 10144;SCH-10144;SEPARIN;TIMOPED;TINACTIN;TINADERM;TINADERM PLUS;TINEAFAX;TOLNAFTATE;TRITIN,CHEMBL83668,BRD:BRD-BRD-K44273375-001-25-0;BRD:BRD-K44273375-001-25-0,rep_primary;rep_single_dose,FUNGAL SQUALENE EPOXIDASE INHIBITOR,,"TINEA PEDIS, TINEA CORPORIS",,LAUNCHED,,Small molecule,4,"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1;CN(C(=S)OC1CCC2CCCCC2C1)C1CCCC(C)C1, CN(C(=S)OC1CCC2CCCCC2C1)C1CCCC(C)C1",FUSNMLFNXJSCDI-UHFFFAOYSA-N
TOLONIDINE,ST 375;ST-375;TOLONIDINE,CHEMBL304253,BRD:BRD-BRD-K82687598-001-01-6;BRD:BRD-K82687598-001-01-6,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A,,,LAUNCHED,,Small molecule,-1,Cc1ccc(NC2=NCCN2)c(Cl)c1;CC1CCC(NC2=NCCN2)C(CL)C1,KWBTZIFLQYYPTH-UHFFFAOYSA-N
TOLONIUM ION,TOLONIUM;TOLONIUM CATION;TOLONIUM ION,CHEMBL1197206;CHEMBL1622638,BRD:BRD-K94882685-003-10-0,rep_single_dose,,,,,,,Small molecule,1,Cc1cc2nc3ccc(N(C)C)cc3[s+]c2cc1N,RQNADZJRELIICT-UHFFFAOYSA-N
TOLOXATONE,HUMORYL;TOLOXATONE,CHEMBL18116,BRD:BRD-A67182178-001-01-7;BRD:BRD-BRD-A67182178-001-01-7,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,MAOA;MAOB,DEPRESSION,,LAUNCHED,,Small molecule,-1,CC1CCCC(C1)N1CC(CO)OC1=O;Cc1cccc(N2CC(CO)OC2=O)c1,MXUNKHLAEDCYJL-UHFFFAOYSA-N
TOLPERISONE HYDROCHLORIDE,MYDETON;N-553 [AS HYDROCHLORIDE];N-553 FREE BASE;NSC-107321;TOLPERISONE;TOLPERISONE HYDROCHLORIDE,CHEMBL1076211,BRD:BRD-A27732521-003-08-3;BRD:BRD-BRD-A27732521-003-08-3,rep_primary;rep_single_dose,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,CYP2C19;CYP2D6,"MUSCLE RELAXANT, MULTIPLE SCLEROSIS, ENCEPHALOMYELITIS, ANKYLOSING SPONDYLITIS, ATHEROSCLEROSIS, RAYNAUD'S DISEASE",,LAUNCHED,,Small molecule,3,"CC(CN1CCCCC1)C(=O)C1CCC(C)CC1, CC(CN1CCCCC1)C(=O)C1CCC(C)CC1;Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1",FSKFPVLPFLJRQB-UHFFFAOYSA-N
TOLRESTAT,"ALDERASE;ALREDASE;AY-27,773;AY-27773;TOLRESTAT",CHEMBL436,BRD:BRD-BRD-K85693895-001-02-9;BRD:BRD-K85693895-001-02-9,rep_primary;rep_single_dose,ALDOSE REDUCTASE INHIBITOR,AKR1A1;AKR1B1;AKR1B10,,,WITHDRAWN,,Small molecule,4,"COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F;COC1CCC2C(CCCC2C1C(F)(F)F)C(=S)N(C)CC(O)=O, COC1CCC2C(CCCC2C1C(F)(F)F)C(=S)N(C)CC(O)=O, COC1CCC2C(CCCC2C1C(F)(F)F)C(=S)N(C)CC(O)=O",LUBHDINQXIHVLS-UHFFFAOYSA-N
TOLTERODINE,BLERONE XL;DETRUSITOL;DETRUSITOL XL;EFFLOSOMYL XL;INCONEX XL;KABI 2234;KABI-2234;MARIOSEA XL;NEDITOL XL;PREBLACON XL;SANTIZOR XL;TOLTERODINE,CHEMBL1382,BRD:BRD-BRD-K54316499-046-04-5;BRD:BRD-K54316499-046-04-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,"URINARY INCONTINENCE, URINARY FREQUENCY",,LAUNCHED,,Small molecule,4,"CC(C)N(CC[C@H](C1CCCCC1)C1CC(C)CCC1O)C(C)C, CC(C)N(CC[C@H](C1CCCCC1)C1CC(C)CCC1O)C(C)C, CC(C)N(CC[C@H](C1CCCCC1)C1CC(C)CCC1O)C(C)C;Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1",OOGJQPCLVADCPB-HXUWFJFHSA-N
TOLTRAZURIL,BAY VI 9142;BAY-VI-9142;NSC-759176;TOLTRAZURIL,CHEMBL2104931,BRD:BRD-BRD-K64514229-001-05-2;BRD:BRD-K64514229-001-05-2,rep_primary;rep_single_dose,ANTIPROTOZOAL AGENT,,COCCIDIOSIS,,LAUNCHED,,Small molecule,-1,"Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(SC(F)(F)F)cc1;CC1CC(CCC1OC1CCC(SC(F)(F)F)CC1)-N1C(=O)[NH]C(=O)N(C)C1=O, CC1CC(CCC1OC1CCC(SC(F)(F)F)CC1)-N1C(=O)[NH]C(=O)N(C)C1=O",OCINXEZVIIVXFU-UHFFFAOYSA-N
TOLVAPTAN,JINARC;JYNARQUE;OPC-41061;OPC-41061(TOLVAPTAN);SAMSCA;TOLVAPTAN,CHEMBL344159,BRD:BRD-A82035391-001-02-7;BRD:BRD-BRD-A82035391-001-02-7,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR ANTAGONIST,AVPR1A;AVPR2,"HYPONATREMIA, CONGESTIVE HEART FAILURE, HEPATIC CIRRHOSIS",,LAUNCHED,,Small molecule,4,"CC1CCCCC1C(=O)NC1CCC(C(=O)N2CCCC(O)C3CC(CL)CCC23)C(C)C1, CC1CCCCC1C(=O)NC1CCC(C(=O)N2CCCC(O)C3CC(CL)CCC23)C(C)C1;Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1",GYHCTFXIZSNGJT-UHFFFAOYSA-N
TOMEGLOVIR,BAY-384766;TOMEGLOVIR,CHEMBL1242035,BRD:BRD-K00003487-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,-1,CN(C)c1cccc2c(S(=O)(=O)Nc3ccc(NC(=O)C(C)(C)CO)cc3)cccc12,OSQAKHSYTKBSPB-UHFFFAOYSA-N
TOMELUKAST,LY-171833;LY-171883;LY171883;TOMELUKAST,CHEMBL162358,BRD:BRD-BRD-K74765201-001-16-7;BRD:BRD-K74765201-001-16-7,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,CYSLTR1,,,PHASE 3,,Small molecule,-1,CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O;CCCC1C(OCCCCC2NNN[NH]2)CCC(C(C)=O)C1O,MWYHLEQJTQJHSS-UHFFFAOYSA-N
TOMIVOSERTIB,EFT 508;EFT-508;EFT508;TOMIVOSERTIB,CHEMBL4073443,BRD:BRD-K00003361-001-01-9,rep_single_dose,MAPK-INTERACTING KINASE INHIBITOR,,,,,,Small molecule,2,Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1,HKTBYUWLRDZAJK-UHFFFAOYSA-N
TONABERSAT,SB-220453;TONABERSAT,CHEMBL318191,BRD:BRD-BRD-K36970462-001-01-6;BRD:BRD-K36970462-001-01-6,rep_primary;rep_single_dose,"GAP JUNCTION MODULATOR, NITRIC OXIDE PRODUCTION INHIBITOR",,,,PHASE 2,,Small molecule,2,CC(=O)c1ccc2c(c1)[C@H](NC(=O)c1ccc(F)c(Cl)c1)[C@H](O)C(C)(C)O2;CC(=O)C1CCC2OC(C)(C)[C@@H](O)[C@@H](NC(=O)C3CCC(F)C(CL)C3)C2C1,XLIIRNOPGJTBJD-ROUUACIJSA-N
TOPILUTAMIDE,BP-766;FLURIDIL;TOPILUTAMIDE,CHEMBL2107790,BRD:BRD-K00003325-001-01-9,rep_single_dose,ANDROGEN RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,CC(O)(CNC(=O)C(F)(F)F)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,YCNCRLKXSLARFT-UHFFFAOYSA-N
USL255,(-)-TOPIRAMATE;EPITOMA;EPITOMAX;EPRONTIA;MCN-4853;QUDEXY;QUDEXY XR;RWJ-17021;RWJ-17021-000;SINCRONIL;TOPAMAC;TOPAMAX;TOPAMAX SPRINKLE;TOPIMAX;TOPINA;TOPIRAMATE;TOPOMAX;TROKENDI XR;USL-255;USL255,CHEMBL220492,BRD:BRD-BRD-K29653726-001-13-4;BRD:BRD-K29653726-001-13-4,rep_primary;rep_single_dose,"CARBONIC ANHYDRASE INHIBITOR, GLUTAMATE RECEPTOR ANTAGONIST, KAINATE RECEPTOR ANTAGONIST",CA1;CA12;CA2;CA4;CA7;GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GRIA1;GRIA2;GRIA3;GRIA4;GRIK1;GRIK2;GRIK3;GRIK4;GRIK5;SCN10A;SCN11A;SCN1A;SCN2A;SCN3A;SCN4A;SCN5A;SCN7A;SCN8A;SCN9A,"EPILEPSY, MIGRAINE HEADACHE",,LAUNCHED,,Small molecule,4,"CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1;CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1, CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1, CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1, CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1",KJADKKWYZYXHBB-XBWDGYHZSA-N
TOPIROXOSTAT,FYX-051;TOPIROXOSTAT,CHEMBL1078685,BRD:BRD-BRD-K77561571-001-01-1;BRD:BRD-K77561571-001-01-1,rep_primary;rep_single_dose,XANTHINE OXIDASE INHIBITOR,XDH,"GOUT, HYPERURICEMIA",,LAUNCHED,,Small molecule,2,N#Cc1cc(-c2n[nH]c(-c3ccncc3)n2)ccn1;N#CC1CC(CCN1)-C1N[NH]C(N1)-C1CCNCC1,UBVZQGOVTLIHLH-UHFFFAOYSA-N
TOPOTECAN TEVA,EVOTOPIN;FF-10850 (LIPOSOMAL TOPOTECAN);HYCAMPTAMINE;HYCAMPTIN;HYCAMTIN;NOGITECAN;NOGITECAN HYDROCHLORIDE;NSC-609699;NSC-641007;NSC-759263;POTACTASOL;SK-S-104864-A;SK&F S-104864-A;SK&F-S-104864A;SKF-104864;TOPOTECAN;TOPOTECAN (AS HYDROCHLORIDE);TOPOTECAN ACTAVIS;TOPOTECAN HCL;TOPOTECAN HOSPIRA;TOPOTECAN HYDROCHLORIDE;TOPOTECAN TEVA,CHEMBL1607;CHEMBL84,BRD:BRD-BRD-K55696337-003-24-4;BRD:BRD-K55696337-003-24-4;CTRP:44580;GDSC2:1808,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP1;TOP1MT,"SMALL CELL LUNG CANCER, CERVICAL CANCER",,LAUNCHED,,Small molecule,4,"CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCC(O)C(CN(C)C)C4CC3CN1C2=O, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCC(O)C(CN(C)C)C4CC3CN1C2=O, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCC(O)C(CN(C)C)C4CC3CN1C2=O, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCC(O)C(CN(C)C)C4CC3CN1C2=O, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCC(O)C(CN(C)C)C4CC3CN1C2=O, CC[C@@]1(O)C(=O)OCC2C1CC1-C3NC4CCC(O)C(CN(C)C)C4CC3CN1C2=O;CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1.Cl",DGHHQBMTXTWTJV-BQAIUKQQSA-N
UPCARD,AC-4464;AC4464;BM-02.015;BM-02015;BM02.015;DEMADEX;LUPRAC;SOAANZ;TORASEMIDE;TORASEMIDE ANHYDROUS;TOREM 10;TOREM 2.5;TOREM 5;TORSEMIDE;UPCARD,CHEMBL1148,BRD:BRD-BRD-K30480208-001-18-5;BRD:BRD-K30480208-001-18-5,rep_multi_dose;rep_primary;rep_single_dose,"ELECTROLYTE REABSORPTION INHIBITOR, THROMBOXANE RECEPTOR ANTAGONIST",SLC12A1,"EDEMA, CONGESTIVE HEART FAILURE, HYPERTENSION",,LAUNCHED,,Small molecule,4,"CC(C)NC(=O)NS(=O)(=O)C1CNCCC1NC1CCCC(C)C1, CC(C)NC(=O)NS(=O)(=O)C1CNCCC1NC1CCCC(C)C1;Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1",NGBFQHCMQULJNZ-UHFFFAOYSA-N
TORCETRAPIB,"CP-529,414;CP-529414;TORCETRAPIB",CHEMBL479527,BRD:BRD-BRD-K55675242-001-03-0;BRD:BRD-K55675242-001-03-0,rep_multi_dose;rep_primary;rep_single_dose,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,CETP,,,PHASE 3,,Small molecule,3,"CCOC(=O)N1[C@H](CC)C[C@H](N(CC2CC(CC(C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C2CC(CCC12)C(F)(F)F, CCOC(=O)N1[C@H](CC)C[C@H](N(CC2CC(CC(C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C2CC(CCC12)C(F)(F)F;CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC",CMSGWTNRGKRWGS-NQIIRXRSSA-N
TORCITABINE,NV-02C;TORCITABINE,CHEMBL554563,BRD:BRD-BRD-K91822704-003-07-2;BRD:BRD-K91822704-003-07-2,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,DCK;TK2,,,PHASE 2,,Small molecule,-1,Nc1ccn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)n1;NC1CCN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)N1,CKTSBUTUHBMZGZ-CHKWXVPMSA-N
TOREMIPHENE,ACAPODENE;CHLORTAMOXIFEN;FARESTONE;GTX-006;J33.157K;TOREMIFENE;TOREMIPHENE,CHEMBL1655,BRD:BRD-BRD-K51350053-048-16-5;BRD:BRD-K51350053-048-16-5,rep_multi_dose;rep_primary;rep_single_dose,"ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",ESR1,BREAST CANCER,,LAUNCHED,,Small molecule,4,"CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1;CN(C)CCOC1CCC(CC1)C(\C1CCCCC1)=C(\CCCL)C1CCCCC1, CN(C)CCOC1CCC(CC1)C(\C1CCCCC1)=C(\CCCL)C1CCCCC1, CN(C)CCOC1CCC(CC1)C(\C1CCCCC1)=C(\CCCL)C1CCCCC1",XFCLJVABOIYOMF-QPLCGJKRSA-N
TORIN 2,TORIN 2,,GDSC1:371,gdsc,,,,,,,,NA,,
TORIN-1,TORIN-1,,BRD:BRD-BRD-K40175214-001-11-6;BRD:BRD-K40175214-001-11-6,rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PRECLINICAL,,,NA,"CCC(=O)N1CCN(CC1)C1CCC(CC1C(F)(F)F)-N1C2C(CCC1=O)CNC1CCC(CC21)-C1CNC2CCCCC2C1, CCC(=O)N1CCN(CC1)C1CCC(CC1C(F)(F)F)-N1C2C(CCC1=O)CNC1CCC(CC21)-C1CNC2CCCCC2C1",
TORIN-2,TORIN-2,,BRD:BRD-BRD-K68174511-001-06-6;BRD:BRD-K68174511-001-06-6,rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PRECLINICAL,,,NA,"NC1CCC(CN1)-C1CCC2NCC3CCC(=O)N(-C4CCCC(C4)C(F)(F)F)C3C2C1, NC1CCC(CN1)-C1CCC2NCC3CCC(=O)N(-C4CCCC(C4)C(F)(F)F)C3C2C1",
TORISEL,CCI-779;TEMSIROLIMUS;TORISEL,CHEMBL1201182,GDSC1:1016;GDSC1:3;GDSC2:1084,gdsc,,,,,,,Small molecule,4,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,CBPNZQVSJQDFBE-FUXHJELOSA-N
TOSEDOSTAT,CHR 2797;CHR-2797;TOSEDOSTAT,CHEMBL2103847,BRD:BRD-BRD-K92241597-001-06-0;BRD:BRD-K92241597-001-06-0;CTRP:417987,ctrp;rep_multi_dose;rep_primary;rep_single_dose,PEPTIDASE INHIBITOR,ANPEP;LAP3;NPEPPS,,,PHASE 2,,Small molecule,2,"CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO;CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C1CCCCC1, CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C1CCCCC1, CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C1CCCCC1, CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C1CCCCC1",FWFGIHPGRQZWIW-SQNIBIBYSA-N
TOSUFLOXACIN TOSILATE,A 61827;A 67107;A-61827;A-67107;ABBOTT 61827;ABBOTT-61827;OZEX;TOSUFLOXACIN;TOSUFLOXACIN TOSILATE,CHEMBL273348,BRD:BRD-A41450521-075-10-8;BRD:BRD-BRD-A41450521-075-10-8,rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,,GRAM-NEGATIVE BACTERIAL INFECTIONS,,LAUNCHED,,Small molecule,-1,"NC1CCN(C1)C1NC2N(CC(C(O)=O)C(=O)C2CC1F)-C1CCC(F)CC1F, NC1CCN(C1)C1NC2N(CC(C(O)=O)C(=O)C2CC1F)-C1CCC(F)CC1F;NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1",WUWFMDMBOJLQIV-UHFFFAOYSA-N
TOVOK,AFATINIB;AFATINIB DIMALEATE;AFATINIB MALEATE;BIBW 2992;BIBW-2992;BIBW-2992 MA2;BIBW-2992-MA2;BIBW-2992MA2;BIBW2992;BIBW2992 MA2;BIBW2992-MA2;GILOTRIF;GIOTRIF;NSC-750691;TOMTOVOK;TOVOK,CHEMBL1173655;CHEMBL2105712,GDSC1:1032;GDSC1:1377;GDSC2:1032,gdsc,,,,,,,Small molecule,4,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1;CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,ULXXDDBFHOBEHA-CWDCEQMOSA-N;USNRYVNRPYXCSP-JUGPPOIOSA-N
TOYOCAMYCIN,TOYOCAMYCIN,CHEMBL99668,BRD:BRD-BRD-K26420709-001-01-7;BRD:BRD-K26420709-001-01-7,rep_primary;rep_single_dose,SERINE/THREONINE KINASE INHIBITOR,ERN1,,,PHASE 1,,Small molecule,NA,N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12;NC1NCNC2N(CC(C#N)C12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,XOKJUSAYZUAMGJ-WOUKDFQISA-N
TOZADENANT,A-2A (3);A2A (3);A2A-(3);RO-4494351;RO-4494351-000;RO-4494351-002;RO-4494351000;RO4494351;RO4494351-000;RO4494351-002;SYN-115;SYN115;TOZADENANT,CHEMBL2105747,BRD:BRD-BRD-K93045741-001-01-0;BRD:BRD-K93045741-001-01-0,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA2A,,,PHASE 3,,Small molecule,3,COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12;COC1CCC(N2CCOCC2)C2SC(NC(=O)N3CCC(C)(O)CC3)NC12,XNBRWUQWSKXMPW-UHFFFAOYSA-N
VX-680,MK-045;MK-0457;TOZASERTIB;VX-68;VX-680,CHEMBL572878,BRD:BRD-BRD-K59369769-001-20-3;BRD:BRD-K59369769-001-20-3;GDSC1:32;GDSC2:1096,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"AURORA KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR, FLT3 INHIBITOR, JAK INHIBITOR",AURKA;AURKB;AURKC;LCK,,,PHASE 2,,Small molecule,2,"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1;CN1CCN(CC1)C1CC(NC2CC(C)[NH]N2)NC(SC2CCC(NC(=O)C3CC3)CC2)N1, CN1CCN(CC1)C1CC(NC2CC(C)[NH]N2)NC(SC2CCC(NC(=O)C3CC3)CC2)N1",GCIKSSRWRFVXBI-UHFFFAOYSA-N
TP-003,TP-003,,BRD:BRD-K87941707-001-02-9,rep_single_dose,GABA RECEPTOR INVERSE AGONIST,GABRA1;GABRA2;GABRA3;GABRA5,,,,,,NA,,
TP0903,DUBERMATINIB;HCL-2084;TP 0903;TP-0903;TP0903,CHEMBL2022968,BRD:BRD-BRD-K84034737-001-01-1;BRD:BRD-K84034737-001-01-1,rep_primary;rep_single_dose,AXL KINASE INHIBITOR,AXL,,,PRECLINICAL,,Small molecule,1,CN(C)S(=O)(=O)C1CCCCC1NC1NC(NC2CCC(CN3CCN(C)CC3)CC2)NCC1CL;CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1,YUAALFPUEOYPNX-UHFFFAOYSA-N
TP-3654,SGI-9481;TP-3654,CHEMBL3975308,BRD:BRD-K00005239-001-01-9,rep_single_dose,"1,4,5-TRISPHOSPHATE INHIBITOR",,,,,,Small molecule,1,CC(C)(O)[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(C(F)(F)F)c4)n3n2)CC1,XRNVABDYQLHODA-JCNLHEQBSA-N
TPCA-1,TPCA-1,,BRD:BRD-BRD-K51575138-001-13-2;BRD:BRD-K51575138-001-13-2;CTRP:375564;GDSC1:305,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,IKK INHIBITOR,IKBKB,,,PRECLINICAL,,,NA,"NC(=O)NC1SC(CC1C(N)=O)-C1CCC(F)CC1, NC(=O)NC1SC(CC1C(N)=O)-C1CCC(F)CC1, NC(=O)NC1SC(CC1C(N)=O)-C1CCC(F)CC1",
TPPS4,TPPS4,,BRD:BRD-BRD-K39805756-001-01-6;BRD:BRD-K39805756-001-01-6,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,OS(=O)(=O)C1CCC(CC1)-C1C2CCC(N2)C(-C2CCC(CC2)S(O)(=O)=O)C2CCC([NH]2)C(-C2CCC(CC2)S(O)(=O)=O)C2CCC(N2)C(-C2CCC(CC2)S(O)(=O)=O)C2CCC1[NH]2,
YONDELIS,ECTEINASCIDIN 743;ECTEINASCIDINS TRABECTEDIN;ET-743;NSC-648766;TRABECTEDIN;YONDELIS,CHEMBL1224207;CHEMBL450449,BRD:BRD-K00003313-001-01-9,rep_single_dose,ANTITUMOR AGENT,,,,,,Small molecule,4,COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(C)c(OC)c3O)C[C@@H]([C@@H]1O)N2C)OCO4,PKVRCIRHQMSYJX-AIFWHQITSA-N
TRABODENOSON,INNO-8875;INO-8875;PJ-875;TRABODENOSON,CHEMBL3545407,BRD:BRD-K00004698-001-01-9,rep_single_dose,ADENOSINE RECEPTOR AGONIST,,,,,,Small molecule,3,O=[N+]([O-])OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O,AQLVRTWKJDTWQQ-SDBHATRESA-N
TRACAZOLATE,"ICI 136,753;ICI-136,753;ICI-136753;TRACAZOLATE",CHEMBL84567,BRD:BRD-BRD-K34154330-003-06-4;BRD:BRD-K34154330-003-06-4,rep_primary;rep_single_dose,GABA RECEPTOR MODULATOR,GABRA1,,,PHASE 2,,Small molecule,-1,CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC;CCCCNC1C(C(=O)OCC)C(C)NC2N(CC)NCC12,PCTRYMLLRKWXGF-UHFFFAOYSA-N
VLY-686,LY-686017;LY686017;TRADIPITANT;VLY-686,CHEMBL3544984,BRD:BRD-K00003222-001-01-9,rep_single_dose,NEUROKININ RECEPTOR ANTAGONIST,,,,,,Small molecule,3,O=C(c1ccccc1Cl)c1cccnc1-c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1,CAVRKWRKTNINFF-UHFFFAOYSA-N
TRAM-39,TRAM-39,,BRD:BRD-K81341251-001-02-9,rep_single_dose,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,KCNN4,,,,,,NA,,
ULTRAM,AMANDA;CG-315E;E-265;ETS-6103;ETS6103;TRAMADOL;U-26255A;ULTRACET;ULTRAM,CHEMBL1237044,BRD:BRD-BRD-K51033547-003-02-6;BRD:BRD-K51033547-003-02-6,rep_primary;rep_single_dose,"NOREPINEPHRINE REPUTAKE INHIBITOR, OPIOID RECEPTOR AGONIST, SEROTONIN REUPTAKE INHIBITOR",CHRFAM7A;CHRM3;GRIN3A;HTR2C;OPRD1;OPRK1;OPRM1;SLC6A2;SLC6A4,"ACUTE PAIN, CHRONIC PAIN",,LAUNCHED,,Small molecule,4,COC1CCCC(C1)[C@]1(O)CCCC[C@H]1CN(C)C;COc1cccc(C2(O)CCCCC2CN(C)C)c1,TVYLLZQTGLZFBW-UHFFFAOYSA-N
TRAMIPROSATE,3-AMINOPROPANE SULFONIC ACID;ACAMPROSATE RELATED COMPOUND A;HOMOTAURINE;NC-758;NSC-77071;TRAMIPROSATE,CHEMBL149082,BRD:BRD-BRD-K82234479-001-09-4;BRD:BRD-K82234479-001-09-4,rep_primary;rep_single_dose,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,APP,,,PHASE 3,,Small molecule,3,NCCCS(=O)(=O)O;NCCCS(O)(=O)=O,SNKZJIOFVMKAOJ-UHFFFAOYSA-N
TRANDOLAPRIL,GOPTEN;INDOLAPRIL;MAVIK;NSC-758939;ODRIK;RU 44570;RU-44570;TRANDOLAPRIL,CHEMBL1519,BRD:BRD-A32505112-001-04-4;BRD:BRD-BRD-A32505112-001-04-4,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,"HYPERTENSION, MYOCARDIAL INFARCTION",,LAUNCHED,,Small molecule,4,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21;CCOC(=O)[C@H](CCC1CCCCC1)N[C@H](C)C(=O)N1C2CCCCC2C[C@H]1C(O)=O,VXFJYXUZANRPDJ-WTNASJBWSA-N
TRANEXAMIC-ACID,TRANEXAMIC-ACID,,BRD:BRD-BRD-K15014948-001-10-3;BRD:BRD-K15014948-001-10-3,rep_primary;rep_single_dose,"ANTIFIBRINOLYTIC, PLASMINOGEN ACTIVATOR INHIBITOR",PLG,HEMOPHILIA,,LAUNCHED,,,NA,"NC[C@H]1CC[C@@H](CC1)C(O)=O, NC[C@H]1CC[C@@H](CC1)C(O)=O, NC[C@H]1CC[C@@H](CC1)C(O)=O, NC[C@H]1CC[C@@H](CC1)C(O)=O, NC[C@H]1CC[C@@H](CC1)C(O)=O",
TRANILAST,MK-341;NSC-758970;RIZABEN;TRANILAST,CHEMBL415324,BRD:BRD-BRD-K17849083-001-31-1;BRD:BRD-BRD-K17849083-001-32-9;BRD:BRD-K17849083-001-31-1;BRD:BRD-K17849083-001-32-9,rep_multi_dose;rep_primary;rep_single_dose,ANGIOGENESIS INHIBITOR,HPGDS;HRH1,ASTHMA,,LAUNCHED,,Small molecule,3,"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC;COC1CCC(\C=C\C(=O)NC2CCCCC2C(O)=O)CC1OC, COC1CCC(\C=C\C(=O)NC2CCCCC2C(O)=O)CC1OC, COC1CCC(\C=C\C(=O)NC2CCCCC2C(O)=O)CC1OC, COC1CCC(\C=C\C(=O)NC2CCCCC2C(O)=O)CC1OC, COC1CCC(\C=C\C(=O)NC2CCCCC2C(O)=O)CC1OC",NZHGWWWHIYHZNX-CSKARUKUSA-N
"TRANS-10,CIS-12-CONJUGATED-LINOLEIC-ACID","TRANS-10,CIS-12-CONJUGATED-LINOLEIC-ACID",,BRD:BRD-BRD-K26222048-001-01-7;BRD:BRD-K26222048-001-01-7,rep_primary;rep_single_dose,,,,,LAUNCHED,,,NA,CCCCC\C=C/C=C/CCCCCCCCC(O)=O,
TRANS-2-UNDECENOIC-ACID,TRANS-2-UNDECENOIC-ACID,,BRD:BRD-BRD-K42959922-001-01-5;BRD:BRD-K42959922-001-01-5,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CCCCCCCC\C=C\C(O)=O,
TRANS-4-HYDROXYCROTONIC-ACID,TRANS-4-HYDROXYCROTONIC-ACID,,BRD:BRD-BRD-K91614056-001-02-2;BRD:BRD-K91614056-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,GAMMA HYDROXYBUTYRIC ACID LIGAND,,,,PRECLINICAL,,,NA,OC\C=C\C(O)=O,
TRANS-4-METHOXYCINNAMIC-ACID,TRANS-4-METHOXYCINNAMIC-ACID,,BRD:BRD-BRD-K26273521-001-07-3;BRD:BRD-K26273521-001-07-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,COC1CCC(CC1)\C=C\C(O)=O,
"TRANS-4-[8-(3-FLUOROPHENYL)-1,7-NAPHTHYRIDIN-6-YL]CYCLOHEXANECARBOXYLIC-ACID","TRANS-4-[8-(3-FLUOROPHENYL)-1,7-NAPHTHYRIDIN-6-YL]CYCLOHEXANECARBOXYLIC-ACID",,BRD:BRD-BRD-K75080769-001-01-6;BRD:BRD-K75080769-001-01-6,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC(=O)C1CCC(CC1)C1CC2CCCNC2C(N1)-C1CCCC(F)C1,
TRANSCROCETINIC ACID,"8,8-DIAPOCAROTENEDIOIC ACID;CI 75100;CI-75100;CROCETIN;LEAF-4L6715;LEAF-4L7520;NSC-407300;TRANS-CROCETIN;TRANSCROCETIN;TRANSCROCETINATE;TRANSCROCETINIC ACID",CHEMBL464792,BRD:BRD-K00003217-304-01-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,,,,,,Small molecule,3,CC(/C=C/C=C(\C)C(=O)O)=C\C=C\C=C(C)\C=C\C=C(/C)C(=O)O,PANKHBYNKQNAHN-MQQNZMFNSA-N
TRANYLCYPROMINE,NSC-80664;TRANYLCYPROMINE,CHEMBL313833;CHEMBL3989843,BRD:BRD-BRD-K47029922-003-10-9;BRD:BRD-K47029922-003-10-9,rep_primary;rep_single_dose,MONOAMINE OXIDASE INHIBITOR,KDM1A;MAOA;MAOB,DEPRESSION,,LAUNCHED,,Small molecule,4,"N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1;N[C@H]1C[C@@H]1C1CCCCC1, N[C@@H]1C[C@H]1C1CCCCC1, NC1C[C@H]1C1CCCCC1, N[C@@H]1C[C@H]1C1CCCCC1, N[C@@H]1C[C@H]1C1CCCCC1;NC1CC1c1ccccc1",AELCINSCMGFISI-UHFFFAOYSA-N;IGLYMJRIWWIQQE-QUOODJBBSA-N
TRAP-101,TRAP-101,,BRD:BRD-BRD-K69837166-003-02-0;BRD:BRD-K69837166-003-02-0,rep_primary;rep_single_dose,"NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST, OPIOID RECEPTOR ANTAGONIST",OPRL1,,,PRECLINICAL,,,NA,"CCN1C2CCCCC2N(C2=C(CO)CN(CC3CCCCCCC3)CC2)C1=O, CCN1C2CCCCC2N(C2=C(CO)CN(CC3CCCCCCC3)CC2)C1=O",
TRAPYMIN,AR 12008;AR-12008;ROCORNAL;TRAPIDIL;TRAPYMIN,CHEMBL132767,BRD:BRD-BRD-K95763993-001-19-3;BRD:BRD-K95763993-001-19-3,rep_multi_dose;rep_primary;rep_single_dose,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,PDGFRA,CORONARY ARTERY DISEASE (CAD),,LAUNCHED,,Small molecule,-1,CCN(CC)c1cc(C)nc2ncnn12;CCN(CC)C1CC(C)NC2NCNN12,GSNOZLZNQMLSKJ-UHFFFAOYSA-N
TRAVOPROST,AL-6221;IZBA;NSC-760366;OTX-TP;TRAVATAN;TRAVATAN Z;TRAVOPROST,CHEMBL1200799,BRD:BRD-BRD-K23976833-001-01-0;BRD:BRD-K23976833-001-01-0,rep_primary;rep_single_dose,PROSTANOID RECEPTOR AGONIST,PTGFR,"OCULAR HYPERTENSION, GLAUCOMA",,LAUNCHED,,Small molecule,4,CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O;CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1CCCC(C1)C(F)(F)F,MKPLKVHSHYCHOC-AHTXBMBWSA-N
TRAXOPRODIL,"CP-101,606;CP-101606;TRAXOPRODIL",CHEMBL17350,BRD:BRD-BRD-K38158531-001-02-1;BRD:BRD-K38158531-001-02-1,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIN2B,,,PHASE 2,,Small molecule,2,C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1;C[C@@H]([C@@H](O)C1CCC(O)CC1)N1CCC(O)(CC1)C1CCCCC1,QEMSVZNTSXPFJA-HNAYVOBHSA-N
TRITTICO,DESYREL;J10.767K;TRAZODONE;TRIALODINE;TRITTICO,CHEMBL621,BRD:BRD-BRD-K70778732-003-26-7;BRD:BRD-K70778732-003-26-7,rep_primary;rep_single_dose,"ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN REUPTAKE INHIBITOR",ADRA1A;ADRA2A;HRH1;HTR1A;HTR2A;HTR2B;HTR2C;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"CLC1CCCC(C1)N1CCN(CCCN2NC3CCCCN3C2=O)CC1, CLC1CCCC(C1)N1CCN(CCCN2NC3CCCCN3C2=O)CC1;O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12",PHLBKPHSAVXXEF-UHFFFAOYSA-N
TRELAGLIPTIN,SYR-472;TRELAGLIPTIN,CHEMBL1650443,BRD:BRD-A88369366-001-01-7;BRD:BRD-BRD-A88369366-001-01-7,rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,DIABETES MELLITUS,,LAUNCHED,,Small molecule,3,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O;CN1C(=O)CC(N2CCCC(N)C2)N(CC2CC(F)CCC2C#N)C1=O,IWYJYHUNXVAVAA-OAHLLOKOSA-N
TREMORINE,TREMORINE,,BRD:BRD-BRD-K08619838-300-05-7;BRD:BRD-K08619838-300-05-7,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,,,,PRECLINICAL,,,NA,C(C#CCN1CCCC1)N1CCCC1,
TREPIBUTONE,SUPACAL;TREPIBUTONE,CHEMBL1725880,BRD:BRD-BRD-K37543758-001-01-3;BRD:BRD-K37543758-001-01-3,rep_primary;rep_single_dose,CHOLINERGIC RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4,IRRITABLE BOWEL SYNDROME,,LAUNCHED,,Small molecule,-1,CCOc1cc(OCC)c(C(=O)CCC(=O)O)cc1OCC;CCOC1CC(OCC)C(CC1OCC)C(=O)CCC(O)=O,YPTFHLJNWSJXKG-UHFFFAOYSA-N
UT-15,15-AU-81;15AU81;L-606;LRX -15;LRX-15;REMODULIN;RUMODOLIN;TREPROSTINIL;TRESPROSTINIL;TYVASO;TYVASO DPI;UNIPROST;UT-15,CHEMBL1237119,BRD:BRD-K19706299-236-02-9,rep_single_dose,PROSTANOID RECEPTOR AGONIST,P2RY12;PPARD;PTGIR,,,,,Small molecule,4,CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O,PAJMKGZZBBTTOY-ZFORQUDYSA-N
TREQUINSIN,TREQUINSIN,CHEMBL285913,BRD:BRD-BRD-K84663978-003-02-9;BRD:BRD-K84663978-003-02-9,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A,,,PHASE 1,,Small molecule,-1,"COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(C)c(=O)n1CC2;COC1CC2CCN3C(C\C(=N/C4C(C)CC(C)CC4C)N(C)C3=O)-C2CC1OC, COC1CC2CCN3C(C\C(=N/C4C(C)CC(C)CC4C)N(C)C3=O)-C2CC1OC",MCMSJVMUSBZUCN-YYDJUVGSSA-N
TRETAZICAR,CB-1954;NSC-115829;TRETAZICAR,CHEMBL23330,BRD:BRD-BRD-K08748705-001-08-2;BRD:BRD-K08748705-001-08-2,rep_primary;rep_single_dose,DNA REPLICATION INHIBITOR,NQO2,,,PHASE 2,,Small molecule,2,NC(=O)c1cc(N2CC2)c([N+](=O)[O-])cc1[N+](=O)[O-];NC(=O)C1CC(N2CC2)C(CC1[N+]([O-])=O)[N+]([O-])=O,WOCXQMCIOTUMJV-UHFFFAOYSA-N
VESANOID,ABEREL;ACTICIN;ALL-TRANS RETINOIC ACID;ALL-TRANS-RETINOIC ACID;ALTRENO;ATRALIN;AVITA;EUDYNA;KERLOCAL;NSC-122758;ORISTAR RNA;RENOVA;RETIN A;RETIN-A;RETIN-A MICRO;RETIN-A-MICRO;RETINOIC ACID;TRETIN-X;TRETINOIN;VESANOID,CHEMBL38,BRD:BRD-K71879491-001-51-5;CTRP:23151;GDSC1:1009,ctrp;gdsc;rep_single_dose,"RETINOID RECEPTOR AGONIST, RETINOID RECEPTOR LIGAND",ALDH1A1;ALDH1A2;GPRC5A;NR0B1;NR2C2;PPARD;RARA;RARB;RARG;RARRES1;RORB;RORC;RXRB;RXRG,,,,,Small molecule,4,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,SHGAZHPCJJPHSC-YCNIQYBTSA-N
TRETINOIN:CARBOPLATIN (2:1 MOL/MOL),TRETINOIN:CARBOPLATIN (2:1 MOL/MOL),,CTRP:660181,ctrp,,,,,,,,NA,,
TRETINOIN:NAVITOCLAX (4:1 MOL/MOL),TRETINOIN:NAVITOCLAX (4:1 MOL/MOL),,CTRP:660179,ctrp,,,,,,,,NA,,
ZLATAL,(R)-;(R)-METHOTREXATE;ABITREXATE;ADX-2191;ADX-2191 SODIUM;AMETHOPTERIN;CL 14377;CL-14377;D-;D-AMETHOPTERIN;D-METHOTREXATE;DISODIUM METHOTREXATE;EBETREX;EMT-25299;EMTEXATE HIGH-POT;EMTEXATE PF;FOLEX;FOLEX PFS;MAXTREX;METHOTREXATE;METHOTREXATE (AS DISODIUM);METHOTREXATE DISODIUM;METHOTREXATE DISODIUM SALT;METHOTREXATE LPF;METHOTREXATE PRESERVATIVE FREE;METHOTREXATE SODIUM;METHOTREXATE SODIUM PRESERVATIVE FREE;METHOTREXATE SODIUM SALT;METHOTREXATUM;METHYLAMINOPTERIN;METOJECT;MEXATE;MEXATE-AQ;MEXATE-AQ PRESERVED;NSC-740;OTREXUP;OTREXUP PFS;R-9985;R-METHOTREXATE;RASUVO;REDITREX;RHEUMATREX;SODIUM SALT;TCMDC-123832;TCMDC-125488;TCMDC-125858;TREXALL;XATMEP;ZLATAL,CHEMBL3244648;CHEMBL34259,GDSC1:1008,gdsc,,,,,,,Small molecule,4,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,FBOZXECLQNJBKD-ZDUSSCGKSA-N
UJOSTABIL,E-1518;E1518;EASTMAN TRIACETIN;ENZACTIN;ESTOL 1581;FEMA NO. 2007;GLYCERYL TRIACETATE;GLYCERYLTRIACETATE;INS NO.1518;INS-1518;NSC-4796;TRIACETIN;UJOSTABIL,CHEMBL1489254,BRD:BRD-BRD-K92844263-001-09-8;BRD:BRD-K92844263-001-09-8,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,2,CC(=O)OCC(COC(C)=O)OC(C)=O,URAYPUMNDPQOKB-UHFFFAOYSA-N
VOLON,ARISTOCORT;ARISTOCORT A;DELPHICORT;FLUOXIPREDNISOLONE;KENACORT;KENALOG;NSC-13397;TRIAMCINOLONE;VOLON,CHEMBL1451,BRD:BRD-BRD-K77554836-001-11-6;BRD:BRD-BRD-K77554836-001-14-0;BRD:BRD-K77554836-001-11-6;BRD:BRD-K77554836-001-14-0,rep_multi_dose;rep_primary;rep_single_dose,GLUCOCORTICOID RECEPTOR AGONIST,NR3C1;SERPINA6,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,Small molecule,4,"C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO;C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F",GFNANZIMVAIWHM-OBYCQNJPSA-N
TRIAMCINOLONE-ACETONIDE,TRIAMCINOLONE-ACETONIDE,,BRD:BRD-A92439610-001-05-7;BRD:BRD-BRD-A92439610-001-05-7,rep_multi_dose;rep_primary;rep_single_dose,"GLUCOCORTICOID RECEPTOR AGONIST, IMMUNOSUPPRESSANT",NR3C1,CORTICOSTEROID-RESPONSIVE DERMATOSES,,LAUNCHED,,,NA,"CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO",
TRIAMCINOLONE-HEXACETONIDE,TRIAMCINOLONE-HEXACETONIDE,,BRD:BRD-K00003338-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,,,,,,,NA,,
TRIAMTERENE,DYRENIUM;DYTAC;NSC-639359;NSC-77625;SK-8542;SK&F 8542;SK&F-8542;TRIAMTERENE,CHEMBL585,BRD:BRD-BRD-K92049597-001-20-8;BRD:BRD-K92049597-001-20-8,rep_multi_dose;rep_primary;rep_single_dose,SODIUM CHANNEL BLOCKER,SCNN1A;SCNN1B;SCNN1D;SCNN1G,"HYPOKALEMIA, HYPERTENSION, EDEMA",,LAUNCHED,,Small molecule,4,"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1;NC1NC(N)C2NC(-C3CCCCC3)C(N)NC2N1, NC1NC(N)C2NC(-C3CCCCC3)C(N)NC2N1",FNYLWPVRPXGIIP-UHFFFAOYSA-N
TRIAPINE,3-AP;NSC-663249;OCX 191;OCX-0191;OCX-191;PAN-811;TRIAPINE,CHEMBL231616,BRD:BRD-BRD-K01669786-001-02-2;BRD:BRD-K01669786-001-02-2,rep_multi_dose;rep_primary;rep_single_dose,RIBONUCLEOTIDE REDUCTASE INHIBITOR,RRM1;RRM2,,,PHASE 2,,Small molecule,3,"NC(=S)N/N=C/c1ncccc1N;NC(=S)N\N=C\C1NCCCC1N, NC(=S)N\N=C\C1NCCCC1N, NC(=S)N\N=C\C1NCCCC1N",XMYKNCNAZKMVQN-NYYWCZLTSA-N
TRIAZAVIRIN,TRIAZAVIRIN,,BRD:BRD-K00091130-325-01-9,rep_single_dose,,,,,,,,NA,,
U-33030,"HALCION;KENTION;N05CD05;TRIAZOLAM;TRIAZOLAM CIV;U-33,030;U-33030",CHEMBL646,BRD:BRD-BRD-K76890464-001-02-3;BRD:BRD-K76890464-001-02-3,rep_primary;rep_single_dose,GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA4;GABRA5;GABRA6;GABRB1;GABRB2;GABRB3;GABRD;GABRE;GABRG1;GABRG2;GABRG3;GABRP;GABRQ;GABRR1;GABRR2;GABRR3;TSPO,,,WITHDRAWN,,Small molecule,4,CC1NNC2CN=C(C3CCCCC3CL)C3CC(CL)CCC3-N12;Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,JOFWLTCLBGQGBO-UHFFFAOYSA-N
TRIAZOLOTHIADIAZINE,TRIAZOLOTHIADIAZINE,,CTRP:385240,ctrp,,,,,,,,NA,,
TRIBOMSALAN,TRIBOMSALAN,,BRD:BRD-BRD-K09118247-001-03-3;BRD:BRD-K09118247-001-03-3,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,OC1C(BR)CC(BR)CC1C(=O)NC1CCC(BR)CC1,
TRIBROMOETHANOL,AVERTIN;TRIBROMOETHANOL,CHEMBL1697852,BRD:BRD-K69632891-001-02-9,rep_single_dose,ANALGESIC AGENT,,,,,,Small molecule,-1,OCC(Br)(Br)Br,YFDSDPIBEUFTMI-UHFFFAOYSA-N
TRICAINE (METHANESULFONATE),TRICAINE (METHANESULFONATE),,BRD:BRD-K44518413-066-04-9,rep_single_dose,,,,,,,,NA,,
TRICAPRYLIN,AC-1202;AC-1204;AXONA;CAPRYLIC ACID TRIGLYCERIDE;CAPRYLIC TRIGLYCERIDE;CER-0001;GLYCERYL TRICAPRYLATE;MIGLYOL 808;NSC-4059;TRICAPRILIN;TRICAPRYLIC GLYCERIDE;TRICAPRYLIN,CHEMBL1406148,BRD:BRD-BRD-K24790130-001-07-1;BRD:BRD-K24790130-001-07-1,rep_primary;rep_single_dose,,,COSMETIC,,LAUNCHED,,Small molecule,3,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,VLPFTAMPNXLGLX-UHFFFAOYSA-N
TRICHLOROMETHIAZIDE,METAHYDRIN;NAQUA;NSC-61560;TRICHLOREX;TRICHLORMAS;TRICHLORMETHIAZIDE;TRICHLOROMETHIAZIDE,CHEMBL1054,BRD:BRD-A28940325-001-24-0;BRD:BRD-BRD-A28940325-001-24-0,rep_primary;rep_single_dose,CHLORIDE CHANNEL BLOCKER,ATP1A1;CA1;CA2;CA4;PTGS1;PTGS2;SLC12A1;SLC12A3,"HYPERTENSION, EDEMA",,LAUNCHED,"Multiple values for repurposing_target: {'ATP1A1;CA1;CA2;CA4;PTGS1;PTGS2;SLC12A1;SLC12A3', 'ATP1A1;CA1;CA2;CA4;SLC12A1;SLC12A3'}, taking the union",Small molecule,4,"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O;NS(=O)(=O)C1CC2C(NC(NS2(=O)=O)C(CL)CL)CC1CL, NS(=O)(=O)C1CC2C(NC(NS2(=O)=O)C(CL)CL)CC1CL, NS(=O)(=O)C1CC2C(NC(NS2(=O)=O)C(CL)CL)CC1CL",LMJSLTNSBFUCMU-UHFFFAOYSA-N
TRICHLOROACETIC-ACID,TRICHLOROACETIC-ACID,,BRD:BRD-BRD-K42090719-001-06-5;BRD:BRD-K42090719-001-06-5,rep_primary;rep_single_dose,,,WARTS,,LAUNCHED,,,NA,"OC(=O)C(CL)(CL)CL, OC(=O)C(CL)(CL)CL",
WESTROSOL,ANAMENTH;CHLORYLEN;DENSINFLUAT;GERMALGENE;NARKOSOID;TRICHLOROETHENE;TRICHLOROETHYLENE;TRILENE;WESTROSOL,CHEMBL279816,BRD:BRD-BRD-K46435528-001-04-4;BRD:BRD-K46435528-001-04-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,4,"ClC=C(Cl)Cl;CLC=C(CL)CL, CLC=C(CL)CL",XSTXAVWGXDQKEL-UHFFFAOYSA-N
TRICHOSTATIN A,TRICHOSTATIN A,,GDSC1:437,gdsc,,,,,,,,NA,,
TRICHOSTATIN-A,TRICHOSTATIN-A,,BRD:BRD-BRD-K68202742-001-16-5;BRD:BRD-K68202742-001-16-5,rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC10;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9,,,PRECLINICAL,,,NA,"C[C@H](\C=C(C)\C=C\C(=O)NO)C(=O)C1CCC(CC1)N(C)C, C[C@H](\C=C(C)\C=C\C(=O)NO)C(=O)C1CCC(CC1)N(C)C",
TRICIRIBINE,NSC-154020;TRICIRIBINE,CHEMBL331237,BRD:BRD-BRD-K80431395-001-07-3;BRD:BRD-BRD-K80431395-001-09-9;BRD:BRD-K80431395-001-07-3;BRD:BRD-K80431395-001-09-9,rep_multi_dose;rep_primary;rep_single_dose,AKT INHIBITOR,AKT1;AKT2;AKT3,,,PHASE 1/PHASE 2,,Small molecule,NA,"CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23;CN1NC(N)C2CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3NCNC1C23, CN1NC(N)C2CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3NCNC1C23, CN1NC(N)C2CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3NCNC1C23, CN1NC(N)C2CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3NCNC1C23",HOGVTUZUJGHKPL-HTVVRFAVSA-N
TRICIRIBINE-PHOSPHATE,TRICIRIBINE-PHOSPHATE,,BRD:BRD-K00004666-001-01-9,rep_single_dose,AKT INHIBITOR,,,,,,,NA,,
TRICLABENDAZOLE,EGA230B;EGATEN;EGATEN TM;FASINEX;NSC-759250;NVP-EGA230;TRICLABENDAZOLE,CHEMBL1086440,BRD:BRD-BRD-K81916719-001-13-9;BRD:BRD-K81916719-001-13-9,rep_multi_dose;rep_primary;rep_single_dose,MICROTUBULE INHIBITOR,DNMT1,TAPEWORM,,LAUNCHED,,Small molecule,4,"CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1;CSC1NC2CC(CL)C(OC3CCCC(CL)C3CL)CC2[NH]1, CSC1NC2CC(CL)C(OC3CCCC(CL)C3CL)CC2[NH]1",NQPDXQQQCQDHHW-UHFFFAOYSA-N
TRICLOCARBAN,"3,4,4'-TRICHLOROCARBANILIDE;NSC-72005;TCC;TCC SOAP;TRICLOCARBAN",CHEMBL1076347,BRD:BRD-BRD-K25029121-001-05-8;BRD:BRD-K25029121-001-05-8,rep_primary;rep_single_dose,OTHER ANTIBIOTIC,,,,LAUNCHED,,Small molecule,4,CLC1CCC(NC(=O)NC2CCC(CL)C(CL)C2)CC1;O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1,ICUTUKXCWQYESQ-UHFFFAOYSA-N
TRICLOSAN,AQUASEPT;CH 3565;CH-3565;CLOXIFENOL;DNDI1246774;GAMOPHEN;INNOXA;MANUSEPT;NSC-759151;SKINSAN;STRI-DEX CLEANSING BAR;STRI-DEX FACE WASH;TEGUSEPT;TRICLOSAN,CHEMBL849,BRD:BRD-BRD-K41731458-001-15-1;BRD:BRD-K41731458-001-15-1,rep_primary;rep_single_dose,ANTIBACTERIAL AGENT,DNMT1,,,LAUNCHED,,Small molecule,4,Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl;OC1CC(CL)CCC1OC1CCC(CL)CC1CL,XEFQLINVKFYRCS-UHFFFAOYSA-N
TRIDIHEXETHYL ION,TRIDIHEXETHYL;TRIDIHEXETHYL CATION;TRIDIHEXETHYL ION,CHEMBL1201354,BRD:BRD-A22152765-003-10-0;BRD:BRD-BRD-A22152765-003-10-0,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3,"PEPTIC ULCER DISEASE (PUD), NYSTAGMUS",,LAUNCHED,,Small molecule,4,CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1;CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1CCCCC1,NPRHVSBSZMAEIN-UHFFFAOYSA-N
TRIETHYLENE TETRAMINE,NSC-443;SYPRINE;TRETHYLENETETRAMINE;TRIENTINE;TRIETHYLENE TETRAAMINE;TRIETHYLENE TETRAMINE,CHEMBL609,BRD:BRD-BRD-K37111771-300-02-6;BRD:BRD-K37111771-300-02-6,rep_primary;rep_single_dose,CHELATING AGENT,CA14,WILSON'S DISEASE,,LAUNCHED,,Small molecule,4,NCCNCCNCCN,VILCJCGEZXAXTO-UHFFFAOYSA-N
TRIFAROTENE,AKLIEF;CD-5789;CD5789;TRIFAROTENE,CHEMBL3707313,BRD:BRD-K00077480-001-02-9,rep_single_dose,,,,,,,Small molecule,4,CC(C)(C)c1cc(-c2cc(-c3ccc(C(=O)O)cc3)ccc2OCCO)ccc1N1CCCC1,MFBCDACCJCDGBA-UHFFFAOYSA-N
TRIFLOXYSTROBIN,TRIFLOXYSTROBIN,CHEMBL1897483,BRD:BRD-K00005342-001-01-9,rep_single_dose,MITOCHONDRIAL ELECTRON TRANSPORT INHIBITOR,,,,,,Small molecule,NA,CO/N=C(/C(=O)OC)c1ccccc1CO/N=C(\C)c1cccc(C(F)(F)F)c1,ONCZDRURRATYFI-TVJDWZFNSA-N
TRIFLUOPERAZINE,AMYLOZINE;APO-TRIFLUOPERAZINE;FLURAZINE;NSC-17474;NSC-46061;RP-7623;STELAZINE;STELAZINE FTE;TRIFLUOPERAZINE,CHEMBL422,BRD:BRD-BRD-K89732114-300-14-7;BRD:BRD-K89732114-300-14-7;CTRP:26914,ctrp;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;CALM1;CALY;DRD2;DRD4;HRH1;HTR2A;HTR2C;S100A4;TNNC1,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1;CN1CCN(CCCN2C3CCCCC3SC3CCC(CC23)C(F)(F)F)CC1, CN1CCN(CCCN2C3CCCCC3SC3CCC(CC23)C(F)(F)F)CC1, CN1CCN(CCCN2C3CCCCC3SC3CCC(CC23)C(F)(F)F)CC1",ZEWQUBUPAILYHI-UHFFFAOYSA-N
VETAME,FLUOPROMAZINE;NIVOMAN;TRIFLUPROMAZINE;VESPRIN;VETAME,CHEMBL570,BRD:BRD-BRD-K63675182-003-23-6;BRD:BRD-K63675182-003-23-6,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;DRD1;DRD2;HTR2B,"PSYCHOSIS, NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,"CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21;CN(C)CCCN1C2CCCCC2SC2CCC(CC12)C(F)(F)F, CN(C)CCCN1C2CCCCC2SC2CCC(CC12)C(F)(F)F",XSCGXQMFQXDFCW-UHFFFAOYSA-N
VIROPTIC,F3DTHD;NSC-529182;NSC-75520;T.F.T.;TRIFLURIDINE;TRIFLURIDINE ;TRIHERPINE;VIROPTIC,CHEMBL1129,BRD:BRD-BRD-K03243820-001-23-8;BRD:BRD-BRD-K03243820-001-25-3;BRD:BRD-K03243820-001-23-8;BRD:BRD-K03243820-001-25-3,rep_multi_dose;rep_primary;rep_single_dose,"DNA DIRECTED DNA POLYMERASE INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",TYMS,VIRUS HERPES SIMPLEX (HSV),,LAUNCHED,,Small molecule,4,"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F;OC[C@H]1O[C@H](C[C@@H]1O)N1CC(C(=O)[NH]C1=O)C(F)(F)F, OC[C@H]1O[C@H](C[C@@H]1O)N1CC(C(=O)[NH]C1=O)C(F)(F)F, OC[C@H]1O[C@H](C[C@@H]1O)N1CC(C(=O)[NH]C1=O)C(F)(F)F, OC[C@H]1O[C@H](C[C@@H]1O)N1CC(C(=O)[NH]C1=O)C(F)(F)F",VSQQQLOSPVPRAZ-RRKCRQDMSA-N
TRIFLUSAL,TRIFLUSAL,CHEMBL1332032,BRD:BRD-BRD-K71696703-001-07-9;BRD:BRD-K71696703-001-07-9,rep_primary;rep_single_dose,"CYCLOOXYGENASE INHIBITOR, PLATELET AGGREGATION INHIBITOR, THROMBOXANE SYNTHASE INHIBITOR",NFKB1;NOS2;PDE10A;PTGS1,"STROKE, MYOCARDIAL INFARCTION, ATRIAL FIBRILLATION (AF)",,LAUNCHED,,Small molecule,3,"CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O;CC(=O)OC1CC(CCC1C(O)=O)C(F)(F)F, CC(=O)OC1CC(CCC1C(O)=O)C(F)(F)F, CC(=O)OC1CC(CCC1C(O)=O)C(F)(F)F, CC(=O)OC1CC(CCC1C(O)=O)C(F)(F)F, CC(=O)OC1CC(CCC1C(O)=O)C(F)(F)F",RMWVZGDJPAKBDE-UHFFFAOYSA-N
TRIGONELLINE,1-METHYL-NICOTINIC ACID ANION(TRIGONELLINE);TRIGONELLINE,CHEMBL350675,BRD:BRD-BRD-K69231085-003-05-7;BRD:BRD-K69231085-003-05-7,rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,NA,C[n+]1cccc(C(=O)[O-])c1;C[N+]1CCCC(C1)C(O)=O,WWNNZCOKKKDOPX-UHFFFAOYSA-N
TRIHEXYPHENIDYL,APO-TRIHEX;NSC-12268;TRIHEXYPHENIDYL,CHEMBL1490,BRD:BRD-A48180038-003-24-3;BRD:BRD-BRD-A48180038-003-24-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5,PARKINSONISM,,LAUNCHED,,Small molecule,4,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1;OC(CCN1CCCCC1)(C1CCCCC1)C1CCCCC1,HWHLPVGTWGOCJO-UHFFFAOYSA-N
TRILACICLIB,G1T28;G1T28-1;TRILACICLIB,CHEMBL3894860,BRD:BRD-K00003412-300-01-9,rep_single_dose,CDK INHIBITOR,,,,,,Small molecule,4,CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1,PDGKHKMBHVFCMG-UHFFFAOYSA-N
WIN-24540,"DESOPAN;MODRASTANE;MODRENAL;NSC-758904;TRILOSTANE;WIN 24,540;WIN-24540",CHEMBL1200907,BRD:BRD-A04497688-001-04-2;BRD:BRD-BRD-A04497688-001-04-2,rep_primary;rep_single_dose,3BETA-HYDROXY-DELTA5-STEROID DEHYDROGENASE INHIBITOR,ESR1;ESR2;HSD3B1;HSD3B2,CUSHING'S SYNDROME,,LAUNCHED,,Small molecule,4,"C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O;C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O",KVJXBPDAXMEYOA-CXANFOAXSA-N
TRIMEBUTINE MALEATE,TRIMEBUTINE;TRIMEBUTINE MALEATE,CHEMBL190044,BRD:BRD-A92630576-050-24-1;BRD:BRD-BRD-A92630576-050-24-1,rep_multi_dose;rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRD1;OPRK1;OPRM1,IRRITABLE BOWEL SYNDROME,,LAUNCHED,,Small molecule,3,"CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C;CCC(COC(=O)C1CC(OC)C(OC)C(OC)C1)(N(C)C)C1CCCCC1, CCC(COC(=O)C1CC(OC)C(OC)C(OC)C1)(N(C)C)C1CCCCC1",LORDFXWUHHSAQU-UHFFFAOYSA-N
VASTAREL MR,40045;DILATAN;TRIMETAZIDINE;VASTAREL;VASTAREL MR,CHEMBL203266,BRD:BRD-BRD-K88366685-300-06-0;BRD:BRD-K88366685-300-06-0,rep_primary;rep_single_dose,3-KETOACYL COA THIOLASE INHIBITOR,ACAA2,ANGINA PECTORIS,,LAUNCHED,,Small molecule,4,COc1ccc(CN2CCNCC2)c(OC)c1OC;COC1CCC(CN2CCNCC2)C(OC)C1OC,UHWVSEOVJBQKBE-UHFFFAOYSA-N
TRIMETHOBENZAMIDE,AMETIK DAMLA;TRIMETHOBENZAMIDE,CHEMBL1201256,BRD:BRD-BRD-K34415467-003-13-0;BRD:BRD-K34415467-003-13-0,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,DRD2,"VOMITING, NAUSEA, GASTROENTERITIS",,LAUNCHED,,Small molecule,4,COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC;COC1CC(CC(OC)C1OC)C(=O)NCC1CCC(OCCN(C)C)CC1,FEZBIKUBAYAZIU-UHFFFAOYSA-N
WELLCOPRIM,BW 56-72;BW-56-72;INFECTOTRIMET;IPRAL;LEDATRIM;MONOTRIM;NIH-204;NSC-106568;POLYTRIM;PRIMSOL;PROLOPRIM;PROLOPRIN;SYRAPRIM;TCMDC-125538;TIEMPE;TRIMETHOPRIM;TRIMETHOPRIMUM;TRIMOGAL;TRIMOPAN;TRIMPEX;TRIMPEX 200;TRIPRIMIX 200;WELLCOPRIM,CHEMBL22,BRD:BRD-BRD-K07208025-001-29-7;BRD:BRD-K07208025-001-29-7,rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR;TYMS,"URINARY TRACT INFECTIONS, EAR INFECTIONS, DIARRHEA",,LAUNCHED,,Small molecule,4,"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC;COC1CC(CC2CNC(N)NC2N)CC(OC)C1OC, COC1CC(CC2CNC(N)NC2N)CC(OC)C1OC",IEDVJHCEMCRBQM-UHFFFAOYSA-N
TRIMETOQUINOL HYDROCHLORIDE,(-)-;(-)-TRETOQUINOL;AQ-110;DL-TRIMETOQUINOL;INOLIN;NSC-288748;RACEMIC-TRIMETOQUINOL;RO-07-5965;S-(-)-TRETOQUINOL;TRETOQUINOL;TRETOQUINOL HYDROCHLORIDE;TRETOQUINOL HYDROCHLORIDE HYDRATE;TRIMETHOQUINOL;TRIMETOQUINOL HYDROCHLORIDE,CHEMBL299175,BRD:BRD-A56241705-003-01-2;BRD:BRD-BRD-A56241705-003-01-2,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRB2;ADRB3,,,LAUNCHED,,Small molecule,-1,COC1CC(CC2NCCC3CC(O)C(O)CC23)CC(OC)C1OC;COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC,RGVPOXRFEPSFGH-UHFFFAOYSA-N
TRIMOLIDE,ABBOTT-22370;NSC-62939;PS 2383;PS-2383;TRIMETOZINE;TRIMOLIDE,CHEMBL1697853,BRD:BRD-BRD-K53220666-001-02-6;BRD:BRD-K53220666-001-02-6,rep_primary;rep_single_dose,SEDATIVE,,SEDATIVE,,LAUNCHED,,Small molecule,-1,COc1cc(C(=O)N2CCOCC2)cc(OC)c1OC;COC1CC(CC(OC)C1OC)C(=O)N1CCOCC1,XWVOEFLBOSSYGM-UHFFFAOYSA-N
TRIMETREXATE,CI-898;NEUTREXIN;NSC-249008;TRIMETREXATE,CHEMBL119,BRD:BRD-K13642819-001-02-9,rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,DHFR,,,,,Small molecule,4,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,NOYPYLRCIDNJJB-UHFFFAOYSA-N
TRIMIPRAMINE,7162 RP;7162-RP;IL 6001;IL-6001;SURMONTIL;TRIMEPROPRIMINE;TRIMIPRAMINE,CHEMBL644,BRD:BRD-A19195498-050-14-1;BRD:BRD-BRD-A19195498-050-14-1,rep_primary;rep_single_dose,"NOREPINEPHRINE REPUTAKE INHIBITOR, TRICYCLIC ANTIDEPRESSANT",ADRA1A;ADRA1B;ADRA2A;ADRA2B;ADRB1;ADRB2;ADRB3;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD5;HRH1;HTR1A;HTR1D;HTR2A;HTR2C;HTR3A;SLC6A2;SLC6A3;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"CC(CN(C)C)CN1C2CCCCC2CCC2CCCCC12, CC(CN(C)C)CN1C2CCCCC2CCC2CCCCC12;CC(CN(C)C)CN1c2ccccc2CCc2ccccc21",ZSCDBOWYZJWBIY-UHFFFAOYSA-N
TRISORALEN,"4,5',8-TRIMETHYLPSORALEN;NSC-71047;TMP (PSORALEN);TRIOXSALEN;TRIOXYSALEN;TRISORALEN",CHEMBL1475,BRD:BRD-BRD-K54790157-001-15-5;BRD:BRD-K54790157-001-15-5,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,"VITILIGO, ECZEMA",,LAUNCHED,,Small molecule,4,Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1;CC1CC2CC3C(C)CC(=O)OC3C(C)C2O1,FMHHVULEAZTJMA-UHFFFAOYSA-N
TRIPELENNAMINE,NSC-118946;PBZ;PBZ-SR;TRIPELENNAMINE,CHEMBL1241,BRD:BRD-BRD-K57033106-003-19-7;BRD:BRD-K57033106-003-19-7,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,"ASTHMA, ALLERGIC RHINITIS, URTICARIA",,LAUNCHED,,Small molecule,4,"CN(C)CCN(Cc1ccccc1)c1ccccn1;CN(C)CCN(CC1CCCCC1)C1CCCCN1, CN(C)CCN(CC1CCCCC1)C1CCCCN1",UFLGIAIHIAPJJC-UHFFFAOYSA-N
TRIPROLIDINE,ACTAHIST;ACTIDIL;ACTIFED;ALLERFED;CORPHED;HISTAFED;MYFED;MYIDYL;TRILITRON;TRIPHED;TRIPROLIDINE,CHEMBL855,BRD:BRD-BRD-K11742128-003-23-4;BRD:BRD-K11742128-003-23-4,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH1,ALLERGIC RHINITIS,,LAUNCHED,,Small molecule,4,"Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1;CC1CCC(CC1)C(=C/CN1CCCC1)\C1CCCCN1, CC1CCC(CC1)C(=C/CN1CCCC1)\C1CCCCN1",CBEQULMOCCWAQT-WOJGMQOQSA-N
TRIPTOLIDE,NSC-163062;TRIPTOLIDE,CHEMBL463763,BRD:BRD-BRD-K39484304-001-16-5;BRD:BRD-K39484304-001-16-5;CTRP:411720,ctrp;rep_multi_dose;rep_primary;rep_single_dose,RNA POLYMERASE INHIBITOR,RELA,,,PHASE 3,,Small molecule,3,"CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O, CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O;CC(C)[C@]12O[C@H]1[C@@H]1O[C@]13[C@]1(O[C@H]1C[C@H]1C4=C(CC[C@@]13C)C(=O)OC4)[C@@H]2O",DFBIRQPKNDILPW-CIVMWXNOSA-N
WY-42462,"ARVEKAP;AY-25650;CL 118,532;CL-118532;DECAPEPTYL;DECAPEPTYL SR;GONAPEPTYL DEPOT;TRIPTODUR;TRIPTORELIN;TRYPTORELIN;WY-42462",CHEMBL1201334,BRD:BRD-BRD-K62685538-001-01-7;BRD:BRD-K62685538-001-01-7,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,GNRHR,"PROSTATE CANCER, BREAST CANCER, PRECOCIOUS PUBERTY, ENDOMETRIOSIS, MYOMA, GENDER DYSPHORIA",,LAUNCHED,,Protein,4,CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O;CC(C)C[C@H](NC(=O)[C@@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1C[NH]C2CCCCC12)NC(=O)[C@H](CC1C[NH]CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,VXKHXGOKWPXYNA-PGBVPBMZSA-N
TRITYLCYSTEINE,NSC 83265;TRITYLCYSTEINE,,GDSC1:41,gdsc,,,,,,,,NA,,
TRODUSQUEMINE,MSI-1436;TRODUSQUEMINE,CHEMBL508583,BRD:BRD-K00003124-389-01-9,rep_single_dose,TYROSINE PHOSPHATASE INHIBITOR,,,,,,Small molecule,1,CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@@H](NCCCNCCCCNCCCN)CC[C@]4(C)[C@H]3CC[C@]12C)OS(=O)(=O)O,WUJVPODXELZABP-FWJXURDUSA-N
Z-4828,A-4828;NSC-109723;TROFOSFAMIDE;TROPHOSPHAMIDE;Z-4828,CHEMBL462019,BRD:BRD-A91386192-001-07-9,rep_single_dose,DNA ALKYLATING AGENT,,,,,,Small molecule,3,O=P1(N(CCCl)CCCl)OCCCN1CCCl,UMKFEPPTGMDVMI-UHFFFAOYSA-N
TROGLITAZONE,CI-991;CS-045;GR-92132X;GR92132X;PRELAY;REZULIN;ROMOZIN;TROGLITAZONE,CHEMBL408,BRD:BRD-A13084692-001-17-3;BRD:BRD-BRD-A13084692-001-17-3,rep_primary;rep_single_dose,"INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",ACSL4;CYP2C8;ESRRA;ESRRG;PPARG;SERPINE1;SLC29A1;TRPM3,,,WITHDRAWN,"Multiple values for repurposing_target: {'ACSL4;CYP2C8;ESRRA;ESRRG;PPARG;SERPINE1;SLC29A1;TRPM3', 'ACSL4;ESRRA;ESRRG;PPARG;SERPINE1;SLC29A1;TRPM3'}, taking the union",Small molecule,4,"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2;CC1C(C)C2OC(C)(COC3CCC(CC4SC(=O)NC4=O)CC3)CCC2C(C)C1O, CC1C(C)C2OC(C)(COC3CCC(CC4SC(=O)NC4=O)CC3)CCC2C(C)C1O",GXPHKUHSUJUWKP-UHFFFAOYSA-N
TROLEANDOMYCIN,ACETYLOLEANDOMYCIN;NSC-108166;OLEANDOMYCIN (AS TROLEANDOMYCIN);OLEANDOMYCIN TRIACETATE ESTER;TRIACETYLOLEANDOMYCIN;TROLEANDOMYCIN,CHEMBL564085,BRD:BRD-A24297246-001-03-9;BRD:BRD-BRD-A24297246-001-03-9,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,"PNEUMONIA, BRONCHITIS, TONSILLITIS, SINUSITIS",,LAUNCHED,,Small molecule,4,CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O;CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](OC3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O,LQCLVBQBTUVCEQ-QTFUVMRISA-N
TROLOX,TROLOX,CHEMBL153,BRD:BRD-A17846016-001-13-9;BRD:BRD-BRD-A17846016-001-13-9,rep_multi_dose;rep_primary;rep_single_dose,ANTIOXIDANT,,,,LAUNCHED,,Small molecule,NA,Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)O)O2;CC1C(C)C2OC(C)(CCC2C(C)C1O)C(O)=O,GLEVLJDDWXEYCO-UHFFFAOYSA-N
TROMARIL,TROMARIL,,BRD:BRD-BRD-K91422571-001-01-8;BRD:BRD-K91422571-001-01-8,rep_primary;rep_single_dose,PROSTANOID RECEPTOR ANTAGONIST,,,,LAUNCHED,,,NA,OC(=O)C1CCCCC1NCCC1CCCCC1,
TROMETHAMINE,NSC-6365;THAM;TRIS-BASE;TRIS(HYDROXYMETHYL)AMINOMETHANE;TRIZMA;TROMETAMOL;TROMETHAMINE,CHEMBL1200391,BRD:BRD-BRD-K47978074-001-02-4;BRD:BRD-K47978074-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,,AMD1;CANT1;DCN;NEIL1;VEGFA,,,LAUNCHED,,Small molecule,4,"NC(CO)(CO)CO;NC(CO)(CO)CO, NC(CO)(CO)CO",LENZDBCJOHFCAS-UHFFFAOYSA-N
"TROPANYL-3,5-DIMETHYLBENZOATE","TROPANYL-3,5-DIMETHYLBENZOATE",,BRD:BRD-A84389633-001-05-7;BRD:BRD-BRD-A84389633-001-05-7,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A;HTR3B,,,PRECLINICAL,,,NA,CN1C2CCC1CC(C2)OC(=O)C1CC(C)CC(C)C1,
TROPESIN,TROPESIN,,BRD:BRD-A34603619-001-01-9;BRD:BRD-BRD-A34603619-001-01-9,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,,,LAUNCHED,,,NA,COC1CCC2N(C(=O)C3CCC(CL)CC3)C(C)C(CC(=O)OCC(C(O)=O)C3CCCCC3)C2C1,
VISUMIDRIATIC,BISTROPAMIDE;MYDRIACYL;MYDRIAFAIR;NODS;NSC-757372;RO-1-7683;TROPICACYL;TROPICAMIDE;TROPICAMIDUM;VISUMIDRIATIC,CHEMBL1200604,BRD:BRD-A79672927-001-20-7;BRD:BRD-BRD-A79672927-001-20-7,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4,"MYDRIASIS DIAGNOSTIC, CYCLOPLEGIA DIAGNOSTIC",,LAUNCHED,,Small molecule,4,"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1;CCN(CC1CCNCC1)C(=O)C(CO)C1CCCCC1, CCN(CC1CCNCC1)C(=O)C(CO)C1CCCCC1, CCN(CC1CCNCC1)C(=O)C(CO)C1CCCCC1, CCN(CC1CCNCC1)C(=O)C(CO)C1CCCCC1",BGDKAVGWHJFAGW-UHFFFAOYSA-N
TROPIFEXOR,LJN-452;LJN452;NVP-LJN452-NXA;TROPIFEXOR,CHEMBL4298169,BRD:BRD-K00003480-001-01-9,rep_single_dose,FXR AGONIST,,,,,,Small molecule,2,O=C(O)c1cc(F)c2nc(N3[C@@H]4CC[C@H]3C[C@@H](OCc3c(-c5ccccc5OC(F)(F)F)noc3C3CC3)C4)sc2c1,VYLOOGHLKSNNEK-PIIMJCKOSA-N
TROPISETRON MONOHYDROCHLORIDE,ICS-205-930;NAVOBAN;NOVABAN;NSC-759842;SDZ-ICS-930;TROPISETRON;TROPISETRON (AS HYDROCHLORIDE);TROPISETRON HCL;TROPISETRON HYDROCHLORIDE;TROPISETRON MONOHYDROCHLORIDE,CHEMBL56564,BRD:BRD-BRD-K50866992-003-09-5;BRD:BRD-BRD-K50866992-003-10-3;BRD:BRD-K50866992-003-09-5;BRD:BRD-K50866992-003-10-3,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,GLRA1;GLRA2;GLRB;HTR3A;HTR4,"NAUSEA, VOMITING, NAUSEA, VOMITING",,LAUNCHED,,Small molecule,4,"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2;CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1C[NH]C2CCCCC12, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1C[NH]C2CCCCC12",ZNRGQMMCGHDTEI-ITGUQSILSA-N
TROSPIUM ION,TROSPIUM;TROSPIUM CATION;TROSPIUM ION,CHEMBL1888176,BRD:BRD-BRD-K69469734-003-02-5;BRD:BRD-K69469734-003-02-5,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1,"URINARY INCONTINENCE, URINARY FREQUENCY",,LAUNCHED,,Small molecule,4,O=C(O[C@H]1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1;OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)(C1CCCCC1)C1CCCCC1,OYYDSUSKLWTMMQ-JKHIJQBDSA-N
TROVAFLOXACIN,CP-99219;TROVAFLOXACIN,CHEMBL428,BRD:BRD-BRD-K00494077-066-01-9;BRD:BRD-K00494077-066-01-9,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL DNA GYRASE INHIBITOR,TOP2A,,,WITHDRAWN,,Small molecule,4,"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12;N[C@H]1[C@@H]2CN(C[C@H]12)C1NC2N(CC(C(O)=O)C(=O)C2CC1F)-C1CCC(F)CC1F, N[C@H]1[C@@H]2CN(C[C@H]12)C1NC2N(CC(C(O)=O)C(=O)C2CC1F)-C1CCC(F)CC1F",WVPSKSLAZQPAKQ-CDMJZVDBSA-N
TROVENTOL,TROVENTOL,,BRD:BRD-A35868371-005-01-6;BRD:BRD-BRD-A35868371-005-01-6,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,CCC(CO)(C(=O)OC1CC2CCC(C1)[N+]2(C)C)C1CCCCC1,
TROVIRDINE,LY-300046;TROVIRDINE,CHEMBL39999,BRD:BRD-BRD-K00989047-001-01-2;BRD:BRD-K00989047-001-01-2,rep_primary;rep_single_dose,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,,,PHASE 1,,Small molecule,-1,BRC1CCC(NC(=S)NCCC2CCCCN2)NC1;S=C(NCCc1ccccn1)Nc1ccc(Br)cn1,HOCFDYZWQYGULA-UHFFFAOYSA-N
Z-6000,"3',4',7-TRIS(HYDROXYETHYL)RUTIN;FLAVONOID;NSC-758937;THR;TRIOXYETHYLRUTIN;TROXERUTIN;VITAMIN P4;Z 6000;Z-6000",CHEMBL3182320,BRD:BRD-BRD-K73529671-001-02-9;BRD:BRD-BRD-K73529671-001-04-5;BRD:BRD-K73529671-001-02-9;BRD:BRD-K73529671-001-04-5,rep_primary;rep_single_dose,ANTIOXIDANT,,,,LAUNCHED,,Small molecule,3,"C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(OCCO)c(OCCO)c4)oc4cc(OCCO)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O;C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3C(OC4CC(OCCO)CC(O)C4C3=O)-C3CCC(OCCO)C(OCCO)C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3C(OC4CC(OCCO)CC(O)C4C3=O)-C3CCC(OCCO)C(OCCO)C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3C(OC4CC(OCCO)CC(O)C4C3=O)-C3CCC(OCCO)C(OCCO)C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O",IYVFNTXFRYQLRP-VVSTWUKXSA-N
TROXIPIDE,APLACE;TROXIPIDE,CHEMBL1566956,BRD:BRD-A68589262-001-04-3;BRD:BRD-BRD-A68589262-001-04-3,rep_primary;rep_single_dose,GLUCOSAMINE SYNTHETASE STIMULANT,,GASTROESOPHAGEAL REFLUX DISEASE (GERD),,LAUNCHED,,Small molecule,-1,"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC;COC1CC(CC(OC)C1OC)C(=O)NC1CCCNC1, COC1CC(CC(OC)C1OC)C(=O)NC1CCCNC1",YSIITVVESCNIPR-UHFFFAOYSA-N
TRV130,OLICERIDINE;OLINVYK;OLYNVIK;TRV-130;TRV130,CHEMBL2443262,BRD:BRD-BRD-K35626314-003-01-1;BRD:BRD-K35626314-003-01-1,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRM1,,,PHASE 3,,Small molecule,4,COC1CCSC1CNCC[C@]1(CCOC2(CCCC2)C1)C1CCCCN1;COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1,DMNOVGJWPASQDL-OAQYLSRUSA-N
TRYPTANTHRIN,GNF-PF-2691;TCMDC-125859;TRYPTANTHRIN,CHEMBL306946,BRD:BRD-BRD-K76973696-001-12-6;BRD:BRD-K76973696-001-12-6,rep_multi_dose;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,IDO1,,,PRECLINICAL,,Small molecule,NA,O=C1c2ccccc2-n2c1nc1ccccc1c2=O;O=C1C2CCCCC2-N2C1NC1CCCCC1C2=O,VQQVWGVXDIPORV-UHFFFAOYSA-N
TRYTOPHAN-,"(-)-TRYPTOPHAN;5-HYDROXY-;5-HYDROXY-L-TRYPTOPHAN;5-HYDROXYTRYPTOPHAN;5-HYDROXYTRYPTOPHAN L-FORM;CINCOFARM;DL;DL-;DL-5-HTP;DL-5-HYDROXYTRYPTOPHAN;DL-HYDROXYTRYPTOPHAN;DL-OXITRIPTAN;GPPE PDR SACH;HYDROXYTRYPTOPHAN;L-;L-5-HTP;L-5-HYDROXYTRYPTOPHAN;L-TRYPTOPHAN;LEVOTHYM;LEVOTININE;LEVOTONINE;NSC-13119;NSC-92523;OPTIMAX;OPTIMAX WV;OXITRIPTAN;OXYFAN;PACITRON;PRETONINE;QUIETIM;SEROTONYL;TELESOL;TRIPTENE;TRYPTOPHAN;TRYPTOPHAN ((-),L,S);TRYTOPHAN-",CHEMBL350221;CHEMBL54976,BRD:BRD-BRD-K83776863-001-08-9;BRD:BRD-K83776863-001-08-9,rep_primary;rep_single_dose,SEROTONIN RECEPTOR PARTIAL AGONIST,CASR;IDO1;SLC36A1;WARS;WARS2,"ANXIETY, BLOATING, CONSTIPATION, FATIGUE, SLEEPLESSNESS",,LAUNCHED,,Small molecule,4,"N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O;N[C@@H](CC1C[NH]C2CCCCC12)C(O)=O, N[C@@H](CC1C[NH]C2CCCCC12)C(O)=O",QIVBCDIJIAJPQS-VIFPVBQESA-N
TS-011,TS-011,,BRD:BRD-K00004685-001-01-9,rep_single_dose,DELAYED VASOSPASM ANTAGONIST,,,,,,,NA,,
TTNPB,TTNPB,,BRD:BRD-BRD-K49685476-001-15-9;BRD:BRD-K49685476-001-15-9,rep_primary;rep_single_dose,RETINOID RECEPTOR AGONIST,RARA;RARB;RARG,,,PHASE 1,,,NA,"C\C(=C/C1CCC(CC1)C(O)=O)C1CCC2C(C1)C(C)(C)CCC2(C)C, C\C(=C/C1CCC(CC1)C(O)=O)C1CCC2C(C1)C(C)(C)CCC2(C)C, C\C(=C/C1CCC(CC1)C(O)=O)C1CCC2C(C1)C(C)(C)CCC2(C)C",
TTP-22,TTP-22,,BRD:BRD-BRD-K64852730-001-01-7;BRD:BRD-K64852730-001-01-7,rep_primary;rep_single_dose,CASEIN KINASE INHIBITOR,CSNK2A1,,,PRECLINICAL,,,NA,CC1CCC(CC1)-C1CSC2NCNC(SCCC(O)=O)C12,
TU-2100,TU-2100,,BRD:BRD-BRD-K44590731-001-01-7;BRD:BRD-K44590731-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 2,,,NA,CCOC(=O)C1CCCCC1OC(=O)CCCCCCCC(=O)OC1CCCCC1C(=O)OCC,
TUAMINOHEPTANE,NSC-1091;TUAMINOHEPTANE,CHEMBL123693,BRD:BRD-A19958636-065-04-4;BRD:BRD-BRD-A19958636-065-04-4,rep_primary;rep_single_dose,,,NASAL CONGESTION,,LAUNCHED,,Small molecule,-1,CCCCCC(C)N,VSRBKQFNFZQRBM-UHFFFAOYSA-N
TUBASTATIN A,TUBASTATIN A,CHEMBL2018302,CTRP:411749;GDSC1:265,ctrp;gdsc,,,,,,,Small molecule,NA,CN1CCc2c(c3ccccc3n2Cc2ccc(C(=O)NO)cc2)C1,GOVYBPLHWIEHEJ-UHFFFAOYSA-N
TUBASTATIN-A,TUBASTATIN-A,,BRD:BRD-BRD-K00627859-003-03-7;BRD:BRD-K00627859-003-03-7,rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC6,,,PRECLINICAL,,,NA,"CN1CCC2C(C1)C1CCCCC1N2CC1CCC(CC1)C(=O)NO, CN1CCC2C(C1)C1CCCCC1N2CC1CCC(CC1)C(=O)NO, CN1CCC2C(C1)C1CCCCC1N2CC1CCC(CC1)C(=O)NO",
TUBOCURARINE ION,D-TUBOCURARINE;TUBOCURARINE;TUBOCURARINE CATION;TUBOCURARINE ION,CHEMBL339427,BRD:BRD-BRD-K99621550-300-01-8;BRD:BRD-K99621550-300-01-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,ACHE;CHRNA2;HTR3A;HTR3B;KCNN1;KCNN2;KCNN3;ZACN,ANESTHETIC,,LAUNCHED,,Small molecule,4,COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C;COC1CC2CCN(C)[C@H]3CC4CCC(OC5C(O)C(OC)CC6CC[N+](C)(C)[C@H](CC7CCC(O)C(OC1CC23)C7)C56)CC4,JFJZZMVDLULRGK-URLMMPGGSA-O
TUCIDINOSTAT,CHIDAMIDE;CS-055;CS055;EPIDAZA;EPIDAZA IN CHINA;HBI-8000;TUCIDINOSTAT,CHEMBL3621988,BRD:BRD-K95216408-001-02-9,rep_single_dose,HDAC INHIBITOR,,,,,,Small molecule,3,Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1,SZMJVTADHFNAIS-BJMVGYQFSA-N
TUFTSIN,TUFTSIN,,BRD:BRD-K00003336-001-01-9,rep_single_dose,MACROPHAGE ACTIVATOR,,,,,,,NA,,
TUG-770,TUG-770,,BRD:BRD-BRD-K56086081-001-01-7;BRD:BRD-K56086081-001-01-7,rep_primary;rep_single_dose,FREE FATTY ACID RECEPTOR AGONIST,FFAR1,,,PRECLINICAL,,,NA,OC(=O)CCC1CCC(CC1F)C#CC1CCCCC1CC#N,
TUG-891,TUG-891,,BRD:BRD-BRD-K24282351-001-01-4;BRD:BRD-K24282351-001-01-4,rep_primary;rep_single_dose,FREE FATTY ACID RECEPTOR AGONIST,FFAR4,,,PRECLINICAL,,,NA,CC1CCC(CC1)-C1CCC(F)CC1COC1CCC(CCC(O)=O)CC1,
TULOBUTEROL HYDROCHLORIDE,ATENOS;BERACHIN;BRELOMAX;BREMAX;CHLIBAMOL;HOKUNALIN;LOBUTEROL;NSC-758643;RESPACAL;TULOBUTEROL;TULOBUTEROL HCL;TULOBUTEROL HYDROCHLORIDE,CHEMBL1159717,BRD:BRD-A37441042-003-04-8;BRD:BRD-BRD-A37441042-003-04-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,ASTHMA,,LAUNCHED,,Small molecule,4,CC(C)(C)NCC(O)c1ccccc1Cl;CC(C)(C)NCC(O)C1CCCCC1CL,YREYLAVBNPACJM-UHFFFAOYSA-N
TULRAMPATOR,TULRAMPATOR,,BRD:BRD-K00005240-001-01-9,rep_single_dose,ANTIDEPRESSANT,,,,,,,NA,,
TW-37,TW-37,,BRD:BRD-BRD-K28360340-001-08-3;BRD:BRD-K28360340-001-08-3;CTRP:609596;GDSC1:1149,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,BCL INHIBITOR,BCL2;BCL2L1;MCL1,,,PRECLINICAL,,,NA,"CC(C)C1CCCCC1CC1CC(C(=O)NC2CCC(CC2)S(=O)(=O)C2CCCCC2C(C)(C)C)C(O)C(O)C1O, CC(C)C1CCCCC1CC1CC(C(=O)NC2CCC(CC2)S(=O)(=O)C2CCCCC2C(C)(C)C)C(O)C(O)C1O",
TW37,TW 37;TW37,,GDSC1:1149,gdsc,,,,,,,,NA,,
TWS-119,TWS-119,,BRD:BRD-BRD-K94176593-001-09-4;BRD:BRD-K94176593-001-09-4,rep_multi_dose;rep_primary;rep_single_dose,GLYCOGEN SYNTHASE KINASE INHIBITOR,GSK3B;JUN;MYC,,,PRECLINICAL,,,NA,"NC1CCCC(C1)-C1CC2C(OC3CCCC(O)C3)NCNC2[NH]1, NC1CCCC(C1)-C1CC2C(OC3CCCC(O)C3)NCNC2[NH]1",
TWS119,TWS119,,GDSC1:366,gdsc,,,,,,,,NA,,
TXA127,5-ILE-ANGIOTENSIN-(1-7);ANGIOTENSIN (1-7);ANGIOTENSIN 1-7;ANGIOTENSIN FRAGMENT 1-7;ANGIOTENSIN PEPTIDE (1-7);ANGIOTENSIN-(1-7);ASP-ARG-VAL-TYR-ILE-HIS-PRO;BF-ANGIOTENSIN 1-7;HUMAN ANGIOTENSIN II (1-7);SH-HEPTAPEPTIDE-13;TXA-127;TXA127,CHEMBL3545347,BRD:BRD-BRD-K36040345-001-01-1;BRD:BRD-K36040345-001-01-1,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR AGONIST,,,,PHASE 2,,Protein,2,"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O;CC[C@H](C)[C@H](NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1C[NH]CN1)C(=O)N1CCC[C@H]1C(O)=O, CC[C@H](C)[C@H](NC(=O)[C@H](CC1CCC(O)CC1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1C[NH]CN1)C(=O)N1CCC[C@H]1C(O)=O",PVHLMTREZMEJCG-GDTLVBQBSA-N
TY-52156,TY-52156,,BRD:BRD-K66584608-001-03-9,rep_single_dose,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,S1PR3,,,,,,NA,,
TYLOSIN A,E713;TYLAN;TYLOSIN;TYLOSIN A,CHEMBL42743,BRD:BRD-BRD-K37753391-046-03-2;BRD:BRD-K37753391-046-03-2,rep_primary;rep_single_dose,PROTEIN SYNTHESIS INHIBITOR,,"GRAM-POSITIVE BACTERIAL INFECTIONS, COLITIS",,LAUNCHED,,Small molecule,-1,"CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC, CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC;CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC",WBPYTXDJUQJLPQ-VMXQISHHSA-N
TYLOXAPOL,ALEVAIRE;NSC-90255;SUPERINONE;TACHOLIQUINE;TYLOXAPOL,CHEMBL1201548,BRD:BRD-BRD-U25960968-000-01-9;BRD:BRD-BRD-U48018661-000-01-9;BRD:BRD-U25960968-000-01-9;BRD:BRD-U48018661-000-01-9,rep_multi_dose;rep_primary;rep_single_dose,NFKB PATHWAY INHIBITOR,LPL;NFKB2,,,LAUNCHED,"Multiple values for structure_id: {'U48018661', 'U25960968'}, defaulting to None",Unknown,4,"C=O.C1CO1.CC(C)(C)CC(C)(C)C1CCC(O)CC1, , , C=O.C1CO1.CC(C)(C)CC(C)(C)C1CCC(O)CC1",
TYLVALOSIN (EMA EPAR: VETERINARY),AIVLOSIN;TYLOSIN ACETATE ISOVALERATE;TYLOSIN ACETATE ISOVALERTE;TYLVALOSIN;TYLVALOSIN (EMA EPAR: VETERINARY),CHEMBL2103834,BRD:BRD-K00079560-001-02-9,rep_single_dose,,,,,,,Small molecule,-1,CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC,KCJJINQANFZSAM-HZDSEHBESA-N
TYRPHOSTIN-A9,TYRPHOSTIN-A9,,BRD:BRD-BRD-K40255344-001-17-6;BRD:BRD-K40255344-001-17-6,rep_multi_dose;rep_primary;rep_single_dose,"PROTEIN TYROSINE KINASE INHIBITOR, TYROSINE KINASE INHIBITOR",,,,PRECLINICAL,,,NA,CC(C)(C)C1CC(C=C(C#N)C#N)CC(C1O)C(C)(C)C,
TYRPHOSTIN-AG-1296,TYRPHOSTIN-AG-1296,,BRD:BRD-BRD-K76064317-001-07-3;BRD:BRD-K76064317-001-07-3,rep_multi_dose;rep_primary;rep_single_dose,FLT3 INHIBITOR,FLT3,,,PRECLINICAL,,,NA,"COC1CC2NCC(NC2CC1OC)-C1CCCCC1, COC1CC2NCC(NC2CC1OC)-C1CCCCC1",
TYRPHOSTIN-AG-1478,TYRPHOSTIN-AG-1478,,BRD:BRD-BRD-K68336408-001-10-9;BRD:BRD-K68336408-001-10-9,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;MAPK14,,,PRECLINICAL,,,NA,COC1CC2NCNC(NC3CCCC(CL)C3)C2CC1OC,
TYRPHOSTIN-AG-18,TYRPHOSTIN-AG-18,,BRD:BRD-BRD-K49657628-001-14-8;BRD:BRD-K49657628-001-14-8,rep_primary;rep_single_dose,"EGFR INHIBITOR, TYROSINE KINASE INHIBITOR",EGFR,,,PRECLINICAL,,,NA,"OC1CCC(C=C(C#N)C#N)CC1O, OC1CCC(C=C(C#N)C#N)CC1O, OC1CCC(C=C(C#N)C#N)CC1O",
TYRPHOSTIN-AG-494,TYRPHOSTIN-AG-494,,BRD:BRD-BRD-K34533029-001-08-5;BRD:BRD-K34533029-001-08-5,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PRECLINICAL,,,NA,OC1CCC(CC1O)\C=C(/C#N)C(=O)NC1CCCCC1,
TYRPHOSTIN-AG-825,TYRPHOSTIN-AG-825,,BRD:BRD-K87919739-001-08-9,rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,ERBB2,,,,,,NA,,
TYRPHOSTIN-AG-835,TYRPHOSTIN-AG-835,,BRD:BRD-BRD-K17415526-001-03-5;BRD:BRD-K17415526-001-03-5,rep_primary;rep_single_dose,PROTEIN TYROSINE KINASE INHIBITOR,EGFR,,,PRECLINICAL,,,NA,C[C@H](NC(=O)C(=C\C1CCC(O)C(O)C1)\C#N)C1CCCCC1,
TYRPHOSTIN-AG-879,TYRPHOSTIN-AG-879,,BRD:BRD-BRD-K59469039-001-08-0;BRD:BRD-K59469039-001-08-0,rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,ERBB2;KDR;NTRK1,,,PRECLINICAL,,,NA,"CC(C)(C)C1CC(CC(C1O)C(C)(C)C)\C=C(/C#N)C(N)=S, CC(C)(C)C1CC(CC(C1O)C(C)(C)C)\C=C(/C#N)C(N)=S",
TYRPHOSTIN-AG-99,TYRPHOSTIN-AG-99,,BRD:BRD-BRD-K60184833-001-05-6;BRD:BRD-K60184833-001-05-6,rep_multi_dose;rep_primary;rep_single_dose,TYROSINE KINASE INHIBITOR,EGFR,,,PRECLINICAL,,,NA,NC(=O)C(=C\C1CCC(O)C(O)C1)\C#N,
TYVERB,GSK-572016;GW-2016;GW-572016;GW-572016X;GW572016;LAPATINIB;TYKERB;TYVERB,CHEMBL554,GDSC1:119;GDSC2:1558,gdsc,,,,,,,Small molecule,4,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,BCFGMOOMADDAQU-UHFFFAOYSA-N
U-0124,U-0124,,BRD:BRD-BRD-K63169195-001-01-5;BRD:BRD-K63169195-001-01-5,rep_primary;rep_single_dose,MEK INHIBITOR,,,,PRECLINICAL,,,NA,CS\C(N)=C(C#N)\C(C#N)=C(/N)SC,
U-0126,U-0126,CHEMBL100473,BRD:BRD-BRD-K18787491-001-08-6;BRD:BRD-BRD-K91701654-001-03-1;BRD:BRD-K18787491-001-08-6;BRD:BRD-K91701654-001-03-1,rep_multi_dose;rep_primary;rep_single_dose,MEK INHIBITOR,AKT1;CHEK1;GSK3B;LCK;MAP2K1;MAP2K2;MAP2K7;MAPK1;MAPK11;MAPK12;MAPK14;MAPK8;PRKCA;RAF1;ROCK1;RPS6KB1;SGK1,,,PRECLINICAL,"Multiple values for structure_id: {'K91701654', 'K18787491'}, defaulting to None",Small molecule,NA,"N\C(SC1CCCCC1N)=C(C#N)/C(C#N)=C(/N)SC1CCCCC1N, N\C(SC1CCCCC1N)=C(C#N)/C(C#N)=C(\N)SC1CCCCC1N, N\C(SC1CCCCC1N)=C(C#N)/C(C#N)=C(/N)SC1CCCCC1N;N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N",DVEXZJFMOKTQEZ-MJZABRMRSA-N
U-0521,U-0521,,BRD:BRD-BRD-K08953028-001-09-6;BRD:BRD-K08953028-001-09-6,rep_primary;rep_single_dose,CATECHOL O METHYLTRANSFERASE INHIBITOR,COMT,,,PRECLINICAL,,,NA,CC(C)C(=O)C1CCC(O)C(O)C1,
U-104,4-{[(4'-FLUOROPHENYL)CARBAMOYL]AMINO}BENZENESULFONAMIDE;NSC-213841;SLC-0111;SLC0111;U-104,CHEMBL1615281,BRD:BRD-BRD-K77867004-001-02-7;BRD:BRD-K77867004-001-02-7,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,CA1;CA12;CA2;CA9,,,PRECLINICAL,,Small molecule,1,"NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1;NS(=O)(=O)C1CCC(NC(=O)NC2CCC(F)CC2)CC1, NS(=O)(=O)C1CCC(NC(=O)NC2CCC(F)CC2)CC1",YJQZNWPYLCNRLP-UHFFFAOYSA-N
U-18666A,U-18666A,,BRD:BRD-BRD-K22025381-003-01-9;BRD:BRD-K22025381-003-01-9,rep_multi_dose;rep_primary;rep_single_dose,OXIDOSQUALENE CYCLASE INHIBITOR,,,,PRECLINICAL,,,NA,CCN(CC)CCO[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3CC=C2C1,
U-19920,"ALEXAN;ALEXAN 100;ARA-C;ARA-CYTIDINE;ARABINOCYTOSINE;ARABINOSYL CYTOSINE;ARACYTIDINE;ARACYTIN;ARACYTINE;CYTARABINE;CYTARABINE LIPOSOME;CYTARABINOSIDE;CYTARABINUM;CYTOSAR;CYTOSAR-U;DEPOCYT;DEPOCYTE;NSC-287459;SPONGOCYTIDINE;TARABINE PFS;U 19920A;U-19,920;U-19920",CHEMBL803,GDSC1:1006;GDSC2:1006,gdsc,,,,,,,Small molecule,4,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
U-50488-(-),U-50488-(-),,BRD:BRD-BRD-K53532120-003-09-5;BRD:BRD-BRD-K53532120-003-11-1;BRD:BRD-K53532120-003-09-5;BRD:BRD-K53532120-003-11-1,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRK1,,,PRECLINICAL,,,NA,"CN([C@H]1CCCC[C@@H]1N1CCCC1)C(=O)CC1CCC(CL)C(CL)C1, CN([C@H]1CCCC[C@@H]1N1CCCC1)C(=O)CC1CCC(CL)C(CL)C1, CN([C@H]1CCCC[C@@H]1N1CCCC1)C(=O)CC1CCC(CL)C(CL)C1",
U-54494A,U-54494A,,BRD:BRD-BRD-K20995441-001-02-5;BRD:BRD-K20995441-001-02-5,rep_primary;rep_single_dose,OPIOID RECEPTOR AGONIST,OPRK1,,,PRECLINICAL,,,NA,CN([C@@H]1CCCC[C@@H]1N1CCCC1)C(=O)C1CCC(CL)C(CL)C1,
U-75799E,U-75799E,,BRD:BRD-BRD-K77070363-001-01-5;BRD:BRD-K77070363-001-01-5,rep_primary;rep_single_dose,GROWTH HORMONE RELEASING FACTOR AGONIST,GHSR,,,PHASE 1,,,NA,C[C@H](NC(=O)[C@@H](CC1C[NH]C2CCCCC12)NC(=O)[C@@H](N)CC1CNC[NH]1)C(=O)N[C@@H](CC1C[NH]C2CCCCC12)C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](CCCCN)C(N)=O,
U-99194,U-99194,,BRD:BRD-BRD-K70281171-050-08-9;BRD:BRD-K70281171-050-08-9,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD3,,,PRECLINICAL,,,NA,CCCN(CCC)C1CC2CC(OC)C(OC)CC2C1,
UAMC-00039,UAMC-00039,,BRD:BRD-K38966689-300-02-9,rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4;DPP7,,,,,,NA,,
UB-165,UB-165,,BRD:BRD-A14574269-051-02-2;BRD:BRD-BRD-A14574269-051-02-2,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA3;CHRNA4;CHRNB2,,,PRECLINICAL,,,NA,"CLC1CCC(CN1)C1=CCCC2CCC1N2, CLC1CCC(CN1)C1=CCCC2CCC1N2",
UBENIMEX,(-)-BESTATIN;BESTATIN;NK-421;NSC-265489;UBENIMEX,CHEMBL29292,BRD:BRD-BRD-K59574735-001-11-8;BRD:BRD-K59574735-001-11-8,rep_multi_dose;rep_primary;rep_single_dose,LEUKOTRIENE SYNTHESIS INHIBITOR,LTA4H;RNPEP,ACUTE MYELOID LEUKEMIA (AML),,LAUNCHED,,Small molecule,2,"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O;CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1CCCCC1)C(O)=O, CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1CCCCC1)C(O)=O",VGGGPCQERPFHOB-RDBSUJKOSA-N
UBP-296,UBP-296,,BRD:BRD-A45499626-001-04-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIK1,,,,,,NA,,
UBP-302,UBP-302,,BRD:BRD-BRD-K79753741-001-01-7;BRD:BRD-K79753741-001-01-7,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIK1,,,PRECLINICAL,,,NA,"N[C@@H](CN1CCC(=O)N(CC2CCCCC2C(O)=O)C1=O)C(O)=O, N[C@@H](CN1CCC(=O)N(CC2CCCCC2C(O)=O)C1=O)C(O)=O, N[C@@H](CN1CCC(=O)N(CC2CCCCC2C(O)=O)C1=O)C(O)=O",
UBP-310,UBP-310,,BRD:BRD-K09597601-001-02-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRIK1;GRIK5,,,,,,NA,,
UBROGEPANT ANHYDROUS,MK-1602;UBRELVY;UBROGEPANT;UBROGEPANT ANHYDROUS,CHEMBL2364638,BRD:BRD-K00090624-001-01-9,rep_single_dose,,,,,,,Small molecule,4,C[C@@H]1[C@H](c2ccccc2)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F,DDOOFTLHJSMHLN-ZQHRPCGSSA-N
UC-112,UC-112,,BRD:BRD-K73610817-001-10-9,rep_single_dose,XIAP INHIBITOR,XIAP,,,,,,NA,,
UCL-2077,UCL-2077,,BRD:BRD-BRD-K50325075-001-02-1;BRD:BRD-K50325075-001-02-1,rep_primary;rep_single_dose,SLOW AFTERHYPERPOLARIZATION CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,"C(NC(C1CCCCC1)(C1CCCCC1)C1CCCCC1)C1CCCNC1, C(NC(C1CCCCC1)(C1CCCCC1)C1CCCCC1)C1CCCNC1",
ZYDENA,DA-8159;UDENAFIL;ZYDENA,CHEMBL2103849,BRD:BRD-K00003266-001-01-9,rep_single_dose,PHOSPHODIESTERASE INHIBITOR,,,,,,Small molecule,3,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1,IYFNEFQTYQPVOC-UHFFFAOYSA-N
UF-010,UF-010,,BRD:BRD-K20480395-001-02-9,rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC2;HDAC3;HDAC8,,,,,,NA,,
UFENAMATE,COMBEC;FLUFENAMIC ACID BUTYL ESTER;UFENAMATE,CHEMBL2105605,BRD:BRD-BRD-K84173274-001-01-6;BRD:BRD-K84173274-001-01-6,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,PTGS1;PTGS2,"ECZEMA, DERMATITIS",,LAUNCHED,,Small molecule,-1,CCCCOC(=O)c1ccccc1Nc1cccc(C(F)(F)F)c1;CCCCOC(=O)C1CCCCC1NC1CCCC(C1)C(F)(F)F,JDLSRXWHEBFHNC-UHFFFAOYSA-N
UH-232-(+),UH-232-(+),,BRD:BRD-BRD-K66715657-050-01-0;BRD:BRD-K66715657-050-01-0,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,DRD2;DRD3;DRD4;HTR1A,,,PRECLINICAL,,,NA,CCCN(CCC)[C@@H]1CCC2C(OC)CCCC2[C@@H]1C,
UK-356618,UK-356618,,BRD:BRD-K57011718-001-01-5,rep_single_dose,METALLOPROTEINASE INHIBITOR,MMP13;MMP14;MMP2;MMP3;MMP9,,,,,,NA,,
UK-383367,UK-383367,,BRD:BRD-BRD-K06294530-001-01-5;BRD:BRD-K06294530-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,"PROCOLLAGEN C-ENDOPEPTIDASE INHIBITOR, PROCOLLAGEN C-ENDOPEPTIDASE INHIBITORS",BMP1,,,PHASE 1,"Multiple values for MOA: {'PROCOLLAGEN C-ENDOPEPTIDASE INHIBITORS', 'PROCOLLAGEN C-ENDOPEPTIDASE INHIBITOR, PROCOLLAGEN C-ENDOPEPTIDASE INHIBITORS'}, defaulting to 'PROCOLLAGEN C-ENDOPEPTIDASE INHIBITOR, PROCOLLAGEN C-ENDOPEPTIDASE INHIBITORS'",,NA,"NC(=O)C1NOC(N1)[C@H](CCCC1CCCCC1)CC(=O)NO, NC(=O)C1NOC(N1)[C@H](CCCC1CCCCC1)CC(=O)NO, NC(=O)C1NOC(N1)[C@H](CCCC1CCCCC1)CC(=O)NO",
UK-5099,UK-5099,,BRD:BRD-K19558579-001-02-9,rep_single_dose,MONOCARBOXYLATE TRANSPORTER INHIBITOR,SLC16A1,,,,,,NA,,
UKI-1,UKI-1,,BRD:BRD-K00003367-001-01-9,rep_single_dose,UROKINASE INHIBITOR,,,,,,,NA,,
ULIFLOXACIN,ULIFLOXACIN,CHEMBL345937,BRD:BRD-A61633223-001-02-8;BRD:BRD-BRD-A61633223-001-02-8,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,-1,"CC1Sc2c(C(=O)O)c(=O)c3cc(F)c(N4CCNCC4)cc3n21;CC1SC2C(C(O)=O)C(=O)C3CC(F)C(CC3N12)N1CCNCC1, CC1SC2C(C(O)=O)C(=O)C3CC(F)C(CC3N12)N1CCNCC1",SUXQDLLXIBLQHW-UHFFFAOYSA-N
ULIPRISTAL ACETATE ULIPRISTAL,ULIPRISNIL;ULIPRISTAL;ULIPRISTAL ACETATE ULIPRISTAL,CHEMBL2103846,BRD:BRD-BRD-K64381438-001-03-8;BRD:BRD-K64381438-001-03-8,rep_multi_dose;rep_primary;rep_single_dose,PROGESTERONE RECEPTOR ANTAGONIST,PGR,CONTRACEPTIVE,,LAUNCHED,,Small molecule,4,"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C;CN(C)C1CCC(CC1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12, CN(C)C1CCC(CC1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12",HKDLNTKNLJPAIY-WKWWZUSTSA-N
UMECLIDINIUM ION,GSK-573719;GSK573719;UMECLIDINIUM;UMECLIDINIUM CATION;UMECLIDINIUM ION,CHEMBL1187833,BRD:BRD-BRD-K46692793-004-01-8;BRD:BRD-K46692793-004-01-8,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3,"CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BRONCHITIS, EMPHYSEMA",,LAUNCHED,,Small molecule,4,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2;OC(C1CCCCC1)(C1CCCCC1)C12CC[N+](CCOCC3CCCCC3)(CC1)CC2,FVTWTVQXNAJTQP-UHFFFAOYSA-N
UMI-77,UMI 77;UMI-77,,GDSC2:1939,gdsc,,,,,,,,NA,,
UNBS-5162,UNBS-5162,,BRD:BRD-BRD-K30933884-001-01-0;BRD:BRD-K30933884-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,,,,PHASE 1,,,NA,CN(C)CCN1C(=O)C2CCCC3CC(NC(N)=O)CC(C1=O)C23,
UNC-0638,UNC 0683;UNC-0638,,GDSC1:1236;GDSC1:245,gdsc,,,,,,,,NA,,
UNC-1215,UNC-1215,,GDSC1:1262,gdsc,,,,,,,,NA,,
UNC2327,UNC-2327;UNC2327,,BRD:BRD-BRD-K60635008-001-01-5;BRD:BRD-K60635008-001-01-5,rep_primary;rep_single_dose,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,PRMT3,,,PRECLINICAL,,,NA,O=C(NCC(=O)N1CCCCC1)NC1CCC2NNSC2C1,
UNC3230,UNC-3230;UNC3230,,BRD:BRD-BRD-K46344388-001-01-3;BRD:BRD-K46344388-001-01-3,rep_primary;rep_single_dose,PHOSPHATIDYL-INOSITOL ACTIVATOR,PIP5K1C,,,PRECLINICAL,,,NA,NC(=O)C1NC(NC2CCCCC2)SC1NC(=O)C1CCCCC1,
UNC926,UNC-926;UNC926,,BRD:BRD-BRD-K22229656-003-01-5;BRD:BRD-K22229656-003-01-5,rep_primary;rep_single_dose,MBT INHIBITOR,L3MBTL1,,,PRECLINICAL,,,NA,BRC1CCCC(C1)C(=O)N1CCC(CC1)N1CCCC1,
UNC0224,UNC0224,,BRD:BRD-BRD-K77428767-001-01-7;BRD:BRD-K77428767-001-01-7,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT1;EHMT2,,,PRECLINICAL,,,NA,"COC1CC2C(NC3CCN(C)CC3)NC(NC2CC1OCCCN(C)C)N1CCCN(C)CC1, COC1CC2C(NC3CCN(C)CC3)NC(NC2CC1OCCCN(C)C)N1CCCN(C)CC1",
UNC0321,UNC0321,,BRD:BRD-BRD-K74236984-001-04-8;BRD:BRD-K74236984-001-04-8;CTRP:635576,ctrp;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT2,,,PRECLINICAL,,,NA,"COC1CC2C(NC3CCN(C)CC3)NC(NC2CC1OCCOCCN(C)C)N1CCCN(C)CC1, COC1CC2C(NC3CCN(C)CC3)NC(NC2CC1OCCOCCN(C)C)N1CCCN(C)CC1",
UNC0631,UNC0631,,BRD:BRD-BRD-K13060017-001-02-1;BRD:BRD-K13060017-001-01-3;BRD:BRD-K13060017-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT2,,,PRECLINICAL,,,NA,"COC1CC2C(NC3CCN(CC4CCCCC4)CC3)NC(NC2CC1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C, COC1CC2C(NC3CCN(CC4CCCCC4)CC3)NC(NC2CC1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C",
UNC0638,UNC0638,,BRD:BRD-BRD-K86856088-001-06-9;BRD:BRD-K86856088-001-06-9;CTRP:594665;GDSC1:1236;GDSC1:245,ctrp;gdsc;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT1;EHMT2,,,PRECLINICAL,,,NA,"COC1CC2C(NC3CCN(CC3)C(C)C)NC(NC2CC1OCCCN1CCCC1)C1CCCCC1, COC1CC2C(NC3CCN(CC3)C(C)C)NC(NC2CC1OCCCN1CCCC1)C1CCCCC1, COC1CC2C(NC3CCN(CC3)C(C)C)NC(NC2CC1OCCCN1CCCC1)C1CCCCC1",
UNC0638:NAVITOCLAX (1:1 MOL/MOL),UNC0638:NAVITOCLAX (1:1 MOL/MOL),,CTRP:660270,ctrp,,,,,,,,NA,,
UNC0642,UNC0642,,BRD:BRD-BRD-K60130390-001-02-1;BRD:BRD-K60130390-001-02-1;GDSC1:1263,gdsc;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT1;EHMT2,,,PRECLINICAL,,,NA,"COC1CC2C(NC3CCN(CC3)C(C)C)NC(NC2CC1OCCCN1CCCC1)N1CCC(F)(F)CC1, COC1CC2C(NC3CCN(CC3)C(C)C)NC(NC2CC1OCCCN1CCCC1)N1CCC(F)(F)CC1, COC1CC2C(NC3CCN(CC3)C(C)C)NC(NC2CC1OCCCN1CCCC1)N1CCC(F)(F)CC1",
UNC0646,UNC0646,,BRD:BRD-BRD-K87465484-001-02-7;BRD:BRD-K87465484-001-02-7,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT2,,,PRECLINICAL,,,NA,"COC1CC2C(NC3CCN(CC3)C3CCCCC3)NC(NC2CC1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C, COC1CC2C(NC3CCN(CC3)C3CCCCC3)NC(NC2CC1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C, COC1CC2C(NC3CCN(CC3)C3CCCCC3)NC(NC2CC1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C",
UNC0737,UNC0737,,BRD:BRD-BRD-K02988401-001-01-2;BRD:BRD-K02988401-001-01-2,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EHMT1;EHMT2,,,PRECLINICAL,,,NA,COC1CC2C(NC(NC2CC1OCCCN1CCCC1)C1CCCCC1)N(C)C1CCN(CC1)C(C)C,
UNC1215,UNC1215,,BRD:BRD-BRD-K83189926-001-03-1;BRD:BRD-K83189926-001-03-1;GDSC1:1262,gdsc;rep_primary;rep_single_dose,L3MBTL ANTAGONIST,L3MBTL3,,,PRECLINICAL,,,NA,"O=C(N1CCC(CC1)N1CCCC1)C1CCC(C(=O)N2CCC(CC2)N2CCCC2)C(NC2CCCCC2)C1, O=C(N1CCC(CC1)N1CCCC1)C1CCC(C(=O)N2CCC(CC2)N2CCCC2)C(NC2CCCCC2)C1",
UNC1999,UNC1999,,BRD:BRD-BRD-K26989966-001-03-5;BRD:BRD-K26989966-001-03-5;BRD:BRD-K26989966-001-07-9,oncref_1;rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,EZH2,,,PRECLINICAL,"Multiple values for MOA: {'INHIBITOR OF EZH2', 'HISTONE LYSINE METHYLTRANSFERASE INHIBITOR'}, defaulting to 'HISTONE LYSINE METHYLTRANSFERASE INHIBITOR'",,NA,"CCCC1CC(C)[NH]C(=O)C1CNC(=O)C1CC(CC2N(NCC12)C(C)C)-C1CCC(NC1)N1CCN(CC1)C(C)C, CCCC1CC(C)[NH]C(=O)C1CNC(=O)C1CC(CC2N(NCC12)C(C)C)-C1CCC(NC1)N1CCN(CC1)C(C)C, CCCC1CC(C)[NH]C(=O)C1CNC(=O)C1CC(CC2N(NCC12)C(C)C)-C1CCC(NC1)N1CCN(CC1)C(C)C",
UNC2025,UNC2025,,BRD:BRD-BRD-K91283740-003-01-6;BRD:BRD-K91283740-003-01-6,rep_primary;rep_single_dose,"MER TYROSINE KINASE INHIBITOR, FLT3 INHIBITOR",FLT3;MERTK,,,PRECLINICAL,"Multiple values for MOA: {'FLT3 INHIBITOR, MER TYROSINE KINASE INHIBITOR', 'MER TYROSINE KINASE INHIBITOR, FLT3 INHIBITOR'}, defaulting to 'MER TYROSINE KINASE INHIBITOR, FLT3 INHIBITOR'",,NA,CCCCNC1NCC2C(CN([C@H]3CC[C@H](O)CC3)C2N1)-C1CCC(CN2CCN(C)CC2)CC1,
UNC2250,UNC2250,,BRD:BRD-BRD-K01773560-001-02-4;BRD:BRD-K01773560-001-02-4,rep_multi_dose;rep_primary;rep_single_dose,MER TYROSINE KINASE INHIBITOR,MERTK,,,PRECLINICAL,,,NA,"CCCCNC1NCC(-C2CCC(CN3CCOCC3)CN2)C(N[C@H]2CC[C@H](O)CC2)N1, CCCCNC1NCC(-C2CCC(CN3CCOCC3)CN2)C(N[C@H]2CC[C@H](O)CC2)N1",
UNC669,UNC669,,BRD:BRD-BRD-K21906513-001-04-0;BRD:BRD-K21906513-001-04-0,rep_primary;rep_single_dose,L3MBTL ANTAGONIST,L3MBTL1,,,PRECLINICAL,,,NA,"BRC1CNCC(C1)C(=O)N1CCC(CC1)N1CCCC1, BRC1CNCC(C1)C(=O)N1CCC(CC1)N1CCCC1",
UNDECYLENIC-ACID,UNDECYLENIC-ACID,,BRD:BRD-K19189338-001-03-2,rep_single_dose,OTHER ANTIFUNGAL,,,,,,,NA,,
UPADACITINIB HYDRATE,ABT-494;RINVOQ;UPADACITINIB;UPADACITINIB ANHYDROUS;UPADACITINIB HEMIHYDRATE;UPADACITINIB HYDRATE,CHEMBL3622821,BRD:BRD-K00003286-001-01-9,rep_single_dose,JAK INHIBITOR,,,,,,Small molecule,4,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,WYQFJHHDOKWSHR-MNOVXSKESA-N
WX-671,MESUPRON;UPAMOSTAT;WX-671,CHEMBL4206119,BRD:BRD-K00003218-001-01-9,rep_single_dose,SERINE PROTEASE INHIBITOR,,,,,,Small molecule,2,CCOC(=O)N1CCN(C(=O)[C@H](Cc2cccc(/C(N)=N\O)c2)NS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)CC1,HUASEDVYRABWCV-NDEPHWFRSA-N
UPF-1069,UPF-1069,,BRD:BRD-BRD-K77950083-001-03-3;BRD:BRD-K77950083-001-03-3,rep_primary;rep_single_dose,PARP INHIBITOR,PARP2,,,PRECLINICAL,,,NA,"O=C(COC1CCCC2C1CC[NH]C2=O)C1CCCCC1, O=C(COC1CCCC2C1CC[NH]C2=O)C1CCCCC1, O=C(COC1CCCC2C1CC[NH]C2=O)C1CCCCC1",
UPRIFOSBUVIR,IDX-21437;IDX21437;MK-3682;UPRIFOSBUVIR,CHEMBL3833371,BRD:BRD-K00003526-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,2,CC(C)OC(=O)[C@@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(Cl)[C@@H]1O)Oc1ccccc1,SFPFZQKYPOWCSI-KHFYHRBSSA-N
UPROSERTIB,AKT INHIBITOR GSK-2141795;AKT INHIBITOR GSK2141795;GSK-2141795;GSK-2141795C;GSK2141795;GSK2141795C;UPROSERTIB,CHEMBL3137336,BRD:BRD-BRD-K38332599-001-01-3;BRD:BRD-K38332599-001-01-3;GDSC2:1553;GDSC2:2106,gdsc;rep_multi_dose;rep_primary;rep_single_dose,AKT INHIBITOR,AKT1;AKT2;AKT3,,,PHASE 2,,Small molecule,2,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl;CN1NCC(CL)C1-C1CC(OC1CL)C(=O)N[C@H](CN)CC1CCC(F)C(F)C1,AXTAPYRUEKNRBA-JTQLQIEISA-N
URACIL,BMS-205603-01;FLUOROURACIL SPECIFIED COMPOUND C;HYBAR X;LAMIVUDINE IMPURITY E;LAMIVUDINE IMPURITY E RS;NSC-3970;PYROD;SQ-6201;SQ-7726;SQ-8493;URACIL,CHEMBL566,BRD:BRD-BRD-K80129304-001-08-1;BRD:BRD-K80129304-001-08-1,rep_multi_dose;rep_primary;rep_single_dose,,DPYD;UCKL1,,,LAUNCHED,,Small molecule,3,"O=c1cc[nH]c(=O)[nH]1;OC1CCNC(O)N1, OC1CCNC(O)N1",ISAKRJDGNUQOIC-UHFFFAOYSA-N
URAPIDIL,EBRANTIL;NSC-310405;URAPIDIL,CHEMBL279229,BRD:BRD-BRD-K73196317-003-14-8;BRD:BRD-K73196317-003-14-8,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,HTR1A,HYPERTENSION,,LAUNCHED,,Small molecule,3,"COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1;COC1CCCCC1N1CCN(CCCNC2CC(=O)N(C)C(=O)N2C)CC1, COC1CCCCC1N1CCN(CCCNC2CC(=O)N(C)C(=O)N2C)CC1, COC1CCCCC1N1CCN(CCCNC2CC(=O)N(C)C(=O)N2C)CC1",ICMGLRUYEQNHPF-UHFFFAOYSA-N
URB597,KDS-4103;ORG-231295;URB 597;URB-597;URB597,CHEMBL184238,BRD:BRD-BRD-K92169341-001-11-2;BRD:BRD-K92169341-001-11-2,rep_primary;rep_single_dose,FAAH INHIBITOR,FAAH;FAAH2;TRPA1,,,PHASE 1,,Small molecule,1,"NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1;NC(=O)C1CCCC(C1)-C1CCCC(OC(=O)NC2CCCCC2)C1, NC(=O)C1CCCC(C1)-C1CCCC(OC(=O)NC2CCCCC2)C1, NC(=O)C1CCCC(C1)-C1CCCC(OC(=O)NC2CCCCC2)C1",ROFVXGGUISEHAM-UHFFFAOYSA-N
UREAPHIL,(13C) UREA;(2-ETHYLCROTONOYL)-;13-C UREA;13-C-UREA;13C-UREA;14C-UREA;AQUADRATE;ASTYN;AZODICARBOXYLIC ACID-DIAMIDE;BALNEUM PLUS;BREATHTEK UBT FOR H-PYLORI;C-13;C-14;CALMURID;CARBAMIDE;CARBON 14 UREA;CARBON-13 UREA;CARBON-14 UREA;CARBONE (13) UREA;CIS-;CIS-(2-ETHYLCROTONYL)UREA;CRONIL;E-927A;E927B;ECTYLCARBAMIDE;ECTYLUREA;EKTYL;EUCERIN;FLEXIFOOT;FLEXITOL;HELICOSOL;HYDROMOL INTENSIVE;INS NO.927A;INS-927A;LEVANIL;MERETEK UBT KIT (W/ PRANACTIN);NEUROPROCIN;NOSTAL;NOSTYN;NSC-163913;NSC-169502;NSC-34375;NUTRAPLUS;PACETYN;PYLORI-CHEK BREATH TEST;PYTEST;PYTEST KIT;SENTIAL E;ST.JAMES BALM;STERILE UREA;UREA;UREA ((SUP 13)C);UREA ((SUP 14)C);UREA (13C);UREA (14C);UREA 13 C;UREA 14 C;UREA C 13;UREA C 14;UREA C-13;UREA C-14;UREA-14C;UREAPHIL,CHEMBL1908316;CHEMBL2096635;CHEMBL2096648;CHEMBL985,BRD:BRD-BRD-K88052444-001-08-8;BRD:BRD-K88052444-001-08-8,rep_primary;rep_single_dose,HYDROXY RADICAL FORMATION STIMULANT,ARG1;CA2;CTNNB1,"PSORIASIS, XEROSIS CUTIS, ICHTHYOSIS VULGARIS, ECZEMA, KERATOSIS, DERMATITIS",,LAUNCHED,,Small molecule,4,NC(N)=O,XSQUKJJJFZCRTK-UHFFFAOYSA-N
URETHANE,CARBAMIC ACID;ETHYL CARBAMATE;ETHYL ESTER;LEUCETHANE;NSC-746;O-ETHYLURETHANE;PRACARBAMINE;URETHAN;URETHANE,CHEMBL462547,BRD:BRD-BRD-K24297741-001-05-2;BRD:BRD-K24297741-001-05-2,rep_primary;rep_single_dose,LOCAL ANESTHETIC,,,,PRECLINICAL,,Small molecule,4,CCOC(N)=O,JOYRKODLDBILNP-UHFFFAOYSA-N
URIC-ACID,URIC-ACID,,BRD:BRD-BRD-K01295354-001-02-8;BRD:BRD-K01295354-001-02-8,rep_multi_dose;rep_primary;rep_single_dose,,PYGL,,,PHASE 3,,,NA,O=C1[NH]C2[NH]C(=O)[NH]C(=O)C2[NH]1,
URIDINE,1-.BETA.-D-RIBOFURANOSYLURACIL;NSC-20256;URACIL RIBOSIDE;URIDINE,CHEMBL100259,BRD:BRD-BRD-K13050303-001-17-3;BRD:BRD-BRD-K13050303-001-18-1;BRD:BRD-K13050303-001-17-3;BRD:BRD-K13050303-001-18-1,rep_multi_dose;rep_primary;rep_single_dose,DOPAMINE RECEPTOR AGONIST,LSM6;TYMP,,,PHASE 2,,Small molecule,3,"O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(=O)[NH]C1=O, OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(=O)[NH]C1=O",DRTQHJPVMGBUCF-XVFCMESISA-N
URIDINE-TRIACETATE,URIDINE-TRIACETATE,,BRD:BRD-BRD-K18323388-001-01-1;BRD:BRD-K18323388-001-01-1,rep_primary;rep_single_dose,,,OROTIC ACIDURIA,,LAUNCHED,,,NA,CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N1CCC(=O)[NH]C1=O,
URMC-099,URMC-099,,BRD:BRD-K66908976-001-01-8,rep_single_dose,MIXED LINEAGE KINASE INHIBITOR,CDKL2;DAPK3;FLT3;LRRK2;MAP3K10;MAP3K11;MAP3K2;MAP3K9;SRPK2,,,,,,NA,,
UROLITHIN-A,UROLITHIN-A,,BRD:BRD-K00003383-001-01-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
URSODOXICOLTAURINE,TAUROURSODEOXYCHOLIC ACID;TAUROURSODESOXYCHOLIC ACID;TAURURSODIOL;UR-906;URSODEOXY CHOLIC ACID;URSODEOXYCHOLYLTAURINE;URSODOXICOLTAURINE,CHEMBL272427,BRD:BRD-BRD-K45245728-335-01-4;BRD:BRD-K45245728-335-01-4,rep_primary;rep_single_dose,CHOLESTEROL INHIBITOR,,,,PHASE 2,,Small molecule,4,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C;C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,BHTRKEVKTKCXOH-LBSADWJPSA-N
URSONORM,ACTIGALL;CHOLURSO;DESTOLIT;NSC-683769;URDOX;URSO;URSO 250;URSO FORTE;URSODEOXYCHOLATE;URSODEOXYCHOLIC ACID;URSODESOXYCHOLIC ACID;URSODIOL;URSOFALK;URSOGAL;URSONORM,CHEMBL1551,BRD:BRD-BRD-K15697815-001-16-2;BRD:BRD-K15697815-001-16-2,rep_primary;rep_single_dose,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",AKR1C2;NR1H4,GALLSTONES,,LAUNCHED,"Multiple values for MOA: {'NUCLEAR FACTOR ERYTHROID DERIVED, LIKE (NRF2) ACTIVATOR', 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'}, defaulting to 'LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED'
Multiple values for repurposing_target: {'AKR1C2;NR1H4', 'NR1H4'}, taking the union",Small molecule,4,"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C;C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C, C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C",RUDATBOHQWOJDD-UZVSRGJWSA-N
URSOLIC-ACID,URSOLIC-ACID,,BRD:BRD-BRD-K68185022-001-14-8;BRD:BRD-K68185022-001-14-8,rep_primary;rep_single_dose,"ATPASE INHIBITOR, NFKB PATHWAY INHIBITOR, STAT INHIBITOR",HSD11B1;PLA2G1B;PTPN1;PYGM,,,PHASE 1,,,NA,"C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O, C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O",
USL311,USL 311;USL-311;USL311,CHEMBL4297449,BRD:BRD-K00091126-001-01-9,rep_single_dose,,,,,,,Small molecule,1,CC(C)N1CCC(N2CCCN(c3cccc(C(=O)Nc4ccncc4)n3)CC2)CC1,XNUNVQKARNSSEO-UHFFFAOYSA-N
USNIACIN-(+),USNIACIN-(+),,BRD:BRD-A12417644-001-07-6;BRD:BRD-BRD-A12417644-001-07-6,rep_multi_dose;rep_primary;rep_single_dose,MAP KINASE ACTIVATOR,PTPN1,,,PRECLINICAL,,,NA,"CC(=O)C1C(=O)C=C2OC3C(C(O)C(C)C(O)C3C(C)=O)[C@@]2(C)C1=O, CC(=O)C1C(=O)C=C2OC3C(C(O)C(C)C(O)C3C(C)=O)[C@@]2(C)C1=O",
V-51,V-51,,BRD:BRD-BRD-K75052463-001-01-4;BRD:BRD-K75052463-001-01-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,PHASE 1,,,NA,COC1CC(CN2CCN(CC2)C2CCC(F)CC2)CC(OC)C1OC,
VABORBACTAM,RPX-7009;RPX7009;VABORBACTAM,CHEMBL3317857,BRD:BRD-K00003306-001-01-9,rep_single_dose,BETA LACTAMASE INHIBITOR,,,,,,Small molecule,4,O=C(O)C[C@@H]1CC[C@H](NC(=O)Cc2cccs2)B(O)O1,IOOWNWLVCOUUEX-WPRPVWTQSA-N
VADADUSTAT,AKB-6548;B-506;B506;PG-1016548;PG1016548;VADADUSTAT,CHEMBL3646221,BRD:BRD-K00003407-001-01-9,rep_single_dose,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,,,,,,Small molecule,3,O=C(O)CNC(=O)c1ncc(-c2cccc(Cl)c2)cc1O,JGRXMPYUTJLTKT-UHFFFAOYSA-N
VAF-347,VAF-347,,CTRP:659226,ctrp,,,,,,,,NA,,
VAL,VAL,,BRD:BRD-BRD-K59424860-001-01-4,rep_primary,,BCAT1;PCCB;VARS,,,PHASE 2,,,NA,CC(C)[C@@H](N)C(O)=O,
VAL-TYR,VAL-TYR,,BRD:BRD-K00004630-001-01-9,rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,,,,,,,NA,,
ZELITREX,VALACICLOVIR;VALACV;VALACYCLOVIR;VALTREX;ZELITREX,CHEMBL1349,BRD:BRD-BRD-K46435977-003-11-1;BRD:BRD-K46435977-003-11-1,rep_primary;rep_single_dose,DNA POLYMERASE INHIBITOR,,"SHINGLES, VIRUS HERPES SIMPLEX (HSV)",,LAUNCHED,,Small molecule,4,"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21;CC(C)[C@H](N)C(=O)OCCOCN1CNC2C1NC(N)[NH]C2=O, CC(C)[C@H](N)C(=O)OCCOCN1CNC2C1NC(N)[NH]C2=O",HDOVUKNUBWVHOX-QMMMGPOBSA-N
VALBENAZINE,MT-5199;NBI-98854;VALBENAZINE,CHEMBL2364639,BRD:BRD-K00003233-001-01-9,rep_single_dose,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,,,,,,Small molecule,4,COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2,GEJDGVNQKABXKG-CFKGEZKQSA-N
VALDYN,BEXTRA;NSC-759846;SC-65872;VALDECOXIB;VALDYN,CHEMBL865,BRD:BRD-BRD-K12994359-001-18-4;BRD:BRD-K12994359-001-18-4;CTRP:32372,ctrp;rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,CA12;PTGS2,,,WITHDRAWN,,Small molecule,4,"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1;CC1ONC(C1-C1CCC(CC1)S(N)(=O)=O)-C1CCCCC1, CC1ONC(C1-C1CCC(CC1)S(N)(=O)=O)-C1CCCCC1",LNPDTQAFDNKSHK-UHFFFAOYSA-N
VALETHAMATE ION,VALETHAMATE;VALETHAMATE CATION;VALETHAMATE ION,CHEMBL2111176,BRD:BRD-A56613951-004-01-1;BRD:BRD-BRD-A56613951-004-01-1,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM1;CHRM4;CHRM5,LABOR INDUCTION,,LAUNCHED,,Small molecule,-1,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1;CCC(C)C(C(=O)OCC[N+](C)(CC)CC)C1CCCCC1,UPPMZCXMQRVMME-UHFFFAOYSA-N
VALGANCICLOVIR,VALGANCICLOVIR,CHEMBL1201314,BRD:BRD-A50922295-001-01-3;BRD:BRD-BRD-A50922295-001-01-3,rep_primary;rep_single_dose,DNA SYNTHESIS INHIBITOR,,CYTOMEGALOVIRUS (CMV),,LAUNCHED,,Small molecule,4,"CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)[nH]c(N)nc21;CC(C)[C@H](N)C(=O)OCC(CO)OCN1CNC2C1NC(N)[NH]C2=O, CC(C)[C@H](N)C(=O)OCC(CO)OCN1CNC2C1NC(N)[NH]C2=O",WPVFJKSGQUFQAP-GKAPJAKFSA-N
VALNEMULIN,VALNEMULIN,CHEMBL1688852,BRD:BRD-BRD-K33813875-003-01-8;BRD:BRD-K33813875-003-01-8,rep_multi_dose;rep_primary;rep_single_dose,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,,"DYSENTRY, COLITIS, PNEUMONIA",,LAUNCHED,,Small molecule,-1,C=C[C@]1(C)C[C@@H](OC(=O)CSC(C)(C)CNC(=O)[C@H](N)C(C)C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O;CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@]23CCC(=O)[C@H]2[C@]1(C)[C@H](C)CC3,LLYYNOVSVPBRGV-MVNKZKPCSA-N
VALNIVUDINE,VALNIVUDINE,CHEMBL4300944,BRD:BRD-K00091275-001-01-9,rep_single_dose,,,,,,,Small molecule,3,CCCCCc1ccc(-c2cc3cn([C@H]4C[C@H](O)[C@@H](COC(=O)[C@@H](N)C(C)C)O4)c(=O)nc3o2)cc1,FJRRWJMFUNGZBJ-RBVMOCNTSA-N
VALPROIC-ACID,VALPROIC-ACID,,BRD:BRD-BRD-K41260949-236-16-8;BRD:BRD-K41260949-236-16-8,rep_primary;rep_single_dose,"BENZODIAZEPINE RECEPTOR AGONIST, HDAC INHIBITOR",ABAT;ACADSB;ALDH5A1;HDAC1;HDAC2;HDAC9;OGDH;SCN10A;SCN11A;SCN1A;SCN1B;SCN2A;SCN2B;SCN3A;SCN3B;SCN4A;SCN4B;SCN5A;SCN7A;SCN8A;SCN9A,SEIZURES,,LAUNCHED,"Multiple values for MOA: {'BENZODIAZEPINE RECEPTOR AGONIST, HDAC INHIBITOR', 'HDAC INHIBITOR'}, defaulting to 'BENZODIAZEPINE RECEPTOR AGONIST, HDAC INHIBITOR'",,NA,"CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O",
VALROCEMIDE,TV-1901;VALROCEMIDE,CHEMBL471638,BRD:BRD-BRD-K32804101-001-01-8;BRD:BRD-K32804101-001-01-8,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,CCCC(CCC)C(=O)NCC(N)=O,RALGCAOVRLYSMA-UHFFFAOYSA-N
VALSTAR PRESERVATIVE FREE,AD 32;AD-32;NSC-246131;VALRUBICIN;VALSTAR;VALSTAR PRESERVATIVE FREE,CHEMBL1096885,BRD:BRD-BRD-K72951360-001-01-4;BRD:BRD-K72951360-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,"DNA INHIBITOR, TOPOISOMERASE INHIBITOR",TOP2A,BLADDER CANCER,,LAUNCHED,,Small molecule,4,CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O;CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C2C(O)C3C(=O)C4C(OC)CCCC4C(=O)C3C(O)C2C1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N
VALSARTAN,CGP 48933;CGP-48933;DIOVAN;EXFORGE;NSC-758927;PREXXARTAN;VALSARTAN,CHEMBL1069,BRD:BRD-BRD-K45158365-001-11-4;BRD:BRD-K45158365-001-11-4,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,"HYPERTENSION, CONGESTIVE HEART FAILURE",,LAUNCHED,,Small molecule,4,"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C;CCCCC(=O)N(CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1)[C@@H](C(C)C)C(O)=O, CCCCC(=O)N(CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1)[C@@H](C(C)C)C(O)=O, CCCCC(=O)N(CC1CCC(CC1)-C1CCCCC1-C1NN[NH]N1)[C@@H](C(C)C)C(O)=O",ACWBQPMHZXGDFX-QFIPXVFZSA-N
VANOLED,FIRVANQ;FIRVANQ KIT;MONOHYDROCHLORIDE;NSC-757377;VANCOCIN;VANCOCIN HYDROCHLORIDE;VANCOCIN MATRIGEL;VANCOLED;VANCOMYCIN;VANCOMYCIN (AS HYDROCHLORIDE);VANCOMYCIN HCL;VANCOMYCIN HYDROCHLORIDE;VANCOMYCIN MONOHYDROCHLORIDE;VANCOR;VANOLED,CHEMBL1200628;CHEMBL262777,BRD:BRD-BRD-K91065602-003-05-5;BRD:BRD-K91065602-003-05-5,rep_primary;rep_single_dose,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,,ENDOCARDITIS,,LAUNCHED,,Small molecule,4,"CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2CCC(OC3CC4CC(OC5CCC(CC5CL)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C1CCC(O)C(C1)-C1C(O)CC(O)CC1[C@H](NC5=O)C(O)=O)C3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)C(CL)C2, CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2CCC(OC3CC4CC(OC5CCC(CC5CL)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C1CCC(O)C(C1)-C1C(O)CC(O)CC1[C@H](NC5=O)C(O)=O)C3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)C(CL)C2, CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2CCC(OC3CC4CC(OC5CCC(CC5CL)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C1CCC(O)C(C1)-C1C(O)CC(O)CC1[C@H](NC5=O)C(O)=O)C3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)C(CL)C2;CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.Cl",LCTORFDMHNKUSG-XTTLPDOESA-N
ZD6474,CAPRELSA;GNF-PF-2188;NSC-744325;NSC-760766;VANDETANIB;ZACTIMA;ZD-64;ZD-6474;ZD6474,CHEMBL24828,BRD:BRD-BRD-K77625799-001-07-7;BRD:BRD-K77625799-001-07-7;CTRP:349002,ctrp;rep_multi_dose;rep_primary;rep_single_dose,"EGFR INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",EGFR;EPHA1;EPHA10;EPHA2;EPHA3;EPHA4;EPHA5;EPHA6;EPHA7;EPHA8;EPHB1;EPHB2;EPHB3;EPHB4;EPHB6;ERBB2;ERBB3;ERBB4;FLT1;FLT4;KDR;PTK6;RET;SRC;TEK;VEGFA,MEDULLARY THYROID CANCER (MTC),,LAUNCHED,,Small molecule,4,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1;COC1CC2C(NC3CCC(BR)CC3F)NCNC2CC1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N
VANILLINE,4-HYDROXY-3-METHOXY-BENZYLDEHYDE;FEMA NO. 3107;H-0264;LIOXIN;METHYLPROTOCATECHUIC ALDEHYDE;NATURAL;NPLC-0145;NSC-15351;NSC-403658;NSC-48383;P-HYDROXY-M-METHOXYBENZALDEHYDE;RHOVANIL;VANILLIC ALDEHYDE;VANILLIN;VANILLIN MELTING POINT STANDARD;VANILLINE,CHEMBL13883,BRD:BRD-BRD-K24258499-001-05-8;BRD:BRD-K24258499-001-05-8,rep_primary;rep_single_dose,,ABAT;ALDH5A1,,,PRECLINICAL,,Small molecule,-1,COc1cc(C=O)ccc1O;COC1CC(C=O)CCC1O,MWOOGOJBHIARFG-UHFFFAOYSA-N
VANILLYLACETONE,VANILLYLACETONE,,BRD:BRD-BRD-K33510429-001-03-1;BRD:BRD-K33510429-001-03-1,rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,"COC1CC(CCC(C)=O)CCC1O, COC1CC(CCC(C)=O)CCC1O",
VANIPREVIR,MK-7009;VANIPREVIR,CHEMBL4525964,BRD:BRD-K00003445-001-01-9,rep_single_dose,SERINE PROTEASE INHIBITOR,,,,,,Small molecule,3,CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1,KUQWGLQLLVFLSM-ONAXAZCASA-N
VANITIOLIDE,NSC-406669;VANITIOLIDE,CHEMBL1380480,BRD:BRD-BRD-K26502378-001-07-9;BRD:BRD-K26502378-001-07-9,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,-1,COc1cc(C(=S)N2CCOCC2)ccc1O;COC1CC(CCC1O)C(=S)N1CCOCC1,WQYRHRAZNNRDIA-UHFFFAOYSA-N
VANOXERINE,GBR 12909;GBR-12909;VANOXERINE,CHEMBL281594,BRD:BRD-BRD-K32501161-300-06-2;BRD:BRD-K32501161-300-06-2,rep_multi_dose;rep_primary;rep_single_dose,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",SLC6A3,,,PHASE 3,"Multiple values for MOA: {'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR', 'DOPAMINE UPTAKE INHIBITOR'}, defaulting to 'DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR'",Small molecule,3,"Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1;FC1CCC(CC1)C(OCCN1CCN(CCCC2CCCCC2)CC1)C1CCC(F)CC1, FC1CCC(CC1)C(OCCN1CCN(CCCC2CCCCC2)CC1)C1CCC(F)CC1",NAUWTFJOPJWYOT-UHFFFAOYSA-N
VAPENDAVIR,BTA-798;BTA798;VAPENDAVIR,CHEMBL2062774,BRD:BRD-K00004577-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,2,CCOc1noc2cc(OCCC3CCN(c4ccc(C)nn4)CC3)ccc12,DKSVBVKHUICELN-UHFFFAOYSA-N
VIVANZA,BAY-389456;BAY38-9456;LEVITRA;VARDENAFIL;VIVANZA,CHEMBL1520,BRD:BRD-BRD-K13926615-003-03-3;BRD:BRD-K13926615-003-03-3,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE5A;PDE6G;PDE6H,ERECTILE DYSFUNCTION,,LAUNCHED,,Small molecule,4,"CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12;CCCC1NC(C)C2N1NC([NH]C2=O)-C1CC(CCC1OCC)S(=O)(=O)N1CCN(CC)CC1, CCCC1NC(C)C2N1NC([NH]C2=O)-C1CC(CCC1OCC)S(=O)(=O)N1CCN(CC)CC1",SECKRCOLJRRGGV-UHFFFAOYSA-N
VARENICLINE,"CHANTIX;CP-526,555;CP-526555;VARENICLINE",CHEMBL1396,BRD:BRD-A86216746-046-02-6;BRD:BRD-BRD-A86216746-046-02-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRNA3;CHRNA4;CHRNA6;CHRNA7,SMOKING CESSATION,,LAUNCHED,,Small molecule,4,C1C2CNCC1C1CC3NCCNC3CC21;c1cnc2cc3c(cc2n1)C1CNCC3C1,JQSHBVHOMNKWFT-UHFFFAOYSA-N
VARESPLADIB SODIUM,LY-315920;LY315920;VAREPLADIB;VARESPLADIB;VARESPLADIB SODIUM,CHEMBL148674,BRD:BRD-BRD-K09711437-001-04-3;BRD:BRD-K09711437-001-04-3,rep_primary;rep_single_dose,SECRETORY PHOSPHOLIPASE INHIBITOR,PLA2G2A,,,PHASE 3,,Small molecule,2,CCc1c(C(=O)C(N)=O)c2c(OCC(=O)O)cccc2n1Cc1ccccc1;CCC1C(C(=O)C(N)=O)C2C(OCC(O)=O)CCCC2N1CC1CCCCC1,BHLXTPHDSZUFHR-UHFFFAOYSA-N
VASOSTRICT,8-L-LYSINE;8-L-LYSINEVASOPRESSIN;ARGININE VASOPRESSIN;ARGIPRESSIN OR LYPRESSIN;BETA-HYPOPHAMINE;DIAPID;L-8;LEIORMONE;LYPRESSIN;LYSINE VASOPRESSIN;PITRESSIN;UNSPECIFIED;VASOPHYSIN;VASOPRESSIN;VASOPRESSIN INJECTION;VASOPRESSIN PIG;VASOSTRICT,CHEMBL1200690;CHEMBL373742,BRD:BRD-BRD-K73028949-001-02-8;BRD:BRD-K73028949-001-02-8,rep_primary;rep_single_dose,VASOPRESSIN RECEPTOR AGONIST,AVPR1A;AVPR1B;AVPR2;OXTR,ABDOMINAL DISTENSION,,LAUNCHED,,Protein,4,N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@H](CC2CCC(O)CC2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O;N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,KBZOIRJILGZLEJ-LGYYRGKSSA-N
ZK222584,BAY-86-5127;CGP-79787;K-222584;NVP-PTK787;PTK-787;PTK787;VATALANIB;VATALANIB SUCCINATE;ZK-222584;ZK222584,CHEMBL101253,BRD:BRD-BRD-K70163715-300-05-7;BRD:BRD-K70163715-300-05-7,rep_multi_dose;rep_primary;rep_single_dose,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",EGFR;FLT1;FLT4;KDR;PDGFRB,,,PHASE 3,,Small molecule,3,"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1;CLC1CCC(NC2NNC(CC3CCNCC3)C3CCCCC23)CC1, CLC1CCC(NC2NNC(CC3CCNCC3)C3CCCCC23)CC1, CLC1CCC(NC2NNC(CC3CCNCC3)C3CCCCC23)CC1",YCOYDOIWSSHVCK-UHFFFAOYSA-N
VATINOXAN,L 659066;L-659066;MK-467;VATINOXAN,CHEMBL4298165,BRD:BRD-K00003277-003-01-9,rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,,,Small molecule,-1,CS(=O)(=O)NCCN1C(=O)NC[C@]12CCN1CCc3c(oc4ccccc34)[C@@H]1C2,GTBKISRCRQUFNL-OXJNMPFZSA-N
VBY-825,VBY-825,,BRD:BRD-K36338614-001-02-1,rep_single_dose,CATHEPSIN INHIBITOR,CTSB;CTSL;CTSS,,,,,,NA,,
VCH-916,VCH-916,,BRD:BRD-BRD-K75956464-237-01-5;BRD:BRD-K75956464-237-01-5,rep_primary;rep_single_dose,HCV INHIBITOR,,,,PHASE 1,,,NA,CO[C@H]1CC[C@@H](CC1)N(C(=O)[C@H]1CC[C@H](C)CC1)C1CC(SC1C(O)=O)C1=CCCCC1,
VE-821,VE-821,,BRD:BRD-BRD-K26756394-001-02-2;BRD:BRD-K26756394-001-02-2;GDSC2:2111,gdsc;rep_multi_dose;rep_primary;rep_single_dose,ATR KINASE INHIBITOR,ATR,,,PRECLINICAL,,,NA,CS(=O)(=O)C1CCC(CC1)-C1CNC(N)C(N1)C(=O)NC1CCCCC1,
VX970,BERZOSERTIB;M-6620;M6620;VE-822;VX-970;VX970,CHEMBL3989870,BRD:BRD-BRD-K04701033-001-04-7;BRD:BRD-K04701033-001-03-9;BRD:BRD-K04701033-001-04-7;GDSC2:1613,gdsc;rep_multi_dose;rep_primary;rep_single_dose,ATR KINASE INHIBITOR,ATM;ATR;MTOR;PIK3CG,,,PHASE 2,,Small molecule,2,"CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1;CNCC1CCC(CC1)-C1CC(ON1)-C1NC(CNC1N)-C1CCC(CC1)S(=O)(=O)C(C)C, CNCC1CCC(CC1)-C1CC(ON1)-C1NC(CNC1N)-C1CCC(CC1)S(=O)(=O)C(C)C, CNCC1CCC(CC1)-C1CC(ON1)-C1NC(CNC1N)-C1CCC(CC1)S(=O)(=O)C(C)C",JZCWLJDSIRUGIN-UHFFFAOYSA-N
VE821,VE 821;VE821,,GDSC2:2111,gdsc,,,,,,,,NA,,
VX970,BERZOSERTIB;M-6620;M6620;VE 822;VE-822;VE822;VX-970;VX970,CHEMBL3989870,GDSC2:1613,gdsc,,,,,,,Small molecule,2,CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1,JZCWLJDSIRUGIN-UHFFFAOYSA-N
VECABRUTINIB,BIIB-062;BSK-4841;FP-0182;FP0182;SNS-062;VECABRUTINIB,CHEMBL4297640,BRD:BRD-K00003503-001-01-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,Small molecule,1,NC(=O)[C@H]1CCN(c2ncnc(N)c2F)C[C@@H]1N1CCC[C@@H](Nc2cc(Cl)cc(C(F)(F)F)c2)C1=O,QLRRJMOBVVGXEJ-XHSDSOJGSA-N
VECURONIUM ION,VECURONIUM;VECURONIUM CATION;VECURONIUM ION,CHEMBL1201219,BRD:BRD-BRD-K20168442-004-06-3;BRD:BRD-K20168442-004-06-3,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRNA2,MUSCLE RELAXANT,,LAUNCHED,,Small molecule,4,"CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1, CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1;CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1",BGSZAXLLHYERSY-XQIGCQGXSA-N
VEDAPROFEN FOR VETERINARY USE,CERM 10202;CERM-10202;PM 150;PM-150;QUADRISOL;VEDAPROFEN;VEDAPROFEN FOR VETERINARY USE,CHEMBL2104464,BRD:BRD-K00004714-001-01-9,rep_single_dose,ANTI-INFLAMMATORY AGENT,PTGS2,,,,,Small molecule,-1,CC(C(=O)O)c1ccc(C2CCCCC2)c2ccccc12,VZUGVMQFWFVFBX-UHFFFAOYSA-N
VELARESOL,12C;VELARESOL,CHEMBL2107643,BRD:BRD-K00004580-001-01-9,rep_single_dose,,,,,,,Small molecule,-1,O=Cc1c(O)cccc1OCCCCC(=O)O,NSUDGNLOXMLAEB-UHFFFAOYSA-N
VELBAN,VELBAN,,GDSC1:1004;GDSC2:1004,gdsc,,,,,,,,NA,,
VELCADE,BORTEZOMIB;BORTEZOMIB ACCORD;BORTEZOMIB HYDRATE;LDP-341;NSC-681239;PS-341;VELCADE,CHEMBL325041,GDSC1:104;GDSC2:1191,gdsc,,,,,,,Small molecule,4,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N
VELEDIMEX,INXN-1001;RG-115932;VELEDIMEX,CHEMBL3039523,BRD:BRD-K00003235-001-01-9,rep_single_dose,CYTOCHROME P450 INHIBITOR,,,,,,Small molecule,2,CCC[C@@H](N(NC(=O)c1cccc(OC)c1CC)C(=O)c1cc(C)cc(C)c1)C(C)(C)C,LZWZPGLVHLSWQX-XMMPIXPASA-N
VELIFLAPON,BAY X 1005;BAY-X-005;BAY-X-1005;DG-031;VELIFLAPON,CHEMBL88712,BRD:BRD-BRD-K12852738-001-01-2;BRD:BRD-K12852738-001-01-2,rep_primary;rep_single_dose,LEUKOTRIENE SYNTHESIS INHIBITOR,ALOX5AP,,,PHASE 3,,Small molecule,3,O=C(O)[C@@H](c1ccc(OCc2ccc3ccccc3n2)cc1)C1CCCC1;OC(=O)[C@H](C1CCCC1)C1CCC(OCC2CCC3CCCCC3N2)CC1,ZEYYDOLCHFETHQ-JOCHJYFZSA-N
VELIPARIB,ABT-888;PARP-1 INHIBITOR ABT-888;VELIPARIB,CHEMBL506871,BRD:BRD-BRD-K12737986-001-01-4;BRD:BRD-K12737986-001-01-4;CTRP:606034;GDSC1:1018,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,PARP INHIBITOR,PARP1;PARP2,,,PHASE 3,,Small molecule,3,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1;C[C@]1(CCCN1)C1NC2C(CCCC2[NH]1)C(N)=O,JNAHVYVRKWKWKQ-CYBMUJFWSA-N
VELNEPERIT,S-2367;VELNEPERIT,CHEMBL2016681,BRD:BRD-BRD-K06357403-001-01-4;BRD:BRD-K06357403-001-01-4,rep_primary;rep_single_dose,NEUROPEPTIDE RECEPTOR ANTAGONIST,NPY5R,,,PHASE 2,,Small molecule,2,"CC(C)(C)S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)NC1CCC(CN1)C(F)(F)F, CC(C)(C)S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)NC1CCC(CN1)C(F)(F)F;CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(C(F)(F)F)cn2)CC1",WGEWUYACXPEFPO-AULYBMBSSA-N
VELPATASVIR,GS-5816;VELPATASVIR,CHEMBL3545062,BRD:BRD-K00003133-001-01-9,rep_single_dose,ANTIVIRAL,,,,,,Small molecule,4,COC[C@H]1C[C@@H](c2nc(-c3ccc4c(c3)COc3cc5c(ccc6nc([C@@H]7CC[C@H](C)N7C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c65)cc3-4)c[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1,FHCUMDQMBHQXKK-CDIODLITSA-N
WINFEX XL,ALVENTA XL;AMPHERO XL;BONILUX XL;DEPEFEX XL;EFECTIN;EFEXOR;EFEXOR XL;EFFEXOR;FORAVEN XL;KANGHONG;MENTAVEN XL;NSC-758676;POLITID XL;RANFAXINE XL;RODOMEL XL;SUNVENIZ XL;TARDCAPS XL;TIFAXIN XL;TONPULAR XL;TREVILOR;TRIXAT XL;VAXALIN XL;VELAFAX;VENAXX XL;VENLABLUE XL;VENLADEX XL;VENLAFAXINE;VENLALIC XL;VENLANEO XL;VENLOR;VENSIR XL;VEXARIN XL;VIEPAX;VIEPAX XL;WINFEX XL,CHEMBL637,BRD:BRD-A51714012-003-13-6;BRD:BRD-BRD-A51714012-003-13-6,rep_primary;rep_single_dose,"ADRENERGIC INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",SLC6A2;SLC6A3;SLC6A4,"DEPRESSION, GENERALIZED ANXIETY DISORDER (GAD), PANIC DISORDERS, SOCIAL ANXIETY DISORDER",,LAUNCHED,,Small molecule,4,"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1;COC1CCC(CC1)C(CN(C)C)C1(O)CCCCC1, COC1CCC(CC1)C(CN(C)C)C1(O)CCCCC1, COC1CCC(CC1)C(CN(C)C)C1(O)CCCCC1",PNVNVHUZROJLTJ-UHFFFAOYSA-N
VENOTOCLAX,ABT-199;GDC-0199;RG-7601;RG7601;VENCLEXTA;VENECLEXTA;VENETOCLAX;VENOTOCLAX,CHEMBL3137309,GDSC1:412;GDSC2:1909,gdsc,,,,,,,Small molecule,4,CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,LQBVNQSMGBZMKD-UHFFFAOYSA-N
VER-155008,VER-155008,,BRD:BRD-K32330832-001-01-0;CTRP:411815,ctrp;rep_single_dose,HSP INHIBITOR,HSPA1A,,,,,,NA,,
VER-49009,VER-49009,,BRD:BRD-BRD-K38548312-001-01-0;BRD:BRD-K38548312-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,HSP90AA1,,,PRECLINICAL,,,NA,CCNC(=O)C1[NH]NC(C1-C1CCC(OC)CC1)-C1CC(CL)C(O)CC1O,
VER-52296,AUY;AUY922;LUMINESPIB;NVP-AUY-922;NVP-AUY922;NVP-AUY922-NX;VER-52296,CHEMBL252164,GDSC1:194;GDSC2:1559,gdsc,,,,,,,Small molecule,2,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,NDAZATDQFDPQBD-UHFFFAOYSA-N
VERALIPRIDE,AGRADIL;AGREAL;VERALIPRIDE,CHEMBL2105581,BRD:BRD-K00003433-001-01-9,rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,,,,,,Small molecule,4,C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC,RYJXBGGBZJGVQF-UHFFFAOYSA-N
VERELAN,"(R)-;(R)-VERAPAMIL;CALAN;COVERA-HS;CP-16,533-1;CP-16533-1;CP-165331;D-365;D-VERAPAMIL;DEXVERAPAMIL;IPROVERATRIL;ISOPTIN;NSC-272306NA;TARKA;VERAPAMIL;VERAPAMIL (R)-FORM;VERAPAMIL SLOW RELEASE;VERELAN",CHEMBL197;CHEMBL6966,BRD:BRD-A09533288-003-31-2;BRD:BRD-BRD-A09533288-003-31-2,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,CACNA1A;CACNA1B;CACNA1C;CACNA1D;CACNA1F;CACNA1G;CACNA1I;CACNA1S;CACNB1;CACNB2;CACNB3;CACNB4;CYP3A4;KCNA10;KCNA7;KCNH2;KCNJ11;NALCN;SCN5A;SLC29A4;SLC6A4,HYPERTENSION,,LAUNCHED,,Small molecule,4,"COC1CCC(CCN(C)CCCC(C#N)(C(C)C)C2CCC(OC)C(OC)C2)CC1OC, COC1CCC(CCN(C)CCCC(C#N)(C(C)C)C2CCC(OC)C(OC)C2)CC1OC;COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",SGTNSNPWRIOYBX-UHFFFAOYSA-N
VERBASCOSIDE,VERBASCOSIDE,,BRD:BRD-BRD-K36201510-001-06-7;BRD:BRD-K36201510-001-06-7,rep_primary;rep_single_dose,"PKC INHIBITOR, NFKB PATHWAY INHIBITOR",,,,PHASE 2/PHASE 3,"Multiple values for MOA: {'NFKB PATHWAY INHIBITOR, PKC INHIBITOR', 'PKC INHIBITOR, NFKB PATHWAY INHIBITOR'}, defaulting to 'PKC INHIBITOR, NFKB PATHWAY INHIBITOR'",,NA,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3CCC(O)C(O)C3)O[C@H](CO)[C@H]2OC(=O)\C=C\C2CCC(O)C(O)C2)[C@H](O)[C@H](O)[C@H]1O,
VERECIMON,CCX-282-B;CCX282;GSK-1605786;GSK1605786;VERCIRNON;VERECIMON,CHEMBL2178578,BRD:BRD-BRD-K47929404-001-01-0;BRD:BRD-K47929404-001-01-0,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR9,,,PHASE 3,,Small molecule,3,CC(C)(C)C1CCC(CC1)S(=O)(=O)NC1CCC(CL)CC1C(=O)C1CC[N+]([O-])CC1;CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1,JRWROCIMSDXGOZ-UHFFFAOYSA-N
VERDINEXOR,KPT-335;VERDINEXOR,CHEMBL3545187,BRD:BRD-K00004674-001-01-9,rep_single_dose,EXPORTIN ANTAGONIST,,,,,,Small molecule,1,O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1,OPAKEJZFFCECPN-XQRVVYSFSA-N
VERDIPERSTAT,AZD 3241;AZD-3241;AZD3241;BHV-3241;BHV-3421;VERDIPERSTAT,CHEMBL4297594,BRD:BRD-K00004612-001-01-9,rep_single_dose,MYELOPEROXIDASE INHIBITOR,,,,,,Small molecule,3,CC(C)OCCn1c(=S)[nH]c(=O)c2[nH]ccc21,FVJCUZCRPIMVLB-UHFFFAOYSA-N
VERQUVO,BAY 1021189;BAY-1021189;MK-1242;VERICIGUAT;VERQUVO,CHEMBL4066936,BRD:BRD-K00003234-001-01-9,rep_single_dose,GUANYLATE CYCLASE STIMULANT,,,,,,Small molecule,4,COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N,QZFHIXARHDBPBY-UHFFFAOYSA-N
VERINURAD,RDEA-3170;RDEA3170;VERINURAD,CHEMBL3707347,BRD:BRD-BRD-K36741660-001-01-1;BRD:BRD-K36741660-001-01-1,rep_primary;rep_single_dose,URATE TRANSPORTER INHIBITOR,SLC22A12,,,PHASE 2,,Small molecule,2,CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(=O)O;CC(C)(SC1CCNCC1-C1CCC(C#N)C2CCCCC12)C(O)=O,YYBOLPLTQDKXPM-UHFFFAOYSA-N
VERNAKALANT,VERNAKALANT,CHEMBL2111112,BRD:BRD-BRD-K19741547-003-01-7;BRD:BRD-K19741547-003-01-7,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNA5,ATRIAL FIBRILLATION (AF),,LAUNCHED,,Small molecule,4,COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC;COC1CCC(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)CC1OC,VBHQKCBVWWUUKN-KZNAEPCWSA-N
VERUBECESTAT,MK-8931;SCH 900931;SCH-900931;SCH900931;VERUBECESTAT,CHEMBL3301601,BRD:BRD-K00003229-001-01-9,rep_single_dose,BETA SECRETASE INHIBITOR,,,,,,Small molecule,3,CN1C(N)=N[C@](C)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)CS1(=O)=O,YHYKUSGACIYRML-KRWDZBQOSA-N
VERUBULIN,AZIXA;MPC-6827;MX-128495;VERUBULIN,CHEMBL492399,BRD:BRD-BRD-K42673188-001-01-1;BRD:BRD-K42673188-001-01-1,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB,,,PHASE 2,,Small molecule,2,"COC1CCC(CC1)N(C)C1NC(C)NC2CCCCC12, COC1CCC(CC1)N(C)C1NC(C)NC2CCCCC12;COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1",SNHCRNMVYDHVDT-UHFFFAOYSA-N
VERUCERFONT,"GSK-561,679;GSK-561679;GSK-561679A;GSK561679;GSK561679A;NBI-77860;VERUCERFONT",CHEMBL1287935,BRD:BRD-K00003180-001-01-9,rep_single_dose,CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST,,,,,,Small molecule,2,CC[C@H](Nc1cc(C)nc2c(-c3ccc(OC)cc3C)c(C)nn12)c1nc(C)no1,VKHVAUKFLBBZFJ-SFHVURJKSA-N
VESAMICOL,(-)-VESAMICOL;(+/-)-VESAMICOL;VESAMICOL,CHEMBL20730,BRD:BRD-BRD-K14765469-003-12-2;BRD:BRD-K14765469-003-12-2,rep_primary;rep_single_dose,ACETYLCHOLINESTERASE INHIBITOR,SLC18A3,,,PRECLINICAL,,Small molecule,NA,"O[C@@H]1CCCC[C@H]1N1CCC(c2ccccc2)CC1;O[C@@H]1CCCC[C@H]1N1CCC(CC1)C1CCCCC1, O[C@@H]1CCCC[C@H]1N1CCC(CC1)C1CCCCC1",YSSBJODGIYRAMI-IAGOWNOFSA-N
VESANOID,ABEREL;ACTICIN;ALL-TRANS RETINOIC ACID;ALL-TRANS-RETINOIC ACID;ALTRENO;ATRA;ATRALIN;AVITA;EUDYNA;KERLOCAL;NSC-122758;ORISTAR RNA;RENOVA;RETIN A;RETIN-A;RETIN-A MICRO;RETIN-A-MICRO;RETINOIC ACID;TRETIN-X;TRETINOIN;VESANOID,CHEMBL38,GDSC1:1009,gdsc,,,,,,,Small molecule,4,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,SHGAZHPCJJPHSC-YCNIQYBTSA-N
VESNARINONE,ARKIN;ARKIN Z;OPC-8212;VESNARINONE,CHEMBL17423,BRD:BRD-BRD-K13414800-001-01-3;BRD:BRD-K13414800-001-01-3,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,KCNH2;PDE3A,CONGESTIVE HEART FAILURE,,LAUNCHED,,Small molecule,2,COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC;COC1CCC(CC1OC)C(=O)N1CCN(CC1)C1CCC2NC(=O)CCC2C1,ZVNYJIZDIRKMBF-UHFFFAOYSA-N
ZENUZOLAC,GIT 27;GIT-027;GIT-27;GLS 1027;GLS-1027;GLS1027;VGX 1027;VGX-1027;VGX1027;ZENUZOLAC,CHEMBL1320667,BRD:BRD-A32269193-001-01-5;BRD:BRD-BRD-A32269193-001-01-5,rep_primary;rep_single_dose,TUMOR NECROSIS FACTOR RECEPTOR ANTAGONIST,TLR4,,,PHASE 1,,Small molecule,2,O=C(O)CC1CC(c2ccccc2)=NO1;OC(=O)CC1CC(=NO1)C1CCCCC1,MUFJHYRCIHHATF-UHFFFAOYSA-N
VICRIVIROC,MK-7690;SCH-351125;SCH-417690 FREE BASE;SCH-D;VICRIVIROC,CHEMBL82301,BRD:BRD-BRD-K84748119-050-01-1;BRD:BRD-K84748119-050-01-1,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR5,,,PHASE 3,,Small molecule,3,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C;COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1C(C)NCNC1C)C1CCC(CC1)C(F)(F)F,CNPVJJQCETWNEU-CYFREDJKSA-N
VIRA-A,ANHYDROUS;ARA-A;ARABINOSYLADENINE;ARASENA-A;CI 673;CI-673;NSC-247519;NSC-404241;NSC-757383;VIDARABINE;VIDARABINE ANHYDROUS;VIDARABINE MONOHYDRATE;VIRA-A,CHEMBL1090,BRD:BRD-BRD-K72093121-001-16-3;BRD:BRD-K72093121-001-16-3,rep_multi_dose;rep_primary;rep_single_dose,ANTIVIRAL,ADA,"VIRUS HERPES SIMPLEX (HSV), VARICELLA-ZOSTER VIRUS (VZV)",,LAUNCHED,,Small molecule,4,"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O;NC1NCNC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O, NC1NCNC2N(CNC12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O",OIRDTQYFTABQOQ-UHTZMRCNSA-N
VINYL GAMMA-AMINOBUTYRIC ACID,"4-AMINO-;5-HEXENOIC ACID;CPP-109;GAMMA VINYL GABA;GAMMA-VINYL GABA;MDL 71,754;MDL-71754;RMI-71754;SABRIL;VIGABATRIN;VINYL GAMMA-AMINOBUTYRIC ACID",CHEMBL89598,BRD:BRD-A07893380-213-01-7;BRD:BRD-BRD-A07893380-213-01-7,rep_primary;rep_single_dose,GABA AMINOTRANSFERASE INHIBITOR,ABAT;GABBR1;SLC32A1,"SEIZURES, SPASMS",,LAUNCHED,,Small molecule,4,C=CC(N)CCC(=O)O;NC(CCC(O)=O)C=C,PJDFLNIOAUIZSL-UHFFFAOYSA-N
VILAZODONE,EMD 515259;EMD-515259;EMD-68-843;VILAZODONE,CHEMBL439849,BRD:BRD-BRD-K58010567-003-02-2;BRD:BRD-K58010567-003-02-2,rep_primary;rep_single_dose,SEROTONIN REUPTAKE INHIBITOR,DRD2;DRD3;HRH1;HTR1A;HTR4;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1;NC(=O)C1CC2CC(CCC2O1)N1CCN(CCCCC2C[NH]C3CCC(CC23)C#N)CC1, NC(=O)C1CC2CC(CCC2O1)N1CCN(CCCCC2C[NH]C3CCC(CC23)C#N)CC1, NC(=O)C1CC2CC(CCC2O1)N1CCN(CCCCC2C[NH]C3CCC(CC23)C#N)CC1",SGEGOXDYSFKCPT-UHFFFAOYSA-N
VITAGLIPTIN,GALVUS;LAF 237;LAF-237;LAF237;NVP-LAF 237;NVP-LAF237;VILDAGLIPTIN;VITAGLIPTIN,CHEMBL142703,BRD:BRD-A94993966-001-04-4;BRD:BRD-A94993966-001-05-1;BRD:BRD-BRD-A94993966-001-04-4;BRD:BRD-BRD-A94993966-001-05-1,rep_primary;rep_single_dose,DIPEPTIDYL PEPTIDASE INHIBITOR,DPP4,DIABETES MELLITUS,,LAUNCHED,,Small molecule,4,"N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2;OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N, OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N",SYOKIDBDQMKNDQ-XWTIBIIYSA-N
VILOXAZINE,VILOXAZIN;VILOXAZINE,CHEMBL306700,BRD:BRD-A59198242-003-02-9;BRD:BRD-BRD-A59198242-003-02-9,rep_primary;rep_single_dose,NOREPINEPHRINE REUPTAKE INHIBITOR,SLC6A2,DEPRESSION,,LAUNCHED,,Small molecule,4,CCOc1ccccc1OCC1CNCCO1;CCOC1CCCCC1OCC1CNCCO1,YWPHCCPCQOJSGZ-UHFFFAOYSA-N
VINBLASTINE,[3H]-VINBLASTINE;NSC-47842;VELBAN;VINBLASTINE,CHEMBL159,BRD:BRD-BRD-K06519765-001-01-1;BRD:BRD-K06519765-001-01-1;BRD:BRD-K06519765-065-01-6;GDSC1:1004;GDSC2:1004,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",JUN;TUBA1A;TUBB;TUBD1;TUBE1;TUBG1,"HODGKIN'S LYMPHOMA, TRUE HISTIOCYTIC LYMPHOMA (THL), MYCOSIS, SMALL LYMPHOCYTIC LYMPHOMA (SLL), TESTICULAR CARCINOMA, KAPOSI SARCOMA",,LAUNCHED,,Small molecule,4,"CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC;CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1",JXLYSJRDGCGARV-CFWMRBGOSA-N
VINBURNINE,"3.ALPHA.,16.ALPHA.-EBURNAMONINE;EBURNAMONINE (-)-FORM;NSC-322920;VINBURNINE",CHEMBL1892145,BRD:BRD-BRD-K40227168-001-12-9;BRD:BRD-K40227168-001-12-9,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4,STROKE,,LAUNCHED,,Small molecule,-1,CC[C@]12CCCN3CCc4c(n(c5ccccc45)C(=O)C1)[C@@H]32;CC[C@@]12CCCN3CCC4C([C@H]13)N(C(=O)C2)C1CCCCC41,WYJAPUKIYAZSEM-MOPGFXCFSA-N
VRAAP,ANGIOPAC;ARTERIOVINCA;CETAL;CETAL RETARD;NSC-91998;OXYGERON;PERVINCAMINE;VINCAFOR;VINCAGIL;VINCAMINE;VINCIMAX;VRAAP,CHEMBL1165342,BRD:BRD-BRD-K89704198-001-12-3;BRD:BRD-K89704198-001-12-3,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,CHRM1;CHRM2;CHRM3;CHRM4,,,WITHDRAWN,,Small molecule,4,CC[C@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@@H]32;CC[C@@]12CCCN3CCC4C([C@H]13)N(C1CCCCC41)[C@@](O)(C2)C(=O)OC,RXPRRQLKFXBCSJ-GIVPXCGWSA-N
VINDESINE,COMPOUND 112531;COMPOUND-112531;VINDESINE,CHEMBL219146;CHEMBL238071,BRD:BRD-BRD-K59753975-001-02-6;BRD:BRD-K59753975-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBB;TUBB1,"BREAST CANCER, NON-SMALL CELL LUNG CANCER (NSCLC), MELANOMA",,LAUNCHED,,Small molecule,4,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1;CC[C@]1(O)C[C@H]2C[N@](CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1;CC[C@]1(O)C[C@H]2CN(C1)CCC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](O)[C@]1(O)C(N)=O,HHJUWIANJFBDHT-KOTLKJBCSA-N;HHJUWIANJFBDHT-ZVTSDNJWSA-N
VINFLUNINE,VINFLUNINE,CHEMBL2110725,BRD:BRD-BRD-K64120610-001-01-4;BRD:BRD-BRD-K64120610-046-01-9;BRD:BRD-K64120610-001-01-4;BRD:BRD-K64120610-046-01-9,rep_multi_dose;rep_primary;rep_single_dose,MICROTUBULE INHIBITOR,,BLADDER CANCER,,LAUNCHED,,Small molecule,4,"CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32;CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)C1CC(OC)C(CC41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CCC3C1[NH]C1CCCCC31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC, CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)C1CC(OC)C(CC41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CCC3C1[NH]C1CCCCC31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC",NMDYYWFGPIMTKO-KLCPSUAYSA-N
VINORELBINE BASE,NAVELBIN;NSC-760087;VINORELBINE;VINORELBINE BASE,CHEMBL553025,BRD:BRD-BRD-K69280563-001-01-8;BRD:BRD-K69280563-001-01-8;GDSC1:140;GDSC2:2048,gdsc;rep_multi_dose;rep_primary;rep_single_dose,TUBULIN POLYMERIZATION INHIBITOR,TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8,NON-SMALL CELL LUNG CANCER (NSCLC),,LAUNCHED,,Small molecule,4,"CCC1=C[C@@H]2C[N@](C1)CC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CCC1=C[C@@H]2CN(C1)CC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CCC1=C[C@@H]2CN(C1)CC1C([NH]C3CCCCC13)[C@@](C2)(C(=O)OC)C1CC2C(CC1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC;CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2",GBABOYUKABKIAF-IELIFDKJSA-N
VINORELBINE TARTRATE (1:2),EXELBINE;LIPOSOMAL VINORELBINE TARTRATE;NAVELBINE;TLC-178;TLC178;VINORELBINE (AS TARTRATE);VINORELBINE DITARTARATE;VINORELBINE DITARTRATE;VINORELBINE LIPOSOMAL;VINORELBINE TARTRATE;VINORELBINE TARTRATE (1:2),CHEMBL3039595;CHEMBL538943,GDSC1:140;GDSC2:2048,gdsc,,,,,,,Small molecule,4,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O,CILBMBUYJCWATM-UDRBCWGGSA-N
VINPORAL,"APOVINCAMINIC ACID ETHYL ESTER;AY-27,255;AY-27255;BRAVINTON;CAVINTON;CERACTIN;ETHYL APOVINCAMIN-22-OATE;NSC-760093;RGH 4405;TCV 3B;ULTRA-VINCA;VINPOCETINE;VINPORAL",CHEMBL71752,BRD:BRD-BRD-K53318339-001-24-9;BRD:BRD-K53318339-001-24-9,rep_primary;rep_single_dose,"PHOSPHODIESTERASE INHIBITOR, SODIUM CHANNEL BLOCKER",PDE1A;PDE1C,,,LAUNCHED,,Small molecule,4,"CCOC(=O)C1=C[C@]2(CC)CCCN3CCC4C([C@H]23)N1C1CCCCC41, CCOC(=O)C1=C[C@]2(CC)CCCN3CCC4C([C@H]23)N1C1CCCCC41, CCOC(=O)C1=C[C@]2(CC)CCCN3CCC4C([C@H]23)N1C1CCCCC41;CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32",DDNCQMVWWZOMLN-IRLDBZIGSA-N
VIPADENANT,BIIB-014;BIIB014;CEB-4520;V-2006;V2006;VER-11135;VER-A-00-11;VER-A-00049;VER-A00-11;VER-A00049;VER-ADO-49;VIPADENANT,CHEMBL447664,BRD:BRD-BRD-K56565215-001-01-9;BRD:BRD-K56565215-001-01-9,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PHASE 1,,Small molecule,2,Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N;CC1CC(CN2NNC3C(NC(N)NC23)-C2CCCO2)CCC1N,HQSBCDPYXDGTCL-UHFFFAOYSA-N
VISOMITIN,VISOMITIN,,BRD:BRD-K00003375-004-01-9,rep_single_dose,ANTIOXIDANT,,,,,,,NA,,
VITAMIN-B12,VITAMIN-B12,,BRD:BRD-A75369945-001-01-2;BRD:BRD-BRD-A75369945-001-01-2,rep_primary;rep_single_dose,,,MEGALOBLASTIC ANEMIA,,LAUNCHED,,,NA,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2[N+]3=C1C(C)=C1[C@@H](CCC(N)=O)C(C)(C)C4=[N+]1[CO]31(C#N)N3C([C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]23C)=C(C)C2=[N+]1C(=C4)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1CNC2CC(C)C(C)CC12,
VIXOTRIGINE,BIIB-074;BIIB074;CNV-1014802;CNV1014802;GSK-1014802;GSK1014802;RAXATRIGINE;VIXOTRIGINE,CHEMBL3544913,BRD:BRD-K00003141-003-01-9,rep_single_dose,SODIUM CHANNEL BLOCKER,,,,,,Small molecule,3,NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1,JESCETIFNOFKEU-SJORKVTESA-N
VL285,VL285,,BRD:BRD-K00005338-001-01-9,rep_single_dose,PROTAC,,,,,,,NA,,
VLX600,DNDI1417324;VLX-600;VLX600,CHEMBL2094620,BRD:BRD-BRD-K26122255-001-01-7;BRD:BRD-BRD-K89053832-001-01-0;BRD:BRD-K26122255-001-01-7;BRD:BRD-K89053832-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,"ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR",TP53;USP14,,,PHASE 1,"Multiple values for MOA: {'ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR', 'UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR', 'ANTITUMOR AGENT'}, defaulting to 'ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR'
Multiple values for MOA: {'ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR', 'UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR'}, defaulting to 'ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR'
Multiple values for SMILES: {'C\\C(=N\\NC1NNC2C(N1)[NH]C1C(C)CCCC21)C1CCCCN1', 'CC1CCCC2C1[NH]C1NC(NNC(=C)C3CCCCN3)NNC21'}, defaulting to 'C\\C(=N\\NC1NNC2C(N1)[NH]C1C(C)CCCC21)C1CCCCN1'
Multiple values for repurposing_target: {'TP53;USP14', 'TP53', 'USP14'}, taking the union
Multiple values for repurposing_target: {'TP53;USP14', 'USP14'}, taking the union
Multiple values for structure_id: {'K26122255', 'K89053832'}, defaulting to None",Small molecule,1,C/C(=N/Nc1nnc2c(n1)[nH]c1c(C)cccc12)c1ccccn1;C\C(=N\NC1NNC2C(N1)[NH]C1C(C)CCCC21)C1CCCCN1,UQOSBPRTQFFUOA-NHDPSOOVSA-N
VLX1570,VLX1570,,BRD:BRD-K00003343-001-01-9,rep_single_dose,DEUBIQUITINASE INHIBITOR,,,,,,,NA,,
VNLG/124,HDAC INHIBITOR XV;VNLG/124,,GDSC1:271,gdsc,,,,,,,,NA,,
VOCLOSPORIN,ISA-247;ISA247;ISATX-247;ISATX247;LUPKYNIS;LX-211;LX211;VOCLOSPORIN,CHEMBL2218919,BRD:BRD-K00003472-001-01-9,rep_single_dose,CALCINEURIN INHIBITOR,,,,,,Protein,4,C=C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,BICRTLVBTLFLRD-JDCIFRKPSA-N
VOGLIBOSE,A-71100;AO-128;BASEN;GLUSTAT;VOGLIBOSE,CHEMBL476960,BRD:BRD-BRD-K66850609-001-07-4;BRD:BRD-K66850609-001-07-4,rep_primary;rep_single_dose,GLUCOSIDASE INHIBITOR,MGAM,"DIABETES MELLITUS, HYPERGLYCEMIA",,LAUNCHED,,Small molecule,3,"OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O;OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O, OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O, OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O",FZNCGRZWXLXZSZ-CIQUZCHMSA-N
VOLASERTIB,BI 6727;BI-6727;VOLASERTIB,CHEMBL1233528,BRD:BRD-BRD-K69776681-001-03-8;BRD:BRD-K69776681-001-03-8,rep_multi_dose;rep_primary;rep_single_dose,PLK INHIBITOR,PLK1,,,PHASE 3,,Small molecule,3,"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C;CC[C@H]1N(C(C)C)C2NC(NC3CCC(CC3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)NCC2N(C)C1=O, CC[C@H]1N(C(C)C)C2NC(NC3CCC(CC3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)NCC2N(C)C1=O",SXNJFOWDRLKDSF-STROYTFGSA-N
VOLINANSERIN,M-100907;M100907;MDL-100.907;MDL-100907;MDL100.907;VOLINANSERIN,CHEMBL74355,BRD:BRD-BRD-K23647661-001-02-2;BRD:BRD-K23647661-001-02-2,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR2A;HTR2B;HTR2C;KCNH2,,,PHASE 3,,Small molecule,3,"COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC;COC1CCCC([C@H](O)C2CCN(CCC3CCC(F)CC3)CC2)C1OC, COC1CCCC([C@H](O)C2CCN(CCC3CCC(F)CC3)CC2)C1OC",HXTGXYRHXAGCFP-OAQYLSRUSA-N
VONOPRAZAN,TAK-438;TAKECAB;VOCINTI;VONOPRAZAN,CHEMBL2079130,BRD:BRD-BRD-K32768103-051-02-6;BRD:BRD-K32768103-051-02-6,rep_primary;rep_single_dose,POTASSIUM-COMPETITIVE ACID ANTAGONIST,ATP4A,PEPTIC ULCER DISEASE (PUD),,LAUNCHED,,Small molecule,4,"CNCC1CC(-C2CCCCC2F)N(C1)S(=O)(=O)C1CCCNC1, CNCC1CC(-C2CCCCC2F)N(C1)S(=O)(=O)C1CCCNC1;CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1",BFDBKMOZYNOTPK-UHFFFAOYSA-N
VORAPAXAR,SCH-530348;VORAPAXAR,CHEMBL493982,BRD:BRD-BRD-K93442924-001-03-4;BRD:BRD-K93442924-001-03-4;CTRP:660136,ctrp;rep_primary;rep_single_dose,"THROMBIN INHIBITOR, THROMBIN RECEPTOR ANTAGONIST",F2R,"MYOCARDIAL INFARCTION, PERIPHERAL ARTERY DISEASE (PAD)",,LAUNCHED,"Multiple values for MOA: {'THROMBIN RECEPTOR ANTAGONIST', 'THROMBIN INHIBITOR, THROMBIN RECEPTOR ANTAGONIST'}, defaulting to 'THROMBIN INHIBITOR, THROMBIN RECEPTOR ANTAGONIST'",Small molecule,4,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1;CCOC(=O)N[C@@H]1CC[C@@H]2[C@H](C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\C2CCC(CN2)-C2CCCC(F)C2)C1,ZBGXUVOIWDMMJE-QHNZEKIYSA-N
VORASIDENIB,AG-881;VORASIDENIB,CHEMBL4279047,BRD:BRD-K00003460-001-01-9,rep_single_dose,ISOCITRATE DEHYDROGENASE INHIBITOR,,,,,,Small molecule,3,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,QCZAWDGAVJMPTA-RNFRBKRXSA-N
VOSAROXIN,AG-7352;SNS-595;SPC-595;VORELOXIN;VOSAROXIN,CHEMBL68117,BRD:BRD-BRD-K23677682-003-01-2;BRD:BRD-K23677682-003-01-2,rep_multi_dose;rep_primary;rep_single_dose,TOPOISOMERASE INHIBITOR,TOP2A,,,PHASE 3,,Small molecule,3,CN[C@H]1CN(C[C@@H]1OC)C1CCC2C(N1)N(CC(C(O)=O)C2=O)-C1NCCS1;CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC,XZAFZXJXZHRNAQ-STQMWFEESA-N
VORICONAZOLE,"NSC-759888;UK-109,496;UK-109496;VFEND;VORICONAZOLE",CHEMBL638,BRD:BRD-BRD-K06557128-001-07-0;BRD:BRD-K06557128-001-07-0,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP2C19;CYP2C9;CYP3A4;CYP3A5;PTGS1,"ESOPHAGEAL CANDIDIASIS, ASPERGILLOSIS, SKIN INFECTIONS",,LAUNCHED,,Small molecule,4,"C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F;C[C@@H](C1NCNCC1F)[C@](O)(CN1CNCN1)C1CCC(F)CC1F, C[C@@H](C1NCNCC1F)[C@](O)(CN1CNCN1)C1CCC(F)CC1F, C[C@@H](C1NCNCC1F)[C@](O)(CN1CNCN1)C1CCC(F)CC1F",BCEHBSKCWLPMDN-MGPLVRAMSA-N
ZOLINZA,MK-0683;MK0683;NSC-701852;NSC-748799;NSC-759852;SUBEROYLANILIDE HYDROXAMIC ACID;VORINOSTAT;ZOLINZA,CHEMBL98,BRD:BRD-BRD-K81418486-001-47-5;BRD:BRD-K81418486-001-44-2;BRD:BRD-K81418486-001-47-5;CTRP:56554;GDSC1:1012;GDSC2:1012,ctrp;gdsc;rep_multi_dose;rep_primary;rep_single_dose,HDAC INHIBITOR,HDAC1;HDAC10;HDAC11;HDAC2;HDAC3;HDAC5;HDAC6;HDAC8;HDAC9,CUTANEOUS T-CELL LYMPHOMA (CTCL),,LAUNCHED,,Small molecule,4,"O=C(CCCCCCC(=O)Nc1ccccc1)NO;ONC(=O)CCCCCCC(=O)NC1CCCCC1, ONC(=O)CCCCCCC(=O)NC1CCCCC1, ONC(=O)CCCCCCC(=O)NC1CCCCC1",WAEXFXRVDQXREF-UHFFFAOYSA-N
VORINOSTAT:CARBOPLATIN (1:1 MOL/MOL),VORINOSTAT:CARBOPLATIN (1:1 MOL/MOL),,CTRP:660131,ctrp,,,,,,,,NA,,
VORINOSTAT:NAVITOCLAX (4:1 MOL/MOL),VORINOSTAT:NAVITOCLAX (4:1 MOL/MOL),,CTRP:660301,ctrp,,,,,,,,NA,,
VORTIOXETINE,BRINTELLIX;LU AA21004;LU-AA21004;LUAA21004;VORTIOXETINE,CHEMBL2104993,BRD:BRD-BRD-K53963539-004-02-0;BRD:BRD-K53963539-004-02-0,rep_primary;rep_single_dose,"SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",HTR1A;HTR1B;HTR2A;HTR2C;HTR3A;HTR5A;HTR6;HTR7;SLC6A4,DEPRESSION,,LAUNCHED,,Small molecule,4,"Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1;CC1CCC(SC2CCCCC2N2CCNCC2)C(C)C1, CC1CCC(SC2CCCCC2N2CCNCC2)C(C)C1",YQNWZWMKLDQSAC-UHFFFAOYSA-N
VORUCICLIB,P1446A-05;VORUCICLIB,CHEMBL3905910,BRD:BRD-K00004725-001-01-9,rep_single_dose,CDK9 INHIBITOR,,,,,,Small molecule,2,CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO,MRPGRAKIAJJGMM-OCCSQVGLSA-N
VOTRIENT,GW-786034B;GW786034;GW786034B;NSC-752782;PAZOPANIB;PAZOPANIB (AS HYDROCHLORIDE);PAZOPANIB HCL;PAZOPANIB HYDROCHLORIDE;PAZOPANIB MONOHYDROCHLORIDE;VOTRIENT,CHEMBL1201733;CHEMBL477772,GDSC1:199,gdsc,,,,,,,Small molecule,4,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O;Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl,CUIHSIWYWATEQL-UHFFFAOYSA-N;MQHIQUBXFFAOMK-UHFFFAOYSA-N
XL765,SAR-245409;SAR245409;VOXTALISIB;XL-765;XL765,CHEMBL3545366,BRD:BRD-BRD-K56291712-001-01-0;BRD:BRD-K56291712-001-01-0;GDSC1:375,gdsc;rep_multi_dose;rep_primary;rep_single_dose,"MTOR INHIBITOR, PI3K INHIBITOR",MTOR;PIK3CA,,,PHASE 2,,Small molecule,2,CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21;CCN1C2NC(N)NC(C)C2CC(-C2CC[NH]N2)C1=O,RGHYDLZMTYDBDT-UHFFFAOYSA-N
VP16,BMY 40481;BMY-40481;EPOSIN;ETOPOPHOS;ETOPOPHOS PRESERVATIVE FREE;ETOPOSIDE PHOSPHATE;VEPESID;VEPESIDE;VP-16;VP16,CHEMBL1200645,GDSC1:134,gdsc,,,,,,,Small molecule,4,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OP(=O)(O)O,LIQODXNTTZAGID-OCBXBXKTSA-N
VP-20629,VP-20629,,BRD:BRD-BRD-K21071223-001-02-8;BRD:BRD-K21071223-001-02-8,rep_primary;rep_single_dose,BETA AMYLOID ANTAGONIST,PLA2G2E;SLC36A1,,,PHASE 1,,,NA,OC(=O)CCC1C[NH]C2CCCCC12,
VRT752271,BVD-523;BVD-ERK;ULIXERTINIB;VRT-752271;VRT752271,CHEMBL3590106,GDSC2:1908;GDSC2:2047,gdsc,,,,,,,Small molecule,2,CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1,KSERXGMCDHOLSS-LJQANCHMSA-N
VS-4718,PND-1186;SR-2516;VS-4718,CHEMBL3040440,BRD:BRD-BRD-K09877029-001-01-2;BRD:BRD-K09877029-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,FOCAL ADHESION KINASE INHIBITOR,,,,PHASE 1,,Small molecule,1,CNC(=O)C1CCCCC1NC1CC(NC2CCC(CC2OC)N2CCOCC2)NCC1C(F)(F)F;CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCOCC3)cc2OC)ncc1C(F)(F)F,IGUBBWJDMLCRIK-UHFFFAOYSA-N
VT-464,SEVITERONEL;VT-464,CHEMBL3264610,BRD:BRD-BRD-K72005722-001-01-2;BRD:BRD-K72005722-001-01-2,rep_primary;rep_single_dose,CYTOCHROME P450 INHIBITOR,CYP17A1,,,PHASE 2,,Small molecule,2,CC(C)[C@](O)(c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1)c1c[nH]nn1;CC(C)[C@@](O)(C1C[NH]NN1)C1CCC2CC(OC(F)F)C(OC(F)F)CC2C1,ZBRAJOQFSNYJMF-SFHVURJKSA-N
VTP-27999,VTP-27999,CHEMBL1276678,BRD:BRD-BRD-K81694556-003-01-9;BRD:BRD-K81694556-003-01-9,rep_multi_dose;rep_primary;rep_single_dose,RENIN INHIBITOR,REN,,,PHASE 1,,Small molecule,1,CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1;CN[C@H](CNC(=O)N1CCC[C@H](C1)[C@@H](OCCNC(=O)OC)C1CCCC(CL)C1)C[C@H]1CCCOC1,NXWASIVXQMMPLM-ZXMXYHOLSA-N
VU0240551,VU-0240551;VU0240551,,BRD:BRD-BRD-K27074404-001-08-4;BRD:BRD-K27074404-001-08-4,rep_primary;rep_single_dose,POTASSIUM/CHLORIDE COTRANSPORTER INHIBITOR,SLC12A5,,,PRECLINICAL,,,NA,CC1CSC(NC(=O)CSC2CCC(NN2)-C2CCCCC2)N1,
VU0364739,VU-0364739;VU0364739,,BRD:BRD-BRD-K93317811-003-02-2;BRD:BRD-K93317811-003-02-2,rep_primary;rep_single_dose,PHOSPHOLIPASE INHIBITOR,PLD2,,,PRECLINICAL,,,NA,FC1CCCC(C1)N1CNC(=O)C11CCN(CCNC(=O)C2CCC3CCCCC3C2)CC1,
VU0422288,VU-0422288;VU0422288,,BRD:BRD-BRD-K68674163-001-01-7;BRD:BRD-K68674163-001-01-7,rep_primary;rep_single_dose,"GLUTAMATE RECEPTOR ALLOSTERIC MODULATOR, GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR",GRM3,,,PRECLINICAL,"Multiple values for MOA: {'GLUTAMATE RECEPTOR ALLOSTERIC MODULATOR', 'GLUTAMATE RECEPTOR ALLOSTERIC MODULATOR, GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR'}, defaulting to 'GLUTAMATE RECEPTOR ALLOSTERIC MODULATOR, GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR'",,NA,CLC1CCC(OC2CCC(NC(=O)C3CCCCN3)CC2CL)NC1,
VU0155056,VU0155056,,CTRP:660119,ctrp,,,,,,,,NA,,
VU0155069,VU0155069,,BRD:BRD-BRD-K48535733-003-01-2;BRD:BRD-K48535733-003-01-2,rep_primary;rep_single_dose,PHOSPHOLIPASE INHIBITOR,PLD1,,,PRECLINICAL,,,NA,"C[C@@H](CN1CCC(CC1)N1C2CCC(CL)CC2[NH]C1=O)NC(=O)C1CCC2CCCCC2C1, C[C@@H](CN1CCC(CC1)N1C2CCC(CL)CC2[NH]C1=O)NC(=O)C1CCC2CCCCC2C1",
VU0238429,VU0238429,,BRD:BRD-BRD-K24187789-001-01-7;BRD:BRD-K24187789-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,CHRM5,,,PRECLINICAL,,,NA,"COC1CCC(CN2C(=O)C(=O)C3CC(OC(F)(F)F)CCC23)CC1, COC1CCC(CN2C(=O)C(=O)C3CC(OC(F)(F)F)CCC23)CC1",
VU0357121,VU0357121,,BRD:BRD-BRD-K86109159-001-02-6;BRD:BRD-K86109159-001-02-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM5,,,PRECLINICAL,,,NA,CCCCOC1CCC(CC1)C(=O)NC1CCC(F)CC1F,
VU0360172,VU0360172,,BRD:BRD-K83649660-003-04-9,rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM5,,,,,,NA,,
VU0361737,VU0361737,,BRD:BRD-BRD-K45462423-001-03-7;BRD:BRD-K45462423-001-03-7,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM4,,,PRECLINICAL,,,NA,"COC1CC(NC(=O)C2CCCCN2)CCC1CL, COC1CC(NC(=O)C2CCCCN2)CCC1CL, COC1CC(NC(=O)C2CCCCN2)CCC1CL",
VU0364439,VU0364439,,BRD:BRD-BRD-K72687424-001-02-6;BRD:BRD-K72687424-001-02-6,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM4,,,PRECLINICAL,,,NA,"CLC1CCCCC1NS(=O)(=O)C1CCC(NC(=O)C2CCCCN2)CC1CL, CLC1CCCCC1NS(=O)(=O)C1CCC(NC(=O)C2CCCCN2)CC1CL",
VU0364770,VU0364770,,BRD:BRD-BRD-K66527818-001-02-6;BRD:BRD-K66527818-001-02-6,rep_multi_dose;rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM4,,,PRECLINICAL,,,NA,CLC1CCCC(NC(=O)C2CCCCN2)C1,
VU10010,VU10010,,BRD:BRD-K12483104-001-02-9,rep_single_dose,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,CHRM4,,,,,,NA,,
VU152100,VU152100,,BRD:BRD-K87727457-001-02-9,rep_single_dose,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,CHRM4,,,,,,NA,,
VU1545,VU1545,,BRD:BRD-BRD-K48371964-001-06-5;BRD:BRD-K48371964-001-06-5,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,GRM5,,,PRECLINICAL,,,NA,[O-][N+](=O)C1CCC(CC1)C(=O)NC1CC(NN1-C1CCCCC1F)-C1CCCCC1,
VU29,VU29,,BRD:BRD-BRD-K54783522-001-01-8;BRD:BRD-K54783522-001-01-8,rep_primary;rep_single_dose,GLUTAMATE RECEPTOR POTENTIATOR,GRM5,,,PRECLINICAL,,,NA,[O-][N+](=O)C1CCC(CC1)C(=O)NC1CC(NN1-C1CCCCC1)-C1CCCCC1,
VU591,VU591,,BRD:BRD-K72063794-003-02-9,rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNJ1,,,,,,NA,,
VUBI1,VUBI1,,BRD:BRD-K00126786-001-01-9;BRD:BRD-U00115433-001-01-9,oncref_1;oncref_2,ACTIVATOR OF SOS1,SOS1,,,,"Multiple values for structure_id: {'U00115433', 'K00126786'}, defaulting to None",,NA,,
VUF10166,VUF10166,,BRD:BRD-BRD-K11046126-001-02-0;BRD:BRD-K11046126-001-02-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A;HTR3B,,,PRECLINICAL,,,NA,CN1CCN(CC1)C1NC2CCCCC2NC1CL,
VUF10460,VUF10460,,BRD:BRD-BRD-K90082312-001-01-5;BRD:BRD-K90082312-001-01-5,rep_primary;rep_single_dose,HISTAMINE RECEPTOR AGONIST,HRH4,,,PRECLINICAL,,,NA,CN1CCN(CC1)C1CC(NC(N)N1)-C1CCCCC1,
VUF11207,VUF11207,,BRD:BRD-A93717708-051-01-2;BRD:BRD-BRD-A93717708-051-01-2,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR AGONIST,ACKR3,,,PRECLINICAL,,,NA,COC1CC(CC(OC)C1OC)C(=O)N(CCC1CCCN1C)C\C(C)=C\C1CCCCC1F,
VUMON,VUMON,,GDSC2:1809,gdsc,,,,,,,,NA,,
VX-11E,VX-11E,,BRD:BRD-BRD-K93725829-001-03-8;BRD:BRD-K93725829-001-03-8;GDSC1:262;GDSC2:2096,gdsc;rep_primary;rep_single_dose,MAP KINASE INHIBITOR,MAPK1,,,PRECLINICAL,,,NA,CC1CNC(NC2CCC(F)CC2CL)NC1-C1C[NH]C(C1)C(=O)N[C@H](CO)C1CCCC(CL)C1,
VX-222,LOMIBUVIR;VCH-222;VX-222,CHEMBL3039503,BRD:BRD-BRD-K70610771-001-02-9;BRD:BRD-K70610771-001-02-9,rep_primary;rep_single_dose,HCV INHIBITOR,,,,PHASE 2,,Small molecule,2,C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]1CC[C@H](O)CC1)C1CC(SC1C(O)=O)C#CC(C)(C)C;CC(C)(C)C#Cc1cc(N(C(=O)[C@H]2CC[C@H](C)CC2)[C@H]2CC[C@H](O)CC2)c(C(=O)O)s1,WPMJNLCLKAKMLA-VVPTUSLJSA-N
VX-680,MK-045;MK-0457;MK0457;TOZASERTIB;TOZASERTIB LACTATE;VX-68;VX-680,CHEMBL2105657;CHEMBL572878,CTRP:340501,ctrp,,,,,,,Small molecule,2,C[C@H](O)C(=O)O.Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1;Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,GCIKSSRWRFVXBI-UHFFFAOYSA-N;MHFUWOIXNMZFIW-WNQIDUERSA-N
VX-680 VX 680 VX-68,MK 0457;MK-045;MK-0457;MK0457;TOZASERTIB;TOZASERTIB LACTATE;VX-68;VX-680;VX-680 VX 680 VX-68,CHEMBL2105657;CHEMBL572878,GDSC1:32;GDSC2:1096,gdsc,,,,,,,Small molecule,2,C[C@H](O)C(=O)O.Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1;Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,GCIKSSRWRFVXBI-UHFFFAOYSA-N;MHFUWOIXNMZFIW-WNQIDUERSA-N
VX-702,VX-702,CHEMBL1090090,BRD:BRD-BRD-K07736136-001-04-6;BRD:BRD-K07736136-001-04-6;GDSC1:1028,gdsc;rep_multi_dose;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,IL1B;IL6;MAPK11;MAPK12;MAPK14;TNF,,,PHASE 2,"Multiple values for repurposing_target: {'IL1B;IL6;MAPK11;MAPK12;MAPK14;TNF', 'MAPK11;MAPK12;MAPK14'}, taking the union",Small molecule,2,"NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F;NC(=O)N(C1CCC(C(N)=O)C(N1)-C1CCC(F)CC1F)C1C(F)CCCC1F, NC(=O)N(C1CCC(C(N)=O)C(N1)-C1CCC(F)CC1F)C1C(F)CCCC1F",FYSRKRZDBHOFAY-UHFFFAOYSA-N
VX-745,"745;NEFLAMAPIMOD;VD-31;VD-31,745;VD-31745;VRT-031745;VX-745",CHEMBL119385,BRD:BRD-BRD-K91900765-001-07-6;BRD:BRD-K91900765-001-07-6,rep_multi_dose;rep_primary;rep_single_dose,P38 MAPK INHIBITOR,MAPK11;MAPK12;MAPK14,,,PHASE 2,,Small molecule,2,"FC1CCC(SC2CCC3C(-C4C(CL)CCCC4CL)C(=O)NCN3N2)C(F)C1, FC1CCC(SC2CCC3C(-C4C(CL)CCCC4CL)C(=O)NCN3N2)C(F)C1, FC1CCC(SC2CCC3C(-C4C(CL)CCCC4CL)C(=O)NCN3N2)C(F)C1, FC1CCC(SC2CCC3C(-C4C(CL)CCCC4CL)C(=O)NCN3N2)C(F)C1;O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl",VEPKQEUBKLEPRA-UHFFFAOYSA-N
VX765,BELNACASAN;VX-765;VX765,CHEMBL2107819,BRD:BRD-BRD-K26712974-001-01-5;BRD:BRD-K26712974-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,CASPASE INHIBITOR,CASP1,,,PHASE 2,,Small molecule,2,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C;CCO[C@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1CCC(N)C(CL)C1)C(C)(C)C,SJDDOCKBXFJEJB-MOKWFATOSA-N
VX-984,VX-984,,BRD:BRD-K00091070-001-01-9,rep_single_dose,,,,,,,,NA,,
VX11E,VX11E,,GDSC1:262;GDSC2:2096,gdsc,,,,,,,,NA,,
VX702,VX 702;VX702,,GDSC1:1028,gdsc,,,,,,,,NA,,
W-54011,W-54011,,BRD:BRD-A00559310-003-01-1,rep_single_dose,ANAPHYLATOXIN CHEMOTACTIC RECEPTOR ANTAGONIST,C5AR1,,,,,,NA,,
WALRYCIN-B,WALRYCIN-B,,BRD:BRD-K01129913-001-01-5,rep_single_dose,TRANSCRIPTIONAL REGULATORY PROTEIN WALR,,,,,,,NA,,
WARFARIN,NSC-59813;WARFARIN,CHEMBL1464,BRD:BRD-A24514565-001-09-7;BRD:BRD-BRD-A24514565-001-09-7,rep_multi_dose;rep_primary;rep_single_dose,VITAMIN K ANTAGONIST,VKORC1,"DEEP VEIN THROMBOSIS (DVT), PULMONARY EMBOLISM (PE), ATRIAL FIBRILLATION (AF), MYOCARDIAL INFARCTION",,LAUNCHED,,Small molecule,4,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O;CC(=O)CC(C1CCCCC1)C1C(O)C2CCCCC2OC1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N
WAY-100635,"WAY-100,635;WAY-100635",CHEMBL31354,BRD:BRD-BRD-K69812556-305-02-0;BRD:BRD-K69812556-305-02-0,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR1A,,,PHASE 1,,Small molecule,NA,COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1;COC1CCCCC1N1CCN(CCN(C(=O)C2CCCCC2)C2CCCCN2)CC1,SBPRIAGPYFYCRT-UHFFFAOYSA-N
WAY-161503,WAY-161503,,BRD:BRD-A62021152-003-03-4;BRD:BRD-BRD-A62021152-003-03-4,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2C,,,PRECLINICAL,,,NA,"CLC1CC2NC(=O)C3CNCCN3C2CC1CL, CLC1CC2NC(=O)C3CNCCN3C2CC1CL",
WAY-170523,WAY-170523,,BRD:BRD-BRD-K36198571-001-02-0;BRD:BRD-K36198571-001-02-0,rep_multi_dose;rep_primary;rep_single_dose,METALLOPROTEINASE INHIBITOR,MMP13,,,PRECLINICAL,,,NA,"CC1CC(C)C(N(CC2CCCCC2)S(=O)(=O)C2CCC(OCCNC(=O)C3CC4CCCCC4O3)CC2)C(C1)C(=O)NO, CC1CC(C)C(N(CC2CCCCC2)S(=O)(=O)C2CCC(OCCNC(=O)C3CC4CCCCC4O3)CC2)C(C1)C(=O)NO",
WAY-181187,WAY-181187,,BRD:BRD-K00079493-001-02-9,rep_single_dose,,,,,,,,NA,,
WAY-200070,WAY-200070,,BRD:BRD-BRD-K08223200-001-01-1;BRD:BRD-K08223200-001-01-1,rep_primary;rep_single_dose,ESTROGEN RECEPTOR AGONIST,ERBB2;ERBB3;ERBB4;ESR2,,,PRECLINICAL,,,NA,"OC1CCC(CC1)-C1NC2CC(O)CC(BR)C2O1, OC1CCC(CC1)-C1NC2CC(O)CC(BR)C2O1",
WAY-207024,WAY-207024,,BRD:BRD-BRD-K08657056-300-01-1;BRD:BRD-K08657056-300-01-1,rep_primary;rep_single_dose,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,GNRHR;HRH2;TACR2,,,PRECLINICAL,,,NA,CC(C)(C)C1CCC(CC1)-C1NC2CCCC(N3CCN(CC4CCC5NCCNC5C4)CC3)C2[NH]1,
WAY-208466,WAY-208466,,BRD:BRD-BRD-K63483542-300-01-6;BRD:BRD-K63483542-300-01-6,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,DRD2;HTR2A;HTR2C;HTR6;HTR7,,,PRECLINICAL,,,NA,CN(C)CCN1CC(C2CCCNC12)S(=O)(=O)C1CCCC(F)C1,
WAY-213613,WAY-213613,,BRD:BRD-BRD-K96758128-001-01-8;BRD:BRD-K96758128-001-01-8,rep_primary;rep_single_dose,GLUTAMATE INHIBITOR,SLC1A2,,,PRECLINICAL,,,NA,"N[C@@H](CC(=O)NC1CCC(OC2CC(F)C(F)CC2BR)CC1)C(O)=O, N[C@@H](CC(=O)NC1CCC(OC2CC(F)C(F)CC2BR)CC1)C(O)=O",
WAY-255348,WAY-255348,,BRD:BRD-K00004556-001-01-9,rep_single_dose,PROGESTERONE RECEPTOR ANTAGONIST,,,,,,,NA,,
WAY-316606,WAY-316606,,BRD:BRD-K61871885-001-01-3,rep_single_dose,SECRETED FRIZZLED RELATED PROTEIN INHIBITOR,SFRP1,,,,,,NA,,
XL335,FXR-450;TUROFEXORATE ISOPROPYL;WAY-362450;XL-335;XL335,CHEMBL454138,BRD:BRD-BRD-K54640016-001-04-7;BRD:BRD-K54640016-001-04-7;CTRP:660821,ctrp;rep_primary;rep_single_dose,FXR AGONIST,NR1H4,,,PHASE 1,,Small molecule,1,CC(C)OC(=O)C1=CN(C(=O)c2ccc(F)c(F)c2)CC(C)(C)c2c1[nH]c1ccccc21;CC(C)OC(=O)C1=CN(CC(C)(C)C2C1[NH]C1CCCCC21)C(=O)C1CCC(F)C(F)C1,INASOKQDNHHMRE-UHFFFAOYSA-N
WAY-600,WAY-600,,BRD:BRD-BRD-K85920262-001-02-1;BRD:BRD-K85920262-001-02-1,rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PRECLINICAL,,,NA,C(N1CCC(CC1)N1NCC2C(NC(NC12)-C1CCC2[NH]CCC2C1)N1CCOCC1)C1CCCNC1,
WAY-629,WAY-629,,BRD:BRD-K55430733-003-03-9,rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR2C,,,,,,NA,,
WB-4101,WB-4101,,BRD:BRD-A01493904-003-12-1;BRD:BRD-BRD-A01493904-003-12-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C;HTR1A,,,PRECLINICAL,,,NA,COC1CCCC(OC)C1OCCNCC1COC2CCCCC2O1,
WDR5-0103,WDR5-0103,,BRD:BRD-BRD-K47726410-001-01-2;BRD:BRD-K47726410-001-01-2,rep_primary;rep_single_dose,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,WDR5,,,PRECLINICAL,,,NA,COC(=O)C1CCC(N2CCN(C)CC2)C(NC(=O)C2CCCC(OC)C2)C1,
WEE1 INHIBITOR,681640;WEE1 INHIBITOR,,GDSC1:1046;GDSC2:1046,gdsc,,,,,,,,NA,,
WEHI-345-ANALOG,WEHI-345-ANALOG,,BRD:BRD-BRD-K55487946-001-01-3;BRD:BRD-K55487946-001-01-3,rep_primary;rep_single_dose,SRC INHIBITOR,,,,PRECLINICAL,,,NA,CC1CCC(CC1)-C1NN(C2NCNC(N)C12)C(C)(C)CNC(=O)C1NCCCC1C,
WEHI539,WEHI-539;WEHI539,,GDSC2:1997,gdsc,,,,,,,,NA,,
WH-4-023,WH-4-023,,BRD:BRD-K50199947-001-07-9;GDSC1:56,gdsc;rep_single_dose,SRC INHIBITOR,LCK;SRC,,,,,,NA,,
WHI-P154,WHI-P154,,BRD:BRD-BRD-K07487750-001-03-3;BRD:BRD-K07487750-001-03-3,rep_multi_dose;rep_primary;rep_single_dose,JAK INHIBITOR,EGFR;JAK1;JAK2;JAK3,,,PRECLINICAL,,,NA,"COC1CC2NCNC(NC3CCC(O)C(BR)C3)C2CC1OC, COC1CC2NCNC(NC3CCC(O)C(BR)C3)C2CC1OC, COC1CC2NCNC(NC3CCC(O)C(BR)C3)C2CC1OC",
WHI-P97,AC1L1GQE;KIN001-055;WHI-P97,,GDSC1:288,gdsc,,,,,,,,NA,,
WIKI-4,WIKI 4;WIKI-4,,GDSC2:1940,gdsc,,,,,,,,NA,,
WIKI4,WIKI4,,BRD:BRD-BRD-K19316653-001-02-0;BRD:BRD-K19316653-001-02-0;GDSC2:1940,gdsc;rep_primary;rep_single_dose,"TANKYRASE INHIBITOR, WNT PATHWAY INHIBITOR",TNKS2,,,PRECLINICAL,"Multiple values for MOA: {'WNT PATHWAY INHIBITOR, TANKYRASE INHIBITOR', 'TANKYRASE INHIBITOR, WNT PATHWAY INHIBITOR'}, defaulting to 'TANKYRASE INHIBITOR, WNT PATHWAY INHIBITOR'",,NA,COC1CCC(CC1)-N1C(SCCCN2C(=O)C3CCCC4CCCC(C2=O)C34)NNC1-C1CCNCC1,
WIN-18446,WIN-18446,,BRD:BRD-BRD-K30930903-001-01-3;BRD:BRD-K30930903-001-01-3,rep_primary;rep_single_dose,ALDEHYDE DEHYDROGENASE INHIBITOR,ALDH1A2,,,PRECLINICAL,,,NA,CLC(CL)C(=O)NCCCCCCCCNC(=O)C(CL)CL,
WIN-64338,WIN-64338,,BRD:BRD-BRD-K22662557-300-01-7;BRD:BRD-K22662557-300-01-7,rep_primary;rep_single_dose,BRADYKININ RECEPTOR ANTAGONIST,BDKRB2,,,PRECLINICAL,,,NA,"CCCC[P+](CCCC)(CCCC)CC1CCC(NC(=O)[C@H](CC2CCC3CCCCC3C2)N\C(NC2CCCCC2)=N\C2CCCCC2)CC1, CCCC[P+](CCCC)(CCCC)CC1CCC(NC(=O)[C@H](CC2CCC3CCCCC3C2)N\C(NC2CCCCC2)=N\C2CCCCC2)CC1",
WISKOSTATIN,WISKOSTATIN,CHEMBL411084,BRD:BRD-A18579359-001-05-9,rep_single_dose,"ACTIN RELATED PROTEIN INHIBITOR, NEURAL WISKOTT-ALDRICH SYNDROME PROTEIN INHIBITOR",WASL,,,,,Small molecule,NA,CN(C)C[C@H](O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21,XUBJEDZHBUPBKL-ZDUSSCGKSA-N
WM-1119,WM-1119,CHEMBL4456585,BRD:BRD-U00115285-001-01-9,oncref_1,INHIBITOR OF KAT6A,KAT6A,,,,,Unknown,NA,O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1,QLXULUNLCRKWRD-UHFFFAOYSA-N
WM-8014,WM-8014,,BRD:BRD-U00115306-001-01-9,oncref_1,INHIBITOR OF KAT6A,KAT6A,,,,,,NA,,
WNT INHIBITOR IWP-2,IWP-2;WNT INHIBITOR IWP-2,,GDSC2:1576,gdsc,,,,,,,,NA,,
WORTMANNIN,WORTMANNIN,CHEMBL428496,BRD:BRD-K87343924-001-16-9,rep_single_dose,PI3K INHIBITOR,PI4KA;PI4KB;PIK3CA;PIK3CD;PIK3CG;PIK3R1;PLK1;PRKDC,,,,,Small molecule,NA,COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O,QDLHCMPXEPAAMD-QAIWCSMKSA-N
WP1066,WP 1066;WP-1066;WP1066,CHEMBL1923234,BRD:BRD-BRD-K05445342-001-05-3;BRD:BRD-K05445342-001-05-3,rep_multi_dose;rep_primary;rep_single_dose,STAT INHIBITOR,STAT3,,,PHASE 1,,Small molecule,1,"C[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1;C[C@H](NC(=O)C(=C\C1CCCC(BR)N1)\C#N)C1CCCCC1, C[C@H](NC(=O)C(=C\C1CCCC(BR)N1)\C#N)C1CCCCC1",VFUAJMPDXIRPKO-LQELWAHVSA-N
WP1130,WP1130,,BRD:BRD-BRD-K43644456-001-04-0;BRD:BRD-K43644456-001-04-0;CTRP:660432,ctrp;rep_multi_dose;rep_primary;rep_single_dose,DEUBIQUITINASE INHIBITOR,JAK2;UCHL5;USP14;USP9X,,,PRECLINICAL,,,NA,"CCC[C@H](NC(=O)C(=C\C1CCCC(BR)N1)\C#N)C1CCCCC1, CCC[C@H](NC(=O)C(=C\C1CCCC(BR)N1)\C#N)C1CCCCC1",
WP921,WP921,,BRD:BRD-K00005248-001-01-9,rep_single_dose,,,,,,,,NA,,
WR99210,WR99210,,BRD:BRD-BRD-K45973863-001-01-4;BRD:BRD-K45973863-001-01-4,rep_primary;rep_single_dose,DIHYDROFOLATE REDUCTASE INHIBITOR,TYMS,MALARIA,,PRECLINICAL,,,NA,CC1(C)N=C(N)N=C(N)N1OCCCOC1CC(CL)C(CL)CC1CL,
WS6,WS6,,BRD:BRD-K00126472-001-01-9,oncref_2,INHIBITOR OF PA2G4,PA2G4,,,,,,NA,,
WWL-113,WWL-113,,BRD:BRD-BRD-K49389158-001-01-3;BRD:BRD-K49389158-001-01-3,rep_primary;rep_single_dose,CARBOXYLESTERASE INHIBITOR,CES3,,,PRECLINICAL,,,NA,CCOC(=O)C1CCC(CC1)-C1CCC(OC(=O)N(C)CC2CCCC(C2)-C2CCNCC2)CC1,
WWL-123,WWL-123,,BRD:BRD-BRD-K83176916-001-01-4;BRD:BRD-K83176916-001-01-4,rep_primary;rep_single_dose,MONOACYLGLYCEROL LIPASE INHIBITOR,ABHD6,,,PRECLINICAL,,,NA,CN(CC1CCCC(C1)-C1CCCCC1)C(=O)OC1CCC(CC1)-C1CCC(CC1)C(N)=O,
WY-090217,40-O-(2-ETHOXYETHYL)RAPAMYCIN;42-O-(2-ETHOXYETHYL) RAPAMYCIN;42-O-(2-ETHOXYETHYL)-;AY-22989;BIOLIMUS;BIOLIMUS A9;FYARRO;HYFTOR;L04AA10;NPC-12G;NSC-226080;RAPALIMUS;RAPAMUNE;RAPAMYCIN;SIROLIMUS;SM-88 COMPONENT SIROLIMUS;TRM 986;TRM-986;UMIROLIMUS;WY-090217,CHEMBL2107380;CHEMBL413,GDSC1:3;GDSC2:1084,gdsc,,,,,,,Small molecule,4,CCOCCO[C@@H]1CC[C@@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)[C@@H](OC)C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC;CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,QFJCIRLUMZQUOT-HPLJOQBZSA-N;YYSFXUWWPNHNAZ-PKJQJFMNSA-N
WY-16922,WY-16922,,BRD:BRD-BRD-K43419711-001-01-4;BRD:BRD-K43419711-001-01-4,rep_primary;rep_single_dose,HISTAMINE RELEASE INHIBITOR,,,,PHASE 1,,,NA,CCOC(=O)C(=O)NC1CCCC(OC)C1C(N)=O,
WYE-125132,WYE-125132,,BRD:BRD-A45498368-001-07-1;BRD:BRD-BRD-A45498368-001-07-1;GDSC1:317,gdsc;rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PRECLINICAL,,,NA,CNC(=O)NC1CCC(CC1)-C1NC(N2CC3CCC(C2)O3)C2CNN(C3CCC4(CC3)OCCO4)C2N1,
WYE-354,WYE-354,,BRD:BRD-BRD-K77008974-001-03-2;BRD:BRD-K77008974-001-03-2,rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PRECLINICAL,,,NA,COC(=O)NC1CCC(CC1)-C1NC(N2CCOCC2)C2CNN(C3CCN(CC3)C(=O)OC)C2N1,
WYE-687,WYE-687,,BRD:BRD-K49900195-300-02-9,rep_single_dose,MTOR INHIBITOR,MTOR,,,,,,NA,,
WZ 4003,WZ 4003,,GDSC2:1614,gdsc,,,,,,,,NA,,
WZ-1-84,KIN001-123;WZ-1-84,,GDSC1:59,gdsc,,,,,,,,NA,,
WZ-3146,WZ-3146,,BRD:BRD-BRD-K73293050-001-03-1;BRD:BRD-K73293050-001-03-1,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PRECLINICAL,,,NA,CN1CCN(CC1)C1CCC(NC2NCC(CL)C(OC3CCCC(NC(=O)C=C)C3)N2)CC1,
WZ-4002,WZ-4002,,BRD:BRD-BRD-K72420232-001-12-3;BRD:BRD-K72420232-001-12-3,rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR;ERBB2,,,PRECLINICAL,,,NA,"COC1CC(CCC1NC1NCC(CL)C(OC2CCCC(NC(=O)C=C)C2)N1)N1CCN(C)CC1, COC1CC(CCC1NC1NCC(CL)C(OC2CCCC(NC(=O)C=C)C2)N1)N1CCN(C)CC1",
WZ3105,WZ3105,,GDSC1:252,gdsc,,,,,,,,NA,,
WZ4002,WZ4002,,CTRP:640366,ctrp,,,,,,,,NA,,
WZ4003,WZ4003,,BRD:BRD-BRD-K45909031-001-01-5;BRD:BRD-K45909031-001-01-5;GDSC2:1614,gdsc;rep_primary;rep_single_dose,AMPK INHIBITOR,NUAK1;NUAK2,,,PRECLINICAL,,,NA,CCC(=O)NC1CCCC(OC2NC(NC3CCC(CC3OC)N3CCN(C)CC3)NCC2CL)C1,
WZ8040,WZ8040,,BRD:BRD-BRD-K81728688-001-04-4;BRD:BRD-K81728688-001-04-4;CTRP:628614,ctrp;rep_multi_dose;rep_primary;rep_single_dose,EGFR INHIBITOR,EGFR,,,PRECLINICAL,,,NA,CN1CCN(CC1)C1CCC(NC2NCC(CL)C(SC3CCCC(NC(=O)C=C)C3)N2)CC1,
WZ811,WZ811,,BRD:BRD-BRD-K25359048-001-02-6;BRD:BRD-K25359048-001-02-6,rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CXCR4,,,PRECLINICAL,,,NA,C(NC1CCCCN1)C1CCC(CNC2CCCCN2)CC1,
XALIPRODEN,SR 57746;SR-57746;XALIPRODEN,CHEMBL1512580,BRD:BRD-BRD-K88358234-003-04-8;BRD:BRD-K88358234-003-04-8,rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A,,,PHASE 3,,Small molecule,3,"FC(F)(F)C1CCCC(C1)C1=CCN(CCC2CCC3CCCCC3C2)CC1, FC(F)(F)C1CCCC(C1)C1=CCN(CCC2CCC3CCCCC3C2)CC1;FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1",WJJYZXPHLSLMGE-UHFFFAOYSA-N
XALKORI,CRIZOTINIB;NSC-756645;PF 2341066;PF-02341066;PF-2341066;PF2341066;XALKORI,CHEMBL601719,GDSC1:37;GDSC2:1083,gdsc,,,,,,,Small molecule,4,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,KTEIFNKAUNYNJU-GFCCVEGCSA-N
XAMOTEROL,"ICI-118,587;ICI-118587;XAMOTEROL",CHEMBL75753,BRD:BRD-A59337442-051-05-3;BRD:BRD-BRD-A59337442-051-05-3,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB1,,,PHASE 3,,Small molecule,4,"O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1;OC(CNCCNC(=O)N1CCOCC1)COC1CCC(O)CC1, OC(CNCCNC(=O)N1CCOCC1)COC1CCC(O)CC1, OC(CNCCNC(=O)N1CCOCC1)COC1CCC(O)CC1",DXPOSRCHIDYWHW-UHFFFAOYSA-N
XANOMELINE,LY-246708;LY-246708 FREE BASE;LY246708;XANOMELINE,CHEMBL21536,BRD:BRD-BRD-K72815923-034-01-2;BRD:BRD-K72815923-034-01-2,rep_multi_dose;rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR AGONIST,CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR6;HTR7,,,PHASE 3,,Small molecule,3,"CCCCCCOc1nsnc1C1=CCCN(C)C1;CCCCCCOC1NSNC1C1=CCCN(C)C1, CCCCCCOC1NSNC1C1=CCCN(C)C1",JOLJIIDDOBNFHW-UHFFFAOYSA-N
XANTHONE,XANTHONE,CHEMBL186784,BRD:BRD-BRD-K27135764-001-08-7;BRD:BRD-K27135764-001-08-7,rep_primary;rep_single_dose,ANTIMALARIAL AGENT,,,,PRECLINICAL,,Small molecule,NA,O=c1c2ccccc2oc2ccccc12;O=C1C2CCCCC2OC2CCCCC12,JNELGWHKGNBSMD-UHFFFAOYSA-N
XAV-939,XAV-939,,BRD:BRD-BRD-K12762134-001-06-2;BRD:BRD-K12762134-001-06-2;GDSC1:1268;GDSC2:1268,gdsc;rep_primary;rep_single_dose,TANKYRASE INHIBITOR,TNKS;TNKS2,,,PRECLINICAL,,,NA,"OC1NC(NC2CCSCC12)-C1CCC(CC1)C(F)(F)F, OC1NC(NC2CCSCC12)-C1CCC(CC1)C(F)(F)F, OC1NC(NC2CCSCC12)-C1CCC(CC1)C(F)(F)F",
XAV939,NVP-XAV939;XAV 939;XAV939,,GDSC1:1268;GDSC2:1268,gdsc,,,,,,,,NA,,
XBD173,AC-5216;EMAPUNIL;XBD-173;XBD173,CHEMBL513922,BRD:BRD-BRD-K45875383-001-01-2;BRD:BRD-K45875383-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR LIGAND,TSPO,,,PHASE 2,,Small molecule,2,"CCN(Cc1ccccc1)C(=O)Cn1c(=O)n(C)c2cnc(-c3ccccc3)nc21;CCN(CC1CCCCC1)C(=O)CN1C2NC(NCC2N(C)C1=O)-C1CCCCC1, CCN(CC1CCCCC1)C(=O)CN1C2NC(NCC2N(C)C1=O)-C1CCCCC1",NBMBIEOUVBHEBM-UHFFFAOYSA-N
XD-14,XD-14,,BRD:BRD-K69211575-001-02-9,rep_single_dose,BROMODOMAIN INHIBITOR,BRD2;BRD3;BRD4;BRDT,,,,,,NA,,
XE-991,XE-991,,BRD:BRD-BRD-K42748308-300-02-0;BRD:BRD-K42748308-300-02-0,rep_primary;rep_single_dose,POTASSIUM CHANNEL BLOCKER,KCNQ1;KCNQ2;KCNQ3;KCNQ4;KCNQ5,,,PRECLINICAL,,,NA,O=C1C2CCCCC2C(CC2CCNCC2)(CC2CCNCC2)C2CCCCC12,
XENALIPIN,BW 207U;BW-207U;XENALIPIN,CHEMBL2104509,BRD:BRD-BRD-K99506538-001-03-8;BRD:BRD-K99506538-001-03-8,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,O=C(O)c1ccccc1-c1ccc(C(F)(F)F)cc1;OC(=O)C1CCCCC1-C1CCC(CC1)C(F)(F)F,IQOMYCGTGFGDFN-UHFFFAOYSA-N
XI-006,NSC-207895;NSC207895;XI-006,,GDSC1:269,gdsc,,,,,,,,NA,,
XIBENOLOL,XIBENOLOL,CHEMBL347795,BRD:BRD-A21446384-001-01-1;BRD:BRD-BRD-A21446384-001-01-1,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,,,,PHASE 3,,Small molecule,-1,Cc1cccc(OCC(O)CNC(C)(C)C)c1C;CC1CCCC(OCC(O)CNC(C)(C)C)C1C,RKUQLAPSGZJLGP-UHFFFAOYSA-N
XILOBAM,MCN-3113;XILOBAM,CHEMBL382769,BRD:BRD-BRD-K79633074-001-01-8;BRD:BRD-K79633074-001-01-8,rep_multi_dose;rep_primary;rep_single_dose,,,,,PHASE 1,,Small molecule,-1,Cc1cccc(C)c1NC(=O)/N=C1\CCCN1C;CN1CCC\C1=N\C(=O)NC1C(C)CCCC1C,PAXRPWSXCPTPCA-NTCAYCPXSA-N
XIPAMIDE,"BE-1293;DIUREXAN;MJF 10,938;MJF-10938;XIPAMIDE",CHEMBL517199,BRD:BRD-BRD-K27393415-001-01-0;BRD:BRD-K27393415-001-01-0,rep_primary;rep_single_dose,CARBONIC ANHYDRASE INHIBITOR,SLC12A3,"EDEMA, HYPERTENSION",,LAUNCHED,,Small molecule,4,CC1CCCC(C)C1NC(=O)C1CC(C(CL)CC1O)S(N)(=O)=O;Cc1cccc(C)c1NC(=O)c1cc(S(N)(=O)=O)c(Cl)cc1O,MTZBBNMLMNBNJL-UHFFFAOYSA-N
XL147,PILARALISIB;SAR-245408;SAR245408;XL-147;XL147,CHEMBL3218575;CHEMBL3360203,BRD:BRD-BRD-K95901403-001-04-5;BRD:BRD-K95901403-001-04-5;GDSC1:372,gdsc;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CA;PIK3CD;PIK3CG,,,PHASE 2,,Small molecule,2,CC1CCC(CC1)S(=O)(=O)NC1NC2CCCCC2NC1NC1CCC2NSNC2C1;Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1;COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1,MQMKRQLTIWPEDM-UHFFFAOYSA-N;QINPEPAQOBZPOF-UHFFFAOYSA-N
XL184,BMS-907351;BMS-907351 FREE BASE;CABOMETYX;CABOZANTINIB;CABOZANTINIB MALATE;CABOZANTINIB S-MALATE;COMETRIQ;XL-184;XL-184 FREE BASE;XL184,CHEMBL2103868;CHEMBL2105717,GDSC1:249,gdsc,,,,,,,Small molecule,4,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC;COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC.O=C(O)C[C@H](O)C(=O)O,HFCFMRYTXDINDK-WNQIDUERSA-N;ONIQOQHATWINJY-UHFFFAOYSA-N
XL647,EXEL-7647;KD-019;KD-020;KD019;TESEVATINIB;XL-647;XL647,CHEMBL3544983,BRD:BRD-BRD-K03765900-001-01-9;BRD:BRD-K03765900-001-01-9,rep_multi_dose;rep_primary;rep_single_dose,"EGFR INHIBITOR, VEGFR INHIBITOR",EGFR;EPHB4;ERBB2;FLT4;KDR,,,PHASE 3,,Small molecule,3,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1;COC1CC2C(NC3CCC(CL)C(CL)C3F)NCNC2CC1OC[C@H]1C[C@H]2CN(C)C[C@H]2C1,HVXKQKFEHMGHSL-QKDCVEJESA-N
XL765,SAR-245409;SAR245409;VOXTALISIB;XL-765;XL765,CHEMBL3545366,GDSC1:375,gdsc,,,,,,,Small molecule,2,CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21,RGHYDLZMTYDBDT-UHFFFAOYSA-N
XL880,EXEL-2880;FORETINIB;GSK-089;GSK-1363089;GSK-1363089G;GSK089;GSK1363089;GSK1363089G;XL-880;XL880,CHEMBL1230609,GDSC1:308;GDSC2:2040,gdsc,,,,,,,Small molecule,2,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,CXQHYVUVSFXTMY-UHFFFAOYSA-N
XL019,XL-019;XL019,CHEMBL3545328,BRD:BRD-BRD-K04266228-001-03-8;BRD:BRD-K04266228-001-03-8,rep_primary;rep_single_dose,JAK INHIBITOR,JAK1;JAK2;JAK3,,,PHASE 1,,Small molecule,1,"O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1;O=C(NC1CCC(CC1)-C1CCNC(NC2CCC(CC2)N2CCOCC2)N1)[C@@H]1CCCN1, O=C(NC1CCC(CC1)-C1CCNC(NC2CCC(CC2)N2CCOCC2)N1)[C@@H]1CCCN1, O=C(NC1CCC(CC1)-C1CCNC(NC2CCC(CC2)N2CCOCC2)N1)[C@@H]1CCCN1, O=C(NC1CCC(CC1)-C1CCNC(NC2CCC(CC2)N2CCOCC2)N1)[C@@H]1CCCN1",ISOCDPQFIXDIMS-UHFFFAOYSA-N
XL041,XL041,,BRD:BRD-K00003439-001-01-9,rep_single_dose,LXR AGONIST,,,,,,,NA,,
XL228,EXEL-2280;XL-228;XL228,CHEMBL3545085,BRD:BRD-BRD-K14274271-001-02-8;BRD:BRD-K14274271-001-02-8,rep_primary;rep_single_dose,"ABL KINASE INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR, SRC INHIBITOR",IGF1R;SRC,,,PHASE 1,,Small molecule,1,"CC(C)C1CC(CNC2NC(NC3CC([NH]N3)C3CC3)CC(N2)N2CCN(C)CC2)ON1, CC(C)C1CC(CNC2NC(NC3CC([NH]N3)C3CC3)CC(N2)N2CCN(C)CC2)ON1;CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1",ALKJNCZNEOTEMP-UHFFFAOYSA-N
XL388,XL388,,BRD:BRD-BRD-K03549949-001-01-0;BRD:BRD-K03549949-001-01-0,rep_multi_dose;rep_primary;rep_single_dose,MTOR INHIBITOR,MTOR,,,PRECLINICAL,,,NA,CC1C(F)C(CCC1C(=O)N1CCOC2CCC(CC2C1)-C1CCC(N)NC1)S(C)(=O)=O,
XL765,SAR-245409;SAR245409;VOXTALISIB;XL-765;XL765,CHEMBL3545366,CTRP:660304,ctrp,,,,,,,Small molecule,2,CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21,RGHYDLZMTYDBDT-UHFFFAOYSA-N
XL888,EXEL-4888;XL-888;XL888,CHEMBL4297451,BRD:BRD-A03506276-001-01-5;BRD:BRD-BRD-A03506276-001-01-5,rep_multi_dose;rep_primary;rep_single_dose,HSP INHIBITOR,,,,PHASE 1,,Small molecule,1,CC[C@@H](C)Nc1cc(C(=O)N[C@H]2C[C@H]3CC[C@@H](C2)N3c2ccc(C(=O)C3CC3)cn2)c(C)cc1C(N)=O;CC[C@@H](C)NC1CC(C(=O)NC2CC3CCC(C2)N3C2CCC(CN2)C(=O)C2CC2)C(C)CC1C(N)=O,LHGWWAFKVCIILM-HLRQEUIKSA-N
XMD 8-92,XMD 8-92,,GDSC1:1164,gdsc,,,,,,,,NA,,
XMD11-85H,XMD11-85H,,GDSC1:1158,gdsc,,,,,,,,NA,,
XMD13-2,XMD13-2,,GDSC1:330,gdsc,,,,,,,,NA,,
XMD14-99,XMD14-99,,GDSC1:253,gdsc,,,,,,,,NA,,
XMD15-27,XMD15-27,,GDSC1:332,gdsc,,,,,,,,NA,,
XMD17-109,XMD17-109,,BRD:BRD-BRD-K48449981-001-02-7;BRD:BRD-K48449981-001-02-7,rep_primary;rep_single_dose,MAP KINASE INHIBITOR,MAPK7,,,PRECLINICAL,,,NA,"CCOC1CC(CCC1NC1NCC2N(C)C(=O)C3CCCCC3N(C3CCCC3)C2N1)C(=O)N1CCC(CC1)N1CCN(C)CC1, CCOC1CC(CCC1NC1NCC2N(C)C(=O)C3CCCCC3N(C3CCCC3)C2N1)C(=O)N1CCC(CC1)N1CCN(C)CC1",
XMD8-85,XMD8-85,,GDSC1:106,gdsc,,,,,,,,NA,,
XMD8-92,XMD8-92,,BRD:BRD-K50387473-001-11-0;GDSC1:1164,gdsc;rep_single_dose,MAP KINASE INHIBITOR,DCLK2;MAPK7;PLK4;TNK1,,,,,,NA,,
XYLAZINE,CHANAZINE;NSC-758142;XYLAZINE,CHEMBL297362,BRD:BRD-BRD-K21565985-001-22-5;BRD:BRD-K21565985-001-22-5,rep_multi_dose;rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA2A;ADRA2B;ADRA2C,ANESTHETIC,,LAUNCHED,,Small molecule,-1,"Cc1cccc(C)c1NC1=NCCCS1;CC1CCCC(C)C1NC1=NCCCS1, CC1CCCC(C)C1NC1=NCCCS1",BPICBUSOMSTKRF-UHFFFAOYSA-N
XYLOMETAZOLINE,BALMINIL;XYLOMETAZOLINE,CHEMBL312448,BRD:BRD-BRD-K08356259-003-24-7;BRD:BRD-K08356259-003-24-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRA1A;ADRA1B;ADRA1D;ADRA2A;ADRA2B;ADRA2C,"NASAL CONGESTION, ALLERGIC RHINITIS",,LAUNCHED,,Small molecule,4,"Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1;CC1CC(CC(C)C1CC1=NCCN1)C(C)(C)C, CC1CC(CC(C)C1CC1=NCCN1)C(C)(C)C",HUCJFAOMUPXHDK-UHFFFAOYSA-N
XYLOSE,FEMA NO. 3606;NSC-122762;XYLO-PFAN;XYLOSE,CHEMBL502135,BRD:BRD-BRD-K10759144-001-04-3;BRD:BRD-K10759144-001-04-3,rep_primary;rep_single_dose,,,,,LAUNCHED,,Small molecule,4,"OC[C@@H](O)[C@H](O)[C@@H](O)C=O, OC[C@@H](O)[C@H](O)[C@@H](O)C=O;OC1OC[C@@H](O)[C@H](O)[C@H]1O",SRBFZHDQGSBBOR-IOVATXLUSA-N
Y-11,Y-11,,BRD:BRD-BRD-K09317629-004-01-7;BRD:BRD-K09317629-004-01-7,rep_primary;rep_single_dose,FOCAL ADHESION KINASE INHIBITOR,PTK2,,,PRECLINICAL,,,NA,OCC[N+]12CN3CN(CN(C3)C1)C2,
Y-134,Y-134,,BRD:BRD-BRD-K94832621-001-02-3;BRD:BRD-K94832621-001-02-3,rep_primary;rep_single_dose,ESTROGEN RECEPTOR ANTAGONIST,ESR1;ESR2,,,PRECLINICAL,,,NA,"CC(C)N1CCN(CC1)C1CCC(CC1)C(=O)C1C(SC2CC(O)CCC12)-C1CCC(O)CC1, CC(C)N1CCN(CC1)C1CCC(CC1)C(=O)C1C(SC2CC(O)CCC12)-C1CCC(O)CC1",
Y-26763,Y-26763,,BRD:BRD-BRD-K45117373-001-02-9;BRD:BRD-K45117373-001-02-9,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNJ8,,,PHASE 1,,,NA,CC(=O)N(O)[C@H]1[C@H](O)C(C)(C)OC2CCC(CC12)C#N,
Y-27152,Y-27152,,BRD:BRD-BRD-K42679050-001-02-1;BRD:BRD-K42679050-001-02-1,rep_primary;rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,KCNJ8,,,PHASE 1,,,NA,CC(=O)N(OCC1CCCCC1)[C@H]1[C@H](O)C(C)(C)OC2CCC(CC12)C#N,
Y-27632,Y-27632,CHEMBL559147,BRD:BRD-BRD-K44084986-300-08-4;BRD:BRD-K44084986-300-08-4,rep_multi_dose;rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,PKIA;PKN2;PRKACA;PRKCE;ROCK1;ROCK2,,,PRECLINICAL,,Small molecule,NA,"C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)NC1CCNCC1, C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)NC1CCNCC1, C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)NC1CCNCC1;C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1",IYOZTVGMEWJPKR-IJLUTSLNSA-N
Y-29794,Y-29794,,BRD:BRD-K48449073-034-03-9,rep_single_dose,PROLYL ENDOPEPTIDASE INHIBITOR,PREP,,,,,,NA,,
Y-320,Y-320,,BRD:BRD-BRD-K96259238-001-01-4;BRD:BRD-K96259238-001-01-4,rep_multi_dose;rep_primary;rep_single_dose,INTERLEUKIN INHIBITOR,IL17A,,,PRECLINICAL,,,NA,CC1C(CNN1-C1CCC(CL)CC1)C(=O)NC1CCC(N2CCC(CC2)N2CCOCC2)C(C1)C#N,
Y-39983,Y-39983,CHEMBL571948,BRD:BRD-BRD-K56751279-300-01-4;BRD:BRD-K56751279-300-01-4;GDSC1:309,gdsc;rep_multi_dose;rep_primary;rep_single_dose,RHO ASSOCIATED KINASE INHIBITOR,ROCK1;ROCK2,,,PHASE 2,,Small molecule,1,C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1;C[C@@H](N)C1CCC(CC1)C(=O)NC1CCNC2[NH]CCC12,JTVBXQAYBIJXRP-SNVBAGLBSA-N
YC-1,YC-1,,BRD:BRD-K60476892-001-17-9,rep_single_dose,GUANYLYL CYCLASE ACTIVATOR,GUCY1A2;GUCY1A3;GUCY1B3;HIF1A,,,,,,NA,,
YIL-781,YIL-781,,BRD:BRD-K91403886-003-02-9,rep_single_dose,GHRELIN RECEPTOR ANTAGONIST,GHSR,,,,,,NA,,
YK 4-279,YK 4-279,,CTRP:632103;GDSC1:1239;GDSC2:1239,ctrp;gdsc,,,,,,,,NA,,
YK-4-279,YK-4-279,,BRD:BRD-A62182663-001-03-0;BRD:BRD-BRD-A62182663-001-03-0;GDSC1:1239;GDSC2:1239,gdsc;rep_primary;rep_single_dose,APOPTOSIS INHIBITOR,EWSR1;FLI1,,,PRECLINICAL,,,NA,"COC1CCC(CC1)C(=O)CC1(O)C(=O)NC2C1C(CL)CCC2CL, COC1CCC(CC1)C(=O)CC1(O)C(=O)NC2C1C(CL)CCC2CL",
YL0919,YL0919,,BRD:BRD-K00003390-003-01-9,rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),,,,,,,NA,,
YL54,YL54,,CTRP:651298,ctrp,,,,,,,,NA,,
YM022,YM-022;YM022,,BRD:BRD-BRD-K09436144-001-01-7;BRD:BRD-K09436144-001-01-7,rep_primary;rep_single_dose,CCK RECEPTOR ANTAGONIST,CCKBR,,,PHASE 2,,,NA,CC1CCCC(NC(=O)N[C@@H]2N=C(C3CCCCC3)C3CCCCC3N(CC(=O)C3CCCCC3C)C2=O)C1,
YM-201636,YM-201636,,BRD:BRD-BRD-K48488978-001-05-3;BRD:BRD-K48488978-001-05-3;GDSC1:310,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,,,,PRECLINICAL,,,NA,NC1CCC(CN1)C(=O)NC1CCCC(C1)-C1NC(N2CCOCC2)C2OC3NCCCC3C2N1,
YM-244769,YM-244769,,BRD:BRD-K52087522-300-02-9,rep_single_dose,SODIUM/CALCIUM EXCHANGE INHIBITOR,,,,,,,NA,,
YM-298198,YM-298198,,BRD:BRD-K59650319-003-04-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM1,,,,,,NA,,
YM-298198-DESMETHYL,YM-298198-DESMETHYL,,BRD:BRD-K48059230-003-03-9,rep_single_dose,GLUTAMATE RECEPTOR ANTAGONIST,GRM1,,,,,,NA,,
YM-511,YM-511,,BRD:BRD-BRD-K38398115-001-01-9;BRD:BRD-K38398115-001-01-9,rep_primary;rep_single_dose,AROMATASE INHIBITOR,CYP19A1,,,PHASE 2,,,NA,BRC1CCC(CN(C2CCC(CC2)C#N)N2CNNC2)CC1,
YM-58483,YM-58483,,BRD:BRD-BRD-K42563464-001-01-9;BRD:BRD-K42563464-001-01-9,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,TRPC3;TRPC5;TRPM4,,,PRECLINICAL,,,NA,"CC1NNSC1C(=O)NC1CCC(CC1)-N1NC(CC1C(F)(F)F)C(F)(F)F, CC1NNSC1C(=O)NC1CCC(CC1)-N1NC(CC1C(F)(F)F)C(F)(F)F",
YM-750,YM-750,,BRD:BRD-BRD-K91716465-001-01-2;BRD:BRD-K91716465-001-01-2,rep_primary;rep_single_dose,ACAT INHIBITOR,SOAT1,,,PHASE 1,,,NA,CC1CC(C)C(NC(=O)N(CC2CCC-3C(CC4CCCCC-34)C2)C2CCCCCC2)C(C)C1,
YM-90709,YM-90709,,BRD:BRD-K06712146-001-04-9,rep_single_dose,IL5 INHIBITOR,CSF2RB;IL5RA,,,,,,NA,,
YM-976,YM-976,,BRD:BRD-BRD-K12932420-001-02-3;BRD:BRD-K12932420-001-02-3,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4A,,,PHASE 1,,,NA,"CCC1CCC2C(NC(=O)N(CC)C2N1)-C1CCCC(CL)C1, CCC1CCC2C(NC(=O)N(CC)C2N1)-C1CCCC(CL)C1",
YM155,SEPANTRONIUM BROMIDE;YM 155;YM-155;YM155,CHEMBL2105734,GDSC1:268;GDSC2:1941,gdsc,,,,,,,Small molecule,2,COCC[n+]1c2c(n(Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O.[Br-],QBIYUDDJPRGKNJ-UHFFFAOYSA-M
YM201636,YM 201636;YM201636,,GDSC1:310,gdsc,,,,,,,,NA,,
YODA-1,YODA-1,,BRD:BRD-BRD-K88570498-001-01-9;BRD:BRD-K88570498-001-01-9,rep_primary;rep_single_dose,PIEZO CHANNEL ACTIVATOR,PIEZO1,,,PRECLINICAL,,,NA,CLC1CCCC(CL)C1CSC1NNC(S1)-C1CNCCN1,
YOHIMBINUM,YOHIMBINE;YOHIMBINUM,CHEMBL15245,BRD:BRD-BRD-K35586044-003-15-4;BRD:BRD-K35586044-003-15-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR ANTAGONIST,ADRA2A;ADRA2B;ADRA2C;DRD2;DRD3;HTR1A;HTR1B;HTR1D;HTR1E;HTR1F;HTR2A;HTR2B;HTR2C;HTR5A;HTR7;KCNJ1;KCNJ10;KCNJ11;KCNJ12;KCNJ14;KCNJ15;KCNJ8,"CARDIAC ARRYTHMIA, BRADYCARDIA",,LAUNCHED,,Small molecule,4,"COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O;COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4C([NH]C5CCCCC45)[C@@H]3C[C@H]12, COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4C([NH]C5CCCCC45)[C@@H]3C[C@H]12, COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4C([NH]C5CCCCC45)[C@@H]3C[C@H]12",BLGXFZZNTVWLAY-SCYLSFHTSA-N
YS-035,YS-035,,BRD:BRD-BRD-K06208435-003-08-2;BRD:BRD-K06208435-003-08-2,rep_primary;rep_single_dose,CALCIUM CHANNEL BLOCKER,,,,PRECLINICAL,,,NA,COC1CCC(CCN(C)CCC2CCC(OC)C(OC)C2)CC1OC,
YS-201,YS-201,,BRD:BRD-K00004746-001-01-9,rep_single_dose,CALCIUM RECEPTOR ANTAGONIST,,,,,,,NA,,
YZ9,YZ9,,BRD:BRD-BRD-K53438416-001-01-9;BRD:BRD-K53438416-001-01-9,rep_primary;rep_single_dose,PHOSPHOFRUCTOKINASE INHIBITOR,MIF;PFKFB3,,,PRECLINICAL,,,NA,CCOC(=O)C1CC2CCC(O)CC2OC1=O,
Z-LLNLE-CHO,GAMMA-SECRETASE INHIBITOR 1;Z-L-NORLEUCINE-CHO;Z-LLNLE-CHO,,GDSC1:45,gdsc,,,,,,,,NA,,
Z160,MK-6721;MK6721;NMED-160;NP-118809;Z-160;Z160,CHEMBL604710,BRD:BRD-BRD-K16037980-001-01-1;BRD:BRD-K16037980-001-01-1,rep_primary;rep_single_dose,N-TYPE CALCIUM CHANNEL BLOCKER,CACNA2D1,,,PHASE 2,,Small molecule,2,O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1;O=C(CC(C1CCCCC1)C1CCCCC1)N1CCN(CC1)C(C1CCCCC1)C1CCCCC1,VCPMZDWBEWTGNW-UHFFFAOYSA-N
ZACOPRIDE,ZACOPRIDE,CHEMBL18041,BRD:BRD-A65615053-003-02-2;BRD:BRD-BRD-A65615053-003-02-2,rep_primary;rep_single_dose,SEROTONIN RECEPTOR ANTAGONIST,HTR3A;HTR3B;HTR4;HTR5A,,,PHASE 2,,Small molecule,-1,"COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2;COC1CC(N)C(CL)CC1C(=O)NC1CN2CCC1CC2, COC1CC(N)C(CL)CC1C(=O)NC1CN2CCC1CC2",FEROPKNOYKURCJ-UHFFFAOYSA-N
ZAFIRLUKAST,"ACCOLATE;ICI 204,219;ICI-204,219;ICI-204219;ZAFIRLUKAST",CHEMBL603,BRD:BRD-BRD-K71289571-001-11-4;BRD:BRD-K71289571-001-11-4,rep_primary;rep_single_dose,LEUKOTRIENE RECEPTOR ANTAGONIST,CYSLTR1;CYSLTR2,ASTHMA,,LAUNCHED,,Small molecule,4,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12;COC1CC(CCC1CC1CN(C)C2CCC(NC(=O)OC3CCCC3)CC12)C(=O)NS(=O)(=O)C1CCCCC1C,YEEZWCHGZNKEEK-UHFFFAOYSA-N
"ZALCITABINE (DIDEOXYCYTIDINE,DDC)","DDC (DDC);DIDEOXYCYTIDINE;HIVID;NSC-606170;RO 24-2027/000;RO-24-2027000;RO-242027000;ZALCITABINE;ZALCITABINE (DIDEOXYCYTIDINE,DDC)",CHEMBL853,BRD:BRD-BRD-K85925969-001-17-4;BRD:BRD-K85925969-001-17-4,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,,HUMAN IMMUNODEFICIENCY VIRUS (HIV-1),,LAUNCHED,,Small molecule,4,"Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1;NC1CCN([C@H]2CC[C@@H](CO)O2)C(=O)N1, NC1CCN([C@H]2CC[C@@H](CO)O2)C(=O)N1",WREGKURFCTUGRC-POYBYMJQSA-N
ZALDARIDE,ZALDARIDE,CHEMBL1474352,BRD:BRD-A26032986-050-02-1;BRD:BRD-BRD-A26032986-050-02-1,rep_multi_dose;rep_primary;rep_single_dose,CALMODULIN ANTAGONIST,CALM1,,,PHASE 3,,Small molecule,-1,"CC1(CN2CCC(CC2)N2C3CCCCC3[NH]C2=O)OCC2CCCCC2-N2CCCC12, CC1(CN2CCC(CC2)N2C3CCCCC3[NH]C2=O)OCC2CCCCC2-N2CCCC12;CC1(CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)OCc2ccccc2-n2cccc21",HTGCJAAPDHZCHL-UHFFFAOYSA-N
ZERENE,"CL 284,846;CL-284846;L-846;L846;LJC 10846;LJC-10846;SKP-1041;SONATA;ZAL-846;ZALEPLON;ZALEPLON CIV;ZERENE",CHEMBL1521,BRD:BRD-BRD-K92657060-001-05-7;BRD:BRD-K92657060-001-05-7,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRB1;GABRG2;TSPO,INSOMNIA,,LAUNCHED,,Small molecule,4,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1;CCN(C(C)=O)C1CCCC(C1)-C1CCNC2C(CNN12)C#N,HUNXMJYCHXQEGX-UHFFFAOYSA-N
ZALTIDINE,ZALTIDINE,CHEMBL70209,BRD:BRD-BRD-K12261274-001-02-4;BRD:BRD-K12261274-001-02-4,rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,HRH2,,,PHASE 3,,Small molecule,-1,"Cc1ncc(-c2csc(N=C(N)N)n2)[nH]1;CC1NCC([NH]1)-C1CSC(NC(N)=N)N1, CC1NCC([NH]1)-C1CSC(NC(N)=N)N1",GIMNAEMRNXUAQP-UHFFFAOYSA-N
ZALTOPROFEN,CN-100;SORETON;ZALTOPROFEN,CHEMBL1765291,BRD:BRD-A00578795-001-04-3;BRD:BRD-BRD-A00578795-001-04-3,rep_primary;rep_single_dose,CYCLOOXYGENASE INHIBITOR,,"FEVER, PAIN RELIEF",,LAUNCHED,,Small molecule,-1,CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2;CC(C(O)=O)C1CCC2SC3CCCCC3C(=O)CC2C1,MUXFZBHBYYYLTH-UHFFFAOYSA-N
ZAMI-633,ZAMI-633,,BRD:BRD-K11984358-001-01-3,rep_single_dose,UREASE INHIBITOR,,,,,,,NA,,
ZAMICASTAT,ZAMICASTAT,CHEMBL4594440,BRD:BRD-K00091086-001-01-9,rep_single_dose,,,,,,,Small molecule,2,Fc1cc(F)c2c(c1)C[C@@H](n1c(CCNCc3ccccc3)c[nH]c1=S)CO2,ZSSLCFLHEFXANG-GOSISDBHSA-N
ZAMIFENACIN,UK-76654-2 [AS FUMARATE];ZAMIFENACIN,CHEMBL27507,BRD:BRD-BRD-K80451230-051-02-6;BRD:BRD-K80451230-051-02-6,rep_primary;rep_single_dose,ACETYLCHOLINE RECEPTOR ANTAGONIST,CHRM3,,,PHASE 3,,Small molecule,-1,"C(CC1CCC2OCOC2C1)N1CCC[C@H](C1)OC(C1CCCCC1)C1CCCCC1, C(CC1CCC2OCOC2C1)N1CCC[C@H](C1)OC(C1CCCCC1)C1CCCCC1;c1ccc(C(O[C@@H]2CCCN(CCc3ccc4c(c3)OCO4)C2)c2ccccc2)cc1",BDNFQGRSKSQXRI-XMMPIXPASA-N
ZANAMIVIR,GG-167;GG167;GR 121167X;GR-121167;GR-121167X;RELENZA;ZANAMIVIR,CHEMBL222813,BRD:BRD-BRD-K23067689-001-02-1;BRD:BRD-K23067689-001-02-1,rep_primary;rep_single_dose,NEURAMINIDASE INHIBITOR,NEU2,INFLUENZA A VIRUS INFECTION,,LAUNCHED,,Small molecule,4,"CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O, CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O;CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N",ARAIBEBZBOPLMB-UFGQHTETSA-N
ZANDELISIB,ACC-524;ME-401;PW-143;PWT-143;PWT143;ZANDELISIB,CHEMBL4650214,BRD:BRD-K00093440-001-01-9,rep_single_dose,,,,,,,Small molecule,3,CN1CCC(c2ccccc2CC(C)(C)Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1,WPFUFWIHMYZXSF-UHFFFAOYSA-N
ZANUBRUTINIB,BGB-3111;BRUKINSA;ZANUBRUTINIB,CHEMBL3936761,BRD:BRD-K00003413-001-01-9,rep_single_dose,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,,,,,,Small molecule,4,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,RNOAOAWBMHREKO-QFIPXVFZSA-N
ZAPA,3-CARBAMIMIDOYLSULFANYL-ACRYLIC ACID;ZAPA,CHEMBL20562,BRD:BRD-BRD-K44825564-065-01-4;BRD:BRD-K44825564-065-01-4,rep_primary;rep_single_dose,,,,,PRECLINICAL,,Small molecule,NA,N=C(N)S/C=C\C(=O)O;NC(=N)S\C=C/C(O)=O,QEYNZJBVNYDZKZ-UPHRSURJSA-N
ZAPRINAST,M&B 22948;NSC-757885;ZAPRINAST,CHEMBL28079,BRD:BRD-BRD-K16542329-001-13-5;BRD:BRD-K16542329-001-13-5,rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,GPR35;PDE1A;PDE4D;PDE5A;PDE9A,,,PHASE 2,,Small molecule,-1,"CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1;CCCOC1CCCCC1-C1NC2[NH]NNC2C(=O)[NH]1, CCCOC1CCCCC1-C1NC2[NH]NNC2C(=O)[NH]1, CCCOC1CCCCC1-C1NC2[NH]NNC2C(=O)[NH]1",REZGGXNDEMKIQB-UHFFFAOYSA-N
ZARDAVERINE,ZARDAVERINE,CHEMBL313842,BRD:BRD-BRD-K37561857-001-15-5;BRD:BRD-K37561857-001-15-5,rep_multi_dose;rep_primary;rep_single_dose,PHOSPHODIESTERASE INHIBITOR,PDE4D,,,PHASE 2,,Small molecule,-1,"COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F;COC1CC(CCC1OC(F)F)-C1CCC(=O)[NH]N1, COC1CC(CCC1OC(F)F)-C1CCC(=O)[NH]N1, COC1CC(CCC1OC(F)F)-C1CCC(=O)[NH]N1",HJMQDJPMQIHLPB-UHFFFAOYSA-N
ZARNESTRA,NSC-702818;R-11577;R-115777;R115777;TIPIFARNIB;ZARNESTRA,CHEMBL289228,GDSC1:204,gdsc,,,,,,,Small molecule,3,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,PLHJCIYEEKOWNM-HHHXNRCGSA-N
ZATEBRADINE,ZATEBRADINE,CHEMBL69679,BRD:BRD-BRD-K92446736-003-02-2;BRD:BRD-K92446736-003-02-2,rep_primary;rep_single_dose,HCN CHANNEL BLOCKER,HCN1;HCN2;HCN3;HCN4,,,PHASE 3,,Small molecule,-1,"COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC;COC1CCC(CCN(C)CCCN2CCC3CC(OC)C(OC)CC3CC2=O)CC1OC, COC1CCC(CCN(C)CCCN2CCC3CC(OC)C(OC)CC3CC2=O)CC1OC, COC1CCC(CCN(C)CCCN2CCC3CC(OC)C(OC)CC3CC2=O)CC1OC",KEDQCFRVSHYKLR-UHFFFAOYSA-N
ZCL-278,ZCL-278,,BRD:BRD-BRD-K22829793-001-01-0;BRD:BRD-K22829793-001-01-0,rep_primary;rep_single_dose,CDC INHIBITOR,CDC42,,,PRECLINICAL,,,NA,"CC1CC(C)NC(NS(=O)(=O)C2CCC(NC(=S)NC(=O)COC3CCC(BR)CC3CL)CC2)N1, CC1CC(C)NC(NS(=O)(=O)C2CCC(NC(=S)NC(=O)COC3CCC(BR)CC3CL)CC2)N1, CC1CC(C)NC(NS(=O)(=O)C2CCC(NC(=S)NC(=O)COC3CCC(BR)CC3CL)CC2)N1",
ZD-0947,ZD-0947,,BRD:BRD-K00004620-001-01-9,rep_single_dose,POTASSIUM CHANNEL ACTIVATOR,,,,,,,NA,,
ZD1839,GEFITINIB;IRESSA;NSC-759856;ZD-1839;ZD1839,CHEMBL939,GDSC1:1010;GDSC2:1010,gdsc,,,,,,,Small molecule,4,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,XGALLCVXEZPNRQ-UHFFFAOYSA-N
ZD2079,ICID-2079;ICID2079;SCH 417849;SCH-417849;TALIBEGRON HCL;TALIBEGRON HYDROCHLORIDE;ZD-2079;ZD2079,CHEMBL1354284,BRD:BRD-BRD-K64157027-003-02-7;BRD:BRD-K64157027-003-02-7,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB3,,,PHASE 2,,Small molecule,-1,Cl.O=C(O)Cc1ccc(OCCNC[C@H](O)c2ccccc2)cc1;O[C@@H](CNCCOC1CCC(CC(O)=O)CC1)C1CCCCC1,KCEFVYIWOQSJCH-LMOVPXPDSA-N
ZD-4190,ZD-4190,CHEMBL281872;CHEMBL3544937,BRD:BRD-K00076465-001-02-9,rep_single_dose,,,,,,,Small molecule,1,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1;COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1.Cl,IOFHDGSCWJNVRZ-UHFFFAOYSA-N;YBTGTVGEKMZEQX-UHFFFAOYSA-N
ZD-7114,ZD-7114,,BRD:BRD-BRD-K28971625-003-01-4;BRD:BRD-K28971625-003-01-4,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB3,,,PHASE 1,,,NA,COCCNC(=O)COC1CCC(OCCNC[C@H](O)COC2CCCCC2)CC1,
ZD-7155,ZD-7155,,BRD:BRD-BRD-K11373525-003-02-1;BRD:BRD-K11373525-003-02-1,rep_primary;rep_single_dose,ANGIOTENSIN RECEPTOR ANTAGONIST,AGTR1,,,PRECLINICAL,,,NA,CCC1CC2N(CC3CCC(CC3)-C3CCCCC3-C3NNN[NH]3)C(=O)CCC2C(CC)N1,
ZD-7288,ZD-7288,,BRD:BRD-BRD-K18678457-003-02-8;BRD:BRD-K18678457-003-02-8,rep_primary;rep_single_dose,HCN CHANNEL BLOCKER,HCN1;HCN2;HCN3;HCN4,,,PHASE 2,,,NA,"CCN(C1CCCCC1)C1CC(NC)[N+](C)C(C)N1, CCN(C1CCCCC1)C1CC(NC)[N+](C)C(C)N1",
ZIBOTENTAN,ZD-4054;ZD4054;ZIBOTENTAN,CHEMBL1628688,GDSC1:266,gdsc,,,,,,,Small molecule,3,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1,FJHHZXWJVIEFGJ-UHFFFAOYSA-N
ZEARALANOL,ZEARALANOL,,BRD:BRD-K11848003-001-17-9,rep_single_dose,,,,,,,,NA,,
ZEATIN,ZEATIN,,BRD:BRD-BRD-K90033078-001-08-7;BRD:BRD-K90033078-001-08-7,rep_primary;rep_single_dose,,,,,PHASE 1,,,NA,C\C(CO)=C/CNC1[NH]CNC2NCNC12,
ZEBULARINE,ZEBULARINE,CHEMBL504567,BRD:BRD-K87714311-001-05-9;CTRP:411739,ctrp;rep_single_dose,DNA METHYLTRANSFERASE INHIBITOR,CDA;DNMT1,,,,,Small molecule,NA,O=c1ncccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,RPQZTTQVRYEKCR-WCTZXXKLSA-N
ZG-10,ZG-10,,GDSC1:1161,gdsc,,,,,,,,NA,,
ZIBOTENTAN,ZD-4054;ZD4054;ZIBOTENTAN,CHEMBL1628688,BRD:BRD-BRD-K31553034-001-03-0;BRD:BRD-K31553034-001-03-0;GDSC1:266,gdsc;rep_multi_dose;rep_primary;rep_single_dose,ENDOTHELIN RECEPTOR ANTAGONIST,EDNRA,,,PHASE 3,,Small molecule,3,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1;COC1NC(C)CNC1NS(=O)(=O)C1CCCNC1-C1CCC(CC1)-C1NNCO1,FJHHZXWJVIEFGJ-UHFFFAOYSA-N
ZIDOVUDINUM,3'-AZT;AZIDOTHYMIDINE;AZT;BW A509U;BW-A-509U;BW-A509U;BWA509U;COMPOUND S;COMPOUND-S;NSC-602670;RETROVIR;ZIDOVUDINE;ZIDOVUDINUM,CHEMBL129,BRD:BRD-A33692381-001-01-9;BRD:BRD-BRD-A33692381-001-01-9,rep_primary;rep_single_dose,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,TERT,"HUMAN IMMUNODEFICIENCY VIRUS (HIV-1), ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)",,LAUNCHED,,Small molecule,4,"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O;CC1CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)[NH]C1=O, CC1CN(C2CC(N=[N+]=[N-])C(CO)O2)C(=O)[NH]C1=O",HBOMLICNUCNMMY-XLPZGREQSA-N
ZYFLO CR,A-64077;ABBOTT-64077;NSC-730712;NSC-759277;ZILEUTON;ZYFLO;ZYFLO CR,CHEMBL93,BRD:BRD-A56359832-001-11-1;BRD:BRD-A56359832-001-16-9;BRD:BRD-BRD-A56359832-001-11-1,rep_primary;rep_single_dose,"LEUKOTRIENE SYNTHESIS INHIBITOR, LIPOXYGENASE INHIBITOR",ALOX5,ASTHMA,,LAUNCHED,,Small molecule,4,"CC(c1cc2ccccc2s1)N(O)C(N)=O;CC(N(O)C(N)=O)C1CC2CCCCC2S1, CC(N(O)C(N)=O)C1CC2CCCCC2S1, CC(N(O)C(N)=O)C1CC2CCCCC2S1, CC(N(O)C(N)=O)C1CC2CCCCC2S1",MWLSOWXNZPKENC-UHFFFAOYSA-N
ZILPATEROL,RU-42173;ZILPATEROL,CHEMBL2218907,BRD:BRD-BRD-K42816473-001-01-0;BRD:BRD-K42816473-001-01-0,rep_primary;rep_single_dose,ADRENERGIC RECEPTOR AGONIST,ADRB2,WEIGHT-GAIN AID,,LAUNCHED,,Small molecule,-1,CC(C)N[C@H]1CCN2C(O)NC3CCCC([C@@H]1O)C23;CC(C)NC1CCn2c(=O)[nH]c3cccc(c32)C1O,ZSTCZWJCLIRCOJ-UHFFFAOYSA-N
ZIMELIDINE,CIS-ZIMELIDINE;NORMUD;ZELMID;ZIMELDINE;ZIMELIDINE,CHEMBL37744,BRD:BRD-BRD-K46914825-300-01-0;BRD:BRD-K46914825-300-01-0,rep_primary;rep_single_dose,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),MAOA;MAOB;SLC6A4,,,WITHDRAWN,,Small molecule,4,CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1;CN(C)C\C=C(\C1CCC(BR)CC1)C1CCCNC1,OYPPVKRFBIWMSX-SXGWCWSVSA-N
ZINC-UNDECYLENATE,ZINC-UNDECYLENATE,,BRD:BRD-K13330768-001-02-9,rep_single_dose,OTHER ANTIFUNGAL,,,,,,,NA,,
ZIPRASIDONE,CP-88059;GEODON;ZIPRADON;ZIPRASIDONE,CHEMBL708,BRD:BRD-BRD-K29582115-066-01-2;BRD:BRD-K29582115-066-01-2,rep_multi_dose;rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA1A;ADRA1B;ADRA2A;ADRA2B;ADRA2C;CHRM1;CHRM2;CHRM3;CHRM4;CHRM5;DRD1;DRD2;DRD3;DRD4;DRD5;HRH1;HTR1A;HTR1B;HTR1D;HTR1E;HTR2A;HTR2C;HTR3A;HTR6;HTR7;SLC6A4,"SCHIZOPHRENIA, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,4,"CLC1CC2NC(=O)CC2CC1CCN1CCN(CC1)C1NSC2CCCCC12, CLC1CC2NC(=O)CC2CC1CCN1CCN(CC1)C1NSC2CCCCC12;O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1",MVWVFYHBGMAFLY-UHFFFAOYSA-N
ZIRITAXESTATN,G-451990;G451990;GLPG-1690;GLPG1690;ZIRITAXESTAT;ZIRITAXESTATN,CHEMBL3828074,BRD:BRD-K00003431-001-01-9,rep_single_dose,AUTOTAXIN INHIBITOR,,,,,,Small molecule,3,CCc1nc2c(C)cc(N3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)c(C#N)s1,REQQVBGILUTQNN-UHFFFAOYSA-N
ZK-164015,ZK-164015,,BRD:BRD-BRD-K05151076-001-02-6;BRD:BRD-K05151076-001-02-6,rep_primary;rep_single_dose,ESTROGEN RECEPTOR ANTAGONIST,ESR1;ESR2,,,PRECLINICAL,,,NA,"CCCCCS(=O)(=O)CCCCCCCCCCN1C(C(C)C2CC(O)CCC12)-C1CCC(O)CC1, CCCCCS(=O)(=O)CCCCCCCCCCN1C(C(C)C2CC(O)CCC12)-C1CCC(O)CC1",
ZK200775,FANAPANEL;ZK-200775;ZK200775,CHEMBL19892,BRD:BRD-BRD-K67525671-001-02-5;BRD:BRD-K67525671-001-02-5,rep_primary;rep_single_dose,KAINATE RECEPTOR ANTAGONIST,,,,PHASE 2,,Small molecule,1,"O=c1[nH]c2cc(C(F)(F)F)c(N3CCOCC3)cc2n(CP(=O)(O)O)c1=O;OP(O)(=O)CN1C2CC(N3CCOCC3)C(CC2[NH]C(=O)C1=O)C(F)(F)F, OP(O)(=O)CN1C2CC(N3CCOCC3)C(CC2[NH]C(=O)C1=O)C(F)(F)F",WZMQMKNCWDCCMT-UHFFFAOYSA-N
ZK811752,BAY-86-5047;BAY-865047;BAY86-5047;BX 471;BX-471;ZK-811752;ZK811752,CHEMBL535607,BRD:BRD-BRD-K91825936-001-01-2;BRD:BRD-K91825936-001-01-2,rep_multi_dose;rep_primary;rep_single_dose,CC CHEMOKINE RECEPTOR ANTAGONIST,CCR1,,,PHASE 2,,Small molecule,2,"C[C@@H]1CN(CC2CCC(F)CC2)CCN1C(=O)COC1CCC(CL)CC1NC(N)=O, C[C@@H]1CN(CC2CCC(F)CC2)CCN1C(=O)COC1CCC(CL)CC1NC(N)=O;C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1ccc(Cl)cc1NC(N)=O.Cl",FRUCNQBAWUHKLS-PFEQFJNWSA-N
ZK-93423,ZK-93423,,BRD:BRD-BRD-K33882852-003-02-8;BRD:BRD-K33882852-003-02-8,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2,,,PHASE 3,,,NA,"CCOC(=O)C1NCC2[NH]C3CCC(OCC4CCCCC4)CC3C2C1COC, CCOC(=O)C1NCC2[NH]C3CCC(OCC4CCCCC4)CC3C2C1COC",
ZK-93426,ZK-93426,,BRD:BRD-BRD-K68392338-003-02-0;BRD:BRD-K68392338-003-02-0,rep_multi_dose;rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR ANTAGONIST,GABRA1;GABRA2;GABRA3;GABRA5,,,PHASE 1,,,NA,"CCOC(=O)C1NCC2[NH]C3CCCC(OC(C)C)C3C2C1C, CCOC(=O)C1NCC2[NH]C3CCCC(OC(C)C)C3C2C1C",
ZLN005,ZLN005,,BRD:BRD-BRD-K73073971-001-01-7;BRD:BRD-K73073971-001-01-7,rep_multi_dose;rep_primary;rep_single_dose,,,,,PRECLINICAL,,,NA,CC(C)(C)C1CCC(CC1)-C1NC2CCCCC2[NH]1,
ZLN024,ZLN024,,BRD:BRD-K64103579-003-02-9,rep_single_dose,AMPK ACTIVATOR,PRKAA1;PRKAB1;PRKAG1,,,,,,NA,,
ZM-226600,ZM-226600,,BRD:BRD-A62209527-001-04-5;BRD:BRD-BRD-A62209527-001-04-5,rep_primary;rep_single_dose,KIR6 CHANNEL (KATP) ACTIVATOR,,,,PRECLINICAL,,,NA,CC(O)(C(=O)NC1CCC(CC1)S(=O)(=O)C1CCCCC1)C(F)(F)F,
ZM-241385,ZM-241385,CHEMBL113142,BRD:BRD-BRD-K19605405-001-02-7;BRD:BRD-K19605405-001-02-7,rep_primary;rep_single_dose,ADENOSINE RECEPTOR ANTAGONIST,ADORA1;ADORA2A;ADORA2B;ADORA3,,,PRECLINICAL,,Small molecule,NA,"Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12;NC1NC(NCCC2CCC(O)CC2)NC2NC(NN12)-C1CCCO1, NC1NC(NCCC2CCC(O)CC2)NC2NC(NN12)-C1CCCO1",PWTBZOIUWZOPFT-UHFFFAOYSA-N
ZM-306416,ZM-306416,,BRD:BRD-BRD-K41337261-001-03-0;BRD:BRD-K41337261-001-03-0,rep_multi_dose;rep_primary;rep_single_dose,"ABL KINASE INHIBITOR, SRC INHIBITOR, VEGFR INHIBITOR",EGFR;FLT1;FLT4;KDR,,,PRECLINICAL,,,NA,"COC1CC2NCNC(NC3CCC(CL)CC3F)C2CC1OC, COC1CC2NCNC(NC3CCC(CL)CC3F)C2CC1OC",
ZM-323881,ZM-323881,,BRD:BRD-BRD-K67831364-003-03-3;BRD:BRD-K67831364-003-03-3,rep_primary;rep_single_dose,VEGFR INHIBITOR,KDR,,,PRECLINICAL,,,NA,"CC1CC(F)C(NC2NCNC3CC(OCC4CCCCC4)CCC23)CC1O, CC1CC(F)C(NC2NCNC3CC(OCC4CCCCC4)CCC23)CC1O, CC1CC(F)C(NC2NCNC3CC(OCC4CCCCC4)CCC23)CC1O",
ZM-336372,ZM-336372,,BRD:BRD-BRD-K73789395-001-10-7;BRD:BRD-K73789395-001-10-7,rep_primary;rep_single_dose,RAF INHIBITOR,BRAF;LCK;MAPK14;RAF1,,,PRECLINICAL,,,NA,"CN(C)C1CCCC(C1)C(=O)NC1CCC(C)C(NC(=O)C2CCC(O)CC2)C1, CN(C)C1CCCC(C1)C(=O)NC1CCC(C)C(NC(=O)C2CCC(O)CC2)C1, CN(C)C1CCCC(C1)C(=O)NC1CCC(C)C(NC(=O)C2CCC(O)CC2)C1, CN(C)C1CCCC(C1)C(=O)NC1CCC(C)C(NC(=O)C2CCC(O)CC2)C1",
ZM-39923,ZM-39923,,BRD:BRD-K40624912-003-17-9,rep_single_dose,JAK INHIBITOR,JAK1;JAK3,,,,,,NA,,
ZM-447439,ZM-447439,,BRD:BRD-BRD-K72703948-001-10-1;BRD:BRD-K72703948-001-10-1;GDSC1:1050;GDSC2:1050,gdsc;rep_multi_dose;rep_primary;rep_single_dose,AURORA KINASE INHIBITOR,AURKA;AURKB,,,PRECLINICAL,,,NA,"COC1CC2C(NC3CCC(NC(=O)C4CCCCC4)CC3)NCNC2CC1OCCCN1CCOCC1, COC1CC2C(NC3CCC(NC(=O)C4CCCCC4)CC3)NCNC2CC1OCCCN1CCOCC1, COC1CC2C(NC3CCC(NC(=O)C4CCCCC4)CC3)NCNC2CC1OCCCN1CCOCC1",
ZM447439,ZM 447439;ZM447439,,GDSC1:1050;GDSC2:1050,gdsc,,,,,,,,NA,,
ZOFENOPRIL-CALCIUM,ZOFENOPRIL-CALCIUM,,BRD:BRD-BRD-K46654563-238-01-0;BRD:BRD-K46654563-238-01-0,rep_primary;rep_single_dose,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,ACE,HYPERTENSION,,LAUNCHED,,,NA,C[C@H](CSC(=O)C1CCCCC1)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1CCCCC1,
ZOLANTIDINE,SK&F-95282;ZOLANTIDINE,CHEMBL419296,BRD:BRD-BRD-K08996725-332-01-7;BRD:BRD-K08996725-332-01-7,rep_multi_dose;rep_primary;rep_single_dose,HISTAMINE RECEPTOR ANTAGONIST,,,,PRECLINICAL,,Small molecule,NA,C(CNC1NC2CCCCC2S1)COC1CCCC(CN2CCCCC2)C1;c1cc(CN2CCCCC2)cc(OCCCNc2nc3ccccc3s2)c1,KUBONGDXTUOOLM-UHFFFAOYSA-N
ZOLEDRONIC-ACID,ZOLEDRONIC-ACID,,BRD:BRD-K84253429-001-06-9,rep_single_dose,BONE RESORPTION INHIBITOR,FDPS;GGPS1,,,,,,NA,,
ZOLIFLODACIN,AZD-0914;AZD0914;ETX-0914;ETX0914;ZOLIFLODACIN,CHEMBL3544978,BRD:BRD-K00003264-001-01-9,rep_single_dose,ANTIBACTERIAL,,,,,,Small molecule,3,C[C@@H]1CN2c3c(cc4c(N5C(=O)OC[C@@H]5C)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@H]2[C@H](C)O1,ZSWMIFNWDQEXDT-ZESJGQACSA-N
ZOLIRIDINE,SOLIMIDIN;ZOLIMIDINE;ZOLIRIDINE,CHEMBL2105534,BRD:BRD-BRD-K45125084-001-01-4;BRD:BRD-K45125084-001-01-4,rep_primary;rep_single_dose,MUCUS PROTECTING AGENT,,,,LAUNCHED,,Small molecule,-1,CS(=O)(=O)c1ccc(-c2cn3ccccc3n2)cc1;CS(=O)(=O)C1CCC(CC1)-C1CN2CCCCC2N1,VSLIUWLPFRVCDL-UHFFFAOYSA-N
ZOLINZA,MK-0683;MK0683;NSC-701852;NSC-748799;NSC-759852;SAHA;SUBERANILOHYDROXAMIC ACID;SUBEROYLANILIDE HYDROXAMIC ACID;VORINOSTAT;ZOLINZA,CHEMBL98,GDSC1:1012;GDSC2:1012,gdsc,,,,,,,Small molecule,4,O=C(CCCCCCC(=O)Nc1ccccc1)NO,WAEXFXRVDQXREF-UHFFFAOYSA-N
ZOMIG-ZMT,311-C-90;311C90;CVT-427;NSC-760383;ZOLMITRIPTAN;ZOMIG;ZOMIG-ZMT,CHEMBL1185,BRD:BRD-BRD-K54314721-001-10-2;BRD:BRD-K54314721-001-10-2,rep_multi_dose;rep_primary;rep_single_dose,SEROTONIN RECEPTOR AGONIST,HTR1A;HTR1B;HTR1D;HTR1E;HTR1F,MIGRAINE HEADACHE,,LAUNCHED,,Small molecule,4,"CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12;CN(C)CCC1C[NH]C2CCC(C[C@H]3COC(=O)N3)CC12, CN(C)CCC1C[NH]C2CCC(C[C@H]3COC(=O)N3)CC12, CN(C)CCC1C[NH]C2CCC(C[C@H]3COC(=O)N3)CC12",ULSDMUVEXKOYBU-ZDUSSCGKSA-N
ZOLPIDEM CIV,AMBIEN;SANVAL;ZOLPIDEM;ZOLPIDEM CIV,CHEMBL911,BRD:BRD-BRD-K44876623-001-03-7;BRD:BRD-K44876623-001-03-7,rep_primary;rep_single_dose,BENZODIAZEPINE RECEPTOR AGONIST,GABRA1;GABRA2;GABRA3,INSOMNIA,,LAUNCHED,,Small molecule,4,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1;CN(C)C(=O)CC1C(NC2CCC(C)CN12)-C1CCC(C)CC1,ZAFYATHCZYHLPB-UHFFFAOYSA-N
ZOMEPIRAC,ZOMEPIRAC,CHEMBL19490,BRD:BRD-BRD-K81326768-001-04-0;BRD:BRD-K81326768-001-04-0,rep_primary;rep_single_dose,PROSTAGLANDIN SYNTHESIS INHIBITOR,PTGDR2,,,WITHDRAWN,,Small molecule,4,"Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1;CC1CC(CC(O)=O)N(C)C1C(=O)C1CCC(CL)CC1, CC1CC(CC(O)=O)N(C)C1C(=O)C1CCC(CL)CC1, CC1CC(CC(O)=O)N(C)C1C(=O)C1CCC(CL)CC1",ZXVNMYWKKDOREA-UHFFFAOYSA-N
ZOMETA,ACLASTA;AK-156;ANHYDROUS ZOLEDRONIC ACID;CGP 42446;CGP-42446;CGP-42446A;NSC-721517;RECLAST;ZERLINDA;ZOLADRONA ACID MYLAN;ZOLEDRONATE;ZOLEDRONATE HYDRATE;ZOLEDRONIC;ZOLEDRONIC ACID;ZOLEDRONIC ACID ACCORD;ZOLEDRONIC ACID ANHYDROUS;ZOLEDRONIC ACID HYDRATE;ZOLEDRONIC ACID MEDAC;ZOLEDRONIC ACID MONOHYDRATE;ZOLEDRONIC ACID TEVA;ZOMETA,CHEMBL924,GDSC2:1802,gdsc,,,,,,,Small molecule,4,O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,XRASPMIURGNCCH-UHFFFAOYSA-N
ZOMETAPINE,CI-781;ZOMETAPINE,CHEMBL174697,BRD:BRD-BRD-K14571191-001-01-6;BRD:BRD-K14571191-001-01-6,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,Cc1nn(C)c2c1C(c1cccc(Cl)c1)=NCCN2;CC1NN(C)C2NCCN=C(C12)C1CCCC(CL)C1,YCWROMXNZZIJDQ-UHFFFAOYSA-N
ZONIPORIDE,ZONIPORIDE,CHEMBL355862,BRD:BRD-BRD-K43992824-300-01-0;BRD:BRD-K43992824-300-01-0,rep_primary;rep_single_dose,SODIUM/HYDROGEN EXCHANGER INHIBITOR,SLC9A1,,,PHASE 3,,Small molecule,-1,N=C(N)NC(=O)c1cnn(-c2cccc3ncccc23)c1C1CC1;NC(N)=NC(=O)C1CNN(C1C1CC1)-C1CCCC2NCCCC12,GDXBRVCQGGKXJY-UHFFFAOYSA-N
ZONISAMIDE,AD-810;CI-912;EXCEGRAN;N03AX15;PD-110843;ZONEGRAN;ZONISADE;ZONISAMIDE,CHEMBL750,BRD:BRD-BRD-K48300629-001-14-5;BRD:BRD-K48300629-001-14-5,rep_primary;rep_single_dose,"SODIUM CHANNEL BLOCKER, T-TYPE CALCIUM CHANNEL BLOCKER",CA1;CA10;CA11;CA12;CA13;CA14;CA2;CA3;CA4;CA5A;CA5B;CA6;CA7;CA8;CA9;CACNA1G;CACNA1H;CACNA1I;MAOA;MAOB;SCN10A;SCN11A;SCN1A;SCN1B;SCN2A;SCN2B;SCN3A;SCN3B;SCN4A;SCN4B;SCN5A;SCN7A;SCN8A;SCN9A,"SEIZURES, EPILEPSY",,LAUNCHED,,Small molecule,4,"NS(=O)(=O)Cc1noc2ccccc12;NS(=O)(=O)CC1NOC2CCCCC12, NS(=O)(=O)CC1NOC2CCCCC12, NS(=O)(=O)CC1NOC2CCCCC12",UBQNRHZMVUUOMG-UHFFFAOYSA-N
ZOPOLRESTAT,"ALOND;CP-73,850;CP-73850;ZOPOLRESTAT",CHEMBL10372,BRD:BRD-BRD-K84459715-001-01-6;BRD:BRD-K84459715-001-01-6,rep_primary;rep_single_dose,,,,,PHASE 2,,Small molecule,-1,O=C(O)Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2ccccc12;OC(=O)C=C1NN(CC2NC3CC(CCC3S2)C(F)(F)F)C(=O)C2CCCCC12,BCSVCWVQNOXFGL-UHFFFAOYSA-N
ZOSUQUIDAR,ZOSUQUIDAR,CHEMBL444172,BRD:BRD-BRD-K70557564-305-03-6;BRD:BRD-K70557564-305-03-6,rep_primary;rep_single_dose,P GLYCOPROTEIN INHIBITOR,ABCB1;ABCB4,,,PHASE 3,,Small molecule,3,"O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1;O[C@@H](COC1CCCC2NCCCC12)CN1CCN(CC1)[C@@H]1C2CCCCC2[C@@H]2[C@H](C3CCCCC13)C2(F)F, O[C@@H](COC1CCCC2NCCCC12)CN1CCN(CC1)[C@@H]1C2CCCCC2[C@@H]2[C@H](C3CCCCC13)C2(F)F",IHOVFYSQUDPMCN-DBEBIPAYSA-N
ZOTAROLIMUS,ABT-578;MDT-4107;ZOTAROLIMUS,CHEMBL219410,BRD:BRD-BRD-K46843573-001-01-9;BRD:BRD-K46843573-001-01-9,rep_primary;rep_single_dose,MTOR INHIBITOR,FKBP1A,CORONARY ARTERY RESTENOSIS,,LAUNCHED,,Small molecule,3,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1N1CNNN1;CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@H](n3cnnn3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,CGTADGCBEXYWNE-JUKNQOCSSA-N
ZOTATIFIN,EFT-226;EFT226;ZOTATIFIN,CHEMBL4303782,BRD:BRD-K00090648-001-01-9,rep_single_dose,,,,,,,Small molecule,1,COc1cc2c(c(OC)n1)[C@]1(O)[C@H](O)[C@H](CN(C)C)[C@@H](c3ccccc3)[C@]1(c1ccc(C#N)cc1)O2,QYCXWOACFWMQFO-WZWZCULESA-N
ZOTEPINE,NIPOLEPT;SETOUS;ZOLEPTIL 100;ZOLEPTIL 25;ZOLEPTIL 50;ZOTEPIN;ZOTEPINE,CHEMBL285802,BRD:BRD-BRD-K64557645-001-02-4;BRD:BRD-K64557645-001-02-4,rep_primary;rep_single_dose,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",ADRA2B;DRD2;DRD3;DRD4;HRH1;HTR1A;HTR1B;HTR1D;HTR1E;HTR2A;HTR2C;HTR6;HTR7;SLC6A2;SLC6A4,SCHIZOPHRENIA,,LAUNCHED,,Small molecule,4,CN(C)CCOC1=CC2CCCCC2SC2CCC(CL)CC12;CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,HDOZVRUNCMBHFH-UHFFFAOYSA-N
ZOXINE,CONTRAZOLE;DEFLEXOL;FLEXIN;MCN-485;MIAZOL;NSC-24995;URI-BOI;ZOXAMINE;ZOXAZOLAMINE;ZOXINE,CHEMBL472566,BRD:BRD-BRD-K66353228-001-14-6;BRD:BRD-K66353228-001-14-6,rep_primary;rep_single_dose,MYORELAXANT,,,,PHASE 2,,Small molecule,-1,"Nc1nc2cc(Cl)ccc2o1;NC1NC2CC(CL)CCC2O1, NC1NC2CC(CL)CCC2O1",YGCODSQDUUUKIV-UHFFFAOYSA-N
ZSET1446,ZSET1446,,BRD:BRD-K35984734-001-02-9,rep_single_dose,NICOTINIC RECEPTOR AGONIST,,,,,,,NA,,
ZSTK 474,KIN001-167;ZSTK 474,,GDSC1:223,gdsc,,,,,,,,NA,,
ZSTK474,GNF-PF-5468;TCMDC-137004;ZSTK-474;ZSTK474,CHEMBL586701;CHEMBL586702,BRD:BRD-BRD-K63068307-001-08-9;BRD:BRD-K63068307-001-08-9;GDSC1:223,gdsc;rep_multi_dose;rep_primary;rep_single_dose,PI3K INHIBITOR,PIK3CB;PIK3CD;PIK3CG,,,PHASE 1/PHASE 2,,Small molecule,2,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1;FC(F)C1NC2CCCCC2N1-C1NC(NC(N1)N1CCOCC1)N1CCOCC1,HGVNLRPZOWWDKD-UHFFFAOYSA-N
ZSTK474,GNF-PF-5468;TCMDC-137004;ZSTK-474;ZSTK474,CHEMBL586702,CTRP:606144;GDSC1:223,ctrp;gdsc,,,,,,,Small molecule,2,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,HGVNLRPZOWWDKD-UHFFFAOYSA-N
ZUCLOPENTHIXOL,CLOPENTHIXOL;CLOPENTHIXOL CIS(Z)-FORM;CLOPIXOL;ZUCLOPENTHIXOL,CHEMBL53904,BRD:BRD-BRD-K28761384-300-01-0;BRD:BRD-K28761384-300-01-0,rep_primary;rep_single_dose,DOPAMINE RECEPTOR ANTAGONIST,ADRA1A;ADRA2A;DRD1;DRD2;DRD5;HRH1;HTR2A,"SCHIZOPHRENIA, BIPOLAR DISORDER",,LAUNCHED,,Small molecule,3,OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1;OCCN1CCN(CC\C=C2\C3CCCCC3SC3CCC(CL)CC23)CC1,WFPIAZLQTJBIFN-DVZOWYKESA-N
ZURANOLONE,S-812217;SAGE-217;SGE-797;ZURANOLONE,CHEMBL4105630,BRD:BRD-K00003448-001-01-9,rep_single_dose,GABA RECEPTOR AGONIST,,,,,,Small molecule,3,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1,HARRKNSQXBRBGZ-GVKWWOCJSA-N
ZYDELIG,CAL-101;GS-1101;GS-11CAL-101;IDELALISIB;ZYDELIG,CHEMBL2216870,GDSC1:238,gdsc,,,,,,,Small molecule,4,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,IFSDAJWBUCMOAH-HNNXBMFYSA-N
ZYNOPLEX,"EMBLON;FENTAMOX 10;FENTAMOX 20;I.C.I.46474 CITRATE;ICI 46,474;ICI-46474;ICI-47699;KENTADEX;KESSAR;KESSAR 10;KESSAR 20;MAMMATON;NOLTAM;NOLVADEX;NOLVADEX D;NOLVADEX FTE;NOURYTAM;NOVALDEX;NSC-180973;NSC-727681;NSC-757345;OESTRIFEN-10;OESTRIFEN-20;OESTRIFEN-40;SOLTAMOX;TAMOFEN;TAMOFENE;TAMOPLEX;TAMOXIFEN;TAMOXIFEN CITRATE;TAMOXIFENI CITRAS;TOMAXASTA;ZEMIDE;ZITAZONIUM;ZYNOPLEX",CHEMBL786;CHEMBL83,GDSC1:1199;GDSC2:1199,gdsc,,,,,,,Small molecule,4,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1;CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O,FQZYTYWMLGAPFJ-OQKDUQJOSA-N;NKANXQFJJICGDU-QPLCGJKRSA-N
